PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	PG	WC	SC	GA	UT	PM
J	Ogasawara, K; Mitsubayashi, K; Tsuru, T; Karube, I				Ogasawara, K; Mitsubayashi, K; Tsuru, T; Karube, I			Electrical conductivity of tear fluid in healthy persons and keratoconjunctivitis sicca patients measured by a flexible conductimetric sensor	GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY			English	Article								Background: It is known that the osmolarity of tears increases in keratoconjunctivitis sicca (KCS) patients and therefore could be a sensitive and specific indicator for the diagnosis of KCS. However, owing to the difficulties in using the current methods of tear fluid measurement, these procedures have not been employed in clinical practice. A newly devised flexible conductimetric sensor fabricated using microelectronic techniques is small and flexible enough to be placed on the ocular surface to measure the electrical conductivity of tear fluid in vivo. Fluid conductivity can be considered as an indirect function of electrolyte activity, or osmolarity. Therefore, we applied this new sensor to measure the tear fluid conductivity in KCS patients and healthy volunteers. Methods: A flexible conductimetric sensor, consisting of a hydrophilic polytetrafluoroethylene membrane placed between two gold-coated layers, was placed directly into the temporal conjunctival cul-de-sac. The tear fluid conductivity was monitored graphically on a computer display. The sodium chloride concentration of tear fluids was calculated from the calibration curve and converted to the equivalent electrolyte concentration. Results: The electrolyte concentrations were 324.8+/-41.0 mEq/l in KCS patients (29 samples obtained from 16 KCS patients) and 296.4+/-30.1 mEq/l in healthy persons (33 samples obtained from 17 healthy persons). The difference was significant (P<0,01). A positive correlation was found between the electrolyte concentrations in KCS and the rose bengal score (coefficient=0.36). Conclusion: The tear fluid conductivity in healthy persons and KCS patients could be monitored without ocular damage, and the measured values were consistent with previous reports. This method will be a new diagnostic tool for detecting tear abnormalities.	UNIV TOKYO,ADV SCI & TECHNOL RES CTR,MEGURO KU,TOKYO 153,JAPAN	Ogasawara, K (reprint author), UNIV TOKYO,SCH MED,DEPT OPHTHALMOL,BUNKYO KU,7-3-1 HONGO,TOKYO 113,JAPAN.						SHEPPARD NF, 1993, ANAL CHEM, V65, P1199, DOI 10.1021/ac00057a016; GILBARD JP, 1978, ARCH OPHTHALMOL-CHIC, V96, P677; BALIK J, 1952, AM J OPHTHALMOL, V35, P773; Farris R L, 1983, CLAO J, V9, P23; FOUKE JM, 1988, IEEE T BIO-MED ENG, V35, P877, DOI 10.1109/10.7296; GRAM HC, 1923, J BIOL CHEM, V1, P590; MITSUBAYASHI K, 1993, ANAL CHEM, V65, P3586, DOI 10.1021/ac00072a010; SCHAEFFER AJ, 1950, ARCH OPHTHALMOL-CHIC, V43, P1026; VANBIJST.OP, 1969, ARCH OPHTHALMOL-CHIC, V82, P10; VANHAERINGEN NJ, 1981, SURV OPHTHALMOL, V26, P84, DOI 10.1016/0039-6257(81)90145-4	10	18	19	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010	0721-832X			GRAEF ARCH CLIN EXP	Graefes Arch. Clin. Exp. Ophthalmol.	SEP	1996	234	9					542	546		10.1007/BF00448797		5	Ophthalmology	Ophthalmology	VG252	WOS:A1996VG25200002		
J	Shinkai, H; Kimura, W; Sata, N; Muto, T; Nagai, H				Shinkai, H; Kimura, W; Sata, N; Muto, T; Nagai, H			A case of gallbladder cancer with para-aortic lymph node metastasis who has survived more than seven years after the primary extended radical operation	HEPATO-GASTROENTEROLOGY			English	Article						gallbladder cancer; para-aortic lymph node metastasis; extended radical operation	PRIMARY-CARCINOMA; COMPUTED-TOMOGRAPHY; RADIATION-THERAPY; DIAGNOSIS	A 55-year-old man with gallbladder cancer was surgically treated in our hospital in July 1988. The tumor was about 8 cm in diameter, replaced the entire gallbladder, and invaded the liver and the hepatoduodenal ligament. In addition, extensive tumor metastasis to lymph nodes, including those of the para-aortic area was noted (Stage IV). Extended cholecystectomy with resection of the liver and lymph node dissection were performed. Although all of the macroscopic tumors were removed surgically, toe believed that the tumor would recur in. the near future, since all of the excised para-aortic lymph nodes were involved by carcinoma histologically. After surgery, the patient received 5'-deoxy-5-fluorouridine (5'-DFUR) orally at a dose of 600mg per day. In December 1993, more than 5 years after the primary operation, cancer recurrence in para-aortic lymph nodes was demonstrated by computed tomography (CT). In June 1994, the patient underwent a second operation for treatment of recurrent tumor. The lymph nodes firmly adhered to both the aorta and left renal vein, and could not be removed. Since August 1994, he has received external radiation therapy, and there has been no further enlargement of the nodes. This is the first reported case of gallbladder cancer with para-aortic lymph node metastasis who survived more than, seven years after the primary extended radical operation with cholecystectomy, resection of the liver, and extended lymph node dissection.	JICHI MED UNIV,DEPT GASTROENTEROL & GEN SURG,MINAMI KAWACHI,TOCHIGI,JAPAN	Shinkai, H (reprint author), UNIV TOKYO,DEPT SURG 1,FAC MED,BUNKYO KU,7-3-1 HONGO,TOKYO 113,JAPAN.						ALDRIDGE MC, 1991, SURGERY, V109, P107; SHIRAI Y, 1992, BRIT J SURG, V79, P659, DOI 10.1002/bjs.1800790721; Boerma E J, 1994, Eur J Surg Oncol, V20, P537; CHAO TC, 1991, J SURG ONCOL, V46, P215, DOI 10.1002/jso.2930460402; DEAX, 1992, CANCER, V69, P60; HATA Y, 1994, JPN J CANC CHEMOTHER, V21, P2639; INOUE M, 1993, JPN J CANC CHEMOTHER, V20, P1676; ITAI Y, 1980, RADIOLOGY, V137, P713; Japanese Society of Biliary Surgery, 1993, GEN RUL SURG PATH ST; KATO K, 1993, JPN J CANC CHEMOTHER, V20, P2341; KOTOH T, 1994, JPN J CANC CHEMOTHER, V21, P881; MAHE M, 1994, RADIOTHER ONCOL, V33, P204, DOI 10.1016/0167-8140(94)90355-7; MAKELA JT, 1993, BRIT J SURG, V80, P912, DOI 10.1002/bjs.1800800739; NADLER LH, 1992, MT SINAI J MED, V59, P47; NAKAMURA S, 1989, SURGERY, V106, P467; OHTA T, 1994, ONCOLOGY, V51, P238; OKADA S, 1991, JPN J CANC CHEMOTHER, V18, P1269; RUIZ R, 1980, J CLIN ULTRASOUND, V8, P489, DOI 10.1002/jcu.1870080608; SHIRAI Y, 1995, CANCER, V75, P2063, DOI 10.1002/1097-0142(19950415)75:8<2063::AID-CNCR2820750806>3.0.CO;2-S; TAKADA T, 1992, JPN J CANC CHEMOTHER, V19, P1295; THORSEN MK, 1984, RADIOLOGY, V152, P479; TODOROKI T, 1991, WORLD J SURG, V15, P357; VALLILENGUA C, 1995, ACTA CYTOL, V39, P19; WEINER SN, 1984, AM J ROENTGENOL, V142, P735; YEH HC, 1979, RADIOLOGY, V133, P167; YUM HY, 1980, RADIOLOGY, V134, P693	26	7	7	H G E UPDATE MEDICAL PUBL LTD.	ATHENS	PO BOX 17160, ATHENS GR-10024, GREECE	0172-6390			HEPATO-GASTROENTEROL	Hepato-Gastroenterol.	SEP-OCT	1996	43	11					1370	1376				7	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	VP418	WOS:A1996VP41800046		
J	Midorikawa, Y; Kubota, K; Koyama, H; Watanabe, S; Kawai, K; Kajiura, N				Midorikawa, Y; Kubota, K; Koyama, H; Watanabe, S; Kawai, K; Kajiura, N			Presacral epidermal cyst: A report of an adult case	HEPATO-GASTROENTEROLOGY			English	Article						epidermal cyst; presacral tumor	RETRORECTAL TUMORS; EXPERIENCE; TERATOMAS	A 46-year-old woman was found to have a giant cyst behind the uterus during preoperative examinations of an uterine myoma. Pelvic and digital examinations revealed an oval, palpable mass behind the uterus with no mucosal lesions on the rectal wall. Ultrasonography and computed tomography showed an uterine myoma with a cystic change and art oval mass behind the uterus, which compressed the rectum to the left side. The patient underwent hysterectomy and tumor resection via laparotomy. The tumor was found to be located in the presacral space. Histological examination showed a cyst lined by keratinized squamous epithelium with no cutaneous adnexal structures and subsequently, the tumor was diagnosed as an epidermal cyst.	TOKYO SEAMENS INSURANCE HOSP,DEPT GYNECOL,MINATO KU,TOKYO 108,JAPAN; UNIV TOKYO,FAC MED,DEPT SURG 2,TOKYO 113,JAPAN	Midorikawa, Y (reprint author), TOKYO SEAMENS INSURANCE HOSP,DEPT SURG,MINATO KU,3-10-11 TAKANAWA,TOKYO 108,JAPAN.						Whittaker LD, 1938, ANN SURG, V107, P96, DOI 10.1097/00000658-193801000-00011; ALTMAN RP, 1974, J PEDIATR SURG, V9, P389; UHLIG BE, 1975, DIS COLON RECTUM, V18, P581, DOI 10.1007/BF02587141; JAO SW, 1985, DIS COLON RECTUM, V28, P644, DOI 10.1007/BF02553440; ASHCRAFT KW, 1974, J PEDIATR SURG, V9, P691, DOI 10.1016/0022-3468(74)90107-9; FUJIMOTO H, 1993, CLIN IMAG, V17, P146, DOI 10.1016/0899-7071(93)90056-S; BERRY CL, 1969, J PATHOL, V98, P241, DOI 10.1002/path.1710980404; BIRKETT J, 1859, GUYS HOSP REP, V5, P247; FORUHAN B, 1978, BRIT J OBSTET GYNAEC, V85, P231; GHAZALI S, 1973, J PEDIATR SURG, V8, P915, DOI 10.1016/0022-3468(73)90011-0; GONZALEZCRUSSI F, 1978, ARCH PATHOL LAB MED, V102, P420; HURDLING HW, 1924, SURG GYNECOL OBSTET, V38, P518; JACKMAN RJ, 1951, JAMA-J AM MED ASSOC, V145, P956; LEVER, LEVERS HISTOPATHOLOG, P460; LOCALIO SA, 1980, ANN SURG, V191, P555, DOI 10.1097/00000658-198005000-00006; MACCARTY CS, 1956, J NEUROSURG, V22, P458; MAHOUR GH, 1974, SURGERY, V76, P309; MCCUNE WS, 1964, ANN SURG, V159, P911, DOI 10.1097/00000658-196406000-00008; MELODY GF, 1952, AM J OBSTET GYNECOL, V63, P1119; MIDDELDORPH K, 1885, ARCH PATHOL ANAT PHY, V1, P122; MYERS W C Jr, 1954, Am Surg, V20, P1180; RONALD OV, 1981, CANCER, V48, P217; SPENCER RJ, 1962, SURG GYNECOL OBSTET, V115, P449; SWIATON NW, 1958, SURG CLIN N AM   JUN, P849	24	3	4	H G E UPDATE MEDICAL PUBL LTD.	ATHENS	PO BOX 17160, ATHENS GR-10024, GREECE	0172-6390			HEPATO-GASTROENTEROL	Hepato-Gastroenterol.	SEP-OCT	1996	43	11					1399	1402				4	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	VP418	WOS:A1996VP41800052		
J	Chun, TH; Itoh, H; Ogawa, Y; Tamura, N; Takaya, K; Igaki, T; Yamashita, J; Doi, K; Inoue, M; Masuda, I; Saito, Y; Korenaga, R; Ando, J; Nakao, K				Chun, TH; Itoh, H; Ogawa, Y; Tamura, N; Takaya, K; Igaki, T; Yamashita, J; Doi, K; Inoue, M; Masuda, I; Saito, Y; Korenaga, R; Ando, J; Nakao, K			Augmented expression of two novel endothelium-derived relaxing peptides, C-type natriuretic peptide (CNP) and adrenomedullin (AM) in endothelial cells (EC) under physiological shear stress	HYPERTENSION			English	Meeting Abstract									KYOTO UNIV,GRAD SCH MED,DEPT MED & CLIN SCI,KYOTO,JAPAN; UNIV TOKYO,FAC MED,DEPT CARDIOVASC BIOMECH,TOKYO,JAPAN								0	0	0	AMER HEART ASSOC	DALLAS	7272 GREENVILLE AVENUE, DALLAS, TX 75231-4596	0194-911X			HYPERTENSION	Hypertension	SEP	1996	28	3					64	64				1	Peripheral Vascular Disease	Cardiovascular System & Cardiology	VF997	WOS:A1996VF99700090		
J	Shimosawa, T; Fujita, T				Shimosawa, T; Fujita, T			Hypotensive effect of a newly identified peptide, proadrenomedullin N-terminal 20 peptide	HYPERTENSION			English	Article						pithed rat; sympathetic nerve activity; norepinephrine	N-TERMINAL-20 PEPTIDE; HUMAN ADRENOMEDULLIN; ENDOTHELIAL-CELLS; RAT; CLONING; FAILURE; PLASMA; GENE	Proadrenomedullin N-terminal 20 peptide (PAMP) and adrenomedullin (AM), which are both derived from proadrenomedullin, exhibit marked hypotensive effects. We recently reported that PAMP but not AM reduced the release of norepinephrine from peripheral sympathetic nerve endings. Our present objective was to clarify the involvement of the sympathetic ner nervous system in the hypotensive action of PAMP and AM. Intravenous administration of PAMP (10, 20, and 50 nmol/kg) to conscious rats induced less reflex tachycardia (5+/-5, 10+/-5, and 14+/-6 beats per minute [bpm]) than that of AM in 0.1, 0.5, and 1.0 nmol/kg doses (5+/-8, 20+/-7, and 38+/-5 bpm, P<.01) although both agents showed similar hypotensive effects. We evaluated the effect of PAMP on blood pressure in pithed rats whose sympathetic nervous systems were abolished. In pithed rats, AM (-2+/-1, -7+/-1, and -10+/-3 mm Hg; NS, P<.05, and P<.01, respectively) but not PAMP evoked hypotension. In contrast, administration of PAMP (-3+/-1, -11+/-2, and -14+/-4 mmHg; P<.05, P<.01, and P<.01, respectively) as well as adrenomedullin (-2+/-2, -10+/-3, and -15+/-4 mm Hg; NS, P<.01, and P<.01) significantly reduced blood pressure in electrically stimulated, pithed rats, which had reached almost the same levels as in conscious rats. In electrically stimulated, pithed rats, plasma norepinephrine level was reduced by PAMP but not by vehicle or AM. These findings suggest that the hypotensive effect of PAMP is mainly due to inhibition of peripheral sympathetic nerve activity.	UNIV TOKYO,SCH MED,DEPT INTERNAL MED 4,BUNKYO KU,TOKYO 112,JAPAN			Shimosawa, Tatsuo/A-2920-2015	Shimosawa, Tatsuo/0000-0002-8742-5129			ISHIMITSU T, 1994, J CLIN INVEST, V94, P2158, DOI 10.1172/JCI117573; SUGO S, 1994, BIOCHEM BIOPH RES CO, V203, P719, DOI 10.1006/bbrc.1994.2241; BREDT DS, 1994, ANNU REV BIOCHEM, V63, P175, DOI 10.1146/annurev.bi.63.070194.001135; FENG CJ, 1994, LIFE SCI, V55, pPL433; KITAMURA K, 1993, BIOCHEM BIOPH RES CO, V194, P720, DOI 10.1006/bbrc.1993.1881; SHIMEKAKE Y, 1995, J BIOL CHEM, V270, P4412; NUKI C, 1993, BIOCHEM BIOPH RES CO, V196, P245, DOI 10.1006/bbrc.1993.2241; RUBANYI GM, 1994, PHARMACOL REV, V46, P325; JOUGASAKI M, 1995, CIRCULATION, V92, P286; SAKATA J, 1993, BIOCHEM BIOPH RES CO, V195, P921, DOI 10.1006/bbrc.1993.2132; Kohno M, 1996, HYPERTENSION, V27, P102; KITAMURA K, 1993, BIOCHEM BIOPH RES CO, V192, P553, DOI 10.1006/bbrc.1993.1451; GANTEN D, 1991, CARDIOVASC DRUG THER, V5, P119; GILLESPI.JS, 1970, BRIT J PHARMACOL, V40, P257; ISHIYAMA Y, 1993, EUR J PHARMACOL, V241, P271, DOI 10.1016/0014-2999(93)90214-3; ITO Y, 1989, CLIN EXP HYPERTENS A, V1, P363; JOUGASAKI M, 1995, AM J PHYSIOL-RENAL, V268, pF657; KIRATA Y, 1995, HYPERTENSION, V25, P790; KITAMURA K, 1994, FEBS LETT, V351, P35, DOI 10.1016/0014-5793(94)00810-8; LIPPTON H, 1994, LIFE SCI, V54, pPL409; PARKES DG, 1995, AM J PHYSIOL-HEART C, V268, pH2574; SHIMOSAWA T, 1995, J CLIN INVEST, V96, P1672, DOI 10.1172/JCI118208; SUGO S, 1994, BIOCHEM BIOPH RES CO, V201, P1160, DOI 10.1006/bbrc.1994.1827; WASHIMINE H, 1994, BIOCHEM BIOPH RES CO, V202, P1081, DOI 10.1006/bbrc.1994.2039	24	37	41	AMER HEART ASSOC	DALLAS	7272 GREENVILLE AVENUE, DALLAS, TX 75231-4596	0194-911X			HYPERTENSION	Hypertension	SEP	1996	28	3					325	329				5	Peripheral Vascular Disease	Cardiovascular System & Cardiology	VF997	WOS:A1996VF99700002		
J	Goto, A; Yamada, K; Hazama, H; Uehara, Y; Atarashi, K; Hirata, Y; Kimura, K; Omata, M				Goto, A; Yamada, K; Hazama, H; Uehara, Y; Atarashi, K; Hirata, Y; Kimura, K; Omata, M			Ouabainlike compound in hypertension associated with ectopic corticotropin syndrome	HYPERTENSION			English	Article						hormones; adrenocorticotropic hormone; Na+,K+-transporting ATPase; sodium-potassium pump; blood pressure; potassium; sodium	REDUCED RENAL MASS; BLOOD-PRESSURE; ENDOGENOUS OUABAIN; PRIMARY ALDOSTERONISM; BOVINE HYPOTHALAMUS; POTASSIUM-DEPLETION; ARTERIAL-PRESSURE; HUMAN PLASMA; RATS; SODIUM	Molecular mechanisms related to sodium retention have been implicated in the pathogenesis of hypertension. It is unclear how sodium retention leads to a rise in blood pressure, but ouabainlike compound may act as a final common pathway in sodium-induced hypertension. In ectopic corticotropin syndrome, hypertension has been attributed to cortisol inactivation overload, giving rise to mineralocorticoid-type hypertension. We sequentially measured plasma and urinary levels of ouabainlike compound over 2 months to evaluate its role in the hypertensive mechanisms in a 64-year-old man with this syndrome caused by lung cancer. His data included hypokalemia and increased cortisol concentrations, corticotropin levels, and urinary 17-hydroxycorticosteroid excretion. Plasma renin activity was suppressed. Plasma and urinary levels of ouabainlike compound were markedly increased concomitantly with high blood pressure. The maximum plasma level was 40-fold the normal range of the subject. After chemotherapy, ouabainlike compound levels gradually decreased in parallel with the decline in blood pressure and rise in potassium concentration. A correlation was observed between plasma and urinary levels of ouabainlike compound (P < .05). plasma and urinary levels of ouabainlike compound correlated with systolic (P < .01) and diastolic (P < .05) pressures, respectively. The peak of ouabainlike compound in plasma and urine coincided with that of authentic ouabain on high-performance liquid chromatography. Ouabainlike compound derived from urine inhibited [H-3]ouabain binding to human erythrocytes. These findings suggest that ouabainlike compound with biological activity could partly account for hypertension in ectopic corticotropin syndrome.	SANRAKU HOSP,DEPT HUMAN DRY DOCK,TOKYO,JAPAN	Goto, A (reprint author), UNIV TOKYO,FAC MED,DEPT INTERNAL MED 2,BUNKYO KU,7-3-1 HONGO,TOKYO 113,JAPAN.						KRISHNA GG, 1989, NEW ENGL J MED, V320, P1177, DOI 10.1056/NEJM198905043201804; KRISHNA GG, 1991, ANN INTERN MED, V115, P77; BLAUSTEIN MP, 1993, AM J PHYSIOL, V264, pC1367; SHIMKETS RA, 1994, CELL, V79, P407, DOI 10.1016/0092-8674(94)90250-X; ZHAO N, 1995, BIOCHEMISTRY-US, V34, P9893, DOI 10.1021/bi00031a010; MUNE T, 1995, NAT GENET, V10, P394, DOI 10.1038/ng0895-394; LIFTON RP, 1992, NATURE, V355, P262, DOI 10.1038/355262a0; ROSSI GP, 1995, J HYPERTENS, V13, P1181, DOI 10.1097/00004872-199510000-00013; BAGROV AY, 1994, J INTERN MED, V235, P63; BERETTAPICCOLI C, 1982, CLIN SCI, V63, P257; BERETTAPICCOLI C, 1982, CLIN SCI, V63, pS89; BOVA S, 1991, HYPERTENSION, V17, P944; BULPITT CJ, 1981, CLIN SCI, V61, pS85; DEWARDENER HE, 1980, KIDNEY INT, V18, P1, DOI 10.1038/ki.1980.104; DORIS PA, 1994, HYPERTENSION, V23, P632; GOMEZSANCHEZ EP, 1994, AM J HYPERTENS, V7, P591; GOTO A, 1992, J HYPERTENS       S4, V10, pS50; GOTO A, 1989, NEW ENGL J MED, V320, P124; GOTO A, 1992, PHARMACOL REV, V44, P377; GRAVES SW, 1993, J CARDIOVASC PHARM, V22, pS54, DOI 10.1097/00005344-199322002-00018; HADDY FJ, 1983, FED PROC, V42, P239; HADDY FJ, 1976, LIFE SCI, V19, P935, DOI 10.1016/0024-3205(76)90284-8; HAMLYN JM, 1991, P NATL ACAD SCI USA, V88, P6259, DOI 10.1073/pnas.88.14.6259; Hollenberg N K, 1995, Hypertens Res, V18, P1, DOI 10.1291/hypres.18.1; HUANG BS, 1994, HYPERTENSION, V23, P1087; LAREDO J, 1994, ENDOCRINOLOGY, V135, P794, DOI 10.1210/en.135.2.794; LICHTSTEIN D, 1993, EUR J BIOCHEM, V216, P261, DOI 10.1111/j.1432-1033.1993.tb18141.x; MANUNTA P, 1994, J HYPERTENS, V12, P569; Manunta P, 1992, J HYPERTENS       S6, V10, pS27; MASUGI F, 1986, BIOCHEM BIOPH RES CO, V135, P41, DOI 10.1016/0006-291X(86)90939-3; NARUSE K, 1994, HYPERTENSION S1, V23, P102; ODELL WD, 1991, ENDOCRIN METAB CLIN, V20, P371; PAMNANI MB, 1990, AM J HYPERTENS, V3, P188; SZYLMAN P, 1990, J LAB CLIN MED, V116, P315; TAMURA M, 1993, EUR J BIOCHEM, V211, P317, DOI 10.1111/j.1432-1033.1993.tb19901.x; TYMIAK AA, 1993, P NATL ACAD SCI USA, V90, P8189, DOI 10.1073/pnas.90.17.8189; ULICK S, 1992, J CLIN ENDOCR METAB, V74, P963, DOI 10.1210/jc.74.5.963; WOOLF AD, 1992, NEW ENGL J MED, V326, P1739, DOI 10.1056/NEJM199206253262604; YAMADA K, 1994, AM J PHYSIOL, V266, pH1357; YUAN CM, 1993, HYPERTENSION, V22, P178	40	21	22	AMER HEART ASSOC	DALLAS	7272 GREENVILLE AVENUE, DALLAS, TX 75231-4596	0194-911X			HYPERTENSION	Hypertension	SEP	1996	28	3					421	425				5	Peripheral Vascular Disease	Cardiovascular System & Cardiology	VF997	WOS:A1996VF99700018		
J	Kijima, K; Matsubara, H; Murasawa, S; Maruyama, K; Mori, Y; Komuro, I; Yazaki, Y; Inada, M				Kijima, K; Matsubara, H; Murasawa, S; Maruyama, K; Mori, Y; Komuro, I; Yazaki, Y; Inada, M			Regulation of angiotensin II AT1 and AT2 receptor expression by mechanical stretch induced myocyte hypertrophy	HYPERTENSION			English	Meeting Abstract									KANSAI MED UNIV,DEPT MED 2,OSAKA,JAPAN; UNIV TOKYO,DEPT MED 3,TOKYO,JAPAN								0	0	0	AMER HEART ASSOC	DALLAS	7272 GREENVILLE AVENUE, DALLAS, TX 75231-4596	0194-911X			HYPERTENSION	Hypertension	SEP	1996	28	3					P106	P106				1	Peripheral Vascular Disease	Cardiovascular System & Cardiology	VF997	WOS:A1996VF99700213		
J	Nagoshi, H; Uehara, Y; Goto, A; Omata, M				Nagoshi, H; Uehara, Y; Goto, A; Omata, M			Prostaglandin D-2 inhibits nitric oxide synthase expression in smooth muscle cells	HYPERTENSION			English	Meeting Abstract									UNIV TOKYO,DEPT INTERNAL MED 2,TOKYO 113,JAPAN								0	0	0	AMER HEART ASSOC	DALLAS	7272 GREENVILLE AVENUE, DALLAS, TX 75231-4596	0194-911X			HYPERTENSION	Hypertension	SEP	1996	28	3					P159	P159				1	Peripheral Vascular Disease	Cardiovascular System & Cardiology	VF997	WOS:A1996VF99700266		
J	Kokubo, E; Ida, S				Kokubo, E; Ida, S			On runaway growth of planetesimals	ICARUS			English	Article							SOLAR GRAVITATIONAL-FIELD; N-BODY SIMULATION; NUMERICAL-SIMULATION; DYNAMIC FRICTION; EVOLUTION; PROTOPLANET; VELOCITY; SWARM; ACCUMULATION; ACCRETION	We have performed 3-D N-body simulations of planetary accretion. The growth mode of planetesimals is investigated with 3000 equal-mass planetesimals under perfect and gas-free accretion. We present conclusive evidence of runaway growth, which was first found through the statistical studies of the coagulation equation with the particle-in-a-box kinetic theory (e.g., Wetherill, G. W., and G. R. Stewart 1989. Icarus 77, 330-367). The statistical approach is based on the averaged quantities and thus would not be suitable for describing runaway growth. Our approach can describe runaway growth naturally. The number of bodies in our simulations is large enough to derive the statistical properties of the system. We find that the mass distribution immediately relaxes into the continuous power-law mass distribution with dN(c)/dm proportional to m(-2.5+/-0.40), where N-c is the cumulative number of bodies. Then the largest body of the continuous mass distribution becomes detached from the continuous mass distribution and shows runaway growth in mass. The velocity dispersion (eccentricity and inclination) is almost inversely proportional to the square-root of mass except for the top and tail parts of the mass distribution. These results agree with the results by the statistical kinetic theory approach. (C) 1996 Academic Press, Inc.	TOKYO INST TECHNOL,DEPT EARTH & PLANETARY SCI,MEGURO KU,TOKYO 152,JAPAN	Kokubo, E (reprint author), UNIV TOKYO,DEPT EARTH SCI & ASTRON,MEGURO KU,TOKYO 153,JAPAN.		Ida, Shigeru/A-7840-2014	Ida, Shigeru/0000-0002-9676-3891			WETHERILL GW, 1989, ICARUS, V77, P330, DOI 10.1016/0019-1035(89)90093-6; IDA S, 1989, ASTRON ASTROPHYS, V224, P303; IDA S, 1992, ICARUS, V96, P107, DOI 10.1016/0019-1035(92)90008-U; GREENZWEIG Y, 1990, ICARUS, V87, P40, DOI 10.1016/0019-1035(90)90021-Z; WETHERILL GW, 1993, ICARUS, V106, P190, DOI 10.1006/icar.1993.1166; SPAUTE D, 1991, ICARUS, V92, P147, DOI 10.1016/0019-1035(91)90041-Q; IDA S, 1990, ICARUS, V88, P129, DOI 10.1016/0019-1035(90)90182-9; IDA S, 1993, ICARUS, V106, P210, DOI 10.1006/icar.1993.1167; GREENBERG R, 1978, ICARUS, V35, P1, DOI 10.1016/0019-1035(78)90057-X; AARSETH SJ, 1993, ASTROPHYS J, V403, P351, DOI 10.1086/172208; KOKUBO E, 1995, ICARUS, V114, P247, DOI 10.1006/icar.1995.1059; BARGE P, 1991, ICARUS, V93, P270, DOI 10.1016/0019-1035(91)90212-C; BEAUGE C, 1990, MON NOT R ASTRON SOC, V245, P30; Hayashi C, 1981, PROG THEOR PHYS SUPP, V70, P35, DOI 10.1143/PTPS.70.35; IDA S, 1992, ICARUS, V98, P28, DOI 10.1016/0019-1035(92)90203-J; LECAR M, 1986, ASTROPHYS J, V305, P564, DOI 10.1086/164269; MAKINO J, 1993, PUBL ASTRON SOC JPN, V45, P349; MAKINO J, 1992, PUBL ASTRON SOC JPN, V44, P141; MAKINO J, 1991, PUBL ASTRON SOC JPN, V43, P859; OHTSUKI K, 1993, PROTOSTARS PLANETS, V3, P1061	20	187	188	ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495	0019-1035			ICARUS	Icarus	SEP	1996	123	1					180	191		10.1006/icar.1996.0148		12	Astronomy & Astrophysics	Astronomy & Astrophysics	VN300	WOS:A1996VN30000012		
J	Brunvand, E; Furber, S; Nanya, T				Brunvand, E; Furber, S; Nanya, T			Asynchronous architecture	IEE PROCEEDINGS-COMPUTERS AND DIGITAL TECHNIQUES			English	Editorial Material									UNIV MANCHESTER,DEPT COMP SCI,MANCHESTER M13 9PL,LANCS,ENGLAND; TOKYO INST TECHNOL,DEPT ELECT ENGN,TOKYO 152,JAPAN; UNIV TOKYO,DEPT MATH ENGN & INFORMAT PHYS,TOKYO 113,JAPAN	Brunvand, E (reprint author), UNIV UTAH,DEPT COMP SCI,SALT LAKE CITY,UT 84112, USA.							0	0	0	IEE-INST ELEC ENG	HERTFORD	MICHAEL FARADAY HOUSE SIX HILLS WAY STEVENAGE, HERTFORD, ENGLAND SG1 2AY	1350-2387			IEE P-COMPUT DIG T	IEE Proc.-Comp. Digit. Tech.	SEP	1996	143	5					249	250		10.1049/ip-cdt:19960812		2	Computer Science, Hardware & Architecture; Computer Science, Theory & Methods	Computer Science	VP481	WOS:A1996VP48100001		
J	Shibata, T; Matsumoto, Y; Kuwahara, T; Inaba, M; Inoue, H				Shibata, T; Matsumoto, Y; Kuwahara, T; Inaba, M; Inoue, H			Development and integration of generic components for a teachable vision-based mobile robot	IEEE-ASME TRANSACTIONS ON MECHATRONICS			English	Article								This paper presents a mobile robotic system for human assistance in navigation-the robot navigates by receiving visual instructions from a human being and is able to replicate them autonomously, We describe three generic components defined as the HOST, the VISION, and the CONTROL components as web as their integration in our teachable mobile robot. These components are connected to each other,ia a transputer serial link, namely they are loosely coupled, they work in parallel and are asynchronous with each other, Each component is described with a peculiar feature of extensibility. Especially in the VISION component, there are two major features, The first one is a correlator which each vision board possesses, The correlator does block-matching between the template and the grabbed images in real-time, The other is the PM Library which manages the visual tasks over limited parallel visual resources of the mobile robot. These features of our design enable the system to be real-time and allow for efficient and extensible software development In order to show the feasibility of our system design, we present a preliminary experiment of the route teaching on our mobile robot.		Shibata, T (reprint author), UNIV TOKYO, DEPT MECHANOINFORMAT, TOKYO 113, JAPAN.						THORPE C, 1988, IEEE T PATTERN ANAL, V10, P362, DOI 10.1109/34.3900; DICKMANNS ED, 1987, P 4 ROB RES, P73; GRAFE V, 1988, IROS 88, P627; HORSWILL I, 1993, PROCEEDINGS OF THE ELEVENTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE, P824; INOUE H, 1992, P 1992 IEEE INT C RO, V5, P1621; INOUE H, 1993, P INT S IND ROB ISIR, P675; ISHIGURO H, 1995, IEEE INT CONF ROBOT, P1068, DOI 10.1109/ROBOT.1995.525423; Pomerleau D. A., 1991, Engineering Applications of Artificial Intelligence, V4, DOI 10.1016/0952-1976(91)90042-5; SHIBATA T, 1995, IEEE INT CONF ROBOT, P1074, DOI 10.1109/ROBOT.1995.525424; THORPE C, 1993, COMPUTER VISION SPAC; TSUBOUCHI T, 1987, MAR P IEEE INT C ROB, P1978	11	8	8	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1083-4435			IEEE-ASME T MECH	IEEE-ASME Trans. Mechatron.	SEP	1996	1	3					230	236		10.1109/3516.537045		7	Automation & Control Systems; Engineering, Manufacturing; Engineering, Electrical & Electronic; Engineering, Mechanical	Automation & Control Systems; Engineering	VY147	WOS:A1996VY14700005		
J	Mizoguchi, H; Sato, T; Ishikawa, T				Mizoguchi, H; Sato, T; Ishikawa, T			Robotic office room to support office work by human behavior understanding function with networked machines	IEEE-ASME TRANSACTIONS ON MECHATRONICS			English	Article						human-robot symbiosis system; behavior; object model; network		This paper proposes a novel human-robot symbiosis system named a Robotic Office Room (ROR), The understanding, recording and retrieving of telephone call behavior are successfully demonstrated as a typical example of an office work-supporting function of ROR. A unique object model is proposed, which accumulates information concerning motion of the object, This model enables the system to understand human behavior, not by monitoring the motion of the human, but by monitoring the motion of the object-typically, a telephone or pen, Since the model requires the system to pay spatial and temporal attention only to the target object and related motions, it saves computing power, Repertoires of understandable behavior can easily be expanded by simply adding new object models. The ROR is equipped with networked machines, The concept of ''ubiquitous link'' consisting of unique image channels and remote control channels is proposed, The image channel and the remote control channel utilize TV images and either ultrasonic waves or infrared rays, respectively, Such cooperative support of humans by networked machines is realized that when a human starts to talk on the phone, the ROR not only starts to record the image of the human's behavior, utilizing a VCR, but also turns down the volume-on an audio set, The experiment proved the feasibility of the ROR as an integrated robotic system to support human office work.	TOKYO ENGN UNIV, TOKYO 192, JAPAN	Mizoguchi, H (reprint author), UNIV TOKYO, ADV SCI & TECHNOL RES CTR, TOKYO 153, JAPAN.						KUNIYOSHI Y, 1994, IEEE T ROBOTIC AUTOM, V10, P799, DOI 10.1109/70.338535; DUDEK G, 1995, P IEEE INT C INT ROB, V2, P268, DOI 10.1109/IROS.1995.526171; IKEUCHI K, 1993, P IEEE RSJ INT C INT, P2294; Kang S. B., 1994, P IEEE RSJ GI INT C, P97; KANG SB, 1994, P IROS 94, P551; Mataric M. J., 1995, P IEEE RSJ INT C INT, V3, P556, DOI 10.1109/IROS.1995.525940; MIURA J, 1995, IEEE INT CONF ROBOT, P1912, DOI 10.1109/ROBOT.1995.525544; SATO T, 1986, J RSJ, V4, P353; SATO T, 1989, P IROS 89, P124; Suzuki S., 1995, P IEEE RSJ INT C INT, V1, P220, DOI 10.1109/IROS.1995.525800; TSO SK, 1995, P IROS 95, V1, P23, DOI 10.1109/IROS.1995.525770; WANG J, 1995, IEEE INT CONF ROBOT, P2561	12	10	10	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1083-4435			IEEE-ASME T MECH	IEEE-ASME Trans. Mechatron.	SEP	1996	1	3					237	244		10.1109/3516.537046		8	Automation & Control Systems; Engineering, Manufacturing; Engineering, Electrical & Electronic; Engineering, Mechanical	Automation & Control Systems; Engineering	VY147	WOS:A1996VY14700006		
J	Nakao, M; Sugiyama, S; Hatamura, Y; Hamaguchi, T; Watanabe, K				Nakao, M; Sugiyama, S; Hatamura, Y; Hamaguchi, T; Watanabe, K			Remote-centered compliance mechanism of micro suspension for contact recording head	IEEE-ASME TRANSACTIONS ON MECHATRONICS			English	Article								To achieve a higher magnetic memory density, contact recording will be a key technology, Seeing that a contact sliding head is always subject to friction, the head has an unstable stick-slip motion in a nose-down attitude, In this paper, the authors present a new micro suspension as an early trial for avoiding the stick-slip, The suspension is formed by a diagonally notched structure, working an ''RCC (Remote Centered Compliance)'' mechanism, It was fabricated from a 125 mu m thick sheet of polyimide using an ultraviolet laser; an inductive head with a 50 x 50 mu m sliding pad was mounted on it, When sliding at 10 m/s under a normal force of 0.7 mN, the head always had an extremely high friction coefficient of 1.6, But the suspension stabilized pitching motion of the head within +/-50 mu rad. in a nose-up attitude, inducing the acceptable modulation of read back signal within +/-5%, The RCC mechanism empirically realized the more stable motion than a non-RCC one, and will be a promising tool for contact recording.	HITACHI LTD,MECH ENGN RES LAB,IBARAKI,OSAKA 300,JAPAN	Nakao, M (reprint author), UNIV TOKYO,DEPT ENGN SYNTH,BUNKYO KU,TOKYO 113,JAPAN.						HACHIUMA H, 1994, P ASPE 94, P186; HATAMURA Y, 1990, IEEE T MAGN, V26, P2484, DOI 10.1109/20.104771; HATAMURA Y, 1988, IEEE T MAGN, V24, P2638, DOI 10.1109/20.92197	3	1	1	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	NEW YORK	345 E 47TH ST, NEW YORK, NY 10017-2394	1083-4435			IEEE-ASME T MECH	IEEE-ASME Trans. Mechatron.	SEP	1996	1	3					245	249		10.1109/3516.537047		5	Automation & Control Systems; Engineering, Manufacturing; Engineering, Electrical & Electronic; Engineering, Mechanical	Automation & Control Systems; Engineering	VY147	WOS:A1996VY14700007		
J	Hoshida, T; Liu, HF; Tsuchiya, M; Ogawa, Y; Kamiya, T				Hoshida, T; Liu, HF; Tsuchiya, M; Ogawa, Y; Kamiya, T			Subharmonic hybrid mode-locking of a monolithic semiconductor laser	IEEE JOURNAL OF SELECTED TOPICS IN QUANTUM ELECTRONICS			English	Article							SOLITON PULSE-TRAIN; MILLIMETER-WAVE SIGNALS; GENERATION; FIBER; SYSTEMS; TRANSMISSION; WAVELENGTH; OPTICS; DIODE	Performance of a subharmonically hybrid mode-locked (SH-ML) monolithic semiconductor laser is investigated. A 33-GHz passively mode-locked distributed Bragg reflector semiconductor laser is stabilized by the injection of an electrical signal with a subharmonic frequency of the laser cavity resonance. Systematic measurements on the phase noise, timing jitter, amplitude modulation, and locking bandwidth are performed for the second- and third-order SH-ML conditions, and the results are compared with the fundamental hybrid mode locking (FH-ML) case. Low timing jitter of less than 0.6 ps, comparable to that under the FH-ML case, is achieved for the both SH-ML cases. The amplitude modulation imposed by the subharmonic driving frequencies is found to be very small (<-24 dBc) for the second-order SH-ML because of the sufficiently low modulation response of the laser at 16.5 GHz. The third-order SH-ML is found to exhibit a very unique locking characteristics, leading to a maximum locking bandwidth of 56 MHz that is even larger than that for the FH-ML case.	OKI ELECT IND CO LTD,SEMICOND TECHNOL LAB,HACHIOJI,TOKYO 193,JAPAN	Hoshida, T (reprint author), UNIV TOKYO,DEPT ELECT ENGN,7-3-1 HONGO,TOKYO 113,JAPAN.						AHMED Z, 1993, IEEE J QUANTUM ELECT, V29, P1714, DOI 10.1109/3.234426; Sato KJ, 1996, APPL PHYS LETT, V69, P2626, DOI 10.1063/1.117556; Barry RA, 1996, IEEE J SEL AREA COMM, V14, P999, DOI 10.1109/49.510923; CHERNIKOV SV, 1993, ELECTRON LETT, V29, P1788, DOI 10.1049/el:19931190; Arahira S, 1996, IEEE J QUANTUM ELECT, V32, P1211, DOI 10.1109/3.517021; OGAWA H, 1992, IEEE T MICROW THEORY, V40, P2285, DOI 10.1109/22.179892; CHEN YK, 1992, IEEE J QUANTUM ELECT, V28, P2176; OREILLY J, 1994, J LIGHTWAVE TECHNOL, V12, P369, DOI 10.1109/50.350584; SANDERS S, 1990, APPL PHYS LETT, V56, P310, DOI 10.1063/1.103187; NOGUCHI K, 1994, ELECTRON LETT, V30, P949, DOI 10.1049/el:19940646; RODWELL MJW, 1989, IEEE J QUANTUM ELECT, V25, P817, DOI 10.1109/3.17346; ARAHIRA S, 1994, OPT LETT, V19, P834, DOI 10.1364/OL.19.000834; Arahira S, 1996, IEEE PHOTONIC TECH L, V8, P191, DOI 10.1109/68.484237; CHERNIKOV SV, 1992, ELECTRON LETT, V28, P931, DOI 10.1049/el:19920589; GEORGES JB, 1994, IEEE PHOTONIC TECH L, V6, P568, DOI 10.1109/68.281829; Hoshida T, 1996, ELECTRON LETT, V32, P572, DOI 10.1049/el:19960405; Hoshida T, 1996, IEEE PHOTONIC TECH L, V8, P1160, DOI 10.1109/68.531822; KATO K, 1994, IEEE PHOTONIC TECH L, V6, P719, DOI 10.1109/68.300173; KIM DY, 1995, ELECTRON LETT, V31, P733, DOI 10.1049/el:19950475; KOMAKI S, 1993, MICROW OPT TECHN LET, V6, P55, DOI 10.1002/mop.4650060115; LAU KY, 1990, IEEE J QUANTUM ELECT, V26, P251; LAU KY, 1989, J LIGHTWAVE TECHNOL, V7, P400, DOI 10.1109/50.17787; LIU HF, 1995, IEEE PHOTONIC TECH L, V7, P1139, DOI 10.1109/68.466570; MARTINS JF, 1995, IEEE J SEL TOP QUANT, V1, P539, DOI 10.1109/2944.401240; NAGARAJAN R, 1993, IEEE PHOTONIC TECH L, V5, P4, DOI 10.1109/68.185042; SPIRIT DM, 1994, IEEE COMMUN MAG, V32, P56, DOI 10.1109/35.336012; SWANSON EA, 1994, IEEE PHOTONIC TECH L, V6, P1194, DOI 10.1109/68.329636; TUCKER RS, 1989, ELECTRON LETT, V25, P621, DOI 10.1049/el:19890421; VONDERLINDE D, 1986, APPL PHYS B-PHOTO, V39, P201; WAKE D, 1995, IEEE T MICROW THEORY, V43, P2270, DOI 10.1109/22.414575; Wang XL, 1996, IEEE PHOTONIC TECH L, V8, P617, DOI 10.1109/68.491557; WEISSER S, 1995, P 21 EUR C OPT COMM, P1015	32	28	29	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	NEW YORK	345 E 47TH ST, NEW YORK, NY 10017-2394	1077-260X			IEEE J SEL TOP QUANT	IEEE J. Sel. Top. Quantum Electron.	SEP	1996	2	3					514	522		10.1109/2944.571752		9	Engineering, Electrical & Electronic; Optics; Physics, Applied	Engineering; Optics; Physics	WX097	WOS:A1996WX09700011		
J	Hoshida, T; Liu, HF; Tsuchiya, M; Ogawa, Y; Kamiya, T				Hoshida, T; Liu, HF; Tsuchiya, M; Ogawa, Y; Kamiya, T			Extremely low-amplitude modulation in a subharmonically hybrid mode-locked monolithic semiconductor laser	IEEE PHOTONICS TECHNOLOGY LETTERS			English	Article							GENERATION	Negligibly small amplitude modulation and sufficiently low timing jitter are achieved simultaneously in a passively mode-locked monolithic semiconductor laser stabilized by applying an electrical signal at the second subharmonic of the pulse repetition frequency, Nearly transform-limited 33 GHz pulse trains with 0.56 ps timing jitter and -23 dBc amplitude modulation are obtained with 23 dBm driving signals at 16.5 GHz, Detailed investigations are carried out on the dependence of the amplitude modulation and timing jitter on RF driving power for the second- and third-order subharmonic cases, The excellent amplitude modulation property of the second subharmonic case with the specific laser used in this work is ascribed to the frequency response characteristics of the device.	OKI ELECT IND CO LTD,SEMICOND TECHNOL LAB,HACHIOJI,TOKYO 193,JAPAN	Hoshida, T (reprint author), UNIV TOKYO,DEPT ELECT ENGN,7-3-1 HONGO,TOKYO 113,JAPAN.						CHEN YK, 1992, IEEE J QUANTUM ELECT, V28, P2176; ARAHIRA S, 1994, OPT LETT, V19, P834, DOI 10.1364/OL.19.000834; HOSHIDA T, 1996, TECH DIG 1996 C LAS, P12; KIM DY, 1995, ELECTRON LETT, V31, P733, DOI 10.1049/el:19950475; LAU KY, 1990, IEEE J QUANTUM ELECT, V26, P250, DOI 10.1109/3.44956; LIU HF, 1995, IEEE PHOTONIC TECH L, V7, P1139, DOI 10.1109/68.466570; VONDERLINDE D, 1986, APPL PHYS B-PHOTO, V39, P201; WAKE D, 1995, IEEE T MICROW THEORY, V43, P2270, DOI 10.1109/22.414575	8	10	11	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	NEW YORK	345 E 47TH ST, NEW YORK, NY 10017-2394	1041-1135			IEEE PHOTONIC TECH L	IEEE Photonics Technol. Lett.	SEP	1996	8	9					1160	1162		10.1109/68.531822		3	Engineering, Electrical & Electronic; Optics; Physics, Applied	Engineering; Optics; Physics	VE155	WOS:A1996VE15500016		
J	Heath, D; Huitema, C; Ishida, H; Mankin, A; Partridge, C				Heath, D; Huitema, C; Ishida, H; Mankin, A; Partridge, C			It's only growing pains	IEEE SPECTRUM			English	Editorial Material									BELLCORE,LIVINGSTON,NJ; UNIV TOKYO,CTR COMP,TOKYO,JAPAN; UNIV SO CALIF,INFORMAT SCI INST LAB E,ARLINGTON,VA; BBN CORP,CAMBRIDGE,MA; STANFORD UNIV,STANFORD,CA 94305	Heath, D (reprint author), INTERNET SOC,12020 SUNRISE VALLEY DR,SUITE 270,RESTON,VA 22091, USA.							0	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	NEW YORK	345 E 47TH ST, NEW YORK, NY 10017-2394	0018-9235			IEEE SPECTRUM	IEEE Spectr.	SEP	1996	33	9					46	&				8	Engineering, Electrical & Electronic	Engineering	VF588	WOS:A1996VF58800013		
J	Kobayashi, T; Yokoyama, A				Kobayashi, T; Yokoyama, A			An adaptive neuro-control system of synchronous generator for power system stabilization	IEEE TRANSACTIONS ON ENERGY CONVERSION			English	Article; Proceedings Paper	1996 IEEE/PES Winter Meeting	JAN 21-25, 1996	BALTIMORE, MD	IEEE PES				This paper proposes a nonlinear adaptive generator control system using neural networks, called an adaptive neuro-control system (ANCS). This system generates supplementary control signals to conventional controllers and works adaptively in response to changes in operating conditions and network configuration. Through digital time simulations for a one-machine infinite bus test power system, the control performance of the ANCS and advanced controllers such as a linear optimal regulator and a self-tuning regulator is evaluated from the viewpoint of stability enhancement. As a result, the proposed ANCS using neural networks with nonlinear characteristics improves system damping more effectively and more adaptively than the other two controllers designed for the linearized model of the power system.	UNIV TOKYO,TOKYO,JAPAN	Kobayashi, T (reprint author), TOSHIBA CO LTD,TOKYO,JAPAN.						IIGUNI Y, 1991, IEEE T NEURAL NETWOR, V2, P410, DOI 10.1109/72.88160; GHOSH A, 1984, IEEE T POWER AP SYST, V103, P1983, DOI 10.1109/TPAS.1984.318503; HIYAMA T, 1994, IEEE T ENERGY CONVER, V9, P451, DOI 10.1109/60.326462; KENNEDY DC, 1993, P ESAP 93, P531; KOBAYASHI T, 1994, P ISAP 94, V1, P55; MORIOKA Y, 1994, IEEE T POWER SYST, V9, P1949, DOI 10.1109/59.331455; PAHALAWATHTHA NC, 1991, IEEE T ENERGY CONVER, V6, P310, DOI 10.1109/60.79638; PARK YM, 1994, P ISAP 94, V1, P305; SOBAJIC DJ, 1992, INT J ELEC POWER, V14, P166, DOI 10.1016/0142-0615(92)90041-7; Yu Y., 1983, ELECT POWER SYSTEM D; ZHANG Y, 1995, IEEE T ENERGY CONVER, V10, P147, DOI 10.1109/60.372580	11	29	29	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	NEW YORK	345 E 47TH ST, NEW YORK, NY 10017-2394	0885-8969			IEEE T ENERGY CONVER	IEEE Trans. Energy Convers.	SEP	1996	11	3					621	627		10.1109/60.537034		7	Energy & Fuels; Engineering, Electrical & Electronic	Energy & Fuels; Engineering	VK804	WOS:A1996VK80400035		
J	Oda, T; Yamashita, R; Tanaka, K; Takahashi, T; Masuda, S				Oda, T; Yamashita, R; Tanaka, K; Takahashi, T; Masuda, S			Analysis of low-temperature surface discharge plasma products from gaseous organic compounds	IEEE TRANSACTIONS ON INDUSTRY APPLICATIONS			English	Article; Proceedings Paper	1994 IEEE Industry-Applications-Society Annual Meeting	OCT 02-07, 1994	DENVER, CO	IEEE, Ind Applicat Soc				Nonequilibrium low-temperature discharge plasma decomposition products of 1000 ppm gaseous organic compounds contaminated in atmospheric pressure air, nitrogen, or oxygen, such as chlorofluorocarbon (CFC-113), organic chloride (trichloroethylene), and carbon tetrachloride, were studied for better understanding of the decomposition mechanism of the plasma processing. A gas chromatograph-mass spectrometer was used as a main analyzing equipment. When the decomposition rate is not high (20-80%) for CFC-113, many various halogenated carbons or halogenated hydrocarbons are identified as intermediate products by the plasma processing. As the electric discharge power consumption increases, the decomposition rate of CFC-113 increases and intermediate products decrease. At the decomposition rate of more than 90%, some elemental products of hydrochloric acid, carbon dioxide, and nitrogen suboxide are recognized as final products. On the other hand, if the environmental gas is pure nitrogen without any oxygen and water vapor, the decomposition products are still intermediate with sufficient electric discharge power consumption, suggesting the existence of double decomposition mechanisms of nitrogen radicals and oxygen radicals. In the case of trichloroethylene decomposition, harmful intermediate decomposition products were observed when the decomposition rate was 20-90%.	MASUDA RES INST,TOKYO 113,JAPAN	Oda, T (reprint author), UNIV TOKYO,DEPT ELECT ENGN,7-3-1 HONGO,TOKYO 113,JAPAN.						YAMAMOTO T, 1992, IEEE T IND APPL, V28, P528, DOI 10.1109/28.137430; MAEKELAE JM, 1994, P 9J RES M I EL JAP, V1, P95; MASUDA S, 1988, IEEE T IND APPL, V24, P223, DOI 10.1109/28.2860; MIZUNO K, COMMUNICATION; Oda T, 1996, IEEE T IND APPL, V32, P118, DOI 10.1109/28.485822; Oda T, 1996, IEEE T IND APPL, V32, P227, DOI 10.1109/28.491469; ODA T, 1993, IAS 93, PTS 1-3, P1983, DOI 10.1109/IAS.1993.299132; ODA T, 1994, P ESA IEJ JOINT S PA; ODA T, 1992, IEEE IAS ANN M, P1570; ODA T, 1993, IEEE T IND APPL, V29, P787, DOI 10.1109/28.231995; WAKABAYASHI T, 1989, P 9 INT S PLASM CHEM, pL111; WASHINO M, 1980, JAERI, V1265; YAMAKUMA S, 1994, P 9J RES M I EL JAP, V1, P69	13	11	13	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	NEW YORK	345 E 47TH ST, NEW YORK, NY 10017-2394	0093-9994			IEEE T IND APPL	IEEE Trans. Ind. Appl.	SEP-OCT	1996	32	5					1044	1050		10.1109/28.536864		7	Engineering, Multidisciplinary; Engineering, Electrical & Electronic	Engineering	VJ560	WOS:A1996VJ56000011		
J	Nakagawa, S; Ueno, S; Iramina, K; Weinberg, H				Nakagawa, S; Ueno, S; Iramina, K; Weinberg, H			MEG and EEG evoked by verbal cognitive tasks	IEEE TRANSACTIONS ON MAGNETICS			English	Article; Proceedings Paper	1996 IEEE International Magnetics Conference (INTERMAG 96)	APR 09-12, 1996	SEATTLE, WA	IEEE				We observed the brain electrical activities associated with verbal cognitive processes by measuring both EEGs and MEGs evoked by visually cognitive tasks. English words, nonsense words and random dots were presented. We discussed the source estimation at a latencies of 150 msec and 360 msec using MEG data. At 150 msec, two equivalent current dipoles are localized in or near the primary visual cortex. The dipole sources for recognition of English words at 360 msec were estimated in both hemispheres, and the dipole moment in the left-hemisphere was larger than the dipole moment of the right hemisphere. However, we could not find sources common to all subjects.	SIMON FRASER UNIV,BRAIN BEHAV LAB,BURNABY,BC V5A 1S6,CANADA	Nakagawa, S (reprint author), UNIV TOKYO,INST MED ELECT,TOKYO 113,JAPAN.		Nakagawa, Shigeki/G-4445-2010				AINE CJ, 1987, BIOM 87 TOK, P242; CURRAN T, 1993, ELECTROEN CLIN NEURO, V88, P188, DOI 10.1016/0168-5597(93)90004-9; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; KUTAS M, 1984, NATURE, V307, P161, DOI 10.1038/307161a0; GEORGE JS, 1987, BIOM 87 TOK, P238; Gordon E, 1990, Clin Exp Neurol, V27, P113; KAUFMAN L, 1992, ELECTROEN CLIN NEURO, V82, P266, DOI 10.1016/0013-4694(92)90107-S; LU ST, 1991, NEUROSCIENCE, V43, P287, DOI 10.1016/0306-4522(91)90293-W	8	2	2	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	NEW YORK	345 E 47TH ST, NEW YORK, NY 10017-2394	0018-9464			IEEE T MAGN	IEEE Trans. Magn.	SEP	1996	32	5	2				4932	4934		10.1109/20.539292		3	Engineering, Electrical & Electronic; Physics, Applied	Engineering; Physics	VM259	WOS:A1996VM25900208		
J	Ohashi, S; Higashi, K; Ohsaki, H; Masada, E				Ohashi, S; Higashi, K; Ohsaki, H; Masada, E			Influence of magnet quench on the superconducting magnetically levitated bogie	IEEE TRANSACTIONS ON MAGNETICS			English	Article; Proceedings Paper	1996 IEEE International Magnetics Conference (INTERMAG 96)	APR 09-12, 1996	SEATTLE, WA	IEEE				Numerical simulation of running characteristics of the superconducting magnetically levitated system has been undertaken. A three-dimensional running simulation program of the bogie motion has been developed to verify the stability in an emergency, that is, in the case of superconducting (SC) coil quenching. The influence of the coil quenching is most pronounced in the SC coil adjacent to the quenched coil. For this SC coil, due to the flux conservation characteristic, its current is changed only 5%. However the levitation and guidance force become about twice and four times as large as those in the normal state respectively.		Ohashi, S (reprint author), UNIV TOKYO,BUNKYO KU,7-3-1 HONGO,TOKYO 113,JAPAN.						ANDRIOLLO M, 1995, IEEE T APPL SUPERCON, V5, P604, DOI 10.1109/77.402623; KISHI H, 1992, P 4 S EL DYN, P159; KISHIKAWA A, 1995, P 14 INT C MAGN LEV, P183	3	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	NEW YORK	345 E 47TH ST, NEW YORK, NY 10017-2394	0018-9464			IEEE T MAGN	IEEE Trans. Magn.	SEP	1996	32	5	2				5046	5048		10.1109/20.539485		3	Engineering, Electrical & Electronic; Physics, Applied	Engineering; Physics	VM259	WOS:A1996VM25900246		
J	Senba, A; Kitahara, H; Ohsaki, H; Masada, E				Senba, A; Kitahara, H; Ohsaki, H; Masada, E			Characteristics of an electromagnetic levitation system using a bulk superconductor	IEEE TRANSACTIONS ON MAGNETICS			English	Article; Proceedings Paper	1996 IEEE International Magnetics Conference (INTERMAG 96)	APR 09-12, 1996	SEATTLE, WA	IEEE				It is beneficial to apply a high-Tc bulk superconductor as a large flux source to an electromagnetic levitation system, which needs large amounts of levitation force. We made an attractive-type electromagnetic levitation system using a hybrid magnet that mainly consisted of bulk superconductor and control coils to confirm the principle of the levitation, and obtained characteristics of its system by both experiment and numerical analysis with magnetic circuit calculation.		Senba, A (reprint author), UNIV TOKYO,DEPT ELECT ENGN,BUNKYO KU,7-3-1 HONGO,TOKYO 113,JAPAN.						KITAHARA H, 1995, ADV SUPERCONDUCTIVIT, V2, P1267; Murakami M., 1992, MELT PROCESSED HIGH; OHSAKI H, 1995, INT S SUP ISS 95	3	13	13	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	NEW YORK	345 E 47TH ST, NEW YORK, NY 10017-2394	0018-9464			IEEE T MAGN	IEEE Trans. Magn.	SEP	1996	32	5	2				5049	5051		10.1109/20.539486		3	Engineering, Electrical & Electronic; Physics, Applied	Engineering; Physics	VM259	WOS:A1996VM25900247		
J	Hayashiya, H; Araki, N; Paddison, JE; Ohsaki, H; Masada, E				Hayashiya, H; Araki, N; Paddison, JE; Ohsaki, H; Masada, E			Magnetic levitation of a flexible steel plate with a vibration suppressing magnet	IEEE TRANSACTIONS ON MAGNETICS			English	Article; Proceedings Paper	1996 IEEE International Magnetics Conference (INTERMAG 96)	APR 09-12, 1996	SEATTLE, WA	IEEE				A magnetic levitation system that has a vibration suppressing electromagnet which use only the velocity of the levitated object for the control has been studied. The proposed system has advantages of the stable levitation of a flexible steel plate which moves with time under the fixed electromagnets, The simulation of levitated plate's response using finite element method and the magnetic levitation experiments using such a vibration suppressing magnet were carried out. The results show the vibration suppressing magnet is able to control the low frequency natural vibration effectively, and a notch filter is able to avoid the excitation of the high frequency natural vibration.		Hayashiya, H (reprint author), UNIV TOKYO,DEPT ELECT ENGN,BUNKYO KU,7-3-1 HONGO,TOKYO 113,JAPAN.						Ackermann J., 1993, ROBUST CONTROL; HAYASHIYA H, 1995, P INT C EL ENG, P525; OSHINOYA Y, 1989, P 11 INT C MAGN LEV, P435	3	11	13	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	NEW YORK	345 E 47TH ST, NEW YORK, NY 10017-2394	0018-9464			IEEE T MAGN	IEEE Trans. Magn.	SEP	1996	32	5	2				5052	5054		10.1109/20.539487		3	Engineering, Electrical & Electronic; Physics, Applied	Engineering; Physics	VM259	WOS:A1996VM25900248		
J	Hyodo, A; Ueno, S				Hyodo, A; Ueno, S			Nerve excitation model for localized magnetic stimulation of finite neuronal structures	IEEE TRANSACTIONS ON MAGNETICS			English	Article; Proceedings Paper	1996 IEEE International Magnetics Conference (INTERMAG 96)	APR 09-12, 1996	SEATTLE, WA	IEEE			HUMAN MOTOR CORTEX; ELECTROMAGNETIC INDUCTION; MYELINATED NERVE; BRAIN	In this paper we focuse on a membrane excitation model of finite and bent nerves elicited by magnetically induced electric fields, We simulated nerve excitation by changing the length of an axon and the distance between the coil and the nerve, The computer simulation suggests that the termination points of nerves or the bending part of an axon are low threshold stimulation sites when magnetically stimulated with a figure-eight coil, We also suggest that a short axon is more easily excited than an infinitely long axon of the same thickness, These results give useful information in understanding neuronal responses to magnetic stimulation of both central and peripheral nervous systems.	KYUSHU UNIV,DEPT COMP SCI & COMMUN ENGN,FUKUOKA 812,JAPAN; UNIV TOKYO,INST MED ELECT,TOKYO 113,JAPAN							CHIU SY, 1979, J PHYSIOL-LONDON, V292, P149; ROTH BJ, 1990, IEEE T BIO-MED ENG, V37, P588, DOI 10.1109/10.55662; UENO S, 1990, IEEE T MAGN, V26, P1539, DOI 10.1109/20.104438; NAGARAJAN SS, 1993, IEEE T BIO-MED ENG, V40, P1175, DOI 10.1109/10.245636; UENO S, 1988, J APPL PHYS, V64, P5862, DOI 10.1063/1.342181; BARKER AT, 1985, LANCET, V1, P1106; BASSER PJ, 1991, MED BIOL ENG COMPUT, V29, P261, DOI 10.1007/BF02446708; MACCABEE PJ, 1993, J PHYSIOL-LONDON, V460, P201; UENO S, 1991, IEEE T MAGN, V27, P5387, DOI 10.1109/20.278847	9	14	14	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	NEW YORK	345 E 47TH ST, NEW YORK, NY 10017-2394	0018-9464			IEEE T MAGN	IEEE Trans. Magn.	SEP	1996	32	5	2				5112	5114		10.1109/20.539507		3	Engineering, Electrical & Electronic; Physics, Applied	Engineering; Physics	VM259	WOS:A1996VM25900268		
J	Iwaki, S; Ueno, S				Iwaki, S; Ueno, S			Comparison of the performance of distributed source estimation in the human brain using normal and vector magnetic field measurements	IEEE TRANSACTIONS ON MAGNETICS			English	Article; Proceedings Paper	1996 IEEE International Magnetics Conference (INTERMAG 96)	APR 09-12, 1996	SEATTLE, WA	IEEE			DIPOLE	In neuromagnetism research, it is important to accurately estimate internal electrical sources in the human brain from the spatial and temporal distributions of magnetoencephalogram (MEG) activities over the head. In this study, we compared the performance of distributed internal source estimation in the human brain under two different MEG measurement conditions: (a) measurements of only the normal components of the external magnetic fields and (b) three-dimensional vector measurements of the external magnetic fields. We applied the sub-optimal least-squares subspace scanning source estimation technique to both measurement conditions. The results showed that with the measurements of only the normal components, distributed source tends to be estimated deeper in the brain than they should be, while the three-dimensional vector measurements had the possibility to provide a better estimation for the depth of the internal source distribution.		Iwaki, S (reprint author), UNIV TOKYO,INST MED ELECT,TOKYO 113,JAPAN.						SARVAS J, 1987, PHYS MED BIOL, V32, P11, DOI 10.1088/0031-9155/32/1/004; COHEN D, 1976, J ELECTROCARDIOL, V9, P409, DOI 10.1016/S0022-0736(76)80041-6; Ilmoniemi R J, 1993, Brain Topogr, V5, P331, DOI 10.1007/BF01128686; MOSHER JC, 1992, IEEE T BIO-MED ENG, V39, P541, DOI 10.1109/10.141192; SCHMIDT RO, 1986, IEEE T ANTENN PROPAG, V34, P276, DOI 10.1109/TAP.1986.1143830; Ueno S., 1983, IL NUOVO CIMENTO D, V2, P558	6	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	NEW YORK	345 E 47TH ST, NEW YORK, NY 10017-2394	0018-9464			IEEE T MAGN	IEEE Trans. Magn.	SEP	1996	32	5	2				5127	5129		10.1109/20.539512		3	Engineering, Electrical & Electronic; Physics, Applied	Engineering; Physics	VM259	WOS:A1996VM25900273		
J	Iwasaka, M; Ueno, S; Tsuda, H				Iwasaka, M; Ueno, S; Tsuda, H			Dissolution of thrombus under high gradient magnetic fields	IEEE TRANSACTIONS ON MAGNETICS			English	Article; Proceedings Paper	1996 IEEE International Magnetics Conference (INTERMAG 96)	APR 09-12, 1996	SEATTLE, WA	IEEE				This study focused on the mechanism of effects of strong magnetic fields on a process of dissolution of fibrin clots. We measured the rate of fibrinolysis using a fibrin column as a model of a thrombus, and investigated the effects of gradient magnetic fields. Fibrin clots in glass tubes were digested by plasmin under magnetic fields of up to 8 T which were produced by a horizontal type of superconducting magnet at 37 degrees C. When a fibrin gel and a plasmin solution were exposed to magnetic fields where a product of magnetic fields and field gradients, B . dB/dz, was 370 T-2/m, dissolution of fibrin was enhanced by 34%. However, we obtained no distinct effects when B . dB/dz was less than 150 T-2/m. As a mechanism, we proposed a model in which fibrin polymers in water magnetophoresically drifted in the direction of increasing magnetic fields, and digestions of fibrin polymers by plasmin were accelerated.	KYUSHU UNIV,FAC MED,DEPT CLIN CHEM,FUKUOKA 812,JAPAN; KYUSHU UNIV,FAC MED,LAB MED,FUKUOKA 812,JAPAN	Iwasaka, M (reprint author), UNIV TOKYO,FAC MED,INST MED ELECT,TOKYO 113,JAPAN.						IWASAKA M, 1994, J APPL PHYS, V75, P7162, DOI 10.1063/1.356715; IWASAKA M, 1994, IEEE T MAGN, V30, P4695, DOI 10.1109/20.334192	2	2	2	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	NEW YORK	345 E 47TH ST, NEW YORK, NY 10017-2394	0018-9464			IEEE T MAGN	IEEE Trans. Magn.	SEP	1996	32	5	2				5130	5132		10.1109/20.539513		3	Engineering, Electrical & Electronic; Physics, Applied	Engineering; Physics	VM259	WOS:A1996VM25900274		
J	Suda, T; Ueno, S				Suda, T; Ueno, S			Microscopic observation of the behaviors of red blood cells with plasma proteins under strong magnetic fields	IEEE TRANSACTIONS ON MAGNETICS			English	Article; Proceedings Paper	1996 IEEE International Magnetics Conference (INTERMAG 96)	APR 09-12, 1996	SEATTLE, WA	IEEE			ORIENTATION; COLLAGEN; FIBRIN	The magnetic orientations of human red blood cells (RBCs) in some media such as phosphate buffer solutions (PBS), serum and plasma were investigated to ascertain the behavior of RBCs under strong magnetic fields in the body, The effects of orientation of RBCs in suspensions were measured by changes in the electrical conductivity of suspensions, The electrical conductivity of the suspensions were increased by application of magnetic fields parallel to the electric field, This phenomenon indicates that RBCs are redirected by a magnetic field, The changes in electrical conductivity of samples of 40 % RBCs suspended in PBS, serum and plasma were 19 %, 9 % and less than 4 % respectively, The electrical conductivity of anticoagulated whole blood was not changed by application of magnetic fields up to 8T, Through microscopic observation of RBCs suspended in plasma under 8T magnetic field, it was revealed that the aggregation of RBCs or rouleau formation occurred in plasma and rouleaux were oriented by the strong magnetic field. The changes in the electrical conductivity of the suspensions and whole blood by the magnetic orientation are prevented by the aggregation and rouleaux formation of RBCs.	UNIV TOKYO,FAC MED,INST MED ELECT,TOKYO 113,JAPAN	Suda, T (reprint author), KAGOSHIMA NATL COLL TECHNOL,KAGOSHIMA 89951,JAPAN.						TORBET J, 1981, NATURE, V289, P91, DOI 10.1038/289091a0; TORBET J, 1984, BIOCHEM J, V219, P1057; YAMAGISHI A, 1992, PHYSICA B, V177, P523, DOI 10.1016/0921-4526(92)90162-L; HUDRYCLERGEON G, 1983, ANN NY ACAD SCI, V408, P380, DOI 10.1111/j.1749-6632.1983.tb23258.x; MURTHY NS, 1984, BIOPOLYMERS, V23, P1261, DOI 10.1002/bip.360230710; SUDA T, 1994, IEEE T MAGN, V30, P4713, DOI 10.1109/20.334198; YAMAGISHI A, 1989, PHYSICA B, V115, P433	7	5	5	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	NEW YORK	345 E 47TH ST, NEW YORK, NY 10017-2394	0018-9464			IEEE T MAGN	IEEE Trans. Magn.	SEP	1996	32	5	2				5136	5138		10.1109/20.539515		3	Engineering, Electrical & Electronic; Physics, Applied	Engineering; Physics	VM259	WOS:A1996VM25900276		
J	Kurosawa, M; Takahashi, M; Higuchi, T				Kurosawa, M; Takahashi, M; Higuchi, T			Ultrasonic linear motor using surface acoustic waves	IEEE TRANSACTIONS ON ULTRASONICS FERROELECTRICS AND FREQUENCY CONTROL			English	Article							ROTOR STATOR CONTACT; VIBRATORS	The first success in the operation of an ultrasonic linear motor at HF band driving frequency using the Rayleigh wave is described, The substrate material is a 127.8 degrees Y-cut LiNbO3 wafer whose diameter is three inches. Four interdigital transducers (IDT's) are arranged to excite x- and y-propagation waves in both directions, The dimensions of the IDT are 25 mm aperture size, 400 mu m pitch, 100 mu m strip width, and 10 pairs, The operation area is about 25 mm square, The driving frequency is about 9.6 MHz in the x direction and about 9.1 MHz in the y direction, The most important point of the success is the shape of the contact surface and slider materials, For the contact materials, small balls about 1 mm in diameter are introduced to obtain sufficient contact pressure around 100 MPa, The use of ruby balls, steel balls, and tungsten carbide balls is investigated, Each slider has three balls to enable stable contact at three points, The maximum transfer speed is about 20 cm/s, The transfer speed is controllable by changing the driving voltage.		Kurosawa, M (reprint author), UNIV TOKYO,GRAD SCH ENGN,DEPT PRECIS MACHINERY ENGN,BUNKYO KU,7-3-1 HONGO,TOKYO 113,JAPAN.		Kurosawa, Minoru/L-7902-2014	Kurosawa, Minoru/0000-0001-6750-9141			MAENO T, 1992, IEEE T ULTRASON FERR, V39, P668, DOI 10.1109/58.165549; NAKAMURA K, 1991, IEEE T ULTRASON FERR, V38, P188, DOI 10.1109/58.79602; MURALT P, 1995, SENSOR ACTUAT A-PHYS, V48, P157, DOI 10.1016/0924-4247(95)00994-9; KIMURA Y, 1984, INTRO TRIBOLOGY, pCH3; KUROSAWA M, 1992, IEEE T ULTRSON FERRO, V38, P89; KUROSAWA M, P IEEE ULTR S, P1187; MAENO T, 1992, IEEE T ULTRASON FERR, V39, P675, DOI 10.1109/58.165550; MANCEAU JF, 1995, IEEE T ULTRASON FERR, V42, P59, DOI 10.1109/58.368312; MORONEY RM, 1989, P IEEE ULTR S MONTR, P745, DOI 10.1109/ULTSYM.1989.67086; Nakamura K, 1990, JPN J APPL PHYS, V29, P160; Ragulskis K., 1988, VIBROMOTORS PRECISIO; TAKANO T, 1990, IEEE T ULTRASON FERR, V37, P224, DOI 10.1109/58.55312; Timoshenko S, 1970, THEORY ELASTICITY, P409; Ueha S., 1993, ULTRASONIC MOTORS TH	14	72	75	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	NEW YORK	345 E 47TH ST, NEW YORK, NY 10017-2394	0885-3010			IEEE T ULTRASON FERR	IEEE Trans. Ultrason. Ferroelectr. Freq. Control	SEP	1996	43	5					901	906		10.1109/58.535493		6	Acoustics; Engineering, Electrical & Electronic	Acoustics; Engineering	VE602	WOS:A1996VE60200018		
J	Cheung, TS; Asada, K				Cheung, TS; Asada, K			Regenerative pass-transistor logic: A circuit technique for high speed digital design	IEICE TRANSACTIONS ON ELECTRONICS			English	Article						pass-transistor logic; dual-rail logic; Monte Carlo method; logic gates; arithmetic logic design	CMOS; MULTIPLIER; REALIZATION	Regenerative Pass-transistor Logic (RPL), a modular dual-rail circuit technique for high speed logic design that gives reasonably low power consumption, was developed. The technique can be applied to basic logic gates, Full adders, multiplier units, and more complicated arithmetic logics like Conditional Carry Select (CCS) circuit. The magnitude of propagation delay time of RPL is smaller than the conventional CPL (Complementary Pass-transistor Logic, or DPL (Double Pass-transistor Logic). Low power consumption fan also be achieved by reduced number of transistors and metal interconnections. Simulation and layout data also proved that RPL is advantageous over existing dual-rail logics while considering speed, poser consumption and layout area.		Cheung, TS (reprint author), UNIV TOKYO, FAC ENGN, DEPT ELECT ENGN, 7-3-1 HONGO, TOKYO 113, JAPAN.						YANO K, 1990, IEEE J SOLID-ST CIRC, V25, P388, DOI 10.1109/4.52161; CHANDRAKASAN AP, 1992, IEEE J SOLID-ST CIRC, V27, P473, DOI 10.1109/4.126534; SUZUKI M, 1993, IEEE J SOLID-ST CIRC, V28, P1145, DOI 10.1109/4.245595; Bedrij O.J., 1962, Institute of Radio Engineers Transactions on Electronic Computers, VEC-11, DOI 10.1109/IRETELC.1962.5407919; Burch R., 1993, IEEE Transactions on Very Large Scale Integration (VLSI) Systems, V1, DOI 10.1109/92.219908; CHU KM, 1987, IEEE J SOLID-ST CIRC, V22, P528, DOI 10.1109/JSSC.1987.1052767; FUKUHARA H, 1995, IEICE T ELECTRON, VE78C, P852; GHOSH D, 1995, IEEE T VLSI SYST, V3, P36, DOI 10.1109/92.365452; HODGES DA, 1988, ANAL DESIGN DIGITAL, P291; LAI FS, 1993, P 1993 INT S VLSI TE, P358; MEAD C, 1988, INTRO VLSI SYSTEMS, P221; OHKUBO N, 1995, IEEE J SOLID-ST CIRC, V30, P251, DOI 10.1109/4.364439; PARAMESWAR A, 1994, IEEE 1994 CICC P, P278; ROTHERMEL A, 1989, IEEE J SOLID-ST CIRC, V24, P558, DOI 10.1109/4.32007; Sklansky J., 1960, Institute of Radio Engineers Transactions on Electronic Computers, VEC-9; WESTE NHE, 1993, PRINCIPLES CMOS VLSI, P520; YUAN J, 1989, IEEE J SOLID-ST CIRC, V24, P62, DOI 10.1109/4.16303	17	9	9	IEICE-INST ELECTRONICS INFORMATION COMMUNICATIONS ENG	TOKYO	KIKAI-SHINKO-KAIKAN BLDG, 3-5-8, SHIBA-KOEN, MINATO-KU, TOKYO, 105-0011, JAPAN	0916-8524	1745-1353		IEICE T ELECTRON	IEICE Trans. Electron.	SEP	1996	E79C	9					1274	1284				11	Engineering, Electrical & Electronic	Engineering	VJ876	WOS:A1996VJ87600017		
J	Mori, T; Imai, H				Mori, T; Imai, H			Viterbi decoding considering synchronization errors	IEICE TRANSACTIONS ON FUNDAMENTALS OF ELECTRONICS COMMUNICATIONS AND COMPUTER SCIENCES			English	Article						synchronization error; insertion/deletion error; Viterbi decoding; Levenshtein distance		Viterbi decoding is known as a decoding scheme that can realize maximum likelihood decoding. However, it is impossible to continue it without re-synchronization even if only an insertion/deletion error occurs in a channel. In this paper, we show that Levenshtein distance is suitable for the metric of Viterbi decoding in a channel where not only symbol errors but also insertion/deletion errors occur under some conditions and we propose a kind of Virerbi decoding considering insertion/deletion errors.		Mori, T (reprint author), UNIV TOKYO, INST IND SCI, TOKYO 106, JAPAN.						AKAGI S, 1995, IT958 IEICE; OKUDA T, 1976, IEEE T COMPUT, V25, P172; KARASAWA Y, 1992, SAT927 IEICE; MORI T, 1994, IT9450 IEICE; MORI T, 1995, IT9515 IEICE; Mori T, 1995, PROCEEDINGS 1995 IEEE INTERNATIONAL SYMPOSIUM ON INFORMATION THEORY, P145, DOI 10.1109/ISIT.1995.531349; TANAKA E, 1976, IEEE T INFORM THEORY, V22, P156, DOI 10.1109/TIT.1976.1055532; YOSHIKAWA H, 1995, P 18 S INF THEOR ITS, P203	8	7	7	IEICE-INST ELECTRONICS INFORMATION COMMUNICATIONS ENG	TOKYO	KIKAI-SHINKO-KAIKAN BLDG, 3-5-8, SHIBA-KOEN, MINATO-KU, TOKYO, 105-0011, JAPAN	0916-8508	1745-1337		IEICE T FUND ELECTR	IEICE Trans. Fundam. Electron. Commun. Comput. Sci.	SEP	1996	E79A	9					1324	1329				6	Computer Science, Hardware & Architecture; Computer Science, Information Systems; Engineering, Electrical & Electronic	Computer Science; Engineering	VJ881	WOS:A1996VJ88100005		
J	MorelosZaragoza, R; Takeshita, OY; Imai, H				MorelosZaragoza, R; Takeshita, OY; Imai, H			Coded modulation for satellite digital video broadcasting	IEICE TRANSACTIONS ON FUNDAMENTALS OF ELECTRONICS COMMUNICATIONS AND COMPUTER SCIENCES			English	Article						coded modulation; digital video; satellite broadcasting	UNEQUAL ERROR PROTECTION; MULTILEVEL	In this paper, coded modulation techniques suitable for satellite broadcasting of digital high-definition TV are studied. An overview of current approaches to satellite broadcasting is presented. New constructions of coded modulation schemes for unequal error protection (UEP), based on both block and trellis codes, are introduced in this paper. The proposed schemes can achieve both better overall performance and enhanced graceful degradation of the received signal, in comparison with existing digital satellite broadcasting approaches.		MorelosZaragoza, R (reprint author), UNIV TOKYO, INST IND SCI, TOKYO 106, JAPAN.						COVER TM, 1972, IEEE T INFORM THEORY, V18, P2, DOI 10.1109/TIT.1972.1054727; IMAI H, 1977, IEEE T INFORM THEORY, V23, P371, DOI 10.1109/TIT.1977.1055718; RAMCHANDRAN K, 1993, IEEE J SEL AREA COMM, V11, P6, DOI 10.1109/49.210540; CALDERBANK AR, 1993, IEEE T INFORM THEORY, V39, P1234, DOI 10.1109/18.243441; CHIANG T, 1994, IEEE COMMUN MAG, V32, P38; Dosch C., 1994, EBU Technical Review; WEI LF, 1993, IEEE T COMMUN, V41, P1439, DOI 10.1109/26.237878; PALICOT J, 1993, IMAGE COMMUNICAT SEP; SABLATASH M, 1994, IEEE T BROADCAST, V40, P102, DOI 10.1109/11.286291; TSUZUKU A, 1993, P 23 EUR MICR C EUM, P110; UNGERBOECK G, 1982, IEEE T INFORM THEORY, V28, P55, DOI 10.1109/TIT.1982.1056454; YAMAGUCHI K, 1993, P 1993 IEEE INT S IN, P64, DOI 10.1109/ISIT.1993.748379; 1994, 1011STEMP3E ITU	13	1	1	IEICE-INST ELECTRONICS INFORMATION COMMUNICATIONS ENG	TOKYO	KIKAI-SHINKO-KAIKAN BLDG, 3-5-8, SHIBA-KOEN, MINATO-KU, TOKYO, 105-0011, JAPAN	0916-8508	1745-1337		IEICE T FUND ELECTR	IEICE Trans. Fundam. Electron. Commun. Comput. Sci.	SEP	1996	E79A	9					1355	1360				6	Computer Science, Hardware & Architecture; Computer Science, Information Systems; Engineering, Electrical & Electronic	Computer Science; Engineering	VJ881	WOS:A1996VJ88100008		
J	Deguchi, K; Sasano, T; Arai, H; Yoshikawa, H				Deguchi, K; Sasano, T; Arai, H; Yoshikawa, H			3-D shape reconstruction from endoscope image sequences by the factorization method	IEICE TRANSACTIONS ON INFORMATION AND SYSTEMS			English	Article						computer vision; shape from motion; factorization method; endoscope image		A new application of the factorization method is reported for 3-D shape reconstruction from endoscope image sequences. The feasibility of the method is verified with some theoretical considerations and results of extensive experiments. This method was developed by Tomasi and Kanade, and improved by Poelman and Kanade, with the aim of achieving accurate shape reconstruction by using a large number of points and images, and robustly applying well-understood matrix computations. However, the latter stage of the method, called normalization, is not as easily understandable as the use of singular value decomposition in the first stage. In fact, as shown in this report, many choices are possible for this normalization and a variety of results have been obtained depending on the choice. This method is easy to understand, easy to implement, and provides sufficient accuracy when the approximation used For the optical system is reasonable. However, the details of the theoretical basis require further study.		Deguchi, K (reprint author), UNIV TOKYO,FAC ENGN,7-3-1 HONGO,TOKYO 113,JAPAN.						CUI N, 1990, THIRD INTERNATIONAL CONFERENCE ON COMPUTER VISION, P222; DEGUCHI K, 1994, FEASIBILITY STUDY FA; KANADE T, 1993, IEICE T, P1497; POELMAN CJ, 1992, PARAPERSPECTIVE FACT; THOMAS JI, 1990, P IM UND, V6, P507; TOMASI C, 1992, P IM UND WORKSH SAN, P459; WENG JY, 1992, IEEE T ROBOTIC AUTOM, V8, P362, DOI 10.1109/70.143354	7	17	17	IEICE-INST ELECTRON INFO COMMUN ENG	TOKYO	KIKAI-SHINKO-KAIKAN BLDG MINATO-KU SHIBAKOEN 3 CHOME, TOKYO 105, JAPAN	0916-8532			IEICE T INF SYST	IEICE Trans. Inf. Syst.	SEP	1996	E79D	9					1329	1336				8	Computer Science, Information Systems; Computer Science, Software Engineering	Computer Science	VJ878	WOS:A1996VJ87800014		
J	Akutsu, T				Akutsu, T			Approximate string matching with variable length don't care characters	IEICE TRANSACTIONS ON INFORMATION AND SYSTEMS			English	Letter						pattern matching; approximate string matching; algorithms; DNA sequence analysis		This paper presents an O(mnlogn) time algorithm for an approximate string matching problem, in which a pattern string may contain variable length don't care characters. This problem is important for searching DNA sequences or amino acid sequences.		Akutsu, T (reprint author), UNIV TOKYO,INST MED SCI,CTR HUMAN GENOME,TOKYO 108,JAPAN.						AKUTSU T, 1995, AL95435 INF PROC SOC, P33; AKUTSU T, 1995, INFORM PROCESS LETT, V55, P235, DOI 10.1016/0020-0190(95)00111-O; LANDAU GM, 1989, J ALGORITHM, V10, P157, DOI 10.1016/0196-6774(89)90010-2; ZHANG KZ, 1994, J ALGORITHM, V16, P33, DOI 10.1006/jagm.1994.1003; Branden C., 1991, INTRO PROTEIN STRUCT; Fisher Michael J., 1974, SIAM AMS P, V7, P113; MANBER U, 1991, INFORM PROCESS LETT, V37, P133, DOI 10.1016/0020-0190(91)90032-D; MYERS EW, 1989, B MATH BIOL, V51, P5, DOI 10.1007/BF02458834	8	8	10	IEICE-INST ELECTRON INFO COMMUN ENG	TOKYO	KIKAI-SHINKO-KAIKAN BLDG MINATO-KU SHIBAKOEN 3 CHOME, TOKYO 105, JAPAN	0916-8532			IEICE T INF SYST	IEICE Trans. Inf. Syst.	SEP	1996	E79D	9					1353	1354				2	Computer Science, Information Systems; Computer Science, Software Engineering	Computer Science	VJ878	WOS:A1996VJ87800017		
J	Pecoraro, MR; Shimojima, M; Maeda, K; Inoshima, Y; Kawaguchi, Y; Kai, C; Mikami, T				Pecoraro, MR; Shimojima, M; Maeda, K; Inoshima, Y; Kawaguchi, Y; Kai, C; Mikami, T			Molecular cloning of the feline CD8 beta-chain	IMMUNOLOGY			English	Article							CD8 BETA-CHAIN; CELL-SURFACE EXPRESSION; LYMPHOCYTES-T; 2ND CHAIN; MHC CLASS; V-LIKE; SEQUENCE; GENES; LY-3; RECOGNITION	Human, mouse and rat CD8 have been described as being disulphide-linked heterodimers of alpha and beta chains. More recently the chicken alpha and beta chains were described. In the bovine and feline immune system only the alpha-chain was reported. In this study we have cloned and determined the nucleotide sequence of a cDNA encoding the beta-chain of the feline T-cell surface antigen CD8. Using a nested polymerase chain reaction (PCR) and two primer pairs designed from the human CD8 beta cDNA nucleotide sequencer we amplified a 430 base pair fragment from a feline thymus cDNA library which was used as a probe for screening the feline library at high stringency. After three rounds of screening, five clones were isolated. A clone, named FTb-6, containing a 3.8 kilobase pair insert was mapped, sequenced and compared with the published sequences of the genes encoding the human, mouse, rat and avian CD8 beta. We have determined the primary structure of the feline CD8 beta. The feline CD8 beta has an open reading frame, 630 nucleotides in length encoding a protein with 210 amino acid residues and its composition showed that the feline molecule is a member of the immunoglobulin gene super family.	UNIV TOKYO,FAC AGR,DEPT VET MICROBIOL,BUNKYO KU,TOKYO 113,JAPAN; UNIV CHICAGO,MARJORIE B KOVLER VIRAL ONCOL LABS,CHICAGO,IL 60637							NAKAYAMA KI, 1992, J IMMUNOL, V148, P1919; TREGASKES CA, 1995, J IMMUNOL, V154, P4485; SWAIN SL, 1983, IMMUNOL REV, V74, P129, DOI 10.1111/j.1600-065X.1983.tb01087.x; LITTMAN DR, 1987, ANNU REV IMMUNOL, V5, P561, DOI 10.1146/annurev.immunol.5.1.561; BLANC D, 1988, EUR J IMMUNOL, V18, P613, DOI 10.1002/eji.1830180419; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DISANTO JP, 1988, EMBO J, V7, P3465; GORMAN SD, 1988, J IMMUNOL, V140, P3646; JOHNSON P, 1986, NATURE, V323, P74, DOI 10.1038/323074a0; KARAKI S, 1992, J IMMUNOL, V149, P1613; KLOTZ FW, 1986, J IMMUNOL, V136, P2510; LITTMAN DR, 1985, CELL, V40, P237, DOI 10.1016/0092-8674(85)90138-2; LUSCHER B, 1985, J IMMUNOL, V135, P1937; NAKAUCHI H, 1987, P NATL ACAD SCI USA, V84, P4210, DOI 10.1073/pnas.84.12.4210; NAKAYAMA K, 1989, J IMMUNOL, V142, P2540; NAKAYAMA K, 1994, SCIENCE, V263, P1131, DOI 10.1126/science.8108731; NORIMINE J, 1992, IMMUNOLOGY, V75, P74; PECORARO MR, 1994, J VET MED SCI, V56, P1001; PECORARO MR, 1994, IMMUNOLOGY, V81, P127; SHIUE L, 1988, J EXP MED, V168, P1993, DOI 10.1084/jem.168.6.1993; WHEELER CJ, 1992, NATURE, V357, P247, DOI 10.1038/357247a0	21	4	5	BLACKWELL SCIENCE LTD	OXFORD	OSNEY MEAD, OXFORD, OXON, ENGLAND OX2 0EL	0019-2805			IMMUNOLOGY	Immunology	SEP	1996	89	1					84	88		10.1046/j.1365-2567.1996.d01-710.x		5	Immunology	Immunology	VF091	WOS:A1996VF09100013		
J	Pocard, M; Tsukui, H; Salmon, RJ; Dutrillaux, B; Poupon, MF				Pocard, M; Tsukui, H; Salmon, RJ; Dutrillaux, B; Poupon, MF			Efficiency of orthotopic xenograft models for human colon cancers	IN VIVO			English	Article						human colon cancer; experimental model; orthotopic xenograft	HUMAN COLORECTAL CARCINOMAS; NUDE-MICE; LIVER METASTASIS; ORGAN ENVIRONMENT; HUMAN-TUMORS; CELLS; GROWTH; TRANSPLANTATION; MODULATION; GLYCOPROTEIN	It is feasible to graft human colon cancer tissue into immuno-deficient nude mice, in older to maintain these tumors in vivo. Analysis of the properties tumors under such conditions might increase our knowledge of their biological characteristics. Xenografts are usually implanted into subcutaneous tissue, a site easily accessible for both graft procedure and observation of armor growth. However these subcutaneous tumors are usually non-invasive and fail to metastasize. To override these limitations we, as others, have tried to improve the tumor xenograft model by transplanting tumors into their original location, designated as the orthotopic site. Transplanted into the cecum of nude mice, human colon cancers were frequently locally invasive and developed liver metastases. These transplantations may be done by injection of colon cancer cell suspensions into the cecal wall. Alternatively orthotopic implantations of histologically intact tissue were performed and the thus-obtained tumors wet-e mole metastatic than tumors obtained after tumor cell injections. The chemosensibility of tumors xenografted into their orthotopic site was different from that of their subcutaneously implanted counterpart. This, added to the enhancement of invasive and metastatic properties, leads us to conclude that colon cancer xenografted into the caecum might be more representative of the clinical situation. We have reviewed the literature and report on the possibilities and limitations different models of colon cancer in vivo.	INST CURIE,UMR 147 CNRS,BIOL SECT,F-75005 PARIS,FRANCE; INST CURIE,UMR 147 CNRS,SURG SERV,F-75005 PARIS,FRANCE; UNIV TOKYO,DEPT SURG,TOKYO,JAPAN							FIDLER IJ, 1991, CANCER METAST REV, V10, P229, DOI 10.1007/BF00050794; MORIKAWA K, 1988, CANCER RES, V48, P6863; NAKAJIMA M, 1990, J NATL CANCER I, V82, P1890, DOI 10.1093/jnci/82.24.1890; FIDLER IJ, 1994, CANCER METAST REV, V13, P209, DOI 10.1007/BF00689637; GIAVAZZI R, 1986, CANCER RES, V46, P1928; SHIMOSATO Y, 1976, J NATL CANCER I, V56, P1251; KUBOTA T, 1994, J CELL BIOCHEM, V56, P4, DOI 10.1002/jcb.240560103; BRESALIER RS, 1987, INT J CANCER, V39, P625, DOI 10.1002/ijc.2910390514; WANG X, 1994, CANCER RES, V54, P4726; WILMANNS C, 1992, INT J CANCER, V52, P98, DOI 10.1002/ijc.2910520118; FOGH J, 1977, J NATL CANCER I, V59, P221; FU XY, 1991, P NATL ACAD SCI USA, V88, P9345, DOI 10.1073/pnas.88.20.9345; CAJOT JF, 1986, J NATL CANCER I, V77, P1099; CARREL S, 1976, CANCER RES, V36, P3978; FIDLER IJ, 1986, CANCER METAST REV, V5, P29, DOI 10.1007/BF00049529; FOGH J, 1980, J NATL CANCER I, V64, P745; FU XY, 1992, ANTICANCER RES, V12, P1395; GOLDROSEN MH, 1980, CANCER, V45, P1223, DOI 10.1002/1097-0142(19800315)45:5+<1223::AID-CNCR2820451330>3.0.CO;2-F; JESSUP JM, 1988, CANCER RES, V48, P1689; KONNO H, 1995, INT J CANCER, V61, P268, DOI 10.1002/ijc.2910610221; KUO TH, 1993, ANTICANCER RES, V13, P293; KURANAMI M, 1995, AM J SURG, V169, P57, DOI 10.1016/S0002-9610(99)80110-X; KYRIAZIS AA, 1980, CANCER RES, V40, P4509; LEFRANCOIS D, 1989, INT J CANCER, V44, P871, DOI 10.1002/ijc.2910440521; LIOTTA LA, 1981, CANCER RES, V41, P4629; MORIKAWA K, 1988, CANCER RES, V48, P1943; PRICE JE, 1994, J CELL BIOCHEM, V56, P16, DOI 10.1002/jcb.240560105; REEVES BR, 1978, BRIT J CANCER, V37, P612, DOI 10.1038/bjc.1978.91; SPREMULLI EN, 1983, CANCER RES, V43, P3828; TAN MH, 1977, J NATL CANCER I, V59, P1537; TOGO S, 1995, CANCER RES, V55, P681; TSUKUI H, 1994, B CANC, V81, P551; TSUKUI H, 1994, GASTRO CLIN BIOL, V18, P112; WANG WR, 1984, IMMUNE DEFICIENT ANI, P239; WILMANNS C, 1993, INT J ONCOL, V3, P413	35	29	29	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDNTIOU-KALAMOU RD KAPANDRITI, POB 22, ATHENS 19014, GREECE	0258-851X			IN VIVO	In Vivo	SEP-OCT	1996	10	5					463	469				7	Medicine, Research & Experimental	Research & Experimental Medicine	VM566	WOS:A1996VM56600001		
J	Nagasawa, H; Kataoka, T; Tojo, H				Nagasawa, H; Kataoka, T; Tojo, H			Changes of plasma levels of human growth hormone with age in relation to mammary tumour appearance in whey acidic protein/human growth hormone (mWAP/hGH) transgenic female and male mice	IN VIVO			English	Article						human growth hormone; age; mammary tumour; whey acidic protein; transgenic mice		Plasma levels of human growth hormone (hGH) were determined in female and male transgenic mice with human growth hormone fusion gene driven by the promoter of mouse whey acidic protein (mWAP/hGH) at 3, 6 and 9 months of age and at mammary tumour appearance In female transgenic mice developing mammary tumours, the plasma hGH level decreased markedly upon tumour appearance, which was associated with little change in body weight. In contrast, the hGH level changed little in transgenic male mice with tumors. In female and male transgenic mice without mammary tumours, the pattern of the change of hGH levels was variable; some showed high levels at all three time points (3, 6, and 9 months) and others had none ol high levels at one or two time points.	UNIV TOKYO,GRAD SCH AGR & LIFE SCI,INST ANIM RESOURCE SCI,DEPT APPL GENET,TOKYO 113,JAPAN	Nagasawa, H (reprint author), MEIJI UNIV,EXPT ANIM RES LAB,TAMA KU,KAWASAKI,KANAGAWA 21471,JAPAN.						DARNELL JH, 1990, MOL CELL BIOL, P955; NAGASAWA H, 1993, ZOOL SCI, V10, P963; NAGASAWA H, 1976, J NATL CANCER I, V57, P425; STAATS J, 1985, CANCER RES, V45, P945; Tojo Hideaki, 1993, Journal of Reproduction and Development, V39, P145	5	2	2	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDNTIOU-KALAMOU RD KAPANDRITI, POB 22, ATHENS 19014, GREECE	0258-851X			IN VIVO	In Vivo	SEP-OCT	1996	10	5					503	505				3	Medicine, Research & Experimental	Research & Experimental Medicine	VM566	WOS:A1996VM56600007		
J	Watanabe, T				Watanabe, T			Expanding spectrum of HTLV-1-related diseases: Implications in understanding the mechanisms of viral pathogenesis	INTERNAL MEDICINE			English	Editorial Material							T-CELL-LEUKEMIA; I-ASSOCIATED MYELOPATHY; VIRUS TYPE-1 UVEITIS; HTLV-I; INFECTION; LYMPHOCYTES; INDUCTION; SELECTIN			Watanabe, T (reprint author), UNIV TOKYO,INST MED SCI,DEPT PATHOL,4-6-1 SHIROKANEDAI,TOKYO,JAPAN.						TERADA K, 1994, LANCET, V344, P1116, DOI 10.1016/S0140-6736(94)90630-0; IWAKURA Y, 1991, SCIENCE, V253, P1026, DOI 10.1126/science.1887217; LAGRENADE L, 1990, LANCET, V336, P1345; DHAWAN S, 1993, VIROLOGY, V197, P778, DOI 10.1006/viro.1993.1656; ISHIKAWA T, 1993, BLOOD, V82, P1590; IWASAKI Y, 1992, AM J PATHOL, V140, P1003; EVANS BK, 1989, NEUROLOGY, V39, P1572; FUKUDOME K, 1992, INT J CANCER, V52, P418, DOI 10.1002/ijc.2910520316; MOCHIZUKI M, 1994, BRIT J OPHTHALMOL, V78, P149, DOI 10.1136/bjo.78.2.149; ONO A, 1995, BRIT J OPHTHALMOL, V79, P270, DOI 10.1136/bjo.79.3.270; OSAME M, 1992, GANN MONOGRAPH CANC, V39, P57; Osato M, 1996, INTERNAL MED, V35, P742, DOI 10.2169/internalmedicine.35.742; Satoh Y., 1995, Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, V10, P217; SUGIMOTO M, 1987, LANCET, V2, P1220; TAKATSUKI K, 1995, INTERNAL MED, V34, P947, DOI 10.2169/internalmedicine.34.947; Takatsuki K, 1992, GANN MONOGRAPH CANCE, V39, P1; TATEWAKI M, 1995, BLOOD, V86, P3109; WATANABE T, 1994, AIDS RES HUM RETROV, V10, P444; YAMAGUCHI K, 1994, BRIT J OPHTHALMOL, V78, P163, DOI 10.1136/bjo.78.3.163; YAMAGUCHI K, 1990, LANCET, V336, P1070, DOI 10.1016/0140-6736(90)92542-P; YOSHIDA M, 1989, ANN NEUROL, V26, P331, DOI 10.1002/ana.410260304	21	1	1	JAPAN SOC INTERNAL MEDICINE	TOKYO	34-3 3-CHOME HONGO BUNKYO-KU, TOKYO 113, JAPAN	0918-2918			INTERNAL MED	Intern. Med.	SEP	1996	35	9					677	678		10.2169/internalmedicine.35.677		2	Medicine, General & Internal	General & Internal Medicine	VQ268	WOS:A1996VQ26800002		
J	Kurabayashi, M; Yazaki, Y				Kurabayashi, M; Yazaki, Y			Molecular genetic approach to the pathophysiology of cardiovascular disease	INTERNATIONAL ANGIOLOGY			English	Article						cardiovascular diseases; molecular genetics	ANGIOTENSIN-CONVERTING-ENZYME; SUPRAVALVULAR AORTIC-STENOSIS; LEFT-VENTRICULAR HYPERTROPHY; SALT-SENSITIVE HYPERTENSION; MYOCARDIAL-INFARCTION; DELETION POLYMORPHISM; VASCULAR DEVELOPMENT; WILLIAMS-SYNDROME; BLOOD-PRESSURE; SMOOTH-MUSCLE	The delineation of the molecular mechanisms of cardiovascular disease is an important initial step in developing improved methods of screening and therapy. Recently, progress has been made in characterizing the molecular basis of several inherited cardiovascular diseases, particularly as to the diseases caused by defects in single gene. When the disease under study has a complex etiology with multiple genetic and environmental components, it becomes much more difficult to dissect out the genetic factors and to distinguish between causation and correlation. Gene targeting in mice provides a means to test the effect of a precise genetic change completely free from the effects of differences in any other genes. Models of several human genetic diseases have been produced by gene targeting and the resulting ''knockout'' mice have often confirmed that the disease is the consequence of the defect of a gene of interest. The review will focus on the how molecular genetic approach is useful: to understand the basic mechanism of complex genetic diseases, including essential hypertension, atherosclerosis, congenital heart disease. Particular emphasis will be given to the renin angiotensin system because a large body of evidence indicates its greater role in the pathogenesis of many complex cardiovascular diseases than has been recognized.		Kurabayashi, M (reprint author), UNIV TOKYO,FAC MED,DEPT INTERNAL MED 3,TOKYO 113,JAPAN.						NAKAI K, 1994, CIRCULATION, V90, P2199; JOHN SWM, 1995, SCIENCE, V267, P679, DOI 10.1126/science.7839143; MCBRIDE W, 1988, NEW ENGL J MED, V318, P1734, DOI 10.1056/NEJM198806303182606; KIM HS, 1995, P NATL ACAD SCI USA, V92, P2735, DOI 10.1073/pnas.92.7.2735; ITO M, 1995, P NATL ACAD SCI USA, V92, P3521, DOI 10.1073/pnas.92.8.3521; LINTS TJ, 1993, DEVELOPMENT, V119, P419; DIETZ HC, 1991, NATURE, V352, P337, DOI 10.1038/352337a0; EWART AK, 1993, P NATL ACAD SCI USA, V90, P3226, DOI 10.1073/pnas.90.8.3226; AIKAWA M, 1993, CIRC RES, V73, P1000; EWART AK, 1993, NAT GENET, V5, P11, DOI 10.1038/ng0993-11; KOMURO I, 1993, P NATL ACAD SCI USA, V90, P8145, DOI 10.1073/pnas.90.17.8145; KIRBY ML, 1995, CIRC RES, V77, P211; BRANNAN CI, 1994, GENE DEV, V8, P1019, DOI 10.1101/gad.8.9.1019; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543; FISHMAN MC, 1994, CIRC RES, V74, P757; HIGASHIYAMA S, 1991, SCIENCE, V251, P936, DOI 10.1126/science.1840698; LIFTON RP, 1995, P NATL ACAD SCI USA, V92, P8545, DOI 10.1073/pnas.92.19.8545; ARCECI RJ, 1993, MOL CELL BIOL, V13, P2235; SUCOV HM, 1994, GENE DEV, V8, P1007, DOI 10.1101/gad.8.9.1007; SHIMKETS RA, 1994, CELL, V79, P407, DOI 10.1016/0092-8674(94)90250-X; ISHIBASHI S, 1993, J CLIN INVEST, V92, P883, DOI 10.1172/JCI116663; JEUNEMAITRE X, 1992, NAT GENET, V1, P72, DOI 10.1038/ng0492-72; LIFTON RP, 1992, NATURE, V355, P262, DOI 10.1038/355262a0; RIGAT B, 1990, J CLIN INVEST, V86, P1343, DOI 10.1172/JCI114844; CURRAN ME, 1993, CELL, V73, P159, DOI 10.1016/0092-8674(93)90168-P; RAYNOLDS MV, 1993, LANCET, V342, P1073, DOI 10.1016/0140-6736(93)92061-W; CAMBIEN F, 1992, NATURE, V359, P641, DOI 10.1038/359641a0; KASTNER P, 1994, CELL, V78, P987, DOI 10.1016/0092-8674(94)90274-7; BAKER KM, 1990, AM J PHYSIOL, V259, pH324; CAULFIELD M, 1994, NEW ENGL J MED, V330, P1629, DOI 10.1056/NEJM199406093302301; CHIEN KR, 1993, SCIENCE, V260, P916, DOI 10.1126/science.8493528; CSERJESI T, 1993, MOL CELL BIOL, V11, P4854; DZAU VJ, 1993, CIRCULATION, V87, P705; EPSTEIN DJ, 1993, P NATL ACAD SCI USA, V90, P532, DOI 10.1073/pnas.90.2.532; GREPIN C, 1995, MOL CELL BIOL, V15, P4095; IWAI N, 1994, CIRCULATION, V90, P2622; JEUNEMAITRE X, 1992, CELL, V71, P169, DOI 10.1016/0092-8674(92)90275-H; KEATING MT, 1995, CIRCULATION, V92, P142; KURIHARA Y, 1995, J CLIN INVEST, V96, P293, DOI 10.1172/JCI118033; KUROO M, 1995, CIRC RES, V76, P148; KUROO M, 1991, J BIOL CHEM, V266, P3768; LUDWIG E, 1995, CIRCULATION, V91, P2120; LYONS I, 1995, GENE DEV, V9, P1654, DOI 10.1101/gad.9.13.1654; SMITHIES O, 1995, P NATL ACAD SCI USA, V92, P5266, DOI 10.1073/pnas.92.12.5266; MARIAN AJ, 1993, LANCET, V342, P1085, DOI 10.1016/0140-6736(93)92064-Z; OHNISHI M, 1993, NAT GENET, V5, P324; PFEFFER MA, 1988, NEW ENGL J MED, V319, P80, DOI 10.1056/NEJM198807143190204; PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001; PLUMB A, 1992, CELL, V71, P342; ROBBINS J, 1993, CIRC RES, V73, P3; ROSS R, 1986, NEW ENGL J MED, V314, P488, DOI 10.1056/NEJM198602203140806; ROSS R, 1991, TRENDS CARDIOVAS MED, V1, P277, DOI 10.1016/1050-1738(91)90043-E; SCHUNKERT H, 1994, NEW ENGL J MED, V330, P1634, DOI 10.1056/NEJM199406093302302; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0	54	0	0	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	0392-9590			INT ANGIOL	Int. Angiol.	SEP	1996	15	3					187	194				8	Peripheral Vascular Disease	Cardiovascular System & Cardiology	VV885	WOS:A1996VV88500001		
J	Komiyama, T; Shigematsu, H; Yasuhara, H; Hosoi, Y; Muto, T				Komiyama, T; Shigematsu, H; Yasuhara, H; Hosoi, Y; Muto, T			An objective evaluation of muscle oxygen content in claudicants receiving drug therapy	INTERNATIONAL ANGIOLOGY			English	Article						spectroscopy, near-infrared; arteriosclerosis obliterans; intermittent claudication; drug therapy PGI(2) analog (beraprost sodium)	PERIPHERAL VASCULAR-DISEASE; NEAR-INFRARED SPECTROSCOPY; MAGNETIC-RESONANCE SPECTROSCOPY; INTERMITTENT CLAUDICATION; NONINVASIVE MEASUREMENT; CEREBRAL OXYGENATION; EXERCISE; INFANTS; TISSUE; TIME	The effects of medical treatment with a prostaglandin I-2 analog (beraprost sodium) were evaluated in 19 of 120 cases studied with near-infrared spectroscopy (NIRS) from January 193 to September 1994. The relative changes in oxygenated (Oxy) and deoxygenated (Deo) hemoglobin (Hb) in the calf muscle were measured during a treadmill walking test and the subsequent recovery period. After medical treatment in these 19 cases, recovery time of OxyHb decreased in 10 cases, increased in 7 cases and remained unchanged in two cases. Pressure studies did not facilitate the assessment of changes in the severity of claudication. Our results demonstrate that NIPS can provide objective information regarding the effects of medical therapy in claudicants.		Komiyama, T (reprint author), UNIV TOKYO,DEPT SURG 1,BUNKYO KU,7-3-1 HONGO,TOKYO 113,JAPAN.						PORTER JM, 1982, SURGERY, V92, P966; WYATT JS, 1986, LANCET, V2, P1063; DELPY DT, 1988, PHYS MED BIOL, V33, P1433, DOI 10.1088/0031-9155/33/12/008; SEIYAMA A, 1988, J BIOCHEM-TOKYO, V103, P419; PATTERSON MS, 1989, APPL OPTICS, V28, P2331, DOI 10.1364/AO.28.002331; CHEATLE TR, 1991, BRIT J SURG, V78, P405, DOI 10.1002/bjs.1800780408; KELLER U, 1985, EUR J CLIN INVEST, V15, P382, DOI 10.1111/j.1365-2362.1985.tb00289.x; BRAZY JE, 1985, PEDIATRICS, V75, P217; MCCULLY KK, 1994, J GERONTOL, V49, pB128; HANDS LJ, 1986, CLIN SCI, V71, P283; JOBSIS FF, 1977, SCIENCE, V198, P1264, DOI 10.1126/science.929199; ZATINA MA, 1986, J VASC SURG, V3, P411; BERGLUND B, 1981, CLIN PHYSIOL, V1, P253, DOI 10.1111/j.1475-097X.1981.tb00893.x; COFFMAN JD, 1979, NEW ENGL J MED, V300, P713; Cui W., 1991, SPIE, V1431, P180, DOI 10.1117/12.44189; DEBLASI RA, 1994, J APPL PHYSIOL, V76, P1388; KOMIYAMA T, 1994, EUR J VASCULAR SURG, V8, P294, DOI 10.1016/S0950-821X(05)80144-6	17	7	7	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	0392-9590			INT ANGIOL	Int. Angiol.	SEP	1996	15	3					215	218				4	Peripheral Vascular Disease	Cardiovascular System & Cardiology	VV885	WOS:A1996VV88500005		
J	Sato, O; Miyata, T; Deguchi, JO; Sugawara, Y; Kimura, H; Tada, Y				Sato, O; Miyata, T; Deguchi, JO; Sugawara, Y; Kimura, H; Tada, Y			Completion arteriography in paramalleolar bypasses: Effect of configurational changes, with special reference to spasm, on long-term outcome	INTERNATIONAL ANGIOLOGY			English	Article						paramalleolar bypass; arterial spasm; arteriography	FREE TISSUE TRANSFER; LATERAL PLANTAR ARTERY; LOWER-EXTREMITY; LIMB SALVAGE; DISTAL REVASCULARIZATION; PEDAL BYPASS; FOOT; OPERATION; GRAFTS; ANKLE	Purpose. The purpose of this study was to ascertain the durability of paramalleolar bypasses and elucidate the effect of configurational changes, especially spasm, seen on the completion arteriography upon the outcome. Design. Retrospective study. Setting. University hospital experience. Patients and Methods. Nineteen paramalleolar bypass operations in sixteen patients performed between April 1988 and March 1995 were studied retrospectively. Reversed saphenous Vein grafts were used in all cases. One patient required an additional microvascular free nap transfer to cover a foot amputation stump. Seventeen completion arteriograms were obtained. Patients were followed for an average of 37 months. Results. One patient died in hospital, giving a hospital death rate of 5.9%. Two grafts failed immediately and could not be salvaged. Inadvertent perforation of one graft required partial replacement with a polytetrafluoroethylene graft; it eventually failed after 42 months. There were no other graft failures during follow-up. Nine completion arteriograms showed spastic change of the run-off artery, but this change had disappeared on repeat angiograms obtained before discharge. Conclusion. Spasm of run-off artery is a frequent finding in distal bypass surgery and adversely affects the immediate outcome. Heparinization during the first 24 hours after surgery may reduce the consequences of spasm, and long-term patency can be expected providing that the whole graft consists of autogenous vein.		Sato, O (reprint author), UNIV TOKYO,FAC MED,DEPT SURG 2,BUNKYO KU,7-3-1 HONGO,TOKYO 113,JAPAN.						ANDROS G, 1989, J VASC SURG, V10, P511; ANDROS G, 1988, J VASC SURG, V7, P785, DOI 10.1067/mva.1988.avs0070785; BRIGGS SE, 1985, J VASC SURG, V2, P806, DOI 10.1067/mva.1985.avs0020806; GLOVICZKI P, 1994, AM J SURG, V168, P76, DOI 10.1016/S0002-9610(94)80040-5; CRONENWETT JL, 1989, ARCH SURG-CHICAGO, V124, P609; ASCER E, 1988, J VASC SURG, V8, P434; BERNHARD VM, 1980, SURGERY, V87, P709; CIRESI KF, 1993, J VASC SURG, V18, P648; DAVIDSON JT, 1993, ANN SURG, V217, P699, DOI 10.1097/00000658-199306000-00012; FRIEDMAN SG, 1990, AM SURGEON, V56, P721; GLOVICZKI P, 1991, MAYO CLIN PROC, V66, P243; MARIN ML, 1993, AM J SURG, V166, P136, DOI 10.1016/S0002-9610(05)81044-X; MILLS JL, 1994, AM J SURG, V217, P646; QUINONESBALDRICH WJ, 1993, AM J SURG, V166, P117, DOI 10.1016/S0002-9610(05)81041-4; RUTHERFORD RB, 1986, J VASC SURG, V4, P80; SAMSON RH, 1982, ARCH SURG-CHICAGO, V117, P973; Sasajima T, 1994, Ann Vasc Surg, V8, P248, DOI 10.1007/BF02018172; SHINDO S, 1992, J CARDIOVASC SURG, V33, P609; VEITH FJ, 1985, J VASC SURG, V2, P552; VEITH FJ, 1981, SURGERY, V90, P980; VLASTOU C, 1994, INT ANGIOL, V13, P124; WOELFLE KD, 1993, EUR J VASCULAR SURG, V7, P409, DOI 10.1016/S0950-821X(05)80258-0	22	2	2	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	0392-9590			INT ANGIOL	Int. Angiol.	SEP	1996	15	3					219	224				6	Peripheral Vascular Disease	Cardiovascular System & Cardiology	VV885	WOS:A1996VV88500006		
J	Seko, Y; Azuma, M; Yagita, H; Okumura, K; Yazaki, Y				Seko, Y; Azuma, M; Yagita, H; Okumura, K; Yazaki, Y			Perforin-positive leukemic cell infiltration in the aortic tissue of a patient with T-cell prolymphocytic leukemia	INTERNATIONAL ANGIOLOGY			English	Article						leukemia; perforin; human leukocyte antigen; intercellular adhesion molecule-1; autoimmune mechanism	KILLER-CELLS; EXPRESSION; LYMPHOCYTES; PROTEIN; INVIVO	Here we report a rare case of T-cell prolymphocytic leukemia in which leukemic killer cells, expressing a cytolytic factor perforin, infiltrated the aorta as well as the heart and may have directly injured aortic vascular cells which strongly expressed human leukocyte antigens (HLAs) and intercellular adhesion molecule-1 (ICAM-1) as well as costimulatory molecules B7 and B70, which are ligands for CD28 expressed on T-cells. In spite of chemotherapy against leukemic cells, this autoimmune process finally caused fatal multi-organ failure.		Seko, Y (reprint author), UNIV TOKYO,FAC MED,DEPT INTERNAL MED 3,BUNKYO KU,7-3-1 HONGO,TOKYO 113,JAPAN.						MATUTES E, 1991, BLOOD, V78, P3269; KAWASAKI A, 1992, EUR J IMMUNOL, V22, P1215, DOI 10.1002/eji.1830220516; AZUMA M, 1993, NATURE, V366, P76, DOI 10.1038/366076a0; KAWASAKI A, 1990, INT IMMUNOL, V2, P677, DOI 10.1093/intimm/2.7.677; SEKO Y, 1991, CIRCULATION, V84, P788; SEKO Y, 1994, J CLIN INVEST, V93, P750, DOI 10.1172/JCI117029; YOUNG JDE, 1989, PHYSIOL REV, V69, P250; YOUNG LHY, 1989, J IMMUNOL, V143, P3994	8	2	2	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	0392-9590			INT ANGIOL	Int. Angiol.	SEP	1996	15	3					245	248				4	Peripheral Vascular Disease	Cardiovascular System & Cardiology	VV885	WOS:A1996VV88500011		
J	Yasuhara, H; Shigematsu, H; Muto, T				Yasuhara, H; Shigematsu, H; Muto, T			A study of the advantages of elastic stockings for leg lymphedema	INTERNATIONAL ANGIOLOGY			English	Article						lymphedema; elastic stockings; long-term results	ANASTOMOSIS; COMPRESSION; LYMPHOEDEMA	To assess the efficacy of compression therapy alone, we report herein the long-term results of leg lymphedema using elastic stockings. Between January 1965 and March 1993, 41 primary lymphedema and 74 secondary lymphedema of the Lower extremities have been treated at our hospital. Ten patients had recurrence of cancer, and 5 patients had surgical therapy. The remaining 100 patients were analyzed for the clinical results following treatment with elastic stockings, During the follow-up period of 5 +/- 0.2 years, 3 of 39 limbs (8% or 30 patients) with primary lymphedema wearing elastic stockings experienced enlargement of limb circumference and 36 Limbs (92% or 27 patients) showed decrease or no change. Without elastic stockings, 1 out of 13 limbs (8% or 8 patients) with primary lymphedema showed worsening of their symptoms, In contrast, only 1 of 61 limbs (1.7%) in 46 patients with secondary lymphedema who wore elastic stockings showed deterioration of their symptoms. Although elastic stockings did not influence the incidence of the lymphangitis, their effect in maintaining Limb circumference was apparent in all the patients with inflammation caused by secondary lymphedema. Among 20 patients with secondary lymphedema who had recurrent lymphangitis, only 1 out of 19 Limbs (5%) in 16 patients experienced deterioration of the symptom with the use of elastic stockings while 1 out of 4 limbs (25%) in 4 patients showed improvement or no change without elastic stockings. Our data demonstrate that compression stockings are associated with long-term maintenance of reduced limb circumference, especially in secondary lymphedema regardless of the association with recurrent lymphangitis.		Yasuhara, H (reprint author), UNIV TOKYO,FAC MED,DEPT SURG 1,TOKYO 113,JAPAN.						Homans J, 1936, NEW ENGL J MED, V215, P1099, DOI 10.1056/NEJM193612102152401; PAPPAS CJ, 1992, J VASC SURG, V16, P555; THOMPSON N, 1970, PLAST RECONSTR SURG, V45, P541, DOI 10.1097/00006534-197006000-00003; GLOVICZKI P, 1986, J VASC SURG, V4, P148; OBRIEN BM, 1990, PLAST RECONSTR SURG, V85, P562, DOI 10.1097/00006534-199004000-00011; KINMONTH JB, 1978, BRIT J SURG, V65, P829, DOI 10.1002/bjs.1800651202; PUCKETT CL, 1980, PLAST RECONSTR SURG, V66, P116, DOI 10.1097/00006534-198007000-00022; BAUMEISTER RG, 1990, PLAST RECONSTR SURG, V85, P64, DOI 10.1097/00006534-199001000-00012; Baumeister R G, 1981, World J Surg, V5, P401; BROWSE NL, 1986, J VASC SURG, V3, P181; CASLEYSMITH JR, 1978, BRIT J EXP PATHOL, V59, P116; CASLEYSMITH JR, 1985, LYMPHOLOGY, V18, P175; CASLEYSMITH JR, 1993, NEW ENGL J MED, V329, P1158, DOI 10.1056/NEJM199310143291604; Charles RH, 1912, SYSTEM TREATMENT, V3; CLODIUS L, 1983, LYMPHANGIOLOGY, P683; DEGNI M, 1978, J CARDIOVASC SURG, V19, P577; DELLON AL, 1977, PLAST RECONSTR SURG, V60, P589, DOI 10.1097/00006534-197710000-00015; FOLDI E, 1989, ANN PLAS SURG, V22, P505; FOLDI M, 1991, LYMPH STASIS, P469; GLOVICZKI P, 1988, J VASC SURG, V7, P647; KINMONTH JB, 1975, LYMPHOLOGY, V8, P56; KRYLOV V, 1982, ANN CHIR GYNAECOL FE, V71, P77; MILLER TA, 1975, PLAST RECONSTR SURG, V56, P633, DOI 10.1097/00006534-197512000-00004; NIELUBOW.J, 1968, BRIT J SURG, V55, P440, DOI 10.1002/bjs.1800550609; O'Brien B M, 1979, World J Surg, V3, P3; OLSZEWSKI WL, 1991, LYMPH STASIS, P525; RICHMAND DM, 1985, ARCH SURG-CHICAGO, V120, P1116; THOMPSON N, 1980, CHIR PLAST, V5, P147; YAMADA Y, 1969, Nagoya Journal of Medical Science, V32, P1	29	13	13	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	0392-9590			INT ANGIOL	Int. Angiol.	SEP	1996	15	3					272	277				6	Peripheral Vascular Disease	Cardiovascular System & Cardiology	VV885	WOS:A1996VV88500018		
J	Suzuki, M; Hirai, K; Kitani, S; Takaishi, T; Kihara, H; Kasahara, T; Ito, K; Morita, Y				Suzuki, M; Hirai, K; Kitani, S; Takaishi, T; Kihara, H; Kasahara, T; Ito, K; Morita, Y			Pharmacologic study of basophil histamine release induced by monocyte chemotactic protein-1 with kinase inhibitors	INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY			English	Article						basophils; chemokine; histamine-releasing factor; monocyte chemotactic protein-1; monocyte chemotactic activating factor; myosin light chain kinase; phosphatidylinositol 3 kinase; protein kinase C; tyrosine kinase; wortmannin	MYOSIN LIGHT CHAIN; HUMAN MONONUCLEAR-CELLS; ACTIVATING FACTOR; MAST-CELLS; CHEMOATTRACTANT PROTEIN-1; RBL-2H3 CELLS; ACTIVITY HRA; POTENT; WORTMANNIN; IGE	Monocyte chemotactic protein-1 (MCP-l)/monocyte chemotactic activating factor has a potent histamine-releasing activity for basophils and is a major component of IgE-independent histamine-releasing factors (HRF). In this study, we examined the effect of a panel of kinase inhibitors on MCP-l-induced histamine release from human basophils to characterize the signaling pathway used by this chemokine. Genistein (3 mu g/ml), an inhibitor of tyrosine kinase, inhibited MCP-l-induced histamine release by 44%. Wortmannin is a specific inhibitor of phosphatidylinositol 3 kinase (PI-3 kinase). It blocked MCP-l-induced histamine release with an IC50 of 3.3 x 10(-8) M indicating a role of PI-3 kinase in this reaction. KT5926, an inhibitor of myosin light chain kinase, also inhibited histamine release in response to MCP-1 with an IC50 of 10(-6) M, Staurosporine, a potent inhibitor of protein kinase C, although being not specific, augmented MCP-1-induced histamine release by 31.9% at 10(-6) M. These results indicate the possible involvement of a series of kinases, including PI-3 kinase, in the signal transduction pathway used by MCP-1.	UNIV TOKYO,FAC MED,DEPT INTERNAL MED & PHYS THERAPY,BUNKYO KU,TOKYO 113,JAPAN; KANTOU CENT HOSP,DEPT RESP MED,TOKYO,JAPAN; KYORITSU COLL PHARMACEUT SCI,DEPT BIOCHEM,TOKYO,JAPAN			Kitani, Seiichi/O-1848-2014				ALAM R, 1985, ANN ALLERGY, V55, P825; ALAM R, 1990, AM REV RESPIR DIS, V141, P666; ALAM R, 1987, J ALLERGY CLIN IMMUN, V79, P103, DOI 10.1016/S0091-6749(87)80023-4; ALAM R, 1992, J CLIN INVEST, V89, P723, DOI 10.1172/JCI115648; AKIYAMA T, 1987, J BIOL CHEM, V262, P5592; BISCHOFF SC, 1992, J EXP MED, V175, P1271, DOI 10.1084/jem.175.5.1271; SAMPSON HA, 1989, NEW ENGL J MED, V321, P228, DOI 10.1056/NEJM198907273210405; MATSUSHIMA K, 1989, J EXP MED, V169, P1485, DOI 10.1084/jem.169.4.1485; KUNA P, 1993, J IMMUNOL, V150, P1932; TURNER L, 1995, J IMMUNOL, V155, P2437; TAMAOKI T, 1986, BIOCHEM BIOPH RES CO, V135, P397, DOI 10.1016/0006-291X(86)90008-2; KUNA P, 1992, J IMMUNOL, V149, P636; YANO H, 1993, J BIOL CHEM, V268, P25846; MACDONALD SM, 1995, SCIENCE, V269, P688, DOI 10.1126/science.7542803; SOZZANI S, 1991, J IMMUNOL, V147, P2215; ALAM R, 1992, J EXP MED, V176, P781, DOI 10.1084/jem.176.3.781; VILLIGER PM, 1992, J IMMUNOL, V149, P722; SOZZANI S, 1993, J IMMUNOL, V150, P1544; ANTONIADES HN, 1992, P NATL ACAD SCI USA, V89, P5371, DOI 10.1073/pnas.89.12.5371; BISCHOFF SC, 1993, EUR J IMMUNOL, V23, P761, DOI 10.1002/eji.1830230329; BRUNET C, 1992, J ALLERGY CLIN IMMUN, V89, P87, DOI 10.1016/S0091-6749(05)80044-2; GELAS P, 1992, BIOCHEM J, V287, P67; HERD ZL, 1994, AM J RESP CRIT CARE, V150, P988; KAPLAN AP, 1994, ALLERGY, V49, P495, DOI 10.1111/j.1398-9995.1994.tb01119.x; KAPLAN AP, 1985, J IMMUNOL, V135, P2027; KITANI S, 1992, BIOCHEM BIOPH RES CO, V183, P48, DOI 10.1016/0006-291X(92)91607-R; KUNA P, 1989, J ALLERGY CLIN IMMUN, V83, P816, DOI 10.1016/0091-6749(89)90020-1; KUNA P, 1992, J EXP MED, V175, P489, DOI 10.1084/jem.175.2.489; NAKANISHI S, 1990, MOL PHARMACOL, V37, P482; NAKANISHI S, 1992, J BIOL CHEM, V267, P2157; NAKANO Y, 1994, INFECT IMMUN, V62, P377; ORCHARD MA, 1986, J IMMUNOL, V136, P2240; SCHULMAN ES, 1985, AM REV RESPIR DIS, V131, P230; SCHULMAN ES, 1988, J IMMUNOL, V140, P2369; SIM TC, 1992, J ALLERGY CLIN IMMUN, V89, P1157, DOI 10.1016/0091-6749(92)90300-Q; SIRAGANI.RP, 1974, ANAL BIOCHEM, V57, P383, DOI 10.1016/0003-2697(74)90093-1; TESHIMA R, 1989, MOL IMMUNOL, V26, P641; THELEN M, 1994, P NATL ACAD SCI USA, V91, P4960, DOI 10.1073/pnas.91.11.4960; THUESON DO, 1979, J IMMUNOL, V123, P626; THUESON DO, 1979, J IMMUNOL, V123, P633; WARNER JA, 1986, J IMMUNOL, V136, P2583; WHITE MV, 1987, J IMMUNOL, V139, P1624; YAMADA K, 1992, J IMMUNOL, V149, P1031; YATOMI Y, 1992, BIOCHEM J, V285, P745	44	11	11	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1018-2438			INT ARCH ALLERGY IMM	Int. Arch. Allergy Immunol.	SEP	1996	111	1					18	22				5	Allergy; Immunology	Allergy; Immunology	VD197	WOS:A1996VD19700004		
J	Miyaguchi, S; Oda, M; Mori, M; Imaeda, H; Tsuzuki, Y; Saito, H; Kamegaya, K; Ishii, H				Miyaguchi, S; Oda, M; Mori, M; Imaeda, H; Tsuzuki, Y; Saito, H; Kamegaya, K; Ishii, H			Immunohistochemical characterization of hepatic eosinophil cationic protein in primary biliary cirrhosis	INTERNATIONAL HEPATOLOGY COMMUNICATIONS			English	Article						primary biliary cirrhosis (PBC); EG2; eosinophil	TRANSENDOTHELIAL MIGRATION; LYMPHOCYTES; CYTOKINES	We have previously reported that serum eosinophil cationic protein (ECP) levels are increased in primary biliary cirrhosis (PBC). However, little is known about the role of eosinophils in the pathogenesis of this disease. In this study, liver biopsy specimens obtained from 27 PBC patients (stage I: 11 cases; stage II: 9 cases; stage III: 5 cases; stage IV: 2 cases) were stained with a monoclonal antibody (EG2) produced against ECP in an attempt to elucidate whether EG2-positive eosinophils are involved in the destruction of bile duct in PBC. Needle liver biopsy specimens obtained from 24 patients with chronic hepatitis C (CHC) were used as controls. In PBC, more than 10 EG2-positive cells were noted per portal tract in 6 cases, less than 10 EG2-positive cells in 10 cases and none in 11 cases. In CHC, more than 10 EG2-positive cells were detected per portal tract in only one case, less than 10 EG2-positive cells in 3 cases and none in 20 cases. According to the semi-morphometric statistical analysis, the hepatic infiltration rate of EG2-positive activated eosinophils into the portal tract was significantly higher in PBC than in CHC. Based on the stages of PBC, the infiltration rate of EG2-positive cells was significantly higher in stages I and II than in stages III and IV. A significant correlation was found between EG2-positive cell infiltration and small round cell infiltration. These findings suggest that EG2-positive, activated eosinophils may be involved in the early stages of PBC when the inflammatory changes are localized in the portal tract, It is tentatively speculated that activated eosinophils may play a role possible as effector cells in the immunopathogenesis of PBC.	KEIO UNIV,DEPT INTERNAL MED,TOKYO,JAPAN; UNIV TOKYO,DEPT PATHOL,TOKYO,JAPAN	Miyaguchi, S (reprint author), TOKYO METROPOLITAN OTSUKA HOSP,DEPT INTERNAL MED,TOSHIMA KU,2-8-1 MINAMI OTSUKA,TOKYO,JAPAN.						EBISAWA M, 1992, J IMMUNOL, V149, P4021; RUBIN E, 1965, AM J PATHOL, V46, P387; Butchers P R, 1990, Agents Actions Suppl, V31, P103; EBISAWA M, 1994, J IMMUNOL, V152, P4590; FOSTER PF, 1991, HEPATOLOGY, V13, P1117, DOI 10.1016/0270-9139(91)92482-N; FREW AJ, 1988, J IMMUNOL, V141, P4158; GLEICH GJ, 1973, J EXP MED, V137, P1459, DOI 10.1084/jem.137.6.1459; LAGENTE V, 1995, AM J RESP CRIT CARE, V151, P1720; MIYAGUCHI S, 1994, INT HEPATOL COMMUN, V2, P285, DOI 10.1016/0928-4346(94)90064-7; ROSENBERG HF, 1994, J LEUKOCYTE BIOL, V56, P502; SASAKI H, 1985, GASTROENTEROL JPN, V20, P477; SCHEUER PJ, 1967, P ROY SOC MED, V60, P1257; SHERLOCK S, 1981, DISEASES LIVER BILIA; SILBERSTEIN DS, 1989, HEMATOL ONCOL CLIN N, V3, P511; TAI PC, 1984, NATURE, V309, P182, DOI 10.1038/309182a0; TERASAKI S, 1993, HEPATOLOGY, V17, P206, DOI 10.1016/0270-9139(93)90078-2; TOMIOKA K, 1993, J IMMUNOL, V151, P4989; WEISNER RH, 1987, AM J MED, V83, P378; WIESNER RH, 1985, GASTROENTEROLOGY, V88, P108; YAMADA G, 1986, HEPATOLOGY, V6, P385, DOI 10.1002/hep.1840060309	20	6	6	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	0928-4346			INT HEPATOL COMMUN	Int. Hepatol. Commun.	SEP	1996	5	4-5					207	214		10.1016/0928-4346(96)00298-8		8	Gastroenterology & Hepatology	Gastroenterology & Hepatology	VK784	WOS:A1996VK78400001		
J	Toru, H; Ra, C; Nonoyama, S; Suzuki, K; Yata, J; Nakahata, T				Toru, H; Ra, C; Nonoyama, S; Suzuki, K; Yata, J; Nakahata, T			Induction of the high-affinity IgE receptor (Fc epsilon RI) on human mast cells by IL-4	INTERNATIONAL IMMUNOLOGY			English	Article						beta-hexosaminidase; IL-6; histamine; stem cell factor	IMMUNOGLOBULIN-E; TRANSFECTED CELLS; SOLUBLE FORM; NASAL-MUCOSA; B-CELLS; EXPRESSION; INTERLEUKIN-4; ANTIGEN; CHAIN; BINDING	The high-affinity IgE receptor (Fc epsilon RI) is necessary for the induction of IgE-mediated allergic reactions, Cross-linking of Fc epsilon RI expressed on mast cells causes the release of various inflammatory mediators, which trigger allergic reactions, Recently, mast cells lacking Fc epsilon RI have been observed in vivo and in vitro, suggesting the presence of regulational mechanisms in the induction of Fc epsilon RI, In this report, we demonstrate that IL-4 up-regulates Fc epsilon RI in cultured human mast cells, which are grown from cord blood mononuclear cells in the presence of stem cell factor and IL-6, and usually lack Fc epsilon RI expression, At the protein level, the induction of Fc epsilon RI was observed by flow cytometric analysis and the induced Fc epsilon RI expression was stable for at least 23 days in the presence of IL-4, Consistently, Northern blot analysis demonstrated the increase of alpha chain mRNA of Fc epsilon RI and revealed that the up-regulation of Fc epsilon RI occurred at the transcriptional level, Fc epsilon RI induced by IL-4 was functional and caused histamine and beta-hexosaminidase release from mast cells upon cross-linking, Taken together, these results indicate a new role of IL-4 in allergic reactions, besides the stimulation of IgE production.	JUNTENDO UNIV,SCH MED,DEPT IMMUNOL,TOKYO 113,JAPAN; UNIV TOKYO,INST MED SCI,DEPT CLIN ONCOL,TOKYO 108,JAPAN	Toru, H (reprint author), TOKYO MED & DENT UNIV,SCH MED,DEPT PEDIAT,BUNKYO KU,YUSHIMA 1-5-45,TOKYO 113,JAPAN.						RA C, 1989, J BIOL CHEM, V264, P15323; PARRONCHI P, 1991, P NATL ACAD SCI USA, V88, P4538, DOI 10.1073/pnas.88.10.4538; BRADDING P, 1993, J IMMUNOL, V151, P3853; NILSSON G, 1994, BLOOD, V84, P1519; DOMBROWICZ D, 1993, CELL, V75, P969, DOI 10.1016/0092-8674(93)90540-7; BLANK U, 1989, NATURE, V337, P187, DOI 10.1038/337187a0; BLANK U, 1991, J BIOL CHEM, V266, P2639; LOUAHED J, 1995, J IMMUNOL, V154, P5061; HAKIMI J, 1990, J BIOL CHEM, V265, P22079; BENTLEY AM, 1992, J ALLERGY CLIN IMMUN, V89, P877, DOI 10.1016/0091-6749(92)90444-7; BRADDING P, 1992, J EXP MED, V176, P1381, DOI 10.1084/jem.176.5.1381; KINZER CA, 1995, J EXP MED, V182, P575, DOI 10.1084/jem.182.2.575; NAKAHATA T, 1995, BIOLOGICAL AND MOLECULAR ASPECTS OF MAST CELL AND BASOPHIL DIFFERENTIATION AND FUNCTION, P13; NILSSON G, 1993, IMMUNOLOGY, V79, P325; ORTEGA E, 1991, INT IMMUNOL, V3, P333, DOI 10.1093/intimm/3.4.333; OSTERHOFF B, 1994, J INVEST DERMATOL, V102, P315, DOI 10.1111/1523-1747.ep12371789; RA C, 1993, INT IMMUNOL, V5, P47, DOI 10.1093/intimm/5.1.47; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; SHAPIRA SK, 1992, J EXP MED, V175, P289, DOI 10.1084/jem.175.1.289; Terada N, 1995, J ALLERGY CLIN IMMUN, V96, P1161, DOI 10.1016/S0091-6749(95)70201-6; YAGI S, 1994, EUR J BIOCHEM, V220, P593, DOI 10.1111/j.1432-1033.1994.tb18660.x; YANAGIHARA Y, 1994, J CLIN INVEST, V94, P2162, DOI 10.1172/JCI117574	22	140	144	OXFORD UNIV PRESS UNITED KINGDOM	OXFORD	WALTON ST JOURNALS DEPT, OXFORD, ENGLAND OX2 6DP	0953-8178			INT IMMUNOL	Int. Immunol.	SEP	1996	8	9					1367	1373				7	Immunology	Immunology	VJ306	WOS:A1996VJ30600005		
J	Shikazono, N; Kasagi, N				Shikazono, N; Kasagi, N			Second-moment closure for turbulent scalar transport at various Prandtl numbers	INTERNATIONAL JOURNAL OF HEAT AND MASS TRANSFER			English	Article							PASSIVE SCALAR; SCHMIDT NUMBERS; FLOW; PREDICTION; EQUATIONS; FIELD	A new second-moment closure model for turbulent scalar transport is proposed on the basis of the correlation coefficients between the flow variables and their derivatives that appear in the scalar-pressure gradient and dissipation terms of a turbulent scalar flux. Since these correlation coefficients should respond sensitively to a change in any of the time scales characteristic of turbulent transport, the model is given as a function of their ratios, which can be written in terms of turbulent Reynolds number, (Re-t = k(2)/nu epsilon),Prandtl number (Pr = nu/alpha) and time scale ratio (R = (k(theta)/epsilon(theta))/(k/epsilon)). The conventional modeling methodology, i.e. the high Reynolds number hypothesis is abandoned,although the proposed model asymptotes to the well-established model expression in high Reynolds/Peclet number flows. As a result, the scalar fluxes are predicted very well in the homogeneous as well as wall-shear flows over a wide Prandtl number range. Copyright (C) 1996 Elsevier Science Ltd	UNIV TOKYO,DEPT ENGN MECH,BUNKYO KU,TOKYO 113,JAPAN							JISCHA M, 1979, INT J HEAT MASS TRAN, V22, P1547, DOI 10.1016/0017-9310(79)90134-0; KASAGI N, 1992, J HEAT TRANS-T ASME, V114, P598, DOI 10.1115/1.2911323; MYONG HK, 1989, JSME INT J II-FLUID, V32, P613; TAVOULARIS S, 1981, J FLUID MECH, V104, P311, DOI 10.1017/S0022112081002930; SIRIVAT A, 1983, J FLUID MECH, V128, P323, DOI 10.1017/S0022112083000506; REYNOLDS AJ, 1975, INT J HEAT MASS TRAN, V18, P1055, DOI 10.1016/0017-9310(75)90223-9; [Anonymous], 1978, ADV APPL MECH, DOI DOI 10.1016/S0065-2156(08)70266-7; SPEZIALE CG, 1991, J FLUID MECH, V227, P245, DOI 10.1017/S0022112091000101; CRAFT TJ, 1991, TFD913 MECH ENG DEP; IIDA O, 1993, T JSME, V59, P3359; IIDA O, 1992, COMMUNICATION; JONES WP, 1988, PHYS FLUIDS, V31, P3589, DOI 10.1063/1.866876; Kasagi N., 1993, TURBULENT SHEAR FLOW, V8, P97; KASAGI N, 1989, T ASME, V111, P385; KAWAMURA H, 1992, P 29 NAT HEAT TRANSF, P380; KIM J, 1987, P 6 S TURB SHEAR FLO, P5; KOLOVANDIN BA, 1991, ADV HEAT TRANSFER, V21, P185, DOI 10.1016/S0065-2717(08)70336-8; LAI YG, 1990, INT J HEAT MASS TRAN, V33, P1429, DOI 10.1016/0017-9310(90)90040-2; Launder B, 1984, TURBULENCE MODELS TH, V2; LIEN FS, 1993, P 9 S TURB SHEAR FLO, V2, P13; MAEKAWA H, 1977, T JPN SOC MECH ENG, V43, P2250; MATSUMOTO A, 1991, P 5 S COMP FLUID DYN, P351; MURAKAMI S, 1993, P 9 S TURB SHEAR FLO, V2, P13; NAGANO Y, 1988, ASME, V110, P583; POPE SB, 1983, PHYS FLUIDS, V26, P404, DOI 10.1063/1.864151; ROBERS MM, 1986, TF25 STANF U DEP MEC; ROGERS MM, 1991, PHYS FLUIDS A-FLUID, V3, P144, DOI 10.1063/1.857873; Shih T.-H., 1992, STUDIES TURBULENCE, P91; SHIH TH, 1990, AIAA J, V28, P610, DOI 10.2514/3.10436; Shih T-H, 1985, FDA853 CORN U SIBL S; SHIKAZONO N, 1993, P 9 S TURB SHEAR FLO, V2, P18; SLEICHER CA, 1975, INT J HEAT MASS TRAN, V18, P677, DOI 10.1016/0017-9310(75)90279-3; Speziale C.G., 1989, THEOR COMP FLUID DYN, V1, P3; SUZUKI K, 1982, LETT HEAT MASS TRANS, V9, P245, DOI 10.1016/0094-4548(82)90033-9; Tennekes H., 1972, 1 COURSE TURBULENCE	35	15	15	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB	0017-9310			INT J HEAT MASS TRAN	Int. J. Heat Mass Transf.	SEP	1996	39	14					2977	2987		10.1016/0017-9310(95)00339-8		11	Thermodynamics; Engineering, Mechanical; Mechanics	Thermodynamics; Engineering; Mechanics	UT279	WOS:A1996UT27900013		
J	Niinaka, Y; Oida, SI; Ishisaki, A; Takeda, K; Iimura, T; Maruoka, Y; Momose, F; Negishi, A; Ichijo, H; Amagasa, T; Sasaki, S; Watanabe, H; Raz, A				Niinaka, Y; Oida, SI; Ishisaki, A; Takeda, K; Iimura, T; Maruoka, Y; Momose, F; Negishi, A; Ichijo, H; Amagasa, T; Sasaki, S; Watanabe, H; Raz, A			Autocrine motility factor and its receptor expressions in human oral squamous cell carcinoma (SCC) cells	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						squamous cell carcinoma; motility	STIMULATING FACTOR; GROWTH-FACTOR; PURIFICATION; PROTEIN; CANCER; FIBROSARCOMA; FIBROBLASTS; MIGRATION; CLONING	Autocrine motility factor (AMF) a tumor-secreted 55 kDa cytokine induces tumor cell motility by a signal transduction pathway mediated by interaction with its receptor (AMFR) a cell surface glycoprotein of 78 kDa (gp78). Here, AMF secreted by the metastatic LMF4 human oral squamous-cell carcinoma (SCC) cells, induced dose- and time-dependent morphological changes and chemotaxis of the producing cells. Expression of AMFR mRNA was associated with the metastatic ability of SCC cell variants. The data presented show for the first time that SCC cells produce AMF and express AMFR and the expression is related to their invasiveness and metastatic potentials.	KARMANOS CANC INST,TUMOR PROGRESS & METASTASIS PROGRAM,DETROIT,MI 48201; WAYNE STATE UNIV,DEPT RADIAT ONCOL,DETROIT,MI 48201; WAYNE STATE UNIV,DEPT PATHOL,DETROIT,MI 48201; UNIV TOKYO,FAC DENT,DEPT BIOCHEM,BUNKYO KU,TOKYO 113,JAPAN; UNIV TOKYO,FAC DENT,DEPT ORAL & MAXILLOFACIAL SURG,BUNKYO KU,TOKYO 113,JAPAN; TORIDE KYODO GEN HOSP,DEPT ORAL SURG,TORIDE,IBARAKI 302,JAPAN; GUNMA UNIV,SCH MED,DEPT ORTHOPAED SURG,MAEBASHI,GUMMA 371,JAPAN							LIOTTA LA, 1983, LAB INVEST, V49, P636; SILLETTI S, 1993, BIOCHEM BIOPH RES CO, V194, P446, DOI 10.1006/bbrc.1993.1840; SILLETTI S, 1991, CANCER RES, V51, P3507; WATANABE H, 1991, J BIOL CHEM, V266, P13442; SILLETTI S, 1994, CANCER RES, V54, P5752; MURATA J, 1994, J BIOL CHEM, V269, P30479; GUIRGUIS R, 1987, NATURE, V329, P261, DOI 10.1038/329261a0; EVANS CP, 1991, INT J CANCER, V49, P109, DOI 10.1002/ijc.2910490120; GUIRGUIS R, 1990, J OCCUP ENVIRON MED, V32, P846, DOI 10.1097/00043764-199009000-00017; HU M, 1995, INT J CANCER, V62, P585, DOI 10.1002/ijc.2910620516; ISHISAKI A, 1994, INT J CANCER, V59, P783, DOI 10.1002/ijc.2910590613; KOHN EC, 1990, BIOCHEM BIOPH RES CO, V166, P757, DOI 10.1016/0006-291X(90)90874-M; LIOTTA LA, 1986, P NATL ACAD SCI USA, V83, P3302, DOI 10.1073/pnas.83.10.3302; MARUYAMA K, 1995, INT J CANCER, V64, P316, DOI 10.1002/ijc.2910640506; MOMOSE F, 1989, J ORAL PATHOL MED, V18, P391, DOI 10.1111/j.1600-0714.1989.tb01570.x; NAKAMORI S, 1994, CANCER, V74, P1855, DOI 10.1002/1097-0142(19941001)74:7<1855::AID-CNCR2820740705>3.0.CO;2-1; OTTO T, 1994, CANCER RES, V54, P3120; SCHOR SL, 1989, IN VITRO CELL DEV B, V25, P737; WATANABE H, 1994, CLIN EXP METASTAS, V12, P155, DOI 10.1007/BF01753982; WATANABE H, 1993, INT J CANCER, V53, P689, DOI 10.1002/ijc.2910530427; YOSHINAGA Y, 1992, JPN J CANCER RES, V83, P1257	21	3	3	INT JOURNAL ONCOLOGY	ATHENS	C/O PROFESSOR D A SPANDIDOS, EDITORIAL OFFICE, 1, S MERKOURI ST, ATHENS 116 35, GREECE	1019-6439			INT J ONCOL	Int. J. Oncol.	SEP	1996	9	3					433	438				6	Oncology	Oncology	VC500	WOS:A1996VC50000007		
J	Hiwasa, T; Tokita, H; Hirose, M; Ike, Y; Ohkoshi, M				Hiwasa, T; Tokita, H; Hirose, M; Ike, Y; Ohkoshi, M			Enhancement of anti-proliferative activities of 5-FU, HCFU, SN-38, THP and ACNU by a serine protease inhibitor, FOY-305	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						serine protease inhibitor; FOY-305; anticancer drug; 5-FU; ras oncogene; MTT assay	SYNTHETIC INHIBITORS; DIETARY ADDITION; MOUSE SKIN; CARCINOGENESIS; CARCINOMA; KINASES; TUMORS; GROWTH; ASSAYS; FAMILY	The effects of a synthetic serine protease inhibitor, FOY-305, on the proliferation of normal and transformed mouse fibroblasts were investigated in vitro by MTT colorimetric assay. FOY-305 inhibited the growth of normal NIH3T3 cells and their src- and erbB2-transformed cells with a half maximum inhibitory concentration (IC50) of 1-1.2 mg/ml whereas it suppressed the growth of ras-transformed cells more effectively (IC50 was 0.5-0.6 mg/ml). Flow cytometric analysis using synchronized NIH3T3 cells has shown that the growth-inhibitory activity of FOY-305 was due to the suppression of G(1)/S transition. The synergistic effects between FOY-305 and traditional anticancer drugs were also investigated by the MTT assay and the results showed that FOY-305 significantly enhanced the antiproliferative activities of 5-fluorouracil (5-FU), 1-hexylcarbamoyl-5-fluorouracil (HCFU), 7-ethyl-1-hydroxy-7-ethyl-10-[4-(1-piperidino)-1-piperidino] camptothecin (SN-38), pirarubicin (THP) and 1-(4-amino-2-methyl-5-pyrimidinyl)-methyl-(2-chloroethyl)-3-nitrosourea hydrochloride (ACNU).	CHIBA CANC CTR,RES INST,DIV ANIM RES,CHUO KU,CHIBA 260,JAPAN; CHIBA CANC CTR,RES INST,CLIN LAB,CHUO KU,CHIBA 260,JAPAN; MITSUI PHARMACEUT INC,POSTMKT SURVEILLANCE DEPT,CHUO KU,TOKYO 103,JAPAN; UNIV TOKYO,FAC MED,DEPT ORAL SURG,BUNKYO KU,TOKYO 113,JAPAN	Hiwasa, T (reprint author), CHIBA CANC CTR,RES INST,DIV BIOCHEM,CHUO KU,666-2 NITONA CHO,CHIBA 260,JAPAN.						AKIYAMA T, 1991, MOL CELL BIOL, V11, P833; AKIYAMA T, 1987, J BIOL CHEM, V262, P5592; KIARIS H, 1995, INT J ONCOL, V7, P413; ERPEL T, 1995, CURR OPIN CELL BIOL, V7, P176, DOI 10.1016/0955-0674(95)80025-5; TAMURA Y, 1977, BIOCHIM BIOPHYS ACTA, V484, P417, DOI 10.1016/0005-2744(77)90097-3; BOS JL, 1989, CANCER RES, V49, P4682; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HIWASA T, 1995, PROTEASES INVOLVED IN CANCER, P153; Hiwasa T, 1996, INT J ONCOL, V8, P125; Hiwasa T, 1996, ONCOL REP, V3, P7; Kennedy AR, 1993, PROTEASE INHIBITORS, P9; LOWY DR, 1993, ANNU REV BIOCHEM, V62, P851, DOI 10.1146/annurev.bi.62.070193.004223; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; MOSMANN TR, 1989, J IMMUNOL METHODS, V116, P151, DOI 10.1016/0022-1759(89)90198-1; OHKOSHI M, 1995, PROTEASES INVOLVED IN CANCER, P125; OHKOSHI M, 1983, J NATL CANCER I, V71, P1053; OHKOSHI M, 1982, GANN, V73, P108; OHKOSHI M, 1993, ANTICANCER RES, V13, P963; OHKOSHI M, 1981, GANN, V72, P959; OHKOSHI M, 1984, J MAXILLOFAC SURG, V12, P148, DOI 10.1016/S0301-0503(84)80235-0; OZAKI T, 1995, CANCER RES, V55, P895; ROSSMAN TG, 1980, CARCINOGENESIS MODIF, P127; STCLAIR WH, 1990, CANCER RES, V50, P580; TATE EH, 1983, CYTOMETRY, V4, P211, DOI 10.1002/cyto.990040304; TROLL W, 1970, SCIENCE, V169, P1211, DOI 10.1126/science.169.3951.1211; UEHARA Y, 1985, JPN J CANCER RES, V76, P672; WEED HG, 1985, CARCINOGENESIS, V6, P1239, DOI 10.1093/carcin/6.8.1239; WITSCHI H, 1989, CARCINOGENESIS, V10, P2275, DOI 10.1093/carcin/10.12.2275; YUASA Y, 1986, JPN J CANCER RES, V77, P901	30	7	7	INT JOURNAL ONCOLOGY	ATHENS	C/O PROFESSOR D A SPANDIDOS, EDITORIAL OFFICE, 1, S MERKOURI ST, ATHENS 116 35, GREECE	1019-6439			INT J ONCOL	Int. J. Oncol.	SEP	1996	9	3					517	520				4	Oncology	Oncology	VC500	WOS:A1996VC50000020		
J	Ito, K; Murofushi, T; Mizuno, M; Semba, T				Ito, K; Murofushi, T; Mizuno, M; Semba, T			Pediatric brain stem gliomas with the predominant symptom of sleep apnea	INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY			English	Article						brain stem; cervical spinal cord; glioma; sleep apnea; children	SHY-DRAGER SYNDROME; CLINICOPATHOLOGICAL ANALYSIS; TUMORS; HYPERVENTILATION; CHILDREN; PATIENT; MR	Two children complaining of sleep apnea presented with brain stem gliomas. In the early stage of their illness, neurological disorders were too subtle to be recognized as significant by the physicians or to be noted by the parents. Case 1 experienced an episode of unsteady gait and weakness in the bilateral alms, at the age of 5. When it recurred after 7 years of remission, the predominant symptom was sleep apnea. Case 2 exhibited nasality of speech as the earliest sign of his illness very early in his life, presumably 5 years before the diagnosis of brain stem glioma. A slight sleep apnea which developed afterwards did not draw attention of the physicians because no neurological signs other than paralyses of the bilateral soft palates were present. MRIs of the both cases revealed diffuse, infiltrating lesions in the pens, the medulla oblongata and the upper cervical spinal cord. Both cases shared some features: (1) diagnostic delay of several years from the first symptom; (2) the main lesion in the medulla oblongata, where important structures for respiratory control are identified, (3) infiltrative growth patterns in the MRI of the tumor, which might account for the uncommon clinical courses.	TAKEDA GEN HOSP,DIV OTOLARYNGOL,AIZU WAKAMATSU,FUKUSHIMA 965,JAPAN	Ito, K (reprint author), UNIV TOKYO,FAC MED,DEPT OTOLARYNGOL,BUNKYO KU,7-3-1 HONGO,TOKYO 113,JAPAN.		Sanguansri, Luz/B-6630-2011	Sanguansri, Luz/0000-0003-1908-7604			JOHNSON PC, 1989, RADIOLOGY, V170, P211; PLUM F, 1959, ARCH NEURO PSYCHIATR, V81, P535; MANTRAVADI RVP, 1982, CANCER, V49, P1294, DOI 10.1002/1097-0142(19820315)49:6<1294::AID-CNCR2820490636>3.0.CO;2-V; EARNEST F, 1988, RADIOLOGY, V166, P823; WILLIAMS A, 1979, J NEUROL NEUROSUR PS, V42, P151, DOI 10.1136/jnnp.42.2.151; BARKOVICH A J, 1990, Pediatric Neurosurgery, V16, P73, DOI 10.1159/000120511; BERGER MS, 1983, NEUROSURGERY, V12, P298; DEVEREAU.MW, 1973, ARCH NEUROL-CHICAGO, V29, P46; ELDRIDGE SA, 1991, J CAN ASSOC RADIOL, V42, P270; FINK FM, 1991, WIEN KLIN WOCHENSCHR, V103, P392; GOLDEN GS, 1972, J NEUROL NEUROSUR PS, V35, P732, DOI 10.1136/jnnp.35.5.732; HIRSCHBERG J, 1983, INT J PEDIATR OTORHI, V5, P199, DOI 10.1016/S0165-5876(83)80026-3; HOFFMAN HJ, 1980, NEUROSURGERY, V7, P243; KOIKE Y, 1980, CLIN NEUROL, V20, P522; LEHRMAN KL, 1978, ARCH INTERN MED, V138, P206; LITTMAN P, 1980, CANCER, V45, P2787, DOI 10.1002/1097-0142(19800601)45:11<2787::AID-CNCR2820451113>3.0.CO;2-V; NAGASHIMA T, 1983, AUTONOMIC NERVOUS SY, V20, P27; NATHAN PW, 1963, J NEUROL NEUROSUR PS, V26, P487, DOI 10.1136/jnnp.26.6.487; NISHIO S, 1988, J NEURO-ONCOL, V6, P245, DOI 10.1007/BF00163708; PITTS RF, 1946, PHYSIOL REV, V26, P609; Pitts RF, 1940, J COMP NEUROL, V72, P605, DOI 10.1002/cne.900720309; PLUM F, 1982, ANN NEUROL, V11, P636, DOI 10.1002/ana.410110615; Plum F, 1970, BREATHING HERING BRE, P159; RODRIGUEZ M, 1982, ANN NEUROL, V11, P625, DOI 10.1002/ana.410110612; STRANGE P, 1982, ACTA NEUROCHIR, V62, P219, DOI 10.1007/BF01403627; STROINK AR, 1986, J NEUROSURG, V65, P745, DOI 10.3171/jns.1986.65.6.0745; TAKEMORI S, 1977, ANN OTO RHINOL LARYN, V86, P80; TALAMAS O, 1989, ARCH NEUROL-CHICAGO, V46, P529; TOKURIKI Y, 1986, ACTA NEUROCHIR, V79, P67, DOI 10.1007/BF01407447; TOMITA T, 1984, J NEURO-ONCOL, V2, P117; VILLANI R, 1975, CHILD BRAIN, V1, P126; WHITE DP, 1985, MED CLIN N AM, V69, P1205; WILSON WB, 1990, NEUROLOGY, V40, P1237; Wolf S M, 1973, Bull Los Angeles Neurol Soc, V38, P202	34	15	15	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	0165-5876			INT J PEDIATR OTORHI	Int. J. Pediatr. Otorhinolaryngol.	SEP	1996	37	1					53	64		10.1016/0165-5876(96)01375-4		12	Otorhinolaryngology; Pediatrics	Otorhinolaryngology; Pediatrics	VF777	WOS:A1996VF77700007		
J	Okubo, S; Fukui, K				Okubo, S; Fukui, K			Complete stress-strain curves for various rock types in uniaxial tension	INTERNATIONAL JOURNAL OF ROCK MECHANICS AND MINING SCIENCES & GEOMECHANICS ABSTRACTS			English	Article							COMPRESSION; BEHAVIOR; TESTS	A simple testing method in uniaxial tension was developed, and uniaxial tension tests of nine Japanese rocks were conducted together with uniaxial compression tests. A closed-loop servo-controlled testing machine was controlled by a method in which a linear combination of stress and strain was used as the feedback signal. It was found that the proposed testing method can be applicable for not only Class I, but also Class II mode failure in tension. Two interesting results were obtained in uniaxial tension: (1) A large amount of residual strength characterises the post-failure region; and (2) the shape of the complete stress-strain curve in tension is similar to that in compression. Copyright (C) 1996 Elsevier Science Ltd		Okubo, S (reprint author), UNIV TOKYO,FAC ENGN,DEPT GEOSYST ENGN,BUNKYO KU,7-3-1 HONGO,TOKYO 113,JAPAN.						CHO H, 1995, SIGEN TO SOZAI, V111, P907; CHU SY, 1995, SIGEN SOCAI, V111, P231; NOVA R, 1990, INT J ROCK MECH MIN, V27, P231, DOI 10.1016/0148-9062(90)90526-8; OKUBO S, 1990, INT J ROCK MECH MIN, V27, P559, DOI 10.1016/0148-9062(90)91007-T; OKUBO S, 1993, INT J ROCK MECH MIN, V23, P363; OKUBO S, 1985, INT J ROCK MECH MIN, V22, P323, DOI 10.1016/0148-9062(85)92064-9; Okubo S, 1984, J SOC MATER SCI JPN, V33, P882; OKUBO S, 1993, INT J ROCK MECH MIN, V30, P247, DOI 10.1016/0148-9062(93)92728-9; PENG SS, 1975, INT J ROCK MECH MIN, V12, P125, DOI 10.1016/0148-9062(75)90006-6	9	37	50	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB	0148-9062			INT J ROCK MECH MIN	Int. J. Rock Mech. Min. Sci.	SEP	1996	33	6					549	556		10.1016/0148-9062(96)00024-1		8	Engineering, Geological; Mining & Mineral Processing	Engineering; Mining & Mineral Processing	VJ664	WOS:A1996VJ66400001		
J	Mitsui, T; Sakurai, K				Mitsui, T; Sakurai, K			Microdegree azimuth polarimeter using optical heterodyne detection	JAPANESE JOURNAL OF APPLIED PHYSICS PART 1-REGULAR PAPERS SHORT NOTES & REVIEW PAPERS			English	Article						optical rotation; polarimeter; blood glucose level; heterodyne detection; laser diode	FM QUANTUM NOISE; SEMICONDUCTOR-LASERS; MULTIPLE-SCATTERING; COHERENT; MEDIA; AM	We have developed a highly accurate azimuth polarimeter using an optical heterodyne technique with a single-mode laser diode as a light source. Its minimum detectable rotation angle is 0.198 mu deg root W/Hz; i.e., it is inversely proportional to the square root of the laser power. Using a glass cell of l-mm optical path length, we have also successfully observed the optical rotatory power of an aqueous glucose solution whose density is close to that of glucose in human blood.		Mitsui, T (reprint author), UNIV TOKYO,DEPT PURE & APPL SCI,MEGURO KU,3-8-1 KOMABA,TOKYO 153,JAPAN.						COLLINS RW, 1990, REV SCI INSTRUM, V61, P2029, DOI 10.1063/1.1141417; CAMERON R, 1993, PHYS REV D, V47, P3707, DOI 10.1103/PhysRevD.47.3707; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; ALLAN DW, 1966, PR INST ELECTR ELECT, V54, P221, DOI 10.1109/PROC.1966.4634; YAMAMOTO Y, 1983, IEEE J QUANTUM ELECT, V19, P47, DOI 10.1109/JQE.1983.1071729; YAMAMOTO Y, 1983, IEEE J QUANTUM ELECT, V19, P34, DOI 10.1109/JQE.1983.1071726; YAMAMOTO Y, 1986, PHYS REV A, V33, P3243, DOI 10.1103/PhysRevA.33.3243; FREUND I, 1988, PHYS REV LETT, V60, P1130, DOI 10.1103/PhysRevLett.60.1130; GILBERT J, 1995, APPL OPTICS, V34, P2045; GILHAM EJ, 1961, J SCI INSTRUM, V38, P21; GOETZ MJ, 1992, P ANN NE BIOENG C I, V18, P97; ISHIKAWA T, 1984, J BIOCHEM-TOKYO, V95, P213; Mitsui T, 1996, APPL OPTICS, V35, P2253, DOI 10.1364/AO.35.002253; TOIDA M, 1991, APPL PHYS B-PHOTO, V52, P391, DOI 10.1007/BF00325156; YOO KM, 1990, OPT LETT, V15, P320, DOI 10.1364/OL.15.000320	15	4	4	JAPAN J APPLIED PHYSICS	MINATO-KU TOKYO	DAINI TOYOKAIJI BLDG 24-8 SHINBASHI 4-CHOME, MINATO-KU TOKYO 105, JAPAN	0021-4922			JPN J APPL PHYS 1	Jpn. J. Appl. Phys. Part 1 - Regul. Pap. Short Notes Rev. Pap.	SEP	1996	35	9A					4844	4847		10.1143/JJAP.35.4844		4	Physics, Applied	Physics	VK795	WOS:A1996VK79500053		
J	Suzuki, H; Okano, A; Ejima, C; Konishi, A; Akiyama, Y; Ozawa, K; Asano, S				Suzuki, H; Okano, A; Ejima, C; Konishi, A; Akiyama, Y; Ozawa, K; Asano, S			Interleukin-6 and granulocyte colony-stimulating factor synergistically increase peripheral blood progenitor cells in myelosuppressive mice	JAPANESE JOURNAL OF CANCER RESEARCH			English	Article						IL-6; G-CSF; myelosuppressive mice; CFU-GM; autologous PBSCT	AUTOLOGOUS BONE-MARROW; HIGH-DOSE CHEMOTHERAPY; STEM-CELLS; G-CSF; IN-VIVO; TRANSPLANTATION; MOBILIZATION; THERAPY; HEMATOPOIESIS; ENGRAFTMENT	We previously reported a successful peripheral blood stem cell harvest by co-administration of recombinant human (rh) interleukin-6 (IL-6) and rh granulocyte colony-stimulating factor (G-CSF) in normal mice. In the present study, to evaluate further the utility of this observation for autologous peripheral blood stem cell transplantation, we examined the effects of rhIL-6 and rhG-CSF on peripheral blood granulocyte-macrophage colony-forming units (CFU-GM) in carboplatin (CBDCA)-induced and irradiation-induced myelosuppressive mouse models. After CBDCA administration, blood cell counts decreased to the nadir, and then recovered to a normal level. In this recovery phase, the peripheral CFU-GM level increased to 3.8-fold higher than the pretreatment level. Administration of rhIL-6 (10 mu g/day) alone induced a 40-fold increase in peripheral CFU-GM from the normal level at day 14. In combination with rhG-CSF (0.35 mu g/day), which alone induced a 74-fold increase, rhIL-6 synergistically increased the CFU-GM level by 1200-fold. In irradiated mice, similar results were observed. Administration of rhIL-6 at 3 and 10 mu g/day significantly increased CFU-GM. Interestingly, in combination with rhG-CSF, a lower dose of rhIL-6 (1 mu g/day) could induce CFU-GM increase. We also examined CFU-GM distribution in bone marrow, spleen and peripheral blood. Cytokine administration induced not only a change of CFU-GM distribution, but also an increase in total CFU-CM counts per mouse. These results suggest that co-administration of rhIL-6 and rhG-CSF may be useful for autologous peripheral blood stem cell transplantation.	AJINOMOTO CO INC,CENT RES LABS,TOTSUKA KU,YOKOHAMA,KANAGAWA 244,JAPAN; UNIV TOKYO,INST MED SCI,DEPT HEMATOL ONCOL,MINATO KU,TOKYO 108,JAPAN							ANDREWS RG, 1995, BLOOD, V85, P15; PETERS WP, 1993, BLOOD, V81, P1709; LATERVEER L, 1995, BLOOD, V85, P2269; YASUEDA H, 1990, BIO-TECHNOL, V8, P1036, DOI 10.1038/nbt1190-1036; STOPPA AM, 1994, BONE MARROW TRANSPL, V13, P541; BENSINGER W, 1993, BLOOD, V81, P3158; BISHOP MR, 1994, BLOOD, V83, P610; Brasel K., 1995, Blood, V86, p463A; BRUGGER W, 1992, BLOOD, V79, P1193; ELIAS AD, 1992, BLOOD, V79, P3036; FIBBE WE, 1992, J IMMUNOL, V148, P417; GRZEGORZEWSKI K, 1994, BLOOD, V83, P377; GUILLAUME T, 1993, STEM CELLS, V11, P173; HAAS R, 1993, EXP HEMATOL, V21, P109; HASTINGS R, 1994, BLOOD, V84, pA23; HATTORI K, 1990, BLOOD, V75, P1228; HOHAUS S, 1993, EXP HEMATOL, V21, P508; JACKSON JD, 1995, BLOOD, V85, P2371; KAWANO Y, 1993, BLOOD, V81, P856; KAWANO Y, 1993, EXP HEMATOL, V21, P103; KIMURA F, 1992, INT J HEMATOL, V55, P147; LANE TA, 1995, BLOOD, V85, P275; MIKSITS K, 1993, BONE MARROW TRANSPL, V11, P375; OHI S, 1995, INT J HEMATOL, V62, P75; OKANO A, 1989, TRANSPLANTATION, V48, P495, DOI 10.1097/00007890-198909000-00028; SCHAAFSMA MR, 1990, BRIT J HAEMATOL, V76, P180, DOI 10.1111/j.1365-2141.1990.tb07869.x; SHEA TC, 1993, CANCER TREAT REV, V19, P11, DOI 10.1016/0305-7372(93)90043-Q; SUZUKI H, 1995, TRANSPLANTATION, V59, P1596; TAKATSUKI F, 1990, CANCER RES, V50, P2885; YAN XQ, 1995, BLOOD, V85, P2303	30	3	3	JAPANESE CANCER ASSOCIATION	TOKYO	EDITORIAL OFFICE 7TH FLOOR, JOHKOH BLDG 2-23-11, KOISHIKAWA, TOKYO 112, JAPAN	0910-5050			JPN J CANCER RES	Jpn. J. Cancer Res.	SEP	1996	87	9					938	944				7	Oncology	Oncology	VL789	WOS:A1996VL78900011		
J	Xu, HL; Ishii, R				Xu, HL; Ishii, R			Wheat cultivar differences in photosynthetic response to low soil water potentials .1. Maintenance of photosynthesis and leaf water potential	JAPANESE JOURNAL OF CROP SCIENCE			Japanese	Article						drought avoidance; drought resistance; drought tolerance; photosynthesis; Triticum aestivum; water stress; wheat	DEFICIT; CROPS	Although many studies have shown cultivar differences in photosynthetic response to water deficit, the understanding of detailed mechanisms is not sufficient. We examined the mechanisms of water stress-resistance in terms of photosynthetic performance under low soil water potential (Psi(soil)) with sixteen cultivars of wheat (Triticum aestivum L.) from different habitats, which had shown different drought resistance on a grain yield basis. Cultivar differences in photosynthetic maintenance in response to decrease of Psi(soil) (water stress resistance), were found at all seedling, booting, and grain filling stages. Cultivars with high drought resistance based on grain yield also showed high water stress resistance in photosynthetic performance. Water stress resistance (R(WS)) was caused more by tolerance (T-WS, maintenance ability of photosynthesis in response to decrease of leaf water potential, Psi(L)) in some cultivars, which maintained relatively high photosynthesis (P-N) in spite of decreases in Psi(L), while it was caused more by water stress avoidance (A(WS), maintenance ability of Psi(L) in response to decreases in Psi(soil)) in other cultivars, which showed a relatively high P-N by maintaining a relatively high Psi(L) under the same low Psi(soil). However, there was a positive correlation between R(WS) and T-WS or between R(WS) and A(WS). It is suggested that avoidance and tolerance usually occur simultaneously in adaptation to low Psi(soil), although water stress resistant cultivars varied in the water stress resistance mechanism.	UNIV TOKYO,GRAD SCH AGR & LIFE SCI,TOKYO 113,JAPAN				Xu, Hui-lian/0000-0002-3031-9085			FISCHER RA, 1978, ANNU REV PLANT PHYS, V29, P277, DOI 10.1146/annurev.pp.29.060178.001425; ZIMMERMANN U, 1978, ANNU REV PLANT PHYS, V29, P121, DOI 10.1146/annurev.pp.29.060178.001005; FISCHER RA, 1981, PLANT SOIL, V58, P249, DOI 10.1007/BF02180056; HSIAO TC, 1973, ANNU REV PLANT PHYS, V24, P519, DOI 10.1146/annurev.pp.24.060173.002511; TURNER NC, 1978, AUST J PLANT PHYSIOL, V5, P597; ASPINAL D, 1965, AUST J AGR RES, V15, P729; Boyer J, 1976, WATER DEFICITS PLANT, V4, P153; Boyer J.B., 1975, ADV AGRON, V27, P1, DOI 10.1016/S0065-2113(08)70006-3; BOYER JS, 1984, ADV PHOTOSYNTHESIS R, V4, P36; BOYER JS, 1970, PLANT PHYSIOL, V46, P236, DOI 10.1104/pp.46.2.236; Cowan I. R., 1977, Advances in Botanical Research, V4, P117; FELLOWS RJ, 1976, PLANTA, V132, P229, DOI 10.1007/BF00399722; FERERES E, 1978, PHYSIOL PLANTARUM, V44, P261, DOI 10.1111/j.1399-3054.1978.tb08629.x; FISCHER RA, 1978, AUST J AGR RES, V29, P897, DOI 10.1071/AR9780897; LEVITT J, 1960, B RES COUNCIL ISR D, V8, P137; Levitte J., 1980, RESPONSES PLANTS ENV, V2, P25; Lieth H., 1976, WATER PLANT LIFE PRO, P392; LUDLOW MM, 1983, AUST J PLANT PHYSL, V10, P449; OWASEYE JA, 1972, J ECOL, V60, P801; WADA M, 1994, JPN J CROP SCI, V63, P339; XU HL, 1990, JPN J CROP SCI, V59, P384	21	10	10	CROP SCIENCE SOC JAPAN	TOKYO	UNIV TOKYO-FACULTY AGR BUNKYO-KU, TOKYO 113, JAPAN	0011-1848			JPN J CROP SCI	Jpn. J. Crop Sci.	SEP	1996	65	3					509	517				9	Agronomy	Agriculture	VG441	WOS:A1996VG44100013		
J	Xu, HL; Ihii, R				Xu, HL; Ihii, R			Wheat cultivar differences in photosynthetic response to low soil water potentials .2. Maintenance of leaf turgor and relative water content	JAPANESE JOURNAL OF CROP SCIENCE			English	Article						cultivar difference; osmotic adjustment; photosynthesis; Triticum aestivum L; turgor potential; water stress; wheat	OSMOTIC ADJUSTMENT; SORGHUM GENOTYPES; OSMOREGULATION; YIELD; CONDUCTANCE; DEFICITS; GROWTH; STRESS; PLANTS; LINES	The capacity for maintenance of turgor potential (Psi(P)) and relative water content (xi) were examined in 16 wheat cultivars from different habitats with different agronomic drought resistance and different photosynthetic responses to water stress. Substantial cultivar differences in Psi(P) and xi maintenance were observed at all of the seedling, booting and grain filling stages. Maintenanccs of Psi(P) and xi positively correlated with photosynthetic maintenance under water deficit conditions, suggesting that capacity of Psi(P) and xi maintenance can he used as drought resistance criteria. In general, the cultivars can bring their abilities of Psi(P) and xi maintenances through the whole growth period, but the abilities were higher at the grain filling stage than the earlier growth stages. With comparison of water-stress resistant cultivars, it was found that some of them could maintain higher photosynthetic activity at lower Psi(P) or xi than the others. Integrated results of the present research suggest that turgor regulation and xi maintenance play important roles in photosynthetic maintenance under low soil water potentials.	UNIV TOKYO,GRAD SCH AGR & LIFE SCI,TOKYO 113,JAPAN				Xu, Hui-lian/0000-0002-3031-9085			ACKERSON RC, 1980, CROP SCI, V20, P10; ADJEI GB, 1980, EUPHYTICA, V29, P155, DOI 10.1007/BF00037261; JOHNSON DA, 1983, CROP SCI, V23, P318; FISCHER RA, 1978, ANNU REV PLANT PHYS, V29, P277, DOI 10.1146/annurev.pp.29.060178.001425; FISCHER RA, 1979, AUST J AGR RES, V30, P1001, DOI 10.1071/AR9791001; BRAY EA, 1993, PLANT PHYSIOL, V103, P1035; JONES MM, 1978, PLANT PHYSIOL, V61, P122, DOI 10.1104/pp.61.1.122; Xu HL, 1996, JPN J CROP SCI, V65, P509; MORGAN JM, 1984, ANNU REV PLANT PHYS, V35, P299, DOI 10.1146/annurev.pp.35.060184.001503; Boyer J, 1976, WATER DEFICITS PLANT, V4, P153; BOYER JS, 1969, ANN REV PLANT PHYSL, V64, P476; CLARKE JM, 1986, CAN J PLANT SCI, V66, P885; CLARKE JM, 1978, AUST J AGR RES, V29, P897; FLOWER DJ, 1990, AUST J PLANT PHYSIOL, V17, P91; GIRMA FS, 1991, PLANT PHYSIOL, V99, P577; JONES HG, 1983, PLANTS MICROCLIMATE, P85; KRAMER PJ, 1983, WATER RELATIONS PLAN, P404; Levitte J., 1980, RESPONSES PLANTS ENV, V2, P25; MEYER RF, 1981, PLANTA, V151, P482, DOI 10.1007/BF00386543; MORGAN JM, 1983, AUST J AGR RES, V34, P607, DOI 10.1071/AR9830607; MORGAN JM, 1986, AUST J AGR RES, V37, P449, DOI 10.1071/AR9860449; TAIZ L, 1984, ANNU REV PLANT PHYS, V35, P585; TURNER NC, 1986, ADV AGRON, V39, P1, DOI 10.1016/S0065-2113(08)60464-2; WRIGHT GC, 1983, AUST J AGR RES, V34, P637, DOI 10.1071/AR9830637; XU HL, 1990, JPN J CROP SCI, V59, P384	25	2	2	CROP SCIENCE SOC JAPAN	TOKYO	UNIV TOKYO-FACULTY AGR BUNKYO-KU, TOKYO 113, JAPAN	0011-1848			JPN J CROP SCI	Jpn. J. Crop Sci.	SEP	1996	65	3					518	524				7	Agronomy	Agriculture	VG441	WOS:A1996VG44100014		
J	Shimoyama, H				Shimoyama, H			A review of studies on student apathy	JAPANESE JOURNAL OF EDUCATIONAL PSYCHOLOGY			Japanese	Review						student apathy; male university students; clinical entity; personality disorder; adolescence in Japan	PERSONALITY; SCALE	The term ''Student Apathy'' was originally proposed in US to describe the male university students who continued to avoid confronting their conflicts. However, it has been studied and conceptualized only in Japan. The primary purpose of this paper was to review the studies on the disorder of Student Apathy and make clear the points of controversy. At first, the trends in conceptualizations were considered from an historical point of view. It was found that the concepts suggested thus far, were so various that it was difficult to categorize the disorder as a clinical entity. Next, the studies were examined from a psychopathological and developmental point of view. It was suggested that the disorder level should he shifted from neurotic to personality disorder and the integrated concept should be formed to distinguish it from generally apathetic tendency found in adolescence in Japan, which should be searched as a background of Student Apathy.		Shimoyama, H (reprint author), UNIV TOKYO, GRAD SCH EDUC, TOKYO, JAPAN.						ALTBACH PG, 1979, HIGH EDUC, V8, P609, DOI 10.1007/BF00215985; MARCIA JE, 1966, J PERS SOC PSYCHOL, V3, P551, DOI 10.1037/h0023281; MARIN RS, 1990, AM J PSYCHIAT, V147, P22; OSIPOW SH, 1976, J VOCAT BEHAV, V9, P233, DOI 10.1016/0001-8791(76)90081-6; HOLLAND JL, 1980, J PERS SOC PSYCHOL, V39, P1191, DOI 10.1037/h0077731; MARIN RS, 1993, J AFFECT DISORDERS, V28, P7, DOI 10.1016/0165-0327(93)90072-R; MARIN RS, 1991, PSYCHIAT RES, V38, P143, DOI 10.1016/0165-1781(91)90040-V; Bishop JH, 1989, EDUC RES, V18, P6, DOI DOI 10.3102/0013189X018001006; BLAINE GB, 1973, J AM COLL HEALTH ASS, V21, P188; Blos P., 1979, ADOLESCENT PASSAGE; Blos P, 1962, ON ADOLESCENCE; Coffield K. E., 1986, COLL STUDENT J, V20, P211; COFFIELD KE, 1985, PSYCHOL REC, V35, P459; COFFIELD KE, 1981, TEACH PSYCHOL, V8, P26, DOI 10.1207/s15328023top0801_7; COHEN DA, 1991, PROTEUS, V8, P27; DAVIOSON GC, 1994, ABNORMAL PSYCHOL; Erikson E. H., 1959, IDENTITY LIFE CYCLE; FARNSWORTH DL, 1973, AM HDB PSYCHIAT, V2, P773; GIBBONS RD, 1985, SCHIZOPHRENIA BULL, V11, P390; GIMENEZ ME, 1989, TEACH SOCIOL, V17, P184, DOI 10.2307/1317458; Glauber IP, 1949, PSYCHOANAL QUART, V18, P67; Grayson P., 1989, COLL PSYCHOTHERAPY; GRINKER RR, 1973, ARCH GEN PSYCHIAT, V28, P168; HALLECK SL, 1967, AM J PSYCHIAT, V124, P96; HARROW M, 1977, AM J PSYCHIAT, V134, P794; HOLLAND JL, 1977, J COUNS PSYCHOL, V24, P404, DOI 10.1037//0022-0167.24.5.404; Jacewicz-Kramarz H, 1982, Psychiatr Pol, V16, P145; Kantor M., 1992, DIAGNOSIS TREATMENT; MARCUS SP, 1977, SOC EDUC, V41, P645; MARIN RS, 1991, J NEUROPSYCH CLIN N, V3, P243; MEYERSOHN R, 1974, CENTERPOINT, V1, P90; MUNDT C, 1983, NERVENARZT, V54, P131; PERKINS DS, 1975, J HIGH EDUC, V46, P471, DOI 10.2307/1980674; REVERS VWJ, 1983, PSYCHOPATHOLOGIE PSY, V31, P4; Robinson T N, 1986, J Am Coll Health, V34, P284; Schneider K., 1950, PSYCHOPATHISCHEN PER, V9th; SCHNEIER FR, 1991, COMPR PSYCHIAT, V32, P496, DOI 10.1016/0010-440X(91)90028-B; Seligman M. E. P., 1975, HELPLESSNESS; SHANLEY RB, 1981, J VOCAT BEHAV, V18, P92; Taylor M E, 1985, J Am Coll Health, V34, P34; TEICHER JD, 1972, AM J PSYCHOTHER, V26, P401; Von Franz M.-L., 1970, PROBLEM PUER AETERNU; WALTERS PAJ, 1961, EMOTIONAL PROBLEM ST; WIDIGER TA, 1970, J ABNORM PSYCHOL, V7, P169	44	2	2	JAPANESE ASSOC EDUCATIONAL PSYCHOLOGY	TOKYO	5-24-6-7F HONGO, BUMKYO-KU, TOKYO, 113-0033, JAPAN	0021-5015			JPN J EDUC PSYCHOL	Jpn. J. Educ. Psychol.	SEP	1996	44	3					350	365				16	Psychology, Educational	Psychology	VM292	WOS:A1996VM29200012		
J	MitsuiSaito, M; Karaki, H				MitsuiSaito, M; Karaki, H			Carbachol but not acetylcholine inhibits contraction by the protein kinase C-dependent and -independent pathways in the smooth muscle of guinea pig Taenia caeci	JAPANESE JOURNAL OF PHARMACOLOGY			English	Article						smooth muscle (intestinal); acetylcholine; carbachol; phorbol ester; protein kinase C	CALCIUM; CELLS; RESPONSES; CECUM; ILEUM	In the intestinal smooth muscle of guinea pig taenia caeci, acetylcholine and carbachol induced a transient contraction followed by a sustained contraction. The magnitudes of the transient and sustained contractions were similar when muscle was stimulated with acetylcholine (0.1 mu M-1 mM) or a lower concentration (0.1 mu M) of carbachol. However, higher concentrations of carbachol (1-100 mu M) induced significantly smaller sustained contraction than the transient contraction. In the 45 mM KCl-stimulated strips, addition of 100 mu M carbachol induced a transient increase followed by a sustained decrease in the contractile tension. In contrast, acetylcholine (0.1 mu M-1 mM) showed only weak inhibitory effects on the high K+-induced contraction either in the absence or presence of a cholinesterase inhibitor, 0.5 mu M diisopropylfluorophosphate. The same concentration of diisopropylfluorophosphate shifted the concentration-response curve for acetylcholine to lower concentrations. In the muscles pretreated with 3 mu M phorbol la-myristate 13-acetate for 24 hr to desensitize protein kinase C, sustained contractions induced by higher concentrations of carbachol (1-100 mu M) were significantly greater than those in the strips without the treatment with phorbol ester. However, the transient contraction and the contraction induced by a lower concentration (0.1 mu M) of carbachol were not changed by the treatment with phorbol ester. Pretreatment with phorbol ester attenuated the inhibitory effect of carbachol on the high K+-induced contraction. These results suggest that the inhibitory effects of carbachol is composed of two phases: protein kinase C-independent transient inhibition and protein kinase C-dependent sustained inhibition.		MitsuiSaito, M (reprint author), UNIV TOKYO,GRAD SCH AGR & LIFE SCI,DEPT VET PHARMACOL,BUNKYO KU,TOKYO 113,JAPAN.						BOLTON TB, 1979, PHYSIOL REV, V59, P606; DUCKLES SP, 1988, J PHARMACOL EXP THER, V246, P929; FURUKAWA K, 1988, J BIOL CHEM, V264, P4844; GARDNER AL, 1988, BRIT J PHARMACOL, V94, P199; HONDA K, 1994, JPN J PHARMACOL, V65, P275, DOI 10.1254/jjp.65.275; KOMORI S, 1991, PFLUG ARCH EUR J PHY, V418, P437, DOI 10.1007/BF00497770; MITCHELSON F, 1984, BRIT J PHARMACOL, V83, P145; MITSUI M, 1990, AM J PHYSIOL, V258, pC787; MITSUI M, 1993, BRIT J PHARMACOL, V109, P229; NAKAJYO S, 1982, JPN J PHARMACOL, V32, P55, DOI 10.1254/jjp.32.55; OBARA K, 1992, JPN J PHARMACOL, V58, pP407; OZAKI H, 1992, AM J PHYSIOL, V263, pC1160; RUSSELL SN, 1990, J PHYSIOL-LONDON, V426, pP23; SASAGURI T, 1989, BRIT J PHARMACOL, V98, P791; SOMLYO AV, 1985, P NATL ACAD SCI USA, V82, P5231, DOI 10.1073/pnas.82.15.5231; TAKAYANAGI I, 1989, ARCH INT PHARMACOD T, V298, P210; UNNO T, 1995, J PHYSIOL-LONDON, V484, P567; VORNANEN M, 1981, ACTA PHYSIOL SCAND, V113, P177, DOI 10.1111/j.1748-1716.1981.tb06879.x	18	4	4	JAPANESE PHARMACOLOGICAL SOC	KYOTO	EDITORIAL OFF, KANTOHYA BLDG GOKOMACHI-EBISUGAWA NAKAGYO-KU, KYOTO 604, JAPAN	0021-5198			JPN J PHARMACOL	Jpn. J. Pharmacol.	SEP	1996	72	1					23	28		10.1254/jjp.72.23		6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	VH862	WOS:A1996VH86200004		
J	Murakami, Y; Kato, S; Nakajima, M; Matsuoka, M; Kawai, H; ShinYa, K; Seto, H				Murakami, Y; Kato, S; Nakajima, M; Matsuoka, M; Kawai, H; ShinYa, K; Seto, H			Formobactin, a novel free radical scavenging and neuronal cell protecting substance from Nocardia sp	JOURNAL OF ANTIBIOTICS			English	Article							GLUTAMATE CYTO-TOXICITY; STRUCTURE ELUCIDATION; BIOLOGICAL PROPERTIES; LIPID-PEROXIDATION; OXIDATIVE STRESS; LINE; INJURY; FERMENTATION; SUPEROXIDE; INHIBITION	Formobactin, a new free radical scavenger, was isolated from the culture of Nocardia sp. strain ND20. The structure of formobactin was determined to be a member of the nocobactin group antibiotics. Formobactin inhibited lipid peroxidation in rat brain homogenate. Formobactin also showed the activity to suppress L-glutamate toxicity in neuronal hybridoma N18-RE-105 cells.	UNIV TOKYO,INST MOL & CELLULAR BIOSCI,BUNKYO KU,TOKYO 113,JAPAN	Murakami, Y (reprint author), KIRIN BREWERY CO LTD,PHARMACEUT RES LAB,TAKASAKI,GUMMA 37012,JAPAN.						MURPHY TH, 1989, NEURON, V2, P1547, DOI 10.1016/0896-6273(89)90043-3; KINOUCHI H, 1991, P NATL ACAD SCI USA, V88, P11158, DOI 10.1073/pnas.88.24.11158; PALINSKI W, 1989, P NATL ACAD SCI USA, V86, P1372, DOI 10.1073/pnas.86.4.1372; SHINYA K, 1993, TETRAHEDRON LETT, V34, P4943, DOI 10.1016/S0040-4039(00)74052-4; KATO S, 1993, J ANTIBIOT, V46, P1485; CHOI DW, 1990, J NEUROSCI, V10, P2493; KATO S, 1989, J ANTIBIOT, V42, P1879; KOH JY, 1988, J NEUROSCI, V8, P2153; GUTTERIDGE JMC, 1979, BIOCHEM J, V184, P469; FLAMM ES, 1978, STROKE, V9, P445; CARMELI S, 1993, TETRAHEDRON LETT, V34, P6681, DOI 10.1016/S0040-4039(00)61674-X; CHEESEMAN KH, 1988, BIOCHEM PHARMACOL, V37, P4225, DOI 10.1016/0006-2952(88)90120-7; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; FANTONE JC, 1985, HUM PATHOL, V16, P973; Hess M L, 1985, Adv Myocardiol, V5, P159; KATO S, 1993, J ANTIBIOT, V46, P892; KUBO K, 1984, ARCH INT PHARMACOD T, V272, P283; LECHEVALIER M P, 1970, International Journal of Systematic Bacteriology, V20, P435; Lechevalier MP, 1981, ZENTRALBL BAKTER 1 S, V1, P111; MALOUF AT, 1984, J BIOL CHEM, V20, P12756; MIYAMOTO M, 1989, J PHARMACOL EXP THER, V250, P1132; MURPHY TH, 1988, BRAIN RES, V460, P155, DOI 10.1016/0006-8993(88)91216-4; MURPHY TH, 1988, BRAIN RES, V444, P325, DOI 10.1016/0006-8993(88)90941-9; RATLEDGE C, 1976, J GEN MICROBIOL, V93, P141; RATLEDGE C, 1974, BIOCHEM J, V139, P407; REHAN A, 1984, LAB INVEST, V51, P396; SHINYA K, 1995, J ANTIBIOT, V48, P574; SHIRLING E. B., 1966, INT J SYST BACTERIOL, V16, P313; SINNHUBER RO, 1958, FOOD TECHNOL-CHICAGO, V12, P9; TRAYSTMAN RJ, 1991, J APPL PHYSIOL, V71, P1185; WALLING C, 1975, ACCOUNTS CHEM RES, V8, P125, DOI 10.1021/ar50088a003	31	44	44	JAPAN ANTIBIOT RES ASSN	TOKYO	2 20 8 KAMIOSAKI SHINAGAWA KU, TOKYO 141, JAPAN	0021-8820			J ANTIBIOT	J. Antibiot.	SEP	1996	49	9					839	845				7	Biotechnology & Applied Microbiology; Immunology; Microbiology; Pharmacology & Pharmacy	Biotechnology & Applied Microbiology; Immunology; Microbiology; Pharmacology & Pharmacy	VJ736	WOS:A1996VJ73600001		
J	Kobayashi, H; Namikoshi, M; Yoshimoto, T; Yokochi, T				Kobayashi, H; Namikoshi, M; Yoshimoto, T; Yokochi, T			A screening method for antimitotic and antifungal substances using conidia of Pyricularia oryzae, modification and application to tropical marine fungi	JOURNAL OF ANTIBIOTICS			English	Article							ANTIBIOTICS	A bioassay method detecting deformations of mycelia germinated from conidia of Pyricularia oryzae P-2b, has been modified to give quantitative estimations. The method was first developed using antimitotic agents which showed characteristic curling effect. Morphological deformations include curling, swelling, hyper-divergency, beads shape and so on, and inhibition of the germination was also observed. For quantitative estimations, indices were introduced for the hyphal growth inhibition and a quantity of conidia in each assay cell and concentration of test solutions were adjusted. Details of the modified method and the application to screening assay of marine fungi isolated in Yap Islands are described. Eight strains of 109 tested showed morphological deformations, and chaetoglobosin A was isolated from the broth filtrate of a strain assigned to Chaetomium sp. This bioassay is a cheap, quick and easy method to be applied to the primary screening for antimitotic and antifungal substances from natural sources.	TOKYO UNIV FISHERIES,DEPT OCEAN SCI,MINATO KU,TOKYO 108,JAPAN; UNIV TOKYO,INST MOL & CELLULAR BIOSCI,BUNKYO KU,TOKYO 113,JAPAN; NATL INST BIOSCI & HUMAN TECHNOL,DEPT APPL MICROBIOL,TSUKUBA,IBARAKI 305,JAPAN							SEKITA S, 1973, TETRAHEDRON LETT, P2109; UMEDA M, 1975, EXPERIENTIA, V31, P435, DOI 10.1007/BF02026363; ISONO K, 1968, AGR BIOL CHEM TOKYO, V32, P792; KOBAYASHI H, 1995, J ANTIBIOT, V48, P42; SEKITA S, 1982, CHEM PHARM BULL, V30, P1609; BEPPU T, 1993, PROTEIN NUCL ACID EN, V38, P1639; BETINA V, 1973, Z ALLG MIKROBIOL, V13, P287, DOI 10.1002/jobm.3630130402; BRIAN PW, 1949, ANN BOT-LONDON, V13, P59; GUNJI S, 1983, AGR BIOL CHEM TOKYO, V47, P2061; MARUMO S, 1982, AGR BIOL CHEM TOKYO, V46, P2399; Richmond D V, 1975, Adv Appl Microbiol, V19, P289, DOI 10.1016/S0065-2164(08)70432-5; SAKAMOTO K, 1995, J ANTIBIOT, V48, P727; SATO Y, 1982, J PHARMACOBIO-DYNAM, V5, P418; SHELANSK.ML, 1973, P NATL ACAD SCI USA, V70, P765, DOI 10.1073/pnas.70.3.765; TAKAHASHI M, 1987, J ANTIBIOT, V40, P66	15	83	122	JAPAN ANTIBIOT RES ASSN	TOKYO	2 20 8 KAMIOSAKI SHINAGAWA KU, TOKYO 141, JAPAN	0021-8820			J ANTIBIOT	J. Antibiot.	SEP	1996	49	9					873	879				7	Biotechnology & Applied Microbiology; Immunology; Microbiology; Pharmacology & Pharmacy	Biotechnology & Applied Microbiology; Immunology; Microbiology; Pharmacology & Pharmacy	VJ736	WOS:A1996VJ73600006		
J	Kim, JS; ShinYa, K; Eishima, J; Furihata, K; Seto, H				Kim, JS; ShinYa, K; Eishima, J; Furihata, K; Seto, H			A novel neuronal cell protecting substance, espicufolin, produced by Streptomyces sp. cu39	JOURNAL OF ANTIBIOTICS			English	Letter							OXIDATIVE STRESS; GLUTAMATE; INHIBITION; TOXICITY; LINE		UNIV TOKYO,DIV AGR & AGR LIFE SCI,BUNKYO KU,TOKYO 113,JAPAN	Kim, JS (reprint author), UNIV TOKYO,INST MOL & CELLULAR BIOSCI,BUNKYO KU,TOKYO 113,JAPAN.						KANE DJ, 1993, SCIENCE, V262, P1274, DOI 10.1126/science.8235659; MURPHY TH, 1989, NEURON, V2, P1547, DOI 10.1016/0896-6273(89)90043-3; FURIHATA K, 1995, TETRAHEDRON LETT, V36, P2817, DOI 10.1016/0040-4039(95)00405-2; MAEDA K, 1956, J ANTIBIOT, V9, P75; CHOI DW, 1990, J NEUROSCI, V10, P2493; KONDO S, 1970, J ANTIBIOT, V23, P354; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; MIYAMOTO M, 1989, J PHARMACOL EXP THER, V250, P1132	8	14	14	JAPAN ANTIBIOT RES ASSN	TOKYO	2 20 8 KAMIOSAKI SHINAGAWA KU, TOKYO 141, JAPAN	0021-8820			J ANTIBIOT	J. Antibiot.	SEP	1996	49	9					947	948				2	Biotechnology & Applied Microbiology; Immunology; Microbiology; Pharmacology & Pharmacy	Biotechnology & Applied Microbiology; Immunology; Microbiology; Pharmacology & Pharmacy	VJ736	WOS:A1996VJ73600019		
J	Hiramoto, S; Kinoshita, N; Hatanaka, S; Seto, H				Hiramoto, S; Kinoshita, N; Hatanaka, S; Seto, H			Stimulation of apolipoprotein E secretion in human hepatoma Hep G2 cells by a cyclic acylpeptide, N-4909	JOURNAL OF ANTIBIOTICS			English	Letter							HERITABLE HYPERLIPIDEMIC RABBITS; CHOLESTEROL; INHIBITOR; CLEARANCE		UNIV TOKYO,INST MOL & CELLULAR BIOSCI,BUNKYO KU,TOKYO 113,JAPAN	Hiramoto, S (reprint author), NISSHIN FLOUR MILLING CO LTD,PHARMACOL & BIOCHEM LAB,5-3-1 TSURUGAOKA,OI,SAITAMA 356,JAPAN.						MAHLEY RW, 1989, J CLIN INVEST, V83, P2125, DOI 10.1172/JCI114126; DALE JA, 1973, J AM CHEM SOC, V95, P512, DOI 10.1021/ja00783a034; YAMADA N, 1989, P NATL ACAD SCI USA, V86, P665, DOI 10.1073/pnas.86.2.665; RASH JM, 1981, BIOCHIM BIOPHYS ACTA, V666, P294, DOI 10.1016/0005-2760(81)90120-X; YAMADA N, 1992, J CLIN INVEST, V89, P706, DOI 10.1172/JCI115639; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Hasumi K, 1995, J ANTIBIOT, V48, P1419; BASHEERUDDIN K, 1992, J BIOL CHEM, V267, P1219; HORIE M, 1993, BIOCHIM BIOPHYS ACTA, V1168, P45; KRAUSE BR, 1993, J LIPID RES, V34, P279; LEBLOND L, 1993, J BIOL CHEM, V268, P1670; YE SQ, 1993, J BIOL CHEM, V268, P8497	12	6	6	JAPAN ANTIBIOT RES ASSN	TOKYO	2 20 8 KAMIOSAKI SHINAGAWA KU, TOKYO 141, JAPAN	0021-8820			J ANTIBIOT	J. Antibiot.	SEP	1996	49	9					949	952				4	Biotechnology & Applied Microbiology; Immunology; Microbiology; Pharmacology & Pharmacy	Biotechnology & Applied Microbiology; Immunology; Microbiology; Pharmacology & Pharmacy	VJ736	WOS:A1996VJ73600020		
J	Yamamoto, Y; Hoshikawa, Y; Miyashita, M				Yamamoto, Y; Hoshikawa, Y; Miyashita, M			Effects of acute exposure to simulated altitude on heart rate variability during exercise	JOURNAL OF APPLIED PHYSIOLOGY			English	Article						autonomic nervous system; spectral analysis; fractal; hypoxia	STEADY-STATE EXERCISE; SPECTRAL-ANALYSIS; FRACTAL DIMENSION; AUTONOMIC CONTROL; MODULATION; COMPONENTS; PRESSURE	It has been shown that fluctuation of human heartbeat intervals [heart rate variability (HRV)] reflects variations in cardiac autonomic nervous system activity. The present study was designed to investigate whether the acute exposure to moderate levels of simulated altitude and the resultant hypoxia could modify HRV during exercise. Seven healthy men completed one resting measurement in the upright sitting position and two submaximal steady-state cycle ergometer exercises at intensities equivalent to 25 and 50% of their estimated maximal work rate. Experiments were conducted in random order at altitude equivalents of 500, 1,500, 2,500, and 3,500 m within 2 h of exposure to that altitude. Beat-to-beat HRV was measured continuously during the tests. HRV data were analyzed by ''coarse-graining spectral analysis'' (Y. Yamamoto and R. I;. Hughson, Physica 68D: 250-264, 1993) to break down their total power (P-T) into harmonic and nonharmonic (fractal) components. The harmonic component was further divided into low (0.0- to 0.15-Hz; P-L)- and high (>0.15-Hz; P-H)- frequency components, and the indicators of relative sympathetic (SNS) and parasympathetic (PNS) nervous system activities were calculated by P-L/P-H and P-H/P-T, respectively The fractal component was used to calculate the spectral exponent (beta) to evaluate the overall ''irregularity'' of HRV. The effects of exercise intensity (increase in heart rate, SNS indicator, and beta and decrease in PNS indicator) were significant (P < 0.05) at all altitude levels. The altitude effects (increase in heart rate and SNS indicator and decrease in PNS indicator) were found only during exercise at 3,500 m (P < 0.05). There was no significant effect of altitude on beta (P > 0.05). These data indicate that acute effects of altitude exposure on HRV were found I) during exercise at moderate altitude (>2,500 m) and 2) mainly for the harmonic components of HRV.		Yamamoto, Y (reprint author), UNIV TOKYO,GRAD SCH EDUC,LAB EXERCISE PHYSIOL & BIOMECHAN,BUNKYO KU,7-3-1 HONGO,TOKYO 113,JAPAN.						RICHALET JP, 1988, J APPL PHYSIOL, V65, P1957; KAMATH MV, 1991, MED SCI SPORT EXER, V23, P428; BUTLER GC, 1993, J APPL PHYSIOL, V75, P2602; LIPSITZ LA, 1990, CIRCULATION, V81, P1803; KOLLER EA, 1988, EUR J APPL PHYSIOL O, V57, P163, DOI 10.1007/BF00640657; BREUER HWM, 1993, BRIT HEART J, V70, P144; SOMERS VK, 1989, J APPL PHYSIOL, V67, P2095; HUGHSON RL, 1994, J APPL PHYSIOL, V77, P2537; PAGANI M, 1986, CIRC RES, V59, P178; ARAI Y, 1989, AM J PHYSIOL, V256, pH132; SKINNER JE, 1990, BIO-TECHNOL, V8, P1018, DOI 10.1038/nbt1190-1018; YAMAMOTO Y, 1991, J APPL PHYSIOL, V71, P1143; YAMAMOTO Y, 1991, J APPL PHYSIOL, V71, P1136; BROWN TE, 1993, J APPL PHYSIOL, V75, P2310; MALLIANI A, 1991, CIRCULATION, V84, P482; BUTLER GC, 1994, AM J PHYSIOL, V267, pR26; CALY MD, 1986, HDB PHYSL RESPIR 2 3, V2, P529; DEERING W, 1992, IEEE ENG MED BIOL, V11, P40, DOI 10.1109/51.139035; HARTLEY LH, 1974, J APPL PHYSIOL, V36, P362; MALIK M, 1993, AM J CARDIOL, V72, P821, DOI 10.1016/0002-9149(93)91070-X; Mandelbrot B. B., 1983, FRACTAL GEOMETRY NAT; MAYERKRESS G, 1988, MATH BIOSCI, V90, P155, DOI 10.1016/0025-5564(88)90063-6; MAZZEO RS, 1991, AM J PHYSIOL, V261, pE419; MIYASHITA M, 1985, SPORTS MED, V2, P159; NAKAMURA Y, 1993, J APPL PHYSIOL, V74, P875; SAUL JP, 1990, NEWS PHYSIOL SCI, V5, P32; SOMERS VK, 1989, J APPL PHYSIOL, V67, P2101; WOLFEL EE, 1991, J APPL PHYSIOL, V70, P1143; YAMAMOTO Y, 1995, AM J PHYSIOL-HEART C, V269, pH480; YAMAMOTO Y, 1994, AM J PHYSIOL, V266, pR40; YAMAMOTO Y, 1995, AM J PHYSIOL-REG I, V269, pR830; YAMAMOTO Y, 1993, PHYSICA D, V68, P250, DOI 10.1016/0167-2789(93)90083-D	32	28	31	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	8750-7587			J APPL PHYSIOL	J. Appl. Physiol.	SEP	1996	81	3					1223	1229				7	Physiology; Sport Sciences	Physiology; Sport Sciences	VH307	WOS:A1996VH30700026		
J	Fukunaga, T; Ito, M; Ichinose, Y; Kuno, S; Kawakami, Y; Fukashiro, S				Fukunaga, T; Ito, M; Ichinose, Y; Kuno, S; Kawakami, Y; Fukashiro, S			Tendinous movement of a human muscle during voluntary contractions determined by real-time ultrasonography	JOURNAL OF APPLIED PHYSIOLOGY			English	Article						pennate muscle; tibialis anterior muscle	FIBER; TENDON; LENGTH; INVIVO; MRI	The degree of shortening or lengthening of muscles during joint actions has not been clarified in humans, although such information is essential in understanding human muscle functions. In this study, the tendinous movement of a muscle was determined by real-time ultrasonography during voluntary contractions. The tibialis anterior muscle (TA) was tested in five healthy men who performed dorsi- and plantar flexion movements (shortening and lengthening of TA) at two frequencies (0.1 and 1.5 Hz). The insertion point (eta) of fascicles onto the aponeurosis was clearly visualized on the ultrasonogram, and its position relative to a fixed marker moved proximally and distally according to dorsi- and plantar flexion of ankle joint. The movement of eta occurred in phase with the angular change of ankle joint, giving high correlations (I = 0.93 to 0.97) between the displacement of eta and the angle. The displacement of eta for one radian of joint angle change, 46.5 +/- 1.7 (SD) mm, was comparable to the reported moment arm of TA. The present method has many potential applications in the field of muscle physiology and biomechanics in humans.	UNIV TSUKUBA,TSUKUBA ADV RES ALLIANCE,TSUKUBA,IBARAKI 305,JAPAN	Fukunaga, T (reprint author), UNIV TOKYO,DEPT LIFE SCI,LAB SPORTS SCI,3-8-1 KOMABA,TOKYO 153,JAPAN.		fukunaga, tetsuo/C-6635-2009				Alexander R.M., 1975, J HUMAN MOVEMENT STU, V1, P115; LOEB GE, 1987, J MORPHOL, V191, P1, DOI 10.1002/jmor.1051910102; SPOOR CW, 1992, J BIOMECH, V25, P201, DOI 10.1016/0021-9290(92)90276-7; KAWAKAMI Y, 1993, J APPL PHYSIOL, V74, P2740; RUGG SG, 1990, J BIOMECH, V23, P495, DOI 10.1016/0021-9290(90)90305-M; AMIS A, 1987, J PHYSIOL-LONDON, V389, P37; WOO SLY, 1981, J BIOMECH ENG-T ASME, V103, P51; FELLOWS SJ, 1987, J PHYSIOL-LONDON, V383, P405; HENRIKSSONLARSEN K, 1992, EUR J APPL PHYSIOL O, V64, P68, DOI 10.1007/BF00376443; KUNO SY, 1995, EUR J APPL PHYSIOL O, V70, P45, DOI 10.1007/BF00601807; RUTHERFORD OM, 1992, EUR J APPL PHYSIOL O, V65, P433, DOI 10.1007/BF00243510; Wilkie DR, 1950, J PHYSIOL-LONDON, V110, P249; ZUURBIER CJ, 1994, J BIOMECH, V27, P445, DOI 10.1016/0021-9290(94)90020-5	13	60	62	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	8750-7587			J APPL PHYSIOL	J. Appl. Physiol.	SEP	1996	81	3					1430	1433				4	Physiology; Sport Sciences	Physiology; Sport Sciences	VH307	WOS:A1996VH30700053		
J	Saito, SY; Watabe, S; Ozaki, H; Kigoshi, H; Yamada, K; Fusetani, N; Karaki, H				Saito, SY; Watabe, S; Ozaki, H; Kigoshi, H; Yamada, K; Fusetani, N; Karaki, H			Novel actin depolymerizing macrolide aplyronine A	JOURNAL OF BIOCHEMISTRY			English	Article						actin; actin depolymerization; aplyronine A; macrolide; mycalolide B	BOUND ADENOSINE 5'-TRIPHOSPHATE; SPONTANEOUS FRAGMENTATION; DEOXYRIBONUCLEASE-I; MYCALOLIDE-B; TROPOMYOSIN; EXCHANGE; FILAMENTS; PROFILIN; SPONGE	Aplyronine A is a macrolide isolated from Aplysia kurodai. By monitoring fluorescent intensity of pyrenyl-actin, it was found that aplyronine A inhibited both the velocity and the degree of actin polymerization. Aplyronine A also quickly depolymerized F-actin. The kinetics of depolymerization suggest that aplyronine A severs F-actin, The relationship between the concentration of total actin and F-actin at different concentrations of aplyronine A suggests that aplyronine A forms a 1:1 complex with G-actin, From these results, it is concluded that aplyronine A inhibits actin polymerization and depolymerizes F-actin by nibbling. Comparison of the chemical structure of aplyronine A and another actin-depolymerizing macrolide, mycalolide B, suggests that the side-chain but not the macrolide ring of aplyronine A may account for its actin binding and severing activity.	UNIV TOKYO,GRAD SCH AGR & LIFE SCI,MARINE BIOCHEM LAB,BUNKYO KU,TOKYO 113,JAPAN; NAGOYA UNIV,FAC SCI,DEPT CHEM,NAGOYA,AICHI 464,JAPAN							ISHIKAWA R, 1989, J BIOL CHEM, V264, P16764; MANNHERZ HG, 1980, EUR J BIOCHEM, V104, P367, DOI 10.1111/j.1432-1033.1980.tb04437.x; MOCKRIN SC, 1980, BIOCHEMISTRY-US, V19, P5359, DOI 10.1021/bi00564a033; WEGNER A, 1979, J MOL BIOL, V131, P839, DOI 10.1016/0022-2836(79)90204-3; YAMADA K, 1993, J AM CHEM SOC, V115, P11020, DOI 10.1021/ja00076a082; HITCHCOCK SE, 1980, J BIOL CHEM, V255, P5668; SAITO S, 1994, J BIOL CHEM, V269, P29710; BAILEY K, 1948, BIOCHEM J, V43, P271; FUSETANI N, 1989, TETRAHEDRON LETT, V30, P2809, DOI 10.1016/S0040-4039(00)99131-7; HORI M, 1993, FEBS LETT, V322, P151, DOI 10.1016/0014-5793(93)81557-G; MABUCHI I, 1983, J CELL BIOL, V97, P1612, DOI 10.1083/jcb.97.5.1612; NISHIDA E, 1985, BIOCHEMISTRY-US, V24, P1160, DOI 10.1021/bi00326a015; SAMPATH P, 1991, BIOCHEMISTRY-US, V30, P1973, DOI 10.1021/bi00221a034; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; TOBACMAN LS, 1982, J BIOL CHEM, V257, P4166; WAECHTER F, 1975, EUR J BIOCHEM, V57, P453, DOI 10.1111/j.1432-1033.1975.tb02320.x; WEGNER A, 1982, J MOL BIOL, V161, P217, DOI 10.1016/0022-2836(82)90149-8; WEGNER A, 1982, NATURE, V296, P266, DOI 10.1038/296266a0	18	53	54	JAPAN BIOCHEMICAL SOC	TOKYO	ISHIKAWA BLDG-3F 25-16 HONGO-5-CHOME, TOKYO TOKYO 113, JAPAN	0021-924X			J BIOCHEM-TOKYO	J. Biochem. (Tokyo)	SEP	1996	120	3					552	555				4	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	VG428	WOS:A1996VG42800016		
J	Nakano, A				Nakano, A			Identification and characterization of extragenic suppressors of the yeast sec12 ts mutation	JOURNAL OF BIOCHEMISTRY			English	Article						endoplasmic reticulum; RST; Saccharomyces cerevisiae; SEC12; vesicular transport	BINDING SAR1 PROTEIN; ENDOPLASMIC-RETICULUM; SECRETORY PATHWAY; GOLGI-APPARATUS; MEMBRANE GLYCOPROTEIN; TRANSMEMBRANE PROTEIN; RESIDENT PROTEINS; TRANSPORT; ER; VESICLES	The product of the yeast SEC12 gene is the most upstream player as far as we know in the events of vesicle budding from the endoplasmic reticulum membrane. To understand how the Sec12p function could be regulated, I identified three extragenic suppressor mutations of the sec12 ts mutation. RST1(DS) is a dominant mutation and causes elevated expression of Sec12p. rst2 and rst3 are recessive and give pleiotropic phenotypes including slow growth at low temperatures and heterogeneous modification of Sec12p. Their possible poles are discussed.		Nakano, A (reprint author), UNIV TOKYO,GRAD SCH SCI,DEPT SCI BIOL,BUNKYO KU,HONGO,TOKYO 113,JAPAN.		Nakano, Akihiko/C-6185-2009				KAISER CA, 1990, CELL, V61, P723, DOI 10.1016/0092-8674(90)90483-U; KOHNO K, 1993, MOL CELL BIOL, V13, P877; MORI K, 1993, CELL, V74, P743; REXACH MF, 1991, J CELL BIOL, V114, P219, DOI 10.1083/jcb.114.2.219; NORMINGTON K, 1989, CELL, V57, P1223, DOI 10.1016/0092-8674(89)90059-7; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; BARLOWE C, 1993, NATURE, V365, P347, DOI 10.1038/365347a0; BEH CT, 1995, P NATL ACAD SCI USA, V92, P9820, DOI 10.1073/pnas.92.21.9820; DENFERT C, 1991, MOL CELL BIOL, V11, P5727; MIZUTA K, 1994, MOL CELL BIOL, V14, P2493; NAKANO A, 1989, J CELL BIOL, V109, P2677, DOI 10.1083/jcb.109.6.2677; NAKANO A, 1994, J BIOCHEM-TOKYO, V116, P243; NAKANO A, 1988, J CELL BIOL, V107, P851, DOI 10.1083/jcb.107.3.851; NISHIKAWA S, 1993, P NATL ACAD SCI USA, V90, P8179, DOI 10.1073/pnas.90.17.8179; NISHIKAWA S, 1991, BIOCHIM BIOPHYS ACTA, V1093, P135, DOI 10.1016/0167-4889(91)90114-D; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; NOVICK P, 1983, J CELL BIOL, V96, P541, DOI 10.1083/jcb.96.2.541; OKA T, 1994, J CELL BIOL, V124, P425, DOI 10.1083/jcb.124.4.425; OKA T, 1991, J CELL BIOL, V114, P671, DOI 10.1083/jcb.114.4.671; SATO K, 1995, MOL BIOL CELL, V6, P1459; Sato M, 1996, J CELL BIOL, V134, P279, DOI 10.1083/jcb.134.2.279; STEVENS T, 1982, CELL, V30, P439, DOI 10.1016/0092-8674(82)90241-0; VAHLENSIECK Y, 1995, YEAST, V11, P901, DOI 10.1002/yea.320111002	24	2	2	JAPAN BIOCHEMICAL SOC	TOKYO	ISHIKAWA BLDG-3F 25-16 HONGO-5-CHOME, TOKYO TOKYO 113, JAPAN	0021-924X			J BIOCHEM-TOKYO	J. Biochem. (Tokyo)	SEP	1996	120	3					642	646				5	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	VG428	WOS:A1996VG42800027		
J	Tanji, M; Yakabe, E; Kageyama, T; Takahashi, K				Tanji, M; Yakabe, E; Kageyama, T; Takahashi, K			The primary structure of the major pepsinogen from the gastric mucosa of tuna stomach	JOURNAL OF BIOCHEMISTRY			English	Article						amino acid sequence; pepsin; pepsinogen; phylogenetic tree; tuna	AMINO-ACID-SEQUENCE; MAXILLARY GLAND RENIN; SPLEEN CATHEPSIN-D; PORCINE PEPSINOGEN; ASPARTIC PROTEINASES; NUCLEOTIDE-SEQUENCE; CHICKEN PEPSINOGEN; MOLECULAR-CLONING; 1.8-A RESOLUTION; C GENE	The complete primary structure of the major component of tuna pepsinogens was determined by conventional protein chemistry methods, It was composed of a prosegment of 37 residues and a pepsin moiety of 323 residues, having a relative molecular mass of 39,364, The essential aspartyl residues in the active site and the three disulfide bonds common to other pepsinogens were conserved; however, several unique substitutions and/or deletions characteristic of tuna pepsinogen were found at various positions, especially in the prosegment and subsite regions, as compared with the sequences of other pepsinogens, which may affect the rate of activation of the zymogen, and/or the catalytic function and substrate specificity of the enzyme, Tuna pepsinogen is the least acidic among pepsinogens, The sequence identity between tuna pepsinogen and other pepsinogens ranged from 45 to 52%, A phylogenetic tree based on the primary structures suggested that tuna pepsinogen diverged from the pepsinogen A and prochymosin groups in an early period of pepsinogen evolution.	TOKYO UNIV PHARM & LIFE SCI,SCH LIFE SCI,HACHIOJI,TOKYO 19203,JAPAN; UNIV TOKYO,GRAD SCH SCI,DEPT BIOPHYS & BIOCHEM,TOKYO 113,JAPAN; AOYAMA GAKUIN UNIV,FAC SCI & TECHNOL,DEPT CHEM,SETAGAYA KU,TOKYO 157,JAPAN; KYOTO UNIV,PRIMATE RES INST,DEPT CELLULAR & MOL BIOL,INUYAMA,AICHI 484,JAPAN							ALJANABI J, 1972, J BIOL CHEM, V247, P4628; SPACKMAN DH, 1958, ANAL CHEM, V30, P1190, DOI 10.1021/ac60139a006; HARTSUCK JA, 1992, PROTEINS, V13, P1, DOI 10.1002/prot.340130102; IMAI T, 1983, P NATL ACAD SCI-BIOL, V80, P7405, DOI 10.1073/pnas.80.24.7405; FITCH WM, 1967, SCIENCE, V155, P279, DOI 10.1126/science.155.3760.279; CRESTFIELD AM, 1963, J BIOL CHEM, V238, P622; TANG J, 1973, P NATL ACAD SCI USA, V70, P3437, DOI 10.1073/pnas.70.12.3437; SIELECKI AR, 1991, J MOL BIOL, V219, P671, DOI 10.1016/0022-2836(91)90664-R; DEREN JS, 1971, AM J CLIN NUTR, V24, P144; JAMES MNG, 1986, NATURE, V319, P33, DOI 10.1038/319033a0; SIELECKI AR, 1990, J MOL BIOL, V214, P143, DOI 10.1016/0022-2836(90)90153-D; FAUST PL, 1985, P NATL ACAD SCI USA, V82, P4910, DOI 10.1073/pnas.82.15.4910; KAPOOR BG, 1975, ADV MAR BIOL, V13, P109; AZUMA T, 1989, J BIOL CHEM, V264, P16748; BAHAK Z, 1969, J BIOL CHEM, V244, P4638; BAUDYS M, 1983, EUR J BIOCHEM, V136, P89, DOI 10.1111/j.1432-1033.1983.tb07709.x; BUSTIN M, 1971, J BIOL CHEM, V246, P615; COOPER JB, 1990, J MOL BIOL, V214, P199, DOI 10.1016/0022-2836(90)90156-G; DE BERNARDO S, 1974, ARCH BIOCHEM BIOPHYS, V163, P390, DOI 10.1016/0003-9861(74)90490-1; Edman P, 1975, PROTEIN SEQUENCE DET, P232; FOLTMANN B, 1966, CR TRAV LAB CARLSB, V35, P143; FOLTMANN B, 1977, P NATL ACAD SCI USA, V74, P2321, DOI 10.1073/pnas.74.6.2321; FOLTMANN B, 1981, ESSAYS BIOCHEM, V17, P52; GILDBERG A, 1988, COMP BIOCHEM PHYS B, V91, P425, DOI 10.1016/0305-0491(88)90002-8; HAYANO T, 1988, J BIOL CHEM, V263, P1382; HAYASHI K, 1988, J BIOCHEM-TOKYO, V103, P290; ICHIHARA Y, 1986, EUR J BIOCHEM, V161, P7, DOI 10.1111/j.1432-1033.1986.tb10117.x; ISHIHARA T, 1989, J BIOL CHEM, V264, P10193; KAGEYAMA T, 1987, EUR J BIOCHEM, V165, P483, DOI 10.1111/j.1432-1033.1987.tb11464.x; KAGEYAMA T, 1992, J BIOL CHEM, V267, P16450; KAGEYAMA T, 1986, J BIOL CHEM, V261, P4406; KAGEYAMA T, 1990, J BIOL CHEM, V265, P17031; KAGEYAMA T, 1986, J BIOL CHEM, V261, P4395; MARCINISZYN J, 1976, J BIOL CHEM, V254, P7095; MCPHIE P, 1974, BIOCHEM BIOPH RES CO, V56, P789, DOI 10.1016/0006-291X(74)90674-3; MISONO KS, 1982, P NATL ACAD SCI-BIOL, V79, P4858, DOI 10.1073/pnas.79.16.4858; ONG EB, 1968, J BIOL CHEM, V243, P6104; PANTHIER JJ, 1982, NATURE, V298, P90, DOI 10.1038/298090a0; PEDERSEN VB, 1973, FEBS LETT, V35, P255, DOI 10.1016/0014-5793(73)80298-4; SCHECHTE.I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; SCHECHTE.I, 1968, BIOCHEM BIOPH RES CO, V32, P898, DOI 10.1016/0006-291X(68)90326-4; SHEWALE JG, 1984, P NATL ACAD SCI-BIOL, V81, P3703, DOI 10.1073/pnas.81.12.3703; SOGAWA K, 1983, J BIOL CHEM, V258, P5306; STEPANOV VM, 1973, BIOCHEM BIOPH RES CO, V54, P1164, DOI 10.1016/0006-291X(73)90814-0; SUZUKI J, 1989, PROTEIN ENG, V2, P563, DOI 10.1093/protein/2.7.563; TAGGART RT, 1989, J BIOL CHEM, V264, P375; Takahashi K., 1985, ASPARTIC PROTEINASES, P265; TAKAHASHI T, 1983, J BIOL CHEM, V258, P6435; TANG J, 1987, J CELL BIOCHEM, V33, P53, DOI 10.1002/jcb.240330106; TANJI M, 1988, EUR J BIOCHEM, V177, P251, DOI 10.1111/j.1432-1033.1988.tb14369.x; TARR GE, 1975, ANAL BIOCHEM, V63, P361, DOI 10.1016/0003-2697(75)90358-9; TSUNASAWA S, 1985, J BIOCHEM-TOKYO, V97, P701; VANEERD JP, 1976, BIOCHEMISTRY-US, V15, P1171, DOI 10.1021/bi00650a033; YAKABE E, 1991, J BIOL CHEM, V266, P22436	54	19	21	JAPAN BIOCHEMICAL SOC	TOKYO	ISHIKAWA BLDG-3F 25-16 HONGO-5-CHOME, TOKYO TOKYO 113, JAPAN	0021-924X			J BIOCHEM-TOKYO	J. Biochem. (Tokyo)	SEP	1996	120	3					647	656				10	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	VG428	WOS:A1996VG42800028		
J	Kojima, T; Fukuda, M; Aruga, J; Mikoshiba, K				Kojima, T; Fukuda, M; Aruga, J; Mikoshiba, K			Calcium-dependent phospholipid binding to the C2A domain of a ubiquitous form of double C2 protein (Doc2 beta)	JOURNAL OF BIOCHEMISTRY			English	Article						C2 domain; Ca2+ sensor; Doc2; rabphilin 3A; synaptotagmin	ANTIBODY INJECTION; SYNAPTOTAGMIN-II; VESICLE PROTEIN; KINASE-C; RABPHILIN-3A; SYNAPSE; RELEASE; FUSION; FAMILY; RAB3A	Rabphilin 3A and Doc2(alpha) are synaptic vesicle-associated proteins, and are thought to function as Ca2+ sensors in neurotransmitter release, If either rabphilin 3A or Doc2(alpha) plays a role in membrane trafficking, like the synaptotagmins, then non-neural forms should be present, Here we describe the isolation of a mouse cDNA which encodes a novel Doc2 homologue (Doc2(beta)) that is present in all tissues, The encoded protein, which is highly homologous to human Doc2(alpha) (70% identity), is composed of 412 amino acids with a calculated relative molecular mass (M(r)) of 45,837, The sequence identity is especially high in two C2 domains (74% in C2A and 84% in C2B), Northern and Western blot analyses have shown that Doc2(beta) is expressed in all cell lines and tissues tested, Ca2+-dependent phospholipid binding assaying of recombinant fusion proteins revealed that the single C2A domain, but not the C2B domain, of Doc2(beta) binds phosphatidycholine and phosphatidylserine (2.5:1, w/w) liposomes, The binding is Ca2+-dependent, with an EC(50) value of approximately 1 mu M and a Hill coefficient of approximately 3, which are comparable to those of synaptotagmins, rabphilin 3A and Doc2(alpha). Our results suggest that Doc2(beta) is involved in constitutive membrane trafficking.	RIKEN,TSUKUBA LIFE SCI CTR,MOL NEUROBIOL LAB,TSUKUBA,IBARAKI 305,JAPAN; UNIV TOKYO,DEPT MOL NEUROBIOL,INST MED SCI,MINATO KU,TOKYO 108,JAPAN; ERATO,CALCIOSIGNAL NET PROJECT,MEGURO KU,TOKYO 153,JAPAN			Aruga, Jun/H-5837-2011; Fukuda, MItsunori/I-1511-2015				FUKUDA M, 1995, P NATL ACAD SCI USA, V92, P10708, DOI 10.1073/pnas.92.23.10708; MIKOSHIBA K, 1995, P NATL ACAD SCI USA, V92, P10703, DOI 10.1073/pnas.92.23.10703; FURUICHI T, 1989, NATURE, V342, P32, DOI 10.1038/342032a0; ELFERINK LA, 1989, J BIOL CHEM, V264, P11061; FERRONOVICK S, 1994, NATURE, V370, P191, DOI 10.1038/370191a0; DAVLETOV BA, 1993, J BIOL CHEM, V268, P26386; WENDLAND B, 1991, NEURON, V6, P993, DOI 10.1016/0896-6273(91)90239-V; PERIN MS, 1990, NATURE, V345, P260, DOI 10.1038/345260a0; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; BENNETT MK, 1993, P NATL ACAD SCI USA, V90, P2559, DOI 10.1073/pnas.90.7.2559; MCMAHON HT, 1993, NATURE, V364, P346, DOI 10.1038/364346a0; LI C, 1995, NATURE, V375, P594, DOI 10.1038/375594a0; SUTTON RB, 1995, CELL, V80, P929, DOI 10.1016/0092-8674(95)90296-1; Fukuda M, 1996, J BIOL CHEM, V271, P8430; BECKERS CJM, 1989, J CELL BIOL, V108, P1245, DOI 10.1083/jcb.108.4.1245; BENNETT MK, 1993, CELL, V74, P863, DOI 10.1016/0092-8674(93)90466-4; Burns M. E., 1995, Society for Neuroscience Abstracts, V21, P326; CHAPMAN ER, 1994, J BIOL CHEM, V269, P5735; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHUNG SH, 1995, J BIOL CHEM, V270, P16714; FUKUDA M, 1995, J BIOL CHEM, V270, P26523; FUKUDA M, 1994, J BIOL CHEM, V269, P29206; GEPPERT M, 1991, J BIOL CHEM, V266, P13548; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LI C, 1995, J BIOL CHEM, V270, P24898; MOCHIDA S, 1995, SAT S 15 ISN M JUN 2, P124; OHARAIMAIZUMI M, 1995, SAT S 15 ISN M JUN 2, P125; ORITA S, 1995, BIOCHEM BIOPH RES CO, V206, P439, DOI 10.1006/bbrc.1995.1062; Orita S, 1996, J BIOL CHEM, V271, P7257; PERIN MS, 1991, J BIOL CHEM, V266, P615; ROSEJOHN S, 1988, GENE, V74, P465, DOI 10.1016/0378-1119(88)90179-5; Sakaguchi G, 1995, BIOCHEM BIOPH RES CO, V217, P1053, DOI 10.1006/bbrc.1995.2876; SHIRATAKI H, 1994, J BIOL CHEM, V269, P32717; SHIRATAKI H, 1993, MOL CELL BIOL, V13, P2061; SOLLNER T, 1994, TRENDS NEUROSCI, V17, P344, DOI 10.1016/0166-2236(94)90178-3; YAMAGUCHI T, 1993, J BIOL CHEM, V268, P27164	36	37	38	JAPAN BIOCHEMICAL SOC	TOKYO	ISHIKAWA BLDG-3F 25-16 HONGO-5-CHOME, TOKYO TOKYO 113, JAPAN	0021-924X			J BIOCHEM-TOKYO	J. Biochem. (Tokyo)	SEP	1996	120	3					671	676				6	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	VG428	WOS:A1996VG42800031		
J	Hung, SC; Kurokawa, T; Nakamura, K; Matsushita, T; Shiro, R; Okazaki, H				Hung, SC; Kurokawa, T; Nakamura, K; Matsushita, T; Shiro, R; Okazaki, H			Narrowing of the joint space of the hip after traumatic shortening of the femur	JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME			English	Article							CARTILAGE	Femoral lengthening has been associated with narrowing of the joint space at the hip, We have studied the joint space before lengthening in 20 patients with a short femur due to a femoral-shaft fracture (15) or distal femoral epiphyseal injury (5), Their mean age at injury was 16 years (3 to 27) and the mean shortening was 5.4 cm (1.1 to 14). We found that the hip joint space of the shortened femur was significantly narrower (p < 0.001) than that on the normal side, with a mean narrowing ratio of 15.5% (-5 to +43), The narrowing ratio was directly related to the period spent non-weightbearing (p < 0.001), but not to the amount of femoral shortening. We have shown that the joint space of the hip in patients with post-traumatic femoral shortening was narrowed even before femoral lengthening had been started.		Hung, SC (reprint author), UNIV TOKYO,FAC MED,DEPT ORTHOPAED SURG,BUNKYO KU,7-3-1 HONGO,TOKYO 113,JAPAN.						PALMOSKI M, 1979, ARTHRITIS RHEUM, V22, P508, DOI 10.1002/art.1780220511; PALMOSKI MJ, 1980, ARTHRITIS RHEUM, V23, P325, DOI 10.1002/art.1780230310; BENICHOU C, 1982, ARTHRITIS RHEUM, V25, P80, DOI 10.1002/art.1780250113; BOLLET AJ, 1969, ARTHRITIS RHEUM, V12, P152, DOI 10.1002/art.1780120212; HIROSHIMA K, 1991, SEIKEISAIGAIGEKA, V35, P15; HUNG SC, 1995, E JPN J CLIN ORTHOP, V7, P47; MORSCHER E, 1977, PROGR ORTHOP SURG, V1, P9; POOL WH, 1974, RADIOLOGY, V112, P47; TESHIMA R, 1992, CLIN ORTHOPAEDICS, V279, P149; TROYER H, 1975, CLIN ORTHOP RELAT R, V107, P249, DOI 10.1097/00003086-197503000-00029	10	3	3	BRITISH EDITORIAL SOC BONE JOINT SURGERY	LONDON	22 BUCKINGHAM STREET, LONDON, ENGLAND WC2N 6ET	0301-620X			J BONE JOINT SURG BR	J. Bone Joint Surg.-Br. Vol.	SEP	1996	78B	5					718	721				4	Orthopedics; Surgery	Orthopedics; Surgery	VH752	WOS:A1996VH75200008		
J	Ochial, N; Nagano, A; Sugioka, H; Hara, T				Ochial, N; Nagano, A; Sugioka, H; Hara, T			Nerve grafting in brachial plexus injuries - Results of free grafts in 40-patients	JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME			English	Article							SOMATOSENSORY EVOKED-POTENTIALS; FREE MUSCLE TRANSPLANTATION; RECONSTRUCTION	We have assessed the efficacy of free nerve grafts in 90 cases of brachial plexus injury. Relatively good recovery of the elbow flexor and extensor muscles and of those of the shoulder girdle was found but recovery of the flexors and extensors of the forearm and of the intrinsic muscles of the hand was extremely poor. Poor results were found when spinal nerve roots seemed normal to the touch and appeared intact but had abnormal somatosensory evoked potentials or myelography. Recovery of the deltoid and infraspinatus muscles was better when injury had occurred to the circumflex and suprascapular nerves rather than to the plexus itself, perhaps because these nerves were explored in their entirety to determine the presence of multiple lesions. It is important to visualise the entire nerve thoroughly to assess the overall condition. Thorough exploration of the plexus and the use of intraoperative recording of somatosensory evoked potentials are essential.	UNIV TOKYO,FAC MED,DEPT ORTHOPAED SURG,BUNKYO KU,TOKYO 113,JAPAN; EBARA MUNICIPAL HOSP,OOTA KU,TOKYO,JAPAN	Ochial, N (reprint author), KANTO TEISHIN HOSP,DEPT ORTHOPAED SURG,SHINAGAWA KU,5-9-22 HIGASHI GOTANDA,TOKYO,JAPAN.						AKASAKA Y, 1991, MICROSURG, V12, P346, DOI 10.1002/micr.1920120506; ALNOT JY, 1988, CLIN ORTHOPAEDICS, V237, P9; HENTZ VR, 1988, ORTHOP CLIN N AM, V19, P107; BIRCH R, 1988, CLIN ORTHOPAEDICS, V237, P96; CHUANG DCC, 1993, J HAND SURG-AM, V18A, P285, DOI 10.1016/0363-5023(93)90363-8; DOI K, 1993, PLAST RECONSTR SURG, V91, P872, DOI 10.1097/00006534-199304001-00021; LANDI A, 1980, J BONE JOINT SURG BR, V62, P492; Millesi H, 1977, J Hand Surg Am, V2, P367; MILLESI H, 1988, CLIN ORTHOPAEDICS, V237, P36; NAGANO A, 1989, J HAND SURG-BRIT EUR, V14B, P59, DOI 10.1016/0266-7681(89)90017-X; OCHIAI N, 1988, J JPN SOC SURG HAND, V5, P151; OKINAGA S, 1990, J JPN SOC SURG HAND, V7, P345; ROGER B, 1988, CLIN ORTHOPAEDICS, V237, P57; SEDEL L, 1988, CLIN ORTHOPAEDICS, V237, P62; SUGIOKA H, 1982, ARCH ORTHOP TRAUM SU, V99, P143, DOI 10.1007/BF00379201	15	29	29	BRITISH EDITORIAL SOC BONE JOINT SURGERY	LONDON	22 BUCKINGHAM STREET, LONDON, ENGLAND WC2N 6ET	0301-620X			J BONE JOINT SURG BR	J. Bone Joint Surg.-Br. Vol.	SEP	1996	78B	5					754	758				5	Orthopedics; Surgery	Orthopedics; Surgery	VH752	WOS:A1996VH75200016		
J	Iida, H; Akutsu, T; Endo, K; Fukuda, H; Inoue, T; Ito, H; Koga, S; Komatani, A; Kuwabara, Y; Momose, T; Nishizawa, S; Odano, I; Ohkubo, M; Sasaki, Y; Suzuki, H; Tanada, B; Toyama, H; Yonekura, Y; Yoshida, T; Uemura, K				Iida, H; Akutsu, T; Endo, K; Fukuda, H; Inoue, T; Ito, H; Koga, S; Komatani, A; Kuwabara, Y; Momose, T; Nishizawa, S; Odano, I; Ohkubo, M; Sasaki, Y; Suzuki, H; Tanada, B; Toyama, H; Yonekura, Y; Yoshida, T; Uemura, K			A multicenter validation of regional cerebral blood flow quantitation using [I-123]iodoamphetamine and single photon emission computed tomography	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						CBF quantitation; single photon emission computed tomography; [I-123]iodoamphetamine	INERT-GAS CONCENTRATIONS; PARTITION-COEFFICIENT; MICROSPHERE MODEL; INHALATION METHOD; DYNAMIC SPECT; HUMAN-BRAIN; IODINE-123-IODOAMPHETAMINE; (H2O)-O-15; IODOAMPHETAMINE; IODINE-123-IMP	Recently, two methods have been proposed for regional cerebral blood flow (rCBF) quantitation using [I-123]iodoamphetamine (IMP) and single-photon emission computed tomography (SPECT). The table look-up (TLU) method has been shown to provide both rCBF and volume of distribution, V-d, images from two SPECT scans, while a single-scan autoradiographic (ARG) technique provided rCBF using a fixed and assumed V-d. In both methods, a single blood sample was referred to calibrate the previously determined standard input function The present multicenter project was designed to evaluate the accuracy of both methods for use as clinical investigative tools. Ten independent institutions performed [I-123]IMP-SPECT studies according to both methods in 76 subjects (10 normal volunteers, 32 patients with cerebrovascular disease, and 34 patients with other diseases). Calculated rCBF values were compared with those obtained by the following reference methods available in the participating institutions; [O-15] H2O positron emission tomography (PET) (five institutions), [Xe-133]SPECT (four institutions), and the [I-123]IMP microsphere method (three institutions). Both ARG and TLU methods provided rCBF values that were significantly correlated with those measured by the [O-15] H2O PET technique (p < 0.001 for all subjects; overall regression equation, y = 15.14 + 0.54x) and those measured by the [I-123]IMP-microsphere method (p < 0.001 for all subjects; y = 2.0 + 0.80x). Significant correlation (p < 0.05) was observed in 18 of 24 subjects studied with the [Xe-133] SPECT reference technique (overall regression equation, y = 15.0 + 0.55x). Mean cortical gray matter rCBF in a group of normal subject was 43.9 +/- 3.3 and 33.4 +/- 2.0 ml/min/100 g for the ARG and TLU methods, respectively. Regional V-d of [I-123]IMP estimated by the TLU method was 45 ml/ml +/- 20% in the normal cortical region, Close agreement between ARG and TLU rCBF values was observed (y = -3.21 + 1.07x, r = 0.97), confirming the validity of assuming a fixed V-d in the ARG method. Results of this study demonstrate that both the ARG and TLU methods accurately and reliably estimate rCBF in a variety of clinical settings.	YAMAGATA UNIV,SCH MED,DEPT RADIOL,YAMAGATA 99023,JAPAN; GUNMA UNIV,SCH MED,DEPT NUCL MED,GUNMA,JAPAN; MIYAGE UNIV,INST DEV AGING & CANC,DEPT RADIOL & NUCL MED,TOHOKU,JAPAN; NIIGATA UNIV,SCH MED,DEPT RADIOL,NIIGATA,JAPAN; UNIV TOKYO,FAC MED,DEPT RADIOL,TOKYO 113,JAPAN; FUJITA HLTH UNIV,SCH MED,DEPT RADIOL,AICHI,JAPAN; KYOTO UNIV,SCH MED,DEPT NUCL MED,KYOTO,JAPAN; EHIME UNIV,SCH MED,DEPT RADIOL,MATSUYAMA,EHIME,JAPAN; KYUSHU UNIV,FAC MED,DEPT RADIOL,FUKUOKA 812,JAPAN	Iida, H (reprint author), RES INST BRAIN & BLOOD VESSELS,DEPT RADIOL & NUCL MED,6-10 SENSHU KUBOTA MACHI,AKITA 010,JAPAN.		Iida, Hidehiro/D-4582-2011				HIROSE Y, 1982, IEEE T NUCL SCI, V29, P520, DOI 10.1109/TNS.1982.4335899; KUHL DE, 1982, J NUCL MED, V23, P196; YAMAGUCHI T, 1986, STROKE, V17, P1220; IIDA H, 1986, J CEREBR BLOOD F MET, V6, P536; CRONE C, 1963, ACTA PHYSIOL SCAND, V58, P292, DOI 10.1111/j.1748-1716.1963.tb02652.x; KANNO I, 1987, J CEREBR BLOOD F MET, V7, P143; RENKIN EM, 1959, AM J PHYSIOL, V197, P1205; FRACKOWIAK RSJ, 1980, J COMPUT ASSIST TOMO, V4, P727, DOI 10.1097/00004728-198012000-00001; IIDA H, 1994, J NUCL MED, V35, P2019; IIDA H, 1989, J CEREBR BLOOD F MET, V9, P874; CHANG LT, 1978, IEEE T NUCL SCI, V25, P638, DOI 10.1109/TNS.1978.4329385; RAICHLE ME, 1983, J NUCL MED, V24, P790; CELSIS P, 1981, J COMPUT ASSIST TOMO, V5, P641, DOI 10.1097/00004728-198110000-00006; EICHLING JO, 1974, CIRC RES, V35, P358; GONG W, 1994, J NUCL MED S, V35, P189; GREENBERG JH, 1990, J NUCL MED, V31, P1364; HANSEN M, 1990, STROKE, V21, P745; HASHIKAWA K, 1994, J NUCL MED, V35, P1226; HAZELRIG JB, 1985, STROKE, V16, P964; IIDA H, 1992, CIBA FDN S, V163, P23; IIDA H, 1988, J CEREBR BLOOD F MET, V8, P285, DOI 10.1038/jcbfm.1988.60; IIDA H, 1988, IEEE T NUCL SCI, V36, P1006; Iida H, 1994, Eur J Nucl Med, V21, P1072; IIDA H, 1995, JPN J NUCL MED, V32, P155; Ito H, 1995, Ann Nucl Med, V9, P75; ITO H, 1995, J NUCL MED, V36, P531; ITO H, 1994, JPN J NUCL MED, V31, P1071; ITO H, 1992, JPN J NUCL MED, V29, P1193; KANNO I, 1979, J COMPUT ASSIST TOMO, V3, P71, DOI 10.1097/00004728-197902000-00012; KANNO I, 1985, J COMPUT ASSIST TOMO, V9, P931, DOI 10.1097/00004728-198509000-00017; KOMATANI A, 1990, J NUCL MED, V27, P65; KOMATANI A, 1990, Brain and Nerve (Tokyo), V42, P889; KOURIS K, 1992, EUR J NUCL MED, V19, P236; KUWABARA Y, 1992, STROKE, V23, P594; KYPROS K, 1993, J NUCL MED, V34, P1778; Munaka M, 1992, JPN J NUCL MED, V29, P263; MURASE K, 1990, MED PHYS, V17, P79, DOI 10.1118/1.596531; MURASE K, 1991, Journal of Nuclear Medicine, V32, P911; NISHIZAWA S, 1989, J NUCL MED, V30, P150; ODANO I, 1994, NUCL MED COMMUN, V15, P560, DOI 10.1097/00006231-199407000-00011; ODANO I, 1993, STROKE, V24, P1167; PANTANO P, 1985, EUR J NUCL MED, V10, P387; PODREKA I, 1989, STROKE, V20, P183; REZAI K, 1988, J NUCL MED, V29, P348; SORENSON J, 1974, QUANTITATIVE MEASURE, P311; Takahashi N, 1994, Ann Nucl Med, V8, P253; TAKESHITA G, 1992, J NUCL MED, V33, P1741; TOYAMA H, 1990, J NUCL MED, V31, P55; WINCHELL HS, 1980, J NUCL MED, V21, P947; YAMAUCHI H, 1993, STROKE, V24, P1885; YOKOI T, 1993, J NUCL MED, V34, P498; YONEKURA Y, 1993, J NUCL MED, V34, P839; YONEKURA Y, 1989, J COMPUT ASSIST TOMO, V13, P732, DOI 10.1097/00004728-198907000-00042	53	64	67	LIPPINCOTT-RAVEN PUBL	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106	0271-678X			J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	SEP	1996	16	5					781	793				13	Endocrinology & Metabolism; Hematology; Neurosciences	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	VE555	WOS:A1996VE55500003		
J	Chambers, J; VanWyk, CB; White, PR; Gerrard, CM; Mori, K				Chambers, J; VanWyk, CB; White, PR; Gerrard, CM; Mori, K			Grain weevil, Sitophilus granarius (L): Antennal and behavioral responses to male-produced volatiles	JOURNAL OF CHEMICAL ECOLOGY			English	Article						Sitophilus granarius; grain weevil; Coleoptera; aggregation pheromone; electroantennogram; coupled GC-EAG; behavioral bioassay; circular dichroism	SURINAMENSIS L COLEOPTERA; AGGREGATION PHEROMONE; MAIZE WEEVIL; CHEMICAL-IDENTIFICATION; RICE WEEVIL; ORYZAE L; BEETLE; ZEAMAIS; 5-HYDROXY-4-METHYL-3-HEPTANONE; CURCULIONIDAE	Coupled GC-EAG techniques have been applied to the study of volatiles from the grain weevil, Sitophilus granarius, for the first time. The size of EAG response was independent of the sex of the responding insect but was consistently larger to extracts of males than those of females. This difference was reflected in a behavioral preference for the male extracts by mated adults of both sexes tested together and virgin adults of both sexes tested separately. The GC-EAG results provide evidence for two materials that are released specifically by the males. Using circular dichroism, one has been found to be identical stereochemically with the (2S,3R)-sitophilate reported by others as the aggregation pheromone in a different strain. This enhances the prospects for the development of a single pheromone lure that would be generally applicable whatever the origin of the strain. The small amount of sitophilate found in the males suggests that it is not stored in large amounts. The other material, present in such a small amount that it has yet to be fully characterized, elicits a higher antennal activity than sitophilate and may have a significant role to play in enhancing the trap catch of this economically important pest.	UNIV OXFORD,DEPT ZOOL,OXFORD OX1 3PS,ENGLAND; UNIV TOKYO,DEPT AGR CHEM,BUNKYO KU,TOKYO 113,JAPAN	Chambers, J (reprint author), MAFF,CENT SCI LAB,LONDON RD,SLOUGH SL3 7HJ,BERKS,ENGLAND.						WHITE PR, 1989, J CHEM ECOL, V15, P999, DOI 10.1007/BF01015195; FAUSTINI DL, 1982, J CHEM ECOL, V8, P679, DOI 10.1007/BF00988309; WHITE PR, 1989, J CHEM ECOL, V15, P1015, DOI 10.1007/BF01015196; CHAMBERS J, 1984, B ENTOMOL RES, V74, P707; CHAMBERS J, 1990, J CHEM ECOL, V16, P3353, DOI 10.1007/BF00982103; COGAN PM, 1994, P 6 INT WORK C STOR, V1, P390; HALSTEAD D. G. H., 1963, Bulletin of Entomological Research, V54, P119; LEVINSON HZ, 1990, J APPL ENTOMOL, V110, P203; MCGREEVY PB, 1993, IOBC WPRS B, V16, P250; MORI K, 1986, TETRAHEDRON, V42, P4421, DOI 10.1016/S0040-4020(01)87281-1; MORI K, 1989, LIEBIGS ANN CHEM, P1263; PHILLIPS JK, 1985, J CHEM ECOL, V11, P1263, DOI 10.1007/BF01024114; PHILLIPS JK, 1987, TETRAHEDRON LETT, V28, P6145, DOI 10.1016/S0040-4039(00)61831-2; PHILLIPS JK, 1989, ENTOMOL EXP APPL, V51, P149; PLARRE R, 1994, P 6 INT WORK C STOR, V1, P570; PRICKETT AJ, 1991, 23 AGR DEV ADV SERV; PRICKETT AJ, 1987, 23 AGR DEV ADV SERV; RATHKE MW, 1970, J ORG CHEM, V35, P3966, DOI 10.1021/jo00836a087; SCHMUFF NR, 1984, TETRAHEDRON LETT, V25, P1533, DOI 10.1016/S0040-4039(01)90002-4; WALGENBACH CA, 1987, J CHEM ECOL, V13, P2159, DOI 10.1007/BF01012564; WALGENBACH CA, 1983, J CHEM ECOL, V9, P831, DOI 10.1007/BF00987808; WHITE PR, 1987, J CHEM ECOL, V13, P1695, DOI 10.1007/BF00980211	22	8	9	PLENUM PUBL CORP	NEW YORK	233 SPRING ST, NEW YORK, NY 10013	0098-0331			J CHEM ECOL	J. Chem. Ecol.	SEP	1996	22	9					1639	1654		10.1007/BF02272404		16	Biochemistry & Molecular Biology; Ecology	Biochemistry & Molecular Biology; Environmental Sciences & Ecology	VL105	WOS:A1996VL10500006		
J	Ren, HW; Shen, XQ; Nishinaga, T				Ren, HW; Shen, XQ; Nishinaga, T			In situ observation of macrostep formation on misoriented GaAs(111)B by molecular beam epitaxy	JOURNAL OF CRYSTAL GROWTH			English	Article; Proceedings Paper	11th International Conference on Crystal Growth	JUN 18-23, 1995	THE HAGUE, NETHERLANDS	Int Org Crystal Growth, Dutch Assoc Crystal Growth			QUANTUM-WIRE STRUCTURES; CHEMICAL VAPOR-DEPOSITION; (111)B GAAS; HIGH-INDEX; ALGAAS; GROWTH; SURFACES; WELL	This paper reports, for the first time, the formation of straight macrosteps during the growth of GaAs on misoriented GaAs(111)B substrates inclined toward the [110] direction, and their in situ observation in a microprobe-reflection high-energy-electron-diffraction/scanning-electron-microscope molecular-beam-epitaxy system. It was found that step bunching usually occurs at a lower As, flux under a root 19 x root 19 surface reconstruction, while smooth surfaces are obtained at higher As-4 flux. In situ observation showed that macrosteps are formed gradually during the growth and finally develop into giant macrosteps consisting of flat terraces and rough risers with straight step edges along the [110] direction. Atomic-force-microscopy studies revealed that these macrosteps are composed of near-(111)B terraces and near-(110) risers.		Ren, HW (reprint author), UNIV TOKYO,FAC ENGN,DEPT ELECT ENGN,BUNKYO KU,7-3-1 HONGO,TOKYO 113,JAPAN.						SATO M, 1995, PHYS REV B, V51, P11172, DOI 10.1103/PhysRevB.51.11172; CHEN P, 1991, APPL PHYS LETT, V58, P1771, DOI 10.1063/1.105086; CHIN A, 1991, APPL PHYS LETT, V59, P1899, DOI 10.1063/1.106182; ELCESS K, 1988, J VAC SCI TECHNOL B, V6, P638, DOI 10.1116/1.584376; HAYAKAWA T, 1987, JPN J APPL PHYS 2, V26, pL302, DOI 10.1143/JJAP.26.L302; HAYAKAWA T, 1987, APPL PHYS LETT, V51, P1705, DOI 10.1063/1.98550; INOUE K, 1993, J CRYST GROWTH, V127, P1041, DOI 10.1016/0022-0248(93)90787-W; KASU M, 1992, JPN J APPL PHYS 2, V31, pL864, DOI 10.1143/JJAP.31.L864; NOTZEL R, 1992, PHYS REV B, V45, P3507, DOI 10.1103/PhysRevB.45.3507; NOTZEL R, 1993, J CRYST GROWTH, V127, P858, DOI 10.1016/0022-0248(93)90747-K; OKAMOTO K, 1992, JPN J APPL PHYS 2, V31, pL820, DOI 10.1143/JJAP.31.L820; SCHWOEBE.RL, 1966, J APPL PHYS, V37, P3682, DOI 10.1063/1.1707904; SCHWOEBE.RL, 1969, J APPL PHYS, V40, P614, DOI 10.1063/1.1657442; SMITH DL, 1986, SOLID STATE COMMUN, V57, P919, DOI 10.1016/0038-1098(86)90924-5; SUZUKI T, 1994, J CRYST GROWTH, V142, P49, DOI 10.1016/0022-0248(94)90268-2; TSUTSUI K, 1990, JPN J APPL PHYS 1, V29, P468, DOI 10.1143/JJAP.29.468; YAMAMOTO T, 1993, J CRYST GROWTH, V127, P865, DOI 10.1016/0022-0248(93)90749-M	17	11	12	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-0248			J CRYST GROWTH	J. Cryst. Growth	SEP	1996	166	1-4					217	221		10.1016/0022-0248(95)00528-5		5	Crystallography; Materials Science, Multidisciplinary; Physics, Applied	Crystallography; Materials Science; Physics	VM089	WOS:A1996VM08900036		
J	Zhao, TR; Hasegawa, M; Takei, H				Zhao, TR; Hasegawa, M; Takei, H			Crystal growth and characterization of cuprous ferrite (CuFeO2)	JOURNAL OF CRYSTAL GROWTH			English	Article; Proceedings Paper	11th International Conference on Crystal Growth	JUN 18-23, 1995	THE HAGUE, NETHERLANDS	Int Org Crystal Growth, Dutch Assoc Crystal Growth			NOBLE METAL OXIDES; DELAFOSSITE; CHEMISTRY	The growth of bulk cuprous ferrite (CuFeO2) single crystals by the travelling-solvent, floating-zone technique is reported. Crystals 5 to 8 mm in diameter by 10 to 30 mm have been grown from two sets of starting materials: Cu2O + Fe2O3 and 2CuO + Fe2O3, respectively. The trigonal unit-cell parameters determined by X-ray diffraction are a(h) = 3.035(1) Angstrom and c(h) = 17.161(4) Angstrom in the hexagonal description. Mossbauer studies reveal an isomer shift for Fe-57 at room temperature of 0.40 mm/s with respect to metallic iron, confirming that iron is in the trivalent state and that CuFeO2 is cuprous metaferrite (Cu+Fe3+O2). Magnetic susceptibility indicates that CuFeO2 undergoes two successive magnetic transition temperatures around T-N1 = 13.5 K and T-N2 = 9.5 K, respectively. Thermal analysis reveals that, under an argon atmosphere, CuFeO2 partially decomposes at 1180 degrees C to form Fe2O3 (or Fe3O4) and Cu2O.		Zhao, TR (reprint author), UNIV TOKYO,INST SOLID STATE PHYS,MINATO KU,7-22-1 ROPPONGI,TOKYO 106,JAPAN.						SHANNON RD, 1971, INORG CHEM, V10, P713, DOI 10.1021/ic50098a011; MEKATA M, 1993, J PHYS SOC JPN, V62, P4474, DOI 10.1143/JPSJ.62.4474; PREWITT CT, 1971, INORG CHEM, V10, P719; MITSUDA S, 1991, J PHYS SOC JPN, V60, P1885, DOI 10.1143/JPSJ.60.1885; APOSTOLOV A, 1966, FIZ PAK, V59, P47; BENKO FA, 1987, J PHYS CHEM SOLIDS, V48, P431, DOI 10.1016/0022-3697(87)90103-X; DORDOR P, 1988, J SOLID STATE CHEM, V75, P105, DOI 10.1016/0022-4596(88)90307-6; KLOCKOW EW, 1988, JCPDS GRANT IN AID R; MUIR AH, 1967, J PHYS CHEM SOLIDS, V28, P65, DOI 10.1016/0022-3697(67)90198-9; MUIR AH, 1969, P C APPL MOSSB EFF T; PABST A, 1946, AM MINERAL, V31, P539; SCHMIDTW.RD, 1974, J CRYST GROWTH, V23, P113, DOI 10.1016/0022-0248(74)90110-9; Soller W., 1935, PHYS REV, V47, P644; ZHAO TR, 1995, J CRYST GROWTH, V148, P189, DOI 10.1016/0022-0248(94)00881-7; ZUCKER RS, 1965, J ELECTROCHEM SOC, V112, P417, DOI 10.1149/1.2423559	15	56	56	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-0248			J CRYST GROWTH	J. Cryst. Growth	SEP	1996	166	1-4					408	413		10.1016/0022-0248(95)00520-X		6	Crystallography; Materials Science, Multidisciplinary; Physics, Applied	Crystallography; Materials Science; Physics	VM089	WOS:A1996VM08900072		
J	Suzuki, T; Yumoto, KI; Hasegawa, M; Takei, H				Suzuki, T; Yumoto, KI; Hasegawa, M; Takei, H			In situ observation of phase changes by X-ray diffraction in the Bi-Sr-Ca-Cu-O system	JOURNAL OF CRYSTAL GROWTH			English	Article; Proceedings Paper	11th International Conference on Crystal Growth	JUN 18-23, 1995	THE HAGUE, NETHERLANDS	Int Org Crystal Growth, Dutch Assoc Crystal Growth			GROWTH	An X-ray powder diffractometer has been equipped with a position-sensitive proportional counter and an optical microscope. This apparatus makes possible in situ microscopy and X-ray observation of the phase transition and phase relations affecting the crystal growth of homologous bismuth-based superconductors. A region of Sr-Ca-Cu-O oxide and liquid is found to exist above the decomposition temperature of Bi-2(Sr,Ca)(2)CuOx, which is formed by the decomposition reaction of Bi2Sr2CaCu2Ox. The stable region of Bi-2(Sr,Ca)(2)CuOx is extremely narrow at 3-7 degrees C. The amount of liquid phase is estimated semi-quantitatively from visualized images through the optical microscope.	TOYO UNIV,FAC ENGN,DEPT APPL CHEM,KAWAGOE,SAITAMA 350,JAPAN	Suzuki, T (reprint author), UNIV TOKYO,INST SOLID STATE PHYS,MINATO KU,7-22-1 ROPPONGI,TOKYO 106,JAPAN.						HASEGAWA T, 1994, PHYSICA C, V222, P111, DOI 10.1016/0921-4534(94)90121-X; KOMATSU H, 1991, PHYSICA C, V190, P14, DOI 10.1016/S0921-4534(05)80185-6; Oyama Y., 1994, Ferroelectrics, V152, DOI 10.1080/00150199408017647; OYAMA Y, 1994, J CRYST GROWTH, V143, P200, DOI 10.1016/0022-0248(94)90056-6; OYAMA Y, 1994, JPN J APPL PHYS 1, V33, P4779, DOI 10.1143/JJAP.33.4779; STROBEL P, 1990, J LESS-COMMON MET, V164, P519, DOI 10.1016/0022-5088(90)90255-I; TAKEI H, 1989, JPN J APPL PHYS 2, V28, pL1193	7	6	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-0248			J CRYST GROWTH	J. Cryst. Growth	SEP	1996	166	1-4					872	877		10.1016/0022-0248(95)00534-X		6	Crystallography; Materials Science, Multidisciplinary; Physics, Applied	Crystallography; Materials Science; Physics	VM089	WOS:A1996VM08900153		
J	Wada, M; Nakamura, Y				Wada, M; Nakamura, Y			Antigenic variation by telomeric recombination of major-surface-glycoprotein genes of Pneumocystis carinii	JOURNAL OF EUKARYOTIC MICROBIOLOGY			English	Article; Proceedings Paper	4th International Workshops on Opportunistic Protists	JUN 11-15, 1996	TUCSON, AZ	Bayer Corp, Bio Merieux, Burroughs Wellcome Fund, Charles River Labs, Ciba Geigy Corp, Glaxo Wellcome Inc, Heska Corp, Hoechst Roussel Agri Vet Co, Meridian Diagnost Inc, NIAID, NHLBI, Pfizer Inc, TAP Holdings						Wada, M (reprint author), UNIV TOKYO,INST MED SCI,PO TAKANAWA,TOKYO 108,JAPAN.						Kitada K, 1994, DNA Res, V1, P57, DOI 10.1093/dnares/1.2.57; Sunkin SM, 1996, MOL MICROBIOL, V19, P283, DOI 10.1046/j.1365-2958.1996.375905.x; TANABE K, 1989, INFECT IMMUN, V57, P1363; Underwood AP, 1996, MOL MICROBIOL, V19, P273, DOI 10.1046/j.1365-2958.1996.374904.x; WADA M, 1995, J INFECT DIS, V171, P1563; Wada M, 1996, DNA Res, V3, P55, DOI 10.1093/dnares/3.2.55; WADA M, 1993, J INFECT DIS, V168, P979; Wada M, 1994, DNA Res, V1, P163, DOI 10.1093/dnares/1.4.163	8	12	12	SOC PROTOZOOLOGISTS	LAWRENCE	810 E 10TH ST, LAWRENCE, KS 66044	1066-5234			J EUKARYOT MICROBIOL	J. Eukaryot. Microbiol.	SEP-OCT	1996	43	5					S8	S8		10.1111/j.1550-7408.1996.tb04949.x		1	Microbiology	Microbiology	VC050	WOS:A1996VC05000012		
J	Hashimoto, K; Sohn, SJ; Levin, SD; Tada, T; Perlmutter, RM; Nakayama, T				Hashimoto, K; Sohn, SJ; Levin, SD; Tada, T; Perlmutter, RM; Nakayama, T			Requirement for p56(lck) tyrosine kinase activation in T cell receptor-mediated thymic selection	JOURNAL OF EXPERIMENTAL MEDICINE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; IMMATURE CD4+CD8+ THYMOCYTES; NEGATIVE SELECTION; MONOCLONAL-ANTIBODY; MICE LACKING; POSITIVE SELECTION; ANTIGEN RECEPTOR; SIGNAL-TRANSDUCTION; I-E; CD4(+)CD8(+) THYMOCYTES	The nonreceptor protein tyrosine kinase p56(lck) (Lck) serves as a fundamental regulator of thymocyte development by delivering signals from the pre-T cell receptor (pre-TCR) that permit subsequent maturation. However, considerable evidence supports the view that Lck also participates in signal transduction from the mature TCR. We have tested this conjecture by expressing a dominant-negative form of Lck under the control of a promoter element (the distal kk promoter) that directs high expression in CD4(+)CD8(+) thymocytes, mature thymocytes, and peripheral T cells, thereby avoiding complications that result from the well-documented ability of dominant-negative Lck to block very early events in thymocyte maturation. Here we report that expression of the catalytically inactive Lck protein at twice normal concentrations inhibits thymocyte positive selection by as much as 80%, while leaving other aspects of T cell maturation intact. This effect was studied in more detail in mice simultaneously bearing the male-specific H-Y alpha/beta TCR transgene and ovalbumin-specific DO10 alpha/beta TCR transgene, where even equimolar expression of the dominant-negative Lck protein substantially vitiated the positive selection process. Although deletion of H-Y alpha/beta thymocytes proceeded normally in male mice despite the presence of catalytically inactive Lck, modest inhibition of superantigen-mediated deletion was in some cases observed. These data further implicate Lck in the propagation of all TCR-derived signals, and indicate that even very modest deficiencies in the representation of functional Lck molecules could, in humans, profoundly alter the character of the peripheral TCR repertoire.	SCI UNIV TOKYO,RES INST BIOL SCI,NODA,CHIBA 278,JAPAN; UNIV TOKYO,FAC MED,DEPT IMMUNOL,TOKYO 113,JAPAN; HOWARD HUGHES MED INST,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT MED,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT BIOCHEM,SEATTLE,WA 98195							ACHAORBEA H, 1985, EUR J IMMUNOL, V15, P31, DOI 10.1002/eji.1830150107; ALBEROLAILA J, 1995, NATURE, V373, P620, DOI 10.1038/373620a0; ANDERSON G, 1995, J IMMUNOL, V154, P3636; ANDERSON SJ, 1994, ADV IMMUNOL, V56, P151, DOI 10.1016/S0065-2776(08)60451-4; FUNGLEUNG WP, 1991, CELL, V65, P443, DOI 10.1016/0092-8674(91)90462-8; MACDONALD HR, 1988, NATURE, V332, P40, DOI 10.1038/332040a0; BRUCE J, 1981, J IMMUNOL, V127, P2496; APPLEBY MW, 1992, CELL, V70, P751, DOI 10.1016/0092-8674(92)90309-Z; BERG LJ, 1989, CELL, V58, P1035, DOI 10.1016/0092-8674(89)90502-3; WILDIN RS, 1995, J IMMUNOL, V155, P1286; NEGISHI I, 1995, NATURE, V376, P435, DOI 10.1038/376435a0; YAMASHITA I, 1993, INT IMMUNOL, V5, P1139, DOI 10.1093/intimm/5.9.1139; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; ARPAIA E, 1994, CELL, V76, P947, DOI 10.1016/0092-8674(94)90368-9; ROBEY E, 1994, ANNU REV IMMUNOL, V12, P675, DOI 10.1146/annurev.immunol.12.1.675; COSGROVE D, 1991, CELL, V66, P1051, DOI 10.1016/0092-8674(91)90448-8; KAPPLER JW, 1988, NATURE, V332, P35, DOI 10.1038/332035a0; ALLEN JM, 1992, MOL CELL BIOL, V12, P2758; WOODLAND D, 1990, SCIENCE, V247, P964, DOI 10.1126/science.1968289; XU H, 1993, CELL, V74, P633, DOI 10.1016/0092-8674(93)90511-N; KILLEEN N, 1993, EMBO J, V12, P1547; NOSSAL GJV, 1994, CELL, V76, P229, DOI 10.1016/0092-8674(94)90331-X; RAHEMTULLA A, 1991, NATURE, V353, P180, DOI 10.1038/353180a0; SALTER RD, 1990, NATURE, V345, P41, DOI 10.1038/345041a0; BORGULYA P, 1992, CELL, V69, P529, DOI 10.1016/0092-8674(92)90453-J; DUPLAY P, 1994, J EXP MED, V179, P1163, DOI 10.1084/jem.179.4.1163; UNKELESS JC, 1979, J EXP MED, V150, P580, DOI 10.1084/jem.150.3.580; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; HASKINS K, 1983, J EXP MED, V157, P1149, DOI 10.1084/jem.157.4.1149; KONIG R, 1992, NATURE, V356, P796; MOLINA TJ, 1992, NATURE, V357, P161, DOI 10.1038/357161a0; BENDELAC A, 1992, J EXP MED, V175, P731, DOI 10.1084/jem.175.3.731; BENOIST C, 1989, CELL, V58, P1027, DOI 10.1016/0092-8674(89)90501-1; BILL J, 1989, J EXP MED, V169, P1405, DOI 10.1084/jem.169.4.1405; BLACKMAN M, 1990, SCIENCE, V248, P1335, DOI 10.1126/science.1972592; CHAN IT, 1993, SCIENCE, V261, P1581, DOI 10.1126/science.8372352; CHAN SH, 1993, CELL, V73, P225, DOI 10.1016/0092-8674(93)90225-F; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COOKE MP, 1991, CELL, V65, P281, DOI 10.1016/0092-8674(91)90162-R; CROMPTON T, 1993, P NATL ACAD SCI USA, V90, P8982, DOI 10.1073/pnas.90.19.8982; CRUMP AL, 1993, P NATL ACAD SCI USA, V90, P10739, DOI 10.1073/pnas.90.22.10739; DAVIS CB, 1993, CELL, V73, P237, DOI 10.1016/0092-8674(93)90226-G; FEHLING HJ, 1995, NATURE, V375, P795, DOI 10.1038/375795a0; GLAICHENHAUS N, 1991, CELL, V64, P511, DOI 10.1016/0092-8674(91)90235-Q; HERMAN A, 1991, ANNU REV IMMUNOL, V9, P745; JAMESON SC, 1995, ANNU REV IMMUNOL, V13, P93, DOI 10.1146/annurev.immunol.13.1.93; KILLEEN N, 1993, NATURE, V364, P729, DOI 10.1038/364729a0; KUBO RT, 1989, J IMMUNOL, V142, P2736; LEDBETTER JA, 1979, IMMUNOL REV, V47, P63, DOI 10.1111/j.1600-065X.1979.tb00289.x; LEVIN SD, 1993, J EXP MED, V178, P245, DOI 10.1084/jem.178.1.245; LEVIN SD, 1993, EMBO J, V12, P1671; MARTH JD, 1988, NATURE, V332, P171, DOI 10.1038/332171a0; MARTH JD, 1985, CELL, V43, P393, DOI 10.1016/0092-8674(85)90169-2; MCCARTHY SA, 1988, NATURE, V336, P76, DOI 10.1038/336076a0; MOMBAERTS P, 1994, IMMUNITY, V1, P261, DOI 10.1016/1074-7613(94)90077-9; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; NAKAYAMA T, 1990, SCIENCE, V249, P1558, DOI 10.1126/science.2120773; NAKAYAMA T, 1989, NATURE, V341, P651, DOI 10.1038/341651a0; NAKAYAMA T, 1993, P NATL ACAD SCI USA, V90, P10534, DOI 10.1073/pnas.90.22.10534; OKADA CY, 1990, J IMMUNOL, V144, P3473; PAGE DM, 1993, J IMMUNOL, V151, P1868; REICH EP, 1989, NATURE, V341, P326, DOI 10.1038/341326a0; RUDD CE, 1988, P NATL ACAD SCI USA, V85, P5190, DOI 10.1073/pnas.85.14.5190; SAINTRUF C, 1994, SCIENCE, V266, P1208, DOI 10.1126/science.7973703; SHAW AS, 1989, CELL, V59, P627, DOI 10.1016/0092-8674(89)90008-1; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; SWAN KA, 1995, EMBO J, V14, P276; SWAT W, 1993, EUR J IMMUNOL, V23, P739, DOI 10.1002/eji.1830230326; TEH HS, 1989, J EXP MED, V169, P795, DOI 10.1084/jem.169.3.795; THE HS, 1988, NATURE, V335, P229; TURKA LA, 1991, SCIENCE, V253, P778, DOI 10.1126/science.1831564; TURNER JM, 1990, CELL, V60, P755, DOI 10.1016/0092-8674(90)90090-2; VANMEERWIJK JPM, 1993, SCIENCE, V261, P911, DOI 10.1126/science.8102208; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; VERNACHIO J, 1989, J IMMUNOL, V142, P48; WANG CR, 1995, J EXP MED, V181, P927, DOI 10.1084/jem.181.3.927; WIEST DL, 1993, J EXP MED, V178, P1701, DOI 10.1084/jem.178.5.1701; ZAMOYSKA R, 1989, NATURE, V342, P278, DOI 10.1038/342278a0	78	70	70	ROCKEFELLER UNIV PRESS	NEW YORK	222 E 70TH STREET, NEW YORK, NY 10021	0022-1007			J EXP MED	J. Exp. Med.	SEP 1	1996	184	3					931	943		10.1084/jem.184.3.931		13	Immunology; Medicine, Research & Experimental	Immunology; Research & Experimental Medicine	VG868	WOS:A1996VG86800015		
J	Kato, H; Konno, A; Maeda, M; Yamaguchi, H				Kato, H; Konno, A; Maeda, M; Yamaguchi, H			Possibility of quantitative prediction of cavitation erosion without model test	JOURNAL OF FLUIDS ENGINEERING-TRANSACTIONS OF THE ASME			English	Article							PARTIAL CAVITIES; CLOUD	A scenario fbr quantitative prediction of cavitation erosion was proposed. The key value is the impact force/pressure spectrum on a solid surface caused by cavitation bubble collapse. As the first step of prediction, the authors constructed the scenario from an estimation of the cavity generation rare to the prediction of impact force spectrum, including the estimations of collapsing cavity number and impact pressure. The prediction was compared with measurements of impact force spectra on a partially cavitating hydrofoil. A good quantitative agreement was obtained between the prediction and the experiment. However, the present method predicted a larger effect of main flow velocity than that observed. The present scenario is promising as a method of predicting erosion without using a model test.		Kato, H (reprint author), UNIV TOKYO,DEPT NAVAL ARCHITECTURE & OCEAN ENGN,BUNKYO KU,TOKYO 113,JAPAN.						HICKLING R, 1964, PHYS FLUIDS, V7, P7, DOI 10.1063/1.1711058; LE Q, 1993, J FLUID ENG-T ASME, V115, P243, DOI 10.1115/1.2910131; CHAHINE GL, 1992, J FLUID ENG-T ASME, V114, P680, DOI 10.1115/1.2910085; BILLET ML, 1975, ASME, V97, P501; BLAKE JR, 1994, 2 INT S CAV TOK, P9; BRENNEN C, 1969, J FLUID MECH, V37, P115, DOI 10.1017/S0022112069000449; FRANC JP, 1994, 2 INT S CAV TOK, P231; GADD GE, 1965, J FLUID MECH, V23, P645, DOI 10.1017/S002211206500160X; *ITTC, 1993, REP ITTC CAV COMM 5, V1, P206; IZUMIDA Y, 1980, IAHR S 1980 TOK, V1, P169; KAMONO H, 1993, CAVITATION MULTIPHAS, V153, P183; KATO H, 1994, WORKSH CAV ER RES TO; KATO H, 1992, INT S PROP CAV HAMB, P224; KUBOTA A, 1989, J FLUID ENG-T ASME, V111, P204; LE Q, 1993, J FLUID ENG-T ASME, V115, P249, DOI 10.1115/1.2910132; MAEDA M, 1994, 2 INT S CAV TOK, P243; MAEDA M, 1991, CAVITATION 91 ASME, V116, P67; Morch K.A., 1981, P ASME CAV POL FLOW, P1; O'Hern T., 1988, ASME, V110, P200; PEREIRA F, 1995, INT S CAV CAV 95 DEA, P257; TAKAHIRA H, 1994, 2 INT S CAV TOK, P263; TOMITA Y, 1977, B JSME, V20, P1453; YAMAGUCHI H, 1990, CAVITATION MULTIPHAS, V98, P115; YOSHIHARA K, 1988, EXPT STUDY INTERNAL, V64, P94	24	18	18	ASME-AMER SOC MECHANICAL ENG	NEW YORK	345 E 47TH ST, NEW YORK, NY 10017	0098-2202			J FLUID ENG-T ASME	J. Fluids Eng.-Trans. ASME	SEP	1996	118	3					582	588		10.1115/1.2817798		7	Engineering, Mechanical	Engineering	VN191	WOS:A1996VN19100023		
J	Petersson, P; Larson, F; Jonsson, L				Petersson, P; Larson, F; Jonsson, L			Measurements of the velocity field downstream of an impeller	JOURNAL OF FLUIDS ENGINEERING-TRANSACTIONS OF THE ASME			English	Article							AXISYMMETRICAL BODY; LASER VELOCIMETER; MARINE PROPELLER; AVERAGED FLOW; STERN; JET	The velocity field downstream of a model impeller operating in water as measured using a two-component laser doppler velocimeter, The investigation focussed on the spatial development of the mean velocity in the axial, radial, and circumferrential direction, although simultaneous measurements were performed of the velocity unsteadiness from which turbulence characteristics were inferred. The measurements extended up to 12 impeller diameters downstream of the blades displaying the properties of the generated swirling jet both in the zone of flow establishment and the zone of established flow. The division between these zones was made based on similarity of the mean axial velocity profile, Integral properties of the flow such as volume and momentum flux were computed from the measured velocity profiles. The transverse spreading of the impeller jet and its development towards self-similarity were examined and compared with non-swirling jets and swirling jets generated by other means.	UNIV TOKYO,DEPT CIVIL ENGN,BUNKYO KU,TOKYO 113,JAPAN; LUND UNIV,DEPT WATER RESOURCES TECHNOL,LUND,SWEDEN	Petersson, P (reprint author), LUND UNIV,DEPT WATER RESOURCES ENGN,BOX 118,S-22100 LUND,SWEDEN.						LIST EJ, 1982, ANNU REV FLUID MECH, V14, P189, DOI 10.1146/annurev.fl.14.010182.001201; CHIGIER NA, 1967, J APPL MECH, V34, P443; ALBERTSON ML, 1950, T AM SOC CIV ENG, V115, P639; FAROKHI S, 1989, AIAA J, V27, P700, DOI 10.2514/3.10168; BIGGERS JC, 1975, J AM HELICOPTER SOC, V20, P2; Coleman H.W., 1989, EXPT UNCERTAINTY ANA; DUQUENNE AM, 1993, CHEM ENG SCI, V48, P3805, DOI 10.1016/0009-2509(93)80223-D; FAHLGREN M, 1992, SCI IMPELLER, V1, P49; HAMILL GA, 1993, J HYDRAUL RES, V31, P605; Hussein J. H., 1994, J FLUID MECH, V258, P31, DOI DOI 10.1017/S002211209400323X; HYUN BS, 1991, EXP FLUIDS, V11, P105; HYUN BS, 1991, EXP FLUIDS, V11, P33, DOI 10.1007/BF00198430; LEPICOVSKY J, 1988, J FLUID ENG-T ASME, V110, P350; LEPICOVSKY J, 1984, J AIRCRAFT, V21, P264, DOI 10.2514/3.48257; PRATTE BD, 1972, ASME, V93, P739; Rose W.G., 1962, J APPL MECH        E, V29, P615, DOI DOI 10.1115/1.3640644; SHIH C, 1994, J FLUID ENG-T ASME, V116, P228, DOI 10.1115/1.2910259; Townsend A. A., 1976, STRUCTURE TURBULENT	18	10	12	ASME-AMER SOC MECHANICAL ENG	NEW YORK	345 E 47TH ST, NEW YORK, NY 10017	0098-2202			J FLUID ENG-T ASME	J. Fluids Eng.-Trans. ASME	SEP	1996	118	3					602	610		10.1115/1.2817801		9	Engineering, Mechanical	Engineering	VN191	WOS:A1996VN19100026		
J	Pecoraro, MR; Tomonaga, K; Miyazawa, T; Kawaguchi, Y; Sugita, S; Tohya, Y; Kai, C; Etcheverrigaray, ME; Mikami, T				Pecoraro, MR; Tomonaga, K; Miyazawa, T; Kawaguchi, Y; Sugita, S; Tohya, Y; Kai, C; Etcheverrigaray, ME; Mikami, T			Genetic diversity of Argentine isolates of feline immunodeficiency virus	JOURNAL OF GENERAL VIROLOGY			English	Article							ENVELOPE GLYCOPROTEINS; SEQUENCE; TYPE-1; NUCLEOTIDE; EVOLUTION; SELECTION; SUBTYPES; DISTINCT; PATTERNS; CATS	We report the nucleotide sequence and genetic diversity of part of the envelope (env) gene of four strains of feline immunodeficiency virus (FIV) isolated from Argentine domestic cats. The DNA encoding the V3 to V5 regions of the env gene of the FIV isolates were amplified by PCR, cloned and sequenced. Phylogenetic analysis revealed that the Argentine isolates did not cluster into a single group; one isolate clustered with subtype B FIV isolated in the USA and Japan, whereas the others formed a new cluster of FIV which might represent a prototype sequence for subtype E.	UNIV TOKYO,FAC AGR,DEPT VET MICROBIOL,BUNKYO KU,TOKYO 113,JAPAN; JAPAN RACING ASSOC,EQUINE RES INST,EPIZOOT RES STN,KOKUBUNJI,TOCHIGI 32904,JAPAN; NATL UNIV LA PLATA,FAC VET SCI,DEPT VIROL,RA-1900 LA PLATA,ARGENTINA							PEDERSEN NC, 1987, SCIENCE, V235, P790, DOI 10.1126/science.3643650; KAKINUMA S, 1995, J VIROL, V69, P3639; SODORA DL, 1994, J VIROL, V68, P2230; GOJOBORI T, 1990, P NATL ACAD SCI USA, V87, P10015, DOI 10.1073/pnas.87.24.10015; HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5; GOJOBORI T, 1982, J MOL EVOL, V18, P414, DOI 10.1007/BF01840889; GREENE WK, 1993, ARCH VIROL, V133, P51, DOI 10.1007/BF01309743; JOHNSON CM, 1994, AIDS RES HUM RETROV, V10, P225, DOI 10.1089/aid.1994.10.225; LOUWAGIE J, 1995, J VIROL, V69, P263; MAKI N, 1992, ARCH VIROL, V123, P29, DOI 10.1007/BF01317136; MIYAZAWA T, 1993, J VET MED SCI, V55, P519; MIYAZAWA T, 1989, ARCH VIROL, V108, P131, DOI 10.1007/BF01313750; PANCINO G, 1993, J VIROL, V67, P664; PANCINO G, 1993, VIROLOGY, V192, P659, DOI 10.1006/viro.1993.1083; RIGBY MA, 1993, J GEN VIROL, V74, P425, DOI 10.1099/0022-1317-74-3-425; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; SODORA DL, 1995, AIDS RES HUM RETROV, V11, P531; Tohya Y., 1994, Revista de Medicina Veterinaria (Buenos Aires), V75, P242; YAMADA H, 1995, ARCH VIROL, V140, P41, DOI 10.1007/BF01309722	19	71	72	SOC GENERAL MICROBIOLOGY	READING	HARVEST HOUSE 62 LONDON ROAD, READING, BERKS, ENGLAND RG1 5AS	0022-1317			J GEN VIROL	J. Gen. Virol.	SEP	1996	77		9				2031	2035		10.1099/0022-1317-77-9-2031		5	Biotechnology & Applied Microbiology; Virology	Biotechnology & Applied Microbiology; Virology	VF330	WOS:A1996VF33000007		
J	Shiokawa, K; Yumoto, K; Nishitani, N; Hayashi, K; Oguti, T; McEwen, DJ; Kiyama, Y; Rich, FJ; Mukai, T				Shiokawa, K; Yumoto, K; Nishitani, N; Hayashi, K; Oguti, T; McEwen, DJ; Kiyama, Y; Rich, FJ; Mukai, T			Quasi-periodic poleward motions of Sun-aligned auroral arcs in the high-latitude morning sector: A case study	JOURNAL OF GEOPHYSICAL RESEARCH-SPACE PHYSICS			English	Article							INTERPLANETARY MAGNETIC-FIELD; POLAR-CAP ARCS; MULTIPLE BRIGHTENINGS; BOUNDARY-LAYER; NORTHWARD; VIKING; MAGNETOSPHERE; RECONNECTION; CONVECTION; SIGNATURES	This is the first payer which reports the characteristics of quasi-periodic poleward motions of Sun-aligned auroral arcs in the high-latitude morning sector. The moving arcs are observed from ground-based stations at magnetic latitudes (MLAT) of 78 degrees and 84 degrees during magnetically quiet intervals (interplanetary magnetic field B-z similar to 0 or > 0). The arcs move poleward repeatedly with a period of several minutes and a velocity of similar to 400-500 m/s and disappear at around 85 degrees MLAT. For the event observed at 78 degrees MLAT, the arcs are repeatedly detached from a stable aurora which is located at the equatorward of the arcs. The moving arcs correspond to accelerated electrons observed by the Exos D satellite. The stable aurora corresponds to continuous precipitation of high-energy electrons which probably originate from the inner part. of the plasma sheet. The ion drift data from the DMSP-F11 satellite show that the poleward moving arcs are located around the boundary of the large-scale sunward flowing region at lower latitudes and the antisunward flowing region at higher latitudes. From these results, we conclude that the area are connected to the boundary region between the plasma sheet and the low-latitude boundary layer in the morningside tail flank. Several mechanisms which can produce the observed motions of the arcs are discussed.	UNIV TOKYO, FAC SCI, BUNKYO KU, TOKYO 113, JAPAN; NIIGATA UNIV, FAC SCI, NIIGATA 95021, JAPAN; UNIV SASKATCHEWAN, INST SPACE & ATMOSPHER STUDIES, SASKATOON, SK S7N 0W0, CANADA; INST SPACE & ASTRONAUT SCI, KANAGAWA 229, JAPAN; USAF, GEOPHYS LAB, BEDFORD, MA 01731 USA; KYUSHU UNIV, DEPT EARTH & PLANETARY SCI, FUKUOKA 812, JAPAN	Shiokawa, K (reprint author), NAGOYA UNIV, SOLAR TERR ENVIRONM LAB, TOYOKAWA 442, JAPAN.						TSYGANENKO NA, 1987, PLANET SPACE SCI, V35, P1347, DOI 10.1016/0032-0633(87)90046-8; FRANK LA, 1982, GEOPHYS RES LETT, V9, P1001, DOI 10.1029/GL009i009p01001; AUSTIN JB, 1993, J GEOPHYS RES, V98, P13545, DOI 10.1029/92JA02898; BERKEY FT, 1976, GEOPHYS RES LETT, V3, P145, DOI 10.1029/GL003i003p00145; BURKE WJ, 1982, J GEOPHYS RES-SPACE, V87, P2431, DOI 10.1029/JA087iA04p02431; CARLSON HC, 1988, J GEOPHYS RES, V93, P14501, DOI 10.1029/JA093iA12p14501; ELIASSON L, 1987, GEOPHYS RES LETT, V14, P451, DOI 10.1029/GL014i004p00451; ELPHINSTONE RD, 1994, NATO ADV SCI INST SE, V425, P189; FASEL GJ, 1992, GEOPHYS RES LETT, V19, P2429, DOI 10.1029/92GL02103; FASEL GJ, 1993, GEOPHYS RES LETT, V20, P2247, DOI 10.1029/93GL02487; FRANK LA, 1986, J GEOPHYS RES, V91, P3177, DOI 10.1029/JA091iA03p03177; GUSSENHOVEN MS, 1989, J GEOPHYS RES, V94, P17121, DOI 10.1029/JA094iA12p17121; GUSSENHOVEN MS, 1982, J GEOPHYS RES-SPACE, V87, P2401, DOI 10.1029/JA087iA04p02401; ISMAIL S, 1982, PLANET SPACE SCI, V30, P319, DOI 10.1016/0032-0633(82)90037-X; ISMAIL S, 1977, J GEOPHYS RES-SPACE, V82, P4741, DOI 10.1029/JA082i029p04741; LASSEN K, 1978, J GEOPHYS RES-SPACE, V83, P5277, DOI 10.1029/JA083iA11p05277; LOCKWOOD M, 1993, NATURE, V361, P424, DOI 10.1038/361424a0; LUNDIN R, 1985, PLANET SPACE SCI, V33, P1389, DOI 10.1016/0032-0633(85)90115-1; LUNDIN R, 1991, AURORAL PHYSICS, P177; MARKLUND GT, 1991, J GEOPHYS RES, V96, P9567, DOI 10.1029/90JA02644; MENG CI, 1981, GEOPHYS RES LETT, V8, P273, DOI 10.1029/GL008i003p00273; MUKAI T, 1990, J GEOMAGN GEOELECTR, V42, P479; MURPHREE JS, 1982, CAN J PHYS, V60, P349; OGINO T, 1994, J GEOPHYS RES, V99, P11027, DOI 10.1029/93JA03313; OGUTI T, 1989, J GEOMAGN GEOELECTR, V41, P879; SANDHOLT PE, 1993, J GEOPHYS RES, V98, P7737, DOI 10.1029/92JA02256; SHIOKAWA K, 1995, J GEOPHYS RES, V100, P21979, DOI 10.1029/95JA01564; VALLADARES CE, 1994, J GEOPHYS RES, V99, P6247, DOI 10.1029/93JA03255; VALLADARES CE, 1991, J GEOPHYS RES, V96, P1379, DOI 10.1029/90JA01765; WINNINGHAM JD, 1975, J GEOPHYS RES-SPACE, V80, P3148, DOI 10.1029/JA080i022p03148; WOCH J, 1993, GEOPHYS RES LETT, V20, P979, DOI 10.1029/93GL00849; WOCH J, 1992, J GEOPHYS RES, V97, P1431, DOI 10.1029/91JA02490	32	14	14	AMER GEOPHYSICAL UNION	WASHINGTON	2000 FLORIDA AVE NW, WASHINGTON, DC 20009 USA	0148-0227			J GEOPHYS RES-SPACE	J. Geophys. Res-Space Phys.	SEP 1	1996	101	A9					19789	19800		10.1029/96JA01202		12	Astronomy & Astrophysics	Astronomy & Astrophysics	VF257	WOS:A1996VF25700015		
J	Matsui, T				Matsui, T			NP-hardness of linear multiplicative programming and related problems	JOURNAL OF GLOBAL OPTIMIZATION			English	Article						NP-hard; minimization of products; linear multiplicative programming; linear fractional programming; multi-ratio programming		The linear multiplicative programming problem minimizes a product of two (positive) variables subject to linear inequality constraints. In this paper, we show NP-hardness of linear multiplicative programming problems and related problems.	UNIV TOKYO,FAC ENGN,DEPT MATH ENGN & INFORMAT PHYS,BUNKYO KU,TOKYO 113,JAPAN			Matsui, Tomomi/B-8863-2015	Matsui, Tomomi/0000-0003-0106-0980			ANEJA YP, 1984, EUR J OPER RES, V18, P62, DOI 10.1016/0377-2217(84)90262-5; Garey M.R., 1979, COMPUTERS INTRACTABI; Karp R. M., 1972, COMPLEXITY COMPUTER; Konno H., 1990, Annals of Operations Research, V25, DOI 10.1007/BF02283691; KONNO H, 1995, HDB GLOBAL OPTIMIZAT; KONNO H, IN PRESS GLOBAL OPTI; KONNO H, 1992, MATH PROGRAM, V56, P51, DOI 10.1007/BF01580893; Konno H., 1991, J GLOBAL OPTIM, V1, P65, DOI 10.1007/BF00120666; Konno H., 1992, COMPUTATIONAL OPTIMI, V1, P227; KUNO T, 1991, J GLOBAL OPTIM, V1, P267, DOI 10.1007/BF00119935; PARDALOS P. M., 1991, J GLOBAL OPTIM, V1, P15, DOI 10.1007/BF00120662; Pardalos P. M., 1990, Optimization, V21, DOI 10.1080/02331939008843615; Swamp K, 1966, CAHIERS CTR ETUDES R, V8, P217; Thoai N.V., 1991, J GLOBAL OPTIM, V1, P341, DOI 10.1007/BF00130830; Tuy H., 1992, Optimization, V24, DOI 10.1080/02331939208843778	15	48	50	KLUWER ACADEMIC PUBL	DORDRECHT	SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS	0925-5001			J GLOBAL OPTIM	J. Glob. Optim.	SEP	1996	9	2					113	119		10.1007/BF00121658		7	Operations Research & Management Science; Mathematics, Applied	Operations Research & Management Science; Mathematics	VL854	WOS:A1996VL85400001		
J	Uehara, Y; Miyazaki, M; Kanase, H; Sugano, K; ToyoOka, T				Uehara, Y; Miyazaki, M; Kanase, H; Sugano, K; ToyoOka, T			Body mass index is a determinant of blood pressure in young adults with essential hypertensive parents	JOURNAL OF HUMAN HYPERTENSION			English	Article						family history; essential hypertension; body mass index; obesity; insulin	5-YEAR FOLLOW-UP; INSULIN SENSITIVITY; FAMILY HISTORY; HYPERINSULINEMIA; DYSLIPIDEMIA; INDIVIDUALS; RESISTANCE; CHILDREN	We analysed blood pressure (BP) and various parameters related to glucose metabolism in 10867 Japanese university students aged 19.22 +/- 0.01 years, and investigated the relationship between the subject's own BP and hypertension in close relatives. After 2 years we also examined a subset of these students enrolled in 1993. BP levels in subjects having hypertensive parents were normotensive, but significantly higher than those in subjects without hypertensive relatives or only with hypertensive grandparents. The closer the genetic relationship was, the higher the subject's own BP levels. In subjects with hypertensive parents, the subject's own mean BP levels correlated significantly with the subject's own body mass indices. This correlation was much weaker in subjects without hypertensive relatives and those having only second degree relatives with hypertension. In addition, the BP levels in the offspring of hypertensive parents correlated with glutamyl-oxaloacetic transaminase. In the follow-up study in 1995, the correlation between BP levels and body mass index (BMI) was observed in this subgroup. Moreover, the subjects with hypertensive parents tended to have a higher plasma insulin level than those without hypertensive relatives. It is suggested that BP is more likely to be determined by BMI in the individuals with a genetic predisposition to hypertension.	UNIV TOKYO,HLTH SERV CTR,BUNKYO KU,TOKYO 113,JAPAN							ALLEMANN Y, 1995, J HYPERTENS, V13, P163; ZINNER SH, 1976, AM J EPIDEMIOL, V104, P124; MUNGER RG, 1988, J HYPERTENS, V6, P647, DOI 10.1097/00004872-198808000-00008; MORRIS AD, 1994, J HYPERTENS, V12, P633; BIANCHETTI MG, 1986, KIDNEY INT, V29, P882, DOI 10.1038/ki.1986.81; DOYLE AE, 1961, LANCET, V2, P509; FACCHINI F, 1992, AM J HYPERTENS, V5, P694; FERRANNINI E, 1987, NEW ENGL J MED, V317, P350, DOI 10.1056/NEJM198708063170605; FERRARI P, 1991, AM J MED, V91, P589, DOI 10.1016/0002-9343(91)90211-F; FERRIER C, 1988, NEW ENGL J MED, V319, P1223; FUKIYAMA K, 1994, HYPERTENS RES, V17, P215, DOI 10.1291/hypres.17.215; HIMMELMANN A, 1994, J HYPERTENS, V12, P89; *HLTH WELF STAT AS, 1994, TRENDS HLTH WELF JAP; HOSHIMOTO R, 1995, HYPERTENSION, V25, P1311; NOMURA G, 1982, JPN CIRC J, V68, P68; NOTO A, 1983, CLIN CHEM, V29, P1713; OHNO Y, 1993, J HYPERTENS, V11, P421, DOI 10.1097/00004872-199304000-00013; Reaven GM, 1988, DIABETES, V37, P1495; SCHIEDER RE, 1991, AM J KIDNEY DIS, V6, P638; VANHOOFT IMS, 1988, J HYPERTENS       S4, V6, P5594; WELMAN E, 1978, CARDIOVASC RES, V12, P99, DOI 10.1093/cvr/12.2.99; WIDGREN BR, 1991, J INTERN MED, V229, P217	22	4	4	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9240			J HUM HYPERTENS	J. Hum. Hypertens.	SEP	1996	10	9					601	606				6	Peripheral Vascular Disease	Cardiovascular System & Cardiology	VW888	WOS:A1996VW88800007		
J	KIBATA, Y				KIBATA, Y			JAPAN ENCOUNTERS THE BARBARIAN, JAPANESE TRAVELLERS IN AMERICA AND EUROPE - BEASLEY,WG	JOURNAL OF IMPERIAL AND COMMONWEALTH HISTORY			English	Book Review										KIBATA, Y (reprint author), UNIV TOKYO,TOKYO 113,JAPAN.						Beasley W. G., 1995, JAPAN ENCOUNTERS BAR	1	0	0	FRANK CASS CO LTD	LONDON	11 GAINSBOROUGH ROAD, LONDON, ENGLAND E11 1RS	0308-6534			J IMP COMMONW HIST	J. Imp. Commonw. Hist.	SEP	1996	24	3					482	483				2	History	History	VK017	WOS:A1996VK01700019		
J	Wang, JB; Zhang, Y; Kasahara, T; Harada, A; Matsushima, K; Mukaida, N				Wang, JB; Zhang, Y; Kasahara, T; Harada, A; Matsushima, K; Mukaida, N			Detection of mouse IL-8 receptor homologue expression on peripheral blood leukocytes and mature myeloid lineage cells in bone marrow	JOURNAL OF LEUKOCYTE BIOLOGY			English	Article						myelopoiesis; stem cells; chemokine receptor	NEUTROPHIL-ACTIVATING PEPTIDE; HUMAN INTERLEUKIN-8 RECEPTOR; NATURAL-KILLER-CELLS; HEMATOPOIETIC PROGENITOR CELLS; TUMOR-NECROSIS-FACTOR; STEM-CELLS; MONOCLONAL-ANTIBODY; MOLECULAR-CLONING; CHEMOTACTIC FACTOR; CDNA CLONING	Interleukin-8 (IL-8) exhibits activities on bone marrow progenitor cells such as regulation of their growth and their mobilization into peripheral blood. In order to clarify the molecular mechanism of the effects of IL-8 on mouse bone marrow cells, we examined the cellular distribution of mouse IL-8 receptor homologue by an immunofluorescence analysis. Peripheral blood Gr-1(+) mature granulocytes, and a substantial portion of NK1.1(+) natural killer cells in peripheral blood and spleen were stained positively with anti-mouse IL-8 receptor homologue antibody, whereas CD4(+), CD8(+), or B220(+) lymphocytes in peripheral blood and spleen, and thymocytes were not. Moreover, a small portion of ER-MP20(+) monocytes in peripheral blood but neither peritoneal resident nor bone marrow macrophages were stained with anti-IL-8 receptor homologue antibody. In bone marrow, mature granulocytes and to a lesser degree, metamyelocytes and myelocytes expressed IL-8 receptor homologue. Moreover, lineage marker (Lin)(-)c-kit(+) bone marrow progenitor cells started to express IL-8 receptor homologue only 5 days after in vitro culture with IL-3 and stem cell factor when metamyelocytes and myelocytes appeared. These results indicated that myeloid lineage cells express a substantial number of IL-8 receptor homologues only at the stage of myelocytes.	KANAZAWA UNIV,CANC RES INST,DEPT PHARMACOL,KANAZAWA,ISHIKAWA 920,JAPAN; KANAZAWA UNIV,SCH MED,DEPT HYG,KANAZAWA,ISHIKAWA 920,JAPAN; KYORITSU COLL PHARMACEUT SCI,DIV BIOCHEM,TOKYO,JAPAN; UNIV TOKYO,GRAD SCH MED,DEPT MOL PREVENT MED,TOKYO,JAPAN			Mukaida, Naofumi/D-7623-2011				HOLMES WE, 1991, SCIENCE, V253, P1278, DOI 10.1126/science.1840701; BOZIC CR, 1994, J BIOL CHEM, V269, P29355; WADA T, 1994, J EXP MED, V180, P1135, DOI 10.1084/jem.180.3.1135; BAGGIOLINI M, 1994, ADV IMMUNOL, V55, P97; GUNJI Y, 1993, BLOOD, V82, P3283; LARSEN CG, 1989, SCIENCE, V243, P1464, DOI 10.1126/science.2648569; ZHANG Y, 1995, BLOOD, V86, P2930; WALZ A, 1987, BIOCHEM BIOPH RES CO, V149, P755, DOI 10.1016/0006-291X(87)90432-3; MURPHY PM, 1991, SCIENCE, V253, P1280, DOI 10.1126/science.1891716; OPPENHEIM JJ, 1991, ANNU REV IMMUNOL, V9, P617; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; MOROHASHI H, 1995, J LEUKOCYTE BIOL, V57, P180; AUSTYN JM, 1981, EUR J IMMUNOL, V11, P805, DOI 10.1002/eji.1830111013; LEI SP, 1987, J BACTERIOL, V169, P4379; KOCH AE, 1992, SCIENCE, V258, P1798, DOI 10.1126/science.1281554; KOO GC, 1984, HYBRIDOMA, V3, P301, DOI 10.1089/hyb.1984.3.301; YOSHIMURA T, 1987, P NATL ACAD SCI USA, V84, P9233, DOI 10.1073/pnas.84.24.9233; SCHRODER JM, 1987, J IMMUNOL, V139, P3474; CACALANO G, 1994, SCIENCE, V265, P682, DOI 10.1126/science.8036519; SEKIDO N, 1993, NATURE, V365, P654, DOI 10.1038/365654a0; BODINE D, 1995, EXP HEMATOL, V23, P293; BROADDUS VC, 1994, J IMMUNOL, V152, P2960; BROXMEYER HE, 1993, J IMMUNOL, V150, P3448; CERRETTI DP, 1993, GENOMICS, V18, P410, DOI 10.1006/geno.1993.1486; CHANTHARAPAI A, 1994, J IMMUNOL, V153, P5682; CHEN C, 1987, MOL CELL BIOL, V7, P2745; DAHINDEN CA, 1989, J EXP MED, V170, P1787, DOI 10.1084/jem.170.5.1787; DETMERS PA, 1991, J IMMUNOL, V147, P4211; DEXTER TM, 1977, J EXP MED, V145, P1612, DOI 10.1084/jem.145.6.1612; EAVES CJ, 1993, BLOOD, V82, P1957; EDELSON PJ, 1976, IN VITRO METHODS CEL, P333; GOODMAN RB, 1992, BIOCHEMISTRY-US, V31, P10483, DOI 10.1021/bi00158a011; HARADA A, 1993, INT IMMUNOL, V5, P681, DOI 10.1093/intimm/5.6.681; HARADA A, 1994, GENE, V142, P297, DOI 10.1016/0378-1119(94)90278-X; HIROSE K, 1993, FASEB J, V7, P361; KANNOURAKIS G, 1988, J IMMUNOL, V140, P2489; KANNOURAKIS G, 1988, BLOOD, V72, P1124; KIMATA H, 1992, J EXP MED, V176, P1227, DOI 10.1084/jem.176.4.1227; LEENEN PJM, 1990, EUR J IMMUNOL, V20, P27, DOI 10.1002/eji.1830200105; LETERVEER L, 1995, BLOOD, V85, P2269; LU L, 1993, EXP HEMATOL, V21, P1442; MATSUMOTO Y, 1994, CYTOKINE, V6, P455, DOI 10.1016/1043-4666(94)90071-X; MURAKAMI S, 1994, J BIOL CHEM, V269, P15118; MURAYAMA T, 1994, J VIROL, V68, P7582; NOMURA H, 1993, INT IMMUNOL, V5, P1239, DOI 10.1093/intimm/5.10.1239; OKADA S, 1991, BLOOD, V78, P1706; PRADO GN, 1994, J BIOL CHEM, V269, P12391; SIMONET WS, 1994, J CLIN INVEST, V94, P1310, DOI 10.1172/JCI117450; THELEN M, 1988, FASEB J, V2, P2702; THOMAS KM, 1991, J BIOL CHEM, V266, P14839; YOSHIMURA T, 1991, J IMMUNOL, V146, P3483; YOSHIMURA T, 1993, J IMMUNOL, V151, P6225	52	20	20	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998	0741-5400			J LEUKOCYTE BIOL	J. Leukoc. Biol.	SEP	1996	60	3					372	381				10	Cell Biology; Hematology; Immunology	Cell Biology; Hematology; Immunology	VH464	WOS:A1996VH46400011		
J	Kudo, I; Matsuzawa, A; Imai, K; Murakami, M; Inoue, K				Kudo, I; Matsuzawa, A; Imai, K; Murakami, M; Inoue, K			Function of type II phospholipase A(2) in dopamine secretion by rat neuronal PC12 cells	JOURNAL OF LIPID MEDIATORS AND CELL SIGNALLING			English	Article; Proceedings Paper	Satellite Symposium of the 15th International-Society-for-Neurochemistry on Lipid Messengers in the Nervous System	JUN 28-30, 1995	TOKYO, JAPAN	Int Soc Neurochem, Nagai Fdn, Tokyo		phospholipase A(2); PC12 cells; exocytosis; glutamate; dopamine	MAST-CELLS; DEGRANULATION; PARTICIPATION; MEMBRANE; VESICLES; FUSION; SYSTEM; ACID	When rat pheochromocytoma PC12 cells, which had differentiated into neuron-like cells following culture with nerve growth factor, were activated with glutamate, approximately 40% of their type II phospholipase A(2) (PLA(2)) was released into the extracellular medium. Glutamate-stimulated secretion of dopamine from PC12 cells was suppressed by type II PLA(2) inhibitors. Exogenous type II PLA(2) added alone directly elicited release of dopamine from PC12 cells. Thus released type II PLA(2) may be involved in the regulation of neurotransmitter exocytosis by PC12 cells.	UNIV TOKYO,FAC PHARMACEUT SCI,BUNKYO KU,TOKYO 113,JAPAN	Kudo, I (reprint author), SHOWA UNIV,SCH PHARMACEUT SCI,SHINAGAWA KU,1-5-8 HATANODAI,TOKYO 142,JAPAN.						LIN LL, 1993, CELL, V72, P269, DOI 10.1016/0092-8674(93)90666-E; FOURCADE O, 1995, CELL, V80, P919, DOI 10.1016/0092-8674(95)90295-3; DENNIS EA, 1994, J BIOL CHEM, V269, P13057; BARBOUR SE, 1993, J BIOL CHEM, V268, P12875; CLARK JD, 1991, CELL, V65, P1043, DOI 10.1016/0092-8674(91)90556-E; KARLI UO, 1990, P NATL ACAD SCI USA, V87, P5912, DOI 10.1073/pnas.87.15.5912; KUDO I, 1993, BIOCHIM BIOPHYS ACTA, V1170, P217, DOI 10.1016/0005-2760(93)90003-R; MORI K, 1985, ANAL BIOCHEM, V146, P283, DOI 10.1016/0003-2697(85)90541-X; MOSKOWITZ N, 1982, SCIENCE, V216, P305, DOI 10.1126/science.6278597; MURAKAMI M, 1993, J IMMUNOL, V151, P5675; MURAKAMI M, 1991, FEBS LETT, V294, P247, DOI 10.1016/0014-5793(91)81440-J; MURAKAMI M, 1991, METHOD ENZYMOL, V197, P223; MURAKAMI M, 1993, J BIOL CHEM, V268, P839; MURAKAMI M, 1992, EUR J BIOCHEM, V209, P257, DOI 10.1111/j.1432-1033.1992.tb17284.x; POOLE AR, 1970, NATURE, V227, P810, DOI 10.1038/227810a0; SUGA H, 1993, EUR J BIOCHEM, V218, P807, DOI 10.1111/j.1432-1033.1993.tb18435.x; YOSHIDA T, 1990, J ANTIBIOT, V44, P1467	17	9	9	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0929-7855			J LIPID MEDIAT CELL	J. Lipid Mediat. Cell Signal.	SEP	1996	14	1-3					25	31		10.1016/0929-7855(96)01504-0		7	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	VN203	WOS:A1996VN20300005		
J	Hattori, M; Aoki, J; Arai, H; Inoue, K				Hattori, M; Aoki, J; Arai, H; Inoue, K			PAF and PAF acetylhydrolase in the nervous system	JOURNAL OF LIPID MEDIATORS AND CELL SIGNALLING			English	Article; Proceedings Paper	Satellite Symposium of the 15th International-Society-for-Neurochemistry on Lipid Messengers in the Nervous System	JUN 28-30, 1995	TOKYO, JAPAN	Int Soc Neurochem, Nagai Fdn, Tokyo		PAF acetylhydrolase; isoforms; Miller-Dicker lissencephaly; Zellweger syndrome	PLATELET-ACTIVATING-FACTOR; SUBUNIT; GENE; PURIFICATION; EXPRESSION	PAF acetylhydrolase is a key enzyme of PAF inactivation. Intracellular PAF acetylhydrolase isoform Ib is a heterotrimeric enzyme composed of alpha-, beta- and gamma-subunits. The beta- and gamma-subunits act as a catalytic unit and their amino acid sequences are homologous. The alpha-subunit is not essential for catalytic activity but is a product of the causative gene for Miller-Dicker lissencephaly, suggesting this subunit plays an important role in brain development.		Hattori, M (reprint author), UNIV TOKYO,FAC PHARMACEUT SCI,BUNKYO KU,7-3-1 HONGO,TOKYO 113,JAPAN.						ADACHI H, 1995, BIOCHEM BIOPH RES CO, V214, P180, DOI 10.1006/bbrc.1995.2272; REINER O, 1995, J NEUROSCI, V15, P3730; TJOELKER LW, 1995, NATURE, V374, P549, DOI 10.1038/374549a0; HATTORI K, 1995, J BIOL CHEM, V270, P22308; HATTORI M, 1993, J BIOL CHEM, V268, P18748; HATTORI M, 1994, NATURE, V370, P216, DOI 10.1038/370216a0; HATTORI M, 1994, J BIOL CHEM, V269, P23150; Hattori M, 1995, J BIOL CHEM, V270, P31345; WANG DS, 1995, BIOCHEM BIOPH RES CO, V209, P622, DOI 10.1006/bbrc.1995.1545	9	13	13	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0929-7855			J LIPID MEDIAT CELL	J. Lipid Mediat. Cell Signal.	SEP	1996	14	1-3					99	102		10.1016/0929-7855(96)00514-7		4	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	VN203	WOS:A1996VN20300015		
J	Shimizu, T; Mori, M; Bito, H; Sakanaka, C; Tabuchi, S; Aihara, M; Kume, K				Shimizu, T; Mori, M; Bito, H; Sakanaka, C; Tabuchi, S; Aihara, M; Kume, K			Platelet-activating factor and somatostatin activate mitogen-activated protein kinase (MAP kinase) and arachidonate release	JOURNAL OF LIPID MEDIATORS AND CELL SIGNALLING			English	Article; Proceedings Paper	Satellite Symposium of the 15th International-Society-for-Neurochemistry on Lipid Messengers in the Nervous System	JUN 28-30, 1995	TOKYO, JAPAN	Int Soc Neurochem, Nagai Fdn, Tokyo		arachidonic acid; phospholipase A(2); Raf-1; Worthmannin; hippocampus; MAP kinase	LONG-TERM POTENTIATION; FACTOR-RECEPTOR; SYNAPTIC TRANSMISSION; ACID; HIPPOCAMPUS; EXPRESSION; CLONING; ENHANCEMENT; CASCADE; TISSUE	Platelet-activating factor (PAF) receptor and somatostatin receptor (SSTR4) were cloned, and their primary structures were identified. They are both highly expressed in the rat hippocampus. When expressed in Chinese hamster ovary cells, these receptors activated mitogen-activated protein (MAP) kinase cascade and phospholipase A(2). Arachidonic acid or its derivatives, thus produced by the activation of these receptors may play some roles in synaptic transmission and synaptic plasticity.		Shimizu, T (reprint author), UNIV TOKYO,FAC MED,DEPT BIOCHEM,BUNKYO KU,TOKYO 113,JAPAN.						SCHWEITZER P, 1990, NATURE, V346, P464, DOI 10.1038/346464a0; SHIMIZU T, 1990, J NEUROCHEM, V55, P1, DOI 10.1111/j.1471-4159.1990.tb08813.x; NAKAMURA M, 1991, J BIOL CHEM, V266, P20400; CLARK GD, 1992, NEURON, V9, P1211, DOI 10.1016/0896-6273(92)90078-R; MILLER B, 1992, NATURE, V355, P722, DOI 10.1038/355722a0; Mori M, 1996, J NEUROSCI, V16, P3590; WILLIAMS JH, 1989, NATURE, V341, P739, DOI 10.1038/341739a0; BITO H, 1994, EUR J BIOCHEM, V221, P211, DOI 10.1111/j.1432-1033.1994.tb18731.x; BITO H, 1994, J BIOL CHEM, V269, P12722; BITO H, 1992, NEURON, V9, P285, DOI 10.1016/0896-6273(92)90167-C; FERBY IM, 1994, J BIOL CHEM, V269, P30485; HONDA Z, 1994, J BIOL CHEM, V269, P2307; HONDA Z, 1991, NATURE, V349, P342, DOI 10.1038/349342a0; Ishii S, 1996, BIOCHEM J, V314, P671; Izumi T, 1995, BBA-LIPID LIPID MET, V1259, P317, DOI 10.1016/0005-2760(95)00171-9; KATO K, 1994, NATURE, V367, P175, DOI 10.1038/367175a0; LYNCH MA, 1990, J NEUROCHEM, V55, P215, DOI 10.1111/j.1471-4159.1990.tb08841.x; MORI M, 1994, ANN NY ACAD SCI, V744, P107; SAKANAKA C, 1994, BIOCHEM BIOPH RES CO, V205, P18, DOI 10.1006/bbrc.1994.2623; SCHWEITZER P, 1993, J NEUROSCI, V13, P2033; WIERASZKO A, 1993, NEURON, V10, P553, DOI 10.1016/0896-6273(93)90342-O; YE RD, 1991, BIOCHEM BIOPH RES CO, V180, P105, DOI 10.1016/S0006-291X(05)81261-6	22	12	12	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0929-7855			J LIPID MEDIAT CELL	J. Lipid Mediat. Cell Signal.	SEP	1996	14	1-3					103	108		10.1016/0929-7855(96)00515-9		6	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	VN203	WOS:A1996VN20300016		
J	Hazeki, O; Hazeki, K; Katada, T; Ui, M				Hazeki, O; Hazeki, K; Katada, T; Ui, M			Inhibitory effect of wortmannin on phosphatidylinositol 3-kinase-mediated cellular events	JOURNAL OF LIPID MEDIATORS AND CELL SIGNALLING			English	Article; Proceedings Paper	Satellite Symposium of the 15th International-Society-for-Neurochemistry on Lipid Messengers in the Nervous System	JUN 28-30, 1995	TOKYO, JAPAN	Int Soc Neurochem, Nagai Fdn, Tokyo		G-protein subunits; inhibitor; phosphoinositide 3-kinase; Wortmannin	3-KINASE; CELLS		INST PHYS & CHEM RES,UI LAB,WAKO,SAITAMA 35101,JAPAN	Hazeki, O (reprint author), UNIV TOKYO,FAC PHARMACEUT SCI,DEPT PHYSIOL CHEM,HONGO 7-3-1,TOKYO 113,JAPAN.						KANAI F, 1993, BIOCHEM BIOPH RES CO, V195, P762, DOI 10.1006/bbrc.1993.2111; STEPHENS L, 1994, CELL, V77, P83, DOI 10.1016/0092-8674(94)90237-2; YANO H, 1993, J BIOL CHEM, V268, P25846; NINOMIYA N, 1994, J BIOL CHEM, V269, P22732; OKADA T, 1994, J BIOL CHEM, V269, P3568; KIMURA K, 1994, J BIOL CHEM, V269, P18961; OKADA T, 1994, J BIOL CHEM, V269, P3563; THOMASON PA, 1994, J BIOL CHEM, V269, P16525	8	19	19	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0929-7855			J LIPID MEDIAT CELL	J. Lipid Mediat. Cell Signal.	SEP	1996	14	1-3					259	261		10.1016/0929-7855(96)00534-2		3	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	VN203	WOS:A1996VN20300035		
J	Lee, C; Kawano, S; Itoh, T; Suga, T				Lee, C; Kawano, S; Itoh, T; Suga, T			Characteristics of sol-gel derived PZT thin films with lead oxide cover layers and lead titanate interlayers	JOURNAL OF MATERIALS SCIENCE			English	Article							ORIENTATION	The set-gel derived PbZr0.53Ti0.47O3 (PZT) films were fabricated on the bare Pt/Ti/SiO2/Si substrates or the same substrates coated by the PbTiO3 (PT) interlayers. The post-deposition annealing temperature and time were optimized when the PbO cover layers and PbO vapour-containing atmosphere were compared with each other and adopted as the method to diminish the lead-loss problem during the high-temperature post-deposition annealing. The X-ray diffraction patterns, microstructures, and electrical properties such as relative permittivity, epsilon(r), remanent polarization, P-r, and coercive electrical field, E(c), were investigated in relation to the annealing conditions. The PZT films deposited on the bare Pt/Ti/SiO2/Si substrates under the PbO vapour-containing atmosphere showed better electrical properties. This indicates that the PbO vapour-containing atmosphere may be the better method of lead-loss-prevention to process the lead-containing films rather than the PbO cover layer method. The electrical characteristics of the PZT films, epsilon(r) = 1150, a dissipation factor of 0.039, P-r = 26 mu C cm(-2), and E(c) = 40.5 kV cm(-1), were measured at 1 kHz. When PZT films were deposited on substrates coated by the PT layers, PZT-PT films with single perovskite phase were derived by post-deposition annealing at 500 degrees C for 1 h. However, the relative electrical properties are very poor, i.e. E(r) = 160, P-r = 2.0 mu C cm(-2) and E(c) = 75 kV cm(-1). The optimum combination for preparing PZT-PT films is a 40 nm PbTiO3 interlayer and annealing conditions of 6 h at 550 degrees C in a PbO vapour-containing atmosphere; the derived films exhibit electrical properties of E(r) = 885, P-r = 21.5 mu C cm(-2) and E(c) = 64 kV cm(-1). The combination of inserting a PT interlayer and annealing in a PbO vapour-containing atmosphere can prevent the formation of electrical short paths. In this case, nearly pin-hole-free PZT films can be grown on the PT (interlayer)/Pt/Ti/SiO2/Si substrates. It is believed that it is possible to prepare the PZT films with nano-scale uniformity, reproducible quality, which may be worth considering for commercial applications.	UNIV TOKYO,ADV SCI & TECHNOL RES CTR,NANOMETRE SCALE MFG SCI LAB,TOKYO 153,JAPAN			Suga, Tadatomo/F-9925-2010	Suga, Tadatomo/0000-0002-1029-0326			ADAMSON AW, 1982, PHYSICAL CHEM SURFAC; YI GH, 1991, AM CERAM SOC BULL, V70, P1173; BROOKS KG, 1994, J MATER RES, V9, P2540, DOI 10.1557/JMR.1994.2540; FOX GR, 1994, J MATER RES, V9, P699, DOI 10.1557/JMR.1994.0699; CHEN KC, 1990, MATER RES SOC SYMP P, V180, P663, DOI 10.1557/PROC-180-663; Flynn A. M., 1992, Journal of Microelectromechanical Systems, V1, DOI 10.1109/84.128055; FRANCIS LF, 1991, J AM CERAM SOC, V74, P3000, DOI 10.1111/j.1151-2916.1991.tb04293.x; JAFFE B, 1971, PIEZOELECTRIC CERAMI, P259; Kugiyama K., 1992, MATER RES SOC S P, V243, P179; KUMAR CVRV, 1991, APPL PHYS LETT, V58, P1161, DOI 10.1063/1.104351; Kwok CK, 1992, CERAM T, V25, P73; KWOK CK, 1993, J MATER RES, V8, P339, DOI 10.1557/JMR.1993.0339; LAKEMAN CDE, 1994, BR CERAM P, V52, P69; Lee C, 1996, MATER CHEM PHYS, V44, P25, DOI 10.1016/0254-0584(95)01647-D; PENG CH, 1992, MATER RES SOC S P, V243, P335; POLLA DL, 1991, APPL PHYS LETT, V59, P3539, DOI 10.1063/1.105650; POLLA DL, 1992, MATER RES SOC S P, V243, P55; Robbins W. P., 1991, Journal of Micromechanics and Microengineering, V1, DOI 10.1088/0960-1317/1/4/006; SATO E, 1994, APPL PHYS LETT, V65, P2678, DOI 10.1063/1.112600; SCOTT JF, 1989, SCIENCE, V246, P1400, DOI 10.1126/science.246.4936.1400; *SOC CAL THERM AN, 1985, DAT SYST MALT VERS 1; SWARTZ SL, 1992, MATER RES SOC S P, V243, P533; TANI T, 1994, J AM CERAM SOC, V77, P1242, DOI 10.1111/j.1151-2916.1994.tb05398.x; Tani T., 1993, MATER RES SOC S P, V310, P269, DOI 10.1557/PROC-310-269	24	21	22	CHAPMAN HALL LTD	LONDON	2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8HN	0022-2461			J MATER SCI	J. Mater. Sci.	SEP 1	1996	31	17					4559	4568		10.1007/BF00366352		10	Materials Science, Multidisciplinary	Materials Science	VF827	WOS:A1996VF82700013		
J	Sumiyama, K; WashioWatanabe, K; Saitou, N; Hayakawa, T; Ueda, S				Sumiyama, K; WashioWatanabe, K; Saitou, N; Hayakawa, T; Ueda, S			Class III POU genes: Generation of homopolymeric amino acid repeats under GC pressure in mammals	JOURNAL OF MOLECULAR EVOLUTION			English	Article						POU; human brain-1; GC pressure; amino acid repeats	DOMAIN TRANSCRIPTION FACTOR; LINKED MIXED DEAFNESS; CAENORHABDITIS-ELEGANS; NUCLEOTIDE-SEQUENCE; CDNA CLONING; HUMAN GENOME; EXPRESSION; BINDING; BRAIN; REGION	The class III POU transcription factor genes play an important role in the nervous system. Comparison of their entire amino acid sequences disclosed a remarkable feature of particular mammalian class III POU genes. Alanine, glycine, and proline repeats were present in the mammalian Brain-1 gene, whereas most of these repeats were absent in the nonmammalian homologue. The mammalian Brain-2 gene had alanine, glycine, proline, and glutamine repeats, which were missing in the nonmammalian homologue. The mammalian Scip gene had alanine, glycine, proline, and histidine repeats, but the nonmammalian homologue completely lacked these repeats. In contrast, the mammalian Brain-4 gene had no amino acid repeats like its nonmammalian homologue. The mammalian genes containing the characteristic amino acid repeats had another feature, higher GC content. We found a positive correlation between the GC content and the amino acid repeat ratio. Those amino acids were encoded by triplet codons with relatively high GC content. These results suggest that the GC pressure has facilitated generation of the homopolymeric amino acid repeats.	UNIV TOKYO,GRAD SCH SCI,BUNKYO KU,TOKYO 113,JAPAN; NATL INST GENET,LAB EVOLUTIONARY GENET,MISHIMA,SHIZUOKA 411,JAPAN			Sumiyama, Kenta/L-5902-2013				AGARWAL VR, 1991, DEV BIOL, V147, P363, DOI 10.1016/0012-1606(91)90294-D; FAUS I, 1994, MOL CELL BIOL, V14, P3263; FUKUTA M, 1993, J BIOL CHEM, V268, P19471; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; SUZUKI N, 1990, EMBO J, V9, P3723; MONUKI ES, 1990, SCIENCE, V249, P1300, DOI 10.1126/science.1975954; ORII H, 1993, BIOCHEM BIOPH RES CO, V192, P1395, DOI 10.1006/bbrc.1993.1571; DEKOK YJM, 1995, SCIENCE, V267, P685, DOI 10.1126/science.7839145; ATANASOSKI S, 1995, GENOMICS, V26, P272, DOI 10.1016/0888-7543(95)80211-4; BALTZINGER M, 1992, NUCLEIC ACIDS RES, V20, P1993, DOI 10.1093/nar/20.8.1993; BERNARDI G, 1993, GENE, V135, P57, DOI 10.1016/0378-1119(93)90049-9; BILLIN AN, 1991, MECH DEVELOP, V34, P75, DOI 10.1016/0925-4773(91)90045-8; BURGLIN TR, 1989, NATURE, V341, P239, DOI 10.1038/341239a0; DOUVILLE PJ, 1994, MAMM GENOME, V5, P180, DOI 10.1007/BF00352353; Duboule D., 1994, GUIDEBOOK HOMEOBOX G; HARA Y, 1992, P NATL ACAD SCI USA, V89, P3280, DOI 10.1073/pnas.89.8.3280; HE X, 1989, Nature (London), V340, P35, DOI 10.1038/340035a0; HE X, 1991, MOL CELL BIOL, V11, P1739; HERR W, 1988, GENE DEV, V2, P1513, DOI 10.1101/gad.2.12a.1513; HIGGINS DG, 1992, COMPUT APPL BIOSCI, V8, P189; HUBER I, 1994, HUM MOL GENET, V3, P1151, DOI 10.1093/hmg/3.7.1151; JOHNSON WA, 1990, NATURE, V343, P467, DOI 10.1038/343467a0; LEMOINE C, 1992, P NATL ACAD SCI USA, V89, P3285; LI P, 1993, GENE DEV, V7, P2483, DOI 10.1101/gad.7.12b.2483; MATHIS JM, 1992, EMBO J, V11, P2551; MATSUZAKI T, 1992, BIOCHEM BIOPH RES CO, V187, P1446, DOI 10.1016/0006-291X(92)90464-V; MEIJER D, 1990, NUCLEIC ACIDS RES, V18, P7357, DOI 10.1093/nar/18.24.7357; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; ROSENFELD MG, 1991, GENE DEV, V5, P897, DOI 10.1101/gad.5.6.897; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Sambrook T., 1989, MOL CLONING LAB MANU; SCHREIBER E, 1993, NUCLEIC ACIDS RES, V21, P253, DOI 10.1093/nar/21.2.253; VERRIJZER CP, 1993, BIOCHIM BIOPHYS ACTA, V1173, P1, DOI 10.1016/0167-4781(93)90237-8; WITTA SE, 1995, DEVELOPMENT, V121, P721; XIA YR, 1993, GENOMICS, V18, P126, DOI 10.1006/geno.1993.1435; ZIMMERMAN EC, 1991, NUCLEIC ACIDS RES, V19, P956, DOI 10.1093/nar/19.4.956	36	35	36	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010	0022-2844			J MOL EVOL	J. Mol. Evol.	SEP	1996	43	3					170	178		10.1007/BF02338824		9	Biochemistry & Molecular Biology; Evolutionary Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Evolutionary Biology; Genetics & Heredity	VF808	WOS:A1996VF80800002		
J	Nicholls, IA; Matsui, J; Krook, M; Mosbach, K				Nicholls, IA; Matsui, J; Krook, M; Mosbach, K			Some recent developments in the preparation of novel recognition systems: A recognition site for the selective catalysis of an aldol condensation using molecular imprinting and specific affinity motifs for alpha-chymotrypsin using a phage display peptide library	JOURNAL OF MOLECULAR RECOGNITION			English	Article						molecular imprinting; phage display; synthetic enzyme; aldol condensation; alpha-chymotrypsin	IN-VITRO SELECTION; ANTIBODY MIMICS; BINDING; POLYMERS; SEPARATION; TECHNOLOGY; PROTEINS	Molecular imprinting and phage display library technologies are rapidly being accepted as useful techniques for the generation of ligand-selective recognition motifs. The use of molecular imprinting to produce a novel type II aldolase mimic selective for the cobalt(LT)-mediated aldol condensation of benzophenone and acetaldehyde is reported here, Furthermore, peptide motifs have been identified which are acting as 'affinity ligands' selective for the recognition of the enzyme alpha-chymotrypsin using phage display techniques.	LUND UNIV,DEPT PURE & APPL BIOCHEM,S-22100 LUND,SWEDEN; UNIV KALMAR,SCH NAT SCI,S-39129 KALMAR,SWEDEN; UNIV TOKYO,ADV SCI & TECHNOL RES CTR,MEGURO KU,TOKYO 153,JAPAN			Nicholls, Ian/A-1976-2009; Mosbach, Klaus/L-1016-2013	Nicholls, Ian/0000-0002-0407-6542; Mosbach, Klaus/0000-0001-7300-3470			ANDERSSON LI, 1995, ACS SYM SER, V586, P89; ANDERSSON LI, 1994, HIGHLY SELECTIVE SEP, P207; MOSBACH K, 1994, TRENDS BIOCHEM SCI, V19, P9, DOI 10.1016/0968-0004(94)90166-X; KOIVUNEN E, 1993, J BIOL CHEM, V268, P20205; NICHOLLS IA, 1995, TRENDS BIOTECHNOL, V13, P47, DOI 10.1016/S0167-7799(00)88904-0; ANDERSSON LI, 1995, P NATL ACAD SCI USA, V92, P4788, DOI 10.1073/pnas.92.11.4788; WULFF G, 1993, TRENDS BIOTECHNOL, V11, P85, DOI 10.1016/0167-7799(93)90056-F; EKBERG B, 1989, TRENDS BIOTECHNOL, V7, P92, DOI 10.1016/0167-7799(89)90006-1; MALLIK S, 1994, NEW J CHEM, V18, P299; HOUGHTEN RA, 1994, CURR BIOL, V4, P564, DOI 10.1016/S0960-9822(00)00127-5; CLACKSON T, 1994, TRENDS BIOTECHNOL, V12, P173, DOI 10.1016/0167-7799(94)90079-5; CWIRLA SE, 1990, P NATL ACAD SCI USA, V87, P6378, DOI 10.1073/pnas.87.16.6378; Matsui J, 1996, J ORG CHEM, V61, P5414, DOI 10.1021/jo9516805; WINTER G, 1994, ANNU REV IMMUNOL, V12, P433, DOI 10.1146/annurev.iy.12.040194.002245; LERNER RA, 1991, SCIENCE, V252, P659, DOI 10.1126/science.2024118; VLATAKIS G, 1993, NATURE, V361, P645, DOI 10.1038/361645a0; [Anonymous], 1994, TRENDS POLYM SCI; FISCHER L, 1991, J AM CHEM SOC, V113, P9358, DOI 10.1021/ja00024a046; JAMIESON AC, 1994, BIOCHEMISTRY-US, V33, P5689, DOI 10.1021/bi00185a004; KROOK M, 1994, BIOCHEM BIOPH RES CO, V204, P849, DOI 10.1006/bbrc.1994.2537; KROOK M, 1995, J CHROMATOGR A, V711, P119, DOI 10.1016/0021-9673(95)00270-W; LOWMAN HB, 1991, BIOCHEMISTRY-US, V30, P10832, DOI 10.1021/bi00109a004; NICHOLLS IA, 1993, Patent No. 93028439; OSHANNESSY DJ, 1989, J CHROMATOGR, V470, P391, DOI 10.1016/S0021-9673(01)83567-6	24	18	19	JOHN WILEY & SONS LTD	W SUSSEX	BAFFINS LANE CHICHESTER, W SUSSEX, ENGLAND PO19 1UD	0952-3499			J MOL RECOGNIT	J. Mol. Recognit.	SEP-DEC	1996	9	5-6					652	657		10.1002/(SICI)1099-1352(199634/12)9:5/6<652::AID-JMR316>3.0.CO;2-6		6	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	WZ027	WOS:A1996WZ02700050		
J	Iijima, Y; Satoh, S				Iijima, Y; Satoh, S			Light signals for indicating course alterations - A report for the Mercantile Marine Institute of Japan	JOURNAL OF NAVIGATION			English	Article						collision avoidance; light signals; navigation lights		This report summarizes a study of signals for indicating course alterations conducted by the Course Signal Committee of The Mercantile Marine Institute of Japan (President Captain Inazo Ara) as part of the 1995 project entitled 'Research on Improving Course Signals etc.' sponsored by The Japan Foundation for Shipbuilding Advancement.		Iijima, Y (reprint author), UNIV TOKYO,TOKYO,JAPAN.							0	1	1	CAMBRIDGE UNIV PRESS	NEW YORK	40 WEST 20TH STREET, NEW YORK, NY 10011-4211	0373-4633			J NAVIGATION	J. Navig.	SEP	1996	49	3					350	361				12	Engineering, Marine; Oceanography	Engineering; Oceanography	VJ054	WOS:A1996VJ05400007		
J	Fukagawa, M; Fukuda, N; Yi, H; Kitaoka, M; Kurokawa, K				Fukagawa, M; Fukuda, N; Yi, H; Kitaoka, M; Kurokawa, K			Derangement of parathyroid function in renal failure: Biological and clinical aspects	JOURNAL OF NEPHROLOGY			English	Review						parathyroid; parathyroid hormone; parathyroid hyperplasia; calcitriol; calcitriol receptor; phosphate; renal failure	VITAMIN-D-RECEPTOR; DIETARY PHOSPHORUS RESTRICTION; CHRONIC DIALYSIS PATIENTS; CALCITRIOL-PULSE THERAPY; STIMULATES PTH SECRETION; SECONDARY HYPERPARATHYROIDISM; ETHANOL INJECTION; INTRAVENOUS CALCITRIOL; EXPERIMENTAL UREMIA; GENE-EXPRESSION	Control of parathyroid hyperfunction is the main objective in the management of renal osteodystrophy. Besides the circulating parathyroid hormone level, parathyroid size may be another useful marker for the assessment of derangement of parathyroid function. Patients with larger parathyroid glands are usually more resistant to calcitriol pulse therapy than those with smaller glands. Such large parathyroid glands indicate nodular hyperplasia with one or several nodules composed of monoclonally proliferating cells. Since calcitriol receptor density in nodular hyperplasia is lower than in diffuse hyperplasia, nodular hyperplasia is more resistant to this treatment. Responsiveness can be restored after selective destruction of large parathyroid glands (>1 cm in diameter) by ethanol injection under ultrasonographic guidance. Direct injections of calcitriol solution into enlarged glands are also effective in patients refractory to calcitriol pulse therapy, further supporting this pathophysiological model. In addition, phosphate may have direct action on parathyroid cells. In conclusion, prevention of parathyroid hyperplasia by the early use of active vitamin D and phosphate restriction is critical for the successful medical management of parathyroid hyperfunction in chronic renal failure.	UNIV TOKYO,SCH MED,DEPT INTERNAL MED 1,TOKYO 113,JAPAN							AKERSTROM G, 1984, SCAND J UROL NEPHROL, V18, P75; Akizawa T, 1993, Curr Opin Nephrol Hypertens, V2, P558, DOI 10.1097/00041552-199307000-00006; ALMADEN Y, 1995, J AM SOC NEPHROL, V6, P957; PORTALE AA, 1986, J CLIN INVEST, V77, P7, DOI 10.1172/JCI112304; LOPEZHILKER S, 1990, AM J PHYSIOL, V259, pF432; FUKUDA N, 1993, J CLIN INVEST, V92, P1436, DOI 10.1172/JCI116720; SHVIL Y, 1990, J AM SOC NEPHROL, V1, P99; FUKAGAWA M, 1990, NEW ENGL J MED, V323, P421; SOLBIATI L, 1985, RADIOLOGY, V155, P607; SLATOPOLSKY E, 1984, J CLIN INVEST, V74, P2136, DOI 10.1172/JCI111639; FUKAGAWA M, 1994, NEPHRON, V68, P221; NAVEHMANY T, 1995, J CLIN INVEST, V96, P1786, DOI 10.1172/JCI118224; QUARLES LD, 1994, KIDNEY INT, V45, P1710, DOI 10.1038/ki.1994.223; ANDRESS DL, 1989, NEW ENGL J MED, V321, P274, DOI 10.1056/NEJM198908033210502; PATEL SR, 1994, KIDNEY INT, V45, P1020, DOI 10.1038/ki.1994.138; ARNOLD A, 1993, J CLIN ENDOCR METAB, V77, P1108, DOI 10.1210/jc.77.5.1108; ARNOLD A, 1995, J CLIN INVEST, V95, P2047, DOI 10.1172/JCI117890; BROWN AJ, 1989, KIDNEY INT, V35, P19, DOI 10.1038/ki.1989.3; Cannella Giuseppe, 1994, Kidney International, V46, P1124, DOI 10.1038/ki.1994.375; Coburn JW, 1994, CLIN DISORDERS FLUID, P1299; DENDA M, 1995, J AM SOC NEPHROL, V6, P959; DRUEKE TB, 1995, KIDNEY INT, V48, P259, DOI 10.1038/ki.1995.292; FALCHETTI A, 1993, J CLIN ENDOCR METAB, V76, P139, DOI 10.1210/jc.76.1.139; FELSENFELD AJ, 1993, KIDNEY INT, V43, P771, DOI 10.1038/ki.1993.111; FUKAGAWA M, IN PRESS NEPHROL DIA; FUKAGAWA M, 1991, KIDNEY INT, V39, P874, DOI 10.1038/ki.1991.110; FUKAGAWA M, 1995, MINER ELECTROL METAB, V21, P97; FUKAGAWA M, 1995, NEPHROL DIAL TRANSPL, V10, P316; FUKUDA N, 1995, J AM SOC NEPHROL, V6, P961; GIANGRANDE A, 1992, NEPHROL DIAL TRANSPL, V7, P412; GOODMAN WG, 1992, ANNU REV MED, V43, P227; GOODMAN WG, 1994, KIDNEY INT, V46, P1160, DOI 10.1038/ki.1994.380; HERCZ G, 1993, KIDNEY INT, V44, P860, DOI 10.1038/ki.1993.323; HSU CH, 1994, KIDNEY INT, V46, P605, DOI 10.1038/ki.1994.312; HYODO T, 1991, NEPHRON, V59, P171, DOI 10.1159/000186546; IIDA K, 1995, P NATL ACAD SCI USA, V92, P6112, DOI 10.1073/pnas.92.13.6112; KILAF R, 1995, J CLIN INVEST, V96, P232; KITAOKA M, 1994, KIDNEY INT, V46, P1110, DOI 10.1038/ki.1994.373; Kitaoka M, 1995, NEPHROLOGY, V1, P563, DOI 10.1111/j.1440-1797.1995.tb00056.x; KORKOR AB, 1987, NEW ENGL J MED, V316, P1573, DOI 10.1056/NEJM198706183162504; KOYAMA H, 1994, AM J PHYSIOL, V266, pF706; LINDALL AW, 1983, J CLIN ENDOCR METAB, V57, P1007; MALLUCHE H, 1990, KIDNEY INT, V38, P193, DOI 10.1038/ki.1990.187; MALMAEUS J, 1984, SCAND J UROL NEPHROL, V18, P157; MERKE J, 1987, KIDNEY INT, V32, P350, DOI 10.1038/ki.1987.216; NAVEHMANY T, 1990, J CLIN INVEST, V86, P1968, DOI 10.1172/JCI114931; Parfitt A. Michael, 1994, P373; PATEL SR, 1995, J CLIN INVEST, V96, P50, DOI 10.1172/JCI118061; QUARLES LD, 1992, J CLIN ENDOCR METAB, V75, P145, DOI 10.1210/jc.75.1.145; REICHEL H, 1993, KIDNEY INT, V44, P1259, DOI 10.1038/ki.1993.377; RUSSELL J, 1993, ENDOCRINOLOGY, V132, P2639, DOI 10.1210/en.132.6.2639; SHERRARD DJ, 1994, J AM SOC NEPHROL, V5, P888; SLATOPOLSKY E, 1995, J AM SOC NEPHROL, V6, P971; SRIUSSADAPORN S, 1995, J BONE MINER RES, V10, P271; TOMINAGA Y, 1985, J JPN SURG SOC, V86, P630; TOMINAGA Y, 1991, ANAL CELL PATHOL, V3, P325; TOMINAGA Y, 1996, IN PRESS CURRENT OPI; TOMINAGA Y, 1995, CLIN NEPHROL, V44, pS42; TOMINAGA Y, 1992, WORLD J SURG, V16, P595; TOMINAGA Y, IN PRESS WORLD J SUR; TSUKAMOTO Y, 1990, NEPHRON, V56, P368, DOI 10.1159/000186177; WALLACE SS, 1988, ENVIRON MOL MUTAGEN, V12, P431, DOI 10.1002/em.2860120411; YI H, 1995, NEPHRON, V70, P242	63	5	5	WICHTIG EDITORE	MILAN	72/74 VIA FRIULI, 20135 MILAN, ITALY	1121-8428			J NEPHROL	J. Nephrol.	SEP-OCT	1996	9	5					219	224				6	Urology & Nephrology	Urology & Nephrology	VW887	WOS:A1996VW88700003		
J	Gu, YJ; Oyama, F; Ihara, Y				Gu, YJ; Oyama, F; Ihara, Y			tau is widely expressed in rat tissues	JOURNAL OF NEUROCHEMISTRY			English	Article						tau; nonneural tissue; small tau; big tau; phosphorylation	PAIRED HELICAL FILAMENTS; MICROTUBULE-ASSOCIATED PROTEIN; PERIPHERAL NERVOUS-SYSTEM; MOLECULAR-WEIGHT TAU; ALZHEIMERS-DISEASE; PHOSPHORYLATION SITES; MALLORY BODIES; MUSCLE-FIBERS; LIVING CELLS; LOCALIZATION	The microtubule-associated protein tau, a major component of paired helical filaments in Alzheimer's disease, had been thought to be a neuron-specific protein. We investigated various rat tissues using both reverse transcriptase-coupled polymerase chain reaction and immunoblotting. tau was found to be widely expressed in many tissues besides the nervous system: at relatively high levels in the heart, skeletal muscle, lung, kidney, and testis and at low levels in the adrenal gland, stomach, and liver. In terms of the tau isoform expression, tissues fall into three classes: those expressing predominantly small tau, those expressing predominantly big tau, and those expressing both at comparable levels. The phosphorylation state of tau varied among the tissues, as shown by differences in the extents of changes in the reactivities with Tau 1 and electrophoretic mobilities after dephosphorylation. It is notable that tau in many nonneural tissues was highly phosphorylated at Ser(396) (according to the numbering of the 441-residue human tau isoform). Thus, tau is widely expressed in rat tissues.	UNIV TOKYO,FAC MED,INST BRAIN RES,DEPT NEUROPATHOL,BUNKYO KU,TOKYO 113,JAPAN							GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; GOEDERT M, 1989, EMBO J, V8, P393; WILLE H, 1992, J CELL BIOL, V118, P573, DOI 10.1083/jcb.118.3.573; DRUBIN DG, 1986, J CELL BIOL, V103, P2739, DOI 10.1083/jcb.103.6.2739; KOSIK KS, 1989, NEURON, V2, P1389, DOI 10.1016/0896-6273(89)90077-9; KANAI Y, 1989, J CELL BIOL, V109, P1173, DOI 10.1083/jcb.109.3.1173; GOEDERT M, 1992, P NATL ACAD SCI USA, V89, P1983, DOI 10.1073/pnas.89.5.1983; CACERES A, 1990, NATURE, V343, P461, DOI 10.1038/343461a0; LEE G, 1989, NEURON, V2, P1615, DOI 10.1016/0896-6273(89)90050-0; GOEDERT M, 1993, TRENDS NEUROSCI, V16, P460, DOI 10.1016/0166-2236(93)90078-Z; NEVE RL, 1986, MOL BRAIN RES, V1, P271, DOI 10.1016/0169-328X(86)90033-1; NISHIMURA M, 1995, AM J PATHOL, V146, P1052; LITMAN P, 1993, NEURON, V10, P627, DOI 10.1016/0896-6273(93)90165-N; LOOMIS PA, 1990, P NATL ACAD SCI USA, V87, P8422, DOI 10.1073/pnas.87.21.8422; KSIEZAKREDING H, 1991, NEURON, V6, P717, DOI 10.1016/0896-6273(91)90169-Z; GOEDERT M, 1995, NEUROSCI LETT, V189, P167, DOI 10.1016/0304-3940(95)11484-E; DRUBIN D, 1986, ANN NY ACAD SCI, V466, P257, DOI 10.1111/j.1749-6632.1986.tb38398.x; HARADA A, 1994, NATURE, V369, P488, DOI 10.1038/369488a0; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; IWATSUBO T, 1994, ACTA NEUROPATHOL, V88, P129; ASHMAN JB, 1992, BIOL REPROD, V46, P120, DOI 10.1095/biolreprod46.1.120; ASKANAS V, 1994, AM J PATHOL, V144, P177; BRAMBLETT GT, 1993, NEURON, V10, P1089, DOI 10.1016/0896-6273(93)90057-X; COUCHIE D, 1992, P NATL ACAD SCI USA, V89, P4378, DOI 10.1073/pnas.89.10.4378; DRUBIN D, 1988, J CELL BIOL, V106, P1583, DOI 10.1083/jcb.106.5.1583; GEORGIEFF IS, 1991, J CELL SCI, V100, P55; GOEDERT M, 1988, P NATL ACAD SCI USA, V85, P4025; HASEGAWA M, 1993, J NEUROCHEM, V60, P2068, DOI 10.1111/j.1471-4159.1993.tb03491.x; HIMMLER A, 1989, MOL CELL BIOL, V9, P1389; KANO Y, 1991, CELL STRUCT FUNCT, V16, P251; KENNER L, 1994, HEPATOLOGY, V20, P1086, DOI 10.1002/hep.1840200442; KOSIK KS, 1988, NEURON, V1, P817, DOI 10.1016/0896-6273(88)90129-8; LEE VMY, 1991, SCIENCE, V251, P675, DOI 10.1126/science.1899488; LIU WK, 1993, J NEUROSCI RES, V34, P371, DOI 10.1002/jnr.490340315; LUBKE U, 1994, AM J PATHOL, V145, P175; MATSUYAMA SS, 1994, J NEUROSCI RES, V39, P519, DOI 10.1002/jnr.490390503; MAVILIA C, 1994, J NEUROCHEM, V63, P2300; MORISHIMAKAWASHIMA M, 1995, J BIOL CHEM, V270, P823; MURAKAMI N, 1995, ACTA NEUROPATHOL, V90, P467; MURAKAMI N, 1995, MUSCLE NERVE, V18, P123, DOI 10.1002/mus.880180120; MURAKAMI N, 1995, ACTA NEUROPATHOL, V89, P29; NAKANO I, 1992, ACTA NEUROPATHOL, V83, P228; OBLINGER MM, 1991, J NEUROSCI, V11, P2453; PREISEGGER KH, 1992, LAB INVEST, V66, P193; Sambrook J., 1989, MOL CLONING LAB MANU; SZENDREI GI, 1993, J NEUROSCI RES, V34, P243, DOI 10.1002/jnr.490340212; WATANABE A, 1993, J BIOL CHEM, V268, P25712; YOSHIDA H, 1993, J NEUROCHEM, V61, P1183, DOI 10.1111/j.1471-4159.1993.tb03642.x; ZATLOUKAL K, 1990, HEPATOLOGY, V11, P652, DOI 10.1002/hep.1840110419	49	75	83	LIPPINCOTT-RAVEN PUBL	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106	0022-3042			J NEUROCHEM	J. Neurochem.	SEP	1996	67	3					1235	1244				10	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	VD232	WOS:A1996VD23200039		
J	Koptelov, EA; Ishino, S; Iwata, S; Sekimura, N				Koptelov, EA; Ishino, S; Iwata, S; Sekimura, N			On density effects in point defect solutions under irradiation .1. Qualitative consideration of quasi-equilibrium states	JOURNAL OF NUCLEAR MATERIALS			English	Article							PRODUCTION BIAS; ACCUMULATION; DEPENDENCE; CASCADES; METALS; TIME	In the paper, an open system of point defects in metals under irradiation at temperatures below one third part of the melting point is considered. A consideration is based on an analysis of chemical potentials of interstitials and vacancies in their supersaturated solid solutions. Density effects in supersaturated solutions that can be naturally ascribed to terms of higher orders in an expansion of the chemical potential over the concentration of the solute species are tken into account. It is shown that the mean square values of spatial fluctuations in the supersaturated solution remarkably increase. Such a situation takes place when, for some irradiation conditions, the temperature of a sample is low enough to reduce mobilities of point defects;The density effects would be expected as to be able to cause a spontaneous clustering process at high supersaturations. Possible consequences of the proposed effect for irradiation experiments are discussed.	TOKAI UNIV,DEPT NUCL ENGN,HIRATSUKA,KANAGAWA 25912,JAPAN; UNIV TOKYO,DEPT QUANTUM ENGN & SYST SCI,BUNKYO KU,TOKYO 113,JAPAN	Koptelov, EA (reprint author), RUSSIAN ACAD SCI,NUCL RES INST,DEPT EXPT PHYS,STATE SCI CTR RUSSIAN FEDERAT,MOSCOW 117312,RUSSIA.						Akhiezer I A, 1985, INTRO THEORETICAL RA; SCHILLING W, 1978, J NUCL MATER, V69-7, P465, DOI 10.1016/0022-3115(78)90261-1; WOO CH, 1992, PHILOS MAG A, V65, P889; WOO CH, 1990, PHYS STATUS SOLIDI B, V159, P609, DOI 10.1002/pssb.2221590210; ZINKLE SJ, 1993, J NUCL MATER, V206, P266, DOI 10.1016/0022-3115(93)90128-L; YOUNG FW, 1978, J NUCL MATER, V69-7, P310, DOI 10.1016/0022-3115(78)90250-7; BACON DJ, 1993, J NUCL MATER, V206, P368, DOI 10.1016/0022-3115(93)90137-N; BALLUFFI RW, 1978, J NUCL MATER, V69-7, P240, DOI 10.1016/0022-3115(78)90247-7; GIRIFALCO LA, 1964, ATOMIC MIGRATION CRY, P162; KIRITANI M, 1989, J NUCL MATER, V169, P415; KIRITANI M, 1993, J NUCL MATER, V206, P156, DOI 10.1016/0022-3115(93)90122-F; KMETYK LN, 1984, J NUCL MATER, V122, P613, DOI 10.1016/0022-3115(84)90668-8; KOPTELOV EA, 1992, AM SOC TEST MATER, V1125, P437, DOI 10.1520/STP17884S; KOPTELOV EA, 1995, J NUCL MATER, V225, P38, DOI 10.1016/0022-3115(95)00064-X; KOPTELOV EA, 1990, J NUCL MATER, V174, P311, DOI 10.1016/0022-3115(90)90243-G; KOTELOV EA, 1993, INR813 RUSS AC SCI; LANDAU LD, 1959, STAT PHYSICS, P271; Mansur L.K., 1987, KINETICS NONHOMOGENE, P377; PETERSON NL, 1978, J NUCL MAT, V69; SINGH BN, 1986, PHILOS MAG A, V53, P233; Stark J. P., 1976, SOLID STATE DIFFUSIO; Thompson M. W., 1969, DEFECTS RAD DAMAGE M; TRINKAUS H, 1990, J NUCL MATER, V174, P178, DOI 10.1016/0022-3115(90)90232-C; van Kampen N G, 1984, STOCHASTIC PROCESSES; WOO CH, 1991, J NUCL MATER, V179, P1207	25	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115			J NUCL MATER	J. Nucl. Mater.	SEP	1996	232	2-3					87	97		10.1016/S0022-3115(96)00407-2		11	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	VV600	WOS:A1996VV60000001		
J	Koptelov, EA; Ishino, S; Iwata, S; Sekimura, N				Koptelov, EA; Ishino, S; Iwata, S; Sekimura, N			On density effects in point defect solutions under irradiation .2. Formation of interstitial dislocation loops	JOURNAL OF NUCLEAR MATERIALS			English	Article							ACCUMULATION; EVOLUTION; MICROSTRUCTURE; TRANSIENT; METALS	The chemical potential approach, malting it possible for one to account for density effects in supersaturated solution of point defects, is applied to consideration of interstitial loop formation kinetics iri metals under homogeneous irradiation. Quasi-chemical rate equations are reformulated ill term of chemical potential, rather than in terms of concentrations of species involved in reactions, following a procedure known in the theory oi irreversible processes, The extension of rate equations is tested on a simpler model of bimolecular reactions, Then the density effect, such as radiation induced spontaneous clustering of interstitials, is investigate in irradiated metals on the background of interstitial loop formation as described by conventional rate equation solution. The phenomenon, that reveals itself by spontaneous formation of di-interstitials, would be expected to become noticeable at irradiation temperatures about 0.25 to 0.3 of the absolute melting temperature if the rate of defect generation is high enough. Wr a steady-start solution analyzed, the density effect brings about the higher number density uf forming interstitial loops with reduced mean dimensions if compared with conventional based consideration. Possibilities of experimental investigations of the proposed mechanism of interstitial loop formation are discussed.	TOKAI UNIV,DEPT NUCL ENGN,HIRATSUKA,KANAGAWA 25912,JAPAN; UNIV TOKYO,DEPT QUANTUM ENGN & SYST SCI,BUNKYO KU,TOKYO 113,JAPAN	Koptelov, EA (reprint author), RUSSIAN ACAD SCI,INST NUCL RES,DEPT EXPT PHYS,STATE SCI CTR RUSSIAN FEDERAT,MOSCOW 117312,RUSSIA.						Akhiezer I A, 1985, INTRO THEORETICAL RA; BRAILSFORD AD, 1980, 854 AERE TP; FRENKEL JI, 1955, KINETIC THEORY LIQUI, P390; GHONIEM NM, 1980, J NUCL MATER, V92, P121, DOI 10.1016/0022-3115(80)90148-8; GHONIEM NM, 1991, J NUCL MATER, V179, P99, DOI 10.1016/0022-3115(91)90022-Y; HAYNS MR, 1975, J NUCL MATER, V56, P267, DOI 10.1016/0022-3115(75)90042-2; KIRITANI M, 1993, J NUCL MATER, V206, P156, DOI 10.1016/0022-3115(93)90122-F; KOPTELOV EA, 1993, INR813 RUSS AC SCI; KOPTELOV EA, 1995, J NUCL MATER, V225, P38, DOI 10.1016/0022-3115(95)00064-X; KOPTELOV EA, UNPUB PHYS SCR; LANDAU LD, 1959, STAT PHYSICS, P271; Mansur L.K., 1987, KINETICS NONHOMOGENE, P377; PREDVODITELEV AA, 1986, PHYSICS CRYSTALS DEF, P51; SINGH BN, 1993, J NUCL MATER, V206, P212, DOI 10.1016/0022-3115(93)90125-I; Stark J. P., 1976, SOLID STATE DIFFUSIO; STRATONOVICH RL, 1985, NONLINEAR NONEQUILIB, P63; SUBBOTIN AV, 1981, ATOM ENERG, V50, P262; TRINKAUS H, 1993, J NUCL MATER, V206, P200, DOI 10.1016/0022-3115(93)90124-H; van Kampen N G, 1984, STOCHASTIC PROCESSES; WIEDERSICH H, 1993, J NUCL MATER, V206, P121, DOI 10.1016/0022-3115(93)90119-J; Zel'dovich Y B, 1942, ZH EKSP TEOR FIZ, V12, P525	21	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115			J NUCL MATER	J. Nucl. Mater.	SEP	1996	232	2-3					98	112		10.1016/S0022-3115(96)00408-4		15	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	VV600	WOS:A1996VV60000002		
J	Kawakami, N; Iwata, N; Tanigawa, T; Oga, H; Araki, S; Fujihara, S; Kitamura, T				Kawakami, N; Iwata, N; Tanigawa, T; Oga, H; Araki, S; Fujihara, S; Kitamura, T			Prevalence of mood and anxiety disorders in a working population in Japan	JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE			English	Article							DIAGNOSTIC INTERVIEW SCHEDULE; PANIC DISORDER; UNITED-STATES; EPIDEMIOLOGY; DEPRESSION; ALCOHOL; QUALITY; ABUSE; LIFE	To learn the prevalence of mood and anxiety disorders (as defined by the Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised) in a working population in Japan, we analyzed data from a population-based survey, Among 140 respondents who had a job, 8% experienced any of seven mood and anxiety disorders in the past 6 months and 19% had in their lifetime. The 6-month and lifetime prevalence rates of major depressive episodes were 4% and 14%, respectively, The 6-month and lifetime prevalence rates of phobic disorders were both 4%. The lifetime prevalence rates for other anxiety disorders were 1% or less. The 6-month rate of any disorder, as well as 6-month and lifetime rates of phobic disorders, was higher in white-collar employees than in self-employed workers (P < 0.05). The multiple logistic regression confirmed the tendency after controlling for sex and age, although the result was not significant (P > 0.05).	UNIV TOKYO, FAC MED, DEPT PUBL HLTH, TOKYO 113, JAPAN; UNIV OCCUPAT & ENVIRONM HLTH, INST IND ECOL SCI, KITAKYUSHU, FUKUOKA 807, JAPAN; YAMANASHI PREFECTURAL MENTAL HLTH & WELF CTR, YAMANASHI, JAPAN; NATL INST MENTAL HLTH, DEPT SOCIOCULTURAL ENVIRONM RES, CHIBA, JAPAN							American Psychiatric Association, 1980, DIAGN STAT MAN MENT; American Psychiatric Association, 1987, DIAGN STAT MAN MENT; MARKOWITZ JS, 1989, ARCH GEN PSYCHIAT, V46, P984; ANTHONY JC, 1985, ARCH GEN PSYCHIAT, V42, P667; ENDICOTT J, 1978, ARCH GEN PSYCHIAT, V35, P837; RASMUSSEN SA, 1990, J CLIN PSYCHIAT, V51, P10; WEISSMAN MM, 1977, ARCH GEN PSYCHIAT, V34, P98; EATON WW, 1990, J OCCUP ENVIRON MED, V32, P1079, DOI 10.1097/00043764-199011000-00006; EATON WW, 1994, AM J PSYCHIAT, V151, P413; AOKI Y, 1994, J AFFECT DISORDERS, V32, P51, DOI 10.1016/0165-0327(94)90061-2; BROMET EJ, 1990, J OCCUP ENVIRON MED, V32, P989; BROMET EJ, 1988, J ORGAN BEHAV, V9, P1, DOI 10.1002/job.4030090102; FUJIHARA S, 1994, 1993 HOKK U SCH MED, P45; FUJIHARA S, 1993, NIHON IJI SHINPOU, V3618, P47; HELZER JE, 1985, ARCH GEN PSYCHIAT, V42, P657; KAWAKAMI N, 1995, ADV HUM FACT ERGON, V20, P705, DOI 10.1016/S0921-2647(06)80298-4; KITAMURA T, 1992, MANUAL TIME ORDERED; ROBERTS RE, 1993, ENVIRON RES, V61, P266, DOI 10.1006/enrs.1993.1071; Robins LN, 1991, PSYCHIAT DISORDERS A, P328; SAS Institute, 1988, SAS STAT US GUID REL; SHOJI M, 1990, Japanese Journal of Industrial Health, V32, P118; WEISSMAN MM, 1991, J CLIN PSYCHIAT, V52, P6; WEISSMAN M M, 1988, Journal of Psychiatric Research, V22, P99, DOI 10.1016/0022-3956(88)90071-4; World Health Organization, 1990, COMP INT DIAGN INT C	24	23	24	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1076-2752			J OCCUP ENVIRON MED	J. Occup. Environ. Med.	SEP	1996	38	9					899	905		10.1097/00043764-199609000-00012		7	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	VH073	WOS:A1996VH07300008		
J	Inaba, T; Saito, H; Fukushima, R; Hashiguchi, Y; Lin, MT; Inoue, T; Fukatsu, K; Muto, T; Takenaka, A; Takahashi, S; Noguchi, T				Inaba, T; Saito, H; Fukushima, R; Hashiguchi, Y; Lin, MT; Inoue, T; Fukatsu, K; Muto, T; Takenaka, A; Takahashi, S; Noguchi, T			Effects of growth hormone and insulin-like growth factor 1 (IGF-1) treatments on the nitrogen metabolism and hepatic IGF-1-messenger RNA expression in postoperative parenterally fed rats	JOURNAL OF PARENTERAL AND ENTERAL NUTRITION			English	Article							FACTOR-I; GASTROINTESTINAL SURGERY; BACTERIAL TRANSLOCATION; PROTEIN-METABOLISM; BINDING-PROTEIN; GENE-EXPRESSION; ENHANCE GROWTH; GUT ATROPHY; LIVER; SOMATOMEDIN	Background: Few studies have made direct comparisons of the metabolic effects of growth hormone (GK) and insulin-like growth factor 1 (IGF-1). We have assessed the dose-dependent effects of GH and IGF-I treatments on nitrogen metabolism, intestinal-structure, and hepatic IGF-l-messenger RNA (mRNA) expression in postoperative parenterally fed rats. Methods: Rats were maintained on total parenteral nutrition (TPN) for 3 days after gastrectomy. GH (0.4 or 0.8 IU/kg/d) or IGF-1 (1, 2, or 4 mg/kg/d) was infused throughout the experimental period. Anabolic effects of GH and IGF-I were assessed by body weight change, nitrogen excretion, and whole-body protein turnover Organ weights, intestinal structure, plasma IGF-1 levels and hepatic IGF-1-mRNA contents were also determined. Results. Both GH and IGF-1 attenuated body weight loss and nitrogen excretion and increased whole-body protein synthesis and spleen weight. These observations suggest that the anabolic effects of 1 mg/kg/d of IGF 1 were equivalent to those of 0.66 IU/kg/d of GH. IGF-1, but not GH, reduced atrophy of the intestinal mucosa GH treatment increased hepatic IGF-1-mRNA and the plasma IGF-1 level, whereas IGF-1 treatment increased the plasma IGF-1 level with no change in the hepatic IGF-1-mRNA content. Conclusions: Administration of GH or IGF-1 attenuates catabolism after surgery. The anabolic effects of I mg/kg/d of IGF-1 are equivalent to those of 0.66 IU/kg/d of GH. IGF-1 reduces intestinal mucosal atrophy. GH increases hepatic IGF-1-mRNA and the plasma IGF-I level.	UNIV TOKYO,FAC MED,SURG CTR,BUNKYO KU,TOKYO 113,JAPAN; UNIV TOKYO,FAC AGR,DEPT AGR CHEM,NUTR CHEM LAB,TOKYO 113,JAPAN	Inaba, T (reprint author), UNIV TOKYO,FAC MED,DEPT SURG 1,BUNKYO KU,7-3-1 HONGO,TOKYO 113,JAPAN.			LIN, MING-TSAN/0000-0001-7313-7057			KUPFER SR, 1993, J CLIN INVEST, V91, P391, DOI 10.1172/JCI116212; MAITER D, 1992, ENDOCRINOLOGY, V130, P3257, DOI 10.1210/en.130.6.3257; ALVERDY JC, 1988, SURGERY, V104, P185; DAUGHADAY WH, 1982, ENDOCRINOLOGY, V110, P575; STREAT SJ, 1987, J TRAUMA, V27, P262, DOI 10.1097/00005373-198703000-00006; HORBER FF, 1990, J CLIN INVEST, V86, P265, DOI 10.1172/JCI114694; ASAKAWA K, 1992, GROWTH REGULAT, V2, P40; CHEN K, 1995, JPEN-PARENTER ENTER, V19, P119, DOI 10.1177/0148607195019002119; DAUGHADA.WH, 1972, NATURE, V235, P107, DOI 10.1038/235107a0; DELBARRIO AS, 1993, ENDOCR RES, V19, P163; DERCOLE AJ, 1984, P NATL ACAD SCI-BIOL, V81, P935, DOI 10.1073/pnas.81.3.935; GOETERS C, 1995, ANN SURG, V222, P646, DOI 10.1097/00000658-199511000-00007; HUANG KF, 1993, ARCH SURG-CHICAGO, V128, P47; INOUE L, 1995, ARCH SURG-CHICAGO, V130, P1115; JACOB R, 1989, J CLIN INVEST, V83, P1717, DOI 10.1172/JCI114072; JIANG ZM, 1989, ANN SURG, V210, P513, DOI 10.1097/00000658-198910000-00012; LEMMEY AB, 1991, AM J PHYSIOL, V260, pE213; LO HC, 1995, AM J PHYSIOL-ENDOC M, V269, pE368; MARTIN AA, 1991, AM J PHYSIOL, V261, pF626; MEHLS O, 1993, KIDNEY INT, V44, P1251, DOI 10.1038/ki.1993.376; MIURA Y, 1992, BRIT J NUTR, V67, P257, DOI 10.1079/BJN19920029; MJAALAND M, 1991, ACTA CHIR-EUR J SURG, V157, P21; MOATSSTAATS BM, 1989, ENDOCRINOLOGY, V125, P2368; PICOU D, 1969, CLIN SCI, V36, P283; SCHWANDER JC, 1983, ENDOCRINOLOGY, V113, P297; SKOTTNER A, 1989, ENDOCRINOLOGY, V124, P2519; TAKAGI K, 1995, NUTRITION, V11, P22; THISSEN JP, 1992, J ENDOCRINOL, V132, P141, DOI 10.1677/joe.0.1320141; WARD HC, 1987, ANN SURG, V206, P56, DOI 10.1097/00000658-198707000-00009; ZHANG W, 1995, TRANSPLANTATION, V59, P755, DOI 10.1097/00007890-199503150-00020; Ziegler T R, 1994, New Horiz, V2, P244	31	17	19	AMER SOC PARENTERAL & ENTERAL NUTRITION	SILVER SPRING	8630 FENTON STREET SUITE 412, SILVER SPRING, MD 20910	0148-6071			JPEN-PARENTER ENTER	J. Parenter. Enter. Nutr.	SEP-OCT	1996	20	5					325	331		10.1177/0148607196020005325		7	Nutrition & Dietetics	Nutrition & Dietetics	VJ047	WOS:A1996VJ04700004		
J	Nakai, D; Seita, T; Terasaki, T; Iwasa, S; Shoji, Y; Mizushima, Y; Sugiyama, Y				Nakai, D; Seita, T; Terasaki, T; Iwasa, S; Shoji, Y; Mizushima, Y; Sugiyama, Y			Cellular uptake mechanism for oligonucleotides: Involvement of endocytosis in the uptake of phosphodiester oligonucleotides by a human colorectal adenocarcinoma cell line, HCT-15	JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS			English	Article							EPIDERMAL GROWTH-FACTOR; RAT-LIVER; PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES; ANTISENSE OLIGONUCLEOTIDE; INFECTED-CELLS; HL-60 CELLS; RECEPTORS; ATP; INTERNALIZATION; HEPATOCYTES	We used a 20-mer antisense oligonucleotide against human MDR1 mRNA to study the mechanism of uptake of oligonucleolides by a human colorectal adenocarcinoma cell line, HCT-15. 5'-end-P-32-labeled oligonucleotides were mainly used. The uptake of phosphodiester oligonucleotides (D-oligo) by HCT-15 cells increased with time, but the uptake of phosphorothioate oligonucleotides (S-oligo) showed minimal increases with time. HeLa cells showed a 4-fold greater D-oligo uptake than did HCT-15 cells, and other cell lines exhibited a 25-fold lower uptake than did HCT-15 cells. On the other hand, S-oligo uptake varied only severalfold among the cell lines used. D-oligo uptake consisted of a saturable component (Michaelis constant K-m = 0.16 mu M and maximal uptake rate V-max = 4.8 pmol/min/mg for HCT-15 cells and K-m = 0.21 mu M and Vmax = 35.6 pmol/min/mg for HeLa cells), i.e., the difference between the cell types was mainly in Vmax. The uptake of labeled D-oligo was inhibited by unlabeled S-oligo at a much lower concentration (K-i = 0.01 mu M) than by unlabeled D-oligo (K-m = 0.16 mu M), although the uptake rate of D-oligo was greater than that of S-oligo. The D-oligo uptake was highly temperature dependent. Of the sulfhydryl-modifying reagents (p-chloromercuriphenyl-sulfonic acid and p-chloromercuribenzoic acid), only p-chloromercuribenzoic acid inhibited D-oligo uptake, suggesting the involvement of a protein whose sulfhydryl residues inside the cell are critical for D-oligo uptake. Chloroquine and monensin, which are known to alter the intracellular fate of ligands and receptors, did not affect D-oligo uptake, but phenylarsine oxide, an inhibitor of internalization processes, inhibited uptake significantly. Down-regulation and recovery of D-oligo uptake induced by excess unlabeled D-oligo pretreatment occurred, but this was only partial. Studies with a digitonin equilibrium method and confocal microscopy indicated that intracellular localization of D-oligo was mainly in a vesicular compartment. More stable 3'-end-P-32-labeled oligonucleotides were also used, to compare their uptake characteristics with those of the 5'-end-labeled oligonucleotides. The uptake characteristics for the two labels were similar in terms of saturability, greater D-oligo uptake, compared with S-oligo, and the inhibitory effect of p-chloromercuribenzoic acid; however, the stable 3'-end label showed greater uptake than the 5'-end label. Our findings suggest that D-oligo uptake by HCT-15 cells is mediated by endocytosis involving binding sites on the plasma membrane.	UNIV TOKYO,FAC PHARMACEUT SCI,BUNKYO KU,TOKYO 113,JAPAN; TAKEDA CHEM IND LTD,DDS RES LABS,OSAKA 532,JAPAN; ST MARIANNA UNIV SCH MED,INST MED SCI,KAWASAKI,KANAGAWA,JAPAN			Terasaki, Tetsuya/K-6730-2012	Terasaki, Tetsuya/0000-0002-6332-7575			AKHTAR S, 1991, LIFE SCI, V49, P1793, DOI 10.1016/0024-3205(91)90480-Y; LARKIN JM, 1985, J CELL PHYSIOL, V124, P372, DOI 10.1002/jcp.1041240303; YAKUBOV LA, 1989, P NATL ACAD SCI USA, V86, P6454, DOI 10.1073/pnas.86.17.6454; STEIN CA, 1988, NUCLEIC ACIDS RES, V16, P3209, DOI 10.1093/nar/16.8.3209; TIDD DM, 1989, BRIT J CANCER, V60, P343, DOI 10.1038/bjc.1989.283; MATSUKURA M, 1989, P NATL ACAD SCI USA, V86, P4244, DOI 10.1073/pnas.86.11.4244; SCHMID SL, 1990, J CELL BIOL, V111, P2307, DOI 10.1083/jcb.111.6.2307; STEIN CA, 1988, CANCER RES, V48, P2659; TONKINSON JL, 1994, NUCLEIC ACIDS RES, V22, P4268, DOI 10.1093/nar/22.20.4268; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; CALABRETTA B, 1991, P NATL ACAD SCI USA, V88, P2351, DOI 10.1073/pnas.88.6.2351; CLARKE BL, 1985, J BIOL CHEM, V260, P128; CORRIAS MV, 1992, ANTICANCER RES, V12, P1431; GIBSON AE, 1989, AM J PHYSIOL, V257, pC182; GULLINO PM, 1966, PROG EXP TUMOR RES, V8, P1; GUTMAN M, 1971, BIOCHEM BIOPH RES CO, V44, P526, DOI 10.1016/S0006-291X(71)80114-6; HERTEL C, 1985, J BIOL CHEM, V260, P12574; HERTEL C, 1986, J BIOL CHEM, V261, P5974; KATO Y, 1992, P NATL ACAD SCI USA, V89, P8507, DOI 10.1073/pnas.89.18.8507; LISZIEWICZ J, 1993, P NATL ACAD SCI USA, V90, P3860, DOI 10.1073/pnas.90.9.3860; LOKE SL, 1989, P NATL ACAD SCI USA, V86, P3474, DOI 10.1073/pnas.86.10.3474; MAY JM, 1985, J BIOL CHEM, V193, P265; MINGYI C, 1991, J BIOL CHEM, V266, P18162; PODDEVIN B, 1994, ANTISENSE RES DEV, V4, P147; RATAJCZAK MZ, 1992, P NATL ACAD SCI USA, V89, P1710, DOI 10.1073/pnas.89.5.1710; SATO H, 1988, P NATL ACAD SCI USA, V85, P8355, DOI 10.1073/pnas.85.21.8355; SHAW JP, 1991, NUCLEIC ACIDS RES, V19, P747, DOI 10.1093/nar/19.4.747; SHOJI Y, 1991, NUCLEIC ACIDS RES, V19, P5543, DOI 10.1093/nar/19.20.5543; Stein C A, 1989, Important Adv Oncol, P79; STEIN CA, 1993, BIOCHEMISTRY-US, V32, P4855, DOI 10.1021/bi00069a022; SUGIYAMA Y, 1989, PHARMACEUT RES, V6, P192, DOI 10.1023/A:1015905331391; TIDD DM, 1990, ANTICANCER RES, V10, P2659; UEDA M, 1985, J BIOL CHEM, V260, P3941; WILEMAN T, 1984, BIOCHEM J, V220, P665; WUPONG S, 1992, PHARMACEUT RES, V9, P1010; WUPONG S, 1994, ANTISENSE RES DEV, V4, P155; YAMAOKA K, 1981, J PHARMACOBIO-DYNAM, V4, P879; YANAI S, 1991, PHARMACEUT RES, V8, P557, DOI 10.1023/A:1015836219502; YANAI S, 1990, AM J PHYSIOL, V258, pG593; Zhao Q, 1993, Antisense Res Dev, V3, P53	40	32	32	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	0022-3565			J PHARMACOL EXP THER	J. Pharmacol. Exp. Ther.	SEP	1996	278	3					1362	1372				11	Pharmacology & Pharmacy	Pharmacology & Pharmacy	VJ018	WOS:A1996VJ01800048		
J	Forsythe, ID; BarnesDavies, M; Tsujimoto, T; Onodera, K; Takahashi, T				Forsythe, ID; BarnesDavies, M; Tsujimoto, T; Onodera, K; Takahashi, T			Presynaptic calcium currents at a glutamatergic synapse in rat brainstem slices	JOURNAL OF PHYSIOLOGY-LONDON			English	Meeting Abstract							RECEPTORS; NEURONS; EPSCS		UNIV LEICESTER,DEPT CELL PHYSIOL & PHARMACOL,LEICESTER LE1 9HN,LEICS,ENGLAND; UNIV TOKYO,FAC MED,DEPT NEUROPHYSIOL,TOKYO 113,JAPAN							EDWARDS FA, 1989, PFLUG ARCH EUR J PHY, V414, P600, DOI 10.1007/BF00580998; Borst JGG, 1995, J PHYSIOL-LONDON, V489, P825; BARNESDAVIES M, 1995, J PHYSIOL-LONDON, V488, P387; BASKYS A, 1991, J PHYSIOL-LONDON, V444, P687; FORSYTHE ID, 1994, J PHYSIOL-LONDON, V479, P381; FORSYTHE ID, 1990, J PHYSIOL-LONDON, V429, P1	6	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	40 WEST 20TH STREET, NEW YORK, NY 10011-4211	0022-3751			J PHYSIOL-LONDON	J. Physiol.-London	SEP	1996	495P						P47	P47				1	Neurosciences; Physiology	Neurosciences & Neurology; Physiology	VJ483	WOS:A1996VJ48300063		
J	Ozeki, Y				Ozeki, Y			Regulation of anthocyanin synthesis in carrot suspension cultured cells	JOURNAL OF PLANT RESEARCH			English	Article						anthocyanin; carrot (Daucus carota); chalcone synthase; 2,4-dichlorophenoxyacetic acid; embryogenesis; phenylalanine ammonia-lyase	PHENYLALANINE AMMONIA-LYASE; TISSUE-SPECIFIC EXPRESSION; CHALCONE SYNTHASE GENE; PHENYLPROPANOID METABOLISM; DAUCUS-CAROTA; 2,4-DICHLOROPHENOXYACETIC ACID; TRANSGENIC TOBACCO; MOLECULAR-BIOLOGY; GROWTH-REGULATORS; MESSENGER-RNAS	From a physiological point of view, a close correlation has been suggested between the induction of embryogenesis, i.e. morphological differentiation, and that of anthocyanin synthesis, i.e. metabolic differentiation, I established a carrot suspension culture system in which anthocyanin synthesis and embryogenesis could be induced in the same culture and studied their relations, The results suggested that induction of anthocyanin and that of cell division, or undifferentiated growth, were the alter natures regulated by 2,4-dichlorophenoxyacetic acid (2,4-D), The activities of phenylalanine ammonia-lyase (PAL) and chalcone synthase (CHS) were found to play key roles in the regulation of anthocyanin synthesis by 2,4-D. PAL and CHS genes and their transcripts were analyzed in detail, which indicated that there are two PAL genes in carrot, one being transiently and rapidly activated by stress, and the other being specifically induced during the 2,4-D regulated anthocyanin synthesis.	UNIV TOKYO,COLL ARTS & SCI,DEPT BIOL,MEGURO KU,TOKYO 153,JAPAN			Ozeki, Yoshihiro/C-2052-2013	Ozeki, Yoshihiro/0000-0002-3002-368X			ALFERMAN.W, 1971, EXPERIENTIA, V27, P353, DOI 10.1007/BF02138194; OZEKI Y, 1986, PLANT CELL PHYSIOL, V27, P1361; REIMOLD U, 1983, EMBO J, V2, P1801; SABLOWSKI RWM, 1994, EMBO J, V13, P128; HAHLBROCK K, 1989, ANNU REV PLANT PHYS, V40, P347, DOI 10.1146/annurev.pp.40.060189.002023; OPPENHEIMER DG, 1991, CELL, V67, P483, DOI 10.1016/0092-8674(91)90523-2; LAMB CJ, 1994, CELL, V76, P419, DOI 10.1016/0092-8674(94)90106-6; TANAKA Y, 1989, PLANT PHYSIOL, V90, P1403, DOI 10.1104/pp.90.4.1403; GROTEWOLD E, 1994, CELL, V76, P543, DOI 10.1016/0092-8674(94)90117-1; URAO T, 1993, PLANT CELL, V5, P1529, DOI 10.1105/tpc.5.11.1529; YAMAKAWA T, 1983, AGR BIOL CHEM TOKYO, V47, P997; HAHLBROCK K, 1979, ANNU REV PLANT PHYS, V30, P105, DOI 10.1146/annurev.pp.30.060179.000541; LIANG X, 1989, P NATL ACAD SCI USA, V86, P9284, DOI 10.1073/pnas.86.23.9284; LOIS R, 1989, EMBO J, V8, P1641; HATTON D, 1995, PLANT J, V7, P859, DOI 10.1046/j.1365-313X.1995.07060859.x; LEYVA A, 1992, PLANT CELL, V4, P263; BEVAN M, 1989, EMBO J, V8, P1899; BIRCHLER J, 1990, TRENDS GENET, V6, P231, DOI 10.1016/0168-9525(90)90188-C; BLAKELY LM, 1961, AM J BOT, V48, P351, DOI 10.2307/2439326; DIXON RA, 1980, PLANTA, V150, P279, DOI 10.1007/BF00384656; DIXON RA, 1983, ADV ENZYMOL RAMB, V55, P1; DOUGALL DK, 1980, PLANTA, V149, P292, DOI 10.1007/BF00384569; FROHNMEYER H, 1992, PLANT J, V2, P899, DOI 10.1111/j.1365-313X.1992.00899.x; FUJIMURA T, 1979, PLANT PHYSIOL, V64, P162, DOI 10.1104/pp.64.1.162; FUJIMURA T, 1975, PLANT SCI LETT, V5, P359, DOI 10.1016/0304-4211(75)90001-2; GLEITZ J, 1989, PLANTA, V179, P323, DOI 10.1007/BF00391077; HAHLBROC.K, 1973, BIOCHIM BIOPHYS ACTA, V304, P702, DOI 10.1016/0304-4165(73)90215-8; HAHLBROCK K, 1975, ARCH BIOCHEM BIOPHYS, V171, P500, DOI 10.1016/0003-9861(75)90059-4; HARRISON MJ, 1991, P NATL ACAD SCI USA, V88, P2515, DOI 10.1073/pnas.88.6.2515; IBRAHIM RK, 1971, LLOYD, V34, P175; JOOS HJ, 1992, EUR J BIOCHEM, V204, P621, DOI 10.1111/j.1432-1033.1992.tb16675.x; KAKEGAWA K, 1987, PHYTOCHEMISTRY, V26, P2261, DOI 10.1016/S0031-9422(00)84696-8; LAWTON MA, 1991, PLANT MOL BIOL, V16, P235, DOI 10.1007/BF00020555; MATSUMOT.T, 1973, AGR BIOL CHEM TOKYO, V37, P561; MINAMIKAWA T, 1964, ARCH BIOCHEM BIOPHYS, V108, P573, DOI 10.1016/0003-9861(64)90444-8; MORI T, 1993, J FOOD SCI, V58, P788, DOI 10.1111/j.1365-2621.1993.tb09359.x; OZEKI Y, 1990, PHYSIOL PLANTARUM, V78, P400, DOI 10.1034/j.1399-3054.1990.780314.x; OZEKI Y, 1993, PLANT CELL PHYSIOL, V34, P1029; OZEKI Y, 1987, PHYSIOL PLANTARUM, V69, P123, DOI 10.1111/j.1399-3054.1987.tb01954.x; OZEKI Y, 1985, PLANT CELL PHYSIOL, V26, P903; OZEKI Y, 1981, PHYSIOL PLANTARUM, V53, P570, DOI 10.1111/j.1399-3054.1981.tb02753.x; OZEKI Y, 1994, PLANT CELL TISS ORG, V38, P221, DOI 10.1007/BF00033880; OZEKI Y, 1985, J BIOCHEM-TOKYO, V98, P9; OZEKI Y, 1990, PHYSIOL PLANTARUM, V80, P379, DOI 10.1034/j.1399-3054.1990.800308.x; SABLOWSKI RWM, 1995, P NATL ACAD SCI USA, V92, P6901, DOI 10.1073/pnas.92.15.6901; SCHMITZ M, 1972, Z PFLANZENPHYSIOL, V68, P259; SHIRAISHI T, 1978, Annals of the Phytopathological Society of Japan, V44, P659; SLABECKASZWEYK. A, 1952, ACT SOC BOT POL, V21, P537; STRAUS J, 1959, PLANT PHYSIOL, V34, P536, DOI 10.1104/pp.34.5.536; SUGANO N, 1967, BOT MAG TOKYO, V80, P440; TAKAHASHI A, 1991, PLANT CELL PHYSIOL, V32, P541; TAKEDA J, 1993, PHYSIOL PLANTARUM, V89, P4; TANAKA Y, 1977, J BIOCHEM-TOKYO, V81, P963; TANAKA Y, 1977, PLANT CELL PHYSIOL, V18, P1209; TANAKA Y, 1977, EUR J BIOCHEM, V73, P255, DOI 10.1111/j.1432-1033.1977.tb11314.x; YAMAMOTO Y, 1989, AGR BIOL CHEM TOKYO, V53, P417	56	3	4	BOTANICAL SOC JAPAN	TOKYO	TOSHIN BUILDING HONGO 2-27-2 BUNKYO-KU, TOKYO 113, JAPAN	0918-9440			J PLANT RES	J. Plant Res.	SEP	1996	109	1095					343	351		10.1007/BF02344483		9	Plant Sciences	Plant Sciences	VT454	WOS:A1996VT45400014		
J	Nozaki, H				Nozaki, H			Morphology and evolution of sexual reproduction in the Volvocaceae (Chlorophyta)	JOURNAL OF PLANT RESEARCH			English	Article						Chlorophyta; cladistic analysis; evolution; molecular phylogeny morphology; sexual reproduction; Volvocaceae; Volvocales	SP-NOV VOLVOCACEAE; PHYLOGENETIC-RELATIONSHIPS; PLEODORINA; EUDORINA; TAXONOMY; JAPAN; NEPAL	Morphological features of sexual reproduction in the Volvocaceae are reviewed, focusing particularly on gametic union and zygote germination. Both of the two conjugating gametes of the isogamous genera Pandorina, Volvulina and Yamagishiella bear a tubular mating structure (mating papilla), and plasmogamy is initiated by union of the papillae tips. On zygote germination, a single biflagellate gone cell is released from the zygote wall. Although all the anisogamous and oogamous genera of the Volvocaceae produce ''sperm packets'' during gametogenesis and a single gone cell at zygote germination, some difference can be recognized in the male gametes. The male gametes of Eudorina bear a tubular cytoplasmic protuberance (putative mating papilla) near the base of the flagella, whereas such a structure recognized at the light microscopic level is not evident in Pleodorina and Volvox, Evolution of the sexual reproduction characteristics of volvocacean algae is discussed on the basis of recent cladistic analysis of morphological data as well as of the ribosomal (r) RNA phylogeny and large subunit of the ribulose-1,5-biphosphate carboxylase/oxygenase(rbcL) gene trees.		Nozaki, H (reprint author), UNIV TOKYO,GRAD SCH SCI,DEPT BIOL SCI,BUNKYO KU,TOKYO 113,JAPAN.						NOZAKI H, 1988, PHYCOLOGIA, V27, P209, DOI 10.2216/i0031-8884-27-2-209.1; NOZAKI H, 1994, J PHYCOL, V30, P353, DOI 10.1111/j.0022-3646.1994.00353.x; NOZAKI H, 1986, PHYCOLOGIA, V25, P29, DOI 10.2216/i0031-8884-25-1-29.1; NOZAKI H, 1983, BOT MAG TOKYO, V96, P103, DOI 10.1007/BF02491095; Nozaki H, 1995, J PHYCOL, V31, P970, DOI 10.1111/j.0022-3646.1995.00970.x; STEIN JR, 1958, AM J BOT, V45, P664, DOI 10.2307/2439502; NOZAKI H, 1992, PHYCOLOGIA, V31, P529, DOI 10.2216/i0031-8884-31-6-529.1; BROOKS AE, 1966, J PROTOZOOL, V13, P367, DOI 10.1111/j.1550-7408.1966.tb01922.x; CAREFOOT JR, 1966, J PHYCOL, V2, P150, DOI 10.1111/j.1529-8817.1966.tb04614.x; COLEMAN AW, 1959, J PROTOZOOL, V6, P249, DOI 10.1111/j.1550-7408.1959.tb04366.x; ETTL H, 1983, SU WASSERFLORA MITTE, V9; HARRIS D O, 1969, Archiv fuer Protistenkunde, V111, P138; LARSON A, 1992, MOL BIOL EVOL, V9, P85; MATSUDA Y, 1987, BOT MAG TOKYO, V100, P373, DOI 10.1007/BF02488856; NOZAKI H, 1979, Journal of Japanese Botany, V54, P363; NOZAKI H, 1981, Journal of Japanese Botany, V56, P65; NOZAKI H, 1989, PHYCOLOGIA, V28, P252, DOI 10.2216/i0031-8884-28-2-252.1; NOZAKI H, 1984, Japanese Journal of Phycology, V32, P130; NOZAKI H, 1990, PHYCOLOGIA, V29, P410, DOI 10.2216/i0031-8884-29-4-410.1; NOZAKI H, 1982, Japanese Journal of Phycology, V30, P303; NOZAKI H, 1986, Japanese Journal of Phycology, V34, P144; NOZAKI H, 1993, J PHYCOL, V29, P369, DOI 10.1111/j.0022-3646.1993.00369.x; NOZAKI H, 1986, Japanese Journal of Phycology, V34, P232; NOZAKI H, 1991, PHYCOLOGIA, V30, P381, DOI 10.2216/i0031-8884-30-5-381.1; NOZAKI H, 1986, Journal of Japanese Botany, V61, P316; NOZAKI H, 1983, Journal of Japanese Botany, V58, P345; NOZAKI H, 1982, Journal of Japanese Botany, V57, P105; NOZAKI H, 1989, PHYCOLOGIA, V28, P77, DOI 10.2216/i0031-8884-28-1-77.1; NOZAKI H, 1991, PHYCOLOGIA, V30, P449, DOI 10.2216/i0031-8884-30-5-449.1; POCOCK M. A., 1933, ANN S AFRICAN MUS, V16, P523; RAYBURN WR, 1974, J PHYCOL, V10, P42, DOI 10.1111/j.0022-3646.1974.00042.x; Smith G. M., 1950, FRESH WATER ALGAE US; SMITH GM, 1955, CRYPTOGAMIC BOTANY, V1; STARR RC, 1962, ARCH MIKROBIOL, V42, P130, DOI 10.1007/BF00408169; Starr R.C., 1980, Developments in Marine Biology, V2, P147; WATERS AJ, 1960, THESIS U CALIFORNIA; Wynne MJ, 1985, INTRO ALGAE	37	19	21	BOTANICAL SOC JAPAN	TOKYO	TOSHIN BUILDING HONGO 2-27-2 BUNKYO-KU, TOKYO 113, JAPAN	0918-9440			J PLANT RES	J. Plant Res.	SEP	1996	109	1095					353	361		10.1007/BF02344484		9	Plant Sciences	Plant Sciences	VT454	WOS:A1996VT45400015		
J	Yamanaka, M; Honjo, S; Hatsugai, Y; Kohmoto, M				Yamanaka, M; Honjo, S; Hatsugai, Y; Kohmoto, M			Exact ground-state correlation functions of one-dimensional strongly correlated electron models with resonating-valence-bond ground state	JOURNAL OF STATISTICAL PHYSICS			English	Article						strongly correlated electron systems; solvable model; correlation function; Kondo insulator; resonating-valence-bond state; transfer matrix; persistent current	PERSISTENT CURRENTS; HEISENBERG-MODEL; SUPERCONDUCTIVITY; HUBBARD; EXCITATIONS; SYSTEMS; RINGS	We investigate one-dimensional strongly correlated electron models which have the resonating-valence-bond state as the exact ground state. The correlation functions are evaluated exactly using the transfer matrix method for the geometric representations of the valence-bond states. In this method, we only treat matrices with small dimensions. This enables us to give analytical results. It is shown that the correlation functions decay exponentially with distance. The result suggests that there is a finite excitation gap, and that the ground state is insulating. Since the corresponding noninteracting systems may be insulating or metallic, we can say that the gap originates from strong correlation. The persistent currents of the present models are also investigated and found to be exactly vanishing.	UNIV TOKYO,INST SOLID STATE PHYS,MINATO KU,TOKYO 106,JAPAN	Yamanaka, M (reprint author), UNIV TOKYO,DEPT APPL PHYS,BUNKYO KU,7-3-1 HONGO,TOKYO 113,JAPAN.		Hatsugai, Yasuhiro/G-3793-2010	Hatsugai, Yasuhiro/0000-0001-6933-5552			ANDERSON PW, 1987, PHYS REV LETT, V58, P2790, DOI 10.1103/PhysRevLett.58.2790; ANDERSON PW, 1974, PHILOS MAG, V30, P423; BUTTIKER M, 1983, PHYS LETT A, V96, P365, DOI 10.1016/0375-9601(83)90011-7; KLEIN DJ, 1985, CHEM PHYS LETT, V120, P367, DOI 10.1016/0009-2614(85)85621-9; BYERS N, 1961, PHYS REV LETT, V7, P46, DOI 10.1103/PhysRevLett.7.46; SUTHERLAND B, 1988, PHYS REV B, V37, P3786, DOI 10.1103/PhysRevB.37.3786; LEVY LP, 1990, PHYS REV LETT, V64, P2074, DOI 10.1103/PhysRevLett.64.2074; ANDERSON PW, 1987, SCIENCE, V235, P1196, DOI 10.1126/science.235.4793.1196; ROKHSAR DS, 1988, PHYS REV LETT, V61, P2376, DOI 10.1103/PhysRevLett.61.2376; BRANDT U, 1992, PHYS REV LETT, V68, P2648, DOI 10.1103/PhysRevLett.68.2648; MAILLY D, 1993, PHYS REV LETT, V70, P2020, DOI 10.1103/PhysRevLett.70.2020; Pauling L, 1937, J CHEM PHYS, V1, P280, DOI 10.1063/1.1749284; TASAKI H, 1993, PHYS REV LETT, V70, P3303, DOI 10.1103/PhysRevLett.70.3303; LIANG S, 1988, PHYS REV LETT, V61, P365, DOI 10.1103/PhysRevLett.61.365; BARES PA, 1993, PHYS REV B, V49, P8882; CHANDRASEKHAR V, 1991, PHYS REV LETT, V67, P3573; FAN Y, 1988, PHYS REV B, V37, P1820, DOI 10.1103/PhysRevB.37.1820; ISKE PL, 1987, PHYSICA A, V142, P360, DOI 10.1016/0378-4371(87)90030-6; KIMURA K, UNPUB; KOHMOTO M, 1988, PHYS REV B, V37, P3812, DOI 10.1103/PhysRevB.37.3812; KOHMOTO M, 1988, PHYS REV B, V38, P5811; KOHMOTO M, 1988, PHYS REV B, V37, P9439, DOI 10.1103/PhysRevB.37.9439; MIELKE A, 1992, J PHYS A-MATH GEN, V25, P6507, DOI 10.1088/0305-4470/25/24/006; PAULING L, 1949, PROC R SOC LON SER-A, V196, P343, DOI 10.1098/rspa.1949.0032; RUNNER G, 1932, NACHR GES WISS GO MN, P337; SHAPIR Y, 1989, PHYS REV B, V39, P4524, DOI 10.1103/PhysRevB.39.4524; STRACK R, 1993, PHYS REV LETT, V70, P833, DOI 10.1103/PhysRevLett.70.833; Tasaki H., COMMUNICATION; TASAKI H, UNPUB; TASAKI H, 1992, PHYS REV B, V42, P2547; TASAKI H, 1993, PHYS REV B, V49, P7763	31	6	6	PLENUM PUBL CORP	NEW YORK	233 SPRING ST, NEW YORK, NY 10013	0022-4715			J STAT PHYS	J. Stat. Phys.	SEP	1996	84	5-6					1133	1208		10.1007/BF02174131		76	Physics, Mathematical	Physics	VL460	WOS:A1996VL46000009		
J	Nakatani, T; Nishimoto, H; Daimon, H; Suga, S; Namba, H; Ohta, T; Kagoshima, Y; Miyahara, T				Nakatani, T; Nishimoto, H; Daimon, H; Suga, S; Namba, H; Ohta, T; Kagoshima, Y; Miyahara, T			Photoelectron holography of the Si(001) surface	JOURNAL OF SYNCHROTRON RADIATION			English	Article						photoelectron holography; photoelectron diffraction; Si(001) surface	ELECTRON-EMISSION HOLOGRAPHY; MULTIPLE-SCATTERING; SI(100)-(2X1)	Three-dimensional images of the near-surface atom arrangement were calculated from two-dimensional photoelectron diffraction data by several imaging algorithms: (i) a basic method with a Fourier transformation at one kinetic energy over k space, considering the phase factor due to the path-length difference; (ii) energy summation of the above results; (iii) Fourier transformation within small k-space windows; and (iv) their combinations. Atomic images produced by these methods from the experimental Si 2p photoelectron diffraction patterns of an Si(001) surface are compared with the crystal geometry. The results show that the energy-summed small-window method, called SWEEP, gives the best images.	UNIV TOKYO,FAC SCI,DEPT CHEM,BUNKYO KU,TOKYO 113,JAPAN; NATL LAB HIGH ENERGY PHYS,PHOTON FACTORY,TSUKUBA,IBARAKI 305,JAPAN	Nakatani, T (reprint author), OSAKA UNIV,FAC ENGN SCI,DEPT PHYS MAT,TOYONAKA,OSAKA 560,JAPAN.						BARTON JJ, 1991, PHYS REV LETT, V67, P3106, DOI 10.1103/PhysRevLett.67.3106; BARTON JJ, 1988, PHYS REV LETT, V61, P1356, DOI 10.1103/PhysRevLett.61.1356; GABOR D, 1948, NATURE, V161, P777, DOI 10.1038/161777a0; BULLOCK EL, 1995, PHYS REV LETT, V74, P2756, DOI 10.1103/PhysRevLett.74.2756; DENECKE R, 1995, SURF SCI, V331, P1085, DOI 10.1016/0039-6028(95)00252-9; DIAMON H, 1990, REV SCI INSTRUM, V61, P205; DIAMON H, 1988, REV SCI INSTRUM, V59, P545; HARDCASTLE S, 1991, SURF SCI, V245, pL190; HOLLAND BW, 1984, SURF SCI, V140, pL269, DOI 10.1016/0039-6028(84)90730-1; HUANG H, 1991, PHYS REV B, V44, P3240, DOI 10.1103/PhysRevB.44.3240; NAMBA H, 1989, REV SCI INSTRUM, V60, P1909, DOI 10.1063/1.1140886; NISHIMOTO H, 1993, REV SCI INSTRUM, V64, P2857, DOI 10.1063/1.1144373; ROESLER JM, 1995, SURF SCI, V329, pL588, DOI 10.1016/0039-6028(95)00232-4; ROUS PJ, 1994, SURF SCI, V316, pL1068; SZOKE A, 1986, AIP C P, V147; TONG SY, 1991, PHYS REV LETT, V67, P3102, DOI 10.1103/PhysRevLett.67.3102; TROMP RM, 1983, SURF SCI, V133, P137, DOI 10.1016/0039-6028(83)90488-0	17	6	6	MUNKSGAARD INT PUBL LTD	COPENHAGEN	35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK	0909-0495			J SYNCHROTRON RADIAT	J. Synchrot. Radiat.	SEP 1	1996	3		5				239	244		10.1107/S0909049596006346		6	Instruments & Instrumentation; Optics; Physics, Applied	Instruments & Instrumentation; Optics; Physics	VG147	WOS:A1996VG14700007		
J	Kadono, T; Kikuchi, K; Kubo, M; Fujimoto, M; Tamaki, K				Kadono, T; Kikuchi, K; Kubo, M; Fujimoto, M; Tamaki, K			Serum concentrations of basic fibroblast growth factor in collagen diseases	JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY			English	Article							SYSTEMIC-SCLEROSIS; TGF-BETA; SCLERODERMA; DERMATOMYOSITIS; INTERLEUKIN-2; POLYMYOSITIS; CLASSIFICATION; IMMUNOASSAY; FIBROSIS; SUBSETS	Background: Basic fibroblast growth factor (bFGF), a cytoplasmic polypeptide growth regulator that induces endothelial cell and fibroblast proliferation, is produced by endothelial cells and skeletal muscle. Objective: We hypothesized that this factor is involved in fibrotic changes in muscle and skin in collagen diseases. Methods: The serum level of bFGF was measured in 74 patients with systemic sclerosis, 12 with systemic lupus erythematosus, 33 with dermatomyositis, 13 with Raynaud's disease, and 20 control subjects. Results: bFGF was undetectable in the serum of normal persons, but detectable levels were found in 31 of 74 patients with systemic sclerosis and 7 of 33 patients with dermatomyositis. Elevated serum bFGF level was correlated with an elevated plasma endothelin level and anticentromere antibody in patients with systemic sclerosis. An elevated serum bFGF level correlated with lung fibrosis and an elevated creatine kinase level in the patients with dermatomyositis. Conclusion: Measurement of the serum bFGF level may be useful to detect vascular damage in patients with systemic sclerosis and muscule fibrosis in patients with dermatomyositis.	UNIV TOKYO,BRANCH HOSP,DEPT DERMATOL,BUNKYO KU,TOKYO 112,JAPAN; UNIV TOKYO,FAC MED,DEPT DERMATOL,TOKYO 113,JAPAN							ABRAHAM JA, 1986, SCIENCE, V233, P545, DOI 10.1126/science.2425435; VLODAVSKY I, 1991, J CELL BIOCHEM, V45, P167, DOI 10.1002/jcb.240450208; LEROY EC, 1988, J RHEUMATOL, V15, P202; VANCHEESWARAN R, 1994, J RHEUMATOL, V21, P1838; BOHAN A, 1975, NEW ENGL J MED, V292, P344, DOI 10.1056/NEJM197502132920706; SIGURGEIRSSON B, 1992, NEW ENGL J MED, V326, P363, DOI 10.1056/NEJM199202063260602; NEEDLEMAN BW, 1992, ARTHRITIS RHEUM, V35, P67, DOI 10.1002/art.1780350111; ZAMORA MR, 1990, LANCET, V336, P1144, DOI 10.1016/0140-6736(90)92766-B; STEEN VD, 1988, ARTHRITIS RHEUM, V31, P196, DOI 10.1002/art.1780310207; COZZOLINO F, 1993, J CLIN INVEST, V91, P2504, DOI 10.1172/JCI116486; DAMORE PA, 1994, ANN NEUROL, V35, P362, DOI 10.1002/ana.410350320; DUNBAR PR, 1993, BRIT J RHEUMATOL, V32, P966; FALANGA V, 1990, ANN NY ACAD SCI, V593, P161, DOI 10.1111/j.1749-6632.1990.tb16108.x; FUJIMOTO K, 1991, BIOCHEM BIOPH RES CO, V180, P386, DOI 10.1016/S0006-291X(05)81305-1; GOSPODAROWICZ D, 1986, CELL DIFFER DEV, V19, P1, DOI 10.1016/0045-6039(86)90021-7; II M, 1993, BIOCHEM BIOPH RES CO, V193, P540, DOI 10.1006/bbrc.1993.1657; KADONO T, 1995, ARCH DERMATOL RES, V297, P439; KAHALEH MB, 1989, ANN INTERN MED, V110, P446; KIKUCHI K, 1992, J INVEST DERMATOL, V99, P201, DOI 10.1111/1523-1747.ep12650432; KOH ET, 1993, ANN RHEUM DIS, V52, P857, DOI 10.1136/ard.52.12.857; MCNEIL PL, 1991, AM SCI, V79, P222; Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee, 1980, ARTHRITIS RHEUM, V23, P581; SNOWDEN N, 1994, ANN RHEUM DIS, V53, P763, DOI 10.1136/ard.53.11.763; TAKEHARA K, 1985, BRIT J DERMATOL, V112, P23, DOI 10.1111/j.1365-2133.1985.tb02287.x; TAKEI Y, 1994, CLIN CHEM, V40, P1980; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Thompson R W, 1990, Growth Factors, V3, P221, DOI 10.3109/08977199009043906; YOUSSEF P, 1995, J RHEUMATOL, V22, P569	28	33	33	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0190-9622			J AM ACAD DERMATOL	J. Am. Acad. Dermatol.	SEP	1996	35	3	1				392	397		10.1016/S0190-9622(96)90603-9		6	Dermatology	Dermatology	VF215	WOS:A1996VF21500005		
J	Tsuda, H; Takahashi, J; Kemmochi, K; Hayashi, R				Tsuda, H; Takahashi, J; Kemmochi, K; Hayashi, R			Fracture process of silicon carbide fiber-reinforced glasses	JOURNAL OF THE AMERICAN CERAMIC SOCIETY			English	Article							CERAMIC-MATRIX COMPOSITES; MECHANICAL-PROPERTIES; INTERFACE; STRENGTH; FAILURE	This paper evaluates the fracture process for fiber-reinforced glasses under tensile loading, Two types of unidirectionally aligned Nicalon SiC-fiber-reinforced glass with different fiber coatings were examined. One channel acoustic emission (AE) measurement was employed during the tensile tests. Probabilistic fracture analysis as well as the replication technique were used to investigate the relation between the AE signals and fracture processes. The AE technique proved to be an effective method for observing fracture processes of the material systems studied. The fracture process could be distinguished in terms of the AE amplitude. AE signals with high amplitudes corresponded to fiber breaking; AE signals with low amplitudes corresponded to matrix cracking, interfacial debonding, and fiber pullout, In the well-toughened material studied the reinforcing fibers would break extensively over 75% load of the ultimate strength.	UNIV TOKYO,ADV SCI & TECHNOL RES CTR,MEGURO KU,TOKYO 153,JAPAN	Tsuda, H (reprint author), NATL INST MAT & CHEM RES,DEPT COMPOSITE MAT,TSUKUBA,IBARAKI 305,JAPAN.						CURTIN WA, 1993, COMPOSITES, V24, P98, DOI 10.1016/0010-4361(93)90005-S; MARSHALL DB, 1984, J AM CERAM SOC, V67, pC259; MARSHALL DB, 1985, J AM CERAM SOC, V68, P225, DOI 10.1111/j.1151-2916.1985.tb15313.x; BEYERLE DS, 1992, J AM CERAM SOC, V75, P2719, DOI 10.1111/j.1151-2916.1992.tb05495.x; CAO HO, 1990, J AM CERAM SOC, V73, P2091, DOI 10.1111/j.1151-2916.1990.tb05273.x; EVANS AG, 1989, ACTA METALL MATER, V37, P2567, DOI 10.1016/0001-6160(89)90291-5; CURTIN WA, 1991, J AM CERAM SOC, V74, P2837, DOI 10.1111/j.1151-2916.1991.tb06852.x; CAO HC, 1990, J AM CERAM SOC, V73, P1691, DOI 10.1111/j.1151-2916.1990.tb09814.x; CRANMER DC, 1989, AM CERAM SOC BULL, V68, P415; KERANS RJ, 1989, AM CERAM SOC BULL, V68, P429; KIM RY, 1991, J AM CERAM SOC, V74, P1082, DOI 10.1111/j.1151-2916.1991.tb04346.x; PREWO KM, 1986, J MATER SCI, V21, P3590, DOI 10.1007/BF00553805; PREWO KM, 1982, J MATER SCI, V17, P1201, DOI 10.1007/BF00543541; PREWO KM, 1980, J MATER SCI, V15, P463, DOI 10.1007/BF00551699; THOULESS MD, 1989, J AM CERAM SOC, V72, P525, DOI 10.1111/j.1151-2916.1989.tb06171.x	15	11	12	AMER CERAMIC SOC	WESTERVILLE	735 CERAMIC PLACE, PO BOX 6136, WESTERVILLE, OH 43081-6136	0002-7820			J AM CERAM SOC	J. Am. Ceram. Soc.	SEP	1996	79	9					2293	2299		10.1111/j.1151-2916.1996.tb08975.x		7	Materials Science, Ceramics	Materials Science	VJ727	WOS:A1996VJ72700009		
J	Akizawa, T; Kurokawa, K; Suzuki, M; Akiba, T; Nishizawa, Y; Ohashi, Y; Ogata, E; Slatopolsky, E				Akizawa, T; Kurokawa, K; Suzuki, M; Akiba, T; Nishizawa, Y; Ohashi, Y; Ogata, E; Slatopolsky, E			Suppressive effect of 22-oxacalcitriol (OCT) on secondary hyperparathyroidism (2 HPT) of hemodialysis (HD) patients. A double-blind comparison among four doses.	JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY			English	Meeting Abstract									SHOWA UNIV,TOKYO,JAPAN; UNIV TOKYO,TOKYO,JAPAN; SHINRAKUEN HOSP,NIIGATA,JAPAN; TOKYO MED & DENT UNIV,TOKYO 113,JAPAN; OSAKA CITY UNIV,OSAKA 558,JAPAN; CANC INST HOSP,TOKYO,JAPAN; WASHINGTON UNIV,ST LOUIS,MO								0	0	0	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	1046-6673			J AM SOC NEPHROL	J. Am. Soc. Nephrol.	SEP	1996	7	9					A2818	A2818				1	Urology & Nephrology	Urology & Nephrology	VK074	WOS:A1996VK07402812		
J	Akizawa, T; Kinugasa, E; Kurihara, R; Tsukamoto, Y; Kawaguchi, Y; Fukagawa, M; Kurokawa, K				Akizawa, T; Kinugasa, E; Kurihara, R; Tsukamoto, Y; Kawaguchi, Y; Fukagawa, M; Kurokawa, K			Very high incidence and relatively mild clinical symptoms of dialysis population with hypoparathyroidism (HYPO).	JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY			English	Meeting Abstract									SHOWA UNIV,YOKOHAMA,KANAGAWA,JAPAN; KASUKABE SHUWA HOSP,YOKOHAMA,KANAGAWA,JAPAN; KITASATO UNIV,YOKOHAMA,KANAGAWA,JAPAN; TOKYO JIKEIKAI UNIV,YOKOHAMA,KANAGAWA,JAPAN; UNIV TOKYO,YOKOHAMA,KANAGAWA,JAPAN								0	0	0	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	1046-6673			J AM SOC NEPHROL	J. Am. Soc. Nephrol.	SEP	1996	7	9					A2696	A2696				1	Urology & Nephrology	Urology & Nephrology	VK074	WOS:A1996VK07402690		
J	Arai, J; Hara, Y; Tsuchiya, K; Kubota, K; Naruse, K; Naruse, M; Sugino, N; Iwamoto, N; Yoshioka, T; Nihei, H				Arai, J; Hara, Y; Tsuchiya, K; Kubota, K; Naruse, K; Naruse, M; Sugino, N; Iwamoto, N; Yoshioka, T; Nihei, H			Natriuresis in L-arginine loading plays an important role in hypotensive effect in patients with chronic renal failure (CRF)	JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY			English	Meeting Abstract									UNIV TOKYO,DEPT MED,TOKYO,JAPAN; TOKYO WOMENS MED COLL,KIDNEY FDN JAPAN,TOKYO 162,JAPAN; INST CLIN ENDOCRINOL,KIDNEY CTR,TOKYO,JAPAN; DEPT PEDIAT NEPHROL,TOKYO,JAPAN; DEPT MED,TOKYO 162,JAPAN								0	0	0	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	1046-6673			J AM SOC NEPHROL	J. Am. Soc. Nephrol.	SEP	1996	7	9					A0340	A0340				1	Urology & Nephrology	Urology & Nephrology	VK074	WOS:A1996VK07400339		
J	Arakawa, T; Okuda, T; Sekita, K; Inishi, Y; Kasuga, M; Kurokawa, K				Arakawa, T; Okuda, T; Sekita, K; Inishi, Y; Kasuga, M; Kurokawa, K			Extracellular Cl- concentration attenuates cultured rat mesangial cell proliferation via PGE2 - cAMP dependent pathway	JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY			English	Meeting Abstract									KOBE UNIV,SCH MED,SUMIYOSHIGAWA HOSP,KOBE 650,JAPAN; UNIV TOKYO,SCH MED,TOKYO 113,JAPAN								0	0	0	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	1046-6673			J AM SOC NEPHROL	J. Am. Soc. Nephrol.	SEP	1996	7	9					A2022	A2022				1	Urology & Nephrology	Urology & Nephrology	VK074	WOS:A1996VK07402018		
J	Bremer, V; Tojo, A; Kimura, K; Hirata, Y; Goto, A; Nagamatsu, T; Suzuki, Y; Omata, M				Bremer, V; Tojo, A; Kimura, K; Hirata, Y; Goto, A; Nagamatsu, T; Suzuki, Y; Omata, M			Differential role of nitric oxide synthase isoforms in nephrotoxic nephritis (NTN).	JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY			English	Meeting Abstract									UNIV TOKYO,TOKYO,JAPAN; MEIJO UNIV,NAGOYA,AICHI,JAPAN								0	0	0	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	1046-6673			J AM SOC NEPHROL	J. Am. Soc. Nephrol.	SEP	1996	7	9					A2411	A2411				1	Urology & Nephrology	Urology & Nephrology	VK074	WOS:A1996VK07402406		
J	Fukagawa, M; Kitaoka, M; Kurokawa, K				Fukagawa, M; Kitaoka, M; Kurokawa, K			A new intensive and safer protocol for percutaneous ethanol injection therapy (PEIT) of severe parathyroid hyperplasia.	JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY			English	Meeting Abstract									UNIV TOKYO,SCH MED,DEPT INTERNAL MED 1,TOKYO 113,JAPAN; SHOWA GEN HOSP,DIV ENDOCRINOL METAB,TOKYO,JAPAN								0	0	0	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	1046-6673			J AM SOC NEPHROL	J. Am. Soc. Nephrol.	SEP	1996	7	9					A2837	A2837				1	Urology & Nephrology	Urology & Nephrology	VK074	WOS:A1996VK07402831		
J	Hirakata, M; Joki, N; Hori, Y; Noda, M; Chung, UG; Kaname, S; Katoh, T; Fujita, T; Kurokawa, K				Hirakata, M; Joki, N; Hori, Y; Noda, M; Chung, UG; Kaname, S; Katoh, T; Fujita, T; Kurokawa, K			Tyrosine kinase dependent gene expression of TGF-beta and extracellular matrix proteins by mechanical stretch in cultured rat mesangial cells.	JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY			English	Meeting Abstract									UNIV TOKYO,DEPT INTERNAL MED 1,TOKYO 113,JAPAN; UNIV TOKYO,DEPT INTERNAL MED 3,TOKYO 113,JAPAN								0	0	0	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	1046-6673			J AM SOC NEPHROL	J. Am. Soc. Nephrol.	SEP	1996	7	9					A2048	A2048				1	Urology & Nephrology	Urology & Nephrology	VK074	WOS:A1996VK07402044		
J	Hori, Y; Hirakata, M; Joki, N; Kaname, S; Fukagawa, M; Okuda, T; Ohashi, H; Katoh, T; Fujita, T; Miyazono, K; Kurokawa, K				Hori, Y; Hirakata, M; Joki, N; Kaname, S; Fukagawa, M; Okuda, T; Ohashi, H; Katoh, T; Fujita, T; Miyazono, K; Kurokawa, K			Anti-latent transforming growth factor-beta binding protein (LTBP) antibody or synthesized oligopeptides inhibit extracellular matrix (ECM) expression induced by stretch in cultured rat mesangial cells (MC).	JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY			English	Meeting Abstract									UNIV TOKYO,SCH MED,DEPT INTERNAL MED 4,TOKYO 112,JAPAN; UNIV TOKYO,SCH MED,DEPT INTERNAL MED 1,TOKYO 112,JAPAN; KIRIN BREWERY CO LTD,TOKYO,JAPAN; SHOWA GEN HOSP,TOKYO,JAPAN; JAPANESE FDN CANC RES,INST CANC,TOKYO 170,JAPAN								0	0	0	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	1046-6673			J AM SOC NEPHROL	J. Am. Soc. Nephrol.	SEP	1996	7	9					A3046	A3046				1	Urology & Nephrology	Urology & Nephrology	VK074	WOS:A1996VK07403040		
J	Horie, K; Miyata, T; Sugiyama, S; Monnier, VM; Kurokawa, K; Maeda, K				Horie, K; Miyata, T; Sugiyama, S; Monnier, VM; Kurokawa, K; Maeda, K			Immunohistochemical co-localization of pentosidine and carboxy-methyllysine (CML) in diabetic renal glomerular lesions implicates glycoxidative stress in the pathogenesis of diabetic nephropathy (DN).	JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY			English	Meeting Abstract									NAGOYA UNIV,SCH MED,DEPT INTERNAL MED,NAGOYA,AICHI 466,JAPAN; CASE WESTERN RESERVE UNIV,INST PATHOL,CLEVELAND,OH 44106; UNIV TOKYO,SCH MED,DEPT INTERNAL MED,TOKYO 113,JAPAN			Monnier, Vincent/B-1371-2009					0	0	0	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	1046-6673			J AM SOC NEPHROL	J. Am. Soc. Nephrol.	SEP	1996	7	9					A3130	A3130				1	Urology & Nephrology	Urology & Nephrology	VK074	WOS:A1996VK07403124		
J	Horie, S; Aruga, S; Tanemoto, M; Kawabe, K; Kakizoe, T; Yoshikura, H; Kurokawa, K				Horie, S; Aruga, S; Tanemoto, M; Kawabe, K; Kakizoe, T; Yoshikura, H; Kurokawa, K			Hepatocyte growth factor (HGF) inhibits Fas-mediated apoptosis.	JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY			English	Meeting Abstract									UNIV TOKYO,TOKYO,JAPAN; NCCH,TOKYO,JAPAN								0	0	0	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	1046-6673			J AM SOC NEPHROL	J. Am. Soc. Nephrol.	SEP	1996	7	9					A2050	A2050				1	Urology & Nephrology	Urology & Nephrology	VK074	WOS:A1996VK07402046		
J	Joki, N; Hirakata, M; Hori, Y; Kaname, S; Katoh, T; Fujita, T; Kurokawa, K				Joki, N; Hirakata, M; Hori, Y; Kaname, S; Katoh, T; Fujita, T; Kurokawa, K			Autocrine/paracrine action of TGF-beta on extracellular matrix mRNA expression induced by mechanical stretch in vascular smooth muscle cells.	JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY			English	Meeting Abstract									UNIV TOKYO,DEPT INTERNAL MED 1,TOKYO,JAPAN; UNIV TOKYO,DEPT INTERNAL MED 4,TOKYO,JAPAN								0	0	0	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	1046-6673			J AM SOC NEPHROL	J. Am. Soc. Nephrol.	SEP	1996	7	9					A1427	A1427				1	Urology & Nephrology	Urology & Nephrology	VK074	WOS:A1996VK07401423		
J	Kamijo, T; Gonzalez, JM; Rouse, D; Suki, WN; Kawabe, K				Kamijo, T; Gonzalez, JM; Rouse, D; Suki, WN; Kawabe, K			Molecular mechanism of hypercalciuria in spontaneously hypertensive rat	JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY			English	Meeting Abstract									UNIV TOKYO,TOKYO,JAPAN; BAYLOR COLL MED,HOUSTON,TX 77030								0	0	0	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	1046-6673			J AM SOC NEPHROL	J. Am. Soc. Nephrol.	SEP	1996	7	9					A2779	A2779				2	Urology & Nephrology	Urology & Nephrology	VK074	WOS:A1996VK07402773		
J	Kaname, S; Hirakata, M; Joki, N; Hori, Y; Katoh, T; Fujita, T; Kurokawa, K				Kaname, S; Hirakata, M; Joki, N; Hori, Y; Katoh, T; Fujita, T; Kurokawa, K			Extracellular matrix expression induced by mechanical stretch is mediated in part by platelet-derived growth factor (PDGF) and transforming growth factor (TGF-beta) in cultured rat mesangial cells.	JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY			English	Meeting Abstract									UNIV TOKYO,SCH MED,DEPT INTERNAL MED 4,TOKYO 112,JAPAN; UNIV TOKYO,SCH MED,DEPT INTERNAL MED 1,TOKYO,JAPAN								0	0	0	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	1046-6673			J AM SOC NEPHROL	J. Am. Soc. Nephrol.	SEP	1996	7	9					A2058	A2058				1	Urology & Nephrology	Urology & Nephrology	VK074	WOS:A1996VK07402054		
J	Koike, T; Fukuda, N; Fukagawa, M; Ota, K; Kurokawa, K				Koike, T; Fukuda, N; Fukagawa, M; Ota, K; Kurokawa, K			Decreased density of vitamin D receptor directly correlates with the proliferative potency of parathyroid cells in hyperplasia.	JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY			English	Meeting Abstract									TOKYO WOMENS MED COLL,DEPT SURG 3,TOKYO 162,JAPAN; UNIV TOKYO,SCH MED,DEPT INTERNAL MED 1,TOKYO 113,JAPAN								0	0	0	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	1046-6673			J AM SOC NEPHROL	J. Am. Soc. Nephrol.	SEP	1996	7	9					A2844	A2844				1	Urology & Nephrology	Urology & Nephrology	VK074	WOS:A1996VK07402838		
J	Miyajima, Y; Takaichi, K; Kurokawa, K; Fujita, T				Miyajima, Y; Takaichi, K; Kurokawa, K; Fujita, T			Alkaline shift of NHE-1 set point by osmotic stimuli requires intact microfilaments and activation of NHE-1 by cytosolic Ca2+.	JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY			English	Meeting Abstract									UNIV TOKYO,TOKYO,JAPAN								0	0	0	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	1046-6673			J AM SOC NEPHROL	J. Am. Soc. Nephrol.	SEP	1996	7	9					A0046	A0046				1	Urology & Nephrology	Urology & Nephrology	VK074	WOS:A1996VK07400045		
J	Nakao, A; Nosaka, K; Taniguchi, S; Asano, K; Suzuki, T; Watanabe, T; Shimizu, T; Kurokawa, K				Nakao, A; Nosaka, K; Taniguchi, S; Asano, K; Suzuki, T; Watanabe, T; Shimizu, T; Kurokawa, K			Localization of mRNA, the protein, and the enzymatic activity of leukotriene (LT) A4 hydrolase in rat kidney and the effects of LTB4 antagonist on puromycin nephrotic rats.	JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY			English	Meeting Abstract									UNIV TOKYO,DEPT MED 1,TOKYO,JAPAN								0	0	0	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	1046-6673			J AM SOC NEPHROL	J. Am. Soc. Nephrol.	SEP	1996	7	9					A2003	A2003				1	Urology & Nephrology	Urology & Nephrology	VK074	WOS:A1996VK07401999		
J	Nomoto, Y; Kawaguchi, Y; Kubo, H; Hirano, H; Sakai, S; Kurokawa, K				Nomoto, Y; Kawaguchi, Y; Kubo, H; Hirano, H; Sakai, S; Kurokawa, K			Sclerosing encapsulating peritonitis in patients undergoing CAPD: A report of the Japanese SEP Study Group.	JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY			English	Meeting Abstract									TOKAI UNIV,SCH MED,DEPT INTERNAL MED,ISEHARA,KANAGAWA 25911,JAPAN; JIKEI UNIV,SCH MED,DEPT INTERNAL MED 2,TOKYO,JAPAN; KAWASAKI MED COLL,DEPT INTERNAL MED,KURASHIKI,OKAYAMA,JAPAN; SHINRAKUEN HOSP,DEPT INTERNAL MED,NIIGATA,JAPAN; UNIV TOKYO,SCH MED,DEPT INTERNAL MED 1,TOKYO 113,JAPAN								0	0	0	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	1046-6673			J AM SOC NEPHROL	J. Am. Soc. Nephrol.	SEP	1996	7	9					A1222	A1222				1	Urology & Nephrology	Urology & Nephrology	VK074	WOS:A1996VK07401218		
J	Shimizu, F; Fukagawa, M; Taniyama, M; Margolin, SM; Kurokawa, K				Shimizu, F; Fukagawa, M; Taniyama, M; Margolin, SM; Kurokawa, K			Pirfenidone prevents the progression of irreversible glomerular sclerotic lesions.	JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY			English	Meeting Abstract									NIIGATA UNIV,INST NEPHROL,DEPT CELL BIOL,NIIGATA,JAPAN; UNIV TOKYO,SCH MED,DEPT INTERNAL MED 1,TOKYO 113,JAPAN; NARITA MEM HOSP,TOYOHASHI,AICHI,JAPAN; MARNAC INC,DALLAS,TX								0	0	0	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	1046-6673			J AM SOC NEPHROL	J. Am. Soc. Nephrol.	SEP	1996	7	9					A2590	A2590				1	Urology & Nephrology	Urology & Nephrology	VK074	WOS:A1996VK07402585		
J	Suzuki, N; Kimura, K; Ohba, S; Mise, N; Tojo, A; Bremer, V; Hirata, Y; Goto, A; Yamamura, Y; Omata, M				Suzuki, N; Kimura, K; Ohba, S; Mise, N; Tojo, A; Bremer, V; Hirata, Y; Goto, A; Yamamura, Y; Omata, M			Arginine vasopressin (AVP) constricts the afferent and efferent arterioles to the same extent via V1 receptors.	JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY			English	Meeting Abstract									UNIV TOKYO,TOKYO,JAPAN; OTSUKA PHARMA CO LTD,TOKUSHIMA,JAPAN								0	0	0	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	1046-6673			J AM SOC NEPHROL	J. Am. Soc. Nephrol.	SEP	1996	7	9					A1465	A1465				1	Urology & Nephrology	Urology & Nephrology	VK074	WOS:A1996VK07401461		
J	Takemoto, F; Uchida, S; Yamada, A; Kurokawa, K				Takemoto, F; Uchida, S; Yamada, A; Kurokawa, K			Receptor phosphorylation by vasopressin (AVP) induces desensitization of endothelin (ET)-1 binding to ETB in rat cortical collecting ducts (CCD).	JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY			English	Meeting Abstract									TORANOMON GEN HOSP,DIV RENAL,TOKYO,JAPAN; TEIKYO UNIV,SCH MED,DEPT MED 1,TOKYO,JAPAN; UNIV TOKYO,SCH MED,TOKYO 113,JAPAN								0	0	0	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	1046-6673			J AM SOC NEPHROL	J. Am. Soc. Nephrol.	SEP	1996	7	9					A2205	A2205				1	Urology & Nephrology	Urology & Nephrology	VK074	WOS:A1996VK07402201		
J	Takeuchi, T; Ikuta, K; Ueki, T; Sasaki, Y; Moriyama, N; Kawabe, K; Miyazaki, J				Takeuchi, T; Ikuta, K; Ueki, T; Sasaki, Y; Moriyama, N; Kawabe, K; Miyazaki, J			Murine IL-4 transgenic heart allograft survival was prolonged with downregulation of TH1 cytokine mRNAs in grafts.	JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY			English	Meeting Abstract									UNIV TOKYO,DEPT UROL,TOKYO 113,JAPAN; UNIV TOKYO,DEPT DIS RELATED GENE REGULAT RES,TOKYO,JAPAN								0	0	0	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	1046-6673			J AM SOC NEPHROL	J. Am. Soc. Nephrol.	SEP	1996	7	9					A3253	A3253				1	Urology & Nephrology	Urology & Nephrology	VK074	WOS:A1996VK07403247		
J	Tojo, A; Wilcox, CS; Bremer, V; Welch, WJ; Kimuru, K; Omata, M; Ogawa, T; Vallance, P				Tojo, A; Wilcox, CS; Bremer, V; Welch, WJ; Kimuru, K; Omata, M; Ogawa, T; Vallance, P			Methyl arginines in rat kidney: Comparison of immunohistochemical localization of demethylating enzyme NG, NG - Dimethylarginine dimethylaminohydrolase (DDAH) with nitric oxide synthase and effects on arginine transport.	JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY			English	Meeting Abstract									UNIV TOKUSHIMA,TOKUSHIMA 770,JAPAN; UNIV TOKYO,TOKYO,JAPAN; GEORGETOWN UNIV,MED CTR,WASHINGTON,DC 20007; UNIV COLL,LONDON,ENGLAND								0	0	0	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	1046-6673			J AM SOC NEPHROL	J. Am. Soc. Nephrol.	SEP	1996	7	9					A1626	A1626				1	Urology & Nephrology	Urology & Nephrology	VK074	WOS:A1996VK07401622		
J	Itoh, T; Nishimura, R; Matsunaga, S; Kodosawa, T; Mochizuki, M; Sasaki, N				Itoh, T; Nishimura, R; Matsunaga, S; Kodosawa, T; Mochizuki, M; Sasaki, N			Syringomyelia and hydrocephalus in a dog	JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION			English	Article						canine species; hydrocephalus; syringomyelia	SURGICAL-TREATMENT; CYSTS	A 7-year-old spayed female Pomeranian with a 6-month history of progressive paraparesis was determined to have syringemyelia accompanied with hydrocephalus. Magnetic resonance imaging clearly revealed severe syringomyelia in the cervical portion of the spinal cord, which was directly connected to the marked dilated fourth ventricle. Acetazolamide was prescribed for 3 weeks, but the neurologic deficits progressed. Laminectomy of the first and second vertebrae, which is one method of treating this type of syringomyelia in human beings, was performed, and then, acetazolamide was continued. The dog had partial amelioration, and further deterioration was not evident in the 12 months after surgery.	UNIV TOKYO,FAC AGR,DEPT VET SURG,BUNKYO KU,TOKYO 113,JAPAN							ANDREWS BT, 1988, J NEUROSURG, V68, P544, DOI 10.3171/jns.1988.68.4.0544; PAUL KS, 1983, J NEUROSURG, V58, P183, DOI 10.3171/jns.1983.58.2.0183; GARDNER WJ, 1965, J NEUROL NEUROSUR PS, V28, P247, DOI 10.1136/jnnp.28.3.247; CAUZINILLE L, 1992, J AM VET MED ASSOC, V201, P1225; CHILD G, 1986, J AM VET MED ASSOC, V189, P909; FURNEAUX RW, 1973, CAN VET J, V14, P317; GEIB LW, 1967, J AM VET MED ASSOC, V150, P618; JACK CR, 1991, J NEUROSURG, V74, P283, DOI 10.3171/jns.1991.74.2.0283; LOGUE V, 1981, J NEUROL NEUROSUR PS, V44, P273, DOI 10.1136/jnnp.44.4.273; PADOVANI R, 1989, SURG NEUROL, V32, P173; QUENCER RM, 1983, RADIOLOGY, V146, P415; SCHMAHL W, 1984, VET PATHOL, V21, P252; THOMSON CE, 1993, VET RADIOL ULTRASOUN, V34, P2, DOI 10.1111/j.1740-8261.1993.tb01986.x; WILLIAMS B, 1973, J NEUROL NEUROSUR PS, V36, P467, DOI 10.1136/jnnp.36.3.467; WILLIAMS B, 1980, J NEUROL SCI, V48, P93, DOI 10.1016/0022-510X(80)90153-7; WILSON JW, 1979, VET PATHOL, V16, P165	16	23	23	AMER VETERINARY MEDICAL ASSOC	SCHAUMBURG	1931 N MEACHAM RD SUITE 100, SCHAUMBURG, IL 60173-4360	0003-1488			J AM VET MED ASSOC	J. Am. Vet. Med. Assoc.	SEP 1	1996	209	5					934	&				4	Veterinary Sciences	Veterinary Sciences	VE248	WOS:A1996VE24800019		
J	Kagawa, Y; Khatri, SC; Koczak, MJ				Kagawa, Y; Khatri, SC; Koczak, MJ			Fabrication of SiC-fiber/Al2O3/Al alloy hybrid composites by directed metal oxidation of molten Al-Mg-Si alloys	JOURNAL OF THE CERAMIC SOCIETY OF JAPAN			English	Article						directed metal oxidation; SiC fiber; continuous fiber; chapped fiber; Al-Mg-Si alloy; Al2O3/Al alloy composite; SiC/Al2O3/Al alloy composite	MAGNESIUM SILICON ALLOYS; AL2O3/METAL COMPOSITES; MICROSTRUCTURE; GROWTH	Al2O3/Al alloy hybrid composites (SiC/Al2O3/Al alloy hybrid composite) reinforced with chopped and continuous SiC fiber (NicalonTM) have been fabricated by directed metal oxidation of Al-Mg-Si alloys. Effects of additive elements, Mg and Si an the in situ formation of SiC/Al2O3/Al alloy composites were studied. In situ infiltration of the Al2O3/Al alloy composite phase into the SiC fiber was possible only when a small quantity of Mg (5 mass%) was used. No infiltration was observed for 10 mass% Mg alloys. Composites fabricated from Al . 5Mg . 5Si and Al . 5Mg . 10Si alloys showed incorporation of Al2O3/Al alloy composite into he SiC fibers. The silicon content of the alloy affected the fabrication of the composite by altering the growth rate of the oxide, and the fastest fabrication of the composite was possible using Al . 5Mg . 5Si alloys. It was concluded that aluminum alloys of lower Mg contents (<5 mass%) are recommendable as a starting aluminum alloy for the incorporation of Al2O3/Al alloy composite phase into the SiC fibers with void free structure. However, degradation of the fiber during incorporation should tee considered the application of this process.	DREXEL UNIV, DEPT MAT ENGN, PHILADELPHIA, PA 19104 USA	Kagawa, Y (reprint author), UNIV TOKYO, INST IND SCI, MINATO KU, 7-22-1 ROPPONGI, TOKYO 106, JAPAN.						AGHAJANIAN MK, 1989, J MATER SCI, V24, P658, DOI 10.1007/BF01107457; ANDERSSON CA, 1988, ASM P INT C WHISK FI, P209; Newkirk MS, 1986, J MATER RES, V1, P81, DOI 10.1557/JMR.1986.0081; NAGELBERG AS, 1992, J AM CERAM SOC, V75, P455, DOI 10.1111/j.1151-2916.1992.tb08201.x; ANTOLIN PB, 1988, CERAM ENG SCI P, V9, P759; ANTOLIN S, 1992, J AM CERAM SOC, V75, P447, DOI 10.1111/j.1151-2916.1992.tb08200.x; COCHRAN CN, 1977, METALL TRANS B, V8, P323, DOI 10.1007/BF02657663; DHANDAPANI SP, 1994, ACTA METALL MATER, V42, P649, DOI 10.1016/0956-7151(94)90261-5; FAREED AS, 1900, ASM P INT C WHISK FI, V11, P782; IMAI Y, COMMUNICATION; KAGAWA Y, 1990, P 5 JAP US C COMP MA, P78; KHATRI SC, 1992, CERAMIC ENG SCI P, V13, P494; KHATRI SC, 1991, P 1 INT S SCI ENG CE, P13; Kubaschewski O., 1979, METALLURGICAL THERMO; LEWIS D, 1991, METAL MATRIX COMPOSI, P121; MANOR E, 1993, J AM CERAM SOC, V76, P1777, DOI 10.1111/j.1151-2916.1993.tb06647.x; NAGELBERG AS, 1989, MATER RES SOC SYMP P, V155, P275, DOI 10.1557/PROC-155-275; NEWKIRK MS, 1987, ASM P INT C WHISK FI, V7, P879; TANG WJ, 1994, MAT SCI ENG A-STRUCT, V177, P135, DOI 10.1016/0921-5093(94)90485-5	19	0	1	CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI	TOKYO	22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN	1882-0743	1348-6535		J CERAM SOC JPN	J. Ceram. Soc. Jpn.	SEP	1996	104	9					802	807		10.2109/jcersj.104.802		6	Materials Science, Ceramics	Materials Science	VJ238	WOS:A1996VJ23800003		
J	Kim, BN; Katsukawa, Y; Ahn, BW; Enoki, M; Kishi, T				Kim, BN; Katsukawa, Y; Ahn, BW; Enoki, M; Kishi, T			Evaluation of R-curve behavior in SIC particle-dispersed Al2O3 composite	JOURNAL OF THE CERAMIC SOCIETY OF JAPAN			Japanese	Article						fracture resistance; crack extension; particle; residual stress; strength; Vickers indentation; composite	BRITTLE MATERIALS; CRACK-GROWTH; GRAIN-SIZE; CERAMICS; STRENGTH; ALUMINA; MICROCRACKING; MECHANICS; TOUGHNESS; SOLIDS	Fracture resistance behavior with respect to crack extension is evaluated from indented strengths for both alumina and alumina matrix composite dispersed with 10% SiC particles. Since residual stresses due to the thermal expansion mismatch between SiC particle and Al2O3 matrix are expected to be exerted on crack surfaces regardless of crack length, the fracture resistance are assumed to be dependent on the square root of crack extension according to fracture-mechanical predictions. R-curves are obtained from the linearity between Vickers-indented strength and alpha(f)(-1/2), where alpha(f) is the critical crack length. A nearly constant fracture resistance curve is obtained for the alumina, while rapidly increasing fracture resistance for the composite. The fracture toughnesses measured independently by the controlled surface daw method are consistent with the obtained fracture resistance. The role of residual stresses is discussed as a characteristic parameter for the fracture resistance of particle-dispersed composites. In addition, the technical aspects during the evaluation process of R-curve are also discussed.	UNIV TOKYO, MEGURO KU, TOKYO 153, JAPAN; TAEJON NATL UNIV TECHNOL, DEPT MECH ENGN, DONG KU, TAEJON 300717, SOUTH KOREA	Kim, BN (reprint author), UNIV TOKYO, ADV SCI & TECHNOL RES CTR, MEGURO KU, 4-6-1 KOMABA, TOKYO 153, JAPAN.						EVANS AG, 1985, ACTA METALL MATER, V33, P1525, DOI 10.1016/0001-6160(85)90053-7; NEWMAN JC, 1981, ENG FRACT MECH, V15, P185, DOI 10.1016/0013-7944(81)90116-8; CHANTIKUL P, 1990, J AM CERAM SOC, V73, P2419, DOI 10.1111/j.1151-2916.1990.tb07607.x; MCMEEKING RM, 1982, J AM CERAM SOC, V65, P242, DOI 10.1111/j.1151-2916.1982.tb10426.x; BINER SB, 1995, ENG FRACT MECH, V51, P555, DOI 10.1016/0013-7944(94)00309-6; BOWER AF, 1993, J ENG MATER-T ASME, V115, P228, DOI 10.1115/1.2904212; EVANS AG, 1972, PHILOS MAG, V26, P1327, DOI 10.1080/14786437208220346; FOOTE RML, 1986, J MECH PHYS SOLIDS, V34, P593, DOI 10.1016/0022-5096(86)90039-6; KRAUSE RF, 1988, J AM CERAM SOC, V71, P338, DOI 10.1111/j.1151-2916.1988.tb05051.x; LI ZH, 1995, ENG FRACT MECH, V51, P497; MAI YW, 1987, J AM CERAM SOC, V70, P289, DOI 10.1111/j.1151-2916.1987.tb04983.x; MAJUMDAR BS, 1988, ENG FRACT MECH, V31, P683, DOI 10.1016/0013-7944(88)90110-5; Miyata N, 1995, MATER SCI RES INT, V1, P213; STEINBRECH RW, 1990, J AM CERAM SOC, V73, P2009, DOI 10.1111/j.1151-2916.1990.tb05260.x; YU CS, 1992, J AM CERAM SOC, V75, P2991, DOI 10.1111/j.1151-2916.1992.tb04376.x	15	2	2	CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI	TOKYO	22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN	1882-0743	1348-6535		J CERAM SOC JPN	J. Ceram. Soc. Jpn.	SEP	1996	104	9					872	876		10.2109/jcersj.104.872		5	Materials Science, Ceramics	Materials Science	VJ238	WOS:A1996VJ23800018		
J	Lee, W; Shibasaki, A; Saito, K; Sugita, K; Okuyama, K; Sugo, T				Lee, W; Shibasaki, A; Saito, K; Sugita, K; Okuyama, K; Sugo, T			Proton transport through polyethylene-tetrafluoroethylene-copolymer-based membrane containing sulfonic acid group prepared by RIGP	JOURNAL OF THE ELECTROCHEMICAL SOCIETY			English	Article							TEFLON-FEP FILMS; EXCHANGE MEMBRANES; STYRENE	A novel sulfonic acid (SO3H) group containing membrane (SH membrane) was prepared by grafting glycidyl methacrylate onto an ethylene-tetrafluoroethylene copolymer film with subsequent sulfonation. The graft chains introduced on the SH membrane form a flexible brush-type structure capable of binding water molecules (30% more than Nafion 117 membrane) and transporting protons. Proton conductivity of the SH membrane was evaluated as a function of SO3H group density. The SH membrane with the SO3H group conversion of 97% and the thickness of 70 mu m had specific resistivity of 24 Omega cm at 303 K, which was comparable to that of Nafion 117 membrane. A uniform distribution of the SO3H group across the SH membrane was verified using an electron probe x-ray microanalyzer.	CHIBA UNIV,DEPT SPECIALTY MAT,INAGE KU,CHIBA 263,JAPAN; ASAHI CHEM IND CO LTD,FUJI,SHIZUOKA 416,JAPAN; JAPAN ATOM ENERGY RES INST,TAKASAKI RADIAT CHEM RES ESTAB,TAKASAKI,GUMMA 37012,JAPAN	Lee, W (reprint author), UNIV TOKYO,DEPT CHEM & BIOTECHNOL,BUNKYO KU,7-3-1 HONGO,TOKYO 113,JAPAN.						VIGO F, 1981, DESALINATION, V37, P313, DOI 10.1016/S0011-9164(00)88655-5; GROT W, 1972, CHEM-ING-TECH, V44, P167, DOI 10.1002/cite.330440408; BUCHI FN, 1992, P IECEC C SAN DIEGO, V3, P419; EISMAN GA, 1986, PV ELECTROCHEMICAL S, V8613, P52; ELLINGHORST G, 1981, RADIAT PHYS CHEM, V18, P889, DOI 10.1016/0146-5724(81)90279-X; GEN YP, 1987, DESALINATION, V62, P265; GROT W, 1975, CHEM-ING-TECH, V47, P617, DOI 10.1002/cite.330471414; Grubb W. T., 1959, U.S. Patent, Patent No. [2,913,511, 2913511]; GUPTA B, 1993, SOLID STATE IONICS, V61, P213, DOI 10.1016/0167-2738(93)90356-8; ROUILLY MV, 1993, J MEMBRANE SCI, V81, P89, DOI 10.1016/0376-7388(93)85033-S; SUGO T, 1989, B SEAWATER SCI JPN, V43, P3; XU ZL, 1983, RADIAT PHYS CHEM, V22, P939; YEO RS, 1981, J MEMBRANE SCI, V9, P273, DOI 10.1016/S0376-7388(00)80269-0	13	23	25	ELECTROCHEMICAL SOC INC	PENNINGTON	10 SOUTH MAIN STREET, PENNINGTON, NJ 08534	0013-4651			J ELECTROCHEM SOC	J. Electrochem. Soc.	SEP	1996	143	9					2795	2799		10.1149/1.1837109		5	Electrochemistry; Materials Science, Coatings & Films	Electrochemistry; Materials Science	VH209	WOS:A1996VH20900032		
J	Konishi, H; OkunoFujiwara, M				Konishi, H; OkunoFujiwara, M			Competition through endogenized tournaments: An interpretation of ''face-to-face'' competition	JOURNAL OF THE JAPANESE AND INTERNATIONAL ECONOMIES			English	Article							PERFECT EQUILIBRIUM; PREEMPTION; TECHNOLOGY; MODEL	This paper presents an alternative solution, called ''face-to-face'' competition, to the hold-up problem of relation-specific investments in the world of incomplete contracts. By inherent multiplicity of equilibria and incentive-compatible equilibrium selection, a tournament among multiple agents is endogenously created in the structure of face-to-face competition to strengthen their investment incentive. This approach also explains, by the reason other than bargaining power and insurance, why typical auto-assemblers in Japan do not vertically integrate a single parts supplier but transact with two potentially competitive suppliers in their developments of new models. J. Japan. Int. Econ., September 1996, 10(3), pp. 199-232. Faculty of Economics, Seikei University; Faculty of Economics, The University of Tokyo; and Faculty of Economics, Hosei University. (C) 1996 Academic Press, Inc.	UNIV TOKYO,FAC ECON,TOKYO,JAPAN; HOSEI UNIV,FAC ECON,TOKYO,JAPAN	Konishi, H (reprint author), SEIKEI UNIV,FAC ECON,MUSASHINO,TOKYO,JAPAN.						HART O, 1990, J POLIT ECON, V98, P1119, DOI 10.1086/261729; GUL F, 1989, ECONOMETRICA, V57, P81, DOI 10.2307/1912573; HARRIS C, 1985, REV ECON STUD, V52, P193, DOI 10.2307/2297616; FUDENBERG D, 1985, REV ECON STUD, V52, P383, DOI 10.2307/2297660; RUBINSTEIN A, 1982, ECONOMETRICA, V50, P97, DOI 10.2307/1912531; FUDENBERG D, 1983, EUR ECON REV, V22, P3, DOI 10.1016/0014-2921(83)90087-9; LAZEAR EP, 1981, J POLIT ECON, V89, P841, DOI 10.1086/261010; Asanumi B., 1989, J JAPANESE INT EC, V3, P1, DOI DOI 10.1016/0889-1583(89)90029-4; GARCIA CM, 1993, UNPUB VERTICAL MARKE; GROSSMAN SJ, 1986, J POLIT ECON, V94, P691, DOI 10.1086/261404; HART S, 1992, UNPUB MODEL N PERSON; ITOH M, 1989, OYO MIKURO KEIZAI GA; KONISHI H, 1993, COMPETITION ENDOGENI; Milgrom P., 1992, EC ORG MANAGEMENT; NALEBUFF BJ, 1983, BELL J ECON, V14, P21, DOI 10.2307/3003535; OSBORNE M., 1994, COURSE GAME THEORY; REINGANUM JF, 1981, REV ECON STUD, V48, P395, DOI 10.2307/2297153; Tirole J., 1988, THEORY IND ORG; WILLIAMSON OLIVER E., 1985, EC I CAPITALISM; WILLIAMSON OLIVER E., 1975, MARKETS HIERARCHIES	20	1	1	ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495	0889-1583			J JPN INT ECON	J. Jpn. Inst. Econ.	SEP	1996	10	3					199	232		10.1006/jjie.1996.0012		34	Economics; International Relations	Business & Economics; International Relations	VT760	WOS:A1996VT76000001		
J	Bentz, W				Bentz, W			Baryons in the NJL model as solutions of the relativistic Faddeev equation	JOURNAL OF THE KOREAN PHYSICAL SOCIETY			English	Article; Proceedings Paper	KOSEF-JSPS Winter School on Recent Developments in Particle and Nuclear Theory	FEB 21-28, 1996	SEOUL, SOUTH KOREA	Japan Soc Promot Sci, Korea Sci & Engn Fdn			JONA-LASINIO MODEL; NAMBU	The relativistic Faddeev equation for three quarks is solved in the flavor SU(2) NJL model to get the nucleon and delta states.		Bentz, W (reprint author), UNIV TOKYO,DEPT PHYS,BUNKYO KU,TOKYO 113,JAPAN.						CAHILL RT, 1989, AUST J PHYS, V42, P129; NAMBU Y, 1961, PHYS REV, V124, P246, DOI 10.1103/PhysRev.124.246; GASSER J, 1982, PHYS REP, V87, P77, DOI 10.1016/0370-1573(82)90035-7; VOGL U, 1991, PROG PART NUCL PHYS, V27, P195, DOI 10.1016/0146-6410(91)90005-9; ISHII N, 1995, NUCL PHYS A, V587, P617, DOI 10.1016/0375-9474(95)00032-V; ASAMI H, 1995, PHYS REV C, V51, P3388, DOI 10.1103/PhysRevC.51.3388; ELLIS J, 1995, PHYS LETT, V341, P347; KATO M, 1993, NUCL PHYS A, V551, P541; NAMBU Y, 1961, PHYS REV, V122, P345, DOI 10.1103/PhysRev.122.345; SIEBER P, 1992, NUCL PHYS A, V547, P459, DOI 10.1016/0375-9474(92)90033-G; WEISS C, 1993, PHYS LETT B, V312, P6, DOI 10.1016/0370-2693(93)90477-Y	11	0	0	KOREAN PHYSICAL SOC	SEOUL	635-4, YUKSAM-DONG, KANGNAM-KU, SEOUL 135-703, SOUTH KOREA	0374-4884			J KOREAN PHYS SOC	J. Korean Phys. Soc.	SEP	1996	29			S			S352	S354				3	Physics, Multidisciplinary	Physics	VH145	WOS:A1996VH14500027		
J	Fujikawa, K				Fujikawa, K			Physical implications of a vector-like extension of the standard model	JOURNAL OF THE KOREAN PHYSICAL SOCIETY			English	Article; Proceedings Paper	KOSEF-JSPS Winter School on Recent Developments in Particle and Nuclear Theory	FEB 21-28, 1996	SEOUL, SOUTH KOREA	Japan Soc Promot Sci, Korea Sci & Engn Fdn			SYMMETRY; BREAKING	Physical implications of a vector-like extension of the standard model for heavier quarks and leptons with SU(2) x U(1) gauge symmetry and only one Higgs doublet are discussed. This scheme incorporates infinitely many fermions, and the chiral structure is realized by a non-vanishing analytic index of mass matrices. The model is perturbatively well controllable, and the physical Higgs particle generally mediates leptonic as well as quark flavor-changing processes at a rate below the present experimental Limit. This model illustrates a general feature of models where some of the fermion masses are of non-Higgs origin.		Fujikawa, K (reprint author), UNIV TOKYO, DEPT PHYS, BUNKYO KU, 7-3-1 HONGO, TOKYO 113, JAPAN.						PECCEI RD, 1991, NUCL PHYS B, V349, P305, DOI 10.1016/0550-3213(91)90327-T; THOOFT G, 1976, PHYS REV LETT, V37, P8, DOI 10.1103/PhysRevLett.37.8; VELTMAN M, 1977, NUCL PHYS B, V123, P89, DOI 10.1016/0550-3213(77)90342-X; GEORGI H, 1979, NUCL PHYS B, V156, P126, DOI 10.1016/0550-3213(79)90497-8; BABU KS, 1995, PHYS REV D, V51, P2451, DOI 10.1103/PhysRevD.51.2451; FUJIKAWA K, 1979, PROG THEOR PHYS, V61, P1186, DOI 10.1143/PTP.61.1186; FUJIKAWA K, 1994, PHYS REV D, V49, P5890, DOI 10.1103/PhysRevD.49.5890; Fujikawa K., 1994, Progress of Theoretical Physics, V92, DOI 10.1143/PTP.92.1149; INOUE K, 1995, PROG THEOR PHYS, V93, P403, DOI 10.1143/PTP.93.403; ZHENG H, HEPPH9602340; ZHENG HQ, 1995, PHYS REV D, V52, P6500, DOI 10.1103/PhysRevD.52.6500	11	1	1	KOREAN PHYSICAL SOC	SEOUL	635-4, YUKSAM-DONG, KANGNAM-KU, SEOUL 135-703, SOUTH KOREA	0374-4884			J KOREAN PHYS SOC	J. Korean Phys. Soc.	SEP	1996	29			S			S247	S250				4	Physics, Multidisciplinary	Physics	VH145	WOS:A1996VH14500012		
J	Morimatsu, O				Morimatsu, O			QCD sum rule approach to hadron-hadron interactions	JOURNAL OF THE KOREAN PHYSICAL SOCIETY			English	Article; Proceedings Paper	KOSEF-JSPS Winter School on Recent Developments in Particle and Nuclear Theory	FEB 21-28, 1996	SEOUL, SOUTH KOREA	Japan Soc Promot Sci, Korea Sci & Engn Fdn			NUCLEON-SCATTERING LENGTHS	Recent work on the QCD sum rule approach to hadron-hadron interactions is reported. First we explain our motivation and present the formulation of calculating hadron-nucleon scattering lengths by the QCD sum rule, where the relation between the hadron mass in nuclear medium and the hadron-nucleon scattering length is also clarified, Secondly we discuss the results of two applications, the nucleon-nucleon and hyperon-nucleon scattering lengths and the pion-nucleon scattering lengths, In the case of the nucleon-nucleon and hyperon-nucleon scattering lengths we show that the results of the QCD sum rule are in qualitative agreement with the experiment. In the case of the pion-nucleon scattering lengths we show that the results of the QCD sum rule ale consistent with the low-energy theorem.		Morimatsu, O (reprint author), UNIV TOKYO,INST NUCL STUDY,MIDORI CHO,TANASHI,TOKYO 188,JAPAN.						ADLER S, 1968, CURRENT ALGEBRA APPL; HATSUDA T, 1993, NUCL PHYS B, V394, P221, DOI 10.1016/0550-3213(93)90107-Z; WEINBERG S, 1968, PHYS REV, V166, P1568, DOI 10.1103/PhysRev.166.1568; WEINBERG S, 1966, PHYS REV LETT, V17, P616, DOI 10.1103/PhysRevLett.17.616; JIN XM, 1993, PHYS REV C, V47, P2882, DOI 10.1103/PhysRevC.47.2882; LACOMBE M, 1980, PHYS REV C, V21, P861, DOI 10.1103/PhysRevC.21.861; HATSUDA T, 1991, PHYS REV LETT, V66, P2851, DOI 10.1103/PhysRevLett.66.2851; HATSUDA T, 1992, PHYS REV C, V46, pR34, DOI 10.1103/PhysRevC.46.R34; KOIKE Y, 1993, PHYS REV D, V48, P2313, DOI 10.1103/PhysRevD.48.2313; REINDERS LJ, 1985, PHYS REP, V127, P1, DOI 10.1016/0370-1573(85)90065-1; DRUKAREV EG, 1990, NUCL PHYS A, V511, P679, DOI 10.1016/0375-9474(90)90117-5; DRUKAREV ED, 1992, NUCL PHYS A, V516, pE715; FURNSTAHL RJ, 1994, PHYS REV LETT, V72, P3128, DOI 10.1103/PhysRevLett.72.3128; Goldberger M. L., 1964, COLLISION THEORY; HATSUDA T, 1990, PHYS REV C, V42, P2212, DOI 10.1103/PhysRevC.42.2212; KONDO Y, UNPUB; KONDO Y, 1994, PHYS REV LETT, V72, P3129, DOI 10.1103/PhysRevLett.72.3129; Kondo Y, 1996, PHYS REV C, V53, P1927, DOI 10.1103/PhysRevC.53.1927; KONDO Y, 1993, PHYS REV LETT, V71, P2855, DOI 10.1103/PhysRevLett.71.2855; SHIFMAN MA, 1979, NUCL PHYS B, V147, P385, DOI 10.1016/0550-3213(79)90022-1; TOMOZAWA Y, 1966, NUOVO CIMENT A, V46, P707, DOI 10.1007/BF02857517	21	0	0	KOREAN PHYSICAL SOC	SEOUL	635-4, YUKSAM-DONG, KANGNAM-KU, SEOUL 135-703, SOUTH KOREA	0374-4884			J KOREAN PHYS SOC	J. Korean Phys. Soc.	SEP	1996	29			S			S320	S325				6	Physics, Multidisciplinary	Physics	VH145	WOS:A1996VH14500023		
J	Yamada, A				Yamada, A			A new method of determining vertical bar V-ub vertical bar/vertical bar V-ts vertical bar by the processes (B)over-bar->rho l(nu)over-bar and (B)over-bar->K*l(l)over-bar	JOURNAL OF THE KOREAN PHYSICAL SOCIETY			English	Article; Proceedings Paper	KOSEF-JSPS Winter School on Recent Developments in Particle and Nuclear Theory	FEB 21-28, 1996	SEOUL, SOUTH KOREA	Japan Soc Promot Sci, Korea Sci & Engn Fdn			MESON EFFECTIVE THEORY; CP-VIOLATION; NONLEPTONIC DECAYS; B-MESONS; RESONANCE; HEAVY; QCD; B->SL+L; MODEL; VUB	The differential decay width of the process (B) over bar --> <rho l(nu)over bar> is related to that of the process (B) over bar --> <K*l(l)over bar> by using the SU(3)-flavor symmetry and heavy quark approximation. The ratio of the Kobayashi-Maskawa matrix elements is obtained in the zero recoil limit of rho and K*, allowing a determination of \V-ub\/\V-ts\, which in turn determines \V-ub\.		Yamada, A (reprint author), UNIV TOKYO,DEPT PHYS,BUNKYO KU,TOKYO 113,JAPAN.						ALI A, CERNTH7346; INAMI T, 1981, PROG THEOR PHYS, V65, P297, DOI 10.1143/PTP.65.297; DESHPANDE NG, 1989, PHYS REV D, V39, P1461, DOI 10.1103/PhysRevD.39.1461; DUNIETZ I, 1986, PHYS REV D, V34, P1404, DOI 10.1103/PhysRevD.34.1404; ISGUR N, 1990, PHYS REV D, V42, P2388, DOI 10.1103/PhysRevD.42.2388; GREUB C, 1995, PHYS LETT B, V346, P149, DOI 10.1016/0370-2693(94)01624-L; LIM CS, 1989, PHYS LETT B, V218, P343, DOI 10.1016/0370-2693(89)91593-1; CARTER AB, 1981, PHYS REV D, V23, P1567, DOI 10.1103/PhysRevD.23.1567; BIGI II, 1981, NUCL PHYS B, V193, P85, DOI 10.1016/0550-3213(81)90519-8; KOBAYASHI M, 1973, PROG THEOR PHYS, V49, P652, DOI 10.1143/PTP.49.652; MISIAK M, 1993, NUCL PHYS B, V393, P23, DOI 10.1016/0550-3213(93)90235-H; CIUCHINI M, 1994, NUCL PHYS B, V415, P403, DOI 10.1016/0550-3213(94)90118-X; BIGI II, 1984, PHYS REV D, V29, P1393, DOI 10.1103/PhysRevD.29.1393; CARTER AB, 1980, PHYS REV LETT, V45, P952, DOI 10.1103/PhysRevLett.45.952; BALL P, 1993, PHYS REV D, V48, P2110, DOI 10.1103/PhysRevD.48.2110; BIGI II, 1987, NUCL PHYS B, V281, P47; Bigi I. I., 1985, Comments on Nuclear and Particle Physics, V14; BLOK B, 1995, PHYS REV D, V51, P2208, DOI 10.1103/PhysRevD.51.2208; CHOUDHURY D, 1992, PHYS REV D, V45, P217, DOI 10.1103/PhysRevD.45.217; DATTA A, UH51182595; DESHPANDE NG, 1993, PHYS LETT B, V319, P313, DOI 10.1016/0370-2693(93)90819-4; DU DS, 1986, PHYS REV D, V34, P3414, DOI 10.1103/PhysRevD.34.3414; DU DS, 1994, PHYS REV D, V50, P4558, DOI 10.1103/PhysRevD.50.4558; DUNIETZ I, CERNTH589990; GRINSTEIN B, 1989, NUCL PHYS B, V319, P271, DOI 10.1016/0550-3213(89)90078-3; KIM CS, HEPPH9605201; KIM CS, 1995, PHYS LETT B, V345, P296, DOI 10.1016/0370-2693(94)01594-3; KIM CS, 1994, PHYS REV D, V50, P5762, DOI 10.1103/PhysRevD.50.5762; KITAZAWA N, 1994, PHYS LETT B, V323, P65, DOI 10.1016/0370-2693(94)00047-6; KITAZAWA N, 1995, PHYS LETT B, V349, P541, DOI 10.1016/0370-2693(95)00304-4; KRAMER G, 1991, Z PHYS C PART FIELDS, V51, P649, DOI 10.1007/BF01565592; LI H, 1995, PHYS REV LETT, V72, P4388; ODA M, NUPA947; SANDA AI, 1995, PHYS REV LETT, V75, P2807, DOI 10.1103/PhysRevLett.75.2807; ODONNELL PJ, 1991, PHYS REV D, V43, pR2067; 1994, PHYS REV D, V51, P1014; 1993, PHYS REV D, V47, P791	37	0	0	KOREAN PHYSICAL SOC	SEOUL	635-4, YUKSAM-DONG, KANGNAM-KU, SEOUL 135-703, SOUTH KOREA	0374-4884			J KOREAN PHYS SOC	J. Korean Phys. Soc.	SEP	1996	29			S			S273	S275				3	Physics, Multidisciplinary	Physics	VH145	WOS:A1996VH14500017		
J	Yazaki, K; Iwama, T; Kohama, A				Yazaki, K; Iwama, T; Kohama, A			Relativistic internal dynamics in nuclear transparency	JOURNAL OF THE KOREAN PHYSICAL SOCIETY			English	Article; Proceedings Paper	KOSEF-JSPS Winter School on Recent Developments in Particle and Nuclear Theory	FEB 21-28, 1996	SEOUL, SOUTH KOREA	Japan Soc Promot Sci, Korea Sci & Engn Fdn			FORM-FACTORS; MOMENTUM-TRANSFER; QUARK MODEL; SCATTERING; DEPENDENCE	The nuclear transparency in electron quasi-elastic scattering is considered in a relativistic harmonic oscillator model for the nucleon. The relativistic effects in the internal dynamics are found to play a crucial role in the large Q behavior of the nuclear transparency.		Yazaki, K (reprint author), UNIV TOKYO,DEPT PHYS,BUNKYO KU,7-3-1 HONGO,TOKYO 113,JAPAN.						BRODSKY SJ, 1982, 13TH P INT S MULT DY, P963; BRODSKY SJ, 1988, PHYS LETT B, V206, P685, DOI 10.1016/0370-2693(88)90719-8; CARROLL AS, 1988, PHYS REV LETT, V61, P1698, DOI 10.1103/PhysRevLett.61.1698; FARRAR GR, 1988, PHYS REV LETT, V61, P686, DOI 10.1103/PhysRevLett.61.686; FRANKFURT L, 1993, NUCL PHYS A, V555, P752, DOI 10.1016/0375-9474(93)90504-Q; FUJIMURA K, 1970, PROG THEOR PHYS, V44, P193, DOI 10.1143/PTP.44.193; FUJIMURA K, 1970, PROG THEOR PHYS, V43, P73, DOI 10.1143/PTP.43.73; IWAMA T, 1996, THESIS U TOKYO; JENNINGS BK, 1990, PHYS LETT B, V236, P209, DOI 10.1016/0370-2693(90)90830-Y; KOHAMA A, 1992, NUCL PHYS A, V536, P716, DOI 10.1016/0375-9474(92)90120-9; KOHAMA A, 1994, NUCL PHYS A, V575, P645, DOI 10.1016/0375-9474(94)90161-9; KOHAMA A, 1993, NUCL PHYS A, V551, P687; MAKINS NCR, 1994, PHYS REV LETT, V72, P1986, DOI 10.1103/PhysRevLett.72.1986; MUELLER A, 1982, P 17 REC MOR; NIKOLAEV NN, 1993, PHYS LETT B, V317, P281, DOI 10.1016/0370-2693(93)90996-U; ONEILL TG, 1995, PHYS LETT B, V351, P87, DOI 10.1016/0370-2693(95)00362-O; ONEILL TG, 1989, PHYS LETT B, V42, P129; RINAT AS, 1994, NUCL PHYS A, V568, P873, DOI 10.1016/0375-9474(94)90364-6	18	1	1	KOREAN PHYSICAL SOC	SEOUL	635-4, YUKSAM-DONG, KANGNAM-KU, SEOUL 135-703, SOUTH KOREA	0374-4884			J KOREAN PHYS SOC	J. Korean Phys. Soc.	SEP	1996	29			S			S388	S391				4	Physics, Multidisciplinary	Physics	VH145	WOS:A1996VH14500034		
J	Hanajima, R; Ugawa, Y; Terao, Y; Ogata, K; Kanazawa, I				Hanajima, R; Ugawa, Y; Terao, Y; Ogata, K; Kanazawa, I			Ipsilateral cortico-cortical inhibition of the motor cortex in various neurological disorders	JOURNAL OF THE NEUROLOGICAL SCIENCES			English	Article						magnetic stimulation; motor cortex; interneuron; inhibition; basal ganglia	PARKINSONS-DISEASE; EXCITABILITY; EXCITATION	We used a paired-pulse magnetic stimulation technique to study ipsilateral cortico-cortical inhibition of the motor cortex in 48 patients with various neurological disorders and in 20 normal volunteers, In the normal subjects, the first subthreshold conditioning stimulus suppressed responses to the second suprathreshold test stimulus at interstimulus intervals (ISIs) of 1-5 ms (inhibition at short intervals), and facilitated them at ISIs of 8-15 ms (facilitation at long intervals). Patients with motor neuron disease, except those in whom brain stimulation produced control responses that were generated by direct activation of corticospinal neurons (D-waves), had normal inhibition at short intervals. Facilitation at long intervals was not elicited in some patients with amyotrophic lateral sclerosis. Less inhibition at short intervals and normal facilitation at long intervals was found for all the patients with progressive myoclonic epilepsy, a condition in which the excitability of cortical inhibitory interneurons is thought to be affected. Inhibition at short intervals was disturbed, but facilitation at long intervals was intact in the patients with movement disorders (Parkinson's disease, corticobasal degeneration, and Wilson's disease). In these patients, positron emission tomography (PET) studies showed decreased regional cerebral blood flow (rCBF) in the basal ganglia in the relaxed state. However, normal suppression was elicited in the patients with Parkinson's disease with normal rCBF. In four patients with chorea, the time-course of inhibition and facilitation was normal, even though PET studies showed decreased rCBF in the basal ganglia in two of them. Normal inhibition could not be elicited in patients who had a small lesion in the basal ganglia or in the pathway from basal ganglia to the primary motor cortex; the putamen, globus pallidus, and supplementary motor cortex. In contrast, patients who had a lesion in a sensory system (sensory cortex or sensory thalamus) or in the pontine nucleus had normal suppression. We conclude that the results of ipsilateral cortico-cortical inhibition with paired magnetic stimulation reflect the excitability of inhibitory interneurons in the motor cortex and that outputs from the basal ganglia markedly affect this inhibition, but outputs from somato-sensory systems or cerebellum do not. Moreover, dysfunction of the corticospinal tract or spinal motoneurons does not affect results obtained by the paired magnetic stimulation technique when the control responses are generated by I-waves (i.e. descending volleys are produced by transsynaptic activation of the corticospinal tract neurons).	UNIV TOKYO,SCH MED,DEPT NEUROL,BUNKYO KU,TOKYO 113,JAPAN							RIDDING MC, 1995, ANN NEUROL, V37, P181, DOI 10.1002/ana.410370208; MARSDEN CD, 1994, BRAIN, V117, P877, DOI 10.1093/brain/117.4.877; KUJIRAI T, 1993, J PHYSIOL-LONDON, V471, P501; UGAWA Y, 1994, ELECTROEN CLIN NEURO, V93, P225, DOI 10.1016/0168-5597(94)90044-2; Terao Y, 1995, ELECTROMYOGR MOTOR C, V97, P375, DOI 10.1016/0924-980X(95)00179-O; CANTELLO R, 1991, NEUROLOGY, V41, P1449; DENOORDHOUT AM, 1992, NEUROLOGY S3, V42; LUHMANN HJ, 1993, EXP BRAIN RES, V97, P209; MATSUMURA M, 1992, J NEUROPHYSIOL, V68, P692; RIDDING MC, 1995, J NEUROL NEUROSUR PS, V59, P493, DOI 10.1136/jnnp.59.5.493; RIDDING MC, 1994, MOV DISORD S1, V9, P29; Roick H, 1992, MOV DISORD S1, V7, P27; RYAN LJ, 1994, BRAIN RES, V651, P241, DOI 10.1016/0006-8993(94)90703-X; UGAWA Y, 1991, ELECTROEN CLIN NEURO, V80, P21, DOI 10.1016/0168-5597(91)90038-Y	14	106	106	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-510X			J NEUROL SCI	J. Neurol. Sci.	SEP 1	1996	140	1-2					109	116		10.1016/0022-510X(96)00100-1		8	Clinical Neurology; Neurosciences	Neurosciences & Neurology	VD771	WOS:A1996VD77100015		
J	Yamamoto, H; Miyakawa, M				Yamamoto, H; Miyakawa, M			Reliability of a circular connected-(r,s)-out-of-(m,n): F lattice system	JOURNAL OF THE OPERATIONS RESEARCH SOCIETY OF JAPAN			English	Article							OUT-OF-N; MINIMIZING ALGORITHM; DISJOINT PRODUCTS; SUM	A circular connected-(r,s)-out-of-(m,n):F lattice system has m n components and is consisted of n rays and m circles. The system fails if and only if a connected (r,s)-matrix of components fail. Firstly, this paper proposes a recursive algorithm for the reliability of the system, which requires O(r(n)n(2)sm) computing time. In the statistically independent identically distributed case, the computing time is able to be reduced. Secondly, the upper and lower bounds for the system reliability are obtained for the circular connected(r,s)-out-of-(m;n):F lattice system. Finally, it is proved that the reliability of the large system tends to exp[-mu lambda(rs)] as n = mu n(eta-1) n --> infinity if every component has failure probability lambda n(-eta/rs), where mu, lambda and eta are constant, mu, lambda > 0, eta > r.	TEIKYO UNIV SCI & TECHNOL,FAC SCI & TECHNOL,DEPT ENGN MANAGEMENT,UENOHARA,YAMANASHI 40901,JAPAN; UNIV TOKYO,GRAD SCH ENGN,DEPT MATH ENGN & INFORMAT PHYS,BUNKYO KU,TOKYO 113,JAPAN							YAMAMOTO H, 1995, IEEE T RELIAB, V44, P333, DOI 10.1109/24.387391; HWANG FK, 1982, IEEE T RELIAB, V31, P447; ZUO MJ, 1993, IEEE T RELIAB, V42, P488, DOI 10.1109/24.257836; FU JC, 1985, IEEE T RELIAB, V34, P127; SALVIA AA, 1990, IEEE T RELIAB, V39, P382, DOI 10.1109/24.103023; BOEHME TK, 1992, IEEE T RELIAB, V41, P451, DOI 10.1109/24.159819; DERMAN C, 1982, IEEE T RELIAB, V31, P57; ABRAHAM JA, 1979, IEEE T RELIAB, V28, P58; LOCKS MO, 1987, IEEE T RELIAB, V36, P445; BOLLINGER RC, 1990, IEEE T RELIAB, V39, P382; WILSON JM, 1990, IEEE T RELIAB, V39, P42, DOI 10.1109/24.52639	11	3	3	OPERATIONS RES SOC JAPAN	BUNKYO-KU TOKYO	GAKKAI-CENTER BLDG 4-16 YAYOI 1-CHOME, BUNKYO-KU TOKYO 113, JAPAN	0453-4514			J OPER RES SOC JPN	J. Oper. Res. Soc. Jpn.	SEP	1996	39	3					389	406				18	Operations Research & Management Science	Operations Research & Management Science	VG492	WOS:A1996VG49200009		
J	Ozaki, T; Kuroda, H				Ozaki, T; Kuroda, H			Space-resolved observation of false gain in soft-x-ray lasers	JOURNAL OF THE OPTICAL SOCIETY OF AMERICA B-OPTICAL PHYSICS			English	Article							SPONTANEOUS EMISSION; RECOMBINING PLASMA; ALPHA-TRANSITION; PICOSECOND-LASER; LINE TRANSFER; XUV LASER; 18.2 NM; AMPLIFICATION; ALUMINUM; SPECTROSCOPY	The results of space-resolved investigations on false amplification observed in soft-x-ray laser experiments that are due to axial plasma expansion are presented. Space-resolved observations show a difference in the spontaneous-emission intensities of the N Balmer-alpha line for plasmas with different active media lengths, which can be a cause of overestimation of gain coefficients. The deviations of the intensities are found to be small for optically thick lines and for lower pump intensities. Modeling calculations that include the effects of axial expansions are also performed that support the experimental observations. The different N Balmer-alpha intensity profiles observed for short and long active media lengths are attributed to expansion of the cylindrical plasma in the axial direction, which tends to force plasmas with smaller volumes to expand and cool at an enhanced rate. (C) 1996 Optical Society of America.		Ozaki, T (reprint author), UNIV TOKYO,INST SOLID STATE PHYS,MINATO KU,7-22-1 RAPPONGI,TOKYO 106,JAPAN.		Ozaki, Tsuneyuki/B-3283-2012; 	Ozaki, Tsuneyuki/0000-0001-8857-3900			FIELDS DJ, 1992, PHYS REV A, V46, P1606, DOI 10.1103/PhysRevA.46.1606; DAWSON JM, 1964, PHYS FLUIDS, V7, P981, DOI 10.1063/1.1711346; MATTHEWS DL, 1985, PHYS REV LETT, V54, P110, DOI 10.1103/PhysRevLett.54.110; ROCCA JJ, 1994, PHYS REV LETT, V73, P2192, DOI 10.1103/PhysRevLett.73.2192; ITOH M, 1987, PHYS REV A, V35, P233, DOI 10.1103/PhysRevA.35.233; BELY O, 1966, P PHYS SOC LOND, V88, P587, DOI 10.1088/0370-1328/88/3/305; BLAHA M, 1969, ASTROPHYS J, V157, P473, DOI 10.1086/150084; CARILLON A, 1992, PHYS REV LETT, V68, P2917, DOI 10.1103/PhysRevLett.68.2917; CARILLON A, 1990, J PHYS B-AT MOL OPT, V23, P147, DOI 10.1088/0953-4075/23/1/015; CHENAISPOPOVICS C, 1987, PHYS REV LETT, V59, P2161, DOI 10.1103/PhysRevLett.59.2161; EDER DC, 1987, J OPT SOC AM B, V4, P1949, DOI 10.1364/JOSAB.4.001949; EDER DC, 1991, J QUANT SPECTROSC RA, V45, P189, DOI 10.1016/0022-4073(91)90053-S; GRANDE M, 1990, OPT COMMUN, V74, P309, DOI 10.1016/0030-4018(90)90389-B; GRIEM H, 1964, PLASMA SPECTROSCOPY, P161; JAMELOT G, 1985, J PHYS B-AT MOL OPT, V18, P4647, DOI 10.1088/0022-3700/18/23/016; KATO Y, 1990, APPL PHYS B-PHOTO, V50, P247, DOI 10.1007/BF00325056; KIEFFER JC, 1991, PHYS FLUIDS B-PLASMA, V3, P463, DOI 10.1063/1.859888; KITA T, 1983, APPL OPTICS, V22, P512; KLISNICK A, 1991, XRAY LASERS 1990, P17; KURODA H, 1994, P SOC PHOTO-OPT INS, V2206, P382, DOI 10.1117/12.184603; LAFONTAINE B, 1993, PHYS REV E, V47, P583, DOI 10.1103/PhysRevE.47.583; LEE YT, 1990, PHYS FLUIDS B-PLASMA, V2, P2731, DOI 10.1063/1.859396; LOTZ W, 1968, Z PHYS, V216, P241, DOI 10.1007/BF01392963; MACGOWAN BJ, 1990, PHYS REV LETT, V65, P420, DOI 10.1103/PhysRevLett.65.420; LEE TN, 1987, PHYS REV LETT, V59, P1185, DOI 10.1103/PhysRevLett.59.1185; MCWHIRTER RWP, 1965, PLASMA DIAGNOSTIC TE, P234; NAGATA Y, 1993, PHYS REV LETT, V71, P3774, DOI 10.1103/PhysRevLett.71.3774; NAKANO N, 1987, PHYS REV A, V35, P4712, DOI 10.1103/PhysRevA.35.4712; NAKANO N, 1983, PHYS REV A, V27, P2168, DOI 10.1103/PhysRevA.27.2168; NAKANO N, 1987, PHYS REV A, V35, P4719, DOI 10.1103/PhysRevA.35.4719; NAKANO N, 1984, APPL OPTICS, V23, P2386; NAM CH, 1986, J OPT SOC AM B, V3, P1199; OZAKI T, 1995, J OPT SOC AM B, V12, P1338, DOI 10.1364/JOSAB.12.001338; OZAKI T, IN PRESS OPT QUANTUM; OZAKI T, 1995, PHYS REV E, V51, pR24, DOI 10.1103/PhysRevE.51.R24; Seaton M.J., 1962, ATOMIC MOL PROCESSES, P375; SHESTAKOV AI, 1989, J QUANT SPECTROSC RA, V42, P483, DOI 10.1016/0022-4073(89)90039-3; SKINNER CH, 1990, J OPT SOC AM B, V7, P2042, DOI 10.1364/JOSAB.7.002042; STEINGRUBER J, 1994, APPL PHYS B-LASERS O, V58, P29, DOI 10.1007/BF01081710; ZHANG J, 1995, PHYS REV LETT, V74, P1335, DOI 10.1103/PhysRevLett.74.1335	40	4	4	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036	0740-3224			J OPT SOC AM B	J. Opt. Soc. Am. B-Opt. Phys.	SEP	1996	13	9					1873	1878		10.1364/JOSAB.13.001873		6	Optics	Optics	VF898	WOS:A1996VF89800006		
J	Uehara, M; Nagata, T; Akimitsu, J; Takahashi, H; Mori, N; Kinoshita, K				Uehara, M; Nagata, T; Akimitsu, J; Takahashi, H; Mori, N; Kinoshita, K			Superconductivity in the ladder material Sr0.4Ca13.6Cu24O41.84	JOURNAL OF THE PHYSICAL SOCIETY OF JAPAN			English	Letter						superconductivity; ladder system; (Sr,Ca)(14)Cu24O4-10 delta high-pressure experiment	SPIN GAPS; SRCU2O3	We have observed superconductivity in the ladder material Sr0.4Ca13.6Cu24O41.84 under pressures of 3 GPa and 4.5 GPa by means of electrical measurements. The superconducting transition temperatures T-c (onset) are 12 K and 9 K at 3 and 4.5 GPa, respectively. The superconducting volume fraction was obtained to be about 5% from magnetization measurement under 3.5 GPa at 4.2 K, indicating the bulk nature of the superconductivity in this system.	UNIV TOKYO, INST SOLID STATE PHYS, MINATO KU, TOKYO 106, JAPAN; NIPPON TELEGRAPH & TEL PUBL CORP, BASIC RES LABS, ATSUGI, KANAGAWA 24301, JAPAN	Uehara, M (reprint author), AOYAMA GAKUIN UNIV, DEPT PHYS, SETAGAYA KU, TOKYO 157, JAPAN.		Uehara, Masatomo/M-4785-2014	Uehara, Masatomo/0000-0001-5221-4463			AKIMITSU J, IN PRESS PHYSICA C; DAGOTTO E, 1992, PHYS REV B, V45, P5744, DOI 10.1103/PhysRevB.45.5744; SIEGRIST T, 1988, MATER RES BULL, V23, P1429, DOI 10.1016/0025-5408(88)90268-1; ECCLESTON RS, 1994, PHYS REV LETT, V73, P2626, DOI 10.1103/PhysRevLett.73.2626; Kato M, 1996, PHYSICA C, V258, P284, DOI 10.1016/0921-4534(95)00802-0; MCCARRON EM, 1988, MATER RES BULL, V23, P1355, DOI 10.1016/0025-5408(88)90124-9; AZUMA M, 1994, PHYS REV LETT, V73, P3463, DOI 10.1103/PhysRevLett.73.3463; Eccleston RS, 1996, PHYS REV B, V53, P14721; GOPALAN S, 1994, PHYS REV B, V49, P8901, DOI 10.1103/PhysRevB.49.8901; HIROI Z, 1995, NATURE, V377, P41, DOI 10.1038/377041a0; ISHIDA K, 1994, J PHYS SOC JPN, V63, P3222, DOI 10.1143/JPSJ.63.3222; KITAOKA Y, COMMUNICATION; MATSUDA M, IN PRESS PHYS REV B; MATSUMOTO S, 1996, IN PRESS PHYS REV B, V53; MORI N, 1993, JJAP SERIES, V8, P182; MOTOYAMA N, COMMUNICATION; RICE TM, 1994, PHYSICA B, V199, P378, DOI 10.1016/0921-4526(94)91843-0; RICE TM, 1993, EUROPHYS LETT, V23, P445, DOI 10.1209/0295-5075/23/6/011; SIGRIST M, 1994, PHYS REV B, V49, P12058, DOI 10.1103/PhysRevB.49.12058; TROYER M, 1994, PHYS REV B, V50, P13515, DOI 10.1103/PhysRevB.50.13515; Uehara M., UNPUB; Uehara M, 1995, PHYSICA C, V255, P193, DOI 10.1016/0921-4534(95)00608-7; YAMANE H, 1990, NIPPON SERAM KYO GAK, V98, P1050	23	598	601	PHYSICAL SOC JAPAN	TOKYO	YUSHIMA URBAN BUILDING 5F, 2-31-22 YUSHIMA, BUNKYO-KU, TOKYO, 113-0034, JAPAN	0031-9015			J PHYS SOC JPN	J. Phys. Soc. Jpn.	SEP	1996	65	9					2764	2767		10.1143/JPSJ.65.2764		4	Physics, Multidisciplinary	Physics	VK272	WOS:A1996VK27200008		
J	Kusakabe, K; Aoki, H				Kusakabe, K; Aoki, H			Detection of pairing from the extended Aharonov-Bohm period in strongly correlated electron systems	JOURNAL OF THE PHYSICAL SOCIETY OF JAPAN			English	Letter						normal-superconductor transition; strongly correlated electron systems; bound states; spectral flow; Hubbard model; t-J ladder	T-J MODEL; HUBBARD-MODEL; SUPERFLUID DENSITY; FLUX-QUANTIZATION; RINGS; SUPERCONDUCTIVITY; TEMPERATURE; INSULATOR; CRITERIA; STATES	Inspired by Sutherland's work [Phys. Rev. Lett. 74 (1995) 816] on the detection of bound spin waves, we propose that bound electron states can he detected from the dependence of interacting electron systems on the Aharonov-Bohm flux in the 'extended zone' scheme. where the electron pairing halves the original period of N-alpha flux quanta in a system of linear size N-alpha. Along with the Bethe ansatz analysis, a numerical implementation for keeping track of the adiabatic flow of energy levels is applied to the attractive/repulsive Hubbard model and the t-J ladder.	UNIV TOKYO, DEPT PHYS, TOKYO 113, JAPAN	Kusakabe, K (reprint author), UNIV TOKYO, INST SOLID STATE PHYS, ROPPONGI, TOKYO 106, JAPAN.		Aoki, Hideo/A-2525-2009	Aoki, Hideo/0000-0002-7332-9355			LEE KJB, 1988, PHYS REV B, V38, P11566, DOI 10.1103/PhysRevB.38.11566; BYERS N, 1961, PHYS REV LETT, V7, P46, DOI 10.1103/PhysRevLett.7.46; SUTHERLAND B, 1995, PHYS REV LETT, V74, P816, DOI 10.1103/PhysRevLett.74.816; LIEB EH, 1968, PHYS REV LETT, V20, P1445, DOI 10.1103/PhysRevLett.20.1445; WHITE SR, 1993, PHYS REV B, V48, P10345, DOI 10.1103/PhysRevB.48.10345; SHASTRY BS, 1990, PHYS REV LETT, V65, P243, DOI 10.1103/PhysRevLett.65.243; IMADA M, 1989, J PHYS SOC JPN, V58, P3752, DOI 10.1143/JPSJ.58.3752; FYE RM, 1991, PHYS REV B, V44, P6909, DOI 10.1103/PhysRevB.44.6909; SCALAPINO DJ, 1993, PHYS REV B, V47, P7995, DOI 10.1103/PhysRevB.47.7995; ASSAAD FF, 1994, PHYS REV B, V50, P12835, DOI 10.1103/PhysRevB.50.12835; DAGOTTO E, 1993, PHYS REV LETT, V70, P682, DOI 10.1103/PhysRevLett.70.682; FERRETTI A, 1992, PHYS REV B, V45, P5486, DOI 10.1103/PhysRevB.45.5486; FURUKAWA N, 1992, J PHYS SOC JPN, V61, P3331, DOI 10.1143/JPSJ.61.3331; HAYWARD CA, 95091239; HAYWARD CA, 1995, PHYS REV LETT, V75, P926, DOI 10.1103/PhysRevLett.75.926; KUSAKABE K, 1992, J PHYS SOC JPN, V61, P1165, DOI 10.1143/JPSJ.61.1165; KUSMARTSEV FV, 1992, PHYS LETT A, V161, P433, DOI 10.1016/0375-9601(92)90684-E; KUSMARTSEV FV, 1994, PHYS REV B, V49, P16234, DOI 10.1103/PhysRevB.49.16234; MOREO A, 1991, PHYS REV B, V43, P11442, DOI 10.1103/PhysRevB.43.11442; Sano K, 1996, J PHYS SOC JPN, V65, P1146, DOI 10.1143/JPSJ.65.1146; SHULTZ HJ, 1993, CORRELATED ELECTRON, P199; Sorella S., 1988, International Journal of Modern Physics B, V2, DOI 10.1142/S0217979288000822; TAKAHASH.M, 1972, PROG THEOR PHYS, V47, P69, DOI 10.1143/PTP.47.69; WOYNAROVICH F, 1983, J PHYS C SOLID STATE, V16, P6593, DOI 10.1088/0022-3719/16/34/009	24	11	11	PHYSICAL SOC JAPAN	TOKYO	YUSHIMA URBAN BUILDING 5F, 2-31-22 YUSHIMA, BUNKYO-KU, TOKYO, 113-0034, JAPAN	0031-9015			J PHYS SOC JPN	J. Phys. Soc. Jpn.	SEP	1996	65	9					2772	2775		10.1143/JPSJ.65.2772		4	Physics, Multidisciplinary	Physics	VK272	WOS:A1996VK27200010		
J	Nakamura, H; Takayanagi, F; Shiga, M; Nishi, M; Kakurai, K				Nakamura, H; Takayanagi, F; Shiga, M; Nishi, M; Kakurai, K			Spin-liquid to spin-glass transition in Y(Sc)(Mn1-xAlx)(2): Polarized neutron scattering study	JOURNAL OF THE PHYSICAL SOCIETY OF JAPAN			English	Letter						YMn2; neutron scattering; spin fluctuations; spin liquid; spin glass	YMN2; FLUCTUATIONS; TEMPERATURE; Y1-XSCXMN2; PRESSURE	The scattering of polarized neutrons has been measured in order to study the spin dynamics in Y0.97Sc0.03Mn2 and Y0.97Sc0.03(Mn0.9Al0.1)(2). A large magnetic scattering peak observed at around Q = 1.6 Angstrom(-1) indicates the existence of strong antiferromagnetic spin fluctuations. The energy and Q spectra obtained at 290 K exhibit nearly the same profiles for both samples, while those obtained at low temperatures are quite different; for Y(Sc)Mn-2 the intensity and the energy width decrease only slightly with decreasing temperature and the intrinsic width remains finite (2 Gamma = 20 +/- 5 meV) at the lowest temperature (10 K), whereas for Y(Sc)(Mn0.9Al0.1)(2), the intensity increases rapidly due to narrowing of the energy spectrum to the resolution limit (2 Gamma(res) = 5.8 meV) at 10 K, and instead, diffuse scattering was clearly observed at positions corresponding to the magnetic Bragg peaks of YMn2, implying a slowing down of spin fluctuations and the presence of short range magnetic order at the low temperature. These results are discussed in terms of a spin-liquid to spin-glass transition caused by Al substitution.	UNIV TOKYO, ISSP, NEUTRON SCATTERING LAB, TOKAI, IBARAKI 31911, JAPAN	Nakamura, H (reprint author), KYOTO UNIV, DEPT MAT SCI & ENGN, KYOTO 60601, JAPAN.						Ballou R, 1996, PHYS REV LETT, V76, P2125, DOI 10.1103/PhysRevLett.76.2125; SHIGA M, 1988, J PHYS SOC JPN, V57, P3141, DOI 10.1143/JPSJ.57.3141; BALLOU R, 1987, J MAGN MAGN MATER, V70, P129, DOI 10.1016/0304-8853(87)90379-9; DEPORTES J, 1987, J PHYS-PARIS, V48, P1029, DOI 10.1051/jphys:019870048060102900; MOTOYA K, 1988, PHYS REV B, V38, P4796, DOI 10.1103/PhysRevB.38.4796; NAKAMURA H, 1988, J PHYS F MET PHYS, V18, P981, DOI 10.1088/0305-4608/18/5/015; NAKAMURA H, 1988, J PHYS-PARIS, V49, P257, DOI 10.1051/jphyscol:19888113; OOMI G, 1987, J MAGN MAGN MATER, V70, P137, DOI 10.1016/0304-8853(87)90381-7; SHIGA M, 1993, J PHYS SOC JPN, V62, P1329, DOI 10.1143/JPSJ.62.1329; SHIGA M, 1994, J PHYS SOC JPN, V63, P1656, DOI 10.1143/JPSJ.63.1656; VILLAIN J, 1979, Z PHYS B CON MAT, V33, P31, DOI 10.1007/BF01325811; WADA H, 1989, PHYSICA B, V161, P197, DOI 10.1016/0921-4526(89)90133-6	12	14	14	PHYSICAL SOC JAPAN	TOKYO	YUSHIMA URBAN BUILDING 5F, 2-31-22 YUSHIMA, BUNKYO-KU, TOKYO, 113-0034, JAPAN	0031-9015			J PHYS SOC JPN	J. Phys. Soc. Jpn.	SEP	1996	65	9					2779	2782		10.1143/JPSJ.65.2779		4	Physics, Multidisciplinary	Physics	VK272	WOS:A1996VK27200012		
J	Takehana, K; Oshikiri, M; Kido, G; Hase, M; Uchinokura, K				Takehana, K; Oshikiri, M; Kido, G; Hase, M; Uchinokura, K			Magnetostriction and thermal expansion measurements of CuGeO3	JOURNAL OF THE PHYSICAL SOCIETY OF JAPAN			English	Letter						CuGeO3; magnetostriction; thermal expansion; spin-Peierls; high magnetic field; phase transition	SPIN-PEIERLS TRANSITION; COMPOUND CUGEO3; SYSTEM CUGEO3; STATE	The magnetostriction and thermal expansion of CuGeO3 have been measured in magnetic fields of up to 14 T using a capacitance method. An anomalous increase and hysteresis were observed in the magnetostriction at the transition between the spin-Peierls (SP) phase and the magnetic (M) phase, which show that the strain introduced at the transition from the uniform (U) phase to the SP phase is partially removed at the transition from the SP phase to the M phase.	RIKEN, INST PHYS & CHEM RES, WAKO, SAITAMA 35101, JAPAN; UNIV TOKYO, DEPT APPL PHYS, BUNKYO KU, TOKYO 113, JAPAN	Takehana, K (reprint author), NATL RES INST MET, TSUKUBA MAGNET LABS, SAKURA 3-13, TSUKUBA, IBARAKI 305, JAPAN.		Hase, Masashi/B-8900-2008	Hase, Masashi/0000-0003-2717-461X			HASE M, 1993, PHYS REV B, V48, P9616, DOI 10.1103/PhysRevB.48.9616; HASE M, 1993, PHYS REV LETT, V70, P3651, DOI 10.1103/PhysRevLett.70.3651; WINKELMANN H, 1995, PHYS REV B, V51, P12884, DOI 10.1103/PhysRevB.51.12884; HARRIS QJ, 1994, PHYS REV B, V50, P12606, DOI 10.1103/PhysRevB.50.12606; HIROTA K, 1994, PHYS REV LETT, V73, P736, DOI 10.1103/PhysRevLett.73.736; KAMIMURA O, 1994, J PHYS SOC JPN, V63, P2467, DOI 10.1143/JPSJ.63.2467; KIRYUKHIN V, 1995, PHYS REV B, V52, pR704, DOI 10.1103/PhysRevB.52.R704; LORENZO JE, 1994, PHYS REV B, V50, P1278, DOI 10.1103/PhysRevB.50.1278; NOJIRI H, 1995, PHYSICA B, V211, P184, DOI 10.1016/0921-4526(94)00980-A; POUGET JP, 1994, PHYS REV LETT, V72, P4037, DOI 10.1103/PhysRevLett.72.4037; Takehana K, 1996, PHYSICA B, V216, P354, DOI 10.1016/0921-4526(95)00516-1	11	6	6	PHYSICAL SOC JAPAN	TOKYO	YUSHIMA URBAN BUILDING 5F, 2-31-22 YUSHIMA, BUNKYO-KU, TOKYO, 113-0034, JAPAN	0031-9015			J PHYS SOC JPN	J. Phys. Soc. Jpn.	SEP	1996	65	9					2783	2785		10.1143/JPSJ.65.2783		3	Physics, Multidisciplinary	Physics	VK272	WOS:A1996VK27200013		
J	Hotta, T; Takada, Y				Hotta, T; Takada, Y			Hopping-integral expansion from the limit of zero bandwidth in the infinite-dimensional Hubbard-Holstein model.	JOURNAL OF THE PHYSICAL SOCIETY OF JAPAN			English	Article						infinite dimensions; effective hopping integral; atomic limit; perturbation expansion; Hubbard-Holstein modal; dynamical localization	CONSISTENT PERTURBATION-THEORY; MOTT TRANSITION; SELF-ENERGY; ELECTRON; FERMIONS; LATTICE	We make a careful perturbation analysis of the electronic self-energy Sigma in terms of the effective electron hopping integral A in the infinite-dimensional system. We apply this formal analysis to the system in which the attractive interaction between electrons mediated by local optic phonons competes with the electron-electron short-range repulsion. By summing the most divergent terms in Sigma up to infinite order, we discuss the dynamical localization-delocalization transition.		Hotta, T (reprint author), UNIV TOKYO, INST SOLID STATE PHYS, MINATO KU, 7-22-1 ROPPONGI, TOKYO 106, JAPAN.						JARRELL M, 1992, PHYS REV LETT, V69, P168, DOI 10.1103/PhysRevLett.69.168; GEORGES A, 1992, PHYS REV LETT, V69, P1240, DOI 10.1103/PhysRevLett.69.1240; MARSIGLIO F, 1988, PHYS REV B, V37, P4965, DOI 10.1103/PhysRevB.37.4965; YASUHARA H, 1991, PHYS REV B, V43, P7200, DOI 10.1103/PhysRevB.43.7200; LUTTINGER JM, 1960, PHYS REV, V118, P1417, DOI 10.1103/PhysRev.118.1417; GEORGES A, 1992, PHYS REV B, V45, P6479, DOI 10.1103/PhysRevB.45.6479; ROZENBERG MJ, 1992, PHYS REV LETT, V69, P1236, DOI 10.1103/PhysRevLett.69.1236; MOTT NF, 1961, PHILOS MAG, V6, P287; METZNER W, 1989, PHYS REV LETT, V62, P324, DOI 10.1103/PhysRevLett.62.324; ANDERSON PW, 1961, PHYS REV, V124, P41, DOI 10.1103/PhysRev.124.41; BICKERS NE, 1987, REV MOD PHYS, V59, P845, DOI 10.1103/RevModPhys.59.845; ROZENBERG MJ, 1994, PHYS REV B, V49, P10181, DOI 10.1103/PhysRevB.49.10181; ZHANG XY, 1993, PHYS REV LETT, V70, P1666, DOI 10.1103/PhysRevLett.70.1666; MULLERHARTMANN E, 1989, Z PHYS B CON MAT, V74, P507, DOI 10.1007/BF01311397; GEORGES A, 1993, PHYS REV B, V48, P7167, DOI 10.1103/PhysRevB.48.7167; GEORGES A, 1992, INT J MOD PHYS B, V6, P257; GEORGES A, 1996, REV MOD PHYS, V68; HOLSTEIN T, 1959, ANN PHYS-NEW YORK, V8, P325, DOI 10.1016/0003-4916(59)90002-8; Hotta T, 1996, PHYS REV LETT, V76, P3180, DOI 10.1103/PhysRevLett.76.3180; HUBBARD J, 1964, PROC R SOC LON SER-A, V281, P401, DOI 10.1098/rspa.1964.0190; Hubbard J., 1967, Proceedings of the Royal Society of London, Series A (Mathematical and Physical Sciences), V296, DOI 10.1098/rspa.1967.0007; JARRELL M, 1993, Z PHYS B CON MAT, V90, P187, DOI 10.1007/BF02198153; JARRELL M, 1993, QUANTUM MONTE CARLO, P221; KURAMOTO Y, 1983, Z PHYS B CON MAT, V53, P37, DOI 10.1007/BF01578246; KURAMOTO Y, 1985, J MAGN MAGN MATER, V47-8, P329, DOI 10.1016/0304-8853(85)90431-7; Lang I.G., 1962, Zhurnal Eksperimental'noi i Teoreticheskoi Fiziki, V43; Mahan G.D., 1981, MANY PARTICLE PHYSIC; METZNER W, 1991, PHYS REV B, V43, P8549, DOI 10.1103/PhysRevB.43.8549; MULLERHARTMANN E, 1989, Z PHYS B CON MAT, V76, P211, DOI 10.1007/BF01312686; MULLERHARTMANN E, 1984, Z PHYS B CON MAT, V57, P281, DOI 10.1007/BF01470417; Nozieres P, 1964, THEORY INTERACTING F; TAKADA Y, 1995, PHYS REV B, V52, P12720, DOI 10.1103/PhysRevB.52.12720; TAKADA Y, UNPUB	33	4	4	PHYSICAL SOC JAPAN	TOKYO	YUSHIMA URBAN BUILDING 5F, 2-31-22 YUSHIMA, BUNKYO-KU, TOKYO, 113-0034, JAPAN	0031-9015			J PHYS SOC JPN	J. Phys. Soc. Jpn.	SEP	1996	65	9					2922	2935		10.1143/JPSJ.65.2922		14	Physics, Multidisciplinary	Physics	VK272	WOS:A1996VK27200035		
J	Kato, T; Imada, M				Kato, T; Imada, M			Macroscopic quantum tunneling of a fluxon in a long Josephson junction	JOURNAL OF THE PHYSICAL SOCIETY OF JAPAN			English	Article						macroscopic quantum tunneling; fluxon; long Josephson junction; dissipation; Caldeira-Leggett theory; sine-Gordon equation; macroscopic quantum coherence	SINE-GORDON SOLITONS; TRANSMISSION-LINE; 2-STATE SYSTEM; FIELD-THEORY; DYNAMICS; PROPAGATION; TEMPERATURE; EXPANSION	Macroscopic quantum tunneling (MQT) for a single fluxon moving along a long Josephson junction is studied theoretically. To introduce a fluxon-pinning force, we consider inhomogeneities made by modifying thickness of an insulating layer locally. Two different situations are studied: one is the quantum tunneling from a metastable state caused by a single inhomogeneity, and the other is the quantum tunneling in a two-state system made by two inhomogeneities. In the quantum tunneling from a metastable state, the decay rate is estimated within the WKB approximation. Dissipation effects on a fluxon dynamics are taken into account by the Caldeira-Leggett theory. We propose a device to observe quantum tunneling of a fluxon experimentally. Required experimental resolutions to observe MQT of a fluxon seem attainable within the presently available micro-fabrication technique. For the two-state system, we study quantum resonance between two stable states, i.e., macroscopic quantum coherence (MQC). From the estimate for dissipation coefficients due to quasiparticle tunneling, the observation of MQC appears to be possible within the Caldeira-Leggett theory.		Kato, T (reprint author), UNIV TOKYO, INST SOLID STATE PHYS, MINATO KU, TOKYO 106, JAPAN.						LEGGETT AJ, 1987, REV MOD PHYS, V59, P1, DOI 10.1103/RevModPhys.59.1; HANGGI P, 1985, PHYS REV LETT, V55, P761, DOI 10.1103/PhysRevLett.55.761; MCLAUGHLIN DW, 1978, PHYS REV A, V18, P1652, DOI 10.1103/PhysRevA.18.1652; USTINOV AV, 1992, PHYS REV LETT, V69, P1815, DOI 10.1103/PhysRevLett.69.1815; CALDEIRA AO, 1983, ANN PHYS-NEW YORK, V149, P374, DOI 10.1016/0003-4916(83)90202-6; LEGGETT AJ, 1985, PHYS REV LETT, V54, P857, DOI 10.1103/PhysRevLett.54.857; AMBEGAOKAR V, 1963, PHYS REV LETT, V10, P486, DOI 10.1103/PhysRevLett.10.486; JACKIW R, 1977, REV MOD PHYS, V49, P681, DOI 10.1103/RevModPhys.49.681; CALLAN CG, 1977, PHYS REV D, V16, P1762, DOI 10.1103/PhysRevD.16.1762; CALDEIRA AO, 1984, ANN PHYS-NEW YORK, V153, P445; CHRIST NH, 1975, PHYS REV D, V12, P1606, DOI 10.1103/PhysRevD.12.1606; DAVIDSON A, 1986, J APPL PHYS, V60, P1447, DOI 10.1063/1.337324; DAVIDSON A, 1985, PHYS REV LETT, V55, P2059, DOI 10.1103/PhysRevLett.55.2059; FUJIMAKI A, 1987, PHYS REV LETT, V59, P2895, DOI 10.1103/PhysRevLett.59.2895; FULTON TA, 1973, SOLID STATE COMMUN, V12, P57, DOI 10.1016/0038-1098(73)90345-1; GERVAIS JL, 1975, PHYS REV D, V12, P1038, DOI 10.1103/PhysRevD.12.1038; HAN S, 1991, PHYS REV LETT, V66, P810, DOI 10.1103/PhysRevLett.66.810; Han SY, 1996, PHYS REV LETT, V76, P3404, DOI 10.1103/PhysRevLett.76.3404; HERMON Z, 1994, PHYS REV B, V49, P9757, DOI 10.1103/PhysRevB.49.9757; HERMON Z, 1995, PHYS REV LETT, V74, P4915, DOI 10.1103/PhysRevLett.74.4915; HIDA K, 1985, PHYS REV B, V32, P4539, DOI 10.1103/PhysRevB.32.4539; LANGER JS, 1967, ANN PHYS-NEW YORK, V41, P108, DOI 10.1016/0003-4916(67)90200-X; LEGGETT AJ, 1995, REV MOD PHYS, V67, P725, DOI 10.1103/RevModPhys.67.725; LOMDAHL PS, 1982, PHYS REV B, V25, P5737, DOI 10.1103/PhysRevB.25.5737; MATSUDA A, 1983, PHYS REV LETT, V51, P694, DOI 10.1103/PhysRevLett.51.694; PEDERSEN NF, 1984, PHYS REV B, V29, P2551, DOI 10.1103/PhysRevB.29.2551; PEDERSEN NF, 1986, LOW TEMPERATURE PHYS, V5; Rajaraman R., 1982, SOLITONS INSTANTONS; SIMANJUNTAK H, 1990, PHYS REV B, V42, P930, DOI 10.1103/PhysRevB.42.930; TOMBOULIS E, 1975, PHYS REV D, V12, P1678, DOI 10.1103/PhysRevD.12.1678; VOSS RF, 1981, PHYS REV LETT, V47, P265, DOI 10.1103/PhysRevLett.47.265; WASHBURN S, 1985, PHYS REV LETT, V54, P2712, DOI 10.1103/PhysRevLett.54.2712; Weiss U., 1993, QUANTUM DISSIPATIVE	33	39	39	PHYSICAL SOC JAPAN	TOKYO	YUSHIMA URBAN BUILDING 5F, 2-31-22 YUSHIMA, BUNKYO-KU, TOKYO, 113-0034, JAPAN	0031-9015			J PHYS SOC JPN	J. Phys. Soc. Jpn.	SEP	1996	65	9					2963	2975		10.1143/JPSJ.65.2963		13	Physics, Multidisciplinary	Physics	VK272	WOS:A1996VK27200040		
J	Ajiki, H; Ando, T				Ajiki, H; Ando, T			Lattice distortion with spatial variation of carbon nanotubes in magnetic fields	JOURNAL OF THE PHYSICAL SOCIETY OF JAPAN			English	Article						graphite; carbon nanotube; fullerene tube; lattice instability; Landau level; effective-mass theory	NANOSCALE GRAPHITIC TUBULES; ELECTRONIC-STRUCTURE; GRAPHENE TUBULES; FULLERENE TUBULES; MODEL; C-60; POLYACETYLENE; MICROTUBULES; SYMMETRY; SOLITONS	A lattice instability of carbon nanotubes induced by a magnetic field perpendicular to the tube axis is studied in a k . p scheme, Both in-plane Kekule and out-of-plane distortions are enhanced drastically with increase of a magnetic field independent of whether a nanotube is metallic or semiconducting and magnetic. Bur passing through the cross section of a nanotube. The distortions become dependent on the position in the circumference direction.	UNIV TOKYO, INST SOLID STATE PHYS, MINATO KU, TOKYO 106, JAPAN							AJIKI H, 1995, P 22 INT C PHYS SEM, V3, P2061; Ajiki H, 1996, PHYSICA B, V216, P358, DOI 10.1016/0921-4526(95)00517-X; AJIKI H, 1994, PHYSICA B, V201, P349, DOI 10.1016/0921-4526(94)91112-6; AJIKI H, IN PRESS PHYSICA B; AJIKI H, 1995, J PHYS SOC JPN, V64, P4382, DOI 10.1143/JPSJ.64.4382; AJIKI H, 1994, J PHYS SOC JPN, V63, P4267, DOI 10.1143/JPSJ.63.4267; AJIKI H, 1993, J PHYS SOC JPN, V62, P2470, DOI 10.1143/JPSJ.62.2470; Ajiki H., 1995, JPN J APPL PHYS S, V34-1, P107; AJIKI H, 1995, J PHYS SOC JPN, V64, P260, DOI 10.1143/JPSJ.64.260; SAITO R, 1992, PHYS REV B, V46, P1804, DOI 10.1103/PhysRevB.46.1804; BETHUNE DS, 1993, NATURE, V363, P605, DOI 10.1038/363605a0; SU WP, 1980, PHYS REV B, V22, P2099, DOI 10.1103/PhysRevB.22.2099; HARIGAYA K, 1993, PHYS REV B, V47, P16563, DOI 10.1103/PhysRevB.47.16563; AJIKI H, 1993, J PHYS SOC JPN, V62, P1255, DOI 10.1143/JPSJ.62.1255; SAITO R, 1993, J APPL PHYS, V73, P494, DOI 10.1063/1.353358; WHITE CT, 1993, PHYS REV B, V47, P5485, DOI 10.1103/PhysRevB.47.5485; SAITO R, 1992, APPL PHYS LETT, V60, P2204, DOI 10.1063/1.107080; Ajiki H, 1996, J PHYS SOC JPN, V65, P505, DOI 10.1143/JPSJ.65.505; VIET NA, 1994, J PHYS SOC JPN, V63, P3036, DOI 10.1143/JPSJ.63.3036; JISHI RA, 1993, CHEM PHYS LETT, V209, P77, DOI 10.1016/0009-2614(93)87205-H; TANAKA K, 1992, CHEM PHYS LETT, V191, P469, DOI 10.1016/0009-2614(92)85410-C; HAMADA N, 1992, PHYS REV LETT, V68, P1579, DOI 10.1103/PhysRevLett.68.1579; ROBERTSON DH, 1992, PHYS REV B, V45, P12592, DOI 10.1103/PhysRevB.45.12592; JISHI RA, 1993, PHYS REV B, V47, P16671, DOI 10.1103/PhysRevB.47.16671; HEEGER AJ, 1988, REV MOD PHYS, V60, P781, DOI 10.1103/RevModPhys.60.781; MINTMIRE JW, 1992, PHYS REV LETT, V68, P631, DOI 10.1103/PhysRevLett.68.631; BLASE X, 1994, PHYS REV LETT, V72, P1878, DOI 10.1103/PhysRevLett.72.1878; Dresselhaus M. S., 1992, ELEMENTARY EXCITATIO, P387; DRESSELHAUS MS, 1992, PHYS REV B, V45, P6234, DOI 10.1103/PhysRevB.45.6234; GAO YD, 1992, MOL PHYS, V77, P585, DOI 10.1080/00268979200102641; HARIGAYA K, 1992, PHYS REV B, V45, P12071, DOI 10.1103/PhysRevB.45.12071; IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0; IIJIMA S, 1993, NATURE, V363, P603, DOI 10.1038/363603a0; TAKAYAMA H, 1980, PHYS REV B, V21, P2388, DOI 10.1103/PhysRevB.21.2388	34	30	30	PHYSICAL SOC JAPAN	TOKYO	YUSHIMA URBAN BUILDING 5F, 2-31-22 YUSHIMA, BUNKYO-KU, TOKYO, 113-0034, JAPAN	0031-9015			J PHYS SOC JPN	J. Phys. Soc. Jpn.	SEP	1996	65	9					2976	2986		10.1143/JPSJ.65.2976		11	Physics, Multidisciplinary	Physics	VK272	WOS:A1996VK27200041		
J	Yamaguchi, M; Furuta, T; Ishikawa, M				Yamaguchi, M; Furuta, T; Ishikawa, M			Calorimetric study of several cuprates with restricted dimensionality	JOURNAL OF THE PHYSICAL SOCIETY OF JAPAN			English	Article						low-dimensional magnetic systems; cuprates; CuWO4; LiCuVO4; CuSb2O6; CuNb2O6; CuBi2O4; specific heat; magnetic susceptibility	RANGE; CUSB2O6; SYSTEM; OXIDE	By means of specific heat and magnetic susceptibility measurements Rie investigated the magnetic compounds of various crystal structure: CuWO4, LiCuVO4, CuSb2O6, CuNb2O6 and CuBi2O4. All of these cuprates revealed strong one-dimensional (1D) correlations persisting up to very high temperatures which are well explained by the S = 1/2 Heisenberg antiferromagnetic linear-chain model. At lower temperatures they showed various long-range magnetic ordering except fur CuNb2O6. In particular, we observed a rather unusual transition at 2.4 K for LiCuVO4 which is conjectured to be a transition to the S = 1/2 quadratic Ising antiferromagnet, thereby demonstrating a dimensional cross-over of correlations from 1D to 2D. The magnetic susceptibility and specific heat exhibit a critical point and a logarithmic divergence at 2.4 K, respectively, as predicted by theory. We herein report the experimental results and the preliminary analyses of these low-dimensional cuprates.		Yamaguchi, M (reprint author), UNIV TOKYO, INST SOLID STATE PHYS, MINATO KU, TOKYO 106, JAPAN.						DUFFY W, 1968, PHYS REV, V165, P647, DOI 10.1103/PhysRev.165.647; DEJONGH LJ, 1974, ADV PHYS, V23, P1, DOI 10.1080/00018739700101558; NAKUA A, 1991, J SOLID STATE CHEM, V91, P105, DOI 10.1016/0022-4596(91)90062-M; EGGERT S, 1994, PHYS REV LETT, V73, P332, DOI 10.1103/PhysRevLett.73.332; LINES ME, 1970, J PHYS CHEM SOLIDS, V31, P101, DOI 10.1016/0022-3697(70)90291-X; YAMAGUCHI M, 1994, J PHYS SOC JPN, V63, P1666, DOI 10.1143/JPSJ.63.1666; NAKUA AM, 1995, J SOLID STATE CHEM, V118, P199, DOI 10.1006/jssc.1995.1331; BONNER JC, 1964, PHYS REV, V135, pA640, DOI 10.1103/PhysRev.135.A640; BLASSE G, 1966, J PHYS CHEM SOLIDS, V27, P612, DOI 10.1016/0022-3697(66)90206-X; BOIVIN JC, 1973, CR ACAD SCI C CHIM, V276, P1105; de Jongh LJ, 1990, MAGNETIC PROPERTIES; DOUMERC JP, 1981, MATER RES BULL, V16, P985, DOI 10.1016/0025-5408(81)90140-9; FISHER ME, 1962, PHILOS MAG, V7, P1731, DOI 10.1080/14786436208213705; FURUTA T, 1994, THESIS U TOKYO; GEBERT E, 1967, ACTA CHEM SCAND, V21, P2575, DOI 10.3891/acta.chem.scand.21-2575; GONZALEZ C, 1994, J MATER SCI, V29, P3458, DOI 10.1007/BF00352049; KRATZHELLER B, 1992, J ALLOY COMPD, V183, P75, DOI 10.1016/0925-8388(92)90732-O; LAFONTAINE MA, 1989, ACTA CRYSTALLOGR C, V45, P1205, DOI 10.1107/S0108270189001551; OGUCHI T, 1964, PHYS REV, V133, P1098; SAJI H, 1972, J PHYS SOC JPN, V33, P671, DOI 10.1143/JPSJ.33.671; SREEDHAR K, 1988, J PHYS C SOLID STATE, V21, P1129, DOI 10.1088/0022-3719/21/6/018; SYKES MF, 1962, PHYSICA, V28, P619	22	27	27	PHYSICAL SOC JAPAN	TOKYO	YUSHIMA URBAN BUILDING 5F, 2-31-22 YUSHIMA, BUNKYO-KU, TOKYO, 113-0034, JAPAN	0031-9015			J PHYS SOC JPN	J. Phys. Soc. Jpn.	SEP	1996	65	9					2998	3006		10.1143/JPSJ.65.2998		9	Physics, Multidisciplinary	Physics	VK272	WOS:A1996VK27200044		
J	Harada, I; Suzuki, T; Kotani, A				Harada, I; Suzuki, T; Kotani, A			Theory of magnetic circular X-ray dichroism at the Fe K-edge in rare-earth iron garnets	JOURNAL OF THE PHYSICAL SOCIETY OF JAPAN			English	Article						MCXD; rare-earth iron garnet; electric-dipole transition; hybridization		A mechanism is proposed for the magnetic circular X-ray dichroism (MCXD) at the pre-peak of the Fe K-edge in rare-earth iron garnets. It is found based on a cluster model that, at the pre-peak, the hybridization between the 3d state and the 4p state of an Fe ion on the tetrahedral site through the ligand 2p states is responsible for the weak electric-dipole absorption while the combined effect of the spin-orbit interaction and the spin polarization in the 3d states give rise to its MCXD. In addition, the configuration interaction is shown to be important in explaining the asymmetric dispersion-type MCXD spectra observed. The effects of the core hole as well as of the band character of the 4p states are discussed briefly in connection is with MCXD observed in the main X-edge region.	UNIV TOKYO, INST SOLID STATE PHYS, MINATO KU, TOKYO 106, JAPAN	Harada, I (reprint author), OKAYAMA UNIV, FAC SCI, DEPT PHYS, OKAYAMA 700, JAPAN.						BOCQUET AE, 1992, PHYS REV B, V46, P3771, DOI 10.1103/PhysRevB.46.3771; IGARASHI J, 1994, PHYS REV B, V50, P17820, DOI 10.1103/PhysRevB.50.17820; GRUNES LA, 1983, PHYS REV B, V27, P2111, DOI 10.1103/PhysRevB.27.2111; HARADA I, 1994, J PHYS SOC JPN, V63, P1285, DOI 10.1143/JPSJ.63.1285; HARADA I, IN PRESS J ELECT SPE; KAWATA H, 1994, RESONANT ANOMALOUS X, P557; MARUYAMA H, 1995, PHYSICA B, V208, P760, DOI 10.1016/0921-4526(94)00802-3; Sette F., 1991, XRAY ABSORPTION FINE, P96; YAMAZAKI H, 1993, JPN J APPL PHYS 1, V32, P317	9	5	5	PHYSICAL SOC JAPAN	TOKYO	YUSHIMA URBAN BUILDING 5F, 2-31-22 YUSHIMA, BUNKYO-KU, TOKYO, 113-0034, JAPAN	0031-9015			J PHYS SOC JPN	J. Phys. Soc. Jpn.	SEP	1996	65	9					3016	3020		10.1143/JPSJ.65.3016		5	Physics, Multidisciplinary	Physics	VK272	WOS:A1996VK27200046		
J	Sakaguchi, T; Kakurai, K; Yokoo, T; Akimitsu, J				Sakaguchi, T; Kakurai, K; Yokoo, T; Akimitsu, J			Neutron scattering study of magnetic excitations in the spin S=1 one-dimensional Heisenberg antiferromagnet Y2BaNiO5	JOURNAL OF THE PHYSICAL SOCIETY OF JAPAN			English	Article						low-dimensional magnetism; neutron scattering; Haldane system	HALDANE-GAP ANTIFERROMAGNETS; SIGMA-MODEL; DYNAMICS; CHAIN; SYSTEM; CSNICL3; AGVP2S6; FIELD; STATE; OXIDE	Magnetic excitations of the ideal one-dimensional, spin S = 1, antiferromagnet Y2BaNiO5 are studied by means of inelastic neutron scattering on single crystal sample. Our experimental results at low temperature indicate that Y2BaNiO5 can be regarded as the best isotropic Haldane-system sofar studied with the intrachain exchange energy J/k(B) = -24.1 meV and the averaged gap Delta(T = 7 K) = 8.5 meV. Y2BaNiO5 exhibits a good magnetic one-dimensionality with the inter-/intrachain exchange ratio of \J'/J\ less than or equal to 10(-4) and has only very small easy-axis and in-plane single ion anisotropy of \D/J\ = 0.03 and \E/J\ similar to 0.01. In addition the temperature dependence of the Haldane gap Delta(T) and its damping rate was determined.	UNIV TOKYO, INST SOLID STATE PHYS, NEUTRON SCATTERING LAB, TOKAI, IBARAKI 31911, JAPAN; AOYAMA GAKUIN UNIV, DEPT PHYS, SETAGAYA KU, TOKYO 157, JAPAN							AFFLECK I, 1987, PHYS REV LETT, V59, P799, DOI 10.1103/PhysRevLett.59.799; DARRIET J, 1993, SOLID STATE COMMUN, V86, P409, DOI 10.1016/0038-1098(93)90455-V; REGNAULT LP, 1994, PHYS REV B, V50, P9174, DOI 10.1103/PhysRevB.50.9174; JOLICOEUR T, 1994, PHYS REV B, V50, P9265, DOI 10.1103/PhysRevB.50.9265; STEINER M, 1987, J APPL PHYS, V61, P3953, DOI 10.1063/1.338595; [Anonymous], 1987, EPL-EUROPHYS LETT; MA SL, 1995, PHYS REV B, V51, P3289, DOI 10.1103/PhysRevB.51.3289; HALDANE FDM, 1983, PHYS REV LETT, V50, P1153, DOI 10.1103/PhysRevLett.50.1153; BUTTREY DJ, 1990, J SOLID STATE CHEM, V88, P291, DOI 10.1016/0022-4596(90)90226-N; GOLINELLI O, 1992, PHYS REV B, V45, P9798, DOI 10.1103/PhysRevB.45.9798; TAKAHASHI M, 1988, PHYS REV B, V38, P5188, DOI 10.1103/PhysRevB.38.5188; MORRA RM, 1988, PHYS REV B, V38, P543, DOI 10.1103/PhysRevB.38.543; BUYERS WJL, 1986, PHYS REV LETT, V56, P371, DOI 10.1103/PhysRevLett.56.371; SORENSEN ES, 1994, PHYS REV B, V49, P15771, DOI 10.1103/PhysRevB.49.15771; HALDANE FDM, 1983, PHYS LETT A, V93, P464, DOI 10.1016/0375-9601(83)90631-X; BATLOGG B, 1994, PHYSICA B, V194, P173, DOI 10.1016/0921-4526(94)90416-2; DITUSA JF, 1994, PHYSICA B, V194, P181, DOI 10.1016/0921-4526(94)90420-0; KAKURAI K, 1991, J PHYS-CONDENS MAT, V3, P715, DOI 10.1088/0953-8984/3/6/008; MUTKA H, 1991, PHYS REV LETT, V67, P497, DOI 10.1103/PhysRevLett.67.497; MUTKA H, 1995, PHYSICA B, V213, P170, DOI 10.1016/0921-4526(95)00094-P; REGNAULT LP, 1995, PHYSICA B, V215, P71, DOI 10.1016/0921-4526(95)00027-7; RENARD JP, 1988, J APPL PHYS, V63, P3538, DOI 10.1063/1.340736; TAKAHASHI M, 1989, PHYS REV LETT, V62, P2313, DOI 10.1103/PhysRevLett.62.2313; TARVIN JA, P104 BNL; XU GQ, IN PRESS; YOKOO T, 1995, J PHYS SOC JPN, V64, P3651, DOI 10.1143/JPSJ.64.3651	26	59	59	PHYSICAL SOC JAPAN	TOKYO	YUSHIMA URBAN BUILDING 5F, 2-31-22 YUSHIMA, BUNKYO-KU, TOKYO, 113-0034, JAPAN	0031-9015			J PHYS SOC JPN	J. Phys. Soc. Jpn.	SEP	1996	65	9					3025	3031		10.1143/JPSJ.65.3025		7	Physics, Multidisciplinary	Physics	VK272	WOS:A1996VK27200048		
J	Goto, A; Yasuoka, H; Ueda, Y				Goto, A; Yasuoka, H; Ueda, Y			Carrier concentration dependence of the spin pseudo-gap behaviors in YBa2Cu3Oy	JOURNAL OF THE PHYSICAL SOCIETY OF JAPAN			English	Article						YBa2Cu3Oy; spin gap; NMR	CU; RELAXATION; DYNAMICS; NMR; OXIDES; TC	Oxygen content (y) dependence of the NMR relaxation rates (1/T-1, 1/T-2G) of the Cu(2) site of YBa2Cu3Oy has been studied to investigate magnetic and spin pseudo-gap phase diagrams of this system. The characteristic spin gap temperature (T-sg) defined by the peak position of (1/T1T) has a plateau as a function of oxygen content (y), at y similar to 6.6, so-called ''60 K'' phase where T-c also has a plateau. This plateau means that T-sg may be a monotonic function of hole concentration. On the other hand, it has been confirmed from the Curie-Weiss T-dependence of T-2G(2) well above T-sg that the ''Weiss Temperature (theta)'' for chi(Q) changes its sign from negative to positive at y similar to 6.85. This means that, unless the spin gap and the superconductivity occurred, the real ground state would change from the weak antiferromagnetic metallic state to the nearly antiferromagnetic One at y similar to 6.85, which is far from the real critical point, y = 6.42.	UNIV TOKYO, INST SOLID STATE PHYS, MINATO KU, TOKYO 106, JAPAN							Altshuler BL, 1996, PHYS REV B, V53, P415, DOI 10.1103/PhysRevB.53.415; WARREN WW, 1989, PHYS REV LETT, V62, P1193, DOI 10.1103/PhysRevLett.62.1193; MILLIS AJ, 1993, PHYS REV LETT, V71, P210, DOI 10.1103/PhysRevLett.71.210; GOTO A, UNPUB; IMAI T, 1989, PHYSICA C, V162, P169, DOI 10.1016/0921-4534(89)90971-4; ITO T, 1993, PHYS REV LETT, V70, P3995, DOI 10.1103/PhysRevLett.70.3995; ITOH Y, 1992, J PHYS SOC JPN, V61, P1287, DOI 10.1143/JPSJ.61.1287; ITOH Y, 1994, J PHYS SOC JPN, V63, P3522, DOI 10.1143/JPSJ.63.3522; ITOH Y, 1995, J PHYS SOC JPN, V64, P684, DOI 10.1143/JPSJ.64.684; ITOH Y, 1995, J PHYS SOC JPN, V64, P3072, DOI 10.1143/JPSJ.64.3072; ITOH Y, 1995, IN PRESS PHYSICA C; ITOH Y, 1994, THESIS U TOKYO; KISHINE J, 1996, UNPUB J PHYS SOC JPN; MATSUMURA M, 1995, J PHYS SOC JPN, V64, P721, DOI 10.1143/JPSJ.64.721; MILLIS AJ, 1993, PHYS REV LETT, V70, P2810, DOI 10.1103/PhysRevLett.70.2810; REYES AP, 1991, PHYS REV B, V43, P2989, DOI 10.1103/PhysRevB.43.2989; Shimizu T., 1990, B MAG RES, V12, P39; TAKIGAWA M, 1992, J PHYS CHEM SOLIDS, V53, P1651, DOI 10.1016/0022-3697(92)90156-8; TAKIGAWA M, 1991, PHYS REV B, V43, P247, DOI 10.1103/PhysRevB.43.247; UBBENS MU, 1994, PHYS REV B, V50, P438, DOI 10.1103/PhysRevB.50.438; YASUOKA H, 1989, HYPERFINE INTERACT, V49, P167, DOI 10.1007/BF02405140; YASUOKA H, 1989, STRONG CORRELATION S	22	22	22	PHYSICAL SOC JAPAN	TOKYO	YUSHIMA URBAN BUILDING 5F, 2-31-22 YUSHIMA, BUNKYO-KU, TOKYO, 113-0034, JAPAN	0031-9015			J PHYS SOC JPN	J. Phys. Soc. Jpn.	SEP	1996	65	9					3043	3048		10.1143/JPSJ.65.3043		6	Physics, Multidisciplinary	Physics	VK272	WOS:A1996VK27200050		
J	Yamanaka, M; Nagaosa, N				Yamanaka, M; Nagaosa, N			Conductance through a magnetic domain wall in double exchange system	JOURNAL OF THE PHYSICAL SOCIETY OF JAPAN			English	Article						double exchange system; doped Mott insulator; La1-xSrxMnO3	MAGNETORESISTANCE; FILMS			Yamanaka, M (reprint author), UNIV TOKYO, DEPT APPL PHYS, BUNKYO KU, 7-3-1 HONGO, TOKYO 113, JAPAN.		Nagaosa, Naoto/G-7057-2012				VONHELMOLT R, 1993, PHYS REV LETT, V71, P2331, DOI 10.1103/PhysRevLett.71.2331; JIN S, 1994, SCIENCE, V264, P413, DOI 10.1126/science.264.5157.413; CHAHARA K, 1993, APPL PHYS LETT, V63, P1990, DOI 10.1063/1.110624; URUSHIBARA A, 1995, PHYS REV B, V51, P14103, DOI 10.1103/PhysRevB.51.14103; ANDERSON PW, 1955, PHYS REV, V100, P675, DOI 10.1103/PhysRev.100.675; TOKURA Y, 1994, J PHYS SOC JPN, V63, P3931, DOI 10.1143/JPSJ.63.3931; BASKARAN G, 1988, PHYS REV B, V37, P580, DOI 10.1103/PhysRevB.37.580; CHAHARA K, 1993, APPL PHYS LETT, V62, P780, DOI 10.1063/1.108577	8	22	22	PHYSICAL SOC JAPAN	TOKYO	YUSHIMA URBAN BUILDING 5F, 2-31-22 YUSHIMA, BUNKYO-KU, TOKYO, 113-0034, JAPAN	0031-9015			J PHYS SOC JPN	J. Phys. Soc. Jpn.	SEP	1996	65	9					3088	3089		10.1143/JPSJ.65.3088		2	Physics, Multidisciplinary	Physics	VK272	WOS:A1996VK27200060		
J	Yasuda, K; Yamanishi, T; Kawabe, K; Ohshima, H; Morita, T				Yasuda, K; Yamanishi, T; Kawabe, K; Ohshima, H; Morita, T			The effect of urapidil on neurogenic bladder: A placebo controlled double-blind study	JOURNAL OF UROLOGY			English	Article						urodynamics; bladder, neurogenic; adrenergic alpha receptor blockaders	BENIGN PROSTATIC HYPERTROPHY; LOWER URINARY-TRACT; BLOCKING-AGENT; PRAZOSIN; DYSFUNCTION; BLOCKERS	Purpose: We assessed the efficacy and safety of urapidil, a new cu-blocker, for the treatment of neurogenic bladder dysfunction in a prospective double-blind trial. Materials and Methods: A total of 136 patients was randomly assigned to receive placebo (group 1), or treatment with 30 mg. of urapidil for 4 weeks (group 2) or 30 mg. for 2 weeks followed by 60 mg. for 2 weeks (group 3). Results: Urinary frequencies decreased significantly only in group 3. The sum of obstructive symptom scores decreased significantly in all groups. However, a significant difference in subjective symptoms was not noted among the groups. Average and maximum flow rates, and residual urine improved significantly in groups 2 and 3 but not in group 1. Regarding cystometric parameters, no significant changes were noted in any group. In the pressure-flow study, the pressure at maximum flow rate and minimum urethral resistance (pressure at maximum flow rate divided by the square of maximum flow rate) decreased significantly only in group 3. In the urodynamic assessment, significant improvement was noted in groups 3 versus 1. There were no significant differences between the sexes or among underlying diseases with regard to symptomatic and urodynamic improvements. Side effects were noted in 2 patients in group 3 and 1 in group 2, none of which was severe. Conclusions: Urapidil improved voiding dysfunction in patients with a neurogenic bladder and decreased urethral resistance in a dose related fashion.	UNIV TOKYO,SCH MED,TOKYO 113,JAPAN; TOKYO MED & DENT UNIV,SCH MED,TOKYO 113,JAPAN	Yasuda, K (reprint author), CHIBA UNIV,SCH MED,DEPT UROL,1-8-1 INOHANA,CHIBA 260,JAPAN.						Abrams P, 1988, Scand J Urol Nephrol Suppl, V114, P5; ANDERSSON KE, 1981, INVEST UROL, V19, P39; KIRBY RS, 1987, BRIT J UROL, V60, P136, DOI 10.1111/j.1464-410X.1987.tb04950.x; ORIORDAN JI, 1995, J UROLOGY, V153, P1114, DOI 10.1016/S0022-5347(01)67524-4; BLAIVAS JG, 1981, J UROLOGY, V125, P545; CAINE M, 1986, J UROLOGY, V136, P1; CRAMER P, 1989, PARAPLEGIA, V27, P119; DONKER PJ, 1972, BRIT J UROL, V44, P150; EDVARDSE.P, 1968, ACTA PHARMACOL TOX, V26, P437; JENSEN D, 1981, SCAND J UROL NEPHROL, V15, P229; KANEKO Y, 1988, DRUGS, V35, P156; KAWABE K, 1993, UROL INT, V50, P27; KOYANAGI T, 1990, Acta Urologica Japonica, V36, P1233; KRANE RJ, 1973, J UROLOGY, V110, P653; LENAGHAN D, 1970, J UROLOGY, V103, P320; NORDLING J, 1986, CLIN SCI           S, V14, pS51; RAZ S, 1973, British Journal of Urology, V45, P663, DOI 10.1111/j.1464-410X.1973.tb12237.x; SUNDIN T, 1977, INVEST UROL, V14, P322; SUSSET JG, 1966, J UROLOGY, V96, P746; WHITFIELD HN, 1976, BRIT J UROL, V47, P823; YAMANISHI T, 1994, PARAPLEGIA, V32, P271; YAMANISHI T, 1991, NISHINIHON J UROL, V53, P283	22	19	19	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	0022-5347			J UROLOGY	J. Urol.	SEP	1996	156	3					1125	1130		10.1016/S0022-5347(01)65723-9		6	Urology & Nephrology	Urology & Nephrology	VB453	WOS:A1996VB45300081		
J	Nishikawa, H; Shimada, T; Koma, A				Nishikawa, H; Shimada, T; Koma, A			Epitaxial growth of TiSe2 thin films on Se-terminated GaAs(111)B	JOURNAL OF VACUUM SCIENCE & TECHNOLOGY A-VACUUM SURFACES AND FILMS			English	Article							TRANSITION-METAL DICHALCOGENIDES; VANDERWAALS EPITAXY; HETEROEPITAXIAL GROWTH	Epitaxial growth of TiSe2 films on Se-terminated GaAs(111)B substrates were carried out at different growth temperature by molecular beam epitaxy. Grown films have been investigated by reflection high energy electron diffraction, Auger electron spectroscopy, and measurements of resistivity parallel to the surface. TiSe2 epitaxial films have been obtained at various temperatures, but the optimum growth temperature was determined to be 400 degrees C. A charge density wave transition has been observed in the resistivity of the film grown at 400 degrees C, indicating that it has a good quality comparable to a bulk single crystal. (C) 1996 American Vacuum Society.		Nishikawa, H (reprint author), UNIV TOKYO,FAC SCI,DEPT CHEM,BUNKYO KU,TOKYO 113,JAPAN.		敏宏, 島田/F-2068-2013	敏宏, 島田/0000-0001-5122-1063			OHUCHI FS, 1990, J APPL PHYS, V68, P2168, DOI 10.1063/1.346574; DISALVO FJ, 1976, PHYS REV B, V14, P4321, DOI 10.1103/PhysRevB.14.4321; KOMA A, 1985, J VAC SCI TECHNOL B, V3, P724, DOI 10.1116/1.583125; KOMA A, 1992, THIN SOLID FILMS, V216, P72, DOI 10.1016/0040-6090(92)90872-9; YAMAMOTO H, 1994, J VAC SCI TECHNOL A, V12, P125, DOI 10.1116/1.578906; GREENAWA.DL, 1965, J PHYS CHEM SOLIDS, V26, P1445, DOI 10.1016/0022-3697(65)90043-0; KOMA A, 1985, 17TH P INT C PHYS SE, P1465; KOMA A, 1986, SURF SCI, V174, P556, DOI 10.1016/0039-6028(86)90471-1; SAKURAI M, 1991, JPN J APPL PHYS 2, V30, pL1892; TAGUCHI I, 1981, PHYSICA B & C, V105, P146, DOI 10.1016/0378-4363(81)90234-5; UENO K, 1990, J VAC SCI TECHNOL A, V8, P68, DOI 10.1116/1.576983; UENO K, 1990, APPL PHYS LETT, V56, P327, DOI 10.1063/1.102817	12	2	2	AMER INST PHYSICS	WOODBURY	CIRCULATION FULFILLMENT DIV, 500 SUNNYSIDE BLVD, WOODBURY, NY 11797-2999	0734-2101			J VAC SCI TECHNOL A	J. Vac. Sci. Technol. A-Vac. Surf. Films	SEP-OCT	1996	14	5					2893	2896		10.1116/1.580240		4	Materials Science, Coatings & Films; Physics, Applied	Materials Science; Physics	VJ242	WOS:A1996VJ24200028		
J	Otsuka, H; Xuan, XN; Shibata, I; Mori, M				Otsuka, H; Xuan, XN; Shibata, I; Mori, M			Protective immunity of bovine herpesvirus-1 (BHV-1) recombinants which express pseudorabies virus (PRV) glycoproteins gB, gC, gD and gE	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						BHV-1; glycoprotein; PRV; recombinant; vaccine	AUJESZKYS DISEASE VIRUS; RHINOTRACHEITIS VIRUS; EXPERIMENTAL-INFECTION; THYMIDINE KINASE; VACCINIA VIRUS; PIGS; SWINE; EPITOPES; STRAIN; GENES	We have constructed recombinants of bovine herpesvirus-1 (BHV-1) which express pseudorabies virus (PRV) gB, gC, gD or gE either individually or in combination. To test the protective immunity, mice were inoculated with these BHV-1 recombinants and challenged three weeks later with virulent PRV. A BHV-1 recombinant, BHV-1/TF7-1, which express PRV gC, gD, gE and gI but not PRV gB, protected all 7 mice from the challenge with 20 LD(50) virulent PRV and 6 cut of 7 from the challenge with 100 LD(50) PRV, while one dead mice survived for 5 days after the challenge. All the control mice died in 3 days. BHV-1 recombinants which express PRV gB, gC and gD individually also gave some protection but not so effective as BHV/TF7-1. Before challenging with virulent PRV, sera were collected from immunized mice and antibody against PRV was assayed. Western blot analyses indicated that all the recombinants induced antibody in mice against PRV gB,gC or go individually or in combination. Virus neutralizing (VN) titer against PRV was highest in mice which were inoculated with BHV-1/ITF6-1, which expresses PRV gB. BHV-1/TF7-1, which was more effective to protect mice from the challenge of virulent PRV, induced lower VN titer.	ZENNOH INST ANIM HLTH,SAKURA,CHIBA 285,JAPAN	Otsuka, H (reprint author), UNIV TOKYO,GRAD SCH AGR SCI,DEPT ANIM RESOURCE SCI,TOKYO 113,JAPAN.						ANDREWS JJ, 1986, P ANN M AM ASS VET L, P513; HENDERSON JP, 1995, VET REC, V136, P555; QUINT W, 1987, J GEN VIROL, V68, P523, DOI 10.1099/0022-1317-68-2-523; VANNIER P, 1985, AM J VET RES, V46, P1498; SPEAR PG, 1972, J VIROL, V9, P143; VANOIRSCHOT JT, 1987, RES VET SCI, V42, P12; Baskerville A., 1973, Veterinary Bulletin, V43, P465; DERBYSHIRE JB, 1976, CAN J COMP MED, V40, P252; DONALDSON AI, 1985, VET REC, V115, P121; ELOIT M, 1992, ARCH VIROL, V123, P135, DOI 10.1007/BF01317144; FLORES EF, 1993, J VET DIAGN INVEST, V5, P534; FUCHS W, 1990, J GEN VIROL, V71, P1141, DOI 10.1099/0022-1317-71-5-1141; Gibbs E. P. J., 1977, Veterinary Bulletin, V47, P317; KIT M, 1991, VACCINE, V9, P564, DOI 10.1016/0264-410X(91)90243-Y; KIT M, 1992, Patent No. 1299; KIT M, 1991, Patent No. 4992051; KIT S, 1994, ACTA VET HUNG, V42, P319; KIT S, 1987, AM J VET RES, V48, P780; KIT S, 1992, ARCH VIROL, V124, P1, DOI 10.1007/BF01314621; KIT S, 1991, ARCH VIROL, V120, P1, DOI 10.1007/BF01310945; LUPTON HW, 1980, CORNELL VET, V70, P77; MARCHIOLI CC, 1987, J VIROL, V61, P3977; MARCHIOLI CC, 1987, AM J VET RES, V48, P1577; MCFERRAN JB, 1979, COMP IMMUNOL MICROB, V2, P327, DOI 10.1016/0147-9571(79)90020-1; MENGELING WL, 1989, AM J VET RES, V50, P1658; MOHANTY SB, 1972, J AM VET MED ASSOC, V160, P879; MULLANEY TP, 1986, P ANN M AM ASS VET L, P497; NELSON DR, 1972, AM J VET RES, V33, P1209; Otsuka H, 1996, ARCH VIROL, V141, P57, DOI 10.1007/BF01718588; PORTER DD, 1975, J CLIN MICROBIOL, V1, P112; RIVIERE M, 1992, J VIROL, V66, P3424; SABO A, 1969, ACTA VIROL, V13, P269; VANOIRSCHOT JT, 1991, AM J VET RES, V52, P1788; VISSER N, 1989, VACCINATION CONTROL, V49, P37; WITMANN G, 1989, DEV VET VIROL NORWEL, V9, P163; ZUFFA A, 1986, J VET MED B, V33, P425	36	3	5	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO 103, JAPAN	0916-7250			J VET MED SCI	J. Vet. Med. Sci.	SEP	1996	58	9					819	824				6	Veterinary Sciences	Veterinary Sciences	VK825	WOS:A1996VK82500001		
J	Nakaichi, M; Takeuchi, A; Sasaki, N; Shitara, N; Takakura, K				Nakaichi, M; Takeuchi, A; Sasaki, N; Shitara, N; Takakura, K			Antitumor activity of natural-type human tumor necrosis factor on experimental brain tumors in rats	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						antitumor activity; brain tumor; inflammatory cytokine; rat; tumor necrosis factor	ADHESION MOLECULE-1 ICAM-1; CENTRAL-NERVOUS-SYSTEM; ENDOTHELIAL-CELLS; CYTO-TOXICITY; FACTOR-ALPHA; PHASE-I; ACTIVATION; PERMEABILITY; NEUTROPHILS; EXPRESSION	The effects of intralesional injection of newly synthesized natural-type human tumor necrosis factor (nh-TNF) on experimental brain tumors in rats were investigated. The repeated injection of 5,000 U of nh-TNF into the tumor resulted in the prolongation of the survival time of the rats. More than half of the nh-TNF treated tumors were red, and were characterized by histopathological features of marked congestion of tumor vessels. Fibrin formations were also found in the tumor vessels. These histological findings were not observed in the control tumors. Furthermore, coagulative necrosis was observed in the center of some reddish tumors. Leukocytes adhering to vascular endothelium and infiltration of the leukocytes were also observed in the tumors of nh-TNF treated rats. In the immunohistochemical examination, these infiltrated cells were primarily polymorphonuclear leukocytes and macrophages. Expression of intercellular adhesion molecule-1 (ICAM-1) increased on the tumor endothelial cells after the administration of nh-TNF. These results suggest that repeated injection of nh-TNF has a therapeutic effect on brain tumors through its extensive influences on tumor vasculature.	UNIV TOKYO, DEPT VET SURG, TOKYO 113, JAPAN; TOKYO METROPOLITAN KOMAGOME HOSP, DEPT VET SURG, TOKYO 113, JAPAN; TOKYO WOMENS MED COLL, DEPT VET SURG, TOKYO 162, JAPAN	Nakaichi, M (reprint author), YAMAGUCHI UNIV, VET HOSP, DEPT VET SURG, YAMAGUCHI 753, JAPAN.						ASHER A, 1987, J IMMUNOL, V138, P963; SHALABY MR, 1985, J IMMUNOL, V135, P2069; NAWROTH P, 1988, J EXP MED, V168, P637, DOI 10.1084/jem.168.2.637; BENDA P, 1968, SCIENCE, V161, P370, DOI 10.1126/science.161.3839.370; POBER JS, 1988, AM J PATHOL, V133, P426; SOBEL RA, 1990, AM J PATHOL, V136, P1309; BENDA P, 1971, J NEUROSURG, V34, P310, DOI 10.3171/jns.1971.34.3.0310; BLICK M, 1987, CANCER RES, V47, P2986; CARSWELL EA, 1975, P NATL ACAD SCI USA, V72, P3666, DOI 10.1073/pnas.72.9.3666; COTRAN RS, 1987, AM J PATHOL, V129, P407; FABRY Z, 1992, J NEUROIMMUNOL, V36, P1, DOI 10.1016/0165-5728(92)90026-H; HARLAN JM, 1985, BLOOD, V65, P513; HUGES CCW, 1988, IMMUNOLOGY, V64, P677; KANAMORI T, 1988, Journal of Kyoto Prefectural University of Medicine, V97, P781; KAWAI T, 1987, VIRCHOWS ARCH B, V52, P489; MANTOVANI A, 1989, IMMUNOL TODAY, V10, P370, DOI 10.1016/0167-5699(89)90270-3; MING WJ, 1987, J IMMUNOL, V138, P1469; MULLIN JM, 1990, CANCER RES, V50, P2172; NOBUHARA M, 1988, Journal of Kyoto Prefectural University of Medicine, V97, P765; PFREUNDSCHUH MG, 1989, EUR J CANCER CLIN ON, V25, P379, DOI 10.1016/0277-5379(89)90034-5; RUTKA JT, 1988, INT J CANCER, V41, P573, DOI 10.1002/ijc.2910410417; SAMPLE AK, 1991, J LEUKOCYTE BIOL, V49, P107; SATO N, 1986, J NATL CANCER I, V76, P1113; SHALABY MR, 1987, J LEUKOCYTE BIOL, V41, P196; STEWART PA, 1985, ACTA NEUROPATHOL, V67, P96; TONNESEN MG, 1989, J INVEST DERMATOL, V93, P53; VANDEWIEL PA, 1989, J PATHOL, V157, P65, DOI 10.1002/path.1711570109; WILCOX CE, 1990, J NEUROIMMUNOL, V30, P43, DOI 10.1016/0165-5728(90)90051-N	28	4	4	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO 103, JAPAN	0916-7250			J VET MED SCI	J. Vet. Med. Sci.	SEP	1996	58	9					885	891				7	Veterinary Sciences	Veterinary Sciences	VK825	WOS:A1996VK82500012		
J	Inoshima, Y; Ikeda, Y; Kohmoto, M; Pecoraro, MR; Shimojima, M; Shimojima, Y; Inada, G; Kawaguchi, Y; Tomonaga, K; Miyazawa, T; Mikami, T				Inoshima, Y; Ikeda, Y; Kohmoto, M; Pecoraro, MR; Shimojima, M; Shimojima, Y; Inada, G; Kawaguchi, Y; Tomonaga, K; Miyazawa, T; Mikami, T			Persistence of high virus neutralizing antibody titers in cats experimentally infected with feline immunodeficiency virus	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						antibody; FIV; neutralization test	EXPERIMENTAL VACCINE PROTECTION; STRAINS; CELLS; FIV; IDENTIFICATION; QUANTIFICATION; ASSAY; JAPAN	The development of virus neutralizing (VN) antibody is one of the most effective host defense mechanisms against virus infection. In the present study, we developed a new VN assay against feline immunodeficiency virus (FIV) using a feline T-lymphoblastoid cell line, MYA-1 cells, based on inhibition of viral reverse transcriptase production. This assay is applicable to strains of FIV which can not infect CRFK cells. By using the assay, we examined long-term responses of VN antibody in cats experimentally infected with FIV. VN antibody titers increased progressively during first 30 weeks post inoculation and remained at high titers thereafter for 7 years of observation periods.	UNIV TOKYO,FAC AGR,DEPT VET MICROBIOL,BUNKYO KU,TOKYO 113,JAPAN							OKADA S, 1994, AIDS RES HUM RETROV, V10, P1739, DOI 10.1089/aid.1994.10.1739; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; ARENDRUP M, 1992, SCAND J INFECT DIS, V24, P21, DOI 10.3109/00365549209048396; BALDINOTTI F, 1994, J VIROL, V68, P4572; DERONDE A, 1994, VIROLOGY, V198, P257, DOI 10.1006/viro.1994.1028; FEVEREIRO M, 1991, J GEN VIROL, V72, P617, DOI 10.1099/0022-1317-72-3-617; HOHDATSU T, 1993, J VIROL, V67, P2344; INOSHIMA Y, 1995, J VET MED SCI, V57, P487; KAWAGUCHI Y, 1992, ARCH VIROL, V125, P347, DOI 10.1007/BF01309653; KAWAGUCHI Y, 1990, ARCH VIROL, V111, P269, DOI 10.1007/BF01311061; KIYOMASU T, 1991, J VIROL, V65, P4539; MAKI N, 1992, ARCH VIROL, V123, P29, DOI 10.1007/BF01317136; MAKOSCHEY B, 1994, J VIROL METHODS, V50, P257, DOI 10.1016/0166-0934(94)90182-1; Matteucci D, 1996, J VIROL, V70, P617; MIYAZAWA T, 1989, ARCH VIROL, V108, P59, DOI 10.1007/BF01313743; MIYAZAWA T, 1989, ARCH VIROL, V108, P131, DOI 10.1007/BF01313750; OSBORNE R, 1994, J GEN VIROL, V75, P3641, DOI 10.1099/0022-1317-75-12-3641; ROBERTGUROFF M, 1987, PEDIATR RES, V21, P547, DOI 10.1203/00006450-198706000-00008; ROBERTSON GA, 1988, J VIROL METHODS, V20, P195, DOI 10.1016/0166-0934(88)90123-1; SIEBELINK KHJ, 1993, J VIROL, V67, P2202; SOAORA DL, 1994, J VIROL, V68, P2230; TOZZINI F, 1992, J VIROL METHODS, V37, P241, DOI 10.1016/0166-0934(92)90026-A; TOZZINI F, 1993, J CLIN MICROBIOL, V31, P1626; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; YAMADA H, 1995, ARCH VIROL, V140, P41, DOI 10.1007/BF01309722; YAMAMOTO JK, 1993, J VIROL, V67, P601; YAMAMOTO JK, 1991, AIDS RES HUM RETROV, V7, P911, DOI 10.1089/aid.1991.7.911	28	8	8	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO 103, JAPAN	0916-7250			J VET MED SCI	J. Vet. Med. Sci.	SEP	1996	58	9					925	927				3	Veterinary Sciences	Veterinary Sciences	VK825	WOS:A1996VK82500020		
J	Shiraishi, JI; Kubo, H; Awata, H; Odake, S				Shiraishi, JI; Kubo, H; Awata, H; Odake, S			A quantum deformation of the Virasoro algebra and the Macdonald symmetric functions	LETTERS IN MATHEMATICAL PHYSICS			English	Article						quantum deformation; Virasoro algebra; bosonic realization; Macdonald symmetric functions	MATRIX MODELS; FIELD-THEORY; LIMIT	A quantum deformation of the Virasoro algebra is defined. The Kac determinants at arbitrary levels are conjectured. We construct a bosonic realization of the quantum deformed Virasoro algebra. Singular vectors are expressed by the Macdonald symmetric functions. This is proved by constructing screening currents acting on the bosonic Fock space.	UNIV TOKYO,FAC SCI,DEPT PHYS,TOKYO 113,JAPAN; KYOTO UNIV,UJI RES CTR,YUKAWA INST THEORET PHYS,UJI 611,JAPAN; SHINSHU UNIV,FAC SCI,DEPT PHYS,MATSUMOTO,NAGANO 390,JAPAN	Shiraishi, JI (reprint author), UNIV TOKYO,INST SOLID STATE PHYS,TOKYO 106,JAPAN.						ANDRIC I, 1983, NUCL PHYS B, V215, P307, DOI 10.1016/0550-3213(83)90218-3; FELDER G, 1989, NUCL PHYS B, V317, P215, DOI 10.1016/0550-3213(89)90568-3; JIMBO M, 1985, LETT MATH PHYS, V10, P63, DOI 10.1007/BF00704588; AWATA H, 1995, PHYS LETT B, V347, P49, DOI 10.1016/0370-2693(95)00055-P; BELAVIN AA, 1984, NUCL PHYS B, V241, P333, DOI 10.1016/0550-3213(84)90052-X; STANLEY RP, 1989, ADV MATH, V77, P76, DOI 10.1016/0001-8708(89)90015-7; JEVICKI A, 1980, NUCL PHYS B, V165, P511, DOI 10.1016/0550-3213(80)90046-2; MACDONALD IG, 1987, LECT NOTES MATH, V1271, P189; AWATA H, QALG9506006; AWATA H, IN PRESS NUCLEAR P B; AWATA H, 1994, COMMUN MATH PHYS, V162, P61, DOI 10.1007/BF02105187; AWATA H, UNPUB; AWATA H, 1994, LETT MATH PHYS, V30, P207; BAZHANOV V, 1992, PHYS LETT A, V171, P243; CALOGERO F, 1969, J MATH PHYS, V10, P2197, DOI 10.1063/1.1664821; DRINFELD VG, 86 ICM; FADDEEV LD, 1985, LECT NOTES MATH, V1060; Feigin B., 1982, FUNCTIONAL ANAL PRIL, V16, P47, DOI 10.1007/BF01081626; FELDER G, 1989, NUCL PHYS B, V324, P548; FRENKEL E, 1995, QALG9505025; GASPER G, 1990, ENCY MATH ITS APPL; KUNIBA A, HEPTH9406180; Macdonald I. G., 1979, SYMMETRIC FUNCTIONS; MIMACHI K, 1994, SINGULAR VECTORS VIR; SUTHERLA.B, 1971, J MATH PHYS, V12, P251, DOI 10.1063/1.1665585; SUTHERLA.B, 1971, J MATH PHYS, V12, P246, DOI 10.1063/1.1665584	26	78	78	KLUWER ACADEMIC PUBL	DORDRECHT	SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS	0377-9017			LETT MATH PHYS	Lett. Math. Phys.	SEP	1996	38	1					33	51		10.1007/BF00398297		19	Physics, Mathematical	Physics	VB282	WOS:A1996VB28200004		
J	Shiota, M; Mori, S				Shiota, M; Mori, S			The clinicopathological features of anaplastic large cell lymphomas expressing p80(NPM/ALK)	LEUKEMIA & LYMPHOMA			English	Review						anaplastic large cell lymphomas; p80(NPM/ALK)	NON-HODGKINS-LYMPHOMA; KI-1 LYMPHOMA; MALIGNANT HISTIOCYTOSIS; CLINICAL-FEATURES; TRANSLOCATION; PROTEIN; T(2-5)(P23-Q35); CLASSIFICATION; BREAKPOINT; LINE	The classification of malignant lymphoma has been based on morphological and immunophenotypical findings for a long time. Recently, as chromosomal and genomic abnormalities which closely relate to the specific subtypes of lymphoma are revealed, these factors becoming much more important in the evaluation of differences in clinicopathological features of the various lymphoma subtypes. Anaplastic large cell lymphoma (ALCL) is a subtype of non-Hodgkin's lymphoma (NHL) involving large CD30+ neoplastic cells, which occasionally carries the chromosomal translocation t(2;5)(p23;q35). We have recently found a novel hyperphosphorylated 80-kDa protein tyrosine kinase, p80 which is expressed specifically in human ALCLs with this translocation. Subsequent cDNA cloning showed p80 to be a fusion protein of two genes, the novel tyrosine kinase gene and the nucleophosmin gene, in accordance with the sequence of the NPM/ALK gene. In order to clarify the clinicopathologic features of p80-carrying ALCLs, we developed an anti-p80 polyclonal antibody, which immunoprecipitated, immunoblotted and immunostained p80 specifically. When paraffin sections of 105 cases of ALCL were stained using the anti-p80 antibody, 30 were shown to be p80 positive Clinicopathological comparison between p80-positive and p80-negative ALCLs revealed that the p80-positive cases occurred in a much younger patient age group and that the patients showed a far better 5-year survival rate. These data suggest that p80-positive ALCL is a distinct entity and should be differentiated from p80-negative ALCL.		Shiota, M (reprint author), UNIV TOKYO,INST MED SCI,DEPT PATHOL,MINATO KU,4-6-1 SHIROKANEDAI,TOKYO 108,JAPAN.						KADIN ME, 1986, BLOOD, V68, P1042; MORRIS SW, 1994, SCIENCE, V263, P1281, DOI 10.1126/science.8122112; [Anonymous], 1982, CANCER, V49, P2112; FISCHER P, 1988, BLOOD, V72, P234; BITTER MA, 1990, AM J SURG PATHOL, V14, P305, DOI 10.1097/00000478-199004000-00001; HARRIS NL, 1994, BLOOD, V84, P1361; SHIOTA M, 1994, ONCOGENE, V9, P1567; AGNARSSON BA, 1988, AM J SURG PATHOL, V12, P264, DOI 10.1097/00000478-198804000-00002; BENZLEMOINE E, 1988, BLOOD, V72, P1045; EBRAHIM SAD, 1990, GENE CHROMOSOME CANC, V2, P27, DOI 10.1002/gcc.2870020106; GERARDMA.R, 1974, LANCET, V2, P406; GREER JP, 1991, J CLIN ONCOL, V9, P539; KANEKO Y, 1989, BLOOD, V73, P806; KRISTOFFERSSON U, 1985, HEREDITAS, V103, P77, DOI 10.1111/j.1601-5223.1985.tb00485.x; LUKES RJ, 1974, CANCER, V34, P1488, DOI 10.1002/1097-0142(197410)34:8+<1488::AID-CNCR2820340822>3.0.CO;2-C; MASON DY, 1990, BRIT J HAEMATOL, V161, P74; MORGAN R, 1986, NEW ENGL J MED, V314, P1322; NAKAMURA S, 1991, CANCER, V68, P118, DOI 10.1002/1097-0142(19910701)68:1<118::AID-CNCR2820680123>3.0.CO;2-R; OFFIT K, 1990, LEUKEMIA, V4, P625; RIMOKH R, 1989, BRIT J HAEMATOL, V71, P31, DOI 10.1111/j.1365-2141.1989.tb06270.x; SHIOTA M, 1995, IN PRESS BLOOD, V86; SHIOTA M, 1994, BLOOD, V84, P3648; STANSFELD AG, 1988, LANCET, V1, P292; VANNIER JP, 1987, PEDIATR HEMAT ONCOL, V4, P177, DOI 10.3109/08880018709141268; YAMORI T, 1991, CANCER RES, V51, P5859	25	23	24	HARWOOD ACAD PUBL GMBH	READING	C/O STBS LTD, PO BOX 90, READING, BERKS, ENGLAND RG1 8JL	1042-8194			LEUKEMIA LYMPHOMA	Leuk. Lymphoma	SEP	1996	23	1-2					25	&		10.3109/10428199609054798		11	Oncology; Hematology	Oncology; Hematology	VL108	WOS:A1996VL10800004		
J	Takahashi, H; Horie, K; Yamashita, T; Machida, S; Hannah, DTB; Sherrington, DC				Takahashi, H; Horie, K; Yamashita, T; Machida, S; Hannah, DTB; Sherrington, DC			Fluorescence study of the microstructure of a lyotropic liquid-crystalline polyester substituted with sulfonato and nitro groups	MACROMOLECULAR CHEMISTRY AND PHYSICS			English	Article							POLY(1,4-BENZAMIDE); SPECTRA	The fluorescence behaviour of a lyotropic liquid-crystalline polyester substituted with sulfonato and nitro groups, poly[potassium oxy(x-sulfonato-1,4-phenylene)oxy(x-nitroterephthaloyl)] (1), was studied in various phases by changing the polymer concentration. This liquid-crystalline polymer is soluble in several organic solvents and water. The observed fluorescence is originated from complexes between the potassium sulfonate-substituted aromatic moiety and the nitro-substituted aromatic moiety, and also from the dimer of the potassium sulfonate-substituted moiety. From the results of fluorescence intensity changes with concentration, the change of phase in this lyotropic liquid-crystalline system is suggested to occur gradually. By comparing the fluorescence behaviour in various phases with those of model compounds, the microstructure of the liquid-crystalline state can be evaluated to some extent.	UNIV STRATHCLYDE,DEPT PURE & APPL CHEM,GLASGOW G1 1XL,LANARK,SCOTLAND	Takahashi, H (reprint author), UNIV TOKYO,GRAD SCH ENGN,DEPT CHEM & BIOTECHNOL,BUNKYO KU,TOKYO 113,JAPAN.						LIN J, 1992, MACROMOLECULES, V25, P7107, DOI 10.1021/ma00052a006; HASEGAWA M, 1989, EUR POLYM J, V25, P349, DOI 10.1016/0014-3057(89)90148-1; BAIR TI, 1977, MACROMOLECULES, V10, P1396, DOI 10.1021/ma60060a042; HASHIMOTO H, 1993, J POLYM SCI POL PHYS, V31, P1187, DOI 10.1002/polb.1993.090310913; HUANG HW, 1995, J POLYM SCI POL PHYS, V33, P1673, DOI 10.1002/polb.1995.090331113; KWOLEK SL, 1977, MACROMOLECULES, V10, P1390, DOI 10.1021/ma60060a041; MORGAN PW, 1977, MACROMOLECULES, V10, P1381, DOI 10.1021/ma60060a040; PANAR M, 1977, MACROMOLECULES, V10, P1401, DOI 10.1021/ma60060a043; SONE M, 1993, POLYM J, V25, P997, DOI 10.1295/polymj.25.997; TAAHASHI H, UNPUB LIQ CRYST; YAMASHITA T, 1993, POLYM DEGRAD STABIL, V39, P279, DOI 10.1016/0141-3910(93)90002-Z	11	13	13	HUTHIG & WEPF VERLAG	BASEL	AUF DEM WOLF 4 FX#001-41-61-317-94-11, CH-4052 BASEL, SWITZERLAND	1022-1352			MACROMOL CHEM PHYSIC	Macromol. Chem. Phys.	SEP	1996	197	9					2703	2712		10.1002/macp.1996.021970909		10	Polymer Science	Polymer Science	VH788	WOS:A1996VH78800010		
J	Yoshihara, H; Ohta, M				Yoshihara, H; Ohta, M			Simulation of fracturing process of wood by finite element method	MATERIALS SCIENCE RESEARCH INTERNATIONAL			English	Article						FEM program; stress-releasing; fracturing process	PREDICTION	An existing FEM program for elastic-plastic problems was modified to the one which can be accommodated to the changing of stiffness matrix and the release of stresses at fractured elements. With this program, the fracturing processes of two different mechanical tests of wood were simulated: the JIS shearing test (JIS Z2114) and the JIS bending test (JIS Z2113). The results are summarized as follows: (1) The shearing strength obtained by the calculation was 8.6MPa. This value agreed with the actual testing data. The fracture initiated and propagated along the grains. This simulated result accorded well with the real fracturing process of the shearing test. (2) The bending strength obtained by the calculation was 127MPa, which was larger than the actual value because the finite element mesh was rough and thus the scale factors for yielding had been estimated larger. The fracture initiated at the bottom of the specimen, grew to the neutral axis and turned its direction to the grain. This simulated result accorded well with the real fracturing process of the bending test.	UNIV TOKYO,DEPT FOREST PROD SCI,BUNKYO KU,TOKYO 113,JAPAN							SWIFT HW, 1952, J MECH PHYS SOLIDS, V1, P1, DOI 10.1016/0022-5096(52)90002-1; Chen W., 1982, PLASTICITY REINFORCE; CHEN WF, 1980, COMPUT STRUCT, V12, P23, DOI 10.1016/0045-7949(80)90091-7; HEARMON RFS, 1948, 7 STAT OFF FOR PROD; HILL R, 1948, PROC R SOC LON SER-A, V193, P281, DOI 10.1098/rspa.1948.0045; Hoffman O, 1967, J COMPOS MATER, V1, P200, DOI DOI 10.1177/002199836700100210; *JPN GOV EXP STA, 1975, 300 KINDS SERV TIMB; KINOSHITA N, 1983, MOKUZAI GAKKAISHI, V29, P871; Masuda M, 1986, B KYOTO U FORESTS, V58, P241; NORRIS CB, 1946, FOR PROD LAB REP, V1328, P1; Okusa K., 1977, Mokuzai Gakkaishi (Journal of the Japan Wood Research Society), V23, P217; Sugiyama S., 1974, Mokuzai Gakkaishi (Journal of the Japan Wood Research Society), V20, P250; TAKAHASHI A, 1973, COMPILATION DATA MEC; TSUJINO T, 1976, MOKUZAI GAKKAISHI, V22, P481; TSUJINO T, 1975, MOKUZAI GAKKAISHI, V21, P265; YAMADA Y, 1980, SOSEI NENDANSEI BAIF; YAMADA Y, 1979, CENT NEWS COMPUT S2, V11, P152; YOSHIHARA H, 1991, MOKUZAI GAKKAISHI, V37, P511; YOSHIHARA HA, UNPUB; ZANDBERGS JG, 1988, WOOD FIBER SCI, V20, P97	20	2	2	SOC MATERIALS SCIENCE, JAPAN	KYOTO	1-101, YOSHIDA-IZUMIDONO-CHO, SAKYO-KU, KYOTO 606, JAPAN	1341-1683			MATER SCI RES INT	Mater. Sci. Res. Int.	SEP	1996	2	3					173	180				8	Materials Science, Multidisciplinary	Materials Science	XY875	WOS:A1996XY87500007		
J	Kobayashi, O; Aizawa, T; Kihara, J				Kobayashi, O; Aizawa, T; Kihara, J			High speed, bulk mechanical alloying of Cu/Ag/Co systems	MATERIALS TRANSACTIONS JIM			English	Article						bulk mechanical alloying; repeated mechanical alloying-forging; plastic flow; process parameters; immiscible systems; solid solubility; imposed power density; atomic volume ratio		Mixing and homogenization, refining and alloying processes in the bulk mechanical alloying by the repeated MA-forging are experimentally investigated to define the standard process condition. Through experimental demonstration of the effect of each process parameter on the above fundamental processes, controllability of the related process parameters to this bulk MA is described towards productive mechanical alloying. The Ag-Cu, Cu-Co and Ag-Co systems are chosen as typical immiscible systems to discuss the intrinsic effect of constituent elements on the solid solubility in the alloying processes.	UNIV TOKYO,DEPT MET,BUNKYO KU,TOKYO 113,JAPAN							AIZAWA T, 1993, P 2 POWD MET WORLD C, P96; AIZAWA T, 1995, P PARTICULATE MAT PO, P153; AIZAWA T, 1996, IN PRESS P POWD MET; Aizawa T., 1993, J FACULTY ENG U TOKY, VXLII, P261; AIZAWA T, 1995, UNPUB MAT T JIM; AIZAWA T, 1996, UNPUB J POWDER POWDE; YAVARI AR, 1992, PHYS REV LETT, V68, P2235, DOI 10.1103/PhysRevLett.68.2235; BENJAMIN JS, 1970, METALL TRANS, V1, P2943; KOCH CC, 1983, APPL PHYS LETT, V43, P1017, DOI 10.1063/1.94213; AIZAWA T, 1995, MATER T JIM, V36, P138; GENETE C, 1993, PHYS REV B, V48, P1324; Hume-Rothery W., 1962, STRUCTURE METALS ALL; KOBAYASHI O, 1995, P 4 INT SAMPE S, P748; LEE PY, 1988, J MATER SCI, V23, P2837, DOI 10.1007/BF00547458; UENISHI K, 1991, MAT SCI ENG A-STRUCT, V134, P1334	15	22	22	JAPAN INST METALS	SENDAI	AOBA ARAMAKI, SENDAI 980, JAPAN	0916-1821			MATER T JIM	Mater. Trans. JIM	SEP	1996	37	9					1497	1504				8	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	VN511	WOS:A1996VN51100008		
J	Takamura, S				Takamura, S			Infinitesimal deformations of complex surfaces with boundary	MATHEMATISCHE ANNALEN			English	Article										Takamura, S (reprint author), UNIV TOKYO,DEPT MATH,HONGO 7-3-1,TOKYO 113,JAPAN.						HOLZAPFEL RP, 1980, MATH NACHR, V98, P211, DOI 10.1002/mana.19800980117; GRAUERT H, 1962, MATH ANN, V146, P331, DOI 10.1007/BF01441136; KAWAMATA Y, 1978, MATH ANN, V235, P247, DOI 10.1007/BF01420124; Barth W., 1987, COMPACT COMPLEX SURF; Bogomolov F., 1993, FILLABILITY CONTACT; Borel A., 1969, INTRO AUX GROUPES AR; CALABI E, 1960, ANN MATH, V71, P472, DOI 10.2307/1969939; Griffiths P., 1978, PRINCIPLES ALGEBRAIC; HAMILTON RS, 1979, J DIFFER GEOM, V14, P409; Hemperly J.C., 1972, AM J MATH, V94, P1078, DOI 10.2307/2373564; HOLZAPFEL R, 1981, NOVA LEOPOLDINA, V240, P109; HOLZAPFEL RP, 1983, ANN GLOB ANAL GEOM, V1, P21, DOI 10.1007/BF02330006; HOLZAPFEL RP, 1981, MATH NACHR, V103, P117, DOI 10.1002/mana.19811030109; KIREMIDJIAN GK, 1979, ANN MATH, V109, P87, DOI 10.2307/1971268; Kodaira K., 1971, COMPLEX MANIFOLDS; LAUFER HB, 1980, ANN SCUOLA NORMALE S, V7, P511; NARASHIMHAN R, 1992, COMPACT RIEMANN SURF; Range R.M., 1986, HOLOMORPHIC FUNCTION; TAKAMURA S, 1994, RIGIDY NONRIGIDITY C	19	1	1	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010	0025-5831			MATH ANN	Math. Ann.	SEP	1996	306	1					195	204		10.1007/BF01445247		10	Mathematics	Mathematics	VG229	WOS:A1996VG22900009		
J	Nakazato, K; Muraoka, M; Adachi, E; Hayashi, T				Nakazato, K; Muraoka, M; Adachi, E; Hayashi, T			Formation and structure of lens capsule type IV collagen gel under physiological pH and NaCl concentration.	MATRIX BIOLOGY			English	Meeting Abstract									TOKYO METROPOLITAN INST MED SCI,TOKYO 113,JAPAN; UNIV TOKYO,DEPT LIFE SCI,GRAD SCH ARTS & SCI,TOKYO,JAPAN; KITASATO UNIV,SCH MED,DEPT CELL BIOL,TOKYO,JAPAN								0	0	0	GUSTAV FISCHER VERLAG	STUTTGART	WOLLGRASWEG 49, D-70599 STUTTGART, GERMANY	0945-053X			MATRIX BIOL	Matrix Biol.	SEP	1996	15	3					156	156		10.1016/S0945-053X(96)90016-5		1	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	VJ836	WOS:A1996VJ83600016		
J	Mizuno, K; Hayashi, T				Mizuno, K; Hayashi, T			Separation of the subtypes of type V collagen molecules, [alpha 1(V)](2)alpha 2(V) and alpha 1(V)alpha 2(V)alpha 3(V), by chain composition-dependent affinity for heparin.	MATRIX BIOLOGY			English	Meeting Abstract									UNIV TOKYO,DEPT LIFE SCI,GRAD SCH ARTS & SCI,TOKYO,JAPAN								0	0	0	GUSTAV FISCHER VERLAG	STUTTGART	WOLLGRASWEG 49, D-70599 STUTTGART, GERMANY	0945-053X			MATRIX BIOL	Matrix Biol.	SEP	1996	15	3					157	157		10.1016/S0945-053X(96)90018-9		1	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	VJ836	WOS:A1996VJ83600018		
J	Sakai, K; Fujisaki, H; Adachi, E; Hattori, S; Hayashi, T				Sakai, K; Fujisaki, H; Adachi, E; Hattori, S; Hayashi, T			Specific function of the multimeric fibronectin formed in vitro as revealed by the interaction with HT-1080 cells.	MATRIX BIOLOGY			English	Meeting Abstract									NIPPI BIOMATRIX RES LAB,TOKYO,JAPAN; KITASATO UNIV,SCH MED,DEPT ANAT & CELL BIOL,SAGAMIHARA,KANAGAWA 228,JAPAN; UNIV TOKYO,DEPT LIFE SCI,GRAD SCH ARTS & SCI,TOKYO,JAPAN								0	0	0	GUSTAV FISCHER VERLAG	STUTTGART	WOLLGRASWEG 49, D-70599 STUTTGART, GERMANY	0945-053X			MATRIX BIOL	Matrix Biol.	SEP	1996	15	3					157	157		10.1016/S0945-053X(96)90017-7		1	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	VJ836	WOS:A1996VJ83600017		
J	Hirose, M; Fukai, F; Katayama, T; Sakai, K; Hayashi, T				Hirose, M; Fukai, F; Katayama, T; Sakai, K; Hayashi, T			Multimeric fibronectin showed a potent inhibition on the differentiation of ST13 into adipocyte.	MATRIX BIOLOGY			English	Meeting Abstract									UNIV TOKYO,FAC PHARMACEUT SCI,DEPT PATHOPHYSIOL,TOKYO 113,JAPAN; NIPPI RES INST MATRIX,TOKYO,JAPAN; UNIV TOKYO,DEPT LIFE SCI,GRAD SCH ARTS & SCI,TOKYO,JAPAN								0	0	0	GUSTAV FISCHER VERLAG	STUTTGART	WOLLGRASWEG 49, D-70599 STUTTGART, GERMANY	0945-053X			MATRIX BIOL	Matrix Biol.	SEP	1996	15	3					158	158		10.1016/S0945-053X(96)90019-0		1	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	VJ836	WOS:A1996VJ83600019		
J	Sasaki, T; Takahashi, S; Takeda, Y; Iwata, M; Yamato, M; Imamura, Y; Sado, Y; Hayashi, T				Sasaki, T; Takahashi, S; Takeda, Y; Iwata, M; Yamato, M; Imamura, Y; Sado, Y; Hayashi, T			Evidence for extracellular processing of type IV collagen alpha chains in human fibroblast culture.	MATRIX BIOLOGY			English	Meeting Abstract									UNIV TOKYO,DEPT LIFE SCI,GRAD SCH ARTS & SCI,TOKYO,JAPAN								0	1	1	GUSTAV FISCHER VERLAG	STUTTGART	WOLLGRASWEG 49, D-70599 STUTTGART, GERMANY	0945-053X			MATRIX BIOL	Matrix Biol.	SEP	1996	15	3					158	158		10.1016/S0945-053X(96)90020-7		1	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	VJ836	WOS:A1996VJ83600020		
J	Takahashi, S; Sasaki, T; Takeda, Y; Imamura, Y; Sado, Y; Yamoto, M; Hayashi, T				Takahashi, S; Sasaki, T; Takeda, Y; Imamura, Y; Sado, Y; Yamoto, M; Hayashi, T			Possible production of type XVIII collagen by fetal lung fibroblast.	MATRIX BIOLOGY			English	Meeting Abstract									UNIV TOKYO,DEPT LIFE SCI,GRAD SCH ARTS & SCI,TOKYO,JAPAN								0	1	1	GUSTAV FISCHER VERLAG	STUTTGART	WOLLGRASWEG 49, D-70599 STUTTGART, GERMANY	0945-053X			MATRIX BIOL	Matrix Biol.	SEP	1996	15	3					158	159		10.1016/S0945-053X(96)90021-9		2	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	VJ836	WOS:A1996VJ83600021		
J	Adachi, E; Muraoka, M; Iwata, M; Sasaki, T; Takeda, Y; Hazeki, N; Nakazato, K; Hopkinson, I; Hayashi, T				Adachi, E; Muraoka, M; Iwata, M; Sasaki, T; Takeda, Y; Hazeki, N; Nakazato, K; Hopkinson, I; Hayashi, T			Aggregates of collagen IV prepared from normal tissues are composed of 16 nm-sided polygons.	MATRIX BIOLOGY			English	Meeting Abstract									KITASATO UNIV,SCH MED,DEPT ANAT & CELL BIOL,KANAGAWA,JAPAN; UNIV TOKYO,COLL ARTS & SCI,DEPT LIFE SCI CHEM,TOKYO 153,JAPAN; UNIV WALES COLL CARDIFF,COLL MED,DEPT SURG,WOUND HEALING RES UNIT,CARDIFF,S GLAM,WALES								0	1	1	GUSTAV FISCHER VERLAG	STUTTGART	WOLLGRASWEG 49, D-70599 STUTTGART, GERMANY	0945-053X			MATRIX BIOL	Matrix Biol.	SEP	1996	15	3					159	159		10.1016/S0945-053X(96)90023-2		1	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	VJ836	WOS:A1996VJ83600023		
J	Yamato, M; Yamamoto, K; Adachi, E; Takahashi, S; Hayashi, T				Yamato, M; Yamamoto, K; Adachi, E; Takahashi, S; Hayashi, T			Dispersed distribution of alpha 2 beta 1 integrin on the entire surface of elongated human fibroblasts cultured in three-dimensional collagen gel: Lack of focal adhesion.	MATRIX BIOLOGY			English	Meeting Abstract									NIHON UNIV,TOKYO 102,JAPAN; UNIV TOKYO,TOKYO,JAPAN; TOKYO METROPOLITAN INST GERONTOL,TOKYO,JAPAN; KITASATO UNIV,SCH MED,TOKYO,JAPAN								0	0	0	GUSTAV FISCHER VERLAG	STUTTGART	WOLLGRASWEG 49, D-70599 STUTTGART, GERMANY	0945-053X			MATRIX BIOL	Matrix Biol.	SEP	1996	15	3					159	159		10.1016/S0945-053X(96)90022-0		1	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	VJ836	WOS:A1996VJ83600022		
J	Guo, SQ; Kagawa, Y; Honda, K				Guo, SQ; Kagawa, Y; Honda, K			Observation of short fatigue crack-growth process in SiC-fiber-reinforced Ti-15-3 alloy composite	METALLURGICAL AND MATERIALS TRANSACTIONS A-PHYSICAL METALLURGY AND MATERIALS SCIENCE			English	Article							METAL-MATRIX COMPOSITES; FRACTURE MECHANISMS; TEMPERATURES; PROPAGATION	The microscopic fatigue damage characteristics and short fatigue crack growth of an unnotched SiC(SCS-6) fiber-reinforced Ti-15-3 alloy composite were investigated in tension-tension fatigue tests (R = 0.1) carried out at room temperature for applied maximum stress of 450, 670, and 880 MPa. In situ observation of the damage-evolution process was done using optical and scanning laser microscopies, which were attached in the fatigue machine. The first damage for the composite started from a cracking of the reaction layer followed by fiber fracture. The matrix cracking initiated near the broken fiber when the microhardness of the matrix just to the side of the fracture fiber reached similar to 6 GPa, and the number of cycles for the initiation of this cracking decreased with the increase of applied stress. The slope of the relation of surface crack growth length vs number of cycles fell into two characteristic stages; in the first stage, the rate was lower than the second stage and accelerated. The surface crack growth rate, d(2c)/dN, vs surface crack length relation also fell into two stages (stages I and II). With the increase in surface crack length, the crack-growth rate, d(2c)/dN, decreased in stage I and increased in stage II. The transition from stage I to stage II occurred due to the fracture of fibers located around the first fractured fiber. It was concluded that the fatigue crack growth resistance of the composite in the short-crack region was controlled by the fiber fracture and matrix work hardening near the fractured fiber. When the fiber fracture occurred, the surface crack growth rate was accelerated and became faster than that of the monolithic matrix.	UNIV TOKYO,INST IND SCI,TOKYO 106,JAPAN	Guo, SQ (reprint author), UNIV TOKYO,FAC ENGN,7-3-1 HONGO,TOKYO 106,JAPAN.						MARTINEAU P, 1984, J MATER SCI, V19, P2749, DOI 10.1007/BF00550832; NING XJ, 1991, J MATER RES, V6, P2234, DOI 10.1557/JMR.1991.2234; BAO G, 1994, ACTA METALL MATER, V42, P2415, DOI 10.1016/0956-7151(94)90320-4; BHATT RT, 1981, ASTM STP, V723, P274; CHAN KS, 1993, METALL TRANS A, V24, P1531, DOI 10.1007/BF02646594; COTTERILL PJ, 1993, COMPOSITES, V24, P214, DOI 10.1016/0010-4361(93)90166-6; DAS G, 1990, METALL TRANS A, V21, P1571, DOI 10.1007/BF02672572; DAVIDSON DL, 1992, METALL TRANS A, V23, P865, DOI 10.1007/BF02675564; FUKUSHIMA A, 1994, P 1994 ANN M JSME MM, VB, P140; GAYDA J, 1994, SCRIPTA METALL MATER, V30, P469, DOI 10.1016/0956-716X(94)90605-X; GUO SQ, 1994, P 1994 ANN M JSME MM, VB, P144; JANSSON S, 1991, METALL TRANS A, V22, P2975, DOI 10.1007/BF02650257; JENG SM, 1992, MAT SCI ENG A-STRUCT, V154, P11, DOI 10.1016/0921-5093(92)90357-7; JENG SM, 1991, MAT SCI ENG A-STRUCT, V138, P169, DOI 10.1016/0921-5093(91)90686-H; JIRA JR, 1994, METALL MATER TRANS A, V25, P1413, DOI 10.1007/BF02665474; BLATT D, 1994, ENG FRACT MECH, V47, P521, DOI 10.1016/0013-7944(94)90252-6; JOHNSON WS, 1993, COMPOSITES, V24, P187, DOI 10.1016/0010-4361(93)90163-3; KAGAWA Y, 1994, SEISAN KENKYU, V46, P465; KAGAWA Y, 1996, IN PRESS ASTM STP, V1253; LEDDET I, 1979, ASTM STP, V674, P581; MAJUMDAR BS, 1992, PHILOS MAG A, V66, P187; HE MY, 1989, INT J SOLIDS STRUCT, V25, P1053, DOI 10.1016/0020-7683(89)90021-8; MITTNIK MA, 1987, METAL MATRIX COMPOSI; RHODES CG, 1987, METALL TRANS A, V18, P2151, DOI 10.1007/BF02647087; Suresh S, 1991, FATIGUE MAT, P291; *TEXTR CORP, 1991, SIL CARB COMP MAT DA; WALLS DP, 1993, ACTA METALL MATER, V41, P2061, DOI 10.1016/0956-7151(93)90375-3; WANG PC, 1995, J MATER SCI, V30, P1818, DOI 10.1007/BF00351616; WANG ZR, 1994, ACTA METALL MATER, V42, P1433, DOI 10.1016/0956-7151(94)90162-7; Williams J.C., 1973, TITANIUM SCI TECHNOL, V3, P1433	30	16	16	MINERALS METALS MATERIALS SOC	WARRENDALE	420 COMMONWEALTH DR, WARRENDALE, PA 15086	1073-5623			METALL MATER TRANS A	Metall. Mater. Trans. A-Phys. Metall. Mater. Sci.	SEP	1996	27	9					2843	2851		10.1007/BF02652376		9	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	VH386	WOS:A1996VH38600043		
J	Kaihara, S				Kaihara, S			Multimedia and telemedicine	METHODS OF INFORMATION IN MEDICINE			English	Editorial Material										Kaihara, S (reprint author), TOKYO UNIV HOSP,HOSP COMP CTR,BUNKYO KU,7 HONGO,TOKYO 113,JAPAN.						vanBemmel JH, 1996, METHOD INFORM MED, V35, P157	1	0	0	F K SCHATTAUER VERLAG GMBH	STUTTGART	P O BOX 10 45 45, LENZHALDE 3, D-70040 STUTTGART, GERMANY	0026-1270			METHOD INFORM MED	Methods Inf. Med.	SEP	1996	35	3					196	196				1	Computer Science, Information Systems; Health Care Sciences & Services; Medical Informatics	Computer Science; Health Care Sciences & Services; Medical Informatics	VP332	WOS:A1996VP33200010		
J	Hirayama, K; Itoh, K; Takahashi, E; Shinozaki, K; Sawasaki, T				Hirayama, K; Itoh, K; Takahashi, E; Shinozaki, K; Sawasaki, T			Composition of faecal microbiota and metabolism of faecal bacteria of pig-flora-associated (PFA) mice	MICROBIAL ECOLOGY IN HEALTH AND DISEASE			English	Article						pig-flora-associated mice; faecal microbiota; putrefactive products; short chain fatty acids	GNOTOBIOTIC MICE; ANIMALS; COLONIZATION; MICROFLORA; FECES; TRACT; RATS	The composition of the faecal microbiota and concentrations of faecal short chain fatty acids (SCFAs) and putrefactive products were studied in pig-flora-associated (PFA) mice inoculated with faecal suspensions from pigs before and after weaning. Major faecal bacteria of pigs colonised the intestine of PFA mice, and the composition of microbiota of the PFA mouse faeces were similar to that of the pig faeces inoculum. Unexpectedly, pig faecal lactobacilli also colonised the intestines of PFA mouse groups at levels of 10(6)-10(9)/g faeces. However, faecal concentrations of putrefactive products in PFA mice did not simulate those in the inocula, although the concentrations of the major components of SCFAs of PFA mice were similar to those of the inocula. These findings indicate that PFA mice are a good model for studying the ecosystem of pig faecal microbiota and the control of SCFAs in the pig intestine, but not for studying putrefactive products generated in the pig intestine.	UNIV TOKYO,FAC AGR,EXPT STN BIOANIM SCI,BUNKYO KU,TOKYO 113,JAPAN	Hirayama, K (reprint author), UNIV TOKYO,FAC AGR,DEPT VET PUBL HLTH,BUNKYO KU,TOKYO 113,JAPAN.						SISSONS JW, 1989, J SCI FOOD AGR, V49, P1, DOI 10.1002/jsfa.2740490102; MITSUOKA T, 1976, ZBL BAKT-INT J MED M, V234, P219; FULLER R, 1989, J APPL BACTERIOL, V66, P365; MITSUOKA T, 1965, ZENTBL BAKTERIOLOG P, V195, P455; LIN JHC, 1984, FEMS MICROBIOL LETT, V24, P67; HIRAYAMA K, 1995, MICROB ECOL HEALTH D, V8, P199; ROWLAND IR, 1993, J APPL BACTERIOL, V74, P667, DOI 10.1111/j.1365-2672.1993.tb05201.x; DUCLUZEAU R, 1978, ANN INST PASTEUR MIC, VB129, P597; DUCLUZEAU R, 1984, ANN INST PASTEUR MIC, VA135, P303, DOI 10.1016/S0769-2609(84)80013-7; FOX SM, 1988, VET MED-US, V83, P806; FUJIWARA S, 1991, FOOD CHEM TOXICOL, V29, P601, DOI 10.1016/0278-6915(91)90141-S; HAZENBERG MP, 1981, J APPL BACTERIOL, V50, P95, DOI 10.1111/j.1365-2672.1981.tb00874.x; HIRATO J, 1994, CLIN NEUROPATHOL, V13, P1; HIRAYAMA K, 1991, Microbial Ecology in Health and Disease, V4, P95; ITOH K, 1980, Z VERSUCHSTIERKD, V22, P173; ITOH K, 1978, Experimental Animals (Tokyo), V27, P13; MAEJIMA K, 1981, Experimental Animals (Tokyo), V30, P157; MORISHIT.Y, 1971, JPN J MICROBIOL, V15, P531; RAIBAUD P, 1980, AM J CLIN NUTR, V33, P2440; RUMNEY CJ, 1993, NUTR CANCER, V19, P67; TANNOCK GW, 1982, CAN J MICROBIOL, V28, P1196; YOSHIHARA I, 1979, AGR BIOL CHEM TOKYO, V43, P1985; YOSHIHARA I, 1981, AGR BIOL CHEM TOKYO, V45, P1973	23	4	4	JOHN WILEY & SONS LTD	W SUSSEX	BAFFINS LANE CHICHESTER, W SUSSEX, ENGLAND PO19 1UD	0891-060X			MICROB ECOL HEALTH D	Microb. Ecol. Health Dis.	SEP-OCT	1996	9	5					199	206		10.1002/(SICI)1234-987X(199609)9:5<199::AID-MEH428>3.3.CO;2-S		8	Ecology; Immunology; Microbiology	Environmental Sciences & Ecology; Immunology; Microbiology	WA446	WOS:A1996WA44600002		
J	Tobe, K; Sabe, H; Yamamoto, T; Yamauchi, T; Asai, S; Kaburagi, Y; Tamemoto, H; Ueki, K; Kimura, H; Akanuma, Y; Yazaki, Y; Hanafusa, H; Kadowaki, T				Tobe, K; Sabe, H; Yamamoto, T; Yamauchi, T; Asai, S; Kaburagi, Y; Tamemoto, H; Ueki, K; Kimura, H; Akanuma, Y; Yazaki, Y; Hanafusa, H; Kadowaki, T			Csk enhances insulin-stimulated dephosphorylation of focal adhesion proteins	MOLECULAR AND CELLULAR BIOLOGY			English	Article							SWISS 3T3 CELLS; PAXILLIN TYROSINE PHOSPHORYLATION; SRC FAMILY KINASES; RECEPTOR SUBSTRATE-1; GROWTH-FACTOR; BINDING-SITE; SH3 DOMAIN; C-SRC; STABLE ASSOCIATION; TERMINAL TYROSINE	Insulin has pleiotropic effects on the regulation of cell physiology through binding to its receptor. The wide variety of tyrosine phosphorylation motifs of insulin receptor substrate 1 (IRS-1), a substrate for the activated insulin receptor tyrosine kinase, may account for the multiple functions of insulin. Recent studies have shown that activation of the insulin receptor leads to the regulation of focal adhesion proteins, such as a dephosphorylation of focal adhesion kinase (pp125(FAK)). We show here that C-terminal Src kinase (Csk), which phosphorylates C-terminal tyrosine residues of Src family protein tyrosine kinases and suppresses their kinase activities, is involved in this insulin-stimulated dephosphorylation of focal adhesion proteins. We demonstrated that the overexpression of Csk enhanced and prolonged the insulin-induced dephosphorylation of pp125(FAK). Another focal adhesion protein, paxillin, was also dephosphorylated upon insulin stimulation, and a kinase-negative mutant of Csk was able to inhibit the insulin-induced dephosphorylation of pp125(FAK) and paxillin. Although we have shown that the Csk Src homology 2 domain can bind to several tyrosine-phosphorylated proteins, including pp125(FAK) and paxillin, a majority of protein which bound to Csk was IRS-1 when cells were stimulated by insulin. Our data also indicated that tyrosine phosphorylation levels of IRS-1 appear to be paralleled by the dephosphorylation of the focal adhesion proteins. We therefore propose that the kinase activity of Csk, through the insulin-induced complex formation of Csk with IRS-1, is involved in insulin's regulation of the phosphorylation levels of the focal adhesion proteins, possibly through inactivation of the kinase activity of c-Src family kinases.	UNIV TOKYO,FAC MED,DEPT INTERNAL MED 3,BUNKYO KU,TOKYO 113,JAPAN; KYOTO UNIV,INST VIRUS RES,SAKYO KU,KYOTO 606,JAPAN; ASAHI LIFE FDN,INST DIABET CARE & RES,CHIYODA KU,TOKYO 100,JAPAN; RES DEV CORP JAPAN,PRECURSORY RES EMBRYON SCI & TECHNOL,KYOTO 61902,JAPAN; ROCKEFELLER UNIV,ONCOL MOL LAB,NEW YORK,NY 10021			Sabe, Hisataka/A-4066-2012				ANDO A, 1992, J BIOL CHEM, V267, P12788; COBB BS, 1994, MOL CELL BIOL, V14, P147; CHEN HC, 1994, P NATL ACAD SCI USA, V91, P10148, DOI 10.1073/pnas.91.21.10148; KASUGA M, 1983, P NATL ACAD SCI-BIOL, V80, P2137, DOI 10.1073/pnas.80.8.2137; SCHALLER MD, 1995, MOL CELL BIOL, V15, P2635; SCHLAEPFER DD, 1994, NATURE, V372, P786; BIRGE RB, 1993, MOL CELL BIOL, V13, P4648; YAMAUCHI K, 1995, P NATL ACAD SCI USA, V92, P664; SCHALLER MD, 1992, P NATL ACAD SCI USA, V89, P5192, DOI 10.1073/pnas.89.11.5192; SCHALLER MD, 1994, CURR OPIN CELL BIOL, V6, P705, DOI 10.1016/0955-0674(94)90097-3; CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514; SKOLNIK EY, 1993, EMBO J, V12, P1929; IMAMOTO A, 1993, CELL, V73, P1117, DOI 10.1016/0092-8674(93)90641-3; OKADA M, 1989, J BIOL CHEM, V264, P20886; BURRIDGE K, 1992, J CELL BIOL, V119, P893, DOI 10.1083/jcb.119.4.893; TAMEMOTO H, 1994, NATURE, V372, P182, DOI 10.1038/372182a0; LEEBLUNDBERG LMF, 1994, J BIOL CHEM, V269, P24328; CALALB MB, 1995, MOL CELL BIOL, V15, P954; ARAKI E, 1994, NATURE, V372, P186, DOI 10.1038/372186a0; HANKS SK, 1992, P NATL ACAD SCI USA, V89, P8487, DOI 10.1073/pnas.89.18.8487; LECHLEIDER RJ, 1993, J BIOL CHEM, V268, P21478; SUN XJ, 1991, NATURE, V352, P73, DOI 10.1038/352073a0; CHOW LML, 1993, NATURE, V365, P156, DOI 10.1038/365156a0; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680; THOMAS SM, 1995, NATURE, V376, P267, DOI 10.1038/376267a0; GUAN JL, 1992, NATURE, V358, P690, DOI 10.1038/358690a0; BACKER JM, 1992, EMBO J, V11, P3469; SUN XJ, 1995, NATURE, V377, P173, DOI 10.1038/377173a0; TOBE K, 1995, J BIOL CHEM, V270, P5698; LI N, 1993, NATURE, V363, P85, DOI 10.1038/363085a0; WHITE MF, 1994, J BIOL CHEM, V269, P1; LIPFERT L, 1992, J CELL BIOL, V119, P905, DOI 10.1083/jcb.119.4.905; BALTENSPERGER K, 1993, SCIENCE, V260, P1950, DOI 10.1126/science.8391166; BERGMAN M, 1995, MOL CELL BIOL, V15, P711; Cooper J. A., 1990, PEPT PROT PHOSPH, P85; COOPER JA, 1993, CELL, V73, P1051, DOI 10.1016/0092-8674(93)90634-3; FUJIMOTO N, UNPUB; FURGA GS, 1993, EMBO J, V12, P2625; FURUSAKA A, 1994, CANCER LETT, V84, P85, DOI 10.1016/0304-3835(94)90361-1; HOWELL BW, 1994, MOL CELL BIOL, V14, P5402; KABURAGI Y, 1993, J BIOL CHEM, V268, P16610; KADOWAKI T, 1987, J BIOL CHEM, V262, P7342; KIMURA H, UNPUB; KNIGHT JB, 1995, J BIOL CHEM, V270, P10199; KUHNE MR, 1993, J BIOL CHEM, V268, P11479; NADA S, 1993, CELL, V73, P1125, DOI 10.1016/0092-8674(93)90642-4; OKADA M, 1991, J BIOL CHEM, V266, P242; OKADA M, 1993, J BIOL CHEM, V268, P18070; PARSONS JT, 1989, CURR TOP MICROBIOL, V147, P79; PILLAY TS, 1995, J BIOL CHEM, V270, P991; RANKIN S, 1994, J BIOL CHEM, V269, P704; SABE H, 1992, P NATL ACAD SCI USA, V89, P2190, DOI 10.1073/pnas.89.6.2190; SABE H, UNPUB; SABE H, 1992, MOL CELL BIOL, V12, P4706; SABE H, 1994, P NATL ACAD SCI USA, V91, P3984, DOI 10.1073/pnas.91.9.3984; SALGIA R, 1995, J BIOL CHEM, V270, P5039; SEUFFERLEIN T, 1994, J BIOL CHEM, V269, P9345; SEUFFERLEIN T, 1994, J BIOL CHEM, V269, P27610; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; TOBE K, 1993, J BIOL CHEM, V268, P11167; TOBE K, 1990, DIABETES, V39, P528, DOI 10.2337/diabetes.39.5.528; TURNER CE, 1994, J CELL SCI, V107, P1583; VUORI K, 1994, SCIENCE, V266, P1576, DOI 10.1126/science.7527156; WHITE MF, 1985, NATURE, V318, P183, DOI 10.1038/318183a0; WHITE MF, 1988, CELL, V54, P641, DOI 10.1016/S0092-8674(88)80008-4; WOOD CK, 1994, J CELL SCI, V107, P709; YAMAMOTOHONDA R, 1993, J BIOL CHEM, V268, P16859; ZACHARY I, 1992, CELL, V71, P891, DOI 10.1016/0092-8674(92)90385-P; ZACHARY I, 1993, J BIOL CHEM, V268, P22060	69	48	48	AMER SOC MICROBIOLOGY	WASHINGTON	1325 MASSACHUSETTS AVENUE, NW, WASHINGTON, DC 20005-4171	0270-7306			MOL CELL BIOL	Mol. Cell. Biol.	SEP	1996	16	9					4765	4772				8	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	VC897	WOS:A1996VC89700020		
J	Latifi, A; Foglino, M; Tanaka, K; Williams, P; Lazdunski, A				Latifi, A; Foglino, M; Tanaka, K; Williams, P; Lazdunski, A			A hierarchical quorum-sensing cascade in Pseudomonas aeruginosa links the transcriptional activators LasR and RhIR (VsmR) to expression of the stationary-phase sigma factor RpoS	MOLECULAR MICROBIOLOGY			English	Article							RHAMNOLIPID BIOSURFACTANT SYNTHESIS; LACTONE SIGNAL MOLECULES; ESCHERICHIA-COLI; VIRULENCE DETERMINANTS; ANTIBIOTIC BIOSYNTHESIS; SECONDARY METABOLITES; ERWINIA-CAROTOVORA; CELL COMMUNICATION; LUX AUTOINDUCER; VIBRIO-FISCHERI	In Pseudomonas aeruginosa, the production of many virulence factors and secondary metabolites is regulated in concert with cell density through quorum sensing. Two quorum-sensing regulons have been identified in which the LuxR homologues LasR and RhlR are activated by N-(3-oxododecanoyl)-L-homoserine lactone (OdDHL) and N-butanoyl-L-homoserine lactone (BHL) respectively. The lasR and rhlR genes are linked to the luxl homologues lasl and rhll, which are responsible for synthesis of OdDHL and BHL, respectively. As lasRl and rhlRl are both involved in regulating synthesis of exoenzymes such as elastase, we sought to determine the nature of their interrelationship. By using lacZ transcriptional fusions in both homologous (P. aeruginosa) and heterologous (Escherichia coli) genetic backgrounds we provide evidence that (i) lasR is expressed constitutively throughout the growth cycle, (ii) rhlR expression is regulated by LasR/OdDHL, and (iii) that RhlR/BHL regulates rhll. We also show that expression of the stationary-phase sigma factor gene rpoS is abolished in a P. aeruginosa lasR mutant and in the pleiotropic BHL-negative mutant PAN067. Furthermore, our data reveal that in E. coli, an rpoS-lacZ fusion is regulated directly by RhlR/BHL. Taken together, these results indicate that P. aeruginosa employs a multilayered hierarchical quorum-sensing cascade involving RhlR/BHL and LasR/OdDHL, interlinked via RpoS, to integrate the regulation of virulence determinants and secondary metabolites with adaptation and survival in the stationary phase.	CNRS, LAB INGN & DYNAM SYST MEMBRANAIRES, F-13402 MARSEILLE 20, FRANCE; UNIV TOKYO, INST MOL & CELLULAR BIOSCI, BUNKYO KU, TOKYO 113, JAPAN; UNIV NOTTINGHAM, DEPT PHARMACEUT SCI, NOTTINGHAM NG7 2RD, ENGLAND			Williams, Paul/A-5629-2011; Tanaka, Kan/E-3724-2015	Tanaka, Kan/0000-0001-7560-7884			WINSON MK, 1995, P NATL ACAD SCI USA, V92, P9427, DOI 10.1073/pnas.92.20.9427; STEVENS AM, 1994, P NATL ACAD SCI USA, V91, P12619, DOI 10.1073/pnas.91.26.12619; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; FUQUA WC, 1994, J BACTERIOL, V176, P2796; LATIFI A, 1995, MOL MICROBIOL, V17, P333, DOI 10.1111/j.1365-2958.1995.mmi_17020333.x; OCHSNER UA, 1995, P NATL ACAD SCI USA, V92, P6424, DOI 10.1073/pnas.92.14.6424; JONES S, 1993, EMBO J, V12, P2477; THROUP JP, 1995, MOL MICROBIOL, V17, P345, DOI 10.1111/j.1365-2958.1995.mmi_17020345.x; SALMOND GPC, 1995, MOL MICROBIOL, V16, P615, DOI 10.1111/j.1365-2958.1995.tb02424.x; FINLAY BB, 1989, MICROBIOL REV, V53, P210; PASSADOR L, 1993, SCIENCE, V260, P1127, DOI 10.1126/science.8493556; FUQUA WC, 1994, J BACTERIOL, V176, P269; PEARSON JP, 1994, P NATL ACAD SCI USA, V91, P197, DOI 10.1073/pnas.91.1.197; FUJITA M, 1994, MOL MICROBIOL, V13, P1071, DOI 10.1111/j.1365-2958.1994.tb00498.x; BAINTON NJ, 1992, BIOCHEM J, V288, P997; PIPER KR, 1993, NATURE, V362, P448, DOI 10.1038/362448a0; EBERHARD A, 1981, BIOCHEMISTRY-US, V20, P2444, DOI 10.1021/bi00512a013; SITNIKOV DM, 1995, MOL MICROBIOL, V17, P801, DOI 10.1111/j.1365-2958.1995.mmi_17050801.x; SPAINK HP, 1987, PLANT MOL BIOL, V9, P27, DOI 10.1007/BF00017984; MORALES VM, 1991, GENE, V97, P39, DOI 10.1016/0378-1119(91)90007-X; GAMBELLO MJ, 1993, INFECT IMMUN, V61, P1180; ZHANG LH, 1993, NATURE, V362, P446, DOI 10.1038/362446a0; OCHSNER UA, 1994, J BACTERIOL, V176, P2044; ARVIDSON DN, 1991, BIOTECHNIQUES, V6, P733; BAINTON NJ, 1992, GENE, V116, P87, DOI 10.1016/0378-1119(92)90633-Z; DEVINE JH, 1988, BIOCHEMISTRY-US, V27, P837, DOI 10.1021/bi00402a052; Eberl L, 1996, MOL MICROBIOL, V20, P127, DOI 10.1111/j.1365-2958.1996.tb02495.x; HENGGEARONIS R, 1993, CELL, V72, P165, DOI 10.1016/0092-8674(93)90655-A; HUISMAN GW, 1994, SCIENCE, V265, P537, DOI 10.1126/science.7545940; LANGE R, 1994, GENE DEV, V8, P1600, DOI 10.1101/gad.8.13.1600; MCGOWAN S, 1995, MICROBIOL-SGM, V141, P541; Miller J. H., 1972, EXPT MOL GENETICS; PEARSON JP, 1995, P NATL ACAD SCI USA, V92, P1490, DOI 10.1073/pnas.92.5.1490; PIERSON LS, 1994, J BACTERIOL, V176, P3966; Sambrook J., 1989, MOL CLONING LAB MANU; SEED PC, 1995, J BACTERIOL, V177, P654; SWIFT S, 1993, MOL MICROBIOL, V10, P511, DOI 10.1111/j.1365-2958.1993.tb00923.x; TAKAYANAGI Y, 1994, MOL GEN GENET, V243, P525, DOI 10.1007/BF00284200; TANAKA K, 1994, GENE, V150, P81; VONBODMAN SB, 1995, J BACTERIOL, V177, P5000; Williams Paul, 1992, FEMS (Federation of European Microbiological Societies) Microbiology Letters, V100, P161, DOI 10.1016/0378-1097(92)90204-2; Wood DW, 1996, GENE, V168, P49, DOI 10.1016/0378-1119(95)00754-7	42	415	431	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0950-382X	1365-2958		MOL MICROBIOL	Mol. Microbiol.	SEP	1996	21	6					1137	1146		10.1046/j.1365-2958.1996.00063.x		10	Biochemistry & Molecular Biology; Microbiology	Biochemistry & Molecular Biology; Microbiology	VJ518	WOS:A1996VJ51800003		
J	Koide, H; Nakamura, T; Kimura, K; Ebihara, I; Nagai, R; Tomino, Y				Koide, H; Nakamura, T; Kimura, K; Ebihara, I; Nagai, R; Tomino, Y			Effect of a low-protein diet on expression of non-muscle type myosin heavy-chain isoforms in glomeruli of rats with puromycin aminonucleoside nephrosis	NEPHROLOGY DIALYSIS TRANSPLANTATION			English	Article						SMemb; phenotype; protein restriction	SMOOTH-MUSCLE; EPITHELIAL-CELLS; GENE-EXPRESSION; CDNA CLONING; RESTRICTION; INJURY; KIDNEY; RNA	Background. We reported that an embryonic type of non-muscle-type myosin heavy-chain isoform (SMemb) may be a molecular marker for phenotypic alteration in initial glomerular injury and that methylprednisolone has no effect on SMemb expression in glomeruli of rats with puromycin aminonucleoside (PAN) nephrosis. The present study was designed to assess whether SMemb mRNA and protein expression in glomeruli are affected by a low-protein diet in rats with PAN-induced nephrosis and in control rats. Methods. Rats were divided into four groups: group 1, PAN-injected rats fed a standard diet containing 22% protein; group 2, PAN-injected rats fed a low-protein diet containing 6% protein, starting on the day of PAN injection; group 3, control rats fed a standard diet; group 4, control rats fed a low-protein diet for the same period. We prepared glomerular RNA and performed Northern blot analysis and immunohistochemistry in all groups. Results. Glomerular SMemb mRNA increased on days 2 and 4 (prior to and soon after the onset of proteinuria), but declined on day 8 (the peak of proteinuria). Myosin heavy-chain protein expression was evaluated immunohistochemically by use of three antibodies against SM1, SM2, and SMemb. SM1 and SM2 were absent from the glomeruli of rats with PAN nephrosis until day 20. The SMemb isoform was barely detectable in normal glomeruli, but substantial amounts of SMemb were demonstrated in the glomeruli of rats with PAN nephrosis. In the latter condition, the number of SMemb-positive glomerular epithelial cells increased on days 3 and 4, then decreased in subsequent days. Moreover, some mesangial cells became SMemb-positive transiently, returning to barely detectable levels on day 20. In addition, alpha-smooth-muscle actin, type I and III collagens were absent from the glomeruli of rats with PAN nephrosis until day 20. Urinary protein excretion was markedly suppressed by the 6% protein diet in PAN nephrosis. The low-protein diet reduced the increased mRNA expression of SMemb as well as the increased number of SMemb-positive cells in the glomeruli of rats with PAN nephrosis. However, the low-protein diet did not affect SMemb mRNA and protein levels in the glomeruli of control rats. Conclusions. In rats with PAN nephrosis, findings suggest that restriction of dietary protein leads to a reduction in glomerular SMemb expression.	UNIV TOKYO,DEPT INTERNAL MED 2,TOKYO 113,JAPAN; UNIV TOKYO,DEPT INTERNAL MED 3,TOKYO 113,JAPAN	Koide, H (reprint author), JUNTENDO UNIV,SCH MED,KOTO HOSP,DEPT MED,DIV NEPHROL,KOTO KU,6-8-5 OJIMA,TOKYO 136,JAPAN.						JOHNSON RJ, 1991, J CLIN INVEST, V87, P847, DOI 10.1172/JCI115089; FISHMAN JA, 1985, AM J PATHOL, V118, P398; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DIAMOND JR, 1987, J LAB CLIN MED, V109, P538; DIAMOND JR, 1990, AM J PHYSIOL, V258, pF1; DING GH, 1994, AM J PHYSIOL-RENAL, V267, pF937; FUKUI M, 1993, J LAB CLIN MED, V121, P224; JOLINS JP, 1995, J LAB CLIN MED, V125, P228; KASINATH BS, 1988, AM J PHYSIOL, V255, pF590; KIMURA K, 1984, HISTOCHEMISTRY, V80, P443, DOI 10.1007/BF00495432; KUROO M, 1991, J BIOL CHEM, V266, P3768; KUROO M, 1989, J BIOL CHEM, V264, P18272; LIAU G, 1985, J BIOL CHEM, V260, P531; NAGAI R, 1989, J BIOL CHEM, V264, P9734; NAKAMURA T, 1995, CLIN SCI, V89, P45; NAKAMURA T, 1994, KIDNEY INT, V45, P1593, DOI 10.1038/ki.1994.210; NARITA I, 1995, LAB INVEST, V72, P17; NATH KA, 1986, J CLIN INVEST, V78, P1199, DOI 10.1172/JCI112703; TAKAHARA T, 1988, LAB INVEST, V59, P509; YAOITA E, 1990, AM J PATHOL, V136, P899	20	0	0	OXFORD UNIV PRESS UNITED KINGDOM	OXFORD	WALTON ST JOURNALS DEPT, OXFORD, ENGLAND OX2 6DP	0931-0509			NEPHROL DIAL TRANSPL	Nephrol. Dial. Transplant.	SEP	1996	11	9					1769	1774				6	Transplantation; Urology & Nephrology	Transplantation; Urology & Nephrology	VJ132	WOS:A1996VJ13200017		
J	Yamamoto, T; Komori, T; Shibata, N; Kobayashi, M; Kondo, E; Saito, K; Osawa, M; Toda, T				Yamamoto, T; Komori, T; Shibata, N; Kobayashi, M; Kondo, E; Saito, K; Osawa, M; Toda, T			Fukuyama congenital muscular dystrophy: Cortical dysplasia of the cerebrum in a 20 week fetus	NEUROPATHOLOGY			English	Article						cerebrum; cortical dysplasia; fetus; Fukuyama congenital muscular dystrophy	CENTRAL NERVOUS-SYSTEM; LOCALIZATION; PATHOGENESIS; MIGRATION; GENE	This report describes cerebral cortical dysplasia in a 20 week fetus, aborted as a result of the prenatal genetic analysis which provided evidence of Fukuyama congenital muscular dystrophy (FCMD), The histological appearance of the brain of this fetus was similar to that of previously described cases, However, cortical dysplasia was less severe in this 20 week fetus, and the interesting finding was the existence of a leptomeningeal lesion probably preceding dysplasia, In this case, abnormal findings were found mainly in the cerebral surface, and maturation of the brain seemed appropriate for the gestational age, Furthermore, periodic acid-methenamine-silver-positive linear structure of the cerebral surface was disrupted irregularly. These findings suggest that defects in the pial-glial barrier of the cerebral surface may play a cardinal role for the genesis of cortical dysplasia, It is suggested that the extracortical abnormal tissue would be detectable morphologically at least in the 12-13th week because cells considered as subpial granular cells were contained in the lesion, This report on the brain of a fetus with FCMD provides information on relatively early central nervous system alterations in this disease, and may be of importance in clarifying their pathogenesis.	TOKYO WOMENS MED COLL,DEPT PATHOL,TOKYO,JAPAN; TOKYO WOMENS MED COLL,DEPT PEDIAT,TOKYO,JAPAN; UNIV TOKYO,GRAD SCH INT HLTH,DEPT HUMAN GENET,TOKYO,JAPAN							MATSUMURA K, 1994, MUSCLE NERVE, V17, P2, DOI 10.1002/mus.880170103; SIDMAN RL, 1973, BRAIN RES, V62, P1, DOI 10.1016/0006-8993(73)90617-3; CARPENTER S, 1984, PATHOLOGY SKELETAL M, P1; Friede R. L., 1989, DEV NEUROPATHOLOGY, P2; Fukuyama Y, 1960, PAEDIATR U TOKYO, V4, P5; FUKUYAMA Y, 1981, BRAIN DEV-JPN, V3, P1; HAYASHI YK, 1993, J NEUROL SCI, V119, P53, DOI 10.1016/0022-510X(93)90191-Z; KAMOSHITA S, 1976, ARCH NEUROL-CHICAGO, V33, P513; KONDO E, IN PRESS AM J MED GE; Larroche JC, 1977, DEV PATHOLOGY NEONAT, P319; Nakano I, 1996, ACTA NEUROPATHOL, V91, P313; OSAWA M, 1993, NEUROPATHOLOGY, V13, P259, DOI 10.1111/j.1440-1789.1993.tb00206.x; RORKE LB, 1994, J NEUROPATH EXP NEUR, V53, P105, DOI 10.1097/00005072-199403000-00001; TAKADA K, 1988, Yonago Acta Medica, V31, P1; TAKADA K, 1987, ACTA NEUROPATHOL, V74, P300; TAKADA K, 1984, J NEUROPATH EXP NEUR, V43, P395, DOI 10.1097/00005072-198407000-00005; TODA T, 1994, AM J HUM GENET, V55, P946; TODA T, 1993, NAT GENET, V5, P283, DOI 10.1038/ng1193-283; TOYOKURA Y, 1979, 1978 ANN REPORT RES, P117	19	9	9	BLACKWELL SCIENCE	CARLTON	54 UNIVERSITY ST, P O BOX 378, CARLTON VICTORIA 3053, AUSTRALIA	0919-6544			NEUROPATHOLOGY	Neuropathology	SEP	1996	16	3					184	189		10.1111/j.1440-1789.1996.tb00180.x		6	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	VJ239	WOS:A1996VJ23900006		
J	Nishiyama, K; Murayama, S; Suzuki, T; Mitsui, Y; Sakaki, Y; Kanazawa, I				Nishiyama, K; Murayama, S; Suzuki, T; Mitsui, Y; Sakaki, Y; Kanazawa, I			Presenilin 1 mRNA expression in hippocampi of sporadic Alzheimer's disease patients	NEUROSCIENCE RESEARCH			English	Article						Presenilin 1; mRNA; in situ hybridization; hippocampus; Alzheimer's disease; neurofibrillary tangle	PRECURSOR PROTEIN GENE; MISSENSE MUTATION; APOLIPOPROTEIN-E; S182 GENE; CHROMOSOME-1; FAMILIES; ALLELE	Missense mutations in presenilin 1 (PSNL1) are known to cause familial Alzheimer's disease which is a subtype of Alzheimer's disease (AD). Our investigation, using an in situ hybridization technique, indicated that the localization of PSNL1 mRNA is similar in sporadic AD affected and normal human brains. Furthermore, the amounts of PSNL1 mRNA in neurofibrillary tangle (NFT)-bearing neurons and those without NFTs did not differ, and the clinical severity of AD was not related to PSNL1 mRNA expression level.	UNIV TOKYO,SCH MED,INST BRAIN RES,DEPT NEUROL,BUNKYO KU,TOKYO 113,JAPAN; UNIV TOKYO,INST MED SCI,CTR HUMAN GENOME,MINATO KU,TOKYO 108,JAPAN							CAMPION D, 1995, HUM MOL GENET, V4, P2373, DOI 10.1093/hmg/4.12.2373; KARLINSKY H, 1992, NEUROLOGY, V42, P1445; MURRELL J, 1991, SCIENCE, V254, P97, DOI 10.1126/science.1925564; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467; Kovacs DM, 1996, NAT MED, V2, P224, DOI 10.1038/nm0296-224; [Anonymous], 1995, NAT GENET, V11, P219; LEVYLAHAD E, 1995, SCIENCE, V269, P970, DOI 10.1126/science.7638621; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; CHARTIERHARLIN MC, 1991, NATURE, V353, P844, DOI 10.1038/353844a0; CRUTS M, 1995, HUM MOL GENET, V4, P2363, DOI 10.1093/hmg/4.12.2363; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; NISHIYAMA K, 1995, NEUROSCI LETT, V194, P205, DOI 10.1016/0304-3940(95)11762-L; SORBI S, 1995, LANCET, V346, P439, DOI 10.1016/S0140-6736(95)92809-X; Suzuki T, 1996, BIOCHEM BIOPH RES CO, V219, P708, DOI 10.1006/bbrc.1996.0299; TANAHASHI H, 1995, LANCET, V346, P440, DOI 10.1016/S0140-6736(95)92810-3; Van Broeckhoven C, 1995, NAT GENET, V11, P230	18	12	12	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	0168-0102			NEUROSCI RES	Neurosci. Res.	SEP	1996	26	1					75	78		10.1016/0168-0102(96)01072-3		4	Neurosciences	Neurosciences & Neurology	VL836	WOS:A1996VL83600007		
J	Furuhata, K; Kakino, J; Miyama, Y; Fukuyo, Y				Furuhata, K; Kakino, J; Miyama, Y; Fukuyo, Y			Elimination of cysts of the toxic dinoflagellates Alexandrium spp contaminated in hard clam	NIPPON SUISAN GAKKAISHI			Japanese	Article									CHIBA PREFECTURAL FISHERIES EXPT STN,FUTTSU BRANCH,FUTTSU,CHIBA 293,JAPAN; CHIBA PREFECTURAL TOKYO BAY FARMING CTR,FUTTSU,CHIBA 293,JAPAN; UNIV TOKYO,ASIAN NAT ENVIRONM SCI CTR,BUNKYO KU,TOKYO 113,JAPAN	Furuhata, K (reprint author), CHIBA PREFECTURAL FISHERIES EXPT STN,CHIBA 295,JAPAN.						HAN MS, 1993, J PLANKTON RES, V15, P1425, DOI 10.1093/plankt/15.12.1425; SCARRATT AM, 1995, J SHELLFISH RES, V12, P383	2	3	3	JAPAN SOC SCI FISHERIES TOKYO UNIV FISHERIES	TOKYO	5-7 KONAN-4 MINATO-KU, TOKYO 108, JAPAN	0021-5392			NIPPON SUISAN GAKK	Nippon Suisan Gakkaishi	SEP	1996	62	5					813	814				2	Fisheries	Fisheries	VN290	WOS:A1996VN29000016		
J	Wakabayashi, H				Wakabayashi, H			The international situation on quarantine of fish diseases	NIPPON SUISAN GAKKAISHI			Japanese	Article										Wakabayashi, H (reprint author), UNIV TOKYO,TOKYO,JAPAN.							0	0	0	JAPAN SOC SCI FISHERIES TOKYO UNIV FISHERIES	TOKYO	5-7 KONAN-4 MINATO-KU, TOKYO 108, JAPAN	0021-5392			NIPPON SUISAN GAKK	Nippon Suisan Gakkaishi	SEP	1996	62	5					830	831				2	Fisheries	Fisheries	VN290	WOS:A1996VN29000027		
J	Ogawa, K				Ogawa, K			Occurrence of fish diseases associated with seed importation - A new skin parasite (Neobenedenia) of cultured marine fishes	NIPPON SUISAN GAKKAISHI			Japanese	Article										Ogawa, K (reprint author), UNIV TOKYO,TOKYO,JAPAN.							0	0	0	JAPAN SOC SCI FISHERIES TOKYO UNIV FISHERIES	TOKYO	5-7 KONAN-4 MINATO-KU, TOKYO 108, JAPAN	0021-5392			NIPPON SUISAN GAKK	Nippon Suisan Gakkaishi	SEP	1996	62	5					832	832				1	Fisheries	Fisheries	VN290	WOS:A1996VN29000029		
J	Yamada, M; Pomphrey, N; Ono, Y; Katsurai, M				Yamada, M; Pomphrey, N; Ono, Y; Katsurai, M			Global stability study of the ultralow aspect ratio tokamak, ULART	NUCLEAR FUSION			English	Letter								By introducing a slender current carrying conductor through the geometric centre axis of the TS-3 device at Tokyo Univesity, ultralow aspect ratio tokamak (ULART) configurations have been generated with aspect ratios as low as 1.1. In this extreme limit the transition of the spheromak (q(edge) = 0, I-1f = 0) to an ULART plasma (q(edge) = 2-20) is studied. The global MHD characteristics of ULART are investigated by comparing the theoretical results viith the experimental data obtained. A small current (compared with the plasma current) in the centre conductor is found to improve significantly the global MHD stability characteristics of the plasmas formed by effectively stabilizing the global tilt/shift mode. Theoretical calculations of the threshold toroidal field current required for stability and the growth rates of the tilt/shift modes agree well with the TS-3 data.	UNIV TOKYO,DEPT ELECT ENGN,TOKYO 113,JAPAN	Yamada, M (reprint author), PRINCETON UNIV,PRINCETON PLASMA PHYS LAB,POB 451,PRINCETON,NJ 08543, USA.		pomphrey, neil/G-4405-2010; Yamada, Masaaki/D-7824-2015	Yamada, Masaaki/0000-0003-4996-1649			ONO Y, 1993, PHYS FLUIDS B-PLASMA, V5, P3691, DOI 10.1063/1.860840; PENG YKM, 1986, NUCL FUSION, V26, P769, DOI 10.1088/0029-5515/26/6/005; BROWNING PK, 1992, PHYS REV LETT, V68, P1722, DOI 10.1103/PhysRevLett.68.1722; BRUHNS H, 1987, NUCL FUSION, V27, P2178, DOI 10.1088/0029-5515/27/12/017; HWANG YS, 1995, P 15 INT C PLASM PHY, V1, P737; KATSURAI M, 1995, FUSION TECHNOL, V27, P97; KATSURAI M, 1994, P PLASM RES M EP94 5, P61; Lyle TR, 1914, PHILOS T R SOC LOND, V213, P421, DOI 10.1098/rsta.1914.0009; MORITA A, 1995, THESIS TOKYO U; NELSON BA, 1994, PHYS REV LETT, V72, P1722; ONO M, 1995, B AM PHYS SOC, V40, P1655; PENG YKM, 1992, FUSION TECHNOL, V21, P1729; POMPHREY N, UNPUB STABILITY ULAR; REBHAN E, 1975, NUCL FUSION, V15, P277, DOI 10.1088/0029-5515/15/2/012; SYKES A, 1993, PLASMA PHYS CONTR F, V35, P1051, DOI 10.1088/0741-3335/35/8/011; YAMADA M, 1995, FUSION TECHNOL, V27, P161; YAMADA M, 1983, MIRROR BASED FIELD R, V2, P463	17	12	12	INT ATOMIC ENERGY AGENCY	VIENNA	WAGRAMERSTRASSE 5, PO BOX 100, A-1400 VIENNA, AUSTRIA	0029-5515			NUCL FUSION	Nucl. Fusion	SEP	1996	36	9					1210	1216		10.1088/0029-5515/36/9/I10		7	Physics, Fluids & Plasmas; Physics, Nuclear	Physics	XY895	WOS:A1996XY89500010		
J	Koizumi, H; Ichikawa, T; Yoshida, H; Shibata, H; Tagawa, S; Yoshida, Y				Koizumi, H; Ichikawa, T; Yoshida, H; Shibata, H; Tagawa, S; Yoshida, Y			Radical formation in the radiolysis of solid alanine by protons and helium ions	NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM INTERACTIONS WITH MATERIALS AND ATOMS			English	Article							IRRADIATION; POLYMERS; DOSIMETER	Radical formation in solid alpha-alanine irradiated with 0.5-, 1-, 2-, and 3-MeV H+, 0.5-, 1-, and 3-MeV He+ ions were studied by means of electron spin resonance. The radical yield (number of radicals per incident ion) is constant below the critical fluence of about 10(12) ions cm(-2). Above the critical fluence, the yield decreases with increasing ion fluence, G-value of the radical formation was obtained from the constant yield at the low fluences, Assuming a simple cylindrical shape of the ion tracks, the average radii of the ion tracks were estimated from the G-values, The estimated value of the radius is from 2 nm to 5 nm, The dependence of the radical yield on the ion fluence was simulated with the cylindrical model of ion tracks and dose-yield relationship for gamma-irradiation. The observed yield decreases more than the simulated one above the critical fluence. This difference is ascribed to higher damage on the solid alanine by the ion irradiation than by gamma-irradiation.	UNIV TOKYO,NUCL SCI & TECHNOL RES CTR,TOKYO 113,JAPAN; UNIV TOKYO,FAC ENGN,TOKAI,IBARAKI 31911,JAPAN	Koizumi, H (reprint author), HOKKAIDO UNIV,GRAD SCH ENGN,KITA KU,SAPPORO,HOKKAIDO 060,JAPAN.		Koizumi, Hitoshi/D-6379-2012				DAVENAS J, 1989, NUCL INSTRUM METH B, V39, P754, DOI 10.1016/0168-583X(89)90891-4; CALCAGNO L, 1995, NUCL INSTRUM METH B, V95, P59, DOI 10.1016/0168-583X(94)00326-2; HANSEN JW, 1985, RADIAT RES, V104, P15, DOI 10.2307/3576774; KATZ R, 1972, NUCL INSTRUM METHODS, V100, P12; KOIZUMI H, IN PRESS APPL RAD IS; KOIZUMI T, 1994, TIARA ANN REP 1993, P68; KOJIMA T, 1993, APPL RADIAT ISOTOPES, V43, P41; KRUSHEV VV, 1994, RADIAT PHYS CHEM, V44, P521, DOI 10.1016/0969-806X(94)90051-5; ROTBLAT J, 1962, PHYS MED BIOL, V7, P489; SAID MA, 1988, J POLYM SCI POL PHYS, V26, P1457, DOI 10.1002/polb.1988.090260709; SASUGA T, 1991, RADIAT PHYS CHEM, V37, P135; SCHNABEL W, 1991, RADIAT PHYS CHEM, V37, P131; SHUKUSHIMA S, 1993, NUCL INSTRUM METH B, V80-1, P1119, DOI 10.1016/0168-583X(93)90749-V; VENKATESAN T, 1983, J APPL PHYS, V54, P3150, DOI 10.1063/1.332471; WALIGORSKI MPR, 1989, APPL RADIAT ISOTOPES, V40, P923; WASCHE M, 1989, RADIAT PHYS CHEM, V33, P9; Ziegler J.B., 1985, STOPPING POWER RANGE, VI	17	15	16	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-583X			NUCL INSTRUM METH B	Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms	SEP	1996	117	3					269	274		10.1016/0168-583X(96)00323-0		6	Instruments & Instrumentation; Nuclear Science & Technology; Physics, Atomic, Molecular & Chemical; Physics, Nuclear	Instruments & Instrumentation; Nuclear Science & Technology; Physics	VH102	WOS:A1996VH10200009		
J	Krogstad, D; Kojima, S; James, SL				Krogstad, D; Kojima, S; James, SL			Parasitology research in the USA and Japan	PARASITOLOGY TODAY			English	Editorial Material							SCHISTOSOMA-MANSONI; IMMUNE-RESPONSE; AEDES-AEGYPTI; ANTIGEN; SUSCEPTIBILITY; MALARIA; MICE		TULANE UNIV,DEPT TROP MED,NEW ORLEANS,LA 70112; UNIV TOKYO,INST MED SCI,DEPT PARASITOL,TOKYO 108,JAPAN; NIAID,PARASITOL & INT PROGRAMS BRANCH,NIH,BETHESDA,MD 20892							HILL AVS, 1991, NATURE, V352, P595, DOI 10.1038/352595a0; THATHY V, 1994, J PARASITOL, V80, P705, DOI 10.2307/3283249; TANABE K, 1987, J MOL BIOL, V195, P273, DOI 10.1016/0022-2836(87)90649-8; BOULANGER D, 1991, PARASITE IMMUNOL, V13, P473, DOI 10.1111/j.1365-3024.1991.tb00545.x; DUKE BOL, 1966, ANN TROP MED PARASIT, V60, P318; HIRAYAMA K, 1987, NATURE, V327, P426, DOI 10.1038/327426a0; KOSTER B, 1993, EXP PARASITOL, V77, P282, DOI 10.1006/expr.1993.1086; OHTA N, 1987, T ROY SOC TROP MED H, V81, P292, DOI 10.1016/0035-9203(87)90245-8; RICHTER D, 1993, J IMMUNOL, V151, P256; Severson David W., 1994, Insect Molecular Biology, V3, P67, DOI 10.1111/j.1365-2583.1994.tb00153.x	10	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB	0169-4758			PARASITOL TODAY	Parasitol. Today	SEP	1996	12	9					332	335		10.1016/0169-4758(96)30012-4		4	Parasitology	Parasitology	VE715	WOS:A1996VE71500002		
J	Ishida, T; Wada, I; Horiuchi, H; Oka, T; Machinami, R				Ishida, T; Wada, I; Horiuchi, H; Oka, T; Machinami, R			Multiple small intestinal stromal tumors with skeinoid fibers in association with neurofibromatosis 1 (von Recklinghausen's disease)	PATHOLOGY INTERNATIONAL			English	Article						gastrointestinal autonomic nerve tumor; gastrointestinal stromal tumor; neurofibromatosis 1; skeinoid fiber; small intestinal stromal tumor	AUTONOMIC NERVE TUMORS; GASTROINTESTINAL-TRACT; VONRECKLINGHAUSENS DISEASE; CD34 EXPRESSION; DIFFERENTIATION	A case of multiple small intestinal stromal tumors (SIST) with skeinoid fibers of the jejunum arising in a 50 year old male with neurofibromatosis 1 (NF-1) is reported. Seven small tumors of the jejunal wall were incidentally found and excised during an operation for abdominal and retroperitoneal neurofibromas. Histologically, the tumors were composed of uniform spindle-shaped cells with fascicular pattern, almost indistinguishable from the histology in leiomyoma. Periodic acid Schiff stain-positive hyaline globules were observed among the tumor cells. Ultrastructurally, these globules were stromal tangles of curvilinear, fluffy fibrils, consistent with skeinoid fibers. The electron-dense granules, possibly neurosecretory granules, were found in the cytoplasm of the tumor cells. Immunohistochemically, the tumor cells were positive for vimentin, neuron specific enolase and CD34, but negative for muscle markers and S100 protein. The association of NF-1 and multiple SIST with skeinoid fibers may have clinical implications. The multiple occurrence of SIST with skeinoid fibers seems to be often cited as one of the gastrointestinal manifestations of NF-1. The possible site of origin of SIST with skeinoid fibers in NF-1 may be the enteric autonomic nerve plexus in the small intestinal wall.		Ishida, T (reprint author), UNIV TOKYO,FAC MED,DEPT PATHOL,BUNKYO KU,7-3-1 HONGO,TOKYO 113,JAPAN.						DAIMARU Y, 1988, HUM PATHOL, V19, P257, DOI 10.1016/S0046-8177(88)80518-5; MIETTINEN M, 1995, AM J SURG PATHOL, V19, P207, DOI 10.1097/00000478-199502000-00009; FULLER CE, 1991, HISTOPATHOLOGY, V19, P1; VANDERIJN M, 1994, HUM PATHOL, V25, P766, DOI 10.1016/0046-8177(94)90245-3; ANTONIOLI DA, 1989, ARCH PATHOL LAB MED, V113, P831; DINGEMANS KP, 1994, ULTRASTRUCT PATHOL, V18, P539; GOLDBLUM JR, 1995, AM J SURG PATHOL, V19, P71, DOI 10.1097/00000478-199501000-00009; HERRERA GA, 1989, ARCH PATHOL LAB MED, V113, P846; HURLIMANN J, 1991, HISTOPATHOLOGY, V19, P311, DOI 10.1111/j.1365-2559.1991.tb00045.x; LAUWERS GY, 1993, AM J SURG PATHOL, V17, P887, DOI 10.1097/00000478-199309000-00004; MAZUR MT, 1983, AM J SURG PATHOL, V7, P507, DOI 10.1097/00000478-198309000-00001; MCDONNELL L, 1993, AM J SURG PATHOL, V17, P954, DOI 10.1097/00000478-199309000-00017; MIETTINEN M, 1988, AM J CLIN PATHOL, V89, P601; MIKHAEL AI, 1994, APPL IMMUNOHISTOCHEM, V2, P89; MIN KW, 1991, ULTRASTRUCT PATHOL, V15, P603; MIN KW, 1993, ULTRASTRUCT PATHOL, V17, P307; MIN KW, 1994, AM J SURG PATHOL, V18, P958, DOI 10.1097/00000478-199409000-00012; MIN KW, 1992, AM J SURG PATHOL, V16, P145, DOI 10.1097/00000478-199202000-00007; NEWMAN PL, 1991, J PATHOL, V164, P107, DOI 10.1002/path.1711640204; PIKE AM, 1988, HUM PATHOL, V19, P830, DOI 10.1016/S0046-8177(88)80267-3; Riccardi V, 1992, NEUROFIBROMATOSIS PH, V2; SCHALDENBRAND JD, 1984, HUM PATHOL, V15, P229, DOI 10.1016/S0046-8177(84)80184-7; VANDERIJN M, 1994, APPL IMMUNOHISTOCHEM, V2, P71; WALKER P, 1986, ARCH PATHOL LAB MED, V110, P309; WALSH NMG, 1990, ARCH PATHOL LAB MED, V114, P522	25	36	36	BLACKWELL SCIENCE	CARLTON	54 UNIVERSITY ST, P O BOX 378, CARLTON VICTORIA 3053, AUSTRALIA	1320-5463			PATHOL INT	Pathol. Int.	SEP	1996	46	9					689	695		10.1111/j.1440-1827.1996.tb03673.x		7	Pathology	Pathology	VL387	WOS:A1996VL38700010		
J	Smriga, M; Saito, H; Shibata, S; Narui, T; Okuyama, T; Nishiyama, N				Smriga, M; Saito, H; Shibata, S; Narui, T; Okuyama, T; Nishiyama, N			PC-2, linear homoglucan with alpha-linkages, peripherally enhances the hippocampal long-term potentiation	PHARMACEUTICAL RESEARCH			English	Article						long-term potentiation; dentate gyrus; PC-2; alpha-glucan; adrenal steroids	DENTATE GYRUS; CHINESE PRESCRIPTION; IN-VIVO; DX-9386; RATS	Purpose. To investigate central effectiveness of PC-2, a glucan from lichen Parmelia caperata with alpha(1-3)(1-4) linkages in the ratio 3:2, with regard to the long-term potentiation (LTP) of evoked potential. Methods. The extent of LTP, induced by high-frequency stimulation of medial perforant pathway, was evaluated as fractional increase in population spike amplitude in dentate gyrus in anesthetized rats. Results. Oral and intravenous application of PC-2 resulted in significant enhancement of LTP elicited by a weak, but not by a strong, tetanic stimulation. No influence of PC-2 on basal evoked synaptic potential was found. Bilateral adrenalectomy profoundly suppressed the positive impact of the glucan on the formation of LTP, but showed no effect upon the magnitude and time-course of population spike enhancement in vehicle-treated subjects. Two related alpha-glucans with different chemical structures did not show any effect comparable to that of PC-2. Conclusions. Peripheral application of PC-2 significantly enhances LTP in dentate gyrus in rats. Results indicate that the effect of PC-2 might be peripherally mediated and that the specific higher structure of PC-2 is crucial for its biological activity.	UNIV TOKYO,FAC PHARMACEUT SCI,DEPT CHEM PHARMACOL,BUNKYO KU,TOKYO 113,JAPAN; SHIVATA LAB NAT MED MAT,SHINJUKU KU,TOKYO 160,JAPAN; MEIJI COLL PHARM,TOKYO 154,JAPAN							ABE K, 1994, BRAIN RES, V649, P7, DOI 10.1016/0006-8993(94)91042-1; GLICK D, 1964, ENDOCRINOLOGY, V74, P653; SMRIGA M, 1995, BIOL PHARM BULL, V18, P518; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Chihara G, 1987, Cancer Detect Prev Suppl, V1, P423; CONRAD CD, 1995, HIPPOCAMPUS, V5, P1, DOI 10.1002/hipo.450050103; FLEMING M, 1967, BIOCHEM J, V104, P32; GRANT SGN, 1994, TRENDS NEUROSCI, V17, P71, DOI 10.1016/0166-2236(94)90077-9; Lien E J, 1990, Prog Drug Res, V34, P395; NISHIYAMA N, 1994, BIOL PHARM BULL, V17, P1481; RADEMACHER TW, 1988, ANNU REV BIOCHEM, V57, P785; SUGIURA M, 1994, J PHARMACOL EXP THER, V271, P703; TAKEDA T, 1970, CHEM PHARM BULL, V18, P1074	13	11	11	PLENUM PUBL CORP	NEW YORK	233 SPRING ST, NEW YORK, NY 10013	0724-8741			PHARMACEUT RES	Pharm. Res.	SEP	1996	13	9					1322	1326		10.1023/A:1016009630329		5	Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Chemistry; Pharmacology & Pharmacy	VL498	WOS:A1996VL49800009		
J	Mimura, M; Tsujikawa, T				Mimura, M; Tsujikawa, T			Aggregating pattern dynamics in a chemotaxis model including growth	PHYSICA A			English	Article						chemotaxis; localized pattern; interface equation; singular perturbation	DIFFUSION-EQUATIONS; GENERATION; INTERFACES; SYSTEM	A population model including diffusion, chemotaxis and growth is studied. Assuming that the diffusion rate and the chemotactic rate are both very small compared with the growth rate, we derive a new equation to describe the time-evolution of the aggregating region of biological individuals and show the conditions for the existence and stability of radially symmetric equilibrium solutions of the equation, which indicate the aggregation of individuals.	HIROSHIMA DENKI INST TECHNOL,FAC ENGN,HIROSHIMA 73903,JAPAN	Mimura, M (reprint author), UNIV TOKYO,GRAD SCH MATH SCI,MEGURO KU,TOKYO 153,JAPAN.						Alt W, 1985, J MATH BIOL, V24, P691; FORD RM, 1991, B MATH BIOL, V53, P721; KELLER EF, 1970, J THEOR BIOL, V26, P399, DOI 10.1016/0022-5193(70)90092-5; FIFE PC, 1977, ARCH RATION MECH AN, V65, P335; ADLER J, 1966, SCIENCE, V153, P708, DOI 10.1126/science.153.3737.708; JAGER W, 1992, T AM MATH SOC, V329, P819, DOI 10.2307/2153966; MAINI PK, 1991, B MATH BIOL, V53, P701, DOI 10.1007/BF02461550; CHEN XF, 1992, J DIFFER EQUATIONS, V96, P116, DOI 10.1016/0022-0396(92)90146-E; Chen X.-Y., 1991, HIROSHIMA MATH J, V21, P47; DALQUIST FW, 1972, NATURE NEW BIOL, V236; FUJII H, 1983, LECT NOTES NUM APPL, V6, P21; FUNAKI M, UNPUB; KOBAYASHI R, 1993, PHYSICA D, V63, P410, DOI 10.1016/0167-2789(93)90120-P; LAUFFENBURGER DA, 1983, J MATH BIOL, V16, P141, DOI 10.1007/BF00276054; Mimura M., 1993, FORMA, V8, P179; MIMURA M, 1982, SIAM J MATH ANAL, V13, P555; DEMOTTONI P, 1990, P ROY SOC EDINB A, V116, P207; MYERSCOUGH MR, 1992, B MATH BIOL, V54, P77, DOI 10.1007/BF02458621; Nagai T., 1995, ADV MATH SCI APPL, V5, P581; OHTA T, 1989, PHYSICA D, V34, P115, DOI 10.1016/0167-2789(89)90230-3; SCHAAF R, 1985, T AM MATH SOC, V292, P531, DOI 10.2307/2000228; TSUJIKAWA T, 1996, IN PRESS J METHODS A, V3	22	72	75	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-4371			PHYSICA A	Physica A	SEP 1	1996	230	3-4					499	543		10.1016/0378-4371(96)00051-9		45	Physics, Multidisciplinary	Physics	VE027	WOS:A1996VE02700011		
J	Wang, FG; Suzuki, M				Wang, FG; Suzuki, M			The phase diagram of the 2D Ising model with anisotropic next-nearest-neighbor and four-spin interactions	PHYSICA A			English	Article						Ising model; eight-vertex model; free-fermion condition	FREE FERMION APPROXIMATION; UNION JACK LATTICE; CRITICAL-BEHAVIOR; CRITICAL INDEXES; UNIVERSALITY	In the present paper, the two-dimensional Ising model with anisotropic nearest-neighbor, next-nearest-neighbor and four-spin interactions has been studied. The ground states and energy of the model have been obtained. The model is equivalent to an eight-vertex model on its dual lattice. In some special cases, the model can be solved exactly as a zero-field eight-vertex model or a free-fermion model. Explicit phase diagrams are obtained exactly.	SHANGHAI JIAO TONG UNIV,DEPT APPL PHYS,SHANGHAI 200030,PEOPLES R CHINA	Wang, FG (reprint author), UNIV TOKYO,DEPT PHYS,BUNKYO KU,HONGO 7-3-1,TOKYO 113,JAPAN.						FAN C, 1970, PHYS REV B, V2, P723, DOI 10.1103/PhysRevB.2.723; BINDER K, 1980, PHYS REV B, V21, P1941, DOI 10.1103/PhysRevB.21.1941; Onsager L, 1944, PHYS REV, V65, P117, DOI 10.1103/PhysRev.65.117; LIPOWSKI A, 1995, J PHYS A-MATH GEN, V28, pL261, DOI 10.1088/0305-4470/28/9/003; NIGHTINGALE MP, 1977, PHYS LETT A, V59, P486, DOI 10.1016/0375-9601(77)90665-X; HURST CA, 1960, J CHEM PHYS, V33, P1059, DOI 10.1063/1.1731333; Baxter R. J., 1982, EXACTLY SOLVED MODEL; BAXTER RJ, 1972, ANN PHYS-NEW YORK, V70, P193, DOI 10.1016/0003-4916(72)90335-1; BAXTER RJ, 1986, P ROY SOC LOND A MAT, V404, P1, DOI 10.1098/rspa.1986.0016; FAN C, 1969, PHYS REV, V179, P560, DOI 10.1103/PhysRev.179.560; KOOIMAN A, 1992, J STAT PHYS, V69, P247, DOI 10.1007/BF01053793; MINAMI K, 1993, PHYSICA A, V195, P457, DOI 10.1016/0378-4371(93)90170-9; Suzuki M., 1995, COHERENT ANOMALY MET; SUZUKI M, 1974, PROG THEOR PHYS, V51, P1992, DOI 10.1143/PTP.51.1992; SUZUKI M, 1994, PHYSICA A, V205, P80, DOI 10.1016/0378-4371(94)90492-8; TANAKA K, 1992, PHYS LETT A, V165, P266, DOI 10.1016/0375-9601(92)90048-Q; TANAKA K, 1993, PHYSICA A, V192, P647, DOI 10.1016/0378-4371(93)90114-J; WANG F, IN PRESS COMMUN THEO; WANG FG, 1994, COMMUN THEOR PHYS, V22, P145; WANG FG, 1993, ACTA PHYS SINICA, V42, P1179; WU FY, 1987, J PHYS A-MATH GEN, V20, P5737, DOI 10.1088/0305-4470/20/16/049; WU FW, 1971, PHYS REV B, V4, P2312, DOI 10.1103/PhysRevB.4.2312; WU FY, 1995, PHYS REV E, V51, P889, DOI 10.1103/PhysRevE.51.889	23	13	13	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-4371			PHYSICA A	Physica A	SEP 1	1996	230	3-4					639	650		10.1016/0378-4371(96)00116-1		12	Physics, Multidisciplinary	Physics	VE027	WOS:A1996VE02700018		
J	Suzuki, T; Ando, T				Suzuki, T; Ando, T			Self-consistent results in quantum wires in magnetic fields: Temperature effects	PHYSICA B			English	Article; Proceedings Paper	3rd International Symposium on New Phenomena in Mesoscopic Structures (NPMS 95)	DEC 04-08, 1995	MAUI, HI	Japan Soc Promot Sci, 151st Comm Electr Propert Extreme Struct		mesoscopic systems; quantum wires; Landau level; edge state	ELECTRON-GAS; HALL REGIME	Results of a self-consistent calculation are reported on the energy level structure of quantum wires formed by a split gate at GaAs/AlGaAs heterostructures in magnetic fields at different temperatures. The electron density associated with partially filled Landau level oscillates spatially to minimize the Coulomb energy and has a characteristic double-step variation near the edge at low temperatures.	UNIV TOKYO,INST SOLID STATE PHYS,MINATO KU,TOKYO 106,JAPAN; SENDAI NATL COLL TECHNOL,DEPT INFORMAT ENGN,AOBA KU,SENDAI,MIYAGI 98931,JAPAN							ZHENG HZ, 1986, PHYS REV B, V34, P5635, DOI 10.1103/PhysRevB.34.5635; THORNTON TJ, 1986, PHYS REV LETT, V56, P1198, DOI 10.1103/PhysRevLett.56.1198; CHKLOVSKII DB, 1993, PHYS REV B, V47, P12605, DOI 10.1103/PhysRevB.47.12605; SUZUKI T, 1993, J PHYS SOC JPN, V62, P2986, DOI 10.1143/JPSJ.62.2986; SUZUKI T, 1994, PHYSICA B, V201, P345, DOI 10.1016/0921-4526(94)91111-8; WULF U, 1988, PHYS REV B, V38, P4218, DOI 10.1103/PhysRevB.38.4218	6	18	18	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0921-4526			PHYSICA B	Physica B	SEP	1996	227	1-4					46	49		10.1016/0921-4526(96)00333-X		4	Physics, Condensed Matter	Physics	VR715	WOS:A1996VR71500013		
J	Nagamune, Y; Noda, T; Watabe, H; Ohno, Y; Sakaki, H; Arakawa, Y				Nagamune, Y; Noda, T; Watabe, H; Ohno, Y; Sakaki, H; Arakawa, Y			Photoluminescence from point contact structures - Direct observation of electron flow	PHYSICA B			English	Article; Proceedings Paper	3rd International Symposium on New Phenomena in Mesoscopic Structures (NPMS 95)	DEC 04-08, 1995	MAUI, HI	Japan Soc Promot Sci, 151st Comm Electr Propert Extreme Struct		point contact; photoluminescence; electron flow; visualization		We demonstrate visualization of electron flow from a point contact by using a micro-photoluminescence measurement technique. It was found that the photoluminescence intensity at the exit of the point contact was strongly reduced by the majority electron flow from the point contact. This is considered to be caused from that the majority electrons with large wave number reduce radiative recombination of the electron-hole pairs generated by the laser illumination, which was also supported by the time and spatial resolved measurement.	UNIV TOKYO,INST IND SCI,MINATO KU,TOKYO 106,JAPAN; UNIV TOKYO,ADV SCI & TECHNOL RES CTR,MEGURO KU,TOKYO 153,JAPAN							VANWEES BJ, 1988, PHYS REV LETT, V60, P848, DOI 10.1103/PhysRevLett.60.848; YACOBY A, 1991, PHYS REV LETT, V66, P1938, DOI 10.1103/PhysRevLett.66.1938; SPECTOR J, 1990, APPL PHYS LETT, V56, P1290, DOI 10.1063/1.102538; FASOL G, 1994, P 22 INT C PHYS SEM, P1645; FONTEIN PF, 1991, PHYS REV B, V43, P12090, DOI 10.1103/PhysRevB.43.12090; HILLMER H, 1989, PHYS REV B, V39, P10901, DOI 10.1103/PhysRevB.39.10901; KLASS U, 1991, PHYSICA B, V196, P363; NAGAMUNE Y, 1994, P 22 INT C PHYS SEMV, P1835; SUGAYA T, 1991, JPN J APPL PHYS 2, V30, pL402, DOI 10.1143/JJAP.30.L402; VANHAREN RJF, 1995, PHYS REV LETT, V74, P1198, DOI 10.1103/PhysRevLett.74.1198; VANHOUTEN H, 1988, EUROPHYS LETT, V5, P721	11	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0921-4526			PHYSICA B	Physica B	SEP	1996	227	1-4					77	81		10.1016/0921-4526(96)00353-5		5	Physics, Condensed Matter	Physics	VR715	WOS:A1996VR71500021		
J	Hiramoto, T; Ishikuro, H; Fujii, T; Saraya, T; Hashiguchi, G; Ikoma, T				Hiramoto, T; Ishikuro, H; Fujii, T; Saraya, T; Hashiguchi, G; Ikoma, T			Characterization of precisely width-controlled Si quantum wires fabricated on SOI substrates	PHYSICA B			English	Article; Proceedings Paper	3rd International Symposium on New Phenomena in Mesoscopic Structures (NPMS 95)	DEC 04-08, 1995	MAUI, HI	Japan Soc Promot Sci, 151st Comm Electr Propert Extreme Struct		Si quantum wire; SOI; Coulomb blockade; quantum dots	COULOMB-BLOCKADE; SILICON; TEMPERATURES	Silicon quantum wire structures with precisely controlled widths have been successfully fabricated on an SOI substrate by an anisotropic etching technique. The width of the wires does not depend on the lithography limit but solely on the thickness of the Si film of the SOI substrate. It is demonstrated that the wires are straight even if the lithography patterns are fluctuated. The minimum width is estimated to be less than 10 nm. This technique has been applied to fabricating a quantum wire FET, which shows fine peaks in drain current as a function of the gate voltage at low temperatures due to the Coulomb blockade of the single electron tunneling. The oscillations remain even at room temperature.	TEXAS INSTRUMENTS INC,TSUKUBA R&D CTR,TSUKUBA,IBARAKI 305,JAPAN; NIPPON STEEL CORP LTD,ELECT RES LABS,SAGAMIHARA,KANAGAWA 229,JAPAN	Hiramoto, T (reprint author), UNIV TOKYO,DEPT IND SCI,MINATO KU,7-22-1 ROPPONGI,TOKYO 106,JAPAN.						LEOBANDUNG E, 1995, APPL PHYS LETT, V67, P938, DOI 10.1063/1.114701; NAKAZATO K, 1994, J APPL PHYS, V75, P5123, DOI 10.1063/1.355758; DEGRAAF C, 1991, PHYS REV B, V44, P9072, DOI 10.1103/PhysRevB.44.9072; HASHIGUCHI G, 1994, JPN J APPL PHYS 2, V33, pL1649; MORIMOTO K, 1993, 1993 INT C SOL STAT, P344; PAUL DJ, 1993, APPL PHYS LETT, V63, P631, DOI 10.1063/1.109972; TAKAHASHI Y, 1994, INTERNATIONAL ELECTRON DEVICES MEETING 1994 - IEDM TECHNICAL DIGEST, P938, DOI 10.1109/IEDM.1994.383257	7	8	8	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0921-4526			PHYSICA B	Physica B	SEP	1996	227	1-4					95	97		10.1016/0921-4526(96)00363-8		3	Physics, Condensed Matter	Physics	VR715	WOS:A1996VR71500025		
J	Iye, Y; Endo, A; Izawa, S; Kato, M; Katsumoto, S				Iye, Y; Endo, A; Izawa, S; Kato, M; Katsumoto, S			Magnetotransport in modulated and magnetic fields	PHYSICA B			English	Article; Proceedings Paper	3rd International Symposium on New Phenomena in Mesoscopic Structures (NPMS 95)	DEC 04-08, 1995	MAUI, HI	Japan Soc Promot Sci, 151st Comm Electr Propert Extreme Struct		magnetotransport; modulated fields; magnetic fields	DIMENSIONAL ELECTRON-GAS; MAGNETORESISTANCE OSCILLATIONS; SUPERLATTICE	We study the effect of spatially periodic magnetic field on the transport in a two-dimensional electron gas in GaAs/AlGaAs heterojunctions. The magnetoresistance curve contains an oscillatory component due to the magnetic modulation as well as one due to the electric potential modulation, and their relative amplitudes can be varied by adjusting the gate bias or the maximum field of field cycling.	UNIV TOKYO,INST SOLID STATE PHYS,TOKYO 106,JAPAN							WINKLER RW, 1989, PHYS REV LETT, V62, P1177, DOI 10.1103/PhysRevLett.62.1177; YE PD, 1995, PHYS REV LETT, V74, P3013, DOI 10.1103/PhysRevLett.74.3013; PEETERS FM, 1993, PHYS REV B, V47, P1466, DOI 10.1103/PhysRevB.47.1466; VASILOPOULOS P, 1989, PHYS REV LETT, V63, P2120, DOI 10.1103/PhysRevLett.63.2120; GERHARDTS RR, 1989, PHYS REV LETT, V62, P1173, DOI 10.1103/PhysRevLett.62.1173; CARMONA HA, 1995, PHYS REV LETT, V74, P3009, DOI 10.1103/PhysRevLett.74.3009; YAGI R, 1993, J PHYS SOC JPN, V62, P1279, DOI 10.1143/JPSJ.62.1279; WEISS D, 1989, EUROPHYS LETT, V8, P179, DOI 10.1209/0295-5075/8/2/012; BEENAKKER CWJ, 1989, PHYS REV LETT, V62, P2020, DOI 10.1103/PhysRevLett.62.2020; IZAWA S, 1995, J PHYS SOC JPN, V64, P706, DOI 10.1143/JPSJ.64.706; XUE DP, 1992, PHYS REV B, V45, P5986, DOI 10.1103/PhysRevB.45.5986; YOSHIOKA D, 1987, J PHYS SOC JPN, V56, P448, DOI 10.1143/JPSJ.56.448	12	5	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0921-4526			PHYSICA B	Physica B	SEP	1996	227	1-4					122	126		10.1016/0921-4526(96)00379-1		5	Physics, Condensed Matter	Physics	VR715	WOS:A1996VR71500033		
J	Nakanishi, T; Ando, T				Nakanishi, T; Ando, T			AAS oscillations in antidot lattices	PHYSICA B			English	Article; Proceedings Paper	3rd International Symposium on New Phenomena in Mesoscopic Structures (NPMS 95)	DEC 04-08, 1995	MAUI, HI	Japan Soc Promot Sci, 151st Comm Electr Propert Extreme Struct		AAS oscillation; antidot lattice; Aharonov-Bohm effect	QUANTUM	Quantum-interference effects on the conductance of antidot lattices are studied with the use of a recursive Green's function technique. It is shown that Aharonov-Bohm (AB) type oscillations varying sensitively with the antidot diameter and period are dominant in the ideal case. The AB oscillations disappear and an AAS oscillation manifests itself in the presence of fluctuations in the size or position of the antidots.		Nakanishi, T (reprint author), UNIV TOKYO,INST SOLID STATE PHYS,MINATO KU,7-22-1 ROPPONGI,TOKYO 106,JAPAN.						ALTSHULER BL, 1993, JETP LETT, V33, P1255; SHARVIN DY, 1981, JETP LETT+, V34, P272; ANDO T, 1991, PHYS REV B, V44, P8017, DOI 10.1103/PhysRevB.44.8017; DOLAN GJ, 1986, PHYS REV LETT, V56, P1493, DOI 10.1103/PhysRevLett.56.1493; NIHEY F, 1995, PHYS REV B, V51, P4649, DOI 10.1103/PhysRevB.51.4649; GUSEV GM, 1992, JETP LETT+, V55, P123; NAKAMURA K, 1994, PHYSICA B, V197, P144, DOI 10.1016/0921-4526(94)90208-9	7	14	14	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0921-4526			PHYSICA B	Physica B	SEP	1996	227	1-4					127	130		10.1016/0921-4526(96)00380-8		4	Physics, Condensed Matter	Physics	VR715	WOS:A1996VR71500034		
J	Uryu, S; Ando, T				Uryu, S; Ando, T			Analysis of antidot lattices with periodic orbit theory	PHYSICA B			English	Article; Proceedings Paper	3rd International Symposium on New Phenomena in Mesoscopic Structures (NPMS 95)	DEC 04-08, 1995	MAUI, HI	Japan Soc Promot Sci, 151st Comm Electr Propert Extreme Struct		antidot lattices; magnetoresistance; periodic orbit theory	QUANTIZATION	The density of states calculated by a full quantum-mechanical method are analyzed semiclassically in terms of the periodic orbit theory. It is revealed that some structures of the density of states are explained by the quantization of the periodic orbits.		Uryu, S (reprint author), UNIV TOKYO,INST SOLID STATE PHYS,MINATO KU,7-22-1 ROPPONGI,TOKYO 106,JAPAN.						FLEISCHMANN R, 1992, PHYS REV LETT, V68, P1367, DOI 10.1103/PhysRevLett.68.1367; WEISS D, 1993, PHYS REV LETT, V70, P4118, DOI 10.1103/PhysRevLett.70.4118; GUTZWILL.MC, 1971, J MATH PHYS, V12, P343, DOI 10.1063/1.1665596; GUTZWILL.MC, 1969, J MATH PHYS, V10, P1004, DOI 10.1063/1.1664927; GUTZWILL.MC, 1970, J MATH PHYS, V11, P1791, DOI 10.1063/1.1665328; GUTZWILL.MC, 1967, J MATH PHYS, V8, P1979, DOI 10.1063/1.1705112; MILLER WH, 1975, J CHEM PHYS, V63, P996, DOI 10.1063/1.431410; NAKAMURA K, 1994, PHYSICA B, V197, P144, DOI 10.1016/0921-4526(94)90208-9; RICHTER K, 1995, EUROPHYS LETT, V29, P7, DOI 10.1209/0295-5075/29/1/002; URYU S, 1995, JPN J APPL PHYS 1, V34, P4295, DOI 10.1143/JJAP.34.4295; Uryu S, 1996, PHYS REV B, V53, P13613, DOI 10.1103/PhysRevB.53.13613	11	6	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0921-4526			PHYSICA B	Physica B	SEP	1996	227	1-4					138	140		10.1016/0921-4526(96)00382-1		3	Physics, Condensed Matter	Physics	VR715	WOS:A1996VR71500036		
J	Kawaguchi, Y; Komiyama, S; Osada, T; Shiraki, Y				Kawaguchi, Y; Komiyama, S; Osada, T; Shiraki, Y			Nonlocal nature of the breakdown of the integer quantum Hall effects	PHYSICA B			English	Article; Proceedings Paper	3rd International Symposium on New Phenomena in Mesoscopic Structures (NPMS 95)	DEC 04-08, 1995	MAUI, HI	Japan Soc Promot Sci, 151st Comm Electr Propert Extreme Struct		integer quantum Hall effect; breakdown; device-length dependence	2-DIMENSIONAL ELECTRON-GAS; HIGH MAGNETIC-FIELDS; GAAS/ALGAAS HETEROSTRUCTURES; RESISTANCE; REGIME; RESISTIVITY; BEHAVIOR	Remarkable device-length dependence is observed in the current-induced breakdown of integer quantum Harl effects (QHE) in 2-3 mu m wide standard Hall bars with different lengths (6-460 mu m) at T = 1.6-4.2 K and Landau-level filling factors of nu = 2 and 4. Samples are fabricated from two GaAs/AlGaAs heterostructures. The diagonal resistance R(x) in longer Hall bars increases sharply to exhibit well-defined characteristics of the IQHE-breakdown at a critical current I-c, but it does not exhibit a sharp increase in shorter Hall bars. The results are consistent with previous observations in devices with narrow constrictions, and establish that IQHE-breakdown is not locally caused by an electric field.	UNIV TOKYO,DEPT PURE & APPL SCI,MEGURO KU,TOKYO 153,JAPAN; UNIV TOKYO,RCAST,MEGURO KU,TOKYO 153,JAPAN							CAGE ME, 1983, PHYS REV LETT, V51, P1374, DOI 10.1103/PhysRevLett.51.1374; KOMIYAMA S, 1985, SOLID STATE COMMUN, V54, P479, DOI 10.1016/0038-1098(85)90651-9; EBERT G, 1983, J PHYS C SOLID STATE, V16, P5441, DOI 10.1088/0022-3719/16/28/012; BALABAN NQ, 1993, PHYS REV LETT, V71, P1443, DOI 10.1103/PhysRevLett.71.1443; CHOE KK, 1987, APPL PHYS LETT, V50, P110; Eaves L, 1986, SEMICOND SCI TECH, V1, P346, DOI 10.1088/0268-1242/1/6/002; HEINONEN O, 1984, PHYS REV B, V30, P3016, DOI 10.1103/PhysRevB.30.3016; KAWAGUCHI Y, 1995, JPN J APPL PHYS 1, V34, P4309, DOI 10.1143/JJAP.34.4309; Kawaji S., 1981, Physics in High Magnetic Fields. Proceedings of the Oji International Seminar; KAWAJI S, 1993, PHYSICA B, V184, P17, DOI 10.1016/0921-4526(93)90313-U; KAWAJI S, 1994, J PHYS SOC JPN, V63, P2303, DOI 10.1143/JPSJ.63.2303; KOMIYAMA S, 1986, SURF SCI, V170, P202; KOMIYAMA S, 1993, PHYSICA B, V184, P7, DOI 10.1016/0921-4526(93)90312-T; KOMIYAMA S, 1991, SOLID STATE COMMUN, V80, P157, DOI 10.1016/0038-1098(91)90173-S; KUCHAR F, 1984, SURF SCI, V142, P196, DOI 10.1016/0039-6028(84)90307-8; MCEUEN PL, 1990, PHYS REV LETT, V64, P2062, DOI 10.1103/PhysRevLett.64.2062; STREDA P, 1984, J PHYS C SOLID STATE, V17, pL483, DOI 10.1088/0022-3719/17/19/002; VANHOUTEN H, 1988, SURF SCI, V196, P144, DOI 10.1016/0039-6028(88)90677-2; von Klitzing K., 1980, PHYS REV LETT, V45, P449; VONSON PC, 1990, PHYS REV B, V42, P11267	20	9	9	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0921-4526			PHYSICA B	Physica B	SEP	1996	227	1-4					183	185		10.1016/0921-4526(96)00393-6		3	Physics, Condensed Matter	Physics	VR715	WOS:A1996VR71500047		
J	Wilkinson, PB; Fromhold, TM; Eaves, L; Sheard, FW; Miura, N; Takamasu, T				Wilkinson, PB; Fromhold, TM; Eaves, L; Sheard, FW; Miura, N; Takamasu, T			Distribution of 'scarred' eigenfunctions in a quantum well with chaotic classical dynamics probed by resonant tunnelling	PHYSICA B			English	Article; Proceedings Paper	3rd International Symposium on New Phenomena in Mesoscopic Structures (NPMS 95)	DEC 04-08, 1995	MAUI, HI	Japan Soc Promot Sci, 151st Comm Electr Propert Extreme Struct		quantum wells; chaotic dynamics; resonant tunnelling	UNSTABLE PERIODIC-ORBITS; WAVE-FUNCTIONS; HYDROGEN-ATOM; SYSTEMS; TRANSPORT; SPECTRUM; STATES; GAAS	Magnetotunnelling spectroscopy is used to probe experimentally electronic wave functions scarred by classic trajectories in a classically chaotic system. The system comprises an electron moving in a 22 nm GaAs quantum well of a double barrier resonant tunnelling diode in the presence of large tilted magnetic fields. Resonant peaks in the current-voltage characteristics are shown to originate from dominant tunnelling transitions into the subset of scarred states in the quantum well.	UNIV NOTTINGHAM,DEPT PHYS,NOTTINGHAM NG7 2RD,ENGLAND; UNIV TOKYO,INST SOLID STATE PHYS,TOKYO 106,JAPAN			Schaff, William/B-5839-2009; 	Fromhold, Timothy/0000-0001-7451-2525			AGAM O, 1994, PHYS REV LETT, V73, P806, DOI 10.1103/PhysRevLett.73.806; FROMHOLD TM, 1994, PHYS REV LETT, V72, P2608, DOI 10.1103/PhysRevLett.72.2608; FROMHOLD TM, 1995, PHYS REV LETT, V75, P1142, DOI 10.1103/PhysRevLett.75.1142; WEISS D, 1993, PHYS REV LETT, V70, P4118, DOI 10.1103/PhysRevLett.70.4118; Wilkinson PB, 1996, NATURE, V380, P608, DOI 10.1038/380608a0; SHEPELYANSKY DL, 1995, PHYS REV LETT, V74, P2098, DOI 10.1103/PhysRevLett.74.2098; LEADBEATER ML, 1991, SEMICOND SCI TECH, V6, P1021, DOI 10.1088/0268-1242/6/10/012; FROMHOLD TM, 1995, PHYS REV B, V51, P18029, DOI 10.1103/PhysRevB.51.18029; HELLER EJ, 1984, PHYS REV LETT, V53, P1515, DOI 10.1103/PhysRevLett.53.1515; HOLLE A, 1988, PHYS REV LETT, V61, P161, DOI 10.1103/PhysRevLett.61.161; JENSEN RV, 1992, NATURE, V355, P311, DOI 10.1038/355311a0; BERRY MV, 1987, PROC R SOC LON SER-A, V413, P183, DOI 10.1098/rspa.1987.0109; BERRY MV, 1989, P ROY SOC LOND A MAT, V423, P219, DOI 10.1098/rspa.1989.0052; BOGOMOLNY EB, 1988, PHYSICA D, V31, P169, DOI 10.1016/0167-2789(88)90075-9; DEPOLAVIEJA GG, 1994, PHYS REV LETT, V73, P1613, DOI 10.1103/PhysRevLett.73.1613; ECKHARDT B, 1989, PHYS REV A, V39, P3776, DOI 10.1103/PhysRevA.39.3776; Gutzwiller M, 1990, CHAOS CLASSICAL QUAN; JENSEN RV, 1989, PHYS REV LETT, V63, P2771, DOI 10.1103/PhysRevLett.63.2771; LEVI AFJ, 1987, PHYS REV B, V36, P9402, DOI 10.1103/PhysRevB.36.9402; MULLER K, 1994, J PHYS B-AT MOL OPT, V27, P2693, DOI 10.1088/0953-4075/27/13/003; SHI JM, 1993, PHYS REV B, V48, P5202, DOI 10.1103/PhysRevB.48.5202; WINTGEN D, 1989, PHYS REV LETT, V63, P1467, DOI 10.1103/PhysRevLett.63.1467; WINTGEN D, 1987, PHYS REV A, V36, P131, DOI 10.1103/PhysRevA.36.131	23	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0921-4526			PHYSICA B	Physica B	SEP	1996	227	1-4					192	196		10.1016/0921-4526(96)00397-3		5	Physics, Condensed Matter	Physics	VR715	WOS:A1996VR71500050		
J	Hirakawa, K; Shimada, Y; Ikoma, T				Hirakawa, K; Shimada, Y; Ikoma, T			Supply-function dependent sequential resonant tunneling in semiconductor multiple quantum well diodes	PHYSICA B			English	Article; Proceedings Paper	3rd International Symposium on New Phenomena in Mesoscopic Structures (NPMS 95)	DEC 04-08, 1995	MAUI, HI	Japan Soc Promot Sci, 151st Comm Electr Propert Extreme Struct		heterostructures; quantum wells; resonant tunneling	SUPERLATTICES; TRANSPORT	We have investigated the tunneling I-V characteristics of Al0.3Ga0.7As/GaAs MQW diodes with different electron densities, N-s. Clear periodic negative differential resistances (NDRs) are observed for the samples with low N-s, while NDRs are completely absent in the first plateau region of the I-V characteristics of the samples with high N-s. It is found that such appearance/disappearance of periodic NDRs in the first plateau region of the I-V characteristics is controlled by the interplay of the transmission probability and the electron supply-function.	TEXAS INSTRUMENTS INC,TSUKUBA RES & DEV CTR,TSUKUBA,IBARAKI 305,JAPAN	Hirakawa, K (reprint author), UNIV TOKYO,INST IND SCI,MINATO KU,7-22-1 ROPPONGI,TOKYO 106,JAPAN.						FAIST J, 1994, SCIENCE, V264, P553, DOI 10.1126/science.264.5158.553; ESAKI L, 1974, PHYS REV LETT, V33, P495, DOI 10.1103/PhysRevLett.33.495; CAPASSO F, 1986, IEEE J QUANTUM ELECT, V22, P1853, DOI 10.1109/JQE.1986.1073171; LEVINE BF, 1993, J APPL PHYS, V74, pR1, DOI 10.1063/1.354252; GUIMARAES PSS, 1993, PHYS REV LETT, V70, P3792, DOI 10.1103/PhysRevLett.70.3792; CHOI KK, 1987, PHYS REV B, V35, P4172, DOI 10.1103/PhysRevB.35.4172; GRAHN HT, 1990, PHYS REV B, V41, P2890, DOI 10.1103/PhysRevB.41.2890; KAZARINO.RF, 1972, SOV PHYS SEMICOND+, V6, P120; VUONG THH, 1989, J APPL PHYS, V66, P3688, DOI 10.1063/1.344081	9	4	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0921-4526			PHYSICA B	Physica B	SEP	1996	227	1-4					202	205		10.1016/0921-4526(96)00399-7		4	Physics, Condensed Matter	Physics	VR715	WOS:A1996VR71500052		
J	Yagi, R; Yamaguchi, T; Kazawa, H; Kobayashi, S				Yagi, R; Yamaguchi, T; Kazawa, H; Kobayashi, S			Capacitance dependence of critical tunneling resistance for superconductor-insulator transition in two-dimensional network of Josephson junctions	PHYSICA B			English	Article; Proceedings Paper	3rd International Symposium on New Phenomena in Mesoscopic Structures (NPMS 95)	DEC 04-08, 1995	MAUI, HI	Japan Soc Promot Sci, 151st Comm Electr Propert Extreme Struct		small Josephson junction; superconductor-insulator transition; K-T transition	CHARGE; COHERENCE; ARRAYS; FILMS	We investigated the superconductor-insulator (S-I) transition in two-dimensional network of Al/AlOx/Al Josephson junction in detail by varying the junction area S from 0.01 to 0.09 mu m(2). It is observed that the critical tunnelling resistance for the S-I transition exhibits significant S-dependence. The resultant phase diagram was reminiscent of that of Fazio and Schon's theory although we observed some differences at large E(J)/E(C) values.		Yagi, R (reprint author), UNIV TOKYO,SCH SCI,DEPT PHYS,BUNKYO KU,1-3-1 HONGO,TOKYO 113,JAPAN.						CHAKRAVARTY S, 1982, PHYS REV LETT, V49, P681, DOI 10.1103/PhysRevLett.49.681; JAEGER HM, 1989, PHYS REV B, V40, P182, DOI 10.1103/PhysRevB.40.182; CHEN CD, 1992, HELV PHYS ACTA, V65, P2406; FAZIO R, 1991, PHYS REV B, V43, P5307, DOI 10.1103/PhysRevB.43.5307; GEERLIGS LJ, 1989, PHYS REV LETT, V63, P326, DOI 10.1103/PhysRevLett.63.326; GUINEA F, 1986, EUROPHYS LETT, V1, P585, DOI 10.1209/0295-5075/1/11/007; KOBAYASHI S, 1988, J PHYS SOC JPN, V57, P1884, DOI 10.1143/JPSJ.57.1884; MOOIJ JE, 1990, PHYS REV LETT, V65, P645, DOI 10.1103/PhysRevLett.65.645; YAGI R, 1995, J PHYS SOC JPN, V64, P375, DOI 10.1143/JPSJ.64.375; YAMADA R, 1992, J PHYS SOC JPN, V61, P2656, DOI 10.1143/JPSJ.61.2656	10	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0921-4526			PHYSICA B	Physica B	SEP	1996	227	1-4					232	234		10.1016/0921-4526(96)00407-3		3	Physics, Condensed Matter	Physics	VR715	WOS:A1996VR71500060		
J	Kanda, A; Kobayashi, S				Kanda, A; Kobayashi, S			Effect of self-capacitance on charge Kosterlitz-Thouless transition in two-dimensional arrays of small tunnel junctions	PHYSICA B			English	Article; Proceedings Paper	3rd International Symposium on New Phenomena in Mesoscopic Structures (NPMS 95)	DEC 04-08, 1995	MAUI, HI	Japan Soc Promot Sci, 151st Comm Electr Propert Extreme Struct		small tunnel junction; Kosterlitz-Thouless transition; screening length	2-DIMENSIONAL ARRAYS; PRECURSOR	We have studied the self-capacitance dependence of zero-bias resistance in two-dimensional arrays of highly resistive small tunnel junctions. All samples showed the square-root-cusp temperature dependence, which is inherent in the precursor of Kosterlitz-Thouless (KT) transition of charge, in a limited temperature range. Deviation from it at lower temperatures is more prominent in arrays with smaller screening length. The results suggest that the finiteness of the screening length is responsible for the disappearance of the charge KT transition in these arrays.	UNIV TOKYO,SCH SCI,DEPT PHYS,BUNKYO KU,TOKYO 113,JAPAN							Kosterlitz JM, 1973, J PHYS C SOLID STATE, V6, P1181, DOI 10.1088/0022-3719/6/7/010; RIMBERG AJ, 1995, PHYS REV LETT, V74, P4714, DOI 10.1103/PhysRevLett.74.4714; BEREZINSKII VL, 1971, ZH EKSP TEOR FIZ, V32, P493; BOBBERT PA, 1991, MACROSCOPIC QUANTUM PHENOMENA, P119; KANDA A, 1994, J PHYS SOC JPN, V63, P4306, DOI 10.1143/JPSJ.63.4306; KANDA A, 1995, J PHYS SOC JPN, V64, P19, DOI 10.1143/JPSJ.64.19; MOOIJ JE, 1990, PHYS REV LETT, V65, P645, DOI 10.1103/PhysRevLett.65.645; YAMADA R, 1995, J PHYS SOC JPN, V64, P360, DOI 10.1143/JPSJ.64.360	8	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0921-4526			PHYSICA B	Physica B	SEP	1996	227	1-4					238	240		10.1016/0921-4526(96)00409-7		3	Physics, Condensed Matter	Physics	VR715	WOS:A1996VR71500062		
J	Ogata, M				Ogata, M			Quantized conductance in a mesoscopic Tomonaga-Luttinger liquid	PHYSICA B			English	Article; Proceedings Paper	3rd International Symposium on New Phenomena in Mesoscopic Structures (NPMS 95)	DEC 04-08, 1995	MAUI, HI	Japan Soc Promot Sci, 151st Comm Electr Propert Extreme Struct		conductance quantization; Tomonaga-Luttinger liquid; quantum wire; Mott transition	CORRELATED HUBBARD-MODEL; COLLAPSE; GAS	The quantized value of conductance in a quantum wire is discussed near the Mott transition. The temperature dependence of the collapse of quantized conductance in the presence of magnetic field is also discussed by taking account of both impurity scattering and mutual Coulomb interactions.		Ogata, M (reprint author), UNIV TOKYO,COLL ARTS & SCI,INST PHYS,MEGURO KU,TOKYO 153,JAPAN.						TARUCHA S, 1993, PHYS REV B, V47, P4064, DOI 10.1103/PhysRevB.47.4064; MORI H, 1965, PROG THEOR PHYS, V33, P423, DOI 10.1143/PTP.33.423; SOLYOM J, 1979, ADV PHYS, V28, P201, DOI 10.1080/00018737900101375; KANE CL, 1992, PHYS REV LETT, V68, P1220, DOI 10.1103/PhysRevLett.68.1220; OGATA M, 1990, PHYS REV B, V41, P2326, DOI 10.1103/PhysRevB.41.2326; APEL W, 1982, PHYS REV B, V26, P7063, DOI 10.1103/PhysRevB.26.7063; TARUCHA S, 1995, SOLID STATE COMMUN, V94, P413, DOI 10.1016/0038-1098(95)00102-6; LUTHER A, 1974, PHYS REV LETT, V33, P589, DOI 10.1103/PhysRevLett.33.589; FUKUYAMA H, 1993, J PHYS SOC JPN, V62, P1109, DOI 10.1143/JPSJ.62.1109; KIMURA T, PREPRINT; LUTHER A, 1974, PHYS REV LETT, V32, P992, DOI 10.1103/PhysRevLett.32.992; OGATA M, 1994, PHYS REV LETT, V73, P468, DOI 10.1103/PhysRevLett.73.468; OGATA M, 1992, PROG THEOR PHYS SUPP, V108, P265; OGATA M, 1991, PHYS REV B, V43, P8401, DOI 10.1103/PhysRevB.43.8401; OGATA M, 1995, JPN J APPL PHYS 1, V34, P4284, DOI 10.1143/JJAP.34.4284; SHIBA H, 1992, PROG THEOR PHYS SUPP, V108, P265, DOI 10.1143/PTPS.108.265	16	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0921-4526			PHYSICA B	Physica B	SEP	1996	227	1-4					252	255		10.1016/0921-4526(96)00413-9		4	Physics, Condensed Matter	Physics	VR715	WOS:A1996VR71500066		
J	Ootuka, Y; Ono, K; Shimada, H; Kobayashi, S				Ootuka, Y; Ono, K; Shimada, H; Kobayashi, S			A new fabrication method of ultra small tunnel junctions	PHYSICA B			English	Article; Proceedings Paper	3rd International Symposium on New Phenomena in Mesoscopic Structures (NPMS 95)	DEC 04-08, 1995	MAUI, HI	Japan Soc Promot Sci, 151st Comm Electr Propert Extreme Struct		micro-fabrication; small tunnel junctions; single-electron charging effect; magnetic valve effect		A new fabrication method of micro-structures is described. Using a Si3N4 membrane having small windows as a mask, a metal film of fine structures are vacuum-deposited directly onto a substrate. By means of piezo-electric actuators or of double-angle evaporation, small tunnel-junctions are formed. This method has an important advantages, that is, the lift-off process after vacuum-deposition is not needed, and the plasma oxidation can be used for making tunnel barriers. We fabricated tunnel-junction arrays made of ferromagnetic metals, which showed both the Coulomb blockade and the magnetic valve effect at low temperatures.	UNIV TOKYO,FAC SCI,DEPT PHYS,BUNKYO KU,TOKYO 113,JAPAN	Ootuka, Y (reprint author), UNIV TOKYO,CRYOGEN CTR,BUNKYO KU,YAYOI 2-11-16,TOKYO 113,JAPAN.		Ono, Keiji/A-2989-2013				Ono K, 1996, JPN J APPL PHYS 1, V35, P2369, DOI 10.1143/JJAP.35.2369; DORAN GJ, 1977, APPL PHYS LETT, V31, P337; MAEKAWA S, 1982, IEEE T MAGN, V18, P707, DOI 10.1109/TMAG.1982.1061834	3	6	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0921-4526			PHYSICA B	Physica B	SEP	1996	227	1-4					307	309		10.1016/0921-4526(96)00427-9		3	Physics, Condensed Matter	Physics	VR715	WOS:A1996VR71500080		
J	Ajiki, H; Ando, T				Ajiki, H; Ando, T			Carbon nanotubes: Effects of magnetic fields on lattice distortions	PHYSICA B			English	Article; Proceedings Paper	3rd International Symposium on New Phenomena in Mesoscopic Structures (NPMS 95)	DEC 04-08, 1995	MAUI, HI	Japan Soc Promot Sci, 151st Comm Electr Propert Extreme Struct		carbon nanotube; fullerene tube; peierls distortion; Landau level	MICROTUBULES	A lattice instability is studied for carbon nanotubes in a magnetic field perpendicular to the tube axis in a k . p approximation. A strong magnetic field dramatically enhances the distortion at the top and bottom parts of the cylinder surface for both metallic and semiconducting nanotubes with large circumference.	UNIV TOKYO, INST SOLID STATE PHYS, MINATO KU, TOKYO 106, JAPAN							AJIKI H, 1995, J PHYS SOC JPN, V64, P260, DOI 10.1143/JPSJ.64.260; BETHUNE DS, 1993, NATURE, V363, P605, DOI 10.1038/363605a0; HARIGAYA K, 1993, PHYS REV B, V47, P16563, DOI 10.1103/PhysRevB.47.16563; AJIKI H, 1993, J PHYS SOC JPN, V62, P1255, DOI 10.1143/JPSJ.62.1255; VIET NA, 1994, J PHYS SOC JPN, V63, P3036, DOI 10.1143/JPSJ.63.3036; HAMADA N, 1992, PHYS REV LETT, V68, P1579, DOI 10.1103/PhysRevLett.68.1579; IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0; IIJIMA S, 1993, NATURE, V363, P603, DOI 10.1038/363603a0	8	3	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0921-4526			PHYSICA B	Physica B	SEP	1996	227	1-4					342	345		10.1016/0921-4526(96)00437-1		4	Physics, Condensed Matter	Physics	VR715	WOS:A1996VR71500090		
J	Kotera, N; Shimamoto, Y; Mishima, T; Miura, N				Kotera, N; Shimamoto, Y; Mishima, T; Miura, N			Study of cyclotron resonance in very high magnetic fields and nonparabolic energy band in InGaAs/InAlAs quantum wells	PHYSICA B			English	Article; Proceedings Paper	3rd International Symposium on New Phenomena in Mesoscopic Structures (NPMS 95)	DEC 04-08, 1995	MAUI, HI	Japan Soc Promot Sci, 151st Comm Electr Propert Extreme Struct		cyclotron resonance; quantum well; effective mass; conduction electron	DIMENSIONAL ELECTRON-GAS; SPECTROSCOPY	Infrared cyclotron resonance of two-dimensional electrons in modulation-doped InGaAs/InAlAs multi-quantum wells lattice-matched to InP substrates has been studied using CO2 laser and pulsed magnetic fields up to 100 T. Apparent cyclotron effective masses in a direction parallel to the quantum well plane were 0.066m(0) at 24 K and 0.067m(0) at room temperature in the 5-nm-wide wells, which were quite larger than the bulk band-edge mass of 0.041m(0). The experiments gave an evidence of strong nonparabolicity in conduction subbands of narrow quantum wells.	UNIV TOKYO,INST SOLID STATE PHYS,MINATO KU,TOKYO 106,JAPAN; HITACHI LTD,CENT RES LAB,TOKYO 185,JAPAN	Kotera, N (reprint author), KYUSHU INST TECHNOL,DEPT COMP SCI & ELECT,IIZUKA,FUKUOKA 820,JAPAN.						ADACHI S, 1993, PROPERTIES LATTICE M, P84; EKENBERG U, 1987, PHYS REV B, V36, P6152, DOI 10.1103/PhysRevB.36.6152; BRUMMELL MA, 1984, SURF SCI, V142, P380, DOI 10.1016/0039-6028(84)90338-8; GULDNER Y, 1982, APPL PHYS LETT, V40, P877, DOI 10.1063/1.92932; KOTERA N, 1995, J APPL PHYS, V78, P5168, DOI 10.1063/1.359750; KOTERA N, 1994, I PHYS C SER, V141, P233; NAJDA SP, 1991, PHYS REV B, V44, P1087, DOI 10.1103/PhysRevB.44.1087; NICHOLAS RJ, 1985, J PHYS C SOLID STATE, V18, pL427, DOI 10.1088/0022-3719/18/15/005; PAMULAPATI J, 1993, OPTICAL PROPERTIES I, P206; YAMADA S, 1985, PHYS REV B, V32, P8078, DOI 10.1103/PhysRevB.32.8078	10	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0921-4526			PHYSICA B	Physica B	SEP	1996	227	1-4					349	351		10.1016/0921-4526(96)00439-5		3	Physics, Condensed Matter	Physics	VR715	WOS:A1996VR71500092		
J	Uchida, K; Miura, N; Kukimoto, H				Uchida, K; Miura, N; Kukimoto, H			Magneto-photoluminescence spectra of excitons in GaP/AlP short period superlattices in high magnetic fields	PHYSICA B			English	Article; Proceedings Paper	3rd International Symposium on New Phenomena in Mesoscopic Structures (NPMS 95)	DEC 04-08, 1995	MAUI, HI	Japan Soc Promot Sci, 151st Comm Electr Propert Extreme Struct		magneto-photoluminescence; excitons; GaP/AlP; superlattices; high magnetic fields	OPTICAL-PROPERTIES; GAP	Magneto-photoluminescence spectra of excitons in (GaP)(n)/(AlP)(n) short period superlattices (pr = 3-9 is the number of monolayers) in high magnetic fields up to 40 T are studied. It was found that the luminescence intensity of the excitons showed a remarkable decrease when a field was applied perpendicular to the superlattices layers, whilst the intensity increased slightly for a held parallel to the layers. Application of a high hydrostatic pressure up to 10 kbar caused a red shift of Delta E/Delta P = -2.0 meV/kbar but the effect of the high pressure on the above feature of the magnetic field dependence was negligibly small. These results were interpreted in terms of the crossover of closely located different conduction bands.	UNIV TOKYO,INST SOLID STATE PHYS,MINATO KU,TOKYO 106,JAPAN; TOKYO INST TECHNOL,IMAGING SCI & ENGN LAB,MIDORI KU,YOKOHAMA,KANAGAWA 227,JAPAN							ABSTREITER G, 1989, J CRYST GROWTH, V95, P431, DOI 10.1016/0022-0248(89)90436-3; Uchida K, 1996, PHYS REV B, V53, P4809, DOI 10.1103/PhysRevB.53.4809; Kobayashi Y, 1996, SOLID STATE COMMUN, V98, P957, DOI 10.1016/0038-1098(96)00166-4; KUMAGAI M, 1988, PHYS REV B, V37, P898, DOI 10.1103/PhysRevB.37.898; MIURA N, 1994, P 11 INT C HIGH MAGN, P324; MORII A, 1992, J CRYST GROWTH, V124, P772, DOI 10.1016/0022-0248(92)90550-3; SHIBATA G, 1994, JPN J APPL PHYS 1, V33, P6121, DOI 10.1143/JJAP.33.6121	7	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0921-4526			PHYSICA B	Physica B	SEP	1996	227	1-4					352	355		10.1016/0921-4526(96)00440-1		4	Physics, Condensed Matter	Physics	VR715	WOS:A1996VR71500093		
J	Yamanaka, K; Momose, H; Mori, N; Hamaguchi, C; Arimoto, H; Imanaka, Y; Shimamoto, Y; Miura, N				Yamanaka, K; Momose, H; Mori, N; Hamaguchi, C; Arimoto, H; Imanaka, Y; Shimamoto, Y; Miura, N			Angular dependent cyclotron resonance in short period (GaAs)(n)/(AlAs)(n) superlattices	PHYSICA B			English	Article; Proceedings Paper	3rd International Symposium on New Phenomena in Mesoscopic Structures (NPMS 95)	DEC 04-08, 1995	MAUI, HI	Japan Soc Promot Sci, 151st Comm Electr Propert Extreme Struct		electron states in superlattices; cyclotron resonance; short period GaAs/AlAs superlattices	EFFECTIVE MASS; FIELD; ALAS	Cyclotron resonance (CR) measurements have been carried out to evaluate the effective masses of electrons at the AlAs X point of the Brillouin zone in short period (GaAs)(n)/(AlAs)(n) superlattices (SLs) with n = 8-14. The longitudinal effective mass was deduced to be m(1) = 1.04m(0) by analyzing a deviation of CR position from the cos 0-dependence for tilted magnetic fields in (GaAs)(14)/(AlAs)(14) SL.	OSAKA UNIV,LOW TEMP CTR,SUITA,OSAKA 565,JAPAN; UNIV TOKYO,INST SOLID STATE PHYS,MINATO KU,TOKYO 106,JAPAN	Yamanaka, K (reprint author), OSAKA UNIV,FAC ENGN,DEPT ELECT ENGN,2-1 YAMADA OKA,SUITA,OSAKA 565,JAPAN.						ANDO T, 1979, PHYS REV B, V19, P2106, DOI 10.1103/PhysRevB.19.2106; STERN F, 1967, PHYS REV, V163, P816, DOI 10.1103/PhysRev.163.816; BROZAK G, 1990, PHYS REV LETT, V64, P471, DOI 10.1103/PhysRevLett.64.471; BRUMMELL MA, 1986, J PHYS C SOLID STATE, V19, pL107, DOI 10.1088/0022-3719/19/5/003; FUKUDA T, IN PRESS SURF SCI; GOIRAN M, 1992, PHYSICA B, V177, P465, DOI 10.1016/0921-4526(92)90151-H; MIURA N, 1991, SOLID STATE COMMUN, V79, P1039, DOI 10.1016/0038-1098(91)90006-H; RHEINLAN.B, 1972, PHYS STATUS SOLIDI B, V49, pK167, DOI 10.1002/pssb.2220490263	8	4	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0921-4526			PHYSICA B	Physica B	SEP	1996	227	1-4					356	359		10.1016/0921-4526(96)00441-3		4	Physics, Condensed Matter	Physics	VR715	WOS:A1996VR71500094		
J	Wang, PD; Merz, JL; Fafard, S; Leon, R; Leonard, D; MedeirosRibeiro, G; Oestreich, M; Petroff, PM; Ledentsov, NN; Kopev, PS; Ustinov, VM; Uchida, K; Miura, N; Akiyama, H; Sakaki, H; Torres, CMS				Wang, PD; Merz, JL; Fafard, S; Leon, R; Leonard, D; MedeirosRibeiro, G; Oestreich, M; Petroff, PM; Ledentsov, NN; Kopev, PS; Ustinov, VM; Uchida, K; Miura, N; Akiyama, H; Sakaki, H; Torres, CMS			Magneto-optical properties of InAs monolayers and InyAl1-yAs self-assembled quantum dots in Ga(Al)As matrices	PHYSICA B			English	Article; Proceedings Paper	3rd International Symposium on New Phenomena in Mesoscopic Structures (NPMS 95)	DEC 04-08, 1995	MAUI, HI	Japan Soc Promot Sci, 151st Comm Electr Propert Extreme Struct		self-assembled quantum dots; InAs-GaAs; InAlAs-AlGaAs	HIGH-INDEX SURFACES; ORGANIZED GROWTH; GAAS MATRIX; SUBMONOLAYER; EXCITONS; TRANSFORMATION; GAAS(100); EPITAXY; ISLANDS; INGAAS	We present magneto-optical studies of both InAs monolayers and InAlAs self-assembled quantum dots grown by molecular beam epitaxy. In both structures, strong exciton binding energy was measured. In the case of InAs monolayers in (311) GaAs matrices, the strong exciton binding energy (12 +/- 1 meV) is caused by the lateral quantum confinement. In the case of InAlAs self-assembled quantum dots, 3D complete quantum confinement is achieved, The excitonic properties of self-assembled quantum dots are discussed.	UNIV CALIF SANTA BARBARA,CTR QUANTIZED ELECT STRUCT,QUEST,SANTA BARBARA,CA 93106; UNIV CALIF SANTA BARBARA,DEPT MAT,SANTA BARBARA,CA 93106; AF IOFFE PHYS TECH INST,ST PETERSBURG 194021,RUSSIA; UNIV TOKYO,INST SOLID STATE PHYS,MINATO KU,TOKYO 106,JAPAN; UNIV TOKYO,ADV SCI & TECHNOL RES CTR,TOKYO,JAPAN; RES DEV CORP JAPAN,QUANTUM TRANSIT PROJECT,MEGURO KU,TOKYO,JAPAN; UNIV GLASGOW,DEPT ELECT & ELECT ENGN,GLASGOW G12 8QQ,LANARK,SCOTLAND	Wang, PD (reprint author), UNIV NOTRE DAME,DEPT ELECT ENGN,NOTRE DAME,IN 46556, USA.		medeiros ribeiro, gilberto/E-1835-2012; Ustinov, Viktor/J-3545-2013; Sotomayor Torres, Clivia/E-8418-2010; 	Sotomayor Torres, Clivia/0000-0001-9986-2716; Oestreich, Michael/0000-0001-5564-9307			ADOLPH B, 1993, PHYS REV B, V48, P15077, DOI 10.1103/PhysRevB.48.15077; AKIMOTO O, 1967, J PHYS SOC JPN, V22, P181, DOI 10.1143/JPSJ.22.181; ALONSO MI, 1993, J APPL PHYS, V74, P7188; ANDROUSSI Y, 1994, APPL PHYS LETT, V65, P1162, DOI 10.1063/1.112128; MARZIN JY, 1994, PHYS REV LETT, V73, P716, DOI 10.1103/PhysRevLett.73.716; MOISON JM, 1994, APPL PHYS LETT, V64, P196, DOI 10.1063/1.111502; MADHUKAR A, 1994, APPL PHYS LETT, V64, P2727, DOI 10.1063/1.111456; LEONARD D, 1994, J VAC SCI TECHNOL B, V12, P1063, DOI 10.1116/1.587088; SNYDER CW, 1991, PHYS REV LETT, V66, P3032, DOI 10.1103/PhysRevLett.66.3032; BELOUSOV MV, 1995, PHYS REV B, V51, P14346, DOI 10.1103/PhysRevB.51.14346; BRESSLERHILL V, 1994, PHYS REV B, V50, P8479, DOI 10.1103/PhysRevB.50.8479; BRYANT GW, 1988, PHYS REV B, V37, P8763, DOI 10.1103/PhysRevB.37.8763; CIRLIN GE, 1995, APPL PHYS LETT, V67, P97, DOI 10.1063/1.115520; FAFARD S, 1994, PHYS REV B, V50; Fock V, 1928, Z PHYS, V47, P446, DOI 10.1007/BF01390750; GOLSTEIN L, 1985, APPL PHYS LETT, V47, P1099; GRUNDMANN M, 1995, PHYS REV LETT, V74, P4043, DOI 10.1103/PhysRevLett.74.4043; HALONEN V, 1992, PHYS REV B, V45, P5980, DOI 10.1103/PhysRevB.45.5980; JAZIRI S, 1994, SEMICOND SCI TECH, V9, P1775, DOI 10.1088/0268-1242/9/10/003; LEDENTSOV NN, 1994, PHYS REV B, V50, P12171, DOI 10.1103/PhysRevB.50.12171; Ledentsov N. N., 1995, 22nd International Conference on the Physics of Semiconductors; LEONARD D, 1994, PHYS REV B, V50, P11687, DOI 10.1103/PhysRevB.50.11687; PEARSALL TP, 1990, PHYSICS SEMICONDUCTO, V32; SOMEYA T, 1995, PHYS REV LETT, V74, P3664, DOI 10.1103/PhysRevLett.74.3664; Wang P P, UNPUB; WANG PD, 1994, APPL PHYS LETT, V64, P1526, DOI 10.1063/1.111880; WANG PD, 1995, APPL PHYS LETT, V66, P112, DOI 10.1063/1.114164; WANG PD, 1994, PHYS REV B, V50, P1604, DOI 10.1103/PhysRevB.50.1604	28	7	7	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0921-4526			PHYSICA B	Physica B	SEP	1996	227	1-4					378	383		10.1016/0921-4526(96)00447-4		6	Physics, Condensed Matter	Physics	VR715	WOS:A1996VR71500099		
J	Nishioka, M; Schur, R; Kitamura, M; Watabe, H; Arakawa, Y				Nishioka, M; Schur, R; Kitamura, M; Watabe, H; Arakawa, Y			Light emission from vertical-microcavity quantum dot laser structures	PHYSICA B			English	Article; Proceedings Paper	3rd International Symposium on New Phenomena in Mesoscopic Structures (NPMS 95)	DEC 04-08, 1995	MAUI, HI	Japan Soc Promot Sci, 151st Comm Electr Propert Extreme Struct		microcavity; quantum dots; MOCVD	CHEMICAL-VAPOR-DEPOSITION; WELL	A vertical microcavity laser structure with an active layer of Stranski-Krastanow quantum dots was fabricated for the first time. The microcavity consists of an InGaAs quantum dot layer grown by MOCVD, located between two AlAs/Al0.2Ga0.8As distributed Bragg-reflector mirrors. The length of the microcavity was 4 lambda(lambda = 884 nm). The cavity effect was evidenced by the difference of the PL linewidths of samples with and without the cavity.	UNIV TOKYO,INST IND SCI,MINATO KU,TOKYO 106,JAPAN			Kitamura, Masatoshi/F-8510-2014	Kitamura, Masatoshi/0000-0003-1342-4796			LEONARD D, 1993, APPL PHYS LETT, V63, P3203, DOI 10.1063/1.110199; YABLONOVITCH E, 1988, PHYS REV LETT, V61, P2546, DOI 10.1103/PhysRevLett.61.2546; Arakawa Y., 1982, APPL PHYS LETT, V40, P11; ARAKAWA Y, 1984, APPL PHYS LETT, V45, P950, DOI 10.1063/1.95453; Bjoerk G., 1991, IEEE J QUANTUM ELECT, V27, P2386; HOROWICZ RJ, 1992, APPL PHYS LETT, V61, P393, DOI 10.1063/1.107893; JEWELL JL, 1989, ELECTRON LETT, V25, P1123, DOI 10.1049/el:19890754; KOYAMA F, 1989, APPL PHYS LETT, V55, P221, DOI 10.1063/1.101913; NAGAMUNE Y, 1994, APPL PHYS LETT, V64, P2495, DOI 10.1063/1.111577; OSHINOWO J, 1994, METAL ORGANIC VAPOR, P986; OSHINOWO J, 1994, JPN J APPL PHYS 2, V33, pL1634	11	6	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0921-4526			PHYSICA B	Physica B	SEP	1996	227	1-4					404	406		10.1016/0921-4526(96)00454-1		3	Physics, Condensed Matter	Physics	VR715	WOS:A1996VR71500106		
J	Ando, T; Hamaguchi, C; Namba, S				Ando, T; Hamaguchi, C; Namba, S			Proceedings of the third international symposium on - New phenomena in mesoscopic structures - Held in Maui, Hawaii, USA 4-8 December 1995 - NPMS '95 - Preface	PHYSICA B			English	Editorial Material									OSAKA UNIV,DEPT ELECT ENGN,SUITA,OSAKA 565,JAPAN; NAGASAKI INST APPL SCI,NAGASAKI,JAPAN	Ando, T (reprint author), UNIV TOKYO,INST SOLID STATE PHYS,TOKYO,JAPAN.							0	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0921-4526			PHYSICA B	Physica B	SEP	1996	227	1-4					R7	R7		10.1016/S0921-4526(96)94140-X		1	Physics, Condensed Matter	Physics	VR715	WOS:A1996VR71500001		
J	Shimazu, Y; Ikehata, S; Kobayashi, S				Shimazu, Y; Ikehata, S; Kobayashi, S			Dependence of Coulomb blockade in ultrasmall single tunnel junctions on tunnel resistance	PHYSICA B-CONDENSED MATTER			English	Article						Coulomb blockade; tunnel junction; superconductor-insulator transition		We studied small-capacitance single tunnel junctions with various tunnel resistances. In order to reduce the environmental effect, high-resistance leads were adopted for measurement. We observed the gradual weakening and disappearance of the Coulomb blockade as the tunnel resistance in the absence of charging effects is lowered below the resistance quantum. As the tunnel resistance increases above the resistance quantum, the zero-bias resistance divided by the tunnel resistance tends to flatten off. The experimental result is in good agreement with the theory of Brown and Simanek.		Shimazu, Y (reprint author), UNIV TOKYO, GRAD SCH SCI, DEPT PHYS, BUNKYO KU, TOKYO 113, JAPAN.			Shimazu, Yoshihiro/0000-0001-9919-1377			INGOLD GL, 1992, NATO ADV SCI I B-PHY, V294, P21; DELSING P, 1989, PHYS REV LETT, V63, P1180, DOI 10.1103/PhysRevLett.63.1180; AVERIN DV, 1986, J LOW TEMP PHYS, V62, P345, DOI 10.1007/BF00683469; BROWN R, 1986, PHYS REV B, V34, P2957, DOI 10.1103/PhysRevB.34.2957; CLERAND AN, 1992, PHYS REV B, V45, P2950; MARTINIS JM, 1989, PHYS REV LETT, V63, P1507, DOI 10.1103/PhysRevLett.63.1507	6	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0921-4526			PHYSICA B	Physica B	SEP	1996	227	1-4					102	104		10.1016/0921-4526(96)00370-5		3	Physics, Condensed Matter	Physics	VR715	WOS:A1996VR71500027		
J	Inoshita, T; Sakaki, H				Inoshita, T; Sakaki, H			Electron-phonon interaction and the so-called phonon bottleneck effect in semiconductor quantum dots	PHYSICA B-CONDENSED MATTER			English	Article						quantum dot; electron-phonon interaction; photoluminescence; laser	BOX SYSTEMS; RELAXATION; PHOTOLUMINESCENCE; GAAS; SCATTERING; WIRES; WELLS	Whether the phonon bottleneck effect, or slowed relaxation of electrons through phonon emission, in quantum dots is detrimental to their application as optical devices has been a matter of debate. We present a theoretical analysis of the bottleneck effect, based on a second-order perturbation calculation of the relaxation time and a Green's function calculation of the electron density of states. Emphasis will be put on multiple-phonon and coherence effects. A brief review of the relevant experiments is given in the second part of the paper.	UNIV TOKYO, RCAST, MEGURO KU, TOKYO 153, JAPAN	Inoshita, T (reprint author), JRDC, QUANTUM TRANSIT PROJECT, MEGURO KU, 4-7-6-4F KOMABA, TOKYO 153, JAPAN.						AKIYAMA H, 1995, APPL PHYS LETT, V67, P2037, DOI 10.1063/1.115070; MARZIN JY, 1994, PHYS REV LETT, V73, P716, DOI 10.1103/PhysRevLett.73.716; BOCKELMANN U, 1990, PHYS REV B, V42, P8947, DOI 10.1103/PhysRevB.42.8947; BOCKELMANN U, 1994, PHYS REV B, V50, P17271, DOI 10.1103/PhysRevB.50.17271; BENISTY H, 1991, PHYS REV B, V44, P10945, DOI 10.1103/PhysRevB.44.10945; BOCKELMANN U, 1992, PHYS REV B, V46, P15574, DOI 10.1103/PhysRevB.46.15574; BRUNNER K, 1992, PHYS REV LETT, V69, P3216, DOI 10.1103/PhysRevLett.69.3216; ARAKAWA Y, 1982, APPL PHYS LETT, V24, P195; ARNOT HEG, 1989, SUPERLATTICE MICROST, V5, P459, DOI 10.1016/0749-6036(89)90333-9; BENISTY H, 1995, PHYS REV B, V51, P13281, DOI 10.1103/PhysRevB.51.13281; BOCKELMANN U, 1995, P 7 INT C MOD SEM ST, P838; BOCKELMANN U, 1995, NATO ADV SCI INST SE, V340, P325; BOCKELMANN U, 1993, PHYS REV B, V48, P17637, DOI 10.1103/PhysRevB.48.17637; COHENTANNOUDJI C, 1992, ATOM PHOTON INTERACT, V2; GERARD JM, 1995, NATO ADV SCI INST SE, V340, P357; GORNIK E, 1991, LANDAU LEVEL SPECTRO, V2, P912; INOSHITA T, 1994, SOLID STATE ELECTRON, V37, P1175, DOI 10.1016/0038-1101(94)90382-4; Inoshita T., 1993, Optoelectronics - Devices and Technologies, V8; INOSHITA T, 1992, PHYS REV B, V46, P7260, DOI 10.1103/PhysRevB.46.7260; INOSHITA T, 1993, P 21 INT C PHYS SEM, P1383; KOHL M, 1989, PHYS REV LETT, V63, P2124, DOI 10.1103/PhysRevLett.63.2124; LEDENTSOV NN, 1993, P 21 INT C PHYS SEM, P1855; LIPSANEN H, 1995, P 7 INT C MOD SEM ST, P909; MCCOMBE BD, 1994, HANDB SEMIC, V2, P285; NOTOMI M, 1991, APPL PHYS LETT, V58, P720, DOI 10.1063/1.104526; PISTOL ME, 1995, P 7 INT C MOD SEM ST, P584; SOPANEN M, 1995, APPL PHYS LETT, V66, P2364, DOI 10.1063/1.113984; WANG G, 1994, APPL PHYS LETT, V64, P2815, DOI 10.1063/1.111434; WANG PD, 1993, J APPL PHYS, V74, P5047, DOI 10.1063/1.354287; WANG PD, 1994, SURF SCI, V305, P585, DOI 10.1016/0039-6028(94)90958-X; WATABE H, 1995, P 7 INT C MOD SEM ST, P832	31	42	42	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0921-4526			PHYSICA B	Physica B	SEP	1996	227	1-4					373	377		10.1016/0921-4526(96)00445-0		5	Physics, Condensed Matter	Physics	VR715	WOS:A1996VR71500098		
J	Kanokogi, H; Sakurai, K				Kanokogi, H; Sakurai, K			Optical dark resonance in multilevel systems with a treelike configuration	PHYSICAL REVIEW A			English	Article							3-LEVEL ATOMS; STATE; FORMALISM; COHERENCE; DYNAMICS; WAVES; LIMIT	Optical dark resonance in systems with arbitrary multilevels and multiphotons is studied theoretically. When the system configuration is treelike (the term of graph theory), all the coherence terms in the system can be categorized into several groups on dark resonance. It is proved for generic system configurations with arbitrary multilevels that the resonance conditions can be obtained successively by setting the determinant of the submatrix of the Hamiltonian with respect to each group to zero. We calculate, as one of the practical examples, all the conditions of dark resonance of potassium atoms with two laser fields and one rf field mixing one excited slats and eight ground states in the hyperfine structure. Although the system configuration is very complicated, the condition is easily obtained in an analytic form and verified by the result of a numerical simulation. Furthermore, our theory can reveal the fine structure of dark lines with power broadening in the observed light-induced-fluorescence spectra and numerical calculations. in addition, the dark lines with the complicated splitting pattern observed in experiments can be assigned to the relevant level configuration and transitions by the present theory.		Kanokogi, H (reprint author), UNIV TOKYO,DEPT PURE & APPL SCI,MEGURO KU,3-8-1 KOMABA,TOKYO 153,JAPAN.						ALZETTA G, 1976, NUOVO CIMENTO B, V36, P5, DOI 10.1007/BF02749417; AGARWAL GS, 1979, J PHYS B-AT MOL OPT, V12, P2655, DOI 10.1088/0022-3700/12/16/013; CASTIN Y, 1989, J OPT SOC AM B, V6, P2046, DOI 10.1364/JOSAB.6.002046; GRAY HR, 1978, OPT LETT, V3, P218, DOI 10.1364/OL.3.000218; ASPECT A, 1988, PHYS REV LETT, V61, P826, DOI 10.1103/PhysRevLett.61.826; HIOE FT, 1981, PHYS REV LETT, V47, P838, DOI 10.1103/PhysRevLett.47.838; WHITLEY RM, 1976, PHYS REV A, V14, P1498, DOI 10.1103/PhysRevA.14.1498; STETTLER JD, 1979, PHYS LETT A, V73, P171, DOI 10.1016/0375-9601(79)90698-4; LETT PD, 1988, PHYS REV LETT, V61, P169, DOI 10.1103/PhysRevLett.61.169; ELGIN JN, 1980, PHYS LETT A, V80, P140, DOI 10.1016/0375-9601(80)90205-4; ARIMONDO E, 1976, LETT NUOVO CIMENTO, V17, P333, DOI 10.1007/BF02746514; ASPECT A, 1989, J OPT SOC AM B, V6, P2122; BONDERUP E, 1989, J OPT SOC AM B, V6, P225; BOUCHENE MA, 1992, EUROPHYS LETT, V18, P409, DOI 10.1209/0295-5075/18/5/006; BREWER RG, 1975, PHYS REV A, V11, P1641, DOI 10.1103/PhysRevA.11.1641; BREWER RG, 1973, PHYS REV A, V8, P464, DOI 10.1103/PhysRevA.8.464; CARDIMONA DA, 1990, PHYS REV A, V41, P5016, DOI 10.1103/PhysRevA.41.5016; CHANG S, 1990, OPT COMMUN, V77, P19, DOI 10.1016/0030-4018(90)90453-Z; DALIBARD J, 1984, J PHYS B-AT MOL OPT, V17, P4577, DOI 10.1088/0022-3700/17/22/018; FAIN B, 1988, J CHEM PHYS, V88, P7559, DOI 10.1063/1.454320; KANOKOGI H, 1996, PHYS REV A, V57, P2650; PRENTISS MG, 1991, OPT LETT, V16, P1695, DOI 10.1364/OL.16.001695; PRIOR Y, 1986, PHYS REV A, V33, P2362, DOI 10.1103/PhysRevA.33.2362; PRIOR Y, 1981, PHYS REV LETT, V46, P111, DOI 10.1103/PhysRevLett.46.111; RADMORE PM, 1982, J PHYS B-AT MOL OPT, V15, P561, DOI 10.1088/0022-3700/15/4/009; SAIKAN S, 1985, J CHEM PHYS, V82, P5409, DOI 10.1063/1.448624; SIEMERS I, 1992, EUROPHYS LETT, V18, P139, DOI 10.1209/0295-5075/18/2/009; UNGAR PJ, 1989, J OPT SOC AM B, V6, P2058, DOI 10.1364/JOSAB.6.002058	28	1	1	AMERICAN PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	1050-2947			PHYS REV A	Phys. Rev. A	SEP	1996	54	3					2334	2346		10.1103/PhysRevA.54.2334		13	Optics; Physics, Atomic, Molecular & Chemical	Optics; Physics	VH090	WOS:A1996VH09000073		
J	Shimomura, S; Terauchi, H; Hamaya, N; Fujii, Y				Shimomura, S; Terauchi, H; Hamaya, N; Fujii, Y			Multicritical point in structurally incommensurate [N(CH3)(4)]2CuCl4 under pressure	PHYSICAL REVIEW B			English	Article							X-RAY-DIFFRACTION; PHASE-TRANSITIONS; RADIATION-DAMAGE; (N(CH3)4)2CUCL4; <N(CH3)4>2CUCL4; CRYSTALS; LINE	The x-ray-diffraction experiment of [N(CH3)(4)]2CuCl4 under hydrostatic pressure has revealed the existence of a special confluent point, denoted by L* in the pressure-temperature (p-T) phase diagram, among the prototypical normal phase, the incommensurate phase, and the commensurate phase characterized by the wave vector q = c*/3. With increasing pressure, the incommensurate phase with q<c*/3 decreases its own stable temperature range and vanishes at L*. The incommensurate region with q>c*/3 appears at L* and widens with increasing pressure. On the p-T phase diagram the second-order normal-incommensurate and the first-order incommensurate-commensurate phase lines meet at L*. The wave vector in both incommensurate regions goes continuously to c*/3 and the jump of the satellite intensity on the first-order incommensurate-to-commensurate phase transition becomes small, as the L* point is approached. These experimental facts show that the L* point is a multicritical point in incommensurate systems. These features of the obtained phase diagram are different from those of the universal one for [N(CH3)(4)](2)MCl(4) (M=Mn, Fe, and Zn) reported previously.	KWANSEI GAKUIN UNIV,DEPT PHYS,NISHINOMIYA,HYOGO 662,JAPAN; OCHANOMIZU UNIV,DEPT PHYS,TOKYO 112,JAPAN; UNIV TOKYO,DEPT SOLID STATE PHYS,NEUTRON SCATTERING LAB,TOKAI,IBARAKI 31911,JAPAN							SAWADA A, 1980, J PHYS SOC JPN, V48, P1773, DOI 10.1143/JPSJ.48.1773; HORNREICH RM, 1980, J MAGN MAGN MATER, V15-8, P387, DOI 10.1016/0304-8853(80)91100-2; HORNREICH RM, 1975, PHYS REV LETT, V35, P1678, DOI 10.1103/PhysRevLett.35.1678; YAMADA Y, 1983, J PHYS SOC JPN, V52, P3466, DOI 10.1143/JPSJ.52.3466; CHEN ZY, 1991, PHYS REV B, V43, P5634, DOI 10.1103/PhysRevB.43.5634; SHIMIZU H, 1980, SOLID STATE COMMUN, V34, P363, DOI 10.1016/0038-1098(80)90576-1; GESI K, 1980, J PHYS SOC JPN, V48, P1775, DOI 10.1143/JPSJ.48.1775; SUGIYAMA J, 1980, J PHYS SOC JPN, V49, P1405, DOI 10.1143/JPSJ.49.1405; Aslanyan T. A., 1978, Soviet Physics - Solid State, V20; BEK P, 1986, PHYS TODAY, V12, P38; BZIOUET M, 1987, J PHYS C SOLID STATE, V20, P2635, DOI 10.1088/0022-3719/20/18/002; CLAY R, 1975, ACTA CRYSTALLOGR B, V31, P289, DOI 10.1107/S056774087500252X; FJAER E, 1985, J PHYS C SOLID STATE, V18, pL41, DOI 10.1088/0022-3719/18/2/001; GESI K, IN PRESS J PHYS SOC; Gesi K., 1986, Ferroelectrics, V66, DOI 10.1080/00150198608227891; GESI K, UNPUB; HAMAYA N, 1987, NUCL INSTRUM METH B, V29, P537, DOI 10.1016/0168-583X(87)90066-8; Janssen T., 1986, Ferroelectrics, V66, DOI 10.1080/00150198608227886; SAWADA S, 1987, J PHYS SOC JPN, V44, P687; SCHNECK J, 1984, PHYS REV B, V29, P1476, DOI 10.1103/PhysRevB.29.1476; Shimomura S, 1996, PHYS REV B, V53, P8975, DOI 10.1103/PhysRevB.53.8975; TOLEDANO P, 1984, MULTICRITICAL PHENOM, P171; VLOKH OG, 1989, PHYS STATUS SOLIDI A, V116, P287, DOI 10.1002/pssa.2211160126	23	12	12	AMERICAN PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	0163-1829			PHYS REV B	Phys. Rev. B	SEP 1	1996	54	10					6915	6920		10.1103/PhysRevB.54.6915		6	Physics, Condensed Matter	Physics	VH082	WOS:A1996VH08200029		
J	Yokoyama, T; Yonamoto, Y; Ohta, T; Ugawa, A				Yokoyama, T; Yonamoto, Y; Ohta, T; Ugawa, A			Anharmonic interatomic potentials of octahedral Pt-halogen complexes studied by extended x-ray-absorption fine structure	PHYSICAL REVIEW B			English	Article							QUANTUM-STATISTICAL APPROACH; THERMAL-EXPANSION; EXAFS; ARXPS; EELS	The temperature dependence of Pt L(III)- and I K-edge extended x-ray-absorption fine-structure spectra of octahedrally coordinated Pt X(6)(2-)(X = Cl, Br, and I) complexes has experimentally been investigated not only for the first-nearest-neighbor (NN) shells but for higher NN ones. The second- and third-order cumulants of a radial distribution function in the octahedral system have been evaluated quantum mechanically by employing the interatomic potential including the third-order force constants. The experimentally obtained second-order cumulants agree with the values expected by the vibrational data and the third-order cumulants have successfully given the anharmonic force constants. Contribution of the bending motions to the cumulants of higher NN shells is discussed in detail.	INST MOL SCI,OKAZAKI,AICHI 444,JAPAN	Yokoyama, T (reprint author), UNIV TOKYO,GRAD SCH SCI,DEPT CHEM,BUNKYO KU,7-3-1 HONGO,TOKYO 113,JAPAN.		Yokoyama, Toshihiko/F-9298-2011				ADAMS DM, 1967, J CHEM SOC A, P1666, DOI 10.1039/j19670001666; MIYANAGA T, 1994, J PHYS SOC JPN, V63, P1036, DOI 10.1143/JPSJ.63.1036; FUJIKAWA T, 1993, J PHYS SOC JPN, V62, P4108, DOI 10.1143/JPSJ.62.4108; ZABINSKY SI, 1995, PHYS REV B, V52, P2995, DOI 10.1103/PhysRevB.52.2995; FRENKEL AI, 1993, PHYS REV B, V48, P585, DOI 10.1103/PhysRevB.48.585; Urey HC, 1931, PHYS REV, V38, P1969, DOI 10.1103/PhysRev.38.1969; TAKAZAWA H, 1990, ACTA CRYSTALLOGR B, V46, P166, DOI 10.1107/S0108768189012693; BUNKER G, 1983, NUCL INSTRUM METHODS, V207, P437, DOI 10.1016/0167-5087(83)90655-5; REHR JJ, 1991, J AM CHEM SOC, V113, P5135, DOI 10.1021/ja00014a001; HIRAISHI J, 1964, SPECTROCHIM ACTA, V20, P819, DOI 10.1016/0371-1951(64)80081-3; HIRAISHI J, 1966, SPECTROCHIM ACTA, V22, P1483, DOI 10.1016/0371-1951(66)80142-X; Koningsberger D., 1988, XRAY ABSORPTION PRIN; LEDERER T, 1993, PHYS REV B, V48, P11277, DOI 10.1103/PhysRevB.48.11277; Nakamoto K., 1986, INFRARED SPECTRA INO; Nomura M., UNPUB; OYANAGI H, UNPUB; PISTORIUS CWFT, 1958, J CHEM PHYS, V29, P1328, DOI 10.1063/1.1744717; RABUS H, 1991, THESIS FREIE U BERLI, P8016; THIELE G, 1983, Z NATURFORSCH B, V38, P905; TROGER L, 1994, PHYS REV B, V49, P888, DOI 10.1103/PhysRevB.49.888; YOKOYAMA T, 1994, SURF SCI, V313, P197, DOI 10.1016/0039-6028(94)91167-3; YOKOYAMA T, 1990, JPN J APPL PHYS 1, V29, P2052, DOI 10.1143/JJAP.29.2052; YOKOYAMA T, 1993, EXAFS ANAL PROGRAM E; YOKOYAMA T, 1989, JPN J APPL PHYS 1, V28, P1905, DOI 10.1143/JJAP.28.1905; Yokoyama T, 1996, PHYS REV B, V53, P6111, DOI 10.1103/PhysRevB.53.6111	25	27	27	AMERICAN PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	0163-1829			PHYS REV B	Phys. Rev. B	SEP 1	1996	54	10					6921	6928		10.1103/PhysRevB.54.6921		8	Physics, Condensed Matter	Physics	VH082	WOS:A1996VH08200030		
J	Tranquada, JM; Axe, JD; Ichikawa, N; Nakamura, Y; Uchida, S; Nachumi, B				Tranquada, JM; Axe, JD; Ichikawa, N; Nakamura, Y; Uchida, S; Nachumi, B			Neutron-scattering study of stripe-phase order of holes and spins in La1.48Nd0.4Sr0.12CuO4	PHYSICAL REVIEW B			English	Article							2-DIMENSIONAL HUBBARD-MODEL; INCOMMENSURATE MAGNETIC CORRELATIONS; HIGH-TEMPERATURE SUPERCONDUCTORS; T-J MODEL; DOPED ANTIFERROMAGNET; CHARGE-TRANSPORT; SINGLE-CRYSTAL; COPPER OXIDES; HARTREE-FOCK; FERMI-LIQUID	We present a neutron diffraction study of charge and spin order within the CuO2 planes of La1.48Nd0.4Sr0.12CuO4, a crystal in which superconductivity is anomalously suppressed. At low temperatures we observe elastic magnetic superlattice peaks of the type (1/2+/-epsilon 1/2,0) and charge-order peaks at (2+/-2 epsilon,0,0), where epsilon=0.118. After cooling the crystal through the low-temperature-orthorhombic (LTO) to low-temperature-tetragonal (LTT) phase transition near 70 K, the charge-order peaks appear first at similar to 60 K, with the magnetic peaks appearing below 50 K. The magnetic peaks increase in intensity by an order of magnitude below 3 K due to ordering of the Nd ions. We show that the observed diffraction features are consistent with stripe-phase order, in which the dopant-induced holes collect in domain walls that separate antiferromagnetic antiphase domains. The Q dependence of the magnetic scattering indicates that the low-temperature correlation length within the planes is substantial (similar to 170 Angstrom), but only very weak correlations exist between next-nearest-neighbor planes. Correlations between nearest-neighbor layers are frustrated by pinning of the charge stripes to the lattice distortions of the LTT phase. The spin-density-wave amplitude corresponds to a Cu moment of 0.10+/-0.03 mu(B). The behavior of the electrical resistivity within the LTT phase is examined, and the significance of stripe-phase correlations for understanding the unusual transport properties of layered cuprates is discussed.	UNIV TOKYO, BUNKYO KU, TOKYO 113, JAPAN; COLUMBIA UNIV, DEPT PHYS, NEW YORK, NY 10027 USA	Tranquada, JM (reprint author), BROOKHAVEN NATL LAB, DEPT PHYS, UPTON, NY 11973 USA.		Tranquada, John/A-9832-2009; Nakamura, Yasunobu/H-1300-2012	Tranquada, John/0000-0003-4984-8857; 			AN GZ, 1991, PHYS REV B, V44, P9410, DOI 10.1103/PhysRevB.44.9410; Ando Y, UNPUB; SCHULZ HJ, 1989, J PHYS-PARIS, V50, P2833, DOI 10.1051/jphys:0198900500180283300; LOW U, 1994, PHYS REV LETT, V72, P1918, DOI 10.1103/PhysRevLett.72.1918; TAKENAKA K, 1994, PHYS REV B, V50, P6534, DOI 10.1103/PhysRevB.50.6534; INUI M, 1991, PHYS REV B, V44, P4415, DOI 10.1103/PhysRevB.44.4415; CASTELLANI C, 1995, PHYS REV LETT, V75, P4650, DOI 10.1103/PhysRevLett.75.4650; EMERY VJ, 1990, PHYS REV LETT, V64, P475, DOI 10.1103/PhysRevLett.64.475; AXE JD, 1994, J LOW TEMP PHYS, V95, P271, DOI 10.1007/BF00754942; KATO M, 1990, J PHYS SOC JPN, V59, P1047, DOI 10.1143/JPSJ.59.1047; CHEONG SW, 1991, PHYS REV LETT, V67, P1791, DOI 10.1103/PhysRevLett.67.1791; AXE JD, 1989, PHYS REV LETT, V62, P2751, DOI 10.1103/PhysRevLett.62.2751; Salkola MI, 1996, PHYS REV LETT, V77, P155, DOI 10.1103/PhysRevLett.77.155; TRANQUADA JM, 1994, PHYS REV LETT, V73, P1003, DOI 10.1103/PhysRevLett.73.1003; KEIMER B, 1993, Z PHYS B CON MAT, V91, P373, DOI 10.1007/BF01344067; BUCHNER B, 1993, EUROPHYS LETT, V21, P953, DOI 10.1209/0295-5075/21/9/013; ZHOU C, 1995, PHYS REV B, V52, P11557; BUCHNER B, 1994, PHYS REV LETT, V73, P1841, DOI 10.1103/PhysRevLett.73.1841; ANDO Y, 1995, PHYS REV LETT, V75, P4662, DOI 10.1103/PhysRevLett.75.4662; SHAMOTO S, 1993, PHYS REV B, V48, P13817, DOI 10.1103/PhysRevB.48.13817; CRAWFORD MK, 1991, PHYS REV B, V44, P7749, DOI 10.1103/PhysRevB.44.7749; MOODENBAUGH AR, 1988, PHYS REV B, V38, P4596, DOI 10.1103/PhysRevB.38.4596; Chayes L, 1996, PHYSICA A, V225, P129, DOI 10.1016/0378-4371(95)00374-6; Ramirez AP, 1996, PHYS REV LETT, V76, P447, DOI 10.1103/PhysRevLett.76.447; TRANQUADA JM, 1995, NATURE, V375, P561, DOI 10.1038/375561a0; ARRIGONI E, 1991, PHYS REV B, V44, P7455, DOI 10.1103/PhysRevB.44.7455; EMERY VJ, 1993, PHYSICA C, V209, P597, DOI 10.1016/0921-4534(93)90581-A; AUERBACH A, 1991, PHYS REV B, V43, P7800, DOI 10.1103/PhysRevB.43.7800; BLUME M, 1962, J CHEM PHYS, V37, P1245, DOI 10.1063/1.1733272; BORSA F, 1995, PHYS REV B, V52, P7334, DOI 10.1103/PhysRevB.52.7334; BUDNICK JI, 1988, EUROPHYS LETT, V5, P651, DOI 10.1209/0295-5075/5/7/014; BULUT N, 1990, PHYS REV LETT, V64, P2723, DOI 10.1103/PhysRevLett.64.2723; Castro Neto AH, 1996, PHYS REV LETT, V76, P2165, DOI 10.1103/PhysRevLett.76.2165; CHEN CH, 1993, PHYS REV LETT, V71, P2461, DOI 10.1103/PhysRevLett.71.2461; CHEONG SW, COMMUNICATION; EMERY VJ, 1995, PHYS REV LETT, V74, P3253, DOI 10.1103/PhysRevLett.74.3253; EMERY VJ, COMMUNICATION; EMERY VJ, 1994, PHYSICA C, V235, P189, DOI 10.1016/0921-4534(94)91345-5; ESKES H, UNPUB; GIAMARCHI T, 1990, PHYS REV B, V42, P10641, DOI 10.1103/PhysRevB.42.10641; Guinier A., 1994, XRAY DIFFRACTION; HAAS S, 1995, PHYS REV B, V51, P5989, DOI 10.1103/PhysRevB.51.5989; HAYDEN SM, 1992, PHYS REV LETT, V68, P1061, DOI 10.1103/PhysRevLett.68.1061; HUNDLEY MF, 1989, PHYSICA C, V158, P102, DOI 10.1016/0921-4534(89)90305-5; KAMIYAMA T, 1990, PHYSICA C, V172, P120, DOI 10.1016/0921-4534(90)90649-Y; KANE CL, 1990, PHYS REV B, V41, P2653, DOI 10.1103/PhysRevB.41.2653; KIVELSON SA, 1994, STRONGLY CORRELATED ELECTRONIC MATERIALS - THE LOS ALAMOS SYMPOSIUM, 1993, P619; KOIKE Y, 1995, PHYSICA B, V213, P84, DOI 10.1016/0921-4526(95)00069-L; KOYAMA Y, 1995, PHYS REV B, V51, P9045, DOI 10.1103/PhysRevB.51.9045; LITTLEWOOD PB, 1993, PHYS REV B, V48, P487, DOI 10.1103/PhysRevB.48.487; LU JP, 1990, PHYS REV LETT, V65, P2466, DOI 10.1103/PhysRevLett.65.2466; LUKE GM, 1991, PHYSICA C, V185, P1175, DOI 10.1016/0921-4534(91)91811-H; MARDER M, 1990, PHYS REV B, V41, P6920, DOI 10.1103/PhysRevB.41.6920; MASON TE, 1992, PHYS REV LETT, V68, P1414, DOI 10.1103/PhysRevLett.68.1414; NACHUMI B, UNPUB; NAKAMURA Y, 1992, PHYS REV B, V46, P5841, DOI 10.1103/PhysRevB.46.5841; POILBLANC D, 1989, PHYS REV B, V39, P9749, DOI 10.1103/PhysRevB.39.9749; PYNN R, 1976, PHYS REV B, V13, P295, DOI 10.1103/PhysRevB.13.295; SACHAN V, 1995, PHYS REV B, V51, P12742, DOI 10.1103/PhysRevB.51.12742; SHAMOTO S, 1992, PHYSICA C, V203, P7, DOI 10.1016/0921-4534(92)90502-4; SHRAIMAN BI, 1989, PHYS REV LETT, V62, P1564, DOI 10.1103/PhysRevLett.62.1564; THURSTON TR, 1992, PHYS REV B, V46, P9128, DOI 10.1103/PhysRevB.46.9128; TRANQUADA JM, 1995, PHYS REV B, V52, P3581, DOI 10.1103/PhysRevB.52.3581; TRANQUADA JM, 1987, PHYS REV B, V36, P8401, DOI 10.1103/PhysRevB.36.8401; TRANQUADA JM, UNPUB; UEMURA YJ, 1988, PHYSICA C, V153, P769, DOI 10.1016/S0921-4534(88)80079-0; VAKNIN D, 1987, PHYS REV LETT, V58, P2802, DOI 10.1103/PhysRevLett.58.2802; VERGES JA, 1991, PHYS REV B, V43, P6099, DOI 10.1103/PhysRevB.43.6099; Wochner P., UNPUB; YAMADA K, 1994, PHYSICA C, V221, P355, DOI 10.1016/0921-4534(94)90242-9; YAMAGUCHI H, 1995, J PHYS SOC JPN, V64, P3614, DOI 10.1143/JPSJ.64.3614; YILDIRIM T, 1994, PHYS REV LETT, V72, P3710, DOI 10.1103/PhysRevLett.72.3710; ZAANEN J, 1989, PHYS REV B, V40, P7391, DOI 10.1103/PhysRevB.40.7391; Zaanen J, 1996, PHYS REV B, V53, P8671, DOI 10.1103/PhysRevB.53.8671; Zaanen J, 1996, ANN PHYS-LEIPZIG, V5, P224; ZAANEN J, 1994, PHYS REV B, V50, P7222, DOI 10.1103/PhysRevB.50.7222; ZHU YM, 1994, PHYS REV LETT, V73, P3026, DOI 10.1103/PhysRevLett.73.3026	77	480	481	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	1098-0121	1550-235X		PHYS REV B	Phys. Rev. B	SEP 1	1996	54	10					7489	7499		10.1103/PhysRevB.54.7489		11	Physics, Condensed Matter	Physics	VH082	WOS:A1996VH08200095		
J	Imai, H; Inabe, T; Otsuka, T; Okuno, T; Awaga, K				Imai, H; Inabe, T; Otsuka, T; Okuno, T; Awaga, K			Molecular spin ladder in the Ni(dmit)(2) (dmit=1,3-dithiol-2-thione-4,5-dithiolate) salt with a nitronyl nitroxide cation	PHYSICAL REVIEW B			English	Article							ANTIFERROMAGNET; RADICALS; GAP	The crystal and magnetic structure of the 1:1 salt of Ni(1,3-dithiol-2-thione-4,5-dithiolate)(2) anionic radical and [Ni(dmit)(2)] p-N-ethylpyridinium alpha-nitronyl nitroxide (p-EPYNN) cationic radical have been studied. Ferromagnetic interaction with J/k(g)=0.16 K has been found to operate in the one-dimensional p-EPYNN chains, while the first molecular antiferromagnetic spin ladder has been found to form in the Ni(dmit)(2) chains.	UNIV TOKYO,DEPT PURE & APPL SCI,MEGURO KU,TOKYO 153,JAPAN	Imai, H (reprint author), HOKKAIDO UNIV,FAC SCI,DEPT CHEM,SAPPORO,HOKKAIDO 060,JAPAN.		Inabe, Tamotsu/A-8846-2012				JOHNSTON DC, 1987, PHYS REV B, V35, P219, DOI 10.1103/PhysRevB.35.219; ECCLESTON RS, 1994, PHYS REV LETT, V73, P2626, DOI 10.1103/PhysRevLett.73.2626; AWAGA K, 1994, PHYS REV B, V49, P3975, DOI 10.1103/PhysRevB.49.3975; AZUMA M, 1994, PHYS REV LETT, V73, P3463, DOI 10.1103/PhysRevLett.73.3463; AWAGA K, 1994, J MATER CHEM, V4, P1377, DOI 10.1039/jm9940401377; AWAGA K, 1992, CHEM PHYS LETT, V195, P21, DOI 10.1016/0009-2614(92)85904-O; AWAGA K, 1993, MOL CRYST LIQ CRYST, V232, P69, DOI 10.1080/10587259308035700; CASSOUX P, 1992, INORG MATER, P2; ISHIDA K, 1994, J PHYS SOC JPN, V63, P3222, DOI 10.1143/JPSJ.63.3222; Kahn O., 1993, MOL MAGNETISM; AWAGA K, 1991, CHEM LETT, P1777, DOI 10.1246/cl.1991.1777; RICE TM, 1993, EUROPHYS LETT, V23, P445, DOI 10.1209/0295-5075/23/6/011; TROYER M, 1994, PHYS REV B, V50, P13515, DOI 10.1103/PhysRevB.50.13515; YAMAGUCHI A, 1993, CHEM LETT, P1443, DOI 10.1246/cl.1993.1443	14	40	40	AMERICAN PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	0163-1829			PHYS REV B	Phys. Rev. B	SEP 1	1996	54	10					R6838	R6840				3	Physics, Condensed Matter	Physics	VH082	WOS:A1996VH08200010		
J	Sasago, Y; Koide, N; Uchinokura, K; Martin, MC; Hase, M; Hirota, K; Shirane, G				Sasago, Y; Koide, N; Uchinokura, K; Martin, MC; Hase, M; Hirota, K; Shirane, G			New phase diagram of Zn-doped CuGeO3	PHYSICAL REVIEW B			English	Article							SPIN-PEIERLS TRANSITION; CUGE1-XSIXO3; ORDER	A series of high-quality single crystals of Cu1-xZnxGeO3 have been examined by neutron-scattering techniques. An antiferromagnetic (AF) ordering is confirmed for four samples in the range 0.009 less than or equal to x less than or equal to 0.047, in complete agreement with previous reports. We show that the spin-Peierls (SP) phase transition persists to 4.7% Zn, whereas previous magnetic-susceptibility measurements reported a deterioration of the SP transition above 2% Zn. We present some details of the successive transitions upon lowering temperature into the spin-Peierls phase which is followed by a transition into an antiferromagnetically ordered phase. Below the Neel temperature we observe the coexistence of the SP lattice dimerization and AF states.	BROOKHAVEN NATL LAB,DEPT PHYS,UPTON,NY 11973	Sasago, Y (reprint author), UNIV TOKYO,DEPT APPL PHYS,BUNKYO KU,7-3-1 HONGO,TOKYO 113,JAPAN.		Hirota, Kazuma/C-6797-2008; Hase, Masashi/B-8900-2008	Hase, Masashi/0000-0003-2717-461X			Hase M, 1996, J PHYS SOC JPN, V65, P1392, DOI 10.1143/JPSJ.65.1392; HASE M, 1993, PHYS REV LETT, V71, P4059, DOI 10.1103/PhysRevLett.71.4059; HASE M, 1993, PHYS REV LETT, V70, P3651, DOI 10.1103/PhysRevLett.70.3651; LUSSIER JG, 1995, J PHYS-CONDENS MAT, V7, pL325, DOI 10.1088/0953-8984/7/25/003; Fukuyama H, 1996, J PHYS SOC JPN, V65, P1182, DOI 10.1143/JPSJ.65.1182; HASE M, 1995, PHYSICA B, V215, P164, DOI 10.1016/0921-4526(95)00405-X; MARTIN MJ, UNPUB; OSEROFF SB, 1995, PHYS REV LETT, V30, P74; POIRIER M, 1995, PHYS REV B, V52, pR6971; REGNAULT LP, 1995, EUROPHYS LETT, V32, P579, DOI 10.1209/0295-5075/32/7/007; RENARD JP, 1995, EUROPHYS LETT, V30, P475, DOI 10.1209/0295-5075/30/8/006	11	76	76	AMERICAN PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	0163-1829			PHYS REV B	Phys. Rev. B	SEP 1	1996	54	10					R6835	R6837				3	Physics, Condensed Matter	Physics	VH082	WOS:A1996VH08200009		
J	Xu, GY; DiTusa, JF; Ito, T; Oka, K; Takagi, H; Broholm, C; Aeppli, G				Xu, GY; DiTusa, JF; Ito, T; Oka, K; Takagi, H; Broholm, C; Aeppli, G			Y2BaNiO5: A nearly ideal realization of the S=1 Heisenberg chain with antiferromagnetic interactions	PHYSICAL REVIEW B			English	Article							TRANSITION-METAL OXIDE; QUANTUM SPIN CHAINS; HALDANE-GAP; MONTE-CARLO; STRUCTURAL CHARACTERIZATION; ENERGY-GAP; DYNAMICS; EXCITATIONS; SYSTEM; AGVP2S6	We report an inelastic-neutron-scattering experiment on single crystals of the one-dimensional spin-one antiferromagnet Y2BaNiO5. The data show that this compound is a nearly ideal material for studying the Haldane conjecture in the Heisenberg limit. In particular, the Haldane gap at (q) over tilde = pi is almost isotropic, taking on the values of 7.5(1), 8.6(1), and 9.6(1) meV for polarizations parallel to the three principal orthorhombic axes respectively. Interchain coupling along the edges of the orthorhombic unit cell is found to be very weak (J'/J less than or equal to 5 x 10(-4)). Finally, we show that defects in our sample at the 1% level cause visible broadening of the excitation at (q) over tilde = pi.	LOUISIANA STATE UNIV,DEPT PHYS & ASTRON,BATON ROUGE,LA 70803; ELECTROTECH LAB,TSUKUBA,IBARAKI 305,JAPAN; UNIV TOKYO,INST SOLID STATE PHYS,TOKYO 106,JAPAN; JOHNS HOPKINS UNIV,DEPT PHYS & ASTRON,BALTIMORE,MD 21218; NATL INST STAND & TECHNOL,GAITHERSBURG,MD 20899; NEC RES INST,PRINCETON,NJ 08540	Xu, GY (reprint author), JOHNS HOPKINS UNIV,DEPT PHYS & ASTRON,BALTIMORE,MD 21218, USA.		Takagi, Hidenori/B-2935-2010; Broholm, Collin/E-8228-2011; Xu, Guangyong/A-8707-2010	Broholm, Collin/0000-0002-1569-9892; Xu, Guangyong/0000-0003-1441-8275			AFFLECK I, 1987, PHYS REV LETT, V59, P799, DOI 10.1103/PhysRevLett.59.799; DARRIET J, 1993, SOLID STATE COMMUN, V86, P409, DOI 10.1016/0038-1098(93)90455-V; REGNAULT LP, 1994, PHYS REV B, V50, P9174, DOI 10.1103/PhysRevB.50.9174; AROVAS DP, 1988, PHYS REV LETT, V60, P531, DOI 10.1103/PhysRevLett.60.531; SAKAI T, 1990, PHYS REV B, V42, P4537, DOI 10.1103/PhysRevB.42.4537; MA SL, 1992, PHYS REV LETT, V69, P3571, DOI 10.1103/PhysRevLett.69.3571; HALDANE FDM, 1983, PHYS REV LETT, V50, P1153, DOI 10.1103/PhysRevLett.50.1153; BUTTREY DJ, 1990, J SOLID STATE CHEM, V88, P291, DOI 10.1016/0022-4596(90)90226-N; GOLINELLI O, 1992, PHYS REV B, V45, P9798, DOI 10.1103/PhysRevB.45.9798; MORRA RM, 1988, PHYS REV B, V38, P543, DOI 10.1103/PhysRevB.38.543; GLARUM SH, 1991, PHYS REV LETT, V67, P1614, DOI 10.1103/PhysRevLett.67.1614; BUYERS WJL, 1986, PHYS REV LETT, V56, P371, DOI 10.1103/PhysRevLett.56.371; GOLINELLI O, 1994, PHYS REV B, V50, P3037, DOI 10.1103/PhysRevB.50.3037; WHITE SR, 1993, PHYS REV B, V48, P3844, DOI 10.1103/PhysRevB.48.3844; HALDANE FDM, 1983, PHYS LETT A, V93, P464, DOI 10.1016/0375-9601(83)90631-X; CHESSER NJ, 1973, ACTA CRYSTALLOGR A, VA 29, P160, DOI 10.1107/S0567739473000422; DEISZ J, 1990, PHYS REV B, V42, P4869, DOI 10.1103/PhysRevB.42.4869; DENNIJS M, 1989, PHYS REV B, V40, P4709, DOI 10.1103/PhysRevB.40.4709; DITUSA JF, 1994, PHYS REV LETT, V73, P1857, DOI 10.1103/PhysRevLett.73.1857; DITUSA JF, 1994, PHYSICA B, V194, P181, DOI 10.1016/0921-4526(94)90420-0; FEYNMAN RP, 1972, STATISTICAL MECHANIC; GARCIAMATRES E, 1993, J SOLID STATE CHEM, V103, P322, DOI 10.1006/jssc.1993.1107; GIRVIN SM, 1985, J MAGN MAGN MATER, V54, P1428; KENNEDY T, 1990, J PHYS-CONDENS MAT, V2, P5737, DOI 10.1088/0953-8984/2/26/010; KOJIMA K, 1995, PHYS REV LETT, V74, P3471, DOI 10.1103/PhysRevLett.74.3471; Lovesey S., 1984, THEORY NEUTRON SCATT; MESHKOV SV, 1993, PHYS REV B, V48, P6167, DOI 10.1103/PhysRevB.48.6167; MITRA PP, 1994, PHYS REV B, V45, P5299; MUTKA H, 1989, PHYS REV B, V39, P4820, DOI 10.1103/PhysRevB.39.4820; NIGHTINGALE MP, 1986, PHYS REV B, V33, P659, DOI 10.1103/PhysRevB.33.659; RAMIREZ AP, 1994, PHYS REV LETT, V72, P3108, DOI 10.1103/PhysRevLett.72.3108; RENARD JP, 1988, J APPL PHYS, V63, P3538, DOI 10.1063/1.340736; SAKAI T, 1990, PHYS REV B, V42, P1090, DOI 10.1103/PhysRevB.42.1090; STSCHIFFLER, 1986, Z ANORG ALLG CHEM, V532, P10; Takigawa M, 1996, PHYS REV LETT, V76, P2173, DOI 10.1103/PhysRevLett.76.2173; TAKIGAWA M, 1995, PHYS REV B, V52, P13087; Ty S., 1990, ZH EKSP TEOR FIZ, V42, P2096; YOKOO T, 1995, J PHYS SOC JPN, V64, P3651, DOI 10.1143/JPSJ.64.3651; ZHELUDEV A, UNPUB	39	88	88	AMERICAN PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	0163-1829			PHYS REV B	Phys. Rev. B	SEP 1	1996	54	10					R6827	R6830				4	Physics, Condensed Matter	Physics	VH082	WOS:A1996VH08200007		
J	Kitazawa, N; Yanagida, T				Kitazawa, N; Yanagida, T			Possible explanation of the Zbb vertex anomaly in one-family technicolor models	PHYSICAL REVIEW D			English	Article							ELECTROWEAK PARAMETERS	In technicolor theories a large radiative correction to the Zbb vertex generally emerges, because of the large top quark mass and SU(2)(L) gauge symmetry. The correction can give us an explanation for the deviation of the experimental value of R(b)=Gamma(b)/Gamma(h) from the standard-model prediction. However, generally the T parameter becomes unacceptably large. We show that in the one-family technicolor model recently proposed by the authors all the S, T, and U parameters can be consistent with the experimental bounds while the observed anomaly of R(b) is naturally explained.	YALE UNIV,DEPT PHYS,NEW HAVEN,CT 06520; UNIV TOKYO,DEPT PHYS,BUNKYO KU,TOKYO 113,JAPAN	Kitazawa, N (reprint author), TOKYO METROPOLITAN UNIV,DEPT PHYS,HACHIOJI,TOKYO 19203,JAPAN.		Yanagida, Tsutomu/A-4394-2011				MANOHAR A, 1984, NUCL PHYS B, V234, P189, DOI 10.1016/0550-3213(84)90231-1; CHIVUKULA RS, 1992, PHYS REV LETT, V69, P575, DOI 10.1103/PhysRevLett.69.575; PESKIN ME, 1992, PHYS REV D, V46, P381, DOI 10.1103/PhysRevD.46.381; GOLDEN M, 1991, NUCL PHYS B, V361, P3, DOI 10.1016/0550-3213(91)90614-4; HAGIWARA K, 1995, PHYS REV D, V52, P5374, DOI 10.1103/PhysRevD.52.5374; HOLDOM B, 1990, PHYS LETT B, V247, P88, DOI 10.1016/0370-2693(90)91054-F; PESKIN ME, 1990, PHYS REV LETT, V65, P964, DOI 10.1103/PhysRevLett.65.964; BUSSEY PJ, 1995, P 27 INT C HIGH EN P; EVANS NL, COMMUNICATION; HAGIWARA K, 1994, Z PHYS C PART FIELDS, V64, P559, DOI 10.1007/BF01957770; KITAZAWA N, IN PRESS PHYS LETT B; KITAZAWA N, IN PRESS P YUK INT S; KITAZAWA N, 1993, PHYS LETT B, V313, P395, DOI 10.1016/0370-2693(93)90009-7; *LEP, 1995, UNPUB LEP EL WORK GR; MATSUMOTO S, 1995, MOD PHYS LETT A, V10, P2553, DOI 10.1142/S0217732395002696; WU GH, 1995, PHYS REV LETT, V74, P4137, DOI 10.1103/PhysRevLett.74.4137; Yoshikawa T, 1996, PHYS LETT B, V368, P209, DOI 10.1016/0370-2693(95)01513-2	17	1	1	AMERICAN PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	0556-2821			PHYS REV D	Phys. Rev. D	SEP 1	1996	54	5					3594	3597		10.1103/PhysRevD.54.3594		4	Astronomy & Astrophysics; Physics, Particles & Fields	Astronomy & Astrophysics; Physics	VF928	WOS:A1996VF92800056		
J	Tanaka, H; Lovinger, AJ; Davis, DD				Tanaka, H; Lovinger, AJ; Davis, DD			Preservation of droplet collision history in phase separation of a binary fluid mixture	PHYSICAL REVIEW E			English	Article							DIGITAL IMAGE-ANALYSIS; SPINODAL DECOMPOSITION; PATTERN-FORMATION; ISOBUTYRIC-ACID; POLYMER SYSTEMS; DYNAMICS; QUENCH; NUCLEATION; GROWTH; WATER	Phase-separation phenomena are widely observed in various kinds of condensed matter. The common feature of these phenomena is the coarsening of a phase-separation pattern driven by the interfacial energy associated with the phase boundary, In contrast to the general phenomenology of liquid-liquid phase separation in which the memory of the structure is continuously lost with time upon coarsening, we have found an unusual phase-separation morphology that records the full history of pattern evolution fur a liquid mixture. The collision history preserved in the trajectory pattern of each droplet demonstrates a strong spatial-temporal correlation in the structural development.	AT&T BELL LABS,LUCENT TECHNOL,MURRAY HILL,NJ 07974	Tanaka, H (reprint author), UNIV TOKYO,INST IND SCI,MINATO KU,TOKYO 106,JAPAN.		Tanaka, Hajime/A-9653-2008	Tanaka, Hajime/0000-0002-4444-1890			ALEXANDER FJ, 1993, PHYS REV B, V48, pR634; SHINOZAKI A, 1993, PHYS REV E, V48, P2622, DOI 10.1103/PhysRevE.48.2622; JAYALAKSHMI Y, 1992, PHYS REV LETT, V69, P3088, DOI 10.1103/PhysRevLett.69.3088; TANAKA H, 1993, PHYS REV LETT, V70, P2770, DOI 10.1103/PhysRevLett.70.2770; TANAKA H, 1993, PHYS REV LETT, V70, P53, DOI 10.1103/PhysRevLett.70.53; HASHIMOTO T, 1986, J CHEM PHYS, V85, P6118, DOI 10.1063/1.451477; KEITH HD, 1964, J APPL PHYS, V35, P1270, DOI 10.1063/1.1713606; GUENOUN P, 1990, PHYS REV LETT, V65, P2406, DOI 10.1103/PhysRevLett.65.2406; KEITH HD, 1963, J APPL PHYS, V34, P2409, DOI 10.1063/1.1702757; PERROT F, 1994, PHYS REV LETT, V73, P688, DOI 10.1103/PhysRevLett.73.688; FURUKAWA H, 1985, ADV PHYS, V34, P703, DOI 10.1080/00018738500101841; TANAKA H, 1990, PHYS REV LETT, V65, P3136, DOI 10.1103/PhysRevLett.65.3136; KOGA T, 1991, PHYS REV A, V44, pR817, DOI 10.1103/PhysRevA.44.R817; BATES FS, 1989, J CHEM PHYS, V91, P3258, DOI 10.1063/1.456901; BENJACOB E, 1985, PHYS REV LETT, V55, P1315, DOI 10.1103/PhysRevLett.55.1315; CHOU YC, 1979, PHYS REV A, V20, P2105, DOI 10.1103/PhysRevA.20.2105; CUMMING A, 1992, PHYS REV A, V45, P885, DOI 10.1103/PhysRevA.45.885; FURUKAWA H, 1986, PHYS REV A, V34, P2315, DOI 10.1103/PhysRevA.34.2315; Gunton J. D., 1983, PHASE TRANSITIONS CR, V8; HOPPER RW, 1990, J FLUID MECH, V213, P349, DOI 10.1017/S002211209000235X; SEUL M, 1994, PHYS REV LETT, V73, P2284, DOI 10.1103/PhysRevLett.73.2284; SHINOZAKI A, 1992, PHYS REV A, V45, pR2161; TANAKA H, 1994, PHYS REV LETT, V72, P3690, DOI 10.1103/PhysRevLett.72.3690; TANAKA H, 1989, J APPL PHYS, V65, P4480, DOI 10.1063/1.343266; TANAKA H, 1991, JPN J APPL PHYS 2, V30, pL1310; TANAKA H, 1995, PHYS REV E, V51, P1313, DOI 10.1103/PhysRevE.51.1313; TANAKA H, 1986, J APPL PHYS, V59, P3627, DOI 10.1063/1.336795; TANAKA H, 1993, PHYS REV E, V47, P2946, DOI 10.1103/PhysRevE.47.2946; WONG NC, 1981, PHYS REV A, V24, P3205, DOI 10.1103/PhysRevA.24.3205	29	3	3	AMERICAN PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	1063-651X			PHYS REV E	Phys. Rev. E	SEP	1996	54	3					R2216	R2219				4	Physics, Fluids & Plasmas; Physics, Mathematical	Physics	VK265	WOS:A1996VK26500010		
J	Zheng, QB; Kobayashi, T				Zheng, QB; Kobayashi, T			Quantum optics as a relativistic theory of light	PHYSICS ESSAYS			English	Article						relational approach to physics; basic physical laws as invariant relationships; inherent ambiguity in the meanings of physical objects, according to the Copenhagen interpretation; mathematical structure of quantum optics as a conceptual map; intrinsic unfalsifiability of Einstein-Podolsky-Rosen paradox		In analogy with Bohm's elucidation of special relativity, in this paper we criticize the Copenhagen interpretation and try to reinterpret quantum theory in the light of new evidence of quantum optics. In doing this, we are led to regard the real photon as only expressing an elemental relationship established between a quantized light field and a detector in the actual detection processes. With this kind of relational approach to quantum physics, new concepts are then needed to describe physical phenomena, and the mathematical structure of quantum theory of radiation is viewed as a conceptual map, in the same way as the Minkowski diagram in Einstein's special relativity, which already has the perspective of the observer implicit in it.		Zheng, QB (reprint author), UNIV TOKYO,GRAD SCH SCI,DEPT PHYS,BUNKYO KU,HONGO 7-3-1,TOKYO 113,JAPAN.						Akhiezer A. I., 1965, QUANTUM ELECTRODYNAM; Heisenberg W, 1925, Z PHYS, V33, P879, DOI 10.1007/BF01328377; BOHM D, 1957, PHYS REV, V108, P1070, DOI 10.1103/PhysRev.108.1070; COOK RJ, 1987, PHYS REV A, V35, P5081, DOI 10.1103/PhysRevA.35.5081; Schrodinger E, 1935, NATURWISSENSCHAFTEN, V23, P807; Einstein A, 1935, PHYS REV, V47, P0777, DOI 10.1103/PhysRev.47.777; ARAKI H, 1960, PHYS REV, V120, P622, DOI 10.1103/PhysRev.120.622; Berestetskii V B, 1982, QUANTUM ELECTRODYNAM; BOHM D, 1977, UNCERTAINTY PRINCIPL, P559; Bohm David, 1965, SPECIAL THEORY RELAT; BORN M, 1968, MY LIFE MY VIEWS, P171; Cohen-Tannoudji C, 1989, PHOTONS ATOMS; Cook R. J., 1990, PROGR OPTICS, V28, P363; Dirac P. A. M., 1958, PRINCIPLES QUANTUM M; DIRAC PAM, 1978, DIRECTIONS PHYSICS, P4; EBERLY JH, 1987, ENCY MODERN PHYSICS, P519; GLAUBER RJ, 1964, QUANTUM OPTICS ELECT, P65; GOLDSTEIN H, 1980, CLASSICAL MECHANICS, P484; GREENBERGER DM, 1993, PHYS TODAY, V46, P22, DOI 10.1063/1.881360; HEISENBERG W, 1972, PHYSICS ENCOUNTERS C, P174; Heisenberg W., 1927, Zeitschrift fur Physik, V43, DOI 10.1007/BF01397280; HEISENBERG W, 1944, PHYSIKALISCHEN PRINZ; JAMMER M, 1974, PHILOS QUANTUM MECHA; JANSZKY J, 1990, OPT COMMUN, V76, P30, DOI 10.1016/0030-4018(90)90551-4; JANSZKY J, 1994, PHYS REV A, V50, P1777, DOI 10.1103/PhysRevA.50.1777; JANSZKY J, 1993, CHEM PHYS LETT, V213, P368, DOI 10.1016/0009-2614(93)85147-G; MEHRA J, 1982, HIST DEV QUANTUM THE, V2, P261; MESCHEDE D, 1992, PHYS REP, V211, P201, DOI 10.1016/0370-1573(92)90110-L; MEYSTRE P, 1992, PROG OPTICS, V30, P261, DOI 10.1016/S0079-6638(08)70100-8; Milonni P. W., 1976, Physics Reports. Physics Letters Section C, V25c, DOI 10.1016/0370-1573(76)90037-5; Milonni P. W., 1984, Wave Particle Dualism. A Tribute to Louis de Broglie on his 90th Birthday. Proceedings of an International Symposium; Minkowski H., 1923, PRINCIPLE RELATIVITY, P75; Newton Isaac, 1952, OPTICKS, P400; PAUL H, 1986, REV MOD PHYS, V58, P209, DOI 10.1103/RevModPhys.58.209; SARGENT M, 1974, LASER PHYSICS, P239; SCHOMMERS W, 1989, QUANTUM THEORY PICTU, P17; SCULLY MO, 1972, PHYS TODAY, V25, P38; Shimony A., 1988, Scientific American, V258; SHIMONY A, 1989, NEW PHYSICS, P373; Wheeler J. A., 1983, QUANTUM THEORY MEASU, P62; WHEELER JA, 1983, QUANTUM THEORY MEASU, P182; WIGNER EP, 1952, Z PHYS, V133, P101, DOI 10.1007/BF01948686; Wigner E.P., 1983, QUANTUM THEORY MEASU, P260; WIGNER EP, 1949, REV MOD PHYS, V21, P400	44	1	1	UNIV TORONTO PRESS INC	TORONTO	JOURNALS DIVISION, 5201 DUFFERIN ST, DOWNSVIEW, TORONTO ON M3H 5T8, CANADA	0836-1398			PHYS ESSAYS	Phys. Essays	SEP	1996	9	3					447	459				13	Physics, Multidisciplinary	Physics	VY954	WOS:A1996VY95400012		
J	Feng, X; Holzscheiter, MH; Charlton, M; Cverna, F; Ichioka, T; King, NSP; Lewis, RA; Morgan, GL; Rochet, J; Yamazaki, Y				Feng, X; Holzscheiter, MH; Charlton, M; Cverna, F; Ichioka, T; King, NSP; Lewis, RA; Morgan, GL; Rochet, J; Yamazaki, Y			Ultralow-energy antiprotons for antihydrogen spectroscopy and antimatter gravity	PHYSICS OF ATOMIC NUCLEI			English	Article; Proceedings Paper	3rd International Conference on Nucleon-Antinucleon Physics	SEP 11-16, 1995	INST THEORET & EXPTL PHYS, MOSCOW, RUSSIA	Russian Acad Sci, Dept Nucl Phys, Russian Fdn Basic Res, Inst Theoret & Exptl Phys, Int Sci Fdn, INFN, Lab Nazl Frascati, Italy	INST THEORET & EXPTL PHYS			Approximately one million antiprotons have been captured in a large-scale Penning trap at the Low Energy Antiproton Ring (LEAR) at CERN. Up to 65% of the captured antiprotons have subsequently been electron cooled to energies below 1 eV and have been stored up to one hour This has opened new discussions of the possible use of ultralow-energy antiprotons for gravitational physics, as well as for precision spectroscopy of antihydrogen for CPT tests.	LOS ALAMOS NATL LAB,DIV PHYS,LOS ALAMOS,NM 87545; UNIV LONDON UNIV COLL,DEPT PHYS & ASTRON,LONDON WC1E 6BT,ENGLAND; UNIV TOKYO,INST PHYS,TOKYO 153,JAPAN; PENN STATE UNIV,OSMOND LAB,UNIVERSITY PK,PA 16802	Feng, X (reprint author), AARHUS UNIV,DEPT PHYS & ASTRON,DK-8000 AARHUS C,DENMARK.						BARKAS WH, 1956, PHYS REV, V101, P778, DOI 10.1103/PhysRev.101.778; HOLZSCHEITER MH, 1992, PHYS SCRIPTA, V46, P272, DOI 10.1088/0031-8949/46/3/011; Penning FM, 1936, PHYSICA, V3, P873; GABRIELSE G, 1990, PHYS REV LETT, V65, P1317, DOI 10.1103/PhysRevLett.65.1317; BEVERINI N, 1986, PSCC862P94 CERN; BEVERINI N, 1988, PHYS SCRIPTA, VT22, P238, DOI 10.1088/0031-8949/1988/T22/035; Dehmelt H G, 1969, ADV ATOM MOL PHYS, V5, P109, DOI 10.1016/S0065-2199(08)60156-6; FENG X, 1996, J APPL PHYS, V79; HOLZSCHEITER MH, 1995, UNPUB PHYS LETT A; Johnson C.D., 1990, CERNPS9042AR; PIERCE JR, 1949, THEORY DESIGN ELECTR; Rolston S. L., 1988, Hyperfine Interactions, V44	12	0	0	AMER INST PHYSICS	WOODBURY	CIRCULATION FULFILLMENT DIV, 500 SUNNYSIDE BLVD, WOODBURY, NY 11797-2999	1063-7788			PHYS ATOM NUCL+	Phys. Atom. Nuclei	SEP	1996	59	9					1492	1496				5	Physics, Nuclear; Physics, Particles & Fields	Physics	VJ078	WOS:A1996VJ07800002		
J	Fukuda, T				Fukuda, T			Japan Hadron Project	PHYSICS OF ATOMIC NUCLEI			English	Article; Proceedings Paper	3rd International Conference on Nucleon-Antinucleon Physics	SEP 11-16, 1995	INST THEORET & EXPTL PHYS, MOSCOW, RUSSIA	Russian Acad Sci, Dept Nucl Phys, Russian Fdn Basic Res, Inst Theoret & Exptl Phys, Int Sci Fdn, INFN, Lab Nazl Frascati, Italy	INST THEORET & EXPTL PHYS			An overview of the Japan Hadron Project is given. The project will open new intensity frontiers for nuclear and particle physics, as well as for muon and neutron sciences.		Fukuda, T (reprint author), UNIV TOKYO,INST NUCL STUDY,TOKYO 188,JAPAN.							0	0	0	AMER INST PHYSICS	WOODBURY	CIRCULATION FULFILLMENT DIV, 500 SUNNYSIDE BLVD, WOODBURY, NY 11797-2999	1063-7788			PHYS ATOM NUCL+	Phys. Atom. Nuclei	SEP	1996	59	9					1596	1600				5	Physics, Nuclear; Physics, Particles & Fields	Physics	VJ078	WOS:A1996VJ07800016		
J	Moriguchi, T; Nishiyama, N; Saito, H; Katsuki, H				Moriguchi, T; Nishiyama, N; Saito, H; Katsuki, H			Trophic effects of aged garlic extract (AGE) and its fractions on primary cultured hippocampal neurons from fetal rat brain	PHYTOTHERAPY RESEARCH			English	Article						aged garlic extract (AGE); protein fraction; hippocampus; neuronal survival; axonal branching	SENESCENCE-ACCELERATED MOUSE; FIBROBLAST GROWTH-FACTOR; GRANULAR STRUCTURES; MURINE MODEL; SAM; SURVIVAL	The effects of aged garlic extract (AGE) and its fractions were studied on the survival and morphology of the primary cultured hippocampal neurons from fetal rat brain. The addition of AGE to the culture medium significantly increased the survival of cultured hippocampal neurons and the number of branching points per axon. The neurotrophic activity of AGE resided in a water-soluble-low-molecular-weight fraction, which is an unrefined fraction that contains 94% of constituents in crude AGE, On the other hand, the protein fraction purified from a high-molecular-weight fraction, showed a potent survival-promoting effect without any effect on the neuronal morphology, These results suggest that AGE contains multiple components which have neurotrophic activity and that AGE and its fractions are useful substances for preventing age-related morphological changes in the central nervous system.		Moriguchi, T (reprint author), UNIV TOKYO,FAC PHARMACEUT SCI,DEPT CHEM PHARMACOL,BUNKYO KU,7-3-1 HONGO,TOKYO 113,JAPAN.						ABE K, 1991, JPN J PHARMACOL, V54, P45; ABE K, 1990, JPN J PHARMACOL, V53, P221, DOI 10.1254/jjp.53.221; ABE K, 1993, BRAIN RES, V605, P322, DOI 10.1016/0006-8993(93)91759-L; TAKEMURA M, 1993, AM J PATHOL, V142, P1887; TAKEDA T, 1991, J AM GERIATR SOC, V39, P911; AKIYAMA H, 1986, ACTA NEUROPATHOL, V72, P124; TAKEDA T, 1981, MECH AGEING DEV, V17, P183, DOI 10.1016/0047-6374(81)90084-1; YAGI H, 1989, J NEUROPATH EXP NEUR, V48, P577, DOI 10.1097/00005072-198909000-00008; Hirao Y, 1987, PHYTOTHER RES, V1, P161, DOI 10.1002/ptr.2650010406; HOSOKAWA M, 1984, MECH AGEING DEV, V26, P91, DOI 10.1016/0047-6374(84)90168-4; IMAI J, 1994, PLANTA MED, V60, P417, DOI 10.1055/s-2006-959522; MIROGUCHI T, 1994, BIOL PHARM BULL, V17, P1589; MIYAGAWA T, 1993, NEUROSCI LETT, V153, P29, DOI 10.1016/0304-3940(93)90069-W; Sugiyama H, 1987, CLIN NEUROL, V27, P841; WEINBERG DS, 1993, J AGR FOOD CHEM, V41, P37, DOI 10.1021/jf00025a008	15	9	9	JOHN WILEY & SONS LTD	W SUSSEX	BAFFINS LANE CHICHESTER, W SUSSEX, ENGLAND PO19 1UD	0951-418X			PHYTOTHER RES	Phytother. Res.	SEP	1996	10	6					468	472				5	Chemistry, Medicinal; Pharmacology & Pharmacy	Pharmacology & Pharmacy	VN088	WOS:A1996VN08800002		
J	Sadakata, M; Xu, YB; Harano, A				Sadakata, M; Xu, YB; Harano, A			A systematic approach for the design of aerosol reactors	POWDER TECHNOLOGY			English	Article; Proceedings Paper	1st International Particle Technology Forum	AUG 17-19, 1994	DENVER, CO	AIChE		aerosol reactor; ultrafine particles; particle synthesis; turbulent theory; systematic reactor design	PARTICLE-PRODUCTION	This study describes a rational design principle of aerosol reactors for synthesis of high yield monosize ultrafine particles formed through a nucleation-driven particle formation process using the relationships among four characteristic times. A systematic approach to the scale-up of aerosol reactors is then discussed based on turbulent theory, with a simple scaling law being subsequently derived, named the 'cube-root law'. Based on these relationships, a procedure is presented for the design of an industrial scale jet mixing type aerosol reactor.		Sadakata, M (reprint author), UNIV TOKYO,DEPT CHEM SYST ENGN,BUNKYO KU,7-3-1 HONGO,TOKYO 113,JAPAN.						CORRSIN S, 1964, AICHE J, V10, P870, DOI 10.1002/aic.690100618; ULRICH GD, 1971, COMBUST SCI TECHNOL, V4, P47, DOI 10.1080/00102207108952471; XIONG Y, 1991, J AEROSOL SCI, V22, P637, DOI 10.1016/0021-8502(91)90017-C; GRANK J, 1975, MATH DIFFUSION, P74; HINZE JO, 1975, TURBULENCE, P539; KODAS TT, 1987, IND ENG CHEM RES, V26, P1999, DOI 10.1021/ie00070a011; MATSUNAMI T, 1990, THESIS GUNMA U JAPAN; OKABE Y, 1980, J CHEM SOC JPN, V2, P180; PRATSINIS SE, 1989, J AEROSOL SCI, V20, P1461, DOI 10.1016/0021-8502(89)90862-8; PRATSINIS SE, 1986, IND ENG CHEM PROC DD, V25, P634, DOI 10.1021/i200034a007; SADAKATA M, 1982, KAGAKU KOGAKU, V5, P18; Smoluchowski M, 1917, Z PHYS CHEM, V92, P129	12	4	4	ELSEVIER SCIENCE SA LAUSANNE	LAUSANNE 1	PO BOX 564, 1001 LAUSANNE 1, SWITZERLAND	0032-5910			POWDER TECHNOL	Powder Technol.	SEP	1996	88	3					261	266		10.1016/S0032-5910(96)03129-4		6	Engineering, Chemical	Engineering	VP608	WOS:A1996VP60800009		
J	Matsuura, A				Matsuura, A			The automorphism group of the Klein curve in the mapping class group of genus 3	PROCEEDINGS OF THE JAPAN ACADEMY SERIES A-MATHEMATICAL SCIENCES			English	Article									UNIV TOKYO, DEPT MATH SCI, TOKYO, JAPAN							Birman J S, 1974, BRAIDS LINKS MAPPING; Coxeter H.S.M., 1972, GENERATORS RELATIONS; KERCKHOFF SP, 1983, ANN MATH, V117, P235, DOI 10.2307/2007076; KLEIN F, 1923, GESAMMELTE MATH ABHA, V3, P90; KURIBAYA.A, 1966, NAGOYA MATH J, V28, P119; Macbeath A.M., 1969, P S PURE MATH, V12, P14; MAGNUS W, 1970, NONEUCLIDEAN TESSELA	7	1	1	JAPAN ACAD	TOKYO	7-32, UENO PARK, TAITO-KU, TOKYO, 110-0007, JAPAN	0386-2194			P JPN ACAD A-MATH	Proc. Jpn. Acad. Ser. A-Math. Sci.	SEP	1996	72	7					139	140				2	Mathematics	Mathematics	VN093	WOS:A1996VN09300002		
J	Battsengel, B				Battsengel, B			The maximal finite subgroup in the mapping class group of genus 5	PROCEEDINGS OF THE JAPAN ACADEMY SERIES A-MATHEMATICAL SCIENCES			English	Article								The automorphism groups of compact Riemann surfaces of genus 5 are enumerated by A. Kuribayashi and H. Kimura. Among them, the group of largest order is a group of order 192. The Riemann surface with this automorphism group is unique, and it is realized as the modular curve X(8) of level 8. By utilizing this, we have explicit construction of the finite subgroup of order 192 in the Teichmuller group of genus 5.	UNIV TOKYO, DEPT MATH SCI, TOKYO, JAPAN							KURIBAYASHI A, 1990, J ALGEBRA, V134, P80, DOI 10.1016/0021-8693(90)90212-7; KERCKHOFF SP, 1983, ANN MATH, V117, P235, DOI 10.2307/2007076; Lehner J., 1964, DISCONTINUOUS GROUPS; MANIN YI, 1972, MATH USSR IZV, V36, P19; MATSUURA A, AUTOMORPHISM GROUP K	5	0	0	JAPAN ACAD	TOKYO	7-32, UENO PARK, TAITO-KU, TOKYO, 110-0007, JAPAN	0386-2194			P JPN ACAD A-MATH	Proc. Jpn. Acad. Ser. A-Math. Sci.	SEP	1996	72	7					141	143				3	Mathematics	Mathematics	VN093	WOS:A1996VN09300003		
J	Kondo, Y; Homma, Y; Aso, Y; Kawabe, K; Mieda, M; Takahashi, H				Kondo, Y; Homma, Y; Aso, Y; Kawabe, K; Mieda, M; Takahashi, H			Relative potency of antiandrogens with reference to intracellular testosterone in the rat prostate	PROSTATE			English	Article						prostate; antiandrogen; relative potency; testosterone	ANDROGEN RECEPTOR; FLUTAMIDE; ANTAGONISTS; CARCINOMA; MECHANISM; BINDING; CANCER	Mechanisms of relative potency in direct action of antiandrogens have not been fully elucidated. Using castrated rats, the effects of antiandrogens on the prostatic weight gain induced by exogenous testosterone (T), and on T uptake into prostatic cells were examined. Tested antiandrogens were cyproterone acetate, chlormadinone acetate, a new steroidal antiandrogen, 17acetoxy-6-chloro-2-oxa-4,6-pregnadiene (TZP-4238), and one nonsteroidal type, flutamide (FL). Suppression of prostatic weight gain, T uptake and serum concentrations of compounds, correlated well each other among steroidal anti-androgens, while FL was five times more active in suppressing weight gain than TZP-4238, associated with a lower nuclear distribution of androgen. The results suggest that 1) suppression of T uptake is a major and common mechanism of steroidal antiandrogens and the relative potency is attributable to pharmacokinetic characteristics in vivo, and 2) FL suppresses nuclear T uptake more specifically than steroidal antiandrogens. (C) 1996 Wiley-Liss, Inc.	UNIV TOKYO,FAC MED,DEPT UROL,BUNKYO KU,TOKYO 113,JAPAN; TEIKOKU HORMONE MFG CO LTD,RES DEPT,KANAGAWA,JAPAN							CRAWFORD ED, 1989, NEW ENGL J MED, V321, P419, DOI 10.1056/NEJM198908173210702; BROGDEN RN, 1989, DRUGS, V38, P185; BAULIEU EE, 1987, J CELL BIOCHEM, V35, P161, DOI 10.1002/jcb.240350209; Belis J A, 1984, Prog Clin Biol Res, V145, P345; CALLAWAY TW, 1982, PROSTATE, V3, P599, DOI 10.1002/pros.2990030609; DUAX WL, 1988, J STEROID BIOCHEM, V31, P481, DOI 10.1016/0022-4731(88)90002-7; FAWELL SE, 1990, P NATL ACAD SCI USA, V87, P6883, DOI 10.1073/pnas.87.17.6883; HONMA S, 1977, CHEM PHARM BULL, V25, P2019; JOHANSSON JE, 1987, UROLOGY, V29, P55, DOI 10.1016/0090-4295(87)90599-1; KONTULA KK, 1985, ENDOCRINOLOGY, V116, P226; LABRIE F, 1993, CANCER, V72, P3816, DOI 10.1002/1097-0142(19931215)72:12+<3816::AID-CNCR2820721711>3.0.CO;2-3; LABRIE F, 1990, J STEROID BIOCHEM, V37, P943, DOI 10.1016/0960-0760(90)90448-T; MIQUEL J, 1988, J STEROID BIOCHEM, V31, P524; Moguilewsky M, 1987, Prog Clin Biol Res, V243A, P315; OJASOO T, 1987, J STEROID BIOCHEM, V27, P255, DOI 10.1016/0022-4731(87)90317-7; SHIBATA K, 1992, CHEM PHARM BULL, V40, P935; STARKA L, 1982, J STEROID BIOCHEM, V17, P331, DOI 10.1016/0022-4731(82)90207-2; SZEGO CM, 1988, AM J PHYSIOL, V254, P775; TAKEZAWA Y, 1992, PROSTATE, V21, P315, DOI 10.1002/pros.2990210408	19	6	7	WILEY-LISS	NEW YORK	DIV JOHN WILEY & SONS INC 605 THIRD AVE, NEW YORK, NY 10158-0012	0270-4137			PROSTATE	Prostate	SEP	1996	29	3					146	152		10.1002/(SICI)1097-0045(199609)29:3<146::AID-PROS1>3.0.CO;2-C		7	Endocrinology & Metabolism; Urology & Nephrology	Endocrinology & Metabolism; Urology & Nephrology	VK288	WOS:A1996VK28800002		
J	Maeda, Y; Ueda, H; Kazami, J; Kawano, G; Suzuki, E; Nagamune, T				Maeda, Y; Ueda, H; Kazami, J; Kawano, G; Suzuki, E; Nagamune, T			Chimeric antibody binding domain - Vargula luciferase engineered for immunological purposes	PROTEIN ENGINEERING			English	Meeting Abstract									UNIV TOKYO,DEPT CHEM & BIOTECHNOL,GRAD SCH ENGN,BUNKYO KU,TOKYO 113,JAPAN; TORAY MED DEVICES & DIAGNOST RES LAB,OTSU,SHIGA 520,JAPAN; AQUAS CORP,TSUKUBA,IBARAKI 30026,JAPAN							Maeda Y, 1996, BIOTECHNIQUES, V20, P116; THOMPSON EM, 1989, P NATL ACAD SCI USA, V86, P6567, DOI 10.1073/pnas.86.17.6567	2	1	1	OXFORD UNIV PRESS UNITED KINGDOM	OXFORD	WALTON ST JOURNALS DEPT, OXFORD, ENGLAND OX2 6DP	0269-2139			PROTEIN ENG	Protein Eng.	SEP	1996	9	9					2	2				1	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	VK019	WOS:A1996VK01900015		
J	Kono, H; Nishiyama, M; Tanokura, M; Doi, J				Kono, H; Nishiyama, M; Tanokura, M; Doi, J			Design of hydrophobic cores of malate dehydrogenases based on the side-chain packing	PROTEIN ENGINEERING			English	Meeting Abstract									UNIV TOKYO,DEPT BIOTECHNOL,TOKYO 113,JAPAN; UNIV TOKYO,BIOTECHNOL RES CTR,TOKYO 113,JAPAN							KONO H, 1994, PROTEINS, V19, P244, DOI 10.1002/prot.340190308	1	0	0	OXFORD UNIV PRESS UNITED KINGDOM	OXFORD	WALTON ST JOURNALS DEPT, OXFORD, ENGLAND OX2 6DP	0269-2139			PROTEIN ENG	Protein Eng.	SEP	1996	9	9					13	13				2	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	VK019	WOS:A1996VK01900026		
J	Zako, T; Ueda, H; Kitayama, A; Nishimura, H; Suzuki, E; Nagamune, T				Zako, T; Ueda, H; Kitayama, A; Nishimura, H; Suzuki, E; Nagamune, T			The structural characteristics of the residues hydrogen bonding with DNA base pairs	PROTEIN ENGINEERING			English	Meeting Abstract									UNIV TOKYO,GRAD SCH ENGN,DEPT CHEM & BIOTECHNOL,BUNKYO KU,TOKYO 113,JAPAN			Zako, Tamotsu/C-3004-2012				ZAKO T, 1994, PROTEIN ENG, V7, P1163	1	0	0	OXFORD UNIV PRESS UNITED KINGDOM	OXFORD	WALTON ST JOURNALS DEPT, OXFORD, ENGLAND OX2 6DP	0269-2139			PROTEIN ENG	Protein Eng.	SEP	1996	9	9					16	16				1	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	VK019	WOS:A1996VK01900029		
J	Ueda, H; Tsumoto, K; Kubota, K; Suzuki, C; Nishimura, H; Nagamune, T; Winter, G; Mahoney, WC; Kumagai, I				Ueda, H; Tsumoto, K; Kubota, K; Suzuki, C; Nishimura, H; Nagamune, T; Winter, G; Mahoney, WC; Kumagai, I			Analysis of intramolecular interaction of an antibody Fv region and its application to immunoassay	PROTEIN ENGINEERING			English	Meeting Abstract									UNIV TOKYO,DEPT CHEM & BIOTECHNOL,TOKYO,JAPAN; TOHOKU UNIV,DEPT BIOCHEM & ENGN,GERDAI,JAPAN; MRC,LONDON W1N 4AL,ENGLAND; BOEHRINGER MANNHEIM CORP,INDIANAPOLIS,IN								0	0	0	OXFORD UNIV PRESS UNITED KINGDOM	OXFORD	WALTON ST JOURNALS DEPT, OXFORD, ENGLAND OX2 6DP	0269-2139			PROTEIN ENG	Protein Eng.	SEP	1996	9	9					21	21				1	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	VK019	WOS:A1996VK01900034		
J	Wakagi, T; Fujii, T; Omori, A; Oshima, T; Matsuzawa, H				Wakagi, T; Fujii, T; Omori, A; Oshima, T; Matsuzawa, H			Structure and function of an extremely stable ferredoxin	PROTEIN ENGINEERING			English	Meeting Abstract									KYOTO UNIV,INST CHEM RES,KYOTO,JAPAN; TOKYO UNIV PHARM & LIFE SCI,MITSUBISHIKAGAKU INST LIFE SCI,TOKYO,JAPAN; TOKYO UNIV PHARM & LIFE SCI,DEPT MOL BIOL,TOKYO,JAPAN; UNIV TOKYO,DEPT BIOTECHNOL,TOKYO,JAPAN							FUJII T, 1991, J BIOCHEM-TOKYO, V110, P427; IWASAKI T, 1994, J BIOL CHEM, V269, P29444; MINAMI Y, 1985, J BIOCHEM-TOKYO, V97, P745	3	0	0	OXFORD UNIV PRESS UNITED KINGDOM	OXFORD	WALTON ST JOURNALS DEPT, OXFORD, ENGLAND OX2 6DP	0269-2139			PROTEIN ENG	Protein Eng.	SEP	1996	9	9					30	30				1	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	VK019	WOS:A1996VK01900043		
J	Ikura, T; Tsurupa, GP; Kuwajima, K				Ikura, T; Tsurupa, GP; Kuwajima, K			Folding reactions of proline mutants of staphylococcal nuclease	PROTEIN ENGINEERING			English	Meeting Abstract									UNIV TOKYO,DEPT PHYS,SCH SCI,BUNKYO KU,TOKYO 113,JAPAN			Ikura, Teikichi/N-1490-2015	Ikura, Teikichi/0000-0003-2377-5434				0	0	0	OXFORD UNIV PRESS UNITED KINGDOM	OXFORD	WALTON ST JOURNALS DEPT, OXFORD, ENGLAND OX2 6DP	0269-2139			PROTEIN ENG	Protein Eng.	SEP	1996	9	9					32	32				2	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	VK019	WOS:A1996VK01900045		
J	Tsurupa, GP; Ikura, T; Kuwajima, K				Tsurupa, GP; Ikura, T; Kuwajima, K			Effect of GroEL on the refolding kinetics of staphylococcal nuclease	PROTEIN ENGINEERING			English	Meeting Abstract									UNIV TOKYO,DEPT PHYS,SCH SCI,BUNKYO KU,TOKYO 113,JAPAN			Ikura, Teikichi/N-1490-2015	Ikura, Teikichi/0000-0003-2377-5434				0	1	1	OXFORD UNIV PRESS UNITED KINGDOM	OXFORD	WALTON ST JOURNALS DEPT, OXFORD, ENGLAND OX2 6DP	0269-2139			PROTEIN ENG	Protein Eng.	SEP	1996	9	9					33	33				1	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	VK019	WOS:A1996VK01900046		
J	Terai, Y; Fujii, I; Byun, SH; Nakajima, O; Hakamatsuka, T; Ebizuka, Y; Sankawa, U				Terai, Y; Fujii, I; Byun, SH; Nakajima, O; Hakamatsuka, T; Ebizuka, Y; Sankawa, U			Cloning of chalcone-flavanone isomerase cDNA from Pueraria lobata and its overexpression in Escherichia coli	PROTEIN EXPRESSION AND PURIFICATION			English	Article							CELL-SUSPENSION CULTURES; PHASEOLUS-VULGARIS L; OXIDATIVE REARRANGEMENT; ISOFLAVONE BIOSYNTHESIS; CHEMICAL MODIFICATION; GENE-EXPRESSION; PETUNIA-HYBRIDA; SYNTHASE; PURIFICATION; INDUCTION	Chalcone-flavanone isomerase (CHI) cDNA was isolated from Pueraria lobata by combination of cDNA library screening using Phaseolus vulgaris CHI cDNA as a probe and polymerase chain reaction techniques. Analysis of nucleotide sequence of the cloned cDNA revealed a 675-bp open reading frame encoding a 225-amino-acid polypeptide with a molecular weight of 23,803 Ha. The CHI cDNA coding region was cloned into pET-3d expression vector and successfully overexpressed in Escherichia coli cells as active CHI enzyme. The recombinant CHI was then purified to apparent homogeneity by DEAE-cellulose column chromatography. Replacement of Cys-119 with Ala was carried out by site-directed mutagenesis and the result that the mutant CHI showed CHI enzyme activity confirmed that Cys-119 is not involved in the CHI catalytic active site. (C) 1996 Academic Press, Inc.	UNIV TOKYO,FAC PHARMACEUT SCI,BUNKYO KU,TOKYO 113,JAPAN							CHAPPELL J, 1984, NATURE, V311, P76, DOI 10.1038/311076a0; VANTUNEN AJ, 1988, EMBO J, V7, P1257; BEDNAR RA, 1989, J BIOL CHEM, V264, P14272; PETERS NK, 1986, SCIENCE, V233, P977, DOI 10.1126/science.3738520; SPARVOLI F, 1994, PLANT MOL BIOL, V24, P743, DOI 10.1007/BF00029856; GROTEWOLD E, 1994, MOL GEN GENET, V242, P1; BEDNAR RA, 1988, J BIOL CHEM, V263, P9582; BEDNAR RA, 1990, ARCH BIOCHEM BIOPHYS, V282, P393, DOI 10.1016/0003-9861(90)90134-K; BEDNAR RA, 1991, BIOCONJUGATE CHEM, V2, P211, DOI 10.1021/bc00010a004; BLYDEN ER, 1991, PLANT MOL BIOL, V16, P167, DOI 10.1007/BF00017927; BOLAND MJ, 1979, BIOORG CHEM, V8, P1, DOI 10.1016/0045-2068(79)90030-0; BOLAND MJ, 1975, EUR J BIOCHEM, V50, P383, DOI 10.1111/j.1432-1033.1975.tb09814.x; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CRAMER CL, 1985, EMBO J, V4, P285; DIXON RA, 1986, BIOL REV, V61, P239, DOI 10.1111/j.1469-185X.1986.tb00719.x; DIXON RA, 1983, ADV ENZYMOL RAMB, V55, P1; DIXON RA, 1982, BIOCHIM BIOPHYS ACTA, V715, P25, DOI 10.1016/0304-4165(82)90045-9; DIXON RA, 1983, PLANTA, V159, P561, DOI 10.1007/BF00409146; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; HAHLBROC.K, 1970, PHYTOCHEMISTRY, V9, P949, DOI 10.1016/S0031-9422(00)85212-7; HAHLBROC.K, 1970, EUR J BIOCHEM, V15, P13, DOI 10.1111/j.1432-1033.1970.tb00969.x; HAKAMATSUKA T, 1990, CHEM PHARM BULL, V38, P1942; HAKAMATSUKA T, 1991, TETRAHEDRON, V47, P5969, DOI 10.1016/S0040-4020(01)86489-9; HAKAMATSUKA T, 1993, J PLANT RES, V3, P129; HAKAMATSUKA T, 1992, Z NATURFORSCH C, V47, P177; HAKAMATSUKA T, 1989, CHEM PHARM BULL, V37, P249; HAKAMATSUKA T, 1988, CHEM PHARM BULL, V36, P4225; HASHIM MF, 1990, FEBS LETT, V271, P219, DOI 10.1016/0014-5793(90)80410-K; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MAKI M, 1987, FEBS LETT, V223, P174, DOI 10.1016/0014-5793(87)80531-8; MCKHANN HI, 1994, PLANT MOL BIOL, V24, P767, DOI 10.1007/BF00029858; MEHDY MC, 1987, EMBO J, V6, P1527; NAKAJIMA O, 1991, CHEM PHARM BULL, V39, P1911; Nakajima O, 1996, BIOL PHARM BULL, V19, P71; PODIVINSKY E, 1993, PLANT MOL BIOL, V21, P737; ROBBINS MP, 1984, EUR J BIOCHEM, V145, P195, DOI 10.1111/j.1432-1033.1984.tb08540.x; Sambrook J., 1989, MOL CLONING LAB MANU; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; VANTUNEN AJ, 1989, PLANT MOL BIOL, V12, P539, DOI 10.1007/BF00036968; WOOD AJ, 1994, PLANT PHYSIOL, V104, P1465, DOI 10.1104/pp.104.4.1465	40	10	12	ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495	1046-5928			PROTEIN EXPRES PURIF	Protein Expr. Purif.	SEP	1996	8	2					183	190		10.1006/prep.1996.0091		8	Biochemical Research Methods; Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	VH084	WOS:A1996VH08400007		
J	Aoyama, T; Kotaki, H; Sawada, Y; Iga, T				Aoyama, T; Kotaki, H; Sawada, Y; Iga, T			Pharmacokinetics and pharmacodynamics of methylphenidate enantiomers in rats	PSYCHOPHARMACOLOGY			English	Article						methylphenidate enantiomers; microdialysis; dopamine level; striatum; locomotor activity; rats	THREO-METHYLPHENIDATE; DOPAMINE RELEASE; BRAIN; NARCOLEPSY; BINDING	We investigated the relationships between methylphenidate (MPD) enantiomers and endogenous dopamine (DA) levels in striatal extracellular fluid, and that between DA level and locomotor activity, after intravenous administration of racemic MPD (2, 5 or 10 mg/kg dose) or the individual enantiomers (2.5 mg/kg dose) to rats. MPD and DA levels in the extracellular fluid were measured by in vivo brain microdialysis. The maximum levels of MPD enantiomers in the striatal extracellular fluid were obtained within 15 min after administration. On the other hand, the mean maximum DA levels after administration of 2-10 mg/kg dose of racemic MPD were obtained within 10 min with values in the range of 3.0- to 8.6-fold higher than the basal DA level. The maximum DA level (4.2-fold of the basal level) after administration of (+)-MPD was greater than that (2.2-fold) of the same dose of (-)-MPD. A clockwise hysteresis was observed between MPD concentration and DA level in the extracellular fluid after MPD administration. Locomotor activity after administration of (+)-MPD was also greater than (-)-MPD. From these results, it was shown that the locomotor activity induced by MPD may be related to the increase of DA level in the extracellular fluid, and the degree of increase of the DA level by (+)-MPD was greater than that of the (-)-isomer.	KYUSHU UNIV,FAC PHARMACEUT SCI,DEPT PHARMACEUT,HIGASHI KU,FUKUOKA 812,JAPAN	Aoyama, T (reprint author), UNIV TOKYO,FAC MED,TOKYO UNIV HOSP,DEPT PHARM,BUNKYO KU,TOKYO 113,JAPAN.						ANDEN NE, 1967, J PHARM PHARMACOL, V19, P627; ERNST AM, 1967, PSYCHOPHARMACOLOGIA, V10, P316, DOI 10.1007/BF00403900; PATRICK KS, 1987, J PHARMACOL EXP THER, V241, P152; SHARP T, 1987, BRAIN RES, V401, P322, DOI 10.1016/0006-8993(87)91416-8; AOYAMA T, 1994, PHARMACEUT RES, V11, P407, DOI 10.1023/A:1018917205292; AOYAMA T, 1989, J CHROMATOGR-BIOMED, V494, P420, DOI 10.1016/S0378-4347(00)82698-5; BARKLEY RA, 1977, J CHILD PSYCHOL PSYC, V18, P137, DOI 10.1111/j.1469-7610.1977.tb00425.x; BUTCHER SP, 1991, NEUROSCI LETT, V122, P245, DOI 10.1016/0304-3940(91)90869-U; DALY DD, 1956, P STAFF M MAYO CLIN, V31, P620; GIBALDI M, 1982, DRUGS PHARM SCI, V15, P45; HIRABAYASHI M, 1981, PHARMACOL BIOCHEM BE, V15, P925, DOI 10.1016/0091-3057(81)90056-3; HONDA Y, 1979, CURR THER RES CLIN E, V25, P288; HURD YL, 1989, EUR J PHARMACOL, V166, P251, DOI 10.1016/0014-2999(89)90066-6; JANOWSKY A, 1985, EUR J PHARMACOL, V108, P187, DOI 10.1016/0014-2999(85)90724-1; KUSHIMA Y, 1989, NEUROPEPTIDES, V14, P225, DOI 10.1016/0143-4179(89)90050-4; LIM HK, 1986, J CHROMATOGR, V378, P109, DOI 10.1016/S0378-4347(00)80704-5; MITLER MM, 1991, SLEEP, V14, P218; SCHAIN RJ, 1975, PEDIATRICS, V55, P709; UNITS AS, 1985, EUR J PHARMACOL, V113, P155; YOSS RE, 1959, NEUROLOGY, V9, P171	20	30	30	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010	0033-3158			PSYCHOPHARMACOLOGY	Psychopharmacology	SEP	1996	127	2					117	122		10.1007/BF02805984		6	Neurosciences; Pharmacology & Pharmacy; Psychiatry	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	VJ421	WOS:A1996VJ42100007		
J	Fujita, N; Fukuda, Y; Matsuura, C; Saigo, K				Fujita, N; Fukuda, Y; Matsuura, C; Saigo, K			Radiation-enhanced H+ generation in iron-containing solution saturated with CO2	RADIATION PHYSICS AND CHEMISTRY			English	Article							HIGH-TEMPERATURE WATER; CARBON-DIOXIDE; PHOTOELECTROCHEMICAL REDUCTION; ELECTROCHEMICAL REDUCTION; COPPER; HYDROGENATION; ELECTRODES; CORROSION; METHANOL; SILICA	In the course of a study of radiation-induced CO2 reduction in CO2-saturated solution with iron powder, an in situ monitoring of pH and redox potential (ORP) was carried out in the four iron-containing solutions as follows: (1) saturated with CO2 and irradiated by gamma-rays of 2 kGy/h; (2) saturated with CO2 and unirradiated; (3) saturated with Ar and irradiated by gamma-rays; (4) saturated with Ar and unirradiated: It was revealed that gamma-rays make the pH decrease by almost 2.5, and that in solution (1) the rate of H+ generation is collectively enhanced 27 times as much as that due to radiolysis alone, Through analyses of d[H+]/dt, it was suggested that corrosion of iron is forced to increase in irradiated solutions (1) and (3), compared to the unirradiated solutions (2) and (4), and that only in solution (1) was the corrosion rate increased in relation to an increase in the amount of iron; it decreased, on the contrary, in the other three solutions. Copyright (C) 1996 Elsevier Science Ltd.	UNIV TOKYO,FAC ENGN,TOKYO 113,JAPAN	Fujita, N (reprint author), UNIV E ASIA,FAC ENGN,3-6-2 KYONAN,MUSASHINO,TOKYO 180,JAPAN.						ALEXMILLS G, 1974, CATAL REV, V8, P159; ZAFRIR M, 1983, J ELECTROANAL CHEM, V159, P373, DOI 10.1016/S0022-0728(83)80635-4; SAITO M, 1981, J CATAL, V67, P296, DOI 10.1016/0021-9517(81)90289-X; HORI Y, 1985, CHEM LETT, P1695, DOI 10.1246/cl.1985.1695; WEATHERBEE GD, 1984, J CATAL, V87, P352, DOI 10.1016/0021-9517(84)90196-9; CANFIELD D, 1983, J ELECTROCHEM SOC, V130, P1772, DOI 10.1149/1.2120090; COOK RL, 1988, J ELECTROCHEM SOC, V135, P1320, DOI 10.1149/1.2095972; FUJITA N, 1994, RADIAT PHYS CHEM, V46, P345; FUJITA N, 1994, RADIAT PHYS CHEM, V44, P349, DOI 10.1016/0969-806X(94)90072-8; FUJITA N, 1994, RADIAT PHYS CHEM, V43, P205, DOI 10.1016/0969-806X(94)90180-5; FUJITA N, 1981, CORROSION, V37, P335; FUJITA N, 1991, TACKLE GLOBAL WARMIN; FUJITA N, 1990, CORROSION, V46, P804; Fujita N, 1996, RADIAT PHYS CHEM, V47, P543, DOI 10.1016/0969-806X(95)00102-4; GASSER D, 1989, APPL CATAL, V48, P279, DOI 10.1016/S0166-9834(00)82799-2; Inui T, 1991, CATAL TODAY, V10, P95, DOI 10.1016/0920-5861(91)80077-M; ISHIGURE K, 1980, NUCL TECHNOL, V50, P169; KIM JJ, 1988, J ELECTROANAL CHEM, V245, P233; KYRIACOU G, 1992, J ELECTROANAL CHEM, V322, P233, DOI 10.1016/0022-0728(92)80079-J; LEIDHEISER H, 1988, CORROS SCI, V28, P631; Macdonald D.D., 1977, TRANSIENT TECHNIQUES; Pourbaix M., 1974, ATLAS ELECTROCHEMICA; Socials J. O. M., 1974, MODERN ELECTROCHEMIS, V2; Spinks J. W. T., 1964, INTRO RAD CHEM; TANIGUCHI I, 1984, J ELECTROANAL CHEM, V161, P385, DOI 10.1016/S0022-0728(84)80195-3; Uhlig H. H., 1948, CORROSION HDB	26	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB				RADIAT PHYS CHEM	Radiat. Phys. Chem.	SEP	1996	48	3					297	304		10.1016/0969-806X(95)00446-5		8	Chemistry, Physical; Nuclear Science & Technology; Physics, Atomic, Molecular & Chemical	Chemistry; Nuclear Science & Technology; Physics	VH305	WOS:A1996VH30500014		
J	Miyashita, M				Miyashita, M			Key factors in success of altitude training for swimming	RESEARCH QUARTERLY FOR EXERCISE AND SPORT			English	Article; Proceedings Paper	1996 International Pre-Olympic Scientific Congress on Physical Activity, Sport, and Health	JUL, 1996	DALLAS, TX							Miyashita, M (reprint author), UNIV TOKYO,GRAD SCH EDUC,DEPT EXERCISE SPORTS & HLTH SCI,BUNKYO KU,731 HONGO,TOKYO,JAPAN.						LAMB DR, 1995, SPROTS SCI EXCHANGE, V8; LEVINE BD, 1992, INT J SPORTS MED, V13, pS209, DOI 10.1055/s-2007-1024642; MIYASHITA M, 1994, 7 INT S BIOM MED SWI; MIYASHITA M, JAPANESE J PHYSICAL, V37, P111; PERONNET F, 1994, INT J SPORTS MED, V15, P335, DOI 10.1055/s-2007-1021070; PUGH LGC, 1967, J PHYSIOL-LONDON, V192, P619; SUTTON JR, 1993, SPORTS SCI EXCHANGE, V6; VASANKARI TJ, 1993, EUR J APPL PHYSIOL O, V66, P221, DOI 10.1007/BF00235097; YAMAMOTO Y, 1988, SWIMMING SCI, V5, P243; ZHOU M, 1994, 7 INT S BIOM MED SWI	10	2	2	AMER ALLIANCE HEALTH PHYS EDUC REC & DANCE	RESTON	1900 ASSOCIATION DRIVE, RESTON, VA 22091	0270-1367			RES Q EXERCISE SPORT	Res. Q. Exerc. Sport	SEP	1996	67	3		S			S76	S78				3	Hospitality, Leisure, Sport & Tourism; Psychology, Applied; Psychology; Sport Sciences	Social Sciences - Other Topics; Psychology; Sport Sciences	VP687	WOS:A1996VP68700012		
J	Shimoyama, I; Yasuda, T; Miura, H; Fujisawa, YK; Ezura, Y				Shimoyama, I; Yasuda, T; Miura, H; Fujisawa, YK; Ezura, Y			Mobile microrobots	ROBOTICA			English	Article						mobile microrobots; scale effects; silicon wafers; microsized module; insects	POLYSILICON	This paper discusses suitable mechanisms and functions of a mobile microrobot from the point of view of scale effects. Several assumptions are made using animal scaling. A large scale model is shown to demonstrate these mechanisms. Moreover, microsized models have been built on silicon wafers by using polysilicon as rigid plates and polyimide as elastic joints. The results show that suitable mechanisms and functions may be different from those of a conventional robot.		Shimoyama, I (reprint author), UNIV TOKYO,DEPT MECHANOINFORMAT,BUNKYO KU,7-3-1 HONGO,TOKYO 113,JAPAN.						Benecke W., 1985, TRANSDUCERS '85. 1985 International Conference on Solid-State Sensors and Actuators. Digest of Technical Papers (Cat. No.85CH2127-9); SUZUKI K, 1994, J MICROELECTROMECH S, V3, P4, DOI 10.1109/84.285718; Brennen R. A., 1990, Proceedings. IEEE Micro Electro Mechanical Systems. An Investigation of Micro Structures, Sensors, Actuators, Machines and Robots (Cat. No.90CH2832-4), DOI 10.1109/MEMSYS.1990.110238; Chapman R. F., 1982, INSECTS STRUCTURE FU; FAN LS, 1988, IEEE T ELECTRON DEV, V35, P724, DOI 10.1109/16.2523; Kim C.- J., 1990, P IEEE SOLID STATE S, P48; MAHADEVAN R, 1990, P MEMS 90, P10; McMahon T. A., 1983, SIZE LIFE; Mehregany M., 1990, P IEEE MICR EL MECH, P1; MEHREGANY M, 1988, IEEE T ELECTRON DEV, V35, P719, DOI 10.1109/16.2522; Pedley TJ., 1977, SCALE EFFECTS ANIMAL; Schmidt-Nielsen K., 1984, SCALING WHY ANIMAL S; Smith J. M., 1968, MATH IDEAS BIOL; Tai Y.-C., 1989, Proceedings: IEEE Micro Electro Mechanical Systems. An Investigation of Micro Structures, Sensors, Actuators, Machines and Robots (IEEE Cat. No.89THO249-3), DOI 10.1109/MEMSYS.1989.77950; TANG WC, 1989, SENSOR ACTUATOR, V20, P25, DOI 10.1016/0250-6874(89)87098-2; WAGNER B, 1991, P MEMS 91, V91, P27	16	1	1	CAMBRIDGE UNIV PRESS	NEW YORK	40 WEST 20TH STREET, NEW YORK, NY 10011-4211	0263-5747			ROBOTICA	Robotica	SEP-OCT	1996	14		5				469	476				8	Robotics	Robotics	VM179	WOS:A1996VM17900002		
J	Fujita, H; Ataka, M; Konishi, S				Fujita, H; Ataka, M; Konishi, S			Group work of distributed microactuators	ROBOTICA			English	Article						distributed microactuators; group work; micromachining; cantilevers; micronozzles		This paper proposes and demonstrates a method to obtain macroscopic work out of distributed microactuators fabricated by IC-compatible micromachining processes. We have coordinated the simple and small motion of microactuators in order to perform a task. The concept and a control scheme are discussed first. In order to show the feasibility, the fabrication and operation of arrayed microactuators for conveyors are described. One uses thermally driven cantilevers and the other uses controlled air flow from micronozzles to carry flat objects.		Fujita, H (reprint author), UNIV TOKYO,INST IND SCI,MINATO KU,7-22-1 ROPPONGI,TOKYO 106,JAPAN.						RIETHMULLER W, 1988, IEEE T ELECTRON DEV, V35, P758, DOI 10.1109/16.2528; FAN LS, 1989, SENSOR ACTUATOR, V20, P41, DOI 10.1016/0250-6874(89)87100-8; SCHMIDT MA, 1988, IEEE T ELECTRON DEV, V35, P750, DOI 10.1109/16.2527; Ataka M., 1993, IEEE ASME J MICROELE, V2, P146; Bobbio S. M., 1993, Proceedings. IEEE. Micro Electro Mechanical Systems. An Investigation of Micro Structures, Sensors, Actuators, Machines and Systems (Cat. No.93CH3265-6), DOI 10.1109/MEMSYS.1993.296931; Chen L.-Y., 1993, Proceedings. IEEE. Micro Electro Mechanical Systems. An Investigation of Micro Structures, Sensors, Actuators, Machines and Systems (Cat. No.93CH3265-6), DOI 10.1109/MEMSYS.1993.296924; FAN LS, 1988, IEEE T ELECTRON DEV, V35, P724, DOI 10.1109/16.2523; FUJITA H, 1991, P INT C SOL STAT SEN, P14; GABRIEL KJ, 1994, J JSME, V97, P272; Guckel H., 1991, P IEEE MICR EL MECH, P74; HOWE RT, 1991, IEEE SPECTRUM    JUN, P29; KONISHI S, 1994, J MICROELECTROMECH S, V3, P54, DOI 10.1109/84.294321; MEHEREGANY M, 1988, IEEE T ELECTRON DEV, V35, P719; Menz W., 1991, Proceedings. IEEE Micro Electro Mechanical Systems. An Investigation of Micro Structures, Sensors, Actuators, Machines and Robots (Cat. No.91CH2957-9), DOI 10.1109/MEMSYS.1991.114771; MINAMI M, 1993, 7 INT C SOL STAT SEN, P2; Pister K. S. J., 1990, Proceedings. IEEE Micro Electro Mechanical Systems. An Investigation of Micro Structures, Sensors, Actuators, Machines and Robots (Cat. No.90CH2832-4), DOI 10.1109/MEMSYS.1990.110250; TAKESHIMA N, 1990, P IEEE WORKSH ADV MO, P219	17	4	4	CAMBRIDGE UNIV PRESS	NEW YORK	40 WEST 20TH STREET, NEW YORK, NY 10011-4211	0263-5747			ROBOTICA	Robotica	SEP-OCT	1996	14		5				487	492				6	Robotics	Robotics	VM179	WOS:A1996VM17900005		
J	Shi, WM; Mochizuki, T; Suzuki, K; Hayashi, H; Chino, M				Shi, WM; Mochizuki, T; Suzuki, K; Hayashi, H; Chino, M			Effects of CaCN2 treatment of seeds of Inubie (Echinochloa oryzicola) on synthesis of protein and RNA during germination	SOIL SCIENCE AND PLANT NUTRITION			English	Article						CaCN2; Echinochloa oryzicola; germination; protein; RNA level		Protein and RNA induction during the germination of Inubie (Echinochloa oryzicola) seeds pretreated with CaCN2 was studied, It was observed that the germination of Echinochloa oryzicola seeds was delayed after pretreatment with a high concentration of CaCN2 for 18 h. A considerable difference in the protein patterns was detected in the SDS-PAGE gel between the control (H2O) and CaCN2 treatment, particularly a 48 kilodalton (kD) protein band disappeared in CaCN2 treatment. At the tested three levels of CaCN2, the induction of this 48 kD protein was apparently inhibited during the germination process even when the duration of the pretreatment was as short as 2 h. When imbibed with water, the amount of the 48 kD protein increased rapidly within 1 h from the trace level in the dry seeds, and reached the maximum level after about 1-2 d. The results showed that the CaCN2 treatment also decreased the total RNA level in the germinating seeds, The relation of this protein induction and RNA decline with the beginning of Echinochloa oryzicola germination was discussed.	YAMANASHI PREFECTURE AGR RES CTR,FUTABA,YAMANASHI 40701,JAPAN; UNIV TOKYO,FAC AGR,TOKYO 113,JAPAN	Shi, WM (reprint author), ACAD SINICA,INST SOIL SCI,NANJING 210008,PEOPLES R CHINA.		shi, weiming/F-2176-2013				HENDRICKS SB, 1975, P NATL ACAD SCI USA, V72, P306, DOI 10.1073/pnas.72.1.306; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; HENDRICKS SB, 1973, PLANT PHYSIOL, V54, P304; INOUE K., 1970, Journal of the Science of Soil and Manure, V41, P377; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MAYER AM, 1982, GERMINATION SEEDS, P111; MENDOZA DM, 1992, THESIS U TOKYO TOKYO; Pollard J W, 1984, Methods Mol Biol, V1, P81, DOI 10.1385/0-89603-062-8:81; ROBERTS EH, 1980, PHYSL BIOCH SEED DOR, P385; Sambrook J., 1989, MOL CLONING LAB MANU; TAYLORSO.RB, 1973, PLANT PHYSIOL, V52, P23, DOI 10.1104/pp.52.1.23; Yamasue Y., 1988, Weed Research, Japan, V33, P172	12	0	0	JAPANESE SOC SOIL SCIENCE PLANT NUTRITION	TOKYO	BUSINESS CENTER ACAD SOC JAPAN 16-9, HONKOMAGOME 5-CHOME, BUNKYO-KU, TOKYO 113, JAPAN	0038-0768			SOIL SCI PLANT NUTR	Soil Sci. Plant Nutr.	SEP	1996	42	3					443	449				7	Plant Sciences; Environmental Sciences; Soil Science	Plant Sciences; Environmental Sciences & Ecology; Agriculture	VE755	WOS:A1996VE75500001		
J	Kanazawa, S; Kunito, T				Kanazawa, S; Kunito, T			A new method for measuring microbial biomass nitrogen in soils: Direct extraction after toluene treatment	SOIL SCIENCE AND PLANT NUTRITION			English	Article						K-N nin factor; microbial biomass nitrogen; ninhydrin-reactive nitrogen; toluene treatment; volcanic ash soil	NINHYDRIN-REACTIVE NITROGEN; CHLOROFORM FUMIGATION; ASSAY	Attempts were made to develop a new method for measuring the microbial biomass N in upland soils by direct extraction after toluene treatment. This method which involves the use of ninhydrin reagent for the estimation of nitrogenous compounds released by autolysis after incubation of the soil with buffered (pH 7.0) toluene at 30 degrees C for 24 h, is rapid, sensitive, and precise. The factors responsible for the difference in the value of the K-N nin. factor between volcanic and non-volcanic ash upland soils were also examined. The results obtained can be summarized as follows: 1) This method can be used to estimate the size of microbial biomass N in volcanic or non-volcanic ash upland soils. For 20 microorganisms (10 bacterial strains and 10 fungal strains) the mean value of the K-N nin. factor was 0.255 for volcanic ash soils and 0.343 for the non-volcanic ash soils. 2) The newly proposed toluene treatment method enabled to extract a much larger quantity of ninhydrin-reactive nitrogen than the chloroform fumigation method. 3) The adsorption of an added amino acid by the older volcanic ash soil samples was the largest, followed by the samples of younger volcanic ash soil which that by the alluvial soil samples was the smallest. These results appeared to reveal a positive correlation with the K-N nin. factor of the respective soil samples.	UNIV TOKYO,FAC AGR,TOKYO 113,JAPAN	Kanazawa, S (reprint author), KAGOSHIMA UNIV,FAC AGR,DEPT ENVIRONM SCI & TECHNOL,KAGOSHIMA 890,JAPAN.		Kunito, Takashi/D-8449-2012				AMATO M, 1994, SOIL BIOL BIOCHEM, V26, P1109, DOI 10.1016/0038-0717(94)90132-5; ANDERSON JPE, 1975, CAN J MICROBIOL, V21, P314; AMATO M, 1988, SOIL BIOL BIOCHEM, V20, P107, DOI 10.1016/0038-0717(88)90134-4; JOERGENSEN RG, 1990, SOIL BIOL BIOCHEM, V22, P1023, DOI 10.1016/0038-0717(90)90027-W; ANTISARI LV, 1990, SOIL BIOL BIOCHEM, V22, P225, DOI 10.1016/0038-0717(90)90091-D; BROOKES PC, 1985, SOIL BIOL BIOCHEM, V17, P837, DOI 10.1016/0038-0717(85)90144-0; Jenkinson D. S., 1988, Advances in nitrogen cycling in agricultural ecosystems, P368; JENKINSON DS, 1981, SOIL BIOCH, P419; Kanazawa S., 1992, Japanese Journal of Soil Science and Plant Nutrition, V63, P310; KANAZAWA S, 1988, SOIL SCI PLANT NUTR, V34, P429; KIKUCHI K, 1975, B HOKKAIDO PREFECT A, V31, P14; MOORE S, 1954, J BIOL CHEM, V211, P907; Stevenson F. J., 1982, Nitrogen in agricultural soils, P67	13	3	3	JAPANESE SOC SOIL SCIENCE PLANT NUTRITION	TOKYO	BUSINESS CENTER ACAD SOC JAPAN 16-9, HONKOMAGOME 5-CHOME, BUNKYO-KU, TOKYO 113, JAPAN	0038-0768			SOIL SCI PLANT NUTR	Soil Sci. Plant Nutr.	SEP	1996	42	3					511	520				10	Plant Sciences; Environmental Sciences; Soil Science	Plant Sciences; Environmental Sciences & Ecology; Agriculture	VE755	WOS:A1996VE75500008		
J	Zhang, BP; Yasui, T; Yasuda, T; Segawa, Y; Yaguchi, H; Shiraki, Y				Zhang, BP; Yasui, T; Yasuda, T; Segawa, Y; Yaguchi, H; Shiraki, Y			Anomalous optical absorption in ZnCdSe/ZnSe single quantum wells	SOLID STATE COMMUNICATIONS			English	Article							OSCILLATOR STRENGTH; EXCITONS; POLARITON; CRYSTALS; SPECTRA	The optical absorption in ZnCdSe/ZnSe single quantum wells was studied by analyzing their reflectance spectra measured by a Fourier transform spectrometer. At lower temperatures, we observed a decrease in the excitonic absorption. This is qualitatively explained using a polariton model with the absorption dominated by phonon scattering. We present a comparison with III-V materials. The result confirms the polariton model of light propagation in quantum wells. Copyright (C) 1996 Published by Elsevier Science Ltd	UNIV TOKYO,DEPT APPL PHYS,TOKYO 113,JAPAN; UNIV TOKYO,ADV SCI & TECHNOL RES CTR,MEGURO KU,TOKYO 153,JAPAN	Zhang, BP (reprint author), INST PHYS & CHEM RES,PHOTODYNAM RES CTR,AOBA KU,19-1399 KOEJI,SENDAI,MIYAGI 980,JAPAN.		Yaguchi, Hiroyuki/B-3902-2012	Yaguchi, Hiroyuki/0000-0003-0621-3501			ASPNES DE, 1973, J OPT SOC AM, V63, P1380, DOI 10.1364/JOSA.63.001380; TASSONE F, 1992, PHYS REV B, V45, P6023, DOI 10.1103/PhysRevB.45.6023; ANDREANI LC, 1991, SOLID STATE COMMUN, V77, P641, DOI 10.1016/0038-1098(91)90761-J; NAKAYAMA M, 1986, SURF SCI, V170, P641, DOI 10.1016/0039-6028(86)91033-2; BAUER S, 1993, J APPL PHYS, V74, P3916, DOI 10.1063/1.354490; GRIBKOVSKII VP, 1989, PHYS STATUS SOLIDI B, V156, P449, DOI 10.1002/pssb.2221560208; GRIBKOVSKII VP, 1990, PHYS STATUS SOLIDI B, V158, P359, DOI 10.1002/pssb.2221580136; HITE GE, 1967, PHYS REV, V156, P850, DOI 10.1103/PhysRev.156.850; Ivchenko E. L., 1991, Soviet Physics - Solid State, V33; KOCHERESHKO VP, 1995, MATER SCI FORUM, V182-, P227; PELEKANOS NT, 1992, PHYS REV B, V45, P6037, DOI 10.1103/PhysRevB.45.6037; PELLEGRINI V, 1994, SOLID STATE COMMUN, V90, P167, DOI 10.1016/0038-1098(94)90335-2; QIANG H, 1992, APPL PHYS LETT, V61, P1411, DOI 10.1063/1.107554; VOIGT J, 1979, PHYS STATUS SOLIDI B, V91, P189, DOI 10.1002/pssb.2220910120; VOIGT J, 1974, PHYS STATUS SOLIDI B, V64, P549, DOI 10.1002/pssb.2220640216; ZHANG BP, 1994, PHYS REV B, V50, P7499, DOI 10.1103/PhysRevB.50.7499; ZHANG BP, 1993, J PHYS SOC JPN, V62, P3031, DOI 10.1143/JPSJ.62.3031	17	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0038-1098			SOLID STATE COMMUN	Solid State Commun.	SEP	1996	99	12					897	900		10.1016/0038-1098(96)00320-1		4	Physics, Condensed Matter	Physics	VF728	WOS:A1996VF72800007		
J	Nakatomi, H; Sasaki, T; Kawamoto, S; Fujimaki, T; Furuya, K; Kirino, T				Nakatomi, H; Sasaki, T; Kawamoto, S; Fujimaki, T; Furuya, K; Kirino, T			Primary cavernous sinus malignant lymphoma treated by gamma knife radiosurgery: Case report and review of the literature	SURGICAL NEUROLOGY			English	Article						cavernous sinus; gamma knife radiosurgery; meningioma; primary malignant lymphoma	CENTRAL-NERVOUS-SYSTEM; SKULL BASE; STEREOTAXIC RADIOSURGERY; MENINGIOMAS	BACKGROUND Malignant lymphomas originating primarily in the cavernous sinus have not been histologically verified by any authors. The first reported case to our knowledge of primary cavernous sinus malignant lymphoma, initially diagnosed as benign meningioma and treated by gamma knife radiosurgery, is presented. CASE DESCRIPTION The patient was a 77-year-old man whose initial symptoms were left facial hypesthesia and diplopia on left gaze, During the 21-month follow-up period after gamma knife radiosurgery, no evidence of tumor regrowth was seen in the irradiated area, but an unirradiated mass expanded with invasion of the brain stem, Subsequent surgery provided histologic verification of the diagnosis. Despite successful local tumor control, the patient died due to sepsis 31 months after the onset of symptoms. Autopsy failed to disclose any remaining lymphoma cells either in the primary lesion or anywhere throughout the entire body. CONCLUSION Primary cavernous sinus malignant lymphoma is an extremely rare brain tumor, but it must be considered in the differential diagnosis of an enhanced mass in the cavernous sinus. Stereotactic radiosurgery using the gamma knife technique for intracranial brain tumors, especially in the cavernous sinus, is associated with risk, as was seen in our patient, Our experience points out the pitfalls of gamma knife radiosurgery; it should be performed only after histologic confirmation has been obtained.	TOKYO UNIV HOSP,DEPT NEUROSURG,TOKYO 113,JAPAN			Kawamoto, Shunsuke/E-9947-2013	Kawamoto, Shunsuke/0000-0002-1388-1287			EBY NL, 1988, CANCER, V62, P2461, DOI 10.1002/1097-0142(19881201)62:11<2461::AID-CNCR2820621135>3.0.CO;2-M; COFFEY RJ, 1993, J NEUROSURG, V78, P903, DOI 10.3171/jns.1993.78.6.0903; AOZASA K, 1990, INT J CANCER, V45, P632, DOI 10.1002/ijc.2910450410; BAUMGARTNER JE, 1990, J NEUROSURG, V73, P206, DOI 10.3171/jns.1990.73.2.0206; DELPASSAND ES, 1988, NEUROSURGERY, V23, P501; DUMA CM, 1993, NEUROSURGERY, V32, P699; HAN MH, 1993, J COMPUT ASSIST TOMO, V17, P567, DOI 10.1097/00004728-199307000-00009; JULIEN J, 1984, J NEUROL NEUROSUR PS, V47, P558, DOI 10.1136/jnnp.47.5.558; KOH CS, 1983, MED J AUSTRALIA, V2, P451; KONDZIOLKA D, 1991, J NEUROSURG, V74, P552, DOI 10.3171/jns.1991.74.4.0552; MITSUMOTO H, 1980, CLEVELAND CLIN Q, V47, P333; OYAMA H, 1992, JPN J CLIN ONCOL, V22, P131; RUBIN MM, 1992, J ORAL MAXIL SURG, V50, P749, DOI 10.1016/0278-2391(92)90112-D; SHIBATA M, 1992, Neurological Surgery, V20, P717; Tanaka Satoshi, 1994, Neurological Surgery, V22, P73	15	30	30	ELSEVIER SCIENCE INC	NEW YORK	655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010	0090-3019			SURG NEUROL	Surg. Neurol.	SEP	1996	46	3					272	278		10.1016/0090-3019(96)00159-0		7	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	VF547	WOS:A1996VF54700025		
J	Cheng, R; Saita, A; Takano, Y; Ukai, Y				Cheng, R; Saita, A; Takano, Y; Ukai, Y			Estimation of the position and effect of a lethal factor locus on a molecular marker linkage map	THEORETICAL AND APPLIED GENETICS			English	Article						mapping; segregation distortion; molecular marker; recombination value; maximum likelihood method	ORYZA-SATIVA L; SHOWING SEGREGATION DISTORTION; MAXIMUM-LIKELIHOOD MODELS; QUANTITATIVE TRAITS; WIDE-COMPATIBILITY; MENDELIAN FACTORS; MULTIPLE ALLELES; HYBRID STERILITY; EM ALGORITHM; RICE	In the mapping of DNA markers the distortion of segregation of marker genotypes is often observed which may be caused by a lethal factor acting in filial generations derived from distant crosses. A method is presented for estimating the recombination values between a lethal factor locus and neighboring molecular markers, and the relative viability or fertilization ability of gametes or zygotes affected by the lethal factor in an F-2 population using the maximum likelihood method and the expectation conditional maximization (ECM) algorithm, Three selection models of gamete or zygote were considered, and the most likely one was determined by goodness of fit of the observed frequency of the phenotypes to the expected ones under the models. The method was applied to segregation data of molecular markers of an F-2 population consisting of 144 individuals derived from a cross between an Indica and a Japonica rice variety. The presence of a lethal factor locus (L) located on chromosome III that caused partial gametic selection in both the male and female sides was suggested. The locus L was tightly linked to RFLP marker number 23 of the RFLP linkage map of Saito et al. (1991a), and the fertilization chance of a male or female gamete possessing the lethal factor was, on average, 41.5% of that of the normal gamete.	MAFF,KYUSHU AGR EXPT STN,KUMAMOTO 86111,JAPAN	Cheng, R (reprint author), UNIV TOKYO,DIV AGR & AGR LIFE SCI,LAB BIOMETR,YAYOI 1-1-1,TOKYO 113,JAPAN.						MENG XL, 1993, BIOMETRIKA, V80, P267, DOI 10.2307/2337198; LORIEUX M, 1995, THEOR APPL GENET, V90, P73, DOI 10.1007/BF00220998; LYTTLE TW, 1991, ANNU REV GENET, V25, P511, DOI 10.1146/annurev.ge.25.120191.002455; MCCOUCH SR, 1988, THEOR APPL GENET, V76, P815, DOI 10.1007/BF00273666; ZIVY M, 1992, THEOR APPL GENET, V83, P919, DOI 10.1007/BF00226716; Haldane JBS, 1919, J GENET, V8, P299; PATERSON AH, 1990, GENETICS, V124, P735; CAUSSE MA, 1994, GENETICS, V138, P1251; PATERSON AH, 1991, GENETICS, V127, P181; Bailey N.T.J., 1961, INTRO MATH THEORY GE; Chao LF, 1928, GENETICS, V13, P191; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1; IKEHASHI H, 1988, JPN J BREED, V38, P283; Ikehashi H., 1986, Rice genetics. Proceedings of the International Rice Genetics Symposium, 27-31 May, 1985, Manila, Philippines., P119, DOI 10.1142/9789812814265_0011; IKEHASHI H, 1984, JPN J BREED, V34, P304; Iwata N, 1964, JPN J BREED, V14, P33; KINOSHITA T, 1984, Journal of the Faculty of Agriculture Hokkaido University, V61, P445; LIN SY, 1993, EUPHYTICA, V67, P35, DOI 10.1007/BF00022722; LORIEUX M, 1995, THEOR APPL GENET, V90, P81, DOI 10.1007/BF00220999; MAEKAWA M, 1982, MEM FAC AGR HOKKAIDO, V13, P147; MAEKAWA M, 1981, Journal of the Faculty of Agriculture Hokkaido University, V60, P107; MAEKAWA M, 1985, JPN J BREED, V35, P25; Mather K, 1963, MEASUREMENT LINKAGE; MIZUSHIMA U, 1960, JPN J BREED, V10, P1; MORI K-I, 1973, Memoirs of the Faculty of Agriculture Hokkaido University, V9, P74; Morishima H, 1992, OXFORD SURV EVOL BIO, V8, P135; Nakagahra M., 1972, Japanese Journal of Breeding (Ikushugaku Zasshi), V22, P305; Nakagahara M., 1972, Japanese Journal of Breeding (Ikushugaku Zasshi), V22, P232; NAKAGAHRA M, 1974, Journal of the Faculty of Agriculture Kyushu University, V18, P157; Oka H, 1953, JPN J BREED, V2, P217; OKA HI, 1953, JPN J BREED, V3, P23; PHAM JL, 1990, GENOME, V33, P348; RAMIAH K, 1931, MEM DEP AGR INDIA BO, V18, P159; SAITO A, 1991, JPN J BREED S1, V41, P158; SAITO A, 1991, JPN J BREED, V41, P665; Sato YI, 1990, RICE GENET NEWSL, V7, P97; SCHON CC, 1991, GENOME, V34, P918; PATERSON AH, 1988, NATURE, V335, P721, DOI 10.1038/335721a0; TORRES AM, 1985, J HERED, V76, P289; WAN JM, 1993, JPN J BREED, V43, P507; WENDEL JF, 1984, BIOCHEM GENET, V22, P739, DOI 10.1007/BF00485857; WU CFJ, 1983, ANN STAT, V11, P95, DOI 10.1214/aos/1176346060; YANAGIHARA S, 1992, JPN J BREED, V42, P15; YANAGIHARA S, 1995, THEOR APPL GENET, V90, P182, DOI 10.1007/BF00222200; YANAGIHARA S, 1992, JPN J BREED, V42, P793	45	24	30	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010	0040-5752			THEOR APPL GENET	Theor. Appl. Genet.	SEP	1996	93	4					494	502		10.1007/BF00417940		9	Agronomy; Plant Sciences; Genetics & Heredity; Horticulture	Agriculture; Plant Sciences; Genetics & Heredity	VG221	WOS:A1996VG22100003		
J	Asai, K; Watanabe, T; Hiroishi, D; Sato, T; Ishigure, K				Asai, K; Watanabe, T; Hiroishi, D; Sato, T; Ishigure, K			Structural changes in molecular assemblies in Langmuir-Blodgett films induced by ionizing radiation	THIN SOLID FILMS			English	Article						fluorescence; Langmuir-Blodgett films; radiation damage; surface morphology	AQUEOUS-SOLUTIONS; CYANINE DYES	Cyanine dye (S120) aggregated into a specific state, a J-aggregate, in monolayer assemblies was irradiated with gamma-rays at room temperature and the structural changes induced thereby were investigated. We prepared samples with control of the fractions of the J-aggregates in a texture through the Langmuir-Blodgett method. Changes in the assembly structure on irradiation were analyzed by absorption spectra by separately estimating the concentration of the J-aggregates and the ''non-J'' part, which practically consists of monomers. As a result, it became apparent that the efficiency of dissociation of S120 was highly influenced by differences in the molecular ordering structure. We proposed a model describing the radiation-induced changes in the molecular concentrations in the J-aggregates and the non-J to explain the experimental data.		Asai, K (reprint author), UNIV TOKYO,DEPT QUANTUM ENGN & SYST SCI,BUNKYO KU,TOKYO 113,JAPAN.						BYERS GW, 1976, PHOTOCHEM PHOTOBIOL, V23, P37, DOI 10.1111/j.1751-1097.1976.tb06768.x; Jelley EE, 1936, NATURE, V138, P1009, DOI 10.1038/1381009a0; FOOTE CS, 1968, SCIENCE, V162, P963, DOI 10.1126/science.162.3857.963; BOURDON J, 1962, B SOC CHIM BELG, V71, P907; FUKUZUMI K, 1971, J AM OIL CHEM SOC, V48, P384, DOI 10.1007/BF02637355; GROSSWEI.LI, 1970, RADIAT RES REV, V2, P345; Hann RA, 1990, LANGMUIRBLODGETT FIL; HARRIMAN A, 1991, J PHYS CHEM-US, V95, P2417; KRASNOVSKII AK, 1962, DOKL AKAD NAUK SS PC, V145, P507; McRAE E. G., 1964, P23; MEIER H, CHEM SYNTHETIC DYES, V4, P389; PENNER TL, 1982, J AM CHEM SOC, V104, P7407, DOI 10.1021/ja00390a004; Scheibe G., 1936, ANGEW CHEM, V49, P563; STURMER DM, 1977, THEORY PHOTOGRAPHIC, pCH7; STURMER DM, 1973, PHOTOGR SCI ENG, V17, P146; SUGI M, 1985, THIN SOLID FILMS, V129, P15, DOI 10.1016/0040-6090(85)90090-2; SUZUKI N, 1975, INT J APPL RADIAT IS, V26, P726; SUZUKI N, 1975, B CHEM SOC JPN, V48, P2158, DOI 10.1246/bcsj.48.2158; SUZUKI N, 1978, INT J APPL RADIAT IS, V29, P103, DOI 10.1016/0020-708X(78)90031-5; TANI T, 1971, J PHOTOGR SCI, V17, P161; TANI T, 1972, PHOTOGR SCI ENG, V16, P258; TIMBERS A, 1975, TETRAHEDRON LETT, P1735	22	2	2	ELSEVIER SCIENCE SA LAUSANNE	LAUSANNE 1	PO BOX 564, 1001 LAUSANNE 1, SWITZERLAND	0040-6090			THIN SOLID FILMS	Thin Solid Films	SEP 1	1996	283	1-2					124	129		10.1016/0040-6090(95)08495-9		6	Materials Science, Multidisciplinary; Materials Science, Coatings & Films; Physics, Applied; Physics, Condensed Matter	Materials Science; Physics	VP001	WOS:A1996VP00100021		
J	Fomin, S; Kirillov, AN				Fomin, S; Kirillov, AN			Combinatorial B-n-analogues of Schubert polynomials	TRANSACTIONS OF THE AMERICAN MATHEMATICAL SOCIETY			English	Article						Yang-Baxter equation; Schubert polynomials; symmetric functions		Combinatorial B-n-analogues of Schubert polynomials and corresponding symmetric functions are constructed and studied. The development is based on an exponential solution of the type B Yang-Baxter equation that involves the nilCoxeter algebra of the hyperoctahedral group.	UNIV TOKYO,DEPT MATH SCI,MEGURO KU,TOKYO 153,JAPAN	Fomin, S (reprint author), MIT,DEPT MATH,CAMBRIDGE,MA 02139, USA.		Fomin, Sergey/A-1158-2007				BOREL A, 1953, ANN MATH, V57, P115, DOI 10.2307/1969728; FOMIN S, 1994, ADV MATH, V103, P196, DOI 10.1006/aima.1994.1009; BILLEY SC, 1993, J ALGEBR COMB, V2, P345, DOI 10.1023/A:1022419800503; Bernstein IN, 1973, RUSS MATH SURV, V28, P1, DOI 10.1070/RM1973v028n03ABEH001557; BILLEY SC, 1993, UNPUB SCHUBERT POLYN; Bourbaki N., 1968, GROUPES ALGEBRES LIE; CHEREDNIK I, 1991, MPI9114; Fomin S., 1994, P 6 INT C FORM POW S, P183; FOMIN S, IN PRESS DISCRETE MA; FOMIN S, IN PRESS LETT MATH P; FULTON W, SCHUBERT VARIETIES F; Lam T. K., 1994, THESIS MIT; LAM TK, 1994, SERIES FORMELLES COM, P315; Lascoux A., 1990, GROTHENDIECK FESTSCH, VIII, P1; LASCOUX A, 1982, CR ACAD SCI I-MATH, V294, P447; LASCOUX A, 1992, SERIES FORMELLES COM, P283; MACDONALD LG, 1991, NOTES SCHUBERT POLYN; Pragacz P., 1991, LECT NOTES MATH, V1478, P130; SAGAN BE, 1990, J COMB THEORY A, V55, P161, DOI 10.1016/0097-3165(90)90066-6; Stanley R. P., 1984, EUROP J COMBINATORIC, V5, P359; Vershik A. M., 1991, AM MATH SOC TRANSL, V148, P1	21	38	38	AMER MATHEMATICAL SOC	PROVIDENCE	201 CHARLES ST, PROVIDENCE, RI 02940-2213	0002-9947			T AM MATH SOC	Trans. Am. Math. Soc.	SEP	1996	348	9					3591	3620		10.1090/S0002-9947-96-01558-9		30	Mathematics	Mathematics	VK109	WOS:A1996VK10900006		
J	Tanaka, S; Ohnoki, S; Shibata, H; Okubo, Y; Yamaguchi, H; Shibata, Y				Tanaka, S; Ohnoki, S; Shibata, H; Okubo, Y; Yamaguchi, H; Shibata, Y			Gene frequencies of human platelet antigens on glycoprotein IIIa in Japanese	TRANSFUSION			English	Article							NEONATAL ALLOIMMUNE THROMBOCYTOPENIA; ALLOANTIGEN SYSTEM; BINDING-PROPERTIES; COMPLEX; IIB; POLYMORPHISM	Background: Polymorphism of glycoprotein IIIa on human platelets is one of the factors in alloimmunization that causes neonatal alloimmune thrombocytopenia and refractoriness to platelet transfusion. Study Design and Methods: DNA typing methods were originally developed to determine the genotypes of five human platelet antigen (HPA) systems located on glycoprotein IIIa: HPA-1, HPA-4, HPA-6W, HPA-7W, and HPA-8W. The gene frequencies of these platelet antigens were determined by DNA typing of 331 unrelated Japanese donors. Results: The gene frequencies of the low-frequency antigens were 0.002, 0.011, and 0.027 for HPA-1b, HPA-4b, and HPA-6W(b), respectively. All 331 Japanese donors tested were HPA-7W(a/a) and HPA-8W(a/a). Moreover, in the present study, none of the donors tested had two or more of these low-frequency antigens. Conclusion: The risk of neonatal alloimmune thrombocytopenia and refractoriness to platelet transfusion induced by the antigens of the HPA-1, HPA-7W, and HPA-8W systems was extremely rare in Japanese, However, attention must be paid to the involvement of the HPA-4 and HPA-6W systems in these clinical disorders.	UNIV TOKYO,FAC MED,DEPT TRANSFUS MED & IMMUNOHEMATOL,TOKYO 113,JAPAN	Tanaka, S (reprint author), OSAKA RED CROSS BLOOD CTR,DEPT RES,JOTO KU,2-4-43 MORINOMIYA,OSAKA 536,JAPAN.						WANG RG, 1993, BLOOD, V82, P3386; ISHIZAWA M, 1991, NUCLEIC ACIDS RES, V19, P5792, DOI 10.1093/nar/19.20.5792; DEMARCO L, 1986, J CLIN INVEST, V77, P1272, DOI 10.1172/JCI112430; Garratty G, 1995, Immunohematology, V11, P112; JENNINGS LK, 1982, J BIOL CHEM, V257, P458; KROLL H, 1990, BLOOD, V76, P2296; KUIJPERS RWAM, 1993, BLOOD, V81, P70; KUNICKI TJ, 1986, CURRENT STUDIES HEMA, V52, P18; MCFARLAND JG, 1993, BLOOD, V81, P3318; Mueller-Eckhardt C, 1990, Transfus Med Rev, V4, P98, DOI 10.1016/S0887-7963(90)70254-4; NEWMAN PJ, 1994, THROMBOSIS HEMORRHAG, P529; NEWMAN PJ, 1994, BLOOD, V83, P1447; NEWMAN PJ, 1989, J CLIN INVEST, V83, P1778, DOI 10.1172/JCI114082; PARISE LV, 1985, J BIOL CHEM, V260, P698; PARISE LV, 1986, J BIOL CHEM, V261, P14011; SANTOSO S, 1994, J BIOL CHEM, V269, P8439; SANTOSO S, 1987, VOX SANG, V53, P48; TANAKA S, 1995, VOX SANG, V68, P225; Tanaka S, 1996, VOX SANG, V70, P40; VONDEMBORNE AE, 1995, BLOOD, V11, P112; WANG L, 1991, P JPN ACAD B-PHYS, V67, P102, DOI 10.2183/pjab.67.102	21	50	53	AMER ASSOC BLOOD BANKS	BETHESDA	8101 GLENBROOK RD, BETHESDA, MD 20814-2749	0041-1132			TRANSFUSION	Transfusion	SEP	1996	36	9					813	817		10.1046/j.1537-2995.1996.36996420760.x		5	Hematology	Hematology	VJ087	WOS:A1996VJ08700012		
J	Minchinton, RM; Dawkins, B; Chynoweth, L; Pearson, H; Lown, JA; Shibata, Y				Minchinton, RM; Dawkins, B; Chynoweth, L; Pearson, H; Lown, JA; Shibata, Y			In pursuit of enigmatic platelet antibodies - Anti-HPA-2b and anti-HPA-3a	TRANSFUSION MEDICINE			English	Letter							IDENTIFICATION		RED CROSS,BLOOD TRANSFUS SERV VICTORIA,BRISBANE,QLD 4000,AUSTRALIA; RED CROSS,BLOOD TRANSFUS SERV NEW S WALES,BRISBANE,QLD 4000,AUSTRALIA; ROYAL PERTH HOSP,DEPT HAEMATOL,PERTH,WA,AUSTRALIA; UNIV TOKYO,DEPT TRANSFUS MED & IMMUNOHAEMATOL,TOKYO,JAPAN	Minchinton, RM (reprint author), RED CROSS,BLOOD TRANSFUS SERV QUEENSLAND,POB 10325,ADELAIDE ST,BRISBANE,QLD 4000,AUSTRALIA.						SHIBATA Y, 1981, VOX SANG, V41, P25; KICKLER TS, 1988, BLOOD, V71, P894; KIEFEL V, 1987, BLOOD, V70, P1722; Lown J A, 1991, Transfus Med, V1, P163, DOI 10.1111/j.1365-3148.1991.tb00026.x; Lown J A, 1995, Immunohematology, V11, P140; MINCHINTON RM, 1992, TRANSFUSION MED, V2, P319, DOI 10.1111/j.1365-3148.1992.tb00176.x; SCHLOSSMAN SF, 1994, IMMUNOL TODAY, V15, P98, DOI 10.1016/0167-5699(94)90149-X; Teramura G, 1996, TRANSFUSION, V36, P75, DOI 10.1046/j.1537-2995.1996.36196190520.x; VONDEMBORNE AEGK, 1978, BRIT J HAEMATOL, V39, P195; VONDEMBORNE AE, 1991, CLIN BASIC SCI ASPEC, P115	10	7	7	BLACKWELL SCIENCE LTD	OXFORD	OSNEY MEAD, OXFORD, OXON, ENGLAND OX2 0EL	0958-7578			TRANSFUSION MED	Transfus. Med.	SEP	1996	6	3					289	291		10.1111/j.1365-3148.1996.tb00081.x		3	Hematology	Hematology	VH137	WOS:A1996VH13700012		
J	Kubo, T; Arai, T; Kawasaki, K; Natori, S				Kubo, T; Arai, T; Kawasaki, K; Natori, S			Insect lectins and epimorphosis	TRENDS IN GLYCOSCIENCE AND GLYCOTECHNOLOGY			English	Review						cockroach; hemolymph lectins; insect; regeneration; self-defense	LIPOPOLYSACCHARIDE-BINDING PROTEIN; COCKROACH PERIPLANETA-AMERICANA; APICAL ECTODERMAL RIDGE; SARCOPHAGA-PEREGRINA; SONIC-HEDGEHOG; FEEDBACK LOOP; LIMB BUD; HEMOLYMPH; PURIFICATION; OPSONIN	Organ regeneration (epimorphosis) differs from development in that morphogenesis occurs in a restricted region neighboring normal tissues. However, the molecular mechanisms specific to epimorphosis are unknown. Previously, we reported that regenectin, a humoral lectin from the American cockroach Periplaneta americana, appears transiently during leg regeneration and is localized around regenerating muscle cells [Kubo, T. et al. (1991) Int. J. Dev. Biol. 35, 83-90]. We recently isolated a cDNA for regenectin and examined the expression of the gene. We found that the gene was activated in the epidermis of the regenerating leg but not during the normal developmental stages. These results suggest that regenectin is specifically synthesized and secreted by the regenerating epidermis and that it plays a role in the formation of muscle in a paracrine manner. Analysis of the primary structure of regenectin revealed that regenectin belongs to the same family as LPS-binding protein, which was purified previously from Periplaneta hemolymph and which participates in the defense system. This implies that epimorphosis and the defense system share some common molecular aspects. In this minireview, we describe recent research on cockroach humoral lectins and discuss molecular mechanisms specific to epimorphosis.	UNIV TOKYO, FAC PHARMACEUT SCI, BUNKYO KU, TOKYO 113, JAPAN							JOMORI T, 1992, FEBS LETT, V296, P283, DOI 10.1016/0014-5793(92)80305-Z; NISWANDER L, 1993, CELL, V75, P579, DOI 10.1016/0092-8674(93)90391-3; KAWASAKI K, 1993, COMP BIOCHEM PHYS B, V106, P675, DOI 10.1016/0305-0491(93)90148-X; LAUFER E, 1994, CELL, V79, P993, DOI 10.1016/0092-8674(94)90030-2; JOMORI T, 1990, EUR J BIOCHEM, V190, P201, DOI 10.1111/j.1432-1033.1990.tb15565.x; KOMANO H, 1980, J BIOL CHEM, V255, P2919; NISWANDER L, 1994, NATURE, V371, P609, DOI 10.1038/371609a0; GIGA Y, 1985, BIOCHEMISTRY-US, V24, P4461, DOI 10.1021/bi00337a030; HAMMARSTROM S, 1969, BIOCHEMISTRY-US, V8, P2629; HURLE JM, 1989, DEV BIOL, V132, P368, DOI 10.1016/0012-1606(89)90233-9; JOMORI T, 1991, J BIOL CHEM, V266, P13318; KAWAGUCHI N, 1991, DEV BIOL, V144, P86, DOI 10.1016/0012-1606(91)90481-H; Kawasaki K, 1996, INSECT BIOCHEM MOLEC, V26, P355, DOI 10.1016/0965-1748(95)00101-8; KOMANO H, 1985, DEV COMP IMMUNOL, V9, P31, DOI 10.1016/0145-305X(85)90057-6; Kubo T, 1992, Tanpakushitsu Kakusan Koso, V37, P810; KUBO T, 1990, INSECT BIOCHEM, V20, P585, DOI 10.1016/0020-1790(90)90070-B; KUBO T, 1993, DEV BIOL, V156, P381, DOI 10.1006/dbio.1993.1085; KUBO T, 1991, SEIBUTSUBUTSURI, V31, P306; KUBO T, 1987, EUR J BIOCHEM, V168, P75, DOI 10.1111/j.1432-1033.1987.tb13389.x; KUBO T, 1991, International Journal of Developmental Biology, V35, P83; Kunkel J.G., 1981, P425; MARCHALO.JJ, 1968, J MOL BIOL, V32, P453, DOI 10.1016/0022-2836(68)90022-3; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; ROWE DA, 1982, DEV BIOL, V93, P83, DOI 10.1016/0012-1606(82)90241-X; SUZUKI T, 1990, J BIOL CHEM, V265, P1274; TUBY PR, 1983, J EMBRYOL EXP MORPH, V75, P151	26	6	6	GAKUSHIN PUBL CO	TOKYO	YUSHOKAIN7F, 1-38-12 NIHONBASHIKAKIGARACHO, CHUO-KU, TOKYO, 103-0014, JAPAN	0915-7352			TRENDS GLYCOSCI GLYC	Trends Glycosci. Glycotechnol.	SEP	1996	8	43					357	364				8	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	VQ055	WOS:A1996VQ05500004		
J	Suzuki, T				Suzuki, T			De-N-glycosylation system does occur ubiquitously in animal cells!	TRENDS IN GLYCOSCIENCE AND GLYCOTECHNOLOGY			English	Review						cytomegalovirus; cytosol; MHC class I molecules; peptide:N-glycanase			UNIV TOKYO, GRAD SCH SCI, DEPT BIOPHYS & BIOCHEM, TOKYO 113, JAPAN			Suzuki, Tadashi/I-4536-2014					0	3	3	GAKUSHIN PUBL CO	TOKYO	YUSHOKAIN7F, 1-38-12 NIHONBASHIKAKIGARACHO, CHUO-KU, TOKYO, 103-0014, JAPAN	0915-7352			TRENDS GLYCOSCI GLYC	Trends Glycosci. Glycotechnol.	SEP	1996	8	43					367	368				2	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	VQ055	WOS:A1996VQ05500006		
J	Inoue, A; Hasan, Z; Hemmi, H; Kanda, N; Hayashi, Y; Ishizawa, T; Tsuchida, Y; Shimatake, H				Inoue, A; Hasan, Z; Hemmi, H; Kanda, N; Hayashi, Y; Ishizawa, T; Tsuchida, Y; Shimatake, H			Competitive polymerase chain reaction for the quantification of N-myc gene copy number in neuroblastoma	TUMOR BIOLOGY			English	Article						polymerase chain reaction; N-myc; amplification; neuroblastoma	BLASTOMA CELL-LINE; ONCOGENE AMPLIFICATION; C-ERBB-2 ONCOGENE; MULTIPLE COPIES; MESSENGER-RNA; BREAST-CANCER; EXPRESSION; ASSOCIATION; PROGRESSION; CARCINOMA	An absolute quantification method for the N-myc gene copy number of neuroblastoma specimens was established by applying the competitive polymerase chain reaction (cPCR). The competitor plasmid (pZH2) lacking an MluI site in the exon 2 was constructed to distinguish two product species amplified from genomic DNA and the competitor plasmid. By using this cPCR system, we could obtain qualitative results within 1 day, i.e. amplified or unamplified, and quantitative results by using radiolabelled nucleotides within 4 days. The copy numbers of N-myc in 47 neuroblastoma specimens by cPCR correlated well with those by Southern hybridization (r = 0.85). We conclude that cPCR is a simple and rapid method, requires only a Amplification small amount (200 ng) of sample DNA, and is expected to be Neuroblastoma used for prognostic evaluation in neuroblastomas.	TOKYO WOMENS MED COLL,DEPT ANAT & DEV BIOL,TOKYO 162,JAPAN; UNIV TOKYO,DEPT PEDIAT,TOKYO,JAPAN; UNIV TOKYO,DEPT PEDIAT SURG,TOKYO,JAPAN	Inoue, A (reprint author), TOHO UNIV,SCH MED,DEPT MOL BIOL,OHTA KU,OHMORI NISHI,TOKYO 143,JAPAN.						BRISON O, 1993, BIOCHIM BIOPHYS ACTA, V1155, P25, DOI 10.1016/0304-419X(93)90020-D; KOHL NE, 1984, SCIENCE, V226, P1335, DOI 10.1126/science.6505694; GILLILAND G, 1990, P NATL ACAD SCI USA, V87, P2725, DOI 10.1073/pnas.87.7.2725; LEE WH, 1984, NATURE, V309, P458, DOI 10.1038/309458a0; BECKERANDRE M, 1989, NUCLEIC ACIDS RES, V17, P9437, DOI 10.1093/nar/17.22.9437; BRODEUR GM, 1984, SCIENCE, V224, P1121, DOI 10.1126/science.6719137; BRODEUR GM, 1990, CANCER SURV, V9, P673; BRODEUR GM, 1981, CANCER RES, V41, P4678; CASPER JT, 1983, CANCER GENET CYTOGEN, V10, P177, DOI 10.1016/0165-4608(83)90122-X; FRIEDRICHS K, 1993, VIRCHOWS ARCH B, V64, P209, DOI 10.1007/BF02915114; GILBERT J, 1993, MOL CELL PROBE, V7, P227, DOI 10.1006/mcpr.1993.1033; GRAMLICH TL, 1994, AM J CLIN PATHOL, V101, P493; HRUZA C, 1993, EUR J CANCER, V29A, P1593, DOI 10.1016/0959-8049(93)90301-U; HUDDART SN, 1993, PEDIATR HEMAT ONCOL, V10, P31, DOI 10.3109/08880019309016525; IMASHUKU S, 1976, J PEDIATR SURG, V11, P949, DOI 10.1016/S0022-3468(76)80072-3; LI BDL, 1994, CANCER, V73, P2771, DOI 10.1002/1097-0142(19940601)73:11<2771::AID-CNCR2820731120>3.0.CO;2-K; NAKAGAWA C, 1989, J MED SOC TOHO, V36, P199; NAU MM, 1986, P NATL ACAD SCI USA, V83, P1092, DOI 10.1073/pnas.83.4.1092; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; Sambrook J., 1989, MOL CLONING LAB MANU; SCHWAB M, 1993, SEMIN CANCER BIOL, V4, P13; SEEGER RC, 1985, NEW ENGL J MED, V313, P1111, DOI 10.1056/NEJM198510313131802; SEKIGUCHI M, 1979, JPN J EXP MED, V49, P67; SESTINI R, 1994, CLIN CHEM, V40, P630; TSUCHIDA Y, 1990, FEBS LETT, V263, P191, DOI 10.1016/0014-5793(90)81370-4; TSUCHIDA Y, 1988, EXP CELL BIOL, V56, P277; TUMILOWI.JJ, 1970, CANCER RES, V30, P2110; WONG AJ, 1986, SCIENCE, V233, P461, DOI 10.1126/science.3014659; YOSHIOKA K, 1986, NUCLEIC ACIDS RES, V14, P3147, DOI 10.1093/nar/14.7.3147; ZHOU DJ, 1987, CANCER RES, V47, P6123	30	4	4	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1010-4283			TUMOR BIOL	Tumor Biol.	SEP-OCT	1996	17	5					262	270				9	Oncology	Oncology	VE965	WOS:A1996VE96500001		
J	Tani, K; Sasabe, H; Toyoshima, C				Tani, K; Sasabe, H; Toyoshima, C			A set of computer programs for determining defocus and astigmatism in electron images	ULTRAMICROSCOPY			English	Article							FROZEN-HYDRATED SPECIMENS; ACETYLCHOLINE-RECEPTOR; CONTRAST TRANSFER; RESOLUTION; MICROGRAPHS; MICROSCOPY	A set of programs has been developed for determining the defocus and astigmatism of an electron image from the modulation of the Fourier transform due to the contrast transfer function (CTF) of a microscope. The set consists of four programs. The first one, SCTRAVGFT, averages the Fourier transform azimuthally over several sectors and makes a table of Fourier amplitudes as a function of spatial frequency. The second one, PLTCTFX, is an X-Windows program that fits theoretical CTFs to background corrected and smoothed Fourier amplitudes for each sector. The third one, CTFFIT, determines the mean defocus and astigmatism by non-linear least squares fitting. The fourth one, PCTFREFN, uses the first program internally to average over points with the same CTF values and refines :he mean defocus and astigmatism. This set of programs is particularly useful when the modulation of a Fourier transform by the CTF is weak or a transform appears to be highly astigmatic.	UNIV TOKYO,INST MOL & CELLULAR BIOL,BUNKYO KU,TOKYO,JAPAN; RIKEN,FRONTIER RES PROGRAM,WAKO,SAITAMA 35101,JAPAN			TANI, Kazutoshi/B-3705-2008	TANI, Kazutoshi/0000-0003-4835-154X			HENDERSON R, 1986, ULTRAMICROSCOPY, V19, P147, DOI 10.1016/0304-3991(86)90203-2; TOYOSHIMA C, 1988, ULTRAMICROSCOPY, V25, P279, DOI 10.1016/0304-3991(88)90003-4; ERICKSON HP, 1971, PHILOS T ROY SOC B, V261, P105, DOI 10.1098/rstb.1971.0040; UNWIN N, 1993, J MOL BIOL, V229, P1101, DOI 10.1006/jmbi.1993.1107; JENG TW, 1989, J MOL BIOL, V205, P251, DOI 10.1016/0022-2836(89)90379-3; THON F, 1966, Z NATURFORSCH PT A, VA 21, P476; DIERCKX P, 1980, COMPUTING, V24, P349, DOI 10.1007/BF02237820; FAN GY, 1990, 12TH P INT C EL MICR, P532; HEGERL R, 1982, ULTRAMICROSCOPY, V9, P109, DOI 10.1016/0304-3991(82)90233-9; HOPPE W, 1970, ACTA CRYSTALL A-CRYS, VA 26, P414, DOI 10.1107/S0567739470001080; MIMORI Y, 1995, J MOL BIOL, V249, P69, DOI 10.1006/jmbi.1995.0281; More J., 1977, LECT NOTES MATH, V630, P105; Saxton WO, 1996, J STRUCT BIOL, V116, P230, DOI 10.1006/jsbi.1996.0035; SPENCE J. C. H., 1988, EXPT HIGH RESOLUTION; STOKES DL, 1990, BIOPHYS J, V57, P1; TOYOSHIMA C, 1993, ULTRAMICROSCOPY, V48, P165, DOI 10.1016/0304-3991(93)90179-2; TOYOSHIMA C, 1990, J CELL BIOL, V111, P2623, DOI 10.1083/jcb.111.6.2623; TOYOSHIMA C, 1988, NATURE, V336, P247, DOI 10.1038/336247a0; TOYOSHIMA C, 1989, ULTRAMICROSCOPY, V30, P439, DOI 10.1016/0304-3991(89)90076-4; Zhou ZH, 1996, J STRUCT BIOL, V116, P216, DOI 10.1006/jsbi.1996.0033	20	34	35	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0304-3991			ULTRAMICROSCOPY	Ultramicroscopy	SEP	1996	65	1-2					31	44		10.1016/S0304-3991(96)00052-6		14	Microscopy	Microscopy	VU971	WOS:A1996VU97100004		
J	Matsuki, N				Matsuki, N			Mechanisms of cytotoxic drug-induced emesis and its prevention	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Review						emesis; vomiting; Suncus murinus; 5-HT3 receptor antagonist; oxygen free radical; cisplatin	CISPLATIN-INDUCED EMESIS; M-RECEPTOR ANTAGONISM; SUNCUS-MURINUS; FREE-RADICALS; EXPERIMENTAL-MODEL; 5-HYDROXYTRYPTAMINE; INDUCTION; BLOCKADE	In this review, I have attempted to provide an overview of the pathways by which cytotoxic drugs induce emesis. The mechanisms of serotonin 5-HT3 antagonists and new antiemetics are also discussed. Old data especially from the experiments employing area postrema ablation must be re-evaluated because it is likely that the operation has damaged other important nucleus in the brain stem. Therefore, the concept of the chemoreceptor trigger zone and ''vomiting center'' proposed by Borison et al. in 1950s is questionable. Nausea and vomiting caused by cytotoxic drugs have been a serious problem in anti-cancer therapy and prompted lots of scientists to find the mechanism and to develop antiemetics. Effectiveness of 5-HT3 antagonists were shown in late 1980s, and now they are clinically available. I have investigated their mechanisms using Suncus murinus and proposed that the pathways by which cisplatin, one of most emetogenic drugs, induces emesis are as follows: 1) cisplatin is converted to an active metabolite(s), 2) the metabolite(s) somehow produces oxygen free radicals in the enterochromaffin cells, 3) the free radicals release serotonin, 4) the released serotonin stimulates 5-HT3 receptors located on the vagus afferents, 5) impulses are transmitted to the brain stem, or emetic pattern generator and initiate emetic reflex. Therefore, scavengers of free radicals and antioxidants can be a new type of antiemetic drug.		Matsuki, N (reprint author), UNIV TOKYO, FAC PHARMACEUT SCI, DEPT CHEM PHARMACOL, TOKYO 113, JAPAN.						Andrews P, 1996, EUR J PHARMACOL, V307, P305, DOI 10.1016/0014-2999(96)00275-0; ANDREWS PLR, 1996, SEROTONIN SCI BASIS, P25; Andrews PLR, 1994, 5 HYDROXYTRYPTAMINE, P255; REYNOLDS DJM, 1991, BRAIN RES, V565, P231, DOI 10.1016/0006-8993(91)91654-J; BORISON HL, 1981, J CLIN PHARMACOL, V21, pS23; BORISON HL, 1959, J PHYSIOL-LONDON, V147, P172; BORISON HL, 1953, PHARMACOL REV, V5, P193; BORISON HL, 1984, FED PROC, V43, P2937; COSTALL B, 1986, NEUROPHARMACOLOGY, V25, P959, DOI 10.1016/0028-3908(86)90030-4; FOZZARD JR, 1984, NEURPHARMACOL, V23, P1473; HAGIWARA H, 1996, SEROTONIN SCI BASIS, P243; KOGA T, 1992, NEUROSCI RES, V12, P471; MATSUKI N, 1966, SEROTONIN SCI BASIS, P77; MATSUKI N, 1993, EXP ANIM TOKYO, V42, P225; MATSUKI N, 1993, EUR J PHARM-ENVIRON, V248, P329; MILLER AD, 1983, BRAIN RES, V270, P154, DOI 10.1016/0006-8993(83)90805-3; MILLER AD, 1994, BRAIN RES, V647, P255, DOI 10.1016/0006-8993(94)91325-0; MILLER AD, 1991, NAUSEA VOMITING RECE, P1; MINER WD, 1986, BRIT J PHARMACOL, V88, P497; MUTOH M, 1992, JPN J PHARMACOL, V58, P321, DOI 10.1254/jjp.58.321; OKADA F, 1994, JPN J PHARMACOL, V64, P109, DOI 10.1254/jjp.64.109; OKADA F, 1995, BRIT J PHARMACOL, V114, P931; OKADA F, IN PRESS EUR J PHARM; RICHARDSON BP, 1996, SEROTONIN SCI BASIS, P50; TORII Y, 1993, EUR J PHARM-ENVIRON, V248, P131; TORII Y, 1991, JPN J PHARMACOL, V55, P107, DOI 10.1254/jjp.55.107; TORII Y, 1991, N-S ARCH PHARMACOL, V344, P564; TORII Y, 1994, BRIT J PHARMACOL, V111, P431; TORII Y, 1993, J RADIAT RES, V34, P164, DOI 10.1269/jrr.34.164; UENO S, 1988, LIFE SCI, V43, P413, DOI 10.1016/0024-3205(88)90520-6; UENO S, 1987, LIFE SCI, V41, P513, DOI 10.1016/0024-3205(87)90229-3	31	7	12	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	SEP	1996	116	9					710	718				9	Pharmacology & Pharmacy	Pharmacology & Pharmacy	VJ981	WOS:A1996VJ98100002		
J	Alexander, G; Allison, J; Altekamp, N; Ametewee, K; Anderson, KJ; Anderson, S; Arcelli, S; Asai, S; Axen, D; Azuelos, G; Ball, AH; Barberio, E; Barlow, RJ; Bartoldus, R; Batley, JR; Beaudoin, G; Bechtluft, J; Beeston, C; Behnke, T; Bell, AN; Bell, KW; Bella, G; Bentvelsen, S; Berlich, P; Bethke, S; Biebel, O; Blobel, V; Bloodworth, IJ; Bloomer, JE; Bock, P; Bosch, HM; Boutemeur, M; Bouwens, BT; Braibant, S; Brown, RM; Burckhart, HJ; Burgard, C; Burgin, R; Capiluppi, P; Carnegie, RK; Carter, AA; Carter, JR; Chang, CY; Charlesworth, C; Charlton, DG; Chrisman, D; Chu, SL; Clarke, PEL; Cohen, I; Conboy, JE; Cooke, OC; Cuffiani, M; Dado, S; Dallapiccola, C; Dallavalle, GM; DeJong, S; delPozo, LA; Desch, K; Dixit, MS; Silva, EDE; Doucet, M; Duchovni, E; Duckeck, G; Duerdoth, IP; Edwards, JEG; Estabrooks, PG; Evans, HG; Evans, M; Fabbri, F; Fath, P; Fiedler, F; Fierro, M; Fischer, HM; Folman, R; Fong, DG; Foucher, M; Fukui, H; Furtjes, A; Gagnon, P; Gaidot, A; Gary, JW; Gascon, J; GasconShotkin, SM; Geddes, NI; GeichGimbel, C; Gentit, FX; Geralis, T; Giacomelli, G; Giacomelli, P; Giacomelli, R; Gibson, V; Gibson, WR; Gingrich, DM; Goldberg, J; Goodrick, MJ; Gorn, W; Grandi, C; Gross, E; Gruwe, M; Hajdu, C; Hanson, GG; Hansroul, M; Hapke, M; Hargrove, CK; Hart, PA; Hartmann, C; Hauschild, M; Hawkes, CM; Hawkings, R; Hemingway, RJ; Herten, G; Heuer, RD; Hildreth, MD; Hill, JC; Hillier, SJ; Hilse, T; Hoare, J; Hobson, PR; Homer, RJ; Honma, AK; Horvath, D; Howard, R; HughesJones, RE; Hutchcroft, DE; IgoKemenes, P; Imrie, DC; Ingram, MR; Jawahery, A; Jeffreys, PW; Jeremie, H; Jimack, M; Joly, A; Jones, CR; Jones, G; Jones, M; Jones, RWL; Jost, U; Jovanovic, P; Junk, TR; Karlen, D; Kawagoe, K; Kawamoto, T; Keeler, RK; Kellogg, RG; Kennedy, BW; King, BJ; Kirk, J; Kluth, S; Kobayashi, T; Kobel, M; Koetke, DS; Kokott, TP; Komamiya, S; Kowalewski, R; Kress, T; Krieger, P; vonKrogh, J; Kyberd, P; Lafferty, GD; Lafoux, H; Lahmann, R; Lai, WP; Lanske, D; Lauber, J; Lautenschlager, SR; Layter, JG; Lazic, D; Lee, AM; Lefebvre, E; Lellouch, D; Letts, J; Levinson, L; Lewis, C; Lloyd, SL; Loebinger, FK; Long, GD; Losty, MJ; Ludwig, J; Luig, A; Malik, A; Mannelli, M; Marcellini, S; Markus, C; Martin, AJ; Martin, JP; Martinez, G; Mashimo, T; Matthews, W; Mattig, P; McDonald, WJ; McKenna, J; Mckigney, EA; McMahon, TJ; McNab, AI; McPherson, RA; Meijers, F; Menke, S; Merritt, FS; Mes, H; Meyer, J; Michelini, A; Mikenberg, G; Miller, DJ; Mir, R; Mohr, W; Montanari, A; Mori, T; Morii, M; Muller, U; Neal, HA; Nellen, B; Nijjhar, B; Nisius, R; ONeale, SW; Oakham, FG; Odorici, F; Ogren, HO; Omori, T; Oreglia, MJ; Orito, S; Palinkas, J; Pansart, JP; Pasztor, G; Pater, JR; Patrick, GN; Pearce, MJ; Petzold, S; Pfeifenschneider, P; Pilcher, JE; Pinfold, J; Plane, DE; Poffenberger, P; Poli, B; Posthaus, A; Przysiezniak, H; Rees, DL; Rigby, D; Robins, SA; Rodning, N; Roney, JM; Rooke, A; Ros, E; Rossi, AM; Rosvick, M; Routenburg, P; Rozen, Y; Runge, K; Runolfsson, O; Ruppel, U; Rust, DR; Rylko, R; Sarkisyan, EKG; Sasaki, M; Sbarra, C; Schaile, AD; Schaile, O; Scharf, F; ScharffHansen, P; Schenk, P; Schmitt, B; Schmitt, S; Schroder, M; SchultzCoulon, HC; Schulz, M; Schutz, P; Scott, WG; Sheras, TG; Shen, BC; ShepherdThemistocleous, CH; Sherwood, P; Siroli, GP; Sittler, A; Skillman, A; Skuja, A; Smith, AM; Smith, TJ; Snow, GA; Sobie, R; SoldnerRembold, S; Springer, RW; Sproston, M; Stahl, A; Starks, M; Steiert, M; Stephens, K; Steuerer, J; Stockhausen, B; Strom, D; Strumia, F; Szymanski, P; Tafirout, R; Talbot, SD; Tanaka, S; Taras, P; Tarem, S; Tecchio, M; Thiergen, M; Thomson, MA; vonTorne, E; Towers, S; Tscheulin, M; Tsukamoto, T; Tsur, E; Turcot, AS; TurnerWatson, MF; Utzat, P; VanKooten, R; Vasseur, G; Verzocchi, M; Vikas, P; Vincter, M; Vokurka, EH; Wackerle, F; Wagner, A; Ward, CP; Ward, DR; Ward, JJ; Watkins, PM; Watson, AT; Watson, NK; Weber, P; Wells, PS; Wermes, N; White, JS; Wilkens, B; Wilson, GW; Wilson, JA; Wlodek, T; Wolf, G; Wotton, S; Wyatt, TR; Yamashita, S; Yekutieli, G; Zacek, V				Alexander, G; Allison, J; Altekamp, N; Ametewee, K; Anderson, KJ; Anderson, S; Arcelli, S; Asai, S; Axen, D; Azuelos, G; Ball, AH; Barberio, E; Barlow, RJ; Bartoldus, R; Batley, JR; Beaudoin, G; Bechtluft, J; Beeston, C; Behnke, T; Bell, AN; Bell, KW; Bella, G; Bentvelsen, S; Berlich, P; Bethke, S; Biebel, O; Blobel, V; Bloodworth, IJ; Bloomer, JE; Bock, P; Bosch, HM; Boutemeur, M; Bouwens, BT; Braibant, S; Brown, RM; Burckhart, HJ; Burgard, C; Burgin, R; Capiluppi, P; Carnegie, RK; Carter, AA; Carter, JR; Chang, CY; Charlesworth, C; Charlton, DG; Chrisman, D; Chu, SL; Clarke, PEL; Cohen, I; Conboy, JE; Cooke, OC; Cuffiani, M; Dado, S; Dallapiccola, C; Dallavalle, GM; DeJong, S; delPozo, LA; Desch, K; Dixit, MS; Silva, EDE; Doucet, M; Duchovni, E; Duckeck, G; Duerdoth, IP; Edwards, JEG; Estabrooks, PG; Evans, HG; Evans, M; Fabbri, F; Fath, P; Fiedler, F; Fierro, M; Fischer, HM; Folman, R; Fong, DG; Foucher, M; Fukui, H; Furtjes, A; Gagnon, P; Gaidot, A; Gary, JW; Gascon, J; GasconShotkin, SM; Geddes, NI; GeichGimbel, C; Gentit, FX; Geralis, T; Giacomelli, G; Giacomelli, P; Giacomelli, R; Gibson, V; Gibson, WR; Gingrich, DM; Goldberg, J; Goodrick, MJ; Gorn, W; Grandi, C; Gross, E; Gruwe, M; Hajdu, C; Hanson, GG; Hansroul, M; Hapke, M; Hargrove, CK; Hart, PA; Hartmann, C; Hauschild, M; Hawkes, CM; Hawkings, R; Hemingway, RJ; Herten, G; Heuer, RD; Hildreth, MD; Hill, JC; Hillier, SJ; Hilse, T; Hoare, J; Hobson, PR; Homer, RJ; Honma, AK; Horvath, D; Howard, R; HughesJones, RE; Hutchcroft, DE; IgoKemenes, P; Imrie, DC; Ingram, MR; Jawahery, A; Jeffreys, PW; Jeremie, H; Jimack, M; Joly, A; Jones, CR; Jones, G; Jones, M; Jones, RWL; Jost, U; Jovanovic, P; Junk, TR; Karlen, D; Kawagoe, K; Kawamoto, T; Keeler, RK; Kellogg, RG; Kennedy, BW; King, BJ; Kirk, J; Kluth, S; Kobayashi, T; Kobel, M; Koetke, DS; Kokott, TP; Komamiya, S; Kowalewski, R; Kress, T; Krieger, P; vonKrogh, J; Kyberd, P; Lafferty, GD; Lafoux, H; Lahmann, R; Lai, WP; Lanske, D; Lauber, J; Lautenschlager, SR; Layter, JG; Lazic, D; Lee, AM; Lefebvre, E; Lellouch, D; Letts, J; Levinson, L; Lewis, C; Lloyd, SL; Loebinger, FK; Long, GD; Losty, MJ; Ludwig, J; Luig, A; Malik, A; Mannelli, M; Marcellini, S; Markus, C; Martin, AJ; Martin, JP; Martinez, G; Mashimo, T; Matthews, W; Mattig, P; McDonald, WJ; McKenna, J; Mckigney, EA; McMahon, TJ; McNab, AI; McPherson, RA; Meijers, F; Menke, S; Merritt, FS; Mes, H; Meyer, J; Michelini, A; Mikenberg, G; Miller, DJ; Mir, R; Mohr, W; Montanari, A; Mori, T; Morii, M; Muller, U; Neal, HA; Nellen, B; Nijjhar, B; Nisius, R; ONeale, SW; Oakham, FG; Odorici, F; Ogren, HO; Omori, T; Oreglia, MJ; Orito, S; Palinkas, J; Pansart, JP; Pasztor, G; Pater, JR; Patrick, GN; Pearce, MJ; Petzold, S; Pfeifenschneider, P; Pilcher, JE; Pinfold, J; Plane, DE; Poffenberger, P; Poli, B; Posthaus, A; Przysiezniak, H; Rees, DL; Rigby, D; Robins, SA; Rodning, N; Roney, JM; Rooke, A; Ros, E; Rossi, AM; Rosvick, M; Routenburg, P; Rozen, Y; Runge, K; Runolfsson, O; Ruppel, U; Rust, DR; Rylko, R; Sarkisyan, EKG; Sasaki, M; Sbarra, C; Schaile, AD; Schaile, O; Scharf, F; ScharffHansen, P; Schenk, P; Schmitt, B; Schmitt, S; Schroder, M; SchultzCoulon, HC; Schulz, M; Schutz, P; Scott, WG; Sheras, TG; Shen, BC; ShepherdThemistocleous, CH; Sherwood, P; Siroli, GP; Sittler, A; Skillman, A; Skuja, A; Smith, AM; Smith, TJ; Snow, GA; Sobie, R; SoldnerRembold, S; Springer, RW; Sproston, M; Stahl, A; Starks, M; Steiert, M; Stephens, K; Steuerer, J; Stockhausen, B; Strom, D; Strumia, F; Szymanski, P; Tafirout, R; Talbot, SD; Tanaka, S; Taras, P; Tarem, S; Tecchio, M; Thiergen, M; Thomson, MA; vonTorne, E; Towers, S; Tscheulin, M; Tsukamoto, T; Tsur, E; Turcot, AS; TurnerWatson, MF; Utzat, P; VanKooten, R; Vasseur, G; Verzocchi, M; Vikas, P; Vincter, M; Vokurka, EH; Wackerle, F; Wagner, A; Ward, CP; Ward, DR; Ward, JJ; Watkins, PM; Watson, AT; Watson, NK; Weber, P; Wells, PS; Wermes, N; White, JS; Wilkens, B; Wilson, GW; Wilson, JA; Wlodek, T; Wolf, G; Wotton, S; Wyatt, TR; Yamashita, S; Yekutieli, G; Zacek, V			A study of charm hadron production in Z(0)->c(c)over-bar and Z(0)->b(b)over-bar decays at LEP	ZEITSCHRIFT FUR PHYSIK C-PARTICLES AND FIELDS			English	Article							E+E ANNIHILATION; QUARK PAIRS; MICROVERTEX DETECTOR; INCLUSIVE PRODUCTION; JET FRAGMENTATION; MESON LIFETIMES; HEAVY QUARKS; B-DECAYS; Z0; BARYONS	Measurements of the production of the weakly decaying charmed hadrons: D-0, D+, D-s(+) and Lambda(c)(+) in both Z(0) --> <c(c)over bar> and Z(0) --> <b(b)over bar> events are reported. By summing the partial contributions from each of these states we measure the partial width for Z(0) decays into a <c(c)over bar> pair as: Gamma(<(cc)over bar>)/Gamma(had) = 0.167 +/- 0.011(stat) +/- 0.011(sys) +/- 0.005(br) where the errors are statistical, systematic and due to the uncertainties in the charmed hadron branching ratios, respectively. The relative production rates for the formation of the charmed hadrons from primary c quarks is found to be in good agreement with continuum e(+)e(-) data at root s approximate to 10 GeV. The measured rates of these four charmed hadrons in b hadron decays is found to account for 1.061 +/- 0.045(stat) +/- 0.060(sys) +/- 0.037(br) c or (c) over bar quarks per b hadron decay. Comparison of the relative rates of the different charmed hadron species with Gamma(4S) data indicates higher rates for D-s(+) and Lambda(c)(+) hadrons and lower rates of D-0 and D+ mesons as expected due to the different mixture of b hadrons.	UNIV BIRMINGHAM, SCH PHYS & SPACE RES, BIRMINGHAM B15 2TT, W MIDLANDS, ENGLAND; UNIV BOLOGNA, DIPARTIMENTO FIS, I-40126 BOLOGNA, ITALY; IST NAZL FIS NUCL, I-40126 BOLOGNA, ITALY; UNIV BONN, INST PHYS, D-53115 BONN, GERMANY; UNIV CALIF RIVERSIDE, DEPT PHYS, RIVERSIDE, CA 92521 USA; UNIV CAMBRIDGE, CAVENDISH LAB, CAMBRIDGE CB3 0HE, ENGLAND; CARLETON UNIV, DEPT PHYS, OTTAWA CARLETON INST PHYS, OTTAWA, ON K1S 5B6, CANADA; CARLETON UNIV, CTR RES PARTICLE PHYS, OTTAWA, ON K1S 5B6, CANADA; CERN, EUROPEAN LAB PARTICLE PHYS, CH-1211 GENEVA 23, SWITZERLAND; UNIV CHICAGO, ENRICO FERMI INST, CHICAGO, IL 60637 USA; UNIV CHICAGO, DEPT PHYS, CHICAGO, IL 60637 USA; UNIV FREIBURG, FAK PHYS, D-79104 FREIBURG, GERMANY; UNIV HEIDELBERG, INST PHYS, D-69120 HEIDELBERG, GERMANY; INDIANA UNIV, DEPT PHYS, BLOOMINGTON, IN 47405 USA; UNIV LONDON QUEEN MARY & WESTFIELD COLL, LONDON E1 4NS, ENGLAND; RHEIN WESTFAL TH AACHEN, INST PHYS 3, D-52056 AACHEN, GERMANY; UCL, LONDON WC1E 6BT, ENGLAND; UNIV MANCHESTER, DEPT PHYS, SCHUSTER LAB, MANCHESTER M13 9PL, LANCS, ENGLAND; UNIV MARYLAND, DEPT PHYS, COLLEGE PK, MD 20742 USA; UNIV MONTREAL, PHYS NUCL LAB, MONTREAL, PQ H3C 3J7, CANADA; UNIV OREGON, DEPT PHYS, EUGENE, OR 97403 USA; RUTHERFORD APPLETON LAB, DIDCOT OX11 0QX, OXON, ENGLAND; CENS, CEA, DAPNIA, SPP, F-91191 GIF SUR YVETTE, FRANCE; TECHNION ISRAEL INST TECHNOL, DEPT PHYS, IL-32000 HAIFA, ISRAEL; UNIV TOKYO, INT ELEMENTARY PARTICLE PHYS, TOKYO 113, JAPAN; UNIV TOKYO, DEPT PHYS, TOKYO 113, JAPAN; KOBE UNIV, KOBE, HYOGO 657, JAPAN; BRUNEL UNIV, UXBRIDGE UB8 3PH, MIDDX, ENGLAND; WEIZMANN INST SCI, PARTICLE PHYS DEPT, IL-76100 REHOVOT, ISRAEL; UNIV HAMBURG, DESY, INST EXPT PHYS 2, D-22607 HAMBURG, GERMANY; UNIV VICTORIA, DEPT PHYS, VICTORIA, BC V8W 3P6, CANADA; UNIV ALBERTA, DEPT PHYS, EDMONTON, AB T6G 2J1, CANADA; DUKE UNIV, DEPT PHYS, DURHAM, NC 27708 USA; RES INST PARTICLE & NUCL PHYS, H-1525 BUDAPEST, HUNGARY; INST NUCL RES, H-4001 DEBRECEN, HUNGARY; TRIUMF, VANCOUVER, BC V6T 2A3, CANADA; INST NUCL RES, H-4001 DEBRECEN, HUNGARY; LAJOS KOSSUTH UNIV, DEPT EXPT PHYS, DEBRECEN, HUNGARY; UNIV MUNICH, MUNICH, GERMANY	Alexander, G (reprint author), TEL AVIV UNIV, DEPT PHYS & ASTRON, IL-69978 TEL AVIV, ISRAEL.		Horvath, Dezso/A-4009-2011; Palinkas, Jozsef/B-2993-2011; Doucet, Mathieu/A-5333-2010; Stahl, Achim/E-8846-2011; Giacomelli, Paolo/B-8076-2009; Montanari, Alessandro/J-2420-2012; Smith, Tim/E-9224-2013; Schmitt, Bernd/H-9365-2013; Grandi, Claudio/B-5654-2015; Jones, Roger/H-5578-2011	Doucet, Mathieu/0000-0002-5560-6478; Stahl, Achim/0000-0002-8369-7506; Montanari, Alessandro/0000-0003-2748-6373; Smith, Tim/0000-0002-1567-7116; Schmitt, Bernd/0000-0002-5778-0680; Grandi, Claudio/0000-0001-5998-3070; Jones, Roger/0000-0002-6427-3513			ABE F, 1994, PHYS REV LETT, V72, P3456, DOI 10.1103/PhysRevLett.72.3456; ABE F, 1995, PHYS REV LETT, V74, P4988, DOI 10.1103/PhysRevLett.74.4988; ABREU P, 1992, PHYS LETT B, V295, P383, DOI 10.1016/0370-2693(92)91580-3; ABREU P, 1995, Z PHYS C PART FIELDS, V68, P375; ABREU P, 1993, Z PHYS C PART FIELDS, V59, P533; Abreu P, 1990, PHYS LETT B, V252, P140, DOI 10.1016/0370-2693(90)91096-T; ABREU P, 1995, Z PHYS C; AKERS R, 1995, PHYS LETT B, V353, P595, DOI 10.1016/0370-2693(95)00633-V; AKERS R, 1995, Z PHYS C PART FIELDS, V66, P19; AKERS R, 1995, PHYS LETT B, V353, P402, DOI 10.1016/0370-2693(95)00553-W; AKERS R, 1995, PHYS LETT B, V350, P273, DOI 10.1016/0370-2693(95)00363-P; AKERS R, 1995, Z PHYS C PART FIELDS, V67, P379; Akers R, 1996, Z PHYS C PART FIELDS, V69, P195, DOI 10.1007/s002880050020; AKERS R, 1995, Z PHYS C PART FIELDS, V67, P27; AKRAWY MZ, 1990, Z PHYS C PART FIELDS, V47, P505; ALBRECHT H, 1991, Z PHYS C PART FIELDS, V52, P353; ALBRECHT H, 1988, PHYS LETT B, V207, P109, DOI 10.1016/0370-2693(88)90896-9; ALBRECHT H, 1992, Z PHYS C PART FIELDS, V54, P1; ALEXANDER G, 1995, PHYS LETT B, V364, P93, DOI 10.1016/0370-2693(95)01293-7; ALEXANDER G, 1991, Z PHYS C PART FIELDS, V52, P175; Alexander G, 1996, Z PHYS C PART FIELDS, V69, P543, DOI 10.1007/s002880050059; ALEXANDER G, IN PRESS Z PHYS C; ALLPORT PP, 1993, NUCL INSTRUM METH A, V324, P34, DOI 10.1016/0168-9002(93)90964-J; ALLPORT PP, 1994, NUCL INSTRUM METH A, V346, P476, DOI 10.1016/0168-9002(94)90583-5; ALTARELLI G, 1991, PHYS LETT B, V261, P303, DOI 10.1016/0370-2693(91)90332-K; ALLISON J, 1992, NUCL INSTRUM METH A, V317, P47, DOI 10.1016/0168-9002(92)90593-S; PETERSON C, 1983, PHYS REV D, V27, P105, DOI 10.1103/PhysRevD.27.105; AHMET K, 1991, NUCL INSTRUM METH A, V305, P275; SJOSTRAND T, 1987, COMPUT PHYS COMMUN, V43, P367, DOI 10.1016/0010-4655(87)90054-3; CRAWFORD G, 1992, PHYS REV D, V45, P752, DOI 10.1103/PhysRevD.45.752; KARTVELISHVILI VG, 1978, PHYS LETT B, V78, P615, DOI 10.1016/0370-2693(78)90653-6; ALBRECHT H, 1988, PHYS LETT B, V210, P263, DOI 10.1016/0370-2693(88)90383-8; SJOSTRAND T, 1986, COMPUT PHYS COMMUN, V39, P347, DOI 10.1016/0010-4655(86)90096-2; ABREU P, 1995, PHYS LETT B, V345, P598, DOI 10.1016/0370-2693(94)01696-A; ANDERSSON B, 1983, Z PHYS C PART FIELDS, V20, P317, DOI 10.1007/BF01407824; BORTOLETTO D, 1988, PHYS REV D, V37, P1719, DOI 10.1103/PhysRevD.37.1719; AVERY P, 1991, PHYS REV D, V43, P3599, DOI 10.1103/PhysRevD.43.3599; BAGAN E, 1994, NUCL PHYS B, V432, P3, DOI 10.1016/0550-3213(94)90591-6; BAGAN E, 1995, PHYS LETT B, V351, P546, DOI 10.1016/0370-2693(95)00437-P; BARDIN D, 1991, PHYS LETT B, V255, P493; BARDIN D, 1991, NUCL PHYS B, V351, P290; BORTOLETTO D, 1989, PHYS REV D, V39, P1471, DOI 10.1103/PhysRevD.39.1471; BORTOLETTO D, 1992, PHYS REV D, V45, P21, DOI 10.1103/PhysRevD.45.21; BROWDER TE, 1995, PROG NUCL PART PHYS, V35; Buskulic D, 1996, Z PHYS C PART FIELDS, V69, P393, DOI 10.1007/s002880050039; BUSKULIC D, 1990, PHYS LETT B, V244, P551; BUSKULIC D, 1995, PHYS LETT B, V357, P685, DOI 10.1016/0370-2693(95)00980-Y; Buskulic D, 1996, Z PHYS C PART FIELDS, V69, P585, DOI 10.1007/s002880050062; BUSKULIC D, 1994, Z PHYS C PART FIELDS, V62, P1; COLLINS PDB, 1985, J PHYS G NUCL PARTIC, V11, P1289, DOI 10.1088/0305-4616/11/12/006; HAUSCHILD M, 1992, NUCL INSTRUM METH A, V314, P74, DOI 10.1016/0168-9002(92)90501-T; BARDIN DY, 1989, Z PHYS C PART FIELDS, V44, P493, DOI 10.1007/BF01415565; KUHN JH, 1980, Z PHYS C PART FIELDS, V5, P117, DOI 10.1007/BF01576192; *LEP COLL LEP EL W, 1995, CERNPPE95172 LEP COL; MONTANET L, 1994, PHYS REV D, V50, P1173, DOI 10.1103/PhysRevD.50.1173; NEUBERT M, 1996, CERNTH9619	56	63	63	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0170-9739			Z PHYS C PART FIELDS	Z. Phys. C-Part. Fields	SEP	1996	72	1					1	16				16	Physics, Particles & Fields	Physics	VV931	WOS:A1996VV93100001		
J	Macrae, RM; Rhodes, CJ; Nishiyama, K; Nagamine, K				Macrae, RM; Rhodes, CJ; Nishiyama, K; Nagamine, K			An unusually small muon-electron coupling constant - Muonium addition to biacetyl	CHEMICAL PHYSICS LETTERS			English	Article							SPIN-RESONANCE; INTERNAL-ROTATION; FREE-RADICALS; SPECTRA; DYNAMICS; LIQUIDS; BOND	The room temperature muon-electron coupling constant in the 2-muoxy-3-ketobut-2-yl radical formed by muonium addition to biacetyl (butane-2,3-dione) has been measured by two separate techniques (time-differential transverse field muon spin rotation and 500 MHz rf muon spin resonance spectroscopy) and corresponds to a H-1 equivalent of 0.65 MHz, the smallest room temperature alpha-hydroxyl coupling so far measured in any radical. Its value is examined in the light of ab initio Hartree-Fock calculations and commented on in the context of the electronic structure of the radical and its relation to that of the parent molecule.	LIVERPOOL JOHN MOORES UNIV,SCH CHEM & PHYS SCI,LIVERPOOL L3 3AF,MERSEYSIDE,ENGLAND; UNIV TOKYO,FAC SCI,MESON SCI LAB,BUNKYO KU,TOKYO 113,JAPAN	Macrae, RM (reprint author), INST PHYS & CHEM RES,MUON SCI LAB,2-1 HIROSAWA,WAKO,SAITAMA 35101,JAPAN.						PERDEW JP, 1986, PHYS REV B, V33, P8800, DOI 10.1103/PhysRevB.33.8800; AYSCOUGH PB, 1971, MOL PHYS, V20, P41, DOI 10.1080/00268977100100051; BENSHAUL A, 1981, SPRINGER SERIES CHEM, V10; BRIERE TM, UNPUB; BUTTAR D, 1990, HYPERFINE INTERACT, V65, P927; BUTTAR D, 1991, J CHEM SOC FARADAY T, V87, P2901, DOI 10.1039/ft9918702901; CIRELLI G, 1982, CHEM PHYS, V72, P15, DOI 10.1016/0301-0104(82)87062-6; COX SFJ, 1986, HYPERFINE INTERACT, V32, P763, DOI 10.1007/BF02394983; COX SFJ, 1987, J PHYS C SOLID STATE, V20, P3187, DOI 10.1088/0022-3719/20/22/005; COX SFJ, 1986, RADIAT PHYS CHEM, V27, P53; DITCHFIE.R, 1971, J CHEM PHYS, V54, P724, DOI 10.1063/1.1674902; DITCHFIELD R, 1972, J CHEM PHYS, V56, P2257; Dupuis M., 1980, NATL RESOURCE COMPUT; FESSENDEN R, 1964, J CHIM PHYS PCB, V61, P1570; HELLER C, 1960, J CHEM PHYS, V32, P1535, DOI 10.1063/1.1730955; Ito Y., 1984, HOT ATOM CHEM, P373; KITAOKA Y, 1982, HYPERFINE INTERACT, V12, P51, DOI 10.1007/BF01026358; KRUSIC PJ, 1971, J PHYS CHEM-US, V75, P3438, DOI 10.1021/j100691a006; LEHNI M, 1983, THESIS ZURICH; MACRAE RM, 1988, IOP SHORT M, V22, P95; MACRAE RM, 1990, THESIS U GLASGOW; MACRAE RM, 1994, J PHYS CHEM-US, V98, P12133, DOI 10.1021/j100098a005; MIYAKE Y, 1986, RADIAT PHYS CHEM, V28, P99; NISHIYAMA K, 1986, HYPERFINE INTERACT, V32, P887, DOI 10.1007/BF02394999; RAMOS MJ, 1984, J CHEM SOC FARAD T 1, V80, P255, DOI 10.1039/f19848000255; RODUNER E, 1981, CHEM PHYS, V54, P261, DOI 10.1016/0301-0104(81)80241-8; SCHMIDT MW, 1990, QCPE B, V10, P52; SENENT ML, 1994, CHEM PHYS LETT, V221, P512, DOI 10.1016/0009-2614(94)00283-5; SIDMAN JW, 1955, J AM CHEM SOC, V77, P6471, DOI 10.1021/ja01629a010; SIDMAN JW, 1955, J AM CHEM SOC, V77, P6461, DOI 10.1021/ja01629a009; SPANGLER LH, 1986, J CHEM PHYS, V84, P4789, DOI 10.1063/1.449965; VANDERWERE R, 1976, CHEM PHYS, V16, P125, DOI 10.1016/0301-0104(76)80049-3; ZELDES H, 1966, J CHEM PHYS, V45, P1245	33	7	8	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0009-2614			CHEM PHYS LETT	Chem. Phys. Lett.	AUG 30	1996	259	1-2					103	112		10.1016/0009-2614(96)00747-6		10	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Chemistry; Physics	VE448	WOS:A1996VE44800015		
J	Braun, JR; Willnow, TE; Ishibashi, S; Ashwell, G; Herz, J				Braun, JR; Willnow, TE; Ishibashi, S; Ashwell, G; Herz, J			The major subunit of the asialoglycoprotein receptor is expressed on the hepatocellular surface in mice lacking the minor receptor subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; ALPHA-2-MACROGLOBULIN RECEPTOR; MEDIATED ENDOCYTOSIS; LIGAND-BINDING; PROTEIN LRP; LIVER; CELLS; LECTIN; OLIGOSACCHARIDES; SEQUENCE	The mammalian asialoglycoprotein receptor (ASGPR) is located on the sinusoidal membrane of hepatocytes where it binds and endocytoses galactose-terminated glycoproteins (asialoglycoproteins). ASGPR is composed of two highly homologous subunits, termed hepatic lectin 1 and 2. Despite numerous studies the contribution of both subunits to biosynthesis and functional activity of ASGPR in vivo has remained controversial. Mice lacking the murine hepatic lectin (MHL)-2 subunit are viable and fertile without obvious phenotypic abnormalities. In the absence of MHL-2, knockout mice express MHL-1 protein at reduced levels. Here, we examine the intracellular fate and function of this remaining subunit. The results show that MHL-1 reaches the hepatocellular surface in knockout mice but is unable to effectively remove any one of three different radiolabeled ligands within 30 min. A small but detectable residual ligand clearance in knockout mice at 4 h is apparently not mediated by remaining MHL-1. Serum concentrations of galactose-terminating glycoproteins are not elevated in these ASGPR-deficient mice. However, competitive in vitro degradation experiments suggest that other endogenous ASGPR ligands, the nature of which remain to be determined, accumulate in serum of knockout animals.	UNIV TEXAS,SW MED CTR,DEPT MOL GENET,DALLAS,TX 75235; UNIV TOKYO,FAC MED,DEPT INTERNAL MED 3,BUNKYO KU,TOKYO 113,JAPAN; NIDDKD,NIH,BETHESDA,MD 20892							ABDULLAH M, 1989, J CELL BIOL, V108, P367, DOI 10.1083/jcb.108.2.367; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; RICE KG, 1990, J BIOL CHEM, V265, P18429; ISHIBASHI S, 1994, J BIOL CHEM, V269, P27803; HERZ J, 1993, P NATL ACAD SCI USA, V90, P2812, DOI 10.1073/pnas.90.7.2812; MORELL AG, 1968, J BIOL CHEM, V243, P155; KRISTENSEN T, 1990, FEBS LETT, V276, P151, DOI 10.1016/0014-5793(90)80530-V; WEIGEL PH, 1980, J BIOL CHEM, V255, P6111; HENIS YI, 1990, J CELL BIOL, V111, P1409, DOI 10.1083/jcb.111.4.1409; CHIU MH, 1994, J BIOL CHEM, V269, P16195; KOLBBACHOFEN V, 1982, CELL, V29, P859, DOI 10.1016/0092-8674(82)90447-0; KLAUNIG JE, 1981, IN VITRO CELL DEV B, V17, P913; ASHWELL G, 1982, ANNU REV BIOCHEM, V51, P531, DOI 10.1146/annurev.bi.51.070182.002531; LEE YC, 1983, J BIOL CHEM, V258, P199; STRICKLAND DK, 1990, J BIOL CHEM, V265, P17401; Willnow TE, 1996, BIOCHEM J, V313, P71; HALBERG DF, 1987, J BIOL CHEM, V262, P9828; BARTLES JR, 1990, METHOD ENZYMOL, V191, P825; BIDER MD, 1995, EUR J BIOCHEM, V230, P207, DOI 10.1111/j.1432-1033.1995.tb20552.x; BISCHOFF J, 1988, J CELL BIOL, V106, P1067, DOI 10.1083/jcb.106.4.1067; BONIFACINO J S, 1991, Current Opinion in Cell Biology, V3, P592, DOI 10.1016/0955-0674(91)90028-W; BRAITERMAN LT, 1989, J BIOL CHEM, V264, P1682; CLARENBURG R, 1983, AM J PHYSIOL, V244, pG247; GRAEVE L, 1990, J BIOL CHEM, V265, P1216; HARDY MR, 1985, BIOCHEMISTRY-US, V24, P22, DOI 10.1021/bi00322a004; HARLOW E, 1988, ANTIBODIES LAB MANUA, P354; HERZ J, 1990, EMBO J, V9, P1769; HSUEH EC, 1986, J BIOL CHEM, V261, P4940; KOWAL RC, 1990, J BIOL CHEM, V265, P10771; KURANDA MJ, 1983, ARCH BIOCHEM BIOPHYS, V224, P526, DOI 10.1016/0003-9861(83)90240-0; LODISH HF, 1991, TRENDS BIOCHEM SCI, V16, P374, DOI 10.1016/0968-0004(91)90154-N; MCPHAUL M, 1986, P NATL ACAD SCI USA, V83, P8863, DOI 10.1073/pnas.83.23.8863; MONROE RS, 1994, GENE, V148, P237, DOI 10.1016/0378-1119(94)90694-7; OZAKI K, 1992, J BIOL CHEM, V267, P9229; SAWYER JT, 1988, J BIOL CHEM, V263, P10534; SCHAUER R, 1985, CLIN CHIM ACTA, V146, P119, DOI 10.1016/0009-8981(85)90050-6; SCHWARTZ AL, 1983, J BIOL CHEM, V258, P1249; SCHWARTZ AL, 1984, CRC CR REV BIOCH MOL, V16, P207, DOI 10.3109/10409238409108716; SHIA MA, 1989, P NATL ACAD SCI USA, V86, P1158, DOI 10.1073/pnas.86.4.1158; SPIESS M, 1990, Biochemistry, V29, P10009, DOI 10.1021/bi00495a001; SPIESS M, 1986, CELL, V44, P177, DOI 10.1016/0092-8674(86)90496-4; WEIGEL PH, 1992, GLYCOCONJUGATES COMP, P491; WEIGEL PH, 1994, BIOESSAYS, V16, P519, DOI 10.1002/bies.950160713; WONG KL, 1974, CLIN SCI MOL MED, V46, P763	44	47	47	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 30	1996	271	35					21160	21166				7	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	VE477	WOS:A1996VE47700032		
J	Nishitoh, H; Ichijo, H; Kimura, M; Matsumoto, T; Makishima, F; Yamaguchi, A; Yamashita, H; Enomoto, S; Miyazono, K				Nishitoh, H; Ichijo, H; Kimura, M; Matsumoto, T; Makishima, F; Yamaguchi, A; Yamashita, H; Enomoto, S; Miyazono, K			Identification of type I and type II serine/threonine kinase receptors for growth/differentiation factor-5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; BONE MORPHOGENETIC PROTEINS; SERINE THREONINE KINASE; TGF-BETA; OSTEOGENIC PROTEIN-1; ACTIVIN RECEPTOR; EXPRESSION CLONING; SUPERFAMILY; DIFFERENTIATION; FAMILY	Growth/differentiation factor-5 (GDF-5) is a member of the bone morphogenetic protein (BMP) family, which plays an important role in bone development in vivo. Mutations in the GDF-5 gene result in brachypodism in mice and Hunter-Thompson type chondrodysplasia in human. BMPs transduce their effects through binding to two different types of serine/threonine kinase receptors, type I and type II. However, binding abilities appear to be different among the members of the BMP family. BMP-4 binds to two different type I receptors, BMP receptors type IA (BMPR-IA) and type IB (BMPR-IB), and a type II receptor, BMP receptor type II (BMPR-II). In addition to these receptors, osteogenic protein-1 (OP-1, also known as BMP-7) binds to activin type I receptor (ActR-I) as well as activin type II receptors (ActR-II and ActR-IIB). Here we investigate the binding and signaling properties of GDF-5 through type I and type II receptors. GDF-5 induced alkaline phosphatase activity in a rat osteoprogenitor-like cell line, ROB-C26. I-125-GDF-5 bound to BMPR-IB and BMPR-II but not to BMPR-IA in ROB-C26 cells and other nontransfected cell lines. Analysis using COS-1 cells transfected with the receptor cDNAs revealed that GDF-5 bound to BMPR-IB but not to the other type I receptors when expressed alone. When COS-1 cells were transfected with type II receptor cDNAs, GDF-5 bound to ActR-II, ActR-IIB, and BMPR-II but not to transforming growth factor-beta type II receptor, In the presence of type II receptors, GDF-5 bound to different sets of type I receptors, but the binding was most efficient to BMPR-IB compared with the other type I receptors. Moreover, a transcriptional activation signal was efficiently transduced by BMPR-IB in the presence of BMPR-II or ActR-II after stimulation by GDF-5. These results suggest that BMPR-IB mediates certain signals for GDF-5 after forming the heteromeric complex with BMPR-II or ActR-II.	JAPANESE FDN CANC RES,INST CANC,DEPT BIOCHEM,TOSHIMA KU,TOKYO 170,JAPAN; TOKYO MED & DENT UNIV,DEPT ORAL & MAXILLOFACIAL SURG 2,BUNKYO KU,TOKYO 113,JAPAN; HOECHST JAPAN LTD,DRUG DISCOVERY RES LABS,PHARMA RES & DEV DIV,KAWAGOE,SAITAMA 35011,JAPAN; SHOWA UNIV,SCH DENT,DEPT ORAL PATHOL,SHINAGAWA KU,TOKYO 142,JAPAN; UNIV TOKYO,FAC MED,DEPT OPHTHALMOL,BUNKYO KU,TOKYO 113,JAPAN							ANDERSSON S, 1989, J BIOL CHEM, V264, P8222; TENDIJKE P, 1994, J BIOL CHEM, V269, P16985; DUDLEY AT, 1995, GENE DEV, V9, P2795, DOI 10.1101/gad.9.22.2795; Massague Joan, 1994, Trends in Cell Biology, V4, P172, DOI 10.1016/0962-8924(94)90202-X; PARALKAR VM, 1992, J CELL BIOL, V119, P1721, DOI 10.1083/jcb.119.6.1721; RUBERTE E, 1995, CELL, V80, P889, DOI 10.1016/0092-8674(95)90292-9; TRUETT MA, 1985, DNA-J MOLEC CELL BIO, V4, P333, DOI 10.1089/dna.1985.4.333; FRANZEN P, 1993, CELL, V75, P681, DOI 10.1016/0092-8674(93)90489-D; KOENIG BB, 1994, MOL CELL BIOL, V14, P5961; TENDIJKE P, 1993, ONCOGENE, V8, P2879; YAMAGUCHI A, 1991, J CELL BIOL, V113, P681, DOI 10.1083/jcb.113.3.681; Thomas JT, 1996, NAT GENET, V12, P315, DOI 10.1038/ng0396-315; KAWABATA M, 1995, J BIOL CHEM, V270, P5625; CHANG SC, 1994, J BIOL CHEM, V269, P28227; CARCAMO J, 1995, MOL CELL BIOL, V15, P1573; SUZUKI A, 1994, P NATL ACAD SCI USA, V91, P10255, DOI 10.1073/pnas.91.22.10255; NOHNO T, 1995, J BIOL CHEM, V270, P22522; LUO G, 1995, GENE DEV, V9, P2808, DOI 10.1101/gad.9.22.2808; MATHEWS LS, 1991, CELL, V65, P973, DOI 10.1016/0092-8674(91)90549-E; ATTISANO L, 1993, CELL, V75, P671, DOI 10.1016/0092-8674(93)90488-C; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; LIU F, 1995, MOL CELL BIOL, V15, P3479; VUKICEVIC S, 1989, P NATL ACAD SCI USA, V86, P8793, DOI 10.1073/pnas.86.22.8793; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; Asahina I, 1996, EXP CELL RES, V222, P38, DOI 10.1006/excr.1996.0005; ROSENZWEIG BL, 1995, P NATL ACAD SCI USA, V92, P7632, DOI 10.1073/pnas.92.17.7632; OZKAYNAK E, 1990, EMBO J, V9, P2085; LETSOU A, 1995, CELL, V80, P899, DOI 10.1016/0092-8674(95)90293-7; Attisano L, 1996, MOL CELL BIOL, V16, P1066; LIN HY, 1992, CELL, V68, P775, DOI 10.1016/0092-8674(92)90152-3; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; STORM EE, 1994, NATURE, V368, P639, DOI 10.1038/368639a0; YAMASHITA H, 1995, J CELL BIOL, V130, P217, DOI 10.1083/jcb.130.1.217; Hotten GC, 1996, GROWTH FACTORS, V13, P65, DOI 10.3109/08977199609034567; OZKAYNAK E, 1992, J BIOL CHEM, V267, P25220; TENDIJKE P, 1994, SCIENCE, V264, P101, DOI 10.1126/science.8140412; ASAHINA I, 1993, J CELL BIOL, V123, P921, DOI 10.1083/jcb.123.4.921; ATTISANO L, 1992, CELL, V68, P97, DOI 10.1016/0092-8674(92)90209-U; BASSING CH, 1994, SCIENCE, V263, P87, DOI 10.1126/science.8272871; DERYNCK R, 1994, TRENDS BIOCHEM SCI, V19, P548, DOI 10.1016/0968-0004(94)90059-0; DEWULF N, 1995, ENDOCRINOLOGY, V136, P2652, DOI 10.1210/en.136.6.2652; EBNER R, 1993, SCIENCE, V262, P900, DOI 10.1126/science.8235612; ESTEVEZ M, 1993, NATURE, V365, P644, DOI 10.1038/365644a0; GRAFF JM, 1994, CELL, V79, P169, DOI 10.1016/0092-8674(94)90409-X; HOTTEN G, 1994, BIOCHEM BIOPH RES CO, V204, P646, DOI 10.1006/bbrc.1994.2508; ICHIJO H, 1993, BIOCHEM BIOPH RES CO, V194, P1508, DOI 10.1006/bbrc.1993.1995; ISHIDOU Y, 1995, J BONE MINER RES, V10, P1651; KINGSLEY DM, 1994, GENE DEV, V8, P133, DOI 10.1101/gad.8.2.133; LAIHO M, 1990, J BIOL CHEM, V265, P18518; MATHEWS LS, 1992, SCIENCE, V255, P1702, DOI 10.1126/science.1313188; Miyazono Kohei, 1994, Seminars in Cell Biology, V5, P389, DOI 10.1006/scel.1994.1046; NISTER M, 1991, J BIOL CHEM, V266, P16755; PERIDES G, 1994, J BIOL CHEM, V269, P765; Reddi A. Hari, 1994, Current Opinion in Genetics and Development, V4, P737, DOI 10.1016/0959-437X(94)90141-O; Reddi A. Hari, 1992, Current Opinion in Cell Biology, V4, P850; VERSCHUEREN K, 1995, MECH DEVELOP, V52, P109, DOI 10.1016/0925-4773(95)00395-H	56	226	234	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 30	1996	271	35					21345	21352				8	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	VE477	WOS:A1996VE47700060		
J	Ohtani, H; Kotaki, H; Sawada, Y; Iga, T				Ohtani, H; Kotaki, H; Sawada, Y; Iga, T			Quantitative determination of epinastine in plasma by highperformance liquid chromatography	JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS			English	Article						epinastine	ELECTROCARDIOGRAPHIC PHARMACODYNAMICS; TERFENADINE; PHARMACOKINETICS	A high-performance liquid chromatographic (HPLC) method for the quantitative determination of epinastine, a nonsedating histamine H-1 receptor antagonist, in rat plasma, was developed. A 100-mu l volume of plasma sample was spiked with a solution of internal standard (diphenidol) and extracted with dichloromethane under alkaline conditions. The extract was applied onto the HPLC system and detected by ultraviolet absorption at a wavelength of 220 nm. The linearity of the calibration curve was preserved over the concentration range of 20-1000 ng/ml. Both intra-assay variation and relative error were less than 5% for the plasma sample containing 50 ng/ml or 1000 ng/ml of epinastine hydrochloride. The analytical method presented here should be useful for the investigation of the pharmacokinetic properties of epinastine, which is of clinical significance.	KYUSHU UNIV,FAC PHARMACEUT SCI,HIGASHI KU,FUKUOKA 812,JAPAN	Ohtani, H (reprint author), TOKYO UNIV HOSP,FAC MED,DEPT PHARM,BUNKYO KU,3-1 HONGO 7 CHOME,TOKYO 113,JAPAN.						SCHILLING JC, 1990, INT J CLIN PHARM TH, V28, P493; HONIG PK, 1992, CLIN PHARMACOL THER, V52, P231; AZUMA J, 1992, RINSHOU IYAKU S1, V8, P3; FUEGNER A, 1988, Arzneimittel-Forschung, V38, P1446; HONIG PK, 1993, CLIN PHARMACOL THER, V53, P630; MISAWA M, 1991, ARZNEIMITTEL-FORSCH, V41-2, P1277; *NIPP BOEHR ING CO, 1994, INT FORM AL; RICHARDS DM, 1984, DRUGS, V28, P38, DOI 10.2165/00003495-198428010-00003	8	7	9	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-4347			J CHROMATOGR B	J. Chromatogr. B-Biomed. Appl.	AUG 30	1996	683	2					281	284		10.1016/0378-4347(96)00094-1		4	Biochemical Research Methods; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	VH540	WOS:A1996VH54000020		
J	Umeda, Y; Yamashita, T; Tada, T; Kame, N				Umeda, Y; Yamashita, T; Tada, T; Kame, N			Possible mechanisms of dynamic nucleation and arresting of shallow earthquake faulting	TECTONOPHYSICS			English	Article; Proceedings Paper	Symposium on Seismic Source Parameters - From Microearthquakes to Large Events, at the General Assembly of the European-Seismological-Commission	SEP, 1994	ATHENS, GREECE	European Seismol Commiss			HIGH-FREQUENCY RADIATION; BRIGHT SPOT; SEISMICITY; SIMULATION; MODELS	The nucleation and arresting mechanisms of large shallow earthquakes are investigated from both observational and theoretical viewpoints. We show that two distinct phases are commonly observed at the initial part of seismograms of large shallow earthquakes. The first phase denotes the onset of the P wave, which shows a very gradual increase in amplitude with time. This gradual change is interrupted by the arrival of the second phase, which causes an abrupt change in the amplitude. Our seismological observation shows that the time interval between the onset of the two phases is strongly correlated with the magnitude of the earthquake. It is probable that the above two phases are related to some aspect of inhomogeneities in the earth's crust. One of the important sources of such inhomogeneities is known to be preexisting cracks and their interactions. We theoretically show in this paper that a rupture occurring in a zone of densely distributed cracks radiates elastic waves that can simulate the features of the above two phases; note that such a rupture is considerably affected by crack interactions. Theoretical calculation is also carried out to investigate the effect of crack interactions on the arresting of rupture propagation. A propagating crack can excite subsidiary cracks ahead of its crack tip, which gives rise to crack interactions. We show that these interactions sometimes facilitate the arresting of rupture propagation.	UNIV TOKYO,EARTHQUAKE RES INST,TOKYO 113,JAPAN; KYOTO UNIV,DISASTER PREVENT RES INST,UJI,KYOTO,JAPAN							Allen CR, 1965, B SEIS S AM, V55, P753; Yamashita T, 1996, GEOPHYS J INT, V125, P459, DOI 10.1111/j.1365-246X.1996.tb00011.x; BAK P, 1989, J GEOPHYS RES-SOLID, V94, P15635, DOI 10.1029/JB094iB11p15635; YAMASHITA T, 1992, J GEOPHYS RES-SOL EA, V97, P19873, DOI 10.1029/92JB01216; CARLSON JM, 1989, PHYS REV LETT, V62, P2632, DOI 10.1103/PhysRevLett.62.2632; ELLSWORTH WL, 1995, SCIENCE, V268, P851, DOI 10.1126/science.268.5212.851; OHTAKE M, 1977, PURE APPL GEOPHYS, V115, P375, DOI 10.1007/BF01637115; COCHARD A, 1994, PURE APPL GEOPHYS, V142, P419, DOI 10.1007/BF00876049; FEDOTOV S.A., 1965, T I FIZ ZEMLI ACAD N, V36, P66; KAME N, 1995, THESIS U TOKYO; KAME N, 1996, UNPUB INT J GEOPHYS; Kostrov B.V., 1966, PMM-J APPL MATH MEC, V30, P1241, DOI 10.1016/0021-8928(66)90087-6; LEARY PC, 1987, GEOPHYS J INT, V91, P461, DOI 10.1111/j.1365-246X.1987.tb05239.x; MADARIAGA R, 1983, ANN GEOPHYS, V1, P17; MADARIAGA R, 1977, GEOPHYS J ROY ASTR S, V51, P625, DOI 10.1111/j.1365-246X.1977.tb04211.x; Mogi K., 1963, B EARTHQ RES I TOKYO, V41, P615; Mogi K., 1969, B EARTHQ RES I TOKYO, V47, P395; OHTAKE M, 1974, PAGEOPH, V114, P1083; OHTAKE M, 1974, URE APPL GEOPHYS, V114, P1083; Rice J, 1992, FAULT MECH TRANSPORT, P475, DOI DOI 10.1016/S0074-6142(08)62835-1; RICE JR, 1993, J GEOPHYS RES-SOL EA, V98, P9885, DOI 10.1029/93JB00191; SEGALL P, 1980, J GEOPHYS RES, V85, P4337, DOI 10.1029/JB085iB08p04337; SIH GC, 1965, J APPL MECH, V32, P51; UMEDA Y, 1992, TECTONOPHYSICS, V211, P13, DOI 10.1016/0040-1951(92)90048-B; UMEDA Y, 1990, TECTONOPHYSICS, V175, P81, DOI 10.1016/0040-1951(90)90131-Q; UMEDA Y, 1981, J PHYS EARTH, V29, P341; UMEDA Y, 1991, PREV RES I, V34, P1; UMEDA Y, 1987, TECTONOPHYSICS, V141, P335, DOI 10.1016/0040-1951(87)90207-1; YAMASHITA T, 1989, GEOPHYS J INT, V96, P389, DOI 10.1111/j.1365-246X.1989.tb06003.x; YAMASHITA T, 1993, J GEOPHYS RES-SOL EA, V98, P12019, DOI 10.1029/93JB00713; YAMASHITA T, 1994, PURE APPL GEOPHYS, V143, P89, DOI 10.1007/BF00874325; YAMASHITA T, 1983, J PHYS EARTH, V31, P1; YAMASHITA T, 1995, J GEOPHYS RES-SOL EA, V100, P8339, DOI 10.1029/95JB00236; ZENG YH, 1993, J GEOPHYS RES-SOL EA, V98, P11981, DOI 10.1029/93JB00346	34	13	13	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0040-1951			TECTONOPHYSICS	Tectonophysics	AUG 30	1996	261	1-3					179	192		10.1016/0040-1951(96)00065-0		14	Geochemistry & Geophysics	Geochemistry & Geophysics	VP834	WOS:A1996VP83400015		
J	Tanaka, N; Ishihara, M; Lamphier, MS; Nozawa, H; Matsuyama, T; Mak, TW; Aizawa, S; Tokino, T; Oren, M; Taniguchi, T				Tanaka, N; Ishihara, M; Lamphier, MS; Nozawa, H; Matsuyama, T; Mak, TW; Aizawa, S; Tokino, T; Oren, M; Taniguchi, T			Cooperation of the tumour suppressors IRF-1 and p53 in response to DNA damage	NATURE			English	Article							TRANSCRIPTION FACTOR IRF-1; CYCLIN-DEPENDENT KINASES; APOPTOSIS; INDUCTION; ARREST; CELLS; P21; CHECKPOINT; INHIBITORS; ACTIVATION	NORMALLY growing cells promptly cease DNA synthesis when exposed to genotoxic stresses, such as radiation, and this cell-cycle arrest prevents the accumulation of mutations(1,2). The transcription factor interferon regulatory factor (IRF)-1 is essential for the regulation of the interferon system(3-5), inhibits cell growth, and manifests tumour-suppressor activities(6,7). Here we show that mouse embryonic fibroblasts (EFs) lacking LRF-1 are deficient in their ability to undergo DNA-damage-induced cell-cycle arrest. A similar phenotype has been observed in EFs lacking the tumour suppressor p53 (refs 8, 9), although the expression of IRF-1 and p53 are independent of one another. Furthermore, we show that transcriptional induction of the gene encoding p21 (WAF1, CIP1)(10-12), a cell-cycle inhibitor, by gamma-irradiation is dependent on both p53 and IRF-1, and that the p21 promoter is activated, either directly or indirectly, by both in a transient cotransfection assay. These two tumour-suppressor transcription factors therefore converge functionally to regulate the cell cycle through the activation of a common target genes.	NARA INST SCI & TECHNOL,NARA 6301,JAPAN; RES DEV CORP JAPAN,PRECURSORY RES PROGRAM EMBRYON SCI & TECHNOL,KYOTO 61902,JAPAN; ONTARIO CANC INST,AMGEN INST,TORONTO,ON M4X 1K9,CANADA; UNIV TORONTO,DEPT IMMUNOL & MED BIOPHYS,TORONTO,ON M4X 1K9,CANADA; KUMAMOTO UNIV,SCH MED,INST MOL EMBRYOL & GENET,KUMAMOTO 860,JAPAN; UNIV TOKYO,INST MED SCI,MOL MED LAB,MINATO KU,TOKYO 108,JAPAN; WEIZMANN INST SCI,DEPT MOL CELL BIOL,IL-76100 REHOVOT,ISRAEL	Tanaka, N (reprint author), UNIV TOKYO,FAC MED,DEPT IMMUNOL,BUNKYO KU,HONGO 7-3-1,TOKYO 113,JAPAN.						ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; HARTWELL L, 1992, CELL, V71, P543, DOI 10.1016/0092-8674(92)90586-2; HARADA H, 1993, SCIENCE, V259, P971, DOI 10.1126/science.8438157; WILLMAN CL, 1993, SCIENCE, V259, P968, DOI 10.1126/science.8438156; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; HALEVY O, 1995, SCIENCE, V267, P1018, DOI 10.1126/science.7863327; HUNTER T, 1994, CELL, V79, P573, DOI 10.1016/0092-8674(94)90543-6; TAMURA T, 1995, NATURE, V376, P596, DOI 10.1038/376596a0; PARKER SB, 1995, SCIENCE, V267, P1024, DOI 10.1126/science.7863329; MATSUYAMA T, 1993, CELL, V75, P83, DOI 10.1016/S0092-8674(05)80086-8; Chin YE, 1996, SCIENCE, V272, P719, DOI 10.1126/science.272.5262.719; LIEBERMANN DA, 1995, ONCOGENE, V11, P199; HAUPT Y, 1995, GENE DEV, V9, P2170, DOI 10.1101/gad.9.17.2170; CROSS SM, 1995, SCIENCE, V267, P1353, DOI 10.1126/science.7871434; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; VOGELSTEIN B, 1992, CELL, V70, P523, DOI 10.1016/0092-8674(92)90421-8; BAKER SJ, 1990, SCIENCE, V249, P912, DOI 10.1126/science.2144057; KIMURA T, 1994, SCIENCE, V264, P1921, DOI 10.1126/science.8009222; KASTAN MB, 1991, CANCER RES, V51, P6304; MATSUSHIME H, 1994, MOL CELL BIOL, V14, P2066; HARPER JW, 1993, CELL, V75, P805; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; ELDEIRY WS, 1995, CANCER RES, V55, P2910; TANAKA N, 1994, CELL, V77, P829, DOI 10.1016/0092-8674(94)90132-5; BRUGAROLAS J, 1995, NATURE, V377, P552, DOI 10.1038/377552a0; ELDEIRY WS, 1994, CANCER RES, V54, P1169; KAMIJO R, 1994, SCIENCE, V263, P1612, DOI 10.1126/science.7510419; LOWE SW, 1993, CELL, V74, P957, DOI 10.1016/0092-8674(93)90719-7; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455	30	257	262	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	AUG 29	1996	382	6594					816	818		10.1038/382816a0		3	Multidisciplinary Sciences	Science & Technology - Other Topics	VE347	WOS:A1996VE34700049		
J	Seki, R; Shoppa, TD; Kohama, A; Yazaki, K				Seki, R; Shoppa, TD; Kohama, A; Yazaki, K			Nuclear correlation and finite interaction-range effects in high-energy (e,e'p) nuclear transparency	PHYSICS LETTERS B			English	Article							MOMENTUM-TRANSFER; SCATTERING; DEPENDENCE; STATE	Nuclear transparency is calculated for high-energy, semi-inclusive (e,e'p) reactions, by accounting for all orders of Glauber multiple-scattering and by using realistic finite-range pN interaction and (dynamically and statistically) correlated nuclear wave functions. The nuclear correlation effect is reduced due to the pN finite-range effect, and is only a few percent for a given one-body density, depending on details of the (presently poorly known) nuclear correlations in finite nuclei.	UNIV TOKYO,FAC SCI,DEPT PHYS,BUNKYO KU,TOKYO 113,JAPAN; CALIF STATE UNIV NORTHRIDGE,DEPT PHYS & ASTRON,NORTHRIDGE,CA 91330	Seki, R (reprint author), CALTECH,WK KELLOGG RADIAT LAB,PASADENA,CA 91125, USA.						WIRINGA RB, 1988, PHYS REV C, V38, P1010, DOI 10.1103/PhysRevC.38.1010; PANDHARIPANDE VR, 1992, PHYS REV C, V45, P791, DOI 10.1103/PhysRevC.45.791; BAYM G, 1995, PHYS REV C, V52, P1604, DOI 10.1103/PhysRevC.52.1604; BENHAR O, 1992, PHYS REV LETT, V69, P881, DOI 10.1103/PhysRevLett.69.881; BENHAR O, 1993, REV MOD PHYS, V65, P817, DOI 10.1103/RevModPhys.65.817; BRODSKY SJ, 1988, PHYS LETT B, V206, P685, DOI 10.1016/0370-2693(88)90719-8; FRANKEL S, 1994, NUCL PHYS A, V580, P595, DOI 10.1016/0375-9474(94)90783-8; FRANKFURT L, 1995, PREPRINT; Glauber R. J., 1959, LECTURES THEORETICAL, V1, P315; KOHAMA A, 1992, NUCL PHYS A, V536, P716, DOI 10.1016/0375-9474(92)90120-9; KOHAMA A, 1993, NUCL PHYS A, V551, P687; MAKINS NCR, 1994, PHYS REV LETT, V72, P1986, DOI 10.1103/PhysRevLett.72.1986; Morimatsu O., 1994, Progress in Particle and Nuclear Physics, V33, DOI 10.1016/0146-6410(94)90051-5; NIKOLAEV NN, 1993, PHYS LETT B, V317, P281, DOI 10.1016/0370-2693(93)90996-U; O'Neill T. G., COMMUNICATION; ONEILL TG, 1995, PHYS LETT B, V351, P87, DOI 10.1016/0370-2693(95)00362-O; ONEILL TG, UNPUB; Pieper S.C., COMMUNICATION; PIEPER SC, 1992, PHYS REV C, V46, P141; REINHARD PG, 1991, COMPUTATIONAL NUCL P, pCH2; RINAT AS, 1995, PHYS REV C, V52, pR28, DOI 10.1103/PhysRevC.52.R28; RINAT AS, 1994, NUCL PHYS A, V568, P873, DOI 10.1016/0375-9474(94)90364-6	22	8	8	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0370-2693			PHYS LETT B	Phys. Lett. B	AUG 29	1996	383	2					133	138		10.1016/0370-2693(96)00735-6		6	Astronomy & Astrophysics; Physics, Nuclear; Physics, Particles & Fields	Astronomy & Astrophysics; Physics	VE514	WOS:A1996VE51400003		
J	Ishii, Y; Tokunaga, S; Seino, H; Hidai, M				Ishii, Y; Tokunaga, S; Seino, H; Hidai, M			Synthesis of tungsten (1-pyridinio)imido complexes: Facile N-N bond cleavage to form pyridine from coordinated dinitrogen	INORGANIC CHEMISTRY			English	Article							HYDRAZIDO(2-) COMPLEXES; DIAZOALKANE COMPLEXES; PYRROLYLIMIDO COMPLEXES; NITROGEN-FIXATION; MOLYBDENUM; LIGAND; PROTONATION; CHEMISTRY; HYDRAZINE; PYRROLE		UNIV TOKYO,GRAD SCH ENGN,DEPT CHEM & BIOCHEM,BUNKYO KU,TOKYO 113,JAPAN							HIDAI M, 1995, CHEM REV, V95, P1115, DOI 10.1021/cr00036a008; CHATT J, 1978, CHEM REV, V78, P589, DOI 10.1021/cr60316a001; SEINO H, 1994, J AM CHEM SOC, V116, P7433, DOI 10.1021/ja00095a067; AOSHIMA T, 1992, J ORGANOMET CHEM, V435, P85, DOI 10.1016/0022-328X(92)83462-Q; AOSHIMA T, 1992, J ORGANOMET CHEM, V423, P39, DOI 10.1016/0022-328X(92)83022-A; BARCLAY JE, 1990, J CHEM SOC DALTON, P2503, DOI 10.1039/dt9900002503; BEVAN PC, 1978, J ORGANOMET CHEM, V160, P165, DOI 10.1016/S0022-328X(00)91210-5; CHATT J, 1978, J CHEM SOC DALTON, P1638, DOI 10.1039/dt9780001638; DILWORTH JR, 1982, COMPREHENSIVE ORGANO, V8, P1073; GALINDO A, 1990, J CHEM SOC DALTON, P283, DOI 10.1039/dt9900000283; GLASSMAN TE, 1992, J AM CHEM SOC, V114, P8098, DOI 10.1021/ja00047a019; HIDAI M, 1976, J AM CHEM SOC, V98, P7824, DOI 10.1021/ja00440a063; HIDAI M, 1978, J AM CHEM SOC, V100, P5740, DOI 10.1021/ja00486a026; Hidai M, 1996, B CHEM SOC JPN, V69, P819, DOI 10.1246/bcsj.69.819; IWANAMI K, 1981, B CHEM SOC JPN, V54, P1773, DOI 10.1246/bcsj.54.1773; KAWAGUCHI H, 1995 INT CHEM C PAC; MIZOBE Y, 1980, B CHEM SOC JPN, V53, P1781, DOI 10.1246/bcsj.53.1781; RICHARDS RL, 1988, CHEM BRIT, V24, P133; SEINO H, UNPUB; SEINO H, 1995, J AM CHEM SOC, V117, P12181, DOI 10.1021/ja00154a019; VALE MG, 1993, INORG CHEM, V32, P2767, DOI 10.1021/ic00064a030; WAGENKNECHT PS, 1995, J AM CHEM SOC, V117, P1841, DOI 10.1021/ja00111a027	22	12	12	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036	0020-1669			INORG CHEM	Inorg. Chem.	AUG 28	1996	35	18					5118	5119		10.1021/ic960632f		2	Chemistry, Inorganic & Nuclear	Chemistry	VE439	WOS:A1996VE43900006		
J	Iwaoka, M; Tomoda, S				Iwaoka, M; Tomoda, S			Nature of the intramolecular Se center dot center dot center dot N nonbonded interaction of 2-selenobenzylamine derivatives. An experimental evaluation by H-1, Se-77, and N-15 NMR spectroscopy	JOURNAL OF THE AMERICAN CHEMICAL SOCIETY			English	Article							EFFECTIVE CORE POTENTIALS; ORGANOSELENIUM CHEMISTRY; MOLECULAR CALCULATIONS; DIVALENT SELENIUM; ASYMMETRIC METHOXYSELENENYLATION; CONVENIENT SYNTHESIS; HYPERVALENT NATURE; CRYSTAL-STATE; BONDS; REAGENTS	H-1 NMR analysis of seven 2-selenobenzylamine derivatives (ArSeX, 1-7) has revealed the existence of attractive nonbonded interaction between the divalent selenium and an unsymmetric amino nitrogen, whose strength significantly depends on the relative electrophilic reactivity of the selenium moiety. In the intermediate cases (5, X=CN; 6, X=SPh), the dissociation energy of the Se ... N nonbonded interaction was evaluated as 12.4 and 10.8 kcal/mol, respectively, by variable-temperature H-1 NMR spectral simulations. The corresponding values were roughly estimated as >18.8 kcal/mol for the strong cases (2, X=Br; 3, X=Cl; 4, X=OAc) and <7.7 kcal/mol for the weak cases (1, X=SeAT; 7, X=Me). In order to elucidate physicochemical properties of the interactilon, N-15-labeled compounds were synthesized. Downfield shifts of N-15 NMR (Delta delta(N)) and increment of J(Se ... N) (coupling constant between Se-77 and N-15) were observed with increasing Se ... N interaction. In the case of strong Se ... N interaction, saturation of coupling constants was observed. These experimental observations as well as large NBO deletion energies (3-21G* and LANL1DZ) between the selenium and the nitrogen for model compounds (9-13) strongly suggested that the observed Se ... N interaction is mainly caused by the orbital interaction between the nitrogen lone pair (n(N)) and the antibonding orbital of the Se-X bond (sigma*(Se-X)).	UNIV TOKYO,COLL ARTS & SCI,DEPT CHEM,MEGURO KU,TOKYO 153,JAPAN							REED AE, 1988, CHEM REV, V88, P899, DOI 10.1021/cr00088a005; WADT WR, 1985, J CHEM PHYS, V82, P284, DOI 10.1063/1.448800; BLICKE FF, 1952, J AM CHEM SOC, V74, P3933, DOI 10.1021/ja01135a503; EPP O, 1983, EUR J BIOCHEM, V133, P51, DOI 10.1111/j.1432-1033.1983.tb07429.x; HAY PJ, 1985, J CHEM PHYS, V82, P299, DOI 10.1063/1.448975; RAMASUBBU N, 1987, PHOSPHORUS SULFUR, V31, P221, DOI 10.1080/03086648708080641; RAMSEY NF, 1953, PHYS REV, V91, P303, DOI 10.1103/PhysRev.91.303; BURLING FT, 1992, J AM CHEM SOC, V114, P2313, DOI 10.1021/ja00033a004; KUBINIOK S, 1988, ANGEW CHEM INT EDIT, V27, P431, DOI 10.1002/anie.198804311; SHARPLESS KB, 1975, J ORG CHEM, V40, P947, DOI 10.1021/jo00895a030; CLIVE DLJ, 1978, TETRAHEDRON, V34, P1049, DOI 10.1016/0040-4020(78)80135-5; DUMONT WW, 1990, INORG CHEM, V29, P4847, DOI 10.1021/ic00349a003; REICH HJ, 1975, J AM CHEM SOC, V97, P5434, DOI 10.1021/ja00852a019; BARTON DHR, 1993, J AM CHEM SOC, V115, P5056, DOI 10.1021/ja00065a015; TOMODA S, 1988, J PHYS ORG CHEM, V1, P179, DOI 10.1002/poc.610010308; REED AE, 1985, J CHEM PHYS, V83, P1736, DOI 10.1063/1.449360; GOLDSTEIN BM, 1990, J AM CHEM SOC, V112, P8265, DOI 10.1021/ja00179a007; REED AE, 1985, J CHEM PHYS, V83, P735, DOI 10.1063/1.449486; REED AE, 1983, J CHEM PHYS, V78, P4066, DOI 10.1063/1.445134; BACK TG, 1980, TETRAHEDRON LETT, V21, P2213, DOI 10.1016/0040-4039(80)80005-0; BACK TG, 1980, TETRAHEDRON LETT, V21, P2215, DOI 10.1016/0040-4039(80)80006-2; BAIWIR PM, 1975, ACTA CRYSTALLOGR B, V31, P2188; BATT L, 1986, CHEM ORGANIC SELENIU, V1; Flohe L., 1982, FREE RADICALS BIOL; FUJITA KI, 1995, J CHEM SOC CHEM COMM, P1641, DOI 10.1039/c39950001641; FUJITA K, 1994, CHEM LETT, P923, DOI 10.1246/cl.1994.923; FUJITA K, 1995, TETRAHEDRON LETT, V36, P5219; GLOVER SA, 1993, J ORG CHEM, V58, P2115, DOI 10.1021/jo00060a030; HARGITTAI I, 1986, CHEM ORGANIC SELENIU, V1; IOAOKA M, 1994, J AM CHEM SOC, V116, P2557; IWAOKA M, 1995, J ORG CHEM, V60, P5299, DOI 10.1021/jo00121a058; IWAOKA M, 1994, J AM CHEM SOC, V116, P4463, DOI 10.1021/ja00089a040; IWAOKA M, 1992, PHOSPHORUS SULFUR, V67, P125, DOI 10.1080/10426509208045827; IWAOKA M, 1992, J CHEM SOC CHEM COMM, P1165, DOI 10.1039/c39920001165; LEVY GC, 1979, NITROGEN 15 NMR SPEC; Liotta D., 1987, ORGANOSELENIUM CHEM; LLABRES G, 1981, ORG MAGN RESONANCE, V15, P152, DOI 10.1002/mrc.1270150208; Luthra N. P., 1986, CHEM ORGANIC SELENIU, V1; MACFARLANE W, 1972, J CHEM SOC A, P1397; MORTIMER CT, 1988, THERMOCHIM ACTA, V131, P91, DOI 10.1016/0040-6031(88)80061-3; NAKANISHI W, 1982, ORG MAGN RESONANCE, V20, P117, DOI 10.1002/mrc.1270200210; NICOLAOU KC, 1984, SELENIUM NATURAL RPO; NISHIMUR.S, 1971, B CHEM SOC JPN, V44, P240, DOI 10.1246/bcsj.44.240; Patai S., 1986, CHEM ORGANIC SELENIU, V1; PAULMIER C, 1986, SELENIUM REAGENTS IN; POPLE JA, 1964, MOL PHYS, V8, P1, DOI 10.1080/00268976400100011; REICH HJ, 1979, ACCOUNTS CHEM RES, V12, P22, DOI 10.1021/ar50133a004; REICH HJ, 1974, J ORG CHEM, V39, P428, DOI 10.1021/jo00917a037; RENY J, 1975, TETRAHEDRON LETT, P503; ROESKY HW, 1985, J CHEM SOC DALTON, P565, DOI 10.1039/dt9850000565; SCHMID GH, 1983, J ORG CHEM, V48, P4169, DOI 10.1021/jo00171a002; SCHULTZ G, 1984, J CHEM SOC FARAD T 2, V80, P1273, DOI 10.1039/f29848001273; Shamberger R.J., 1983, BIOCH SELENIUM; SHARPLES.KB, 1973, J AM CHEM SOC, V95, P6137, DOI 10.1021/ja00799a062; SHARPLES.KB, 1974, J ORG CHEM, V39, P429, DOI 10.1021/jo00917a038; STEINER T, 1993, J AM CHEM SOC, V115, P4540, DOI 10.1021/ja00064a016; Stephenson D. S., 1978, QUANTUM CHEM PROGRAM, V11, P365; Tayor R, 1984, ACCOUNTS CHEM RES, V17, P320; TOMODA S, 1981, CHEM LETT, P1069, DOI 10.1246/cl.1981.1069; TOMODA S, 1982, J CHEM SOC CHEM COMM, P871, DOI 10.1039/c39820000871; TOMODA S, 1990, J CHEM SOC CHEM COMM, P231, DOI 10.1039/c39900000231; TOSHIMITSU A, 1977, J CHEM SOC CHEM COMM, P166, DOI 10.1039/c39770000166; UEMURA S, 1979, CHEM LETT, P1359, DOI 10.1246/cl.1979.1359; UGI I, 1973, ORG SYNTH, V5, P301; HAY PJ, 1985, J CHEM PHYS, V82, P270, DOI 10.1063/1.448799; WIBERG KB, 1991, J AM CHEM SOC, V113, P971, DOI 10.1021/ja00003a034	66	175	175	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036	0002-7863			J AM CHEM SOC	J. Am. Chem. Soc.	AUG 28	1996	118	34					8077	8084		10.1021/ja953358h		8	Chemistry, Multidisciplinary	Chemistry	VE266	WOS:A1996VE26600022		
J	Kuwahara, M; Hashimoto, S; Ishii, K; Yagi, Y; Hada, T; Hiraga, A; Kai, M; Kubo, K; Oki, H; Tsubone, H; Sugano, S				Kuwahara, M; Hashimoto, S; Ishii, K; Yagi, Y; Hada, T; Hiraga, A; Kai, M; Kubo, K; Oki, H; Tsubone, H; Sugano, S			Assessment of autonomic nervous function by power spectral analysis of heart rate variability in the horse	JOURNAL OF THE AUTONOMIC NERVOUS SYSTEM			English	Article						autonomic blockade; blood pressure variability; heart rate variability; coherence; fast Fourier transform	ARTERIAL-PRESSURE; EXERCISE; SYSTEM; PIGS	We studied power spectral analysis of heart rate (HR) variability in the horse, with the hypothesis that the quantitative information provided by the spectral analysis of HR variability reflects the interaction between sympathetic and parasympathetic regulatory activities. For this purpose, electrocardiogram, blood pressure (BP) and respiratory (Resp) waveform were simultaneously recorded from Thoroughbred horses (3-5 years old) and analyzed by power spectrum. There were two major spectral components at low-frequency (LF) and high-frequency (HF) bands for HR variability. The peak of Resp variability clearly occurred at the HF range. in contrast to Resp variability, the power spectra of BP variability occurred at lower frequencies, The maximum coherence between HR and Resp variabilities and HR and BP variabilities occurred at similar to 0.15 and similar to 0.03 Hz, respectively. These relationships were similar to the ensemble spectra, On the basis of these data, we have defined two frequency bands of interest: LF (0.01-0.07 Hz) and HF (0.07-0.6 Hz). Therefore, we believe that power spectral analysis of HR variability provides a very powerful technique for assessing autonomic nervous activity in the horse.	JAPAN RACING ASSOC,EQUINE RES INST,TOKYO,JAPAN	Kuwahara, M (reprint author), UNIV TOKYO,GRAD SCH AGR & LIFE SCI,DEPT COMPARAT PATHOPHYSIOL,BUNKYO KU,1-1-1 YAYOI,TOKYO,JAPAN.						AKSELROD S, 1981, SCIENCE, V213, P220, DOI 10.1126/science.6166045; AKSELROD S, 1987, AM J PHYSIOL, V253, pH176; HAMLIN RL, 1972, AM J PHYSIOL, V222, P976; PAGANI M, 1986, CIRC RES, V59, P178; MATSUI K, 1987, JPN J VET SCI, V49, P637; WALSH RR, 1969, AM J PHYSIOL, V217, P1139; LOMBARDI F, 1987, AM J CARDIOL, V60, P1239, DOI 10.1016/0002-9149(87)90601-1; MALLIANI A, 1991, CIRCULATION, V84, P482; CERUTTI C, 1991, AM J PHYSIOL, V261, pH1292; JOSE AD, 1967, CIRC RES S3, V20, P231; JOSE AD, 1970, CARDIOVASC RES, V4, P160, DOI 10.1093/cvr/4.2.160; KUWAHARA M, 1986, JPN J VET SCI, V48, P703; KUWAHARA M, 1994, J ELECTROCARDIOL, V27, P333, DOI 10.1016/S0022-0736(05)80272-9; MARASLAND WP, 1968, J APPL PHYSIOL, V24, P98; MONTANO N, 1992, J AUTONOM NERV SYST, V40, P21, DOI 10.1016/0165-1838(92)90222-3; PERSSON PB, 1992, AM J PHYSIOL, V263, pH1348; PHYSICKSHEARD PW, 1985, VET CLIN N AM-EQUINE, V1, P383; RANDALL DC, 1991, AM J PHYSIOL, V260, pH985; REEF VB, 1985, VET CLIN N AM-EQUINE, V1, P275; SENTA T, 1970, CORNELL VET, V60, P552; TAVERNOR VO, 1969, AM J VET RES, V30, P1881	21	42	43	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-1838			J AUTONOM NERV SYST	J. Auton. Nerv. Syst.	AUG 27	1996	60	1-2					43	48		10.1016/0165-1838(96)00028-8		6	Neurosciences	Neurosciences & Neurology	VH574	WOS:A1996VH57400006		
J	Ohya, Y; Caplin, BE; Qadota, H; Tibbetts, MF; Anraku, Y; Pringle, JR; Marshall, MS				Ohya, Y; Caplin, BE; Qadota, H; Tibbetts, MF; Anraku, Y; Pringle, JR; Marshall, MS			Mutational analysis of the beta-subunit of yeast geranylgeranyl transferase I	MOLECULAR & GENERAL GENETICS			English	Article						prenylation; geranylgeranyl transferase I; CAL1; CDC43	MAMMALIAN PROTEIN GERANYLGERANYLTRANSFERASE; SACCHAROMYCES-CEREVISIAE; CELL POLARITY; ALPHA-SUBUNIT; GENE-PRODUCT; POSTTRANSLATIONAL MODIFICATIONS; METAL REQUIREMENTS; PEPTIDE-BINDING; CDNA CLONING; RAS PROTEINS	The gene CAL1 (also known as CDC43) of Saccharomyces cerevisiae encodes the beta subunit of geranylgeranyl transferase I (GGTase I), which modifies several small GTPases. Biochemical analyses of the mutant enzymes encoded by cal1-1, and cdc43-2 to cdc43-7, expressed in bacteria, have shown that all of the mutant enzymes possess reduced activity, and that none shows temperature-sensitive enzymatic activities. Nonetheless, all of the cal1/cdc43 mutants show temperature-sensitive growth phenotypes. Increase in soluble pools of the small GTPases was observed in the yeast mutant cells at the restrictive temperature in vivo, suggesting that the yeast prenylation pathway itself is temperature sensitive, The cal1-1 mutation, located most proximal to the C-terminus of the protein, differs from the other cdc43 mutations in several respects. An increase in soluble Rho1p was observed in the cal1-1 strain grown at the restrictive temperature. The temperature-sensitive phenotype of cal1-1 is most efficiently suppressed by overproduction of Rho1p, Overproduction of the other essential target, Cdc42p, in contrast, is deleterious in cal1-1 cells, but not in other cdc43 mutants or the wild-type strains. The cdc43-5 mutant cells accumulate Cdc42p in soluble pools and cdc43-5 is suppressed by overproduction of Cdc42p. Thus, several phenotypic differences are observed among the cal1/cdc43 mutations, possibly due to alterations in substrate specificity caused by the mutations.	STANFORD UNIV,SCH MED,DEPT GENET,STANFORD,CA 94305; INDIANA UNIV,SCH MED,DIV HEMATOL & ONCOL,INDIANAPOLIS,IN 46202; INDIANA UNIV,SCH MED,WALTHER ONCOL CTR,INDIANAPOLIS,IN 46202; INDIANA UNIV,SCH MED,DEPT BIOCHEM & MOL BIOL,INDIANAPOLIS,IN 46202; UNIV MICHIGAN,DEPT BIOL,ANN ARBOR,MI 48109	Ohya, Y (reprint author), UNIV TOKYO,GRAD SCH SCI,DEPT SCI BIOL,BUNKYO KU,TOKYO 113,JAPAN.						ADAMS AEM, 1990, J CELL BIOL, V111, P131, DOI 10.1083/jcb.111.1.131; MADAULE P, 1987, P NATL ACAD SCI USA, V84, P779, DOI 10.1073/pnas.84.3.779; ADAMSON P, 1992, J BIOL CHEM, V267, P20033; SIKORSKI RS, 1989, GENETICS, V122, P19; SEABRA MC, 1992, CELL, V70, P1049, DOI 10.1016/0092-8674(92)90253-9; QADOTA H, 1994, P NATL ACAD SCI USA, V91, P9317, DOI 10.1073/pnas.91.20.9317; ARMSTRONG SA, 1995, J BIOL CHEM, V270, P7864; SEABRA MC, 1991, CELL, V65, P429, DOI 10.1016/0092-8674(91)90460-G; REISS Y, 1990, CELL, V62, P81, DOI 10.1016/0092-8674(90)90242-7; DIAZ M, 1993, EMBO J, V12, P5245; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; OMER CA, 1994, MOL MICROBIOL, V11, P219, DOI 10.1111/j.1365-2958.1994.tb00302.x; MOORES SL, 1991, J BIOL CHEM, V266, P14603; ITO H, 1983, J BACTERIOL, V153, P163; BOGUSKI MS, 1992, NEW BIOL, V4, P408; CAPLIN BE, 1994, BBA-PROTEIN STRUCT M, V1205, P39, DOI 10.1016/0167-4838(94)90089-2; CHEN WJ, 1991, CELL, V66, P327, DOI 10.1016/0092-8674(91)90622-6; CHEN WJ, 1991, P NATL ACAD SCI USA, V88, P11368, DOI 10.1073/pnas.88.24.11368; CLARKE S, 1992, ANNU REV BIOCHEM, V61, P355; DOLENCE JM, 1995, P NATL ACAD SCI USA, V92, P5008, DOI 10.1073/pnas.92.11.5008; FINEGOLD AA, 1991, P NATL ACAD SCI USA, V88, P4448, DOI 10.1073/pnas.88.10.4448; FUJIMURA K, 1994, J BIOL CHEM, V269, P9205; GOODMAN LE, 1988, YEAST, V4, P271, DOI 10.1002/yea.320040405; HE B, 1991, P NATL ACAD SCI USA, V88, P11373, DOI 10.1073/pnas.88.24.11373; JOHNSON DI, 1991, GENE, V98, P149, DOI 10.1016/0378-1119(91)90119-V; JOHNSON DI, 1990, J CELL BIOL, V111, P143, DOI 10.1083/jcb.111.1.143; KALMAN VK, 1995, J BIOL CHEM, V270, P14835; KINSELLA BT, 1991, P NATL ACAD SCI USA, V88, P8934, DOI 10.1073/pnas.88.20.8934; KOHL NE, 1991, J BIOL CHEM, V266, P18884; MAYER ML, 1992, J BIOL CHEM, V267, P20589; MITSUZAWA H, 1995, P NATL ACAD SCI USA, V92, P1704, DOI 10.1073/pnas.92.5.1704; MOOMAW JF, 1992, J BIOL CHEM, V267, P17438; OHYA Y, 1993, MOL BIOL CELL, V4, P1017; OHYA Y, 1991, J BIOL CHEM, V266, P12356; OHYA Y, 1984, MOL GEN GENET, V193, P389, DOI 10.1007/BF00382073; ORRWEAVER TL, 1983, METHOD ENZYMOL, V101, P228; QUDOTA H, 1992, YEAST, V8, P735; REISS Y, 1991, P NATL ACAD SCI USA, V88, P732, DOI 10.1073/pnas.88.3.732; REISS Y, 1991, J BIOL CHEM, V266, P10672; ROSSI G, 1991, NATURE, V351, P158, DOI 10.1038/351158a0; Sambrook J., 1989, MOL CLONING LAB MANU; SCHAFER WR, 1992, ANNU REV GENET, V26, P209, DOI 10.1146/annurev.ge.26.120192.001233; SEABRA MC, 1993, SCIENCE, V259, P377, DOI 10.1126/science.8380507; TRUEBLOOD CE, 1993, MOL CELL BIOL, V13, P4260; VIEIRA J, 1987, METHOD ENZYMOL, V153, P3; WINSON RMD, 1990, METHODS YEAST GENETI; YOKOYAMA K, 1993, J BIOL CHEM, V268, P4055; YOKOYAMA K, 1995, BIOCHEMISTRY-US, V34, P1344, DOI 10.1021/bi00004a029; YOKOYAMA K, 1991, P NATL ACAD SCI USA, V88, P5302, DOI 10.1073/pnas.88.12.5302; ZHANG FL, 1994, J BIOL CHEM, V269, P3175; ZIMAN M, 1993, MOL BIOL CELL, V4, P1307	51	12	12	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010	0026-8925			MOL GEN GENET	Mol. Gen. Genet.	AUG 27	1996	252	1-2					1	10		10.1007/BF02173199		10	Biochemistry & Molecular Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Genetics & Heredity	VH657	WOS:A1996VH65700001		
J	Arakawa, T; Watabe, H; Nagamune, Y; Arakawa, Y				Arakawa, T; Watabe, H; Nagamune, Y; Arakawa, Y			Fabrication and microscopic photoluminescence imaging of ridge-type InGaAs quantum wires grown on a (110) cleaved plane of AlGaAs/GaAs superlattice	APPLIED PHYSICS LETTERS			English	Article							CHEMICAL-VAPOR-DEPOSITION; SELECTIVE GROWTH; NATIVE-OXIDE; WELL; GAAS; LASERS; EPITAXY; OMCVD	We have fabricated ridge-type InGaAs quantum wire structures on a (110) cleaved plane of AlGaAs/GaAs superlattice using selective metalorganic chemical vapor deposition growth. The lateral width of the quantum wires was about 25 nm. Spatially resolved photoluminescence (PL) of the quantum wires was observed by using microscopic photoluminescence measurement at low temperature, showing PL from the quantum wire region and its polarization dependence. (C) 1996 American Institute of Physics.		Arakawa, T (reprint author), UNIV TOKYO,INST IND SCI,MINATO KU,7-22-1 ROPPONGI,TOKYO 106,JAPAN.			Arakawa, Taro/0000-0001-9474-7399			WEGSCHEIDER W, 1993, PHYS REV LETT, V71, P4071, DOI 10.1103/PhysRevLett.71.4071; TSUKAMOTO S, 1992, J APPL PHYS, V71, P533, DOI 10.1063/1.350695; ARAKAWA T, 1993, JPN J APPL PHYS 2, V32, pL1377; ARAKAWA T, 1994, APPL PHYS LETT, V64, P2200, DOI 10.1063/1.111672; ARAKAWA Y, 1982, APPL PHYS LETT, V40, P939, DOI 10.1063/1.92959; ARAKAWA Y, 1984, APPL PHYS LETT, V45, P950, DOI 10.1063/1.95453; BHAT R, 1988, J CRYST GROWTH, V93, P850, DOI 10.1016/0022-0248(88)90630-6; CHANG YC, 1985, APPL PHYS LETT, V47, P1324, DOI 10.1063/1.96268; FUKUI T, 1990, APPL PHYS LETT, V57, P1209, DOI 10.1063/1.103487; HIRATANI Y, 1990, JPN J APPL PHYS 2, V29, pL1360; JONES SH, 1987, J ELECTROCHEM SOC, V134, P3149, DOI 10.1149/1.2100360; NAGAMUNE Y, 1995, APPL PHYS LETT, V67, P1535, DOI 10.1063/1.114484; NAGAMUNE Y, 1993, J CRYST GROWTH, V126, P707, DOI 10.1016/0022-0248(93)90822-E; NOTOMI M, 1995, JPN J APPL PHYS 1, V34, P1451, DOI 10.1143/JJAP.34.1451; NOTOMI M, 1991, APPL PHYS LETT, V58, P720, DOI 10.1063/1.104526; SOMEYA T, 1995, PHYS REV LETT, V74, P3664, DOI 10.1103/PhysRevLett.74.3664; TSAI CS, 1992, APPL PHYS LETT, V60, P240, DOI 10.1063/1.106976; TSUKAMOTO S, 1993, APPL PHYS LETT, V63, P355, DOI 10.1063/1.110041	18	8	8	AMER INST PHYSICS	WOODBURY	CIRCULATION FULFILLMENT DIV, 500 SUNNYSIDE BLVD, WOODBURY, NY 11797-2999	0003-6951			APPL PHYS LETT	Appl. Phys. Lett.	AUG 26	1996	69	9					1294	1296		10.1063/1.117396		3	Physics, Applied	Physics	VD632	WOS:A1996VD63200040		
J	Sato, K; Shimizu, TM; Yamada, S				Sato, K; Shimizu, TM; Yamada, S			Gravitational collapse of rotating stellar cores and supernovae	NUCLEAR PHYSICS A			English	Article							NEUTRON-STAR MASS; EXPLOSIVE NUCLEOSYNTHESIS; WEAK INTERACTION; RADIATION; 1987A; SPECTROPOLARIMETRY; PROPAGATION; CONVECTION; MECHANISM; BURST	As is well known, massive stars, which would be the progenitor of type II supernovae, are rapid rotators. It is obviously necessary to investigate the effects of rotation on gravitational collapse of stellar cores and supernova explosions. We review (i) rotational core collapse, (ii) jet-like explosion induced by rotation and asymmetric neutrino emission from proto-neutron-stars, and (iii) explosive nucleosynthesis when an asymmetric jet-like explosion occurs, based on our recent work.		Sato, K (reprint author), UNIV TOKYO,SCH SCI,DEPT PHYS,BUNKYO KU,TOKYO 113,JAPAN.						BIONTA RM, 1987, PHYS REV LETT, V58, P1494, DOI 10.1103/PhysRevLett.58.1494; HIRATA K, 1987, PHYS REV LETT, V58, P1490, DOI 10.1103/PhysRevLett.58.1490; WOOSLEY SE, 1986, ANNU REV ASTRON ASTR, V24, P205, DOI 10.1146/annurev.astro.24.1.205; Burrows A, 1996, PHYS REV LETT, V76, P352, DOI 10.1103/PhysRevLett.76.352; TRAMMELL SR, 1993, ASTROPHYS J, V414, pL21, DOI 10.1086/186986; NOMOTO K, 1988, PHYS REP, V163, P13, DOI 10.1016/0370-1573(88)90032-4; SHIMIZU T, 1994, ASTROPHYS J, V432, pL119, DOI 10.1086/187526; MONCHMEYER R, 1991, ASTRON ASTROPHYS, V246, P417; BURROWS A, 1995, ASTROPHYS J, V450, P830, DOI 10.1086/176188; BODENHEIMER P, 1983, ASTROPHYS J, V269, P281, DOI 10.1086/161040; COLGATE SA, 1966, ASTROPHYS J, V143, P626, DOI 10.1086/148549; FINN LS, 1990, ASTROPHYS J, V351, P588, DOI 10.1086/168497; HERANT M, 1994, ASTROPHYS J, V435, P339, DOI 10.1086/174817; YAMADA S, 1991, ASTROPHYS J, V382, P594, DOI 10.1086/170746; LEBLANC JM, 1970, ASTROPHYS J, V161, P541, DOI 10.1086/150558; BAZAN G, 1994, ASTROPHYS J, V433, pL41, DOI 10.1086/187543; BROWN GE, 1994, ASTROPHYS J, V423, P659, DOI 10.1086/173844; CROPPER M, 1988, MON NOT R ASTRON SOC, V231, P695; BETHE HA, 1995, ASTROPHYS J, V445, pL129, DOI 10.1086/187906; BROWN GE, 1988, PHYS REP, V163, P1; FINN LS, 1991, ANN NY ACAD SCI, V156; HASHIMOTO M, 1989, ASTRON ASTROPHYS, V210, pL5; HASHIMTO M, 1992, PROG THEOR PHYS, V94, P663; JANKA HT, 1995, ASTROPHYS J, V448, pL109, DOI 10.1086/309604; KOYAMA K, 1986, PUBL ASTRON SOC JPN, V38, P121; MONCHMEYER R, 1989, TIMING NEUTRON STARS; MULLER E, 1979, ASTRON ASTROPHYS, V80, P147; MULLER E, 1980, ASTRON ASTROPHYS, V81, P288; MULLER E, 1981, ASTRON ASTROPHYS, V103, P358; NAGATAKI S, 1996, IN PRESS AP J; PAPALIOLIOS C, 1989, NATURE, V338, P565, DOI 10.1038/338565a0; SATO K, 1975, PROG THEOR PHYS, V53, P595, DOI 10.1143/PTP.53.595; SATO K, 1975, PROG THEOR PHYS, V54, P1325, DOI 10.1143/PTP.54.1325; SATO K, 1995, NUCL PHYS A, V588, pC345, DOI 10.1016/0375-9474(95)00160-3; SHIMIZU TM, 1995, THESIS U TOKYO; SOFUE Y, 1988, WORKSH PART ASTR KEK; SYMBALISTY E, 1984, ASTROPHYS J, V360, P242; TAKAHARA M, 1992, PROG THEOR PHYS, V68, P795; TASSOUR JL, 1978, THEORY ROTATING STAR; THIELEMANN FK, 1990, ASTROPHYS J, V349, P222, DOI 10.1086/168308; Thorne K. S., 1987, 300 YEARS GRAVITATIO, P330; THORNE KS, 1992, SCIENCE, V256, P325; TOHLINE JE, 1980, SPACE SCI REV, V27, P555; WANG L, 9602155; Wilson J. R., 1985, NUMERICAL ASTROPHYSI, P422; WILSON JR, 1986, ANN NY ACAD SCI, V470, P267, DOI 10.1111/j.1749-6632.1986.tb47980.x; WOOSLEY SE, 1995, ASTROPHYS J SUPPL S, V101, P181, DOI 10.1086/192237; WOOSLEY SE, 1988, PHYS REP, V163, P79, DOI 10.1016/0370-1573(88)90037-3; YAMADA S, 1995, ASTROPHYS J, V450, P245, DOI 10.1086/176135; YAMADA S, 1994, ASTROPHYS J, V434, P268, DOI 10.1086/174724	50	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0375-9474			NUCL PHYS A	Nucl. Phys. A	AUG 26	1996	606	1-2					118	136		10.1016/0375-9474(96)00236-9		19	Physics, Nuclear	Physics	VH279	WOS:A1996VH27900008		
J	Suzuki, K; Ono, T; Kambe, T				Suzuki, K; Ono, T; Kambe, T			Riemannian geometrical analysis of the motion of a vortex filament: A system of C-infinity(S-1, SO(3))	PHYSICAL REVIEW LETTERS			English	Article							DIFFEOMORPHISMS; HIERARCHY; FLUIDS	The motion of an isolated vortex filament with small curvature is governed by the local induction equation. The present work is an attempt to study such an integrable system based on the Riemannian geometry of the solution manifold, by reformulating the governing equation as the geodesic equation on an infinite dimensional Lie group C-infinity(S-1,SO(3)). The sectional curvatures for the vector fields along the geodesic curves and their perturbations are calculated to show their tendency to be positive for some typical filaments such as a straight vortex, a helical vortex, and a vortex soliton.		Suzuki, K (reprint author), UNIV TOKYO,GRAD SCH SCI,DEPT PHYS,BUNKYO KU,TOKYO 113,JAPAN.						ABRAHAM R, 1978, F MECHANICS; MARSDEN J, 1983, PHYSICA D, V7, P305, DOI 10.1016/0167-2789(83)90134-3; ARMS RJ, 1965, PHYS FLUIDS, V8, P553, DOI 10.1063/1.1761268; HASIMOTO H, 1972, J FLUID MECH, V51, P477, DOI 10.1017/S0022112072002307; ARNOLD V, 1966, ANN I FOURIER, V16, P319; RICCA RL, 1991, NATURE, V352, P561, DOI 10.1038/352561a0; Arnold V. I., 1978, MATH METHODS CLASSIC; DOLIWA A, 1995, J MATH PHYS, V36, P1259, DOI 10.1063/1.531119; Faddeev LD, 1980, HAMILTONIAN METHODS; GUILLEMIN V, 1980, ANN PHYS-NEW YORK, V127, P220, DOI 10.1016/0003-4916(80)90155-4; KAMBE T, 1971, J PHYS SOC JPN, V31, P591, DOI 10.1143/JPSJ.31.591; KOBAYASHI S, 1963, F DIFFERENTIAL GEOME; KONOPELCHENKO BG, 1993, PHYS LETT A, V183, P153, DOI 10.1016/0375-9601(93)91162-X; Langer J., 1991, J NONLIN SCI, V1, P71, DOI 10.1007/BF01209148; LEVICIVITA T, 1932, ATTRAZIONE NEWTONIA; Marsden J. E., 1994, INTRO MECH SYMMETRY; MISIOLEK G, 1993, INDIANA U MATH J, V42, P215, DOI 10.1512/iumj.1993.42.42011; MISIOLEK G, IN PRESS CONJUGATE P; NAKAMURA F, 1992, J PHYS A-MATH GEN, V25, pL45, DOI 10.1088/0305-4470/25/2/003; Rios L.S. Da, 1906, REND CIRC MAT PALERM, V22, P117; Saffman P. G., 1992, VORTEX DYNAMICS	21	8	8	AMERICAN PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	0031-9007			PHYS REV LETT	Phys. Rev. Lett.	AUG 26	1996	77	9					1679	1682		10.1103/PhysRevLett.77.1679		4	Physics, Multidisciplinary	Physics	VD430	WOS:A1996VD43000005		
J	Fukuda, Y; Hayakawa, T; Inoue, K; Ishihara, K; Ishino, H; Joukou, S; Kajita, T; Kasuga, S; Koshio, Y; Kumita, T; Matsumoto, K; Nakahata, M; Nakamura, K; Okumura, K; Sakai, A; Shiozawa, M; Suzuki, J; Suzuki, Y; Tomoeda, T; Totsuka, Y; Hirata, KS; Kihara, K; Oyama, Y; Koshiba, M; Nishijima, K; Horiuchi, T; Fujita, K; Hatakeyama, S; Koga, M; Maruyama, T; Suzuki, A; Mori, M; Kajimura, T; Suda, T; Suzuki, AT; Ishizuka, T; Miyano, K; Okazawa, H; Hara, T; Nagashima, Y; Takita, M; Yamaguchi, T; Hayato, Y; Kaneyuki, K; Suzuki, T; Takeuchi, Y; Tanimori, T; Tasaka, S; Ichihara, E; Miyamoto, S; Nishikawa, K				Fukuda, Y; Hayakawa, T; Inoue, K; Ishihara, K; Ishino, H; Joukou, S; Kajita, T; Kasuga, S; Koshio, Y; Kumita, T; Matsumoto, K; Nakahata, M; Nakamura, K; Okumura, K; Sakai, A; Shiozawa, M; Suzuki, J; Suzuki, Y; Tomoeda, T; Totsuka, Y; Hirata, KS; Kihara, K; Oyama, Y; Koshiba, M; Nishijima, K; Horiuchi, T; Fujita, K; Hatakeyama, S; Koga, M; Maruyama, T; Suzuki, A; Mori, M; Kajimura, T; Suda, T; Suzuki, AT; Ishizuka, T; Miyano, K; Okazawa, H; Hara, T; Nagashima, Y; Takita, M; Yamaguchi, T; Hayato, Y; Kaneyuki, K; Suzuki, T; Takeuchi, Y; Tanimori, T; Tasaka, S; Ichihara, E; Miyamoto, S; Nishikawa, K			Solar neutrino data covering solar cycle 22	PHYSICAL REVIEW LETTERS			English	Article							KAMIOKANDE-II DETECTOR; REAL-TIME; MATTER; OSCILLATIONS; B-8	Results from 1036 days of solar neutrino data accumulated in the upgraded Kamiokande detector (Kamiokande III) are presented. The B-8 solar neutrino flux observed in Kamiokande III is 2.82(-0.24)(+0.25)(stat) +/- 0.27(syst) x 10(6) cm(-2) s(-1); the combined flux from Kamiokande II and III (2079 days in total) is 2.80 +/- 0.19 (stat) +/- 0.33 (syst) x 10(6) cm(-2) s(-1), which is 49% to 64% of the standard solar models. These combined data from January 1987 to February 1995, covering an entire period of solar cycle 22, enabled us to study a correlation between the neutrino flux and the solar activity in detail: no strong correlation of the solar neutrino flux with the sunspot numbers was found within experimental errors. The result on a search for the daytime and nighttime flux difference is also reported.	NATL LAB HIGH ENERGY PHYS,KEK,TSUKUBA,IBARAKI 305,JAPAN; TOKAI UNIV,INST RES & DEV,SHIBUYA KU,TOKYO 151,JAPAN; TOKAI UNIV,DEPT PHYS,HIRATSUKA,KANAGAWA 25912,JAPAN; TOHOKU UNIV,GRAD SCH SCI,DEPT PHYS,SENDAI,MIYAGI 98077,JAPAN; MIYAGI UNIV EDUC,DEPT PHYS,SENDAI,MIYAGI 980,JAPAN; KOBE UNIV,DEPT PHYS,KOBE,HYOGO 657,JAPAN; NIIGATA UNIV,NIIGATA 95021,JAPAN; OSAKA UNIV,DEPT PHYS,TOYONAKA,OSAKA 560,JAPAN; TOKYO INST TECHNOL,DEPT PHYS,MEGURO KU,TOKYO 152,JAPAN; GIFU UNIV,DEPT PHYS,GIFU 50111,JAPAN; UNIV TOKYO,INST NUCL STUDY,TANASHI,TOKYO 188,JAPAN	Fukuda, Y (reprint author), UNIV TOKYO,INST COSM RAY RES,TANASHI,TOKYO 188,JAPAN.		Takeuchi, Yasuo/A-4310-2011; Nakamura, Kenzo/F-7174-2010; Suzuki, Yoichiro/F-7542-2010; Ishino, Hirokazu/C-1994-2015; Koshio, Yusuke/C-2847-2015	Ishino, Hirokazu/0000-0002-8623-4080; Koshio, Yusuke/0000-0003-0437-8505			LIM CS, 1988, PHYS REV D, V37, P1368, DOI 10.1103/PhysRevD.37.1368; HIRATA KS, 1990, PHYS REV LETT, V65, P1297, DOI 10.1103/PhysRevLett.65.1297; MIKHEEV SP, 1985, SOV J NUCL PHYS+, V42, P913; ABDURASHITOV JN, 1994, PHYS LETT B, V328, P234, DOI 10.1016/0370-2693(94)90454-5; HIRATA KS, 1991, PHYS REV LETT, V66, P9, DOI 10.1103/PhysRevLett.66.9; WOLFENSTEIN L, 1978, PHYS REV D, V17, P2369, DOI 10.1103/PhysRevD.17.2369; TURCKCHIEZE S, 1993, ASTROPHYS J, V408, P347, DOI 10.1086/172592; AKHMEDOV EK, 1988, PHYS LETT B, V213, P64, DOI 10.1016/0370-2693(88)91048-9; BAHCALL JN, 1995, PHYS REV D, V51, P6146, DOI 10.1103/PhysRevD.51.6146; ANSELMANN P, 1995, PHYS LETT B, V342, P440, DOI 10.1016/0370-2693(94)01586-2; HIRATA KS, 1991, PHYS REV D, V44, P2241, DOI 10.1103/PhysRevD.44.2241; BAHCALL JN, 1992, REV MOD PHYS, V64, P885, DOI 10.1103/RevModPhys.64.885; HIRATA KS, 1992, PHYS REV D, V45, P2170, DOI 10.1103/PhysRevD.45.2170; ANSELMANN P, 1994, PHYS LETT B, V327, P377, DOI 10.1016/0370-2693(94)90744-7; BAHCALL JN, 1986, PHYS REV C, V33, P2121, DOI 10.1103/PhysRevC.33.2121; Cleveland B. T., 1995, Nuclear Physics B, Proceedings Supplements, V38, DOI 10.1016/0920-5632(94)00732-B; DAVIS R, 1994, PROG PART NUCL PHYS, V32, P13, DOI 10.1016/0146-6410(94)90004-3; FUKUDA Y, IN PRESS; INOUE K, 1994, 3289423 ICRR; Okun L., 1986, SOV J NUCL PHYS, V44, P440; TAKEUCHI Y, TITHPE9501	21	711	712	AMERICAN PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	0031-9007			PHYS REV LETT	Phys. Rev. Lett.	AUG 26	1996	77	9					1683	1686		10.1103/PhysRevLett.77.1683		4	Physics, Multidisciplinary	Physics	VD430	WOS:A1996VD43000006		
J	Stadnik, ZM; Purdie, D; Garnier, M; Baer, Y; Tsai, AP; Inoue, A; Edagawa, K; Takeuchi, S				Stadnik, ZM; Purdie, D; Garnier, M; Baer, Y; Tsai, AP; Inoue, A; Edagawa, K; Takeuchi, S			Electronic structure of icosahedral alloys studied by ultrahigh energy resolution photoemission spectroscopy	PHYSICAL REVIEW LETTERS			English	Article							AL-CU-FE; RU QUASI-CRYSTALS; DIFFUSE-SCATTERING; TRANSPORT; APPROXIMANT; BEHAVIOR; STATES; PHASE; AL-27; NMR	The results of a systematic ultrahigh resolution ultraviolet photoemission study of the electronic structure of stable icosahedral alloys Al64Cu24Fe12, Al65Cu20Fe15, Al70Pd20Mn10, and Al70.5Pd21Re8.5 are presented. It is shown that all icosahedral alloys have a clearly developed Fermi edge and are thus metallic down to the temperature of measurement (14-45 K). A marked decrease of the spectral intensity towards the Fermi level in these alloys is demonstrated to be consistent with the existence of the theoretically predicted pseudogap. With an experimental resolution of 6 meV, no evidence of the theoretically predicted spikiness of the density of states could be observed.	UNIV NEUCHATEL,INST PHYS,CH-2000 NEUCHATEL,SWITZERLAND; TOHOKU UNIV,INST MAT RES,SENDAI,MIYAGI 980,JAPAN; UNIV TOKYO,INST SOLID STATE PHYS,MINATO KU,TOKYO 106,JAPAN	Stadnik, ZM (reprint author), UNIV OTTAWA,DEPT PHYS,OTTAWA,ON K1N 6N5,CANADA.		Inoue, Akihisa/E-5271-2015				AKIYAMA H, 1993, JPN J APPL PHYS 2, V32, pL1003; SHASTRI A, 1994, PHYS REV B, V50, P15651, DOI 10.1103/PhysRevB.50.15651; BIGGS BD, 1990, PHYS REV LETT, V65, P2700, DOI 10.1103/PhysRevLett.65.2700; PIERCE FS, 1993, SCIENCE, V261, P737, DOI 10.1126/science.261.5122.737; BERGER C, 1993, SOLID STATE COMMUN, V87, P977, DOI 10.1016/0038-1098(93)90543-V; CHAPUIS G, 1995, APERIODIC 94; DELAISSARDIERE GT, 1994, PHYS REV B, V50, P5999, DOI 10.1103/PhysRevB.50.5999; DiVincenzo D P, 1991, QUASICRYSTALS STATE; Fujiwara T., 1990, QUASICRYSTALS; FUJIWARA T, 1993, PHYS REV LETT, V71, P4166, DOI 10.1103/PhysRevLett.71.4166; GRIONI M, 1995, J LOW TEMP PHYS, V99, P195, DOI 10.1007/BF00752287; HONDA Y, 1994, JPN J APPL PHYS 1, V33, P4929, DOI 10.1143/JJAP.33.4929; HRADIL K, 1995, PHIL MAG LETT, V71, P199, DOI 10.1080/09500839508241282; Janot C., 1994, QUASICRYSTALS PRIMER; KRAJCI M, 1995, PHYS REV B, V51, P17355, DOI 10.1103/PhysRevB.51.17355; LEVINE LE, 1995, PHIL MAG LETT, V71, P213, DOI 10.1080/09500839508241284; MORI M, 1991, J PHYS-CONDENS MAT, V3, P767, DOI 10.1088/0953-8984/3/6/013; PIERCE FS, 1994, PHYS REV LETT, V73, P2220, DOI 10.1103/PhysRevLett.73.2220; POON SJ, 1992, ADV PHYS, V41, P303, DOI 10.1080/00018739200101513; SHASTRI A, 1994, PHYS REV B, V50, P4224, DOI 10.1103/PhysRevB.50.4224; SHASTRI A, 1995, PHYS REV B, V52, P12681, DOI 10.1103/PhysRevB.52.12681; STADNIK ZM, MOSSBAUER SPECTROSCO, V2, P125; STADNIK ZM, 1993, PHYS REV B, V47, P100, DOI 10.1103/PhysRevB.47.100; STADNIK ZM, IN PRESS; STADNIK ZM, 1995, PHYS REV B, V51, P4023, DOI 10.1103/PhysRevB.51.4023; TAKEUCHI S, 1994, MATER SCI FORUM, V150, P35; TAMURA R, 1994, PHYS REV B, V50, P9640, DOI 10.1103/PhysRevB.50.9640; VERNIER N, 1993, EUROPHYS LETT, V22, P187, DOI 10.1209/0295-5075/22/3/005; WU X, 1995, PHYS REV LETT, V75, P4540, DOI 10.1103/PhysRevLett.75.4540; ZHANG GW, 1994, PHYS REV B, V50, P6696, DOI 10.1103/PhysRevB.50.6696	30	72	73	AMERICAN PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	0031-9007			PHYS REV LETT	Phys. Rev. Lett.	AUG 26	1996	77	9					1777	1780		10.1103/PhysRevLett.77.1777		4	Physics, Multidisciplinary	Physics	VD430	WOS:A1996VD43000030		
J	Yasuda, K; Shindo, M; Koga, K				Yasuda, K; Shindo, M; Koga, K			Enantioselective Michael reaction of ketone lithium enolates using a chiral amine ligand	TETRAHEDRON LETTERS			English	Article							ALPHA-CYANO CARBOXYLATES; ADDITIONS; COMPLEXES; CATALYST; AMIDES; ENONE	The enantioselective Michael reaction of ketone lithium enolates using a chiral amine ligand (1) was studied. Michael adducts (4) of up to 94% ee were obtained by the reaction between methyl ketones (2) and Michael accepters (3) having a benzylidene group. Copyright (C) 1996 Elsevier Science Ltd	UNIV TOKYO,FAC PHARMACEUT SCI,BUNKYO KU,TOKYO 113,JAPAN							SASAI H, 1995, J AM CHEM SOC, V117, P6194, DOI 10.1021/ja00128a005; SASAI H, 1994, J AM CHEM SOC, V116, P1571, DOI 10.1021/ja00083a053; IMAI M, 1994, J AM CHEM SOC, V116, P8829, DOI 10.1021/ja00098a061; Arai T, 1996, ANGEW CHEM INT EDIT, V35, P104, DOI 10.1002/anie.199601041; HAYASHI Y, 1991, B CHEM SOC JPN, V64, P2122, DOI 10.1246/bcsj.64.2122; BERNARDI A, 1995, TETRAHEDRON LETT, V36, P1363, DOI 10.1016/0040-4039(94)02478-T; BOTTEGHI C, 1991, J MOL CATAL, V66, P7, DOI 10.1016/0304-5102(91)85016-U; CRAM DJ, 1981, J CHEM SOC CHEM COMM, P625, DOI 10.1039/c39810000625; DESIMONI G, 1995, TETRAHEDRON, V51, P4131, DOI 10.1016/0040-4020(95)00130-Z; ENDERS D, 1987, CHEM BER-RECL, V120, P1731, DOI 10.1002/cber.19871201019; JUARISTI E, 1993, SYNTHESIS-STUTTGART, P1271; KAWARA A, 1994, TETRAHEDRON LETT, V35, P8805, DOI 10.1016/S0040-4039(00)78503-0; KUMAMOTO T, 1994, TETRAHEDRON-ASYMMETR, V5, P1431, DOI 10.1016/0957-4166(94)80103-7; LABADIE JW, 1983, J ORG CHEM, V48, P4634, DOI 10.1021/jo00172a038; MURAKATA M, 1990, J CHEM SOC CHEM COMM, P1657, DOI 10.1039/c39900001657; Noyori R., 1994, ASYMMETRIC CATALYSIS; Ojima I., 1993, CATALYTIC ASYMMETRIC; SAWAMURA M, 1994, TETRAHEDRON, V50, P4439, DOI 10.1016/S0040-4020(01)89377-7; SAWAMURA M, 1992, J AM CHEM SOC, V114, P8295, DOI 10.1021/ja00047a053; Schuster P, 1964, MH CHEM, V95, P53, DOI 10.1007/BF00909251; SHIRAI R, 1994, CHEM PHARM BULL, V42, P690; TOMIOKA K, 1986, TETRAHEDRON LETT, V27, P4611, DOI 10.1016/S0040-4039(00)85018-2; YAMAGUCHI M, 1994, TETRAHEDRON LETT, V35, P8233, DOI 10.1016/0040-4039(94)88290-8; YAMAGUCHI M, 1993, ANGEW CHEM INT EDIT, V32, P1176, DOI 10.1002/anie.199311761; YURA T, 1988, CHEM LETT, P1021, DOI 10.1246/cl.1988.1021	25	42	42	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB	0040-4039			TETRAHEDRON LETT	Tetrahedron Lett.	AUG 26	1996	37	35					6343	6346		10.1016/0040-4039(96)01367-6		4	Chemistry, Organic	Chemistry	VD891	WOS:A1996VD89100030		
J	Hayakawa, Y; Yamamoto, H; Tsuge, N; Seto, H				Hayakawa, Y; Yamamoto, H; Tsuge, N; Seto, H			Structure of a new microbial metabolite, neuchromenin	TETRAHEDRON LETTERS			English	Article							CHROMONES	The structure of a new microbial metabolite, neuchromenin, was elucidated to be as shown in Fig. 1 by NMR spectral analysis including a variety of two-dimensional techniques. Neuchromenin was found to possess a novel pyranochromene skeleton. Copyright (C) 1996 Elsevier Science Ltd		Hayakawa, Y (reprint author), UNIV TOKYO,INST MOL & CELLULAR BIOSCI,BUNKYO KU,TOKYO 113,JAPAN.						HURD RE, 1991, J MAGN RESON, V91, P648, DOI 10.1016/0022-2364(91)90395-A; BARDE YA, 1989, NEURON, V2, P1525, DOI 10.1016/0896-6273(89)90040-8; BITTNER M, 1988, PHYTOCHEMISTRY, V27, P3263, DOI 10.1016/0031-9422(88)80039-6; BOHLMANN F, 1977, PHYTOCHEMISTRY, V16, P1261, DOI 10.1016/S0031-9422(00)94370-X; Hirao T, 1995, J ANTIBIOT, V48, P1494	5	6	6	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB	0040-4039			TETRAHEDRON LETT	Tetrahedron Lett.	AUG 26	1996	37	35					6363	6364		10.1016/0040-4039(96)01372-X		2	Chemistry, Organic	Chemistry	VD891	WOS:A1996VD89100035		
J	Hashimoto, K; Akutsu, Y; Arai, M; Tamura, M				Hashimoto, K; Akutsu, Y; Arai, M; Tamura, M			Chemical kinetics of cetane number improving agents	ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY			English	Meeting Abstract									UNIV TOKYO,SCH ENGN,DEPT CHEM SYST ENGN,TOKYO,JAPAN								0	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036	0065-7727			ABSTR PAP AM CHEM S	Abstr. Pap. Am. Chem. Soc.	AUG 25	1996	212		1				21	FUEL				1	Chemistry, Multidisciplinary	Chemistry	VA915	WOS:A1996VA91501832		
J	Isobe, H; Tokuyama, H; Sawamura, M; Nakamura, E				Isobe, H; Tokuyama, H; Sawamura, M; Nakamura, E			Regio- and diastereocontrolled double cycloaddition to C-60 with new tris-annulating reagents	ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY			English	Meeting Abstract									UNIV TOKYO,DEPT CHEM,BUNKYO KU,TOKYO 113,JAPAN								0	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036	0065-7727			ABSTR PAP AM CHEM S	Abstr. Pap. Am. Chem. Soc.	AUG 25	1996	212		2				57	ORGN				1	Chemistry, Multidisciplinary	Chemistry	VB009	WOS:A1996VB00900057		
J	Fujita, K; Murata, K; Iwaoka, M; Tomoda, S				Fujita, K; Murata, K; Iwaoka, M; Tomoda, S			Asymmetric oxyselenenylation of olefins using an optically active diaryl diselenide derived from D-mannitol	ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY			English	Meeting Abstract									NATL INST MAT & CHEM RES,TSUKUBA,IBARAKI 305,JAPAN; UNIV TOKYO,GRAD SCH ARTS & SCI,DEPT LIFE & ENVIRONM SCI,TOKYO 153,JAPAN								0	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036	0065-7727			ABSTR PAP AM CHEM S	Abstr. Pap. Am. Chem. Soc.	AUG 25	1996	212		2				58	ORGN				1	Chemistry, Multidisciplinary	Chemistry	VB009	WOS:A1996VB00900058		
J	Shibusawa, Y				Shibusawa, Y			Purification of lactate dehydrogenase from bovine heart crude extract by countercurrent chromatography.	ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY			English	Meeting Abstract									UNIV TOKYO,SCH PHARM,DEPT ANALYT CHEM,HACHIOJI,TOKYO 19203,JAPAN; NHLBI,BIOPHYS CHEM LAB,NIH,BETHESDA,MD 20892								0	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036	0065-7727			ABSTR PAP AM CHEM S	Abstr. Pap. Am. Chem. Soc.	AUG 25	1996	212		1				64	ANYL				1	Chemistry, Multidisciplinary	Chemistry	VA915	WOS:A1996VA91500309		
J	Uryu, T; Katsuraya, K; Nakashima, H				Uryu, T; Katsuraya, K; Nakashima, H			Synthesis and structures of highly anti-HIV active oligosaccharide derivatives.	ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY			English	Meeting Abstract									UNIV TOKYO,INST IND SCI,MINATO KU,TOKYO 106,JAPAN; YAMANASHI MED UNIV,DEPT MICROBIOL,YAMANASHI 40938,JAPAN								0	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036	0065-7727			ABSTR PAP AM CHEM S	Abstr. Pap. Am. Chem. Soc.	AUG 25	1996	212		1				101	CELL				1	Chemistry, Multidisciplinary	Chemistry	VA915	WOS:A1996VA91500648		
J	Komiyama, M				Komiyama, M			Organic and inorganic synergisms for the efficient hydrolysis of DNA and RNA.	ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY			English	Meeting Abstract									UNIV TOKYO,GRAD SCH ENGN,DEPT CHEM & BIOTECHNOL,TOKYO 113,JAPAN							1992, NUCLEIC ACIDS S SER, V27, P33; 1995, J BIOCH, V118, P665	2	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036	0065-7727			ABSTR PAP AM CHEM S	Abstr. Pap. Am. Chem. Soc.	AUG 25	1996	212		1				240	INOR				1	Chemistry, Multidisciplinary	Chemistry	VA915	WOS:A1996VA91502361		
J	Yashiro, M; Ishikubo, A; Komiyama, M				Yashiro, M; Ishikubo, A; Komiyama, M			RNA hydrolysis by dinuclear Zn(II) and La(III) complexes as promising active centers of artificial ribonucleases.	ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY			English	Meeting Abstract									UNIV TOKYO,DEPT CHEM & BIOTECHNOL,TOKYO 113,JAPAN								0	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036	0065-7727			ABSTR PAP AM CHEM S	Abstr. Pap. Am. Chem. Soc.	AUG 25	1996	212		1				303	INOR				1	Chemistry, Multidisciplinary	Chemistry	VA915	WOS:A1996VA91502424		
J	Iwaoka, M; Tomoda, S				Iwaoka, M; Tomoda, S			Intramolecular Se center dot center dot center dot N nonbonded interaction of 2-selenobenzylamine derivatives.	ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY			English	Meeting Abstract									UNIV TOKYO,GRAD SCH ARTS & SCI,DEPT CHEM,MEGURO KU,TOKYO 153,JAPAN								0	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036	0065-7727			ABSTR PAP AM CHEM S	Abstr. Pap. Am. Chem. Soc.	AUG 25	1996	212		2				334	ORGN				1	Chemistry, Multidisciplinary	Chemistry	VB009	WOS:A1996VB00900333		
J	Sawamoto, K; Okabe, M; Tanimura, T; Mikoshiba, K; Nishida, Y; Okano, H				Sawamoto, K; Okabe, M; Tanimura, T; Mikoshiba, K; Nishida, Y; Okano, H			The Drosophila secreted protein argos regulates signal transduction in the Ras/MAPK pathway	DEVELOPMENTAL BIOLOGY			English	Article							RECEPTOR TYROSINE KINASE; GUANINE-NUCLEOTIDE EXCHANGE; CELL FATE DECISIONS; EGF RECEPTOR; PATTERN-FORMATION; PHOTORECEPTOR DETERMINATION; FUNCTIONS DOWNSTREAM; GENETIC MOSAICS; AXON GUIDANCE; GIANT-LENS	The Drosophila argos gene encodes a secreted protein with an EGF motif which acts as an inhibitor of cellular differentiation in multiple developmental processes. To investigate the cellular pathways regulated by Argos, we screened for mutations which could modify the phenotype caused by overexpression of argos. We show that the effects of argos overexpression on the eye and wing vein development are suppressed by gain-of-function mutations of the MAPKK/D-MEK gene (Dsor1/D-mek) and the MAPK/ERK-A gene (rolled) and were enhanced by loss-of-function mutations of Star. Loss-of-function mutations in components of the Ras/MAPK signaling cascade act as dominant suppressors of the phenotype caused by the argos null mutation. A loss-of-function argos mutation enhanced the overproduction of R7 neurons caused by gain-of-function alleles of Son of sevenless and Dsor1. Conversely, overexpression of argos inhibited formation of the extra R7 cells that was caused by high-level MAPK/ERK-A activity. A phenotype of the sev; argos double mutants revealed that sev is epistatic to argos. These results provide evidence that Argos negatively regulates signal transduction events in the Ras/MAPK cascade. (C) 1996 Academic Press, Inc.	UNIV TSUKUBA,INST BASIC MED SCI,DEPT MOL NEUROBIOL,TSUKUBA,IBARAKI 305,JAPAN; UNIV TOKYO,INST MED SCI,DEPT MOL NEUROBIOL,MINATO KU,TOKYO 108,JAPAN; UNIV TSUKUBA,CTR TARA,TSUKUBA,IBARAKI 305,JAPAN; JIKEI UNIV,SCH MED,DEPT MICROBIOL,MINATO KU,TOKYO 105,JAPAN; KYUSHU UNIV,FAC SCI,DEPT BIOL,FUKUOKA 810,JAPAN; INST PHYS & CHEM RES,MOL NEUROBIOL LAB,TSUKUBA LIFE SCI CTR,TSUKUBA,IBARAKI 305,JAPAN; EXPLORATORY RES ADV TECHNOL,MIKOSHIBA CALCIOSIGNAL NET PROJECT,MEGURO KU,TOKYO 153,JAPAN; NAGOYA UNIV,SCH SCI,DEPT BIOL,NAGOYA,AICHI 464,JAPAN			Okano, Hideyuki/J-5973-2013; 	Sawamoto, Kazunobu/0000-0003-1984-5129			AMBROSIO L, 1989, NATURE, V342, P288, DOI 10.1038/342288a0; SCHWEITZER R, 1995, GENE DEV, V9, P1518, DOI 10.1101/gad.9.12.1518; STURTEVANT MA, 1993, GENE DEV, V7, P961, DOI 10.1101/gad.7.6.961; XU T, 1993, DEVELOPMENT, V117, P1223; SPRENGER F, 1989, NATURE, V338, P478, DOI 10.1038/338478a0; SCHWEITZER R, 1995, NATURE, V376, P699, DOI 10.1038/376699a0; FREEMAN M, 1994, DEVELOPMENT, V120, P2297; BIGGS WH, 1994, EMBO J, V13, P1628; REBAY I, 1991, CELL, V67, P687, DOI 10.1016/0092-8674(91)90064-6; SAWAMOTO K, 1994, DEV BIOL, V164, P267, DOI 10.1006/dbio.1994.1197; SCHUPBACH T, 1987, CELL, V49, P699, DOI 10.1016/0092-8674(87)90546-0; TOMLINSON A, 1986, SCIENCE, V231, P400, DOI 10.1126/science.231.4736.400; FEHON RG, 1990, CELL, V61, P523, DOI 10.1016/0092-8674(90)90534-L; SIMON MA, 1991, CELL, V67, P701, DOI 10.1016/0092-8674(91)90065-7; FREEMAN M, 1992, CELL, V69, P963, DOI 10.1016/0092-8674(92)90615-J; DIAZBENJUMEA FJ, 1994, DEVELOPMENT, V120, P569; DIAZBENJUMEA FJ, 1990, P ROY SOC B-BIOL SCI, V242, P36, DOI 10.1098/rspb.1990.0100; FORTINI ME, 1992, NATURE, V355, P559, DOI 10.1038/355559a0; BAKER NE, 1989, NATURE, V340, P150, DOI 10.1038/340150a0; BAKER NE, 1992, DEV BIOL, V150, P381, DOI 10.1016/0012-1606(92)90250-K; BANERJEE U, 1987, CELL, V49, P281, DOI 10.1016/0092-8674(87)90569-1; BASLER K, 1988, CELL, V54, P299; BASLER K, 1991, CELL, V64, P1069, DOI 10.1016/0092-8674(91)90262-W; BEGEMANN G, 1995, DEVELOPMENT, V121, P225; BIGGS WH, 1992, P NATL ACAD SCI USA, V89, P6295; BOWTELL DDL, 1988, GENE DEV, V2, P620, DOI 10.1101/gad.2.6.620; BRUNNER A, 1994, MECH DEVELOP, V48, P175, DOI 10.1016/0925-4773(94)90058-2; BRUNNER D, 1994, CELL, V76, P875, DOI 10.1016/0092-8674(94)90362-X; COCHET C, 1984, J BIOL CHEM, V259, P2553; CULLEN PJ, 1995, NATURE, V376, P527, DOI 10.1038/376527a0; DICKSON B, 1992, NATURE, V360, P600, DOI 10.1038/360600a0; Dickson Barry, 1993, P1327; Dickson Barry, 1994, Current Opinion in Genetics and Development, V4, P64, DOI 10.1016/0959-437X(94)90092-2; DOYLE HJ, 1993, GENE DEV, V7, P633, DOI 10.1101/gad.7.4.633; FREEMAN M, 1994, MECH DEVELOP, V48, P25, DOI 10.1016/0925-4773(94)90003-5; GAUL U, 1992, CELL, V68, P1007, DOI 10.1016/0092-8674(92)90073-L; HAFEN E, 1987, SCIENCE, V236, P55, DOI 10.1126/science.2882603; HEBERLEIN U, 1993, DEV BIOL, V160, P51, DOI 10.1006/dbio.1993.1285; HEITZLER P, 1991, CELL, V64, P1083, DOI 10.1016/0092-8674(91)90263-X; HOU XS, 1995, CELL, V81, P63, DOI 10.1016/0092-8674(95)90371-2; HSU JC, 1994, GENE DEV, V8, P2176, DOI 10.1101/gad.8.18.2176; KLINGLER M, 1988, NATURE, V335, P275, DOI 10.1038/335275a0; KOLODKIN AL, 1994, DEVELOPMENT, V120, P1731; KRETZSCHMAR D, 1992, EMBO J, V11, P2531; LU XY, 1994, EMBO J, V13, P2592; NISHIDA Y, 1988, EMBO J, V7, P775; Okabe M, 1996, DEV BIOL, V175, P37, DOI 10.1006/dbio.1996.0093; OKANO H, 1992, DIFFERENTIATION, V52, P1, DOI 10.1111/j.1432-0436.1992.tb00494.x; OLIVIER JP, 1993, CELL, V73, P179, DOI 10.1016/0092-8674(93)90170-U; ROGGE RD, 1991, CELL, V64, P39, DOI 10.1016/0092-8674(91)90207-F; Sawamoto K, 1996, DEV DYNAM, V205, P162; SIMON MA, 1993, CELL, V73, P169, DOI 10.1016/0092-8674(93)90169-Q; TIO M, 1994, MECH DEVELOP, V48, P13, DOI 10.1016/0925-4773(94)90002-7; TSUDA L, 1993, CELL, V72, P407, DOI 10.1016/0092-8674(93)90117-9; WEMMER T, 1995, GENETICS, V140, P629	55	20	20	ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495	0012-1606			DEV BIOL	Dev. Biol.	AUG 25	1996	178	1					13	22		10.1006/dbio.1996.0194		10	Developmental Biology	Developmental Biology	VE622	WOS:A1996VE62200002		
J	Okada, K; TakanoOhmuro, H; Obinata, T; Abe, H				Okada, K; TakanoOhmuro, H; Obinata, T; Abe, H			Dephosphorylation of cofilin in polymorphonuclear leukocytes derived from peripheral blood	EXPERIMENTAL CELL RESEARCH			English	Article							ACTIN DEPOLYMERIZING FACTOR; GTP-BINDING PROTEIN; OKADAIC ACID; F-ACTIN; PHOSPHATIDYLINOSITOL 3-KINASE; PHOSPHOINOSITIDE 3-KINASE; HUMAN-NEUTROPHILS; KINASE-C; ACTIVATION; CALCIUM	We show that human and porcine polymorphonuclear leukocytes express significant amounts of cofilin, a low-molecular-weight actin regulatory protein, as well as profilin. Fifty percent of the cofilin in the resting state was phosphorylated and dephosphorylation occurred after activation by fMLP or TPA. The time course of the dephosphorylation induced by fMLP was very rapid, ending within 1 min, while TPA induced relatively gradual dephosphorylation over a period of 10 min. Surprisingly, okadaic acid and calyculin A, potent inhibitors specific for phosphatase, both induced dephosphorylation of cofilin. This suggests that type 1 alone or both type 1 and 2A phosphatases are involved in the maintenance of the level of phosphorylation of cofilin in resting cells. The dephosphorylation of cofilin was barely detected by in vitro phosphatase assays, which can distinguish activities of types 1, 2B, and 2C. This indicates that cofilin is not dephosphorylated by conventional phosphatases. Although the dephosphorylation of cofilin was observed in cells treated with the calcium ionophore A23187, the phosphorylation level of cofilin was restored when the cells were further incubated in the presence of EGTA. Reactivation of these cells with TPA resulted in the dephosphorylation of cofilin; fMLP activation did not lead to dephosphorylation. Furthermore, a submicromolar concentration of wortmannin, which is an inhibitor specific for phosphatidylinositol 3-kinase, completely inhibited dephosphorylation of cofilin induced by fMLP, but did not suppress TPA-induced dephosphorylation. Thus, we conclude that the dephosphorylation of cofilin is differently regulated depending on either fMLP or TPA activation. (C) 1996 Academic Press, Inc.	CHIBA UNIV,DEPT BIOL,INAGE KU,CHIBA 263,JAPAN; UNIV TOKYO,FAC MED,DEPT PHARMACOL,BUNKYO KU,TOKYO 113,JAPAN							AGNEW BJ, 1995, J BIOL CHEM, V270, P17582; SHAAFI RI, 1988, PROG ALLERGY, V42, P1; OFARRELL PZ, 1977, CELL, V12, P1133, DOI 10.1016/0092-8674(77)90176-3; SUZUKI K, 1995, J BIOL CHEM, V270, P19551; ABE H, 1989, J BIOCHEM-TOKYO, V106, P696; ARCARO A, 1993, BIOCHEM J, V296, P297; DOWNEY GP, 1992, J CELL BIOL, V116, P695, DOI 10.1083/jcb.116.3.695; LOWRY OH, 1990, ANNU REV BIOCHEM, V59, P1; SAFER D, 1992, J MUSCLE RES CELL M, V13, P269, DOI 10.1007/BF01766454; ZHENG Y, 1994, J BIOL CHEM, V269, P18727; MAJUMDAR S, 1991, J BIOL CHEM, V266, P9285; SOUTHWICK FS, 1990, J CELL BIOL, V110, P1965, DOI 10.1083/jcb.110.6.1965; Moriyama K, 1996, GENES CELLS, V1, P73, DOI 10.1046/j.1365-2443.1996.05005.x; DAVIDSON MML, 1994, BIOCHEM J, V301, P41; BAMBURG JR, 1987, J CELL BIOL, V105, P2817, DOI 10.1083/jcb.105.6.2817; HANNAPPEL E, 1987, J CHROMATOGR, V397, P279, DOI 10.1016/S0021-9673(01)85010-X; BAORTO DM, 1992, J CELL BIOL, V117, P357, DOI 10.1083/jcb.117.2.357; BIALOJAN C, 1988, BIOCHEM J, V256, P283; BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77; CASSIMERIS L, 1992, J CELL BIOL, V119, P1261, DOI 10.1083/jcb.119.5.1261; DELLABIANCA V, 1986, BIOCHEM BIOPH RES CO, V135, P556; DOWNEY GP, 1990, J CELL BIOL, V110, P1975, DOI 10.1083/jcb.110.6.1975; DOWNEY GP, 1993, J CELL PHYSIOL, V155, P505, DOI 10.1002/jcp.1041550309; FECHHEIMER M, 1983, CELL MOTIL CYTOSKEL, V3, P349; HAWKINS M, 1993, BIOCHEMISTRY-US, V32, P9985, DOI 10.1021/bi00089a014; HAYDEN SM, 1993, BIOCHEMISTRY-US, V32, P9994, DOI 10.1021/bi00089a015; HOWARD T, 1990, J CELL BIOL, V110, P1983, DOI 10.1083/jcb.110.6.1983; ISHIHARA H, 1989, BIOCHEM BIOPH RES CO, V159, P871, DOI 10.1016/0006-291X(89)92189-X; KOTANI K, 1995, BIOCHEM BIOPH RES CO, V208, P985, DOI 10.1006/bbrc.1995.1431; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LU DJ, 1992, AM J PHYSIOL, V262, pC39; MORGAN TE, 1993, J CELL BIOL, V122, P623, DOI 10.1083/jcb.122.3.623; NACHMIAS V T, 1991, Journal of Cell Biology, V115, p374A; NAGAOKA R, 1996, IN PRESS J MUSCLE RE; NOBES CD, 1995, J CELL SCI, V108, P225; OHTA Y, 1989, J BIOL CHEM, V264, P16143; OKADA T, 1994, J BIOL CHEM, V269, P3563; SAITO T, 1994, EXP CELL RES, V212, P49, DOI 10.1006/excr.1994.1117; SAMSTAG Y, 1994, P NATL ACAD SCI USA, V91, P4494, DOI 10.1073/pnas.91.10.4494; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WATTS RG, 1992, CELL MOTIL CYTOSKEL, V21, P25, DOI 10.1002/cm.970210104; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; WHITE JR, 1983, J BIOL CHEM, V258, P4041; YONEZAWA N, 1985, J BIOL CHEM, V260, P4410; YONEZAWA N, 1987, CELL STRUCT FUNCT, V12, P443; ZHANG J, 1993, J BIOL CHEM, V268, P22251	46	59	59	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4827			EXP CELL RES	Exp. Cell Res.	AUG 25	1996	227	1					116	122		10.1006/excr.1996.0256		7	Oncology; Cell Biology	Oncology; Cell Biology	VF741	WOS:A1996VF74100014		
J	Akishita, M; Ouchi, Y; Miyoshi, H; Orimo, A; Kozaki, K; Eto, M; Ishikawa, M; Kim, S; Toba, K; Orimo, H				Akishita, M; Ouchi, Y; Miyoshi, H; Orimo, A; Kozaki, K; Eto, M; Ishikawa, M; Kim, S; Toba, K; Orimo, H			Estrogen inhibits endothelin-1 production and c-fos gene expression in rat aorta	ATHEROSCLEROSIS			English	Article						estrogen; endothelin; c-fos; atherosclerosis; smooth muscle cell	VASCULAR SMOOTH-MUSCLE; CORONARY-ARTERY; POSTMENOPAUSAL WOMEN; CELL-PROLIFERATION; FOLLOW-UP; RECEPTOR; PLASMA; ESTRADIOL; ATHEROSCLEROSIS; MYC	In order to clarify the mechanism underlying the preventive effect of estrogen on atherogenesis, we investigated the role of estrogen in the regulation of endothelin-1 (ET-1) production and c-Sos mRNA expression, which may contribute to atherogenesis. Plasma ET-1 concentration in ovariectomized rats (OVX) was twice as high as that in sham-operated female rats (Sham). Estradiol replacement in OVX rats (OVX + E) decreased plasma ET-1 to the level in Sham (Sham, 0.68 +/- 0.14; OVX, 1.32 +/- 0.14; OVX + E, 0.85 +/- 0.12 pg/ml). Metabolic clearance rate of ET-1 was similar in these three groups of rats, suggesting that the difference in plasma ET-1 was due to production rather than degradation. Measurement of immunoreactive ET-1 in tissue extract and immunohistochemical examination showed that expression of ET-1 in the aortic smooth muscle cells of OVX was increased. The expression of c-fos mRNA in the aorta was also increased in OVX compared with Sham and OVX + E. Intravenous infusion of ET-1 to Sham induced c-fos expression in the aorta, suggesting the contribution of ET-1 to c-fos expression. Tissue culture study revealed that DNA synthesis was increased in the aorta and femoral artery of OVX. These results suggest that inhibition of ET-1 and c-fos expression is involved in the anti-atherogenic action of estrogen.	UNIV TOKYO,FAC MED,DEPT GERIATR,BUNKYO KU,TOKYO 113,JAPAN							ADAMS MR, 1989, TRANSPLANT P, V21, P3662; JIANG CW, 1991, BRIT J PHARMACOL, V104, P1033; KARAS RH, 1994, CIRCULATION, V89, P1943; MATSUMOTO H, 1989, BIOCHEM BIOPH RES CO, V164, P74, DOI 10.1016/0006-291X(89)91684-7; POLDERMAN KH, 1993, ANN INTERN MED, V118, P429; ALBERTS GF, 1994, J BIOL CHEM, V269, P10112; COLDITZ GA, 1987, NEW ENGL J MED, V316, P1105, DOI 10.1056/NEJM198704303161801; GIBBS FP, 1981, ENDOCRINOLOGY, V109, P1796; MIYAUCHI T, 1992, AM HEART J, V123, P1092, DOI 10.1016/0002-8703(92)90734-D; COLBURN P, 1978, SCIENCE, V201, P817, DOI 10.1126/science.684408; ORIMO A, 1993, BIOCHEM BIOPH RES CO, V195, P730, DOI 10.1006/bbrc.1993.2106; URBAN RJ, 1991, J CLIN ENDOCR METAB, V73, P818; WALSH BW, 1991, NEW ENGL J MED, V325, P1196, DOI 10.1056/NEJM199110243251702; GREEN S, 1988, TRENDS GENET, V4, P309, DOI 10.1016/0168-9525(88)90108-4; SEILLAN C, 1983, PROSTAGLANDINS, V26, P3, DOI 10.1016/0090-6980(83)90069-2; LERMAN A, 1991, NEW ENGL J MED, V325, P997, DOI 10.1056/NEJM199110033251404; OUCHI Y, 1987, HYPERTENSION, V9, P172; WEISZ A, 1990, NUCLEIC ACIDS RES, V18, P5097, DOI 10.1093/nar/18.17.5097; BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; BUSH TL, 1987, CIRCULATION, V75, P1102; CHANG WC, 1980, BIOCHIM BIOPHYS ACTA, V619, P107; CHENG LP, 1991, TRANSPLANTATION, V52, P967, DOI 10.1097/00007890-199112000-00006; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CURRAN T, 1985, CANCER SURV, V4, P655; DILLEY RJ, 1987, ATHEROSCLEROSIS, V63, P99, DOI 10.1016/0021-9150(87)90109-2; DOUGLAS SA, 1994, CIRC RES, V75, P190; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; HAMAOKI M, 1990, HYBRIDOMA, V9, P63, DOI 10.1089/hyb.1990.9.63; HAN SZ, 1995, CIRC RES, V77, P673; HAN SZ, 1995, CIRCULATION, V91, P2619; HIRATA Y, 1989, ATHEROSCLEROSIS, V78, P225, DOI 10.1016/0021-9150(89)90227-X; IMAI T, 1992, HYPERTENSION, V19, P753; INOUE A, 1989, J BIOL CHEM, V264, P14956; INOUE S, 1993, ARTERIOSCLER THROMB, V13, P1859; KACZMAREK L, 1989, EXP CELL RES, V183, P24, DOI 10.1016/0014-4827(89)90415-1; KANNEL WB, 1976, ANN INTERN MED, V85, P47; KOMURO I, 1988, FEBS LETT, V238, P249, DOI 10.1016/0014-5793(88)80489-7; KUSHWAHA RS, 1981, METABOLISM, V30, P359, DOI 10.1016/0026-0495(81)90116-5; LOBO RA, 1991, J CLIN ENDOCR METAB, V73, P925; MIYAUCHI T, 1989, LANCET, V2, P53; NAKAO J, 1981, ATHEROSCLEROSIS, V38, P75, DOI 10.1016/0021-9150(81)90105-2; REIS SE, 1994, CIRCULATION, V89, P52; ROSSELLI M, 1995, HYPERTENSION, V25, P848; STAMPFER MJ, 1991, NEW ENGL J MED, V325, P756, DOI 10.1056/NEJM199109123251102; SUZUKI N, 1989, J IMMUNOL METHODS, V118, P245, DOI 10.1016/0022-1759(89)90012-4; VANBUREN G, 1992, AM J OBSTET GYNECOL, V16, P828; VARGAS R, 1993, BRIT J PHARMACOL, V109, P612; WEISZ A, 1988, MOL ENDOCRINOL, V2, P816; WILLIAMS JK, 1990, CIRCULATION, V81, P1680; WINKLES JA, 1993, BIOCHEM BIOPH RES CO, V191, P1081, DOI 10.1006/bbrc.1993.1327; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0	51	39	38	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	0021-9150			ATHEROSCLEROSIS	Atherosclerosis	AUG 23	1996	125	1					27	38		10.1016/0021-9150(96)05836-4		12	Peripheral Vascular Disease	Cardiovascular System & Cardiology	UZ298	WOS:A1996UZ29800003		
J	Nishiyama, M; Kinoshita, M; Kudo, H; Horinouchi, S; Tanokura, M				Nishiyama, M; Kinoshita, M; Kudo, H; Horinouchi, S; Tanokura, M			Enhancement of the turnover number of thermostable malate dehydrogenase by deleting hydrogen bonds around the catalytic site	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article							THERMOPHILE THERMUS-FLAVUS; NEUTRAL PROTEASE; CLONING; MUTAGENESIS; VECTORS; GENE	In malate dehydrogenase from Thermus flavus, substitution of lie for Thr189, which is involved in hydrogen-bond network around a loop containing catalytic His186, caused an increase in the turnover number at room temperatures. Ln order to examine the effect of disruption of the hydrogen bonds on the catalytic activity, residues participating in the network were replaced by others which cannot form hydrogen bond by site-directed mutagenesis. All the mutations caused increases in the turnover number at room temperatures. This result suggests that an increase in flexibility introduced around catalytic site enhanced the catalytic activity of the malate dehydrogenase. (C) 1996 Academic Press. Inc.	UNIV TOKYO,DEPT BIOTECHNOL,BUNKYO KU,TOKYO 113,JAPAN	Nishiyama, M (reprint author), UNIV TOKYO,BIOTECHNOL RES CTR,BUNKYO KU,YAYOI 1-1-1,TOKYO 113,JAPAN.			Kudo, Hiromi/0000-0003-4313-7165			YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; VRIEND G, 1991, PROTEIN ENG, V4, P941, DOI 10.1093/protein/4.8.941; MESSING J, 1983, METHOD ENZYMOL, V101, P20; KELLY CA, 1993, BIOCHEMISTRY-US, V32, P3913, DOI 10.1021/bi00066a010; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Cleland W W, 1979, Methods Enzymol, V63, P103; EIJSINK VGH, 1992, PROTEIN ENG, V5, P165; FERSHT AR, 1974, PROC R SOC SER B-BIO, V187, P397, DOI 10.1098/rspb.1974.0084; IIJIMA S, 1980, BIOCHIM BIOPHYS ACTA, V613, P1, DOI 10.1016/0005-2744(80)90185-0; IIJIMA S, 1986, AGR BIOL CHEM TOKYO, V50, P589; IMANAKA T, 1986, NATURE, V324, P695, DOI 10.1038/324695a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; NISHIYAMA M, 1986, J BIOL CHEM, V261, P14178; NISHIYAMA M, 1993, J BIOL CHEM, V268, P4656; NISHIYAMA M, 1991, J BIOL CHEM, V266, P14294	17	6	7	ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495	0006-291X			BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	AUG 23	1996	225	3					844	848		10.1006/bbrc.1996.1261		5	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	VE458	WOS:A1996VE45800025		
J	Nakagawa, H; Nihonmatsu, N; Ohta, S; Hirobe, M				Nakagawa, H; Nihonmatsu, N; Ohta, S; Hirobe, M			Effects of new endogenous nonprotein amino acids, 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid derivatives, on behavior of mice	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article							GUINEA-PIG ILEUM; RAT-BRAIN; MOUSE-BRAIN; TETRAHYDROISOQUINOLINE; 1-METHYL-1,2,3,4-TETRAHYDROISOQUINOLINE; 1-METHYL-TETRAHYDROISOQUINOLINE; CATECHOLAMINES; SALSOLINOL	Several 1,2,3,4-tetrahydroisoquinoline-3-carboxyl acids were synthesized and found to have a transiently increasing effect on the locomotor activity of mice after peripheral injection. Three of the active compounds were detected in the brain after intraperitoneal administration. Two of them, the 7-hydroxy and 7-hydroxy-6-methoxy derivatives, were found as endogenous compounds in untreated rat brain and may play a physiological role. The effects of some of these compounds on the level of various endogenous amines, amino acids and metabolites were examined. (C) 1996 Academic Press. Inc.	UNIV TOKYO,FAC PHARMACEUT SCI,TOKYO 113,JAPAN; UNIV TOKYO,FAC MED,TOKYO 113,JAPAN							KOTAKE Y, 1995, J NEUROCHEM, V65, P2633; GIOVINE A, 1976, PHARMACOLOGY, V14, P86, DOI 10.1159/000136583; CHRISTENSEN HN, 1990, PHYSIOL REV, V70, P43; BLUM K, 1987, BIOGENIC AMINES, V4, P259; COLLINS MA, 1983, J NEUROCHEM, V41, P1569, DOI 10.1111/j.1471-4159.1983.tb00866.x; DALY SA, 1993, PSYCHOPHARMACOLOGY, V113, P45, DOI 10.1007/BF02244332; GIBSON CJ, 1982, PSYCHOPHARMACOLOGY, V76, P118, DOI 10.1007/BF00435264; Hall CS, 1934, J COMP PSYCHOL, V17, P89, DOI 10.1037/h0073676; HAMILTON MG, 1979, LIFE SCI, V25, P2205, DOI 10.1016/0024-3205(79)90093-6; KOHNO M, 1986, BIOCHEM BIOPH RES CO, V140, P448, DOI 10.1016/0006-291X(86)91111-3; LEFAUCONNIER JM, 1992, HDB EXPT PHARM, V103, P117; LIPTROT J, 1993, J NEUROCHEM, V61, P2199, DOI 10.1111/j.1471-4159.1993.tb07460.x; LUCCHI L, 1981, BRAIN RES, V232, P506; MAKINO Y, 1990, BIOMED ENVIRON MASS, V19, P415, DOI 10.1002/bms.1200190706; MARSHALL A, 1977, EXPERIENTIA, V33, P754, DOI 10.1007/BF01944172; MCCRODDEN J M, 1988, Pharmacological Research Communications, V20, P113, DOI 10.1016/S0031-6989(88)80565-4; MICZEK KA, 1994, NEUROSCI BIOBEHAV R, V18, P97, DOI 10.1016/0149-7634(94)90040-X; Misu Y, 1995, Adv Pharmacol, V32, P427, DOI 10.1016/S1054-3589(08)61019-4; MIYAKE A, 1984, Journal of Takeda Research Laboratories, V43, P53; NIWA T, 1987, BIOCHEM BIOPH RES CO, V144, P1084, DOI 10.1016/S0006-291X(87)80075-X; NORTH RA, 1981, EUR J PHARMACOL, V71, P489, DOI 10.1016/0014-2999(81)90194-1; OHTA S, 1987, BIOMED RES-TOKYO, V8, P453; ORIGITANO TC, 1984, J CHROMATOGR, V311, P17, DOI 10.1016/S0378-4347(00)84687-3; TASAKI Y, 1991, J NEUROCHEM, V57, P1940, DOI 10.1111/j.1471-4159.1991.tb06407.x	24	14	14	ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495	0006-291X			BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	AUG 23	1996	225	3					1027	1034		10.1006/bbrc.1996.1289		8	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	VE458	WOS:A1996VE45800053		
J	Carrillo, MC; Kitani, K; Kanai, S; Sato, Y; Ivy, GO; Miyasaka, K				Carrillo, MC; Kitani, K; Kanai, S; Sato, Y; Ivy, GO; Miyasaka, K			Long term treatment with (-)deprenyl reduces the optimal dose as well as the effective dose range for increasing antioxidant enzyme activities in old mouse brain	LIFE SCIENCES			English	Article						(-)deprenyl; superoxide dismutase; catalase; long term treatment; substantia nigra; striatum; brain	SUPEROXIDE-DISMUTASE; LIFE-SPAN; MALE-RATS; GLUTATHIONE-PEROXIDASE; CATALASE; STRIATUM; REGIONS; INHIBITION; PROLONGS; SURVIVAL	C57BL mice of the male sex received different doses of (-)deprenyl (0.25, 0.5, 1.0 mg/kg per injection 3 times a week, s.c.) for 3 months beginning at the age of 26 months. At the age of 29 months, animals were sacrificed and superoxide dismutase (SOD) and catalase (CAT) activities were examined in several brain regions. The dose of 0.5 mg/kg (3 times a week) was most effective in increasing SOD and CAT activities in S. nigra, striatum and cerebral cortex but not in hippocampus or cerebellum. The dose of 0.25 mg/kg was also effective in increasing enzyme activities, but the effect was much lower than the dose of 0.5 mg/kg. The magnitudes of increase in enzyme activities with the dose of 0.5 mg/kg, however, were generally much lower than respective values we previously found in animals treated with (-)deprenyl for only 3 weeks. The highest dose of 1.0 mg/kg had negligible effect. Enzyme activities in all groups of animals that were examined 2 weeks after the last (-)deprenyl dose were practically the same as respective control values. Together with the results from our previous study with short term (-)deprenyl treatment in old mice, these results replicate our previous findings in old female rats. We showed that longer term treatment with (-)deprenyl reduces the optimal dose for increasing antioxidant enzyme activities by a factor of 5 to 10. The present study further indicates that longer term treatment with (-)deprenyl also reduces the effective dose range of (-)deprenyl as well as the magnitude of increase of enzyme activities. If the effect of (-)deprenyl for increasing these antioxidant enzyme activities in selective brain regions is causally related to its effect of increasing average life expectancies of animals, the selection of a proper dose of the drug may be a critical factor for life span studies in which the drug is administered for more than one year.	UNIV TOKYO,FAC MED,RADIOISOTOPE RES INST,BUNKYO KU,TOKYO 113,JAPAN; TOKYO METROPOLITAN INST GERONTOL,DEPT CLIN PHYSIOL,ITABASHI KU,TOKYO 173,JAPAN; NATL INST LONGEV SCI,MORIOKA,AICHI 474,JAPAN; UNIV TORONTO,DIV LIFE SCI,SCARBOROUGH,ON M1C 1A4,CANADA							INGRAM DK, 1993, NEUROBIOL AGING, V14, P431, DOI 10.1016/0197-4580(93)90101-G; ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730; BEERS RF, 1952, J BIOL CHEM, V195, P133; ELSTNER EF, 1976, ANAL BIOCHEM, V70, P616, DOI 10.1016/0003-2697(76)90488-7; TETRUD JW, 1989, SCIENCE, V245, P519, DOI 10.1126/science.2502843; CARRILLO MC, 1994, LIFE SCI, V54, P1483, DOI 10.1016/0024-3205(94)90015-9; CARRILLO MC, 1991, LIFE SCI, V48, P517, DOI 10.1016/0024-3205(91)90466-O; CARRILLO MC, 1994, BIOCHEM PHARMACOL, V47, P1333, DOI 10.1016/0006-2952(94)90331-X; CARRILLO MC, 1992, EXP NEUROL, V116, P286, DOI 10.1016/0014-4886(92)90008-E; CARRILLO MC, 1994, LIFE SCI, V54, P975, DOI 10.1016/0024-3205(94)00499-4; COHEN G, 1984, EUR J PHARMACOL, V106, P209, DOI 10.1016/0014-2999(84)90700-3; KITANI K, 1994, ANN NY ACAD SCI, V717, P60, DOI 10.1111/j.1749-6632.1994.tb12073.x; KITANI K, 1993, LIFE SCI, V52, P281, DOI 10.1016/0024-3205(93)90219-S; KITANI K, 1988, LIFE CHEM REPORTS, V6, P143; KITANI K, 1993, 15 C INT ASS GER, P164; KNOLL J, 1965, ARCH INT PHARMACOD T, V155, P154; KNOLL J, 1988, MECH AGEING DEV, V46, P237, DOI 10.1016/0047-6374(88)90128-5; MILGRAM NW, 1990, LIFE SCI, V47, P415, DOI 10.1016/0024-3205(90)90299-7; PIANTANELLI L, 1994, ANN NY ACAD SCI, V717, P72, DOI 10.1111/j.1749-6632.1994.tb12074.x; SALO PT, 1992, J NEUROSCI RES, V31, P394, DOI 10.1002/jnr.490310223; STROLIN BM, 1980, J NEUROCHEM, V35, P957; VISUETE ML, 1993, NEUROSCI LETT, V152, P113; WU RM, 1993, EUR J PHARMACOL, V243, P241; YOSHIDA T, 1987, XENOBIOTICA, V8, P957; 1989, NEW ENGL J MED, V321, P1364; 1993, NEW ENGL J MED, V328, P176	26	14	14	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB	0024-3205			LIFE SCI	Life Sci.	AUG 23	1996	59	13					1047	1057		10.1016/0024-3205(96)00420-1		11	Medicine, Research & Experimental; Pharmacology & Pharmacy	Research & Experimental Medicine; Pharmacology & Pharmacy	VD718	WOS:A1996VD71800005		
J	Kanemaru, K; Iwatsubo, T; Ihara, Y				Kanemaru, K; Iwatsubo, T; Ihara, Y			Comparable amyloid beta-protein (A beta) 42(43) and A beta 40 deposition in the aged monkey brain	NEUROSCIENCE LETTERS			English	Article						amyloid beta-protein; aged monkey brain; Alzheimer's disease	ALZHEIMERS-DISEASE; SENILE PLAQUES	Two distinct species of amyloid beta-protein (A beta), A beta 42(43) and A beta 40, are deposited in the brains of patients with Alzheimer's disease and normal aged individuals. A beta 42(43), the long tailed A beta, is the initially and predominantly deposited species in senile plaques. Deposition of A beta is also observed in the aged monkey brains. We investigated the A beta species in the aged monkey brains immunocytochemically using monoclonal antibodies that discriminate between the C-termini of A beta 42(43) and A beta 40. We report here that A beta 40 as well as A beta 42(43) deposit in various types of senile plaques, including diffuse plaques of the aged monkey brain and that the ratio of A beta 40 to A beta 42(43) is higher compared with that in human brain.	UNIV TOKYO,FAC PHARMACEUT SCI,DEPT NEUROPATHOL & NEUROSCI,TOKYO 113,JAPAN; UNIV TOKYO,INST BRAIN RES,DEPT NEUROPATHOL,TOKYO,JAPAN	Kanemaru, K (reprint author), TOKYO METROPOLITAN GERIATR HOSP,DEPT NEUROL,ITABASHI KU,35-2 SAKAE CHO,TOKYO 173,JAPAN.						IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; MORI H, 1992, J BIOL CHEM, V267, P17082; ROHER AE, 1993, J BIOL CHEM, V268, P3072; MA JY, 1994, NATURE, V372, P92, DOI 10.1038/372092a0; SELKOE DJ, 1987, SCIENCE, V235, P873, DOI 10.1126/science.3544219; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; Fukumoto H, 1996, AM J PATHOL, V148, P259; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Gearing M, 1996, ANN NEUROL, V39, P395, DOI 10.1002/ana.410390320; IHARA Y, 1988, BRAIN RES, V459, P138, DOI 10.1016/0006-8993(88)90293-4; JOACHIM CL, 1988, BRAIN RES, V474, P100, DOI 10.1016/0006-8993(88)90673-7; KANEMARU K, 1990, AM J PATHOL, V137, P677; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; KITAMOTO T, 1987, LAB INVEST, V57, P230; Nakamura S, 1995, NEUROSCI LETT, V201, P151, DOI 10.1016/0304-3940(95)12160-9; PODURI A, 1994, AM J PATHOL, V144, P1183; SUENAGA T, 1990, ACTA NEUROPATHOL, V80, P280	18	14	14	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	0304-3940			NEUROSCI LETT	Neurosci. Lett.	AUG 23	1996	214	2-3					196	198		10.1016/0304-3940(96)12893-7		3	Neurosciences	Neurosciences & Neurology	VF281	WOS:A1996VF28100031		
J	Komura, S; Seto, H; Takeda, T; Nagao, M; Ito, YJ; Imai, M				Komura, S; Seto, H; Takeda, T; Nagao, M; Ito, YJ; Imai, M			Structural evolution and microscopic interactions in a three-component amphiphilic microemulsion system	JOURNAL OF CHEMICAL PHYSICS			English	Article							ANGLE NEUTRON-SCATTERING; SPINODAL DECOMPOSITION; BICONTINUOUS MICROEMULSIONS; PHASE-EQUILIBRIA; STATISTICAL THERMODYNAMICS; MICRO-EMULSIONS; LATTICE MODEL; BINARY FLUIDS; POLYMER; REGION	Structures and interaction parameters of a three-component amphiphilic microemulsion system consisting of n-decane, water, and an amphiphile AOT (sodium-di-2-ethylhexylsulfosuccinate) have been studied by means of small angle neutron scattering. The scattering curves are fitted with Teubuer and Strey's formula, from which three structural parameters are extracted; the average periodic distance D between the oil and water, the structural correlation length xi, and the area a(H) per amphiphile molecule. The same data are further examined in terms of Gompper and Schick's formula, from which three interaction parameters are obtained; the strength of segregation J/T among the oil and water, the amphiphilicity L/T of the amphiphile toward the oil and water, and the critical surfactant volume fraction phi(s)(c). These interaction parameters have right order of magnitudes and their implications to structural evolution are discussed. (C) 1996 American Institute of Physics.	UNIV TOKYO, INST SOLID STATE PHYS, MINATO KU, TOKYO 106, JAPAN	Komura, S (reprint author), HIROSHIMA UNIV, FAC INTEGRATED ARTS & SCI, HIGASHIHIROSHIMA 739, JAPAN.						ANDELMAN D, 1987, J CHEM PHYS, V87, P7229, DOI 10.1063/1.453367; WIDOM B, 1965, J CHEM PHYS, V43, P3898, DOI 10.1063/1.1696618; TALMON Y, 1982, J CHEM PHYS, V76, P1535, DOI 10.1063/1.443113; TALMON Y, 1978, J CHEM PHYS, V69, P2984, DOI 10.1063/1.437016; CHEN SH, 1991, J PHYS CHEM-US, V95, P7427, DOI 10.1021/j100172a058; CHEN SH, 1990, J CHEM PHYS, V93, P1907, DOI 10.1063/1.459068; TEUBNER M, 1987, J CHEM PHYS, V87, P3195, DOI 10.1063/1.453006; SCHUBERT KV, 1994, J CHEM PHYS, V101, P5343, DOI 10.1063/1.467387; SCHUBERT KV, 1991, J CHEM PHYS, V95, P8532, DOI 10.1063/1.461282; AUVRAY L, 1984, J PHYS-PARIS, V45, P913, DOI 10.1051/jphys:01984004505091300; KOGA T, 1991, PHYS REV A, V44, pR817, DOI 10.1103/PhysRevA.44.R817; BATES FS, 1989, J CHEM PHYS, V91, P3258, DOI 10.1063/1.456901; CHEN SH, 1990, PROG COLL POL SCI S, V81, P30; CHEN SH, 1991, J APPL CRYSTALLOGR, V24, P721, DOI 10.1107/S0021889891001462; DEGIORGIO V, 1985, PHYSICS AMPHIPHILES; Gelbart WM, 1994, MICELLES MEMBRANES M; Gompper G., 1994, PHASE TRANSITIONS CR, V16; GOMPPER G, 1990, PHYS REV LETT, V65, P1116, DOI 10.1103/PhysRevLett.65.1116; GOMPPER G, 1989, PHYS REV LETT, V62, P1647, DOI 10.1103/PhysRevLett.62.1647; GOMPPER G, 1990, PHYS REV B, V41, P9148, DOI 10.1103/PhysRevB.41.9148; HASHIMOTO T, 1991, J APPL CRYSTALLOGR, V24, P457, DOI 10.1107/S0021889891000444; ITO Y, 1995, PHYSICA B, V213, P889, DOI 10.1016/0921-4526(95)00314-Y; JOUFFROY J, 1982, J PHYS-PARIS, V43, P1241, DOI 10.1051/jphys:019820043080124100; KAWAKATSU T, 1995, J CHEM PHYS, V102, P2247, DOI 10.1063/1.468745; KOGA T, 1993, PHYSICA A, V198, P473, DOI 10.1016/0378-4371(93)90235-V; KOTLARCHYK M, 1984, PHYS REV A, V29, P2054, DOI 10.1103/PhysRevA.29.2054; KOTLARCHYK M, 1984, PHYS REV LETT, V53, P941, DOI 10.1103/PhysRevLett.53.941; KUWAHARA N, 1993, PHYS REV E, V47, P1132, DOI 10.1103/PhysRevE.47.1132; LIPOWSKY R, 1992, STRUCTURE CONFORMATI; MAGID L, 1988, J APPL CRYSTALLOGR, V21, P832, DOI 10.1107/S0021889888004674; MEUNIER J, 1987, PHYSICS AMPHIPHILIC; MILNER ST, 1988, J PHYS-PARIS, V49, P1065, DOI 10.1051/jphys:019880049060106500; OHTA T, 1989, SPRINGER SERIES CHEM, V51, P51; Stauffer D., 1985, INTRO PERCOLATION TH; Tartaglia P., 1992, STRUCTURE DYNAMICS S	35	15	15	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	0021-9606			J CHEM PHYS	J. Chem. Phys.	AUG 22	1996	105	8					3264	3277		10.1063/1.471842		14	Physics, Atomic, Molecular & Chemical	Physics	VC506	WOS:A1996VC50600034		
J	Tazaki, K; Doi, J				Tazaki, K; Doi, J			Effective atomic charge model for solvent and ion screening effect in iterative calculation and application to Monte Carlo simulation	JOURNAL OF PHYSICAL CHEMISTRY			English	Article							POISSON-BOLTZMANN EQUATION; ELECTROSTATIC INTERACTIONS; DYNAMICS SIMULATIONS; ALANINE DIPEPTIDE; PROTEIN; ENERGY; COMPUTATION; MOLECULES; SURFACE; SYSTEM	We developed a new method to apply the continuum model to iterative simulations of an ionic solution. This method is composed of two steps. For the first step, the Poisson-Boltzmann equation is solved to obtain the electrostatic potential. For the second step, the ''effective'' atomic charge at each atomic center is calculated to approximate the electrostatic potential. This method enables avoidance of solving the Poisson-Boltzmann equation in every conformational change step. The solvation free energy is calculated to within 4% compared to the FDPB method. The calculated conformational preference of the alanine dipeptide is in good agreement with the experimental results. The computational time for the MC simulation of the alanine dipeptide is reduced one-5000th as compared to the result of the simulation with FDPB calculation in every one MC step. The method will be helpful in analyzing the solvent and ion screening effect of proteins and nucleic acids.		Tazaki, K (reprint author), UNIV TOKYO,DEPT BIOTECHNOL,DOI LAB,BUNKYO KU,1-1-1 YAYOI,TOKYO 113,JAPAN.						HOLST M, 1994, PROTEINS, V18, P231, DOI 10.1002/prot.340180304; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; YOON BJ, 1992, J PHYS CHEM-US, V96, P3130, DOI 10.1021/j100186a064; GILSON MK, 1988, PROTEINS, V4, P7, DOI 10.1002/prot.340040104; SHARP KA, 1990, ANNU REV BIOPHYS BIO, V19, P301, DOI 10.1146/annurev.bb.19.060190.001505; JUFFER AH, 1991, J COMPUT PHYS, V97, P144, DOI 10.1016/0021-9991(91)90043-K; BEGLOV D, 1994, J CHEM PHYS, V100, P9050, DOI 10.1063/1.466711; NICHOLLS A, 1991, J COMPUT CHEM, V12, P435, DOI 10.1002/jcc.540120405; BROOKS CL, 1993, CHEM REV, V93, P2487, DOI 10.1021/cr00023a008; DAVIS ME, 1991, J COMPUT CHEM, P12; GILSON MK, 1993, J PHYS CHEM-US, V97, P3591, DOI 10.1021/j100116a025; GILSON MK, 1995, J COMPUT CHEM, V16, P1081, DOI 10.1002/jcc.540160904; GOULD IR, 1993, J CHEM SOC CHEM COMM, V951, P952; KNELLER GR, 1992, J CHEM PHYS, P97; LUTTY BA, 1992, J COMPUT CHEM, V13, P768; MADISON V, 1980, J AM CHEM SOC, V102, P4855, DOI 10.1021/ja00535a001; MARLOW GE, 1993, CHEM REV, V93, P2503, DOI 10.1021/cr00023a009; NAKAMURA H, 1987, J PHYS SOC JPN, V56, P1609, DOI 10.1143/JPSJ.56.1609; NIEDERMEIER C, 1992, MOL SIMULAT, V8, P361, DOI 10.1080/08927029208022491; ROGERS NK, 1984, J MOL BIOL, V174, P527, DOI 10.1016/0022-2836(84)90334-6; SCHMIDT AB, 1994, MOL SIMULAT, V13, P347, DOI 10.1080/08927029408021998; SHARP K, 1991, J COMPUT CHEM, V12, P454, DOI 10.1002/jcc.540120407; SMITH PE, 1993, J PHYS CHEM-US, V97, P6907, DOI 10.1021/j100128a027	23	8	8	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036	0022-3654			J PHYS CHEM-US	J. Phys. Chem.	AUG 22	1996	100	34					14520	14525		10.1021/jp9536312		6	Chemistry, Physical	Chemistry	VD991	WOS:A1996VD99100035		
J	Matsuda, T				Matsuda, T			Gaugino condensation in the early universe	PHYSICS LETTERS B			English	Article							4D SUPERSTRING MODELS; SUPERSYMMETRY BREAKING; DUALITY; UNIFICATION; COUPLINGS	We examine the process of formation of the gaugino condensation within a Nambu-Jona-Lasinio type approach. We construct an effective Lagrangian description for the gaugino condensation which include a Weyl compensator superfield whose vacuum expectation value is related to the gaugino condensation.		Matsuda, T (reprint author), UNIV TOKYO,DEPT PHYS,BUNKYO KU,TOKYO 113,JAPAN.						FONT A, 1990, PHYS LETT B, V245, P401, DOI 10.1016/0370-2693(90)90665-S; KOUNNAS C, 1987, PHYS LETT B, V191, P91, DOI 10.1016/0370-2693(87)91327-X; KAPLUNOVSKY V, 1994, NUCL PHYS B, V422, P57, DOI 10.1016/0550-3213(94)00150-2; FERRARA S, 1983, PHYS LETT B, V125, P457, DOI 10.1016/0370-2693(83)91325-4; DERENDINGER JP, 1985, PHYS LETT B, V155, P65, DOI 10.1016/0370-2693(85)91033-0; NILLES HP, 1990, PHYS LETT B, V248, P268, DOI 10.1016/0370-2693(90)90290-M; DINE M, 1985, PHYS LETT B, V156, P55, DOI 10.1016/0370-2693(85)91354-1; BINETURY P, 1991, NUCL PHYS B, V358, P194; DECARLOS B, 1993, NUCL PHYS B, V399, P623, DOI 10.1016/0550-3213(93)90512-N; DELAMACORRA A, 1993, NUCL PHYS B, V404, P321, DOI 10.1016/0550-3213(93)90482-5; DELAMACORRA A, 1994, PHYS LETT B, V325, P85, DOI 10.1016/0370-2693(94)90076-0; DELAMACORRA A, 1995, NUCL PHYS B, V443, P127, DOI 10.1016/0550-3213(95)00039-U; FERRARA S, 1990, PHYS LETT B, V245, P243; GOLDBERG H, 1995, PHYS LETT B, V357, P588, DOI 10.1016/0370-2693(95)00873-J	14	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0370-2693			PHYS LETT B	Phys. Lett. B	AUG 22	1996	383	1					28	30		10.1016/0370-2693(96)00715-0		3	Astronomy & Astrophysics; Physics, Nuclear; Physics, Particles & Fields	Astronomy & Astrophysics; Physics	VC384	WOS:A1996VC38400006		
J	Kitazawa, N; Yanagida, T				Kitazawa, N; Yanagida, T			A viable one-family technicolor model	PHYSICS LETTERS B			English	Article							ELECTROWEAK RADIATIVE-CORRECTIONS; PARAMETER-S; MASSES	We construct a one-family technicolor model which is consistent with the precision experiments on the electroweak interaction. The Majorana mass of the right-handed techni-neutrino is introduced and the techni-U(1)(B-L) symmetry is gauged to obtain the correct breaking of the electroweak symmetry. The tree-level kinetic mixing between the techni-U(1)(B-L) and U(1)(y) gauge bosons plays an important role for having the consistent value of the S parameter.	UNIV TOKYO,DEPT PHYS,BUNKYO KU,TOKYO 113,JAPAN; UNIV CALIF SANTA BARBARA,INST THEORET PHYS,SANTA BARBARA,CA 93106	Kitazawa, N (reprint author), TOKYO METROPOLITAN UNIV,DEPT PHYS,HACHIOJI,TOKYO 19203,JAPAN.		Yanagida, Tsutomu/A-4394-2011				KENNEDY DC, 1989, NUCL PHYS B, V322, P1, DOI 10.1016/0550-3213(89)90483-5; HOLDOM B, 1985, PHYS LETT B, V150, P301, DOI 10.1016/0370-2693(85)91015-9; APPELQUIST T, 1993, PHYS LETT B, V315, P139, DOI 10.1016/0370-2693(93)90171-D; YAMAWAKI K, 1986, PHYS REV LETT, V56, P1335, DOI 10.1103/PhysRevLett.56.1335; APPELQUIST T, 1987, PHYS REV D, V35, P774, DOI 10.1103/PhysRevD.35.774; APPELQUIST T, 1992, PHYS LETT B, V278, P345, DOI 10.1016/0370-2693(92)90204-H; PESKIN ME, 1992, PHYS REV D, V46, P381, DOI 10.1103/PhysRevD.46.381; GOLDEN M, 1991, NUCL PHYS B, V361, P3, DOI 10.1016/0550-3213(91)90614-4; HAGIWARA K, 1995, PHYS REV D, V52, P5374, DOI 10.1103/PhysRevD.52.5374; HOLDOM B, 1990, PHYS LETT B, V247, P88, DOI 10.1016/0370-2693(90)91054-F; AKIBA T, 1986, PHYS LETT B, V169, P432, DOI 10.1016/0370-2693(86)90385-0; SUNDRUM R, 1993, NUCL PHYS B, V391, P127, DOI 10.1016/0550-3213(93)90144-E; LUTY MA, 1993, PHYS REV LETT, V70, P529, DOI 10.1103/PhysRevLett.70.529; GATES E, 1991, PHYS REV LETT, V67, P1840, DOI 10.1103/PhysRevLett.67.1840; PESKIN ME, 1990, PHYS REV LETT, V65, P964, DOI 10.1103/PhysRevLett.65.964; EVANS NJ, 1994, NUCL PHYS B, V417, P151, DOI 10.1016/0550-3213(94)90541-X; EVANS NJ, 1993, PHYS LETT B, V303, P295, DOI 10.1016/0370-2693(93)91435-P; HOLDOM B, 1991, PHYS LETT B, V259, P329, DOI 10.1016/0370-2693(91)90836-F; KITAZAWA N, 1995, TMUPHEL9509; MATSUMOTO S, 1995, MOD PHYS LETT A, V10, P2553, DOI 10.1142/S0217732395002696; WU GH, 1995, PHYS REV LETT, V74, P4137, DOI 10.1103/PhysRevLett.74.4137; YSOHIKAWA T, 1996, PHYS LETT B, V368, P209	22	3	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0370-2693			PHYS LETT B	Phys. Lett. B	AUG 22	1996	383	1					78	86		10.1016/0370-2693(96)00705-8		9	Astronomy & Astrophysics; Physics, Nuclear; Physics, Particles & Fields	Astronomy & Astrophysics; Physics	VC384	WOS:A1996VC38400013		
J	Suzuki, T; Hazeki, O; Hazeki, K; Ui, M; Katada, T				Suzuki, T; Hazeki, O; Hazeki, K; Ui, M; Katada, T			Involvement of the beta gamma subunits of inhibitory GTP-binding protein in chemoattractant receptor-mediated potentiation of cyclic AMP formation in guinea pig neutrophils	BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH			English	Article						adenylyl cyclase; G-protein; neutrophil; signal transduction	ENDOGENOUSLY PRODUCED ADENOSINE; ADENYLATE-CYCLASE RESPONSE; CHEMOTACTIC PEPTIDE; RAT-BRAIN; PHOSPHOLIPASE-C; STIMULATION; FORSKOLIN; CALMODULIN; PURIFICATION; EXPRESSION	Cellular cyclic AMP formation in response to prostaglandin (PG) E-1 was markedly potentiated by the chemoattractant formyl-Met-Leu-Phe (fMLP) in guinea pig neutrophils. This potentiation by fMLP was abolished by prior treatment of the cells with pertussis toxin, but not by the prevention of an fMLP-induced intracellular Ca2+ increase in the cells, indicating the direct involvement of the inhibitory GTP-binding protein (G(i)), but not Ca2+, in the fMLP-induced potentiation of cyclic AMP formation, Cyclic AMP formation-in the neutrophils was also unique in response to forskolin; the diterpene inhibited cyclic AMP formation stimulated by PGE(1) plus fMLP at low concentrations, but it slightly stimulated the basal and fMLP-induced cyclic AMP formation at high concentrations. Such a forskolin-induced inhibition was also observed in the adenylyl cyclase of the cell membranes and detergent extract therefrom only when the cyclase was activated by GTP or its nonhydrolyzable analogue (GTP gamma S). The forskolin-inhibitable activity could be affinity-purified from the GTP gamma S-treated cell membranes with a forskolin-agarose column. The cyclase appeared to be purified as a complex with the GTP gamma S-bound alpha subunit of the stimulatory GTP-binding protein (G(s) alpha), but not with the beta gamma subunits, as judged from immunoblot analysis with specific antisera. The GTP gamma S-bound G(s) alpha-stimulated cyclase activity was further enhanced by beta gamma, and this enhancement was again inhibited by forskolin. These results suggest that the GTP-bound G(s) alpha produced by PGE(1) receptor stimulation and the beta gamma subunits released from G(i) by fMLP receptor stimulation were acting synergistically in the cyclic AMP formation of intact neutrophils.	UNIV TOKYO, FAC PHARMACEUT SCI, DEPT PHYSIOL CHEM, BUNKYO KU, TOKYO 113, JAPAN; INST PHYS & CHEM RES, UI LAB, WAKO, SAITAMA 35101, JAPAN							STEPHENS L, 1994, CELL, V77, P83, DOI 10.1016/0092-8674(94)90237-2; HIGASHIJIMA T, 1990, J BIOL CHEM, V265, P14176; CALI JJ, 1994, J BIOL CHEM, V269, P12190; BOKOCH GM, 1984, J BIOL CHEM, V259, P3560; IANNONE MA, 1989, J BIOL CHEM, V264, P20177; HUDSON TH, 1983, J BIOL CHEM, V258, P9755; SALOMON Y, 1974, ANAL BIOCHEM, V58, P541, DOI 10.1016/0003-2697(74)90222-X; ARAD H, 1984, P NATL ACAD SCI-BIOL, V81, P6579, DOI 10.1073/pnas.81.21.6579; BOKOCH GM, 1987, J BIOL CHEM, V262, P589; CAMPS M, 1992, EUR J BIOCHEM, V206, P821, DOI 10.1111/j.1432-1033.1992.tb16990.x; CAMPS M, 1992, NATURE, V360, P684, DOI 10.1038/360684a0; CHOI EJ, 1992, BIOCHEMISTRY-US, V31, P6492, DOI 10.1021/bi00143a019; FEDERMAN AD, 1992, NATURE, V356, P159, DOI 10.1038/356159a0; FEINSTEIN PG, 1991, P NATL ACAD SCI USA, V88, P10173, DOI 10.1073/pnas.88.22.10173; GAO BN, 1991, P NATL ACAD SCI USA, V88, P10178, DOI 10.1073/pnas.88.22.10178; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HIGASHIJIMA T, 1988, J BIOL CHEM, V263, P6491; HILL DR, 1985, BRIT J PHARMACOL, V84, P249; HONMA M, 1977, BIOCHEM MED METAB B, V18, P257, DOI 10.1016/0006-2944(77)90060-6; HUFF RM, 1986, J BIOL CHEM, V261, P1105; IANNONE MA, 1991, BIOCHEM PHARMACOL, V42, pS105, DOI 10.1016/0006-2952(91)90399-P; ISHITOYA J, 1987, J IMMUNOL, V138, P1201; JAKOBS KH, 1985, BIOCHIM BIOPHYS ACTA, V846, P356, DOI 10.1016/0167-4889(85)90006-0; KARBON EW, 1985, MOL PHARMACOL, V27, P53; KATZ A, 1992, NATURE, V360, P686, DOI 10.1038/360686a0; KONTANI K, 1992, ARCH BIOCHEM BIOPHYS, V294, P527, DOI 10.1016/0003-9861(92)90720-H; MARBACH I, 1990, J BIOL CHEM, V265, P9999; MIYAMOTO K, 1989, EXP CELL RES, V184, P219, DOI 10.1016/0014-4827(89)90379-0; OKADA T, 1994, J BIOL CHEM, V269, P3563; OKAJIMA F, 1985, J BIOL CHEM, V260, P6761; PFEUFFER T, 1983, FEBS LETT, V164, P154, DOI 10.1016/0014-5793(83)80040-4; PFEUFFER T, 1991, METHOD ENZYMOL, V195, P44; SMIGEL MD, 1986, J BIOL CHEM, V261, P1976; TANG WJ, 1991, SCIENCE, V254, P1500, DOI 10.1126/science.1962211; TANG WJ, 1991, J BIOL CHEM, V266, P8595; TAUSSIG R, 1993, J BIOL CHEM, V268, P9; VERGHESE MW, 1985, J BIOL CHEM, V260, P6769; WATANABE Y, 1986, MOL PHARMACOL, V29, P258	38	12	12	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-4889	0006-3002		BBA-MOL CELL RES	Biochim. Biophys. Acta-Mol. Cell Res.	AUG 21	1996	1313	1					72	78		10.1016/0167-4889(96)00048-1		7	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	VE147	WOS:A1996VE14700011		
J	Kim, M; Kiyohara, S; Konishi, S; Tsuneda, S; Saito, K; Sugo, T				Kim, M; Kiyohara, S; Konishi, S; Tsuneda, S; Saito, K; Sugo, T			Ring-opening reaction of poly-GMA chain grafted onto a porous membrane	JOURNAL OF MEMBRANE SCIENCE			English	Article						radiation-induced graft polymerization; porous membrane; glycidyl methacrylate; epoxy ring; ring-opening reaction	PERFUSION CHROMATOGRAPHY; GLYCIDYL METHACRYLATE; AFFINITY MEMBRANE; HOLLOW FIBER; ADSORPTION; PROTEINS; EXCHANGE; DIMETHACRYLATE; LYSOZYME	An epoxy-group-containing polymer chain was grafted onto a porous polyethylene membrane of hollow-fiber form by applying radiation-induced graft polymerization, The produced epoxide was converted into a diol group, ion-exchange (diethylamino and sulfonic acid) and chelate-forming (ethylenediamine and iminodiacetic acid) groups, and pseudoaffinity ligands (phenylalanine and tryptophan), The conversion of the epoxide into the functional group was investigated as a function of the degree of GMA grafting and molecular weight of the reactants. A reactant with low molecular weight exhibited a high conversion. The high conversion of the epoxide into the ion-exchange group caused the extension of the polymer chain grafted onto the pore interface and decreased the water permeability through the hollow-fiber membrane.	CHIBA UNIV,FAC ENGN,DEPT SPECIALTY MAT,INAGE,CHIBA 263,JAPAN; UNIV TOKYO,FAC ENGN,DEPT CHEM ENGN,TOKYO 113,JAPAN; NISSHIN FLOUR MILLING CO LTD,PHARMACEUT RES CTR,IRUMA,SAITAMA 356,JAPAN; JAPAN ATOM ENERGY RES INST,TAKASAKI RADIAT CHEM RES ESTAB,TAKASAKI,GUMMA 37012,JAPAN							AFEYAN NB, 1990, J CHROMATOGR, V519, P1, DOI 10.1016/0021-9673(90)85132-F; KIM M, 1991, J CHROMATOGR, V586, P27, DOI 10.1016/0021-9673(91)80021-8; REGNIER FE, 1991, NATURE, V350, P634, DOI 10.1038/350634a0; AFEYAN NB, 1991, J CHROMATOGR, V544, P267, DOI 10.1016/S0021-9673(01)83991-1; SHINANO H, 1993, BIOTECHNOL PROGR, V9, P193, DOI 10.1021/bp00020a012; BRANDT S, 1988, BIO-TECHNOL, V6, P779, DOI 10.1038/nbt0788-779; HRUDKOVA H, 1977, BRIT POLYM J, V9, P238, DOI 10.1002/pi.4980090313; IWAKURA Y, 1961, J POLYM SCI C, V4, P673; IWAKURA Y, 1966, MAKROMOLEKUL CHEM, V97, P128; JELINKOVA M, 1989, REACT POLYM, V11, P253, DOI 10.1016/0923-1137(89)90111-5; Kalal J., 1974, J POLYM SCI, V47, P155; KALALOVA E, 1977, EUR POLYM J, V13, P293, DOI 10.1016/0014-3057(77)90084-2; KIM M, 1991, J CHROMATOGR, V585, P45, DOI 10.1016/0021-9673(91)85055-K; KIM M, 1994, BIOTECHNOL PROGR, V10, P114, DOI 10.1021/bp00025a013; KIYOHARA S, 1996, J MEMBRANE SCI, V109, P97; KONISHI S, 1992, IND ENG CHEM RES, V31, P2722, DOI 10.1021/ie00012a014; IWATA H, 1991, BIOTECHNOL PROGR, V7, P412, DOI 10.1021/bp00011a005; TSUNEDA S, 1991, J MEMBRANE SCI, V58, P221, DOI 10.1016/S0376-7388(00)82458-8; TSUNEDA S, 1995, J CHROMATOGR A, V689, P211, DOI 10.1016/0021-9673(94)00911-R; TSUNEDA S, 1994, BIOTECHNOL PROGR, V10, P76, DOI 10.1021/bp00025a009; YAMAGISHI H, 1991, IND ENG CHEM RES, V30, P2234, DOI 10.1021/ie00057a028	21	42	44	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0376-7388			J MEMBRANE SCI	J. Membr. Sci.	AUG 21	1996	117	1-2					33	38		10.1016/0376-7388(96)00026-9		6	Engineering, Chemical; Polymer Science	Engineering; Polymer Science	UZ775	WOS:A1996UZ77500002		
J	Sakuda, S; Ono, M; Furihata, K; Nakayama, J; Suzuki, A; Isogai, A				Sakuda, S; Ono, M; Furihata, K; Nakayama, J; Suzuki, A; Isogai, A			Aflastatin A, a novel inhibitor of aflatoxin production of Aspergillus parasiticus, from Streptomyces	JOURNAL OF THE AMERICAN CHEMICAL SOCIETY			English	Article							BIOSYNTHETIC ORIGIN		MORINAGA & CO LTD,RES INST,TSURUMI KU,YOKOHAMA,KANAGAWA 230,JAPAN; NARA INST SCI & TECHNOL,GRAD SCH BIOL SCI,NARA 63001,JAPAN	Sakuda, S (reprint author), UNIV TOKYO,DEPT APPL BIOL CHEM,BUNKYO KU,TOKYO 113,JAPAN.						HABER A, 1977, J AM CHEM SOC, V99, P3541, DOI 10.1021/ja00452a079; HAYAKAWA Y, 1991, J ANTIBIOT, V44, P288; KANAZAWA S, 1993, TETRAHEDRON LETT, V34, P1065, DOI 10.1016/S0040-4039(00)77493-4; MATSUNAGA S, 1991, J AM CHEM SOC, V113, P9690, DOI 10.1021/ja00025a054; OMURA S, 1983, J ANTIBIOT, V36, P611; PHILLIPS NJ, 1989, J AM CHEM SOC, V111, P8223, DOI 10.1021/ja00203a025; SAKUDA S, 1995, BIOSCI BIOTECH BIOCH, V59, P133	7	45	45	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036	0002-7863			J AM CHEM SOC	J. Am. Chem. Soc.	AUG 21	1996	118	33					7855	7856		10.1021/ja960899d		2	Chemistry, Multidisciplinary	Chemistry	VD328	WOS:A1996VD32800032		
J	Nagai, Y; Saito, H; Iwata, T; Nagashima, Y; Hyodo, T; Uchida, H; Omura, T				Nagai, Y; Saito, H; Iwata, T; Nagashima, Y; Hyodo, T; Uchida, H; Omura, T			A new two-dimensional angular correlation of annihilation radiation apparatus using position-sensitive photomultiplier tubes	NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT			English	Letter							SCINTILLATION DETECTOR; POSITRON; SPECTROMETER; RAYS	A new two-dimensional angular correlation of annihilation radiation apparatus is described. Position-sensitive photomultiplier tubes coupled with two-dimensional arrays of small EGO scintillator blocks make simple and compact position-sensitive gamma-ray detectors. With a sample-detector distance of 5 m, an angular resolution of 1.1 mrad FWHM and a coincidence count rate of similar to 2.4 cps per mCi are obtained. Its performance is demonstrated by the result of a test measurement for KI crystal in which non-localized positronium exists at low temperatures.	UNIV TOKYO,COLL ARTS & SCI,INST PHYS,MEGURO KU,TOKYO 153,JAPAN; HAMAMATSU PHOTON KK,CENT RES LAB,HAMAKITA 434,JAPAN			Nagai, Yasuyoshi/A-8995-2011				Berko S, 1983, POSITRON SOLID STATE, P64; BERKO S, 1977, PHYS LETT A, V63, P335, DOI 10.1016/0375-9601(77)90922-7; BIRD AJ, 1991, NUCL INSTRUM METH A, V310, P332, DOI 10.1016/0168-9002(91)91053-X; HAILEY CJ, 1989, NUCL INSTRUM METH A, V276, P340, DOI 10.1016/0168-9002(89)90650-5; HE Z, 1992, 1992 IEEE NUCL SCI S, P129; JEAVONS AP, 1978, IEEE T NUCL SCI, V25, P164, DOI 10.1109/TNS.1978.4329298; KASAI J, 1988, J PHYS SOC JPN, V57, P329, DOI 10.1143/JPSJ.57.329; KUME H, 1986, IEEE T NUCL SCI, V33, P359, DOI 10.1109/TNS.1986.4337119; MILLS AP, 1991, J PHYS CHEM SOLIDS, V52, P1589, DOI 10.1016/0022-3697(91)90144-O; NAGAI Y, 1994, NUCL INSTRUM METH A, V349, P285, DOI 10.1016/0168-9002(94)90635-1; POULSEN JM, 1991, NUCL INSTRUM METH A, V310, P398, DOI 10.1016/0168-9002(91)91068-7; SAITO H, 1992, MATER SCI FORUM, V105, P1967; UCHIDA H, 1986, IEEE T NUCL SCI, V33, P464, DOI 10.1109/TNS.1986.4337144; WEST NR, 1995, POSITRON SPECTROSCOP; WEST RN, 1981, J PHYS E SCI INSTRUM, V14, P478, DOI 10.1088/0022-3735/14/4/021	15	13	13	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-9002			NUCL INSTRUM METH A	Nucl. Instrum. Methods Phys. Res. Sect. A-Accel. Spectrom. Dect. Assoc. Equip.	AUG 21	1996	378	3					629	632		10.1016/0168-9002(96)00424-X		4	Instruments & Instrumentation; Nuclear Science & Technology; Physics, Particles & Fields; Spectroscopy	Instruments & Instrumentation; Nuclear Science & Technology; Physics; Spectroscopy	VH095	WOS:A1996VH09500041		
J	Sanz, JL; MartinezGonzalez, E; Cayon, L; Silk, J; Sugiyama, N				Sanz, JL; MartinezGonzalez, E; Cayon, L; Silk, J; Sugiyama, N			Cosmic microwave background radiation power spectrum in cold dark matter open universes up to second-order perturbations	ASTROPHYSICAL JOURNAL			English	Article						cosmic microwave background; cosmology, theory	NONLINEAR STRUCTURES; ANISOTROPY; FLUCTUATIONS; OMEGA	A second-order perturbation theory approach is developed to calculate temperature anisotropies in the cosmic microwave background. Results are given for open universes and fluctuations corresponding to cold dark matter models with either Harrison-Zeldovich (HZ) or Lyth-Stewart-Ratra-Peebles (LSRP) primordial energy-density fluctuation power spectrum. Our perturbation theory approach provides a distinctive multipole contribution as compared to the primary one, the amplitude of the effect being very dependent on normalization. For low-Omega models, the contribution of the secondary multipoles to the radiation power spectrum is negligible for both standard recombination and reionized scenarios, with the 2 year COBE DMR normalization. For a flat universe this contribution is approximate to 0.1%-10% depending on the reionization history of the universe and on the normalization of the power spectrum.	UNIV CALIF BERKELEY,DEPT ASTRON,BERKELEY,CA 94720; UNIV CALIF BERKELEY,DEPT PHYS,BERKELEY,CA 94720; UNIV CALIF BERKELEY,CTR PARTICLE ASTROPHYS,BERKELEY,CA 94720; UNIV TOKYO,DEPT PHYS,TOKYO 113,JAPAN; UNIV TOKYO,RES CTR EARLY UNIVERSE,TOKYO 113,JAPAN	Sanz, JL (reprint author), UNIV CANTABRIA,CSIC,INST FIS CANTABRIA,E-39005 SANTANDER,SPAIN.		Martinez-Gonzalez, Enrique/E-9534-2015; 	silk, joe/0000-0002-1566-8148			ANILE AM, 1976, ASTROPHYS J, V207, P685, DOI 10.1086/154536; CATELAN P, 1995, MON NOT R ASTRON SOC, V276, P39; RATRA B, 1994, ASTROPHYS J, V432, pL5, DOI 10.1086/187498; Seljak U, 1996, ASTROPHYS J, V460, P549, DOI 10.1086/176991; VISHNIAC ET, 1987, ASTROPHYS J, V322, P597, DOI 10.1086/165755; REES MJ, 1968, NATURE, V217, P511, DOI 10.1038/217511a0; ABBOTT LF, 1986, ASTROPHYS J, V308, P546, DOI 10.1086/164525; SACHS RK, 1967, ASTROPHYS J, V147, P73, DOI 10.1086/148982; TULUIE R, 1995, ASTROPHYS J, V445, pL73, DOI 10.1086/187893; GOUDA N, 1991, PROG THEOR PHYS, V85, P1023, DOI 10.1143/PTP.85.1023; GOROFF MH, 1986, ASTROPHYS J, V311, P6, DOI 10.1086/164749; LYTH DH, 1990, PHYS LETT B, V252, P336, DOI 10.1016/0370-2693(90)90548-K; GELB JM, 1994, ASTROPHYS J, V436, P467, DOI 10.1086/174922; BOND JR, 1991, ASTROPHYS J, V367, P420, DOI 10.1086/169640; BOUCHET FR, 1992, ASTROPHYS J, V394, pL5, DOI 10.1086/186459; CAYON L, 1995, IN PRESS MNRAS; GORSKI KM, 1995, ASTROPHYS J, V444, pL65, DOI 10.1086/187861; HU W, 1994, PHYS REV D, V50, P627, DOI 10.1103/PhysRevD.50.627; MARTINEZGONZALEZ E, 1994, ASTROPHYS J, V436, P1, DOI 10.1086/174874; MARTINEZGONZALEZ E, 1990, ASTROPHYS J, V355, pL5, DOI 10.1086/185725; MARTINEZGONZALEZ E, 1992, PHYS REV D, V46, P4193, DOI 10.1103/PhysRevD.46.4193; Peebles P. J. E, 1980, LARGE SCALE STRUCTUR; SUTO Y, 1991, PHYS REV LETT, V66, P265; TRASCHEN J, 1986, PHYS REV D, V34, P1665, DOI 10.1103/PhysRevD.34.1665	24	12	12	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0004-637X			ASTROPHYS J	Astrophys. J.	AUG 20	1996	467	2	1				485	488		10.1086/177625		4	Astronomy & Astrophysics	Astronomy & Astrophysics	VD218	WOS:A1996VD21800002		
J	Kriss, GA; Krolik, JH; Otani, C; Espey, BR; Turner, TJ; Kii, T; Tsvetanov, Z; Takahashi, T; Davldsen, AF; Tashiro, M; Zheng, W; Murakami, S; Petre, R; Mihara, T				Kriss, GA; Krolik, JH; Otani, C; Espey, BR; Turner, TJ; Kii, T; Tsvetanov, Z; Takahashi, T; Davldsen, AF; Tashiro, M; Zheng, W; Murakami, S; Petre, R; Mihara, T			ASCA observations of the composite warm absorber in NGC 3516	ASTROPHYSICAL JOURNAL			English	Article						galaxies, active; galaxies, individual (NGC 3516); galaxies, nuclei; galaxies, Seyfert; X-ray, galaxies	ACTIVE GALACTIC NUCLEI; X-RAY-ABSORPTION; ULTRAVIOLET-SPECTRUM; GALAXY NGC-3516; COLD MATTER; NGC-4151; NGC-5548	We obtained X-ray spectra of the Seyfert 1 galaxy NGC 3516 in 1995 March using the Japanese X-ray satellite, ASCA. Simultaneous far-UV observations were obtained with the Hopkins Ultraviolet Telescope on the Astro-2 shuttle mission. The ASCA spectrum shows a lightly absorbed power law of energy index 0.78. The low-energy absorbing column is significantly less than previously seen. Prominent O VII and O VIII absorption edges are visible, but, consistent with the much lower total absorbing column, no Fe K absorption edge is detectable. A weak, narrow Fe K alpha emission line from cold material is present as well as a broad Fe K alpha line. These features are similar to those reported in other Seyfert 1 galaxies. A single warm absorber model provides only an imperfect description of the low-energy absorption. In addition to a highly ionized absorber with ionization parameter U = 1.66 and a total column density of 1.4 x 10(22) cm(-2), adding a lower ionization absorber with U = 0.32 and a total column of 6.9 x 10(21) cm(-2) significantly improves the fit. The contribution of resonant line scattering to our warm absorber models limits the Doppler parameter to less than 160 km s(-1) at 90% confidence. Turbulence at the sound speed of the photoionized gas provides the best fit. None of the warm absorber models fitted to the X-ray spectrum can match the observed equivalent widths of all the UV absorption lines. Accounting for the X-ray and UV absorption simultaneously requires an absorbing region with a broad range of ionization parameters and column densities.	RIKEN,INST PHYS & CHEM RES,WAKO,SAITAMA 35101,JAPAN; NASA,GODDARD SPACE FLIGHT CTR,HIGH ENERGY ASTROPHYS LAB,GREENBELT,MD 20771; UNIV SPACE RES ASSOC,COLUMBIA,MD; INST SPACE & ASTRONAUT SCI,SAGAMIHARA,KANAGAWA 229,JAPAN; UNIV TOKYO,DEPT PHYS,BUNKYO KU,TOKYO 113,JAPAN; OSAKA CITY UNIV,DEPT PHYS,SUMIYOSHI KU,OSAKA 558,JAPAN	Kriss, GA (reprint author), JOHNS HOPKINS UNIV,DEPT PHYS & ASTRON,BALTIMORE,MD 21218, USA.		Tashiro, Makoto/J-4562-2012; 	Espey, Brian/0000-0002-2457-1380			GEORGE IM, 1991, MON NOT R ASTRON SOC, V249, P352; TANAKA Y, 1994, PUBL ASTRON SOC JPN, V46, pL37; KROLIK JH, 1995, ASTROPHYS J, V447, P512, DOI 10.1086/175896; SERLEMITSOS PJ, 1995, PUBL ASTRON SOC JPN, V47, P105; TARTER CB, 1969, ASTROPHYS J, V156, P943, DOI 10.1086/150026; MATHUR S, 1995, ASTROPHYS J, V452, P230, DOI 10.1086/176294; TANAKA Y, 1995, NATURE, V375, P659, DOI 10.1038/375659a0; LIGHTMAN AP, 1988, ASTROPHYS J, V335, P57, DOI 10.1086/166905; VERNER DA, 1995, ASTRON ASTROPHYS SUP, V109, P125; BURKE BE, 1994, IEEE T NUCL SCI, V41, P375, DOI 10.1109/23.281527; FABIAN AC, 1995, IN PRESS MNRAS; Halpern J. P., 1982, THESIS HARVARD U; HALPERN JP, 1984, ASTROPHYS J, V281, P90, DOI 10.1086/162077; KOLMAN M, 1993, ASTROPHYS J, V403, P592, DOI 10.1086/172230; KORATKAR A, 1996, UNPUB APJ; KRISS GA, 1995, ASTROPHYS J, V454, pL7, DOI 10.1086/309761; KRISS GA, 1996, APJ, V467; KRISS GA, 1985, ASTROPHYS J, V297, P177, DOI 10.1086/163514; MAKISHIMA K, 1996, IN PRESS PASJ; MATHUR S, 1995, ASTROPHYS J, V455, pL9, DOI 10.1086/309820; MATHUR S, 1994, ASTROPHYS J, V434, P493, DOI 10.1086/174750; MUSHOTZKY RF, 1995, MON NOT R ASTRON SOC, V272, pL9; NANDRA K, 1994, MON NOT R ASTRON SOC, V268, P405; NETZER H, 1993, ASTROPHYS J, V411, P594, DOI 10.1086/172861; OTANI C, 1996, IN PRESS RONTGENSSTR; OTANI C, 1996, IN PRESS PASJ; REYNOLDS CS, 1995, MON NOT R ASTRON SOC, V273, P1167; SHAFER RA, 1989, XSPEC XRAY SPECTRAL; STARK AA, 1992, ASTROPHYS J SUPPL S, V79, P77, DOI 10.1086/191645; TURNER TJ, 1993, ASTROPHYS J, V419, P127, DOI 10.1086/173466; ULRICH MH, 1983, ASTROPHYS J, V267, P515, DOI 10.1086/160888; VOIT GM, 1987, ASTROPHYS J, V316, P573, DOI 10.1086/165226; VRTILEK JM, 1985, ASTROPHYS J, V294, P106, DOI 10.1086/163279; WALTER R, 1990, ASTRON ASTROPHYS, V233, P53; YAQOOB T, 1995, APJ, V499, pL99; YAQOOB T, 1989, MON NOT R ASTRON SOC, V236, P153; YQOOB T, 1993, MNRAS, V262, P435	37	54	54	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0004-637X			ASTROPHYS J	Astrophys. J.	AUG 20	1996	467	2	1				629	635		10.1086/177638		7	Astronomy & Astrophysics	Astronomy & Astrophysics	VD218	WOS:A1996VD21800015		
J	Aikawa, Y; Miyama, SM; Nakano, T; Umebayashi, T				Aikawa, Y; Miyama, SM; Nakano, T; Umebayashi, T			Evolution of molecular abundance in gaseous disks around young stars: Depletion of CO molecules	ASTROPHYSICAL JOURNAL			English	Article						circumstellar matter; ISM, abundances; ISM, molecules; planetary systems; stars, formation; stars, pre-main-sequence	T-TAURI STARS; LOCAL SHEAR INSTABILITY; WEAKLY MAGNETIZED DISKS; PRIMORDIAL SOLAR NEBULA; RAY-INDUCED DESORPTION; GG-TAURI; INTERSTELLAR GRAINS; CIRCUMSTELLAR GAS; STELLAR OBJECTS; ZETA-OPHIUCHI	We investigate the evolution of the molecular abundance in circumstellar disks around pre-main-sequence stars, taking into account the adsorption of molecules onto grains as well as the reactions in the gas phase. We follow the molecular evolution for some model disks, solving numerically the reaction equations. We show only the results on the abundance of CO molecules in the gas phase. There is a critical distance from the star, R(crit), at which the temperature is equal to the critical temperature approximate to 20 K for the adsorption of CO molecules. At R > R(crit), CO molecules are depleted rather rapidly from the gas phase mainly because of adsorption. Even in the region just inside R(crit), CO molecules are depleted slowly because by gas-phase reactions, they are transformed into the other molecules that can be adsorbed more easily than CO. For the minimum-mass solar nebula extended to the region of radius R approximate to 800 AU, for example, CO molecules in the gas phase at R > R(crit) approximate to 200 AU are depleted by a few orders of magnitude in 10(5)-10(6) yr, while at R < R(crit), the depletion of CO is not significant in these timescales. This is consistent with the recent observations of the gaseous disks around some T Tauri stars.	UNIV TOKYO,DEPT EARTH & PLANETARY SCI,BUNKYO KU,TOKYO 113,JAPAN; NATL ASTRON OBSERV,NOBEYAMA RADIO OBSERV,MINAMISA KU,NAGANO 38413,JAPAN; YAMAGATA UNIV,DATA PROC CTR,YAMAGATA 990,JAPAN	Aikawa, Y (reprint author), NATL ASTRON OBSERV,MITAKA,TOKYO 181,JAPAN.		MIYAMA, Shoken/A-3598-2015				HAWLEY JF, 1991, ASTROPHYS J, V376, P223, DOI 10.1086/170271; SANDFORD SA, 1990, ICARUS, V87, P188; ADAMS FC, 1987, ASTROPHYS J, V312, P788, DOI 10.1086/164924; UMEBAYASHI T, 1990, MON NOT R ASTRON SOC, V243, P103; ALLEN M, 1977, ASTROPHYS J, V212, P396, DOI 10.1086/155059; PRASAD SS, 1980, ASTROPHYS J SUPPL S, V43, P1, DOI 10.1086/190665; BERGIN EA, 1995, ASTROPHYS J, V441, P222, DOI 10.1086/175351; DUTREY A, 1994, ASTRON ASTROPHYS, V286, P149; BALLY J, 1982, ASTROPHYS J, V255, P143, DOI 10.1086/159812; NAKAGAWA Y, 1981, ICARUS, V45, P517, DOI 10.1016/0019-1035(81)90018-X; MITCHELL GF, 1993, ASTROPHYS J, V404, pL79, DOI 10.1086/186748; KENYON SJ, 1987, ASTROPHYS J, V323, P714, DOI 10.1086/165866; STROM KM, 1989, ASTRON J, V97, P1451, DOI 10.1086/115085; BALBUS SA, 1991, ASTROPHYS J, V376, P214, DOI 10.1086/170270; KUSAKA T, 1970, PROG THEOR PHYS, V44, P1580, DOI 10.1143/PTP.44.1580; SANDFORD SA, 1988, ICARUS, V76, P201, DOI 10.1016/0019-1035(88)90069-3; BECKWITH SVW, 1990, ASTRON J, V99, P924, DOI 10.1086/115385; LANGER WD, 1993, ASTROPHYS J, V408, P539, DOI 10.1086/172611; MATHIS JS, 1977, ASTROPHYS J, V217, P425, DOI 10.1086/155591; BELL KR, 1994, ASTROPHYS J, V427, P987, DOI 10.1086/174206; HASEGAWA TI, 1993, MON NOT R ASTRON SOC, V261, P83; DHENDECOURT LB, 1982, ASTRON ASTROPHYS, V109, pL12; APPENZELLER I, 1984, ASTRON ASTROPHYS, V141, P108; Avgul N. N., 1970, CHEMISTRY PHYSICS CA, V6, P1; BERTOUT C, 1989, ANNU REV ASTRON ASTR, V27, P351; CAMERON AGW, 1985, PROTOSTARS PLANETS, V2, P1073; DHENDECOURT LB, 1985, ASTRON ASTROPHYS, V152, P130; DULEY WW, INTERSTELLAR CHEM; GUILLOTEAU S, 1994, ASTRON ASTROPHYS, V291, pL23; HANDA T, 1995, ASTROPHYS J, V449, P894, DOI 10.1086/176107; HARTQUIST TW, 1990, MON NOT R ASTRON SOC, V247, P343; HAWKINS I, 1993, ASTROPHYS J, V407, P185, DOI 10.1086/172504; Hayashi C, 1981, PROG THEOR PHYS SUPP, V70, P35, DOI 10.1143/PTPS.70.35; Hayashi C., 1985, PROTOSTARS PLANETS, VII, P1100; HERBIG GH, 1986, ASTROPHYS J, V309, P294, DOI 10.1086/164600; Herbst E, 1993, DUST CHEM ASTRONOMY, P183; IMHOFF CL, 1987, SCI ACCOMPLISHMENTS, P295; Irvine W. M., 1987, INTERSTELLAR PROCESS, P561; KAWABE R, 1993, ASTROPHYS J, V404, pL63, DOI 10.1086/186744; LEGER A, 1985, ASTRON ASTROPHYS, V144, P147; MONTMERLE T, 1993, PROTOSTARS PLANETS, V3, P689; MORTON DC, 1974, ASTROPHYS J, V193, pL35, DOI 10.1086/181625; NAKANO T, 1991, MEM SOC ASTRON ITAL, V62, P841; OHASHI N, 1991, ASTRON J, V102, P2054, DOI 10.1086/116029; POLLACK JB, 1985, ICARUS, V64, P471, DOI 10.1016/0019-1035(85)90069-7; PRINN RG, 1993, PROTOSTARS PLANETS, V3, P1005; RUCINSKI SM, 1985, ASTRON J, V90, P2321, DOI 10.1086/113937; SAITO M, 1995, ASTROPHYS J, V453, P384, DOI 10.1086/176398; SIMON M, 1992, ASTROPHYS J, V397, pL47, DOI 10.1086/186541; SKRUTSKIE MF, 1993, ASTROPHYS J, V409, P422, DOI 10.1086/172675; SPITZER L, 1968, ASTROPHYS J, V152, P971, DOI 10.1086/149610; Tielens A.G.G.M., 1987, INTERSTELLAR PROCESS, P397; Umebayashi T., 1988, PROG THEOR PHYS SUPP, V96, P151, DOI 10.1143/PTPS.96.151; van Dishoeck E. F., 1993, PROTOSTARS PLANETS, VIII, P163; WILLACY K, 1993, MON NOT R ASTRON SOC, V260, P635; Williams D., 1993, DUST CHEM ASTRONOMY, P143	56	64	64	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0004-637X			ASTROPHYS J	Astrophys. J.	AUG 20	1996	467	2	1				684	697		10.1086/177644		14	Astronomy & Astrophysics	Astronomy & Astrophysics	VD218	WOS:A1996VD21800021		
J	Ozaki, K; Yoshida, T; Ide, H; Saito, I; Ikeda, Y; Sugimura, T; Terada, M				Ozaki, K; Yoshida, T; Ide, H; Saito, I; Ikeda, Y; Sugimura, T; Terada, M			Use of von Willebrand factor promoter to transduce suicidal gene to human endothelial cells, HUVEC	HUMAN GENE THERAPY			English	Article							SUPPRESSES TUMOR-GROWTH; VONWILLEBRAND-FACTOR; IN-VIVO; ANGIOGENESIS INHIBITOR; MONOCLONAL-ANTIBODY; BREAST-CARCINOMA; MAMMALIAN-CELLS; EXPRESSION; METASTASIS; HETEROGENEITY	Angiogenesis is an essential component of multifactorial carcinogenesis and thus a potential target of therapeutic intervention, To develop a novel cancer gene therapy strategy based on suppression of tumor angiogenesis, we examined the feasibility of targeting and preferential killing of proliferating endothelial cells by use of the von Willebrand factor (vWf) promoter and herpes simplex virus thymidine kinase gene (HSV-TK). Based on previous reports on the vWf promoter, we tested two putative vWf promoter regions, The luciferase assay showed that the shorter region, which encompasses most of the first noncoding exon, had stronger activity in endothelial cells, Although the promoter activity was low when employed as an internal promoter for retroviral and adenoviral vectors, endothelial cell specificity was suggested; the promoter, when used to drive the HSV-TK gene, could preferentially suppress endothelial cell growth in the presence of prodrug ganciclovir, suggesting the feasibility of designing an anti-angiogenesis gene therapy using the vWf promoter and the suicide gene/prodrug strategy.	NATL CANC CTR,RES INST,DIV GENET,CHUO KU,TOKYO 104,JAPAN; KEIO UNIV,SCH MED,DEPT HEMATOL,TOKYO 160,JAPAN; UNIV TOKYO,INST MED SCI,GENET MOL LAB,TOKYO 108,JAPAN							FOLKMAN J, 1973, J EXP MED, V138, P745, DOI 10.1084/jem.138.4.745; OREILLY MS, 1994, CELL, V79, P315, DOI 10.1016/0092-8674(94)90200-3; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; MILLAUER B, 1994, NATURE, V367, P576, DOI 10.1038/367576a0; FIDLER IJ, 1994, CELL, V79, P185, DOI 10.1016/0092-8674(94)90187-2; JAHROUDI N, 1994, MOL CELL BIOL, V14, P999; GIMBRONE MA, 1972, J EXP MED, V136, P261, DOI 10.1084/jem.136.2.261; WU QY, 1987, ARTERIOSCLEROSIS, V7, P47; OLSON KA, 1995, P NATL ACAD SCI USA, V92, P442, DOI 10.1073/pnas.92.2.442; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; HORI A, 1991, CANCER RES, V51, P6180; WEIDNER N, 1992, J NATL CANCER I, V84, P1875, DOI 10.1093/jnci/84.24.1875; KANEGAE Y, 1995, NUCLEIC ACIDS RES, V23, P3816, DOI 10.1093/nar/23.19.3816; AIRD WC, 1995, P NATL ACAD SCI USA, V92, P4567, DOI 10.1073/pnas.92.10.4567; WEIDNER N, 1993, AM J PATHOL, V143, P401; Macgregor G R, 1991, Methods Mol Biol, V7, P217, DOI 10.1385/0-89603-178-0:217; BLOOD CH, 1990, BIOCHIM BIOPHYS ACTA, V1032, P89, DOI 10.1016/0304-419X(90)90014-R; TAKEBE Y, 1988, MOL CELL BIOL, V8, P466; MANCUSO DJ, 1989, J BIOL CHEM, V264, P19514; Ausubel F.M., 1987, CURRENT PROTOCOLS MO; BAHNAK BR, 1989, J CELL PHYSIOL, V138, P305, DOI 10.1002/jcp.1041380212; BROOKS PC, 1994, CELL, V79, P1157, DOI 10.1016/0092-8674(94)90007-8; FERREIRA V, 1993, BIOCHEM J, V293, P641; FOLKMAN J, 1992, J BIOL CHEM, V267, P10931; Folkman J., 1989, J NATL CANCER I, V82, P4; GUMKOWSKI F, 1987, BLOOD VESSELS, V24, P11; HOYER LW, 1973, J CLIN INVEST, V52, P2737, DOI 10.1172/JCI107469; KIM KJ, 1993, NATURE, V362, P841, DOI 10.1038/362841a0; MILLER AD, 1989, BIOTECHNIQUES, V7, P980; Miyake S, 1996, P NATL ACAD SCI USA, V93, P1320, DOI 10.1073/pnas.93.3.1320; MUKAI K, 1980, AM J SURG PATHOL, V4, P273, DOI 10.1097/00000478-198006000-00008; NAKAJIMA K, 1993, FEBS LETT, V315, P129, DOI 10.1016/0014-5793(93)81148-S; NGUYEN VT, 1988, ANAL BIOCHEM, V171, P404, DOI 10.1016/0003-2697(88)90505-2; OLSON KA, 1994, CANCER RES, V54, P4576; YAMAOKA M, 1993, CANCER RES, V53, P4262	35	38	38	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538	1043-0342			HUM GENE THER	Hum. Gene Ther.	AUG 20	1996	7	13					1483	1490		10.1089/hum.1996.7.13-1483		8	Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine, Research & Experimental	Biotechnology & Applied Microbiology; Genetics & Heredity; Research & Experimental Medicine	WD322	WOS:A1996WD32200001		
J	Takahashi, Y; Ametani, A; Totsuka, M; Kaminogawa, S				Takahashi, Y; Ametani, A; Totsuka, M; Kaminogawa, S			The direct cloning of the immunoglobulin V-H genes from primary cultured B cells specific for a short peptide	JOURNAL OF BIOTECHNOLOGY			English	Article						peptide-specific B cells; magnetic beads; V-H gene; polymerase chain reaction	ANTIBODY-RESPONSE; IMMUNE-RESPONSE; HEAVY-CHAIN; LIBRARY; CONSTRUCTION; HYBRIDOMAS; STRATEGIES; GENERATION; REPERTOIRE; SELECTION	A new and simple method was devised to obtain immunoglobulin V-H genes directly from primary cultured B cells specific for a short peptide. Peptide-specific B cells were separated from splenocytes of peptide-immunized BALB/c mice with antigen-coated magnetic beads, and were cloned by a limitedly diluted culture in the presence of lipopolysaccharide, recombinant interleukin (rIL) -2, rIL-4 and rIL-5, and 3T3 fibroblasts as filler cells for 7 days. Seventeen clones were obtained from 3 x 10(3) fractionated cells by screening the positive wells containing anti-peptide antibody-secreting cells by an enzyme-linked immunosorbent assay (ELISA). The V-H cDNAs of these clones were amplified by a set of primers; a primer complementary to the mu-chain constant region gene and the other with high complementarity to most of the V-H genes. This is the first report of success in obtaining unknown V-H genes directly from primary B cell clones, after their antigen-specificity has been confirmed by ELISA. This new method will provide a powerful tool for designing specific recombinant antibodies.		Takahashi, Y (reprint author), UNIV TOKYO,DEPT APPL BIOL CHEM,BUNKYO KU,1-1-1 YAYOI,TOKYO 113,JAPAN.						AMES RS, 1995, J IMMUNOL, V154, P6355; CUMANO A, 1985, EUR J IMMUNOL, V15, P512, DOI 10.1002/eji.1830150517; BOULIANNE GL, 1984, NATURE, V312, P643, DOI 10.1038/312643a0; SASTRY L, 1989, P NATL ACAD SCI USA, V86, P5728, DOI 10.1073/pnas.86.15.5728; KUPPERS R, 1993, EMBO J, V12, P4955; SHAWLER DL, 1985, J IMMUNOL, V135, P1530; HUSE WD, 1989, SCIENCE, V246, P1275, DOI 10.1126/science.2531466; CHATENOUD L, 1986, J IMMUNOL, V137, P830; GHERARDI E, 1992, NATURE, V357, P201, DOI 10.1038/357201a0; HAWKINS RE, 1992, EUR J IMMUNOL, V22, P867, DOI 10.1002/eji.1830220336; HORTON JK, 1989, J IMMUNOL METHODS, V124, P225, DOI 10.1016/0022-1759(89)90357-8; KAARTINEN M, 1983, NATURE, V304, P320, DOI 10.1038/304320a0; Kabat E. A., 1987, SEQUENCES PROTEINS I; KAUFMAN RJ, 1982, MOL CELL BIOL, V2, P1304; KAVALER J, 1990, J IMMUNOL, V145, P2312; LARRICK J W, 1984, Biotechniques, V2, P6; LEFKOVITS I, 1979, LIMITING DILUTION AN; LIU AH, 1992, P NATL ACAD SCI USA, V89, P7610, DOI 10.1073/pnas.89.16.7610; MCHEYZERWILLIAMS MG, 1989, EUR J IMMUNOL, V19, P2025, DOI 10.1002/eji.1830191109; MCHEYZERWILLIAMS MG, 1991, NATURE, V350, P502, DOI 10.1038/350502a0; MORRISON SL, 1985, SCIENCE, V229, P1202, DOI 10.1126/science.3929380; MORRISON SL, 1992, ANNU REV IMMUNOL, V10, P239, DOI 10.1146/annurev.immunol.10.1.239; OHSHIBA A, 1991, J ALLERGY CLIN IMMUN, V87, P729, DOI 10.1016/0091-6749(91)90396-6; SAHAGAN BG, 1986, J IMMUNOL, V137, P1066; SAKURAI T, 1993, INT IMMUNOL, V5, P793, DOI 10.1093/intimm/5.7.793	25	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-1656			J BIOTECHNOL	J. Biotechnol.	AUG 20	1996	49	1-3					201	210		10.1016/0168-1656(96)01506-4		10	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	VY214	WOS:A1996VY21400019		
J	Sasaki, M; Matsumori, N; Maruyama, T; Nonomura, T; Murata, M; Tachibana, K; Yasumoto, T				Sasaki, M; Matsumori, N; Maruyama, T; Nonomura, T; Murata, M; Tachibana, K; Yasumoto, T			The complete structure of maitotoxin .1. Configuration of the C1-C14 side chain	ANGEWANDTE CHEMIE-INTERNATIONAL EDITION IN ENGLISH			English	Article						configuration determination; conformation; maitotoxin; natural products; NMR spectroscopy	COUPLING-CONSTANTS; STEREOCHEMICAL ASSIGNMENT; ASYMMETRIC EPOXIDATION; ACYCLIC LINKAGE; CHLORIDE; CONFIRMATION; ALDEHYDES; REDUCTION; REAGENTS		UNIV TOKYO,SCH SCI,DEPT CHEM,BUNKYO KU,TOKYO 113,JAPAN; TOHOKU UNIV,FAC AGR,SENDAI,MIYAGI 980,JAPAN							NAKATA T, 1983, TETRAHEDRON LETT, V24, P2653, DOI 10.1016/S0040-4039(00)87969-1; HANSEN PE, 1981, PROG NUCL MAG RES SP, V14, P175, DOI 10.1016/0079-6565(81)80001-5; TAKAI K, 1986, J AM CHEM SOC, V108, P7408, DOI 10.1021/ja00283a046; SCHWARCZ JA, 1975, CAN J CHEM, V53, P1872, DOI 10.1139/v75-262; YASUMOTO T, 1976, B JPN SOC SCI FISH, V42, P359; TAKAI K, 1983, TETRAHEDRON LETT, V24, P5281, DOI 10.1016/S0040-4039(00)88417-8; GAO Y, 1987, J AM CHEM SOC, V109, P5765, DOI 10.1021/ja00253a032; KATSUKI T, 1980, J AM CHEM SOC, V102, P5974, DOI 10.1021/ja00538a077; YOKOYAMA A, 1988, J BIOCHEM-TOKYO, V104, P184; JIN H, 1986, J AM CHEM SOC, V108, P5644, DOI 10.1021/ja00278a057; TAKAI K, 1986, J AM CHEM SOC, V108, P6048, DOI 10.1021/ja00279a068; BARTON DHR, 1975, J CHEM SOC PERK T 1, P1574, DOI 10.1039/p19750001574; GUSOVSKY F, 1990, BIOCHEM PHARMACOL, V39, P1633, DOI 10.1016/0006-2952(90)90105-T; JOHNSON MR, 1979, TETRAHEDRON LETT, P4343; MATSUMORI N, 1995, TETRAHEDRON, V51, P12229, DOI 10.1016/0040-4020(95)00790-F; Matsumori N, 1996, TETRAHEDRON LETT, V37, P1269, DOI 10.1016/0040-4039(95)02413-1; MURATA M, 1994, J AM CHEM SOC, V116, P7098, DOI 10.1021/ja00095a013; MURATA M, 1993, J AM CHEM SOC, V115, P2060, DOI 10.1021/ja00058a075; Nonomura T., 1996, ANGEW CHEM, V108, P1786, DOI 10.1002/ange.19961081512; Nonomura T, 1996, ANGEW CHEM INT EDIT, V35, P1675, DOI 10.1002/anie.199616751; ROUSH WR, 1983, TETRAHEDRON LETT, V24, P1377, DOI 10.1016/S0040-4039(00)81660-3; SASAKI M, 1995, TETRAHEDRON LETT, V36, P9007, DOI 10.1016/0040-4039(95)01972-K; SASAKI M, 1994, TETRAHEDRON LETT, V35, P5023, DOI 10.1016/S0040-4039(00)73310-7; SASAKI M, 1995, TETRAHEDRON LETT, V36, P9011, DOI 10.1016/0040-4039(95)01973-L; SATAKE M, 1995, J AM CHEM SOC, V117, P7019, DOI 10.1021/ja00131a032; SUZUKI T, 1982, TETRAHEDRON LETT, V23, P3597, DOI 10.1016/S0040-4039(00)87680-7; WOLLBORN U, 1992, J MAGN RESON, V98, P142, DOI 10.1016/0022-2364(92)90117-P; YAMASHITA M, 1980, CHEM LETT, P847, DOI 10.1246/cl.1980.847	28	86	88	VCH PUBLISHERS INC	DEERFIELD BEACH	303 NW 12TH AVE, DEERFIELD BEACH, FL 33442-1788	0570-0833			ANGEW CHEM INT EDIT	Angew. Chem.-Int. Edit. Engl.	AUG 19	1996	35	15					1672	&		10.1002/anie.199616721		5	Chemistry, Multidisciplinary	Chemistry	VE349	WOS:A1996VE34900008		
J	Nonomura, T; Sasaki, M; Matsumori, N; Murata, M; Tachibana, K; Yasumoto, T				Nonomura, T; Sasaki, M; Matsumori, N; Murata, M; Tachibana, K; Yasumoto, T			The complete structure of maitotoxin .2. Configuration of the C135-C142 side chain and absolute configuration of the entire molecule	ANGEWANDTE CHEMIE-INTERNATIONAL EDITION IN ENGLISH			English	Article						asymmetric syntheses; maitotoxin; natural products; NMR spectroscopy; structure elucidation	ASYMMETRIC DIHYDROXYLATION; EPOXIDATION; ALCOHOLS; ACID		UNIV TOKYO,SCH SCI,DEPT CHEM,BUNKYO KU,TOKYO 113,JAPAN; TOHOKU UNIV,FAC AGR,SENDAI,MIYAGI 980,JAPAN							SCHWARCZ JA, 1975, CAN J CHEM, V53, P1872, DOI 10.1139/v75-262; KOLB HC, 1994, CHEM REV, V94, P2483, DOI 10.1021/cr00032a009; GAO Y, 1987, J AM CHEM SOC, V109, P5765, DOI 10.1021/ja00253a032; KATSUKI T, 1980, J AM CHEM SOC, V102, P5974, DOI 10.1021/ja00538a077; FURUTA K, 1986, TETRAHEDRON LETT, V27, P4507, DOI 10.1016/S0040-4039(00)84991-6; SHARPLESS KB, 1992, J ORG CHEM, V57, P2768, DOI 10.1021/jo00036a003; ROBINS MJ, 1983, J AM CHEM SOC, V105, P4059, DOI 10.1021/ja00350a052; HEATHCOCK CH, 1989, J MED CHEM, V32, P197, DOI 10.1021/jm00121a036; KISHI Y, COMMUNICATION; MATSUMORI N, 1995, TETRAHEDRON, V51, P12229, DOI 10.1016/0040-4020(95)00790-F; MURATA M, 1994, J AM CHEM SOC, V116, P7098, DOI 10.1021/ja00095a013; NICOLAOU KC, 1990, J AM CHEM SOC, V112, P3040, DOI 10.1021/ja00164a026; ROUSH WR, 1983, TETRAHEDRON LETT, V24, P1377, DOI 10.1016/S0040-4039(00)81660-3; Sasaki M., 1996, ANGEW CHEM, V108, P1782, DOI 10.1002/ange.19961081511; Sasaki M, 1996, ANGEW CHEM INT EDIT, V35, P1672, DOI 10.1002/anie.199616721; SASAKI M, 1995, TETRAHEDRON LETT, V36, P9011, DOI 10.1016/0040-4039(95)01973-L; SCHWARCZ JA, 1981, PROGR NMR SPECTR, V14, P175; SUZUKI T, 1982, TETRAHEDRON LETT, V23, P3597, DOI 10.1016/S0040-4039(00)87680-7	18	82	84	VCH PUBLISHERS INC	DEERFIELD BEACH	303 NW 12TH AVE, DEERFIELD BEACH, FL 33442-1788	0570-0833			ANGEW CHEM INT EDIT	Angew. Chem.-Int. Edit. Engl.	AUG 19	1996	35	15					1675	1678		10.1002/anie.199616751		4	Chemistry, Multidisciplinary	Chemistry	VE349	WOS:A1996VE34900009		
J	Kubokawa, K; Miyashita, T; Nagasawa, H; Kubo, Y				Kubokawa, K; Miyashita, T; Nagasawa, H; Kubo, Y			Cloning and characterization of a bifunctional metabotropic receptor activated by both extracellular calcium and glutamate	FEBS LETTERS			English	Article						bifunctional; metabotropic; receptor; calcium; glutamate; cDNA; cloning	LONG-TERM DEPRESSION; MGLUR1 MUTANT MICE; MOLECULAR CHARACTERIZATION; FUNCTIONAL EXPRESSION; SIGNAL-TRANSDUCTION; SEQUENCE ALIGNMENT; SENSING RECEPTOR; XENOPUS OOCYTES; RAT	A cDNA from salmon brain which induces a consistent activation of Ca2+ dependent Cl- (Ca2+-Cl-) current in Xenopus oocytes in the saline solution was isolated by an expression cloning method, The primary structure showed a high homology with the metabotropic glutamate receptors (mGluR), and a limited homology with the Ca2+/polyvalent cation receptors (CaR), The encoded protein was functionally characterized for the sensitivity to extracellular Ca2+ (Ca-0(2+)), and the consistent activation of Ca2+-Cl- current was determined to be due to Ca2+ contained in the saline solution, It was also confirmed that the encoded protein has a function to sense glutamate. An increase in inositol 1,4,5-triphosphate turnover was observed when either Ca2+ or glutamate was applied. Thus, the encoded protein was identified as a bifunctional metabotropic receptor for both Ca2+ and glutamate, In addition, rat mGluR1 alpha was also shown to be activated by Ca-0(2+). This is the first report of a G-protein coupled receptor which is activated by two totally different physiological agonists.	TOKYO METROPOLITAN INST NEUROSCI,DEPT NEUROPHYSIOL,FUCHU,TOKYO 183,JAPAN; UNIV TOKYO,OCEAN RES INST,LAB MOLEC BIOL MARINE ORGANISMS,NAKANO KU,TOKYO 164,JAPAN							GARRETT JE, 1995, J BIOL CHEM, V270, P12919; AIBA A, 1994, CELL, V79, P377; MASU M, 1991, NATURE, V349, P760, DOI 10.1038/349760a0; RICCARDI D, 1995, P NATL ACAD SCI USA, V92, P131, DOI 10.1073/pnas.92.1.131; HIGGINS DG, 1988, GENE, V73, P237, DOI 10.1016/0378-1119(88)90330-7; NAKAJIMA Y, 1993, J BIOL CHEM, V268, P11868; AIBA A, 1994, CELL, V79, P365, DOI 10.1016/0092-8674(94)90204-6; ABE T, 1992, J BIOL CHEM, V267, P13361; SUGIYAMA H, 1987, NATURE, V325, P531, DOI 10.1038/325531a0; OKAMOTO N, 1994, J BIOL CHEM, V269, P1231; DUVOISIN RM, 1995, J NEUROSCI, V15, P3075; SHIGEMOTO R, 1994, NEURON, V12, P1245, DOI 10.1016/0896-6273(94)90441-3; RUAT M, 1995, P NATL ACAD SCI USA, V92, P3161, DOI 10.1073/pnas.92.8.3161; TANABE Y, 1992, NEURON, V8, P169, DOI 10.1016/0896-6273(92)90118-W; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; DASCAL N, 1987, CRIT REV BIOCHEM MOL, V22, P317, DOI 10.3109/10409238709086960; KUBO Y, 1996, IN PRESS J BIOL CHEM; KUBO Y, 1993, NATURE, V362, P127, DOI 10.1038/362127a0; KUBO Y, 1994, NEUROSCI RES       S, V19, pS92, DOI 10.1016/0921-8696(94)92522-4; PROBST WC, 1992, DNA CELL BIOL, V11, P1, DOI 10.1089/dna.1992.11.1; VARNOLD RL, 1990, DEVELOPMENT, V109, P597	21	27	27	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0014-5793			FEBS LETT	FEBS Lett.	AUG 19	1996	392	1					71	76		10.1016/0014-5793(96)00786-7		6	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Biochemistry & Molecular Biology; Biophysics; Cell Biology	VD666	WOS:A1996VD66600016		
J	Miyata, T; Nakajima, K; Aruga, J; Takahashi, S; Ikenaka, K; Mikoshiba, K; Ogawa, M				Miyata, T; Nakajima, K; Aruga, J; Takahashi, S; Ikenaka, K; Mikoshiba, K; Ogawa, M			Distribution of a reeler gene-related antigen in the developing cerebellum: An immunohistochemical study with an allogeneic antibody CR-50 on normal and reeler mice	JOURNAL OF COMPARATIVE NEUROLOGY			English	Article						neuronal migration; cerebellar cortex; cerebellar granule neuron; Purkinje cell; extracellular matrix	PURKINJE-CELLS; MUTANT MOUSE; EMBRYONIC-DEVELOPMENT; CORTICAL DEVELOPMENT; NEURONAL MIGRATION; RAT CEREBELLUM; PROTEIN; INVITRO; CORTEX; BRAIN	We have immunohistochemically investigated the expression of a reeler gene-related antigen in the mouse cerebellum by using a monoclonal antibody, CR-50. This antibody probes a distinct allelic antigen present in normal but not in reeler mutant mice, and this antigen is localized in the brain regions in which morphological abnormalities occur in reeler mice (Ogawa et al., Neuron 14: 899-912, 1995). The developing normal cerebellum showed transient immunoreactivity to CR-50 in a limited set of neurons and in the extracellular space near the pial surface. An early population of CR-50-labeled cells emerged on embryonic day (E) 13 along the dorsal cerebellar surface, comprising the nuclear transitory zone (NTZ). Bromodeoxyuridine labeling revealed the time of origin of these cells to be at E11-12. From E14 to E18, some CR-50-labeled cells were stacked in the inner border of the external granular layer (EGL), whereas others were scattered in deep areas, such as the cerebellar nuclei and the surrounding intermediate zone or white matter. In the first postnatal week, these subcortical structures became immunonegative. However, CR-50 antigen was continuously produced until the second postnatal week by another population of cells occupying i) the premigratory zone (PMZ), the inner half of the EGL, and ii) the internal granular layer (IGL). These later CR-50-positive cells were smaller than the earlier type and showed the morphology typical of granule neurons. Both types of CR-50-labeled cells were positive for a DNA-binding protein, tie. By treating living cerebellar slices with CR-50, the extracellular antigen was localized as a puncutate staining pattern in the NTZ, PMZ, and molecular layer (ML), but not in the subcortical regions and IGL. Purkinje cells were negative for CR-50 and aligned as a monolayer adjacent to the PMZ, though their dendritic trees were closely associated with the extracellular CR-50-antigen in the PMZ and ML. Staining of dissociated cells suggested that the extracellular antigen is initially present throughout the surfaces of the CR-50/anti-zic double positive neurons, acid is then rearranged to concentrate on their processes contacting with Purkinje cells. The spatiotemporal expressions of the CR-50 antigen in the cerebellum are consistent with the possibility that this antigen is involved in cell-cell interactions related to the histogenetic assembly of Purkinje cells. (C) 1996 Wiley-Liss, Inc.	RIKEN,INST PHYS & CHEM RES,TSUKUBA LIFE SCI CTR,MOL NEUROBIOL LAB,TSUKUBA,IBARAKI 305,JAPAN; NATL INST PHYSIOL SCI,LAB NEURAL INFORMAT,OKAZAKI,AICHI 444,JAPAN; UNIV TOKYO,INST MED SCI,DEPT MOL NEUROBIOL,MINATO KU,TOKYO 108,JAPAN	Miyata, T (reprint author), KOCHI MED SCH,DEPT PHYSIOL,NANKOKU,KOCHI 783,JAPAN.		Aruga, Jun/H-5837-2011; Nakajima, Kazunori/L-3396-2013				FUJITA S, 1967, J CELL BIOL, V32, P277, DOI 10.1083/jcb.32.2.277; GAO WQ, 1991, NEURON, V6, P705, DOI 10.1016/0896-6273(91)90168-Y; BAPTISTA CA, 1994, NEURON, V12, P243, DOI 10.1016/0896-6273(94)90268-2; ARUGA J, 1994, J NEUROCHEM, V63, P1880; SIDMAN RL, 1973, BRAIN RES, V62, P1, DOI 10.1016/0006-8993(73)90617-3; OGAWA M, 1995, NEURON, V14, P899, DOI 10.1016/0896-6273(95)90329-1; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; RAKIC P, 1995, NEURON, V14, P1101, DOI 10.1016/0896-6273(95)90258-9; HIROTSUNE S, 1995, NAT GENET, V10, P77, DOI 10.1038/ng0595-77; CAVINESS VS, 1978, ANNU REV NEUROSCI, V1, P297, DOI 10.1146/annurev.ne.01.030178.001501; ALTMAN J, 1985, J COMP NEUROL, V231, P27, DOI 10.1002/cne.902310104; FALCONER DS, 1951, J GENET, V50, P192, DOI 10.1007/BF02996215; HATTEN ME, 1995, ANNU REV NEUROSCI, V18, P385, DOI 10.1146/annurev.neuro.18.1.385; RAKIC P, 1990, EXPERIENTIA, V46, P882, DOI 10.1007/BF01939380; ALTMAN J, 1985, J COMP NEUROL, V231, P1, DOI 10.1002/cne.902310103; ALTMAN J, 1972, J COMP NEUROL, V145, P353, DOI 10.1002/cne.901450305; RAKIC P, 1971, J COMP NEUROL, V141, P283, DOI 10.1002/cne.901410303; ALTMAN J, 1978, J COMP NEUROL, V179, P23, DOI 10.1002/cne.901790104; MIALE IL, 1961, EXP NEUROL, V4, P277, DOI 10.1016/0014-4886(61)90055-3; MCLEAN IW, 1974, J HISTOCHEM CYTOCHEM, V22, P1077; BOURRAT F, 1986, BRAIN RES, V378, P69, DOI 10.1016/0006-8993(86)90287-8; CHUONG CM, 1987, J CELL BIOL, V104, P331, DOI 10.1083/jcb.104.2.331; GOFFINET AM, 1995, NATURE, V374, P675, DOI 10.1038/374675a0; GOFFINET AM, 1984, BRAIN RES REV, V7, P261, DOI 10.1016/0165-0173(84)90013-4; GOFFINET AM, 1983, ANAT EMBRYOL, V168, P73, DOI 10.1007/BF00305400; HATTEN ME, 1985, J CELL BIOL, V100, P384, DOI 10.1083/jcb.100.2.384; HOFFMAN S, 1982, J BIOL CHEM, V257, P7720; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; LINDNER J, 1983, NATURE, V305, P427, DOI 10.1038/305427a0; MAEDA N, 1989, DEV BIOL, V133, P67, DOI 10.1016/0012-1606(89)90297-2; MARIANI J, 1977, PHILOS T ROY SOC B, V281, P1, DOI 10.1098/rstb.1977.0121; MIKOSHIBA K, 1980, DEV BIOL, V79, P64, DOI 10.1016/0012-1606(80)90073-1; MULLEN RJ, 1978, SOC NEUROSCIENCE S, V2, P47; Mullen R. J., 1984, Chimeras in developmental biology., P353; NAKATSUJI N, 1991, DEVELOPMENT, V106, P441; NIINOBE M, 1988, J NEUROCHEM, V51, P1132, DOI 10.1111/j.1471-4159.1988.tb03078.x; PIERCE E T, 1975, Brain Research, V95, P503, DOI 10.1016/0006-8993(75)90124-9; RAPER JA, 1990, NEURON, V2, P21; RUDEBERG SI, 1961, THESIS U LUND; SORIANO E, 1991, J HISTOCHEM CYTOCHEM, V39, P255; TERASHIMA T, 1986, J COMP NEUROL, V252, P264, DOI 10.1002/cne.902520209; WASSEF M, 1985, DEV BIOL, V111, P129, DOI 10.1016/0012-1606(85)90441-5; YUASA S, 1993, ANAT EMBRYOL, V188, P317	43	77	78	WILEY-LISS	NEW YORK	DIV JOHN WILEY & SONS INC 605 THIRD AVE, NEW YORK, NY 10158-0012	0021-9967			J COMP NEUROL	J. Comp. Neurol.	AUG 19	1996	372	2					215	228				14	Neurosciences; Zoology	Neurosciences & Neurology; Zoology	VC486	WOS:A1996VC48600005		
J	Sklyanin, EK; Takebe, T				Sklyanin, EK; Takebe, T			Algebraic Bethe ansatz for the XYZ Gaudin model	PHYSICS LETTERS A			English	Article							SPIN	The eigenvectors of the Hamiltonians of the XYZ Gaudin model are constructed by means of the algebraic Bethe ansatz. The construction is based on the quasiclassical limit of the corresponding results for the inhomogeneous higher spin eight vertex model.	VA STEKLOV MATH INST,ST PETERSBURG BRANCH,ST PETERSBURG 191011,RUSSIA; UNIV TOKYO,DEPT MATH SCI,MEGURO KU,TOKYO 153,JAPAN				Sklyanin, Evgeny/0000-0003-2194-0643			BAXTER RJ, 1972, ANN PHYS-NEW YORK, V70, P323, DOI 10.1016/0003-4916(72)90270-9; GAUDIN M, 1976, J PHYS-PARIS, V37, P1087, DOI 10.1051/jphys:0197600370100108700; GAUDIN M, 1973, 15592 CEA; Gaudin M, 1983, FONCTION ONDE BETHE; GAUDIN M, 1972, 15591 CEA; Kulish P P, 1982, LECTURE NOTES PHYSIC, V151, P61; MUMFORD D, 1982, TATA LECTURES THETA; SKLYANIN EK, 1983, FUNCT ANAL APPL, V16, P263, DOI 10.1007/BF01077848; SKLYANIN EK, 1984, FUNCT ANAL APPL, V17, P273, DOI 10.1007/BF01076718; SKLYANIN EK, UNPUB; Sklyanin E.K., 1989, J SOVIET MATH, V47, P2473, DOI 10.1007/BF01840429; TAKEBE T, 1992, P 21 C DIFF GEOM MET; Takebe T, 1995, J PHYS A-MATH GEN, V28, P6675, DOI 10.1088/0305-4470/28/23/019; TAKEBE T, 1993, INT J MOD PHYS A, V3, P440; TAKEBE T, 1992, J PHYS A-MATH GEN, V25, P1071, DOI 10.1088/0305-4470/25/5/015; Takhtadzhan L. A., 1979, RUSS MATH SURV, V34, P11, DOI 10.1070/RM1979v034n05ABEH003909	16	47	48	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0375-9601			PHYS LETT A	Phys. Lett. A	AUG 19	1996	219	3-4					217	225		10.1016/0375-9601(96)00448-3		9	Physics, Multidisciplinary	Physics	VE045	WOS:A1996VE04500014		
J	Sato, S; Nakada, M; Shibasaki, M				Sato, S; Nakada, M; Shibasaki, M			The first chemical synthesis of wortmannin by starting from hydrocortisone	TETRAHEDRON LETTERS			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE; INHIBITOR	The first chemical synthesis of wortmannin, a potent and specific inhibitor of PI 3-kinases, was achieved by starting from commercially available and optically pure hydrocortisone. Copyright (C) 1996 Elsevier Science Ltd	UNIV TOKYO,FAC PHARMACEUT SCI,BUNKYO KU,TOKYO 113,JAPAN							KANAI F, 1993, BIOCHEM BIOPH RES CO, V195, P762, DOI 10.1006/bbrc.1993.2111; EVANS DA, 1988, J AM CHEM SOC, V110, P3560, DOI 10.1021/ja00219a035; ARCARO A, 1993, BIOCHEM J, V296, P297; YANO H, 1993, J BIOL CHEM, V268, P25846; HAEFLIGER W, 1975, HELV CHIM ACTA, V58, P1620, DOI 10.1002/hlca.19750580616; APSIMON JW, 1969, CAN J CHEMISTRY, V47, P1989, DOI 10.1139/v69-321; BRIAN PW, 1957, T BRIT MYCOL SOC, V40, P366; BROKA CA, 1992, J ORG CHEM, V57, P4888, DOI 10.1021/jo00044a025; DODGE JA, 1995, BIOORG MED CHEM LETT, V5, P1713, DOI 10.1016/0960-894X(95)00291-Z; Honzawa S, 1995, CHEM PHARM BULL, V43, P2276; KUROSU H, 1995, BIOCHEM BIOPH RES CO, V216, P655, DOI 10.1006/bbrc.1995.2672; MACMILLA.J, 1972, J CHEM SOC CHEM COMM, P1063, DOI 10.1039/c39720001063; NAKANISHI S, 1992, J BIOL CHEM, V267, P2157; OKADA T, 1994, J BIOL CHEM, V269, P3563; PARKER PJ, 1992, CELL GROWTH DIFFER, V3, P747; PETCHER TJ, 1972, J CHEM SOC CHEM COMM, P1061, DOI 10.1039/c39720001061; STEPHENS L, 1995, BIOCHEM SOC T, V23, P207; STEPHENS LR, 1993, BIOCHIM BIOPHYS ACTA, V1179, P27, DOI 10.1016/0167-4889(93)90072-W; MACMILLA.J, 1972, J CHEM SOC PERK T 1, P2898, DOI 10.1039/p19720002898; Vlahos Chris J., 1995, Drugs of the Future, V20, P165; WIESINGER D, 1974, EXPERIENTIA, P135; ZHAO QJ, 1994, STEROIDS, V59, P190, DOI 10.1016/0039-128X(94)90027-2	22	26	26	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB	0040-4039			TETRAHEDRON LETT	Tetrahedron Lett.	AUG 19	1996	37	34					6141	6144		10.1016/0040-4039(96)01332-9		4	Chemistry, Organic	Chemistry	VC820	WOS:A1996VC82000031		
J	Liu, CQ; Hashimoto, Y; Saigo, K				Liu, CQ; Hashimoto, Y; Saigo, K			Regio- and stereoselective ring opening reaction of 2,3-epoxy amines with organo-aluminum reagents leading to 2-substituted 3-amino alcohols	TETRAHEDRON LETTERS			English	Article							ACID INDUCED REARRANGEMENT; ASYMMETRIC EPOXIDATION	Alkylation, alkynylation, and hydride reduction occurred regioselectively at the C-2 position of 2,3-epoxy amines with retention of the configuration at the C-2 upon treatment with organoaluminum reagents to give 2-substituted 3-amino alcohols. The reactions are considered to proceed via aziridinium ion intermediates. Copyright (C) 1996 Elsevier Science Ltd	UNIV TOKYO,GRAD SCH ENGN,DEPT CHEM & BIOTECHNOL,BUNKYO KU,TOKYO 113,JAPAN							HANSON RM, 1991, CHEM REV, V91, P437, DOI 10.1021/cr00004a001; KATSUKI T, 1980, J AM CHEM SOC, V102, P5974, DOI 10.1021/ja00538a077; RAO AS, 1983, TETRAHEDRON, V39, P2323, DOI 10.1016/S0040-4020(01)91961-1; Behrens C. H., 1983, ALDRICHIM ACTA, V16, P67; Finn M.G., 1985, ASYMMETRIC SYNTHESIS, V5, P247; GILL GM, 1996, TETRAHEDRON, V52, P3609; Glasby J., 1979, ENCY ANTIBIOTICS; Johnson R. A., 1991, COMPREHENSIVE ORGANI, V7, P389; LIU C, 1996, IN PRESS B CHEM SOC, V69; LIU QY, 1995, SYNLETT, P1037; LIU QY, 1994, J CHEM SOC PERK T 1, P1363, DOI 10.1039/p19940001363; PFENNINGER A, 1986, SYNTHESIS-STUTTGART, P89; Rosenthal G, 1982, PLANT NONPROTEIN AMI; Rossiter B. E., 1985, ASYMMETRIC SYNTHESIS, V5, P193; SHARPLESS KB, 1984, ORG SYNTH, V63, P66; WESTWELL AD, 1995, J CHEM SOC PERK T 1, P847, DOI 10.1039/p19950000847	16	9	9	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB	0040-4039			TETRAHEDRON LETT	Tetrahedron Lett.	AUG 19	1996	37	34					6177	6180		10.1016/0040-4039(96)01341-X		4	Chemistry, Organic	Chemistry	VC820	WOS:A1996VC82000040		
J	Takeshima, H; Ikemoto, T; Nishi, M; Nishiyama, N; Shimuta, M; Sugitani, Y; Kuno, J; Saito, I; Saito, H; Endo, M; Iino, M; Noda, T				Takeshima, H; Ikemoto, T; Nishi, M; Nishiyama, N; Shimuta, M; Sugitani, Y; Kuno, J; Saito, I; Saito, H; Endo, M; Iino, M; Noda, T			Generation and characterization of mutant mice lacking ryanodine receptor type 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-RELEASE CHANNEL; BINDING-PROTEIN ISOFORMS; BULLFROG SKELETAL-MUSCLE; SARCOPLASMIC-RETICULUM; RABBIT BRAIN; CA2+ RELEASE; DNA; EXPRESSION; GENE	The ryanodine receptor type 3 (RyR-3) functions as a Ca2+-induced Ca2+ release (CICR) channel and is distributed in a wide variety of cell types including skeletal muscle and smooth muscle cells, neurons, and certain non-excitable cells. However, the physiological roles of RyR-3 are totally unclear. To gain an insight into the function of RyR-3 in vivo, we have generated mice lacking RyR-3 by means of the gene targeting technique. The mutant mice thus obtained showed apparently normal growth and reproduction. Although Ca2+-induced Ca2+ release from intracellular Ca2+ stores of the mutant skeletal muscle differed in Ca2+ sensitivity from that of wild-type muscle, excitation-contraction coupling of the mutant muscle seemed to be normal. Moreover, we could not find any significant disturbance in the smooth muscle and lymphocytes from the mutant mice. On the other hand, the mutant mice showed increased locomotor activity, which was about a-fold greater than that of the control mice. These results indicate that the loss of RyR-3 causes no gross abnormalities and suggest that the lack of RyR-3-mediated Ca2+ signaling results in abnormalities of certain neurons in the central nervous system.	SAITAMA MED SCH,DEPT PHARMACOL,MOROYAMA,SAITAMA 35001,JAPAN; TOKYO INST PSYCHIAT,DEPT NEUROCHEM,SETAGAYA KU,TOKYO 156,JAPAN; UNIV TOKYO,FAC PHARMACEUT SCI,DEPT CHEM PHARMACOL,BUNKYO KU,TOKYO 113,JAPAN; TOKYO MED & DENT UNIV,MED RES INST,DIV IMMUNOL DIS,BUNKYO KU,TOKYO 113,JAPAN; JAPANESE FDN CANC RES,INST CANC,DEPT CELL BIOL,TOSHIMA KU,TOKYO 170,JAPAN	Takeshima, H (reprint author), UNIV TOKYO,FAC MED,DEPT PHARMACOL,BUNKYO KU,HONGO 7-3-1,TOKYO 113,JAPAN.						FURUICHI T, 1994, J NEUROSCI, V14, P4794; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GIANNINI G, 1995, J CELL BIOL, V128, P893, DOI 10.1083/jcb.128.5.893; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; TAKESHIMA H, 1994, NATURE, V369, P556, DOI 10.1038/369556a0; ZHANG YX, 1994, BRAIN RES, V658, P127; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; TIMERMAN AP, 1993, J BIOL CHEM, V268, P22992; BRILLANTES AMB, 1994, CELL, V77, P513, DOI 10.1016/0092-8674(94)90214-3; CHRIST M, 1994, J IMMUNOL, V153, P1936; ENDO M, 1977, PHYSIOL REV, V57, P71; FLEISCHER S, 1989, ANNU REV BIOPHYS BIO, V18, P333, DOI 10.1146/annurev.biophys.18.1.333; GIANNINI G, 1992, SCIENCE, V257, P91, DOI 10.1126/science.1320290; HAKAMATA Y, 1994, FEBS LETT, V352, P206, DOI 10.1016/0014-5793(94)00955-4; HAKAMATA Y, 1992, FEBS LETT, V312, P229, DOI 10.1016/0014-5793(92)80941-9; IINO M, 1989, Journal of General Physiology, V94, P363, DOI 10.1085/jgp.94.2.363; MCPHERSON PS, 1993, J BIOL CHEM, V268, P13765; MEISSNER G, 1994, ANNU REV PHYSIOL, V56, P485, DOI 10.1146/annurev.ph.56.030194.002413; MURAYAMA T, 1992, J BIOCHEM-TOKYO, V112, P514; Ottini L, 1996, BIOCHEM J, V315, P207; OYAMADA H, 1994, J BIOL CHEM, V269, P17206; RIOS E, 1994, PHYSIOL REV, V71, P840; Southern E, 1979, Methods Enzymol, V68, P152; SUTKO JL, 1991, J CELL BIOL, V113, P793, DOI 10.1083/jcb.113.4.793; TAKESHIMA H, 1995, EMBO J, V14, P2999; TAKESHIMA H, 1989, NATURE, V339, P439, DOI 10.1038/339439a0	26	129	133	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 16	1996	271	33					19649	19652				4	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	VC669	WOS:A1996VC66900005		
J	Haq, S; Kubo, T; Kurata, S; Kobayashi, A; Natori, S				Haq, S; Kubo, T; Kurata, S; Kobayashi, A; Natori, S			Purification, characterization, and cDNA cloning of a galactose-specific C-type lectin from Drosophila melanogaster	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEREGRINA HUMORAL LECTIN; MANNOSE-BINDING PROTEIN; SARCOPHAGA-PEREGRINA; PERIPLANETA-AMERICANA; HEMOLYMPH; COCKROACH; MECHANISM; IMMUNITY; OPSONIN; DEFENSE	We purified a lectin from a pupal extract of Drosophila melanogaster. This lectin agglutinated trypsinized and glutaraldehyde-fixed bovine red blood cells in the presence of calcium or magnesium, The hapten sugar of this lectin was galactose, The molecular mass of the intact lectin was determined to be 41 kDa, and it comprised 14- and 17-kDa subunits, The 17-kDa subunit was shown to be a glycosylated form of the 14-kDa subunit. Analysis of the cDNA for this lectin revealed that the 14-kDa subunit consists of 163 amino acid residues and contains all residues conserved in various C-type lectins. It was suggested that the Drosophila lectin and Sarcophaga lectin share some properties and function similarly in defense and development, but probably they are not structural homologues.	UNIV TOKYO,FAC PHARMACEUT SCI,BUNKYO KU,TOKYO 113,JAPAN							WEIS WI, 1992, NATURE, V360, P127, DOI 10.1038/360127a0; NOWAK TP, 1976, BIOCHEM BIOPH RES CO, V68, P650, DOI 10.1016/0006-291X(76)91195-5; JOMORI T, 1992, FEBS LETT, V296, P283, DOI 10.1016/0014-5793(92)80305-Z; DRICKAMER K, 1988, J BIOL CHEM, V263, P9557; KYLSTEN P, 1990, EMBO J, V9, P217; DRICKAMER K, 1992, NATURE, V360, P183, DOI 10.1038/360183a0; KAWASAKI K, 1993, COMP BIOCHEM PHYS B, V106, P675, DOI 10.1016/0305-0491(93)90148-X; UMETSU K, 1984, J BIOCHEM-TOKYO, V95, P239; KOMANO H, 1980, J BIOL CHEM, V255, P2919; YEATON RW, 1981, DEV COMP IMMUNOL, V5, P391; Ashburner M., 1989, DROSOPHILA LAB MANUA; BALDO BA, 1978, BIOCHEM J, V175, P467; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; GIGA Y, 1985, BIOCHEMISTRY-US, V24, P4461, DOI 10.1021/bi00337a030; HAMMARSTROM S, 1969, BIOCHEMISTRY-US, V8, P2629; KAWAGUCHI N, 1991, DEV BIOL, V144, P86, DOI 10.1016/0012-1606(91)90481-H; KOMANO H, 1985, DEV COMP IMMUNOL, V9, P31, DOI 10.1016/0145-305X(85)90057-6; KOMANO H, 1981, J BIOL CHEM, V256, P7087; KOMANO H, 1983, J BIOL CHEM, V258, P2143; KUBO T, 1990, INSECT BIOCHEM, V20, P585, DOI 10.1016/0020-1790(90)90070-B; KUBO T, 1987, EUR J BIOCHEM, V168, P75, DOI 10.1111/j.1432-1033.1987.tb13389.x; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LACKIE AM, 1981, J INSECT PHYSIOL, V27, P139, DOI 10.1016/0022-1910(81)90120-7; LACKIE AM, 1980, PARASITOLOGY, V80, P393; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARCHALO.JJ, 1968, J MOL BIOL, V32, P453, DOI 10.1016/0022-2836(68)90022-3; MARSHALL RD, 1974, BIOCH SOC S, V40, P7; MURAMOTO K, 1986, BIOCHIM BIOPHYS ACTA, V874, P285, DOI 10.1016/0167-4838(86)90027-0; Natori Shunji, 1994, P67; NATORI S, 1990, RES IMMUNOL, V141, P938, DOI 10.1016/0923-2494(90)90198-8; RAVINDRANATH MH, 1985, J BIOL CHEM, V260, P8850; TAKAHASHI H, 1986, J INSECT PHYSIOL, V32, P771, DOI 10.1016/0022-1910(86)90080-6; TAKAHASHI H, 1985, J BIOL CHEM, V260, P2228; TEICHBERG VI, 1975, P NATL ACAD SCI USA, V72, P1383, DOI 10.1073/pnas.72.4.1383	34	41	46	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 16	1996	271	33					20213	20218				6	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	VC669	WOS:A1996VC66900090		
J	Onishi, M; Mui, ALF; Morikawa, Y; Cho, L; Kinoshita, S; Nolan, GP; Gorman, DM; Miyajima, A; Kitamura, T				Onishi, M; Mui, ALF; Morikawa, Y; Cho, L; Kinoshita, S; Nolan, GP; Gorman, DM; Miyajima, A; Kitamura, T			Identification of an oncogenic form of the thrombopoietin receptor MPL using retrovirus-mediated gene transfer	BLOOD			English	Article							COLONY-STIMULATING FACTOR; COMMON BETA-SUBUNIT; C-MPL; SIGNAL-TRANSDUCTION; TYROSINE KINASE; CELL-LINE; GM-CSF; LIGAND THROMBOPOIETIN; MOLECULAR-CLONING; POINT MUTATIONS	Thrombopoietin and its receptor (MPL) are important regulators of megakaryopoiesis, We have identified an activating mutation of MPL using a combination of a retrovirus-mediated gene transfer and polymerase chain reaction-driven random mutagenesis. This point mutation causes a single amino acid substitution from Ser(498) to Asn(498) in the transmembrane region and abrogates factor-dependency of all interleukin-3-dependent cell lines tested, Murine interleukin-3-dependent Ba/F3 cells expressing the mutated but not the normal form of MPL were tumorigenic when transduced into syngeneic mice, Analysis of intracellular signaling pathways indicated that the mutant MPL protein constitutively activated two distinct signaling pathways, SHC-Raf-MAPK and JAK2-STAT3/STAT5. (C) 1996 by The American Society of Hematology.	DNAX RES INST MOL & CELLULAR BIOL INC,DEPT CELL SIGNALING,PALO ALTO,CA 94304; STANFORD UNIV,DEPT MOL PHARMACOL,STANFORD,CA 94305; UNIV TOKYO,INST MOL & CELLULAR BIOSCI,BUNKYO KU,TOKYO,JAPAN			Loewen, Nils/E-9946-2014	Loewen, Nils/0000-0001-7167-1213			AHMED SA, 1994, J IMMUNOL METHODS, V170, P211; ALEXANDER WS, 1995, EMBO J, V14, P5569; WATOWICH SS, 1994, MOL CELL BIOL, V14, P3535; IHLE JN, 1995, TRENDS GENET, V11, P69, DOI 10.1016/S0168-9525(00)89000-9; SATTLER M, 1995, EXP HEMATOL, V23, P1040; SILVENNOINEN O, 1993, P NATL ACAD SCI USA, V90, P8429, DOI 10.1073/pnas.90.18.8429; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; LOK S, 1994, NATURE, V369, P565, DOI 10.1038/369565a0; LIN JX, 1995, IMMUNITY, V2, P331, DOI 10.1016/1074-7613(95)90141-8; MUI ALF, 1995, EMBO J, V14, P1166; KAUSHANSKY K, 1994, NATURE, V369, P568, DOI 10.1038/369568a0; BAZAN JF, 1990, P NATL ACAD SCI USA, V87, P6934, DOI 10.1073/pnas.87.18.6934; DRACHMAN JG, 1995, J BIOL CHEM, V270, P4979; METHIA N, 1993, BLOOD, V82, P1395; KITAYAMA H, 1995, BLOOD, V85, P790; GURNEY AL, 1994, SCIENCE, V265, P1445, DOI 10.1126/science.8073287; WEINER DB, 1989, NATURE, V339, P230, DOI 10.1038/339230a0; KITAMURA T, 1989, J CELL PHYSIOL, V140, P323, DOI 10.1002/jcp.1041400219; DESAUVAGE FJ, 1994, NATURE, V369, P533, DOI 10.1038/369533a0; KATO T, 1995, J BIOCHEM-TOKYO, V118, P229; SOUYRI M, 1990, CELL, V63, P1137, DOI 10.1016/0092-8674(90)90410-G; WAKAO H, 1994, EMBO J, V13, P2182; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; GREENBERGER JS, 1983, P NATL ACAD SCI-BIOL, V80, P2931, DOI 10.1073/pnas.80.10.2931; Mui ALF, 1996, EMBO J, V15, P2425; VIGON I, 1992, P NATL ACAD SCI USA, V89, P5640, DOI 10.1073/pnas.89.12.5640; PALACIOS R, 1985, CELL, V41, P727, DOI 10.1016/S0092-8674(85)80053-2; AZAM M, 1995, EMBO J, V14, P1402; BARTLEY TD, 1994, CELL, V77, P1117, DOI 10.1016/0092-8674(94)90450-2; DANDREA R, 1994, BLOOD, V83, P2802; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; GURNEY AL, 1995, P NATL ACAD SCI USA, V92, P5292, DOI 10.1073/pnas.92.12.5292; HAWLEY TS, 1991, CYTOKINE, V3, P60, DOI 10.1016/1043-4666(91)90011-2; JENKINS BJ, 1995, EMBO J, V14, P4276; KITAMURA T, 1995, P NATL ACAD SCI USA, V92, P9146, DOI 10.1073/pnas.92.20.9146; MIYAJIMA A, 1987, GENE, V58, P273, DOI 10.1016/0378-1119(87)90382-9; MIYAJIMA A, 1993, BLOOD, V82, P1960; MIYAZAKI T, 1994, SCIENCE, V266, P1045, DOI 10.1126/science.7973659; MUI ALF, 1994, P SOC EXP BIOL MED, V206, P284; OKUDA K, 1992, BLOOD, V79, P2880; PALLARD C, 1995, EMBO J, V14, P2847; RUSSELL SM, 1994, SCIENCE, V266, P1042, DOI 10.1126/science.7973658; SATO N, 1993, EMBO J, V12, P4181; SKODA RC, 1993, EMBO J, V12, P2645; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; VIGON I, 1993, ONCOGENE, V8, P2607; WELHAM MJ, 1992, J IMMUNOL, V149, P1683; WITTHUHN BA, 1994, NATURE, V370, P153, DOI 10.1038/370153a0; YOSHIMURA A, 1990, NATURE, V348, P647, DOI 10.1038/348647a0	49	73	74	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399	0006-4971			BLOOD	Blood	AUG 15	1996	88	4					1399	1406				8	Hematology	Hematology	VC854	WOS:A1996VC85400030		
J	Onda, T; Yoshikawa, H; Yokota, H; Yasugi, T; Taketani, Y				Onda, T; Yoshikawa, H; Yokota, H; Yasugi, T; Taketani, Y			Assessment of metastases to aortic and pelvic lymph nodes in epithelial ovarian carcinoma - A proposal for essential sites for lymph node biopsy	CANCER			English	Article						ovarian cancer; lymph node metastasis; aortic and pelvic lymph nodes; lymphadenectomy; selective lymph node biopsy	PARAAORTIC LYMPHADENECTOMY; OPERATIVE TREATMENT; CANCER; INVOLVEMENT; SURVIVAL; SPREAD	BACKGROUND. In staging epithelial ovarian carcinoma, it is necessary to assess the presence of lymph node metastases. However, the essential sites of selective lymph node biopsy have yet to be determined. METHODS. The distribution of metastatic aortic and pelvic lymph nodes was studied in 48 patients with positive lymph nodes of 110 patients with ovarian carcinoma who underwent systematic lymphadenectomy of the aortic and pelvic regions extending to the level of the renal vessels. For purpose of analysis, the lymph nodes were classified into five subgroups: the aortic lymph nodes above the inferior mesenteric artery (A1), the aortic lymph nodes below the inferior mesenteric artery (A2), the common iliac and sacral lymph nodes (P1), the internal and external iliac and obturator lymph nodes (P2), and the suprainguinal (the lowest external iliac) lymph nodes (P3). RESULTS. The incidence of metastases to A1, A2, P1, P2, and P3 was 79%, 71%, 46%, 77%, and 40%, respectively. Provided that 2 of the 5 lymph node subgroups were selected for biopsy, the combination of A1 and P2 gave the best results in sensitivity (94% [45 of 48 patients]) and negative (95% [62 of 65 patients]) predictive value for detection of lymph node metastases. CONCLUSIONS. These data indicate that aortic lymph nodes above the inferior mesenteric artery and the internal and external iliac and obturator lymph nodes are essential sites for selective lymph node biopsy in staging epithelial ovarian carcinoma. (C) 1996 American Cancer Society.		Onda, T (reprint author), UNIV TOKYO,DEPT OBSTET & GYNECOL,BUNKYO KU,HONGO 7-3-1,TOKYO 131,JAPAN.						BURGHARDT E, 1991, GYNECOL ONCOL, V40, P103, DOI 10.1016/0090-8258(91)90099-Q; BURGHARDT E, 1986, AM J OBSTET GYNECOL, V155, P315; SCARABELLI C, 1995, GYNECOL ONCOL, V56, P328, DOI 10.1006/gyno.1995.1059; AVERETTE HE, 1983, CANCER CAMPAIGN, V7, P101; BARBER HRK, 1989, BAILLIERE CLIN OB GY, V3, P23, DOI 10.1016/S0950-3552(89)80038-0; BURGHARDT E, 1989, BAILLIERE CLIN OB GY, V3, P157, DOI 10.1016/S0950-3552(89)80050-1; BURGHARDT E, 1984, EUR J GYNECOL ONCOL, V3, P155; CHEN SS, 1987, GYNECOL ONCOL, V27, P368, DOI 10.1016/0090-8258(87)90260-5; CHEN SS, 1983, GYNECOL ONCOL, V16, P95, DOI 10.1016/0090-8258(83)90013-6; DIRE F, 1989, BAILLIERE CLIN OB GY, V3, P131, DOI 10.1016/S0950-3552(89)80048-3; HACKER NF, 1995, GYNECOL ONCOL, V56, P325, DOI 10.1006/gyno.1995.1058; Kigawa J, 1993, Eur J Surg Oncol, V19, P273; PETRU E, 1994, AM J OBSTET GYNECOL, V170, P656; PLENTL AA, 1973, MAJOR PROBLEMS OBSTE, P173; SEVIN BU, 1989, BAILLIERE CLIN OB GY, V3, P13, DOI 10.1016/S0950-3552(89)80037-9; TSURUCHI N, 1993, GYNECOL ONCOL, V49, P51, DOI 10.1006/gyno.1993.1085; WU PC, 1989, BAILLIERE CLIN OB GY, V3, P143, DOI 10.1016/S0950-3552(89)80049-5; WU PC, 1989, BAILLIERE CLIN OB GY, V3, P95, DOI 10.1016/S0950-3552(89)80045-8; WU PC, 1986, AM J OBSTET GYNECOL, V155, P1103; 1987, INT J GYNECOL OBSTET, V25, P87	20	74	79	WILEY-LISS	NEW YORK	DIV JOHN WILEY & SONS INC 605 THIRD AVE, NEW YORK, NY 10158-0012	0008-543X			CANCER	Cancer	AUG 15	1996	78	4					803	808		10.1002/(SICI)1097-0142(19960815)78:4<803::AID-CNCR17>3.0.CO;2-Z		6	Oncology	Oncology	VA437	WOS:A1996VA43700017		
J	Shimizu, M; Yamamoto, A; Nakano, H; Matsuzawa, A				Shimizu, M; Yamamoto, A; Nakano, H; Matsuzawa, A			Augmentation of antitumor immunity with bacterial superantigen, Staphylococcal enterotoxin B-bound tumor cells	CANCER RESEARCH			English	Article							TOXIC-SHOCK SYNDROME; T-CELLS; IL-2 RECEPTORS; LYMPHOCYTES-T; MOUSE SPLEEN; BETA; MICE; STIMULATION; MHC; ACTIVATION	We have examined the effectiveness of a bacterial superantigen, staphylococcal enterotoxin B (SEB)-coupled tumor cells, to induce antitumor activity. SEB was chemically conjugated to tumor cells using a heterobifunctional cross-linking agent acting through NH2 and SH groups. V pst T cells were activated and increased in number after the culture with SEB-bound Meth A cells. The cultured T cells exhibited an antitumor activity in the Winn assay. Interleukin 2 (IL-2) receptor alpha+ (IL-2R(+)) V beta 8(+) T cells but not IL-2R(+) V beta 6(+) T cells increased in number in mice injected with SEB-bound Meth A cells. However, the percentages of V beta 8(+) and beta 6(+) T cells did not change by this immunization. The antitumor effector cells were V beta 7(-)8(-) CD4(+) T cells. In vivo immunization with SEE-bound cells induced a strong antitumor activity, i.e., tumor-free mice/total mice = 14 of 15 (93%) for Meth A and 7 of 15 (47%) for hepatoma MH134. The induced antitumor activity was both dose dependent and tumor specific. Treatment with SEE-bound cells prolonged the survival days of Meth A-bearing mice by 62%. These results suggest that SEB-bound tumor cells may be a powerful method for induction of in vivo antitumor activity.	UNIV TOKYO,INST MED SCI,LAB ANIM RES CTR,MINATO KU,TOKYO 108,JAPAN	Shimizu, M (reprint author), TOKYO METROPOLITAN INST MED SCI,DEPT CANC THERAPEUT,BUNKYO KU,HONKOMAGOME 3-18-22,TOKYO 113,JAPAN.						MARRACK P, 1990, SCIENCE, V248, P705, DOI 10.1126/science.2185544; HANSEN MB, 1989, J IMMUNOL METHODS, V119, P203, DOI 10.1016/0022-1759(89)90397-9; SETH A, 1994, NATURE, V369, P324, DOI 10.1038/369324a0; WINN HJ, 1961, J IMMUNOL, V86, P228; TREDE NS, 1991, J IMMUNOL, V146, P2310; CHEN LP, 1992, CELL, V71, P1093, DOI 10.1016/S0092-8674(05)80059-5; SCHLIEVERT PM, 1981, J INFECT DIS, V143, P509; WYSOCKI LJ, 1978, P NATL ACAD SCI USA, V75, P2844, DOI 10.1073/pnas.75.6.2844; FISCHER H, 1990, J IMMUNOL, V144, P4663; Bergdoll M. S., 1979, FOOD BORNE INFECTION, P443; BETTE M, 1993, J EXP MED, V178, P1531, DOI 10.1084/jem.178.5.1531; CALLAHAN JE, 1990, J IMMUNOL, V144, P2473; DOHLSTEN M, 1991, EUR J IMMUNOL, V21, P1229, DOI 10.1002/eji.1830210520; FRASER JD, 1989, NATURE, V339, P221, DOI 10.1038/339221a0; GONZALEZQUINTIAL R, 1992, J IMMUNOL, V149, P230; GROSSMAN D, 1992, INFECT IMMUN, V60, P5190; HARADA M, 1993, CANCER RES, V53, P106; HERMAN A, 1991, ANNU REV IMMUNOL, V9, P745; HERRMANN T, 1991, J IMMUNOL, V146, P2504; HUANG IY, 1970, J BIOL CHEM, V245, P3518; KATAOKA T, 1983, JPN J CANCER RES, V74, P412; KAWABE Y, 1990, J EXP MED, V172, P1065, DOI 10.1084/jem.172.4.1065; LANDO PA, 1993, CANCER IMMUNOL IMMUN, V36, P223, DOI 10.1007/BF01740903; LAPEYRE C, 1987, MOL IMMUNOL, V24, P1243, DOI 10.1016/0161-5890(87)90118-0; LOWENTHAL JW, 1985, J IMMUNOL, V135, P3988; MACDONALD HR, 1991, EUR J IMMUNOL, V21, P1963, DOI 10.1002/eji.1830210827; MEHRISHI JN, 1969, NATURE, V224, P563, DOI 10.1038/224563a0; MOURAD W, 1989, J EXP MED, V170, P2011, DOI 10.1084/jem.170.6.2011; NEWELL KA, 1991, P NATL ACAD SCI USA, V88, P1074, DOI 10.1073/pnas.88.3.1074; OCHI A, 1993, J IMMUNOL, V151, P3180; OKADA CY, 1990, J IMMUNOL, V144, P3473; OSTRANDROSENBERG S, 1990, J IMMUNOL, V144, P4068; OZAWA H, 1987, J IMMUNOL, V139, P3896; PAYNE J, 1988, P NATL ACAD SCI USA, V85, P7695, DOI 10.1073/pnas.85.20.7695; PEAVY DL, 1970, J IMMUNOL, V105, P1453; ROTT O, 1995, CELL IMMUNOL, V161, P158, DOI 10.1006/cimm.1995.1022; SHIMIZU M, 1992, ELECTROPHORESIS, V13, P136, DOI 10.1002/elps.1150130128; SHU SY, 1994, J IMMUNOL, V152, P1277; CARLSSON R, 1985, CELL IMMUNOL, V96, P175, DOI 10.1016/0008-8749(85)90349-1; SPERO L, 1965, BIOCHEMISTRY-US, V4, P1024, DOI 10.1021/bi00882a007; STAERZ UD, 1985, J IMMUNOL, V134, P3994; TOMONARI K, 1990, IMMUNOGENETICS, V31, P333, DOI 10.1007/BF02115007; WHITE J, 1989, CELL, V56, P27, DOI 10.1016/0092-8674(89)90980-X	43	10	12	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	PUBLIC LEDGER BLDG, SUITE 816, 150 S. INDEPENDENCE MALL W., PHILADELPHIA, PA 19106	0008-5472			CANCER RES	Cancer Res.	AUG 15	1996	56	16					3731	3736				6	Oncology	Oncology	VB986	WOS:A1996VB98600025		
J	Suzuki, M; Kametani, S; Uchida, K; Akanuma, H				Suzuki, M; Kametani, S; Uchida, K; Akanuma, H			Production of 1,5-anhydroglucitol from 1,5-anhydrofructose in erythroleukemia cells	EUROPEAN JOURNAL OF BIOCHEMISTRY			English	Article						1,5-anhydroglucitol; 1,5-anhydrofructose; glycogen; glycogenolysis	PLASMA 1,5-ANHYDROGLUCITOL; DIABETIC-PATIENTS; MAJOR POLYOL; 1,5-ANHYDRO-D-GLUCITOL; TRANSPORT; GLUCOSE; ENZYME; RATS	The pyranoid polyol 1,5-anhydroglucitol (1,5AnGlc-ol) occurs in a wide variety of organisms. Tn humans, it is present as one of the major monosaccharide components in body fluids and serves as an indicator for glycemic control in diabetic care. However, its metabolic origin and fate have been poorly understood. Here we demonstrate that 1,5AnGlc-ol is produced from glucose in erythroleukemia cells, K-562. We show the occurrence of 1,5-anhydrofructose (1,5AnFru), a derivative of 1,5AnGlc-ol oxidized at the C2 position, in K-562 cells. In addition, several pieces of evidence indicated that 1,5AnFru, rather than glucose, was the immediate precursor in 1,5AnGlc-ol production in erythroleukemia cells: exogenous 1,5AnFru was readily taken up into the cells and reduced to 1,5AnGlc-ol, but the reverse reaction, oxidation of 1,5AnGlc-ol to 1,5AnFru, was scarcely observed. The apparent K-m of the overall cellular reduction for 1,5AnFru was estimated as 70 mg/l. This reduction was markedly inhibited by glucose in the culture medium but not by 1,5AnGlc-ol or glucitol. Since 1,5AnFru arises from alpha-1,4-glucans through lyase reactions in fungi and algae, we suggest the possibilities that glycogen is the precursor of 1,5AnFru and, therefore, 1,5AnGlc-ol originates from glycogen in mammals.	UNIV TOKYO,GRAD SCH ARTS & SCI,DEPT LIFE SCI CHEM,MEGURO KU,TOKYO 153,JAPAN; SAITAMA UNIV,FAC ENGN,DEPT FUNCT MAT SCI,URAWA,SAITAMA,JAPAN							AKANUMA Y, 1988, DIABETOLOGIA, V31, P831; AKANUMA H, 1981, J BIOCHEM-TOKYO, V90, P157; BAUTE MA, 1988, PHYTOCHEMISTRY, V27, P3401, DOI 10.1016/0031-9422(88)80738-6; BOEYENS JC, 1983, PHYTOCHEMISTRY, V22, P959; KAMETANI S, 1996, J BIOCHEM-TOKYO, V19, P180; KAMETANI S, 1987, J BIOCHEM-TOKYO, V102, P1599; NAKAMURA T, 1986, J BIOCHEM-TOKYO, V99, P607; NESS RK, 1950, J AM CHEM SOC, V72, P4547, DOI 10.1021/ja01166a059; OKUNO Y, 1992, J BIOCHEM-TOKYO, V111, P99; PITKANEN E, 1973, CLIN CHIM ACTA, V48, P159, DOI 10.1016/0009-8981(73)90361-6; SHIGA Y, 1993, J BACTERIOL, V175, P7138; SUZUKI M, 1988, J BIOCHEM-TOKYO, V104, P956; SUZUKI M, 1994, J BIOCHEM-TOKYO, V115, P87; YAMANOUCHI T, 1994, J BIOL CHEM, V269, P9664; YAMANOUCHI T, 1986, DIABETES, V35, P204, DOI 10.2337/diabetes.35.2.204; YAMANOUCHI T, 1989, DIABETES, V38, P723, DOI 10.2337/diabetes.38.6.723; YAMANOUCHI T, 1992, AM J PHYSIOL, V263, pE268; YU S, 1993, BIOCHIM BIOPHYS ACTA, V1156, P313, DOI 10.1016/0304-4165(93)90049-E	18	28	28	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010	0014-2956			EUR J BIOCHEM	Eur. J. Biochem.	AUG 15	1996	240	1					23	29		10.1111/j.1432-1033.1996.0023h.x		7	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	VE196	WOS:A1996VE19600003		
J	Hashizume, T; Heike, S; Lutwyche, MI; Watanabe, S; Nakajima, K; Nishi, T; Wada, Y				Hashizume, T; Heike, S; Lutwyche, MI; Watanabe, S; Nakajima, K; Nishi, T; Wada, Y			Interaction of Ga adsorbates with dangling bonds on the hydrogen terminated Si(100) surface	JAPANESE JOURNAL OF APPLIED PHYSICS PART 2-LETTERS			English	Article						hydrogen terminated; Si(100); Ga; adsorption; dangling bond; atomic wire	SCANNING-TUNNELING-MICROSCOPY; ELECTRONIC-STRUCTURE; FIRST-PRINCIPLES; FIELD	Adsorption of Ga on the hydrogen terminated Si(100)-2 x 1-H surface has been investigated by scanning tunneling microscopy (STM). We have found that the thermally deposited Ga atoms preferentially adsorb on the hydrogen-missing dangling bonds and on the surface impurities. We desorb hydrogen atoms by the STM current and fabricate atomic-scale dangling-bond wires, in the similar way as was reported by Lyding et al. [Appl. Phys. Lett. 64 (1994) 2010]. In order to fabricate more detailed dangling bond structures, several methods of manipulating (detaching, attaching and moving) the individual hydrogen atoms are tested. We are able to thermally deposit Ga atoms on a dangling-bond wire and fabricate an atomic-scale Ga wire on the Si surface.	UNIV TOKYO,DEPT APPL PHYS,BUNKYO KU,TOKYO 113,JAPAN	Hashizume, T (reprint author), HITACHI LTD,ADV RES LAB,HATOYAMA,SAITAMA 35003,JAPAN.		Nakajima, Ken/A-7875-2010; Nishi, Toshio/A-8112-2010	Nakajima, Ken/0000-0001-7495-0445; Nishi, Toshio/0000-0001-7997-0875			HIROSE K, 1995, PHYS REV B, V51, P5278, DOI 10.1103/PhysRevB.51.5278; LYDING JW, 1994, APPL PHYS LETT, V64, P2010, DOI 10.1063/1.111722; BASKI AA, 1990, J VAC SCI TECHNOL A, V8, P245, DOI 10.1116/1.577076; BINNING G, 1982, PHYS REV LETT, V49, P57, DOI 10.1103/PhysRevLett.49.57; BOLAND JJ, 1993, ADV PHYS, V42, P129, DOI 10.1080/00018739300101474; EIGLER DM, 1990, NATURE, V325, P600; Feynman R. P., 1992, Journal of Microelectromechanical Systems, V1, DOI 10.1109/84.128057; Grey F, 1996, NATO ADV SCI INST SE, V313, P463; HASHIZUME T, 1990, J VAC SCI TECHNOL A, V8, P233, DOI 10.1116/1.577073; HEIKE S, 1995, JPN J APPL PHYS 2, V34, pL1061; NOGAMI J, 1988, APPL PHYS LETT, V53, P2086, DOI 10.1063/1.100289; SAKURAI T, 1990, J VAC SCI TECHNOL A, V8, P259, DOI 10.1116/1.577080; SAKURAI T, 1990, PROG SURF SCI, V33, P3, DOI 10.1016/0079-6816(90)90012-9; TANIDA Y, 1995, IN PRESS SURF SCI; vanderWielen MCMM, 1996, PHYS REV LETT, V76, P1075, DOI 10.1103/PhysRevLett.76.1075; WADA Y, 1993, J APPL PHYS, V74, P7321, DOI 10.1063/1.354999; WATANABE S, UNPUB PHYS REV B; WATANABE S, IN PRESS; WATANABE S, 1995, PHYS REV B, V52, P10768, DOI 10.1103/PhysRevB.52.10768	19	128	128	JAPAN J APPLIED PHYSICS	MINATO-KU TOKYO	DAINI TOYOKAIJI BLDG 24-8 SHINBASHI 4-CHOME, MINATO-KU TOKYO 105, JAPAN	0021-4922			JPN J APPL PHYS 2	Jpn. J. Appl. Phys. Part 2 - Lett.	AUG 15	1996	35	8B					L1085	L1088				4	Physics, Applied	Physics	VF057	WOS:A1996VF05700023		
J	Shigekawa, H; Miyake, K; Ishida, M; Hata, K; Oigawa, H; Nannichi, Y; Yoshizaki, R; Kawazu, A; Abe, T; Ozawa, T; Nagamura, T				Shigekawa, H; Miyake, K; Ishida, M; Hata, K; Oigawa, H; Nannichi, Y; Yoshizaki, R; Kawazu, A; Abe, T; Ozawa, T; Nagamura, T			Phase transition between c(4x2) and p(2x2) structures of the Si(100) surface at 6K caused by the fluctuation of phase defects on dimer rows due to dimer flip-flop motion	JAPANESE JOURNAL OF APPLIED PHYSICS PART 2-LETTERS & EXPRESS LETTERS			English	Article						STM; Si(100); surface reconstruction; dimer; c(4x2); p(2x2)	SCANNING-TUNNELING-MICROSCOPY; LOW-TEMPERATURE; SI(001)	Dimers of the Si(100) surface previously observed at 120-140 K, which partially appeared to be symmetric, were frozen at 6 K, and an atomically resolved structural change between c(4 x 2) and p(2 x 2) arrangements of the Si(100) surface was observed for the first time by scanning tunneling microscopy. The observed change was due to the fluctuation of phase defects of a new type on dimer rows, which have a structure similar to that of the type-C defect. Dimer flip-flop motion at the phase boundary which induces the apparent phase transition; and creation and annihilation of the anti-phase domain were clearly observed.	UNIV TSUKUBA, TSUKUBA ADV RES ALLIANCE, CTR TARA, TSUKUBA, IBARAKI 305, JAPAN; UNISOKU CO LTD, HIRAKATA, OSAKA 57301, JAPAN; UNIV TSUKUBA, INST APPL PHYS, TSUKUBA, IBARAKI 305, JAPAN; UNIV TSUKUBA, CRYOGEN CTR, TSUKUBA, IBARAKI 305, JAPAN; UNIV TOKYO, DEPT APPL PHYS, TOKYO 113, JAPAN	Shigekawa, H (reprint author), UNIV TSUKUBA, TSUKUBA ADV RES ALLIANCE, INST SCI MAT, TSUKUBA, IBARAKI 305, JAPAN.		hata, kenji/B-3262-2009; Miyake, Koji/E-5280-2015				WOLKOW RA, 1992, PHYS REV LETT, V68, P2636, DOI 10.1103/PhysRevLett.68.2636; HAMERS RJ, 1986, PHYS REV B, V34, P5343, DOI 10.1103/PhysRevB.34.5343; HAMERS RJ, 1989, J VAC SCI TECHNOL A, V7, P2854, DOI 10.1116/1.576158; MIYAKE K, 43 SPRING M JAP SOC; NAKAMURA Y, 1995, PHYS REV B, V52, P8231, DOI 10.1103/PhysRevB.52.8231; RAMSTAD A, 1995, PHYS REV B, V51, P14504, DOI 10.1103/PhysRevB.51.14504; SHIGEKAWA H, UNPUB PHYS REV B; SHIGEKAWA H, UNPUB; SHKREBTII AI, 1995, PHYS REV B, V51, P11201, DOI 10.1103/PhysRevB.51.11201; TOCHIHARA H, 1994, PHYS REV B, V50, P12262, DOI 10.1103/PhysRevB.50.12262	10	44	44	JAPAN SOC APPLIED PHYSICS	TOKYO	KUDAN-KITA BUILDING 5TH FLOOR, 1-12-3 KUDAN-KITA, CHIYODA-KU, TOKYO, 102-0073, JAPAN	0021-4922			JPN J APPL PHYS 2	Jpn. J. Appl. Phys. Part 2 - Lett. Express Lett.	AUG 15	1996	35	8B					L1081	L1084				4	Physics, Applied	Physics	VF057	WOS:A1996VF05700022		
J	Takeuchi, S; Masuda, T; Kobayashi, T				Takeuchi, S; Masuda, T; Kobayashi, T			Visible to near-infrared femtosecond dynamics of photoexcited gap states in substituted polyacetylenes	JOURNAL OF CHEMICAL PHYSICS			English	Article							RESOLVED PHOTOINDUCED ABSORPTION; TI-SAPPHIRE LASER; TRANS-POLYACETYLENE; PICOSECOND DYNAMICS; CONJUGATED POLYMERS; CONDUCTING POLYMERS; EXCITED-STATES; SOLITON EXCITATIONS; CHARGED SOLITONS; PULSE GENERATION	Visible to near-infrared transient spectra were measured for thin films of three substituted polyacetylenes with a time-resolution less than or equal to 300 fs. A hot self-trapped exciton (STE) and an oppositely charged, spatially confined soliton-antisoliton pair were temporally and spectrally resolved in detail, which reveals a formation process of the localized excitations with geometrical relaxation taking place-within a subpicosecond time scale. The hot STE showing an exponential decay (tau=115-135 fs) has a spectral peak in the energy region of 1.4-1.5 eV. The transition energies from the hot STE both to continuum state and to a biexciton state are discussed with referring to strength of the Coulomb interactions between the conjugated pi electrons. The soliton-antisoliton pair which decays with a power-law behavior has a dual-peaks spectrum below the band gap energy and the two peak energies vary depending on the polymers. A pi-conjugation length (lambda(c)), a soliton size (xi), and a distance (d) between the soliton and antisoliton were evaluated based on the experimental results for each polymer. The distance was found to be nearly proportional to the conjugation length with a ratio of d/lambda(c)=0.4, indicating that an overall size of the soliton-antisoliton pair approximatedly given by 2 xi+d is limited just within a segmented conjugation chain. The decay kinetics of photoexcitations in both degenerate and nondegenerate systems has been discussed together using an adiabatic potential surface in a configuration space. (C) 1996 American Institute of Physics.	UNIV TOKYO,DEPT PHYS,BUNKYO KU,TOKYO 113,JAPAN; KYOTO UNIV,DEPT POLYMER CHEM,SAKYO KU,KYOTO 606,JAPAN							SU WP, 1980, P NATL ACAD SCI USA, V77, P5626, DOI 10.1073/pnas.77.10.5626; SHANK CV, 1982, PHYS REV LETT, V49, P1660, DOI 10.1103/PhysRevLett.49.1660; SU WP, 1980, PHYS REV B, V22, P2099, DOI 10.1103/PhysRevB.22.2099; FESSER K, 1983, PHYS REV B, V27, P4804, DOI 10.1103/PhysRevB.27.4804; ABE S, 1992, PHYS REV B, V45, P8264, DOI 10.1103/PhysRevB.45.8264; ASAKI MT, 1993, OPT LETT, V18, P977, DOI 10.1364/OL.18.000977; SPENCE DE, 1991, OPT LETT, V16, P42, DOI 10.1364/OL.16.000042; ROSSI G, 1989, J CHEM PHYS, V90, P7594, DOI 10.1063/1.456193; SU WP, 1979, PHYS REV LETT, V42, P1698, DOI 10.1103/PhysRevLett.42.1698; BRAZOVSKII SA, 1981, JETP LETT+, V33, P4; HEEGER AJ, 1988, REV MOD PHYS, V60, P781, DOI 10.1103/RevModPhys.60.781; BALL R, 1983, J PHYS PARIS C, V3, P429; CHOI HY, 1991, MOL CRYST LIQ CRYST, V194, P23, DOI 10.1080/00268949108041147; COLANERI NF, 1988, PHYS REV B, V38, P3960, DOI 10.1103/PhysRevB.38.3960; FANN WS, 1989, PHYS REV LETT, V62, P1492, DOI 10.1103/PhysRevLett.62.1492; FELDBLUM A, 1982, PHYS REV B, V26, P815, DOI 10.1103/PhysRevB.26.815; GRABOWSKI M, 1985, PHYS REV B, V31, P7850, DOI 10.1103/PhysRevB.31.7850; GUO F, 1994, P OPTICAL PROBES CON; HAGLER TW, 1992, CHEM PHYS LETT, V189, P333, DOI 10.1016/0009-2614(92)85211-R; HALLE SD, 1992, SYNTHETIC MET, V49, P429; HALVORSON C, 1993, CHEM PHYS LETT, V216, P488, DOI 10.1016/0009-2614(93)90132-K; HATTORI T, 1987, CHEM PHYS LETT, V133, P230, DOI 10.1016/0009-2614(87)87056-2; HAYDEN GW, 1986, PHYS REV B, V34, P5484, DOI 10.1103/PhysRevB.34.5484; ISHIDA K, 1994, SOLID STATE COMMUN, V90, P89, DOI 10.1016/0038-1098(94)90937-7; KOBAYASHI T, 1992, IEICE T FUND ELECTR, VE75A, P38; Kobayashi T., 1993, RELAXATION POLYM; KOBAYASHI T, 1990, J OPT SOC AM B, V7, P1559; KOBAYASHI T, 1989, SPRINGER P PHYSICS, V36; LANZANI G, 1992, PHYS REV B, V46, P10721, DOI 10.1103/PhysRevB.46.10721; LENG JM, 1994, PHYS REV LETT, V72, P156, DOI 10.1103/PhysRevLett.72.156; LINLIU YR, 1980, PHYS REV B, V22, P5754, DOI 10.1103/PhysRevB.22.5754; MASUDA T, 1990, MACROMOLECULES, V23, P1374, DOI 10.1021/ma00207a023; MCBRANCH D, 1990, PHYS REV B, V42, P3011, DOI 10.1103/PhysRevB.42.3011; ORENSTEIN J, 1982, PHYS REV LETT, V49, P1043, DOI 10.1103/PhysRevLett.49.1043; PHILLIPS SD, 1989, PHYS REV B, V40, P9751, DOI 10.1103/PhysRevB.40.9751; ROTHBERG L, 1987, PHYS REV B, V36, P7529, DOI 10.1103/PhysRevB.36.7529; ROTHBERG L, 1991, MOL CRYST LIQ CRYST, V194, P1, DOI 10.1080/00268949108041145; Rothberg L., 1985, PHYS REV LETT, V57, P3229; SALIN F, 1991, OPT LETT, V16, P1964, DOI 10.1364/OL.16.001964; SHANK CV, 1983, PHYS REV B, V28, P6095, DOI 10.1103/PhysRevB.28.6095; STAMM U, 1990, MOL CRYST LIQ CRYST, V182, P147, DOI 10.1080/00268949008047796; SU WP, 1995, PHYS REV LETT, V74, P1167, DOI 10.1103/PhysRevLett.74.1167; SUM U, 1987, SOLID STATE COMMUN, V61, P607, DOI 10.1016/0038-1098(87)90370-X; TAKAYAMA H, 1980, PHYS REV B, V21, P2388, DOI 10.1103/PhysRevB.21.2388; TAKEUCHI S, 1992, IEEE J QUANTUM ELECT, V28, P2508, DOI 10.1109/3.159557; TAKEUCHI S, 1994, J APPL PHYS, V75, P2757, DOI 10.1063/1.356213; TAKEUCHI S, 1995, PHYS REV B, V52, P7166, DOI 10.1103/PhysRevB.52.7166; TAKEUCHI S, 1994, OPT COMMUN, V109, P518, DOI 10.1016/0030-4018(94)90508-8; TAKEUCHI S, 1993, SOLID STATE COMMUN, V87, P655, DOI 10.1016/0038-1098(93)90132-7; TOWNSEND PD, 1989, PHYS REV B, V40, P3112, DOI 10.1103/PhysRevB.40.3112; VARDENY Z, 1984, PHYSICA B & C, V127, P338, DOI 10.1016/S0378-4363(84)80054-6; VARDENY Z, 1989, SYNTHETIC MET, V28, pC299; VARDENY Z, 1982, PHYS REV LETT, V49, P1657, DOI 10.1103/PhysRevLett.49.1657; WU WK, 1986, PHYS REV B, V33, P8546, DOI 10.1103/PhysRevB.33.8546; YOSHIZAWA M, 1987, J PHYS SOC JPN, V56, P768, DOI 10.1143/JPSJ.56.768; YOSHIZAWA M, 1988, PHYS REV B, V37, P8988, DOI 10.1103/PhysRevB.37.8988; YOSHIZAWA M, 1989, IEEE J QUANTUM ELECT, V25, P2532, DOI 10.1109/3.40639; YOSHIZAWA M, 1991, APPL PHYS B-PHOTO, V53, P296, DOI 10.1007/BF00331817; YOSHIZAWA M, 1994, PHYS REV B, V49, P13259, DOI 10.1103/PhysRevB.49.13259; YOSHIZAWA M, 1988, PHYS REV B, V37, P10301, DOI 10.1103/PhysRevB.37.10301; ZHOU SQ, 1992, POLYMER, V33, P2189, DOI 10.1016/0032-3861(92)90887-3; ZOZULENKO IV, 1990, SOLID STATE COMMUN, V76, P1035, DOI 10.1016/0038-1098(90)90079-Q	62	26	26	AMER INST PHYSICS	WOODBURY	CIRCULATION FULFILLMENT DIV, 500 SUNNYSIDE BLVD, WOODBURY, NY 11797-2999	0021-9606			J CHEM PHYS	J. Chem. Phys.	AUG 15	1996	105	7					2859	2874		10.1063/1.472148		16	Physics, Atomic, Molecular & Chemical	Physics	VB452	WOS:A1996VB45200036		
J	Park, HC; Lee, SH; Ryu, BK; Son, MM; Lee, HS; Yasui, I				Park, HC; Lee, SH; Ryu, BK; Son, MM; Lee, HS; Yasui, I			Nucleation and crystallization kinetics of CaO-Al2O3-2SiO(2) in powdered anorthite glass	JOURNAL OF MATERIALS SCIENCE			English	Article							DIFFERENTIAL THERMAL-ANALYSIS; CORDIERITE GLASS; CERAMICS; BEHAVIOR; EXPANSION; SYSTEM; DTA	The nucleation and crystallization kinetics of CaO-Al2O3-2SiO(2) crystals in powdered anorthite glass with particle size < 44 mu m in which CaO-Al2O3-2SiO(2) crystals were found to crystallize in the heating process of the glass, were studied by nonisothermal measurements using differential thermal analysis (DTA). The temperature of maximum nucleation rate was determined from the DTA curves of samples heat treated at different temperatures. The activation energy and kinetic parameters were simultaneously calculated from the DTA data using previously reported kinetic models. The crystallization process of a sample heat treated at the temperature of the maximum nucleation rate was fitted to kinetic equations with an Avrami constant, n congruent to 2 and a dimensionality of crystal growth, m congruent to 2, indicating that the constant number of nuclei of CaO-Al2O3-2SiO(2) precipitated in a glass matrix grew two-dimensionally with an activation energy taken as an average of the values calculated by the Kissinger and also the Augis and Bennett method of 679 +/- 4 kJ mol(-1).	DAEGU TECH COLL,DEPT CERAM,TAEGU 704120,SOUTH KOREA; UNIV TOKYO,INST IND SCI,TOKYO 106,JAPAN	Park, HC (reprint author), PUSAN NATL UNIV,DEPT INORGAN MAT ENGN,PUSAN 609735,SOUTH KOREA.						TUMMALA RR, 1991, J AM CERAM SOC, V74, P895, DOI 10.1111/j.1151-2916.1991.tb04320.x; AUGIS JA, 1978, J THERM ANAL, V13, P283, DOI 10.1007/BF01912301; GREGORY AG, 1971, J MATER SCI, V6, P1312, DOI 10.1007/BF00552045; MAROTTA A, 1981, J MATER SCI, V16, P341, DOI 10.1007/BF00738622; KISSINGER HE, 1956, J RES NAT BUR STAND, V57, P217, DOI 10.6028/jres.057.026; MATUSITA K, 1980, J NON-CRYST SOLIDS, V38-9, P741, DOI 10.1016/0022-3093(80)90525-6; RABINOVICH EM, 1985, J MATER SCI, V20, P4259, DOI 10.1007/BF00559317; OZAWA T, 1971, POLYMER, V12, P150, DOI 10.1016/0032-3861(71)90041-3; KNICKERBOCKER SH, 1993, AM CERAM SOC BULL, V72, P90; XU XJJ, 1991, J AM CERAM SOC, V74, P909, DOI 10.1111/j.1151-2916.1991.tb04321.x; AWANO M, 1992, J AM CERAM SOC, V35, P2535; BRIDGE DR, 1985, GLASS TECHNOL, V26, P286; DONALD IW, 1995, J MATER SCI, V30, P904, DOI 10.1007/BF01178424; Geiss E. A., 1984, J AM CERAM SOC, V67, P549; HAYWARD PJ, 1987, AM CERAM SOC BULL, V66, P1620; HIROSE Y, 1984, J MATER SCI LETT, V3, P153, DOI 10.1007/BF00723101; KNICKERBOCKER S, 1989, J AM CERAM SOC, V72, P1873, DOI 10.1111/j.1151-2916.1989.tb05994.x; MCCOY MA, 1988, J AM CERAM SOC, V71, P673, DOI 10.1111/j.1151-2916.1988.tb06387.x; Morrell R., 1979, P BRIT CERAMIC SOC, V28, P53; MULLER R, 1989, J THERM ANAL CALORIM, V35, P823, DOI 10.1007/BF02057238; OTA R, 1992, J NON-CRYST SOLIDS, V144, P81, DOI 10.1016/S0022-3093(05)80386-2; PARTRIDGE G, 1994, GLASS TECHNOL, V35, P116; RUDOLPH T, 1993, J NON-CRYST SOLIDS, V155, P273, DOI 10.1016/0022-3093(93)91262-2; RYU BG, 1994, J MATER SCI, V29, P3323, DOI 10.1007/BF00356680; SUNG YM, 1994, J EUR CERAM SOC, V14, P455, DOI 10.1016/0955-2219(94)90084-1; TANIGUCHI A, 1995, J AM CERAM SOC, V72, P460; WATANABE K, 1985, J MATER SCI, V20, P508, DOI 10.1007/BF01026520; ZHIEN L, 1995, J MATER SCI, V30, P390, DOI 10.1007/BF00354401	28	28	29	CHAPMAN HALL LTD	LONDON	2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8HN	0022-2461			J MATER SCI	J. Mater. Sci.	AUG 15	1996	31	16					4249	4253		10.1007/BF00356446		5	Materials Science, Multidisciplinary	Materials Science	VF661	WOS:A1996VF66100012		
J	Ito, Y; Mohamed, HFM; Shiotani, M				Ito, Y; Mohamed, HFM; Shiotani, M			Vacancies in the solids of low molecular weight organic compounds observed by positron annihilation	JOURNAL OF PHYSICAL CHEMISTRY			English	Article							TEMPERATURE; DEPENDENCE; CYCLOHEXANE; LIFETIMES; CATION; ESR	Positron lifetime spectra were measured for several low molecular weight organic compounds, normal and cyclic hydrocarbons and their perfluorinated versions, from room temperature down to about 40 K, and information about the vacancies in them has been extracted from the lifetime and intensity of the ortho-positronium (o-Ps) component. Normally the sizes of vacancies were larger in the solids comprising larger molecules, showing that o-Ps can represent the vacancy size. In the special case of perfluorocyclohexane, the solid of which had to be prepared by sublimation, the vacancy size was larger than expected. In all of the solid molecules studied, two o-Ps states could be observed and their relative importance could easily change, showing a hysteresis-like behavior. At lower temperatures of around 40 K the o-Ps state with longer lifetime and larger intensity became overwhelming for all of the molecules. A further remarkable observation is that o-Ps lifetime and intensity were not very sensitive to most of the phase transitions, including the melting points.	UNIV TOKYO,NUCL SCI & TECHNOL RES CTR,TOKAI,IBARAKI 31911,JAPAN; HIROSHIMA UNIV,FAC ENGN,HIGASHIHIROSHIMA 739,JAPAN			Mohamed, Hamdy/B-2430-2013	Mohamed, Hamdy/0000-0003-2547-4520			Abbe J. Ch., 1985, Positron Annihilation. Proceedings of the Seventh International Conference; ELDRUP M, 1981, CHEM PHYS, V63, P51, DOI 10.1016/0301-0104(81)80307-2; KAJCSOS Z, 1974, APPL PHYS, V5, P53, DOI 10.1007/BF01193395; TAO SJ, 1972, J CHEM PHYS, V56, P5499, DOI 10.1063/1.1677067; Aston JG, 1943, J AM CHEM SOC, V65, P1135, DOI 10.1021/ja01246a034; CHACHATY CBB, 1971, CAN J CHEM, V49, P2953; CHRISTOFFERS HJ, 1947, J AM CHEM SOC, V69, P2502, DOI 10.1021/ja01202a074; CHUANG SY, 1976, APPL PHYS, V11, P247, DOI 10.1007/BF00897060; DWORKIN A, 1969, C R, V269, P73; ELDRUP M., 1982, POSITRON ANNIHILATIO, P753; FRATIELLO A, 1964, J CHEM PHYS, V41, P974, DOI 10.1063/1.1726041; GOWOREK T, 1984, CHEM PHYS LETT, V106, P482, DOI 10.1016/0009-2614(84)85344-0; GOWOREK T, 1990, P 3 INT WORKSH POS P, P533; HIRADE T, 1993, CHEM PHYS, V170, P249, DOI 10.1016/0301-0104(93)80070-P; ITO Y, 1993, J PHYS IV, V3, P241, DOI 10.1051/jp4:1993436; ITO Y, 1988, POSITRON POSITRONIUM, pCH4; JAIN PC, 1986, CHEM PHYS, V106, P303, DOI 10.1016/0301-0104(86)80147-1; KELLY TM, 1965, PHYS LETT, V18, P115, DOI 10.1016/0031-9163(65)90675-X; KOMAGUCHI K, 1996, IN PRESS J PHYS CHEM; LIGHTBODY D, 1985, CHEM PHYS, V93, P475, DOI 10.1016/0301-0104(85)87012-9; LINDGREN M, 1991, RADICAL IONIC SYSTEM, pCH15; Mogensen O. E., 1995, SPRINGER SERIES CHEM, V58; MOGENSEN OE, 1982, POSITRON ANNIHILATIO, P763; Nakanishi H., 1988, POSITRON POSITRONIUM; SHIOTANI M, 1990, J AM CHEM SOC, V112, P967, DOI 10.1021/ja00159a010; Shiotani M., 1987, Magnetic Resonance Review, V12; SHIOTANI M, 1992, CHEM PHYS LETT, V188, P93, DOI 10.1016/0009-2614(92)85094-Q	27	5	5	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036	0022-3654			J PHYS CHEM-US	J. Phys. Chem.	AUG 15	1996	100	33					14161	14165		10.1021/jp9604002		5	Chemistry, Physical	Chemistry	VC550	WOS:A1996VC55000040		
J	Makino, T; Chikaizumi, R; Nagaoka, T; Furuhara, T; Makino, T				Makino, T; Chikaizumi, R; Nagaoka, T; Furuhara, T; Makino, T			Microstructure development in a thermomechanically processed Ti-15V-3Cr-3Sn-3Al alloy	MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES MICROSTRUCTURE AND PROCESSING			English	Article; Proceedings Paper	2nd International Symposium on Metallurgy and Technology of Titanium Alloys	SEP 25-28, 1995	TOKYO, JAPAN			titanium alloys; microstructure; thermomechanical processing; crystallography; alpha precipitates	MICRODUPLEX STRUCTURE	Using a Ti-15V-3Cr-3Sn-3Al alloy, the process of (alpha + beta) microstructure development was studied in heavily cold rolled (by 80%) and aged specimens and in specimens which were rolled, recovered and aged. By aging after 80% cold rolling, cc phase precipitates on dislocations introduced by deformation at all aging temperatures were examined (773-973 K). The rearrangement of dislocations in beta matrix proceeds, resulting in the formation of subgrains as aging is prolonged. In this case; the variants of alpha phase are restricted to a few numbers. On the other hand, in the case of the specimen aged at 933 K after 80% cold rolling and annealing at 1073 K for 30 s, alpha phase precipitates at the subgrain boundary in the recovered beta region. More variants in the Burgers relationship are observed than in the rolled aged specimens. In aging at 773 K after the recovery treatment, alpha precipitates form within beta subgrains as well as the subgrain boundaries.	UNIV TOKYO,TOKYO 113,JAPAN; KYOTO UNIV,DEPT MAT SCI & ENGN,SAKYO KU,KYOTO 60601,JAPAN	Makino, T (reprint author), KYOTO UNIV,NAGOYA INST TECHNOL,DEPT MECH ENGN,NAGOYA,AICHI 466,JAPAN.		Furuhara, Tadashi/B-2149-2010				AMEYAMA K, 1989, J JPN I MET, V53, P1098; AMEYAMA K, 1985, J JPN I MET, V49, P1045; NIWA N, 1991, ISIJ INT, V31, P856, DOI 10.2355/isijinternational.31.856; FURUHARA T, 1992, MATER T JIM, V33, P585; FURUHARA T, IN PRESS METALL MA A; INABA T, 1991, ISIJ INT, V31, P792, DOI 10.2355/isijinternational.31.792; OUCHI C, 1989, 6 WORLD C TIT, P819	7	21	21	ELSEVIER SCIENCE SA LAUSANNE	LAUSANNE 1	PO BOX 564, 1001 LAUSANNE 1, SWITZERLAND	0921-5093			MAT SCI ENG A-STRUCT	Mater. Sci. Eng. A-Struct. Mater. Prop. Microstruct. Process.	AUG 15	1996	213	1-2					51	60		10.1016/0921-5093(96)10236-7		10	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Science & Technology - Other Topics; Materials Science; Metallurgy & Metallurgical Engineering	VG745	WOS:A1996VG74500009		
J	Mashino, S; Mashimo, Y; Horiya, T; Shiwa, M; Kishi, T				Mashino, S; Mashimo, Y; Horiya, T; Shiwa, M; Kishi, T			Analysis of microfracture mechanism of titanium alloy by acoustic emission technique	MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES MICROSTRUCTURE AND PROCESSING			English	Article; Proceedings Paper	2nd International Symposium on Metallurgy and Technology of Titanium Alloys	SEP 25-28, 1995	TOKYO, JAPAN			acoustic emission; fracture toughness; microcracks; fracture mode	FRACTURE-TOUGHNESS	Microfracture mechanism in fracture toughness test of Ti-8Al-1Mo-1V alloy was examined by the newly developed AE wave analysis system termed dynamic crack microscopy (DCM). The specimen with acicular alpha microstructure had higher fracture toughness than that with equiaxed alpha microstructure, In the acicular alpha microstructure, there were many AE events corresponding to the generation of microcracks before the final fracture. AE source characterization indicated that in the case of acicular alpha microstructure, many microcracks of 110 similar to 370 mu m were nucleated in mixed mode ahead of the crack lip, and main crack extended by coalescence of these microcracks in shear mode. From these results, fracture toughness was evaluated quantitatively, using ductile fracture criterion, and it was found that the colony size had a significant influence on the fracture toughness of the acicular alpha microstructure.	JAPAN RES & DEV CTR MET,MINATO KU,TOKYO 105,JAPAN; JAPAN POWER ENGN & INSPECT CORP,TSURUMI KU,YOKOHAMA,KANAGAWA 230,JAPAN; UNIV TOKYO,RES CTR ADV SCI & TECHNOL,MEGURO KU,TOKYO 153,JAPAN	Mashino, S (reprint author), JAPAN TOBACCO INC,CTR RES DEV & ENGN,1-31 KUROBEOKA HIRATSUKA,KANAGAWA 254,JAPAN.						ENOKI M, 1988, INT J FRACTURE, V38, P295; ENOKI M, 1986, P 3 INT AC EM S JPN, P763; HORIYA T, 1990, TETSU TO HAGANE, V76, P606; KISHI T, 1986, TETSU TO HAGANE, V72, P123; MASHINO S, 1991, P 5 INT S NOND CHAR, P93; MASHINO S, 1990, P 10 INT AC EM S JPN, P387	6	9	9	ELSEVIER SCIENCE SA LAUSANNE	LAUSANNE 1	PO BOX 564, 1001 LAUSANNE 1, SWITZERLAND	0921-5093			MAT SCI ENG A-STRUCT	Mater. Sci. Eng. A-Struct. Mater. Prop. Microstruct. Process.	AUG 15	1996	213	1-2					66	70		10.1016/0921-5093(96)10235-5		5	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Science & Technology - Other Topics; Materials Science; Metallurgy & Metallurgical Engineering	VG745	WOS:A1996VG74500011		
J	Itoh, G; Kanno, M; Niwa, N				Itoh, G; Kanno, M; Niwa, N			Mechanical properties of a Ti-15V-3Cr-3Sn-3Al alloy affected by the impurity hydrogen	MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES MICROSTRUCTURE AND PROCESSING			English	Article; Proceedings Paper	2nd International Symposium on Metallurgy and Technology of Titanium Alloys	SEP 25-28, 1995	TOKYO, JAPAN			beta titanium alloy; hydrogen; impurity effect; ductility; hydrogen charging; dehydrogenation		The effect of hydrogen on the tensile properties of a beta titanium alloy (Ti-15V-3Cr-3Sn-3Al) has been studied. Cold-rolled specimens and specimens charged with hydrogen (annealed at 500 degrees C for Ih at atmospheric pressure of hydrogen gas) were solution-treated at 800 degrees C for 1 h, water-quenched and subsequently aged at 510 degrees C. Significant retardation in the age-hardening characteristics of the alloy occurred by the hydrogen charging. The effect of hydrogen charging on the ductility was not found except in the as-solution-treated condition, where slight decrease (from 65% to 60%) in the reduction in area by the charging was detected. However, when tensile tests were carried out using a unique testing machine equipped with an ultra high vacuum chamber and a quadrupole mass spectrometer, a large amount of hydrogen gas was evolved from the specimen at the moment of fracture. Furthermore, the ductility of the uncharged specimen was improved with a reduction in the hydrogen content. Thus it can be concluded that the impurity hydrogen event at the uncharged level has a strong correlation with the fracture and causes a deleterious effect on the ductility.	KOGAKUIN UNIV,DEPT ENGN MECH,KOGAKUIN 160,JAPAN	Itoh, G (reprint author), UNIV TOKYO,FAC ENGN,DEPT MAT SCI,TOKYO,JAPAN.						Bania P. J., 1983, BETA TITANIUM ALLOYS, P209; CHIKAIZUMI R, 1995, MATER RES SOC SYMP P, V364, P1153; HINO T, 1993, SCRIPTA METALL MATER, V29, P1029, DOI 10.1016/0956-716X(93)90172-O; KANNO M, 1995, J JPN I MET, V59, P596; LEDERICH RJ, 1993, BETA TITANIUM ALLOYS IN THE 1990S, P159; NAKASA K, 1991, J JPN I MET, V55, P922; Paton N. E., 1974, HYDROGEN METALS, P409; SHIH DS, 1986, SCRIPTA METALL MATER, V20, P1261, DOI 10.1016/0036-9748(86)90044-X; YOUNG GA, 1993, BETA TITANIUM ALLOYS IN THE 1990S, P147; YOUNG GA, 1993, SCRIPTA METALL MATER, V28, P507, DOI 10.1016/0956-716X(93)90091-6	10	3	3	ELSEVIER SCIENCE SA LAUSANNE	LAUSANNE 1	PO BOX 564, 1001 LAUSANNE 1, SWITZERLAND	0921-5093			MAT SCI ENG A-STRUCT	Mater. Sci. Eng. A-Struct. Mater. Prop. Microstruct. Process.	AUG 15	1996	213	1-2					93	97		10.1016/0921-5093(96)10230-6		5	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Science & Technology - Other Topics; Materials Science; Metallurgy & Metallurgical Engineering	VG745	WOS:A1996VG74500015		
J	Katoh, M; Hirai, M; Sugimura, T; Terada, M				Katoh, M; Hirai, M; Sugimura, T; Terada, M			Cloning, expression and chromosomal localization of Wnt-13, a novel member of the Wnt gene family	ONCOGENE			English	Article						Wnt gene family; human carcinogenesis; gastric cancer	RECEPTOR TYROSINE KINASE; TRANSGENIC MICE; MAMMARY CARCINOGENESIS; MOLECULAR-CLONING; SEQUENCE; INT-1; INT-2/FGF-3; ONCOGENE; WELL	The Wnt genes, encoding structurally-related secreted glycoproteins, are implicated in mammary carcinogenesis induced by mouse mammary tumor virus, In search of the Wnt gene(s) expressed in human gastric cancer, a WTGC1 cDNA fragment sharing 66.9% amino-acid homology with human and mouse Wnt-2 was isolated by degenerate polymerase chain reaction. The human gene corresponding to WTGC1 was designated as Wnt-13 and overlapping Wnt-13 cDNAs were cloned, Nucleotide sequence analysis indicated that the Wnt-13 gene encodes the protein of 372 amino acids, including a signal peptide, two potential N-glycosylation sites and 24 cystein residues highly conserved among members of the Wnt gene family, The Wnt-13 mRNA of 2.5 kb in size was detected in heart, brain, placenta, lung, prostate, testis, ovary, small intestine and colon of adult human and also in brain, lung and kidney of fetal human, Among various cancer cell lines, the Wnt-13 mRNA was detected in HeLa (cervical cancer), MKN28 and MKN74 (gastric cancer), The Wnt-13 gene has been mapped to human chromosome 1p13, These results suggest that the Wnt-13 gene may be involved in normal human development or differentiation as well as in human carcinogenesis.	NATL CANC CTR,RES INST,DIV GENET,CHUO KU,TOKYO 104,JAPAN; UNIV TOKYO,GRAD SCH SCI,DEPT ANTHROPOL,BUNKYO KU,TOKYO 113,JAPAN							NUSSE R, 1982, CELL, V31, P99, DOI 10.1016/0092-8674(82)90409-3; GAVIN BJ, 1990, GENE DEV, V4, P2319, DOI 10.1101/gad.4.12b.2319; LEE FS, 1995, P NATL ACAD SCI USA, V92, P2268, DOI 10.1073/pnas.92.6.2268; WONG GT, 1994, MOL CELL BIOL, V14, P6278; KWAN H, 1992, MOL CELL BIOL, V12, P147; TSUKAMOTO AS, 1988, CELL, V55, P619, DOI 10.1016/0092-8674(88)90220-6; KATOH M, 1993, BIOCHEM BIOPH RES CO, V192, P1189, DOI 10.1006/bbrc.1993.1542; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; ADAMSON MC, 1994, GENOMICS, V24, P9, DOI 10.1006/geno.1994.1575; NUSSE R, 1992, CELL, V69, P1073, DOI 10.1016/0092-8674(92)90630-U; CLARK CC, 1993, GENOMICS, V18, P249, DOI 10.1006/geno.1993.1463; HIRAI M, 1994, CYTOGENET CELL GENET, V66, P149, DOI 10.1159/000133687; HUGUET EL, 1994, CANCER RES, V54, P2615; IOZZO RV, 1995, CANCER RES, V55, P3495; KATOH M, 1992, P NATL ACAD SCI USA, V89, P2960, DOI 10.1073/pnas.89.7.2960; KATOH M, 1995, ONCOGENE, V10, P1447; MACARTHUR CA, 1995, J VIROL, V69, P2501; NAKATANI H, 1990, JPN J CANCER RES, V81, P707; ROELINK H, 1993, GENOMICS, V17, P790, DOI 10.1006/geno.1993.1412; SHACKLEFORD GM, 1993, P NATL ACAD SCI USA, V90, P740, DOI 10.1073/pnas.90.2.740; VANOOYEN A, 1985, EMBO J, V4, P2905; WAINWRIGHT BJ, 1988, EMBO J, V7, P1743; WOLDA SL, 1992, ONCOGENE, V7, P1941	23	147	149	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	AUG 15	1996	13	4					873	876				4	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	VD433	WOS:A1996VD43300023		
J	Yeom, HW; Abukawa, T; Takakuwa, Y; Mori, Y; Shimatani, T; Kakizaki, A; Kono, S				Yeom, HW; Abukawa, T; Takakuwa, Y; Mori, Y; Shimatani, T; Kakizaki, A; Kono, S			Surface core levels of In adsorption on Si(001)2x1	PHYSICAL REVIEW B			English	Article							LOW-COVERAGE; SI(100); GA; AL; SPECTROSCOPY; ORIENTATION; DIMERS; SI	The noble surface reconstructions of 2x2, 2x3, and 4x3 induced by In adsorption on a Si(001) surface have been studied by high-resolution photoelectron spectroscopy using synchrotron radiation. The surface core-level shifts of Si 2p were resolved, for the first time, for group-III adsorption on Si(001). It is shown that the Si dimers not bonded to In in the 2x3 phase are buckled and the Si dimers bonded to In are symmetric in both the 2x2 and 2x3 phases. In 4d spectra for all the three phases show a single component in agreement with the prevailing structure models of 2x3 and 2x2 phases but in contradiction to those of 4x3.	TOHOKU UNIV,FAC SCI,DEPT PHYS,SENDAI,MIYAGI 98077,JAPAN; UNIV TOKYO,SYNCHROTRON RADIAT LAB,ISSP,TOKYO 106,JAPAN; TOHOKU UNIV,SCI MEASUREMENTS RES INST,SENDAI,MIYAGI 98077,JAPAN							ADAMS GB, 1992, J VAC SCI TECHNOL A, V10, P2046, DOI 10.1116/1.578022; Grehk TM, 1995, PHYS REV B, V52, P16593, DOI 10.1103/PhysRevB.52.16593; PEHLKE E, 1993, PHYS REV LETT, V71, P2338, DOI 10.1103/PhysRevLett.71.2338; BRINGANS RD, 1987, PHYS REV B, V36, P9569, DOI 10.1103/PhysRevB.36.9569; BROCKS G, 1993, PHYS REV LETT, V70, P2786, DOI 10.1103/PhysRevLett.70.2786; BULLOCK EL, 1995, PHYS REV LETT, V74, P2756, DOI 10.1103/PhysRevLett.74.2756; CHAO YC, 1995, PHYS REV B, V52, P2579, DOI 10.1103/PhysRevB.52.2579; CHEN X, INP RESS J ELECT SPE; FINK R, 1994, STRUCTURE SURFACES, V4, P87; HIMPSEL FJ, 1990, PHOTOEMISSION ABSORP; KONO S, 1994, SURF REV LETT, V1, P359, DOI 10.1142/S0218625X94000345; LANDEMARK E, 1992, PHYS REV LETT, V69, P1588, DOI 10.1103/PhysRevLett.69.1588; LELAY G, 1994, SURF SCI, V307, P280, DOI 10.1016/0039-6028(94)90408-1; NORTHRUP JE, 1991, PHYS REV B, V44, P13799, DOI 10.1103/PhysRevB.44.13799; QIAN Y, 1994, PHYS REV LETT, V73, P1521, DOI 10.1103/PhysRevLett.73.1521; RICH DH, 1987, PHYS REV LETT, V58, P579, DOI 10.1103/PhysRevLett.58.579; SAKAMA H, 1993, PHYS REV B, V48, P5278, DOI 10.1103/PhysRevB.48.5278; SAKAMA H, 1994, PHYS REV B, V50, P14977, DOI 10.1103/PhysRevB.50.14977; SHIMIZU N, 1995, PHYS REV B, V51, P5550, DOI 10.1103/PhysRevB.51.5550; STEELE BE, 1993, PHYS REV B, V47, P9925, DOI 10.1103/PhysRevB.47.9925; STEELE BE, 1994, NUCL INSTRUM METH B, V85, P414, DOI 10.1016/0168-583X(94)95855-6; TANG S, 1995, PHYS REV B, V51, P1593, DOI 10.1103/PhysRevB.51.1593; YAMAZAKI Y, 1994, UNPUB MRS S P, V318, P318; YEOM HW, IN PRESS; YEOM HW, 1995, SURF SCI, V341, P328, DOI 10.1016/0039-6028(95)00688-5; Yeom HW, 1996, PHYS REV B, V53, P1948, DOI 10.1103/PhysRevB.53.1948; YEOM HW, 1995, SURF SCI, V340, pL983, DOI 10.1016/0039-6028(95)00722-9	27	35	35	AMERICAN PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	0163-1829			PHYS REV B	Phys. Rev. B	AUG 15	1996	54	7					4456	4459		10.1103/PhysRevB.54.4456		4	Physics, Condensed Matter	Physics	VE488	WOS:A1996VE48800022		
J	Hatsugai, Y; Kohmoto, M; Wu, YS				Hatsugai, Y; Kohmoto, M; Wu, YS			Hidden massive Dirac fermions in effective field theory for integral quantum Hall transitions	PHYSICAL REVIEW B			English	Article							MAGNETIC-FIELD; GAUGE-THEORIES; EDGE STATES; CONDUCTANCE; LATTICE; QUANTIZATION; DIMENSIONS; NEUTRINOS; HOMOTOPY; ABSENCE	Integral quantum Hall plateau transitions in a planar lattice system due to gap collapse can be described by an effective field theory with Dirac fermions. We discuss how to reproduce the correct integral values for the Hall conductance sigma(xy) before and after the plateau transition, which are dictated by the microscopic topological invariant. In addition to the massless Dirac fermions that appear at gap closing, the matching condition of sigma(xy) requires the introduction of massive Dirac fermions, as ''spectators,'' in the effective field theory. For noninteracting electrons on the lattice, we give a general prescription to determine these massive spectators, based on microscopic information on the vortices in the magnetic Brillouin zone which are closely related to edge states. Our description is demonstrated in a model with both nearest-neighbor and next-nearest-neighbor hoppings.	UNIV TOKYO,INST SOLID STATE PHYS,MINATO KU,TOKYO 106,JAPAN; UNIV UTAH,DEPT PHYS,SALT LAKE CITY,UT 84112	Hatsugai, Y (reprint author), UNIV TOKYO,DEPT APPL PHYS,BUNKYO KU,7-3-1 HONGO,TOKYO 113,JAPAN.		Hatsugai, Yasuhiro/G-3793-2010	Hatsugai, Yasuhiro/0000-0001-6933-5552			THOULESS DJ, 1982, PHYS REV LETT, V49, P405, DOI 10.1103/PhysRevLett.49.405; HATSUGAI Y, 1993, PHYS REV LETT, V71, P3697, DOI 10.1103/PhysRevLett.71.3697; ISHIKAWA K, 1984, PHYS REV LETT, V53, P1615, DOI 10.1103/PhysRevLett.53.1615; AVRON JE, 1983, PHYS REV LETT, V51, P51, DOI 10.1103/PhysRevLett.51.51; REDLICH AN, 1984, PHYS REV D, V29, P2366, DOI 10.1103/PhysRevD.29.2366; COLEMAN S, 1985, PHYS LETT B, V159, P184, DOI 10.1016/0370-2693(85)90883-4; NIEMI AJ, 1983, PHYS REV LETT, V51, P2077, DOI 10.1103/PhysRevLett.51.2077; ZUMINO B, 1984, NUCL PHYS B, V239, P477, DOI 10.1016/0550-3213(84)90259-1; CHEN W, 1993, PHYS REV B, V48, P13749, DOI 10.1103/PhysRevB.48.13749; NIU Q, 1985, PHYS REV B, V31, P3372, DOI 10.1103/PhysRevB.31.3372; AVRON JE, 1985, PHYS REV LETT, V54, P259, DOI 10.1103/PhysRevLett.54.259; HATSUGAI Y, 1993, PHYS REV B, V48, P11851, DOI 10.1103/PhysRevB.48.11851; NIELSEN HB, 1981, NUCL PHYS B, V193, P173, DOI 10.1016/0550-3213(81)90524-1; NIELSEN HB, 1981, NUCL PHYS B, V185, P20, DOI 10.1016/0550-3213(81)90361-8; JACKIW R, 1984, PHYS REV D, V29, P2375, DOI 10.1103/PhysRevD.29.2375; HALDANE FDM, 1988, PHYS REV LETT, V61, P2015, DOI 10.1103/PhysRevLett.61.2015; DESER S, 1982, ANN PHYS-NEW YORK, V140, P372, DOI 10.1016/0003-4916(82)90164-6; HATSUGAI Y, 1990, PHYS REV B, V42, P8282, DOI 10.1103/PhysRevB.42.8282; Kohmoto M, 1985, ANN PHYS-NEW YORK, V160, P355; KOHMOTO M, 1989, PHYS REV B, V39, P11943, DOI 10.1103/PhysRevB.39.11943; NIEMI AJ, 1986, NUCL PHYS B, V276, P173, DOI 10.1016/0550-3213(86)90019-2; OSHIKAWA M, 1994, PHYS REV B, V50, P17357, DOI 10.1103/PhysRevB.50.17357; PRYADKO L, 1994, PHYS REV LETT, V73, P3282, DOI 10.1103/PhysRevLett.73.3282; SEMENOFF GW, 1989, PHYS REV LETT, V62, P715, DOI 10.1103/PhysRevLett.62.715; THOOFT GT, 1980, RECENT DEV GAUGE THE; WEN XG, 1993, PHYS REV LETT, V70, P1501, DOI 10.1103/PhysRevLett.70.1501; WEN XG, 1989, NUCL PHYS B, V316, P641, DOI 10.1016/0550-3213(89)90062-X	27	16	16	AMERICAN PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	0163-1829			PHYS REV B	Phys. Rev. B	AUG 15	1996	54	7					4898	4906		10.1103/PhysRevB.54.4898		9	Physics, Condensed Matter	Physics	VE488	WOS:A1996VE48800078		
J	Hatsugai, Y; Kohmoto, M; Koma, T; Wu, YS				Hatsugai, Y; Kohmoto, M; Koma, T; Wu, YS			Mutual-exclusion statistics in exactly solvable models in one and higher dimensions at low temperatures	PHYSICAL REVIEW B			English	Article							THERMAL BETHE-ANSATZ; HEISENBERG-MODEL; FRACTIONAL-STATISTICS; COMPLEX WAVENUMBERS; HUBBARD CHAIN; STATES; THERMODYNAMICS; SPIN; COMPLETENESS; EXCITATIONS	We study statistical characterization of the many-body states in exactly solvable models with internal degrees of freedom. The models under consideration include the isotropic and anisotropic Heisenberg spin chains, the Hubbard chain, and a model in higher dimensions which exhibits the Mott metal-insulator transition. It is shown that the ground states of these systems are all described by that of a generalized ideal gas of particles (called exclusons) which have mutual-exclusion statistics, either between different rapidities or between different species. For the Bethe ansatz solvable models, the low-temperature properties are well described by the excluson description if the degeneracies due to string solutions with complex rapidities are taken into account correctly. For the Hubbard chain with strong but finite coupling, charge-spin separation is shown for thermodynamics at low temperatures. Moreover, we present an exactly solvable model in arbitrary dimensions which, in addition to giving a perspective view of spin-charge separation, constitutes an explicit example of mutual-exclusion statistics in more than two dimensions.	UNIV TOKYO, INST SOLID STATE PHYS, MINATO KU, TOKYO 106, JAPAN; GAKUSHUIN UNIV, DEPT PHYS, TOSHIMA KU, TOKYO 171, JAPAN; UNIV UTAH, DEPT PHYS, SALT LAKE CITY, UT 84112 USA			Hatsugai, Yasuhiro/G-3793-2010	Hatsugai, Yasuhiro/0000-0001-6933-5552			CONTINENTINO MA, 1994, PHYS REP, V239, P179, DOI 10.1016/0370-1573(94)90112-0; YANG CN, 1969, J MATH PHYS, V10, P1115, DOI 10.1063/1.1664947; WU YS, 1984, PHYS REV LETT, V52, P2103, DOI 10.1103/PhysRevLett.52.2103; FADDEEV LD, 1981, PHYS LETT A, V85, P375, DOI 10.1016/0375-9601(81)90335-2; WU YS, 1994, PHYS REV LETT, V73, P922, DOI 10.1103/PhysRevLett.73.922; SUZUKI J, 1990, J PHYS SOC JPN, V59, P2667, DOI 10.1143/JPSJ.59.2667; HALPERIN BI, 1984, PHYS REV LETT, V52, P1583, DOI 10.1103/PhysRevLett.52.1583; OGATA M, 1990, PHYS REV B, V41, P2326, DOI 10.1103/PhysRevB.41.2326; BABUJIAN HM, 1983, NUCL PHYS B, V215, P317, DOI 10.1016/0550-3213(83)90668-5; LIEB EH, 1963, PHYS REV, V130, P1605, DOI 10.1103/PhysRev.130.1605; LIEB EH, 1968, PHYS REV LETT, V20, P1445, DOI 10.1103/PhysRevLett.20.1445; MATTIS DC, 1965, J MATH PHYS, V6, P304, DOI 10.1063/1.1704281; KATSURA S, 1962, PHYS REV, V127, P1508, DOI 10.1103/PhysRev.127.1508; AFFLECK I, 1986, PHYS REV LETT, V56, P746, DOI 10.1103/PhysRevLett.56.746; CALOGERO F, 1969, J MATH PHYS, V10, P2191, DOI 10.1063/1.1664820; YANG CN, 1966, PHYS REV, V150, P321, DOI 10.1103/PhysRev.150.321; FISHER MPA, 1989, PHYS REV B, V40, P546, DOI 10.1103/PhysRevB.40.546; HALDANE FDM, 1991, PHYS REV LETT, V67, P937, DOI 10.1103/PhysRevLett.67.937; KATSURA S, 1963, PHYS REV, V129, P2835, DOI 10.1103/PhysRev.129.2835.4; KOMA T, 1987, PROG THEOR PHYS, V78, P1213, DOI 10.1143/PTP.78.1213; WILCZEK F, 1982, PHYS REV LETT, V48, P1144, DOI 10.1103/PhysRevLett.48.1144; DESTRI C, 1992, PHYS REV LETT, V69, P2313, DOI 10.1103/PhysRevLett.69.2313; YAMADA T, 1969, PROG THEOR PHYS, V41, P880, DOI 10.1143/PTP.41.880; Bethe H, 1931, Z PHYS, V71, P205, DOI 10.1007/BF01341708; BASKARAN G, 1991, INT J MOD PHYS LET B, V5, P643; BERNARD D, 1995, P 6 NANK WORKSH TIAN; BYCZUK K, 1995, PHYS REV B, V50, P11403; CALOGERO F, 1969, J MATH PHYS, V10, P2197, DOI 10.1063/1.1664821; CONTINENTINO MA, 1994, SOLID STATE COMMUN, V90, P619, DOI 10.1016/0038-1098(94)90533-9; des Clpizeaux J., 1962, Physical Review, V128, DOI 10.1103/PhysRev.128.2131; DORLAS TC, 1993, COMMUN MATH PHYS, V154, P347, DOI 10.1007/BF02097001; DORLAS TC, 1989, COMMUN MATH PHYS, V124, P365, DOI 10.1007/BF01219656; Faddeev L D, 1984, J SOVIET MATH, V24, P241, DOI DOI 10.1007/BF01087245; FUKUI T, 1995, PHYS REV B, V51, P5239, DOI 10.1103/PhysRevB.51.5239; HATSUGAI Y, 1992, J PHYS SOC JPN, V61, P2056, DOI 10.1143/JPSJ.61.2056; KOMA T, 1987, PROG THEOR PHYS, V78, P1009, DOI 10.1143/PTP.78.1009; KOMA T, 1989, PROG THEOR PHYS, V81, P783, DOI 10.1143/PTP.81.783; LIEB E, 1961, ANN PHYS-NEW YORK, V16, P407, DOI 10.1016/0003-4916(61)90115-4; NOMURA K, 1991, PHYS REV B, V43, P8217, DOI 10.1103/PhysRevB.43.8217; SPALEK J, 1988, PHYS REV B, V37, P1532, DOI 10.1103/PhysRevB.37.1532; SUTHERLAND B, 1985, LECT NOTES PHYS, V242, P1; SUTHERLA.B, 1971, J MATH PHYS, V12, P251, DOI 10.1063/1.1665585; TAKAHASH.M, 1972, PROG THEOR PHYS, V48, P2187, DOI 10.1143/PTP.48.2187; TAKAHASH.M, 1973, PROG THEOR PHYS, V50, P1519, DOI 10.1143/PTP.50.1519; Wilczek F., 1989, FRACTIONAL STAT ANYO; WOYNAROVICH F, 1982, J PHYS C SOLID STATE, V15, P85, DOI 10.1088/0022-3719/15/1/007; WOYNAROVICH F, 1982, J PHYS C SOLID STATE, V15, P97, DOI 10.1088/0022-3719/15/1/008; WU YS, 1984, PHYS REV LETT, V53, P111, DOI 10.1103/PhysRevLett.53.111; WU YS, 1995, PHYS REV LETT, V75, P890, DOI 10.1103/PhysRevLett.75.890	49	20	20	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	1098-0121	1550-235X		PHYS REV B	Phys. Rev. B	AUG 15	1996	54	8					5358	5367		10.1103/PhysRevB.54.5358		10	Physics, Condensed Matter	Physics	VF929	WOS:A1996VF92900035		
J	Mizokawa, T; Fujimori, A				Mizokawa, T; Fujimori, A			Electronic structure and orbital ordering in perovskite-type 3d transition-metal oxides studied by Hartree-Fock band-structure calculations	PHYSICAL REVIEW B			English	Article							RAY-ABSORPTION SPECTROSCOPY; INSULATOR-TRANSITION; NEUTRON-DIFFRACTION; MOTT INSULATORS; HUBBARD GAP; RNIO3 R=PR; PHOTOEMISSION; ND; SPECTRA; SEMICONDUCTOR	We have studied transition-metal 3d-oxygen 2p lattice models, where full degeneracy of transition-metal 3d and oxygen 2p orbitals and on-site Coulomb and exchange interactions between 3d electrons are taken into account, by means of a spin- and orbital-unrestricted Hartree-Fock (HF) approximation. The electronic-structure parameters deduced from the cluster-model analyses of the photoemission spectra are used as input. We have applied this method to perovskite-type 3d transition-metal oxides, which exhibit various electrical and magnetic properties. It is shown that the HF results can explain the ground-state properties of insulating oxides. The relationship between spin- and orbital-ordered solutions and the Jahn-Teller-type and GdFeO3-type distortions in RTiO(3), RVO(3), RMnO(3), and RNiO(3) (R is a rare earth atom or Y) is extensively studied. Single-particle excitation spectra calculated using Koopmans' theorem give us an approximate but relevant picture on the electronic structure of the perovskite-type 3d transition-metal oxides. As a drawback, the HF calculations tend to overestimate the magnitude of the band gap compared with the experimental results and to predict some paramagnetic metals as antiferromagnetic insulators.		Mizokawa, T (reprint author), UNIV TOKYO, DEPT PHYS, BUNKYO KU, 7-3-1 HONGO, TOKYO 113, JAPAN.		Mizokawa, Takashi/E-3302-2015	Mizokawa, Takashi/0000-0002-7682-2348			BOCQUET AE, 1992, PHYS REV B, V46, P3771, DOI 10.1103/PhysRevB.46.3771; BRANDOW BH, 1977, ADV PHYS, V26, P651, DOI 10.1080/00018737700101443; UOZUMI T, 1993, J PHYS SOC JPN, V62, P2595, DOI 10.1143/JPSJ.62.2595; SAITOH T, 1995, PHYS REV B, V51, P13942, DOI 10.1103/PhysRevB.51.13942; LACORRE P, 1991, J SOLID STATE CHEM, V91, P225, DOI 10.1016/0022-4596(91)90077-U; Sawada H, 1996, PHYS REV B, V53, P12742, DOI 10.1103/PhysRevB.53.12742; CYROT M, 1975, J PHYS-PARIS, V36, P253, DOI 10.1051/jphys:01975003603025300; GARCIAMUNOZ JL, 1992, PHYS REV B, V46, P4414, DOI 10.1103/PhysRevB.46.4414; GOODENOUGH JB, 1955, PHYS REV, V100, P564, DOI 10.1103/PhysRev.100.564; CZYZYK MT, 1994, PHYS REV B, V49, P14211, DOI 10.1103/PhysRevB.49.14211; KAWANO H, 1994, J PHYS SOC JPN, V63, P2857, DOI 10.1143/JPSJ.63.2857; FUJIMORI A, 1984, PHYS REV B, V30, P957, DOI 10.1103/PhysRevB.30.957; TAGUCHI Y, 1993, PHYS REV B, V48, P511, DOI 10.1103/PhysRevB.48.511; ZAANEN J, 1985, PHYS REV LETT, V55, P418, DOI 10.1103/PhysRevLett.55.418; KANAMORI J, 1963, PROG THEOR PHYS, V30, P275, DOI 10.1143/PTP.30.275; OKIMOTO Y, 1995, PHYS REV B, V51, P9581, DOI 10.1103/PhysRevB.51.9581; MAHAJAN AV, 1992, PHYS REV B, V46, P10966, DOI 10.1103/PhysRevB.46.10966; KANAMORI J, 1959, J PHYS CHEM SOLIDS, V10, P87, DOI 10.1016/0022-3697(59)90061-7; ARIMA T, 1993, PHYS REV B, V48, P17006, DOI 10.1103/PhysRevB.48.17006; SLATER JC, 1954, PHYS REV, V94, P1498, DOI 10.1103/PhysRev.94.1498; GOODENOUGH J, 1961, PHYS REV, V124, P373, DOI 10.1103/PhysRev.124.373; ANISIMOV VI, 1991, PHYS REV B, V44, P943, DOI 10.1103/PhysRevB.44.943; TOKURA Y, 1993, PHYS REV LETT, V70, P2126, DOI 10.1103/PhysRevLett.70.2126; CASTELLANI C, 1978, PHYS REV B, V18, P4945, DOI 10.1103/PhysRevB.18.4945; RACCAH PM, 1967, PHYS REV, V155, P932, DOI 10.1103/PhysRev.155.932; TOKURA Y, 1994, J PHYS SOC JPN, V63, P3931, DOI 10.1143/JPSJ.63.3931; LIECHTENSTEIN AI, 1995, PHYS REV B, V52, pR5467; WOLLAN EO, 1955, PHYS REV, V100, P545, DOI 10.1103/PhysRev.100.545; BORDET P, 1993, J SOLID STATE CHEM, V106, P253, DOI 10.1006/jssc.1993.1285; Bocquet AE, 1996, PHYS REV B, V53, P1161, DOI 10.1103/PhysRevB.53.1161; KOEHLER WC, 1957, J PHYS CHEM SOLIDS, V2, P100, DOI 10.1016/0022-3697(57)90095-1; SAITOH T, 1995, PHYS REV B, V52, P7934, DOI 10.1103/PhysRevB.52.7934; JONKER GH, 1950, PHYSICA, V16, P337, DOI 10.1016/0031-8914(50)90033-4; DEGROOT FMF, 1989, PHYS REV B, V40, P5715, DOI 10.1103/PhysRevB.40.5715; CHAINANI A, 1992, PHYS REV B, V46, P9976, DOI 10.1103/PhysRevB.46.9976; GARCIAMUNOZ JL, 1992, EUROPHYS LETT, V20, P241, DOI 10.1209/0295-5075/20/3/009; ASHKENAZ.J, 1973, ADV PHYS, V22, P207, DOI 10.1080/00018737300101289; BRINGLEY JF, 1993, PHYS REV B, V47, P15269, DOI 10.1103/PhysRevB.47.15269; CHAINANI A, 1993, PHYS REV B, V47, P15397, DOI 10.1103/PhysRevB.47.15397; CRANDLES DA, 1992, PHYSICA C, V201, P407, DOI 10.1016/0921-4534(92)90491-T; CYROT M, 1977, J PHYS F MET PHYS, V7, pL15; DEMAZEAU G, 1972, MATER RES BULL, V7, P913, DOI 10.1016/0025-5408(72)90080-3; ELEMANS JBA, 1971, J SOLID STATE CHEM, V3, P328; FUJISHIMA Y, 1992, PHYS REV B, V46, P11167, DOI 10.1103/PhysRevB.46.11167; GARCIAMUNOZ JL, 1994, PHYS REV B, V50, P978, DOI 10.1103/PhysRevB.50.978; GARRET JD, 1981, INORG CHEM, V20, P1025; GORAL JP, 1982, J SOLID STATE CHEM, V43, P244, DOI 10.1016/0022-4596(82)90236-5; GORAL JP, 1983, J MAGN MAGN MATER, V37, P315, DOI 10.1016/0304-8853(83)90062-8; Hamada N, 1995, SPRINGER SERIES SOLI, V119, P95; Harrison W. A., 1989, ELECTRONIC STRUCTURE; HUBBARD J, 1963, PROC R SOC LON SER-A, V276, P238, DOI 10.1098/rspa.1963.0204; HUBBARD J, 1964, PROC R SOC LON SER-A, V281, P401, DOI 10.1098/rspa.1964.0190; HUBBARD J, 1964, PROC R SOC LON SER-A, V277, P237, DOI 10.1098/rspa.1964.0019; HUFNER S, 1985, Z PHYS B CON MAT, V61, P135, DOI 10.1007/BF01307767; HUTCHING.MT, 1969, PHYS REV, V188, P919, DOI 10.1103/PhysRev.188.919; Inagaki S., 1973, International Journal of Magnetism, V4; INAGAKI S, 1975, J PHYS SOC JPN, V39, P596, DOI 10.1143/JPSJ.39.596; JONKER GH, 1953, PHYSICA, V19, P120, DOI 10.1016/S0031-8914(53)80011-X; KOROTIN MA, UNPUB; Kugel' K. I., 1973, Soviet Physics - JETP, V37; KUMAGAI K, 1993, PHYS REV B, V48, P7636, DOI 10.1103/PhysRevB.48.7636; MACLEAN DA, 1979, J SOLID STATE CHEM, V30, P35, DOI 10.1016/0022-4596(79)90127-0; MANN JB, 1967, LASL3690; MATSUMOT.G, 1970, J PHYS SOC JPN, V29, P606, DOI 10.1143/JPSJ.29.606; MATTHEIS.LF, 1972, PHYS REV B, V5, P290, DOI 10.1103/PhysRevB.5.290; Mizokawa T, 1996, PHYS REV B, V53, pR4201; MIZOKAWA T, 1995, PHYS REV B, V51, P12880, DOI 10.1103/PhysRevB.51.12880; MIZOKAWA T, 1995, PHYS REV B, V52, P13865, DOI 10.1103/PhysRevB.52.13865; MOTT NF, 1949, P PHYS SOC LOND A, V62, P416, DOI 10.1088/0370-1298/62/7/303; Mott N.F., 1990, METAL INSULATOR TRAN; OKAZAKI A, 1969, J PHYS SOC JPN, V26, P870, DOI 10.1143/JPSJ.26.870; SAITOH T, 1996, THESIS U TOKYO; SAWADA H, COMMUNICATION; SHIRAKAWA N, 1991, JPN J APPL PHYS, V30, pL775; THORNTON G, 1982, SOLID STATE COMMUN, V44, P1213, DOI 10.1016/0038-1098(82)91088-2; TOMIMOTO K, COMMUNICATION; TORRANCE JB, 1992, PHYS REV B, V45, P8209, DOI 10.1103/PhysRevB.45.8209; TOWLER MD, 1995, PHYS REV B, V52, P10150, DOI 10.1103/PhysRevB.52.10150; TSUKUDA N, 1972, J PHYS SOC JPN, V33, P1088, DOI 10.1143/JPSJ.33.1088; van Elp J., 1991, THESIS U GRONINGEN; ZUBKOV VG, 1974, SOV PHYS JETP, V39, P896; ZUBKOV VG, 1973, SOV PHYS-SOLID STATE, V15, P107	82	331	331	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	1098-0121			PHYS REV B	Phys. Rev. B	AUG 15	1996	54	8					5368	5380		10.1103/PhysRevB.54.5368		13	Physics, Condensed Matter	Physics	VF929	WOS:A1996VF92900036		
J	Hotta, T; Fujimoto, S				Hotta, T; Fujimoto, S			Perturbation study on the spin and charge susceptibilities of the two-dimensional Hubbard model	PHYSICAL REVIEW B			English	Article							DENSITY-OF-STATES; T-J MODEL; MAGNETIC-PROPERTIES; NQR; NMR; DYNAMICS; CU; SUPERCONDUCTORS; LA2-XSRXCUO4; BEHAVIOR	We investigate the spin and charge susceptibilities of the two-dimensional Hubbard model based upon the perturbative calculation in the strength of correlation U. For U comparable to a bare bandwidth, the charge susceptibility decreases near half filling as hole doping approaches zero. This behavior suggesting the precursor of the Mott-Hubbard gap formation cannot be obtained without the vertex corrections beyond the random-phase approximation. In the low-temperature region, the spin susceptibility deviates from the Curie-Weiss-like law and finally turns to decrease with the decrease of temperature. This spin-gap-like behavior originates from the van Hove singularity in the density of states.	KYOTO UNIV,DEPT PHYS,KYOTO 606,JAPAN	Hotta, T (reprint author), UNIV TOKYO,INST SOLID STATE PHYS,MINATO KU,7-22-1 ROPPONGI,TOKYO 106,JAPAN.						TANAMOTO T, 1993, J PHYS SOC JPN, V62, P717, DOI 10.1143/JPSJ.62.717; WARREN WW, 1989, PHYS REV LETT, V62, P1193, DOI 10.1103/PhysRevLett.62.1193; WALSTEDT RE, 1991, PHYS REV B, V44, P7760, DOI 10.1103/PhysRevB.44.7760; USUKI T, 1989, PHYS LETT A, V135, P476, DOI 10.1016/0375-9601(89)90052-2; MOTT NF, 1961, PHILOS MAG, V6, P287; LUTTINGER JM, 1960, PHYS REV, V119, P1153, DOI 10.1103/PhysRev.119.1153; FURUKAWA N, 1991, J PHYS SOC JPN, V60, P3604, DOI 10.1143/JPSJ.60.3604; HOTTA T, 1995, J PHYS SOC JPN, V64, P2923, DOI 10.1143/JPSJ.64.2923; HUBBARD J, 1964, PROC R SOC LON SER-A, V281, P401, DOI 10.1098/rspa.1964.0190; KITAOKA Y, 1991, PHYSICA C, V185, P98, DOI 10.1016/0921-4534(91)91957-6; KITAOKA Y, 1990, PHYSICA C, V170, P189, DOI 10.1016/0921-4534(90)90310-B; KOHNO H, 1991, PROG THEOR PHYS, V85, P13; MACHI T, 1990, PHYSICA C, V173, P32; MILLIS AJ, 1993, PHYS REV LETT, V70, P2810, DOI 10.1103/PhysRevLett.70.2810; MOREO A, 1990, PHYS REV B, V41, P2313, DOI 10.1103/PhysRevB.41.2313; OHSUGI S, 1991, J PHYS SOC JPN, V60, P2351, DOI 10.1143/JPSJ.60.2351; OTSUKA H, 1990, J PHYS SOC JPN, V59, P2916, DOI 10.1143/JPSJ.59.2916; PRESS WH, 1986, NUMERICAL RECIPES, P490; ROSENBERG MJ, 1992, PHYS REV LETT, V69, P1236; SCHWEITZER H, 1991, Z PHYS B CON MAT, V83, P93, DOI 10.1007/BF01314402; SERENE JW, 1991, PHYS REV B, V44, P3391, DOI 10.1103/PhysRevB.44.3391; TAKIGAWA M, 1991, PHYS REV B, V43, P247, DOI 10.1103/PhysRevB.43.247; TANAMOTO T, 1992, J PHYS SOC JPN, V61, P1886, DOI 10.1143/JPSJ.61.1886; TSUEI CC, 1992, PHYS REV LETT, V69, P2134, DOI 10.1103/PhysRevLett.69.2134; YSUOKA H, 1989, STRONG CORRELATION S, P254; ZHENG GQ, 1993, J PHYS SOC JPN, V62, P2591, DOI 10.1143/JPSJ.62.2591; ZIMMERMANN H, 1989, PHYSICA C, V159, P681, DOI 10.1016/0921-4534(89)91304-X; ZLATIC V, 1995, PHYS REV B, V52, P3639, DOI 10.1103/PhysRevB.52.3639	28	11	11	AMERICAN PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	0163-1829			PHYS REV B	Phys. Rev. B	AUG 15	1996	54	8					5381	5388		10.1103/PhysRevB.54.5381		8	Physics, Condensed Matter	Physics	VF929	WOS:A1996VF92900037		
J	Yamauchi, J; Tsukada, M; Watanabe, S; Sugino, O				Yamauchi, J; Tsukada, M; Watanabe, S; Sugino, O			First-principles study on energetics of c-BN(001) reconstructed surfaces	PHYSICAL REVIEW B			English	Article							CUBIC BORON-NITRIDE; ELECTRONIC-STRUCTURE CALCULATION; POLAR SEMICONDUCTOR SURFACES; HARTREE-FOCK CALCULATIONS; SELF-CONSISTENT; ULTRASOFT PSEUDOPOTENTIALS; 2X2 RECONSTRUCTIONS; MOLECULAR-DYNAMICS; GAAS(100) SURFACES; PERIODIC-SYSTEMS	Total energies of cubic boron nitride (c-BN) (001) surfaces are systematically studied for various reconstructed configurations by the local density-functional approach with ultrasoft pseudopotentials. Stable phases as a function of nitrogen chemical potential are predicted theoretically. We examine the validity of the electron counting (EC) rule, which plays an important role for the study of the GaAs surfaces, and obtain supplemental factors to determine stable surface structures. The results of the total-energy minimization calculation demonstrate that the EC rule holds very well within the models that contain at most one layer with defects and no interlayer N-N and B-B bonds, and that next to the EC rule, the electrostatic energy has the most important role in determining stable structures. Furthermore, in the nitrogen-rich region, we found that the EC rule does not hold, because the energy difference between the N-B and N-N bonds is larger than the energy gain from using the EC model. We suggest that the important factors for determining stable structures of the c-BN(001) surface are N-B bond saturation, the EC rule, and electrostatic energy, whose effect decreases in this order. The difference between c-BN and GaAs surfaces is also discussed.	UNIV TOKYO,FAC SCI,DEPT PHYS,TOKYO 113,JAPAN; JRCC,EXPLORATORY RES ADV TECHNOL,AONO ATOMCRAFT PROJECT,ITABASHI KU,TOKYO 173,JAPAN; NEC CORP LTD,TSUKUBA,IBARAKI 305,JAPAN			Tsukada, Masaru/E-5182-2010				ANDOH Y, 1990, NUCL INSTRUM METH B, V43, P128; PERDEW JP, 1986, PHYS REV B, V33, P8800, DOI 10.1103/PhysRevB.33.8800; POWERS JM, 1991, PHYS REV B, V44, P11159, DOI 10.1103/PhysRevB.44.11159; STICH I, 1989, PHYS REV B, V39, P4997, DOI 10.1103/PhysRevB.39.4997; Murnaghan FD, 1944, P NATL ACAD SCI USA, V30, P244, DOI 10.1073/pnas.30.9.244; XU YN, 1991, PHYS REV B, V44, P7787, DOI 10.1103/PhysRevB.44.7787; FURTHMULLER J, 1994, PHYS REV B, V50, P15606, DOI 10.1103/PhysRevB.50.15606; SHIRAISHI K, 1990, J PHYS SOC JPN, V59, P3455, DOI 10.1143/JPSJ.59.3455; INAGAWA K, 1987, J VAC SCI TECHNOL A, V5, P2696, DOI 10.1116/1.574722; QIAN GX, 1988, PHYS REV B, V38, P7649, DOI 10.1103/PhysRevB.38.7649; WENTZCOVITCH RM, 1988, PHYS REV B, V38, P6191, DOI 10.1103/PhysRevB.38.6191; LAASONEN K, 1993, PHYS REV B, V47, P10142, DOI 10.1103/PhysRevB.47.10142; CHADI DJ, 1987, J VAC SCI TECHNOL A, V5, P834, DOI 10.1116/1.574366; TROULLIER N, 1990, SOLID STATE COMMUN, V74, P613, DOI 10.1016/0038-1098(90)90686-6; TETER MP, 1989, PHYS REV B, V40, P12255, DOI 10.1103/PhysRevB.40.12255; PERDEW JP, 1981, PHYS REV B, V23, P5048, DOI 10.1103/PhysRevB.23.5048; WENTORF RH, 1957, J CHEM PHYS, V26, P956, DOI 10.1063/1.1745964; CEPERLEY DM, 1980, PHYS REV LETT, V45, P566, DOI 10.1103/PhysRevLett.45.566; WENTZCOVITCH RM, 1986, PHYS REV B, V34, P1071, DOI 10.1103/PhysRevB.34.1071; VANDERBILT D, 1990, PHYS REV B, V41, P7892, DOI 10.1103/PhysRevB.41.7892; BIRCH F, 1978, J GEOPHYS RES, V83, P1257, DOI 10.1029/JB083iB03p01257; PASHLEY MD, 1989, PHYS REV B, V40, P10481, DOI 10.1103/PhysRevB.40.10481; Wigner E, 1938, T FARADAY SOC, V34, P0678, DOI 10.1039/tf9383400678; KNITTLE E, 1989, NATURE, V337, P349, DOI 10.1038/337349a0; BYLANDER DM, 1990, PHYS REV B, V42, P1394, DOI 10.1103/PhysRevB.42.1394; BADZIAG P, 1991, PHYS REV B, V44, P11143, DOI 10.1103/PhysRevB.44.11143; DOLL GL, 1991, PHYS REV B, V43, P6816, DOI 10.1103/PhysRevB.43.6816; DOVESI R, 1981, PHYS REV B, V24, P4170, DOI 10.1103/PhysRevB.24.4170; DOVESI R, 1980, INT J QUANTUM CHEM, V17, P517, DOI 10.1002/qua.560170312; GASHTOLD VN, 1970, ELEKTRON TEKH, V12, P58; HANEMAN D, 1961, PHYS REV, V121, P1093, DOI 10.1103/PhysRev.121.1093; HELLWEGE KH, 1982, LANDOLTBORNSTEIN C, V7; HOHENBERG P, 1964, PHYS REV B, V136, pB864, DOI 10.1103/PhysRev.136.B864; Huber KP, 1979, MOL SPECTRA MOL STRU, VIV; IKEDA T, 1990, J VAC SCI TECHNOL A, V8, P3168, DOI 10.1116/1.576602; JORDAN TH, J CHEM PHYS, V41, P756; KAXIRAS E, 1987, PHYS REV B, V35, P9625, DOI 10.1103/PhysRevB.35.9625; KAXIRAS E, 1987, PHYS REV B, V35, P9636, DOI 10.1103/PhysRevB.35.9636; KOHN W, 1965, PHYS REV, V140, P1133, DOI 10.1103/PhysRev.140.A1133; KOIZUMI S, 1990, APPL PHYS LETT, V57, P563, DOI 10.1063/1.103647; LAM PK, 1990, SYNTHESIS PROPERTIES, P165; MIYAMOTO Y, 1992, PHYS REV B, V46, P6915, DOI 10.1103/PhysRevB.46.6915; Morosin B, 1986, AIP C P, V86, P70; MURAKAWA M, 1990, SURF COAT TECH, V43-4, P128, DOI 10.1016/0257-8972(90)90067-M; NONOYAMA S, 1993, PHYS REV B, V47, P7622, DOI 10.1103/PhysRevB.47.7622; NORTHRUP JE, 1993, PHYS REV LETT, V71, P2276, DOI 10.1103/PhysRevLett.71.2276; OHNO T, 1993, PHYS REV LETT, V70, P631, DOI 10.1103/PhysRevLett.70.631; OSUCH K, 1993, SURF SCI, V285, P59, DOI 10.1016/0039-6028(93)90913-5; PAINTER GS, 1982, PHYS REV B, V26, P1781, DOI 10.1103/PhysRevB.26.1781; PARK KT, 1987, J PHYS C SOLID STATE, V20, P1241, DOI 10.1088/0022-3719/20/9/014; Pauling L., 1967, NATURE CHEM BOND, V3rd; PICKETT WE, 1988, PHYS REV B, V38, P1316, DOI 10.1103/PhysRevB.38.1316; Pouch J J, 1990, SYNTHESIS PROPERTIES; Press W. H., 1986, NUMERICAL RECIPES; REN SF, 1989, PHYS REV B, V41, P7705; SAITOH H, 1989, SURF COAT TECH, V39, P265, DOI 10.1016/0257-8972(89)90060-1; SATOU M, 1983, JPN J APPL PHYS 2, V22, pL171, DOI 10.1143/JJAP.22.L171; SHANFIELD S, 1983, J VAC SCI TECHNOL A, V1, P323, DOI 10.1116/1.572124; VENABLES JA, 1973, ACTA CRYSTALLOGR B, V30, P929; WEISSMANTEL C, 1980, THIN SOLID FILMS, V72, P19, DOI 10.1016/0040-6090(80)90554-4; WENTZCOVITCH RM, 1987, PHYS REV B, V36, P6053; YAMAUCHI J, 1994, APPL SURF SCI, V75, P58, DOI 10.1016/0169-4332(94)90136-8; YAMAUCHI J, 1994, SURF SCI, V306, P42, DOI 10.1016/0039-6028(94)91183-5; YAMAUCHI J, 1995, SURF SCI, V341, pL1037; YAMAUCHI J, 1995, 22 INT C PHYS SEM, V1, P509; ZUNGER A, 1978, PHYS REV B, V17, P2030, DOI 10.1103/PhysRevB.17.2030	66	341	341	AMERICAN PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	0163-1829			PHYS REV B	Phys. Rev. B	AUG 15	1996	54	8					5586	5603		10.1103/PhysRevB.54.5586		18	Physics, Condensed Matter	Physics	VF929	WOS:A1996VF92900062		
J	Furusaki, A; Nagaosa, N				Furusaki, A; Nagaosa, N			Tunneling through a barrier in a Tomonaga-Luttinger liquid connected to reservoirs	PHYSICAL REVIEW B			English	Article							QUANTIZED CONDUCTANCE; LOCALIZATION; TRANSPORT; SYSTEM; GAS	The transport through a barrier is studied for a Tomonaga-Luttinger liquid of finite length connected to reservoirs. An effective action for the phase variable at the barrier is derived for spatially varying electric field. In the dc limit only the total voltage drop between the left and right reservoirs appears in the action. We discuss crossovers of the renormalization group flow and hence of the temperature and wire length dependence of the conductance, taking into account the location of the barrier.	UNIV TOKYO,DEPT APPL PHYS,BUNKYO KU,TOKYO 113,JAPAN	Furusaki, A (reprint author), KYOTO UNIV,YUKAWA INST THEORET PHYS,KYOTO 60601,JAPAN.		Furusaki, Akira/B-3204-2008; Nagaosa, Naoto/G-7057-2012	Furusaki, Akira/0000-0001-8394-0003; 			PONOMARENKO VV, 1995, PHYS REV B, V52, pR8666; KANE CL, 1992, PHYS REV LETT, V68, P1220, DOI 10.1103/PhysRevLett.68.1220; TARUCHA S, 1995, SOLID STATE COMMUN, V94, P413, DOI 10.1016/0038-1098(95)00102-6; KANE CL, 1992, PHYS REV B, V46, P15233, DOI 10.1103/PhysRevB.46.15233; FURUSAKI A, 1993, PHYS REV B, V47, P4631, DOI 10.1103/PhysRevB.47.4631; MATVEEV KA, 1993, PHYS REV LETT, V71, P3351, DOI 10.1103/PhysRevLett.71.3351; EMERY VJ, 1979, HIGHLY CONDUCTING ON; FUKUYAMA H, 1985, ELECT PROPERTIES INO; Kawabata A, 1996, J PHYS SOC JPN, V65, P30, DOI 10.1143/JPSJ.65.30; MASLOV DL, 1995, PHYS REV B, V52, P14368; MASLOV DL, 1995, PHYS REV B, V52, pR5539; NAGAOSA N, 1994, J PHYS SOC JPN, V63, P413, DOI 10.1143/JPSJ.63.413; OGATA M, 1994, PHYS REV LETT, V73, P468, DOI 10.1103/PhysRevLett.73.468; Safi I, 1995, PHYS REV B, V52, P17040; SCHMID A, 1983, PHYS REV LETT, V51, P1506, DOI 10.1103/PhysRevLett.51.1506; SHIMIZU A, IN PRESS J PHYS SOC; Solyom J., 1979, ADV PHYS, V28, P209	17	58	58	AMERICAN PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	0163-1829			PHYS REV B	Phys. Rev. B	AUG 15	1996	54	8					R5239	R5242				4	Physics, Condensed Matter	Physics	VF929	WOS:A1996VF92900012		
J	Kawasaki, M; Sugiyama, N; Yanagida, T				Kawasaki, M; Sugiyama, N; Yanagida, T			Isocurvature and adiabatic fluctuations of the axion in chaotic inflation models and large scale structure	PHYSICAL REVIEW D			English	Article							MASS FLUCTUATIONS; CP INVARIANCE; UNIVERSE; DENSITY; PERTURBATIONS; ANISOTROPIES; COSMOLOGY; CONSTANT; VACUUM; FIELDS	In chaotic inflation models, quantum fluctuations from axion fields lead to overproduction of domain walls and overly large isocurvature fluctuations, which is inconsistent with observations of cosmic microwave background anisotropies. These problems are solved by assuming a very flat potential for the Peccei-Quinn scalar field. As the simplest possibility, we consider a model where the Peccei-Quinn scalar is an inflaton itself, and show that the isocurvature fluctuations can be comparable with the adiabatic ones. We investigate the cosmological implications of the case when both adiabatic and isocurvature fluctuations exist, and find that the amplitude of the matter spectrum becomes smaller than that for the pure adiabatic case. This leads to a relatively high bias parameter (b similar or equal to 2) which is favored by the current observations.	UNIV TOKYO,INST COSM RAY RES,TANASHI,TOKYO 188,JAPAN; UNIV TOKYO,SCH SCI,DEPT PHYS,TOKYO 113,JAPAN; UNIV TOKYO,SCH SCI,RES CTR EARLY UNIVERSE,TOKYO 113,JAPAN; UNIV TOKYO,SCH SCI,DEPT PHYS,TOKYO 113,JAPAN			Yanagida, Tsutomu/A-4394-2011				OSTRIKER JP, 1995, NATURE, V377, P600, DOI 10.1038/377600a0; GUTH AH, 1981, PHYS REV D, V23, P347, DOI 10.1103/PhysRevD.23.347; SATO K, 1981, MON NOT R ASTRON SOC, V195, P467; KIM JE, 1979, PHYS REV LETT, V43, P103, DOI 10.1103/PhysRevLett.43.103; LINDE A, 1991, PHYS LETT B, V259, P38, DOI 10.1016/0370-2693(91)90130-I; LYTH DH, 1992, PHYS REV D, V45, P3394, DOI 10.1103/PhysRevD.45.3394; HU W, 1995, PHYS REV D, V51, P2599, DOI 10.1103/PhysRevD.51.2599; BARDEEN JM, 1986, ASTROPHYS J, V304, P15, DOI 10.1086/164143; LINDE AD, 1983, PHYS LETT B, V129, P177, DOI 10.1016/0370-2693(83)90837-7; LYTH DH, 1990, PHYS LETT B, V236, P408, DOI 10.1016/0370-2693(90)90374-F; DINE M, 1981, PHYS LETT B, V104, P199, DOI 10.1016/0370-2693(81)90590-6; WILCZEK F, 1978, PHYS REV LETT, V40, P279, DOI 10.1103/PhysRevLett.40.279; THOOFT G, 1976, PHYS REV LETT, V37, P8, DOI 10.1103/PhysRevLett.37.8; PEACOCK JA, 1994, MON NOT R ASTRON SOC, V267, P1020; PECCEI RD, 1977, PHYS REV LETT, V38, P1440, DOI 10.1103/PhysRevLett.38.1440; SMOOT GF, 1992, ASTROPHYS J, V396, pL1, DOI 10.1086/186504; SHIFMAN MA, 1980, NUCL PHYS B, V166, P493, DOI 10.1016/0550-3213(80)90209-6; SECKEL D, 1985, PHYS REV D, V32, P3178, DOI 10.1103/PhysRevD.32.3178; STRAUSS MA, 1995, PHYS REP, V261, P271, DOI 10.1016/0370-1573(95)00013-7; TURNER MS, 1991, PHYS REV LETT, V66, P5, DOI 10.1103/PhysRevLett.66.5; AXENIDES M, 1983, PHYS LETT B, V126, P178, DOI 10.1016/0370-2693(83)90586-5; BARTLETT JG, 1995, SCIENCE, V267, P980, DOI 10.1126/science.267.5200.980; Efstathiou G., 1987, Monthly Notices of the Royal Astronomical Society, V227; EFSTATHIOU G, 1992, MON NOT R ASTRON SOC, V258, pP1; Kasuya S., UNPUB; KERNAN PJ, 1994, PHYS REV LETT, V72, P3309, DOI 10.1103/PhysRevLett.72.3309; Kodama H., 1986, INT J MOD PHYS A, VA 1, P265, DOI 10.1142/S0217751X86000137; KOFMAN LA, 1987, NUCL PHYS B, V282, P55; Kolb E. W., 1990, EARLY UNIVERSE; LYTH DH, 1992, PHYS REV D, V46, P532, DOI 10.1103/PhysRevD.46.532; SIKIVIE P, 1982, PHYS REV LETT, V48, P1156, DOI 10.1103/PhysRevLett.48.1156; STEINHARDT PJ, 1983, PHYS LETT B, V129, P51, DOI 10.1016/0370-2693(83)90727-X; Stompor R, 1996, ASTROPHYS J, V463, P8, DOI 10.1086/177219; WALKER TP, 1991, ASTROPHYS J, V376, P51, DOI 10.1086/170255; WHITE M, 1995, ASTROPHYS J, V450, P477, DOI 10.1086/176158; WHITE M, 1995, MNRAS, V276, P69; WHITE SDM, 1993, MON NOT R ASTRON SOC, V262, P1023; ZAROUBI S, ASTROPH9603068	38	33	33	AMERICAN PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	0556-2821			PHYS REV D	Phys. Rev. D	AUG 15	1996	54	4					2442	2446		10.1103/PhysRevD.54.2442		5	Astronomy & Astrophysics; Physics, Particles & Fields	Astronomy & Astrophysics; Physics	VD678	WOS:A1996VD67800004		
J	Itakura, K				Itakura, K			Boson expansion methods in (1+1)-dimensional light-front QCD	PHYSICAL REVIEW D			English	Article							MASSIVE SCHWINGER MODEL; SPONTANEOUS SYMMETRY-BREAKING; TAMM-DANCOFF APPROXIMATION; FIELD-THEORY; 2-DIMENSIONAL QCD; PHI(4) THEORY; 2 DIMENSIONS; CONE; QUANTIZATION; UNIFICATION	We derive a bosonic Hamiltonian from two-dimensional QCD on the light front. To obtain the bosonic theory we find that it is useful to apply the boson expansion method which is the standard technique in quantum many-body physics. We introduce bilocal boson operators to represent the gauge-invariant quark bilinears and then local boson operators as the collective states of the bilocal bosons. If we adopt the Holstein-Primakoff type among various representations, we obtain a theory of infinitely many interacting bosons, whose masses are the eigenvalues of the 't Hooft equation. In the large N Limit, since the interaction disappears and the bosons are identified with mesons, we obtain a free Hamiltonian with infinite kinds of mesons.		Itakura, K (reprint author), UNIV TOKYO,INST PHYS,MEGURO KU,TOKYO 153,JAPAN.						KLEIN A, 1991, REV MOD PHYS, V63, P375, DOI 10.1103/RevModPhys.63.375; DOBACZEWSKI J, 1981, NUCL PHYS A, V369, P237, DOI 10.1016/0375-9474(81)90018-X; DIRAC PAM, 1949, REV MOD PHYS, V21, P392, DOI 10.1103/RevModPhys.21.392; WITTEN E, 1979, NUCL PHYS B, V160, P57, DOI 10.1016/0550-3213(79)90232-3; BLAIZOT JP, 1978, NUCL PHYS A, V309, P422, DOI 10.1016/0375-9474(78)90489-X; WILSON KG, 1994, PHYS REV D, V49, P6720, DOI 10.1103/PhysRevD.49.6720; BARS I, 1978, PHYS REV D, V17, P537, DOI 10.1103/PhysRevD.17.537; Holstein T, 1940, PHYS REV, V58, P1098, DOI 10.1103/PhysRev.58.1098; DANCOFF SM, 1950, PHYS REV, V78, P382, DOI 10.1103/PhysRev.78.382; COLEMAN S, 1973, COMMUN MATH PHYS, V31, P259, DOI 10.1007/BF01646487; DYSON FJ, 1956, PHYS REV, V102, P1217, DOI 10.1103/PhysRev.102.1217; DOBACZEWSKI J, 1981, NUCL PHYS A, V369, P213, DOI 10.1016/0375-9474(81)90017-8; THOOFT G, 1974, NUCL PHYS B, VB 75, P461, DOI 10.1016/0550-3213(74)90088-1; BARBON JLF, 1995, NUCL PHYS B, V434, P109, DOI 10.1016/0550-3213(94)00442-H; BELIAEV ST, 1962, NUCL PHYS, V39, P582, DOI 10.1016/0029-5582(62)90416-9; BENDER CM, 1993, PHYS REV D, V48, P816, DOI 10.1103/PhysRevD.48.816; BERGKNOFF H, 1977, NUCL PHYS B, V122, P215, DOI 10.1016/0550-3213(77)90204-8; BURKARDT M, 1996, ADV NUCL PHYSICS, V23; CAVICCHI M, 1995, INT J MOD PHYS A, V10, P167, DOI 10.1142/S0217751X95000097; DHAR A, 1995, INT J MOD PHYS A, V10, P15; DHAR A, 1994, PHYS LETT B, V329, P15, DOI 10.1016/0370-2693(94)90511-8; Donoghue J. F., 1992, DYNAMICS STANDARD MO; HARADA K, 1994, PHYS REV D, V49, P4226, DOI 10.1103/PhysRevD.49.4226; HARADA K, 1995, PHYS REV D, V52, P2429, DOI 10.1103/PhysRevD.52.2429; HEYSSLER M, 1995, PHYS LETT B, V354, P453, DOI 10.1016/0370-2693(95)00654-4; HORNBOSTEL K, 1988, THESIS STANFORD U; HORNBOSTEL K, 1990, PHYS REV D, V41, P3814, DOI 10.1103/PhysRevD.41.3814; KIKKAWA K, 1981, ANN PHYS, V66, P3633; KIM Y, 1995, PHYS REV LETT, V74, P4771, DOI 10.1103/PhysRevLett.74.4771; MARUMORI T, 1964, PROG THEOR PHYS, V32, P726, DOI 10.1143/PTP.32.726; MARUMORI T, 1964, PROG THEOR PHYS, V31, P1009, DOI 10.1143/PTP.31.1009; MASKAWA T, 1976, PROG THEOR PHYS, V56, P270, DOI 10.1143/PTP.56.270; MO YZ, 1993, J COMPUT PHYS, V108, P159, DOI 10.1006/jcph.1993.1171; NAKAMURA A, 1982, NUCL PHYS B, V202, P457, DOI 10.1016/0550-3213(82)90410-2; NAKAMURA A, 1981, PHYS LETT B, V105, P392, DOI 10.1016/0370-2693(81)90786-3; PERRY RJ, 1995, HADRON PHYSICS 94; PERRY RJ, 1990, PHYS REV LETT, V65, P2959, DOI 10.1103/PhysRevLett.65.2959; PINSKY SS, 1995, PHYS REV D, V51, P726, DOI 10.1103/PhysRevD.51.726; PINSKY SS, 1994, PHYS REV D, V49, P2001, DOI 10.1103/PhysRevD.49.2001; RAJEEV SG, 1994, INT J MOD PHYS A, V9, P5583, DOI 10.1142/S0217751X94002284; RING P, 1980, NUCLEAR MANY BODY PR, pCH9; Schwinger J., 1965, QUANTUM THEORY ANGUL, P229; SUGIHARA T, 1994, PHYS REV D, V50, P5274, DOI 10.1103/PhysRevD.50.5274; Tamm I.Y., 1945, J PHYS USSR, V9, P449; USUI T, 1960, PROG THEOR PHYS, V23, P787, DOI 10.1143/PTP.23.787; ZHANG WM, 1994, CHINESE J PHYS, V32, P717	46	10	10	AMERICAN PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	0556-2821			PHYS REV D	Phys. Rev. D	AUG 15	1996	54	4					2853	2862		10.1103/PhysRevD.54.2853		10	Astronomy & Astrophysics; Physics, Particles & Fields	Astronomy & Astrophysics; Physics	VD678	WOS:A1996VD67800040		
J	Zhou, HS; Wada, T; Sasabe, H; Komiyama, H				Zhou, HS; Wada, T; Sasabe, H; Komiyama, H			Synthesis and optical properties of nanocomposite silver-polydiacetylene	SYNTHETIC METALS			English	Article; Proceedings Paper	2nd Japan/France Joint Forum on Organic Materials and Optoelectronic Devices (JFJF 2)	NOV 23-24, 1995	PARIS, FRANCE			nanocomposites; silver; polydiacetylene; synthesis; optical properties	COATED NANOPARTICLES; CONJUGATED POLYMER; MULTILAYERS; PARTICLES; SIZE; GOLD	Optical phase conjugation can be enhanced in composite nanometer-size particles of nonlinear core and metallic shell suspended in a host medium because the optical held is concentrated in both the interior and exterior neighborhoods of the particles and magnified by the surface mediated plasmon. Greatly enhanced effective third-order nonlinear susceptibility of metal coated nanoparticles has been theoretically predicted, and the metal coated semiconductor nanoparticles have been synthesized. We report the synthesis of stable nanometer-size silver coated polydiacetylene (PDA) particles. At first, an ethanol solution of DA is dispersed into a Ag+ ion containing aqueous solution. Silver ions are attracted to -COO- anions of DA, and monomer DA vesicles coated by silver ions are formed by a long-term ultra-sonication treatment. Then, the monomer DA vesicles are photopolymerized and the sliver ions are photoreduced simultaneously to form nanocornposite. Absorption spectra of the excitonic pi conjugation in the PDA backbone and the surface plasma resonant absorption band of a large silver metal cluster have been observed as the synthesis proceeds. The shell structure of silver coated PDA nanoparticle has been proved by transmission electron microscopy (TEM) images and electron diffraction.	UNIV TOKYO,FAC ENGN,DEPT CHEM SYST ENGN,BUNKYO KU,TOKYO 113,JAPAN	Zhou, HS (reprint author), RIKEN,INST PHYS & CHEM RES,FRONTIER RES PROGRAM,NANOPHOTON LAB,HIROSAWA 2-1,WAKO,SAITAMA 35101,JAPAN.						HAUS JW, 1993, J APPL PHYS, V73, P1043, DOI 10.1063/1.353290; ZHOU HS, 1994, PHYS REV B, V50, P12052, DOI 10.1103/PhysRevB.50.12052; JAIN RK, 1983, J OPT SOC AM, V73, P647, DOI 10.1364/JOSA.73.000647; RICARD D, 1985, OPT LETT, V10, P511, DOI 10.1364/OL.10.000511; HACHE F, 1986, J OPT SOC AM B, V3, P1647; KALYANIWALLA N, 1990, PHYS REV A, V42, P5613, DOI 10.1103/PhysRevA.42.5613; BASSLER H, 1984, ADV POLYM SCI, V63; BAUGHMAN RH, 1976, J POLYM SCI POL PHYS, V14, P2037, DOI 10.1002/pol.1976.180141109; BLOEMER MJ, 1990, J OPT SOC AM B, V7, P790, DOI 10.1364/JOSAB.7.000790; BLOOR D, 1974, CHEM PHYS LETT, V24, P407, DOI 10.1016/0009-2614(74)85289-9; BUBECK C, 1983, THIN SOLID FILMS, V99, P103, DOI 10.1016/0040-6090(83)90365-6; Flytzanis C., 1992, CONT NONLINEAR OPTIC; KANETAKE T, 1985, SOLID STATE COMMUN, V56, P803, DOI 10.1016/0038-1098(85)90313-8; KASAI H, 1992, JPN J APPL PHYS 2, V31, pL1132; NEEVES AE, 1908, J OPT SOC AM B, V6, P795; RINGSDORF H, 1986, POLYM PREPR-ACS, V27, P127; SINGH A, 1994, MATER RES SOC SYMP P, V351, P67; SUKUMAR V, 1993, J MATER RES, V8, P2686, DOI 10.1557/JMR.1993.2686; TIEKE B, 1979, J POLYM SCI POL CHEM, V17, P1631, DOI 10.1002/pol.1979.170170607; WEGNER G, 1971, J POLYM SCI POL LETT, V9, P33; WEGNER G, 1977, PURE APPL CHEM, V49, P433; WILSON EG, 1975, J PHYS C SOLID STATE, V8, P727, DOI 10.1088/0022-3719/8/5/019; ZHOU HS, 1995, J CHEM SOC CHEM COMM, V15, P1525	23	26	28	ELSEVIER SCIENCE SA LAUSANNE	LAUSANNE 1	PO BOX 564, 1001 LAUSANNE 1, SWITZERLAND	0379-6779			SYNTHETIC MET	Synth. Met.	AUG 15	1996	81	2-3					129	132		10.1016/S0379-6779(96)03754-X		4	Materials Science, Multidisciplinary; Physics, Condensed Matter; Polymer Science	Materials Science; Physics; Polymer Science	VV109	WOS:A1996VV10900006		
J	Ando, J; Tsuboi, H; Korenaga, R; Takahashi, K; Kosaki, K; Isshiki, M; Tojo, T; Takada, Y; Kamiya, A				Ando, J; Tsuboi, H; Korenaga, R; Takahashi, K; Kosaki, K; Isshiki, M; Tojo, T; Takada, Y; Kamiya, A			Differential display and cloning of shear stress-responsive messenger RNAs in human endothelial cells	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article							KAPPA-B; CHAIN; GENE; EXPRESSION; PROTEIN; ELEMENT	To investigate the effect of shear stress on endothelial gene expression, we performed differential display of mRNAs from cultured human umbilical vein endothelial cells either incubated under static conditions or exposed to shear stress (15 dynes/cm(2)) for 6 h in a flow-chamber. Around 4% of the total number of mRNAs detected were either up- or down-regulated by shear stress. DNA sequencing of some of these shear stress-responsive mRNAs revealed homology of several clones to known gene sequences and many other clones for unknown genes. Known genes, including those for human laminin B1 chain, H+-ATP synthase coupling factor 6, lysyl oxidase, myosin light chain kinase, and interleukin-8 receptor, were upregulated by shear stress, while the gene encoding NADH dehydrogenase was down-regulated. The present results suggest that shear stress can change the expression of numerous genes in endothelial cells, far more than reported to date, and that mRNA differential display is quite useful for cloning known and unknown shear stress-responsive genes. (C) 1996 Academic Press, Inc.	ASAHI CHEM IND CO LTD,LIFE SCI RES INST,FUJI,SHIZUOKA 416,JAPAN; UNIV TOKYO,FAC MED,INST MED ELECT,TOKYO 113,JAPAN	Ando, J (reprint author), UNIV TOKYO,FAC MED,DEPT CARDIOVASC BIOMECH,BUNKYO KU,7-3-1 HONGO,TOKYO 113,JAPAN.						Ando Joji, 1993, Frontiers of Medical and Biological Engineering, V5, P245; ANDO J, 1994, AM J PHYSIOL, V267, pC679; ANDO J, 1996, JPN HEART J, V7, P19; LAN QX, 1994, BIOCHEM BIOPH RES CO, V201, P950, DOI 10.1006/bbrc.1994.1794; RESNICK N, 1993, P NATL ACAD SCI USA, V90, P4591, DOI 10.1073/pnas.90.10.4591; SHYY YJ, 1994, P NATL ACAD SCI USA, V91, P4678, DOI 10.1073/pnas.91.11.4678; MARCHESE A, 1994, GENOMICS, V23, P609, DOI 10.1006/geno.1994.1549; LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393; ARIZMENDI JM, 1992, FEBS LETT, V313, P80, DOI 10.1016/0014-5793(92)81189-S; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; GALLAGHER PJ, 1991, J BIOL CHEM, V266, P23936; HAMALAINEN ER, 1993, GENOMICS, V17, P544, DOI 10.1006/geno.1993.1369; JAVED AA, 1991, GENE, V97, P307, DOI 10.1016/0378-1119(91)90068-M; KHACHIGIAN LM, 1995, J CLIN INVEST, V96, P1169, DOI 10.1172/JCI118106; LIANG P, 1993, NUCLEIC ACIDS RES, V21, P3269, DOI 10.1093/nar/21.14.3269; LIANG P, 1992, CANCER RES, V52, P6966; PIKKARAINEN T, 1987, J BIOL CHEM, V262, P10454	17	39	39	ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495	0006-291X			BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	AUG 14	1996	225	2					347	351		10.1006/bbrc.1996.1178		5	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	VD344	WOS:A1996VD34400003		
J	Asano, K; Taniguchi, S; Nakao, A; Watanabe, T; Kurokawa, K				Asano, K; Taniguchi, S; Nakao, A; Watanabe, T; Kurokawa, K			Distribution of platelet activating factor receptor mRNA along the rat nephron segments	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article							MESSENGER-RNA EXPRESSION; THICK ASCENDING LIMB; URINARY-EXCRETION; MOLECULAR-CLONING; KIDNEY; TRANSPORT; CELLS; CDNA; ANTAGONIST; PAF	Platelet activating factor (PAF) receptor mRNA was semi-quantitated in microdissected rat nephron segments by the reverse transcription-polymerase chain reaction (RT PCR), PCR primers were designed from two alternative splicing isoforms of rat PAF receptor cDNA; a homologue of human leukocyte PAF receptor cDNA (p172) and the other with a unique sequence in the 5'-noncoding region upstream of the splice acceptor site (p18). Only the expression of mRNA corresponding to p172 was detectable, which was most abundant in the glomerulus, followed in order by: proximal convoluted tubule > proximal straight tubule > outer medullary and cortical collecting duct, distal convoluted tubuIe > thick ascending limb of Henle's loop. These results suggest the potential physiological roles of PaF in the entire renal tubule as well as in the glomerulus. (C) 1996 Academic Press, Inc.	UNIV TOKYO,FAC MED,DEPT INTERNAL MED 1,TOKYO 113,JAPAN							TERADA Y, 1991, AM J PHYSIOL, V261, pF1080; NAKAMURA M, 1991, J BIOL CHEM, V266, P20400; BRAQUET P, 1987, PHARMACOL REV, V39, P97; ARDAILLOU N, 1985, AM J PHYSIOL, V248, pF240; BAILLY C, 1992, KIDNEY INT, V41, P269, DOI 10.1038/ki.1992.38; BENIGNI A, 1992, LANCET, V339, P835, DOI 10.1016/0140-6736(92)90281-7; BITO H, 1994, EUR J BIOCHEM, V221, P211, DOI 10.1111/j.1432-1033.1994.tb18731.x; BONVENTRE JV, 1988, AM J PHYSIOL, V254, pF87; DOSSANTOS OFP, 1991, KIDNEY INT, V40, P742; HONDA Z, 1994, J BIOL CHEM, V269, P2307; HONDA Z, 1991, NATURE, V349, P342, DOI 10.1038/349342a0; IIDA K, 1993, BIOCHEM BIOPH RES CO, V194, P659, DOI 10.1006/bbrc.1993.1872; JAMIL KMA, 1992, BIOCHEM BIOPH RES CO, V187, P767, DOI 10.1016/0006-291X(92)91261-N; KRAUT JA, 1990, KIDNEY INT, V37, P372; KUNZ D, 1992, J BIOL CHEM, V267, P9101; MACCONI D, 1991, LIFE SCI, V48, P1429, DOI 10.1016/0024-3205(91)90179-F; MUTOH H, 1993, FEBS LETT, V322, P129, DOI 10.1016/0014-5793(93)81552-B; NEANT F, 1994, J CLIN INVEST, V94, P1156, DOI 10.1172/JCI117431; NORIS M, 1993, KIDNEY INT, V43, P426, DOI 10.1038/ki.1993.62; ORTIZ A, 1991, LIPIDS, V26, P1310; PERICO N, 1988, LAB INVEST, V58, P163; SCHLONDORFF D, 1986, AM J PHYSIOL, V251, pF1; SHIMIZU T, 1992, BIOCHEM PHARMACOL, V44, P1001; SUGIMOTO T, 1992, BIOCHEM BIOPH RES CO, V189, P617, DOI 10.1016/0006-291X(92)92245-S; TAKANO T, 1991, BIOCHEM BIOPH RES CO, V177, P54, DOI 10.1016/0006-291X(91)91947-B; TANIGUCHI S, 1993, FEBS LETT, V318, P65, DOI 10.1016/0014-5793(93)81329-X; TANIGUCHI S, 1991, J AM SOC NEPHROL, V2, P465; TORRAS J, 1993, TRANSPLANT INT, V6, P236, DOI 10.1111/j.1432-2277.1993.tb00654.x; YE RD, 1991, BIOCHEM BIOPH RES CO, V180, P105, DOI 10.1016/S0006-291X(05)81261-6	29	10	12	ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495	0006-291X			BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	AUG 14	1996	225	2					352	357		10.1006/bbrc.1996.1179		6	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	VD344	WOS:A1996VD34400004		
J	Tanase, T; Doi, M; Nouchi, R; Kato, M; Sato, Y; Ishida, K; Kobayashi, K; Sakurai, T; Yamamoto, Y; Yano, S				Tanase, T; Doi, M; Nouchi, R; Kato, M; Sato, Y; Ishida, K; Kobayashi, K; Sakurai, T; Yamamoto, Y; Yano, S			Assembly of carbohydrates on a nickel(II) center by utilizing N-glycosidic bond formation with tris(2-aminoethyl)amine (tren). Syntheses and characterization of [Ni{N-(aldosyl)-tren}(H2O)](2+), [Ni{N,N'-bis(aldosyl)-tren}](2+) and [Ni{N,N',N''-tris(aldosyl)-tren}](2+)	INORGANIC CHEMISTRY			English	Article							RAY CRYSTAL-STRUCTURE; C-2 EPIMERIZATION; METAL-COMPLEXES; COBALT(III) COMPLEXES; ISOTOPIC MULTIPLETS; METHANOL SOLVATE; CARBON SKELETON; HEMI METHANOL; SUGAR UNITS; D-MANNOSE	Reactions of [Ni(tren)(H2O)(2)]X(2) (tren = tris(2-aminoethyl)amine; X = Cl (1a), Br (1b); X(2) = SO4 (1c)) with mannose-type aldoses, having a 2,3-cis configuration (D-mannose and L-rhamnose), afforded {bis(N-aldosyl-2- aminoethyl) (2-aminoethyl)amine}nickel(II) complexes, [Ni(N,N'-(aldosyl)(2)-tren)]X(2) (aldosyl = D-mannosyl, X = Cl (2a), Br (2b), X(2) = SO4 (2c); aldosyl = L-rhamnosyl, X(2) = SO4 (3c)). The structure of 1c was confirmed by X-ray crystallography to be a mononuclear [(NiN4O2)-N-III] complex with the tren acting as a tetradentate ligand (1c . 2H(2)O: orthorhombic, Pbca, a = 15.988(2) Angstrom, b = 18.826(4) Angstrom, c = 10.359(4) Angstrom, V = 3118 Angstrom(3), Z = 8, R = 0.047, and R(w) = 0.042). Complexes 2a,c and 3c were characterized by X-ray analyses to have a mononuclear octahedral Ni(II) structure ligated by a hexadentate N-glycoside ligand, bis(N-aldosyl-2-aminoethyl) (2-aminoethyl)amine (2a . CH3OH: orthorhombic, P2(1)2(1)2(1), a = 16.005(3) Angstrom, b = 20.095(4) Angstrom, c = 8.361(1) Angstrom, V = 2689 Angstrom(3), Z = 4, R = 0.040, and R(w) = 0.027. 2c . 3CH(3)OH: orthorhombic, P2(1)2(1)2(1), a = 14.93(2) Angstrom, b = 21.823(8) Angstrom, c = 9.746(2) Angstrom, V = 3176 Angstrom(3), Z = 4, R = 0.075, and R(w) = 0.080. 3c . 3CH(3)OH: orthorhombic, P2(1)2(1)2(1), a = 14.560(4) Angstrom, b = 21.694(5) Angstrom, c = 9.786(2) Angstrom, V = 3091 Angstrom(3), Z = 4, R = 0.072, and R(w) = 0.079). The sugar part of the complex involves novel intramolecular sugar-sugar hydrogen bondings around the metal center. The similar reaction with D-glucose, D-glucosamine, and D-galactosamine, having a 2,3-trans configuration, resulted in the formation of a mono(sugar) complex, [Ni(N-(aldosyl)-tren)(H2O)(2)]Cl-2 (aldosyl = D-glucosyl (4b), 2-amino-2-deoxy-D-glucosyl (5a), and 2-amino-2-deoxy-D-galactosyl (5b)), instead of a bis(sugar) complex. The hydrogen bondings between the sugar moieties as observed in 2 and 3 should be responsible for the assembly of two sugar molecules on the metal center. Reactions of tris(N-aldosyl-2-aminoethyl)amine with nickel(II) salts gave the tris(sugar) complexes, [Ni(N,N',N''-(aldosyl)(3)-tren)]X(2) (aldosyl = D-mannosyl, X = Cl (6a), Br (6b); L-rhamnosyl, X = Cl (7a), Br (7b); D-glucosyl, X = Cl (9); maltosyl, X = Br (10); and melibiosyl, X = Br (11)), which were assumed to have a shuttle-type C-3 symmetrical structure with Delta helical configuration for D-type aldoses on the basis of circular dichroism and C-13 NMR spectra. When tris(N-rhamnosyl)-tren was reacted with NiSO4 . 6H(2)O at low temperature, a labile neutral complex, [Ni(N,N',N''-(L-rhamnosyl)(3)-tren)(SO4)] (8), was successfully isolated and characterized by X-ray crystallography, in which three sugar moieties are anchored only at the N atom of the C-1 position (8 . 3CH(3)OH . H2O: orthorhombic, P2(1)2(1)2(1), a = 16.035(4) Angstrom, b = 16.670(7) Angstrom, c = 15.38(1) Angstrom, V = 4111 Angstrom(3), Z = 4, R = 0.084, and R(w) = 0.068). Complex 8 could be regarded as an intermediate species toward the C-3 symmetrical tris(sugar) complexes 7, and in fact, it was readily transformed to 7b by an action of BaBr2.	NARA WOMENS UNIV, FAC SCI, DEPT CHEM, NARA 630, JAPAN; UNIV TOKYO, FAC ENGN, DEPT SYNTHET CHEM, BUNKYO KU, TOKYO 113, JAPAN; INST PHYS & CHEM RES, WAKO, SAITAMA 351, JAPAN	Tanase, T (reprint author), TOHO UNIV, FAC SCI, DEPT CHEM, MIYAMA 2-2-1, FUNABASHI, CHIBA 274, JAPAN.		Kato, Masako/D-7778-2012				ANGYAL SJ, 1980, CHEM SOC REV, V9, P415, DOI 10.1039/cs9800900415; CROMER DT, 1965, ACTA CRYSTALLOGR, V18, P17, DOI 10.1107/S0365110X6500004X; [Anonymous], 1985, TEXSAN; WHITFIELD DM, 1993, COORDIN CHEM REV, V122, P171, DOI 10.1016/0010-8545(93)80045-7; TANASE T, 1988, INORG CHEM, V27, P4085, DOI 10.1021/ic00296a004; [Anonymous], 1989, ADV CARBOHYD CHEM BI; BOSTRUP O, 1957, ACTA CHEM SCAND, V11, P1223, DOI 10.3891/acta.chem.scand.11-1223; CHRISTOFIDES JC, 1983, J AM CHEM SOC, V105, P5099, DOI 10.1021/ja00353a040; COTTON FA, 1980, ADV INORG CHEM, P787; Cromer D. T., 1974, INT TABLES XRAY CRYS, V4; FAN HF, 1988, RSAPI88 RIG CORP; GILMORE CJ, 1984, J APPL CRYSTALLOGR, V17, P42, DOI 10.1107/S0021889884010992; HARDING MJ, 1973, J CHEM SOC DALTON, P955, DOI 10.1039/dt9730000955; ISHIDA K, 1989, J CHEM SOC DALTON, P1241, DOI 10.1039/dt9890001241; ISHIDA K, 1986, INORG CHEM, V25, P3552, DOI 10.1021/ic00240a003; ISHIDA K, 1988, J AM CHEM SOC, V110, P2015, DOI 10.1021/ja00214a084; ISHIDA K, 1989, J AM CHEM SOC, V111, P1599, DOI 10.1021/ja00187a011; JOHNSON CK, 1976, ORTEP II; JORGENSEN CK, 1956, ACTA CHEM SCAND, V10, P887, DOI 10.3891/acta.chem.scand.10-0887; Kennedy JF, 1983, BIOACTIVE CARBOHYDRA; MAIN P, 1978, MULTAN SYSTEM COMPUT; PARTHASARATHI V, 1983, ACTA CRYSTALLOGR A, V39, P860, DOI 10.1107/S0108767383001737; Sacconi L., 1968, TRANSITION METAL CHE, V4, P199; SAKURAI T, 1979, RIKAGAKU KENKYUSHO H, V55, P69; TANASE T, 1987, J CHEM SOC CHEM COMM, P659, DOI 10.1039/c39870000659; SHIOI H, 1983, J CHEM SOC CHEM COMM, P201, DOI 10.1039/c39830000201; TAKEI T, 1991, CHEM LETT, P1629, DOI 10.1246/cl.1991.1629; TAKIZAWA S, 1980, J AM CHEM SOC, V102, P7969, DOI 10.1021/ja00547a040; TANASE T, 1993, J CHEM SOC DALTON, P2645, DOI 10.1039/dt9930002645; TANASE T, 1988, CHEM LETT, P327, DOI 10.1246/cl.1988.327; TANASE T, 1992, J CHEM RES M, P1922; TANASE T, 1985, J CHEM SOC CHEM COMM, P1562, DOI 10.1039/c39850001562; TANASE T, 1987, J CHEM SOC JPN, V3, P322; TANASE T, 1994, INORG CHEM, V33, P6; TANASE T, 1986, J CHEM SOC CHEM COMM, P1001, DOI 10.1039/c39860001001; TANASE T, 1987, INORG CHEM, V26, P3134, DOI 10.1021/ic00266a015; TANASE T, 1992, J CHEM RES-S, P252; TANASE T, 1987, CHEM LETT, P1409, DOI 10.1246/cl.1987.1409; TSUBOMURA T, 1984, B CHEM SOC JPN, V57, P1833, DOI 10.1246/bcsj.57.1833; TSUBOMURA T, 1985, INORG CHEM, V24, P3218, DOI 10.1021/ic00214a026; TSUBOMURA T, 1983, POLYHEDRON, V2, P123, DOI 10.1016/S0277-5387(00)84687-2; WEBB GA, 1970, ANNU REP NMR SPECTRO, V3, P211, DOI 10.1016/S0066-4103(08)60370-1; WILSON LJ, 1968, J AM CHEM SOC, V90, P6041, DOI 10.1021/ja01024a018; YANO S, 1993, J CHEM SOC DALTON, P1699, DOI 10.1039/dt9930001699; YANO S, 1985, CARBOHYD RES, V142, P179, DOI 10.1016/0008-6215(85)85021-7; YANO S, 1988, COORDIN CHEM REV, V92, P113, DOI 10.1016/0010-8545(88)85007-0; YANO S, 1985, INORG CHEM, V24, P498, DOI 10.1021/ic00198a014; YANO S, IN PRESS MOL CRYST L; YANO S, IN PRESS INORG CHIM; YANO S, 1987, CHEM LETT, P2153, DOI 10.1246/cl.1987.2153	50	22	22	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0020-1669	1520-510X		INORG CHEM	Inorg. Chem.	AUG 14	1996	35	17					4848	4857		10.1021/ic960012e		10	Chemistry, Inorganic & Nuclear	Chemistry	VC197	WOS:A1996VC19700007		
J	Hata, Y; Ota, S; Hiraishi, H; Terano, A; Ivey, KJ				Hata, Y; Ota, S; Hiraishi, H; Terano, A; Ivey, KJ			Nitric oxide enhances cytotoxicity of cultured rabbit gastric mucosal cells induced by hydrogen peroxide	BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS			English	Article						nitric oxide; hydrogen peroxide; reactive oxygen metabolite; gastric cytoprotection; mucous glycoprotein; prostaglandin E(2); (rabbit gastric mucosal cell)	INDUCED DAMAGE; RAT STOMACH; BLOOD-FLOW; OXYGEN; MUCUS; PROSTAGLANDIN-E2; SECRETION	While NO has been reported to act as a protective factor to gastric mucosa, it has been shown to be cytotoxic to various cells. NO also has been demonstrated to stimulate prostaglandin (PG) release and mucous glycoprotein secretion which could result in the activation of gastric defensive mechanisms. We examined the effect of NO on cytotoxicity induced by hydrogen peroxide, and mucous glycoprotein secretion and PGE(2) release from cultured rabbit gastric mucosal cells. NO enhanced cytotoxicity induced by hydrogen peroxide. Defensive prostaglandin E(2) release and mucous glycoprotein secretion were not altered by NO. Under certain circumstances, NO might behave as an aggressive factor in gastric mucosal injury.	VET AFFAIRS MED CTR,DEPT MED,LONG BEACH,CA; UNIV CALIF IRVINE,IRVINE,CA 92717	Hata, Y (reprint author), UNIV TOKYO,DEPT INTERNAL MED 2,BUNKYO KU,7-3-1 HONGO,TOKYO 174,JAPAN.						SALVEMINI D, 1993, P NATL ACAD SCI USA, V90, P7240, DOI 10.1073/pnas.90.15.7240; WINK DA, 1993, P NATL ACAD SCI USA, V90, P9813, DOI 10.1073/pnas.90.21.9813; GRISHAM MB, 1986, AM J PHYSIOL, V251, pG567; IOANNIDIS I, 1993, BIOCHEM J, V296, P341; BROWN JF, 1993, AM J PHYSIOL, V265, pG418; CROSS CE, 1984, LANCET, V1, P1328; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; BROWN JF, 1992, BIOCHEM BIOPH RES CO, V184, P680, DOI 10.1016/0006-291X(92)90643-Y; BROWN JF, 1992, EUR J PHARMACOL, V223, P103, DOI 10.1016/0014-2999(92)90824-N; HIBBS JB, 1988, BIOCHEM BIOPH RES CO, V157, P87, DOI 10.1016/S0006-291X(88)80015-9; HIRAISHI H, 1991, AM J PHYSIOL, V261, pG662; HIRAISHI H, 1987, AM J PHYSIOL, V253, pG40; KAWABE T, 1993, GASTROENTEROLOGY, V104, pA722; KONTUREK SJ, 1994, DIGEST DIS SCI, V39, P593, DOI 10.1007/BF02088348; MACNAUGHTON WK, 1989, LIFE SCI, V45, P1869, DOI 10.1016/0024-3205(89)90540-7; MUTOH H, 1990, AM J PHYSIOL, V258, pG603; NORONHADUTRA AA, 1993, FEBS LETT, V321, P59, DOI 10.1016/0014-5793(93)80621-Z; OLSON CE, 1989, AM J PHYSIOL, V256, pG925; OTA S, 1990, Gastroenterologia Japonica, V25, P1; PIQUE JM, 1989, EUR J PHARMACOL, V174, P293, DOI 10.1016/0014-2999(89)90324-5; TERANO A, 1984, GUT, V25, P19, DOI 10.1136/gut.25.1.19; WALDER CE, 1990, P ROY SOC B-BIOL SCI, V241, P195, DOI 10.1098/rspb.1990.0085	22	17	17	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0304-4165			BBA-GEN SUBJECTS	Biochim. Biophys. Acta-Gen. Subj.	AUG 13	1996	1290	3					257	260		10.1016/0304-4165(96)00024-4		4	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	VD349	WOS:A1996VD34900008		
J	Tanaka, T; Zhang, ZL; Nishioka, M; Arakawa, Y				Tanaka, T; Zhang, ZL; Nishioka, M; Arakawa, Y			Magnetic field dependence of exciton oscillator strength by measurements of magnetoexciton-polariton mode splitting in quantum wells with a microcavity	APPLIED PHYSICS LETTERS			English	Article							SEMICONDUCTOR MICROCAVITY; EMISSION	Exciton-polariton mode splitting of quantum wells (QWs) in a microcavity is experimentally and theoretically investigated under a high magnetic field up to 14.5 T. The magnetic field dependence of the splitting interval has been measured for the precisely tuned photon and exciton mode. It is found that the splitting interval increases with an increase of the magnetic field, which shows enhancement of magnetoexciton-photon interaction. Theoretical analysis using a transfer matrix method and a variational method demonstrates that these properties are mainly caused by the increase of exciton oscillator strength due to the magnetic field. The effect of the number of QWs on the mode splitting is also discussed. (C) 1996 American Institute of Physics.		Tanaka, T (reprint author), UNIV TOKYO,INST IND SCI,MINATO KU,7-22-1 ROPPONGI,TOKYO 106,JAPAN.						ANDREANI LC, 1995, PHYS STATUS SOLIDI B, V188, P29, DOI 10.1002/pssb.2221880103; YOKOYAMA H, 1992, SCIENCE, V256, P66, DOI 10.1126/science.256.5053.66; NORRIS TB, 1994, PHYS REV B, V50, P14663, DOI 10.1103/PhysRevB.50.14663; WEISBUCH C, 1992, PHYS REV LETT, V69, P3314, DOI 10.1103/PhysRevLett.69.3314; HOUDRE R, 1995, PHYS REV B, V52, P7810, DOI 10.1103/PhysRevB.52.7810; AKSENOV I, 1995, PHYS REV B, V51, P4278, DOI 10.1103/PhysRevB.51.4278; ZHU YF, 1990, PHYS REV LETT, V64, P2499, DOI 10.1103/PhysRevLett.64.2499; Born M., 1986, PRINCIPLES OPTICS; FISHER TA, 1995, PHYS REV B, V51, P2600, DOI 10.1103/PhysRevB.51.2600; GREENE RL, 1983, SOLID STATE COMMUN, V45, P831, DOI 10.1016/0038-1098(83)90810-4; HOUDRE R, 1994, PHYS REV LETT, V73, P2043, DOI 10.1103/PhysRevLett.73.2043; JACOBSON J, 1995, PHYS REV A, V51, P2542, DOI 10.1103/PhysRevA.51.2542; MIURA N, 1984, 17TH P INT C PHYS SE, P359; TARUCHA S, 1984, SOLID STATE COMMUN, V52, P815, DOI 10.1016/0038-1098(84)90012-7; TIGNON J, 1995, PHYS REV LETT, V74, P3967, DOI 10.1103/PhysRevLett.74.3967; YAMAUCHI T, 1991, APPL PHYS LETT, V58, P2339, DOI 10.1063/1.104918; ZHANG ZL, 1995, PAC RIM C LAS EL CHI, P92	17	25	25	AMER INST PHYSICS	WOODBURY	CIRCULATION FULFILLMENT DIV, 500 SUNNYSIDE BLVD, WOODBURY, NY 11797-2999	0003-6951			APPL PHYS LETT	Appl. Phys. Lett.	AUG 12	1996	69	7					887	889		10.1063/1.117977		3	Physics, Applied	Physics	VB474	WOS:A1996VB47400007		
J	Sugishita, M; Takayama, Y; Shiono, T; Yoshikawa, K; Takahashi, Y				Sugishita, M; Takayama, Y; Shiono, T; Yoshikawa, K; Takahashi, Y			Functional magnetic resonance imaging (fMRI) during mental writing with phonograms	NEUROREPORT			English	Article						functional magnetic resonance imaging (fMRI); writing; intraparietal sulcus; middle frontal gyrus; internal word generation; pure agraphia; Kana; Kanji; phonogram; imagery	ACALCULIA; IMAGERY; CORTEX	Functional magnetic resonance imaging (fMRI) at 1.5 T using a gradient echo echo-planar sequence was employed to identify brain regions activated during the performance of a mental writing task using phonograms. Four regions were activated in all six subjects; the region surrounding the left intraparietal sulcus, the region surrounding the middle part of the left precentral sulcus and the posterior part of the left superior frontal sulcus, the region surrounding the right intraparietal sulcus, and the region surrounding either or both of the left and right cingulate sulci. The left intraparietal region was usually the most extensively activated. The results suggest that these four regions particularly the left intraparietal region, are essential in writing with phonograms. Since the left hemisphere was more extensively activated than the right, fMRI during the mental writing task is a good candidate for determining non-invasively which hemisphere is dominant for language.	UNIV TOKYO,INST IND SCI,DEPT RADIOL,TOKYO,JAPAN; DOKKYO UNIV,KOSHIGAYA HOSP,DEPT RADIOL,SCH MED,MIBU,TOCHIGI,JAPAN; GE YOKOGAWA MED,HINO,TOKYO,JAPAN	Sugishita, M (reprint author), UNIV TOKYO,FAC MED,DEPT COGNIT NEUROSCI,BUNKYO KU,7-3-1 HONGO,TOKYO 113,JAPAN.						PETRIDES M, 1995, P NATL ACAD SCI USA, V92, P5803, DOI 10.1073/pnas.92.13.5803; JEANNEROD M, 1995, NEUROPSYCHOLOGIA, V33, P1419, DOI 10.1016/0028-3932(95)00073-C; TOHGI H, 1995, J NEUROL NEUROSUR PS, V58, P629, DOI 10.1136/jnnp.58.5.629; HALLETT M, 1994, BEHAV BRAIN SCI, V17, P210; HINKE RM, 1993, NEUROREPORT, V4, P675, DOI 10.1097/00001756-199306000-00018; DECETY J, 1988, EUR ARCH PSY CLIN N, V238, P33, DOI 10.1007/BF00381078; CUENOD CA, 1995, NEUROLOGY, V45, P1821; DOHI M, 1995, P SOC MAGN RES 3 EUR, V1, P452; ROELTGEN DP, 1988, CLIN NEUROPSYCHOLOGY, P116; SUGISHITA M, 1992, BRAIN, V115, P1563, DOI 10.1093/brain/115.5.1563; TAKAYAMA Y, 1994, ARCH NEUROL-CHICAGO, V51, P286	11	31	34	RAPID SCIENCE PUBLISHERS	LONDON	2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8NH	0959-4965			NEUROREPORT	Neuroreport	AUG 12	1996	7	12					1917	1921		10.1097/00001756-199608120-00009		5	Neurosciences	Neurosciences & Neurology	VP159	WOS:A1996VP15900009		
J	Anan, H; Seki, N; Noshiro, O; Honda, K; Yasumuro, K; Ozasa, T; Fusetani, N				Anan, H; Seki, N; Noshiro, O; Honda, K; Yasumuro, K; Ozasa, T; Fusetani, N			Total synthesis of cyclostellettamine C, a bispyridinium macrocyclic alkaloid having muscarinic acetylcholine receptor antagonistic activity	TETRAHEDRON			English	Article							GENUS HALICLONA; SPONGE	Cyclostellettamine C (1), a bispyridinium macrocyclic compound having muscarinic acetylcholine receptor antagonistic activity, was synthesized by the stepwise ring closure method via 3-(13-hydroxytridecyl)-1-[13-(3-pyridyl)tridecyl]pyridinium trifluoromethanesulfonate (21). Through this study, the structure of naturally originating 1 was synthetically and biologically confirmed. Copyright (C) 1996 Published by Elsevier Science Ltd	UNIV TOKYO,GRAD SCH AGR LIFE SCI,LAB AQUAT NAT PROD CHEM,BUNKYO KU,TOKYO 113,JAPAN	Anan, H (reprint author), YAMANOUCHI PHARMACEUT CO LTD,INST DRUG DISCOVERY RES,21 MIYUKIGAOKA,TSUKUBA,IBARAKI 305,JAPAN.						DAVIESCOLEMAN MT, 1993, J ORG CHEM, V58, P5925, DOI 10.1021/jo00074a017; SCHMITZ FJ, 1978, J ORG CHEM, V43, P3916, DOI 10.1021/jo00414a026; JUNG ME, 1977, J ORG CHEM, V42, P3761, DOI 10.1021/jo00443a033; CLASSON B, 1988, J ORG CHEM, V53, P6126, DOI 10.1021/jo00261a032; FUSETANI N, 1989, TETRAHEDRON LETT, V30, P6891, DOI 10.1016/S0040-4039(01)93381-7; WESS J, 1993, TRENDS PHARMACOL SCI, V14, P308, DOI 10.1016/0165-6147(93)90049-P; YAZAWA H, 1993, JPN J PHARMACOL, V61, P319, DOI 10.1254/jjp.61.319	7	26	26	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB	0040-4020			TETRAHEDRON	Tetrahedron	AUG 12	1996	52	33					10849	10860		10.1016/0040-4020(96)00628-X		12	Chemistry, Organic	Chemistry	VB815	WOS:A1996VB81500004		
J	Sako, T; Muraki, Y; Matsubara, Y; Sato, M; Niwa, K; Nakamura, M; Sato, S; Nakano, T; Tanaka, Y; Okuno, H				Sako, T; Muraki, Y; Matsubara, Y; Sato, M; Niwa, K; Nakamura, M; Sato, S; Nakano, T; Tanaka, Y; Okuno, H			R&D for high energy gamma-ray telescope using scintillation fiber with image intensifiers	NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT			English	Article							NEUTRAL PARTICLES; CYGNUS-X-3; CALORIMETER	A new gamma-ray telescope using scintillation fiber together with an image intensifier is presented. The image intensifier we used has been improved in the sensitive range of the wavelength (beyond 300 nm) and the quantum efficiency (maximum 20%). The results of the beam test using the accelerator and the Monte Carlo simulation for the prototype telescope show that the device has the angular resolution of 0.5 degrees at 900 MeV. On the basis of results of the prototype telescope, we propose a new SCIFI (SCIntillation Fiber) telescope for future gamma-ray astronomy. The new telescope has achieved a large solid angle. With this merit, the new telescope can investigate very dark gamma-ray sources and monitor transient events such as gamma-ray burst. In addition, the cost of devices used in the telescope is not expensive so that an extension of the area of the telescope is easily realized in comparison with telescopes using silicon detector such as GLAST.	NAGOYA UNIV,DEPT PHYS,NAGOYA,AICHI 46401,JAPAN; UNIV TOKYO,INST NUCL STUDY,TOKYO 188,JAPAN	Sako, T (reprint author), NAGOYA UNIV,SOLAR TERR ENVIRONM LAB,TIKUSA KU,FURO CHO,NAGOYA,AICHI 46401,JAPAN.						PUNCH M, 1992, NATURE, V358, P477, DOI 10.1038/358477a0; HILLAS AM, 1984, NATURE, V312, P50, DOI 10.1038/312050a0; Hess VF, 1912, PHYS Z, V13, P1084; VACANTI G, 1991, ASTROPHYS J, V377, P467, DOI 10.1086/170376; BOUROTTE J, 1989, NUCL INSTRUM METH A, V274, P129, DOI 10.1016/0168-9002(89)90370-7; CASSIDAY GL, 1989, PHYS REV LETT, V62, P383, DOI 10.1103/PhysRevLett.62.383; FICHTEL CE, 1994, ASTROPHYS J SUPPL S, V94, P551, DOI 10.1086/192082; HERMSEN W, 1985, 19TH INT COSM RAY C, V1, P95; *I NUCL STUD, 1993, 1 3 GEV EL SYNCHR US; KASHIWAGI T, 1990, NUCL INSTRUM METH A, V290, P579, DOI 10.1016/0168-9002(90)90578-T; KIFUNE T, 1995, ASTROPHYS J, V438, pL92; MICHELSON PF, 1994, MAJOR ATMOSPHERIC CH, V3, P321; NAKAMOTO A, 1986, NUCL INSTRUM METH A, V251, P275, DOI 10.1016/0168-9002(86)90791-6; NAKANO T, 1992, IEEE T NUCL SCI, V39, P680, DOI 10.1109/23.159687; SAMORSKI M, 1983, ASTROPHYS J, V268, pL17, DOI 10.1086/184021; TESHIMA M, 1990, PHYS REV LETT, V64, P1628, DOI 10.1103/PhysRevLett.64.1628; THOMPSON DJ, 1993, ASTROPHYS J SUPPL S, V86, P629, DOI 10.1086/191793; TORII S, 1992, 220 SPIE, P1734; WDOWCZYK J, 1983, NATURE, V305, P609, DOI 10.1038/305609a0	19	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-9002			NUCL INSTRUM METH A	Nucl. Instrum. Methods Phys. Res. Sect. A-Accel. Spectrom. Dect. Assoc. Equip.	AUG 11	1996	378	1-2					185	195		10.1016/0168-9002(96)00064-2		11	Instruments & Instrumentation; Nuclear Science & Technology; Physics, Particles & Fields; Spectroscopy	Instruments & Instrumentation; Nuclear Science & Technology; Physics; Spectroscopy	VB362	WOS:A1996VB36200016		
J	DeBoer, J; Feher, L				DeBoer, J; Feher, L			An explicit construction of Wakimoto realizations of current algebras	MODERN PHYSICS LETTERS A			English	Article							CONFORMAL FIELD-THEORIES; KAC-MOODY ALGEBRAS; FEIGIN-FUCHS REPRESENTATIONS; QUANTUM GROUP-STRUCTURE; ZUMINO-WITTEN MODEL; AFFINE LIE-ALGEBRA; FOCK REPRESENTATIONS; BOSONIZATION; RESOLUTIONS	It is known from a work of Feigin and Frenkel that a Wakimoto type, generalized free held realization of the current algebra (G) over cap(k) can be associated with each parabolic subalgebra P = (G(0) + G(+)) of the Lie algebra G, where in the standard case G(0) is the Cartan and P is the Borel subalgebra. In this letter we obtain an explicit formula for the Wakimoto realization in the general case. Using Hamiltonian reduction of the WZNW model, we first derive a Poisson bracket realization of the G-valued current in terms of symplectic bosons belonging to G(+) and a current belonging to G(0). We then quantize the formula by determining the correct normal ordering. We also show that the affine-Sugawara stress-energy tensor takes the expected quadratic form in the constituents.	UNIV TOKYO, INST NUCL STUDIES, TANASHI, TOKYO 188, JAPAN	DeBoer, J (reprint author), SUNY STONY BROOK, INST THEORET PHYS, STONY BROOK, NY 11794 USA.		Feher, Laszlo/H-1332-2012	Feher, Laszlo/0000-0003-2000-7755			ABRAHAM R, 1978, FDN CLASSICAL MECH; FEIGIN B, 1990, PHYS LETT B, V246, P75, DOI 10.1016/0370-2693(90)91310-8; GERASIMOV A, 1990, INT J MOD PHYS A, V5, P2495, DOI 10.1142/S0217751X9000115X; BOUWKNEGT P, 1990, PHYS LETT B, V234, P297, DOI 10.1016/0370-2693(90)91930-A; WITTEN E, 1984, COMMUN MATH PHYS, V92, P455, DOI 10.1007/BF01215276; GEBERT RW, 1993, INT J MOD PHYS A, V8, P5441, DOI 10.1142/S0217751X93002162; BERNARD D, 1990, COMMUN MATH PHYS, V127, P145, DOI 10.1007/BF02096498; AWATA H, 1991, NUCL PHYS B, V365, P680, DOI 10.1016/0550-3213(91)90515-Y; BAIS FA, 1988, NUCL PHYS B, V304, P348, DOI 10.1016/0550-3213(88)90631-1; BERSHADSKY M, 1989, COMMUN MATH PHYS, V126, P49, DOI 10.1007/BF02124331; BOUWKNEGT P, 1990, COMMUN MATH PHYS, V131, P125, DOI 10.1007/BF02097682; BOUWKNEGT P, 1990, PROG THEOR PHYS SUPP, P67; BOUWKNEGT P, 1992, STRINGS SYMMETRIES 1, P407; DEBOER J, 1994, COMMUN MATH PHYS, V160, P317; DEBOER J, UNPUB; Feigin B., 1990, PHYS MATH STRINGS, P271; FEIGIN BL, 1990, COMMUN MATH PHYS, V128, P161; Feigin B. L., 1988, USP MAT NAUK, V43, P227; FEIGIN BL, 1990, LETT MATH PHYS, V19, P307, DOI 10.1007/BF00429950; FEIGIN BL, 1988, RUSS MATH SURV+, V43, P221, DOI 10.1070/RM1988v043n05ABEH001935; FEIGIN BL, 1992, INT J MOD PHYS A S, V1, P197; FIGUEROAOFARRILL JM, 1990, NUCL PHYS B, V343, P450, DOI 10.1016/0550-3213(90)90478-V; FRENKEL E, 1991, THESIS HARVARD U; FRENKEL E, 1992, NATO ADV SCI INST SE, V295, P433; FRENKEL E, HEPTH9408109; Gorbatsevich V.V., 1994, ENCY MATH SCI, V41; HARNAD J, 1995, J GEOM PHYS, V16, P168, DOI 10.1016/0393-0440(94)00027-2; ITO K, 1990, MOD PHYS LETT A, V5, P215, DOI 10.1142/S0217732390000263; ITO K, 1991, MOD PHYS LETT A, V6, P581, DOI 10.1142/S0217732391000609; ITO K, 1990, PHYS LETT B, V252, P69, DOI 10.1016/0370-2693(90)91082-M; KOSTANT B, 1975, LECT NOTES MATH, V466, P101; KUWAHARA M, 1990, NUCL PHYS B, V340, P448, DOI 10.1016/0550-3213(90)90454-L; KUWAHARA M, 1990, PHYS LETT B, V235, P52, DOI 10.1016/0370-2693(90)90096-O; KUWAHARA M, 1990, PHYS LETT B, V235, P57, DOI 10.1016/0370-2693(90)90097-P; MOROZOV A, 1989, JETP LETT+, V49, P345; OHTA N, 1990, NUCL PHYS B, V332, P146, DOI 10.1016/0550-3213(90)90033-A; WAKIMOTO M, 1986, COMMUN MATH PHYS, V104, P605, DOI 10.1007/BF01211068	37	9	9	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	0217-7323			MOD PHYS LETT A	Mod. Phys. Lett. A	AUG 10	1996	11	24					1999	2011		10.1142/S0217732396001995		13	Physics, Nuclear; Physics, Particles & Fields; Physics, Mathematical	Physics	VE629	WOS:A1996VE62900008		
J	Hasegawa, M; Matsushita, Y; Takei, H				Hasegawa, M; Matsushita, Y; Takei, H			Local structural changes in Tl2Ba2Ca2Cu3O10 single crystal between 90 K and 290 K	PHYSICA C			English	Article							SUPERCONDUCTING TRANSITION-TEMPERATURE; X-RAY-DIFFRACTION; NEUTRON-DIFFRACTION; PRESSURE-DEPENDENCE; POWDER NEUTRON; TL2BA2CACU2O8; ENHANCEMENT; YBA2CU3O7; GROWTH; T(C)	The local structure changes of a Tl2Ba2Ca2Cu3O10 single crystal (T-c = 117 K) with good crystallinity and superconducting properties have been investigated between 290 K and 90 K using an X-ray diffraction technique. The linear thermal expansion coefficients are obtained to be alpha(a)= 1.0(1) X 10(-5) K-1 and alpha(c)= 1.9(2) X 10(-5) K-1 in the a- and c-axes, respectively. The oxygen atoms in the thallium layers are found to exist at the disordered two split sites above around T-c and become ordered at a fixed site below around T-c. The mobile in-plane oxygen atom in the CuO5 square pyramid induced the local structure changes in and around the pyramid. Besides, it should be noted that they are extremely correlated with the superconductivity of the cuprate superconductors.	OSAKA UNIV,FAC SCI,TOYONAKA,OSAKA 560,JAPAN	Hasegawa, M (reprint author), UNIV TOKYO,INST SOLID STATE PHYS,MINATO KU,7-22-1 ROPPONGI,TOKYO,JAPAN.						ADAMS RD, 1992, J SUPERCOND, V5, P33, DOI 10.1007/BF00617994; ANDERSEN OK, 1991, PHYSICA C, V185, P147, DOI 10.1016/0921-4534(91)91964-6; ANDERSEN OK, 1994, PHYS REV B, V49, P4145, DOI 10.1103/PhysRevB.49.4145; MATSUSHITA Y, 1995, J SOLID STATE CHEM, V114, P289, DOI 10.1006/jssc.1995.1043; [Anonymous], 1974, INT TABLES XRAY CRYS, V4; SINCLAIR DC, 1994, PHYSICA C, V225, P307, DOI 10.1016/0921-4534(94)90728-5; CONRADSON SD, 1989, SCIENCE, V243, P1340, DOI 10.1126/science.243.4896.1340; SENDYKA TR, 1995, PHYS REV B, V51, P6747, DOI 10.1103/PhysRevB.51.6747; [Anonymous], 1992, TEXSAN; TOBY BH, 1990, PHYS REV LETT, V64, P2414, DOI 10.1103/PhysRevLett.64.2414; KOYAMA Y, 1992, PHYS REV B, V46, P5757, DOI 10.1103/PhysRevB.46.5757; COX DE, 1988, PHYS REV B, V38, P6624, DOI 10.1103/PhysRevB.38.6624; ARAI M, 1992, PHYS REV LETT, V69, P359, DOI 10.1103/PhysRevLett.69.359; BILLINGE SJL, 1993, PHYS REV B, V47, P14386, DOI 10.1103/PhysRevB.47.14386; BRESE NE, 1989, J SOLID STATE CHEM, V83, P1, DOI 10.1016/0022-4596(89)90047-9; EGAMI T, 1994, PROG MATER SCI, V38, P359, DOI 10.1016/0079-6425(94)90005-1; HASEGAWA M, 1994, PHYSICA C, V231, P161, DOI 10.1016/0921-4534(94)90156-2; HASEGAWA M, 1995, ADV SUPERCONDUCTIVIT, V7, P723; KAJITANI T, 1990, PHYSICA C, V161, P483; KAJITANI T, 1990, PHYSICA C, V167, P212, DOI 10.1016/0921-4534(90)90505-9; KLEHE AK, UNPUB PHYS REV; LIN SY, 1994, PHYSICA C, V229, P346, DOI 10.1016/0921-4534(94)90516-9; MATSUSHITA Y, 1995, ADV SUPERCONDUCTIVIT, V7, P317; MATSUSHITA Y, 1995, JPN J APPL PHYS 2, V34, pL1263; METZGER J, 1993, PHYSICA C, V214, P371, DOI 10.1016/0921-4534(93)90840-M; MOLCHANOV VN, 1994, PHYSICA C, V229, P331, DOI 10.1016/0921-4534(94)90515-0; MUSTREDELEON J, 1990, PHYS REV LETT, V65, P1765; NUNEZREGUEIRO M, 1993, SCIENCE, V262, P97, DOI 10.1126/science.262.5130.97; OGBORNE DM, 1992, PHYSICA C, V200, P167, DOI 10.1016/0921-4534(92)90333-8; OTTO HH, 1988, NATURWISSENSCHAFTEN, V75, P509, DOI 10.1007/BF00361285; RUCK K, 1994, Z NATURFORSCH B, V49, P635; SCHIRBER JE, 1993, PHYS REV B, V48, P6506, DOI 10.1103/PhysRevB.48.6506; SCHWEISS P, 1994, PHYS REV B, V49, P1387, DOI 10.1103/PhysRevB.49.1387; SIEBURGER R, 1991, PHYSICA C, V173, P403, DOI 10.1016/0921-4534(91)90742-H; SULLIVAN JD, 1993, PHYS REV B, V48, P10638, DOI 10.1103/PhysRevB.48.10638; Takahashi H, 1996, STUDIES HIGH TEMPERA, V16, P1; TAKAHASHI H, 1992, PHYSICA C, V191, P248, DOI 10.1016/0921-4534(92)90655-V; TAKAHASHI H, 1993, PHYSICA C, V217, P163, DOI 10.1016/0921-4534(93)90807-3; TORARDI CC, 1988, SCIENCE, V240, P631, DOI 10.1126/science.240.4852.631; VERNOOY PD, 1991, J SOLID STATE CHEM, V95, P270, DOI 10.1016/0022-4596(91)90105-Q; WACKER N, 1983, ACTA CRYSTALLOGR A, V39, P158; YOU HD, 1988, PHYS REV B, V38, P9213, DOI 10.1103/PhysRevB.38.9213	42	14	14	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0921-4534			PHYSICA C	Physica C	AUG 10	1996	267	1-2					31	44		10.1016/0921-4534(96)00328-0		14	Physics, Applied	Physics	VD683	WOS:A1996VD68300005		
J	Ikebukuro, K; Shimomura, M; Onuma, N; Watanabe, A; Nomura, Y; Nakanishi, K; Arikawa, Y; Karube, I				Ikebukuro, K; Shimomura, M; Onuma, N; Watanabe, A; Nomura, Y; Nakanishi, K; Arikawa, Y; Karube, I			A novel biosensor system for cyanide based on a chemiluminescence reaction	ANALYTICA CHIMICA ACTA			English	Article						cyanide; rhodanese; sulfite oxidase; luminol; chemiluminescence; flow injection	FLOW; PEROXIDASE	A highly sensitive biosensor system has been developed for cyanide detection, based on the rhodanese-sulfite oxidase reaction and subsequent luminol chemiluminescence reaction. The system consists of an immobilized rhodanese column, an immobilized sulfite oxidase column, a mixing chamber for the chemiluminescence reaction and a photomultiplier tube, The sulfite generated by the reaction of cyanide and sodium thiosulfate catalyzed by rhodanese reacts with sulfite oxidase and produces sulfate and hydrogen peroxide. The hydrogen peroxide then reacts with luminol and peroxidase (from Arthromyces ramosus (E.C. 1.11.1.7)) and the consequent chemiluminescence is detected. This system uses a flow injection analysis (FIA) system resulting in the rapid determination of cyanide, which takes approximately 2 min per measurement. A linear response was observed from 120nM to 3.8 mu M cyanide with a relative standard deviation for 380nM was less than 5% (n=6). The detection limit was 12nM. The immobilized rhodanese and sulfite oxidase column can be used 150 times.	UNIV TOKYO,ADV SCI & TECHNOL RES CTR,MEGURO KU,TOKYO 153,JAPAN; OCHANOMIZU UNIV,FAC SCI,DEPT CHEM & BIOL SCI,BUNKYO KU,TOKYO 112,JAPAN			Ikebukuro, Kazunori/B-9957-2013	Ikebukuro, Kazunori/0000-0003-2838-0562			AKIMOTO K, 1990, ANAL BIOCHEM, V189, P182, DOI 10.1016/0003-2697(90)90104-H; ASMUS E, 1953, FRESEN Z ANAL CHEM, V138, P414, DOI 10.1007/BF00461093; BASHEER S, 1993, BIOTECHNOL BIOENG, V41, P465, DOI 10.1002/bit.260410410; BUNDE RL, 1993, MICROCHEM J, V47, P148, DOI 10.1006/mchj.1993.1025; EPSTEIN J, 1947, ANAL CHEM, V19, P272, DOI 10.1021/ac60004a018; FONONG T, 1987, ANALYST, V112, P1033, DOI 10.1039/an9871201033; FRANT MS, 1972, ANAL CHEM, V44, P2227, DOI 10.1021/ac60321a038; GROOM CA, 1991, J BIOTECHNOL, V21, P161, DOI 10.1016/0168-1656(91)90268-Z; *JAP WAT WORKS ASS, 1993, STAND METH EX WAT, P174; KUWANA T, 1963, J ELECTROANAL CH INF, V6, P164, DOI 10.1016/S0022-0728(63)80155-2; LU JZ, 1995, ANAL CHIM ACTA, V304, P369; MATTIASSON B, 1977, BIOTECHNOL BIOENG, V19, P1643, DOI 10.1002/bit.260191104; NAGASHIMA S, 1978, ANAL CHIM ACTA, V99, P197, DOI 10.1016/S0003-2670(01)84514-1; NAKANISHI K, 1995, UNPUB APPL BIOTECHNO; *RIV BUR MIN CONST, 1990, ANN OBS REC RIV WAT, P31; SMIT MH, 1990, ANAL CHEM, V62, P2429, DOI 10.1021/ac00221a004; SORBO BH, 1953, ACTA CHEM SCAND, V7, P1137, DOI 10.3891/acta.chem.scand.07-1137; WILD SR, 1994, SCI TOTAL ENVIRON, V156, P93, DOI 10.1016/0048-9697(94)90346-8; YEE JI, 1995, UNPUB; 1988, JAPANESE STANDARDS A, V38, P127	20	20	21	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0003-2670			ANAL CHIM ACTA	Anal. Chim. Acta	AUG 9	1996	329	1-2					111	116		10.1016/0003-2670(96)00094-3		6	Chemistry, Analytical	Chemistry	VB446	WOS:A1996VB44600014		
J	Hayashi, KJ; Sasaki, S; Ikebukuro, K; Karube, I				Hayashi, KJ; Sasaki, S; Ikebukuro, K; Karube, I			Highly sensitive chemiluminescence flow injection analysis system using microbial peroxidase and a photodiode detector	ANALYTICA CHIMICA ACTA			English	Article						photodiode; chemiluminescence; Artheromyces ramosus peroxidase; flow injection; hypoxanthine		A highly sensitive chemiluminescence flow injection analysis system (CL-FIA) was developed using an Si-photodiode as a detector. The CL-FIA system with peroxidase from Artheromyces ramosus (ARP) showed a higher chemiluminescence intensity than that with the enhanced chemiluminescence of horse radish peroxidase (HRP) and p-iodophenol. The optimum conditions for chemiluminescence using ARP were a carbonate buffer (pH 10.1) containing 17.5 mu M luminol in the flow cell. The photocurrent of the photodiode was linearly related to the hydrogen peroxide concentration in a log-log plot from 3 nM to 10 mu M under these optimum conditions. The RSD was estimated to be 3.2% for 1 mu M of hydrogen peroxide, and the time for one analysis was less than 20 s. A CL-FIA system for hypoxanthine (Hx) measurement was also constructed with this CL-FIA system by addition of a bioreactor column of xanthine oxidase. With its compactness, ease of use, and sensitivity comparable with CL-FIA using a photomultiplier tube, this system has potential applicability for daily measurements in the industrial field.	UNIV TOKYO,ADV SCI & TECHNOL RES CTR,MEGURO KU,TOKYO 153,JAPAN; NICHIREI CORP,CHUO KU,TOKYO 104,JAPAN			Ikebukuro, Kazunori/B-9957-2013	Ikebukuro, Kazunori/0000-0003-2838-0562			AKIMOTO K, 1990, ANAL BIOCHEM, V189, P182, DOI 10.1016/0003-2697(90)90104-H; HEMMI A, 1995, ANAL CHIM ACTA, V316, P323, DOI 10.1016/0003-2670(95)00371-6; SHINMEN Y, 1986, AGR BIOL CHEM TOKYO, V50, P247; HAYAKAWA T, 1989, CHEMILUMINESCENCE BI, P154; HOOL K, 1987, ANAL CHEM, V59, P869, DOI 10.1021/ac00133a018; MALE KB, 1991, BIOSENS BIOELECTRON, V6, P581, DOI 10.1016/0956-5663(91)80023-Q; TABATA K, 1989, CHEMILUMINESCENCE BI, P242; TABATA M, 1984, Journal of Applied Biochemistry, V6, P251; YAO T, 1988, BUNSEKI KAGAKU, V37, P236	9	14	16	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0003-2670			ANAL CHIM ACTA	Anal. Chim. Acta	AUG 9	1996	329	1-2					127	134		10.1016/0003-2670(96)00125-0		8	Chemistry, Analytical	Chemistry	VB446	WOS:A1996VB44600016		
J	Matsui, J; Nicholls, IA; Karube, I; Mosbach, K				Matsui, J; Nicholls, IA; Karube, I; Mosbach, K			Carbon-carbon bond formation using substrate selective catalytic polymers prepared by molecular imprinting: An artificial class II aldolase	JOURNAL OF ORGANIC CHEMISTRY			English	Article							BINDING; RECOGNITION; MIMICS; ANTIBODIES; CAVITIES; SITES; NMR	A class II aldolase-mimicking synthetic polymer was prepared by the molecular imprinting of a complex between dibenzoylmethane (1) and cobalt(II) ion in a 4-vinylpyridine-styrene-divinylbenzene copolymer. This polymer was capable of selectively catalyzing the reaction of acetophenone (2) and benzaldehyde (3) to produce chalcone (4). The polymer, which demonstrated substrate selectivity and turnover, increased reaction rate eight-fold, relative to the solution reaction. The polymer was able to withstand vigourous reaction conditions, DMF and 100 degrees C for several weeks, while retaining most (80-95%) of its initial activity. This is the first reported example of catalytic carbon-carbon bond formation using the molecular imprinting technique.	LUND UNIV,DEPT PURE & APPL BIOCHEM,S-22100 LUND,SWEDEN; UNIV TOKYO,ADV SCI & TECHNOL RES CTR,MEGURO KU,TOKYO 153,JAPAN			Nicholls, Ian/A-1976-2009; Mosbach, Klaus/L-1016-2013	Nicholls, Ian/0000-0002-0407-6542; Mosbach, Klaus/0000-0001-7300-3470			ANDERSSON LI, 1994, HIGHLY SELECTIVE SEP, P207; ANDERSSON LI, ACS S SERIES, V586; MOSBACH K, 1994, TRENDS BIOCHEM SCI, V19, P9, DOI 10.1016/0968-0004(94)90166-X; SELLERGREN B, 1994, TETRAHEDRON-ASYMMETR, V5, P1403, DOI 10.1016/0957-4166(94)80096-0; MULLER R, 1993, MAKROMOL CHEM-RAPID, V14, P637; LEONHARDT A, 1987, REACT POLYM, V6, P285, DOI 10.1016/0167-6989(87)90099-7; SELLERGREN B, 1988, J AM CHEM SOC, V110, P5853, DOI 10.1021/ja00225a041; BEACH JV, 1994, J AM CHEM SOC, V116, P379, DOI 10.1021/ja00080a047; NICHOLLS IA, 1995, TRENDS BIOTECHNOL, V13, P47, DOI 10.1016/S0167-7799(00)88904-0; ANDERSSON LI, 1995, P NATL ACAD SCI USA, V92, P4788, DOI 10.1073/pnas.92.11.4788; WULFF G, 1993, TRENDS BIOTECHNOL, V11, P85, DOI 10.1016/0167-7799(93)90056-F; NICHOLLS IA, 1995, CHEM LETT, P1035, DOI 10.1246/cl.1995.1035; LERNER RA, 1991, SCIENCE, V252, P659, DOI 10.1126/science.2024118; VLATAKIS G, 1993, NATURE, V361, P645, DOI 10.1038/361645a0; [Anonymous], 1994, TRENDS POLYM SCI; BATT DG, 1993, J MED CHEM, P1434; DANISHEFSKY S, 1993, SCIENCE, V259, P469, DOI 10.1126/science.8424168; HEILMANN J, 1995, Z NATURFORSCH B, V50, P460; HEILMANN J, 1994, ANGEW CHEM INT EDIT, V33, P471, DOI 10.1002/anie.199404711; HERON EJ, 1975, BIOCHIM BIOPHYS ACTA, V403, P563, DOI 10.1016/0005-2744(75)90085-6; HORI K, 1987, TETRAHEDRON LETT, V28, P5883, DOI 10.1016/S0040-4039(01)81080-7; MATSUISHI T, 1994, B CHEM SOC JPN, V67, P748, DOI 10.1246/bcsj.67.748; NELSON JO, 1995, AM CHEM SOC, P89; RAMSTROM O, 1994, TETRAHEDRON-ASYMMETR, V5, P679; ROBINSON DK, 1989, J CHEM SOC CHEM COMM, V14, P969; SHEA KJ, 1991, J AM CHEM SOC, V113, P4109, DOI 10.1021/ja00011a009; WATANABE K, 1982, B CHEM SOC JPN, V55, P3208, DOI 10.1246/bcsj.55.3208; WULFF G, 1987, MAKROMOL CHEM, V188, P731	28	140	146	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036	0022-3263			J ORG CHEM	J. Org. Chem.	AUG 9	1996	61	16					5414	5417		10.1021/jo9516805		4	Chemistry, Organic	Chemistry	VD350	WOS:A1996VD35000035		
J	Mishima, K; Higashiyama, S; Nagashima, Y; Miyagi, Y; Tamura, A; Kawahara, N; Taniguchi, N; Asai, A; Kuchino, Y; Kirino, T				Mishima, K; Higashiyama, S; Nagashima, Y; Miyagi, Y; Tamura, A; Kawahara, N; Taniguchi, N; Asai, A; Kuchino, Y; Kirino, T			Regional distribution of heparin-binding epidermal growth factor-like growth factor mRNA and protein in adult rat forebrain	NEUROSCIENCE LETTERS			English	Article						heparin-binding EGF-like growth factor; in situ hybridization; immunohistochemistry; rat brain	FACTOR IMMUNOREACTIVE MATERIAL; NEURONS INVITRO; FACTOR-ALPHA; EGF; LOCALIZATION; BRAIN; SURVIVAL; CULTURE; CELLS	Heparin-binding epidermal growth factor-like growth factor (HB-EGF) is a recently described member of the EGF family that binds to and stimulates phosphorylation of the EGF receptor (EGFR). In this study, we examined the cellular localization of HB-EGF gene transcripts and protein in adult rat forebrain. In situ hybridization studies showed that neurons in various regions, including cortex, hippocampus, and deep structures, express HB-EGF mRNA. Positively labeled cells were also present in white matter, which suggests that both neurons and glia express HB-EGF mRNA. Immunohistochemical studies with an antibody specific to proHB-EGF, a transmembrane form of HB-EGF, demonstrated ubiquitous immunoreactivity in neurons and glial cells in white matter. In view of the wide expression of its cognitive receptor, EGFR, in central nervous system neurons, our results suggest that HB-EGF is an endogenous ligand for EGFR in the central nervous system and may play an important role in physiological conditions.	UNIV TOKYO,FAC MED,DEPT NEUROSURG,BUNKYO KU,TOKYO 113,JAPAN; OSAKA UNIV,SCH MED,DEPT BIOCHEM,OSAKA,JAPAN; YOKOHAMA CITY UNIV,DEPT PATHOL 2,YOKOHAMA,KANAGAWA 232,JAPAN; TEIKYO UNIV,DEPT NEUROSURG,TOKYO 173,JAPAN; NATL CANC CTR,RES INST,TOKYO 104,JAPAN							ABRAHAM JA, 1993, BIOCHEM BIOPH RES CO, V190, P125, DOI 10.1006/bbrc.1993.1020; Alexi T., 1992, Society for Neuroscience Abstracts, V18, P1292; SHING Y, 1993, SCIENCE, V259, P1604, DOI 10.1126/science.8456283; FALLON JH, 1984, SCIENCE, V224, P1107, DOI 10.1126/science.6144184; MAIESE K, 1993, J NEUROSCI, V13, P3034; HIGASHIYAMA S, 1991, SCIENCE, V251, P936, DOI 10.1126/science.1840698; SHOYAB M, 1989, SCIENCE, V243, P1074, DOI 10.1126/science.2466334; HIGASHIYAMA S, 1992, J BIOL CHEM, V267, P6205; CASPER D, 1991, J NEUROSCI RES, V30, P372, DOI 10.1002/jnr.490300213; CHALAZONITIS A, 1992, J NEUROSCI, V12, P583; FAUNDEZ V, 1992, J BIOL CHEM, V28, P20363; HIGASHIYAMA S, 1995, J CELL BIOL, V128, P929, DOI 10.1083/jcb.128.5.929; KATO M, 1995, J NEUROSCI RES, V42, P486, DOI 10.1002/jnr.490420407; KORNBLUM HI, 1990, BRAIN RES, V535, P255, DOI 10.1016/0006-8993(90)91608-J; MASSAGUE J, 1990, J BIOL CHEM, V265, P21393; MIYAGAWA J, 1995, J CLIN INVEST, V95, P404, DOI 10.1172/JCI117669; MORRISON RS, 1987, SCIENCE, V238, P72, DOI 10.1126/science.3498986; SCHAUDIES RP, 1989, J BIOL CHEM, V264, P10447; SEROOGY KB, 1993, J NEUROCHEM, V60, P1777, DOI 10.1111/j.1471-4159.1993.tb13403.x; Ventrella L L, 1993, J Neurosurg Sci, V37, P1	20	37	38	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	0304-3940			NEUROSCI LETT	Neurosci. Lett.	AUG 9	1996	213	3					153	156				4	Neurosciences	Neurosciences & Neurology	VD297	WOS:A1996VD29700002		
J	Terada, S; Nakata, T; Peterson, AC; Hirokawa, N				Terada, S; Nakata, T; Peterson, AC; Hirokawa, N			Visualization of slow axonal transport in vivo	SCIENCE			English	Article							RECOMBINANT ADENOVIRUSES IMPROVES; NEURONAL INTERMEDIATE FILAMENTS; INVIVO GENE-TRANSFER; NF-M; NEUROFILAMENT PROTEIN; CYSTIC-FIBROSIS; MODEL SYSTEM; CYTOSKELETON; SEQUENCE; VECTOR	In axons, cytoskeletal constituents move by slow transport, However, it remains controversial whether axonal neurofilaments are dynamic structures in which only subunits are transported or whether filaments assemble in the proximal axon and are transported intact as polymers to the axon terminus. To investigate the form neurofilament proteins rake during transport, neurons of transgenic mice lacking axonal neurofilaments were infected with a recombinant adenoviral vector encoding epitope-tagged neurofilament M. Confocal and electron microscopy revealed that the vitally encoded neurofilament M was transported in unpolymerized form along axonal microtubules. Thus, neurofilament proteins are probably transported as subunits or small oligomers along microtubules, which are major routes for slow axonal transport.	UNIV TOKYO,BRAIN RES INST,FAC MED,BUNKYO KU,TOKYO 113,JAPAN; UNIV TOKYO,FAC MED,DEPT ANAT & CELL BIOL,BUNKYO KU,TOKYO 113,JAPAN; MCGILL UNIV,MOL ONCOL GRP,MONTREAL,PQ H3A 1A1,CANADA							AKLI S, 1993, NAT GENET, V3, P224, DOI 10.1038/ng0393-224; NAKAGAWA T, 1995, J CELL BIOL, V129, P411, DOI 10.1083/jcb.129.2.411; TAKEDA S, 1994, J CELL BIOL, V127, P173, DOI 10.1083/jcb.127.1.173; DAVIDSON BL, 1993, NAT GENET, V3, P219, DOI 10.1038/ng0393-219; HIROKAWA N, 1982, J CELL BIOL, V94, P129, DOI 10.1083/jcb.94.1.129; KANEGAE Y, 1995, NUCLEIC ACIDS RES, V23, P3816, DOI 10.1093/nar/23.19.3816; ENGELHARDT JF, 1994, P NATL ACAD SCI USA, V91, P6196, DOI 10.1073/pnas.91.13.6196; TASHIRO T, 1989, J NEUROSCI, V9, P760; Hirokawa N, 1996, TRENDS CELL BIOL, V6, P135, DOI 10.1016/0962-8924(96)10003-9; KANEGAE Y, 1994, JPN J MED SCI BIOL, V47, P157; BAJOCCHI G, 1993, NAT GENET, V3, P229, DOI 10.1038/ng0393-229; BLUM JJ, 1989, CELL MOTIL CYTOSKEL, V12, P53, DOI 10.1002/cm.970120107; CHING GY, 1993, J CELL BIOL, V122, P1323, DOI 10.1083/jcb.122.6.1323; CLEVELAND DW, 1991, CELL, V67, P453, DOI 10.1016/0092-8674(91)90518-4; EVAN GI, 1985, MOL CELL BIOL, V5, P3610; EYER J, 1994, NEURON, V12, P389, DOI 10.1016/0896-6273(94)90280-1; GEISLER N, 1984, EMBO J, V3, P2701; GRAFSTEIN B, 1980, PHYSIOL REV, V60, P1167; GRUBB BR, 1994, NATURE, V371, P802, DOI 10.1038/371802a0; Hayat MA., 1989, PRINCIPLES TECHNIQUE; HIROKAWA N, 1985, J CELL BIOL, V101, P227, DOI 10.1083/jcb.101.1.227; Hirokawa Nobutaka, 1993, Current Opinion in Neurobiology, V3, P724, DOI 10.1016/0959-4388(93)90144-N; HOLLENBECK PJ, 1990, NATURE, V343, P408, DOI 10.1038/343408a0; JOSHI HC, 1993, J CELL BIOL, V121, P1191, DOI 10.1083/jcb.121.6.1191; JULIEN J, UNPUB; KOMIYA Y, 1986, BIOMED RES-TOKYO, V7, P359; LASALLE GL, 1993, SCIENCE, V259, P988; Lasek R J, 1986, J Cell Sci Suppl, V5, P161; LASEK RJ, 1984, J CELL BIOL, V99, pS212, DOI 10.1083/jcb.99.1.212s; LASEK RJ, 1982, PHILOS T ROY SOC B, V299, P313, DOI 10.1098/rstb.1982.0135; LEE MK, 1993, J CELL BIOL, V122, P1337, DOI 10.1083/jcb.122.6.1337; LEVY E, 1987, EUR J BIOCHEM, V166, P71, DOI 10.1111/j.1432-1033.1987.tb13485.x; Miyake S, 1996, P NATL ACAD SCI USA, V93, P1320, DOI 10.1073/pnas.93.3.1320; MYERS MW, 1987, EMBO J, V6, P1617; NAPOLITANO EW, 1987, J NEUROSCI, V7, P2590; NIXON RA, 1991, NEURONAL CYTOSKELETO; NIXON RA, 1986, J CELL BIOL, V102, P647, DOI 10.1083/jcb.102.2.647; OHARA O, 1993, J CELL BIOL, V121, P387, DOI 10.1083/jcb.121.2.387; OKABE S, 1993, J CELL BIOL, V121, P375, DOI 10.1083/jcb.121.2.375; SAITO I, 1985, J VIROL, V54, P711; STAUFENBIEL M, 1986, J VIROL, V60, P1186; YAMASAKI H, 1992, LAB INVEST, V66, P734; YANG YP, 1994, NAT GENET, V7, P362, DOI 10.1038/ng0794-362; YANG YP, 1994, P NATL ACAD SCI USA, V91, P4407, DOI 10.1073/pnas.91.10.4407; ZOPF D, 1990, NUCLEIC ACIDS RES, V18, P521, DOI 10.1093/nar/18.3.521	45	78	78	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	AUG 9	1996	273	5276					784	788		10.1126/science.273.5276.784		5	Multidisciplinary Sciences	Science & Technology - Other Topics	VB429	WOS:A1996VB42900039		
J	Deutsch, SE; Miller, JT; Tomishige, K; Iwasawa, Y; Weber, WA; Gates, BC				Deutsch, SE; Miller, JT; Tomishige, K; Iwasawa, Y; Weber, WA; Gates, BC			Supported Ir and Pt clusters: Reactivity with oxygen investigated by extended X-ray absorption fine structure spectroscopy	JOURNAL OF PHYSICAL CHEMISTRY			English	Article							IRIDIUM CATALYSTS; HYDROGEN CHEMISORPTION; METAL-CATALYSTS; PARTICLE-SIZE; PLATINUM; INTERFACE; EXAFS; PRETREATMENT; AMPLITUDE; ZEOLITE	Extended X-ray absorption fine structure (EXAFS) spectroscopy was used to investigate the effects of oxidation and reduction on supported noble metal clusters. After long-term exposure to laboratory air at room temperature, platinum clusters with an average diameter of approximately 7 Angstrom inside the pores of BaKLTL zeolite were almost completely fragmented. The EXAFS data indicate small, highly disordered platinum-platinum contributions but no bulk platinum oxides. Treatment in H-2 at 450 degrees C led to the formation of platinum clusters about 10 Angstrom in average diameter, and exposure of these to air at room temperature led to the formation of a disordered platinum-oxide-like phase covering a core of platinum atoms. The reactivity of platinum clusters with oxygen is size-dependent, and platinum cluster growth by oxidation-reduction cycles may be inhibited by the size of the zeolite pores. Similarly, iridium clusters on MgO, approximated as Ir-4, were fragmented by treatment in O-2, but treatment of the oxidized iridium clusters with H-2 at 573 K resulted in the formation of clusters with an Ir-Ir coordination number of 2.7 (and an Ir-Ir distance of 2.68 Angstrom), indicating slightly less than four Ir atoms per cluster. These data are nearly the same as those characterizing the original sample prior to oxidation, suggesting that the clusters had been reformed into almost their original state. This is the first evidence of supported metal clusters being oxidized and then regenerated nearly intact, The near reversibility of the oxidation-reduction process may be unique to iridium, being related to its slight but non-negligible oxophilicity and its resistance to sintering.	UNIV CALIF DAVIS,DEPT MAT SCI & CHEM ENGN,DAVIS,CA 95616; AMOCO CORP,DEPT RES & DEV,NAPERVILLE,IL 60566; UNIV TOKYO,DEPT CHEM,FAC SCI,BUNKYO KU,TOKYO 113,JAPAN							ALEXEEV O, IN PRESS; HUIZINGA T, 1984, APPL CATAL, V10, P199, DOI 10.1016/0166-9834(84)80104-9; ANDERSON PJ, 1965, T FARADAY SOC, V61, P2754, DOI 10.1039/tf9656102754; GATES BC, 1995, CHEM REV, V95, P511, DOI 10.1021/cr00035a003; VANZON FBM, 1993, J AM CHEM SOC, V115, P10317, DOI 10.1021/ja00075a055; EISENBERGER P, 1979, SOLID STATE COMMUN, V29, P481, DOI 10.1016/0038-1098(79)90790-7; TAUSTER SJ, 1978, J CATAL, V55, P29, DOI 10.1016/0021-9517(78)90182-3; KIP BJ, 1987, J CATAL, V105, P26, DOI 10.1016/0021-9517(87)90005-4; REHR JJ, 1991, J AM CHEM SOC, V113, P5135, DOI 10.1021/ja00014a001; BROOKS CS, 1970, J COLLOID INTERF SCI, V34, P419, DOI 10.1016/0021-9797(70)90201-8; COTTON FA, 1985, STRUCT BOND, V62, P1; DASILVA PN, 1989, APPL CATAL, V54, P203, DOI 10.1016/S0166-9834(00)82365-9; FALCONER JL, 1976, J CATAL, V45, P248, DOI 10.1016/0021-9517(76)90139-1; FIEDOROW RMJ, 1978, J CATAL, V51, P193, DOI 10.1016/0021-9517(78)90293-2; FOLEFOC GN, 1992, J CATAL, V136, P43, DOI 10.1016/0021-9517(92)90104-P; FRETY R, 1990, APPL CATAL, V58, P175, DOI 10.1016/S0166-9834(00)82287-3; FUKUSHIMA T, 1981, P 7 INT C CAT, P79; HUGHES TR, 1986, 7TH P INT ZEOL C ELS, P725; JAEGER NI, 1991, J CHEM SOC FARADAY T, V87, P1251, DOI 10.1039/ft9918701251; KAMPERS FWH, 1990, J PHYS CHEM-US, V94, P8574, DOI 10.1021/j100386a017; KAMPERS FWH, 1988, THESIS U EINDHOVEN N; KOBAYASHI M, 1980, J CATAL, V64, P74, DOI 10.1016/0021-9517(80)90480-7; KONINGSBERGER DC, 1992, CATAL LETT, V14, P271, DOI 10.1007/BF00769664; KUBA T, 1972, B CHEM SOC JPN, V45, P607; LANE GS, 1991, J CATAL, V129, P145, DOI 10.1016/0021-9517(91)90018-Y; MARQUES EC, 1982, J CHEM PHYS, V77, P1027, DOI 10.1063/1.443914; MCCABE RW, 1988, J CATAL, V114, P354, DOI 10.1016/0021-9517(88)90039-5; MCVICKER GB, 1993, J CATAL, V139, P48, DOI 10.1006/jcat.1993.1006; MCVICKER GB, 1978, J CATAL, V54, P129, DOI 10.1016/0021-9517(78)90036-2; NANDI RK, 1982, J CATAL, V78, P289, DOI 10.1016/0021-9517(82)90314-1; PURNELL SK, 1994, J PHYS CHEM-US, V98, P1205, DOI 10.1021/j100055a027; ROBOTA HJ, 1988, MATER RES SOC S P, V111, P201; RUCKENSTEIN E, 1986, J CATAL, V100, P1, DOI 10.1016/0021-9517(86)90066-7; TRIANTAFILLOU ND, 1994, J PHYS CHEM-US, V98, P8431, DOI 10.1021/j100085a026; VAARKAMP M, 1990, CATAL LETT, V6, P369, DOI 10.1007/BF00764004; VAARKAMP M, 1993, J CATAL, V144, P611, DOI 10.1006/jcat.1993.1357; Vaarkamp M., 1995, PHYSICA B, V209, P159; Zhao A, 1996, J AM CHEM SOC, V118, P2458, DOI 10.1021/ja952996x	38	24	24	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036	0022-3654			J PHYS CHEM-US	J. Phys. Chem.	AUG 8	1996	100	32					13408	13415		10.1021/jp960507p		8	Chemistry, Physical	Chemistry	VB315	WOS:A1996VB31500014		
J	Bando, KK; Asakura, K; Arakawa, H; Isobe, K; Iwasawa, Y				Bando, KK; Asakura, K; Arakawa, H; Isobe, K; Iwasawa, Y			Surface structures and catalytic hydroformylation activities of Rh dimers attached on various inorganic oxide supports	JOURNAL OF PHYSICAL CHEMISTRY			English	Article							CO-BREATHING RUTHENIUM; IRIDIUM COMPLEXES; CARBON-MONOXIDE; METAL BONDS; RHODIUM; SPECTROSCOPY; CLUSTERS; EXAFS; HYDROGENATION; INSERTION	trans-[(RhCp*CH3)2(mu-CH2)(2)] (Cp* = pentamethylcyclopentadienyl) was chemically attached to inorganic oxides such as SiO2, Al2O3, TiO2, and MgO to prepare Rh dimer catalysts. The catalytic activities of the obtained supported Rh dimers for ethene hydroformylation depended on the kinds of supports. The SiO2-attached Rh dimers showed highest activity and selectivity for the hydroformylation. Surface structure and behavior of he Rh sites during CO insertion process were examined by in situ FT-IR and EXAFS techniques. Similarly to the previous observation that Rh-Rh metal bonding in the Rh dimers on SiO2 alternately broken and formed in the course of the catalytic hydroformylation, Rh dimers on TiO2 showed a reversible bond break formation, but CO-bridged Rh dimers inactive for the hydroformylation were produced unlike the case of Rh dimer/SiO2. On Al2O3 mast of Rh dimers were degraded to monomers which exhibited no activity for the hydroformylation. The Rh dimers on MgO were aggregated to metal clusters. These structural behaviors of Rh sites are discussed in terms of the interaction between the Rh dimer and the support.	UNIV TOKYO,GRAD SCH SCI,DEPT CHEM,BUNKYO KU,TOKYO 113,JAPAN; UNIV TOKYO,FAC SCI,RES CTR SPECTROCHEM,BUNKYO KU,TOKYO 113,JAPAN; NATL INST MAT & CHEM RES,TSUKUBA,IBARAKI 305,JAPAN; OSAKA CITY UNIV,FAC SCI,DEPT MAT SCI,OSAKA 558,JAPAN			Asakura, Kiyotaka/G-6052-2010	Asakura, Kiyotaka/0000-0003-1077-5996			STERN EA, 1993, PHYS REV B, V48, P9825, DOI 10.1103/PhysRevB.48.9825; ASAKURA K, 1990, J AM CHEM SOC, V112, P9096, DOI 10.1021/ja00181a010; ASAKURA K, 1990, J AM CHEM SOC, V112, P3242, DOI 10.1021/ja00164a072; LYTLE FW, 1989, PHYSICA B, V158, P701; MUETTERTIES EL, 1979, CHEM REV, V79, P479, DOI 10.1021/cr60322a001; TEO BK, 1979, J AM CHEM SOC, V101, P2815, DOI 10.1021/ja00505a003; YATES JT, 1979, J CHEM PHYS, V70, P1219, DOI 10.1063/1.437603; ASAKURA K, 1990, J CHEM SOC FARADAY T, V86, P2657, DOI 10.1039/ft9908602657; ASAKURA K, 1990, J CHEM SOC FARADAY T, V86, P2645, DOI 10.1039/ft9908602645; ASAKURA K, 1985, CHEM LETT, P511, DOI 10.1246/cl.1985.511; BAIRD MC, 1967, J CHEM SOC A, P1347, DOI 10.1039/j19670001347; BANDO K, 1993, THESIS U TOKYO; BARNES CE, 1995, J AM CHEM SOC, V117, P5861, DOI 10.1021/ja00126a030; CALDERAZZO F, 1977, ANGEW CHEM INT EDIT, V16, P299, DOI 10.1002/anie.197702991; DEMIGUEL AV, 1982, J CHEM SOC CHEM COMM, P758, DOI 10.1039/c39820000758; HERRMANN WA, 1981, ANGEW CHEM INT EDIT, V20, P193, DOI 10.1002/anie.198101931; ICHIKAWA M, 1979, J CATAL, V59, P67, DOI 10.1016/S0021-9517(79)80046-9; ISOBE K, 1981, J CHEM SOC CHEM COMM, P809, DOI 10.1039/c39810000809; ISOBE K, 1983, J CHEM SOC DALTON, P1441, DOI 10.1039/dt9830001441; IWASAWA Y, 1993, CATAL TODAY, V18, P21, DOI 10.1016/0920-5861(93)80101-6; Iwasawa Y., 1986, TAILORED METAL CATAL; IZUMI Y, 1992, J CHEM SOC DA, V14, P2287; IZUMI Y, 1994, CHEMTECH, V24, P20; IZUMI Y, 1993, J AM CHEM SOC, V115, P6462, DOI 10.1021/ja00067a092; JEN SF, 1992, INORG CHEM, V31, P2651, DOI 10.1021/ic00038a062; KANG JW, 1971, J ORGANOMET CHEM, V26, P393, DOI 10.1016/S0022-328X(00)82621-2; KITAMURABANDO K, 1990, J CHEM SOC, V3, P253; KOSUGI N, EXAFS ANAL PROGRAM E; PLANK J, 1980, ANGEW CHEM INT EDIT, V19, P937, DOI 10.1002/anie.198009371; CLAUSS AD, 1980, J ORGANOMET CHEM, V201, pC31, DOI 10.1016/S0022-328X(00)87942-5; Teo B.K., 1986, INORGANIC CHEM CONCE, V9	31	31	31	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036	0022-3654			J PHYS CHEM-US	J. Phys. Chem.	AUG 8	1996	100	32					13636	13645		10.1021/jp953124k		10	Chemistry, Physical	Chemistry	VB315	WOS:A1996VB31500046		
J	Sueyoshi, T; Sasaki, T; Iwasawa, Y				Sueyoshi, T; Sasaki, T; Iwasawa, Y			Coadsorption of NO and NH3 on Cu(111): The formation of the stabilized (2x2) coadlayer	JOURNAL OF PHYSICAL CHEMISTRY			English	Article							ENERGY ELECTRON-DIFFRACTION; EXCHANGED ZSM-5 ZEOLITES; CARBON-MONOXIDE; VIBRATIONAL-SPECTRA; AMMONIA ADSORPTION; NITROGEN MONOXIDE; CATALYTIC PROCESS; CRYSTAL-SURFACES; NITRIC-OXIDE; CO OXIDATION	The coadsorption of NO and NH3 on Cu(111) was investigated by means of LEED, HREELS, and TPD. A new ordered (2 x 2) structure was found after annealing to 180 K NO-NH3 coadlayers prepared from various relative exposures of NO and NH3 at 100 K. A N2O desorption peak from the coadlayer appeared at 220 K, which was 70 K higher than the desorption peak From a pure NO layer. A new NH3 desorption peak also appeared al 220 K, while there was only a broad peak centered at 150 K for a pure ammonia adlayer. These results suggest that the coadlayer is more stabilized than the pure layers owing to the attractive interaction between NO(a) and NH3(a). While NO in pure NO layers adsorbs on atop, bridge, and 3-fold hollow sites, it was found that NO in the (2 x 2) structure occupied only 3-fold hollow sites in a linear configuration and the frequency of v(N-O) shifted downward from that in pure NO layers. This change in adsorption state of NO correlates with enhanced occupation of the antibonding 2 pi* orbital of NO due to charge transfer from NH3 through the substrate, leading to more attractive interaction. A real space model for the (2 x 2) structure was proposed on the basis of the results of TPD and HREELS.	UNIV TOKYO,GRAD SCH SCI,DEPT CHEM,BUNKYO KU,TOKYO 113,JAPAN							AMINPIROOZ S, 1992, PHYS REV B, V45, P6337, DOI 10.1103/PhysRevB.45.6337; SEXTON BA, 1980, SURF SCI, V99, P523, DOI 10.1016/0039-6028(80)90551-8; AFSIN B, 1993, SURF SCI, V284, P109, DOI 10.1016/0039-6028(93)90529-S; RAVAL R, 1988, SURF SCI, V203, P353, DOI 10.1016/0039-6028(88)90088-X; FISHER GB, 1981, CHEM PHYS LETT, V79, P452, DOI 10.1016/0009-2614(81)85013-0; IWAMOTO M, 1991, J PHYS CHEM-US, V95, P3727, DOI 10.1021/j100162a053; ASENSIO MC, 1992, CHEM PHYS LETT, V192, P259, DOI 10.1016/0009-2614(92)85462-J; BENNDORF C, 1983, SURF SCI, V135, P164, DOI 10.1016/0039-6028(83)90217-0; BERTEL E, 1986, SURF SCI, V172, pL515; BOZSO F, 1984, SURF SCI, V141, P591, DOI 10.1016/0039-6028(84)90151-1; BUGYI L, 1987, SURF SCI, V188, P475, DOI 10.1016/S0039-6028(87)80200-5; BURGESS D, 1989, SURF SCI, V214, P358, DOI 10.1016/0039-6028(89)90176-3; CEYER ST, 1985, SURF SCI, V155, P584, DOI 10.1016/0039-6028(85)90015-9; DAVIES PR, 1992, J CHEM SOC FARADAY T, V88, P361, DOI 10.1039/ft9928800361; DAVIES PR, 1995, SURF SCI, V325, P50, DOI 10.1016/0039-6028(94)00788-8; ERLEY W, 1982, SURF SCI, V119, pL357; ERLEY W, 1988, SURF SCI, V205, pL771, DOI 10.1016/0039-6028(88)90158-6; GLAND JL, 1981, J CATAL, V68, P286, DOI 10.1016/0021-9517(81)90098-1; GLAND JL, 1982, SURF SCI, V115, P623, DOI 10.1016/0039-6028(82)90392-2; HAYDEN BE, 1985, SURF SCI, V155, P533; HEIMANN PA, 1989, SURF SCI, V210, P282, DOI 10.1016/0039-6028(89)90117-9; HERTEL T, 1995, J CHEM PHYS, V102, P3414, DOI 10.1063/1.469215; HO P, 1984, SURF SCI, V137, P117, DOI 10.1016/0039-6028(84)90680-0; HUBER W, 1989, SURF SCI, V217, P103, DOI 10.1016/0039-6028(89)90538-4; IBACH H, 1978, SURF SCI, V76, P1, DOI 10.1016/0039-6028(78)90065-1; IWAMOTO M, 1992, J PHYS CHEM-US, V96, P9360, DOI 10.1021/j100202a055; JACOB P, 1990, SURF SCI, V235, P15; JOHNSON DW, 1979, J CHEM SOC FARAD T 1, V75, P2143, DOI 10.1039/f19797502143; KAO CT, 1988, J VAC SCI TECHNOL A, V6, P786, DOI 10.1116/1.575117; KIRSTEIN W, 1986, SURF SCI, V176, P505, DOI 10.1016/0039-6028(86)90052-X; KISKINOVA M, 1984, SURF SCI, V136, P285, DOI 10.1016/0039-6028(84)90612-5; SASAKI T, 1989, SURF SCI, V224, pL969; LACKEY D, 1987, J CHEM SOC FARAD T 1, V83, P2001, DOI 10.1039/f19878302001; MAPLEDORAM LD, 1993, CHEM PHYS LETT, V208, P409, DOI 10.1016/0009-2614(93)87164-X; MATE CM, 1988, SURF SCI, V206, P145, DOI 10.1016/0039-6028(88)90019-2; MATE CM, 1985, SURF SCI, V160, P542, DOI 10.1016/0039-6028(85)90793-9; MATERER N, 1994, SURF SCI, V303, P319, DOI 10.1016/0039-6028(94)90779-X; MUHA RJ, 1985, REV SCI INSTRUM, V56, P613, DOI 10.1063/1.1138298; MUNAKATA T, 1993, SURF SCI, V286, P73, DOI 10.1016/0039-6028(93)90557-Z; NAKAYAMA K, 1974, JPN J APPL PHYS 1 S, V2; OGLETREE DF, 1987, SURF SCI, V183, P1, DOI 10.1016/S0039-6028(87)80332-1; OHTANI H, 1988, PHYS REV LETT, V60, P2398, DOI 10.1103/PhysRevLett.60.2398; OHTANI H, 1988, J PHYS CHEM-US, V92, P3974, DOI 10.1021/j100324a057; PARMETER JE, 1988, J CHEM PHYS, V88, P5255; PEEBLES DE, 1984, SURF SCI, V148, P656, DOI 10.1016/0039-6028(84)90603-4; RAJUMON MK, 1990, SURF SCI, V233, pL237, DOI 10.1016/0039-6028(90)90169-9; RAUCHER H, 1990, SURF SCI, V234, P108; RODRIGUEZ JA, 1992, SURF SCI, V271, P333, DOI 10.1016/0039-6028(92)90897-F; SASAKI T, 1992, SURF SCI, V278, P291, DOI 10.1016/0039-6028(92)90666-T; SASAKI T, 1991, SURF SCI, V249, pL347; SASAKI T, 1994, SURF SCI, V316, pL1081; SASAKI T, 1990, SURF SCI, V240, P223, DOI 10.1016/0039-6028(90)90744-S; SASAKI T, 1992, SURF SCI, V276, P69, DOI 10.1016/0039-6028(92)90696-4; SEXTON BA, 1980, SURF SCI, V99, P539, DOI 10.1016/0039-6028(80)90552-X; SO SK, 1989, J CHEM PHYS, V91, P5701, DOI 10.1063/1.457524; SO SK, 1991, J CHEM PHYS, V95, P1385, DOI 10.1063/1.461120; SOMORJAI GA, 1994, ANNU REV PHYS CHEM, V45, P721; SPITZER A, 1982, SURF SCI, V118, P136, DOI 10.1016/0039-6028(82)90019-X; SUEYOSHI T, 1995, SURF SCI, V343, P1, DOI 10.1016/0039-6028(95)00811-X; SUEYOSHI T, 1995, CHEM PHYS LETT, V241, P189, DOI 10.1016/0009-2614(95)00625-E; URAM KJ, 1986, SURF SCI, V177, P253, DOI 10.1016/0039-6028(86)90138-X; VANHOVE MA, 1986, J AM CHEM SOC, V108, P2532, DOI 10.1021/ja00270a007; WENDELKEN JF, 1982, J VAC SCI TECHNOL, V20, P884, DOI 10.1116/1.571377; ZEBISCH P, 1991, SURF SCI, V258, P1, DOI 10.1016/0039-6028(91)90895-Y	64	6	6	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036	0022-3654			J PHYS CHEM-US	J. Phys. Chem.	AUG 8	1996	100	32					13646	13654		10.1021/jp9606265		9	Chemistry, Physical	Chemistry	VB315	WOS:A1996VB31500047		
J	Saruta, F; Hirawake, H; Takamiya, S; Ma, YC; Aoki, T; Sekimizu, K; Kojima, S; Kita, K				Saruta, F; Hirawake, H; Takamiya, S; Ma, YC; Aoki, T; Sekimizu, K; Kojima, S; Kita, K			Cloning of a cDNA encoding the small subunit of cytochrome b(558) (cybS) of mitochondrial fumarate reductase (complex II) from adult Ascaris suum	BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS			English	Article						complex II; fumarate reductase; cytochrome b; cDNA; (Ascaris suum)	SUCCINATE-UBIQUINONE REDUCTASE; BACILLUS-SUBTILIS SUCCINATE; ELECTRON-TRANSFER COMPLEXES; ESCHERICHIA-COLI; NUCLEOTIDE-SEQUENCE; PARASITIC NEMATODE; FLAVOPROTEIN SUBUNIT; MUSCLE MITOCHONDRIA; AXIAL LIGANDS; IDENTIFICATION	Complex II in the mitochondria of the adult parasitic nematode, Ascaris suum, exhibits high fumarate reductase activity in addition to succinate dehydrogenase activity and plays a key role in the anaerobic energy metabolism of the worm. In this study, the amino acid sequence of the small subunit of cytochrome b(558) (cybS) in adult complex II was deduced from the cDNA isolated by immunoscreening an A. suum muscle cDNA library. Histidine residues, which are possible heme axial ligands in cytochrome b(558), were found in the second transmembrane segment of the subunit. This is the first report of the primary structure of the small subunit In the two-subunit cytochrome b in mitochondrial complex II from a multicellular eukaryote.	UNIV TOKYO,INST MED SCI,DEPT PARASITOL,MINATO KU,TOKYO 108,JAPAN; JUNTENDO UNIV,SCH MED,DEPT PARASITOL,TOKYO,JAPAN; KYUSHU UNIV,FAC PHARMACEUT SCI,FUKUOKA 812,JAPAN							ABRAHAM PR, 1994, MOL GEN GENET, V242, P708; ACKRELL BAC, 1992, CHEM BIOCH FLAVOENZY, V3, P229; YU L, 1987, J BIOL CHEM, V262, P1137; KITA K, 1990, BIOCHEM BIOPH RES CO, V166, P101, DOI 10.1016/0006-291X(90)91916-G; BULLIS BL, 1994, J BIOL CHEM, V269, P6543; CAPALDI RA, 1972, P NATL ACAD SCI USA, V69, P930, DOI 10.1073/pnas.69.4.930; COCHRAN B, 1994, BBA-BIOENERGETICS, V1188, P162, DOI 10.1016/0005-2728(94)90035-3; COLE ST, 1982, EUR J BIOCHEM, V122, P479; COLE ST, 1985, BIOCHIM BIOPHYS ACTA, V811, P381, DOI 10.1016/0304-4173(85)90008-4; CROUSE BR, 1995, FEBS LETT, V367, P1, DOI 10.1016/0014-5793(95)00522-B; DAIGNANFORNIER B, 1994, J BIOL CHEM, V269, P15469; FRIDEN H, 1990, MOL MICROBIOL, V4, P1045, DOI 10.1111/j.1365-2958.1990.tb00677.x; HAGERHALL C, 1995, BIOCHEMISTRY-US, V34, P11080; Hederstedt L., 1992, MOL MECH BIOENERGETI, P163; HURT EC, 1986, TRENDS BIOCHEM SCI, V11, P204, DOI 10.1016/0968-0004(86)90007-1; KITA K, 1992, PARASITOL TODAY, V8, P155, DOI 10.1016/0169-4758(92)90009-Q; KITA K, 1988, BIOCHIM BIOPHYS ACTA, V935, P130, DOI 10.1016/0005-2728(88)90210-1; KITA K, 1990, HIGHLIGHTS IN UBIQUINONE RESEARCH, P174; KORTNER C, 1990, MOL MICROBIOL, V4, P855, DOI 10.1111/j.1365-2958.1990.tb00657.x; KURAMOCHI T, 1994, MOL BIOCHEM PARASIT, V68, P177, DOI 10.1016/0166-6851(94)90163-5; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LEE GY, 1995, J BIOL CHEM, V270, P6193; MAGNUSSON K, 1986, J BACTERIOL, V166, P1067; Nakamura K, 1996, J BIOL CHEM, V271, P521; NILSEN TW, 1989, MOL CELL BIOL, V9, P3543; PETERSON J, 1994, FEBS LETT, V355, P155, DOI 10.1016/0014-5793(94)01189-3; PROUDFOOT NJ, 1976, NATURE, V263, P211, DOI 10.1038/263211a0; SARUTA F, 1995, J BIOL CHEM, V270, P928; SCHILLING RJ, 1982, FED PROC, V41, P896; TAKAMIYA S, 1993, BIOCHIM BIOPHYS ACTA, V1141, P65, DOI 10.1016/0005-2728(93)90190-Q; TAKAMIYA S, 1986, BIOCHIM BIOPHYS ACTA, V848, P99, DOI 10.1016/0005-2728(86)90165-9; TAKAMIYA S, 1990, BIOCHEM INT, V21, P1073; VANHELLEMOND JJ, 1994, BIOCHEM J, V304, P321; WESTENBERG DJ, 1993, J BIOL CHEM, V268, P815; WOOD D, 1984, BIOCHEM J, V222, P519; YU CA, 1982, J BIOL CHEM, V257, P6127; YU L, 1992, J BIOL CHEM, V267, P24508	37	14	15	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0005-2728			BBA-BIOENERGETICS	Biochim. Biophys. Acta-Bioenerg.	AUG 7	1996	1276	1					1	5		10.1016/0005-2728(96)00070-9		5	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	VC054	WOS:A1996VC05400001		
J	Nakamura, E; Isobe, H; Tokuyama, H; Sawamura, M				Nakamura, E; Isobe, H; Tokuyama, H; Sawamura, M			Regio- and diastereo-controlled double cycloaddition to [60]fullerene: One-step synthesis of Cs and C-2 chiral organofullerenes with new tris-annulating reagents	CHEMICAL COMMUNICATIONS			English	Article							C-60; CYCLOPENTADIENE; REGIOCHEMISTRY; ADDUCTS; ACETALS	Double cycloaddition of new tris-annulation reagents to [60]fullerene creates a tricyclic system constructed on the [60]fullerene sphere, providing Cs symmetric and C-2 chiral non-racemic organofullerenes.		Nakamura, E (reprint author), UNIV TOKYO,DEPT CHEM,BUNKYO KU,TOKYO 113,JAPAN.		Isobe, Hiroyuki/C-2069-2008; Sawamura, Masaya/G-1428-2012; NAKAMURA, EIICHI/G-5041-2014	Isobe, Hiroyuki/0000-0001-8907-0694; 			BOUTORINE AS, 1994, ANGEW CHEM INT EDIT, V33, P2462; TSUDA M, 1993, J CHEM SOC CHEM COMM, P1296, DOI 10.1039/c39930001296; KOLB HC, 1994, CHEM REV, V94, P2483, DOI 10.1021/cr00032a009; HIRSCH A, 1994, ANGEW CHEM INT EDIT, V33, P437, DOI 10.1002/anie.199404371; MOHAMADI F, 1990, J COMPUT CHEM, V11, P440, DOI 10.1002/jcc.540110405; HIRSCH A, 1994, J AM CHEM SOC, V116, P9385, DOI 10.1021/ja00099a088; ISAACS L, 1994, ANGEW CHEM INT EDIT, V33, P2339, DOI 10.1002/anie.199423391; TOKUYAMA H, 1993, J AM CHEM SOC, V115, P7918, DOI 10.1021/ja00070a064; Boger D. L., 1990, ADV CYCLOADDITION, V2, P147; CARDULLO F, 1996, J CHEM SOC CHEM COMM, P797; HAWKINS JM, 1993, J AM CHEM SOC, V115, P9844, DOI 10.1021/ja00074a079; HERRMANN A, 1995, HELV CHIM ACTA, V78, P1673, DOI 10.1002/hlca.19950780705; Hirsch A, 1994, CHEM FULLERENE; ISAKA M, 1992, TETRAHEDRON, V48, P2045, DOI 10.1016/S0040-4020(01)88873-6; KRAUTLER B, 1995, ANGEW CHEM INT EDIT, V34, P87, DOI 10.1002/anie.199500871; MEIDINE MF, 1993, J CHEM SOC CHEM COMM, P1342, DOI 10.1039/c39930001342; TOKUYAMA H, 1995, B CHEM SOC JPN, V68, P935, DOI 10.1246/bcsj.68.935; TOKUYAMA H, 1992, J AM CHEM SOC, V114, P5523, DOI 10.1021/ja00040a006; YAMAGO S, 1994, J CHEM SOC CHEM COMM, P2093, DOI 10.1039/c39940002093	19	38	38	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK MILTON ROAD, CAMBRIDGE, CAMBS, ENGLAND CB4 4WF	1359-7345			CHEM COMMUN	Chem. Commun.	AUG 7	1996		15					1747	1748		10.1039/cc9960001747		2	Chemistry, Multidisciplinary	Chemistry	VA968	WOS:A1996VA96800017		
J	Ninomiya, K; Satoh, H; Sugiyama, T; Shinomiya, M; Kuroda, R				Ninomiya, K; Satoh, H; Sugiyama, T; Shinomiya, M; Kuroda, R			Photoactivated thiazole-based DNA-cleaving agents: Dramatic change of recognition sequence depending on the number of thiazole units	CHEMICAL COMMUNICATIONS			English	Article							PHOTOCLEAVING AGENTS; SPECIFICITY; DERIVATIVES; CLEAVAGE; GUANINE; ACIDS	By increasing the number of thiazole units in the photoactive DNA cleaving compounds, 4-(3-dimethylsulfoniopropyl-aminocarbonyl)-2-[2-(4-nitrobenzoylamino)ethyl]oligo- thiazole, from one or two to three, the specificity of their DNA cleavage was dramatically altered from 5'-AAATN-3' (N not equal G) to 5'-GG-3'.	UNIV TOKYO, GRAD SCH ARTS & SCI, DEPT LIFE SCI, MEGURO KU, TOKYO 153, JAPAN							HAMADA Y, 1987, J ORG CHEM, V52, P1252, DOI 10.1021/jo00383a014; SAITO I, 1995, J AM CHEM SOC, V117, P5590, DOI 10.1021/ja00125a023; MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560; SAITO I, 1995, J AM CHEM SOC, V117, P6406, DOI 10.1021/ja00128a050; KOBAYASHI S, 1992, SYNLETT, P59; KURODA R, 1995, NUCLEIC ACIDS RES, V23, P1524, DOI 10.1093/nar/23.9.1524; KURODA R, 1991, BIOCHEM BIOPH RES CO, V181, P1266, DOI 10.1016/0006-291X(91)92075-U; KURODA R, UNPUB; NIELSEN PE, 1988, BIOCHEMISTRY-US, V27, P6338, DOI 10.1021/bi00417a021; SHINOMIYA M, 1992, TETRAHEDRON LETT, V33, P2697, DOI 10.1016/S0040-4039(00)79060-5; SUTCLIFFE JG, 1979, COLD SPRING HARB SYM, V43, P77	11	8	8	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1359-7345			CHEM COMMUN	Chem. Commun.	AUG 7	1996		15					1825	1826		10.1039/cc9960001825		2	Chemistry, Multidisciplinary	Chemistry	VA968	WOS:A1996VA96800056		
J	Bessho, F				Bessho, F			Effects of mass screening on age-specific incidence of neuroblastoma	INTERNATIONAL JOURNAL OF CANCER			English	Article							NEURO-BLASTOMA; INFANTS; CHROMOSOME; CHILDREN; CANCER	Using data from the Japan Children's Cancer Registry, we estimated the age-specific incidence rates of neuroblastoma. Before the neuroblastoma screening program started in 1985, the age-standardized incidence rates of neuroblastoma ranged from 7.5 to 9.1 x 10(-6) for children under 15 years of age. After the introduction of the screening program, the annual incidence rate rose to 19.5 x 10(-6). The annual incidence rate for neuroblastoma in children under 1 year of age was 150.60 x 10(-6) in the years 1989 to 1992, whereas the incidence rates only varied between 23.6 and 34.13 x 10(-6) in the 3 preceding 5-year periods. This increase in incidence for infants was accompanied by a minor decrease in incidence for children 2 to 3 years of age. However, this decrease may only partly explain the large increase in incidence for infants. Therefore, we suggest that screening may result in the detection of otherwise spontaneously regressing tumors. It is urgent to determine the contribution of screening to decreasing mortality before deciding whether this screening program should be continued. (C) 1996 Wiley-liss, Inc.		Bessho, F (reprint author), TOKYO UNIV HOSP,DEPT PEDIAT,BUNKYO KU,7-3-1 HONGO,TOKYO 113,JAPAN.						PARKIN DM, 1988, INT J CANCER, V42, P511, DOI 10.1002/ijc.2910420408; BESSHO F, 1991, J PEDIATR-US, V119, P237, DOI 10.1016/S0022-3476(05)80733-4; HAAS D, 1988, CANCER, V62, P818, DOI 10.1002/1097-0142(19880815)62:4<818::AID-CNCR2820620430>3.0.CO;2-K; HAYASHI Y, 1988, J PEDIATR-US, V112, P567, DOI 10.1016/S0022-3476(88)80168-9; *JAP CHILDR CANC R, 1987, 5 YEAR REP JAP CHILD, V3; *JAP CHILDR CANC R, 1975, 5 YEAR REP JAP CHILD, V1; *JAP CHILDR CANC R, 1983, 5 YEAR REP JAP CHILD, V2; KANEKO Y, 1990, J CLIN ONCOL, V8, P2005; MAUER AM, 1988, J PEDIATR-US, V112, P576, DOI 10.1016/S0022-3476(88)80171-9; MURPHY SB, 1991, LANCET, V337, P344; NISHI M, 1995, INT J PEDIATR HEMATO, V1, P557; Parkin DM, 1988, IARC SCI PUBLICATION, V87; PARKIN DM, 1988, IARC SCI PUBL, V87, P17; SAWAGUCHI S, 1979, J JAP SOC PEDIAT SUR, V15, P1119; STILLER CA, 1993, EUR J CANCER, V29A, P1008, DOI 10.1016/S0959-8049(05)80213-8; TUCHMAN M, 1990, PEDIATRICS, V86, P791; UEDA H, 1995, J JAP PEDIAT SOC, V99, P862; WOODS WG, 1987, PEDIATRICS, V79, P869; YAMAMOTO K, 1994, P 3 INT S NEUR SCREE, P24; 1989, PEDIAT ONCOL, V26, P103; 1994, PEDIAT ONCOL, V31, P159; 1990, PEDIAT ONCOL, V27, P511; 1988, PEDIAT ONCOL, V24, P443; 1992, PEDIAT ONCOL, V29, P459; 1995, PEDIAT ONCOL, V32, P77; 1993, PEDIAT ONCOL, V30, P201; 1987, PEDIAT ONCOL, V22, P315; 1991, PEDIAT ONCOL, V28, P735	28	36	36	WILEY-LISS	NEW YORK	DIV JOHN WILEY & SONS INC 605 THIRD AVE, NEW YORK, NY 10158-0012	0020-7136			INT J CANCER	Int. J. Cancer	AUG 7	1996	67	4					520	522		10.1002/(SICI)1097-0215(19960807)67:4<520::AID-IJC10>3.0.CO;2-B		3	Oncology	Oncology	VA338	WOS:A1996VA33800010		
J	Lammertsma, K; Ohwada, T				Lammertsma, K; Ohwada, T			Three-center, two-electron systems. Origin of the tilting of their substituents	JOURNAL OF THE AMERICAN CHEMICAL SOCIETY			English	Article							HYDROCARBON PROPERTIES; THEORETICAL-ANALYSIS; MOLECULES; ISOMERS; SI2H2; STABILITY; ENERGIES; ABINITIO; SILICON; CARBON	The origin of the tilting of the H-substituents of 14 parent three-center, two-electron (3c-2e) systems, C2H3+, C2H42+, C2H5+, B2H3-, B2H3-, B2H5-, Be2H42-, Si2H3+, Si2H42+, Si2H5+, Al2H3-, Al2H4, Al2H5-,and Mg2H42- is analyzed. The mixing of the sigma and pi orbitals underlies the upward tilt of these hydrogen substituents. Except for the ethyl cation and the ethylene dication, all 3c-2e sytems have all their hydrogens on one side of a plane that contains both heavy elements. These elements thus have inverted geometries. It is shown that the geometrical tilt angles between the X-Ht and the X-X bonds of all the 3c-2e electron systems (anions, cations, dianions, dications, and neutrals containing eight different elements of the first and second rows) correlate linearly with the electronegativities of the heavy elements. The electronic structures of these systems are also reported. They highlight the convex curvature of the X-X bonds. All the investigated 3c-2e systems are either minima or transition structures. The minima associated with the transition structures are identified.	UNIV TOKYO,FAC PHARMACEUT SCI,BUNKYO KU,TOKYO 113,JAPAN	Lammertsma, K (reprint author), UNIV ALABAMA,DEPT CHEM,UAB STN,BIRMINGHAM,AL 35294, USA.						Albright T. A., 1985, ORBITAL INTERACTIONS; ALLEN LC, 1989, J AM CHEM SOC, V111, P9003, DOI 10.1021/ja00207a003; ALLRED AL, 1958, J INORG NUCL CHEM, V5, P269, DOI 10.1016/0022-1902(58)80004-4; DEWAR MJS, 1979, J AM CHEM SOC, V101, P783, DOI 10.1021/ja00498a001; LUKE BT, 1986, J AM CHEM SOC, V108, P270, DOI 10.1021/ja00262a014; OLAH GA, 1983, ACCOUNTS CHEM RES, V16, P440, DOI 10.1021/ar00096a003; WIBERG KB, 1987, J AM CHEM SOC, V109, P1001, DOI 10.1021/ja00238a005; MOHR RR, 1986, INORG CHEM, V25, P1053, DOI 10.1021/ic00227a033; OLBRICH G, 1986, CHEM PHYS LETT, V130, P115, DOI 10.1016/0009-2614(86)80436-5; JEMMIS ED, 1982, J AM CHEM SOC, V104, P7017, DOI 10.1021/ja00389a021; WIBERG KB, 1987, J AM CHEM SOC, V109, P985, DOI 10.1021/ja00238a004; BADER RFW, 1985, ACCOUNTS CHEM RES, V18, P9, DOI 10.1021/ar00109a003; Bader R.F.W., ATOMS MOL QUANTUM TH; BARONE V, 1994, J PHYS CHEM-US, V98, P13185, DOI 10.1021/j100101a016; BIGOT B, 1978, NOUV J CHIM, V2, P449; BINKLEY JS, 1984, J AM CHEM SOC, V106, P603, DOI 10.1021/ja00315a024; BOGEY M, 1991, PHYS REV LETT, V66, P413, DOI 10.1103/PhysRevLett.66.413; BOHME DK, 1981, J AM CHEM SOC, V103, P2173, DOI 10.1021/ja00399a006; CHANDRASEKHAR J, 1979, TETRAHEDRON LETT, P4057; COLEGROVE BT, 1990, J PHYS CHEM-US, V94, P5593, DOI 10.1021/j100377a036; CRABTREE RH, 1988, ORGANIC CHEM TRANSIT; CURTISS LA, 1991, J CHEM PHYS, V95, P2433, DOI 10.1063/1.460948; Frisch M. J., 1992, GAUSSIAN 92; GIORDANO C, 1977, J AM CHEM SOC, V99, P5181, DOI 10.1021/ja00457a050; GREV RS, 1992, J CHEM PHYS, V97, P7990, DOI 10.1063/1.463422; Hehre W.J., 1986, AB INITIO MOL ORBITA; HOGEVEEN H, 1975, ACCOUNTS CHEM RES, V8, P413, DOI 10.1021/ar50096a004; JEMMIS ED, 1982, J AM CHEM SOC, V104, P4781, DOI 10.1021/ja00382a008; JEMMIS ED, 1985, THEOCHEM-J MOL STRUC, V22, P305; KAUFMANN E, 1988, INORG CHEM, V27, P3987, DOI 10.1021/ic00295a019; KIRILLOV YB, 1985, SOVI J COORD CHEM, V11, P429; KIRILLOV YB, 1985, KOORDINATS KHIM, V11, P749; LAMMERTSMA K, 1986, J AM CHEM SOC, V108, P5127, DOI 10.1021/ja00277a015; LAMMERTSMA K, UNPUB; LAMMERTSMA K, 1989, INORG CHEM, V28, P313, DOI 10.1021/ic00301a032; LAMMERTSMA K, 1990, J PHYS CHEM-US, V94, P2806, DOI 10.1021/j100370a016; LAMMERTSMA K, 1983, J AM CHEM SOC, V105, P5252, DOI 10.1021/ja00354a012; LAMMERTSMA K, 1982, J AM CHEM SOC, V104, P6851, DOI 10.1021/ja00388a095; LAMMERTSMA K, 1990, J PHYS CHEM-US, V94, P5543, DOI 10.1021/j100377a025; LAUBE T, 1995, ACCOUNTS CHEM RES, V28, P399, DOI 10.1021/ar00058a001; LESZCZYNSKI J, 1991, J PHYS CHEM-US, V95, P3941, DOI 10.1021/j100163a010; NOBES RH, 1987, CHEM PHYS LETT, V136, P299, DOI 10.1016/0009-2614(87)80255-5; Olah G. A., 1987, HYPERCARBON CHEM; Olah G. A., 1991, ELECT DEFICIENT BORO; PALAGYI Z, 1993, J AM CHEM SOC, V115, P1936, DOI 10.1021/ja00058a046; PALAGYI Z, 1993, J AM CHEM SOC, V115, P6901, DOI 10.1021/ja00068a056; PALAGYI Z, 1993, CHEM PHYS LETT, V203, P195, DOI 10.1016/0009-2614(93)85386-3; RAGHAVACHARI K, 1981, J AM CHEM SOC, V103, P5649, DOI 10.1021/ja00409a004; SANA M, 1989, THEOCHEM-J MOL STRUC, V56, P233; SANA M, 1987, THEOCHEM-J MOL STRUC, V36, P307; SANNIGRAHI AB, 1992, CHEM PHYS LETT, V188, P575, DOI 10.1016/0009-2614(92)80869-D; SOUTER PF, 1994, J PHYS CHEM-US, V98, P12824, DOI 10.1021/j100100a004; Stang P. J., 1979, VINYL CATIONS; STANTON JF, 1992, J CHEM PHYS, V97, P1211, DOI 10.1063/1.463247; TRINQUIER G, 1992, CHEM PHYS LETT, V188, P572, DOI 10.1016/0009-2614(92)80868-C; VANDERWOERD MJ, 1991, J CHEM PHYS, V95, P1160, DOI 10.1063/1.461146; WIBERG KB, 1983, J AM CHEM SOC, V105, P1227, DOI 10.1021/ja00343a025; WIBERG KB, 1982, J AM CHEM SOC, V104, P5239, DOI 10.1021/ja00383a046; WONG MW, 1987, J AM CHEM SOC, V109, P3181, DOI 10.1021/ja00245a001; ZYUBIN AS, 1987, SOV J COORD CHEM, V13, P882; ZYUBIN AS, 1986, ZH NEORG KHIM+, V31, P2495; ZYUBIN AS, 1986, ZH STRUKT KHIM, V27, P45	62	43	43	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036	0002-7863			J AM CHEM SOC	J. Am. Chem. Soc.	AUG 7	1996	118	31					7247	7254		10.1021/ja960004x		8	Chemistry, Multidisciplinary	Chemistry	VB310	WOS:A1996VB31000001		
J	Fukuyama, T; Liu, G				Fukuyama, T; Liu, G			Stereocontrolled total synthesis of (+/-)-gelsemine	JOURNAL OF THE AMERICAN CHEMICAL SOCIETY			English	Article							ESTERS		RICE UNIV,DEPT CHEM,HOUSTON,TX 77005	Fukuyama, T (reprint author), UNIV TOKYO,FAC PHARMACEUT SCI,BUNKYO KU,TOKYO 113,JAPAN.						TEBBE FN, 1978, J AM CHEM SOC, V100, P3611, DOI 10.1021/ja00479a061; BENHAMOU MC, 1979, SYNTHESIS-STUTTGART, P891; BROWN HC, 1982, J ORG CHEM, V47, P1604, DOI 10.1021/jo00347a057; CONROY H, 1959, TETRAHEDRON LETT, P6; DEZIEL R, 1987, TETRAHEDRON LETT, V28, P4371, DOI 10.1016/S0040-4039(00)96512-2; DUTTON JK, 1994, J CHEM SOC CHEM COMM, P765, DOI 10.1039/c39940000765; FLEMING I, 1991, J CHEM SOC PERK T 1, P617, DOI 10.1039/p19910000617; Hudlicky T., 1992, ORG REACTIONS, V41, P1; KONDO K, 1978, TETRAHEDRON LETT, V19, P3927, DOI 10.1016/S0040-4039(01)95100-7; KUZMICH D, 1994, J AM CHEM SOC, V116, P6943, DOI 10.1021/ja00094a062; Liu Z.-J., 1988, ALKALOIDS, V33, P83, DOI 10.1016/S0099-9598(08)60297-7; LOVELL FM, 1959, TETRAHEDRON LETT, P1; MADIN A, 1992, TETRAHEDRON LETT, V33, P4859, DOI 10.1016/S0040-4039(00)61217-0; NEWCOMBE NJ, 1994, J CHEM SOC CHEM COMM, P767, DOI 10.1039/c39940000767; PFITZNER KE, 1965, J AM CHEM SOC, V87, P5661, DOI 10.1021/ja00952a026; Saxton J. E., 1965, ALKALOIDS, V8, P93, DOI 10.1016/S1876-0813(08)60045-7; STORK G, 1988, TETRAHEDRON LETT, V29, P2283, DOI 10.1016/S0040-4039(00)86038-4	17	60	60	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036	0002-7863			J AM CHEM SOC	J. Am. Chem. Soc.	AUG 7	1996	118	31					7426	7427		10.1021/ja961701s		2	Chemistry, Multidisciplinary	Chemistry	VB310	WOS:A1996VB31000034		
J	Jalilehvand, F; Ishii, Y; Hidai, M; Fukuda, Y				Jalilehvand, F; Ishii, Y; Hidai, M; Fukuda, Y			Syntheses of new copper(II) mixed-ligand complexes and their chromotropic properties in solution and in the solid state	JOURNAL OF THE CHEMICAL SOCIETY-DALTON TRANSACTIONS			English	Article							N-ALKYLATED DIAMINE; ELECTRONIC-SPECTRA; BETA-DIKETONATE; N,N,N',N'-TETRAMETHYLETHYLENEDIAMINE; SOLVENT; ANIONS	Reaction of acetylacetone (Hacac) with aldehyde (RCHO; R = p-MeOC(6)H(4), p-ClC6H4 or Ph) in 2: 1 mol ratio resulted in the formation of new triketones (HL(2)), which were previously characterized as bis(beta-diketones) of the type [(MeCO)(2)CHCHRCH(COMe)(2)](H(2)L(1)). Mixed-ligand copper(II) complexes with N,N,N',N'-tetramethylethane-1,2-diamine (tmen) and the beta-diketonate moiety of these triketones, [CuCl(L(2))(tmen)], were synthesized and their solvatochromic properties in organic solvents (due to the acceptor properties of the solvent) investigated. The colour of these five-co-ordinated complexes in the solid state gradually changes from green in [CuCl(L(2))(tmen)] through bluish green, [CuCl(L(2))(tmen)]. CH2Cl2, to blue, [CuCl(L(2))(tmen)]. MeOH . CH2Cl2. Crystallographic studies showed that this phenomenon arises from an intermolecular hydrogen bond between the co-ordinated chloride of one complex and the OH group of a triketonate ligand of an adjacent complex and/or cocrystallized MeOH molecule.	OCHANOMIZU UNIV,FAC SCI,DEPT CHEM,BUNKYO KU,TOKYO 112,JAPAN; UNIV TOKYO,GRAD SCH ENGN,DEPT CHEM & BIOTECHNOL,BUNKYO KU,TOKYO 113,JAPAN							FUKUDA Y, 1972, J INORG NUCL CHEM, V34, P2315, DOI 10.1016/0022-1902(72)80168-4; FUKUDA Y, 1974, J INORG NUCL CHEM, V36, P1265, DOI 10.1016/0022-1902(74)80062-X; [Anonymous], 1974, INT TABLES XRAY CRYS, V4; FUKUDA Y, 1985, B CHEM SOC JPN, V58, P3518, DOI 10.1246/bcsj.58.3518; [Anonymous], 1992, INT TABLES XRAY CRYS, VC; REEVES LW, 1957, CAN J CHEM, V35, P1351, DOI 10.1139/v57-179; FUKUDA Y, 1988, CHEM LETT, P687; FUKUDA Y, 1982, B CHEM SOC JPN, V55, P3738, DOI 10.1246/bcsj.55.3738; FUKUDA Y, 1977, B CHEM SOC JPN, V50, P313, DOI 10.1246/bcsj.50.313; FUKUDA Y, 1981, B CHEM SOC JPN, V54, P428, DOI 10.1246/bcsj.54.428; FUKUDA Y, 1977, B CHEM SOC JPN, V50, P142, DOI 10.1246/bcsj.50.142; GEARY WJ, 1971, COORDIN CHEM REV, V7, P81, DOI 10.1016/S0010-8545(00)80009-0; Gutmann V., 1978, DONOR ACCEPTOR APPRO; HOLTZCLAW HF, 1957, J AM CHEM SOC, V79, P3318, DOI 10.1021/ja01570a006; JALILEHVAND F, 1995, CHEM LETT, P743, DOI 10.1246/cl.1995.743; Johnson C. K., 1976, ORNL5138 ORTEP; KAMBAYASHI H, 1991, CHEM LETT, P303, DOI 10.1246/cl.1991.303; KAMBAYASHI H, 1995, Z NATURFORSCH B, V50, P536; LABUDA J, 1990, B CHEM SOC JPN, V63, P2610, DOI 10.1246/bcsj.63.2610; LINERT W, 1990, MONATSH CHEM, V121, P765, DOI 10.1007/BF00808369; LINERT W, 1993, J CHEM SOC DALTON, P3181, DOI 10.1039/dt9930003181; MARTIN DF, 1958, J AM CHEM SOC, V80, P5851, DOI 10.1021/ja01554a068; MAYER U, 1983, IONS MOL SOLUTIONS, P251; *MOL STRUCT CORP, 1985, TEXSAN TEXRAY; NATARJAN K, 1992, SYN REACT INORG MET, V22, P171; NATARJAN K, 1994, SYN REACT INORG MET, V24, P553; SHARMA RK, 1985, MONATSH CHEM, V116, P297, DOI 10.1007/BF00799963	27	8	8	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK MILTON ROAD, CAMBRIDGE, CAMBS, ENGLAND CB4 4WF	0300-9246			J CHEM SOC DALTON	J. Chem. Soc.-Dalton Trans.	AUG 7	1996		15					3251	3256		10.1039/dt9960003251		6	Chemistry, Inorganic & Nuclear	Chemistry	VC801	WOS:A1996VC80100014		
J	Yamazaki, H; Nakata, T; Okada, Y; Hirokawa, N				Yamazaki, H; Nakata, T; Okada, Y; Hirokawa, N			Cloning and characterization of KAP3: A novel kinesin superfamily-associated protein of KIF3A/3B	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						microtubule; axonal transport; motor protein	AXONAL-TRANSPORT; HETEROTRIMERIC KINESIN; MEMBRANOUS ORGANELLES; ANTEROGRADE MOTOR; GLOBULAR PROTEINS; MONOMERIC MOTOR; ATPASE ACTIVITY; NERVOUS-SYSTEM; LIGHT-CHAINS; HEAVY-CHAIN	We previously reported that KIF3A and KIF3B form a heterodimer that functions as a microtubule-based fast anterograde translocator of membranous organelles. We have also shown that this KIF3A/3B forms a complex with other associated polypeptides, named kinesin superfamily-associated protein 3 (KAP3). In the present study, we purified KAP3 protein by immunoprecipitation using anti-KIF3B antibody from mouse testis, Microsequencing was carried out, and we cloned the full-length KAP3 cDNA from a mouse brain cDNA library, Two isoforms of KAP3 exist [KAP3A (793 aa) and KAP3B (772 aa)], generated by alternative splicing in the carboxyl terminus region, Their amino acid sequences have no homology with those of any other known proteins, and prediction of their secondary structure indicated that almost the entire KAP3 molecule is alpha-helical, We produced recombinant KAP3 and KIF3A/3B using a baculovirus-Sf9 expression system, A reconstruction study in Sf9 cells revealed that KAP3 is a globular protein that binds to the tail domain of KIF3A/3B. The immunolocalization pattern of KAP3 was similar to that of KIF3A/3E in nerve cells. In addition, we found that KAP3 does not affect the motor activity of KIF3A/3B, KAP3 was associated with a membrane-bound form of KIF3A/3B in a fractional immunoprecipitation experiment, and since the KIF3 complex was found to bind to membranous organelles in an EM study, KAP3 may regulate membrane binding of the KIF3 complex.	UNIV TOKYO,FAC MED,DEPT ANAT & CELL BIOL,BUNKYO KU,TOKYO 113,JAPAN			Okada, Yasushi/N-5067-2015	Okada, Yasushi/0000-0003-2601-3689			NAKATA T, 1991, NEURON, V7, P461, DOI 10.1016/0896-6273(91)90298-E; Wedaman KP, 1996, J CELL BIOL, V132, P371, DOI 10.1083/jcb.132.3.371; SEALS JR, 1978, ANAL BIOCHEM, V90, P785, DOI 10.1016/0003-2697(78)90169-0; NAKATA T, 1995, J CELL BIOL, V131, P1039, DOI 10.1083/jcb.131.4.1039; OKADA Y, 1995, CELL, V81, P769, DOI 10.1016/0092-8674(95)90538-3; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; AIZAWA H, 1992, J CELL BIOL, V119, P1287, DOI 10.1083/jcb.119.5.1287; YAMAZAKI H, 1995, J CELL BIOL, V130, P1387, DOI 10.1083/jcb.130.6.1387; HIROKAWA N, 1982, J CELL BIOL, V94, P129, DOI 10.1083/jcb.94.1.129; NANGAKU M, 1994, CELL, V79, P1209, DOI 10.1016/0092-8674(94)90012-4; SEKINE Y, 1994, J CELL BIOL, V127, P187, DOI 10.1083/jcb.127.1.187; KOZMINSKI KG, 1995, J CELL BIOL, V131, P1517, DOI 10.1083/jcb.131.6.1517; NODA Y, 1995, J CELL BIOL, V129, P157, DOI 10.1083/jcb.129.1.157; Hirokawa N, 1996, TRENDS CELL BIOL, V6, P135, DOI 10.1016/0962-8924(96)10003-9; WALTHER Z, 1994, J CELL BIOL, V126, P175, DOI 10.1083/jcb.126.1.175; BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; BLOOM GS, 1994, PROTEIN PROFILE, V1, P1059; BRADY ST, 1985, NATURE, V317, P73, DOI 10.1038/317073a0; BRADY ST, 1995, CURR OPIN NEUROBIOL, V5, P551, DOI 10.1016/0959-4388(95)80058-1; COLE DG, 1993, NATURE, V366, P268, DOI 10.1038/366268a0; COLE DG, 1992, J CELL SCI, V101, P291; CYR JL, 1991, P NATL ACAD SCI USA, V88, P10114, DOI 10.1073/pnas.88.22.10114; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; GAUGER AK, 1993, J BIOL CHEM, V268, P13657; GOLDSTEIN LSB, 1993, ANNU REV GENET, V27, P319; HACKNEY DD, 1991, BIOCHEM BIOPH RES CO, V174, P810, DOI 10.1016/0006-291X(91)91490-4; HACKNEY DD, 1992, J BIOL CHEM, V267, P8696; HENSON JH, 1995, DEV BIOL, V171, P182, DOI 10.1006/dbio.1995.1270; HIROKAWA N, 1986, CELL MOTIL CYTOSKEL, V6, P458, DOI 10.1002/cm.970060504; Hirokawa Nobutaka, 1993, Current Opinion in Neurobiology, V3, P724, DOI 10.1016/0959-4388(93)90144-N; HIROKAWA N, 1989, CELL, V56, P867, DOI 10.1016/0092-8674(89)90691-0; HIROKAWA N, 1991, J CELL BIOL, V114, P295, DOI 10.1083/jcb.114.2.295; KONDO S, 1994, J CELL BIOL, V125, P1095, DOI 10.1083/jcb.125.5.1095; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; MATTHIES HJG, 1993, J BIOL CHEM, V268, P11176; NICLAS J, 1994, NEURON, V12, P1059, DOI 10.1016/0896-6273(94)90314-X; O'Reilly DR, 1992, BACULOVIRUS EXPRESSI; PESAVENTO PA, 1994, J CELL BIOL, V127, P1041, DOI 10.1083/jcb.127.4.1041; RASHID DJ, 1995, J MOL BIOL, V252, P157, DOI 10.1006/jmbi.1995.0484; ROBSON B, 1976, J MOL BIOL, V107, P327, DOI 10.1016/S0022-2836(76)80008-3; SHAKIR MA, 1993, NEUROREPORT, V4, P891, DOI 10.1097/00001756-199307000-00013; STEWART RJ, 1991, P NATL ACAD SCI USA, V88, P8470, DOI 10.1073/pnas.88.19.8470; TABISH M, 1995, J MOL BIOL, V247, P377, DOI 10.1006/jmbi.1994.0146; Takemura R, 1996, J NEUROSCI, V16, P31; VALE RD, 1985, CELL, V42, P39, DOI 10.1016/S0092-8674(85)80099-4; VALE RD, 1985, CELL, V40, P559, DOI 10.1016/0092-8674(85)90204-1; WEDAMAN KP, 1993, J MOL BIOL, V231, P155, DOI 10.1006/jmbi.1993.1267	47	130	131	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	AUG 6	1996	93	16					8443	8448		10.1073/pnas.93.16.8443		6	Multidisciplinary Sciences	Science & Technology - Other Topics	VB325	WOS:A1996VB32500053		
J	Toda, Y; Kourogi, M; Ohtsu, M; Nagamune, Y; Arakawa, Y				Toda, Y; Kourogi, M; Ohtsu, M; Nagamune, Y; Arakawa, Y			Spatially and spectrally resolved imaging of GaAs quantum-dot structures using near-field optical technique	APPLIED PHYSICS LETTERS			English	Article							SCANNING TUNNELING MICROSCOPE; FIBER PROBE; SPECTROSCOPY; GROWTH	We present experimental result on spatially and spectrally resolved imaging of GaAs quantum dot (QD) structures using a near-field optical microscope. Three photoluminescence (PL) peaks which originate from QD, quantum well (QW), and bulk regions were observed at liquid-He temperature. Carriers were observed to diffuse effectively from the AlGaAs barriers to the QD and QW regions. The region of the intension carrier capture manifests itself by emitting a sharp PL peak, and is estimated to be about 300 nm. (C) 1996 American Institute of Physics.	UNIV TOKYO,INST IND SCI,MINATO KU,TOKYO 106,JAPAN; KANAGAWA ACAD SCI & TECHNOL,TAKATSU KU,KAWASAKI,KANAGAWA 213,JAPAN	Toda, Y (reprint author), TOKYO INST TECHNOL,INTERDISCIPLINARY GRAD SCH SCI & ENGN,MIDORI KU,4259 NAGATSUDA,YOKOHAMA,KANAGAWA 226,JAPAN.		Ohtsu, Motoichi/B-6926-2008				BETZIG E, 1992, APPL PHYS LETT, V60, P2484, DOI 10.1063/1.106940; HESS HF, 1994, SCIENCE, V264, P1740, DOI 10.1126/science.264.5166.1740; GOLDSTEIN L, 1985, APPL PHYS LETT, V47, P1099, DOI 10.1063/1.96342; ARAKAWA Y, 1982, APPL PHYS LETT, V40, P929; GROBER RD, 1994, APPL PHYS LETT, V64, P1421, DOI 10.1063/1.111903; MOHIDEEN U, 1995, QUANTUM ELECT LASER, V16, P95; MONONOBE S, UNPUB APPL OPT; NAGAMUNE Y, 1993, J CRYST GROWTH, V126, P707, DOI 10.1016/0022-0248(93)90822-E; OHTSU M, 1995, J LIGHTWAVE TECHNOL, V13, P1200, DOI 10.1109/50.400696; OSHINOWO J, 1994, APPL PHYS LETT, V65, P1421, DOI 10.1063/1.112070; PANGRIBUAN T, 1993, ELECTRON LETT, V29, P1978, DOI 10.1049/el:19931317; SAIKI T, 1995, APPL PHYS LETT, V67, P2191, DOI 10.1063/1.115099; TSUTSUI K, 1993, JPN J APPL PHYS 1, V32, P6233, DOI 10.1143/JJAP.32.6233	13	41	41	AMER INST PHYSICS	WOODBURY	CIRCULATION FULFILLMENT DIV, 500 SUNNYSIDE BLVD, WOODBURY, NY 11797-2999	0003-6951			APPL PHYS LETT	Appl. Phys. Lett.	AUG 5	1996	69	6					827	829		10.1063/1.117905		3	Physics, Applied	Physics	VA292	WOS:A1996VA29200037		
J	Yamada, H; Seki, G; Taniguchi, S; Uwatoko, S; Suzuki, K; Kurokawa, K				Yamada, H; Seki, G; Taniguchi, S; Uwatoko, S; Suzuki, K; Kurokawa, K			Effect of ionomycin on cell pH in isolated renal proximal tubules	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article							BICARBONATE ABSORPTION; BASOLATERAL MEMBRANE; CONVOLUTED TUBULE; INTRACELLULAR PH; COTRANSPORT; INHIBITION; IONOPHORE; CALCIUM; A23187	In isolated rabbit proximal tubules the addition of 2.0 mu M but not 0.2 mu M ionomycin induced a sustained increase in cell pH ([pH](i)). This [pH](i) response to 2.0 mu M ionomycin was shown to be independent of several transporters such as Na+/H+ exchanger, Na+-HCO3- cotransporter, Cl-/HCO3- exchanger, or H+-ATPase. On the other hand, the removal of extracellular Ca2+ abolished the [pH](i) increase or even induced a transient [pH](i) decrease in the presence of ionomycin. These results are consistent with the induction of Ca2+/H+ exchange by ionomycin. Therefore Ca2+ ionophores should be used with caution as probes to estimate renal tubule functions. (C) 1996 Academic Press, Inc.	UNIV TOKYO,SCH MED,DEPT INTERNAL MED 1,BUNKYO KU,TOKYO 113,JAPAN; TOKYO UNIV AGR & TECHNOL,HLTH SERV CTR,FUCHU,TOKYO 183,JAPAN							HARRIS PJ, 1977, PFLUG ARCH EUR J PHY, V367, P295, DOI 10.1007/BF00581370; THOMAS JA, 1979, BIOCHEMISTRY-US, V18, P2210, DOI 10.1021/bi00578a012; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; REED PW, 1972, J BIOL CHEM, V247, P6970; ASEM EK, 1992, J MOL ENDOCRINOL, V9, P1; GEIBEL J, 1990, P NATL ACAD SCI USA, V87, P7917, DOI 10.1073/pnas.87.20.7917; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; IINO Y, 1979, AM J PHYSIOL, V236, pF387; JEHMLICH K, 1991, KIDNEY INT, V40, pS64; KAUFFMAN RF, 1980, J BIOL CHEM, V255, P2735; KRAPF R, 1987, J GEN PHYSIOL, V90, P833, DOI 10.1085/jgp.90.6.833; LIU FY, 1990, AM J PHYSIOL, V259, pF451; RUIZ OS, 1992, AM J PHYSIOL, V262, pF560; SEKI G, 1993, PFLUG ARCH EUR J PHY, V425, P409, DOI 10.1007/BF00374866; SEKI G, 1993, J CLIN INVEST, V92, P1229, DOI 10.1172/JCI116694; WANG T, 1990, PFLUG ARCH EUR J PHY, V415, P533, DOI 10.1007/BF02583503; Yamada H, 1996, AM J PHYSIOL-CELL PH, V270, pC1096	17	4	4	ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495	0006-291X			BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	AUG 5	1996	225	1					215	218		10.1006/bbrc.1996.1156		4	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	VE983	WOS:A1996VE98300036		
J	Yu, YS; Suzuki, Y; Yoshitomo, K; Muramatsu, MA; Yamaguchi, N; Sugano, S				Yu, YS; Suzuki, Y; Yoshitomo, K; Muramatsu, MA; Yamaguchi, N; Sugano, S			Promoter structure of TGF-beta type II receptor revealed by ''oligo-capping'' method and deletion analysis	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article							CLONING; EXPRESSION; KINASE; REGION; GENE	The promoter of TGF-beta type II receptor lacks TATA box or CAAT box, In order to define the exact transcriptional start site(s), we used ''oligo-capping'' method developed by ourselves, The major transcripts were started from GAA located between -35 and -33 relative to 5' end of cDNA. Other minor transcripts started from -4, +11 and +17. Deletion analysis of this promoter region revealed that it contained two adjacently located promoters (Pi and P2) capable of acting by itself. The P1 is located between -22 and +55 which covers the minor transcriptional start sites described above. The P2 is located just upstream of the P1 between -137 and -22. The results showed all of the transcripts were started either from P1 or P2. (C) 1996 Academic Press, Inc.	UNIV TOKYO,INST MED SCI,DEPT VIROL,MINATO KU,TOKYO 108,JAPAN; UNIV TOKYO,INST MED SCI,DEPT MOL GENET,MINATO KU,TOKYO 108,JAPAN; UNIV TOKYO,MEGURO KU,TOKYO 153,JAPAN							FRANZEN P, 1993, CELL, V75, P681, DOI 10.1016/0092-8674(93)90489-D; JENSEN FC, 1964, P NATL ACAD SCI USA, V52, P53, DOI 10.1073/pnas.52.1.53; ATTISANO L, 1993, CELL, V75, P671, DOI 10.1016/0092-8674(93)90488-C; SMALE ST, 1989, CELL, V57, P103, DOI 10.1016/0092-8674(89)90176-1; LIN HY, 1992, CELL, V68, P775, DOI 10.1016/0092-8674(92)90152-3; MARUYAMA K, 1994, GENE, V138, P171; BAE HW, 1995, J BIOL CHEM, V270, P29460; EBNER R, 1993, SCIENCE, V260, P1344, DOI 10.1126/science.8388127; HUMPHRIES DE, 1994, BIOCHEM BIOPH RES CO, V203, P1020, DOI 10.1006/bbrc.1994.2284; MASSAGUE J, 1990, CELL BIOL, V6, P597; UCHIUMI F, 1992, MOL CELL BIOL, V12, P3784	11	9	9	ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495	0006-291X			BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	AUG 5	1996	225	1					302	306		10.1006/bbrc.1996.1170		5	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	VE983	WOS:A1996VE98300050		
J	Steiner, M; Kakurai, K; Dorner, B; Pynn, R; Akimitsu, J				Steiner, M; Kakurai, K; Dorner, B; Pynn, R; Akimitsu, J			The change of the symmetry of the soft-mode spin wave at the spin-flop transition as observed in MnTiO3 using inelastic polarized neutron scattering	JOURNAL OF PHYSICS-CONDENSED MATTER			English	Article							ANTIFERROMAGNET	The energy and the eigenvector of the spin waves in MnTiO3 have been studied as functions of the applied magnetic field using inelastic neutron scattering with and without polarization analysis. It is found that the behaviour depends on the distance q from the antiferromagnetic zone centre: for q congruent to 0 the mode softens completely at the spin-flop field H-sf, but it has finite energy for q > 0; the eigenvector retains its Ising character for small q up to the highest fields measured (5 T = 0.86H(sf), assuming H-sf = 5.8 T), but it changes continuously with held from Ising to Heisenberg character for large q. A very strong, temperature-dependent line width was found at H = 6 T, close to H-sf which is interpreted as further evidence for the soft-mode instability at the spin-flop transition.	UNIV TOKYO,ISSP,NEUTRON SCATTERING LAB,TOKAI,IBARAKI 31911,JAPAN; INST MAX VON LAUE PAUL LANGEVIN,F-38042 GRENOBLE,FRANCE; LOS ALAMOS NATL LAB,LANSCE,LOS ALAMOS,NM; AOYAMA GAKUIN UNIV,DEPT PHYS,TOKYO 157,JAPAN	Steiner, M (reprint author), HAHN MEITNER INST BERLIN GMBH,GLIENICKER STR 100,D-14109 BERLIN,GERMANY.						AKIMITSU J, 1977, J PHYS SOC JPN, V42, P462, DOI 10.1143/JPSJ.42.462; RAUH H, 1986, J PHYS C SOLID STATE, V19, P4503, DOI 10.1088/0022-3719/19/23/013; BASTEN JAJ, 1980, PHYS REV B, V22, P1429, DOI 10.1103/PhysRevB.22.1429; BIRGENEA.RJ, 1973, PHYS REV B, V8, P304, DOI 10.1103/PhysRevB.8.304; FEDER J, 1968, PHYS REV, V168, P640, DOI 10.1103/PhysRev.168.640; GRIEB T, 1984, SOLID STATE COMMUN, V51, P923, DOI 10.1016/0038-1098(84)90353-3; KAKURAI K, 1993, INT J MOD PHYS B, V7, P3095, DOI 10.1142/S0217979293003176; KOPINGA K, 1984, 5 ARB NEUTR; ROHRER H, 1977, PHYS REV LETT, V38, P909, DOI 10.1103/PhysRevLett.38.909; STICKLER JJ, 1967, PHYS REV, V164, P765, DOI 10.1103/PhysRev.164.765; TODATE Y, 1986, J PHYS SOC JPN, V55, P4464, DOI 10.1143/JPSJ.55.4464; WANG YL, 1964, J PHYS CHEM SOLIDS, V25, P1459; YAMAUCHI H, 1983, J MAGN MAGN MATER, V31-4, P1071, DOI 10.1016/0304-8853(83)90802-8	13	0	0	IOP PUBLISHING LTD	BRISTOL	TECHNO HOUSE, REDCLIFFE WAY, BRISTOL, ENGLAND BS1 6NX	0953-8984			J PHYS-CONDENS MAT	J. Phys.-Condes. Matter	AUG 5	1996	8	32					5905	5914		10.1088/0953-8984/8/32/010		10	Physics, Condensed Matter	Physics	VB658	WOS:A1996VB65800010		
J	Hayashida, N; Honda, K; Honda, M; Inoue, N; Kadota, K; Kakimoto, F; Kamata, K; Kawaguchi, S; Kawasumi, N; Matsubara, Y; Murakami, K; Nagano, M; Ohoka, H; Sakaki, N; Souma, N; Takeda, M; Teshima, M; Tsushima, I; Uchihori, Y; Yoshida, S; Yoshii, H				Hayashida, N; Honda, K; Honda, M; Inoue, N; Kadota, K; Kakimoto, F; Kamata, K; Kawaguchi, S; Kawasumi, N; Matsubara, Y; Murakami, K; Nagano, M; Ohoka, H; Sakaki, N; Souma, N; Takeda, M; Teshima, M; Tsushima, I; Uchihori, Y; Yoshida, S; Yoshii, H			Possible clustering of the most energetic cosmic rays within a limited space angle observed by the Akeno giant air shower array	PHYSICAL REVIEW LETTERS			English	Article							SPECTRUM; CUTOFF; WELL	Accumulated data of the Akeno Giant Air Shower Array (AGASA) indicate that arrival directions of a significant fraction of extremely high energy cosmic rays (EHECR) are uniformly distributed over the observable sky. However, three pairs of showers with angular separation of less than 2.5 degrees within the pair are observed among the 36 events above 40 EeV (4 x 10(19) eV), corresponding to a chance probability of 2.9% from uniform distribution. It should be noted that two pairs of them are observed to be within 2.0 degrees of the supergalactic plane.	YAMANASHI UNIV,FAC EDUC,KOFU,YAMANASHI 400,JAPAN; SAITAMA UNIV,DEPT PHYS,URAWA,SAITAMA 338,JAPAN; TOKYO INST TECHNOL,DEPT PHYS,TOKYO 152,JAPAN; NISHINA MEM FDN,TOKYO 188,JAPAN; HIROSAKI UNIV,FAC GEN EDUC,HIROSAKI,AOMORI 036,JAPAN; NAGOYA UNIV,SOLAR TERR ENVIRONM LAB,NAGOYA,AICHI 46401,JAPAN; NAGOYA UNIV FOREIGN STUDIES,AICHI 47001,JAPAN; EHIME UNIV,DEPT PHYS,MATSUYAMA,EHIME 790,JAPAN	Hayashida, N (reprint author), UNIV TOKYO,INST COSM RAY RES,TANASHI,TOKYO 188,JAPAN.						GREISEN K, 1966, PHYS REV LETT, V16, P748, DOI 10.1103/PhysRevLett.16.748; BHATTACHARJEE P, 1989, PHYS REV D, V40, P3968, DOI 10.1103/PhysRevD.40.3968; BHATTACHARJEE P, 1992, PHYS REV LETT, V69, P567, DOI 10.1103/PhysRevLett.69.567; BIRD DJ, 1995, ASTROPHYS J, V441, P144, DOI 10.1086/175344; CHIBA N, 1992, NUCL INSTRUM METH A, V311, P338, DOI 10.1016/0168-9002(92)90882-5; CORBATO SC, 1992, NUCL PHYS B        S, V28, P36, DOI 10.1016/0920-5632(92)90106-3; Cronin J. W., 1992, NUCL PHYS B        S, V28, P213, DOI 10.1016/0920-5632(92)90134-E; CUNNINGHAM G, 1980, CATALOGUE HIGHEST EN, V1, P63; DAWSON BR, 1993, P TOKYO WORKSHOP TEC, P125; de Vaucouleurs G., 1956, VISTAS ASTRON, V2, P1584, DOI 10.1016/0083-6656(56)90087-3; DOI T, 1996, 353964 ICRR, P1; EFIMOV NN, 1990, ASTROPHYSICAL ASPECT, P20; HAYASHIDA N, 1994, PHYS REV LETT, V73, P3491, DOI 10.1103/PhysRevLett.73.3491; LINSLEY J, 1980, CATALOGUE HIGHEST EN, V1, P3; NAGANO M, 1990, ASTROPHYSICAL ASPECT, P252; SHAVER PA, 1989, ASTRON ASTROPHYS, V220, P35; STANEV T, 1995, PHYS REV LETT, V75, P3056, DOI 10.1103/PhysRevLett.75.3056; Teshima M., 1992, NUCL PHYS B        S, V28, P169, DOI 10.1016/0920-5632(92)90124-B; Watson A., COMMUNICATION; YOSHIDA S, 1995, ASTROPART PHYS, V3, P105, DOI 10.1016/0927-6505(94)00036-3; Zatsepin G. T., 1966, JETP LETT, V4, P114	21	158	158	AMERICAN PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	0031-9007			PHYS REV LETT	Phys. Rev. Lett.	AUG 5	1996	77	6					1000	1003		10.1103/PhysRevLett.77.1000		4	Physics, Multidisciplinary	Physics	VA476	WOS:A1996VA47600005		
J	Edagawa, K; Chernikov, MA; Bianchi, AD; Felder, E; Gubler, U; Ott, HR				Edagawa, K; Chernikov, MA; Bianchi, AD; Felder, E; Gubler, U; Ott, HR			Low-temperature thermodynamic and thermal-transport properties of decagonal Al65Cu20Co15	PHYSICAL REVIEW LETTERS			English	Article							QUASI-CRYSTALS; ICOSAHEDRAL AL70MN9PD21; QUASICRYSTALS; CONDUCTIVITY; AL62SI3CU20CO15; PHASES	We report measurements of the specific heat C-p(T) and of the thermal conductivities lambda(p)(T) along the periodic direction and lambda(q)(T) along a direction in the quasiperiodic plane for decagonal Al65Cu20Co15 at low temperatures. The phonon contribution to lambda(p)(T) shows a maximum at 25 K, typical for periodic crystals. The dominant feature in the phonon contribution to lambda(q)(T) is an extended plateau between 30 and 70 K, in agreement with the concept of generalized umklapp processes in quasicrystals. The coefficient gamma = 0.512 mJ g atom(-1) K-2 Of the linear term to C-p(T) indicates a low density of electronic states at E(F).	UNIV TOKYO, INST IND SCI, MINATO KU, TOKYO 106, JAPAN	Edagawa, K (reprint author), ETH ZURICH, FESTKORPERPHYS LAB, CH-8093 ZURICH, SWITZERLAND.		Bianchi, Andrea/E-9779-2010	Bianchi, Andrea/0000-0001-9340-6971			ANDERSON PW, 1972, PHILOS MAG, V25, P1, DOI 10.1080/14786437208229210; BANCEL PA, 1986, PHYS REV B, V33, P7917, DOI 10.1103/PhysRevB.33.7917; DELAISSARDIERE GT, 1994, PHYS REV B, V50, P9843; BASOV DN, 1994, PHYS REV LETT, V72, P1937, DOI 10.1103/PhysRevLett.72.1937; Berman R., 1976, THERMAL CONDUCTION S; CHERNIKOV MA, 1995, PHYS REV B, V51, P153, DOI 10.1103/PhysRevB.51.153; CHERNIKOV MA, IN PRESS EUROPHYS LE; CHERNIKOV MA, 1993, PHYS REV B, V48, P3058, DOI 10.1103/PhysRevB.48.3058; DEGIORGI L, 1993, SOLID STATE COMMUN, V87, P721, DOI 10.1016/0038-1098(93)90214-8; FRIEDEL J, 1988, HELV PHYS ACTA, V61, P538; HE LX, 1988, J MATER SCI LETT, V7, P1284, DOI 10.1007/BF00719959; Kalugin PA, 1996, PHYS REV B, V53, P14145, DOI 10.1103/PhysRevB.53.14145; KIMURA K, 1991, QUASICRYSTALS STATE, P313; KORTAN AR, 1989, PHYS REV B, V40, P9397, DOI 10.1103/PhysRevB.40.9397; LEGAULT S, P 5 INT C QUAS; LIN SY, 1990, PHYS REV B, V41, P9625; Peierls R, 1929, ANN PHYS-BERLIN, V3, P1055; PERROT A, 1995, P 5 INT C QUAS; Phillips WA, 1972, J LOW TEMP PHYS, V7, P351, DOI 10.1007/BF00660072; POON SJ, 1992, ADV PHYS, V41, P303, DOI 10.1080/00018739200101513; STADNIK ZM, 1995, PHYS LETT A, V198, P237, DOI 10.1016/0375-9601(95)00046-6; TSAI AP, 1989, MATER T JIM, V30, P463; VERNIER N, 1993, EUROPHYS LETT, V22, P187, DOI 10.1209/0295-5075/22/3/005; WANG YP, 1993, PHYS REV B, V48, P10542, DOI 10.1103/PhysRevB.48.10542; ZHANG DL, 1991, PHYS REV LETT, V66, P2778	25	39	40	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	0031-9007			PHYS REV LETT	Phys. Rev. Lett.	AUG 5	1996	77	6					1071	1074		10.1103/PhysRevLett.77.1071		4	Physics, Multidisciplinary	Physics	VA476	WOS:A1996VA47600023		
J	Sakuda, S; Zhou, ZY; Takao, H; Yamada, Y				Sakuda, S; Zhou, ZY; Takao, H; Yamada, Y			Mechanism of the cyclopentane ring formation of allosamizoline, an aminocyclitol derivative of the chitinase inhibitor allosamidin	TETRAHEDRON LETTERS			English	Article							BIOSYNTHESIS; CARBON	Feeding experiments to study the mechanism of cyclopentane ring formation of allosamizoline with [3-H-2], [4-H-2]-, [5-H-2]-, and [6-(2)H2]-D-glucosamine indicated that the cyclization to form the cyclopentanoid moiety of allosamizoline proceeds via an intermediate 6-aldehyde glucosamine derivative. Copyright (C) 1996 Elsevier Science Ltd	OSAKA UNIV,FAC ENGN,DEPT BIOTECHNOL,SUITA,OSAKA 565,JAPAN	Sakuda, S (reprint author), UNIV TOKYO,DEPT APPL BIOL CHEM,BUNKYO KU,TOKYO 113,JAPAN.						NISHIMOTO Y, 1991, J ANTIBIOT, V44, P716; FLESCH G, 1988, EUR J BIOCHEM, V175, P405, DOI 10.1111/j.1432-1033.1988.tb14210.x; SAKUDA S, 1987, J ANTIBIOT, V40, P296; BUNDLE DR, 1973, CAN J CHEM, V51, P3812, DOI 10.1139/v73-571; BUTLER AR, 1991, EUR J BIOCHEM, V199, P483, DOI 10.1111/j.1432-1033.1991.tb16147.x; CABIB E, 1992, J GEN MICROBIOL, V138, P97; JENKINS GN, 1995, CHEM SOC REV, P169; KOGA D, 1987, AGR BIOL CHEM TOKYO, V51, P471; MACKIE W, 1965, CAN J CHEMISTRY, V43, P2645, DOI 10.1139/v65-370; MOSS G, 1960, ARCH BIOCHEM BIOPHYS, V90, P111, DOI 10.1016/0003-9861(60)90620-2; NISHIDA Y, 1987, CARBOHYD RES, V170, P106, DOI 10.1016/0008-6215(87)85008-5; PARRY RJ, 1989, J AM CHEM SOC, V111, P5819, DOI 10.1021/ja00197a048; SAKUDA S, 1990, AGR BIOL CHEM TOKYO, V54, P1333; Sakuda S, 1993, ACTINOMYCETOL, V7, P50, DOI 10.3209/saj.7_50; SAKUDA S, 1987, AGR BIOL CHEM TOKYO, V51, P3251; SAKUDA S, 1988, AGR BIOL CHEM TOKYO, V52, P1615; SAKUDA S, 1986, TETRAHEDRON LETT, V27, P2474; WELLER DD, 1978, J AM CHEM SOC, V100, P6757, DOI 10.1021/ja00489a039; ZHOU ZY, 1992, J CHEM SOC PERK T 1, P1649, DOI 10.1039/p19920001649	19	6	6	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB	0040-4039			TETRAHEDRON LETT	Tetrahedron Lett.	AUG 5	1996	37	32					5711	5714		10.1016/0040-4039(96)01207-5		4	Chemistry, Organic	Chemistry	VA711	WOS:A1996VA71100024		
J	Nishi, K; Sekiya, H; Hamabe, H; Nishimura, Y; Mochida, T; Sugawara, T				Nishi, K; Sekiya, H; Hamabe, H; Nishimura, Y; Mochida, T; Sugawara, T			Fluorescence excitation spectra of jet-cooled 9-hydroxyphenalenone derivatives. Effects of symmetrical substitution on deuterium atom tunneling	CHEMICAL PHYSICS LETTERS			English	Article							ELECTRONIC-SPECTRUM; METHYL-GROUP; SOLID NEON; STATES; TROPOLONE; SPECTROSCOPY; SPLITTINGS; DYNAMICS; S1	The fluorescence excitation spectra of symmetrically substituted 5-bromo-9-hydroxyphenalenone-d, 5-chloro-9-hydroxyphenalenone-d, and 5-methyl-9-hydroxyphenalenone-d have been measured in helium jets, The 0(0)(0) tunneling doublet splittings of the three molecules have been determined, A comparison of these splittings with that of 9-hydroxyphenalenone-d suggests that electron releasing from the Br or Cl atom to the phenalenone ring significantly decreases the potential energy barrier to tunneling in the S-1 state.	KYUSHU UNIV,GRAD SCH ENGN SCI,DEPT MOL SCI & TECHNOL,KASUGA,FUKUOKA 816,JAPAN; KYUSHU UNIV,INST ADV MAT STUDY,KASUGA,FUKUOKA 816,JAPAN; INST MOL SCI,OKAZAKI,AICHI 444,JAPAN; UNIV TOKYO,DEPT PURE & APPL SCI,GRAD SCH ARTS & SCI,MEGURO KU,TOKYO 153,JAPAN			Mochida, Tomoyuki/F-8555-2012	Mochida, Tomoyuki/0000-0002-3446-2145			ALVES ACP, 1985, J MOL SPECTROSC, V109, P99, DOI 10.1016/0022-2852(85)90054-2; BONDYBEY VE, 1984, J CHEM PHYS, V80, P5432, DOI 10.1063/1.446650; ROSSETTI R, 1981, J AM CHEM SOC, V103, P4303, DOI 10.1021/ja00405a004; OZEKI H, 1993, J CHEM PHYS, V99, P56, DOI 10.1063/1.465783; GILLISPIE GD, 1986, J PHYS CHEM-US, V90, P2596, DOI 10.1021/j100403a011; TSUJI T, 1992, J CHEM PHYS, V97, P6032, DOI 10.1063/1.463713; BUSCH JH, 1986, J AM CHEM SOC, V108, P3984, DOI 10.1021/ja00274a021; BONDYBEY VE, 1984, J AM CHEM SOC, V106, P5969, DOI 10.1021/ja00332a036; HADDON R, 1980, MOL ELECT DEVICES, pCH2; HADDON RC, 1986, J ORG CHEM, V46, P4587; MOCHIDA T, 1994, J CHEM PHYS, V101, P7971, DOI 10.1063/1.468224; MOCHIDA T, 1995, THESIS U TOKYO; NISHI K, IN PRESS; ROSSETTI R, 1980, J AM CHEM SOC, V102, P6913, DOI 10.1021/ja00543a002; SEKIYA H, 1991, J PHYS CHEM-US, V95, P10311, DOI 10.1021/j100178a015; SEKIYA H, 1990, J CHEM PHYS, V92, P5761, DOI 10.1063/1.458396; SEKIYA H, 1995, CHEM LETT, P893, DOI 10.1246/cl.1995.893; SEKIYA H, 1994, J CHEM PHYS, V101, P3464, DOI 10.1063/1.468466; TAKADA S, COMMUNICATION; TANAKA K, 1992, P INT S MOL SPECTR O; TAYYARI SF, 1979, SPECTROCHIM ACTA A, V35, P1289, DOI 10.1016/0584-8539(79)80079-3	21	10	10	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0009-2614			CHEM PHYS LETT	Chem. Phys. Lett.	AUG 2	1996	257	5-6					499	506		10.1016/0009-2614(96)00573-8		8	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Chemistry; Physics	VA859	WOS:A1996VA85900014		
J	Novak, U; Mui, A; Miyajima, A; Paradiso, L				Novak, U; Mui, A; Miyajima, A; Paradiso, L			Formation of STAT5-containing DNA binding complexes in response to colony-stimulating factor-1 and platelet-derived growth factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE PHOSPHORYLATION; TRANSCRIPTION FACTOR; INTERFERON-ALPHA; SERINE PHOSPHORYLATION; SIGNAL-TRANSDUCTION; STAT3 ACTIVATION; FACTOR-RECEPTOR; GENE FAMILY; CELL-LINE; PROLACTIN	Colony-stimulating factor (CSF-1) activates several members belonging to the STAT (signal transducers and activators of transcription) family of transcription factors. We investigated the DNA binding complexes activated by CSF-1 in several cell lines and compared them with complexes activated by platelet-derived growth factor and interleukin 3. Our results indicate that the SIE-A complex activated by CSF-1 and platelet-derived growth factor may contain STAT3/STAT5 heterodimers binding to the high affinity SIF binding site, m67. In addition, both growth factors activate one or several STATE-containing protein complexes binding to the prolactin-inducible element, PIE. The formation of these complexes was cell type and growth factor specific, Interleukin 3 activated only PIE binding complexes containing STAT5A and STAT5B and did not activate m67 binding complexes. It appears, therefore, that STATE cannot bind to m67 as a homodimer, but it can bind if it is dimerized with STAT3, whereas it can bind to the PIE element without being either complexed with STAT3 or any other known STAT protein, possibly as a homodimer or as STAT5A/STAT5B heterodimer. However, in addition, STATE may heterodimerize with other proteins and form novel PIE binding complexes.	DNAX RES INST MOL & CELLULAR BIOL INC,DEPT CELL BIOL,PALO ALTO,CA 94304; UNIV TOKYO,INST MOL & CELLULAR BIOSCI,BUNKYO KU,TOKYO 113,JAPAN	Novak, U (reprint author), UNIV MELBOURNE,ROYAL MELBOURNE HOSP,DEPT MED,MELBOURNE,VIC 3050,AUSTRALIA.						Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; RIPPERGER JA, 1995, J BIOL CHEM, V270, P29998; LEUNG S, 1995, MOL CELL BIOL, V15, P1312; HOU JZ, 1994, SCIENCE, V265, P1701, DOI 10.1126/science.8085155; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422; MULLER M, 1993, EMBO J, V12, P4221; LAI CF, 1995, J BIOL CHEM, V270, P23254; GOUILLEUX F, 1994, EMBO J, V13, P4361; SCHAEFER TS, 1995, P NATL ACAD SCI USA, V92, P9097, DOI 10.1073/pnas.92.20.9097; WAKAO H, 1994, EMBO J, V13, P2182; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; FU XY, 1990, P NATL ACAD SCI USA, V87, P8555, DOI 10.1073/pnas.87.21.8555; BACON CM, 1995, FEBS LETT, V370, P63, DOI 10.1016/0014-5793(95)00796-C; FU XY, 1992, P NATL ACAD SCI USA, V89, P7840, DOI 10.1073/pnas.89.16.7840; EILERS A, 1995, MOL CELL BIOL, V15, P3579; FUKUNAGA R, 1991, EMBO J, V10, P2855; RUFFJAMISON S, 1995, P NATL ACAD SCI USA, V92, P4215, DOI 10.1073/pnas.92.10.4215; BARAHMANDPOUR F, 1995, FEBS LETT, V360, P29, DOI 10.1016/0014-5793(95)00072-H; BOULTON TG, 1995, P NATL ACAD SCI USA, V92, P6915, DOI 10.1073/pnas.92.15.6915; BOURETTE RP, 1995, CELL GROWTH DIFFER, V6, P631; DAMEN JE, 1995, EMBO J, V14, P5557; DAVID M, 1995, SCIENCE, V269, P1721, DOI 10.1126/science.7569900; FUJII H, 1995, P NATL ACAD SCI USA, V92, P5482, DOI 10.1073/pnas.92.12.5482; GOUILLEUX F, 1995, ENDOCRINOLOGY, V136, P5700, DOI 10.1210/en.136.12.5700; GOUILLEUX F, 1995, EMBO J, V14, P2005; JOHNSTON JA, 1995, P NATL ACAD SCI USA, V92, P5705; LIOUBIN MN, 1994, MOL CELL BIOL, V14, P5682; MIU ALF, 1996, EMBO J, V15, P2425; MUI ALF, 1995, EMBO J, V14, P1165; NOVAK U, 1995, BLOOD, V86, P2948; NOVAK U, 1996, IN PRESS GROWTH FACT; PALLARD C, 1995, J BIOL CHEM, V270, P15942; SCHINDLER C, 1995, ANNU REV BIOCHEM, V64, P621, DOI 10.1146/annurev.bi.64.070195.003201; SCHINDLER C, 1992, SCIENCE, V257, P809, DOI 10.1126/science.1496401; WAGNER BJ, 1990, EMBO J, V9, P4477; WAKAO H, 1995, EMBO J, V14, P2527; WEINSTEIN Y, 1986, P NATL ACAD SCI USA, V83, P5010, DOI 10.1073/pnas.83.14.5010	38	39	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 2	1996	271	31					18350	18354				5	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	VB683	WOS:A1996VB68300014		
J	Fukuda, M; Mikoshiba, K				Fukuda, M; Mikoshiba, K			Structure-function relationships of the mouse Gap1(m) - Determination of the inositol 1,3,4,5-tetrakisphosphate-binding domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEIN; 1,4,5-TRISPHOSPHATE BINDING DOMAIN; SQUID GIANT SYNAPSE; SIGNALING PROTEINS; TYROSINE KINASE; GENE-PRODUCT; PH DOMAIN; TRISPHOSPHATE; RECEPTOR; CALCIUM	Gap1(IP4BP), one of a member of Ras GTPase-activating proteins, has been identified as a specific inositol 1,3,4,5-tetrakisphosphate (IP4)-binding protein (Cullen, P. J., Hsuan, J, J., Truong, O., Letcher, A, J,, Jackson, T, R., Dawson, A. P., and Irvine, R. F. (1995) Nature 386, 527-530). In this paper we describe Gap1(m), which is closely related to Gap1(IP4BP), to also be an IP4-binding protein and show that the pleckstrin homology domain (PH) is the central IP4-binding domain by expressing fragments of the mouse Gap1(m) in Escherichia coli as fusion proteins and examining their activities. However, in addition to the PH domain, an adjacent GAP-related domain and carboxyl terminus are required for high affinity specific IP4 binding. The PH domain is highly conserved in the Gap1 family and also has striking homology to the amino-terminal region of Bruton's tyrosine kinase. Substitution of Cys for Arg at position 628 in the PH domain corresponding to the mutation of Bruton's tyrosine kinase observed in X-linked immunodeficiency mice results in a dramatic reduction of IP4 binding activity as well as phospholipid binding capacity of Gap1(m). This mutant also showed the GAP activity against Ha-Pas to be similar to that of the wild type Gap1(m). Our results suggest that the PH domain of Gap1(m) functions as a modulatory domain of GAP activity by binding IF4 and phospholipids.	UNIV TOKYO,INST MED SCI,DEPT MOL NEUROBIOL,TOKYO 108,JAPAN; ERATO,CALCIOSIGNAL NET PROJECT,MEGURO KU,TOKYO 153,JAPAN	Fukuda, M (reprint author), RIKEN,INST PHYS & CHEM RES,TSUKUBA LIFE SCI CTR,MOL NEUROBIOL LAB,3-1-1 KOYADAI,TSUKUBA,IBARAKI 305,JAPAN.		Fukuda, MItsunori/I-1511-2015				FUKUDA M, 1995, P NATL ACAD SCI USA, V92, P10708, DOI 10.1073/pnas.92.23.10708; HARLAN JE, 1994, NATURE, V371, P168, DOI 10.1038/371168a0; RAWLINGS DJ, 1993, SCIENCE, V261, P358, DOI 10.1126/science.8332901; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; MIKOSHIBA K, 1995, P NATL ACAD SCI USA, V92, P10703, DOI 10.1073/pnas.92.23.10703; HYVONEN M, 1995, EMBO J, V14, P4676; FURUICHI T, 1995, J NEUROCHEM, V64, P953; DAVLETOV BA, 1993, J BIOL CHEM, V268, P26386; MAYER BJ, 1993, CELL, V73, P629, DOI 10.1016/0092-8674(93)90244-K; Fukuda M, 1996, J BIOL CHEM, V271, P8430; BABA H, 1995, J NEUROSCI RES, V41, P846, DOI 10.1002/jnr.490410615; BOLLAG G, 1991, NATURE, V351, P576, DOI 10.1038/351576a0; CALES C, 1988, NATURE, V332, P548, DOI 10.1038/332548a0; CHANGYA L, 1989, FEBS LETT, V251, P43, DOI 10.1016/0014-5793(89)81425-5; CULLEN PJ, 1995, BIOCHEM J, V305, P139; CULLEN PJ, 1995, NATURE, V376, P527, DOI 10.1038/376527a0; CULLEN PJ, 1995, FEBS LETT, V358, P240, DOI 10.1016/0014-5793(94)01435-4; ELY JA, 1990, BIOCHEM J, V268, P333; FUKUDA M, 1995, J BIOL CHEM, V270, P26523; FUKUDA M, 1994, J BIOL CHEM, V269, P29206; GAUL U, 1992, CELL, V68, P1007, DOI 10.1016/0092-8674(92)90073-L; HASIAM RJ, 1993, NATURE, V363, P309; HILL TD, 1988, SCIENCE, V242, P1176, DOI 10.1126/science.2847317; HIRATA M, 1994, BIOCHEM BIOPH RES CO, V205, P1563, DOI 10.1006/bbrc.1994.2845; IRVINE RF, 1986, NATURE, V320, P631, DOI 10.1038/320631a0; IRVINE RF, 1987, BIOCHEM BIOPH RES CO, V146, P284, DOI 10.1016/0006-291X(87)90723-6; LI C, NATURE, V385, P594; LLINAS R, 1994, P NATL ACAD SCI USA, V91, P12990, DOI 10.1073/pnas.91.26.12990; MAEKAWA M, 1993, J BIOL CHEM, V268, P22948; MAEKAWA M, 1994, MOL CELL BIOL, V14, P6879; MOCHIDA S, 1995, SAT S 15 ISN M JUN 2, P124; MORRIS AP, 1987, NATURE, V330, P653, DOI 10.1038/330653a0; MUSACCHIO A, 1993, TRENDS BIOCHEM SCI, V18, P343, DOI 10.1016/0968-0004(93)90071-T; OHARAIMAIZUMI M, 1995, SAT S 15 ISN M JUN 2, P125; PARKER I, 1987, PROC R SOC SER B-BIO, V232, P59, DOI 10.1098/rspb.1987.0061; SNYDER PM, 1988, J BIOL CHEM, V263, P11048; TOUHARA K, 1994, J BIOL CHEM, V269, P10217; YAGISAWA H, 1994, J BIOL CHEM, V269, P20179; YOO SH, 1991, BIOCHEM J, V278, P381	39	70	71	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 2	1996	271	31					18838	18842				5	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	VB683	WOS:A1996VB68300081		
J	Sopyan, I; Watanabe, M; Murasawa, S; Hashimoto, K; Fujishima, A				Sopyan, I; Watanabe, M; Murasawa, S; Hashimoto, K; Fujishima, A			An efficient TiO2 thin-film photocatalyst: Photocatalytic properties in gas-phase acetaldehyde degradation	JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY A-CHEMISTRY			English	Article						TiO2 film; active photocatalyst; acetaldehyde degradations	TITANIUM(IV) OXIDE PHOTOCATALYSTS; 3-CHLOROSALICYLIC ACID; SURFACTANT VESICLES; WATER-PURIFICATION; CERAMIC MEMBRANES; HYDROGEN; CDS; OXIDATION; GLASS; DIOXIDE	A semitransparent TiO2 film with extraordinarily high photocatalytic activity was prepared on a glass substrate by sintering a TiO2 sol at 450 degrees C. Crystallographic analysis by X-ray diffraction and Raman spectroscopy showed that the film was purely anatase. The photocatalytic properties of the film were investigated by measuring the photodegradative oxidation of gaseous acetaldehyde at various concentrations under strong and weak UV light irradiation conditions. The photocatalytic activity of the film was higher than that of one of the most active commercial TiO2 powders, Degussa P-25. The kinetics of acetaldehyde degradation as catalyzed by the TiO2 film as well as by P-25 powder were analyzed in terms of the Langmuir-Hinshelwood model. It is shown that the number of adsorption sites per unit true surface area is larger with the TiO2 film, as analyzed in the powder form, than with P-25 powder. Meanwhile, the first-order reaction rate constant is also much larger with the film than with P-25 powder. Moreover, under most experimental conditions, particularly with high concentrations of acetaldehyde and weak UV illumination intensity, the quantum efficiency was found to exceed 100% on an absorbed-photon basis, assuming that only photo-generated holes play a major role in the reaction. This leads to the conclusion that the photodegradative oxidation of acetaldehyde is not mediated solely by hydroxyl radicals, generated via hole capture by surface hydroxyl ions or water molecules, but also by photocatalytically generated superoxide ion, which can be generated by the reduction of adsorbed oxygen with photogenerated electrons.	UNIV TOKYO,FAC ENGN,DEPT APPL CHEM,BUNKYO KU,TOKYO 113,JAPAN; ISHIHARA SANGYO KAISHA LTD,CENT RES INST,KUSATSU,SHIGA 525,JAPAN			Fujishima, Akira/G-7701-2012; Hashimoto, Kazuhito/C-5011-2012	Hashimoto, Kazuhito/0000-0002-8384-8749			AGUADO MA, 1993, SOL ENERG MAT SOL C, V28, P345, DOI 10.1016/0927-0248(93)90122-J; SCHWITZGEBEL J, 1995, J PHYS CHEM-US, V99, P5633, DOI 10.1021/j100015a055; HARBOUR JR, 1985, CAN J CHEM, V63, P204, DOI 10.1139/v85-032; MILLS A, 1993, CHEM SOC REV, V22, P417, DOI 10.1039/cs9932200417; SERPONE N, 1986, SOL ENERG MATER, V14, P121, DOI 10.1016/0165-1633(86)90070-5; BICKLEY RI, 1973, J CATAL, V31, P389, DOI 10.1016/0021-9517(73)90310-2; MATTHEWS RW, 1987, SOL ENERGY, V38, P405, DOI 10.1016/0038-092X(87)90021-1; CUNNINGHAM J, 1990, J CHEM SOC FARADAY T, V86, P3935, DOI 10.1039/ft9908603935; CAI R, 1992, CHEM LETT, P427, DOI 10.1246/cl.1992.427; WOLD A, 1993, CHEM MATER, V5, P280, DOI 10.1021/cm00027a008; VINODGOPAL K, 1993, J PHYS CHEM-US, V97, P9040, DOI 10.1021/j100137a033; PAPP J, 1993, CHEM MATER, V5, P284, DOI 10.1021/cm00027a009; BORGARELLO E, 1985, GAZZ CHIM ITAL, V115, P599; CHEE YH, 1992, J RAMAN SPECTROSC, V23, P161, DOI 10.1002/jrs.1250230307; CUI H, 1993, MATER RES BULL, V28, P195, DOI 10.1016/0025-5408(93)90152-4; DIBBLE LA, 1990, CATAL LETT, V4, P345, DOI 10.1007/BF00765320; ENEA O, 1986, J PHYS CHEM-US, V90, P301, DOI 10.1021/j100274a020; EXARHOS GJ, 1992, THIN SOLID FILMS, V220, P254, DOI 10.1016/0040-6090(92)90581-U; FOX MA, 1992, CHEMTECH, V11, P680; FRASER IM, 1965, J CHEM SOC F1, V82, P2747; FUJIHIRA M, 1982, B CHEM SOC JPN, V55, P666, DOI 10.1246/bcsj.55.666; GAO YM, 1993, MAT RES B, V27, P1023; KAKUTA N, 1985, J PHYS CHEM-US, V89, P1732; KRISHNAN M, 1983, J AM CHEM SOC, V105, P7002, DOI 10.1021/ja00361a064; LEE W, 1992, MATER RES BULL, V27, P685, DOI 10.1016/0025-5408(92)90075-B; MATTHEW RW, 1988, J CATAL, V111, P64; MATTHEWS RW, 1987, J PHYS CHEM-US, V91, P3328, DOI 10.1021/j100296a044; MAU AWH, 1984, J AM CHEM SOC, V106, P6537, DOI 10.1021/ja00334a014; MEISSNER D, 1983, CHEM PHYS LETT, V96, P34, DOI 10.1016/0009-2614(83)80112-2; MEYER M, 1980, J CHEM SOC CHEM COMM, P90; MONTOYA IA, 1992, CATAL LETT, V15, P207, DOI 10.1007/BF00770913; OHTANI B, 1990, J CHEM SOC PERK T 2, P1955, DOI 10.1039/p29900001955; Pichat P., 1989, PHOTOCATALYSIS FUNDA, P217; RAUPP GB, 1993, APPL SURF SCI, V72, P321, DOI 10.1016/0169-4332(93)90369-M; Ross A.B., 1985, J PHYS CHEM-US, V14, P1041; SABATE J, 1991, J CATAL, V127, P167, DOI 10.1016/0021-9517(91)90217-R; SABATE J, 1992, J CATAL, V134, P36, DOI 10.1016/0021-9517(92)90207-X; SAKAI H, 1993, TR MET ENV, V3, P651; SAKATA T, 1989, PHOTOCATALYSIS FUNDA, P328; SHEN HS, 1993, J SOLID STATE CHEM, V106, P288; SOPYAN I, UNPUB; SOPYAN I, 1994, CHEM LETT, P723, DOI 10.1246/cl.1994.723; SUZUKI K, 1992, TRACE MET ENV, V3, P421; TRICOT YM, 1984, J AM CHEM SOC, V106, P7359, DOI 10.1021/ja00336a011; TRICOT YM, 1984, J AM CHEM SOC, V106, P2475, DOI 10.1021/ja00320a063; TUNESI S, 1991, J PHYS CHEM-US, V95, P3399, DOI 10.1021/j100161a078	46	331	344	ELSEVIER SCIENCE SA LAUSANNE	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	1010-6030			J PHOTOCH PHOTOBIO A	J. Photochem. Photobiol. A-Chem.	AUG 2	1996	98	1-2					79	86		10.1016/1010-6030(96)04328-6		8	Chemistry, Physical	Chemistry	XG246	WOS:A1996XG24600011		
J	Kaneshima, S; Kawakatsu, H; Matsubayashi, H; Sudo, Y; Tsutsui, T; Ohminato, T; Ito, H; Uhira, K; Yamasato, H; Oikawa, J; Takeo, M; Iidaka, T				Kaneshima, S; Kawakatsu, H; Matsubayashi, H; Sudo, Y; Tsutsui, T; Ohminato, T; Ito, H; Uhira, K; Yamasato, H; Oikawa, J; Takeo, M; Iidaka, T			Mechanism of phreatic eruptions at Aso volcano inferred from near-field broadband seismic observations	SCIENCE			English	Article							SAKURAJIMA VOLCANO; JAPAN; TREMOR; CRACK	Broadband seismometers deployed at Aso volcano in Japan have detected a hydrothermal reservoir 1 to 1.5 kilometers beneath the crater that is continually resonating with periods as long as 15 seconds. When phreatic eruptions are observed, broadband seismograms elucidate a dynamic interplay between the reservoir and discharging flow along the conduit: gradual pressurization and long-period (similar to 20 seconds) pulsations of the reservoir during the 100 to 200 seconds before the initiation of the discharge, followed by gradual deflation of the reservoir concurrent with the discharging flow. The hydrothermal reservoir, where water and heat from the deeper magma chamber probably interact, appears to help control the surface activity at Aso volcano.	UNIV TOKYO,EARTHQUAKE RES INST,BUNKYO KU,TOKYO 113,JAPAN; UNIV TOKYO,FAC SCI,DEPT EARTH & PLANETARY PHYS,BUNKYO KU,TOKYO 113,JAPAN; KYOTO UNIV,FAC SCI,ASO VOLCANOL LAB,ASO,KUMAMOTO 86914,JAPAN; GEOL SURVEY JAPAN,TSUKUBA,IBARAKI 305,JAPAN; JAPAN METEOROL AGCY,CHIYODA KU,TOKYO 110,JAPAN; METEOROL RES INST,TSUKUBA,IBARAKI 305,JAPAN							KAWAKATSU H, 1992, GEOPHYS RES LETT, V19, P1959, DOI 10.1029/92GL01964; KIEFFER SW, 1977, J GEOPHYS RES, V82, P2895, DOI 10.1029/JB082i020p02895; NEUBERG J, 1994, GEOPHYS RES LETT, V21, P749, DOI 10.1029/94GL00377; Chouet BA, 1996, NATURE, V380, P309, DOI 10.1038/380309a0; KANAMORI H, 1982, J GEOPHYS RES, V87, P5422, DOI 10.1029/JB087iB07p05422; CHOUET B, 1986, J GEOPHYS RES-SOLID, V91, P13967, DOI 10.1029/JB091iB14p13967; CHUREI M, 1985, B VOLCANOL SOC JPN, V30, P71; Dreier R., 1994, ACTA VULCANOL, V5, P165; FALSAPERLA S, 1994, ACTA VULCANOL, V5, P173; FERRAZZINI V, 1987, J GEOPHYS RES-SOLID, V92, P9215, DOI 10.1029/JB092iB09p09215; Gold T., 1985, PURE APPL GEOPHYS, V122, P492, DOI 10.1007/BF00874614; HASHIDA T, 1990, B VOLCANOL SOC JPN, V35, P323; HELLWEG P, 1994, EOS, V75, P313, DOI 10.1029/94EO00969; KAMO K, 1986, B DISASTER PREV RES, V29, P1; KAWAKATSU H, 1994, GEOPHYS RES LETT, V21, P1963, DOI 10.1029/94GL01683; KIEFER SW, 1984, J GEOPHYS RES, V89, P8523; KIKUCHI S, 1974, B DISASTER PREV RE B, V17, P1; Koyanagi R. Y., 1987, VOLCANISM HAWAII, P1221; LINDE AT, 1993, NATURE, V365, P737, DOI 10.1038/365737a0; MATSUBAYASHI H, 1995, THESIS TOKYO U; Mogi K., 1958, B EARTHQ RES I TOKYO, V36, P99; NEIDEL N, 1971, GEOPHYSICS, V36, P483; OHMINATO T, 1993, EOS, V74, P648; Sassa K., 1935, MEM COLLEGE SCI KYOT, V18, P255; STEINBERG GS, 1975, J GEOPHYS RES, V80, P1600, DOI 10.1029/JB080i011p01600; TANAKA Y, 1993, J VOLCANOL GEOTHERM, V2, P319; UHIRA K, 1994, J GEOPHYS RES-SOL EA, V99, P17775, DOI 10.1029/94JB00990; Wohletz K., 1992, VOLCANOLOGY GEOTHERM	28	58	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	AUG 2	1996	273	5275					642	645		10.1126/science.273.5275.642		4	Multidisciplinary Sciences	Science & Technology - Other Topics	VA249	WOS:A1996VA24900046		
J	Yokoi, M; Kobayashi, K; Manabe, T; Takahashi, T; Sakaguchi, I; Katsuura, G; Shigemoto, R; Ohishi, H; Nomura, S; Nakamura, K; Nakao, K; Katsuki, M; Nakanishi, S				Yokoi, M; Kobayashi, K; Manabe, T; Takahashi, T; Sakaguchi, I; Katsuura, G; Shigemoto, R; Ohishi, H; Nomura, S; Nakamura, K; Nakao, K; Katsuki, M; Nakanishi, S			Impairment of hippocampal mossy fiber LTD in mice lacking mGluR2	SCIENCE			English	Article							LONG-TERM POTENTIATION; METABOTROPIC GLUTAMATE RECEPTORS; GUINEA-PIG; SYNAPTIC TRANSMISSION; TARGETED DISRUPTION; 2 FORMS; RAT; LOCALIZATION; MODULATION; RESPONSES	Subtype 2 of the metabotropic glutamate receptor (mGluR2) is expressed in the presynaptic elements of hippocampal messy fiber-GAS synapses. Knockout mice deficient in mGluR2 showed no histological changes and no alterations in basal synaptic transmission, paired-pulse facilitation, or tetanus-induced long-term potentiation (LTP) al the messy fiber-CA3 synapses. Long-term depression (LTD) induced by low-frequency stimulation, however, was almost fully abolished. The mutant mice performed normally in water maze learning tasks. Thus, the presynaptic mGluR2 is essential for inducing LTD at the mossy fiber-CA3 synapses, but this hippocampal LTD does not seem to be required for spatial learning.	KYOTO UNIV,FAC MED,DEPT BIOL SCI,KYOTO 606,JAPAN; UNIV TOKYO,FAC MED,BRAIN RES INST,DEPT NEUROPHYSIOL,TOKYO 113,JAPAN; SHIONOGI & CO LTD,ABURAHI LABS,SHIGA 52034,JAPAN; KYOTO UNIV,FAC MED,DEPT MORPHOL BRAIN SCI,KYOTO 606,JAPAN; KYOTO UNIV,COLL MED TECHNOL,KYOTO 606,JAPAN; KYUSHU UNIV,MED INST BIOREGULAT,FUKUOKA 812,JAPAN							ABELIOVICH A, 1993, CELL, V75, P1263, DOI 10.1016/0092-8674(93)90614-V; MANABE T, 1993, J NEUROPHYSIOL, V70, P1451; CASTILLO PE, 1994, NEURON, V12, P261, DOI 10.1016/0896-6273(94)90269-0; HARRIS EW, 1986, NEUROSCI LETT, V70, P132, DOI 10.1016/0304-3940(86)90451-9; MAYFORD M, 1995, CELL, V81, P891, DOI 10.1016/0092-8674(95)90009-8; OHISHI H, 1993, NEUROSCIENCE, V53, P1009, DOI 10.1016/0306-4522(93)90485-X; MORRIS RGM, 1981, LEARN MOTIV, V12, P239, DOI 10.1016/0023-9690(81)90020-5; Huang YY, 1995, CELL, V83, P1211, DOI 10.1016/0092-8674(95)90146-9; HUANG YY, 1994, CELL, V79, P69, DOI 10.1016/0092-8674(94)90401-4; NASIR J, 1995, CELL, V81, P811, DOI 10.1016/0092-8674(95)90542-1; MASU M, 1995, CELL, V80, P757, DOI 10.1016/0092-8674(95)90354-2; WEISSKOPF MG, 1994, SCIENCE, V265, P1878, DOI 10.1126/science.7916482; ZALUTSKY RA, 1990, SCIENCE, V248, P1619, DOI 10.1126/science.2114039; TANABE Y, 1992, NEURON, V8, P169, DOI 10.1016/0896-6273(92)90118-W; Bach Mary Elizabeth, 1995, Cell, V81, P905, DOI 10.1016/0092-8674(95)90010-1; HAYASHI Y, 1993, NATURE, V366, P687, DOI 10.1038/366687a0; Kobayashi K, 1996, SCIENCE, V273, P648, DOI 10.1126/science.273.5275.648; LANTHORN TH, 1984, BRAIN RES, V290, P174, DOI 10.1016/0006-8993(84)90750-9; MANZONI OJ, 1995, NEUROPHARMACOLOGY, V34, P965, DOI 10.1016/0028-3908(95)00060-J; MCDONALD RJ, 1994, BEHAV NEURAL BIOL, V61, P260, DOI 10.1016/S0163-1047(05)80009-3; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; OHISHI H, 1994, NEURON, V13, P55, DOI 10.1016/0896-6273(94)90459-6; SHIGEMOTO R, 1995, SOC NEUR ABSTR, V21, P33820; SHIGEMOTO R, 1995, INT BRAIN RES ORG AB, V4	24	254	261	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	AUG 2	1996	273	5275					645	647		10.1126/science.273.5275.645		3	Multidisciplinary Sciences	Science & Technology - Other Topics	VA249	WOS:A1996VA24900047		
J	Kobayashi, K; Manabe, T; Takahashi, T				Kobayashi, K; Manabe, T; Takahashi, T			Presynaptic long-term depression at the hippocampal mossy fiber-CA3 synapse	SCIENCE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; CA3 PYRAMIDAL NEURONS; RAT HIPPOCAMPUS; VISUAL-CORTEX; AREA CA1; 2 FORMS; POTENTIATION; MECHANISMS; INDUCTION; EXPRESSION	Long-term potentiation (LTP) and long-term depression (LTD) of synaptic strength may underlie learning and memory in the brain. The induction of LTP occurs in postsynaptic cells in the hippocampal CA1 region but is presynaptic in CA3. LTD is also well characterized in CA1 but not in CA3. Low-frequency stimulation of mouse hippocampal slices caused homosynaptic LTD at the messy fiber-CA3 synapse, which may be induced presynaptically by activation of metabotropic glutamate receptors. Thus, the efficacy of messy fiber-CA3 synapses can be regulated bidirectionally, which may contribute to neuronal information processing.	UNIV TOKYO,FAC MED,INST BRAIN RES,BUNKYO KU,TOKYO 113,JAPAN							MALENKA RC, 1993, TRENDS NEUROSCI, V16, P521, DOI 10.1016/0166-2236(93)90197-T; CASTILLO PE, 1994, NEURON, V12, P261, DOI 10.1016/0896-6273(94)90269-0; HARRIS EW, 1986, NEUROSCI LETT, V70, P132, DOI 10.1016/0304-3940(86)90451-9; SELIG DK, 1995, J NEUROPHYSIOL, V74, P1075; Yokoi M, 1996, SCIENCE, V273, P645, DOI 10.1126/science.273.5275.645; Takei Y, 1995, J CELL BIOL, V131, P1789, DOI 10.1083/jcb.131.6.1789; LINDEN DJ, 1995, ANNU REV NEUROSCI, V18, P319, DOI 10.1146/annurev.neuro.18.1.319; GUERINEAU NC, 1995, J NEUROSCI, V15, P4395; Kutsuwada T, 1996, NEURON, V16, P333, DOI 10.1016/S0896-6273(00)80051-3; TANABE Y, 1993, J NEUROSCI, V13, P1372; BRADLER JE, 1989, SYNAPSE, V4, P132, DOI 10.1002/syn.890040207; REGEHR WG, 1994, J NEUROSCI, V14, P523; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; ITO I, 1991, NEUROREPORT, V2, P333, DOI 10.1097/00001756-199106000-00008; KIRKWOOD A, 1994, J NEUROSCI, V14, P3404; KIRKWOOD A, 1993, SCIENCE, V260, P1518, DOI 10.1126/science.8502997; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; WEISSKOPF MG, 1995, NATURE, V376, P256, DOI 10.1038/376256a0; ZALUTSKY RA, 1990, SCIENCE, V248, P1619, DOI 10.1126/science.2114039; TANABE Y, 1992, NEURON, V8, P169, DOI 10.1016/0896-6273(92)90118-W; BATTISTIN T, 1994, EUR J NEUROSCI, V6, P1750, DOI 10.1111/j.1460-9568.1994.tb00567.x; BOLSHAKOV VY, 1994, SCIENCE, V264, P1148, DOI 10.1126/science.7909958; HARUTA H, 1994, NEUROREPORT, V5, P1829, DOI 10.1097/00001756-199409080-00036; HAYASHI Y, 1994, J NEUROSCI, V14, P3370; JAFFE D, 1990, J NEUROPHYSIOL, V64, P948; KATSUKI H, 1991, NEUROSCI RES, V12, P393, DOI 10.1016/0168-0102(91)90070-F; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; SHIGEMOTO R, 1995, INT BRAIN RES ORG AB, V4; STAUBLI U, 1990, SYNAPSE, V5, P333, DOI 10.1002/syn.890050410; WEISSKOPF MG, 1993, NATURE, V362, P423, DOI 10.1038/362423a0; WILLIAMS S, 1989, NEURON, V3, P583, DOI 10.1016/0896-6273(89)90268-7; XIANG ZX, 1994, J NEUROPHYSIOL, V71, P2552; YAMAMOTO C, 1992, NEUROSCI LETT, V138, P111, DOI 10.1016/0304-3940(92)90484-O	33	115	120	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	AUG 2	1996	273	5275					648	650		10.1126/science.273.5275.648		3	Multidisciplinary Sciences	Science & Technology - Other Topics	VA249	WOS:A1996VA24900048		
J	Yoshikawa, K; Yagi, K; Nanjo, S; Seno, A; Shiono, T; Tobe, K; Suzuki, S				Yoshikawa, K; Yagi, K; Nanjo, S; Seno, A; Shiono, T; Tobe, K; Suzuki, S			Contrast agent for magnetic resonance angiography: Experimental evaluation of superparamagnetic iron oxide composed of polysaccharide complex involving chondroitinsulfuric acid	ACADEMIC RADIOLOGY			English	Article; Proceedings Paper	Contrast Media Research Symposium	JUN 17-22, 1995	NAANTALI, FINLAND				INITIAL CLINICAL-EXPERIENCE; FOCAL HEPATIC-LESIONS		MIE UNIV,FAC ENGN,MIE,JAPAN; TOHO UNIV,DEPT MED 1,TOKYO,JAPAN	Yoshikawa, K (reprint author), UNIV TOKYO,INST MED SCI,DEPT RADIOL,MINATO KU,4-6-1 SHIROKANEDAI,TOKYO 108,JAPAN.						ANZAI Y, 1994, RADIOLOGY, V192, P709; BACHGANSMO T, 1993, BRIT J RADIOL, V66, P420; WINTER TC, 1993, AM J ROENTGENOL, V161, P1191; SAINI S, 1995, AM J ROENTGENOL, V164, P1147; VASSALLO P, 1994, RADIOLOGY, V193, P501; YAGI K, 1991, MED PHYS BIOMED ENG, V29, P430; YAMAMOTO H, 1995, RADIOLOGY, V195, P106	7	2	2	ASSOC UNIV RADIOLOGISTS	RESTON	1891 PRESTON WHITE DR, RESTON, VA 22091	1076-6332			ACAD RADIOL	Acad. Radiol.	AUG	1996	3			2			S297	S298		10.1016/S1076-6332(96)80562-9		2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	VD757	WOS:A1996VD75700041		
J	Honda, K; Kagawa, Y				Honda, K; Kagawa, Y			Debonding criterion in the pushout process of fiber-reinforced ceramics	ACTA MATERIALIA			English	Article							INTERFACIAL STRESS STATE; MATRIX COMPOSITES; BRITTLE MATRIX; GLASS-MATRIX; OUT TEST; FRICTION; ROUGHNESS	An interfacial debonding process and a debonding criterion, taking into account the distribution of thermally-induced stress, of SiC fiber-reinforced glass matrix composites in a thin specimen pushout test have been examined both experimentally and by FEA. The interfacial fracture process during the pushout was determined by in situ observation and AE event results. The interfacial debonding initiated near the pushing surface of the specimen and proceeded spontaneously in unit length approximately 3R(f). The initiation of debonding caused rapid cracking at the interface at an applied load of 1.5-2.0 N. This debonding load was independent of specimen thickness. Comparison with FEA results indicates that the interfacial debonding initiated when the peak shear stress near the pushing surface of the specimen reached a critical value. The peak shear stress was represented as a function of the applied load during the pushout test, and experimental debonding load as a critical interfacial shear stress of the composites revealed its value to be 85-95 MPa. The FEA results showed that the thermally-induced shear stress played an important role in interfacial debonding. The effect of thermally-induced stress on debonding events of the pushout, pushin and pullout test was discussed. Copyright (C) 1996 Acta Metallurgica Inc.		Honda, K (reprint author), UNIV TOKYO, INST IND SCI, MINATO KU, 7-22-1 ROPPONGI, TOKYO 106, JAPAN.						COX BN, 1994, ACTA METALL MATER, V42, P341, DOI 10.1016/0956-7151(94)90492-8; MARSHALL DB, 1984, J AM CERAM SOC, V67, pC259; BRIGHT JD, 1989, J AM CERAM SOC, V72, P1891, DOI 10.1111/j.1151-2916.1989.tb05997.x; KERANS RJ, 1991, J AM CERAM SOC, V74, P1585, DOI 10.1111/j.1151-2916.1991.tb07144.x; EVANS AG, 1989, ACTA METALL MATER, V37, P2567, DOI 10.1016/0001-6160(89)90291-5; Avenston J, 1971, C P NAT PHYS LAB GUI, P15; CARTER WC, 1991, SCRIPTA METALL MATER, V25, P579, DOI 10.1016/0956-716X(91)90095-I; DOLLAR A, 1993, J AM CERAM SOC, V76, P897, DOI 10.1111/j.1151-2916.1993.tb05313.x; ELKIND A, 1992, J AM CERAM SOC, V75, P2871, DOI 10.1111/j.1151-2916.1992.tb05520.x; FULLER ER, 1991, NATO ADV SCI I E-APP, V195, P385; GHOSN LJ, 1994, ACTA METALL MATER, V42, P3895, DOI 10.1016/0956-7151(94)90455-3; Goettler RW, 1989, COMPOS SCI TECHNOL, V37, P129; HONDA K, 1995, ACTA METALL MATER, V43, P1477, DOI 10.1016/0956-7151(94)00355-L; HONDA K, 1992, J JPN I MET, V56, P481; HONDA K, 1992, J JPN I MET, V56, P1360; JERO PD, 1990, SCRIPTA METALL MATER, V24, P2315, DOI 10.1016/0956-716X(90)90085-U; KAGAWA Y, 1992, J JPN I MET, V56, P278; KAGAWA Y, 1991, CERAM ENG SCI P, V12, P1127; KALLAS MN, 1992, J MATER SCI, V27, P3821, DOI 10.1007/BF00545464; KERANS RJ, 1989, AM CERAM SOC BULL, V68, P429; KISHI T, 1992, FRACT MECH, V9, P1; LIANG C, 1993, MECH MATER, V14, P207, DOI 10.1016/0167-6636(93)90067-2; MACKIN TJ, 1992, ACTA METALL MATER, V40, P1251, DOI 10.1016/0956-7151(92)90424-D; MARSHALL DB, 1992, ACTA METALL MATER, V40, P427, DOI 10.1016/0956-7151(92)90391-Q; PARTHASARATHY TA, 1994, ACTA METALL MATER, V42, P3373; SHETTY DK, 1988, J AM CERAM SOC, V71, pC107; SINGH RN, 1987, CERAM ENG SCI P, V8, P636; WEIHS TP, 1988, SCRIPTA METALL MATER, V22, P271, DOI 10.1016/S0036-9748(88)80347-8; 1990, CONT SIL CARB MET MA, P15	29	30	33	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1359-6454			ACTA MATER	Acta Mater.	AUG	1996	44	8					3267	3277		10.1016/1359-6454(95)00417-3		11	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	UY539	WOS:A1996UY53900022		
J	Shinka, T; Nakahori, Y				Shinka, T; Nakahori, Y			The azoospermic factor on the Y chromosome	ACTA PAEDIATRICA JAPONICA			English	Article						azoospermia; DAZ gene; spermatogenesis; Y chromosome; YRRM gene	UBIQUITIN-ACTIVATING ENZYME-E1; SPINAL MUSCULAR-ATROPHY; RNA-BINDING PROTEINS; LONG ARM; H-Y; SPERMATOGENESIS GENE; IDENTIFICATION; EXPRESSION; DROSOPHILA; HOMOLOGY	Azoospermia is the most frequent cause of male infertility. After excluding the obvious urological reasons and the effect of Klinefelter's syndrome, azoospermia may be caused by an abnormality in the crucial gene(s) expressed during male germ cell differentiation. Recently, two candidate genes for azoospermia have been cloned from the azoospermic factor (AZF) locus on the Y chromosome long arm (Yq). One is YRRM (Y chromosome RNA recognition motif) gene, and the other is DAZ (deletion in azoospermia) gene. Both genes encode RNA binding protein and their expression is restricted to the testis. Therefore they are good candidates for AZF, although their function remains unclear. Here, the genes on the Y chromosome possibly involved in spermatogenesis and the role of the Y chromosome in evolution are discussed.	UNIV TOKYO,GRAD SCH INT HLTH,DEPT HUMAN GENET,BUNKYO KU,TOKYO 113,JAPAN; TOHOKU UNIV,SCH MED,DEPT PEDIAT,SENDAI,MIYAGI,JAPAN							AGULNIK AI, 1994, HUM MOL GENET, V3, P873, DOI 10.1093/hmg/3.6.873; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; TIEPOLO L, 1976, HUM GENET, V34, P119, DOI 10.1007/BF00278879; WANG W, 1995, SCIENCE, V269, P1588, DOI 10.1126/science.7667640; ROY N, 1995, CELL, V80, P167, DOI 10.1016/0092-8674(95)90461-1; ADAM SA, 1986, MOL CELL BIOL, V6, P2932; SACHS AB, 1986, CELL, V45, P827, DOI 10.1016/0092-8674(86)90557-X; BURGOYNE PS, 1992, CELL, V71, P391, DOI 10.1016/0092-8674(92)90509-B; ARNEMANN J, 1991, GENOMICS, V11, P108, DOI 10.1016/0888-7543(91)90107-P; CHANDLEY AC, 1994, HUM MOL GENET, V3, P1449; GE H, 1991, CELL, V66, P373, DOI 10.1016/0092-8674(91)90626-A; GRAVES JAM, 1995, BIOESSAYS, V17, P311, DOI 10.1002/bies.950170407; KARSCHMIZRACHI I, 1993, NUCLEIC ACIDS RES, V21, P2229; KAY GF, 1991, NATURE, V354, P486, DOI 10.1038/354486a0; KOBAYASHI K, 1994, HUM MOL GENET, V3, P1965, DOI 10.1093/hmg/3.11.1965; KRAINER AR, 1991, CELL, V66, P383, DOI 10.1016/0092-8674(91)90627-B; LAMAR EE, 1984, CELL, V37, P171, DOI 10.1016/0092-8674(84)90312-X; MA K, 1992, HUM MOL GENET, V1, P29, DOI 10.1093/hmg/1.1.29; MA K, 1993, CELL, V75, P1287, DOI 10.1016/0092-8674(93)90616-X; MITCHELL MJ, 1991, NATURE, V354, P483, DOI 10.1038/354483a0; NAGAFUCHI S, 1993, J UROLOGY, V150, P1155; NAKAHORI Y, 1994, HUM MOL GENET, V3, P1709, DOI 10.1093/hmg/3.9.1709; Nakahori Y, 1996, HORM RES, V46, P20; NAKAHORI Y, 1996, SEX DIFFERENTIATION, P1; Ohno S., 1967, SEX CHROMOSOMES SEX; REIJOR, 1995, NAT GENET, V10, P383; ROSENBERG M, 1994, P NATL ACAD SCI USA, V91, P6113, DOI 10.1073/pnas.91.13.6113; SARA A, 1987, P 12 WORLD C FERT ST, V4, P91; SCOTT DM, 1995, NATURE, V376, P695, DOI 10.1038/376695a0; STRAUSS D, 1990, P NATL ACAD SCI USA, V87, P4889; SUTCLIFFE MJ, 1989, DEVELOPMENT, V107, P373; VOGT P, 1992, HUM GENET, V89, P49; VOLLRATH D, 1992, SCIENCE, V258, P52, DOI 10.1126/science.1439769	34	7	7	BLACKWELL SCIENCE	CARLTON	54 UNIVERSITY ST, P O BOX 378, CARLTON VICTORIA 3053, AUSTRALIA	0374-5600			ACTA PAEDIATR JAPON	Acta Pediatr. Jpn.	AUG	1996	38	4					399	404				6	Pediatrics	Pediatrics	VE587	WOS:A1996VE58700021		
J	Takafuji, S; Tadokoro, K; Ito, K				Takafuji, S; Tadokoro, K; Ito, K			Effects of interleukin (IL)-3 and IL-5 on human eosinophil degranulation induced by complement components C3a and C5a	ALLERGY			English	Article						complement; cytokine; degranulation; eosinophil	PLATELET-ACTIVATING-FACTOR; BRONCHIAL-ASTHMA; DE-GRANULATION; LEUKOTRIENE C4; CYTOCHALASIN-B; STIMULATION; EXOCYTOSIS; PROTEIN	It is suggested that eosinophils (Eos) play an important role in the pathogenesis of bronchial asthma by releasing cytotoxic cationic eosinophil granule proteins and damaging bronchial epithelial cells. However, the exact nature of the actual inducer of eosinophil degranulation in vivo is unclear. We examined eosinophil cationic protein (ECP) release from human Eos in response to soluble agonists such as C5a, C3a, platelet-activating factor, and FMLP with or without interleukin (IL)-3 or IL-5 priming, Eosinophil degranulation induced by these soluble agonists required the pretreatment of Eos by cytochalasin B even in IL-3 priming. Among four agonists, C5a was the most effective stimulus of ECP release either with or without IL-5 priming. IL-3 and IL-5 remarkably enhanced ECP release in Eos triggered by C3a and C5a, The enhancement of ECP release by IL-3 and IL-5 occurred at 0.1-0.3 ng/ml and became maximal at 10-30 ng/ml, concentration-dependently. The enhancement of ECP release by cytokines became optimal at an interval of 10 min. Our data support the importance of complement components and cytokines in eosinophil degranulation in vivo.	RED CROSS BLOOD CTR,TOKYO,JAPAN	Takafuji, S (reprint author), UNIV TOKYO,FAC MED,DEPT MED & PHYS THERAPY,BUNKYO KU,7-3-1 HONGO,TOKYO 113,JAPAN.						ABUGHAZALEH RI, 1989, J IMMUNOL, V142, P2393; SEDGWICK JB, 1991, AM REV RESPIR DIS, V144, P1274; KROEGEL C, 1989, J IMMUNOL, V142, P3518; AUNIS D, 1988, J EXP BIOL, V139, P253; ARROYAVE CM, 1977, CLIN ALLERGY, V7, P173, DOI 10.1111/j.1365-2222.1977.tb01439.x; BENGTSSON T, 1991, J LEUKOCYTE BIOL, V49, P236; CALLERAM.ML, 1971, NEW ENGL J MED, V284, P459, DOI 10.1056/NEJM197103042840902; CARLSON M, 1991, J ALLERGY CLIN IMMUN, V87, P27, DOI 10.1016/0091-6749(91)90209-7; DAHINDEN C, 1983, J IMMUNOL, V130, P863; EDWARDS JH, 1976, CLIN ALLERGY, V6, P19, DOI 10.1111/j.1365-2222.1976.tb01408.x; EGESTEN A, 1993, J LEUKOCYTE BIOL, V53, P287; FRIGAS E, 1986, J ALLERGY CLIN IMMUN, V77, P527, DOI 10.1016/0091-6749(86)90341-6; FRIGAS E, 1981, MAYO CLIN PROC, V56, P345; FUJISAWA T, 1990, J IMMUNOL, V144, P642; GLEICH GJ, 1990, J ALLERGY CLIN IMMUN, V85, P422, DOI 10.1016/0091-6749(90)90151-S; HANSEL TT, 1991, J IMMUNOL METHODS, V145, P105, DOI 10.1016/0022-1759(91)90315-7; HORIE S, 1994, J IMMUNOL, V152, P5457; HUGLI TE, 1981, MOL CELL BIOCHEM, V41, P59; KERNEN P, 1991, J CLIN INVEST, V87, P2012, DOI 10.1172/JCI115230; OLENCHOCK SA, 1980, ANN ALLERGY, V44, P23; Takafuji S, 1996, J IMMUNOL, V156, P3980; TAKAFUJI S, 1991, J IMMUNOL, V147, P3855; TAKAFUJI S, 1992, EUR J IMMUNOL, V22, P969, DOI 10.1002/eji.1830220414; VANDERZEE JS, 1988, MOL IMMUNOL, V25, P345, DOI 10.1016/0161-5890(88)90029-6; ZECKKAPP G, 1995, ALLERGY, V50, P34, DOI 10.1111/j.1398-9995.1995.tb02481.x	25	23	23	MUNKSGAARD INT PUBL LTD	COPENHAGEN	35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK	0105-4538			ALLERGY	Allergy	AUG	1996	51	8					563	568				6	Allergy; Immunology	Allergy; Immunology	VE425	WOS:A1996VE42500007		
J	Murata, K; Araki, S				Murata, K; Araki, S			Assessment of autonomic neurotoxicity in occupational and environmental health as determined by ECC R-R interval variability: A review	AMERICAN JOURNAL OF INDUSTRIAL MEDICINE			English	Article						heart rate variability (CVRR); occupational and environmental factors; autonomic nervous system; parasympathetic and sympathetic functions; humans; review	HEART-RATE-VARIABILITY; CENTRAL-NERVOUS-SYSTEM; HAND-ARM VIBRATION; POWER SPECTRUM ANALYSIS; CARDIOVASCULAR CONTROL; ARTERIAL-PRESSURE; ALCOHOL INGESTION; ORGANIC-SOLVENTS; NORMAL-HEXANE; SHORT-TERM	Measurement of heart rate variability (coefficient of variation of ECG R-R intervals, CVRR) provides a useful approach for the objective assessment of the autonomic nervous function. It is noninvasive and clinically practical, although it tends to be distorted by confounding factors such as age, alcohol, and tobacco. Specifically, two component coefficients of variation of the respiratory sinus arrhythmia (RSA) and Mayer wave-related sinus arrhythmia (MWSA) in the CVRR (i.e., C-CVRSA and C-CVMWSA), computed from component spectral powers by autoregressive spectral and component analyses, are expected to reflect parasympathetic and sympathetic functions, respectively. This article is intended to present an overview of research, utilizing the CVRR method including the C-CVRSA and C-CVMWSA in occupational and environmental health. The available literature, addressing the impact of some chemicals and work-related factors on human autonomic nervous system, indicates that parasympathetic activity appears to be more vulnerable to these factors than does sympathetic activity. Since decreased cardiac vagal tone is associated with an increased risk of sudden cardiac death or coronary artery disease, attention should be directed to further discovery of hazardous factors in the environment and work place, which are likely to affect the autonomic nervous system. (C) 1996 Wiley-Liss, Inc.	UNIV TOKYO,FAC MED,DEPT PUBL HLTH,BUNKYO KU,TOKYO 113,JAPAN							*AG TOX SUBST DIS, 1989, TOXICOLOGY PROFILE T; AKAIKE H, 1969, ANN I STAT MATH, V21, P243, DOI 10.1007/BF02532251; AKSELROD S, 1995, HDB AUTONOMIC NERVOU, P469; AKSELROD S, 1981, SCIENCE, V213, P220, DOI 10.1126/science.6166045; MURATA K, 1992, J AUTONOM NERV SYST, V37, P199, DOI 10.1016/0165-1838(92)90041-E; SAYERS BM, 1973, ERGONOMICS, V16, P17; SHANNON DC, 1987, AM J PHYSIOL, V253, pH874; MURATA K, 1994, J AUTONOM NERV SYST, V48, P105, DOI 10.1016/0165-1838(94)90026-4; PAGANI M, 1986, CIRC RES, V59, P178; SCHAUMBURG HH, 1976, BRAIN, V99, P183, DOI 10.1093/brain/99.2.183; KRISTALBONEH E, 1995, SCAND J WORK ENV HEA, V21, P85; AKSELROD S, 1985, AM J PHYSIOL, V249, pH867; HAYANO J, 1990, AM J CARDIOL, V65, P84, DOI 10.1016/0002-9149(90)90030-5; PAGANI M, 1988, J AUTONOM NERV SYST, V23, P143, DOI 10.1016/0165-1838(88)90078-1; CHANG YC, 1987, J NEUROL NEUROSUR PS, V50, P269, DOI 10.1136/jnnp.50.3.269; TRAPJENSEN J, 1988, AM HEART J, V115, P263, DOI 10.1016/0002-8703(88)90647-3; MALLIANI A, 1991, CIRCULATION, V84, P482; MURATA K, 1991, INT ARCH OCC ENV HEA, V63, P109, DOI 10.1007/BF00379073; Araki S, 1994, NEUROBEHAVIORAL METH; Araki Shunichi, 1994, Annals Academy of Medicine Singapore, V23, P710; ARAKI S, 1994, P INT S ASS ENV POLL, P141; BLEECKER ML, 1994, OCCUPATIONAL NEUROLO, P207; CULLEN MR, 1983, MEDICINE, V62, P221; DUPUIS H, 1985, INT ARCH OCC ENV HEA, V55, P185, DOI 10.1007/BF00378382; ECKBERG DL, 1983, J APPL PHYSIOL, V54, P961; Ewing D, 1992, AUTONOMIC FAILURE TX, P312; GENNART JP, 1992, INT ARCH OCC ENV HEA, V64, P49, DOI 10.1007/BF00625951; GRASSO R, 1995, J AUTONOM NERV SYST, V50, P323, DOI 10.1016/0165-1838(94)00103-Q; GUO YP, 1987, J NEUROL NEUROSUR PS, V50, P1449, DOI 10.1136/jnnp.50.11.1449; HARADA N, 1987, Japanese Journal of Industrial Health, V29, P152; HARADA N, 1990, BRIT J IND MED, V47, P263; HARADA N, 1989, INT ARCH OCC ENV HEA, V61, P369, DOI 10.1007/BF00381026; HAYANO J, 1988, JIRITSUSHINKEI, V25, P334; HAYANO J, 1994, AM J PHYSIOL, V267, pH33; HAYANO J, 1990, AM J PHYSIOL, V258, pH642; HAYANO J, 1991, AM HEART J, V121, P1070, DOI 10.1016/0002-8703(91)90664-4; HEINONEN E, 1987, BRIT J IND MED, V44, P412; HIRATA M, 1987, Japanese Journal of Industrial Health, V29, P145; HIRATA M, 1984, Japanese Journal of Industrial Health, V26, P283; Janin Y, 1985, Surg Annu, V17, P287; JAPUNDZIC N, 1990, J AUTONOM NERV SYST, V30, P91, DOI 10.1016/0165-1838(90)90132-3; JUNTUNEN J, 1985, ACTA NEUROL SCAND, V75, P512; Kaufmann H, 1995, HDB AUTONOMIC NERVOU, P427; KOBAYASHI F, 1987, IND HEALTH, V25, P83; KOSKINEN P, 1994, CLIN SCI, V87, P225; KUNITAKE T, 1992, J AUTONOM NERV SYST, V38, P45, DOI 10.1016/0165-1838(92)90215-3; LaDou J, 1990, OCCUPATIONAL MED; LAZAR RB, 1983, NEUROLOGY, V33, P1337; MACKAY JD, 1980, DIABETOLOGIA, V18, P471; MARTIN GJ, 1987, AM J CARDIOL, V60, P86, DOI 10.1016/0002-9149(87)90990-8; MATIKAINEN E, 1985, J NEUROL NEUROSUR PS, V48, P1021, DOI 10.1136/jnnp.48.10.1021; MURATA K, 1991, INT ARCH OCC ENV HEA, V63, P205, DOI 10.1007/BF00381570; MURATA K, 1991, AM J IND MED, V20, P775, DOI 10.1002/ajim.4700200609; MURATA K, 1994, NEUROTOXICOLOGY, V15, P867; MURATA K, 1990, INT ARCH OCC ENV HEA, V62, P183, DOI 10.1007/BF00379429; MURATA K, 1995, AM J IND MED, V28, P233, DOI 10.1002/ajim.4700280208; MURATA K, 1991, AM J IND MED, V20, P663, DOI 10.1002/ajim.4700200509; MURATA K, 1991, INT ARCH OCC ENV HEA, V63, P335, DOI 10.1007/BF00381584; MURATA K, 1993, IND HEALTH, V31, P79; MUTO T, 1987, JPN J PUBLIC HTLH, V34, P388; MYERS GA, 1986, IEEE T BIO-MED ENG, V33, P1149, DOI 10.1109/TBME.1986.325694; NOVAK DJ, 1974, ARCH NEUROL-CHICAGO, V30, P273; PAGANI M, 1994, CLIN SCI, V87, P655; POMERANTZ B, 1985, AM J PHYSIOL, V249, pH151; PYYKKO I, 1986, SCAND J WORK ENV HEA, V12, P439; ROBERTSON D, 1988, AM HEART J, V115, P258, DOI 10.1016/0002-8703(88)90646-1; RUIJTEN MWMM, 1990, BRIT J IND MED, V47, P589; RUIJTEN MWMM, 1994, ARCH ENVIRON HEALTH, V49, P188; RUIJTEN MWMM, 1991, BRIT J IND MED, V48, P87; SASAKI H, 1987, Japanese Journal of Industrial Health, V29, P459; SASAKI H, 1987, Japanese Journal of Industrial Health, V29, P136; SHIMOMURA C, 1991, No To Hattatsu, V23, P26; SINGER DH, 1988, J ELECTROCARDIOL S, V21, P46; Stockard JJ, 1986, ELECTRODIAGNOSIS CLI, P467; TERUYA K, 1991, INT ARCH OCC ENV HEA, V62, P549, DOI 10.1007/BF00381107; TOIVANEN H, 1993, SCAND J WORK ENV HEA, V19, P319; URBANOMARQUEZ A, 1989, NEW ENGL J MED, V320, P409, DOI 10.1056/NEJM198902163200701; VALLSSOLE J, 1991, J NEUROL SCI, V102, P233, DOI 10.1016/0022-510X(91)90074-H; VANRAVENSWAAIJARTS CMA, 1993, ANN INTERN MED, V118, P436; WEISE F, 1986, DRUG ALCOHOL DEPEN, V17, P89, DOI 10.1016/0376-8716(86)90040-2; WHEELER T, 1973, BRIT MED J, V4, P584; YOKOYAMA A, 1991, ALCOHOL CLIN EXP RES, V15, P761, DOI 10.1111/j.1530-0277.1991.tb00595.x	82	32	34	WILEY-LISS	NEW YORK	DIV JOHN WILEY & SONS INC 605 THIRD AVE, NEW YORK, NY 10158-0012	0271-3586			AM J IND MED	Am. J. Ind. Med.	AUG	1996	30	2					155	163		10.1002/(SICI)1097-0274(199608)30:2<155::AID-AJIM6>3.0.CO;2-#		9	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	VA198	WOS:A1996VA19800006		
J	Nagase, T; Ohga, E; Sudo, E; Katayama, H; Uejima, Y; Matsuse, T; Fukuchi, Y				Nagase, T; Ohga, E; Sudo, E; Katayama, H; Uejima, Y; Matsuse, T; Fukuchi, Y			Intercellular adhesion molecule-1 mediates acid aspiration-induced lung injury	AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE			English	Article							TISSUE RESPONSES; INDUCED CONSTRICTION; ICAM-1; AIRWAY; RATS; MECHANISMS; ELASTICITY; ADHERENCE; ANTIGEN; ASTHMA	Acid-aspiration-induced injury is one of the leading causes of adult respiratory distress syndrome. Intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte-function-associated antigen-1 alpha (LFA-1 alpha), and it has been shown to be required for leukocyte migration into inflamed areas. The purpose of this report was to investigate the role of the ICAM-1/LFA-1 alpha pathway in a rat model of acid-aspiration-induced injury. Animals received 3.0 ml/kg HCl (0.1 N; pH, 1.0) intratracheally pretreated with control monoclonal antibodies (mAbs) (HCl group) or anti-ICAM-1 and LFA-1 alpha mAbs (Test group). In the HCl group, increases in lung resistance (RL) (229 +/- 23% baseline), lung wet-to-dry weight ratio (W/D) (11.9 +/- 0.4), protein concentration (TP) (0.447 +/- 0.054 mg/ml), and the number of neutrophils (PMN) (159.0 +/- 19.4 x 10(4)) Of bronchoalveolar lavage fluid were observed. In the Test group, HCl-induced injury was significantly reduced (RL, 122 +/- 7% baseline; W/D, 7.2 +/- 0.1; TP, 0.277 +/- 0.016 mg/ml; PMN, 8.8 +/- 0.8 x 10(4)). The administration of mAbs to ICAM-1 and LFA-1 alpha after HCl instillation partially attenuated HCl-induced responses. These observations suggest that the ICAM-1/LFA-1 alpha pathway might be involved in the pathogenesis of adult respiratory distress syndrome caused by acid aspiration.		Nagase, T (reprint author), UNIV TOKYO,FAC MED,DEPT GERIATR,BUNKYO KU,7-3-1 HONGO,TOKYO 113,JAPAN.						FREDBERG JJ, 1984, J APPL PHYSIOL, V57, P788; EIJKING EP, 1993, ANESTHESIOLOGY, V78, P1145, DOI 10.1097/00000542-199306000-00019; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; KAPANCI Y, 1974, J CELL BIOL, V60, P375, DOI 10.1083/jcb.60.2.375; BOYD AW, 1988, P NATL ACAD SCI USA, V85, P3095, DOI 10.1073/pnas.85.9.3095; MEAD J, 1970, J APPL PHYSIOL, V28, P596; FOLKESSON HG, 1995, J CLIN INVEST, V96, P107, DOI 10.1172/JCI118009; INGENITO EP, 1994, J APPL PHYSIOL, V77, P2689; JAMES AL, 1988, AM REV RESPIR DIS, V138, P136; MEAD J, 1961, PHYSIOL REV, V41, P281; FREDBERG JJ, 1989, J APPL PHYSIOL, V67, P2408; MITZNER W, 1992, J APPL PHYSIOL, V72, P158; MARLIN SD, 1987, CELL, V51, P813, DOI 10.1016/0092-8674(87)90104-8; SMITH CW, 1988, J CLIN INVEST, V82, P1746, DOI 10.1172/JCI113788; BARNAS GM, 1992, J APPL PHYSIOL, V73, P1040; BARTON RW, 1989, J IMMUNOL, V143, P1278; GOLDMAN G, 1992, SURGERY, V111, P55; GOLDMAN G, 1990, ANN SURG, V212, P513, DOI 10.1097/00000658-199010000-00013; GOLDMAN G, 1992, J APPL PHYSIOL, V73, P571; KANG BH, 1993, AM J RESP CELL MOL, V9, P350; LUDWIG MS, 1987, J APPL PHYSIOL, V62, P807; MONTEFORT S, 1994, AM J RESP CRIT CARE, V149, P1149; NAGASE T, 1995, AM J RESP CRIT CARE, V151, P1244; NAGASE T, 1991, CRIT CARE MED, V19, P950, DOI 10.1097/00003246-199107000-00021; NAGASE T, 1994, AM J RESP CRIT CARE, V149, P1342; NAGASE T, 1992, J APPL PHYSIOL, V73, P1900; NAGASE T, 1994, AM J RESP CRIT CARE, V150, P218; RABB HA, 1994, AM J RESP CRIT CARE, V149, P1186; SHIJUBO N, 1993, AM REV RESPIR DIS, V148, P1298; SLY PD, 1991, J APPL PHYSIOL, V71, P886; TAMATANI T, 1990, INT IMMUNOL, V2, P165, DOI 10.1093/intimm/2.2.165; TAMATANI T, 1991, EUR J IMMUNOL, V21, P621; THURLBEC.WM, 1967, AM REV RESPIR DIS, V95, P765; UTSUNOMIYA T, 1982, AM J PHYSIOL, V243, pH903; WEGNER CD, 1990, SCIENCE, V247, P456, DOI 10.1126/science.1967851	35	35	37	AMER LUNG ASSOC	NEW YORK	1740 BROADWAY, NEW YORK, NY 10019	1073-449X			AM J RESP CRIT CARE	Am. J. Respir. Crit. Care Med.	AUG	1996	154	2					504	510				7	Critical Care Medicine; Respiratory System	General & Internal Medicine; Respiratory System	VB858	WOS:A1996VB85800036		
J	Chervet, P; Isaka, H; Nakajima, T				Chervet, P; Isaka, H; Nakajima, T			Influence of crystal shapes on radiative fluxes in visible wavelength: Ice crystals randomly oriented in space	ANNALES GEOPHYSICAE-ATMOSPHERES HYDROSPHERES AND SPACE SCIENCES			English	Article							CIRRUS CLOUDS; LIGHT-SCATTERING; APPROXIMATION; ATMOSPHERES	Radiative properties of cirrus clouds are one of the major unsolved problems in climate studies and global radiation budget. These clouds are generally composed of various ice-crystal shapes, so we tried to evaluate effects of the ice-crystal shape on radiative fluxes. We calculated radiative fluxes of cirrus clouds with a constant geometrical depth, composed of ice crystals with different shapes (hexagonal columns, bullets, bullet-rosettes), sizes and various concentrations. We considered ice particles randomly oriented in space (3D case) and their scattering phase functions were calculated by a ray-tracing method. We calculated radiative fluxes for cirrus layers for different microphysical characteristics by using a discrete-ordinate radiative code. Results showed that the foremost effect of the ice-crystal shape on radiative properties of cirrus clouds was that on the optical thickness, while the variation of the scattering phase function with the ice shape remained less than 3% for our computations. The ice-water content may be a better choice to parameterize the optical properties of cirrus, but the shape effect must be included.	LAB METEOROL PHYS,CNRS,URA 267,F-63177 CLERMONT FERRAN,FRANCE; UNIV TOKYO,CTR CLIMATE SYST RES,MEGURO KU,TOKYO 153,JAPAN			Nakajima, Teruyuki/H-2370-2013	Nakajima, Teruyuki/0000-0002-9042-504X			TAKAHASHI T, 1982, J CRYST GROWTH, V59, P441, DOI 10.1016/0022-0248(82)90365-7; WISCOMBE WJ, 1977, J ATMOS SCI, V34, P1408, DOI 10.1175/1520-0469(1977)034<1408:TDMRYA>2.0.CO;2; LIOU KN, 1972, J ATMOS SCI, V29, P524, DOI 10.1175/1520-0469(1972)029<0524:LSBICI>2.0.CO;2; HEYMSFIELD AJ, 1984, J ATMOS SCI, V41, P846, DOI 10.1175/1520-0469(1984)041<0846:APOTPS>2.0.CO;2; MUINONEN K, 1989, APPL OPTICS, V28, P3044, DOI 10.1364/AO.28.003044; STEPHENS GL, 1980, J ATMOS SCI, V37, P2095, DOI 10.1175/1520-0469(1980)037<2095:RTOALL>2.0.CO;2; ONO A, 1969, J ATMOS SCI, V26, P138, DOI 10.1175/1520-0469(1969)026<0138:TSARPO>2.0.CO;2; NAKAJIMA T, 1988, J QUANT SPECTROSC RA, V40, P51, DOI 10.1016/0022-4073(88)90031-3; NAKAJIMA T, 1986, J QUANT SPECTROSC RA, V35, P13, DOI 10.1016/0022-4073(86)90088-9; ASANO S, 1983, APPL OPTICS, V22, P1390; CAI Q, 1982, APPL OPTICS, V21, P3569, DOI 10.1364/AO.21.003569; COLEMAN RF, 1981, J ATMOS SCI, V38, P1260, DOI 10.1175/1520-0469(1981)038<1260:LSBHIC>2.0.CO;2; DARLISON AG, 1988, P 10 INT CLOUD PHYS; FEBVRE G, 1994, J ATMOS OCEAN TECH, V11, P1231, DOI 10.1175/1520-0426(1994)011<1231:LDIFCC>2.0.CO;2; GAYET JF, 1993, J ATMOS OCEAN TECH, V10, P180, DOI 10.1175/1520-0426(1993)010<0180:ACOICM>2.0.CO;2; GREENLER R, 1991, RAINBOWS HALOS GLORI; HEYMSFIE.AJ, 1972, J ATMOS SCI, V29, P1358, DOI 10.1175/1520-0469(1972)029<1358:POCGC>2.0.CO;2; IAQUINTA J, 1995, J ATMOS SCI, V52, P1401, DOI 10.1175/1520-0469(1995)052<1401:SPFOBR>2.0.CO;2; KINNE S, 1992, MON WEATHER REV, V120, P661, DOI 10.1175/1520-0493(1992)120<0661:CMARTC>2.0.CO;2; Kinne S, 1989, ATMOS RES, V24, P273, DOI 10.1016/0169-8095(89)90049-5; LIOU KN, 1986, MON WEATHER REV, V114, P1167, DOI 10.1175/1520-0493(1986)114<1167:IOCCOW>2.0.CO;2; MACKE A, 1993, APPL OPTICS, V32, P2780, DOI 10.1364/AO.32.002780; MASUDA K, 1992, REMOTE SENS ENVIRON, V39, P45, DOI 10.1016/0034-4257(92)90139-B; MASUDA K, 1990, REMOTE SENS ENVIRON, V31, P65, DOI 10.1016/0034-4257(90)90077-Y; MILOSHEVICH LM, 1992, P 11 INT C CLOUDS PR, P525; NAKAJIMA T, 1992, APPL OPTICS, V31, P7669, DOI 10.1364/AO.31.007669; PLASS GN, 1968, APPL OPTICS, V10, P738; PLATT CMR, 1978, J APPL METEOROL, V17, P1220, DOI 10.1175/1520-0450(1978)017<1220:SMPOAI>2.0.CO;2; ROCKWITZ KD, 1989, APPL OPTICS, V28, P4103, DOI 10.1364/AO.28.004103; STAMNES K, 1981, J ATMOS SCI, V38, P2696, DOI 10.1175/1520-0469(1981)038<2696:ANLATD>2.0.CO;2; TAKANO Y, 1989, J ATMOS SCI, V46, P3, DOI 10.1175/1520-0469(1989)046<0003:SRTICC>2.0.CO;2; TAKANO Y, 1995, J ATMOS SCI, V52, P818, DOI 10.1175/1520-0469(1995)052<0818:RTICCP>2.0.CO;2; Uyeda H., 1979, J METEOR SOC JAPAN, V57, P488; WELCH RM, 1980, APPL OPTICS, V19, P3057, DOI 10.1364/AO.19.003057; WENDLING P, 1979, APPL OPTICS, V18, P2663, DOI 10.1364/AO.18.002663	35	3	3	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010	0992-7689			ANN GEOPHYS	Ann. Geophys.-Atmos. Hydrospheres Space Sci.	AUG	1996	14	8					837	844				8	Astronomy & Astrophysics; Geosciences, Multidisciplinary; Meteorology & Atmospheric Sciences	Astronomy & Astrophysics; Geology; Meteorology & Atmospheric Sciences	VC864	WOS:A1996VC86400008		
J	Adachi, N; Terashima, I; Takahashi, M				Adachi, N; Terashima, I; Takahashi, M			Mechanisms of central die-back of Reynoutria japonica in the volcanic desert on Mt Fuji. A stochastic model analysis of rhizome growth	ANNALS OF BOTANY			English	Article						below-ground morphology; branching angle; central die-back; clonal plant; computer simulation; Japanese knotweed; Reynoutria japonica Houttuyn; rhizome growth pattern	MEDEOLA-VIRGINIANA CLONES; SOLIDAGO-ALTISSIMA; VEGETATIVE SPREAD; ARCHITECTURE; PLANT; SIMULATION; POPULATION; PATTERNS; GEOMETRY; TREES	Reynoutria japonica (Polygonaceae) is a pioneer clonal herb colonising the volcanic desert on Mt. Fuji (height 3776 m), central Japan; establishment of secondary successional species occurs only in the central die-back parts of the clonal stands of R. japonica. Clonal stands were excavated and the morphology and growth pattern of the rhizomes were investigated with special reference to the mechanisms of central die-back. Four morphological parameters. length of mother rhizomes, and number, branching positions and branching angle of daughter rhizomes on respective mother rhizomes were measured or counted, and their roles in rhizome growth were examined employing a stochastic computer simulation model of the whole stand development. The simulations clarified that, of these four parameters, the branching angle was the most influential determinant of the whole pattern of shoot distribution and that the central die-back was produced when the mean branching angle was 40 degrees or smaller. These results strongly infer that the onset of central die-back is caused intrinsically by R. japonica itself by having the mean branching angle of 40 degrees. The adaptive significance of the growth pattern is discussed in relation to resource acquiring and habitat exploitation strategies of this species. (C) 1996 Annals of Botany Company	UNIV TSUKUBA,INST BIOL SCI,TSUKUBA,IBARAKI 305,JAPAN; UNIV TOKYO,FAC SCI,DEPT PLANT SCI,BUNKYO KU,TOKYO 113,JAPAN			TERASHIMA, ICHIRO/G-4943-2014	TERASHIMA, ICHIRO/0000-0001-7680-9867			BORCHERT R, 1981, BOT GAZ, V142, P394, DOI 10.1086/337238; Adachi N, 1996, ANN BOT-LONDON, V77, P477, DOI 10.1006/anbo.1996.0058; HONDA H, 1971, J THEOR BIOL, V31, P331, DOI 10.1016/0022-5193(71)90191-3; BELL AD, 1980, BOT J LINN SOC, V80, P125, DOI 10.1111/j.1095-8339.1980.tb01662.x; SUTHERLAND WJ, 1988, OIKOS, V52, P239, DOI 10.2307/3565196; Batschelet E., 1981, CIRCULAR STATISTICS; BELL AD, 1979, ANN BOT-LONDON, V43, P209; BELL AD, 1974, J ARNOLD ARBORETUM, V55, P458; BELL AD, 1979, J THEOR BIOL, V81, P351, DOI 10.1016/0022-5193(79)90172-3; BORCHERT R, 1984, AM J BOT, V71, P958, DOI 10.2307/2443666; BORCHERT R, 1984, BOT GAZ, V142, P184; CAIN ML, 1988, AM J BOT, V75, P732, DOI 10.2307/2444205; CAIN ML, 1990, J ECOL, V78, P27, DOI 10.2307/2261034; CAIN ML, 1991, OECOLOGIA, V88, P477; CAIN ML, 1995, AM NAT, V145, P888, DOI 10.1086/285775; CALLAGHAN TV, 1990, OIKOS, V57, P257, DOI 10.2307/3565948; COOK RE, 1988, AM J BOT, V75, P725, DOI 10.2307/2444204; Cook RE, 1985, POPULATION BIOL EVOL, P259; De Kroon H, 1990, CLONAL GROWTH PLANTS, P113; DEKROON H, 1994, ADV ECOL RES, V25, P159; EDWARDS J, 1984, B TORREY BOT CLUB, V111, P28, DOI 10.2307/2996207; ERIKSSON O, 1980, CLONAL GROWTH PLANTS, P79; Harper J.L., 1985, P1; Harper J. L., 1981, THEORETICAL ECOLOGY, P53; HIROSE T, 1984, OECOLOGIA, V61, P218, DOI 10.1007/BF00396764; KERSHAW KA, 1958, J ECOL, V46, P571, DOI 10.2307/2257540; KERSHAW KA, 1962, J ECOL, V50, P171, DOI 10.2307/2257202; Marshall C., 1990, CLONAL GROWTH PLANTS, P23; MARUTA E, 1981, JAPANESE J ECOLOGY, V31, P441; Masuzawa T, 1991, P NAT I POL RES S PO, V4, P155; Pitelka L. F., 1985, POPULATION BIOL EVOL, P399; SHIRREFFS DA, 1984, ANN BOT-LONDON, V54, P315; SMITH AP, 1976, NATURE, V261, P232, DOI 10.1038/261232a0; Sutherland W.J., 1990, CLONAL GROWTH PLANTS, P95; TSUYA H, 1971, FUJISAN MT FUJI, P1; Waller D. M., 1988, Plant reproductive ecology: patterns and strategies, P203; Waller D.M., 1985, P225; WATT AS, 1970, NEW PHYTOL, V69, P431, DOI 10.1111/j.1469-8137.1970.tb02442.x; Watt Alex S., 1945, NEW PHYTOL, V44, P156, DOI 10.1111/j.1469-8137.1945.tb05029.x; WHITE J, 1979, ANNU REV ECOL SYST, V10, P109, DOI 10.1146/annurev.es.10.110179.000545	40	28	28	ACADEMIC PRESS LTD	LONDON	24-28 OVAL RD, LONDON, ENGLAND NW1 7DX	0305-7364			ANN BOT-LONDON	Ann. Bot.	AUG	1996	78	2					169	179		10.1006/anbo.1996.0110		11	Plant Sciences	Plant Sciences	VD247	WOS:A1996VD24700006		
J	Li, B; Watkinson, AR; Hara, T				Li, B; Watkinson, AR; Hara, T			Dynamics of competition in populations of carrot (Daucus carota)	ANNALS OF BOTANY			English	Article						allometry; carrot; coefficient of variation; competition; Daucus carota L; monoculture; nutrient availability; size variability; yield/density relationship	SELF-THINNING RULE; PLANT MONOCULTURES; STAND STRUCTURE; DENSITY; GROWTH; SIZE; MODEL; WEIGHT; ROOT; DISTRIBUTIONS	Populations of carrot (Daucus carota) were raised over a wide range of densities (79-5763 plants m(-2)) to examine the dynamics of competition in terms of yield-density relationships and size variability, and to investigate the effects of nutrient supply on competition. While the relationship between shoot yield and density was asymptotic, the relationship between root and total yield and density tended to be parabolic. For a given time and density series the relationship between yield per unit area and density could best be described by the model: where y is the yield per unit area, D is density, w(m), a and b are fitted parameters. The parameters w(m) and a increased over time but nutrient availability affected only w(m). An extension of the basic yield-density model is proposed to describe the dynamics of the yield-density relationship over time: y=kD/[1 + c exp(-rt)]{1 + alpha[k/(1 + c exp(-rt))](beta) D}(b) in which t is time, k, c, r, alpha and beta are fitted parameters, and the other parameters are as previously defined. Size variability of individuals, measured by the coefficient of variation (CV), was influenced by both density and time after sowing. The general relationship between CV and the logarithm of mean weight per plant, after first harvest, could be described by a linear regression model, with a slope of approximately -0.2. A theoretical justification for a monotonically declining relationship between CV and mean plant weight is proposed. The magnitude of size variability was ranked in the order: root weight > total weight > shoot weight. The differences in the magnitude of size variability in yield components were due in part to allometric growth of plant parts. Nutrient availability, however, had no influence on size variability. (C) 1996 Annals of Botany Company	UNIV E ANGLIA,SCH BIOL SCI,NORWICH NR4 7TJ,NORFOLK,ENGLAND; UNIV E ANGLIA,SCH ENVIRONM SCI,NORWICH NR4 7TJ,NORFOLK,ENGLAND; UNIV TOKYO,DEPT SYST SCI,BIOL SECT,TOKYO 153,JAPAN			Hara, Toshihiko/D-8016-2012; Watkinson, Andrew/N-1649-2013; Li, Bo/B-8016-2010	Li, Bo/0000-0002-0439-5666			AIKMAN DP, 1994, ANN BOT-LONDON, V73, P185, DOI 10.1006/anbo.1994.1022; OBEID M, 1967, CROP SCI, V7, P471; TURNER MD, 1983, ECOLOGY, V64, P469, DOI 10.2307/1939966; WEINER J, 1986, OIKOS, V47, P211, DOI 10.2307/3566048; LONSDALE WM, 1990, ECOLOGY, V71, P1373, DOI 10.2307/1938275; SCAIFE MA, 1976, J AGR SCI, V86, P83; BENDEL RB, 1989, OECOLOGIA, V78, P394, DOI 10.1007/BF00379115; MOHLER CL, 1978, J ECOL, V66, P599, DOI 10.2307/2259153; ANTONOVICS J, 1980, ANNU REV ECOL SYST, V11, P411, DOI 10.1146/annurev.es.11.110180.002211; HARA T, 1984, J THEOR BIOL, V110, P223, DOI 10.1016/S0022-5193(84)80055-7; BAEUMER K., 1968, NETH J AGR SCI, V16, P103; BARNES A, 1979, ANN BOT-LONDON, V43, P487; BARNES A, 1977, ANN BOT-LONDON, V41, P883; BENJAMIN LR, 1988, ANN BOT-LONDON, V62, P199; BENJAMIN LR, 1995, ANN BOT-LONDON, V76, P31, DOI 10.1006/anbo.1995.1075; BENJAMIN LR, 1992, J AGR SCI, V119, P59; BENJAMIN LR, 1978, J EXP BOT, V29, P425, DOI 10.1093/jxb/29.2.425; BLEASDALE JKA, 1960, NATURE, V188, P342, DOI 10.1038/188342a0; BLEASDAL.JK, 1967, J HORTIC SCI BIOTECH, V42, P51; CURRAH IE, 1979, ANN BOT-LONDON, V43, P475; CURRAH IE, 1975, THESIS U LONDON; FIRBANK LG, 1985, J THEOR BIOL, V116, P291, DOI 10.1016/S0022-5193(85)80269-1; Goel N. W., 1974, STOCHASTIC MODELS BI; HARA T, 1986, ANN BOT-LONDON, V57, P55; HARA T, 1988, TRENDS ECOL EVOL, V3, P129, DOI 10.1016/0169-5347(88)90175-9; HARA T, 1984, J THEOR BIOL, V109, P173, DOI 10.1016/S0022-5193(84)80002-8; HARDWICK RC, 1983, J APPL ECOL, V20, P905, DOI 10.2307/2403135; HOLE CC, 1983, ANN BOT-LONDON, V51, P175; HUTCHINGS M.J, 1986, PLANT ECOL, P97; KOYAMA HIROSI, 1956, JOUR INST POLYTECH OSAKA CITY UNIV SER D BIOL, V7, P73; LI B, 1995, THESIS U E ANGLIA; MACKERRON DKL, 1988, POTATO RES, V31, P279, DOI 10.1007/BF02365536; MORRIS EC, 1984, AUST J ECOL, V9, P51, DOI 10.1111/j.1442-9993.1984.tb01618.x; MORRIS EC, 1987, ANN BOT-LONDON, V59, P629; MUTSAERS HJW, 1989, ANN BOT-LONDON, V64, P521; SCAIFE A, 1987, ANN BOT-LONDON, V59, P325; SHINOZAKI KICHIRO, 1956, JOUR INST POLYTECH OSAKA CITY UNIV SER D BIOL, V7, P35; STANHILL G, 1977, ANN BOT-LONDON, V41, P541; STANHILL G, 1977, ANN BOT-LONDON, V41, P533; SUTHERLAND RA, 1993, ANN BOT-LONDON, V71, P131, DOI 10.1006/anbo.1993.1016; *SYSTAT, 1992, SYSTAT VERS 5 2 EDN; WATKINSON AR, 1984, ANN BOT-LONDON, V53, P469; WATKINSON AR, 1980, J THEOR BIOL, V83, P345, DOI 10.1016/0022-5193(80)90297-0; Weiner J, 1988, PLANT POPULATION ECO, P59; WEINER J, 1985, ECOLOGY, V66, P743, DOI 10.2307/1940535; WESTOBY M, 1984, ADV ECOL RES, V14, P167, DOI 10.1016/S0065-2504(08)60171-3; Willey RW, 1969, ADV AGRON, V21, P281, DOI 10.1016/S0065-2113(08)60100-5; YODA KYOJI, 1963, J BIOL OSAKA CITY UNIV, V14, P107; YOKOZAWA M, 1992, ANN BOT-LONDON, V70, P305	49	16	20	ACADEMIC PRESS LTD	LONDON	24-28 OVAL RD, LONDON, ENGLAND NW1 7DX	0305-7364			ANN BOT-LONDON	Ann. Bot.	AUG	1996	78	2					203	214		10.1006/anbo.1996.0114		12	Plant Sciences	Plant Sciences	VD247	WOS:A1996VD24700010		
J	Mann, DMA; Iwatsubo, T; Cairns, NJ; Lantos, PL; Nochlin, D; Sumi, SM; Bird, TD; Poorkaj, P; Hardy, J; Hutton, M; Prihar, G; Crook, R; Rossor, MN; Haltia, M				Mann, DMA; Iwatsubo, T; Cairns, NJ; Lantos, PL; Nochlin, D; Sumi, SM; Bird, TD; Poorkaj, P; Hardy, J; Hutton, M; Prihar, G; Crook, R; Rossor, MN; Haltia, M			Amyloid beta protein (A beta) deposition in chromosome 14-linked Alzheimer's disease: Predominance of A beta(42(43))	ANNALS OF NEUROLOGY			English	Article							HEREDITARY CEREBRAL-HEMORRHAGE; MISSENSE MUTATION; S182 GENE; LOCUS; FAMILIES; A-BETA-42(43); 14Q24.3	Amyloid beta protein (A beta) deposition was investigated in the frontal cortex of 8 cases of (genetically confirmed) chromosome 14-linked Alzheimer's disease (AD) using the end-specific monoclonal antibodies BA27 and BC05 to detect the presence of A beta(40) and A beta(42(43)), respectively. In all patients, A beta(42(43)) was the predominant peptide species present. The total amount of A beta(40) and A beta(42(43)) deposited was more than twice the amount deposited in cases of sporadic AD of similar disease duration, although the ratio between the extent of A beta(40) and A beta(42(43)) deposition was unaltered, compared with sporadic AD. Therefore, (one of) the effects of the mutations in the presenilin 1:PS-1 (S182) gene may be to cause or at least promote an early and excessive deposition of A beta(42(43)) within the brain, a property shared with other inherited forms of AD, such as those due to amyloid precursor protein mutations, and Down's syndrome (trisomy 21).	INST PSYCHIAT, BRAIN BANK, DEPT NEUROPATHOL, LONDON, ENGLAND; UCL NATL HOSP NEUROL & NEUROSURG, DEPT NEUROL, LONDON, ENGLAND; UNIV TOKYO, DIV PHARMACEUT SCI, DEPT NEUROPATHOL & NEUROSCI, TOKYO, JAPAN; HELSINKI UNIV, DEPT PATHOL, HELSINKI, FINLAND; UNIV WASHINGTON, DEPT PATHOL, DIV NEUROPATHOL, SEATTLE, WA 98195 USA; DEPT VET AFFAIRS, SEATTLE, WA USA; VET ADM MED CTR, CTR GERIATR RES EDUC & CLIN, SEATTLE, WA 98108 USA; UNIV S FLORIDA, DEPT PSYCHIAT, TAMPA, FL USA	Mann, DMA (reprint author), UNIV MANCHESTER, DIV MOL PATHOL, DEPT PATHOL SCI, OXFORD RD, MANCHESTER M13 9PL, LANCS, ENGLAND.		Hardy, John/C-2451-2009				CLARK RF, 1995, NAT GENET, V11, P219, DOI 10.1038/ng1095-219; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; CAMPION D, 1995, HUM MOL GENET, V4, P2373, DOI 10.1093/hmg/4.12.2373; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; SCHELLENBERG GD, 1992, SCIENCE, V258, P668, DOI 10.1126/science.1411576; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; LEVYLAHAD E, 1995, SCIENCE, V269, P970, DOI 10.1126/science.7638621; LEVY E, 1990, SCIENCE, V248, P1124, DOI 10.1126/science.2111584; VAN BROECKHOVEN C, 1992, NAT GENET, V2, P335, DOI 10.1038/ng1292-335; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; LANNFELT L, 1994, NEUROSCI LETT, V168, P254, DOI 10.1016/0304-3940(94)90463-4; STGEORGEHYSLOP P, 1992, NAT GENET, V2, P330, DOI 10.1038/ng1292-330; CRUTS M, 1995, HUM MOL GENET, V4, P2363, DOI 10.1093/hmg/4.12.2363; MULLAN M, 1992, NAT GENET, V2, P340, DOI 10.1038/ng1292-340; IWATSUBO T, 1995, ANN NEUROL, V37, P294, DOI 10.1002/ana.410370305; ROSES AD, 1994, J NEUROPATH EXP NEUR, V53, P429, DOI 10.1097/00005072-199409000-00002; Fukumoto H, 1996, AM J PATHOL, V148, P259; BIRD TD, 1989, ANN NEUROL, V25, P12, DOI 10.1002/ana.410250104; HALTIA M, 1994, ANN NEUROL, V36, P362, DOI 10.1002/ana.410360307; HENDRIKS L, 1992, NAT GENET, V1, P218, DOI 10.1038/ng0692-218; KENNEDY AM, 1995, BRAIN, V118, P185, DOI 10.1093/brain/118.1.185; LAMPE TH, 1994, ANN NEUROL, V36, P368, DOI 10.1002/ana.410360308; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; MAK K, 1994, BRAIN RES, V667, P138, DOI 10.1016/0006-8993(94)91725-6; Mann DMA, 1996, AM J PATHOL, V148, P1257; MARTIN JJ, 1991, NEUROLOGY, V41, P62; MULLAN M, 1993, NEUROBIOL AGING, V14, P407, DOI 10.1016/0197-4580(93)90099-W; MURPHY GM, 1994, AM J PATHOL, V144, P1082; PEREZTUR J, 1996, NEUROREPORT, V7, P204; ROAGEV EI, 1995, NATURE, V376, P775; SORBI S, 1995, LANCET, V346, P439, DOI 10.1016/S0140-6736(95)92809-X; TAMAOKA A, 1994, J BIOL CHEM, V269, P32721; TANAHASHI H, 1995, LANCET, V346, P440, DOI 10.1016/S0140-6736(95)92810-3; Van Broeckhoven C, 1995, NAT GENET, V11, P230; VANDUINEN SG, 1987, P NATL ACAD SCI USA, V84, P5991; WASCO W, 1995, NAT MED, V1, P848, DOI 10.1038/nm0995-848a; YOUNKIN SG, 1995, AMYLOID BETA PROTEIN	37	158	159	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	0364-5134			ANN NEUROL	Ann. Neurol.	AUG	1996	40	2					149	156		10.1002/ana.410400205		8	Clinical Neurology; Neurosciences	Neurosciences & Neurology	VC689	WOS:A1996VC68900004		
J	Yamada, M; Itoh, Y; Suematsu, N; Otomo, E; Matsushita, M				Yamada, M; Itoh, Y; Suematsu, N; Otomo, E; Matsushita, M			Apolipoprotein E genotype in elderly nondemented subjects without senile changes in the brain	ANNALS OF NEUROLOGY			English	Article							ALZHEIMERS-DISEASE; TYPE-4 ALLELE; RISK	Only a small minority of elderly subjects can survive with a brain free of senile changes (senile plaques, neurofibrillary tangles, and amyloid angiopathy) beyond the age of 80 years. We demonstrated that an increase of epsilon 2 allele frequency and a decrease of epsilon 4 allele frequency of the apolipoprotein E gene are associated with such brain aging without senile changes.	YOKUFUKAI GERIATR HOSP,DEPT INTERNAL MED,TOKYO,JAPAN; YOKUFUKAI GERIATR HOSP,DEPT PATHOL,TOKYO,JAPAN; UNIV TOKYO,DEPT PSYCHIAT,TOKYO,JAPAN	Yamada, M (reprint author), TOKYO MED & DENT UNIV,DEPT NEUROL,BUNKYO KU,1-5-45 YUSHIMA,TOKYO 113,JAPAN.						SCHACHTER F, 1994, NAT GENET, V6, P29, DOI 10.1038/ng0194-29; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467; MIRRA SS, 1991, NEUROLOGY, V41, P479; POLVIKOSKI T, 1995, NEW ENGL J MED, V333, P1242, DOI 10.1056/NEJM199511093331902; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Itoh Y, 1996, STROKE, V27, P216; VANDUIJN CM, 1995, ANN NEUROL, V37, P605, DOI 10.1002/ana.410370510	10	12	14	LITTLE BROWN CO	BOSTON	34 BEACON STREET, BOSTON, MA 02108-1493	0364-5134			ANN NEUROL	Ann. Neurol.	AUG	1996	40	2					243	245		10.1002/ana.410400217		3	Clinical Neurology; Neurosciences	Neurosciences & Neurology	VC689	WOS:A1996VC68900016		
J	Miyaji, K; Furuse, A; Takeda, M; Chikada, M; Ono, M; Kawauchi, M				Miyaji, K; Furuse, A; Takeda, M; Chikada, M; Ono, M; Kawauchi, M			Successful conduit repair using aortic homograft in a Jehovah's witness child	ANNALS OF THORACIC SURGERY			English	Article							CONGENITAL HEART-DISEASE; OPERATIONS	A 10-year-old female child of the Jehovah's Witness faith presented with congenitally corrected transposition of the great arteries {S,L,L}, pulmonary atresia, and a ventricular septal defect. A successful surgical correction was performed using an aortic homograft as a valved extracardiac conduit without the use of homologous blood or blood products. We used permanent splinting of the sternum with a methyl methacrylate resin plate to prevent compression of the conduit.	UNIV TOKYO,FAC MED,DEPT CARDIOTHORAC SURG,TOKYO 113,JAPAN							LEWIS CTP, 1991, ANN THORAC SURG, V51, P448; DELEVAL MR, 1979, J THORAC CARDIOV SUR, V78, P515; CHIKADA M, IN PRESS CARDIOVASC; HENLING CE, 1985, J THORAC CARDIOV SUR, V89, P914; Kawauchi M, 1996, ANN THORAC SURG, V61, P1245, DOI 10.1016/0003-4975(95)00916-7; OTT DA, 1977, JAMA-J AM MED ASSOC, V238, P1256, DOI 10.1001/jama.238.12.1256; SALIM MA, 1995, ANN THORAC SURG, V59, P67, DOI 10.1016/0003-4975(94)00674-V	7	3	3	ELSEVIER SCIENCE INC	NEW YORK	655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010	0003-4975			ANN THORAC SURG	Ann. Thorac. Surg.	AUG	1996	62	2					590	591		10.1016/0003-4975(96)00415-8		2	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	VA287	WOS:A1996VA28700071		
J	Nakanishi, K; Ikebukuro, K; Karube, I				Nakanishi, K; Ikebukuro, K; Karube, I			Determination of cyanide using a microbial sensor	APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY			English	Article						Saccharomyces cerevisiae; microbial biosensor; immobilized cell; cyanide determination; respiration inhibition	ELECTRODE	A microbial cyanide sensor was prepared, consisting of immobilized Saccharomyces cerevisiae and an oxygen electrode. When the electrode was inserted into a solution containing glucose, the respiration activity of the microorganisms increased. The change in the respiration activity is monitored with the oxygen electrode. When cyanide is added to the sample solution, the electron transport chain reaction of the respiration system in the mitochondria is inhibited, resulting in a decrease in respiration. The inhibition is caused by cyanide binding with respiration enzymes such as the cytochrome oxidase complex in the mitochondrial inner membrane. Therefore, the cyanide concentration can be measured from the change in the respiration rate. When the sensor was applied to a batch system at pH 8.0 and 30 degrees C, the cyanide calibration curve showed linearity in the concentration range between 0.3 mu M and 150 mu M CN-.	UNIV TOKYO,ADV SCI & TECHNOL RES CTR,MEGURO KU,TOKYO 153,JAPAN			Ikebukuro, Kazunori/B-9957-2013	Ikebukuro, Kazunori/0000-0003-2838-0562			KARUBE I, 1977, BIOTECHNOL BIOENG, V19, P1535, DOI 10.1002/bit.260191010; FONONG T, 1987, ANALYST, V112, P1033, DOI 10.1039/an9871201033; Franson M. A. H., 1980, STANDARD METHODS EXA; FRANT MS, 1972, ANAL CHEM, V44, P2227, DOI 10.1021/ac60321a038; GROOM CA, 1991, J BIOTECHNOL, V21, P161, DOI 10.1016/0168-1656(91)90268-Z; HIKUMA M, 1979, EUR J APPL MICROBIOL, V8, P289, DOI 10.1007/BF00508793; KARUBE I, 1993, CURRENT OPINION BIOT, V5, P54; KARUBE I, 1994, IEEE ENG MED BIOL, P365; Karube I., 1990, BIOSENSORS PRACTICAL, P155; MATTIASSON B, 1977, BIOTECHNOL BIOENG, V19, P1643, DOI 10.1002/bit.260191104; MATTIASSON B, 1979, J SOL-PHASE BIOCHEM, V4, P263, DOI 10.1007/BF02998680; VANEEDEN CHP, 1985, Z LEBENSM UNTERS FOR, V181, P412; ZOLLNER H, 1989, HDB ENZYME INHIBITOR, P273	13	21	22	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512	0273-2289			APPL BIOCHEM BIOTECH	Appl. Biochem. Biotechnol.	AUG	1996	60	2					97	106		10.1007/BF02788064		10	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	VJ815	WOS:A1996VJ81500001		
J	Fang, SN; Fujimoto, K				Fang, SN; Fujimoto, K			Direct synthesis of dimethyl carbonate from carbon dioxide and methanol catalyzed by base	APPLIED CATALYSIS A-GENERAL			English	Letter						dimethyl carbonate; carbon dioxide; methanol; base		The new synthesis route of dimethyl carbonate (DMC) was found from carbon dioxide and methanol catalyzed by base catalysts and in the presence of CH3I promoter.		Fang, SN (reprint author), UNIV TOKYO,FAC ENGN,DEPT APPL CHEM,BUNKYO KU,3-1 HONGO,TOKYO 11,JAPAN.						ROMANO U, 1980, IND ENG CHEM PROD RD, V19, P396, DOI 10.1021/i360075a021; TUNDO P, 1989, IND ENG CHEM RES, V28, P881, DOI 10.1021/ie00091a001; BRAUNSTEIN P, 1988, CHEM REV, V88, P747, DOI 10.1021/cr00087a003; JURAJ K, 1993, COLLECT CZECH CHEM C, V58, P1399; LEE MY, 1991, STUD SURF SCI CATAL, V66, P631; SAKAI S, 1975, NIPPON KAGAKU KAISHI, V10, P1789; YAMAZAKI N, 1979, IND ENG CHEM PROD RD, V18, P249, DOI 10.1021/i360072a004; YAMAZAKI N, Patent No. 7903012	8	123	146	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0926-860X			APPL CATAL A-GEN	Appl. Catal. A-Gen.	AUG 1	1996	142	1					L1	L3		10.1016/0926-860X(96)00081-6		3	Chemistry, Physical; Environmental Sciences	Chemistry; Environmental Sciences & Ecology	UZ780	WOS:A1996UZ78000001		
J	Yang, Z; Suzuki, H; Sasaki, S; Karube, I				Yang, Z; Suzuki, H; Sasaki, S; Karube, I			Disposable sensor for biochemical oxygen demand	APPLIED MICROBIOLOGY AND BIOTECHNOLOGY			English	Article							BOD	Disposable-type microbial sensors were prepared for the determination of biochemical oxygen demand (BOD). The yeast, Trichosporon cutaneum, was directly immobilized on the surface of miniature oxygen electrodes using an ultraviolet crosslinking resin (ENT-3400). The oxygen electrodes (15 mm x 2 mm x 0.4 mm) were made on silicon substrates using micromachining techniques. They were Clark-type two-electrode systems with -1021 mV applied to the working electrode. Typical response times of the BOD sensors were in the range of 7-20 min. At 20 degrees C, the sensors' dynamic range was from 0 to 18 mg/l BOD when a glucose/glutamate BOD standard solution was used. The lower limit of detection was 0.2 mg/l BOD. This value was one order of magnitude lower than that of sensors previously reported. The sensors' operational lifetime of 3 days was satisfactory for a disposable type. The sensors' responses were reproducible to within 8% relative standard deviation. The BOD sensors' were applied to untreated and treated waste waters from industrial effluents and municipal sewage. BOD values determined using these sensors correlated well with those determined by the conventional 5-day BOD determination method.	UNIV TOKYO,ADV SCI & TECHNOL RES CTR,MEGURO KU,TOKYO 153,JAPAN; FUJITSU LABS LTD,ATSUGI,KANAGAWA 24301,JAPAN							KARUBE I, 1977, BIOTECHNOL BIOENG, V19, P1535, DOI 10.1002/bit.260191010; PREININGER C, 1994, ANAL CHEM, V66, P1841, DOI 10.1021/ac00083a011; Fukui S., 1984, ADV BIOCHEM ENG BIOT, V29, P1; HIKUMA M, 1979, EUR J APPL MICROBIOL, V8, P289, DOI 10.1007/BF00508793; HYUN CK, 1993, BIOTECHNOL BIOENG, V41, P1107, DOI 10.1002/bit.260411114; *JAP IND STAND COM, 1993, TEST METH IND WAST W, P48; RIEDEL K, 1988, APPL MICROBIOL BIOT, V28, P316; TAN TC, 1992, SENSOR ACTUAT B-CHEM, V8, P167, DOI 10.1016/0925-4005(92)80175-W; TAN TC, 1993, SENSOR ACTUAT B-CHEM, V10, P137, DOI 10.1016/0925-4005(93)80037-C	9	58	62	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010	0175-7598			APPL MICROBIOL BIOT	Appl. Microbiol. Biotechnol.	AUG	1996	46	1					10	14				5	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	VD858	WOS:A1996VD85800002		
J	Hashimoto, M; Hamaguchi, HO				Hashimoto, M; Hamaguchi, HO			Construction of a multichannel Fourier transform infrared spectrometer for single-event time-resolved spectroscopy	APPLIED SPECTROSCOPY			English	Article						infrared; time-resolved spectroscopy; phase transitions; FT-IR; n-alkane; multichannel detector	CRYSTALLINE NORMAL-ALKANES	A newly designed multichannel Fourier transform infrared spectrometer has been constructed for single-event time-resolved spectroscopy. It is capable of measuring unrepeatable transient events such as phase transitions, explosions, etc., with a time resolution of up to 5.14 ms. The mid-infrared region of 4500-2500 cm(-1) is covered with a maximum spectral resolution of 13 cm(-1). The developed system is used to measure the phase transitions of alkanes. The solid-solid and solid-liquid phase transitions of octadecane and nonadecane have been studied with time resolutions of 5-50 ms.	KANAGAWA ACAD SCI & TECHNOL,TAKATSU KU,KAWASAKI,KANAGAWA 213,JAPAN; UNIV TOKYO,GRAD SCH ARTS & SCI,DEPT BASIC SCI,MEGURO KU,TOKYO 153,JAPAN			Hashimoto, Mamoru/E-1028-2014				OKAMOTO T, 1984, APPL OPTICS, V23, P269; JOHNSON TJ, 1993, APPL SPECTROSC, V47, P1376, DOI 10.1366/0003702934067397; SNYDER RG, 1981, SCIENCE, V214, P188, DOI 10.1126/science.214.4517.188; CASAL HL, 1983, CAN J CHEM, V61, P1736, DOI 10.1139/v83-297; GRIFFITHS PR, 1986, FOURIER TRANSFORM IN; HABENSCHUSS A, 1990, J CHEM PHYS, V92, P5692, DOI 10.1063/1.458500; HASHIMOTO M, 1992, APPL OPTICS, V31, P6096, DOI 10.1364/AO.31.006096; LAU A, 1993, TIME RESOLVED VIBRAT; MARONCELLI M, 1985, J CHEM PHYS, V82, P2811, DOI 10.1063/1.448280; OWRUTSKY JC, 1992, J CHEM PHYS, V97, P4421, DOI 10.1063/1.463884; Press WH, 1988, NUMERICAL RECIPES C; STROKE GW, 1965, PHYS LETT, V16, P272, DOI 10.1016/0031-9163(65)90846-2; SWEEDLER JV, 1989, APPL SPECTROSC, V43, P1378, DOI 10.1366/0003702894204506; TAKAHASHI H, 1991, TIME RESOLVED VIBRAT; UMEMURA J, 1981, J COLLOID INTERF SCI, V83, P558, DOI 10.1016/0021-9797(81)90350-7; YOSHIHAR.K, 1967, JPN J APPL PHYS, V6, P116, DOI 10.1143/JJAP.6.116; YUZAWA T, 1994, APPL SPECTROSC, V48, P684, DOI 10.1366/000370294774368947	17	5	5	SOC APPLIED SPECTROSCOPY	FREDERICK	PO BOX 1438, FREDERICK, MD 21701	0003-7028			APPL SPECTROSC	Appl. Spectrosc.	AUG	1996	50	8					1030	1033		10.1366/0003702963905376		4	Instruments & Instrumentation; Spectroscopy	Instruments & Instrumentation; Spectroscopy	VD855	WOS:A1996VD85500014		
J	Shiraki, Y; Sunamura, H; Usami, N; Fukatsu, S				Shiraki, Y; Sunamura, H; Usami, N; Fukatsu, S			Formation and optical properties of SiGe/Si quantum structures	APPLIED SURFACE SCIENCE			English	Article; Proceedings Paper	International Symposium on Si Heterostructures - From Physics to Devices	SEP 11-14, 1995	IRAKLION, GREECE				MOLECULAR-BEAM EPITAXY; WELL STRUCTURES; LUMINESCENCE; PHOTOLUMINESCENCE; GROWTH	Quantum structures consisting of Si and Ge were successfully formed by using gas source molecular beam epitaxy (GSMBE). The growth was strongly dependent on growth temperature and crystalline orientation. The SiGe/Si quantum wells grown by the method clearly showed size quantization effects when the well width as well as Ge content were changed and coupling of wells was well understood in terms of effective mass approximation. The luminescence peak energy, however, was found not to precisely follow the Ge content dependence, theoretically predicted above 40% of Ge. It was also followed by the deviation of Ge content dependence of activation energy of PL intensity. These properties were shown to come from island formation on SiGe layers. In the case of pure Ge wells, the critical thickness where the PL properties significantly changed was found to be 3.7 MLs above which quantum islands were formed on wet layers with 3 MLs thickness. When the Ge thickness was reduced to sub-monolayer, the formation of quantum wires was found, which was confirmed both in PL aspects as well as TEM observation. Band filling effect characteristic of SiGe/Si quantum wells diminished probably due to the change in the density of states and a new luminescence which was reasonably assigned to biexcitons was found to be formed in the wires. The formation of quantum structures in the Si/Ge system was promising to realize optoelectronic devices and light emitting diodes operating at room temperature was demonstrated.	UNIV TOKYO,DEPT PURE & APPL SCI,MEGURO KU,TOKYO 153,JAPAN	Shiraki, Y (reprint author), UNIV TOKYO,ADV SCI & TECHNOL RES CTR,MEGURO KU,4-6-1 KOMABA,TOKYO 153,JAPAN.		Usami, Noritaka/C-1720-2009				VAN DE WALLE CG, 1986, PHYS REV B, V34, P5621, DOI 10.1103/PhysRevB.34.5621; COPEL M, 1991, APPL PHYS LETT, V58, P2648, DOI 10.1063/1.104796; FUKATSU S, 1993, 1993 INT C SOL STAT, P895; FUKATSU S, 1992, THIN SOLID FILMS, V222, P1, DOI 10.1016/0040-6090(92)90025-7; FUKATSU S, 1994, SOLID STATE ELECTRON, V37, P817, DOI 10.1016/0038-1101(94)90305-0; FUKATSU S, 1994, J VAC SCI TECHNOL B, V12, P1160, DOI 10.1116/1.587073; FUKATSU S, 1993, JPN J APPL PHYS 1, V32, P1502, DOI 10.1143/JJAP.32.1502; FUKATSU S, 1992, JPN J APPL PHYS 2, V31, pL1319; FUKATSU S, 1994, J CRYST GROWTH, V136, P315, DOI 10.1016/0022-0248(94)90432-4; KATO Y, 1993, APPL PHYS LETT, V63, P2414, DOI 10.1063/1.110492; NAYAK DK, 1993, APPL PHYS LETT, V63, P3509, DOI 10.1063/1.110110; OTA G, 1994, APPL PHYS LETT, V65, P2975; SUNAMURA H, 1995, APPL PHYS LETT, V66, P953, DOI 10.1063/1.113608; USAMI N, 1993, APPL PHYS LETT, V63, P2789, DOI 10.1063/1.110335; USAMI N, 1994, APPL PHYS LETT, V64, P1126, DOI 10.1063/1.110827	15	18	18	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0169-4332			APPL SURF SCI	Appl. Surf. Sci.	AUG	1996	102						263	271		10.1016/0169-4332(96)00062-1		9	Chemistry, Physical; Materials Science, Coatings & Films; Physics, Applied; Physics, Condensed Matter	Chemistry; Materials Science; Physics	VJ861	WOS:A1996VJ86100056		
J	Mishima, HK; Masuda, K; Kitazawa, Y; Azuma, I; Araie, M				Mishima, HK; Masuda, K; Kitazawa, Y; Azuma, I; Araie, M			A comparison of latanoprost and timolol in primary open-angle glaucoma and ocular hypertension - A 12-week study	ARCHIVES OF OPHTHALMOLOGY			English	Article							PROSTAGLANDIN-F-2-ALPHA-ISOPROPYLESTER EYE DROPS; INTRAOCULAR-PRESSURE; PROSTAGLANDIN-F2-ALPHA ANALOG; PHXA41; REDUCTION; DYNAMICS	Objective: To evaluate the intraocular pressure (IOP)reducing effect and the side effects of latanoprost (PhXA41), a new phenyl-substituted prostaglandin F-2 alpha-isopropyl ester analogue, in patients with elevated IOP, using timolol maleate as the reference drug. Methods: A total of 184 patients with primary open-angle glaucoma or ocular hypertension at 35 medica!centers participated in this randomized double-masked study. The patients were randomized to receive either 0.005% latanoprost once daily or 0.5% timolol maleate twice daily, for a period of 12 weeks. Intraocular pressure was measured 24 hours after the administration of timolol, at 2, 4, 8, and 12 weeks of treatment. Results: Latanoprost reduced IOP at the end of 12 weeks by 6.2 +/- 2.7 mm Hg (mean +/- SD) (26.8%), while timolol reduced IOP by 4.4 +/- 2.3 mm Hg (19.9%). At all visits latanoprost reduced TOP significantly more than timolol did. The main ocular side effects observed in both groups were conjunctival hyperemia and smarting. The main systemic side effect was a reduced pulse rate, which occurred in patients treated with timolol. Conclusions: The results of this study demonstrated that 0.005% latanoprost taken once daily is well tolerated and more effective in reducing TOP than 0.5% timolol taken twice daily. Thus, latanoprost may become an important choice for the medical treatment of glaucoma.	UNIV TOKYO,TOKYO,JAPAN; GIFU UNIV,GIFU,JAPAN; OSAKA MED COLL,OSAKA,JAPAN	Mishima, HK (reprint author), HIROSHIMA UNIV,DEPT OPHTHALMOL,HIROSHIMA,JAPAN.						ALM A, 1993, OPHTHALMOLOGY, V100, P1312; ALM A, 1995, BRIT J OPHTHALMOL, V79, P12, DOI 10.1136/bjo.79.1.12; Alm A, 1995, OPHTHALMOLOGY, V102, P1743; RESUL B, 1993, J MED CHEM, V36, P243, DOI 10.1021/jm00054a008; LEE PY, 1988, INVEST OPHTH VIS SCI, V29, P1474; Watson P, 1996, OPHTHALMOLOGY, V103, P126; VILLUMSEN J, 1989, BRIT J OPHTHALMOL, V73, P975, DOI 10.1136/bjo.73.12.975; ZIAI N, 1993, ARCH OPHTHALMOL-CHIC, V111, P1351; VILLUMSEN J, 1989, BRIT J OPHTHALMOL, V73, P419, DOI 10.1136/bjo.73.6.419; Camras CB, 1996, OPHTHALMOLOGY, V103, P138; CAMRAS CB, 1989, OPHTHALMOLOGY, V96, P1329; GIUFFE G, 1985, GRAEFES ARCH CLIN EX, V22, P139; HOTEHAMA Y, 1993, JPN J OPHTHALMOL, V37, P270; HOTEHAMA Y, 1993, JPN J OPHTHALMOL, V37, P259; KERSTETTER JR, 1988, AM J OPHTHALMOL, V105, P30; NAGASUBRAMANIAN S, 1993, OPHTHALMOLOGY, V100, P1305; RACZ P, 1993, ARCH OPHTHALMOL-CHIC, V111, P657; SHERWOOD MB, 1993, SURV OPHTHALMOL, V37, P293, DOI 10.1016/0039-6257(93)90013-W; STJERNSCHANTZ J, 1995, ADV PROSTAG THROMB L, V23, P513; STJERNSCHANTZ J, 1992, Drugs of the Future, V17, P691; TORIS CB, 1993, OPHTHALMOLOGY, V100, P1297	21	137	139	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0003-9950			ARCH OPHTHALMOL-CHIC	Arch. Ophthalmol.	AUG	1996	114	8					929	932				4	Ophthalmology	Ophthalmology	VB183	WOS:A1996VB18300003		
J	Fujii, Y				Fujii, Y			How natural is a small but nonzero cosmological constant?	ASTROPARTICLE PHYSICS			English	Article							DISTANCE	Based on our previous attempt, we propose a better way to understand a small but nonzero cosmological constant, as indicated by a number of recent observational studies. We re-examine the assumptions of our model of two scalar fields, trying to explain the basic mechanism resulting in a series of mini-inflations occurring nearly periodically with respect to In t with t the cosmic time. We also discuss how likely the solution of this type would be, depending on the choice of the parameters.	UNIV TOKYO,INST COSM RAY RES,TANASHI,TOKYO 188,JAPAN	Fujii, Y (reprint author), NIHON FUKUSHI UNIV,HANDA,AICHI 475,JAPAN.						BRANS C, 1961, PHYS REV, V124, P925, DOI 10.1103/PhysRev.124.925; FREEDMAN WL, 1994, NATURE, V371, P757, DOI 10.1038/371757a0; FUJII Y, 1991, PHYS LETT B, V254, P347, DOI 10.1016/0370-2693(91)91167-T; Dolgov A.D., 1982, VERY EARLY UNIVERSE; FORD LH, 1987, PHYS REV D, V35, P2339, DOI 10.1103/PhysRevD.35.2339; FUJII Y, 1994, PROG THEOR PHYS, V92, P521, DOI 10.1143/PTP.92.521; FUJII Y, 1990, PHYS REV D, V42, P361, DOI 10.1103/PhysRevD.42.361; FUKLUGITA M, 1994, YITPK1098; FUKUGITA M, 1993, NATURE, V366, P309, DOI 10.1038/366309a0; Ostriker J., ASTROPH9505066	10	5	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0927-6505			ASTROPART PHYS	Astropart Phys.	AUG	1996	5	2					133	138		10.1016/0927-6505(96)00012-6		6	Astronomy & Astrophysics; Physics, Particles & Fields	Astronomy & Astrophysics; Physics	VE116	WOS:A1996VE11600004		
J	Mushotzky, R; Loewenstein, M; Arnaud, KA; Tamura, T; Fukazawa, Y; Matsushita, K; Kikuchi, K; Hatsukade, I				Mushotzky, R; Loewenstein, M; Arnaud, KA; Tamura, T; Fukazawa, Y; Matsushita, K; Kikuchi, K; Hatsukade, I			Measurement of the elemental abundances in four rich clusters of galaxies .1. Observations	ASTROPHYSICAL JOURNAL			English	Article						galaxies, abundances; galaxies, clusters, individual (Abell 496, Abell 1060, Abell 2199, AWM 7); X-rays, galaxies	SOLID-STATE SPECTROMETER; X-RAY-SPECTRA; ELLIPTIC GALAXIES; CHEMICAL EVOLUTION; MAGELLANIC CLOUDS; ASCA OBSERVATIONS; HOT PLASMA; IRON; TEMPERATURE; METALLICITY	The elemental abundances of O, Ne, Mg, Si, S, Ca, Ar, and Fe for four clusters of galaxies (Abell 496, 1060, 2199, and AWM 7) are determined from X-ray spectra derived from Advanced Satellite for Cosmology and Astrophysics performance verification phase observations. Since the gas in the outer parts of the cluster is optically thin and virtually isothermal, the abundance analysis is very straightforward compared to the analysis of stellar or H II region spectra. We find that the abundance ratios of all four clusters are very similar. The mean abundances of O, Ne, Si, S, and Fe are 0.48, 0.62, 0.65, 0.25, and 0.32, respectively, relative to solar. The abundances of Si, S, and Fe are unaffected by the uncertainties in the atomic physics of the Fe L shell. The abundances of Ne and Mg and to a lesser extent O are affected by the present uncertainties in Fe L physics and are thus somewhat more uncertain. The Fe abundances derived from the Fe L lines agree well with those derived from the Fe K lines for these clusters. The observed ratio of the relative abundance of elements is consistent with an origin of all the metals in Type II supernovae. The presence of large numbers of Type II supernovae during the early stages of evolution of cluster galaxies is a very strong constraint on all models of galaxy and chemical evolution and implies either a very flat initial mass function or bimodal star formation during the period when most of the metals were created.	UNIV TOKYO,DEPT PHYS,BUNKYO KU,TOKYO 113,JAPAN; TOKYO METROPOLITAN UNIV,DEPT PHYS,HACHIOJI,TOKYO 19202,JAPAN; MIYAZAKI UNIV,FAC ENGN,MIYAZAKI 88912,JAPAN; UNIV SPACE RES ASSOC,WASHINGTON,DC; UNIV MARYLAND,COLLEGE PK,MD 20742	Mushotzky, R (reprint author), NASA,GODDARD SPACE FLIGHT CTR,CODE 666,GREENBELT,MD 20771, USA.		Kikuchi, Kenichi/H-3382-2011; Tamura, Takayuki/K-8236-2012	Kikuchi, Kenichi/0000-0002-2088-0717; 			WOOSLEY SE, 1986, ANNU REV ASTRON ASTR, V24, P205, DOI 10.1146/annurev.astro.24.1.205; MATTEUCCI F, 1989, MON NOT R ASTRON SOC, V239, P885; TANAKA Y, 1994, PUBL ASTRON SOC JPN, V46, pL37; CIOTTI L, 1991, ASTROPHYS J, V376, P380, DOI 10.1086/170289; Thielemann FK, 1996, ASTROPHYS J, V460, P408, DOI 10.1086/176980; RAYMOND JC, 1977, ASTROPHYS J SUPPL S, V35, P419, DOI 10.1086/190486; NOMOTO K, 1984, ASTROPHYS J, V286, P644, DOI 10.1086/162639; RUSSELL SC, 1992, ASTROPHYS J, V384, P508, DOI 10.1086/170893; Singh KP, 1996, ASTROPHYS J, V456, P766, DOI 10.1086/176695; WORTHEY G, 1992, ASTROPHYS J, V398, P69, DOI 10.1086/171836; LIEDAHL DA, 1995, ASTROPHYS J, V438, pL115, DOI 10.1086/187729; LUCK RE, 1992, ASTROPHYS J SUPPL S, V79, P303, DOI 10.1086/191655; ANTUNES A, 1994, ASTROPHYS J, V436, pL83, DOI 10.1086/187638; ARNAUD K, 1994, HEAD NAP VALL M; ARNAUD K, 1986, THESIS CAMBRIDGE U; ARNAUD M, 1992, ASTRON ASTROPHYS, V254, P49; ARNAUD M, 1995, CLUSTERS GALAXIES, P211; AWAKI H, 1994, PUBL ASTRON SOC JPN, V46, pL65; BORKOWSKI K, 1995, COMMUNICATION; CANIZARES CR, 1982, ASTROPHYS J, V262, P33, DOI 10.1086/160393; DAVID L, 1991, APJ, V359, P29; DAVID LP, 1995, PREPRINT; DOPITA MA, 1991, P ASTRON SOC AUST, V9, P234; ELBAZ D, 1995, ASTRON ASTROPHYS, V303, P345; FABIAN AC, 1994, ASTROPHYS J, V436, pL63, DOI 10.1086/187633; FRANCESCHINI A, 1994, ASTROPHYS J, V427, P140, DOI 10.1086/174127; GRATTON RG, 1986, ASTRON ASTROPHYS, V169, P201; GRENDREAU K, 1995, PASJ, V47, P5; HATSUKADE I, 1995, 11 INT C UV XRAY SPE; HATSUKADE I, 1989, THESIS OSAKA U; HENRIKSEN MJ, 1985, ASTROPHYS J, V292, P441, DOI 10.1086/163172; HENRY RBC, 1992, MON NOT R ASTRON SOC, V258, P321; HILL RJ, 1994, ASTROPHYS J, V429, P204, DOI 10.1086/174312; HU E, 1985, APJS, V59, P44; HUGHES JP, 1993, ASTROPHYS J, V404, P611, DOI 10.1086/172314; KAASTRA J, 1995, COMMUNICATION; Loewenstein M, 1996, ASTROPHYS J, V466, P695, DOI 10.1086/177542; LOEWENSTEIN M, 1991, ASTROPHYS J, V373, P445, DOI 10.1086/170063; LOEWENSTEIN M, 1994, ASTROPHYS J, V436, pL75, DOI 10.1086/187636; MATHEWS WG, 1989, ASTRON J, V97, P42, DOI 10.1086/114955; MEWE R, 1992, INTERNAL SRON LEIDEN; MITCHELL R, 1975, MNRAS, V175, P29; MUSHOTZKY R, 1995, NEW HORIZON XRAY AST, P243; MUSHOTZKY RF, 1981, ASTROPHYS J, V244, pL47, DOI 10.1086/183477; MUSHOTZKY RF, 1984, PHYS SCRIPTA, VT7, P157, DOI 10.1088/0031-8949/1984/T7/036; MUSHOTZKY RF, 1994, ASTROPHYS J, V436, pL79, DOI 10.1086/187637; MUSHOTZKY RF, 1978, ASTROPHYS J, V225, P21, DOI 10.1086/156465; OHASHI T, 1995, NEW HORIZON XRAY AST, P234; PACHECO JAD, 1993, ASTROPHYS J, V403, P673; RENZINI A, 1993, ASTROPHYS J, V419, P52, DOI 10.1086/173458; ROTHENFLUG R, 1984, ASTROPHYS J, V279, P53, DOI 10.1086/161864; SERLEMITSOS P, 1976, APJ, V211, pL63; SERLEMITSOS PJ, 1993, ASTROPHYS J, V413, P518, DOI 10.1086/173021; TIMMES FX, 1995, ASTROPHYS J SUPPL S, V98, P617, DOI 10.1086/192172; TSURU T, 1993, THESIS U TOKYO; WHITE DA, 1995, MON NOT R ASTRON SOC, V273, P72; WHITE RE, 1994, ASTROPHYS J, V433, P583, DOI 10.1086/174669; Yamashita K., 1992, FRONTIERS XRAY ASTRO, P475	58	166	166	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0004-637X			ASTROPHYS J	Astrophys. J.	AUG 1	1996	466	2	1				686	694		10.1086/177541		9	Astronomy & Astrophysics	Astronomy & Astrophysics	UZ546	WOS:A1996UZ54600007		
J	Keating, TJ; Fukami, K; Robinson, KR				Keating, TJ; Fukami, K; Robinson, KR			Inhibition of protein synthesis in frog (Xenopus laevis) egg extracts by an antibody against phosphatidylinositol 4,5-bisphosphate	BIOCHEMICAL JOURNAL			English	Article							CELL-CYCLE; INOSITOL TRISPHOSPHATE	The antibody kt10, which is directed against the phospholipid PtdIns(4,5)P-2, inhibits protein synthesis when added to cytosolic extracts prepared from frog eggs. Addition of stable analogues of diacylglycerol and Ins(1,4,5)P-3 failed to rescue the inhibition of translation, suggesting that the effect of the antibody was not to block hydrolysis of PtdIns(4,5)P-3. Neomycin, which also binds PtdIns(4,5)P-2, produced a similar reduction in protein-synthesis levels in the extract system, supporting the idea that it is the interaction of the antibody with PtdIns(4,5)P-2 that is producing the effect.	PURDUE UNIV,DEPT BIOL SCI,W LAFAYETTE,IN 47907; UNIV TOKYO,INST MED SCI,DEPT MOL ONCOL,MINATO KU,TOKYO 108,JAPAN							DIVECHA N, 1993, CELL, V74, P405, DOI 10.1016/0092-8674(93)80041-C; HAN JK, 1992, J CELL BIOL, V116, P147, DOI 10.1083/jcb.116.1.147; HARLAN JE, 1994, NATURE, V371, P168, DOI 10.1038/371168a0; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; MURRAY AW, 1989, NATURE, V339, P275, DOI 10.1038/339275a0; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; DIVECHA N, 1995, CELL, V80, P269, DOI 10.1016/0092-8674(95)90409-3; BLOW JJ, 1986, CELL, V47, P577, DOI 10.1016/0092-8674(86)90622-7; BAUDET S, 1994, METHOD CELL BIOL, V40, P93; CARNEY DH, 1985, CELL, V42, P749; FUKAMI K, 1988, P NATL ACAD SCI USA, V85, P9057, DOI 10.1073/pnas.85.23.9057; FUKAMI K, 1992, NATURE, V359, P150, DOI 10.1038/359150a0; GARCIN D, 1990, EUR J BIOCHEM, V194, P279, DOI 10.1111/j.1432-1033.1990.tb19454.x; Harlow E.D., 1988, ANTIBODIES LAB MANUA; JAMNEY PA, 1994, ANNU REV PHYSIOL, V56, P169; KANKI JP, 1991, DEV BIOL, V146, P198, DOI 10.1016/0012-1606(91)90460-K; NIGGLI V, 1993, NATURE, V361, P214, DOI 10.1038/361214b0; SULLIVAN KMC, 1993, CELL, V73, P1411, DOI 10.1016/0092-8674(93)90366-X; YAO Y, 1993, J PHYSIOL-LONDON, V468, P275	19	1	1	PORTLAND PRESS	LONDON	59 PORTLAND PLACE, LONDON, ENGLAND W1N 3AJ	0264-6021			BIOCHEM J	Biochem. J.	AUG 1	1996	317		3				643	646				4	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	VC348	WOS:A1996VC34800002		
J	Yokoyama, H; Niwa, S; Itoh, K; Mazuka, R				Yokoyama, H; Niwa, S; Itoh, K; Mazuka, R			Fractal property of eye movements in schizophrenia	BIOLOGICAL CYBERNETICS			English	Article								On the basis of a temporal model of animal behavior we conducted temporal analysis of eye movements in schizophrenic subjects (n = 10) and normal controls (n = 10). We found a fractal property in schizophrenic subjects, the fixation time of eye movement during reading ambiguous and difficult sentences showing a clear inverse power law distribution. An exponential distribution of a nonfractal nature was found in normal controls.	UNIV TOKYO,SCH MED,RES INST LOGOPED & PHOMIATR,TOKYO 113,JAPAN; DUKE UNIV,DEPT PSYCHOL,DURHAM,NC 27706	Yokoyama, H (reprint author), FUKUSHIMA MED COLL,DEPT NEUROPSYCHIAT,1 HIKARIGAOKA,FUKUSHIMA 96012,JAPAN.						Anderson NC, 1982, AM J PSYCHIAT, V139, P297; ANGRIST B, 1974, AM J PSYCHIAT, V131, P817; SHLESINGER MF, 1981, PHYSICA A, V109, P597, DOI 10.1016/0378-4371(81)90015-7; SHIMADA I, 1993, BIOL CYBERN, V68, P477, DOI 10.1007/BF00200806; Frith C. D., 1992, COGNITIVE NEUROPSYCH; Seidman LJ, 1992, CLIN SYNDROMES ADULT, P381; SONOBE N, 1993, INT J PSYCHOPHYSIOL, V15, P73, DOI 10.1016/0167-8760(93)90098-A; WEST BJ, 1990, FRACTAL PHYSL CHAOS, P67	8	5	6	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010	0340-1200			BIOL CYBERN	Biol. Cybern.	AUG	1996	75	2					137	140		10.1007/s004220050281		4	Computer Science, Cybernetics; Neurosciences	Computer Science; Neurosciences & Neurology	VH418	WOS:A1996VH41800005		
J	Sekizawa, Y; Ohta, N; Natori, S; Kobayashi, H				Sekizawa, Y; Ohta, N; Natori, S; Kobayashi, H			Immunocytochemical localization of lysenin, a novel protein isolated from the coelomic fluid of the earthworm Eisenia foetida	BIOMEDICAL RESEARCH-TOKYO			English	Article							CELOMIC FLUID; NERVOUS-SYSTEM	Lysenin is a novel protein that was purified from the coelomic fluid of the earthworm Eisenia foetida (Lumbricidae), and it causes contraction of the rat aorta (12). The distribution of this protein was examined immunocytochemically in this species and in the earthworm Pheretima communissima (Megascolecidae) with an antiserum raised in rabbit against lysenin. A positive immunoreaction was detected only in the large coelomocytes of E. foetida. In P. communissima, no immunoreaction was detected in any tissues including coelomocytes. Thus, lysenin seems to be synthesized and stored specifically in the large coelomocytes of E. foetida.	UNIV TOKYO,FAC PHARMACEUT SCI,BUNKYO KU,TOKYO 113,JAPAN	Sekizawa, Y (reprint author), ZENYAKU KOGYO CO LTD,RES LAB,NERIMA KU,TOKYO 178,JAPAN.						CARRAWAY R, 1982, PEPTIDES, V3, P115, DOI 10.1016/0196-9781(82)90038-9; Cooper Edwin L., 1995, Animal Biology, V4, P25; FUJII K, 1989, ZOOL SCI, V6, P951; HASEGAWA K, 1991, GEN COMP ENDOCR, V81, P433, DOI 10.1016/0016-6480(91)90171-2; KINOSHITA K, 1986, J MORPHOL, V187, P343, DOI 10.1002/jmor.1051870306; LASSALLE F, 1988, COMP BIOCHEM PHYS B, V91, P187, DOI 10.1016/0305-0491(88)90133-2; OHTA N, 1996, IN PRESS FRONTIERS E; OUMI T, 1994, BIOCHEM BIOPH RES CO, V198, P393, DOI 10.1006/bbrc.1994.1055; PORCHET M, 1988, NEUROHORMONES INVERT, P219, DOI 10.1017/CBO9780511752230.013; ROCH P, 1984, J CHROMATOGR, V290, P231, DOI 10.1016/S0021-9673(01)93578-2; ROCH P, 1981, COMP BIOCHEM PHYS B, V69, P829, DOI 10.1016/0305-0491(81)90390-4; Sekizawa Y, 1996, BIOMED RES-TOKYO, V17, P197; UKENA K, 1995, PEPTIDES, V16, P995, DOI 10.1016/0196-9781(95)00071-Q	13	5	5	BIOMED RES FOUND	TOKYO	KANDA PO BOX 182 CHIYODAKU, TOKYO 101-91, JAPAN	0388-6107			BIOMED RES-TOKYO	Biomed. Res.	AUG	1996	17	4					327	330				4	Medicine, Research & Experimental	Research & Experimental Medicine	VG331	WOS:A1996VG33100009		
J	Komai, T; Higashida, S; Sakurai, M; Nitta, T; Kasuya, A; Miyamaoto, S; Yagi, R; Ozawa, Y; Handa, H; Mohri, H; Yasuoka, A; Oka, S; Nishigaki, T; Kimura, S; Shimada, K; Yabe, Y				Komai, T; Higashida, S; Sakurai, M; Nitta, T; Kasuya, A; Miyamaoto, S; Yagi, R; Ozawa, Y; Handa, H; Mohri, H; Yasuoka, A; Oka, S; Nishigaki, T; Kimura, S; Shimada, K; Yabe, Y			Structure-activity relationships of HIV-1 PR inhibitors containing AHPBA .2. Modification of pyrrolidine ring at P1' proline	BIOORGANIC & MEDICINAL CHEMISTRY			English	Article							PROTEASE; DESIGN; AIDS	Systematic replacement in the 3- or 4-position of the pyrrolidine ring at P1' proline was carried out. Compound 26, which has a C1 atom in the 4(S)-position was the most active among inhibitors substituted with other halogen atoms or other substituents. Furthermore, the replacement of the Z group in compound 26 with five- or six-membered fused aromatic heterocycle carbonyl groups produced more potent inhibitors. 7-Methoxybenzofuran-2-carbonyl derivative (44) was the best of these and showed K-i = 4.5 nM against HIV PR and IC(50)s 0.58 mu M and 0.06 mu M in chronic and acute infections, respectively. These results suggest that the combination of the 4(S)-Cl atom and fused bicyclic heterocycles may be effective in improving their cellular penetration. Copyright (C) 1996 Elsevier Science Ltd	SANKYO CO LTD,BIOL RES LABS,SHINAGAWA KU,TOKYO 140,JAPAN; SANKYO CO LTD,EXPLORATORY CHEM RES LAB,SHINAGAWA KU,TOKYO 140,JAPAN; TOKYO INST TECHNOL,FAC BIOSCI & BIOTECHNOL,MIDORI KU,YOKOHAMA,KANAGAWA 227,JAPAN; UNIV TOKYO,INST MED SCI,MINATO KU,TOKYO 108,JAPAN							KOHL NE, 1988, P NATL ACAD SCI USA, V85, P4686, DOI 10.1073/pnas.85.13.4686; MILLER M, 1989, SCIENCE, V246, P1149, DOI 10.1126/science.2686029; DEBOUCK C, 1992, AIDS RES HUM RETROV, V8, P153, DOI 10.1089/aid.1992.8.153; MITSUYA H, 1990, SCIENCE, V249, P1533, DOI 10.1126/science.1699273; Sakurai M, 1994, Bioorg Med Chem, V2, P807, DOI 10.1016/S0968-0896(00)82181-1; BERNSTEIN FC, 1987, CRYSTALLOGRAPHIC DAT, P107; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; EWING WR, 1988, HETEROCYCLES, V27, P2843; HO DD, 1989, NEW ENGL J MED, V321, P1621, DOI 10.1056/NEJM198912143212401; KOMAI T, UNPUB J ANTIBIOT; KRAMER RA, 1986, SCIENCE, V231, P1580, DOI 10.1126/science.2420008; MARTIN JA, 1992, ANTIVIR RES, V17, P265, DOI 10.1016/0166-3542(92)90022-W; MIMOTO T, 1992, PEPTIDE CHEM 1991, P305; MIMOTO T, 1992, CHEM PHARM BULL, V40, P2251; RICH DH, 1985, J MED CHEM, V28, P263, DOI 10.1021/jm00381a001; RICH DH, 1986, PROTEINASE INHIBITOR, P179; WEST ML, 1995, TRENDS PHARMACOL SCI, V16, P67, DOI 10.1016/S0165-6147(00)88980-4; WLODAWER A, 1993, ANNU REV BIOCHEM, V62, P543, DOI 10.1146/annurev.bi.62.070193.002551	18	15	16	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB	0968-0896			BIOORGAN MED CHEM	Bioorg. Med. Chem.	AUG	1996	4	8					1365	1377		10.1016/0968-0896(96)00130-7		13	Biochemistry & Molecular Biology; Chemistry, Medicinal; Chemistry, Organic	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Chemistry	VG136	WOS:A1996VG13600024		
J	Tanabe, S; Arai, S; Watanabe, M				Tanabe, S; Arai, S; Watanabe, M			Modification of wheat flour with bromelain and baking hypoallergenic bread with added ingredients	BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY			English	Article						hypoallergenic flour; hypoallergenic bread; allergy; bromelain; wheat	PROTEINS	Based on the wheat glutenin IgE-binding epitope, Gln-Gln-Gln-Pro-Pro, a practical method is proposed for the production of hypoallergenic wheat flour. Bromelain was found effective for decomposing the epitope structure. In practice, soft flour was mixed with water dissolving bromelain and the mixture was incubated at 37 degrees C for 4h. The result of IgE-ELISA (enzyme-linked immunosorbent assay) suggested negative allergenicity. A mixture of bromelain-modified flour, glucose, citric acid, a surfactant and sodium hydrogen carbonate was baked to produce hypoallergenic bread, resembling English muffins.	UNIV TOKYO, DIV AGR & AGRICULTURAL LIFE SCI, DEPT APPL BIOL CHEM, BUNKYO KU, TOKYO 113, JAPAN	Tanabe, S (reprint author), TOKYO GAKUGEI UNIV, FOOD SCI LAB, FAC EDUC, KOGANEI, TOKYO 184, JAPAN.						*AM ASS CER CHEM, 1983, APPR METH AACC, P10; Tanabe S, 1996, BIOCHEM BIOPH RES CO, V219, P290, DOI 10.1006/bbrc.1996.0225; VANWART HE, 1981, ANAL BIOCHEM, V113, P356, DOI 10.1016/0003-2697(81)90089-0; WALSH BJ, 1989, J IMMUNOL METHODS, V121, P275, DOI 10.1016/0022-1759(89)90171-3; WATANABE M, 1994, BIOSCI BIOTECH BIOCH, V58, P388; FISHER RA, 1958, STAT METHODS RES WOR, P122; GOMEZ L, 1990, FEBS LETT, V261, P85, DOI 10.1016/0014-5793(90)80642-V; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LUCHSINGER WW, 1962, ANAL BIOCHEM, V4, P346, DOI 10.1016/0003-2697(62)90098-2; YOSHIDA ETUSUKO, 1965, BIOCHIM BIOPHYSACTA, V105, P562; WATANABE M, 1995, BIOSCI BIOTECH BIOCH, V59, P1596; WATANABE M, 1994, BIOSCI BIOTECH BIOCH, V58, P2061	12	40	42	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0916-8451	1347-6947		BIOSCI BIOTECH BIOCH	Biosci. Biotechnol. Biochem.	AUG	1996	60	8					1269	1272				4	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Chemistry, Applied; Food Science & Technology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Chemistry; Food Science & Technology	VE149	WOS:A1996VE14900011		
J	Hashimoto, Y; Kobayashi, E; Endo, T; Nishiyama, M; Horinouchi, S				Hashimoto, Y; Kobayashi, E; Endo, T; Nishiyama, M; Horinouchi, S			Conversion of a cyanhydrin compound into S-(-)-3-phenyllactic acid by enantioselective hydrolytic activity of Pseudomonas sp BC-18	BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY			English	Article						(S)-3-phenyllactic acid; cyanhydrin; Pseudomonas; enantioselective hydrolysis	ALCALIGENES-FAECALIS ATCC-8750; RHODOCOCCUS-RHODOCHROUS J1; NITRILE HYDRATASE GENE; EXPRESSION; MANDELONITRILE; IDENTIFICATION; ACRYLAMIDE; RESIDUE	A Pseudomonas strain, named BC-18, which can convert racemic phenylacetaldehyde-cyanhydrin (3-phenyllactonitrile) enantioselectively to S-(-)3-phenyllactic acid (S-PLA), was isolated from soil. Although PLA produced with intact cells contained the S enantiomers of approximately 75% enantiomeric excess (% e.e.), repeated crystallization gave a higher purity (99.8% e.e.) of the S configuration product. Production of S-PLA was significantly increased when 2.0% (w/v) of calcium chloride were added to the reaction mixture for precipitation of S-PLA. Chemical mutagenesis yielded a mutant strain, named BC348-9, with 16 times higher activity (40 mU/OD630), compared with that of the parent strain (2.5 mU/OD630), When the mutant strain BC348-9 was used, approximately 18 g/OD630 was produced, which is 12 times higher than that of the parent strain. The final accumulation of PLA exceeded 6.0%, 1.2 times higher than that of the parent strain.	NITTO CHEM IND CO LTD, CENT RES LAB, TSURUMI KU, YOKOHAMA, KANAGAWA 230, JAPAN; UNIV TOKYO, BIOTECHNOL RES CTR, BUNKYO KU, TOKYO 113, JAPAN; UNIV TOKYO, DEPT BIOTECHNOL, BUNKYO KU, TOKYO 113, JAPAN							KOBAYASHI M, 1994, FEMS MICROBIOL LETT, V120, P217, DOI 10.1111/j.1574-6968.1994.tb07036.x; KOBAYASHI M, 1993, P NATL ACAD SCI USA, V90, P247, DOI 10.1073/pnas.90.1.247; YAMAMOTO K, 1991, APPL ENVIRON MICROB, V57, P3028; BUDT KH, 1991, Patent No. 4030350; CHOI S Y, 1986, Archives of Pharmacal Research (Seoul), V9, P45, DOI 10.1007/BF02857706; Endo T., 1994, US Patent, Patent No. [5296373, 5326702]; HASHIMOTO Y, 1994, Patent No. 284899; HASHIMOTO Y, 1992, J GEN MICROBIOL, V138, P1003; HASHIMOTO Y, 1994, BIOSCI BIOTECH BIOCH, V58, P1859; HEMMI K, 1990, Patent No. 4921855; KANO S, 1988, J ORG CHEM, V53, P3865, DOI 10.1021/jo00251a042; KOBAYASHI M, 1992, J BIOL CHEM, V267, P20746; KOBAYASHI M, 1992, BIOCHEMISTRY-US, V31, P9000, DOI 10.1021/bi00152a042; LAYH N, 1992, ARCH MICROBIOL, V158, P405; NAGASAWA T, 1993, APPL MICROBIOL BIOT, V40, P189; NAGASAWA T, 1989, TRENDS BIOTECHNOL, V7, P153, DOI 10.1016/0167-7799(89)90026-7; RYUNO K, 1988, AGR BIOL CHEM TOKYO, V52, P1813; URBAN FJ, 1992, J HETEROCYCLIC CHEM, V29, P431; YAMAMOTO K, 1992, J FERMENT BIOENG, V73, P425, DOI 10.1016/0922-338X(92)90131-D; YAMAMOTO K, 1990, APPL ENVIRON MICROB, V56, P3125; YOSHIDA N, 1994, J FERMENT BIOENG, V77, P636, DOI 10.1016/0922-338X(94)90146-5	21	15	18	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0916-8451	1347-6947		BIOSCI BIOTECH BIOCH	Biosci. Biotechnol. Biochem.	AUG	1996	60	8					1279	1283				5	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Chemistry, Applied; Food Science & Technology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Chemistry; Food Science & Technology	VE149	WOS:A1996VE14900013		
J	Qiu, Y; Nakahara, Y; Ogawa, T				Qiu, Y; Nakahara, Y; Ogawa, T			Design and synthesis of gentiohexaosyl derivatives for an ANP receptor antagonist, HS-142-1	BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY			English	Article						gentiohexaose; beta 1->6-glycosylation; ANP antagonist; HS-142-1	CARBOHYDRATE-CHEMISTRY; GLYCOSYLATION; ALLYL	A hexaosyl fragment of the major component of lipooligosaccharide HS-142-1, O-(3-O-caproyl-beta-D-glncopyranosyl)-(1 --> 6)-[O-(beta-D-glucopyranosyl)-(1 --> 6)-O-(3-O-caproyl-beta-D-glucopyranosyl)-(1 --> 6)](2)-D-glucopyranose (1), was efficiently synthesized by block synthesis. More stable analogs, O-(3-O-hexyl-beta-D-glucopyranosyl)-(1 --> 6)-[O-(beta-D-glucopyranosyl)-(1 --> 6)-O-(3-O-hexyl-beta-D-glucopyranosyl)-(1 --> 6)](2)-D-glucopyranose (4) and O-(3-O-caproyl-2,4,6-tri-O-methyl-beta-D-glucopyranosyl)-(1 --> 6)-[O-(2,3,4-tri-O-methyl-beta-D-glucopyranosyl)-(1 --> 6)-O-(3-O-caproyl-2,4-di-O-methyl-beta-D-glucopyranosyl)-(1 --> 6)](2)-2,3,3-tri-O-methyl-D-glucopyranose (2), were also designed and synthesized in a similar manner.	UNIV TOKYO, GRAD SCH AGR & LIFE SCI, BUNKYO KU, TOKYO 113, JAPAN; RIKEN, WAKO, SAITAMA 35101, JAPAN			Ogawa, Tomoya/C-3655-2009				VANBOECKEL CAA, 1993, ANGEW CHEM INT EDIT, V32, P1671, DOI 10.1002/anie.199316713; JANSSON K, 1988, J ORG CHEM, V53, P5629, DOI 10.1021/jo00259a006; DOUGLAS SP, 1993, J CARBOHYD CHEM, V12, P131, DOI 10.1080/07328309308018547; GAREGG PJ, 1979, ACTA CHEM SCAND B, V33, P116, DOI 10.3891/acta.chem.scand.33b-0116; GIGG R, 1982, CARBOHYD RES, V100, pC5, DOI 10.1016/S0008-6215(00)81058-7; HOLST O, 1995, ANGEW CHEM INT EDIT, V34, P2000, DOI 10.1002/anie.199520001; KOENERS HJ, 1981, RECL TRAV CHIM PAY B, V100, P65; KUYAMA H, 1995, CARBOHYD RES, V268, pC1, DOI 10.1016/0008-6215(94)00372-M; MATSUDA Y, 1993, CARDIOVASC DRUG REV, V11, P45, DOI 10.1111/j.1527-3466.1993.tb00266.x; Qiu Y, 1996, BIOSCI BIOTECH BIOCH, V60, P986; SAITOH Y, COMMUNICATION; SLAGHEK TM, 1989, CARBOHYD RES, V195, P75, DOI 10.1016/0008-6215(89)85090-6; OLTVOORT JJ, 1981, SYNTHESIS-STUTTGART, P305	13	1	1	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0916-8451	1347-6947		BIOSCI BIOTECH BIOCH	Biosci. Biotechnol. Biochem.	AUG	1996	60	8					1308	1316				9	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Chemistry, Applied; Food Science & Technology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Chemistry; Food Science & Technology	VE149	WOS:A1996VE14900019		
J	Ihara, S; Nishikawa, T; Kimura, K; Fujiyoshi, T; Shirai, T; Komi, A; Kanda, H; Yamori, T; Fukui, Y				Ihara, S; Nishikawa, T; Kimura, K; Fujiyoshi, T; Shirai, T; Komi, A; Kanda, H; Yamori, T; Fukui, Y			A novel differentiation factor for PC12 cells from culture supernatant of mouse hepatocyte cell line MLE-15A2	BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY			English	Article						PC12 cells; differentiation factor; signal transduction; neurite	NERVE GROWTH-FACTOR; MAP KINASE KINASE; PHOSPHATIDYLINOSITOL 3-KINASE; NEURONAL DIFFERENTIATION; NEURITE OUTGROWTH; PHEOCHROMOCYTOMA CELLS; NEUROTROPHIC FACTOR; DEVELOPING AXONS; ACTIVATION; GUIDANCE	We have found a factor that induces neurite outgrowth of rat PC12 cells in the culture supernatant of the cell line MLE-15A2. This factor was designated as MDDF. The factor was sensitive to protease, dithiothreitol, and high-temperature treatments. The apparent molecular mass was 80 kDa on Superdex 200 gel filtration. No significant tyrosine phosphorylation was detected after MDDF stimulation in Western blotting analysis with anti-phosphotyrosine antibody, suggesting that the signal transduction may not be mediated by a tyrosine kinase cascade that is involved in signaling of most of the known factors. Activation of MAP kinase was very weak and was seen only 5 min after stimulation, suggesting that prolonged activation of MAP kinase was not required for neurite outgrowth induced by MDDF. Because the biochemical characteristics of MDDF are different from those of any known peptide factors that induce neurite outgrowth of PC12 cells, MDDF may be a novel differentiation factor for PC12 cells.	JAPANESE FDN CANC RES, CTR CANC CHEMOTHERAPY, TOSHIMA KU, TOKYO 170, JAPAN	Ihara, S (reprint author), UNIV TOKYO, DEPT AGR & LIFE SCI, BUNKYO KU, 1-1-1 YAYOI, TOKYO 113, JAPAN.		Fukui, Yasuhisa/E-8806-2010				PARALKAR VM, 1992, J CELL BIOL, V119, P1721, DOI 10.1083/jcb.119.6.1721; KEYNES R, 1995, CELL, V83, P161, DOI 10.1016/0092-8674(95)90157-4; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; SCHNELL L, 1994, NATURE, V367, P170, DOI 10.1038/367170a0; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; TRAVERSE S, 1992, BIOCHEM J, V288, P351; PANG L, 1995, J BIOL CHEM, V270, P13585; MARK MD, 1995, J CELL BIOL, V130, P701, DOI 10.1083/jcb.130.3.701; AIGNER L, 1995, CELL, V83, P269, DOI 10.1016/0092-8674(95)90168-X; NGUYEN TT, 1993, J BIOL CHEM, V268, P9803; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; RYDEL RE, 1987, J NEUROSCI, V7, P3639; BARDE YA, 1989, NEURON, V2, P1525, DOI 10.1016/0896-6273(89)90040-8; Kennedy Timothy E., 1995, Current Opinion in Neurobiology, V5, P83, DOI 10.1016/0959-4388(95)80091-3; GOTOH Y, 1990, EUR J BIOCHEM, V193, P661, DOI 10.1111/j.1432-1033.1990.tb19384.x; CARTER AN, 1992, J BIOL CHEM, V267, P14563; HEASLEY LE, 1992, MOL BIOL CELL, V3, P545; HEFFNER CD, 1990, SCIENCE, V247, P217, DOI 10.1126/science.2294603; HOYLE GW, 1993, NEURON, V10, P1019, DOI 10.1016/0896-6273(93)90051-R; HUFF K, 1981, J CELL BIOL, V88, P189, DOI 10.1083/jcb.88.1.189; KIM UH, 1991, J BIOL CHEM, V266, P1359; KIMURA K, 1994, J BIOL CHEM, V269, P18961; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LUMSDEN AGS, 1983, NATURE, V306, P786, DOI 10.1038/306786a0; LUMSDEN AGS, 1986, NATURE, V323, P538, DOI 10.1038/323538a0; Menesini Chen M G, 1978, Arch Ital Biol, V116, P53; MUROYA K, 1992, ONCOGENE, V7, P277; OKUMURA N, 1994, J BIOCHEM-TOKYO, V115, P304; Qui MS, 1991, NEURON, V7, P937, DOI 10.1016/0896-6273(91)90339-2; ROSENTHAL A, 1990, NEURON, V4, P767, DOI 10.1016/0896-6273(90)90203-R; SATOH T, 1988, MOL CELL BIOL, V8, P3546; SKENE JHP, 1989, ANNU REV NEUROSCI, V12, P127, DOI 10.1146/annurev.neuro.12.1.127; SOLTOFF SP, 1992, J BIOL CHEM, V267, P17472; TESSIERLAVIGNE M, 1988, NATURE, V336, P775, DOI 10.1038/336775a0; TOGARI A, 1985, J NEUROSCI, V5, P307; XING P, 1995, NEURON, V15, P395; Yamori T, 1996, JPN J CANCER RES, V87, P146	38	1	1	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0916-8451	1347-6947		BIOSCI BIOTECH BIOCH	Biosci. Biotechnol. Biochem.	AUG	1996	60	8					1339	1345				7	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Chemistry, Applied; Food Science & Technology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Chemistry; Food Science & Technology	VE149	WOS:A1996VE14900024		
J	Oyama, T; Myojin, M; Nitta, Y; Toda, H; Nagashima, T; Kitamoto, K				Oyama, T; Myojin, M; Nitta, Y; Toda, H; Nagashima, T; Kitamoto, K			Property of taka-amylase A with Glu or Asp of the catalytic residue replaced by the corresponding amine	BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY			English	Article						site-directed mutagenesis; catalytic residue; Taka-amylase A; difference spectrum	SITE-DIRECTED MUTAGENESIS; SEQUENCE	Compared with the enzyme activity of a recombinant Taka-amylase A (wild TAA) at 25 degrees C and pH 5.3, those of two mutants (E230Q and D297N) were 1/10,000 and 1/16,000 for amylase activity, and 1/920 and less than 1/20,000 for maltosidase activity, respectively. This indicates that all residual activities of E230Q are not due to contamination by wild-type TAA. The results from difference spectroscopy suggested that E230Q retains amylose binding ability.	UNIV OSAKA PREFECTURE, COLL AGR, BIOPHYS CHEM LAB, SAKAI, OSAKA 593, JAPAN; OSAKA UNIV, INST PROT RES, SUITA, OSAKA 565, JAPAN; SHIN NIHON CHEM CO LTD, ANJO 446, JAPAN; UNIV TOKYO, DEPT BIOTECHNOL, BUNKYO KU, TOKYO 113, JAPAN							PARK JT, 1949, J BIOL CHEM, V181, P149; MATSUURA Y, 1984, J BIOCHEM-TOKYO, V95, P697; Folin O, 1927, J BIOL CHEM, V73, P627; HIROMI K, 1963, B CHEM SOC JPN, V36, P563, DOI 10.1246/bcsj.36.563; KITA Y, 1982, J BIOCHEM-TOKYO, V92, P1499; KUNIKATA T, 1978, J BIOCHEM-TOKYO, V83, P1435; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MATSUBARA S, 1959, J BIOCHEM-TOKYO, V46, P425; MATSUURA Y, 1991, DENPUN KAGAKU, V38, P137; NAGASHIMA T, 1992, BIOSCI BIOTECH BIOCH, V56, P207; TADA S, 1989, AGR BIOL CHEM TOKYO, V53, P593; TAKASE K, 1992, BIOCHIM BIOPHYS ACTA, V1120, P281, DOI 10.1016/0167-4838(92)90249-D; TODA H, 1982, P JPN ACAD B-PHYS, V58, P208, DOI 10.2183/pjab.58.208	13	2	2	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0916-8451	1347-6947		BIOSCI BIOTECH BIOCH	Biosci. Biotechnol. Biochem.	AUG	1996	60	8					1351	1352				2	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Chemistry, Applied; Food Science & Technology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Chemistry; Food Science & Technology	VE149	WOS:A1996VE14900027		
J	Irie, K; Nakamura, Y; Ohigashi, H; Tokuyama, H; Yamago, S; Nakamura, E				Irie, K; Nakamura, Y; Ohigashi, H; Tokuyama, H; Yamago, S; Nakamura, E			Photocytotoxicity of water-soluble fullerene derivatives	BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY			English	Article						fullerene; pheophorbide a; photocytotoxicity; photodynamic therapy; porphyrin	PHOTOPHYSICAL PROPERTIES; PHOTODYNAMIC THERAPY; PHOTOTHERAPY	New water-soluble fullerene carboxylic acids (1 and 2) derived from C-60 and C-70 fullerenes, respectively, were examined for photocytotoxicity toward Raji cells (B lymphocyte). These compounds did not show any photocytotoxic effect even at 50 mu M, while pheophorbide alpha showed significant photocytotoxicity at 0.5 mu M. Therefore, fullerene derivatives derived from C-60 and C-70 would not be practical agents for photodynamic therapy.	UNIV TOKYO, FAC PHARMACEUT SCI, BUNKYO KU, TOKYO 113, JAPAN; KYOTO UNIV, DEPT SYNTHET CHEM & BIOL CHEM, KYOTO 606, JAPAN; UNIV TOKYO, SCH SCI, DEPT CHEM, BUNKYO KU, TOKYO 113, JAPAN	Irie, K (reprint author), KYOTO UNIV, FAC AGR, DEPT FOOD SCI & TECHNOL, SAKYO KU, KYOTO 606, JAPAN.		NAKAMURA, EIICHI/G-5041-2014; Irie, Kazuhiro/A-6121-2014	Irie, Kazuhiro/0000-0001-7109-8568			ANDO T, 1991, TETRAHEDRON LETT, V32, P5107, DOI 10.1016/S0040-4039(00)93440-3; ANDO T, 1990, TETRAHEDRON, V46, P5921, DOI 10.1016/S0040-4020(01)87917-5; ANDO T, 1993, PHOTOCHEM PHOTOBIOL, V57, P629, DOI 10.1111/j.1751-1097.1993.tb02928.x; ROSENTHAL I, 1991, PHOTOCHEM PHOTOBIOL, V53, P859; YAMAGO S, 1995, CHEM BIOL, V2, P385, DOI 10.1016/1074-5521(95)90219-8; MOAN J, 1986, PHOTOCHEM PHOTOBIOL, V43, P681, DOI 10.1111/j.1751-1097.1986.tb05647.x; ARBOGAST JW, 1991, J AM CHEM SOC, V113, P8886, DOI 10.1021/ja00023a041; ARBOGAST JW, 1991, J PHYS CHEM-US, V95, P11, DOI 10.1021/j100154a006; TOKUYAMA H, 1993, J AM CHEM SOC, V115, P7918, DOI 10.1021/ja00070a064; GOMER CJ, 1989, RADIAT RES, V129, P1; KESSEL D, 1984, PHOTOCHEM PHOTOBIOL, V39, P851, DOI 10.1111/j.1751-1097.1984.tb08871.x; MORGAN AR, 1991, J MED CHEM, V34, P2126, DOI 10.1021/jm00111a031; NOURSE WL, 1988, BIOCHEM BIOPH RES CO, V151, P506, DOI 10.1016/0006-291X(88)90622-5; TAKEMURA T, 1989, PHOTOCHEM PHOTOBIOL, V50, P339, DOI 10.1111/j.1751-1097.1989.tb04167.x; TOKUYAMA H, 1995, B CHEM SOC JPN, V68, P935, DOI 10.1246/bcsj.68.935	15	53	56	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0916-8451	1347-6947		BIOSCI BIOTECH BIOCH	Biosci. Biotechnol. Biochem.	AUG	1996	60	8					1359	1361				3	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Chemistry, Applied; Food Science & Technology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Chemistry; Food Science & Technology	VE149	WOS:A1996VE14900030		
J	Tonouchi, N; Tsuchida, T; Yoshinaga, F; Beppu, T; Horinouchi, S				Tonouchi, N; Tsuchida, T; Yoshinaga, F; Beppu, T; Horinouchi, S			Characterization of the biosynthetic pathway of cellulose from glucose and fructose in Acetobacter xylinum	BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY			English	Article						Acetobacter; cellulose-producing microorganism; biosynthesis; fructose-specific phosphotransferase system	BACTERIAL CELLULOSE; NUCLEOTIDE-SEQUENCE; TRANSPORT; SYSTEM; GENE	For characterization of the biosynthetic pathway of cellulose in a cellulose-producing Acetobacter xylinum strain BPR2001, the activities of several enzymes were measured. The activity of phosphoglucose isomerase catalyzing the conversion of fructose-6-phosphate into glucose-6-phosphate was greatly increased by fructose in the medium. The UDP-glucose pyrophosphorylase activity catalyzing the synthesis of UDP-glucose was very high in strain BPR2001, consistent with the idea that this is the key enzyme in cellulose biosynthesis. Strain BPR2001 was found to have a fructose-specific phosphoenolpyruvate-dependent phosphotransferase system (PTS).	UNIV TOKYO, DEPT BIOTECHNOL, DIV AGR & LIFE SCI, BUNKYO KU, TOKYO 113, JAPAN	Tonouchi, N (reprint author), BIOPOLYMER RES CO LTD, TAKATSU KU, 3-2-1 SAKATO, KAWASAKI, KANAGAWA 213, JAPAN.						Anderson R L, 1975, Methods Enzymol, V42, P63; SWISSA M, 1980, J BACTERIOL, V143, P1142; DILLS SS, 1980, MICROBIOL REV, V44, P385; GROMET Z, 1957, BIOCHEM J, V67, P679; TOYOSAKI H, 1995, BIOSCI BIOTECH BIOCH, V59, P1498; ROSS P, 1991, MICROBIOL REV, V55, P35; OKUMURA H, 1985, AGR BIOL CHEM TOKYO, V49, P1011; ALVAREZ B, 1995, CAN J MICROBIOL, V41, P918; BENZIMAN M, 1973, J BIOL CHEM, V248, P1603; BENZIMAN M, 1991, J BACTERIOL, V111, P325; BOUVET OMM, 1987, ANN INST PASTEUR MIC, V138, P3, DOI 10.1016/0769-2609(87)90048-2; BREDE G, 1991, J BACTERIOL, V173, P7042; DECRECYLAGARD V, 1991, MOL GEN GENET, V227, P465; FJAERVIK E, 1973, FEMS MICROBIOL LETT, V77, P315; GRACY RM, 1966, METHOD ENZYMOL, V9, P392; HESMAN TL, 1991, J BACTERIOL, V173, P3215; RAGUNATHAN S, 1994, ARCH BIOCHEM BIOPHYS, V310, P360, DOI 10.1006/abbi.1994.1179; SPRINGGATE CF, 1982, METHOD ENZYMOL, V90, P378; TOYOSAKI H, 1995, J GEN APPL MICROBIOL, V41, P307, DOI 10.2323/jgam.41.307; UJITA S, 1982, METHOD ENZYMOL, V90, P235	20	25	29	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0916-8451	1347-6947		BIOSCI BIOTECH BIOCH	Biosci. Biotechnol. Biochem.	AUG	1996	60	8					1377	1379				3	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Chemistry, Applied; Food Science & Technology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Chemistry; Food Science & Technology	VE149	WOS:A1996VE14900036		
J	Ishikawa, K; Mizusawa, H; Saito, M; Tanaka, H; Nakajima, N; Kondo, N; Kanazawa, I; Shoji, S; Tsuji, S				Ishikawa, K; Mizusawa, H; Saito, M; Tanaka, H; Nakajima, N; Kondo, N; Kanazawa, I; Shoji, S; Tsuji, S			Autosomal dominant pure cerebellar ataxia - A clinical and genetic analysis of eight Japanese families	BRAIN			English	Article						autosomal dominant pure cerebellar ataxia (ADCA) type III; anticipation; linkage analysis; genetic heterogeneity	MACHADO-JOSEPH DISEASE; TRINUCLEOTIDE REPEAT EXPANSION; CAG REPEAT; LATE-ONSET; DREW FAMILY; MAPS; INSTABILITY; WALWORTH; MARKERS; LOCUS	We carried out linkage analysis and clinical assessment on 41 patients with autosomal dominant pure cerebellar ataxia (ADCA) type III from eight Japanese families. The presenting symptom was gait ataxia in all patients, with the average age of onset at 46.0 +/- 9.0 (SD) years. The mean age of onset was 3.2 +/- 7.7 years earlier in offsprings than in their parents, suggesting mild, but not dramatic, anticipation. Other neurological features were restricted to cerebellar symptoms in spite of a long duration of illness of up to 41 years. The disease progression was uniformly slow, and earlier onset did not show different or severe clinical phenotype. Linkage analysis using four microsatellite markers (D11S905, D11S903, GATA2A01 and D11S913) excluded the first gene locus for ADCA type III [spinocerebellar ataxia (SCA) type 5]. The present study provides new genetic evidence, in addition to that suggested by clinical difference, that ADCA type III represents a group of heterogeneous conditions.	UNIV TSUKUBA,INST CLIN MED,DEPT NEUROL,TSUKUBA,IBARAKI 305,JAPAN; NATL INST ENVIRONM STUDIES,BIOTECHNOL RES TEAM,TSUKUBA,IBARAKI,JAPAN; NIIGATA UNIV,BRAIN RES INST,DEPT NEUROL,NIIGATA 951,JAPAN; UNIV TOKYO,INST BRAIN RES,DEPT NEUROL,TOKYO,JAPAN							GISPERT S, 1993, NAT GENET, V4, P295, DOI 10.1038/ng0793-295; LASPADA AR, 1994, ANN NEUROL, V36, P814, DOI 10.1002/ana.410360604; ANSORGE W, 1987, NUCLEIC ACIDS RES, V15, P4593, DOI 10.1093/nar/15.11.4593; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; YAKURA H, 1974, NEW ENGL J MED, V291, P154; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; HARDING AE, 1982, BRAIN, V105, P1, DOI 10.1093/brain/105.1.1; AOKI M, 1994, HUM MOL GENET, V3, P1197, DOI 10.1093/hmg/3.7.1197; CHUNG MY, 1993, NAT GENET, V5, P254, DOI 10.1038/ng1193-254; DURR A, 1993, BRAIN, V116, P1497, DOI 10.1093/brain/116.6.1497; Eadie MJ., 1991, HDB CLIN NEUROLOGY H, V60, P569; ENEVOLDSON TP, 1994, BRAIN, V117, P445, DOI 10.1093/brain/117.3.445; FRONTALI M, 1992, BRAIN, V115, P1647, DOI 10.1093/brain/115.6.1647; GARDNER K, 1994, NEUROLOGY, V44, pA361; GIUNTI P, 1995, BRAIN, V118, P1077, DOI 10.1093/brain/118.5.1077; GIUNTI P, 1994, BRAIN, V117, P645, DOI 10.1093/brain/117.4.645; GYAPAY G, 1994, NAT GENET, V7, P219; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HALL B, 1945, MED J AUSTRALIA, V1, P101; Hall B, 1941, BRAIN, V64, P178, DOI 10.1093/brain/64.2-3.178; Hirayama K, 1994, Acta Neurol Scand Suppl, V153, P1; HOFFMAN PM, 1971, NEUROLOGY, V21, P771; JODICE C, 1994, AM J HUM GENET, V54, P959; KLOCKGETHER T, 1990, J NEUROL NEUROSUR PS, V53, P297, DOI 10.1136/jnnp.53.4.297; MENOMAR A, 1994, ANN NEUROL, V35, P439; MENOMAR A, 1995, NAT GENET, V10, P84; MOSCHNER C, 1994, BRAIN, V117, P15, DOI 10.1093/brain/117.1.15; Ott J., 1991, ANAL HUMAN GENETIC L; PLAITAKIS A, 1992, CEREBELLAR DEGENERAT, P305; POLO JM, 1991, BRAIN, V114, P855, DOI 10.1093/brain/114.2.855; RANUM LPW, 1994, NAT GENET, V8, P280, DOI 10.1038/ng1194-280; RICHTER RB, 1950, AM J HUM GENET, V2, P1; Sambrook J., 1989, MOL CLONING LAB MANU; STEVANIN G, 1994, AM J HUM GENET, V54, P11; TAKIYAMA Y, 1993, NAT GENET, V4, P300, DOI 10.1038/ng0793-300; TAKIYAMA Y, 1994, NEUROLOGY, V44, P1302; TAKIYAMA Y, 1995, HUM MOL GENET, V4, P1137, DOI 10.1093/hmg/4.7.1137; Taniwaki M, 1994, NAT GENET, V8, P213; Weber FP, 1942, BRAIN, V65, P220, DOI 10.1093/brain/65.2.220; ZEE DS, 1976, BRAIN, V99, P207, DOI 10.1093/brain/99.2.207; ZOGHBI HY, 1991, AM J HUM GENET, V49, P23	42	17	17	OXFORD UNIV PRESS UNITED KINGDOM	OXFORD	WALTON ST JOURNALS DEPT, OXFORD, ENGLAND OX2 6DP	0006-8950			BRAIN	Brain	AUG	1996	119		4				1173	1182		10.1093/brain/119.4.1173		10	Clinical Neurology; Neurosciences	Neurosciences & Neurology	VJ953	WOS:A1996VJ95300012		
J	Furue, M; Chang, CH; Tamaki, K				Furue, M; Chang, CH; Tamaki, K			Interleukin-1 but not tumour necrosis factor alpha synergistically upregulates the granulocyte-macrophage colony-stimulating factor-induced B7-1 expression of murine Langerhans cells	BRITISH JOURNAL OF DERMATOLOGY			English	Article							IMMUNOSTIMULATORY DENDRITIC CELLS; CTLA-4 COUNTER-RECEPTOR; COSTIMULATORY MOLECULE; EPIDERMAL-CELLS; LYMPHOCYTES-T; MATURATION; INDUCTION; VIABILITY; CYTOKINES; INVITRO	Epidermal Langerhans cells (LC) express several co-stimulatory molecules such as B7/BB1, which has been implicated as one of the important determinants for potent antigen-presenting function of LC. Recent studies have shown that B7/BB1 antigens comprise three distinct molecules termed B7-1, B7-2 and B7-3. Previous studies have revealed that the phenotypic and functional properties of murine LC are enormously affected by various cytokines including granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-1 (IL-1), and tumour necrosis factor alpha (TNF-alpha) derived from surrounding keratinocytes. We have already demonstrated that the expression of B7-1 of murine LC is significantly enhanced by GM-CSF, IL-1 or TNF-alpha. In this paper, we present that IL-1, but not TNF-alpha, synergistically up-regulates the GM-CSF-induced B7-1 expression of murine LC.	KAOHSIUNG MED COLL,DEPT DERMATOL,KAOHSIUNG,TAIWAN; UNIV TOKYO,DEPT DERMATOL,TOKYO 113,JAPAN	Furue, M (reprint author), UNIV TOKYO,BRANCH HOSP,DEPT DERMATOL,BUNKYO KU,3-28-6 MEJIRODAI,TOKYO 112,JAPAN.		Chang, Chung-Hsing /B-4077-2010				SCHWARTZ RH, 1990, SCIENCE, V248, P1349, DOI 10.1126/science.2113314; LARSEN CP, 1992, J EXP MED, V176, P1215, DOI 10.1084/jem.176.4.1215; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; LARSEN CP, 1994, J IMMUNOL, V152, P5208; INABA K, 1986, J EXP MED, V164, P605, DOI 10.1084/jem.164.2.605; DAMLE NK, 1992, J IMMUNOL, V148, P1985; CHANG CH, 1995, EUR J IMMUNOL, V25, P394, DOI 10.1002/eji.1830250213; FREEMAN GJ, 1993, SCIENCE, V262, P909, DOI 10.1126/science.7694363; HEUFLER C, 1988, J EXP MED, V167, P700, DOI 10.1084/jem.167.2.700; CHANG CH, 1994, EUR J IMMUNOL, V24, P2889, DOI 10.1002/eji.1830241146; FREEMAN GJ, 1993, SCIENCE, V262, P907, DOI 10.1126/science.7694362; FURUE M, 1988, J IMMUNOL, V140, P4139; FURUE M, 1989, J INVEST DERMATOL, V92, P342, DOI 10.1111/1523-1747.ep12277165; HATHCOCK KS, 1993, SCIENCE, V262, P905, DOI 10.1126/science.7694361; KOCH F, 1990, J EXP MED, V171, P159, DOI 10.1084/jem.171.1.159; KOIDE SL, 1987, J EXP MED, V165, P515, DOI 10.1084/jem.165.2.515; LEE MG, 1993, J INVEST DERMATOL, V101, P883, DOI 10.1111/1523-1747.ep12371712; SCHULER G, 1985, J EXP MED, V161, P526, DOI 10.1084/jem.161.3.526; SYMINGTON FW, 1993, J IMMUNOL, V150, P1286; TAMAKI K, 1985, J INVEST DERMATOL, V85, P20, DOI 10.1111/1523-1747.ep12274517; TAN P, 1993, J EXP MED, V177, P165, DOI 10.1084/jem.177.1.165; WITMERPACK MD, 1987, J EXP MED, V166, P1484, DOI 10.1084/jem.166.5.1484	22	21	21	BLACKWELL SCIENCE LTD	OXFORD	OSNEY MEAD, OXFORD, OXON, ENGLAND OX2 0EL	0007-0963			BRIT J DERMATOL	Br. J. Dermatol.	AUG	1996	135	2					194	198		10.1111/j.1365-2133.1996.tb01146.x		5	Dermatology	Dermatology	VB508	WOS:A1996VB50800004		
J	Mahmud, N; Katayama, N; Itoh, R; Tanaka, R; Ohishi, K; Masuya, M; Mimami, N; Shiku, H				Mahmud, N; Katayama, N; Itoh, R; Tanaka, R; Ohishi, K; Masuya, M; Mimami, N; Shiku, H			A possible change in doubling time of haemopoietic progenitor cells with stem cell development	BRITISH JOURNAL OF HAEMATOLOGY			English	Article						haemopoietic progenitor cells; doubling time; clonal assay; stem cell development; serum-free culture	MULTIPOTENTIAL HEMATOPOIETIC PROGENITORS; BONE-MARROW; CFU-S; INTERLEUKIN-3-DEPENDENT PROLIFERATION; C-KIT; MURINE; DIFFERENTIATION; PLURIPOTENT; EXPRESSION; CULTURE	We separated haemopoietic progenitors derived from marrow cells of 5-fluorouracil (5-FU)-treated mice into three groups, based on the stages of stem cell development and studied doubling time, using a serum-free clonal culture system. Stage I progenitors were those present in primary marrow cells from 5-FU-treated mice. Stages II and III progenitors were early and late progenies in culture of stage I progenitors, respectively. The morphological analysis of colonies derived from stage I, II and III progenitors demonstrated an association of progression of stages with loss of multipotentiality. The doubling time of haemopoietic progenitors was estimated by sequential analysis of colony formation and studies of growth fraction. The time required for haemopoietic progenitors to double shortened as their stage of development progressed. Alteration in one doubling time of haemopoietic progenitors at progressive stages of stem cell development was seen in cultures supported by various combinations of growth factors, including interleukin-3 (IL-3), IL-11, and steel factor (SF). Cell-cycle analysis suggested that reduction of the doubling time of haemopoietic progenitors is probably due to a decrease in the time spent in the G1 phase of the cell cycle, Our results suggest that in early haemopoiesis the doubling time of haemopoietic progenitors may change with stem cell development.	MIE UNIV,SCH MED,DEPT INTERNAL MED 2,TSU,MIE 514,JAPAN; MIE UNIV HOSP,BLOOD TRANSFUS SERV,TSU,MIE,JAPAN; UNIV TOKYO,INST MED SCI,DEPT CLIN ONCOL,TOKYO,JAPAN							BAUM CM, 1992, P NATL ACAD SCI USA, V89, P2804, DOI 10.1073/pnas.89.7.2804; MUSASHI M, 1991, P NATL ACAD SCI USA, V88, P765, DOI 10.1073/pnas.88.3.765; BECKER AJ, 1963, NATURE, V197, P452, DOI 10.1038/197452a0; SPANGRUDE GJ, 1991, BLOOD, V78, P1395; KELLER G, 1985, NATURE, V318, P149, DOI 10.1038/318149a0; SMITH LG, 1991, P NATL ACAD SCI USA, V88, P2788, DOI 10.1073/pnas.88.7.2788; ABRAMSON S, 1977, J EXP MED, V145, P1567, DOI 10.1084/jem.145.6.1567; OGAWA M, 1983, BLOOD, V61, P823; SZILVASSY SJ, 1990, P NATL ACAD SCI USA, V87, P8736, DOI 10.1073/pnas.87.22.8736; OGAWA M, 1993, BLOOD, V81, P2844; LEMISCHKA IR, 1986, CELL, V45, P917, DOI 10.1016/0092-8674(86)90566-0; LAJTHA LG, 1979, DIFFERENTIATION, V14, P23, DOI 10.1111/j.1432-0436.1979.tb01007.x; BECKER AJ, 1965, BLOOD-J HEMATOL, V26, P296; DICK JE, 1985, CELL, V42, P71, DOI 10.1016/S0092-8674(85)80102-1; HODGSON GS, 1979, NATURE, V281, P381, DOI 10.1038/281381a0; IKEBUCHI K, 1987, P NATL ACAD SCI USA, V84, P9035, DOI 10.1073/pnas.84.24.9035; IKEBUCHI K, 1988, P NATL ACAD SCI USA, V85, P3445, DOI 10.1073/pnas.85.10.3445; ISCOVE NN, 1980, EXP CELL RES, V126, P121, DOI 10.1016/0014-4827(80)90476-0; KATAYAMA N, 1993, BLOOD, V81, P610; KATAYAMA N, 1993, BLOOD, V82, P2353; LAJTHA LG, 1969, CELL TISSUE KINET, V2, P39, DOI 10.1111/j.1365-2184.1969.tb00336.x; LI CL, 1992, J EXP MED, V175, P1443, DOI 10.1084/jem.175.6.1443; Mahmud N, 1996, INT J ONCOL, V8, P453; MOORE T, 1994, J IMMUNOL, V153, P4978; Ohishi K, 1996, BLOOD, V87, P1718; PLOEMACHER RE, 1988, EXP HEMATOL, V16, P21; RUSTEN LS, 1994, BLOOD, V84, P1473; SCHOFIELD R, 1980, J CELL PHYSIOL, V103, P355, DOI 10.1002/jcp.1041030221; SHIH JP, 1992, LEUKEMIA, V6, P193; SUDA T, 1983, J CELL PHYSIOL, V117, P308, DOI 10.1002/jcp.1041170305; TANAKA R, 1995, BLOOD, V86, P73; TESTA NG, 1973, CELL TISSUE KINET, V6, P425, DOI 10.1111/j.1365-2184.1973.tb01629.x; TSUJI K, 1991, BLOOD, V78, P1223	33	4	4	BLACKWELL SCIENCE LTD	OXFORD	OSNEY MEAD, OXFORD, OXON, ENGLAND OX2 0EL	0007-1048			BRIT J HAEMATOL	Br. J. Haematol.	AUG	1996	94	2					242	249		10.1046/j.1365-2141.1996.d01-1801.x		8	Hematology	Hematology	VB265	WOS:A1996VB26500004		
J	Yamagata, T; Mitani, K; Kanda, Y; Yazaki, Y; Hirai, H				Yamagata, T; Mitani, K; Kanda, Y; Yazaki, Y; Hirai, H			Elevated platelet count features the variant type of BCR/ABL junction in chronic myelogenous leukaemia	BRITISH JOURNAL OF HAEMATOLOGY			English	Article						BCR/ABL; c3-a2 type; chronic myelogenous leukaemia; essential thrombocythaemia; interferon-alpha	BCR GENES; ABL; LEUKEMIA; PROTEIN	A variant form of BCR/ABL junction was identified in a patient with chronic myelogenous leukaemia (CML). The BCR/ABL fusion mRNA of this patient showed in-frame junction between BCR exon c3 and ABL exon 2. Although the diagnosis of CML was made, the patient showed clinical features of essential thrombocythaemia (ET) rather than that of typical CML. Treatment with interferon-alpha showed no cytogenetic response, The c3-a2 type of BCR/ABL junction seems to be associated with elevated platelet count and thus could form a novel clinical entity different from typical CML.	UNIV TOKYO,FAC MED,DEPT INTERNAL MED 3,BUNKYO KU,TOKYO 113,JAPAN							SHTIVELMAN E, 1985, NATURE, V315, P550, DOI 10.1038/315550a0; PUIL L, 1994, EMBO J, V13, P764; GROFFEN J, 1984, CELL, V36, P93, DOI 10.1016/0092-8674(84)90077-1; PENDERGAST AM, 1993, CELL, V75, P175, DOI 10.1016/S0092-8674(05)80094-7; ITO T, 1993, JPN J CANCER RES, V84, P105; LIFSHITZ B, 1988, ONCOGENE, V2, P113; MURPHY S, 1982, CANCER TREAT REP, V66, P1495; SAGLIO G, 1990, BLOOD, V76, P1819; WADA H, 1995, CANCER RES, V55, P3192	9	30	31	BLACKWELL SCIENCE LTD	OXFORD	OSNEY MEAD, OXFORD, OXON, ENGLAND OX2 0EL	0007-1048			BRIT J HAEMATOL	Br. J. Haematol.	AUG	1996	94	2					370	372		10.1046/j.1365-2141.1996.d01-1798.x		3	Hematology	Hematology	VB265	WOS:A1996VB26500020		
J	Abe, F; Karaki, H; Endoh, M				Abe, F; Karaki, H; Endoh, M			Effects of cyclopiazonic acid and ryanodine on cytosolic calcium and contraction in vascular smooth muscle	BRITISH JOURNAL OF PHARMACOLOGY			English	Article						sarcoplasmic reticulum; cyclopiazonic acid; ryanodine; cytosolic Ca2+ level; Ca2+ localization; ferret portal vein	SARCOPLASMIC-RETICULUM; RELEASE	1 In smooth muscle, both Ca2+ release from the sarcoplasmic reticulum (SR) and Ca2+ influx across the plasma membrane are responsible for the increase in the cytosolic Ca2+ level ([Ca2+](i)). To understand further the role of SR on smooth muscle contraction, the effects of an inhibitor of the SR Ca2+ pump, cyclopiazonic acid (CPA 10 mu M), an inhibitor of the Ca2+-induced Ca2+ release, ryanodine, (10 mu M), and an activator of the Ca2+-induced Ca2+ release, caffeine (20 mM), on [Ca2+](i) and contractile force were examined in the ferret portal vein loaded with a photoprotein, aequorin. 2 CPA induced a small increase in the aequorin signal reaching a maximum at 7 min. Several minutes after the increase in the aequorin signal, muscle tension increased reaching a maximum at 21.5 min. In contrast, ryanodine changed neither the aequorin signal nor contraction. In the presence of ryanodine, caffeine induced a sustained increase in the aequorin signal and transient contraction. After washing ryanodine and caffeine, the aequorin signal and muscle tone returned to their respective control levels. After treatment with ryanodine and caffeine, the second addition of caffeine was almost ineffective whereas CPA still increased the aequorin signal and muscle tension. 3 In the presence of external Ca2+, noradrenaline (NA, 10 mu M) induced a transient increase followed by a sustained increase in the aequorin signal and sustained contraction. In contrast, KCl (70 mM) induced sustained increases in the aequorin signal and sustained contraction. In Ca2+-free solution, NA induced a small transient increase in the aequorin signal and a small transient contraction. These changes were inhibited in the presence of CPA or on pretreatment of the muscle with ryanodine and caffeine. These results suggest that CPA or ryanodine and caffeine depleted Ca2+ in SR. High K+ was ineffective in the absence of external Ca2+. 4 In the presence of external Ca2+ and CPA, NA and high K+ induced larger aequorin signals than in the absence of CPA, whereas the magnitude and shape of the contractions did not change. In contrast, pretreatment with ryanodine and caffeine did not have such an effect. In the muscle pretreated with ryanodine and caffeine, CPA changed the responses to high K+ and NA in a similar manner to that in the muscle without the pretreatment with ryanodine and caffeine. 5 Dissociation of contraction from [Ca2+](i) as measured with aequorin suggests that NA and high K+ increase Ca2+ in two compartments: a compartment containing contractile elements (contractile compartment) and another compartment unrelated to contractile elements (non-contractile compartment). Because CPA augmented the stimulant-induced increase in aequorin signal without changing contraction, the non-contractile compartment may be located near the SR and the CPA-sensitive SR Ca2+ pump may regulate the Ca2+ level in this compartment. However, because CPA changed neither the magnitude nor shape of the contractions in the presence of external Ca2+, the SR Ca2+ pump may have little effect on regulation of Ca2+ level in the contractile compartment. Furthermore, the release of Ca2+ from SR seems to have little effect on the increase in the contractile Ca2+ because ryanodine and caffeine changed neither the aequorin signals nor contractions induced by NA and high K+ in the presence of external Ca2+ in the ferret portal vein.	UNIV TOKYO,DEPT VET PHARMACOL,GRAD SCH AGR & LIFE SCI,BUNKYO KU,TOKYO 113,JAPAN	Abe, F (reprint author), YAMAGATA UNIV,SCH MED,DEPT PHARMACOL,YAMAGATA 99023,JAPAN.						ABE F, 1995, BRIT J PHARMACOL, V116, P3000; Abe Fujio, 1995, Japanese Journal of Pharmacology, V67, p175P; ABE F, 1990, Japanese Journal of Pharmacology, V52, p343P; UYAMA Y, 1992, BRIT J PHARMACOL, V106, P208; BELTZER FO, 1988, TRANSPLANTATION, V45, P673; CLAPHAM DE, 1993, NATURE, V364, P763, DOI 10.1038/364763a0; Darby Peter J., 1993, Biological Signals, V2, P293; DELAFUENTE PG, 1995, PFLUG ARCH EUR J PHY, V429, P617; ENDO M, 1977, PHYSIOL REV, V57, P71; HWANG KS, 1987, PFLUG ARCH EUR J PHY, V408, P343, DOI 10.1007/BF00581127; IRVINE RF, 1992, FASEB J, V6, P3085; ITO K, 1986, CIRC RES, V58, P730; JEFFREY ER, 1987, AM J PHYSIOL, V253, pC364; KARAKI H, 1989, TRENDS PHARMACOL SCI, V10, P320; KUREBAYASHI N, 1991, J MUSCLE RES CELL M, V12, P355, DOI 10.1007/BF01738590; MAURER EJ, 1990, TRANSPLANT P, V22, P548; MUNRO DD, 1994, CELL CALCIUM, V15, P369, DOI 10.1016/0143-4160(94)90012-4; SATO K, 1988, N-S ARCH PHARMACOL, V338, P443; VANBREEMEN C, 1995, TRENDS PHARMACOL SCI, V16, P98, DOI 10.1016/S0165-6147(00)88990-7	19	40	40	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0007-1188			BRIT J PHARMACOL	Br. J. Pharmacol.	AUG	1996	118	7					1711	1716				6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	VA411	WOS:A1996VA41100021		
J	Honda, H; Shimizu, Y; Misumi, K; Niimi, M; Ohashi, Y				Honda, H; Shimizu, Y; Misumi, K; Niimi, M; Ohashi, Y			Cumulative incidence and prevalence of childhood autism in children in Japan	BRITISH JOURNAL OF PSYCHIATRY			English	Article							INFANTILE-AUTISM; TOTAL POPULATION; EPIDEMIOLOGY; CLASSIFICATION; DISORDER	Background. An epidemiological survey of childhood autism as defined in ICD-10 Research Criteria was conducted in the northern part of Yokohama, Japan. Method. The routine health checkup for 18-month-old children served as the initial mass-screening, and all facilities which provide child care services function to detect all cases with childhood autism and refer them to the Yokohama Rehabilitation Centre. Cumulative incidence of childhood autism up to 5 years of age among the birth cohort of 1988, and prevalence on 1 January 1994, among residents born in 1988 were estimated. Results. Cumulative incidence and prevalence were 16.2 per 10 000 and 21.1 per 10 000, respectively. Children with high-functioning autism who had IQs of 70 and over constituted approximately half of all the children with childhood autism. Conclusion. it was confirmed through better detection of high-functioning cases that childhood autism in Japan is more common than formerly estimated.	UNIV TSUKUBA,GRAD SCH MED SCI,DEPT EPIDEMIOL & MED INFORMAT SCI,TSUKUBA,IBARAKI 305,JAPAN; UNIV TOKYO,FAC MED,SCH HLTH SCI & NURSING,DEPT EPIDEMIOL & BIOSTAT,BUNKYO KU,TOKYO 113,JAPAN	Honda, H (reprint author), YOKOHAMA REHABIL CTR,DEPT MED,KOHOKU KU,1770 TORIYAMA CHO,YOKOHAMA,KANAGAWA 222,JAPAN.						American Psychiatric Association, 1994, DIAGN STAT MAN MENT; BARONCOHEN S, 1992, BRIT J PSYCHIAT, V161, P839, DOI 10.1192/bjp.161.6.839; KURITA H, 1985, J AM ACAD CHILD PSY, V24, P191, DOI 10.1016/S0002-7138(09)60447-7; EHLERS S, 1993, J CHILD PSYCHOL PSYC, V34, P1327, DOI 10.1111/j.1469-7610.1993.tb02094.x; WING L, 1979, J AUTISM DEV DISORD, V9, P11, DOI 10.1007/BF01531288; CHESS S, 1971, J AUTISM CHILD SCHIZ, V1, P33, DOI 10.1007/BF01537741; VOLKMAR FR, 1994, AM J PSYCHIAT, V151, P1361; Cox Roger D., 1995, P57; FOMBONNE E, 1992, SOC PSYCH PSYCH EPID, V27, P203, DOI 10.1007/BF00789007; Frith U, 1991, AUTISM ASPERGER SYND; GILLBERG C, 1991, BRIT J PSYCHIAT, V158, P403, DOI 10.1192/bjp.158.3.403; JOHNSON MH, 1992, DEV MED CHILD NEUROL, V34, P316; Lotter V, 1966, SOC PSYCHIAT, V1, P124, DOI DOI 10.1007/BF00584048; RUTTER M, 1992, J AUTISM DEV DISORD, V22, P459, DOI 10.1007/BF01046322; STEIN Z, 1981, J AM ACAD CHILD PSY, V20, P444, DOI 10.1016/S0002-7138(09)61639-3; STEINHAUSEN HC, 1986, J AM ACAD CHILD PSY, V25, P186, DOI 10.1016/S0002-7138(09)60225-9; SUGIYAMA T, 1989, J AUTISM DEV DISORD, V19, P87, DOI 10.1007/BF02212720; TANOUE Y, 1988, J AUTISM DEV DISORD, V18, P155, DOI 10.1007/BF02211943; Tsai L. Y., 1992, HIGH FUNCTIONING IND, P11; VOLKMAR FR, 1989, J CHILD PSYCHOL PSYC, V30, P717, DOI 10.1111/j.1469-7610.1989.tb00784.x; Wing L, 1993, Eur Child Adolesc Psychiatry, V2, P61, DOI 10.1007/BF02098832; World Health Organization, 1992, ICD 10 CLASS MENT BE; World Health Organization, 1993, ICD 10 CLASS MENT BE	23	84	86	ROYAL COLLEGE OF PSYCHIATRISTS	LONDON	BRITISH JOURNAL OF PSYCHIATRY 17 BELGRAVE SQUARE, LONDON, ENGLAND SW1X 8PG	0007-1250			BRIT J PSYCHIAT	Br. J. Psychiatry	AUG	1996	169	2					228	235		10.1192/bjp.169.2.228		8	Psychiatry	Psychiatry	VB341	WOS:A1996VB34100016		
J	Nakamura, E; Tokuyama, H; Yamago, S; Shiraki, T; Sugiura, Y				Nakamura, E; Tokuyama, H; Yamago, S; Shiraki, T; Sugiura, Y			Biological activity of water-soluble fullerenes. Structural dependence of DNA cleavage, cytotoxicity, and enzyme inhibitory activities including HIV-protease inhibition	BULLETIN OF THE CHEMICAL SOCIETY OF JAPAN			English	Article							ELECTRON-TRANSFER; C-60; CHEMISTRY; PEPTIDE; SYSTEM; ACID; C60	Two different classes of water-soluble fullerene derivatives, detergent-type and sphere-type, were synthesized. The derivatives were evaluated for their biological activities including cytotoxicity, DNA cleavage, and inhibition of HIV-protease and other enzymes. Both classes of compounds display generally similar behavior except for their cytotoxicity spectra against several cell lines. The fullerene derivatives bearing N-methylpyrrole were found to be photo-inactive with respect to DNA cleaving activity and cytotoxicity. A study on the kinetics for the inhibition of HIV-protease with detergent type derivative revealed that the compound is a potent fullerene-based HIV protease inhibitor, inhibiting the enzyme activity in a reversible and competitive manner with a K-i value of 0.32 mu M.	UNIV TOKYO, FAC PHARMACEUT SCI, BUNKYO KU, TOKYO 113, JAPAN; KYOTO UNIV, DEPT SYNTHET CHEM & BIOL CHEM, SAKYO KU, KYOTO 60601, JAPAN; KYOTO UNIV, INST CHEM RES, UJI, KYOTO 611, JAPAN	Nakamura, E (reprint author), UNIV TOKYO, SCH SCI, DEPT CHEM, BUNKYO KU, 7-3-1 HONGO, TOKYO 113, JAPAN.		NAKAMURA, EIICHI/G-5041-2014				AN YZ, 1993, J ORG CHEM, V58, P4799, DOI 10.1021/jo00070a010; CLOSS GL, 1988, J AM CHEM SOC, V110, P2652, DOI 10.1021/ja00216a051; COLL M, 1987, P NATL ACAD SCI USA, V84, P8385, DOI 10.1073/pnas.84.23.8385; ZIMMER C, 1986, PROG BIOPHYS MOL BIO, V47, P31, DOI 10.1016/0079-6107(86)90005-2; TONIOLO C, 1994, J MED CHEM, V37, P4558, DOI 10.1021/jm00052a015; KEMPF DJ, 1990, J MED CHEM, V33, P2687, DOI 10.1021/jm00172a002; ALLEY MC, 1988, CANCER RES, V48, P589; YAMAGO S, 1995, CHEM BIOL, V2, P385, DOI 10.1016/1074-5521(95)90219-8; ARBOGAST JW, 1992, J AM CHEM SOC, V114, P2277, DOI 10.1021/ja00032a063; TSUCHIYA T, 1995, BIOCHEM BIOPH RES CO, V206, P885, DOI 10.1006/bbrc.1995.1126; WILLIAMS RM, 1995, J AM CHEM SOC, V117, P4093, DOI 10.1021/ja00119a025; FRIEDMAN SH, 1993, J AM CHEM SOC, V115, P6506, DOI 10.1021/ja00068a005; WUDL F, 1992, ACS SYM SER, V481, P161; HIRSCH A, 1991, ANGEW CHEM INT EDIT, V30, P1309, DOI 10.1002/anie.199113091; PRATO M, 1993, J ORG CHEM, V58, P5578, DOI 10.1021/jo00073a004; SHEU C, 1993, J AM CHEM SOC, V115, P10446, DOI 10.1021/ja00075a105; TOKUYAMA H, 1993, J AM CHEM SOC, V115, P7918, DOI 10.1021/ja00070a064; FINLAY AC, 1951, J AM CHEM SOC, V73, P341, DOI 10.1021/ja01145a113; TAYLOR R, 1993, NATURE, V363, P685, DOI 10.1038/363685a0; SCHINAZI RF, 1993, ANTIMICROB AGENTS CH, V37, P1707; BOUTORINE AS, 1909, ANGEW CHEM INT EDIT, V433, P2462; CHIANG LY, 1992, J AM CHEM SOC, V114, P10154, DOI 10.1021/ja00052a010; DEVAN PD, 1993, TETRAHEDRON LETT, V34, P669; Diederich F, 1996, SCIENCE, V271, P317, DOI 10.1126/science.271.5247.317; DUBOIS D, 1991, J AM CHEM SOC, V113, P7773, DOI 10.1021/ja00020a056; ERICKSONVIITANEN S, 1994, ANTIMICROB AGENTS CH, V38, P1628; FOOTE CS, 1994, TOP CURR CHEM, V169, P347; FRIEDMAN SH, 1994, P ELECTROCHEM SOC, V94, P662; HANSCH C, 1976, SUBSTITUENT CONSTANT; HIRSCH KA, 1994, CHEM FULLERENES; IRIE K, UNPUB BIOSCI BIOTECH; KOGISHI H, 1995, TETRAHEDRON LETT, V36, P5349; LI J, 1993, J CHEM SOC CHEM COMM, P1784, DOI 10.1039/c39930001784; MARKY LA, 1987, P NATL ACAD SCI USA, V84, P4539; NISHIWAKI E, 1988, HETEROCYCLES, V27, P1945; TOKUYAMA H, 1995, B CHEM SOC JPN, V68, P935, DOI 10.1246/bcsj.68.935; TOKUYAMA H, 1993, TETRAHEDRON LETT, V34, P7429, DOI 10.1016/S0040-4039(00)60144-2; TOKUYAMA H, 1994, J ORG CHEM, V59, P1135, DOI 10.1021/jo00084a036; YAMAGO S, 1993, J ORG CHEM, V58, P4796, DOI 10.1021/jo00070a009	39	175	180	CHEMICAL SOC JAPAN	TOKYO	1-5 KANDA-SURUGADAI CHIYODA-KU, TOKYO, 101-8307, JAPAN	0009-2673	1348-0634		B CHEM SOC JPN	Bull. Chem. Soc. Jpn.	AUG	1996	69	8					2143	2151		10.1246/bcsj.69.2143		9	Chemistry, Multidisciplinary	Chemistry	VF681	WOS:A1996VF68100002		
J	Mochizuki, T; Hayakawa, S; Narasaka, K				Mochizuki, T; Hayakawa, S; Narasaka, K			Sulfonylation and phosphinylation of olefinic compounds with radical species generated by the oxidation of sodium sulfinates and diphenylphosphine oxide	BULLETIN OF THE CHEMICAL SOCIETY OF JAPAN			English	Article							BETA-KETO RADICALS; MANGANESE(III) 2-PYRIDINECARBOXYLATE; CYCLOPROPANOL DERIVATIVES; RUTHENIUM(II) COMPLEX; ADDITION-REACTION; CHLORIDES; TRIS(2-PYRIDINECARBOXYLATE); IODIDES	Sodium arenesulfinates are oxidized with manganese(III) 2-pyridinecarboxylate or ammonium cerium(IV) nitrates to generate sulfonyl radicals, which add to olefinic compounds to afford sulfonylated products in good yield. When 1-vinyl cyclic alcohols are used as sulfonyl radical accepters, sulfonylation proceeds with ring-enlargement. Diphenylphosphinyl radical can also be generated by treating diphenylphosphine oxide with manganese(III) 2-pyridinecarboxylate and reacts with olefinic compounds, giving phosphinylated products.	UNIV TOKYO, DEPT CHEM, GRAD SCH SCI, BUNKYO KU, TOKYO 113, JAPAN							KAMIGATA N, 1985, J ORG CHEM, V50, P5045, DOI 10.1021/jo00225a009; IWASAWA N, 1993, B CHEM SOC JPN, V66, P819, DOI 10.1246/bcsj.66.819; PASTO DJ, 1992, J ORG CHEM, V57, P1139, DOI 10.1021/jo00030a020; GANCARZ RA, 1981, J ORG CHEM, V46, P4899, DOI 10.1021/jo00337a015; LIU LK, 1980, J ORG CHEM, V45, P406, DOI 10.1021/jo01291a006; KAMIGATA N, 1983, J ORG CHEM, V48, P3793, DOI 10.1021/jo00169a038; PUDOVIK AN, 1979, SYNTHESIS-STUTTGART, P81; TRUCE WE, 1971, J ORG CHEM, V36, P1727, DOI 10.1021/jo00812a001; BACK TG, 1981, J ORG CHEM, V46, P3249, DOI 10.1021/jo00329a021; BRAUNSTEIN P, 1992, INORG CHEM, V31, P4203, DOI 10.1021/ic00046a040; GODA K, 1977, B CHEM SOC JPN, V50, P545, DOI 10.1246/bcsj.50.545; IWASAWA N, 1991, CHEM LETT, P1193, DOI 10.1246/cl.1991.1193; IWASAWA N, 1994, CHEM LETT, P1697, DOI 10.1246/cl.1994.1697; IWASAWA N, 1993, CHEM LETT, P545, DOI 10.1246/cl.1993.545; JOHNSON CR, 1973, J ORG CHEM, V38, P3153, DOI 10.1021/jo00958a017; KAMIGATA N, 1984, PHOSPHORUS SULFUR, V19, P199, DOI 10.1080/03086648408077580; KAYA R, 1981, J ORG CHEM, V46, P196, DOI 10.1021/jo00314a050; KHARASCH MS, 1952, J ORG CHEM, V17, P453, DOI 10.1021/jo01137a018; KOPECKY KR, 1978, CAN J CHEM, V56, P1114, DOI 10.1139/v78-188; LEY SV, 1986, TETRAHEDRON, V42, P4333, DOI 10.1016/S0040-4020(01)87660-2; MCMILLAN M, 1966, J CHEM SOC B, P422, DOI 10.1039/j29660000422; MUATHEN HA, 1991, INDIAN J CHEM B, V30, P522; NARASAKA K, 1994, CHEM LETT, P1705, DOI 10.1246/cl.1994.1705; NARASAKA K, 1993, CHEM LETT, P1269, DOI 10.1246/cl.1993.1269; NARASAKA K, 1989, CHEM LETT, P2169, DOI 10.1246/cl.1989.2169; NEWMAN MS, 1973, J ORG CHEM, V38, P2910, DOI 10.1021/jo00956a040; PRICE CC, 1953, J AM CHEM SOC, V75, P4750, DOI 10.1021/ja01115a040; RAY MM, 1966, AUST J CHEM, V19, P1737; Simpkins N. S., 1993, SULPHONES ORGANIC SY; SMILES S, ORG SYNTH C, V1, P7; WALSHE NDA, 1986, ORG SYNTH, V65, P1; WILDEMAN J, 1979, SYNTHESIS-STUTTGART, P733	32	26	26	CHEMICAL SOC JAPAN	TOKYO	1-5 KANDA-SURUGADAI CHIYODA-KU, TOKYO, 101-8307, JAPAN	0009-2673	1348-0634		B CHEM SOC JPN	Bull. Chem. Soc. Jpn.	AUG	1996	69	8					2317	2325		10.1246/bcsj.69.2317		9	Chemistry, Multidisciplinary	Chemistry	VF681	WOS:A1996VF68100029		
J	Yan, H; Wang, HJ; Adisasmito, S; Toshima, N				Yan, H; Wang, HJ; Adisasmito, S; Toshima, N			Novel syntheses of poly(o-aminobenzoic acid) and copolymers of o-aminobenzoic acid and aniline as potential candidates for precursor of polyaniline	BULLETIN OF THE CHEMICAL SOCIETY OF JAPAN			English	Article							DERIVATIVES; POLYMERIZATION; FILM	Poly(o-aminobenzoic acid) and copolymers of o-aminobenzoic acid and aniline were synthesized as excellent candidates for the precursor of polyaniline. The reaction conditions were optimized with emphasis on the isolated yield. The polymers were characterized by a number of techniques including infrared spectroscopy, ultraviolet-visible spectroscopy, X-ray photoelectron spectroscopy, thermal analyses, and scanning electron microscopy. The yield of poly(o-aminobenzoic acid) was remarkably improved by addition of sodium hydroxide (an equivalent mole amount to the monomer) into the reaction system. Spectroscopic results indicate that the polymer has principally an Emeraldine structure. The copolymers were also obtained at high yield by addition of sodium hydroxide (an equivalent mole amount to o-aminobenzoic acid). The polymerization mechanism was briefly discussed on the basis of the pH effect upon the yield and easy elimination of the carboxyl group via a ring structure. The copolymer as well as poly(o-aminobenzoic acid) were found to be the precursors to produce polyaniline with elimination of carbon dioxide by heat treatment.	UNIV TOKYO, SCH ENGN, DEPT APPL CHEM, BUNKYO KU, TOKYO 113, JAPAN							WEI Y, 1989, J PHYS CHEM-US, V93, P495, DOI 10.1021/j100338a095; CHAN HSO, 1992, MACROMOLECULES, V25, P6029, DOI 10.1021/ma00048a026; MANOHAR SK, 1989, SYNTHETIC MET, V29, pE349; KOBAYASHI T, 1984, J ELECTROANAL CHEM, V161, P419, DOI 10.1016/S0022-0728(84)80201-6; LU FL, 1986, J AM CHEM SOC, V108, P8311, DOI 10.1021/ja00286a057; MACDIARMID AG, 1985, MOL CRYST LIQ CRYST, V121, P187, DOI 10.1080/00268948508074859; BOYLE A, 1992, J POLYM SCI POL PHYS, V30, P265, DOI 10.1002/polb.1992.090300306; ARMES SP, 1988, SYNTHETIC MET, V22, P385, DOI 10.1016/0379-6779(88)90109-9; CHIANG JC, 1986, SYNTHETIC MET, V13, P193, DOI 10.1016/0379-6779(86)90070-6; GAGNON DR, 1984, POLYM B, V12, P93; GIN DL, 1990, J AM CHEM SOC, V114, P3169; KIM YH, 1987, SYNTHETIC MET, V29, pE285; NAKAJIMA T, 1989, SYNTHETIC MET, V28, pC629; RAY A, 1990, MATER RES SOC SYMP P, V173, P353; ROBERTS JD, 1965, BASIC PRINCIPLES ORG, P523; SNAUWAET P, 1981, SYNTHETIC MET, V21, P181; TOSHIMA N, 1994, CHEM LETT, P2229, DOI 10.1246/cl.1994.2229; TOSHIMA N, 1994, B CHEM SOC JPN, V67, P1947, DOI 10.1246/bcsj.67.1947; TOSHIMA N, 1995, B CHEM SOC JPN, V68, P1056, DOI 10.1246/bcsj.68.1056; WANG ZH, 1990, PHYS REV B, V42, P5411, DOI 10.1103/PhysRevB.42.5411; WEI Y, 1989, J POLYM SCI POL CHEM, V27, P435; WUDL F, 1987, J AM CHEM SOC, V109, P3677, DOI 10.1021/ja00246a026; Yue J., 1990, J AM CHEM SOC, V112, P2800, DOI 10.1021/ja00163a051	23	20	20	CHEMICAL SOC JAPAN	TOKYO	1-5 KANDA-SURUGADAI CHIYODA-KU, TOKYO, 101-8307, JAPAN	0009-2673	1348-0634		B CHEM SOC JPN	Bull. Chem. Soc. Jpn.	AUG	1996	69	8					2395	2401		10.1246/bcsj.69.2395		7	Chemistry, Multidisciplinary	Chemistry	VF681	WOS:A1996VF68100040		
J	Iida, S; Kakudo, S; Mori, Y; Matsui, M; Magota, K; Kitajima, Y; Nakamura, N; Mano, H; Hakeda, Y; Azuma, H; Kurokawa, T; Kumegawa, M				Iida, S; Kakudo, S; Mori, Y; Matsui, M; Magota, K; Kitajima, Y; Nakamura, N; Mano, H; Hakeda, Y; Azuma, H; Kurokawa, T; Kumegawa, M			Human calcitonin has the same inhibitory effect on osteoclastic bone resorption by human giant cell tumor cells as salmon calcitonin	CALCIFIED TISSUE INTERNATIONAL			English	Article						human calcitonin; pit assay; human osteoclasts; inhibition bone; resorption	RECEPTORS	Human calcitonin (hCT) has been reported to have a less hypocalcemizing effect on rats and to have a lower binding affinity for the receptor of mouse osteoclasts than salmon CT(sCT). In this study we comparatively examined the effect of hCT and sCT on osteoclastic bone-resorbing activity of unfractionated cells obtained from human giant cell tumor of bone and from rabbit and mouse long bones. We found that hCT had the same inhibitory effect as sCT on the bone-resorbing activity of human and rabbit osteoclastic cells, but a different one on that of mouse cells. These results indicate that the activity of drugs should be assayed using human cells if possible.	MEIKAI UNIV, SCH DENT, DEPT ORAL ANAT, SAKADO, SAITAMA 35002, JAPAN; SAITAMA MED SCH, DEPT ORTHOPED SURG, MOROYAMA, SAITAMA 35004, JAPAN; UNIV TOKYO, SCH MED, DEPT ORTHOPED SURG, TOKYO 113, JAPAN; SUNTORY INST BIOMED RES, MISHIMA, OSAKA 618, JAPAN; OSAKA UNIV, SCH MED, DEPT ORTHOPED SURG, OSAKA 618, JAPAN							AKATSU T, 1992, J BONE MINER RES, V7, P1297; YABUTA M, 1995, APPL MICROBIOL BIOT, V42, P703; CHAMBERS TJ, 1986, J CLIN ENDOCR METAB, V63, P1080; COPP DH, 1962, ENDOCRINOLOGY, V70, P683; FINDLAY DM, 1980, CANCER RES, V40, P4764; FOSTER GV, 1964, NATURE, V202, P1303, DOI 10.1038/2021303a0; GALANTE L, 1976, CLIN SCI MOL MED, V44, P605; GENNARI C, 1981, CURR THER RES CLIN E, V30, P1024; GOLTZMAN D, 1980, ENDOCRINOLOGY, V106, P510; Guttmann S., 1981, CALCITONIN 1980 CHEM, P11; MARX SJ, 1972, SCIENCE, V178, P999, DOI 10.1126/science.178.4064.999; MARX ST, 1975, ENDOCRINOLOGY, V97, P449; MINAMITAKE Y, 1990, CHEM PHARM BULL, V38, P1920; TAKADA Y, 1992, BONE MINER, V17, P347, DOI 10.1016/0169-6009(92)90785-C	14	7	7	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010	0171-967X			CALCIFIED TISSUE INT	Calcif. Tissue Int.	AUG	1996	59	2					100	104				5	Endocrinology & Metabolism	Endocrinology & Metabolism	UX970	WOS:A1996UX97000006		
J	Nakanishi, S; Fujii, A; Nakade, S; Mikoshiba, K				Nakanishi, S; Fujii, A; Nakade, S; Mikoshiba, K			Immunohistochemical localization of inositol 1,4,5-trisphosphate receptors in non-neural tissues, with special reference to epithelia, the reproductive system, and muscular tissues	CELL AND TISSUE RESEARCH			English	Article						inositol 1,4,5-trisphosphate receptors; epithelium; reproductive system; muscular tissue; mouse (C57BL, ICR)	RECONSTITUTED LIPID VESICLES; CEREBELLAR PURKINJE NEURONS; INTERNAL CA2+ RELEASE; PROTEIN KINASE-II; TRISPHOSPHATE RECEPTOR; ENDOPLASMIC-RETICULUM; INSP3 RECEPTOR; SARCOPLASMIC-RETICULUM; MOUSE CEREBELLUM; IP(3) RECEPTOR	Although the pharmacological properties and distribution of inositol 1,4,5-trisphosphate (IP3)-sensitive calcium stores vary considerably among tissues, studies of its localization have been devoted mostly to the central nervous system. In this report we have analyzed the localization of IP3 receptors in diverse non-neural tissues of the mouse, using polyclonal antibodies raised against purified IP3 receptors through immunoblotting and immunohistochemistry. These antibodies mainly recognized type 1 IP3 receptors, although they also reacted with other types of IP3 receptors. The receptors were localized in the apical surface areas of highly polarized epithelia, such as the choroid plexus, retinal pigment epithelium, and columnar epithelium lining the interlobular ducts in the sublingual and submaxillary salivary glands. Immunoelectron microscopy of choroidal cells revealed that IF3 receptors are localized on the surfaces of several structures, including clear vesicles, tubules and vesicular profiles of smooth endoplasmic reticulum, rough endoplasmic reticulum and a part of the nuclear envelope; as well as clusters of ribosomes in the cytoplasmic matrix. The surface areas of ciliated epithelia, such as those of the trachea and oviduct, also stained positive. The cytoplasmic distribution was homogeneous in mesangial cells, myoepithelial cells, and endothelial cells accompanying muscle, as well as in a population of endocrine cells. Intense immunostaining was found in the surface areas as well as in the cytoplasm of diverse smooth muscle cells. Staining intensity of smooth muscle varied among cells in the same tissue. Staining was intense in the cytoplasm of premature oocytes in the primary follicle, but then attenuated as these cells matured. The Sertoli cells with clusters of elongating maturing sperm were stained, but mature sperm were unstained. These results indicate a heterogeneous cellular distribution, and possibly a heterogeneous subcellular distribution, of a population of IF3 receptors in a variety of non-neural tissues.	ONO PHARMACEUT CO LTD,MINASE RES INST,BASIC PHARMACEUT LABS,SHIMAMOTO,OSAKA 618,JAPAN; UNIV TOKYO,INST MED SCI,DEPT MOLEC NEUROBIOL,MINATO KU,TOKYO 108,JAPAN; INST PHYS & CHEM RES,TSUKUBA LIFE SCI CTR,MOLEC NEUROBIOL LAB,TSUKUBA,IBARAKI 305,JAPAN	Nakanishi, S (reprint author), JT INC,PHARMACEUT BASIC RES LABS,KANAZAWA KU,1-13-2,YOKOHAMA,KANAGAWA 236,JAPAN.						NAKADE S, 1994, J BIOL CHEM, V269, P6735; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; KUME S, 1993, CELL, V73, P555, DOI 10.1016/0092-8674(93)90142-D; FURUICHI T, 1989, NATURE, V342, P32, DOI 10.1038/342032a0; SOMLYO AV, 1977, J CELL BIOL, V74, P828, DOI 10.1083/jcb.74.3.828; MIGNERY GA, 1989, NATURE, V342, P192, DOI 10.1038/342192a0; BOURGUIGNON LYW, 1994, J CELL PHYSIOL, V159, P29, DOI 10.1002/jcp.1041590105; SHARP AH, 1993, J NEUROSCI, V13, P3051; MARRS JA, 1993, J CELL BIOL, V123, P149, DOI 10.1083/jcb.123.1.149; PENG YW, 1991, NEURON, V6, P525, DOI 10.1016/0896-6273(91)90055-5; FERRIS CD, 1992, ANNU REV PHYSIOL, V54, P469, DOI 10.1146/annurev.physiol.54.1.469; ROSS CA, 1992, P NATL ACAD SCI USA, V89, P4265, DOI 10.1073/pnas.89.10.4265; NAKANISHI S, 1991, J NEUROSCI, V11, P2075; TAKEI K, 1992, J NEUROSCI, V12, P489; KHAN AA, 1992, SCIENCE, V257, P815, DOI 10.1126/science.1323146; YAMAMOTO A, 1991, CELL STRUCT FUNCT, V16, P419; FUKUNAGA K, 1988, J NEUROCHEM, V51, P1070, DOI 10.1111/j.1471-4159.1988.tb03070.x; BARNETT R, 1990, AM J PHYSIOL, V258, pC37; BLONDEL O, 1993, J BIOL CHEM, V268, P11356; BOURGUIGNON LYW, 1993, J BIOL CHEM, V268, P7290; BOURGUIGNON LYW, 1993, CELL BIOL INT, V17, P751, DOI 10.1006/cbir.1993.1136; CHADWICK CC, 1990, P NATL ACAD SCI USA, V87, P2132, DOI 10.1073/pnas.87.6.2132; CONN PJ, 1986, P NATL ACAD SCI USA, V83, P4086, DOI 10.1073/pnas.83.11.4086; DANOFF SK, 1991, P NATL ACAD SCI USA, V88, P2951, DOI 10.1073/pnas.88.7.2951; Ebashi S, 1968, Prog Biophys Mol Biol, V18, P123, DOI 10.1016/0079-6107(68)90023-0; EHRLICH BE, 1988, NATURE, V336, P583, DOI 10.1038/336583a0; FERRIS CD, 1991, P NATL ACAD SCI USA, V88, P2232, DOI 10.1073/pnas.88.6.2232; FERRIS CD, 1989, NATURE, V342, P87, DOI 10.1038/342087a0; FLEISCHER S, 1989, ANNU REV BIOPHYS BIO, V18, P333, DOI 10.1146/annurev.biophys.18.1.333; FUJIMOTO T, 1992, J CELL BIOL, V119, P1507, DOI 10.1083/jcb.119.6.1507; FURUICHI T, 1990, FEBS LETT, V267, P85, DOI 10.1016/0014-5793(90)80294-S; GLENNON MC, 1992, J BIOL CHEM, V267, P25568; GUNDERSEN D, 1991, J CELL BIOL, V112, P863, DOI 10.1083/jcb.112.5.863; JOSEPH SK, 1993, J BIOL CHEM, V268, P6477; KIJIMA Y, 1993, J BIOL CHEM, V268, P3499; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LI W, 1992, CELL PROLIFERAT, V25, P651, DOI 10.1111/j.1365-2184.1992.tb01467.x; MAEDA N, 1988, J NEUROCHEM, V51, P1724, DOI 10.1111/j.1471-4159.1988.tb01151.x; MAEDA N, 1990, EMBO J, V9, P61; MAEDA N, 1991, J BIOL CHEM, V266, P1109; MAKHLOUF GM, 1990, GASTROINTEST ENDOSC, P73; MELDOLESI J, 1990, BIOCHIM BIOPHYS ACTA, V1055, P130, DOI 10.1016/0167-4889(90)90113-R; MICHAEL AF, 1980, KIDNEY INT, V17, P141, DOI 10.1038/ki.1980.18; MIGNERY GA, 1990, EMBO J, V9, P3893; MIGNERY GA, 1990, J BIOL CHEM, V265, P12679; MIYAZAKI S, 1992, SCIENCE, V257, P251, DOI 10.1126/science.1321497; MORATO AR, 1994, J BIOL CHEM, V269, P1222; MOUREY RJ, 1990, BIOCHEM J, V272, P383; NAKADE S, 1991, BIOCHEM J, V277, P125; NAKAGAWA T, 1991, J NEUROCHEM, V57, P1807, DOI 10.1111/j.1471-4159.1991.tb06385.x; NEWTON CL, 1994, J BIOL CHEM, V269, P28613; OTSU H, 1990, CELL STRUCT FUNCT, V15, P167; PARYS JB, 1994, DEV BIOL, V161, P466, DOI 10.1006/dbio.1994.1045; PARYS JB, 1992, J BIOL CHEM, V267, P18776; ROSS CA, 1989, NATURE, V339, P468, DOI 10.1038/339468a0; ROSSIER MF, 1991, TRENDS NEUROSCI, V14, P310, DOI 10.1016/0166-2236(91)90143-I; ROUELLEROSSIER VB, 1993, J HISTOCHEM CYTOCHEM, V41, P1155; SATOH T, 1990, J CELL BIOL, V111, P615, DOI 10.1083/jcb.111.2.615; SCHAFER R, 1993, BIOPHYS J, V66, pA146; SCHLONDORFF D, 1987, AM J PHYSIOL, V253, pC113; SHARP AH, 1992, J BIOL CHEM, V267, P7444; SHARP AH, 1993, NEUROSCIENCE, V53, P927, DOI 10.1016/0306-4522(93)90478-X; SHIRAISHI K, 1995, DEV BIOL, V170, P594, DOI 10.1006/dbio.1995.1239; SOMLYO AP, 1986, HEART CARDIOVASCULAR, P845; STOSSEL TP, 1989, J BIOL CHEM, V264, P18261; SUDHOF TC, 1991, EMBO J, V10, P3199; SUPATTAPONE S, 1988, J BIOL CHEM, V263, P1530; THOMAS AP, 1992, ADV 2 MESSENGER PHOS, P225; VALDIVIA C, 1992, BIOPHYS J, V61, P1184; VILLA A, 1993, J CELL BIOL, V121, P1041, DOI 10.1083/jcb.121.5.1041; WALKER JW, 1987, NATURE, V327, P249, DOI 10.1038/327249a0; WALTON PD, 1991, J CELL BIOL, V113, P1145, DOI 10.1083/jcb.113.5.1145; WORLEY PF, 1989, J NEUROSCI, V9, P338; YAMAMOTO H, 1989, J NEUROCHEM, V53, P917, DOI 10.1111/j.1471-4159.1989.tb11792.x	74	27	28	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010	0302-766X			CELL TISSUE RES	Cell Tissue Res.	AUG	1996	285	2					235	251		10.1007/s004410050641		17	Cell Biology	Cell Biology	UY856	WOS:A1996UY85600008		
J	Urakami, T; Tanaka, A; Tanimoto, T; Niki, E				Urakami, T; Tanaka, A; Tanimoto, T; Niki, E			Synthesis and aldose reductase-inhibitory activity of imidazopyrroloquinoline esters	CHEMICAL & PHARMACEUTICAL BULLETIN			English	Article						pyrroloquinoline quinone; imidazopyrroloquinoline; aldose reductase inhibitor; pyrroloquinoline quinone derivative; imidazopyrroloquinoline compound	DIABETIC-LIKE RETINOPATHY; PYRROLOQUINOLINE QUINONE; RABBIT LENS; NERVE; RAT; PURIFICATION; DERIVATIVES; NEUROPATHY; SORBITOL; OXAZOLE	Derivatives of imidazopyrroloquinoline (IPQ) and its esters were synthesized. Some of these compounds potently inhibited aldose reductases of rabbit lens and dog kidney, as well as the human recombinant enzyme, though the coenzyme pyrroloquinoline quinone (PQQ) was a relatively poor inhibitor. The IPQ esters with a methyl substituent at the C-3 carboxyl group were less potent inhibitors than the analogs without esterification at this position. An IPQ ester with the free carboxyl group at C-3 inhibited sorbitol accumulation in rat red blood cells.	MITSUBISHI GAS CHEM CO, NIIGATA RES LAB, TAYUHAMA, NIIGATA 95031, JAPAN; NATL INST HYG SCI, OSAKA BRANCH, DIV BIOL CHEM, CHUO KU, OSAKA 540, JAPAN; UNIV TOKYO, ADV SCI & TECHNOL RES CTR, MEGURO KU, TOKYO 153, JAPAN	Urakami, T (reprint author), MITSUBISHI GAS CHEM CO, DIV BIOCHEM, CHIYODA KU, MARUNOUCHI, TOKYO 100, JAPAN.						AIDA K, 1986, HORUMON TO RINSHO, V34, P523; ROBISON WG, 1983, SCIENCE, V221, P1177, DOI 10.1126/science.6612330; ENGERMAN RL, 1984, DIABETES, V33, P97, DOI 10.2337/diabetes.33.1.97; DUINE JA, 1981, EUR J BIOCHEM, V118, P395; YAMAGUCHI K, 1993, BIOSCI BIOTECH BIOCH, V57, P1231; PETERSON MJ, 1979, METABOLISM, V28, P456, DOI 10.1016/0026-0495(79)90056-8; KILLGORE J, 1989, SCIENCE, V245, P850, DOI 10.1126/science.2549636; KUMAZAWA T, 1992, BIOCHIM BIOPHYS ACTA, V1156, P62, DOI 10.1016/0304-4165(92)90096-D; NAITO Y, 1993, LIFE SCI, V52, P1909, DOI 10.1016/0024-3205(93)90631-C; SALISBURY SA, 1979, NATURE, V280, P843, DOI 10.1038/280843a0; DUINE JA, 1987, ADV ENZYMOL RAMB, V59, P169; GIUGLIANO D, 1993, ANN INTERN MED, V118, P7; GREENE DA, 1984, DIABETES, V33, P712, DOI 10.2337/diabetes.33.8.712; HAMAGISHI Y, 1990, J PHARMACOL EXP THER, V255, P980; KINOSHITA JH, 1988, DIABETES METAB REV, V4, P323; MALONE JI, 1980, DIABETES, V29, P861, DOI 10.2337/diabetes.29.11.861; MINCEY T, 1981, BIOCHEMISTRY-US, V20, P7502, DOI 10.1021/bi00529a027; MIYAHARA N, 1992, CHEM PHARM BULL, V40, P245; NISHIGORI H, 1989, LIFE SCI, V45, P593, DOI 10.1016/0024-3205(89)90044-1; NISHIMURA C, 1991, BIOCHIM BIOPHYS ACTA, V1078, P171; NISHIMURA C, 1987, J NEUROCHEM, V49, P290, DOI 10.1111/j.1471-4159.1987.tb03428.x; OHTA M, 1991, BIOCHIM BIOPHYS ACTA, V1078, P395, DOI 10.1016/0167-4838(91)90162-S; ROBISON WG, 1989, INVEST OPHTH VIS SCI, V30, P2285; SIMA AAF, 1990, J CLIN INVEST, V85, P1410, DOI 10.1172/JCI114585; TANIMOTO T, 1983, CHEM PHARM BULL, V31, P2395; TANIMOTO T, 1984, CHEM PHARM BULL, V32, P1032; URAKAMI T, 1995, INT J SYST BACTERIOL, V45, P528; URAKAMI T, 1993, BITAMINS, V67, P485; Urakami T, 1995, BIOFACTORS, V5, P75; URAKAMI T, 1992, APPL ENVIRON MICROB, V58, P3970; URAKMAI T, 1996, IN PRESS BIOFACTORS; WATANABE W, 1988, CURR THER RES, V44, P896	32	6	6	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0009-2363			CHEM PHARM BULL	Chem. Pharm. Bull.	AUG	1996	44	8					1493	1497				5	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	VE167	WOS:A1996VE16700011		
J	Lovallo, MC; Tsapatsis, M; Okubo, T				Lovallo, MC; Tsapatsis, M; Okubo, T			Preparation of an asymmetric zeolite L film	CHEMISTRY OF MATERIALS			English	Article							COMPOSITE MEMBRANES; POROUS ALPHA-AL2O3; ZSM-5 MEMBRANES; PERMEATION; CATALYSTS; CRYSTALS	A self-supported asymmetric zeolite L film has been prepared through zeolite colloidal suspension processing followed by secondary (seeded) growth. Secondary growth is implemented to reduce interzeolitic (meso) porosity in the film. The resulting film varies in both porosity and grain size with a continuous, intergrown, thin (<200 nm) top layer (shown here) of zeolite L crystals.	UNIV MASSACHUSETTS,DEPT CHEM ENGN,AMHERST,MA 01003; UNIV TOKYO,DEPT CHEM SYST ENGN,BUNKYO KU,TOKYO 113,JAPAN							ANDERSON MW, 1992, J MATER CHEM, V2, P255, DOI 10.1039/jm9920200255; PERSSON AE, 1994, ZEOLITES, V14, P557, DOI 10.1016/0144-2449(94)90191-0; YAN YS, 1995, IND ENG CHEM RES, V34, P1652, DOI 10.1021/ie00044a018; YAN YS, 1995, J CHEM SOC CHEM COMM, P227, DOI 10.1039/c39950000227; ROLISON DR, 1990, CHEM REV, V90, P867, DOI 10.1021/cr00103a011; ARMOR JN, 1994, CHEM MATER, V6, P730, DOI 10.1021/cm00042a006; PERSSON AE, 1995, ZEOLITES, V15, P611, DOI 10.1016/0144-2449(95)00070-M; JIA MD, 1991, J MEMBRANE SCI, V57, P289, DOI 10.1016/S0376-7388(00)80684-5; BEIN T, 1989, ZEOLITES FACTS FIGUR; BEIN T, 1989, J AM CHEM SOC, V111, P7641; Bhave R.R., 1991, INORGANIC MEMBRANES; DAVIS ME, 1991, IND ENG CHEM RES, V30, P1675, DOI 10.1021/ie00056a001; GEUS ER, 1993, MICROPOROUS MATER, V1, P131, DOI 10.1016/0927-6513(93)80019-Q; HENNEPE H J C, 1987, Journal of Membrane Science, V35, P39; Hennepe T., 1990, Pervaporation process and membrane, Patent No. [US 4925562, 4925562]; Hirsch P., 1977, ELECT MICROSCOPY THI; JIA MD, 1994, J MEMBRANE SCI, V90, P1, DOI 10.1016/0376-7388(94)80029-4; LAO H, 1994, J MATER SCI LETT, V13, P895, DOI 10.1007/BF00273242; Meier W., 1992, ATLAS ZEOLITE STRUCT; MENG X, 1993, P 9 INT ZEOL C; OTTERSTEDT JE, 1993, Patent No. 9405597; OZIN GA, 1989, ANGEW CHEM INT EDIT, V28, P359, DOI 10.1002/anie.198903591; SANO T, 1991, ZEOLITES, V11, P842, DOI 10.1016/S0144-2449(05)80066-1; SANO T, 1994, STUD SURF SCI CATAL, V84, P1175; SANO T, 1995, CHEM LETT, V2, P153; Spence J. C., 1992, ELECT MICRODIFFRACTI; TSAPATSIS M, 1995, CHEM MATER, V7, P1734, DOI 10.1021/cm00057a025; TSAPATSIS M, 1995, MATER RES SOC SYMP P, V371, P21; Tsapatsis M, 1996, MICROPOROUS MATER, V5, P381, DOI 10.1016/0927-6513(95)00069-0; TSIKOYIANNIS JG, 1992, ZEOLITES, V12, P126, DOI 10.1016/0144-2449(92)90070-6; VERDUIJN JP, 1991, Patent No. 5064630; WERNER L, 1992, ZEOLITES, V12, P658, DOI 10.1016/0144-2449(92)90111-2; YAMAMURA M, 1994, ZEOLITES, V14, P643, DOI 10.1016/0144-2449(94)90121-X; YAMAZAKI S, 1995, MICROPOROUS MATER, V4, P205, DOI 10.1016/0927-6513(95)00006-U	34	75	80	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036	0897-4756			CHEM MATER	Chem. Mat.	AUG	1996	8	8					1579	&		10.1021/cm960037b		6	Chemistry, Physical; Materials Science, Multidisciplinary	Chemistry; Materials Science	VC732	WOS:A1996VC73200004		
J	Fujimoto, M; Sato, S; Ihn, H; Tamaki, T; Kikuchi, K; Soma, Y; Tamaki, K				Fujimoto, M; Sato, S; Ihn, H; Tamaki, T; Kikuchi, K; Soma, Y; Tamaki, K			Autoantibodies to mitochondrial 2-oxo-acid dehydrogenase complexes in localized scleroderma	CLINICAL AND EXPERIMENTAL IMMUNOLOGY			English	Article						anti-mitochondrial antibodies; pyruvate dehydrogenase complex	PRIMARY BILIARY-CIRRHOSIS; SINGLE-STRANDED-DNA; SYSTEMIC-SCLEROSIS; ANTIHISTONE ANTIBODIES; AUTO-ANTIGENS; IDENTIFICATION; SPECIFICITY; DISEASES	Sera from patients with localized scleroderma frequently produce cytoplasmic staining by indirect immunofluorescence, although the antigen remains to be determined. We studied the prevalence, antigen specificity and associated clinical characteristics of anti-cytoplasmic antibodies in localized scleroderma. Serum samples from 60 patients with localized scleroderma were examined by indirect immunofluorescence analysis and immunoblotting. By immunofluorescence analysis on HEp-2 cell substrate, seven of 60 (12%) patients were shown to be positive for anti-cytoplasmic antibodies. Among these, six patients with generalized morphea had anti-mitochondrial antibodies as shown by immunoblotting: they showed reactivity with the E2 component of pyruvate dehydrogenase complex (PDC), with protein X, and with the E2 component of alpha-oxo-glutarate dehydrogenase complex, while two of them showed reactivity with PDC-E1 alpha. One of these patients who was positive for anti-PDC-E1 alpha antibody showed laboratory abnormalities, suggesting the presence of primary biliary cirrhosis. The age of disease onset was significantly higher in these six patients than in those without anti-mitochondrial antibodies. Furthermore, five of them were classified into generalized morphea with multiple plaque lesions but without linear lesions (multiple plaque type). These observations suggest that major antigens for anti-cytoplasmic antibodies in patients with localized scleroderma are mitochondrial enzymes, 2-oxo-acid dehydrogenase complexes. Patients with anti-mitochondrial antibodies may comprise a unique subset of localized scleroderma designated multiple plaque type of generalized morphea of older onset.	UNIV TOKYO,FAC MED,DEPT DERMATOL,TOKYO 113,JAPAN; TOKYO METROPOLITAN POLICE HOSP,DIV DERMATOL,TOKYO,JAPAN							BIRDI N, 1993, ARTHRITIS RHEUM, V36, P410, DOI 10.1002/art.1780360318; GERSHWIN ME, 1987, J IMMUNOL, V138, P3525; SURH CD, 1989, HEPATOLOGY, V9, P63, DOI 10.1002/hep.1840090110; GERSHWIN ME, 1991, GASTROENTEROLOGY, V100, P822; BASSENDINE MF, 1989, SEMIN LIVER DIS, V9, P124, DOI 10.1055/s-2008-1040503; FALANGA V, 1986, ANN INTERN MED, V104, P849; Falanga V, 1985, ARCH DERMATOL, V123, P350; FALANGA V, 1985, ARCH DERMATOL, V121, P345, DOI 10.1001/archderm.121.3.345; FREGEAU DR, 1988, ARTHRITIS RHEUM, V31, P386, DOI 10.1002/art.1780310310; FUJIMOTO M, 1995, ARTHRITIS RHEUM, V38, P985, DOI 10.1002/art.1780380715; FUJIMOTO M, 1995, ARCH DERMATOL RES, V287, P581, DOI 10.1007/BF00374080; FUSSEY SPM, 1989, CLIN SCI, V77, P365; GUPTA RC, 1984, CLIN EXP IMMUNOL, V58, P68; JABLONSKA S, 1962, DERMATOLOGICA, V125, P140; KAPLAN MM, 1987, NEW ENGL J MED, V316, P521, DOI 10.1056/NEJM198702263160907; MOURITSEN S, 1986, CLIN EXP IMMUNOL, V66, P68; SATO S, 1994, ARCH DERMATOL, V130, P1273, DOI 10.1001/archderm.130.10.1273; SATO S, 1993, ARTHRITIS RHEUM, V36, P1137, DOI 10.1002/art.1780360815; SCAROLA JA, 1975, ARTHRITIS RHEUM, V18, P526; TAKEHARA K, 1983, ARTHRITIS RHEUM, V26, P612, DOI 10.1002/art.1780260506; TUFFANELLI D, 1961, ARCH DERMATOL, V84, P359; ZURGIL N, 1992, J CLIN IMMUNOL, V12, P201, DOI 10.1007/BF00918090	22	10	10	BLACKWELL SCIENCE LTD	OXFORD	OSNEY MEAD, OXFORD, OXON, ENGLAND OX2 0EL	0009-9104			CLIN EXP IMMUNOL	Clin. Exp. Immunol.	AUG	1996	105	2					297	301		10.1046/j.1365-2249.1996.d01-756.x		5	Immunology	Immunology	UZ369	WOS:A1996UZ36900017		
J	Saito, S; Karaki, H				Saito, S; Karaki, H			A family of novel actin-inhibiting marine toxins	CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY			English	Article						actin; aplyronine A; bistheonellide A; marine toxins; mycalolide B	MYCALOLIDE-B; SWINHOLIDE-A; SPONGE; POLYMERIZATION; FILAMENTS; CYTOCHALASIN; PHALLOIDIN; ELONGATION; PROFILIN; SEA	1. We have examined the effects of marine toxins with a macrolide structure on actin, These toxins include mycalolide B, aplyronine A and bistheonellide A. 2. Measuring actin polymerization by monitoring fluorescent intensity of pyrenyl-actin, mycalolide B did not accelerate the actin polymerization but quickly depolymerized F-actin. In contrast, cytochalasin D, which inhibits actin polymerization by binding to the barbed end of F-actin, accelerated actin nucleation and depolymerized F-actin at a slower rate. 3. Analysing the kinetics of depolymerization by monitoring the rate of spontaneous depolymerization of F-actin under the unpolymerizable state or the rate of polymerization where F-actin was seeded as a nucleus, mycalolide B was suggested to sever F-actin. 4. The relationship between the concentration of total actin and F-actin at different concentrations of mycalolide B suggests that mycalolide B forms a 1:1 complex with G-actin, Viscometry and electron microscopic observations further suggest that the actin filament was depolymerized by mycalolide B. Furthermore, mycalolide B suppressed actin-activated myosin Mg2+-ATPase activity, although cytochalasin D did not, Aplyronine A has similar effects on actin. 5. Bistheonellide A also depolymerized F-actin and sequestered G-actin by forming a 1:2 complex with G-actins, hut, its severing effect was not detected, We conclude that mycalolide B, aplyronine A and bistheonellide A are novel types of actin-depolymerizing agents, the mechanism of action of which is different from that of cytochalasin D. These structurally related marine toxins may be categorized as 'actin depolymerizing macrolides' and may serve as novel pharmacological tools for analysing actin-mediated cell functions.	UNIV TOKYO,GRAD SCH AGR & LIFE SCI,DEPT VET PHARMACOL,BUNKYO KU,TOKYO 113,JAPAN							POLLARD TD, 1984, BIOCHEMISTRY-US, V23, P6631, DOI 10.1021/bi00321a054; CARMELY S, 1985, TETRAHEDRON LETT, V26, P511, DOI 10.1016/S0040-4039(00)61925-1; BUBB MR, 1995, J BIOL CHEM, V270, P3463; KATO Y, 1987, TETRAHEDRON LETT, V28, P6225, DOI 10.1016/S0040-4039(00)61853-1; YAMADA K, 1993, J AM CHEM SOC, V115, P11020, DOI 10.1021/ja00076a082; ISHIBASHI M, 1986, J ORG CHEM, V51, P5300, DOI 10.1021/jo00376a047; COOPER JA, 1987, J CELL BIOL, V105, P1473, DOI 10.1083/jcb.105.4.1473; SAITO S, 1994, J BIOL CHEM, V269, P29710; COOPER JA, 1991, ANNU REV PHYSIOL, V53, P585, DOI 10.1146/annurev.physiol.53.1.585; FUSETANI N, 1989, TETRAHEDRON LETT, V30, P2809, DOI 10.1016/S0040-4039(00)99131-7; FUSETANI N, 1990, NEW J CHEM, V14, P721; Fusetani N., 1987, BIOORGANIC MARINE CH, V1, P61; HORI M, 1993, FEBS LETT, V322, P151, DOI 10.1016/0014-5793(93)81557-G; HOWARD TH, 1979, J SUPRAMOL STR CELL, V11, P283, DOI 10.1002/jss.400110303; LAL AA, 1985, J BIOL CHEM, V260, P132; MACIVER SK, 1991, J CELL BIOL, V115, P1611, DOI 10.1083/jcb.115.6.1611; NISHIDA E, 1983, J BIOCHEM-TOKYO, V93, P1011; OFFER G, 1972, J MOL BIOL, V66, P435, DOI 10.1016/0022-2836(72)90425-1; PATTERSON GML, 1993, CELL MOTIL CYTOSKEL, V24, P39, DOI 10.1002/cm.970240105; SAITO S, 1995, J MUSCLE RES CELL M, V16, P340; Saito Shin-Ya, 1995, Japanese Journal of Pharmacology, V67, p205P; SAMPATH P, 1991, BIOCHEMISTRY-US, V30, P1973, DOI 10.1021/bi00221a034; STOSSEL TP, 1989, J BIOL CHEM, V264, P18261	23	25	25	BLACKWELL SCIENCE	CARLTON	54 UNIVERSITY ST, P O BOX 378, CARLTON VICTORIA 3053, AUSTRALIA	0305-1870			CLIN EXP PHARMACOL P	Clin. Exp. Pharmacol. Physiol.	AUG	1996	23	8					743	746		10.1111/j.1440-1681.1996.tb01770.x		4	Pharmacology & Pharmacy; Physiology	Pharmacology & Pharmacy; Physiology	VE531	WOS:A1996VE53100023		
J	Kotaki, H; Tayama, N; Ito, K; Mitomi, N; Tezuka, K; Kaga, K; Sawada, Y; Iga, T				Kotaki, H; Tayama, N; Ito, K; Mitomi, N; Tezuka, K; Kaga, K; Sawada, Y; Iga, T			Safe and effective topical application dose of lidocaine for surgery with laryngomicroscopy	CLINICAL PHARMACOLOGY & THERAPEUTICS			English	Editorial Material							VISCOUS LIDOCAINE; LIVER-DISEASE; ANESTHESIA	A clinical case of a patient in whom seizure developed after topical application of lidocaine to the oropharyngeal region was described. The exploratory studies on the optimal dosage of lidocaine in the surgery under laryngomicroscope was performed in 22 patients. During the application of 2% lidocaine viscous and 4% lidocaine solution to the oropharyngeal region, the patient was instructed to expectorate the excess intermittently to avoid absorption. In addition, the oropharyngeal region was swabbed with gauze. The serum Lidocaine concentrations after application were less than 1.8 mu g/ml. The total application dose of the drug was within the range of 324 to 640 mg, and the total recovery rate from the saliva and gauze was 52% to 81%. We found a good correlation between net application dose (total application dose minus excessive lidocaine dose) and serum lidocaine concentration. In this study, it was shown that the safe and effective net application dose of Lidocaine for the surgery may be within the range of 127 to 260 mg.	UNIV TOKYO HOSP,FAC MED,DEPT OTOLARYNGOL,BUNKYO KU,TOKYO 113,JAPAN; KYUSHU UNIV,FAC PHARMACEUT SCI,FUKUOKA 812,JAPAN	Kotaki, H (reprint author), UNIV TOKYO HOSP,FAC MED,DEPT PHARM,BUNKYO KU,TOKYO 113,JAPAN.						THOMSON PD, 1973, ANN INTERN MED, V78, P499; WU FL, 1993, PHARMACOTHERAPY, V13, P72; BUCKMAN K, 1980, CLIN PHARMACOL THER, V28, P177; FORREST JAH, 1977, BRIT MED J, V1, P1384; FRUNCILLO RJ, 1985, NEW ENGL J MED, V306, P426; GIANELLY R, 1967, NEW ENGL J MED, V277, P1215, DOI 10.1056/NEJM196712072772301; GIARD MJ, 1983, CLIN PHARMACY, V2, P110; KEENAGHAN J B, 1972, Journal of Pharmacology and Experimental Therapeutics, V180, P454; MOFENSON HC, 1983, CLIN PEDIATR, V22, P190, DOI 10.1177/000992288302200306; NATION RL, 1977, BRIT J CLIN PHARMACO, V4, P439; PARISH RC, 1985, DRUG INTEL CLIN PHAR, V19, P199; PIEPER JA, 1990, APPL PHARMACOKINETIC, P21; Ritchie JM, 1985, PHARMACOL BASIS THER, P303; ROTHSTEIN P, 1982, J PEDIATR-US, V101, P461, DOI 10.1016/S0022-3476(82)80088-7; 1995, PHYSICIANS DESK REFE, P580	15	4	4	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0009-9236			CLIN PHARMACOL THER	Clin. Pharmacol. Ther.	AUG	1996	60	2					229	235		10.1016/S0009-9236(96)90139-3		7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	VJ969	WOS:A1996VJ96900014		
J	Awata, H; Kubo, H; Odake, S; Shiraishi, J				Awata, H; Kubo, H; Odake, S; Shiraishi, J			Quantum W-N algebras and Macdonald polynomials	COMMUNICATIONS IN MATHEMATICAL PHYSICS			English	Article							CALOGERO-SUTHERLAND MODEL; FIELD-THEORY	We derive a quantum deformation of the W-N algebra and its quantum Miura transformation, whose singular vectors realize the Macdonald polynomials.	UNIV TOKYO,FAC SCI,DEPT PHYS,TOKYO 113,JAPAN; SHINSHU UNIV,FAC SCI,DEPT PHYS,MATSUMOTO,NAGANO 390,JAPAN; UNIV TOKYO,INST SOLID STATE PHYS,TOKYO 106,JAPAN	Awata, H (reprint author), KYOTO UNIV,YUKAWA INST THEORET PHYS,KYOTO 606,JAPAN.						AWATA H, 1995, NUCL PHYS B, V449, P347, DOI 10.1016/0550-3213(95)00286-2; AWATA H, 1995, PHYS LETT B, V347, P49, DOI 10.1016/0370-2693(95)00055-P; FATEEV VA, 1988, INT J MOD PHYS A, V3, P507, DOI 10.1142/S0217751X88000205; STANLEY RP, 1989, ADV MATH, V77, P76, DOI 10.1016/0001-8708(89)90015-7; AWATA H, IN PRESS COMMUN MATH; AWATA H, 1995, HEPTH9503028, V91, P169; CHEREDNIK L, 1991, RISM776; FRENKEL E, QALG9505025; LAPOINTE L, HEPTH9507073; Macdonald I. G., 1995, SYMMETRIC FUNCTIONS; MATSUO A, 1992, INVENT MATH, V110, P95, DOI 10.1007/BF01231326; MIMACHI K, 1994, WORKSH HYP FUNCT RIM; MIMACHI K, IN PRESS COMMUN MATH; PUGAI Y, HEPTH9412128; RUIJSENAARS SNM, 1987, COMMUN MATH PHYS, V110, P191, DOI 10.1007/BF01207363; SHIRAISHI J, IN PRESS LETT MATH P; SUTHERLA.B, 1972, PHYS REV A-GEN PHYS, V5, P1372, DOI 10.1103/PhysRevA.5.1372; SUTHERLA.B, 1971, PHYS REV A, V4, P2019, DOI 10.1103/PhysRevA.4.2019	18	72	73	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010	0010-3616			COMMUN MATH PHYS	Commun. Math. Phys.	AUG	1996	179	2					401	415		10.1007/BF02102595		15	Physics, Mathematical	Physics	UZ582	WOS:A1996UZ58200006		
J	Yanagi, T; Tadokoro, K; Saino, T				Yanagi, T; Tadokoro, K; Saino, T			Observation of convergence, divergence and sinking velocity at a thermohaline front in the Kii Channel, Japan	CONTINENTAL SHELF RESEARCH			English	Article							SEA FRONT	Detailed Row structure around a thermohaline front in the Kii Channel, Japan, was observed for the first time with the use of an 130 kHz Acoustic Doppler Current Profiler (ADCP). Surface water converged with counter-clockwise motion at the interface between cold coastal water and warm offshore water. After sinking, these waters diverged with a clockwise motion, forming skirt-like distributions in the lower layer below the front. The maximum surface convergence and sinking velocity were 2.0 x 10(-4) s(-1) and 0.25 cm s(-1), respectively. These observations and our results substantiate previous numerical studies. (C) 1996 Elsevier Science Ltd	UNIV TOKYO,OCEAN RES INST,NAKANO KU,TOKYO 130,JAPAN	Yanagi, T (reprint author), EHIME UNIV,DEPT CIVIL & OCEAN ENGN,MATSUYAMA,EHIME 790,JAPAN.						AKAMATSU H, 1975, UMI SORA, V50, P123; Akitomo K., 1988, J OCEANOGRAPHIC SOC, V44, P171, DOI 10.1007/BF02302641; AKITOMO K, 1990, J PHYS OCEANOGR, V20, P172, DOI 10.1175/1520-0485(1990)020<0172:ANSOAS>2.0.CO;2; BOUCHER J, 1987, J MAR RES, V45, P133; MOLINARI R, 1975, J PHYS OCEANOGR, V5, P483, DOI 10.1175/1520-0485(1975)005<0483:CODKPF>2.0.CO;2; KIORBOE T, 1988, MAR ECOL PROG SER, V44, P205, DOI 10.3354/meps044205; ENDOH M, 1977, J OCEANOGRAPHIC SOC, V33, P6, DOI 10.1007/BF02110843; Harashima A, 1981, J OCEANOGR SOC JPN, V37, P49, DOI 10.1007/BF02342314; HORNE EP, 1978, OCEANIC FRONTS COAST, P105; *IGBP, 1993, 25 IGBP; ISHIMARU T, 1984, Journal of the Oceanographical Society of Japan, V40, P207, DOI 10.1007/BF02302554; KUNISHI H, 1971, ANN REPORT DISASTER, V14, P511; Lie H. -J., 1985, J OCEANOGRAPHICAL SO, V41, P291, DOI 10.1007/BF02109236; Nagashima H., 1979, B COASTAL OCEANOGRAP, V16, P76; TOMOSADA A, 1986, B TOKAI REG FISHERIE, V120, P11; Uye S.-I., 1992, Fisheries Oceanography, V1, P216, DOI 10.1111/j.1365-2419.1992.tb00040.x; YANAGI T, 1992, B COASTAL OCEANOGRAP, V30, P108; YANAGI T, 1992, DYNAMICS EXCHANGES E, P617; YANAGI T, 1989, CONT SHELF RES, V9, P77, DOI 10.1016/0278-4343(89)90084-8; Yanagi T., 1980, J OCEANOGR SOC JAPAN, V35, P253, DOI 10.1007/BF02108930; Yoshioka H., 1988, UMI TO SORA, V64, P79	21	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB	0278-4343			CONT SHELF RES	Cont. Shelf Res.	AUG	1996	16	10					1319	&		10.1016/0278-4343(95)00073-9		9	Oceanography	Oceanography	UQ378	WOS:A1996UQ37800005		
J	Nogami, J; Nakasuka, S; Tanabe, T				Nogami, J; Nakasuka, S; Tanabe, T			Real-time decision support for air traffic management, utilizing machine learning	CONTROL ENGINEERING PRACTICE			English	Article						air traffic control; scheduling algorithms; decision support systems; machine learning; optimization problems; neural networks; real-time systems		Intelligent air traffic management (ATM) systems will be necessary for future air traffic control (ATC), which can manage air traffic hows and flight schedules efficiently in a real-time fashion. To meet this objective, in this paper, an automated decision support system is described. This system consists of several distributed decision-makers, and uses the concept learning scheme using neural networks. The system has the capability to find a suboptimal solution without interrupting the actual operations, in order to deal with various constraints. Simulation studies show that the proposed scheduling strategy works rather more efficiently than the current ATC procedures based on fixed heuristic rules.		Nogami, J (reprint author), UNIV TOKYO,FAC ENGN,DEPT AERONAUT & ASTRONAUT,BUNKYO KU,HONGO 7,TOKYO 113,JAPAN.						Bianco L., 1993, LARGE SCALE COMPUTAT, P47; ERZBERGER H, 1994, P AGARD GUID CONTR P; GREFENSTETTE JJ, 1990, MACHINE LEARNING; IBA H, 1992, EVOLUTIONARY LEARNIN; LEVIN KM, 1994, P AGARD GUID CONTR P; NAKASUKA S, 1992, INT J PROD RES, V30, P411, DOI 10.1080/00207549208942903; NAKASUKA S, 1994, T JPN SOC AERONAUT S, V37, P113; NEUMAN F, 1990, 102795 NASA TM; NOGAMI J, 1995, THESIS U TOKYO; NOGAMI J, 1995, P 33 AIRCR S, P677; QIAO M, 1994, REAL TIME AIR TRAFFI, V94, P9; RIOLO RL, 1991, FROM ANIMALS TO ANIMATS, P316; Sato Y., 1994, Proceedings of the First IEEE Conference on Evolutionary Computation. IEEE World Congress on Computational Intelligence (Cat. No.94TH0650-2), DOI 10.1109/ICEC.1994.349959; SYNNESTVEDT RG, 1995, 4700 NASA TM; TOBIAS L, 1986, 88234 NASA TM; VISSER HG, 1991, AEROSPACE SCI, V28, P323; VOLCKERS U, 1989, 893627 AIAA; VRANAS PB, 1992, THESIS MIT	18	4	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB	0967-0661			CONTROL ENG PRACT	Control Eng. Practice	AUG	1996	4	8					1129	1141		10.1016/0967-0661(96)00113-X		13	Automation & Control Systems; Engineering, Electrical & Electronic	Automation & Control Systems; Engineering	VC589	WOS:A1996VC58900012		
J	Suzuki, T; Itoh, K; Hagiwara, T; Nakayama, H; Honjyo, K; Hirota, Y; Kaneko, T; Suzuki, H				Suzuki, T; Itoh, K; Hagiwara, T; Nakayama, H; Honjyo, K; Hirota, Y; Kaneko, T; Suzuki, H			Inhibition of bacterial translocation from the gastrointestinal tract of mice injected with cyclophosphamide	CURRENT MICROBIOLOGY			English	Article							INDIGENOUS BACTERIA; ESCHERICHIA-COLI; LYMPH-NODES; INTESTINES; ORGANS; MODEL	Effects of intraperitoneal injection of cyclophosphamide, an immunosuppressant, on the degree of bacterial translocation and morphological changes of Peyer's patches (PP) in the intestine were investigated with antibiotic-decontaminated SPF mice and germfree mice monoassociated with Escherichia coli C25. It has been reported that treatment with cyclophosphamide induces bacterial translocation. Cyclophosphamide treatment in this study, however, significantly decreased E. coli C25 translocation from the gastrointestinal tract to the mesenteric lymph nodes (MLN), although the numbers of lymphoid cells, especially B cells, in the PP, MLN, and spleen were remarkably reduced. Four injections of cyclophosphamide at a dose of 100 mg/kg inhibited bacterial translocation more than one injection at a dose of 200 mg/kg in SPF mice. Germfree mice, however, treated with one dose of 200 mg/kg showed the same inhibition of bacterial translocation as those given 100 mg/kg four times. In cyclophosphamide-treated mice, lymph follicles in the PP were obviously smaller than those in control mice, M-cells were similar in appearance to absorption epithelial cells except for short microvilli, and immune cells among the M-cells had disappeared, These data suggested that inhibition of bacterial translocation in mice treated with cyclophosphamide may be the result of morphological and physiological changes of epithelial cells in the gastrointestinal tract, especially M-cells, as a point of entry of invading bacteria, independent of the changes in immunological function.	UNIV TOKYO,FAC AGR,DEPT VET PUBL HLTH,BUNKYO KU,TOKYO 113,JAPAN; MEIJI MILK PROD,CENT RES INST,TOKYO 189,JAPAN; UNIV TOKYO,FAC AGR,DEPT VET PATHOL,BUNKYO KU,TOKYO 113,JAPAN; NATL INST ANIM HLTH,LAB IMMUNE CYTOL,TSUKUBA,IBARAKI 305,JAPAN							BERG RD, 1979, INFECT IMMUN, V23, P403; HARMSEN AG, 1985, SCIENCE, V230, P1277, DOI 10.1126/science.4071052; BERG RD, 1988, ARCH SURG-CHICAGO, V123, P1359; BERG RD, 1983, CURR MICROBIOL, V8, P285, DOI 10.1007/BF01577729; BERG RD, 1985, EXP ANIM TOKYO, V34, P1; BERG RD, 1980, INFECT IMMUN, V29, P1073; BERG RD, 1986, MICROECOL THER, V16, P131; EDMISTON CE, 1991, SURG GYNECOL OBSTET, V173, P73; FUJIMURA Y, 1990, Kawasaki Medical Journal, V16, P181; GEBBERS JO, 1984, MICROECOLOGY THERAPY, V14, P137; GRUTZKAU A, 1990, GUT, V31, P1011, DOI 10.1136/gut.31.9.1011; MOREHOUSE JL, 1986, GASTROENTEROLOGY, V91, P673; PAPPO J, 1989, CLIN EXP IMMUNOL, V76, P144; PENN RL, 1991, J INFECT DIS, V164, P1168; SAVIDGE TC, 1989, J PHYSL, V422, P84; WELLS CL, 1988, REV INFECT DIS, V10, P958	16	3	3	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010	0343-8651			CURR MICROBIOL	Curr. Microbiol.	AUG	1996	33	2					78	83		10.1007/s002849900078		6	Microbiology	Microbiology	UX966	WOS:A1996UX96600002		
J	Kusumi, A; Sako, Y				Kusumi, A; Sako, Y			Cell surface organization by the membrane skeleton	CURRENT OPINION IN CELL BIOLOGY			English	Article							SINGLE-PARTICLE TRACKING; LOW-DENSITY-LIPOPROTEIN; LATERAL DIFFUSION; PLASMA-MEMBRANE; NANOVID MICROSCOPY; CYTOPLASMIC BARRIERS; IMAGING MICROSCOPY; OPTICAL MICROSCOPY; GROWTH CONE; RECEPTOR	Single-particle tracking and laser tweezers have facilitated the observation of the mechanics of molecular interactions in the plasma membrane of living cells at the level of single (or a few) molecules at nanometer/piconewton precision. These techniques have recently revealed that the membrane skeleton provides both confining and binding effects on the movement of membrane proteins, and that it can play a pivotal role in the molecular organization of the plasma membrane, especially in the formation of special membrane domains.		Kusumi, A (reprint author), UNIV TOKYO,GRAD SCH ARTS & SCI,DEPT LIFE SCI,MEGURO KU,KOMABA 3-8-1,TOKYO 153,JAPAN.		Sako, Yasushi/B-3253-2015	Sako, Yasushi/0000-0002-5707-5455			GHISLAIN LP, 1993, OPT LETT, V18, P1678, DOI 10.1364/OL.18.001678; SAXTON MJ, 1995, BIOPHYS J, V69, P389; SAXTON MJ, 1993, BIOPHYS J, V64, P1766; JACOBSON K, 1995, SCIENCE, V268, P1441, DOI 10.1126/science.7770769; KUSUMI A, 1993, BIOPHYS J, V65, P2021; DISCHER DE, 1994, SCIENCE, V266, P1032, DOI 10.1126/science.7973655; BENNETT V, 1993, ANNU REV CELL BIOL, V9, P27, DOI 10.1146/annurev.cb.09.110193.000331; ASHKIN A, 1987, NATURE, V330, P769, DOI 10.1038/330769a0; HWANG J, 1995, SCIENCE, V270, P610, DOI 10.1126/science.270.5236.610; EDIDIN M, 1991, SCIENCE, V254, P1379, DOI 10.1126/science.1835798; SIMSON R, 1995, BIOPHYS J, V69, P989; GADELLA TWJ, 1995, J CELL BIOL, V129, P1543, DOI 10.1083/jcb.129.6.1543; ASHKIN A, 1990, NATURE, V348, P346, DOI 10.1038/348346a0; SCHNITZER JE, 1995, SCIENCE, V269, P1435, DOI 10.1126/science.7660128; SAKO Y, 1995, J CELL BIOL, V129, P1559, DOI 10.1083/jcb.129.6.1559; METZGER H, 1992, J IMMUNOL, V149, P1477; KLYMKOWSKY MW, 1995, CELL, V83, P5, DOI 10.1016/0092-8674(95)90226-0; SAKO Y, 1994, J CELL BIOL, V125, P1251, DOI 10.1083/jcb.125.6.1251; GHOSH RN, 1994, BIOPHYS J, V66, P1301; HELDIN CH, 1995, CELL, V80, P213, DOI 10.1016/0092-8674(95)90404-2; Qian H, 1991, BIOPHYS J, V60, P910; GRASBERGER B, 1986, P NATL ACAD SCI USA, V83, P6258, DOI 10.1073/pnas.83.17.6258; MCNEILL H, 1993, J CELL BIOL, V120, P1217, DOI 10.1083/jcb.120.5.1217; MIYAMOTO S, 1995, SCIENCE, V267, P883, DOI 10.1126/science.7846531; PETERSEN NO, 1993, BIOPHYS J, V65, P1135; EDIDIN M, 1994, P NATL ACAD SCI USA, V91, P3378, DOI 10.1073/pnas.91.8.3378; DAI JW, 1995, BIOPHYS J, V68, P988; EVANS E, 1995, BIOPHYS J, V68, P2580; PARTON RG, 1995, SCIENCE, V269, P1398, DOI 10.1126/science.7660120; SAXTON MJ, 1987, BIOPHYS J, V52, P989; MIYAMOTO S, 1995, J CELL BIOL, V131, P791, DOI 10.1083/jcb.131.3.791; ASHKIN A, 1986, OPT LETT, V11, P288, DOI 10.1364/OL.11.000288; LUNA EJ, 1992, SCIENCE, V258, P955, DOI 10.1126/science.1439807; PARTON RG, 1994, J CELL BIOL, V127, P1199, DOI 10.1083/jcb.127.5.1199; SAXTON MJ, 1990, BIOPHYS J, V57, P1167; LEE GM, 1993, J CELL BIOL, V120, P25, DOI 10.1083/jcb.120.1.25; ASHIKAWA I, 1994, BIOCHEMISTRY-US, V33, P4947, DOI 10.1021/bi00182a025; ANDERSON CM, 1992, J CELL SCI, V101, P415; SAXTON MJ, 1989, BIOPHYS J, V56, P615; MURATA M, 1995, P NATL ACAD SCI USA, V92, P10339, DOI 10.1073/pnas.92.22.10339; BENNETT V, 1990, PHYSIOL REV, V70, P1029; BOAL DH, 1995, BIOPHYS J, V69, P372; Cherry Richard J., 1992, Trends in Cell Biology, V2, P242, DOI 10.1016/0962-8924(92)90312-B; CORBETT JD, 1994, J CLIN INVEST, V94, P683, DOI 10.1172/JCI117385; DAI JW, 1995, CELL, V83, P693; DEBRABANDER M, 1991, J CELL BIOL, V112, P111, DOI 10.1083/jcb.112.1.111; EDIDIN M, 1991, J CELL BIOL, V112, P1143, DOI 10.1083/jcb.112.6.1143; Edidin M, 1993, J Cell Sci Suppl, V17, P165; Edidin Michael, 1992, Trends in Cell Biology, V2, P376, DOI 10.1016/0962-8924(92)90050-W; FLORIN EL, 1996, BIOPHYS J, V70, P431; GEERTS H, 1991, NATURE, V351, P765, DOI 10.1038/351765a0; GELLES J, 1988, NATURE, V331, P450, DOI 10.1038/331450a0; HIKICHI MY, 1995, THESIS U TOKYO TOKYO; HITT AL, 1994, CURR OPIN CELL BIOL, V6, P120, DOI 10.1016/0955-0674(94)90125-2; KUCIK DF, 1991, J CELL BIOL, V114, P1029, DOI 10.1083/jcb.114.5.1029; Kuo S C, 1992, Trends Cell Biol, V2, P116, DOI 10.1016/0962-8924(92)90016-G; MURAMATSU H, 1995, APPL PHYS LETT, V66, P3245, DOI 10.1063/1.113392; NELSON WJ, 1992, SCIENCE, V258, P948, DOI 10.1126/science.1439806; SAXTON, 1996, BIOPHYS J, V70, pA334; SAXTON MJ, 1994, BIOPHYS J, V66, P683; SAXTON MJ, 1982, BIOPHYS J, V39, P165; SCHMIDT CE, 1993, J CELL BIOL, V123, P977, DOI 10.1083/jcb.123.4.977; SHEETS ED, 1995, CURR OPIN CELL BIOL, V7, P707, DOI 10.1016/0955-0674(95)80113-8; SHEETZ MP, 1980, NATURE, V285, P510, DOI 10.1038/285510a0; SHEETZ MP, 1989, NATURE, V340, P284, DOI 10.1038/340284a0; SHEETZ MP, 1993, ANNU REV BIOPH BIOM, V22, P417, DOI 10.1146/annurev.bb.22.060193.002221; SVOBODA K, 1994, ANNU REV BIOPH BIOM, V23, P247, DOI 10.1146/annurev.bb.23.060194.001335; TORNISHIGE M, 1995, THESIS U TOKYO TOKYO; TSUJI A, 1988, BIOCHEMISTRY-US, V27, P7447, DOI 10.1021/bi00419a041; TSUJI A, 1986, BIOCHEMISTRY-US, V25, P6133, DOI 10.1021/bi00368a045; van Meer G, 1993, CURR OPIN CELL BIOL, V5, P661; WANG YL, 1994, J CELL BIOL, V127, P963, DOI 10.1083/jcb.127.4.963; WEBB WW, 1994, BIOPHYS J, V66, P18; YECHIEL E, 1987, J CELL BIOL, V105, P755, DOI 10.1083/jcb.105.2.755; ZHANG F, 1992, BIOPHYS J, V62, P92, DOI 10.1016/S0006-3495(92)81789-7; ZHANG F, 1991, J CELL BIOL, V115, P75, DOI 10.1083/jcb.115.1.75	76	244	247	CURRENT BIOLOGY LTD	LONDON	34-42 CLEVELAND STREET, LONDON, ENGLAND W1P 6LB	0955-0674			CURR OPIN CELL BIOL	Curr. Opin. Cell Biol.	AUG	1996	8	4					566	574		10.1016/S0955-0674(96)80036-6		9	Cell Biology	Cell Biology	UZ653	WOS:A1996UZ65300018		
J	Seo, GT; Suzuki, Y; Ohgaki, S				Seo, GT; Suzuki, Y; Ohgaki, S			Biological powdered activated carbon (BPAC) microfiltration for wastewater reclamation and reuse	DESALINATION			English	Article; Proceedings Paper	International Water Specialists Conference	DEC 01-02, 1994	MURDOCH UNIV, PERTH, AUSTRALIA	Int Assoc Water Qual, Int Desalinat Assoc, Austr Water & Wastewater Assoc, Murdoch Univ, Inst Environm Sci, Remote Area Dev Grp	MURDOCH UNIV	biological powdered activated carbon; crossflow filtration; microfiltration; refractory organics; virus removal; coliphage Q beta; wastewater reclamation; water reuse	DISINFECTION; ORGANICS; PAC	The experiment was conducted to evaluate a biological powdered activated carbon (BPAC) microfiltration (MF) system as an alternative for wastewater reclamation and reuse. A synthetic secondary sewage effluent contains refractory organic compounds such as humin, tannin, lignin, protein and high molecular carbohydrates as well as coliphage Q beta as a mode]. virus, The system performance was investigated at the activated carbon concentration of 20 g/l, water temperature 25 degrees C and transmembrane pressure of 55 kPa, It was noted that organic removal occurred mainly at the membrane module, This was caused by the accumulation of the powdered activated carbon in the membrane module. The average organic removal efficiency was 83%, resulting in an effluent TOC concentration of 1-2 mg/l. The performance of the process did not deteriorate at water temperature of 15 degrees C, showing an organic removal efficiency of 89.6%. It was estimated that the higher removal efficiency at lower water temperature was mainly due to the less self-degradation of microorganisms because the permeate flux of the membrane was maintained at the same level by increasing the transmembrane pressure up to 80 kPa. The removal of virus by the BPAC-MF system was significant. From the mass balance at steady state, 99.9997% of fed coliphage Q beta was removed from the system. Especially coliphage Q beta showed a strong adsorbability on powdered activated carbon (PAC). For 1 h contact with PAC, the removal of Q beta was 99.999% even at PAC concentrations of 0.55 g/l. It was obvious that the virus removed was inactivated in the system.	PUBL WORKS RES INST,ADV WASTEWATER TREATMENT DIV,TSUKUBA,IBARAKI 305,JAPAN; UNIV TOKYO,DEPT URBAN ENGN,BUNKYO KU,TOKYO 113,JAPAN	Seo, GT (reprint author), CHANGWON NATL UNIV,DEPT ENVIRONM ENGN,CHANGWON KYUNGNAM 641773,SOUTH KOREA.						ADHAM SS, 1991, J AM WATER WORKS ASS, V83, P81; KOLEGA M, 1991, WATER SCI TECHNOL, V23, P1609; FANE AG, 1994, KOREA AUSTR JOINT S, P45; FUJITA K, 1991, J JAP WATER WORKS AS, V60, P13; KETRATANAKUL A, 1988, P 2 IAWPRC AS C WAT, P321; LANGLAIS B, 1992, P IAWPRC SPEC C MEMB; PIRBAZARI M, 1992, J AM WATER WORKS ASS, V84, P95; ROGERS SE, 1986, J WATER POLLUT CON F, V58, P193; Smith C.W., 1969, 24 ANN PURD IND WAST, P1300; Water Pollution Control Federation, 1989, WAT REUS	10	43	45	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0011-9164			DESALINATION	Desalination	AUG	1996	106	1-3					39	45				7	Engineering, Chemical; Water Resources	Engineering; Water Resources	VE638	WOS:A1996VE63800007		
J	Kaiya, Y; Itoh, Y; Fujita, K; Takizawa, S				Kaiya, Y; Itoh, Y; Fujita, K; Takizawa, S			Study on fouling materials in the membrane treatment process for potable water	DESALINATION			English	Article; Proceedings Paper	International Water Specialists Conference	DEC 01-02, 1994	MURDOCH UNIV, PERTH, AUSTRALIA	Int Assoc Water Qual, Int Desalinat Assoc, Austr Water & Wastewater Assoc, Murdoch Univ, Inst Environm Sci, Remote Area Dev Grp	MURDOCH UNIV	membrane fouling; microfiltration; drinking water treatment; organic matter; manganese		Studies were made on a water treatment process which used hollow fiber microfiltration membranes for potable water, The influent, which was from a eutrophic lake named Kasumigaura, was provided directly into the treatment system, and no pre-treatment such as coagulation was done. Dead-end filtration was carried out under constant rate permeation, and membranes were washed by air-scrubbing. The trans-membrane pressure CTMP) had increased to 100 kPa, and the color of the membranes turned brown after 19 days of operation. X-ray microanalyzer (XMA) revealed that the brown material on the membrane surface was manganese. Furthermore, the amount of total organic carbon (TOC) and manganese in the fouling materials were one order of magnitude higher than that of other inorganic elements. TOC and manganese were dominant fouling materials, By correlating the amount of extracted fouling materials and the recovery of membrane permeability, it was concluded that the decline in membrane permeability was mainly caused by organic matter.	EBARA CORP,MINATO KU,TOKYO 113,JAPAN; UNIV TOKYO,DEPT URBAN ENGN,BUNKYO KU,TOKYO 113,JAPAN; UNIV TOKYO,ENGN RES INST,BUNKYO KU,TOKYO 113,JAPAN	Kaiya, Y (reprint author), EBARA RES CO LTD,4-2-1 HON FUJISAWA,FUJISAWA,KANAGAWA 251,JAPAN.						BERSILLON JL, 1989, FUTURE IND PROSPECTS; FUKAGAWA M, 1992, P ENV SANITARY ENG R, V28, P125; ISHIGURO K, 1994, DESALINATION, V98, P119, DOI 10.1016/0011-9164(94)00136-7; LAHOUSSINETURCA.V, 1991, J JAP WATER WORKS AS, V82, P76; LIU G, 1993, P ENV ENG RES, V30, P303; Mallevialle J., 1989, AQUATIC HUMIC SUBSTA; TAKIZAWA S, IN PRESS J JAP SOC W; TAMBO N, 1994, J JAP WATER WORKS AS, V63, P16	8	52	54	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0011-9164			DESALINATION	Desalination	AUG	1996	106	1-3					71	77				7	Engineering, Chemical; Water Resources	Engineering; Water Resources	VE638	WOS:A1996VE63800011		
J	Takizawa, S; Fujita, K; Soo, KH				Takizawa, S; Fujita, K; Soo, KH			Membrane fouling decrease by microfiltration with ozone scrubbing	DESALINATION			English	Article; Proceedings Paper	International Water Specialists Conference	DEC 01-02, 1994	MURDOCH UNIV, PERTH, AUSTRALIA	Int Assoc Water Qual, Int Desalinat Assoc, Austr Water & Wastewater Assoc, Murdoch Univ, Inst Environm Sci, Remote Area Dev Grp	MURDOCH UNIV	membrane fouling; microfiltration; ozone scrubbing; drinking water treatment		In order to control membrane fouling in the microfiltration process for drinking water production, a hollow-fiber membrane module was scrubbed with ozone gas (0.0435 mgO(3)/l) for 20 s every 1 h, In comparison with a control experiment, it was proved that membrane fouling can be significantly subdued by ozone scrubbing. Preozonation of raw water also had the same effect of decreasing membrane fouling.	UNIV TOKYO,FAC ENGN,DEPT URBAN ENGN,BUNKYO KU,TOKYO 113,JAPAN	Takizawa, S (reprint author), UNIV TOKYO,FAC ENGN,ENGN RES INST,BUNKYO KU,2-11-16 YAYOI,TOKYO 113,JAPAN.						SOO KY, 1994, THESIS U TOKYO; WONG YK, 1990, P ANN M ENV SAN ENG, P71	2	17	19	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0011-9164			DESALINATION	Desalination	AUG	1996	106	1-3					423	426				4	Engineering, Chemical; Water Resources	Engineering; Water Resources	VE638	WOS:A1996VE63800058		
J	Nakagawa, Y; Kaneko, T; Ogura, T; Suzuki, T; Torii, M; Kaibuchi, K; Arai, K; Nakamura, S; Nakafuku, M				Nakagawa, Y; Kaneko, T; Ogura, T; Suzuki, T; Torii, M; Kaibuchi, K; Arai, K; Nakamura, S; Nakafuku, M			Roles of cell-autonomous mechanisms for differential expression of region-specific transcription factors in neuroepithelial cells	DEVELOPMENT			English	Article						neural development; regional specification; neural stem cells; neuromere; homeobox gene; rat	SONIC-HEDGEHOG; MOUSE FOREBRAIN; HOMEOBOX GENES; FLOOR PLATE; NEURONAL DIFFERENTIATION; EMBRYONIC FOREBRAIN; PATTERN-FORMATION; CHICK HINDBRAIN; NEURAL PLATE; SPINAL-CORD	Although a number of genes have been found to have restricted expression domains in the embryonic forebrain and midbrain, it remains largely unknown how the expression of these genes is regulated at the cellular level. In this study, we explored the mechanisms for the differential expression of region-specific transcription factors in neuroepithelial cells by using both primary and immortalized neuroepithelial cells from the rat brain at embryonic day 11.5. We found that differential expression patterns of Pax-3, Pax-5, Pax-6, Dlx-1, Dlx-2, Emx2, Otx1 and Dbx observed in vivo were maintained even when the cells were isolated and cultured in vitro, free from environmental influences. Furthermore, in response to Sonic hedgehog, which is a major inductive signal from the environment for regional specification, neuroepithelial cells that maintain distinct regional identities expressed different sets of ventral-specific genes including Islet-1, Nkx-2.1 and Nkx-2.2. The results suggest that certain cell-autonomous mechanisms play important roles in regulating both environmental signal-dependent and -independent expression of region-specific genes, Thus, we propose that use of the in vitro culture systems we describe in this study facilitates the understanding of regulatory mechanisms of region-specific genes in neuroepithelial cells.	NATL INST NEUROL & PSYCHIAT, INST NEUROSCI, DIV BIOCHEM & CELLULAR BIOL, KODAIRA, TOKYO, JAPAN; UNIV TOKYO, INST MED SCI, DEPT MOL & DEV BIOL, MINATO KU, TOKYO, JAPAN; NARA INST SCI & TECHNOL, DIV SIGNAL TRANSDUCT, GRAD SCH BIOL SCI, IKOMA, NARA, JAPAN							ALTABA ARI, 1994, TRENDS NEUROSCI, V17, P233; BARBE MF, 1991, J NEUROSCI, V11, P519; Shimamura K, 1995, DEVELOPMENT, V121, P3923; ROELINK H, 1995, CELL, V81, P445, DOI 10.1016/0092-8674(95)90397-6; BARTH KA, 1995, DEVELOPMENT, V121, P1755; MACDONALD R, 1994, NEURON, V13, P1039, DOI 10.1016/0896-6273(94)90044-2; LIEM KF, 1995, CELL, V82, P969, DOI 10.1016/0092-8674(95)90276-7; EKKER SC, 1995, CURR BIOL, V5, P944, DOI 10.1016/S0960-9822(95)00185-0; DAVIS CA, 1991, DEVELOPMENT, V111, P287; BULFONE A, 1993, J NEUROSCI, V13, P3155; STOYKOVA A, 1994, J NEUROSCI, V14, P1395; ARIMATSU Y, 1992, P NATL ACAD SCI USA, V89, P8879, DOI 10.1073/pnas.89.19.8879; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; RUBENSTEIN JLR, 1994, SCIENCE, V266, P578, DOI 10.1126/science.7939711; MURPHY M, 1990, J NEUROSCI RES, V25, P463, DOI 10.1002/jnr.490250404; SIMEONE A, 1992, NATURE, V358, P687, DOI 10.1038/358687a0; HYNES M, 1995, NEURON, V15, P35, DOI 10.1016/0896-6273(95)90062-4; SCHNEEBERGER C, 1995, PCR METH APPL, V4, P234; BASLER K, 1993, CELL, V73, P687, DOI 10.1016/0092-8674(93)90249-P; SCHERER SS, 1994, NEURON, V12, P1363, DOI 10.1016/0896-6273(94)90451-0; Robel L, 1995, J NEUROSCI, V15, P7879; MARTI E, 1995, NATURE, V375, P322, DOI 10.1038/375322a0; GOULDING MD, 1991, EMBO J, V10, P1135; WALTHER C, 1991, DEVELOPMENT, V113, P1435; GOULDING MD, 1993, DEVELOPMENT, V117, P1001; SIMEONE A, 1992, EMBO J, V11, P2541; PRICE M, 1992, NEURON, V8, P241, DOI 10.1016/0896-6273(92)90291-K; ERICSON J, 1995, CELL, V81, P747, DOI 10.1016/0092-8674(95)90536-7; ASANO M, 1992, MECH DEVELOP, V39, P29, DOI 10.1016/0925-4773(92)90023-D; GUAZZI S, 1990, EMBO J, V9, P3631; PUELLES L, 1987, J COMP NEUROL, V266, P247, DOI 10.1002/cne.902660210; NAKAMURA H, 1990, BRAIN RES, V511, P122, DOI 10.1016/0006-8993(90)90231-Y; JOYNER AL, 1987, GENE DEV, V1, P29, DOI 10.1101/gad.1.1.29; Ogura T, 1996, DEVELOPMENT, V122, P537; BIRGBAUER E, 1994, DEVELOPMENT, V120, P1347; BONCINELLI E, 1993, J NEUROBIOL, V24, P1356, DOI 10.1002/neu.480241008; Boncinelli Edoardo, 1994, Current Opinion in Neurobiology, V4, P29, DOI 10.1016/0959-4388(94)90028-0; BURNCROT DA, 1995, MOL CELL BIOL, V15, P2294; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; EDWARDS MA, 1990, NEUROSCIENCE, V36, P121, DOI 10.1016/0306-4522(90)90356-9; EILERS M, 1989, NATURE, V340, P66, DOI 10.1038/340066a0; FERRI RT, 1993, CEREB CORTEX, V3, P187, DOI 10.1093/cercor/3.3.187; FIGDOR MC, 1993, NATURE, V363, P630, DOI 10.1038/363630a0; GARD AL, 1990, NEURON, V5, P615, DOI 10.1016/0896-6273(90)90216-3; GRAVEL M, 1994, J NEUROSCI RES, V38, P243, DOI 10.1002/jnr.490380302; GUTHRIE S, 1995, TRENDS NEUROSCI, V18, P74, DOI 10.1016/0166-2236(95)80027-Y; GUTHRIE S, 1992, NATURE, V356, P157, DOI 10.1038/356157a0; HORTON HL, 1988, J NEUROSCI, V8, P4653; JESSELL TM, 1992, HARVEY LECT, V86, P87; JOHNSON RL, 1995, CELL, V81, P313, DOI 10.1016/0092-8674(95)90381-X; KINDLER S, 1990, NUCLEIC ACIDS RES, V18, P2822, DOI 10.1093/nar/18.9.2822; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; LEVINE SM, 1988, J NEUROSCI, V8, P3992; LEWIS SA, 1984, P NATL ACAD SCI-BIOL, V81, P2743, DOI 10.1073/pnas.81.9.2743; LU S, 1992, P NATL ACAD SCI USA, V89, P8053, DOI 10.1073/pnas.89.17.8053; Lumsden A, 1995, CURR BIOL, V5, P1347, DOI 10.1016/S0960-9822(95)00266-1; LUMSDEN A, 1994, DEVELOPMENT, V120, P1581; LUMSDEN A, 1990, TRENDS NEUROSCI, V13, P329, DOI 10.1016/0166-2236(90)90144-Y; MARTINEZ S, 1992, DEVELOPMENT, V116, P1069; NAKAFUKU M, 1995, J NEUROSCI RES, V41, P153, DOI 10.1002/jnr.490410203; NAKAMURA H, 1988, DEV GROWTH DIFFER, V30, P717; NUDEL U, 1983, NUCLEIC ACIDS RES, V11, P1759, DOI 10.1093/nar/11.6.1759; PRICE M, 1993, J NEUROBIOL, V24, P1385, DOI 10.1002/neu.480241010; PUELLES L, 1993, TRENDS NEUROSCI, V16, P472, DOI 10.1016/0166-2236(93)90080-6; ROELINK H, 1994, CELL, V76, P716; SALINAS PC, 1992, MECH DEVELOP, V39, P151, DOI 10.1016/0925-4773(92)90042-I; SIMON H, 1995, CURR BIOL, V5, P205, DOI 10.1016/S0960-9822(95)00041-8; STUART ET, 1993, ANNU REV GENET, V27, P219; VICARIOABEJON C, 1995, J NEUROSCI, V15, P6351; WILKINSON DG, 1989, NATURE, V337, P461, DOI 10.1038/337461a0; WILKINSON DG, 1989, NATURE, V341, P405, DOI 10.1038/341405a0; WILLIAMS RW, 1992, TRENDS NEUROSCI, V15, P368, DOI 10.1016/0166-2236(92)90181-7; WILSON SW, 1993, TRENDS NEUROSCI, V16, P316, DOI 10.1016/0166-2236(93)90108-X	73	53	53	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	0950-1991	1477-9129		DEVELOPMENT	Development	AUG	1996	122	8					2449	2464				16	Developmental Biology	Developmental Biology	VC220	WOS:A1996VC22000014		
J	Sensui, N; Morisawa, M				Sensui, N; Morisawa, M			Effect of Ca2+ on deformation, polar body extrusion and pronucleus formation in the egg of the ascidian, Ciona savignyi	DEVELOPMENT GROWTH & DIFFERENTIATION			English	Article						ascidian egg; Ca2+ injection; egg deformation; meiotic division; polar body extrusion	SEA-URCHIN EGGS; FREE CALCIUM WAVE; OOPLASMIC SEGREGATION; CORTICAL CONTRACTION; OOCYTE MATURATION; ORYZIAS-LATIPES; CELL-CYCLE; FERTILIZATION; ACTIVATION; RELEASE	Cortical deformation and polar body extrusion are the principal events that occur at fertilization in the ascidian egg. We demonstrated that the intracellular Ca2+ concentration ([Ca2+](i)) in the fertilized egg of Ciona savignyi increased at egg deformation (main peak) and then several small Ca2+ spikes (Isi spikes) appeared before the first polar body extrusion. Brief Ca2+ spikes (2nd spikes), then appeared in the period between the first and second polar body extrusion. When eggs were fertilized in Ca2+-free artificial seawater, the main peak and Ist spikes appeared, but the 2nd spikes did not, suggesting that the Ca2+ required for the main peak and 1 st spikes is released from the intracellular store in this species and that extracellular Ca2+ is required for the 2nd spikes. When [Ca2+](i) was clamped at a low level (0.03-0.13 mu mol/L) by injecting the egg with low-Ca2+ buffers and the egg was then inseminated, deformation, polar body extrusion and pronucleus formation were suppressed. In contrast, egg deformation and first polar body extrusion were induced without insemination when [Ca2+](i) was 0.9 mu mol/L. A higher Ca2+ concentration of 1.2-10.1 mu mol/L was required for extrusion of the second polar body and pronucleus formation. These data suggest that sequential Ca2+ increases (i.e. main peak and 1 st and 2nd spikes) are prerequisite for the deformation and polar body extrusion of the egg. Furthermore, in eggs arrested at the second meiotic metaphase after first polar body extrusion by the injection of Ca2+ buffer, subsequent injection of excess Ca2+ caused formation of an irregular second polar body-like protrusion, suggesting latent arrest at the second meiotic metaphase in the ascidian egg.	UNIV TOKYO,GRAD SCH SCI,MISAKI MARINE BIOL STN,MIURA 23802,JAPAN							MIYAZAKI S, 1986, DEV BIOL, V118, P259, DOI 10.1016/0012-1606(86)90093-X; EISEN A, 1984, J CELL BIOL, V99, P1878, DOI 10.1083/jcb.99.5.1878; SAWADA T, 1988, CELL MOTIL CYTOSKEL, V9, P219, DOI 10.1002/cm.970090304; DEGUCHI R, 1994, DEV BIOL, V163, P162, DOI 10.1006/dbio.1994.1132; Masui Y, 1979, Int Rev Cytol, V57, P185, DOI 10.1016/S0074-7696(08)61464-3; KLINE D, 1988, DEV BIOL, V126, P346, DOI 10.1016/0012-1606(88)90145-5; GILKEY JC, 1978, J CELL BIOL, V76, P448, DOI 10.1083/jcb.76.2.448; RINK TJ, 1980, NATURE, V283, P658, DOI 10.1038/283658a0; CUTHBERTSON KSR, 1981, NATURE, V294, P754, DOI 10.1038/294754a0; WHITAKER M, 1990, DEVELOPMENT, V108, P525; SAWADA T-O, 1981, Wilhelm Roux's Archives of Developmental Biology, V190, P208, DOI 10.1007/BF00848304; STEINHARDT R, 1977, DEV BIOL, V58, P185, DOI 10.1016/0012-1606(77)90084-7; BEVAN SJ, 1977, CELL DIFFER DEV, V6, P313, DOI 10.1016/0045-6039(77)90006-9; BROWNLEE C, 1990, PROC R SOC SER B-BIO, V239, P321, DOI 10.1098/rspb.1990.0019; BUSA WB, 1985, J CELL BIOL, V100, P1325, DOI 10.1083/jcb.100.4.1325; Conklin EG, 1905, J ACAD NATL SCI PHIL, VXIII, P1; EISEN A, 1984, J CELL BIOL, V99, P1647, DOI 10.1083/jcb.99.5.1647; GILKEY JC, 1983, J CELL BIOL, V97, P669, DOI 10.1083/jcb.97.3.669; GOLDSTEIN DA, 1979, BIOPHYS J, V26, P235; GOUDEAU M, 1993, DEV BIOL, V160, P165, DOI 10.1006/dbio.1993.1295; HAMAGUCHI Y, 1981, EXP CELL RES, V134, P171, DOI 10.1016/0014-4827(81)90474-2; HAMAGUCHI Y, 1990, CELL STRUCT FUNCT, V15, P159; HEPLER PK, 1989, J CELL BIOL, V109, P2567, DOI 10.1083/jcb.109.6.2567; HIRAMOTO Y, 1974, EXP CELL RES, V87, P403, DOI 10.1016/0014-4827(74)90503-5; JEFFERY WR, 1984, BIOL BULL, V166, P277, DOI 10.2307/1541217; KAWAHARA H, 1994, DEV BIOL, V166, P623, DOI 10.1006/dbio.1994.1342; KOZUKA M, 1982, J PHYSIOL-LONDON, V323, P267; KUBOTA HY, 1987, DEV BIOL, V119, P129, DOI 10.1016/0012-1606(87)90214-4; Lambert C., 1994, Molecular Biology of the Cell, V5, p461A; LAMBERT CC, 1989, DEVELOPMENT, V105, P415; LAMBERT CC, 1994, DEV GROWTH DIFFER, V36, P133; MASUDA H, 1983, EXP CELL RES, V143, P79, DOI 10.1016/0014-4827(83)90111-8; MCDOUGALL A, 1995, ZYGOTE, V3, P251; MIYAZAKI S, 1991, CELL CALCIUM, V12, P205, DOI 10.1016/0143-4160(91)90021-6; MORISAWA M, 1984, ZOOL SCI, V1, P237; REVERBERI G, 1971, ASCIDIANS EXPT EMBRY; SARDET C, 1989, DEVELOPMENT, V105, P237; SAWADA T-O, 1983, Bulletin of the Marine Biological Station of Asamushi, V17, P123; SAWADA T, 1989, DEV BIOL, V132, P331, DOI 10.1016/0012-1606(89)90230-3; SENSUI N, 1994, DEV GROWTH DIFFER, V36, P373; SHROEDER TE, 1974, EXP CELL RES, V83, P139; SPEKSNIJDER JE, 1990, J CELL BIOL, V110, P1589, DOI 10.1083/jcb.110.5.1589; SPEKSNIJDER JE, 1990, DEV BIOL, V142, P246, DOI 10.1016/0012-1606(90)90168-I; SPEKSNIJDER JE, 1992, DEV BIOL, V153, P259, DOI 10.1016/0012-1606(92)90111-S; SPEKSNIJDER JE, 1989, DEV BIOL, V135, P182, DOI 10.1016/0012-1606(89)90168-1; STEINHAR.RA, 1974, P NATL ACAD SCI USA, V71, P1915, DOI 10.1073/pnas.71.5.1915; STEINHAR.RA, 1974, NATURE, V252, P41, DOI 10.1038/252041a0; YOSHIMOTO Y, 1986, DEV GROWTH DIFFER, V28, P583	48	16	16	BLACKWELL SCIENCE	CARLTON	54 UNIVERSITY ST, P O BOX 378, CARLTON VICTORIA 3053, AUSTRALIA	0012-1592			DEV GROWTH DIFFER	Dev. Growth Diff.	AUG	1996	38	4					341	350				10	Cell Biology; Developmental Biology	Cell Biology; Developmental Biology	UZ172	WOS:A1996UZ17200002		
J	Terauchi, Y; Tobe, K; Iwamoto, K; Nakajima, H; Hanafusa, T; Matsuzawa, Y; Yazaki, Y; Kadowaki, T				Terauchi, Y; Tobe, K; Iwamoto, K; Nakajima, H; Hanafusa, T; Matsuzawa, Y; Yazaki, Y; Kadowaki, T			Defect in glucose homeostasis in mice lacking a regulator Y subunit of phosphatidylinositol-3-kinase	DIABETOLOGIA			English	Meeting Abstract									UNIV TOKYO,TOKYO,JAPAN; OSAKA UNIV,OSAKA,JAPAN								0	0	0	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010	0012-186X			DIABETOLOGIA	Diabetologia	AUG	1996	39			1			37	37				1	Endocrinology & Metabolism	Endocrinology & Metabolism	VA493	WOS:A1996VA49300038		
J	Lang, J; Fukuda, M; Zhang, H; Kiraly, C; Mikoshiba, K; Wollheim, CB				Lang, J; Fukuda, M; Zhang, H; Kiraly, C; Mikoshiba, K; Wollheim, CB			Subcellular localisation and role of synaptotagmin in insulin secreting pancreatic beta-cell lines	DIABETOLOGIA			English	Meeting Abstract									UNIV GENEVA,CMU,DEPT MED,DIV BIOCHIM CLIN,GENEVA,SWITZERLAND; UNIV TOKYO,INST MED SCI,DEPT MOL NEUROBIOL,TOKYO,JAPAN								0	0	0	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010	0012-186X			DIABETOLOGIA	Diabetologia	AUG	1996	39			1			432	432				1	Endocrinology & Metabolism	Endocrinology & Metabolism	VA493	WOS:A1996VA49300429		
J	Adachi, N; Terashima, I; Takahashi, M				Adachi, N; Terashima, I; Takahashi, M			Nitrogen translocation via rhizome systems in monoclonal stands of Reynoutria japonica in an oligotrophic desert on Mt Fuji: Field experiments	ECOLOGICAL RESEARCH			English	Article						clonal plant; nitrogen translocation; physiological integration; Reynoutria japonica; volcanic desert	EARLY PRIMARY SUCCESSION; HYDROCOTYLE-BONARIENSIS; POLYGONUM-CUSPIDATUM; FRAGARIA-CHILOENSIS; GROWTH; RAMETS; PLANT; PHOTOSYNTHESIS; INTEGRATION; DYNAMICS	Mechanisms which enable Reynoutria japonica, a dominant pioneer herb, to be successful in maintaining large stands in an oligotrophic volcanic desert on Mt Fuji were investigated with special reference to its nitrogen acquisition. Reynoutria japonica forms circular stands, each of which comprises only one genet. As a stand develops outwards, the number of aerial shoots per unit area decreases in the center. Shoots grow vigorously in the peripheral area where the available nitrogen from soil and precipitation (about 2.4 g m(-2) year(-2)) was much less than total nitrogen in the shoots (6.1-9.1 g m(-2)). Leaf nitrogen content per unit mass was also greater in the leaves of the peripheral shoots. When rhizomes extending radially from the center to the periphery were severed, the dry mass of shoots in the periphery diminished by 75% on a ground area basis. In the periphery, leaf nitrogen content also reduced significantly and no flowers were produced. When fertilizer was applied to the peripheral shoots with severed rhizomes, neither growth, survival nor flower production of the shoots was significantly smaller than the control levels. In these shoots, it is also found that the nitrogen content in the youngest leaves decreased for about 1 month and then increased to above that in the control leaves. These results suggest that (i) nitrogen accumulated in the central part is translocated to peripheral shoots via rhizomes, and that long-distance translocation enables the stands to develop outwards, and (ii) aerial shoots in the periphery utilize the nitrogen translocated by rhizomes in the beginning of the growth season, whereas once the shoots have established, they begin to take up nitrogen with their own roots. Since the peripheral shoots are in sunnier environments than the shoots inside the stand, the acropetal nitrogen translocation via rhizomes will raise the production efficiency of a whole stand.	UNIV TOKYO,FAC SCI,DEPT PLANT SCI,BUNKYO KU,TOKYO 113,JAPAN			TERASHIMA, ICHIRO/G-4943-2014	TERASHIMA, ICHIRO/0000-0001-7680-9867			HIROSE T, 1987, OECOLOGIA, V72, P520, DOI 10.1007/BF00378977; CHAPIN FS, 1980, ANNU REV ECOL SYST, V11, P233, DOI 10.1146/annurev.es.11.110180.001313; ALPERT P, 1986, OECOLOGIA, V70, P227, DOI 10.1007/BF00379244; Adachi N, 1996, ANN BOT-LONDON, V77, P477, DOI 10.1006/anbo.1996.0058; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; BAZZAZ FA, 1979, ANNU REV ECOL SYST, V10, P351, DOI 10.1146/annurev.es.10.110179.002031; HARTNETT DC, 1983, ECOLOGY, V64, P779, DOI 10.2307/1937201; EVANS JP, 1988, OECOLOGIA, V77, P64, DOI 10.1007/BF00380926; CALLAGHAN TV, 1984, J ECOL, V72, P529, DOI 10.2307/2260064; CARLSSON BA, 1990, CLONAL GROWTH PLANTS, P131; CHIBA N, 1993, FUNCT ECOL, V7, P287, DOI 10.2307/2390207; DEKROON H, 1991, FUNCT ECOL, V5, P360; DELMORAL R, 1993, AM J BOT, V80, P981; ELLENBERG H, 1971, PRODUCTIVITY FOREST, P509; EVANS JP, 1991, OECOLOGIA, V86, P268, DOI 10.1007/BF00317540; FRIEDMAN D, 1991, OECOLOGIA, V86, P76, DOI 10.1007/BF00317392; HEADLEY AD, 1988, NEW PHYTOL, V110, P487, DOI 10.1111/j.1469-8137.1988.tb00287.x; HEWITT EJ, 1975, PLANT MINERAL NUTRIT; HIROSE T, 1987, PHYSIOL PLANTARUM, V70, P215, DOI 10.1111/j.1399-3054.1987.tb06134.x; HIROSE T, 1984, OECOLOGIA, V61, P218, DOI 10.1007/BF00396764; HUTCHINGS MJ, 1986, BIOSCIENCE, V36, P178, DOI 10.2307/1310305; JONSDOTTIR IS, 1990, NEW PHYTOL, V114, P419, DOI 10.1111/j.1469-8137.1990.tb00409.x; Marshall C., 1990, CLONAL GROWTH PLANTS, P23; MARUTA E, 1981, JAPANESE J ECOLOGY, V31, P441; OHBA T, 1975, B KANAGAWA PREFECTUR, V8, P91; OHBA T, 1969, B KANAGAWA PREFECTUR, V1, P23; OHGA N, 1971, FUJISAN MT FUJI, P422; OHSAWA M, 1971, FUJISAN MT FUJI, P371; OLFF H, 1993, J ECOL, V81, P693, DOI 10.2307/2261667; Paul E.A., 1981, TERRESTRIAL NITROGEN, P179; Pitelka L. F., 1985, POPULATION BIOL EVOL, P399; SALZMAN AG, 1985, OECOLOGIA, V65, P273, DOI 10.1007/BF00379229; Satake Y., 1989, WILD FLOWERS JAPAN W, V1; SATAKE Y, 1982, WILD FLOWERS JAPAN H, V2; Satake Y, 1982, WILD FLOWERS JAPAN H, VI-III; SATAKE YJ, 1981, WILD FLOWERS JAPAN H, V3; SUZUKI J, 1994, ANN BOT-LONDON, V73, P629, DOI 10.1006/anbo.1994.1079; TAGAWA H, 1964, MEM FAC SCI KYUSHU E, V3, P165; TAGAWA H, 1965, JPN J BOT, V19, P127; TATENO M, 1987, Ecological Research, V2, P113, DOI 10.1007/BF02346920; TEZUKA YASUHIKO, 1961, JAPANESE JOUR BOT, V17, P371; Tilman D., 1988, PLANT STRATEGIES DYN; TILMAN GD, 1984, ECOLOGY, V65, P1445, DOI 10.2307/1939125; TILMAN D, 1989, FUNCT ECOL, V3, P425, DOI 10.2307/2389616; TSUYA H, 1971, FUJISAN MT FUJI, P1; Vitousek PM, 1987, COLONIZATION SUCCESS, P207; WALKER LR, 1986, ECOLOGY, V67, P1508, DOI 10.2307/1939082	47	14	14	BLACKWELL SCIENCE	CARLTON	54 UNIVERSITY ST, P O BOX 378, CARLTON VICTORIA 3053, AUSTRALIA	0912-3814			ECOL RES	Ecol. Res.	AUG	1996	11	2					175	186		10.1007/BF02347683		12	Ecology	Environmental Sciences & Ecology	VB560	WOS:A1996VB56000006		
J	Uesaka, Y; Terao, Y; Ugawa, Y; Yumoto, M; Hanajima, R; Kanazawa, I				Uesaka, Y; Terao, Y; Ugawa, Y; Yumoto, M; Hanajima, R; Kanazawa, I			Magnetoencephalographic analysis of cortical myoclonic jerks	ELECTROENCEPHALOGRAPHY AND CLINICAL NEUROPHYSIOLOGY			English	Article						cortical myoclonus; magnetoencephalography; pre-myoclonus spike	EPILEPSIA PARTIALIS CONTINUA; SOMATOSENSORY EVOKED-POTENTIALS; REFLEX MYOCLONUS; LOCALIZATION; SPIKES; SEP	We studied the pre-myoclonus spike using magnetoencephalography in patients with cortical myoclonus (6 with cortical reflex myoclonus and one with epilepsia partialis continua), The spike was estimated as a single current dipole on the pre-central gyrus in one patient with epilepsia partialis continua. In contrast, it was estimated as a single dipole on the post-central gyrus in 5 of 6 patients with cortical reflex myoclonus, and as two dipoles on the pre- and post-central gyrus in the remaining patient. We conclude that there are 3 physiological types of cortical myoclonus, (1) abnormal discharges in the motor cortex produce the myoclonus; (2) the source of the myoclonus is mainly the sensory cortex; (3) both the motor and sensory cortices play important roles in the production of myoclonus.	UNIV TOKYO,SCH MED,INST BRAIN RES,DEPT NEUROL,BUNKYO KU,TOKYO 113,JAPAN; UNIV TOKYO,SCH MED,DEPT LAB MED,BUNKYO KU,TOKYO 113,JAPAN							KIDO DK, 1980, RADIOLOGY, V135, P373; CHADWICK D, 1977, BRAIN, V100, P455, DOI 10.1093/brain/100.3.455; SARVAS J, 1987, PHYS MED BIOL, V32, P11, DOI 10.1088/0031-9155/32/1/004; BARRETT G, 1985, ELECTROEN CLIN NEURO, V60, P271; CELESIA GG, 1994, ELECTROEN CLIN NEURO, V90, P316, DOI 10.1016/0013-4694(94)90151-1; COWAN JMA, 1986, J NEUROL NEUROSUR PS, V49, P796, DOI 10.1136/jnnp.49.7.796; HALLETT M, 1979, NEUROLOGY, V29, P1107; KAKIGI R, 1987, BRAIN, V110, P1359, DOI 10.1093/brain/110.5.1359; MONTEMURRO DG, 1988, HUMAN BRAIN DISSECTI, P34; SAKAI K, 1993, EUR NEUROL, V33, P83, DOI 10.1159/000116909; SHIBASAKI H, 1975, ELECTROEN CLIN NEURO, V39, P455, DOI 10.1016/0013-4694(75)90046-2; SHIBASAKI H, 1991, ELECTROEN CLIN NEURO, V81, P31, DOI 10.1016/0168-5597(91)90101-3; SHIBASAKI H, 1978, BRAIN, V101, P447, DOI 10.1093/brain/101.3.447; STIEGFRIED J, 1976, ACTA NEUROCHIR, V23, P183; TAKEZAWA C, 1995, NEUROL MED, V43, P251; UESAKA Y, 1993, ELECTROEN CLIN NEURO, V87, P300, DOI 10.1016/0013-4694(93)90183-V; UGAWA Y, 1991, ELECTROEN CLIN NEURO, V80, P21, DOI 10.1016/0168-5597(91)90038-Y; WIESER HG, 1978, ELECTROEN CLIN NEURO, V44, P14, DOI 10.1016/0013-4694(78)90101-3; YAMAMOTO T, 1988, P NATL ACAD SCI USA, V85, P8732, DOI 10.1073/pnas.85.22.8732	19	31	31	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	0013-4694			ELECTROEN CLIN NEURO	Electroencephalogr. Clin. Neurophysiol.	AUG	1996	99	2					141	148		10.1016/0013-4694(96)95209-8		8	Engineering, Biomedical; Clinical Neurology	Engineering; Neurosciences & Neurology	VD310	WOS:A1996VD31000004		
J	Morino, H; Aoki, T; Aida, H; Saito, T				Morino, H; Aoki, T; Aida, H; Saito, T			An effective access control method for high-speed local area networks and metropolitan area networks	ELECTRONICS AND COMMUNICATIONS IN JAPAN PART I-COMMUNICATIONS			English	Article						ultrahigh-speed LAN; MAN; broadband ISDN; slotted ring		This paper proposes an access protocol with a high throughput for the ultrahigh-speed local area network (LAN) and metropolitan area network (MAN) with the transmission capacity exceeding 100 Mbps. The slotted-ring configuration is suited to the access method for the ultrahigh-speed LAN/MAN. Several protocols have been proposed, such as DQDB and ATMR, which, however, have problems in that the throughput in DQDB cannot reach the transmission capacity and the throughput in ATMR decreases when the traffic is nonuniform. In the proposed protocol, the reset signal circulates the ring and the fairness of the access is ensured by limiting the number of slots to be sent by each node by the window size. The number of slots to be sent is not limited if none of the downstream nodes has data to be sent, This helps to realize: a high throughput independently of the traffic situation. As the result of performance evaluation, it is verified that the proposed protocol is useful in the following two points: (1) approximately 1.8 times higher throughput is realized compared to the existing protocols when the traffic concentrates to a particular node; and (2) the delay time is suppressed to a love value for burst traffic such as video.		Morino, H (reprint author), UNIV TOKYO,FAC ENGN,TOKYO 113,JAPAN.						CIDON I, 1993, IEEE T COMMUN, V41, P110, DOI 10.1109/26.212370; DAVIDS P, 1990, IEEE COMPUT SOC INT, V22, P548; *IEEE, 1990, STAND LOC METR AR NE; ITO M, 1991, 5012 MULT SPEED DIST, P50	4	0	0	SCRIPTA TECHNICA PUBL	SILVER SPRING	7961 EASTERN AVE, SILVER SPRING, MD 20910	8756-6621			ELECTRON COMM JPN 1	Electron. Commun. Jpn. Pt. I-Commun.	AUG	1996	79	8					40	49		10.1002/ecja.4410790804		10	Engineering, Electrical & Electronic; Telecommunications	Engineering; Telecommunications	VE707	WOS:A1996VE70700004		
J	Saito, T; Aida, H; Kim, B				Saito, T; Aida, H; Kim, B			A new access control method based upon frame addressing for distributed access subscriber network	ELECTRONICS AND COMMUNICATIONS IN JAPAN PART I-COMMUNICATIONS			English	Article						B-ISDN subscriber network; distributed access network; media access control; frame addressing method		A distributed access network in which the optical fiber is shared among terminals through media access control has been examined as the subscriber part of broadband integrated services digital network (B-ISDN). In a distributed access subscriber network, unlike peer-to-peer communications which can be seen in local area networks, the main traffic flows are between exchange node and terminals. Therefore, a new access control scheme based on this characteristic should be developed. In this paper, a new access control method based on frame addressing is proposed and simulation analysis is performed. Compared with other methods, it is shown that, by employing cyclic reset and back-pressure mechanism into the access control, a fair and efficient network access can be achieved for various types of traffic.		Saito, T (reprint author), UNIV TOKYO,FAC ENGN,TOKYO 113,JAPAN.						DAVIDS P, 1990, IEEE 9 INT PHOEN C C; ITO T, 1991, STUDIES MULTIMEDIA C; KIM BS, 1993, IEICE, pB559; MUKHERJEE B, 1993, IEEE T COMMUN, V42, P2; SAITO T, 1978, IEEE T COMMUN, V26, P8	5	0	0	SCRIPTA TECHNICA PUBL	SILVER SPRING	7961 EASTERN AVE, SILVER SPRING, MD 20910	8756-6621			ELECTRON COMM JPN 1	Electron. Commun. Jpn. Pt. I-Commun.	AUG	1996	79	8					64	75		10.1002/ecja.4410790806		12	Engineering, Electrical & Electronic; Telecommunications	Engineering; Telecommunications	VE707	WOS:A1996VE70700006		
J	Wang, D; Morikawa, H; Mizumachi, M				Wang, D; Morikawa, H; Mizumachi, M			Rapid ambiguity resolution for kinematic GPS based on integer constraints	ELECTRONICS AND COMMUNICATIONS IN JAPAN PART I-COMMUNICATIONS			English	Article						navigation; positioning; kinematic GPS; ambiguity		The kinematic GPS is a method in which the positioning with an accuracy of several centimeters is realized using continuous tracking by a mobile user for the phase of the carrier sent from the GPS satellite. In the mobile positioning system based on the carrier phase, there exists a phase bias uncertainty (ambiguity) corresponding to the integer multiple of the wavelength in the phase measurement; and there must be a processing that can resolve the phase ambiguity with a high speed while the user is moving. This paper indicates that an integer constraint exists based on the geometrical positions of the observation point and the satellite as well as the ambiguity and presents a method that can resolve the ambiguity with a high speed by utilizing the integer constraint. In other words, a method is presented that earn resolve the ambiguity with high speed by noting the time redundancy contained in the result of measurement and by applying the smoothing along the time axis.		Wang, D (reprint author), UNIV TOKYO,FAC ENGN,TOKYO 103,JAPAN.						Abidin H.Z., 1993, J I NAVIGATION, V40, P321; ALTSCHULER E, 1974, AFCRTR01981; BROWN A, 1989, J I NAVIGATION, V36, P265; ERICKSON C, 1992, PROCEEDINGS OF ION GPS-92, P453; Frei E., 1990, Manuscripta Geodaetica, V15; GEORGIADOU Y, 1989, P IAG INT S, V102, P82; GREEN CGB, 1989, J I NAVIGATION, V36, P9; HATCH R, 1990, P IAG INT S, V107, P299; *JAP SOC GEOD, 1989, GPS PREC POS SYST MA; Lachapelle G., 1992, Marine Geodesy, V15; MIZUMACHI M, 1993, GUIDE INTRODUCING GP; Rao C. R., 1973, LINEAR STATISTICAL I; REDMONDI DBW, 1993, J I NAVIGATION, V40, P199; WANG D, 1994, SANE9384 IEICE; WANG D, 1994, SANE93105 IEICE	15	0	0	SCRIPTA TECHNICA PUBL	SILVER SPRING	7961 EASTERN AVE, SILVER SPRING, MD 20910	8756-6621			ELECTRON COMM JPN 1	Electron. Commun. Jpn. Pt. I-Commun.	AUG	1996	79	8					90	102		10.1002/ecja.4410790808		13	Engineering, Electrical & Electronic; Telecommunications	Engineering; Telecommunications	VE707	WOS:A1996VE70700008		
J	Okamoto, T; Takeda, S; Giambarella, U; Murayama, Y; Matsui, T; Katada, T; Matsuura, Y; Nishimoto, I				Okamoto, T; Takeda, S; Giambarella, U; Murayama, Y; Matsui, T; Katada, T; Matsuura, Y; Nishimoto, I			Intrinsic signaling function of APP as a novel target of three V642 mutations linked to familial Alzheimer's disease	EMBO JOURNAL			English	Article						amyloid precursor protein; familial Alzheimer V642 mutations; G protein coupling; mutationally activated molecule	AMYLOID PRECURSOR PROTEIN; MANNOSE 6-PHOSPHATE RECEPTOR; LONG-TERM POTENTIATION; GROWTH-FACTOR-II; NEURITE OUTGROWTH; PERTUSSIS TOXIN; ALPHA-SUBUNITS; CELL-SURFACE; CAENORHABDITIS-ELEGANS; MISSENSE MUTATIONS	APP(695) is a transmembrane precursor of A beta amyloid. In familial Alzheimer's disease (FAD), three mutations V642Y/F/G were discovered in APP(695), which has been suggested by multiple studies to be a cell surface signaling receptor. We previously reported that normal APP(695) encodes a potential G(o)-linked receptor with ligand-regulated function and that expression of the three FAD mutants (FAD-APPs), not normal APP, induces cellular outputs by G(o)-dependent mechanisms. This suggests that FAD-APPs are constitutively active G(o)-linked receptors. Here, we provide direct evidence for this notion. Reconstitution of either recombinant FAD-APP with G(o) into vesicles induced activation of G(o), which was inhibitable by pertussis toxin, sensitive to Mg2+ and proportional in quantity to the reconstituted amounts of FAD-APP. Consistent with the dominant inheritance of this type of FAD, this function was dominant over normal APP, because little activation was observed in APP(695)-G(o) vesicles. Experiments with antibody competition and sequence deletion indicated that His657-Lys676 of FAD-APP, which has been specified as the ligand-dependent G(o)-coupling domain of normal APP, was responsible for this constitutive activation, confirming that the three FAD-APPs are mutationally activated APP(695). This study identifies the intrinsic signaling function of APP to be a novel target of hereditary Alzheiner's disease mutations, providing an in vitro system for the screening of potential FAD inhibitors.	HARVARD UNIV,MASSACHUSETTS GEN HOSP,SCH MED,DEPT MED,CARDIOVASC RES CTR,BOSTON,MA 02129; UNIV TOKYO,SCH MED,DEPT INTERNAL MED 4,BUNKYO KU,TOKYO 112,JAPAN; UNIV TOKYO,FAC PHARMACEUT SCI,BUNKYO KU,TOKYO 113,JAPAN; NATL INST HLTH,LAB HEPATITIS VIRUSES,DEPT VIROL 2,SHINJUKU KU,TOKYO 160,JAPAN							MENDEL JE, 1995, SCIENCE, V267, P1652, DOI 10.1126/science.7886455; SCHUBERT W, 1991, BRAIN RES, V563, P184, DOI 10.1016/0006-8993(91)91532-6; BOND RA, 1995, NATURE, V374, P272, DOI 10.1038/374272a0; KARLINSKY H, 1992, NEUROLOGY, V42, P1445; MURRELL J, 1991, SCIENCE, V254, P97, DOI 10.1126/science.1925564; FERREIRA A, 1993, J NEUROSCI, V13, P3112; GAMES D, 1995, NATURE, V373, P523, DOI 10.1038/373523a0; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; GONG XH, 1995, SCIENCE, V269, P1718, DOI 10.1126/science.7569899; NISHIMOTO I, 1993, NATURE, V362, P75, DOI 10.1038/362075a0; LEBLANC AC, 1992, J NEUROSCI RES, V31, P635, DOI 10.1002/jnr.490310407; STRITTMATTER SM, 1990, NATURE, V344, P836, DOI 10.1038/344836a0; FRANK DA, 1994, CELL, V79, P5, DOI 10.1016/0092-8674(94)90394-8; STRITTMATTER SM, 1994, J NEUROSCI, V14, P2327; Yamatsuji T, 1996, EMBO J, V15, P498; SMALL DH, 1994, J NEUROSCI, V14, P2117; STRITTMATTER SM, 1993, P NATL ACAD SCI USA, V90, P5327, DOI 10.1073/pnas.90.11.5327; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; CHARTIERHARLIN MC, 1991, NATURE, V353, P844, DOI 10.1038/353844a0; PARMA J, 1993, NATURE, V365, P649, DOI 10.1038/365649a0; MILWARD EA, 1992, NEURON, V9, P129, DOI 10.1016/0896-6273(92)90228-6; ZHENG H, 1995, CELL, V81, P525, DOI 10.1016/0092-8674(95)90073-X; JIN LW, 1994, J NEUROSCI, V14, P5461; OKAMOTO T, 1995, J BIOL CHEM, V270, P4205; Fiore F, 1995, J BIOL CHEM, V270, P30853; SEGALAT L, 1995, SCIENCE, V267, P1648, DOI 10.1126/science.7886454; NEVE RL, 1988, NEURON, V1, P669, DOI 10.1016/0896-6273(88)90166-3; KJELSBERG MA, 1992, J BIOL CHEM, V267, P1430; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; ALLINQUANT B, 1995, J CELL BIOL, V128, P919, DOI 10.1083/jcb.128.5.919; BREEN KC, 1991, J NEUROSCI RES, V28, P90, DOI 10.1002/jnr.490280109; DOHERTY P, 1991, CELL, V67, P21, DOI 10.1016/0092-8674(91)90569-K; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; GOH JW, 1989, SCIENCE, V244, P980, DOI 10.1126/science.2543072; Ikezu T, 1996, EMBO J, V15, P2468; IKEZU T, 1995, J BIOL CHEM, V270, P29224; ITO I, 1988, NEUROSCI LETT, V90, P181, DOI 10.1016/0304-3940(88)90808-7; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; KATADA T, 1986, J BIOL CHEM, V261, P8182; KNOPS J, 1991, J BIOL CHEM, V266, P7285; LANG J, 1995, EMBO J, V14, P3635; LEVITAN D, 1995, NATURE, V377, P351, DOI 10.1038/377351a0; MURAYAMA Y, 1990, J BIOL CHEM, V265, P17456; NARUSE S, 1991, LANCET, V337, P978, DOI 10.1016/0140-6736(91)91612-X; OKAMOTO T, 1992, J BIOL CHEM, V267, P8342; OKAMOTO T, 1994, J BIOL CHEM, V269, P13756; OKAMOTO T, 1990, CELL, V62, P709, DOI 10.1016/0092-8674(90)90116-V; SAMAMA P, 1993, J BIOL CHEM, V268, P4625; SCHUCH U, 1989, NEURON, V3, P13, DOI 10.1016/0896-6273(89)90111-6; SEBOK K, 1993, J IMMUNOL, V150, P1524; SHENKER A, 1993, NATURE, V365, P652, DOI 10.1038/365652a0; STERN DF, 1988, MOL CELL BIOL, V8, P3969; STRITTMATTER SM, 1991, J BIOL CHEM, V266, P22465; WEIDEMANN A, 1989, CELL, V57, P115, DOI 10.1016/0092-8674(89)90177-3; YOSHIKAWA K, 1992, NATURE, V359, P64, DOI 10.1038/359064a0; YOSHIOKA K, 1991, BIOCHEM BIOPH RES CO, V178, P1141, DOI 10.1016/0006-291X(91)91011-Z	57	53	54	OXFORD UNIV PRESS UNITED KINGDOM	OXFORD	WALTON ST JOURNALS DEPT, OXFORD, ENGLAND OX2 6DP	0261-4189			EMBO J	Embo J.	AUG 1	1996	15	15					3769	3777				9	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	VC667	WOS:A1996VC66700001		
J	Mine, T; Yasuda, H; Fujita, T; Hasegawa, Y				Mine, T; Yasuda, H; Fujita, T; Hasegawa, Y			Effects of inhibin on activin A-induced glucose metabolism in rat hepatocytes	ENDOCRINE			English	Article						activin A; inhibin; hepatocytes	ERYTHROID-DIFFERENTIATION FACTOR; FOLLICLE-STIMULATING-HORMONE; INOSITOL PHOSPHATES; FLUID INHIBIN; CELL-GROWTH; CYCLIC-AMP; SECRETION; MESSENGER; MECHANISM; PROTEINS	This study was conducted to investigate the effects of inhibin on hepatic glucose metabolism. We have previously reported that activin A induced a dose-dependent glycogenolytic action on hepatocytes, and that 10(-9)M activin A induced a maximum glycogenolytic effect. Inhibin itself induced no increase or decrease in glucose output at any dose tested. At a concentration of 10(-10)M, inhibin was seen to inhibit 10(-9)M activin A-induced glucose output by 30% as compared to the control. In contrast to its inhibitory effect on the action of activin A, 10(-10)M and higher concentrations of inhibin did not inhibit angiotensin II- or vasopressin-induced glycogenolysis. We further investigated the mechanism of the inhibitory effect of inhibin on activin A-induced glycogenolysis, and found that 10(-10)M inhibin did inhibit the increase in cytoplasmic-free calcium concentration that was seen with 10(-9)M activin A. We also investigated the effects of inhibin on the activin A-induced production of inositol trisphosphates, and the results showed that 10(-10)M inhibin inhibited the activin A-induced production of inositol trisphosphates by 30% compared to the control. Furthermore, it was demonstrated that inhibin did not affect the binding of activin A to isolated hepatocytes. These data demonstrated that inhibin inhibited the activin A-induced glycogenolysis by inhibiting the increases of inositol trisphosphates and cytoplasmic free calcium concentrations.	KITASATO UNIV,SCH VET MED & ANIM SCI,FAC VET MED,TOWADA,AOMORI 034,JAPAN	Mine, T (reprint author), UNIV TOKYO,SCH MED,DEPT INTERNAL MED 4,BUNKYO KU,3-28-6 MEJIRODAI,TOKYO 112,JAPAN.						BERRIDGE MJ, 1983, BIOCHEM J, V212, P473; VALE W, 1986, NATURE, V321, P776, DOI 10.1038/321776a0; RIVIER C, 1986, SCIENCE, V234, P205, DOI 10.1126/science.3092356; HILLIER SG, 1991, J ENDOCRINOL, V131, P171, DOI 10.1677/joe.0.1310171; MURATA M, 1988, P NATL ACAD SCI USA, V85, P2434, DOI 10.1073/pnas.85.8.2434; BERRY MN, 1969, J CELL BIOL, V43, P506, DOI 10.1083/jcb.43.3.506; BORLE AB, 1986, AM J PHYSIOL, V251, pC323; CORVERA S, 1986, BIOCHIM BIOPHYS ACTA, V4304, P434; ESCH FS, 1987, MOL ENDOCRINOL, V1, P388; ETO Y, 1987, BIOCHEM BIOPH RES CO, V142, P1095, DOI 10.1016/0006-291X(87)91528-2; FUKUDA M, 1986, MOL CELL ENDOCRINOL, V44, P55, DOI 10.1016/0303-7207(86)90105-X; HASHIMOTO M, 1990, BIOCHEM BIOPH RES CO, V173, P193, DOI 10.1016/S0006-291X(05)81040-X; KATAYAMA T, 1990, MOL CELL ENDOCRINOL, V69, P179, DOI 10.1016/0303-7207(90)90011-V; KITAOKA M, 1987, BIOCHEM BIOPH RES CO, V146, P1382, DOI 10.1016/0006-291X(87)90802-3; KOJIMA I, 1989, BIOCHEM BIOPH RES CO, V159, P1107, DOI 10.1016/0006-291X(89)92223-7; LING N, 1985, P NATL ACAD SCI USA, V82, P7217, DOI 10.1073/pnas.82.21.7217; LING N, 1986, NATURE, V321, P179; MINE T, 1988, BIOCHIM BIOPHYS ACTA, V970, P166, DOI 10.1016/0167-4889(88)90175-9; MINE T, 1989, ENDOCRINOLOGY, V125, P586; MINE T, 1989, BIOCHEM J, V258, P889; MINE T, 1990, ENDOCRINOLOGY, V126, P2831; MINE T, 1992, BIOCHEM BIOPH RES CO, V186, P205, DOI 10.1016/S0006-291X(05)80794-6; MIYAMOTO K, 1985, BIOCHEM BIOPH RES CO, V129, P396, DOI 10.1016/0006-291X(85)90164-0; NISHIMURA M, 1991, BIOCHEM BIOPH RES CO, V181, P1042, DOI 10.1016/0006-291X(91)92042-I; SCHUBERT D, 1990, NATURE, V344, P868, DOI 10.1038/344868a0; SCHWALL RH, 1993, HEPATOLOGY, V18, P347, DOI 10.1016/0270-9139(93)90018-I; SHIOZAKI M, 1992, P NATL ACAD SCI USA, V89, P1653; SMITH JC, 1990, NATURE, V345, P729, DOI 10.1038/345729a0; SNOWDOWNE KW, 1984, AM J PHYSIOL, V246, pE198; SOKOL S, 1991, NATURE, V351, P409, DOI 10.1038/351409a0; TAYLOR SJ, 1991, NATURE, V350, P516, DOI 10.1038/350516a0; TOTSUKA Y, 1988, BIOCHEM BIOPH RES CO, V156, P335, DOI 10.1016/S0006-291X(88)80845-3; XU JM, 1995, J BIOL CHEM, V270, P6308; YASUDA H, 1993, ENDOCRINOLOGY, V133, P624, DOI 10.1210/en.133.2.624; YASUDA H, 1993, J CLIN INVEST, V92, P1491, DOI 10.1172/JCI116727; YING SY, 1988, ENDOCR REV, V9, P267; YU J, 1987, NATURE, V330, P765, DOI 10.1038/330765a0	37	4	4	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512	0969-711X			ENDOCRINE	Endocrine	AUG	1996	5	1					41	46		10.1007/BF02738654		6	Endocrinology & Metabolism	Endocrinology & Metabolism	VF516	WOS:A1996VF51600006		
J	Thapar, K; Yamada, Y; Scheithauer, B; Kovacs, K; Yamada, S; Stefaneanu, L				Thapar, K; Yamada, Y; Scheithauer, B; Kovacs, K; Yamada, S; Stefaneanu, L			Assessment of mitotic activity in pituitary adenomas and carcinomas	ENDOCRINE PATHOLOGY			English	Article						pituitary adenomas; pituitary carcinomas; mitotic index; invasiveness; Ki-67; proliferation markers	BREAST CARCINOMAS; MARKERS	Assessment of mitotic activity represents one of the oldest and most routinely used histopathologic methods of evaluating the biological aggressiveness of human tumors. In the case of pituitary tumors, however, the relevance of this approach as a means of gaging tumor behavior remains ill-defined. In this article, the relationship between the mitotic index and biological aggressiveness of pituitary tumors was evaluated in a series of 54 pituitary adenomas and 6 primary pituitary carcinomas. All tumors were fully classified by immunohistochemistry and electron microscopy; adenomas were further stratified on the basis of their invasion status, the latter being defined as gross, operatively, or radiologically apparent infiltration of dura or bone. Mitotic figures were present in 11 tumors, 10 being either invasive adenomas or pituitary carcinomas, A significant association between the presence of mitotic figures and tumor behavior was noted, as evidenced by progressive increments in the proportion of cases expressing mitotic figures in the categories of noninvasive adenoma, invasive adenoma, and pituitary carcinoma (3.9, 21.4, and 66.7%, respectively; Fisher's exact test, two-tailed, p < 0.001). The mitotic index, however, appeared to be a less informative parameter, being extremely low in all cases (mean = 0.016% +/- 0.005 [+/- SEM]). Although the mean mitotic index in pituitary carcinomas (0.09% +/- 0.035) was significantly higher than the mean mitotic index of either noninvasive adenomas (0.002% +/- 0.002) or invasive adenomas (0.013% +/- 0.005), no practical I threshold value capable of distinguishing these three groups was evident. Comparison of the mitotic index with Ki-67 derived growth fractions in these tumors revealed a significant but weak linear correlation (r = 0.41, p < 0.01). These data suggest that when, mitotic figures are present, they do provide some indication of the behavior and invasive potential of pituitary tumors. For routine diagnostic purposes, however, the discriminating power of this parameter is somewhat limited, being superseded by alternative and more informative methods of growth fraction determination such as that provided by the Ki-67 immunolabeling.	UNIV TORONTO,ST MICHAELS HOSP,DEPT PATHOL,TORONTO,ON M5B 1W8,CANADA; UNIV TOKYO,FAC MED,TOKYO 113,JAPAN; MAYO CLIN & MAYO GRAD SCH MED,DEPT PATHOL & LAB MED,ROCHESTER,MN 55901; TORANOMON GEN HOSP,DEPT NEUROSURG,TOKYO,JAPAN	Thapar, K (reprint author), UNIV TORONTO,ST MICHAELS HOSP,DIV NEUROSURG,30 BOND ST,TORONTO,ON M5B 1W8,CANADA.						WILSON CB, 1984, J NEUROSURG, V61, P814, DOI 10.3171/jns.1984.61.5.0814; Thapar K, 1996, NEUROSURGERY, V38, P99, DOI 10.1097/00006123-199601000-00024; HSU SM, 1981, AM J CLIN PATHOL, V75, P816; SCHEITHAUER BW, 1986, J NEUROSURG, V65, P733, DOI 10.3171/jns.1986.65.6.0733; CLAYTON F, 1991, CANCER, V68, P1309, DOI 10.1002/1097-0142(19910915)68:6<1309::AID-CNCR2820680621>3.0.CO;2-I; CLAYTON F, 1993, CANCER, V71, P1780, DOI 10.1002/1097-0142(19930301)71:5<1780::AID-CNCR2820710512>3.0.CO;2-2; KRAMER A, 1994, ENDOCR PATHOL, V5, P198, DOI 10.1007/BF02921487; LAWS ER, 1995, BAILLIERE CLIN ENDOC, V9, P391, DOI 10.1016/S0950-351X(95)80418-8; LAWS ER, 1984, J NEUROSURG, V63, P35; RANDALL RV, 1983, MAYO CLIN PROC, V58, P108; SELMAN WR, 1986, J NEUROSURG, V64, P402, DOI 10.3171/jns.1986.64.3.0402; TAYLOR CR, 1994, HUM PATHOL, V25, P263, DOI 10.1016/0046-8177(94)90198-8; VANDIEST PJ, 1991, HUM PATHOL, V22, P326, DOI 10.1016/0046-8177(91)90080-9; Wilson C B, 1990, Neurosurg Clin N Am, V1, P139	14	29	29	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512	1046-3976			ENDOCR PATHOL	Endocr. Pathol.	AUG	1996	7	3					215	221		10.1007/BF02739924		7	Endocrinology & Metabolism; Pathology	Endocrinology & Metabolism; Pathology	VJ937	WOS:A1996VJ93700005		
J	Kim, GB; Tanabe, S; Iwakiri, R; Tatsukawa, R; Amano, M; Miyazaki, N; Tanaka, H				Kim, GB; Tanabe, S; Iwakiri, R; Tatsukawa, R; Amano, M; Miyazaki, N; Tanaka, H			Accumulation of butyltin compounds in Risso's dolphin (Grampus griseus) from the Pacific coast of Japan: Comparison with organochlorine residue pattern	ENVIRONMENTAL SCIENCE & TECHNOLOGY			English	Article							MARINE MAMMALS; UNITED-STATES; TRIBUTYLTIN CONTAMINATION; ORGANOTIN COMPOUNDS; SMALL CETACEANS; WEST COASTS; TOXICITY; IMPOSEX; BLUBBER; PROFILE	Concentrations of butyltins (BTs) in the liver and organochlorine compounds (OCs) in the blubber of Risso's dolphins collected off Taiji, Japan, in 1991 were determined. Mean and range concentrations (wet weight basis) of these compounds were 3.6 mu g/g (0.55-6.0 mu g/g) for BTs, 25 mu g/g (1.7-120 mu g/g) for PCBs, 17 mu g/g (0.45-77 mu g/g) for DDTs, 4.0 mu g/g (0.19-16 mu g/g) for CHLs, and 0.16 mu g/g (0.008-0.74 mu g/g) for HCHs. OCs concentrations increased with age in males in contrast to that in females, which showed a decreasing trend after maturity. On the other hand, no difference was observed in BT concentrations between male and female, which showed increasing levels until maturity (8-10 years) and then remained constant. It is suggested that, unlike OCs, BTs were less transferable to young ones in reproductive processes. Risso's dolphins showed higher biomagnification factor (about 6) than Steller sea lion (0.6), implying a slower excretion rate of BTs in cetaceans than in pinnipeds due to the lower degradation capacity of xenobiotics and the lack of physiological processes such as shedding of hair in cetaceans.	EHIME UNIV,DEPT ENVIRONM CONSERVAT,MATSUYAMA,EHIME 790,JAPAN; UNIV TOKYO,OCEAN RES INST,OTSUCHI MARINE RES CTR,OTSUCHI,IWATE 02811,JAPAN; NATL RES INST FAR SEAS FISHERIES,SHIMIZU,SHIZUOKA 424,JAPAN			Tanabe, Shinsuke/G-6950-2013; 	Miyazaki, Nobuyuki/0000-0001-8094-683X			ALZIEU C, 1986, OCEANS 86 P, V4, P1130; ALZIEU C, 1979, OCEANOL ACTA, V2, P107; CORSOLINI S, 1995, MAR ENVIRON RES, V40, P33, DOI 10.1016/0141-1136(94)00003-8; KAWANO M, 1988, ENVIRON SCI TECHNOL, V22, P792, DOI 10.1021/es00172a008; BRYAN GW, 1988, J MAR BIOL ASSOC UK, V68, P733; WADE TL, 1988, ENVIRON SCI TECHNOL, V22, P1488, DOI 10.1021/es00177a016; AGUILAR A, 1984, CAN J FISH AQUAT SCI, V41, P840; ADDISON RF, 1977, J FISH RES BOARD CAN, V34, P937; ALI AA, 1990, B ENVIRON CONTAM TOX, V44, P29; DAVIS A, 1987, MUTAT RES, V188, P65, DOI 10.1016/0165-1218(87)90096-6; TANABE S, 1988, MAR MAMMAL SCI, V4, P103, DOI 10.1111/j.1748-7692.1988.tb00191.x; NAKATA H, 1995, ENVIRON SCI TECHNOL, V29, P2877, DOI 10.1021/es00011a026; ALZIEU C, 1991, MAR ENVIRON RES, V32, P7, DOI 10.1016/0141-1136(91)90029-8; GIBBS PE, 1990, J MAR BIOL ASSOC UK, V70, P639; AUCAMP P J, 1971, Marine Pollution Bulletin, V2, P190, DOI 10.1016/0025-326X(71)90089-0; CRAIG PJ, 1983, COMPREHENSIVE ORGANO, V2, P979; DEKOCK AC, 1994, SCI TOTAL ENVIRON, V154, P153, DOI 10.1016/0048-9697(94)90085-X; DUINKER J C, 1989, Aquatic Mammals, V15, P95; ELFERINK JGR, 1986, BIOCHEM PHARMACOL, V35, P3727, DOI 10.1016/0006-2952(86)90657-X; ESPOURTEILLE FA, 1993, ENVIRON TOXICOL CHEM, V12, P305, DOI 10.1897/1552-8618(1993)12[305:MOTCOS]2.0.CO;2; FENT K, 1995, ENVIRON TOXICOL CHEM, V14, P1123, DOI 10.1897/1552-8618(1995)14[1123:OIFHAR]2.0.CO;2; GIBBS PE, 1991, J MAR BIOL ASSOC UK, V91, P827; GURUGE KS, IN PRESS ARCH ENV CO; IWAI T, 1990, BASIC AQUATIC ANIMAL, P104; IWATA H, 1994, MAR POLLUT BULL, V28, P607, DOI 10.1016/0025-326X(94)90362-X; IWATA H, 1995, ENVIRON SCI TECHNOL, V29, P2959, DOI 10.1021/es00012a011; Kasuya T., 1976, Scientific Rep Whales Res Inst Tokyo, VNo. 28, P73; KAWAI S, 1981, STUDIES LEVELS ORGAN, P85; KAWANO M, 1990, THESIS KYUSHU U JAPA, P256; KIM GB, IN PRESS MAR POLLUT; KIM GB, IN PRESS ENV TOXICOL; LEE JS, IN PRESS MAR POLLUT; MIZUE K, 1962, B FAC FISH NAGASAKI, V12, P45; NOLAND EA, 1983, J TOXICOL ENV HEALTH, V12, P89; ORR RT, 1966, J MAMMAL, V47, P341, DOI 10.2307/1378142; Pilleri G., 1969, Zeitschrift fuer Tierpsychologie, V26, P48; ROSS GJB, 1984, ANN CAPE PROV MUS NA, V15, P287; SHORT JW, 1989, ENVIRON SCI TECHNOL, V23, P740, DOI 10.1021/es00064a014; SMITH PJ, 1979, PESTIC SCI, V10, P419, DOI 10.1002/ps.2780100509; STROUD RK, 1968, J MAMMAL, V49, P347, DOI 10.2307/1378014; Subramanian A., 1987, P NIPR S POLAR BIOL, P205; TANABE S, 1981, AGR BIOL CHEM TOKYO, V45, P2569; TANABE S, 1994, SCI TOTAL ENVIRON, V154, P163, DOI 10.1016/0048-9697(94)90086-8; TANABE S, 1994, ENVIRON POLLUT, V85, P305, DOI 10.1016/0269-7491(94)90052-3; TSUTSUMI T, 1954, B FAC FISH NAGASAKI, V11, P19; UHLER AD, 1993, ENVIRON TOXICOL CHEM, V12, P139, DOI 10.1897/1552-8618(1993)12[139:TLIBMF]2.0.CO;2; WATANABE S, 1989, MAR ENVIRON RES, V27, P51, DOI 10.1016/0141-1136(89)90018-4	47	63	64	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036	0013-936X			ENVIRON SCI TECHNOL	Environ. Sci. Technol.	AUG	1996	30	8					2620	2625		10.1021/es9600486		6	Engineering, Environmental; Environmental Sciences	Engineering; Environmental Sciences & Ecology	VA637	WOS:A1996VA63700054		
J	Suzuki, M; Kaga, K				Suzuki, M; Kaga, K			Effect of cisplatin on the negative charge barrier in strial vessels of the guinea pig - A transmission electron microscopic study using polyethyleneimine molecules	EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY			English	Article						cisplatin; basement membrane anionic sites; cochlea; stria vascularis; polyethyleneimine tracer	BASEMENT-MEMBRANE; ANIONIC SITES; OTOTOXICITY; VASCULARIS; PERMEABILITY; TRACER	The anionic sites on the basement membrane in the cochlea are believed to act as a charge barrier. Using polyethyleneimine (PEI) as a cationic tracer, we examined the effects of cisplatin (CDDP) on anionic sites in the basement membrane in the cochlea. Eight Hartley-strain guinea pigs were separated into control (buffer administration) and CDDP groups. Ultrathin sections of the basal and third turns of the cochlear ducts were examined using a transmission electron microscope. A marked decrease of PEI distribution was noted in the strial vessels of the CDDP group compared to the control group. However, the two groups showed no signigicant differences in PEI particles on the basement membranes in the basilar and Reissner's membranes, or in the basal and third turns. These findings suggest that the charge barrier in the stria vascularis may be easily injured by the administration of CDDP.	UNIV TOKYO,DEPT OTOLARYNGOL,BUNKYO KU,TOKYO 113,JAPAN	Suzuki, M (reprint author), TOHSEI NATL HOSP,DEPT OTOLARYNGOL,762-1 NAGASAWA,SHIMIZU,SHIZUOKA,JAPAN.						RENNKE HG, 1975, J CELL BIOL, V67, P638, DOI 10.1083/jcb.67.3.638; JUHN SK, 1981, ACTA OTO-LARYNGOL, V91, P529, DOI 10.3109/00016488109138538; NAKAI Y, 1982, ACTA OTO-LARYNGOL, V93, P227, DOI 10.3109/00016488209130876; TANGE RA, 1984, ARCH OTO-RHINO-LARYN, V239, P41, DOI 10.1007/BF00454261; CAULFIELD JP, 1978, LAB INVEST, V39, P505; FURNESS PN, 1986, J PATHOL, V150, P267, DOI 10.1002/path.1711500406; KOHN S, 1988, LARYNGOSCOPE, V98, P865; KOHN S, 1991, LARYNGOSCOPE, V101, P709; LAURELL G, 1989, HEARING RES, V38, P19, DOI 10.1016/0378-5955(89)90124-X; MACROALGARRA J, 1985, ACTA OTOLARYNGOL STO, V99, P343; PILIA PA, 1985, AM J PATHOL, V121, P474; SCHURER JW, 1978, J HISTOCHEM CYTOCHEM, V26, P688; SCHURER JW, 1977, J HISTOCHEM CYTOCHEM, V25, P384; SCHWEITZER VG, 1993, LARYNGOSCOPE, V103, P1, DOI 10.1288/00005537-199304000-00001; Suzuki M, 1991, Acta Otolaryngol Suppl, V481, P112; TAKUMIDA M, 1988, ARCH OTO-RHINO-LARYN, V245, P266, DOI 10.1007/BF00464628; WADA N, 1991, JPN J NEPHROL, V33, P9; XU RD, 1994, ORL J OTO-RHINO-LARY, V56, P183; YAMANE H, 1983, ARCH OTO-RHINO-LARYN, V238, P273, DOI 10.1007/BF00453938	19	10	11	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010	0937-4477			EUR ARCH OTO-RHINO-L	Eur. Arch. Oto-Rhino-Laryn.	AUG	1996	253	6					351	355				5	Otorhinolaryngology	Otorhinolaryngology	VC280	WOS:A1996VC28000007		
J	Kim, DM; Kigawa, T; Choi, CY; Yokoyama, S				Kim, DM; Kigawa, T; Choi, CY; Yokoyama, S			A highly efficient cell-free protein synthesis system from Escherichia coli	EUROPEAN JOURNAL OF BIOCHEMISTRY			English	Article						in vitro protein synthesis; cell extract; coupled transcription/translation; T7 RNA polymerase; chloramphenicol acetyltransferase	FREE TRANSLATION SYSTEM; COUPLED TRANSCRIPTION-TRANSLATION; TRANSFER-RNA SYNTHETASE; MESSENGER-RNA; PREPARATIVE-SCALE; INVITRO SYNTHESIS; GENE-EXPRESSION; POLYPEPTIDE; POLYAMINES; PURIFICATION	We modified a cell-free coupled transcription/translation system from Escherichia coli with the T7 phage RNA polymerase, and achieved a productivity as high as 0.4 mg protein/ml reaction mixture. First, we found that the optimal concentrations of phosphoenolpyruvate and poly(ethylene glycol) are interdependent; higher concentrations of the former should be used at higher concentrations of the latter. Second, the use of a condensed 30 000Xg cell extract, in place of the conventional one, significantly increased the initial rate of protein synthesis. This phenomenon was demonstrated to be due to a reason other than elimination of inhibitory molecule(s) from the extract. For this system with the condensed extract, the phosphoenolpyruvate and poly(ethylene glycol) concentrations were again co-optimized, resulting in production of chloramphenicol acetyltransferase at a productivity of 0.3 mg/ml. Finally, the productivity was further increased up to 0.4 mg/ml, by supplementation of the pool of amino acids. This improved cell-free protein synthesis system is superior in productivity to any other cell-free systems reported so far, including the continuous-flow cell-free system.	UNIV TOKYO,GRAD SCH SCI,DEPT BIOPHYS & BIOCHEM,BUNKYO KU,TOKYO 113,JAPAN; SEOUL NATL UNIV,COLL ENGN,INTERDISCIIPLINARY PROGRAM BIOCHEM ENGN & TECHNOL,SEOUL,SOUTH KOREA; RIKEN,CELLULAR SIGNALING LAB,WAKO,SAITAMA 35101,JAPAN; SEOUL NATL UNIV,COLL ENGN,DEPT CHEM TECHNOL,SEOUL,SOUTH KOREA			Kigawa, Takanori/A-7679-2010	Kigawa, Takanori/0000-0003-0146-9719			AMARA SG, 1980, J BIOL CHEM, V255, P2645; SPIRIN AS, 1988, SCIENCE, V242, P1162, DOI 10.1126/science.3055301; KOHNO T, 1990, J BIOL CHEM, V265, P6931; CHUNG HH, 1993, SCIENCE, V259, P806, DOI 10.1126/science.8430333; MARSTON FAO, 1986, BIOCHEM J, V240, P1; NOREN CJ, 1989, SCIENCE, V244, P182, DOI 10.1126/science.2649980; ATKINS JF, 1975, J BIOL CHEM, V250, P5688; BARANOV VI, 1989, GENE, V84, P463, DOI 10.1016/0378-1119(89)90521-0; BARANOV VI, 1993, METHOD ENZYMOL, V217, P123; BRANDSMA M, 1995, EUR J BIOCHEM, V233, P277, DOI 10.1111/j.1432-1033.1995.277_1.x; CHARLES IG, 1993, BIOCHEM BIOPH RES CO, V196, P1481, DOI 10.1006/bbrc.1993.2419; CHEN HZ, 1983, METHOD ENZYMOL, V101, P674; CHRUNYK BA, 1993, J BIOL CHEM, V268, P18053; DAVANLOO P, 1984, P NATL ACAD SCI-BIOL, V81, P2035, DOI 10.1073/pnas.81.7.2035; ENDO Y, 1992, J BIOTECHNOL, V25, P221, DOI 10.1016/0168-1656(92)90157-5; FEDOROV AN, 1992, J MOL BIOL, V225, P927, DOI 10.1016/0022-2836(92)90092-X; FUCHS E, 1976, EUR J BIOCHEM, V63, P15, DOI 10.1111/j.1432-1033.1976.tb10201.x; GOFF SA, 1987, J BIOL CHEM, V262, P4508; GOODMAN RH, 1979, BIOCHEM BIOPH RES CO, V91, P932, DOI 10.1016/0006-291X(79)91969-7; HENRICH B, 1982, MOL GEN GENET, V185, P493, DOI 10.1007/BF00334146; IGARASHI K, 1980, BIOCHEM BIOPH RES CO, V93, P360, DOI 10.1016/0006-291X(80)91085-2; JACOBS JW, 1979, J BIOL CHEM, V254, P600; KIGAWA T, 1991, J BIOCHEM-TOKYO, V110, P166; KIGAWA T, 1995, J BIOMOL NMR, V6, P129; KOLOSOV MI, 1992, BIOTECHNOL APPL BIOC, V16, P125; KONECKI D, 1975, ARCH BIOCHEM BIOPHYS, V169, P192, DOI 10.1016/0003-9861(75)90332-X; KUDLICKI W, 1992, ANAL BIOCHEM, V206, P389, DOI 10.1016/0003-2697(92)90383-I; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MA CH, 1993, BIOCHEMISTRY-US, V32, P7939, DOI 10.1021/bi00082a015; MATTINGLY JR, 1993, J BIOL CHEM, V268, P26320; MAURIZI MR, 1987, J BIOL CHEM, V262, P2696; NAKANO H, 1994, BIOSCI BIOTECH BIOCH, V58, P631; NEGRUTSKII BS, 1994, P NATL ACAD SCI USA, V91, P964, DOI 10.1073/pnas.91.3.964; Pratt J. M., 1984, TRANSCRIPTION TRANSL, P179; RYABOVA L, 1994, J BIOL CHEM, V269, P1501; RYABOVA LA, 1989, NUCLEIC ACIDS RES, V17, P4412, DOI 10.1093/nar/17.11.4412; UZAWA T, 1993, J BIOCHEM-TOKYO, V114, P478; VOLYANIK EV, 1993, ANAL BIOCHEM, V214, P289, DOI 10.1006/abio.1993.1490	38	149	155	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010	0014-2956			EUR J BIOCHEM	Eur. J. Biochem.	AUG 1	1996	239	3					881	886		10.1111/j.1432-1033.1996.0881u.x		6	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	VB017	WOS:A1996VB01700044		
J	Tsurumi, C; Shimizu, Y; Saeki, M; Kato, S; DeMartino, GN; Slaughter, CA; Fujimuro, M; Yokosawa, H; Yamasaki, M; Hendil, KB; TohE, A; Tanahashi, N; Tanaka, K				Tsurumi, C; Shimizu, Y; Saeki, M; Kato, S; DeMartino, GN; Slaughter, CA; Fujimuro, M; Yokosawa, H; Yamasaki, M; Hendil, KB; TohE, A; Tanahashi, N; Tanaka, K			cDNA cloning and functional analysis of the p97 subunit of the 26S proteasome, a polypeptide identical to the type-1 tumor-necrosis-factor-receptor-associate protein-2/55.11	EUROPEAN JOURNAL OF BIOCHEMISTRY			English	Article						proteasome; ubiquitin; type-1 tumor-necrosis-factor receptor; p97 subunit	ATP-DEPENDENT ACTIVATOR; PROTEIN-DEGRADATION; REGULATORY COMPLEX; MOLECULAR-CLONING; GENE DISRUPTION; UBIQUITIN; YEAST; ACID; IDENTIFICATION; PEPTIDES	Molecular cloning of cDNA for a new regulatory subunit, designated p97, of the human 26S proteasome showed that the polypeptide consists of 908 amino acid residues with a calculated molecular mass of 100 184 Da and an isoelectric point of 4.94, Computer analysis showed that p97 is very similar to type-1 tumor-necrosis-factor(TNF)-receptor-associated protein (TRAP)-2 and 55.11, both of which were identified recently as binding proteins of the cytoplasmic domain of type-1 TNF receptor by yeast two-hybrid screening. This finding suggests that the 26S proteasome might serve as a mediator molecule in the TNF signaling pathway in cells. Computer-assisted similarity analysis also revealed the high sequence similarity of p97 with a yeast protein whose function is yet unknown, the gene for which is here termed NAS1 (non-ATPase subunit 1), Disruption of NAS1 resulted in several phenotypes, including lethality and temperature-sensitive growth, depending on the genetic background of the cells used, The human p97 cDNA suppressed the growth defect of nas1 disruptant cells, when expressed from single-copy or multicopy vectors, indicating that p97 is functionally equivalent to yeast Nas1p. Culturing of the temperature-sensitive nas1 cells at the restrictive temperature promoted the accumulation polyubiquitinated cellular proteins, implying that the 26S proteasome requires a functional Nas1p subunit for ubiquitin-dependent proteolysis. These results indicate that p97/Nas1p plays an important regulatory role in the function of the 26S proteasome.	UNIV TOKUSHIMA, INST ENZYME RES, TOKUSHIMA 770, JAPAN; SAGAMI CHEM RES CTR, KANAGAWA, JAPAN; UNIV TEXAS, SW MED CTR, DEPT PHYSIOL, DALLAS, TX 75235 USA; UNIV TEXAS, SW MED CTR, DEPT BIOCHEM, DALLAS, TX 75235 USA; UNIV TEXAS, SW MED CTR, HOWARD HUGHES MED INST, DALLAS, TX 75235 USA; HOKKAIDO UNIV, FAC PHARMACEUT SCI, DEPT BIOCHEM, SAPPORO, HOKKAIDO 060, JAPAN; KYOWA HAKKO KOGYO CO LTD, TOKYO RES LABS, TOKYO 194, JAPAN; UNIV COPENHAGEN, AUGUST KROGH INST, DK-2100 COPENHAGEN, DENMARK; UNIV TOKYO, GRAD SCH SCI, DEPT BIOL SCI, GENET LAB, TOKYO 113, JAPAN							AKIYAMA K, 1995, FEBS LETT, V363, P151, DOI 10.1016/0014-5793(95)00304-R; TANAHASHI N, 1993, ENZYME PROTEIN, V47, P241; HSU HL, 1995, CELL, V81, P495, DOI 10.1016/0092-8674(95)90070-5; AKIYAMA KY, 1994, SCIENCE, V265, P1231, DOI 10.1126/science.8066462; FUJIMURO M, 1994, FEBS LETT, V349, P173, DOI 10.1016/0014-5793(94)00647-4; HEEMELS MT, 1995, ANNU REV BIOCHEM, V64, P463, DOI 10.1146/annurev.bi.64.070195.002335; AHN JY, 1995, FEBS LETT, V366, P37; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; SUTTON A, 1991, MOL CELL BIOL, V11, P2133; SONG HY, 1995, J BIOL CHEM, V270, P3574; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; TANAKA K, 1995, MOL BIOL REP, V21, P21, DOI 10.1007/BF00990966; vanNocker S, 1996, P NATL ACAD SCI USA, V93, P856, DOI 10.1073/pnas.93.2.856; DEVERAUX Q, 1994, J BIOL CHEM, V269, P7059; ITO H, 1983, J BACTERIOL, V153, P163; BOLDIN MP, 1995, FEBS LETT, V367, P39, DOI 10.1016/0014-5793(95)00534-G; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CIECHANOVER A, 1994, CELL, V79, P13, DOI 10.1016/0092-8674(94)90396-4; CONFALONIERI F, 1995, BIOESSAYS, V17, P639, DOI 10.1002/bies.950170710; DEMARINI DJ, 1995, MOL CELL BIOL, V15, P6331; DeMartino GN, 1996, J BIOL CHEM, V271, P3112; DEMARTINO GN, 1994, J BIOL CHEM, V269, P20878; DEVERAUX Q, 1995, J BIOL CHEM, V270, P29660; DUBIEL W, 1992, J BIOL CHEM, V267, P22669; DUBIEL W, 1995, MOL BIOL REP, V21, P27, DOI 10.1007/BF00990967; FUJIWARA T, 1990, J BIOL CHEM, V265, P16604; FUJIWARA T, 1996, IN PRESS FEBS LETT; GOLDBERG AL, 1992, NATURE, V357, P375, DOI 10.1038/357375a0; GORDON C, 1993, NATURE, V366, P3655; GRINDLEY T, 1990, DEVELOPMENT, V109, P235; HARACSKA L, 1995, EUR J BIOCHEM, V231, P720, DOI 10.1111/j.1432-1033.1995.tb20753.x; HERSHKO A, 1992, ANNU REV BIOCHEM, V61, P761, DOI 10.1146/annurev.bi.61.070192.003553; HOCHSTRASSER M, 1995, CURR OPIN CELL BIOL, V7, P215, DOI 10.1016/0955-0674(95)80031-X; KATO S, 1994, GENE, V150, P243; KOMINAMI K, 1995, EMBO J, V14, P3105; MA CP, 1994, J BIOL CHEM, V269, P3539; NEEDLEMA.SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; NELBOCK P, 1990, SCIENCE, V248, P1650, DOI 10.1126/science.2194290; PETERS JM, 1994, TRENDS BIOCHEM SCI, V19, P377, DOI 10.1016/0968-0004(94)90115-5; REALINI C, 1994, J BIOL CHEM, V269, P20727; REALINI C, 1994, FEBS LETT, V348, P109, DOI 10.1016/0014-5793(94)00569-9; RECHSTEINER M, 1993, J BIOL CHEM, V268, P6065; [Anonymous], 1991, METHOD ENZYMOL; SHIBUYA H, 1992, NATURE, V357, P700, DOI 10.1038/357700a0; SKOOG B, 1986, TRAC-TREND ANAL CHEM, V5, P82, DOI 10.1016/0165-9936(86)80045-0; TANAKA K, 1990, BIOCHEMISTRY-US, V29, P3777, DOI 10.1021/bi00467a026; TSUBUKI S, 1994, FEBS LETT, V344, P229, DOI 10.1016/0014-5793(94)00388-2; TSURUMI C, 1995, BIOCHEM BIOPH RES CO, V210, P600, DOI 10.1006/bbrc.1995.1701; Yokota K, 1996, MOL BIOL CELL, V7, P853	51	53	55	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0014-2956			EUR J BIOCHEM	Eur. J. Biochem.	AUG 1	1996	239	3					912	921		10.1111/j.1432-1033.1996.0912u.x		10	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	VB017	WOS:A1996VB01700048		
J	Gabius, S; Kayser, K; Bovin, NV; Yamazaki, N; Kojima, S; Kaltner, H; Gabius, HJ				Gabius, S; Kayser, K; Bovin, NV; Yamazaki, N; Kojima, S; Kaltner, H; Gabius, HJ			Endogenous lectins and neoglycoconjugates: A sweet approach to tumour diagnosis and targeted drug delivery	EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS			English	Review						lectin; neoglycoconjugate; liposome; drug targeting; tumour therapy/diagnosis	CARBOHYDRATE-BINDING PROTEINS; N-LINKED OLIGOSACCHARIDES; MEMBRANE LECTINS; IN-VIVO; IMMOBILIZED NEOGLYCOPROTEINS; RECOGNITION MOLECULES; ANIMAL LECTINS; LUNG-CANCER; CELL-LINES; CARRIERS	Rational interference with disease processes by biopharmaceutical approaches requires an understanding of the biochemical basis for recognitive interactions on the level of molecules, organelles, cells and tissues. Whereas the pivotal role of nucleic acids and proteins is now well established, research efforts on a third class of information-bearing biomolecules have only recently been gaining momentum. Although progress in this field had been hampered by comparatively delayed development of adequate analytical and synthetic procedures, the presently available evidence for a physiological significance of the carbohydrate part of cellular glycoconjugates is already convincing. It includes demonstration of the participation in cell-cell and cell-matrix interactions, elicitation of biosignalling as well as cell type-specific endocytosis and intracellular routing. Within an accurately tuned molecular interplay, sugar receptors like endogenous lectins enable to transduce the informational contents of distinct oligosaccharide sequences into apparent effects. Technically, covalent attachment of such glycoligand structures to an otherwise inert carrier is proven to be valuable for unequivocal lectin detection. In histopathology these custom-made neoglycoconjugates have allowed to delineate tumour cell type-, and differentiation-associated expression of receptor sites that may in certain cases exhibit prognostic relevance. In addition to diagnostic applications, the presence of cell surface lectins can be exploited as target for drug delivery, deliberately inhibiting cell-cell interactions in infectious processes or inflammation and aiming at cell type-specific uptake of therapeuticals. Conversely, the target selectivity of tissue lectins can similarly be taken advantage of to direct the transport of any medical substance or to elicit pharmacological responses with assumed clinical benefit such as enhanced cytokine secretion. The presently dynamic development in glycobiology establishes the indispensable prerequisites to thoroughly, patiently and critically evaluate the practical efficacy of the outlined approaches.	UNIV MUNICH,INST PHYSIOL CHEM,D-80539 MUNICH,GERMANY; HOSP THORAC DIS,DEPT PATHOL,HEIDELBERG,GERMANY; RUSSIAN ACAD SCI,INST BIOORGAN CHEM,MOSCOW,RUSSIA; INST MAT & CHEM RES,FUNCT MOL LAB,IBARAKI,OSAKA,JAPAN; UNIV TOKYO,RES INST BIOSCI,CHIBA,JAPAN							ALLEN HJ, 1990, BIOCHEM BIOPH RES CO, V172, P335, DOI 10.1016/S0006-291X(05)80214-1; ANDERSSON M, 1993, BIOCONJUGATE CHEM, V4, P246, DOI 10.1021/bc00021a010; POZNANSKY MJ, 1984, PHARMACOL REV, V36, P277; MIYAKE M, 1992, NEW ENGL J MED, V327, P14, DOI 10.1056/NEJM199207023270103; GABIUS HJ, 1991, BIOCHIM BIOPHYS ACTA, V1071, P1, DOI 10.1016/0304-4157(91)90010-T; MONSIGNY M, 1994, ADV DRUG DELIVER REV, V14, P1, DOI 10.1016/0169-409X(94)90003-5; IRIMURA T, 1991, CANCER RES, V51, P387; DERRIEN D, 1989, GLYCOCONJUGATE J, V6, P241, DOI 10.1007/BF01050652; MOLEMA G, 1994, ADV DRUG DELIVER REV, V14, P25, DOI 10.1016/0169-409X(94)90004-3; KAYSER K, 1994, EUR J CANCER, V30A, P653, DOI 10.1016/0959-8049(94)90538-X; SHARON N, 1989, SCIENCE, V246, P227, DOI 10.1126/science.2552581; ROCHE AC, 1990, RES VIROLOGY, V141, P243, DOI 10.1016/0923-2516(90)90028-H; HOLMSKOV U, 1994, IMMUNOL TODAY, V15, P67, DOI 10.1016/0167-5699(94)90136-8; RAZ A, 1987, CANCER METAST REV, V6, P433, DOI 10.1007/BF00144274; GABIUS S, 1990, INT J CANCER, V46, P500, DOI 10.1002/ijc.2910460329; Stowell C P, 1980, Adv Carbohydr Chem Biochem, V37, P225; DANGUY A, 1994, HISTOL HISTOPATHOL, V9, P155; GABIUS HJ, 1991, PROG HISTOCHEM CYTOC, V22, P1; VANDERSLUIJS P, 1986, HEPATOLOGY, V6, P723, DOI 10.1002/hep.1840060431; ALLEN TM, 1994, TRENDS PHARMACOL SCI, V15, P215, DOI 10.1016/0165-6147(94)90314-X; GABIUS HJ, 1987, CANCER INVEST, V5, P39, DOI 10.3109/07357908709020305; CHIU MH, 1994, J BIOL CHEM, V269, P16195; BARONDES SH, 1981, ANNU REV BIOCHEM, V50, P207, DOI 10.1146/annurev.bi.50.070181.001231; Bovin NV, 1995, CHEM SOC REV, V24, P413, DOI 10.1039/cs9952400413; FIUME L, 1983, FEBS LETT, V153, P6, DOI 10.1016/0014-5793(83)80108-2; ASHWELL G, 1982, ANNU REV BIOCHEM, V51, P531, DOI 10.1146/annurev.bi.51.070182.002531; KOBATA A, 1992, EUR J BIOCHEM, V209, P483, DOI 10.1111/j.1432-1033.1992.tb17313.x; SALTZMAN WM, 1993, CRIT REV THER DRUG, V10, P111; GABIUS S, 1994, ANN HEMATOL, V68, P125, DOI 10.1007/BF01727416; DRICKAMER K, 1993, ANNU REV CELL BIOL, V9, P237, DOI 10.1146/annurev.cb.09.110193.001321; VARKI A, 1994, P NATL ACAD SCI USA, V91, P7390, DOI 10.1073/pnas.91.16.7390; APLIN JD, 1981, CRC CR REV BIOCH MOL, V10, P259, DOI 10.3109/10409238109113601; BARDOSI A, 1991, ANTICANCER RES, V11, P1180; BARDOSI A, 1988, VIRCHOWS ARCH B, V56, P35, DOI 10.1007/BF02889999; BARRATT G, 1986, BIOCHIM BIOPHYS ACTA, V862, P153, DOI 10.1016/0005-2736(86)90479-7; BLITHE DL, 1993, TRENDS GLYCOSCI GLYC, V5, P87; BODMER JL, 1985, METHOD ENZYMOL, V112, P298; BONFILS E, 1992, NUCLEIC ACIDS RES, V20, P4621, DOI 10.1093/nar/20.17.4621; Boren Thomas, 1994, Trends in Microbiology, V2, P221, DOI 10.1016/0966-842X(94)90626-2; BOVIN NV, 1993, LECTINS GLYCOBIOLOGY, P23; BRADY RO, 1991, LECTINS CANC, P237; CHADLI A, 1992, ANAL BIOCHEM, V204, P198, DOI 10.1016/0003-2697(92)90161-Y; CHAKRABORTY P, 1990, J PROTOZOOL, V37, P358, DOI 10.1111/j.1550-7408.1990.tb01158.x; CHEN VJ, 1986, MICROBIOLOGY, P297; Cook G M, 1986, J Cell Sci Suppl, V4, P45; CUMMING D A, 1991, Glycobiology, V1, P115, DOI 10.1093/glycob/1.2.115; DINTZIS RZ, 1989, J IMMUNOL, V143, P1239; EDGINGTON SM, 1992, BIO-TECHNOL, V10, P383; EDWARDS DC, 1981, TRENDS BIOCHEM SCI, V6, P313, DOI 10.1016/0968-0004(81)90112-2; ELBEIN AD, 1991, TRENDS BIOTECHNOL, V9, P346, DOI 10.1016/0167-7799(91)90117-Z; FACY P, 1990, EXP CELL RES, V190, P151, DOI 10.1016/0014-4827(90)90179-E; FIANI ML, 1989, TRENDS BIOTECHNOL, V7, P57, DOI 10.1016/0167-7799(89)90064-4; FRESE J, 1994, ADV DRUG DELIVER REV, V14, P137, DOI 10.1016/0169-409X(94)90009-4; GABIUS HJ, 1989, CLIN EXP METASTAS, V7, P571, DOI 10.1007/BF01753816; GABIUS HJ, 1991, NATURWISSENSCHAFTEN, V70, P230; GABIUS HJ, 1994, PLANTA MED, V60, P2, DOI 10.1055/s-2006-959396; GABIUS HJ, IN PRESS CANC INVEST; GABIUS HJ, 1993, BIOREGULATORS, V1, P18; Gabius H.-J., 1993, LECTINS GLYCOBIOLOGY; Gabius H.-J., 1991, LECTINS CANC; GABIUS HJ, 1988, ISI ATLAS-BIOCHEM, V1, P210; GABIUS HJ, 1992, ANTICANCER RES, V12, P987; GABIUS HJ, 1991, VIRCHOWS ARCH A, V419, P217, DOI 10.1007/BF01626351; GABIUS HJ, 1993, HISTOL HISTOPATHOL, V8, P369; GABIUS HJ, 1992, ADV LECTIN RES, V5, P123; GABIUS HJ, 1994, METHOD ENZYMOL, V242, P37; GABIUS HJ, 1989, ANTICANCER RES, V9, P1599; Gabius Hans-Joachim, 1994, P403; GABIUS HJ, 1994, BERL MUNCH TIERARZTL, V107, P376; GABIUS HJ, 1988, ANGEW CHEM INT EDIT, V27, P1267, DOI 10.1002/anie.198812671; GABIUS HJ, 1996, GLYCOSCIENCES STATUS; GABIUS HJ, 1994, TRENDS GLYCOSCI GLYC, V6, P229; GABIUS S, 1990, ANTICANCER RES, V10, P1005; GABIUS S, 1992, INT J ONCOL, V1, P705; GEELHOED GW, 1988, S AFR J SURG, V26, P1; GEISOW MJ, 1991, TRENDS BIOTECHNOL, V9, P221, DOI 10.1016/0167-7799(91)90074-R; GLAVES D, 1989, INT J CANCER, V44, P506, DOI 10.1002/ijc.2910440322; GUPTA D, 1994, GLYCOCONJUGATE J, V11, P558, DOI 10.1007/BF00731307; HEICAPPELL R, 1991, LECTINS CANC, P105; Houston L. L., 1993, Current Opinion in Biotechnology, V4, P739, DOI 10.1016/0958-1669(93)90059-6; Hughes RC, 1992, CURR OPIN STRUC BIOL, V2, P687; JONAH MM, 1978, BIOCHIM BIOPHYS ACTA, V541, P321, DOI 10.1016/0304-4165(78)90192-7; KARLSSON KA, 1991, TRENDS PHARMACOL SCI, V12, P265, DOI 10.1016/0165-6147(91)90568-D; KAYSER K, 1993, ANAL CELL PATHOL, V5, P225; KAYSER K, 1990, ANAL CELL PATHOL, V2, P167; Kayser K., 1993, In Vivo (Attiki), V7, P387; KAYSER K, 1992, LUNG CANCER, V8, P185, DOI 10.1016/0169-5002(92)90006-6; Kayser K., 1992, ANAL LUNG PATHOLOGY; KAYSER K, 1995, ANAL QUANT CYTOL, V17, P135; KAYSER K, 1994, GLYCOCONJUGATE J, V11, P339, DOI 10.1007/BF00731207; KAYSER K, 1991, LECTINS CANC, P71; KAYSER K, 1989, PATHOL RES PRACT, V184, P621; KAYSER K, 1994, RADIOL ONCOL, V28, P282; KOJIMA S, 1990, BIOL CHEM HOPPESEYLE, V371, P332; KOJIMA S, 1989, EUR J NUCL MED, V15, P373, DOI 10.1007/BF00449227; KOJIMA S, 1988, J CANCER RES CLIN, V114, P468, DOI 10.1007/BF00391493; Lee Y. C., 1994, NEOGLYCOCONJUGATES P; LEE YC, 1992, FASEB J, V6, P3193; Lee-Young Alfred W., 1994, P511; LIS H, 1993, EUR J BIOCHEM, V218, P1, DOI 10.1111/j.1432-1033.1993.tb18347.x; MARSHALL D, 1995, BRIT J CANCER, V71, P18, DOI 10.1038/bjc.1995.5; McBroom C. R., 1972, METHODS ENZYMOLOGY B, V28, P212; MEDDA S, 1993, BIOTECHNOL APPL BIOC, V17, P37; MONSIGNY M, 1983, BIOL CELL, V47, P95; MONSIGNY M, 1988, LECTINS GLYCOCONJUGA, P25; MURRAY GJ, 1987, METHOD ENZYMOL, V149, P25; NAISBETT B, 1993, LECTINS GLYCOBIOLOGY, P304; NICOLAU C, 1983, BIOL CELL, V47, P121; Ouchi Tatsuro, 1994, P465; Peltz Gary, 1993, Current Opinion in Biotechnology, V4, P745, DOI 10.1016/0958-1669(93)90060-A; RADEMACHER TW, 1988, ANNU REV BIOCHEM, V57, P785; RAO BNN, 1994, J BIOL CHEM, V269, P19663; Rasmussen JR, 1992, CURR OPIN STRUC BIOL, V2, P682, DOI 10.1016/0959-440X(92)90201-H; REICHERT CM, 1994, METHOD ENZYMOL, V242, P108; ROCHE AC, 1985, INVAS METAST, V5, P218; RUDIGER H, 1993, DTSCH APOTHEKER ZTG, V133, P2371; SASTRY K, 1993, CURR OPIN IMMUNOL, V5, P59, DOI 10.1016/0952-7915(93)90082-4; SHARMA SK, 1994, CANCER, V73, P1114, DOI 10.1002/1097-0142(19940201)73:3+<1114::AID-CNCR2820731352>3.0.CO;2-L; SHARON N, 1987, TRENDS BIOCHEM SCI, V12, P488, DOI 10.1016/0968-0004(87)90235-0; SHIER WT, 1985, METHOD ENZYMOL, V112, P248; SHIKHMAN AR, 1994, J IMMUNOL, V153, P5593; SINGH V, 1989, INT J PEPT PROT RES, V33, P22; TAKAKURA Y, 1994, BIOCHEM PHARMACOL, V47, P853, DOI 10.1016/0006-2952(94)90485-5; TAVASSOLI M, 1991, P SOC EXP BIOL MED, V196, P367; TUOMANEN E, 1994, J CLIN INVEST, V93, P917, DOI 10.1172/JCI117094; VALLERA DA, 1994, BLOOD, V83, P309; VASTA GR, 1994, ANN NY ACAD SCI, V712, P55, DOI 10.1111/j.1749-6632.1994.tb33562.x; VELLUPILLAI P, 1994, P NATL ACAD SCI USA, V91, P18; VIDALVANACLOCHA F, 1990, INT J CANCER, V46, P908, DOI 10.1002/ijc.2910460526; WEIGEL PH, 1992, GLYCOCONJUGATES COMP, P421; WELPLY JK, 1994, GLYCOBIOLOGY, V4, P259, DOI 10.1093/glycob/4.3.259; WELPLY JK, 1994, BBA-REV BIOMEMBRANES, V1197, P215, DOI 10.1016/0304-4157(94)90006-X; WINTERBU.PJ, 1972, NATURE, V236, P147, DOI 10.1038/236147a0; YAMAZAKI N, 1994, METHOD ENZYMOL, V242, P56; YAMAZAKI N, 1992, INT J BIOCHEM, V24, P99; ZENG FY, 1993, INT J BIOCHEM, V25, P1019, DOI 10.1016/0020-711X(93)90116-V; ZENG FY, 1993, ARCH BIOCHEM BIOPHYS, V303, P74, DOI 10.1006/abbi.1993.1257	137	20	20	MEDPHARM GMBH SCIENTIFIC PUBL	STUTTGART	POSTFACH 10 10 61, D-70009 STUTTGART, GERMANY	0939-6411			EUR J PHARM BIOPHARM	Eur. J. Pharm. Biopharm.	AUG	1996	42	4					250	261				12	Pharmacology & Pharmacy	Pharmacology & Pharmacy	VF374	WOS:A1996VF37400005		
J	Okada, F; Saito, H; Matsuki, N				Okada, F; Saito, H; Matsuki, N			Prophylactic effect of serotonin uptake inhibitors against motion sickness in Suncus murinus	EUROPEAN JOURNAL OF PHARMACOLOGY			English	Article						5-HT (5-hydroxytryptamine, serotonin) uptake inhibitor; imipramine; fluoxetine; motion sickness	INDUCED EMESIS; CISPLATIN; XYLAZINE; DRUGS; CAT	The prophylactic effect of serotonin uptake inhibitors, imipramine and fluoxetine, against motion sickness was investigated in Suncus murinus. Imipramine (s.c.) and fluoxetine (i.p.) inhibited motion-induced emesis dose dependently with ID50 values of 1.7 and 26 mg/kg, respectively. The results suggest that increasing the concentration of serotonin in the synaptic cleft can prevent motion induced emesis and that serotonin uptake inhibitors are effective as anti-motion sickness drugs.	UNIV TOKYO,FAC PHARMACEUT SCI,DEPT CHEM PHARMACOL,TOKYO 113,JAPAN							ANGEL I, 1993, EUR J PHARMACOL, V232, P139, DOI 10.1016/0014-2999(93)90767-C; BROWNLEE KA, 1953, J AM STAT ASSOC, V48, P262, DOI 10.2307/2281287; HALL H, 1981, EUR J PHARMACOL, V70, P393, DOI 10.1016/0014-2999(81)90172-2; FULLER RW, 1990, ANN NY ACAD SCI, V600, P68, DOI 10.1111/j.1749-6632.1990.tb16873.x; HOLLISTER LE, 1993, ANN REV PHARM TOXICO, V32, P165; LUCOT JB, 1987, AVIAT SPACE ENVIR MD, V58, P989; LUCOT JB, 1989, PHARMACOL BIOCHEM BE, V33, P627, DOI 10.1016/0091-3057(89)90399-7; OKADA F, 1994, JPN J PHARMACOL, V64, P109, DOI 10.1254/jjp.64.109; OKADA F, 1995, BRIT J PHARMACOL, V114, P931; PERRY KW, 1992, LIFE SCI, V50, P1683, DOI 10.1016/0024-3205(92)90423-M; SANGER GJ, 1990, CAN J PHYSIOL PHARM, V68, P314; UENO S, 1988, LIFE SCI, V43, P413, DOI 10.1016/0024-3205(88)90520-6	12	12	12	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0014-2999			EUR J PHARMACOL	Eur. J. Pharmacol.	AUG 1	1996	309	1					33	35		10.1016/0014-2999(96)00407-4		3	Pharmacology & Pharmacy	Pharmacology & Pharmacy	VC281	WOS:A1996VC28100005		
J	Manabe, S; Yuan, J; Takahashi, T; Urban, RC				Manabe, S; Yuan, J; Takahashi, T; Urban, RC			Age-related accumulation of 1-methyl-1,2,3,4-tetrahydro-beta-carboline-3-carboxylic acid in human lens	EXPERIMENTAL EYE RESEARCH			English	Article						lens; aging; fluorogen; beta-carboline	POSSIBLE CAUSATIVE SUBSTANCE; NON-TRYPTOPHAN FLUORESCENCE; RISK-FACTORS; ALCOHOL-USE; IDENTIFICATION; CATARACT; PROTEIN; EYE; INGESTION; OPACITIES	A fluorescent beta-carboline, 1-methyl-1,2,3,4-tetrahydro-beta-carboline-3-carboxylic acid (MTCA) was identified in human normal lenses and cataractous lenses. The mean total amounts of MTCA in normal lenses (n = 7), diabetic cataractous lenses (n = 15), and senile cataractous lenses (n = 15) were 0.64 +/- 0.76 ng, 1.79 +/- 0.94 ng, and 3.66 +/- 1.04 ng, respectively. The MTCA levels in human lenses increased linearly with the age of the lenses, and there was a significant correlation between the total amount of MTCA in human lenses and the age of the lens. In all types of lenses, the concentrations of MTCA in the insoluble-protein fraction [pg (mg protein)(-1)] were significantly higher than those in the water-soluble protein fraction. These results suggest that MTCA may be one of the age-related fluorogens. In vitro experiments revealed that MTCA, a condensation reaction product of tryptophan with acetaldehyde, can be formed in the mixture of tryptophan and glucose by low temperature heating. Furthermore, the MTCA levels in the homogenate of cataractous lenses were significantly increased with the heating time, when the homogenate without addition of glucose and tryptophan was heated at 60 degrees C. This indicates that enough material such as tryptophan for MTCA formation is present in human cataractous lenses. Therefore, it may be that MTCA is formed in human lens. However, we can not rule out the possibility that MTCA in the lens may be derived from other sources, and deposited in the lens since MTCA is reported to be present in various foodstuffs and alcoholic beverages. (C) 1996 Academic Press Limited	UNIV TOKYO,FAC MED,DEPT BIOCHEM,BUNKYO KU,TOKYO 113,JAPAN; UNIV S FLORIDA,COLL MED,DEPT OPHTHALMOL,TAMPA,FL 33612	Manabe, S (reprint author), UNIV TOKYO,FAC MED,DEPT HYG & PREVENT MED,BUNKYO KU,7-3-1 HONGO,TOKYO 113,JAPAN.						ADACHI J, 1991, ARCH TOXICOL, V65, P505, DOI 10.1007/BF01977365; ANDERSON EI, 1978, EXP EYE RES, V26, P407, DOI 10.1016/0014-4835(78)90128-8; BROSSI A, 1973, J MED CHEM, V16, P418, DOI 10.1021/jm00262a027; ADACHI J, 1991, J NUTR, V121, P646; LERMAN S, 1976, OPHTHALMIC RES, V8, P335; BOSIN TR, 1986, J AGR FOOD CHEM, V34, P843, DOI 10.1021/jf00071a020; CLARK R, 1969, EXP EYE RES, V8, P172, DOI 10.1016/S0014-4835(69)80029-1; CLAYTON RM, 1980, EXP EYE RES, V31, P553, DOI 10.1016/S0014-4835(80)80014-5; CLAYTON RM, 1982, T OPHTHAL SOC UK, V102, P331; COTLIER E, 1981, EXP EYE RES, V33, P247, DOI 10.1016/S0014-4835(81)80048-6; COTLIER E, 1980, LANCET          0315, P607; DICKINSO.JC, 1968, INVEST OPHTH VISUAL, V7, P551; DILLON J, 1976, NATURE, V259, P422, DOI 10.1038/259422a0; FLAYE DE, 1989, EYE, V3, P379; FUKUSHIMA S, 1991, ALCOHOL, V9, P31; GARCIACASTINEIRAS S, 1978, EXP EYE RES, V26, P461, DOI 10.1016/0014-4835(78)90132-X; HARDING JJ, 1988, BRIT J OPHTHALMOL, V72, P809, DOI 10.1136/bjo.72.11.809; Harding J J, 1989, Dev Ophthalmol, V17, P13; HOLMSTEDT B, 1982, BETA CARBOLINES TETR, P3; Klang G., 1948, ACTA OPHTHALMOL SUPPL [COPENHAGEN], V31, P1; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUTHRA M, 1994, FEBS LETT, V349, P39, DOI 10.1016/0014-5793(94)00635-0; LUTHRA M, 1994, J BIOL CHEM, V269, P22678; MANABE S, 1984, J CLIN INVEST, V73, P1803; MANABE S, 1992, CARCINOGENESIS, V13, P827, DOI 10.1093/carcin/13.5.827; MANABE S, 1993, EXP EYE RES, V57, P319, DOI 10.1006/exer.1993.1130; MANABE S, 1989, EXP EYE RES, V48, P351, DOI 10.1016/S0014-4835(89)80004-1; MUNOZ B, 1993, ARCH OPHTHALMOL-CHIC, V111, P110; NAGAHARA A, 1991, FOOD CHEM TOXICOL, V29, P243, DOI 10.1016/0278-6915(91)90021-X; OGAWA Y, 1993, ARCH TOXICOL, V67, P290, DOI 10.1007/BF01974349; RITTER LL, 1993, ARCH OPHTHALMOL-CHIC, V111, P113; Rommelspacher H, 1985, Prog Drug Res, V29, P415; SATOH K, 1973, EXP EYE RES, V16, P167, DOI 10.1016/0014-4835(73)90311-4; SATOH K, 1972, EXP EYE RES, V16, P53; SPECTOR A, 1975, EXP EYE RES, V21, P9, DOI 10.1016/0014-4835(75)90053-6; TAYLOR HR, 1980, BRIT J OPHTHALMOL, V64, P303, DOI 10.1136/bjo.64.5.303; WAKABAYASHI K, 1983, P NATL ACAD SCI-BIOL, V80, P2912, DOI 10.1073/pnas.80.10.2912	37	12	12	ACADEMIC PRESS LTD	LONDON	24-28 OVAL RD, LONDON, ENGLAND NW1 7DX	0014-4835			EXP EYE RES	Exp. Eye Res.	AUG	1996	63	2					179	186		10.1006/exer.1996.0106		8	Ophthalmology	Ophthalmology	VD544	WOS:A1996VD54400006		
J	Eliason, JF; Hirabayashi, Y; Inoue, T				Eliason, JF; Hirabayashi, Y; Inoue, T			Inhibition of stem cell proliferation in long-term cultures by mofarotene.	EXPERIMENTAL HEMATOLOGY			English	Meeting Abstract									KARMANOS CANC INST,DETROIT,MI; UNIV TOKYO,INST MED SCI,TOKYO,JAPAN; NATL INST HLTH SCI,TOKYO,JAPAN								0	0	0	CARDEN JENNINGS PUBL CO LTD	CHARLOTTESVILLE	BLAKE CTR, STE 200, 1224 W MAIN ST, CHARLOTTESVILLE, VA 22903	0301-472X			EXP HEMATOL	Exp. Hematol.	AUG	1996	24	9					8	8				1	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	VC092	WOS:A1996VC09200009		
J	Tani, K; Hibino, H; Wu, S; Ikebuchi, K; Suzuki, S; Tanioka, K; Sugimoto, Y; Tojo, A; Nakahata, T; Saitoh, I; Mulligan, RC; Asano, S				Tani, K; Hibino, H; Wu, S; Ikebuchi, K; Suzuki, S; Tanioka, K; Sugimoto, Y; Tojo, A; Nakahata, T; Saitoh, I; Mulligan, RC; Asano, S			Characterization of hematopoietic stem cells of common marmoset to establish the preclinical primate model system for human gene therapy.	EXPERIMENTAL HEMATOLOGY			English	Meeting Abstract									HOKKAIDO RED CROSS BLOOD CTR,SAPPORO,HOKKAIDO,JAPAN; CENT INST EXPT ANIM,KAWASAKI,KANAGAWA,JAPAN; JAPANESE FDN CANC RES,CTR CANC CHEMOTHERAPY,TOKYO 170,JAPAN; MIT,WHITEHEAD INST,BOSTON,MA; UNIV TOKYO,INST MED SCI,TOKYO,JAPAN								0	0	0	CARDEN JENNINGS PUBL CO LTD	CHARLOTTESVILLE	BLAKE CTR, STE 200, 1224 W MAIN ST, CHARLOTTESVILLE, VA 22903	0301-472X			EXP HEMATOL	Exp. Hematol.	AUG	1996	24	9					201	201				1	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	VC092	WOS:A1996VC09200200		
J	Onishi, M; Yahata, T; Kanakura, Y; Hayashi, Y; Kamada, N; Gorman, DM; Kitamura, T				Onishi, M; Yahata, T; Kanakura, Y; Hayashi, Y; Kamada, N; Gorman, DM; Kitamura, T			The oncogenic mutation in the transmembrane domain of the thrombopoietin receptor is rare in patients' leukemic cells.	EXPERIMENTAL HEMATOLOGY			English	Meeting Abstract									DNAX RES INST MOL & CELLULAR BIOL INC,PALO ALTO,CA 94304; TOKAI UNIV,SCH MED,DEPT IMMUNOL,ISEHARA,KANAGAWA 25911,JAPAN; OSAKA UNIV,SCH MED,DEPT INT MED 2,SUITA,OSAKA 565,JAPAN; UNIV TOKYO,DEPT PEDIAT,TOKYO,JAPAN; HIROSHIMA UNIV,INST RADIAT BIOL & MED,HIROSHIMA,JAPAN								0	0	0	CARDEN JENNINGS PUBL CO LTD	CHARLOTTESVILLE	BLAKE CTR, STE 200, 1224 W MAIN ST, CHARLOTTESVILLE, VA 22903	0301-472X			EXP HEMATOL	Exp. Hematol.	AUG	1996	24	9					256	256				1	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	VC092	WOS:A1996VC09200255		
J	Asano, S				Asano, S			New therapies using G-CSF.	EXPERIMENTAL HEMATOLOGY			English	Meeting Abstract									UNIV TOKYO,IMSUT,INST MED SCI,RES HOSP,TOKYO,JAPAN								0	0	0	CARDEN JENNINGS PUBL CO LTD	CHARLOTTESVILLE	BLAKE CTR, STE 200, 1224 W MAIN ST, CHARLOTTESVILLE, VA 22903	0301-472X			EXP HEMATOL	Exp. Hematol.	AUG	1996	24	9					444	444				1	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	VC092	WOS:A1996VC09200443		
J	Watanabe, S; Itoh, T; Muto, A; Arai, K				Watanabe, S; Itoh, T; Muto, A; Arai, K			Roles of tyrosine phosphorylation and JAK2 in hGM-CSF signal transduction	EXPERIMENTAL HEMATOLOGY			English	Meeting Abstract									UNIV TOKYO,INST MED SCI,DEPT MOL DEV BIOL,MINATO KU,TOKYO,JAPAN								0	0	0	CARDEN JENNINGS PUBL CO LTD	CHARLOTTESVILLE	BLAKE CTR, STE 200, 1224 W MAIN ST, CHARLOTTESVILLE, VA 22903	0301-472X			EXP HEMATOL	Exp. Hematol.	AUG	1996	24	9					454	454				1	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	VC092	WOS:A1996VC09200453		
J	Odai, H; Sasaki, K; Mitani, K; Yazaki, Y; Hirai, H				Odai, H; Sasaki, K; Mitani, K; Yazaki, Y; Hirai, H			A new signaling molecule binding to Grb2/Ash in hematopoietic cells.	EXPERIMENTAL HEMATOLOGY			English	Meeting Abstract									UNIV TOKYO,FAC MED,DEPT INTERNAL MED 3,TOKYO,JAPAN								0	0	0	CARDEN JENNINGS PUBL CO LTD	CHARLOTTESVILLE	BLAKE CTR, STE 200, 1224 W MAIN ST, CHARLOTTESVILLE, VA 22903	0301-472X			EXP HEMATOL	Exp. Hematol.	AUG	1996	24	9					472	472				1	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	VC092	WOS:A1996VC09200471		
J	Chiba, S; Nagai, B; Nakamura, S; Bollekens, JA; Minowada, J; Hirai, H; Takeshita, K; Ruddle, FH				Chiba, S; Nagai, B; Nakamura, S; Bollekens, JA; Minowada, J; Hirai, H; Takeshita, K; Ruddle, FH			Human DLX-1 gene: cDNA cloning from erythroleukemia cell line, genomic structure and expression analysis in hematopoietic cells	EXPERIMENTAL HEMATOLOGY			English	Meeting Abstract									YALE UNIV,DEPT BIOL,NEW HAVEN,CT 06520; YALE UNIV,DEPT MED,NEW HAVEN,CT 06520; YALE UNIV,DEPT HUMAN GENET,NEW HAVEN,CT 06520; UNIV TOKYO,DEPT INTERNAL MED 3,FAC TOKYO,TOKYO 113,JAPAN; HAYASHIBARA BIOCHEM LABS INC,FUJISAKI CELL CTR,OKAYAMA,JAPAN; MT SINAI HOSP,SAMUEL LUNENFELD RES INST,DIV MOL & DEV BIOL,TORONTO,ON M5G 1X5,CANADA; NYU,MED CTR,DIV HEMATOL,NEW YORK,NY 10016								0	0	0	CARDEN JENNINGS PUBL CO LTD	CHARLOTTESVILLE	BLAKE CTR, STE 200, 1224 W MAIN ST, CHARLOTTESVILLE, VA 22903	0301-472X			EXP HEMATOL	Exp. Hematol.	AUG	1996	24	9					565	565				1	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	VC092	WOS:A1996VC09200564		
J	Kato, S; Kodera, Y; Okamoto, S; Asano, S; Masaoka, T				Kato, S; Kodera, Y; Okamoto, S; Asano, S; Masaoka, T			Effects of rHuEPO on anemia following allogeneic BMT: A double-blind randomized trial.	EXPERIMENTAL HEMATOLOGY			English	Meeting Abstract									TOKAI UNIV,HIRATSUKA,KANAGAWA 25912,JAPAN; NAGOYA FIRST RED CROSS HOSP,NAGOYA,AICHI,JAPAN; KEIO UNIV,TOKYO 108,JAPAN; UNIV TOKYO,TOKYO,JAPAN; OSAKA CTR ADULT DIS,OSAKA,JAPAN								0	0	0	CARDEN JENNINGS PUBL CO LTD	CHARLOTTESVILLE	BLAKE CTR, STE 200, 1224 W MAIN ST, CHARLOTTESVILLE, VA 22903	0301-472X			EXP HEMATOL	Exp. Hematol.	AUG	1996	24	9					653	653				1	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	VC092	WOS:A1996VC09200652		
J	Hatae, K; Nakai, H; Tanaka, C; Shimada, A; Watabe, S				Hatae, K; Nakai, H; Tanaka, C; Shimada, A; Watabe, S			Taste and texture of abalone meat after extended cooking	FISHERIES SCIENCE			English	Article						abalone; cook; taste; texture; collagen; amino acid; oligopeptide; sensory test	MUSCLE; ARAI	Abalone meat was cooked for 0, 15, 30, 60, 180, and 360 min, and changes in the taste and texture during cooking were studied. During cooking, the weight of meat decreased, and it was 65% of the original weight after cooking for 360 min. Collagen content in the meat decreased with a concomitant decrease in the hardness of meat (r=0.82). The amount of adenosine 5'-monophosphate increased after cooking for 15 min and leveled off. The total amount of free amino acids increased after 15-30 min, then decreased. On the contrary, the amount of oligopeptide-bound amino acids kept increasing until 360 min, both in the cooked meat and the drip. In the dominant amino acids of the oligopeptides, collagen constituents amino acids such as glycine, hydroxyproline, and proline were included. By the sensory test, the characteristic abalone taste and odor became stronger as the cooking time increased. This might be the reason why Japanese cookbooks recommend cooking for an extended period such as 15 or 180 min.	UNIV TOKYO,FAC AGR,MARINE BIOCHEM LAB,BUNKYO KU,TOKYO 113,JAPAN	Hatae, K (reprint author), OCHANOMIZU UNIV,DEPT NUTR & FOOD SCI,BUNKYO KU,TOKYO 112,JAPAN.						SIKORSKI ZE, 1984, CRC CR REV FOOD SCI, V20, P301; Olley J, 1977, Adv Food Res, V23, P143, DOI 10.1016/S0065-2628(08)60328-6; NEWELL GJ, 1987, J FOOD SCI, V52, P1721, DOI 10.1111/j.1365-2621.1987.tb05913.x; CROSS HR, 1986, MUSCLE FOOD, P291; FUKE S, 1994, OLFACTION TASTE, V11, P357; GOTOH K, 1994, NIPPON AWABI, P53; HATAE K, 1995, J FOOD SCI, V60, P39; HATAE K, 1991, NIPPON SUISAN GAKK, V57, P2133; Hatae K., 1986, Bulletin of the Japanese Society of Scientific Fisheries [Nihon Suisan Gakkai-shi], V52, P2001; HATAE K, 1995, J FOOD SCI, V60, P32, DOI 10.1111/j.1365-2621.1995.tb05600.x; HATANO K, 1994, NIHON RYORI GIJUTSU, V6, P38; Ishii K, 1995, J HOME EC JPN, V46, P229; KIMURA S, 1994, SOME PROPERTIES COLL, V34, P925; Konosu S., 1973, NIPPON SHOKUHIN KOGY, V20, P432; KUBOTA M, 1977, FISH PROTEIN, P59; MATSUMOTO M, 1991, NIPPON SUISAN GAKK, V57, P1383; OCHIAI Y, 1985, J FOOD SCI, V50, P981, DOI 10.1111/j.1365-2621.1985.tb12994.x; SUGITA K, 1977, NIPPON SHOKUHIN KOGY, V24, P311; OLAECHEA RP, 1993, BIOSCI BIOTECH BIOCH, V57, P6	19	17	20	JAPAN SOC SCI FISHERIES TOKYO UNIV FISHERIES	TOKYO	5-7 KONAN-4 MINATO-KU, TOKYO 108, JAPAN	0919-9268			FISHERIES SCI	Fish. Sci.	AUG	1996	62	4					643	647				5	Fisheries	Fisheries	VH661	WOS:A1996VH66100028		
J	Tada, M				Tada, M			Ki-ras mutations in chronic pancreatitis: Which relevance? Reply	GASTROENTEROLOGY			English	Letter										Tada, M (reprint author), UNIV TOKYO,DEPT MED 2,BUNKYO KU,7-3-1 HONGO,TOKYO 113,JAPAN.						TADA M, 1993, CANCER RES, V53, P2472; Tada M, 1996, GASTROENTEROLOGY, V110, P227, DOI 10.1053/gast.1996.v110.pm8536861; YANAGISAWA A, 1993, CANCER RES, V53, P953	3	2	2	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399	0016-5085			GASTROENTEROLOGY	Gastroenterology	AUG	1996	111	2					566	567				2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	UZ864	WOS:A1996UZ86400036		
J	Innan, H; Tajima, F; Terauchi, R; Miyashita, NT				Innan, H; Tajima, F; Terauchi, R; Miyashita, NT			Intragenic recombination in the Adh locus of the wild plant Arabidopsis thaliana	GENETICS			English	Article							ALCOHOL-DEHYDROGENASE LOCUS; NUCLEOTIDE POLYMORPHISM; MOLECULAR EVOLUTION; DNA POLYMORPHISM; L HEYNH; SEQUENCES; SELECTION; MODEL; RATES; GENE	Nucleotide variation in the Adh region of the wild plant Arabidopsis thaliana was analyzed in 17 ecotypes sampled worldwide to investigate DNA polymorphism in natural plant populations. The investigated 2.4-kb Adh region was divided into four blocks by intragenic recombinations between two parental sequence types that diverged 6.3 million years (Myr) ago, if the nucleotide mutation rate mu = 10(-9) is assumed. Within each block, dimorphism of segregating variations was observed with intermediate frequencies, which caused a substantial amount of nucleotide variation in A. thaliana at the species level. The first recombination introduced the divergent variation that resulted in dimorphism in this plant species similar to 3.3 Myr ago, and three subsequent intragenic recombinations have occurred sporadically in similar to 1.1-Myr intervals. It was shown that there was only a limited number (six) of sequence types in this species and that no clear association was observed between sequence type and geographic origin. Taken together, these results suggest that A. thaliana has spread over the world only recently. It can be concluded that recombination played an important role in the evolutionary history of A. thaliana, especially through the generation of DNA polymorphism in the natural populations of this plant species.	KYOTO UNIV,FAC AGR,GENET LAB,SAKYO KU,KYOTO 60601,JAPAN; UNIV TOKYO,GRAD SCH SCI,DEPT BIOL SCI,TOKYO 113,JAPAN; KYOTO UNIV,FAC SCI,LAB PLANT SYSTEMAT,KYOTO 60601,JAPAN							NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; ABBOTT RJ, 1989, HEREDITY, V62, P411, DOI 10.1038/hdy.1989.56; FU YX, 1993, GENETICS, V133, P693; TERAUCHI R, 1994, GENOME, V37, P794; TAJIMA F, 1984, MOL BIOL EVOL, V1, P269; TAJIMA F, 1989, GENETICS, V123, P585; HUDSON RR, 1988, GENETICS, V120, P831; GAUT BS, 1993, P NATL ACAD SCI USA, V90, P5095, DOI 10.1073/pnas.90.11.5095; KREITMAN M, 1983, NATURE, V304, P412, DOI 10.1038/304412a0; TAJIMA F, 1989, GENETICS, V123, P597; EKLUND H, 1976, J MOL BIOL, V102, P27, DOI 10.1016/0022-2836(76)90072-3; CHANG C, 1986, P NATL ACAD SCI USA, V83, P1408, DOI 10.1073/pnas.83.5.1408; CROW JAMES F., 1965, AMER NATUR, V99, P439, DOI 10.1086/282389; DOLFERUS R, 1984, BIOCHEM GENET, V22, P817, DOI 10.1007/BF00499475; GAUT BS, 1993, GENETICS, V135, P1091; Gillespie J.H., 1991, CAUSES MOL EVOLUTION; HANFSTINGL U, 1994, GENETICS, V138, P811; HUDSON RR, 1983, THEOR POPUL BIOL, V23, P183, DOI 10.1016/0040-5809(83)90013-8; INA Y, 1992, ODEN; JUKES T H, 1969, P21; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kimura M., 1983, NEUTRAL THEORY MOL E; Miyashita NT, 1996, MOL BIOL EVOL, V13, P433; Nei M., 1987, MOL EVOLUTIONARY GEN; Price R.A., 1994, ARABIDOPSIS, P7; STEPHENS JC, 1985, MOL BIOL EVOL, V2, P539; TAJIMA F, 1991, J MOL EVOL, V33, P470, DOI 10.1007/BF02103140; TODOKORO S, 1995, JPN J GENET, V70, P543, DOI 10.1266/jjg.70.543; YOKOYAMA S, 1993, MOL BIOL EVOL, V10, P1215; YOKOYAMA S, 1990, MOL BIOL EVOL, V7, P143	30	101	108	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202	0016-6731			GENETICS	Genetics	AUG	1996	143	4					1761	1770				10	Genetics & Heredity	Genetics & Heredity	VA244	WOS:A1996VA24400023		
J	Ikegawa, S; Toda, T; Okui, K; Nakamura, Y				Ikegawa, S; Toda, T; Okui, K; Nakamura, Y			Structure and chromosomal assignment of the human S1-5 gene (FBNL) that is highly homologous to fibrillin	GENOMICS			English	Article								The human S1-5 gene (fibrillin-like; FBNL) was originally isolated from a subtractively enriched cDNA library established from a subject with Werner syndrome (WS). We isolated genomic clones containing the entire S1-5 gene and determined its genomic structure including the exon-intron organization. The gene spanned approximately 18 kb of genomic DNA and consisted of 12 exons. Its expression was abundant in all tissues examined except brain and peripheral leukocytes, where it was undetectable. In addition, we have mapped S1-5 by fluorescence in situ hybridization to chromosome 2p16, a position that excludes it as a candidate for WS. Our data should facilitate an understanding of the function and regulation of S1-5 in human tissues. (C) 1996 Academic Press, Inc.	INST CANC RES,DEPT BIOCHEM,TOSHIMA KU,TOKYO 170,JAPAN; UNIV TOKYO,SCH INT HLTH,DEPT HUMAN GENET,BUNKYO KU,TOKYO 113,JAPAN	Ikegawa, S (reprint author), UNIV TOKYO,INST MED SCI,MOL MED LAB,MINATO KU,4-6-1 SHIROKANEDAI,TOKYO 108,JAPAN.						BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; DIETZ HC, 1991, NATURE, V352, P337, DOI 10.1038/352337a0; LECKACZERNIK B, 1995, MOL CELL BIOL, V15, P120; PUTNAM EA, 1995, NAT GENET, V11, P456, DOI 10.1038/ng1295-456; EPSTEIN CJ, 1966, MEDICINE, V45, P177; HANDFORD PA, 1991, NATURE, V351, P164, DOI 10.1038/351164a0; DEVEREUX RB, 1987, AM HEART J, V113, P1265, DOI 10.1016/0002-8703(87)90955-0; GOTO M, 1992, NATURE, V355, P735, DOI 10.1038/355735a0; SCHELLENBERG GD, 1992, LANCET, V339, P1002, DOI 10.1016/0140-6736(92)91590-5; SUDO K, 1994, GENOMICS, V24, P276, DOI 10.1006/geno.1994.1616; WALKER BA, 1969, ANN INTERN MED, V71, P349	11	19	20	ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495	0888-7543			GENOMICS	Genomics	AUG 1	1996	35	3					590	592		10.1006/geno.1996.0402		3	Biotechnology & Applied Microbiology; Genetics & Heredity	Biotechnology & Applied Microbiology; Genetics & Heredity	VB758	WOS:A1996VB75800024		
J	Li, SW; Satoh, H; Watanabe, T; Nakamura, S; Hattori, S				Li, SW; Satoh, H; Watanabe, T; Nakamura, S; Hattori, S			cDNA cloning and chromosomal mapping of a novel human GAP (GAP1M), a GTPase-activating protein of Ras	GENOMICS			English	Article							NEUROFIBROMATOSIS TYPE-1 GENE; HUMAN TUMORS; MUTATIONS	We have previously isolated a novel Pas GTPase-activating protein (Pas GAP), Gap1(m), from rat brain. Gap1(m) is considered to be a negative regulator of the Pas signaling pathways, like other Pas GAPs, neurofibromin, which is a gene product of the neurofibromatosis type I gene, and p120GAP. In this study we have isolated a human cDNA of this Gap and mapped the gene. The gene encodes a protein of 853 amino acids that shows 89% sequence identity to rat Gap1(m) The human gene was mapped to chromosome 3 by PCR analysis on a panel of human-mouse hybrid cells, FISH analysis refined the location of the gene further to 3q22-q23. (C) 1996 Academic Press, Inc.	NATL INST NEUROSCI,NATL CTR NEUROL & PSYCHIAT,DIV BIOCHEM & CELLULAR BIOL,KODAIRA,TOKYO 187,JAPAN; UNIV TOKYO,INST MED SCI,DEPT PATHOL,MINATO KU,TOKYO 108,JAPAN							BRANNAN CI, 1994, GENE DEV, V8, P1019, DOI 10.1101/gad.8.9.1019; LI Y, 1992, CELL, V69, P275, DOI 10.1016/0092-8674(92)90408-5; CULLEN PJ, 1995, NATURE, V376, P527, DOI 10.1038/376527a0; FRIEDMAN E, 1993, NAT GENET, V5, P242, DOI 10.1038/ng1193-242; GAUL U, 1992, CELL, V68, P1007, DOI 10.1016/0092-8674(92)90073-L; GUTMANN DH, 1993, NEURON, V10, P335, DOI 10.1016/0896-6273(93)90324-K; HENG HHQ, 1992, P NATL ACAD SCI USA, V89, P9509, DOI 10.1073/pnas.89.20.9509; LOWY DR, 1993, ANNU REV BIOCHEM, V62, P851, DOI 10.1146/annurev.bi.62.070193.004223; MAEKAWA M, 1994, MOL CELL BIOL, V14, P6879; SATOH H, 1993, CYTOGENET CELL GENET, V62, P49, DOI 10.1159/000133443; SENBA K, 1985, SCIENCE, V227, P1038	11	7	8	ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495	0888-7543			GENOMICS	Genomics	AUG 1	1996	35	3					625	627		10.1006/geno.1996.0412		3	Biotechnology & Applied Microbiology; Genetics & Heredity	Biotechnology & Applied Microbiology; Genetics & Heredity	VB758	WOS:A1996VB75800034		
J	Miyamoto, M; Mikouchi, T				Miyamoto, M; Mikouchi, T			Platinum catalytic effect on oxygen fugacity of CO2-H-2 gas mixtures measured with ZrO2 oxygen sensor at 10(5) Pa from 1300 to 700 degrees C	GEOCHIMICA ET COSMOCHIMICA ACTA			English	Article								The oxygen fugacity of CO2-H-2 gas mixtures were measured with a ZrO2 oxygen sensor at high temperatures in a furnace. We confirmed that the oxygen fugacity values measured by the ZrO2 cell are more reducing than those of the CO2-H-2 gas mixtures calculated by using JANAF data at temperatures below 1150 degrees C as was previously reported by Huebner (1975). We successfully decreased the deviation of the measured oxygen-fugacity value from the calculated one down to temperature of 800 degrees C by using a Pt catalyst. Our results suggest that the deviation is probably due to incomplete equilibration of the gases.		Miyamoto, M (reprint author), UNIV TOKYO,GRAD SCH SCI,INST MINERAL,TOKYO 113,JAPAN.						EUGSTER HP, 1962, J PETROL, V3, P82; BURKHARD DJM, 1995, GEOCHIM COSMOCHIM AC, V59, P1699, DOI 10.1016/0016-7037(95)00076-C; Deines P, 1974, SCI B EXP STATION, V88; Huebner J.S., 1987, HYDROTHERMAL EXPT TE, P20; HUEBNER JS, 1975, AM MINERAL, V60, P815; Nafziger R., 1971, RES TECHNIQUES HIGH, P9; PRUNIER AR, 1981, B GEOL SOC AM 2, V92, P1039; Sato M., 1971, RES TECHNIQUES HIGH, P43; ULMER GC, 1984, AM CERAM SOC ADV CER, V12, P660	9	8	8	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB	0016-7037			GEOCHIM COSMOCHIM AC	Geochim. Cosmochim. Acta	AUG	1996	60	15					2917	2920		10.1016/0016-7037(96)00129-9		4	Geochemistry & Geophysics	Geochemistry & Geophysics	VC088	WOS:A1996VC08800015		
J	Suzuki, K; Shimizu, H; Masuda, A				Suzuki, K; Shimizu, H; Masuda, A			Re-Os dating of molybdenites from ore deposits in Japan: Implication for the closure temperature of the Re-Os system for molybdenite and the cooling history of molybdenum ore deposits	GEOCHIMICA ET COSMOCHIMICA ACTA			English	Article							K-AR AGES; RB-SR; MINERALIZATION; ROCKS	Rhenium and Osmium abundances were determined on molybdenites from eighteen ore deposits in Japan; fifteen vein-type, a skarn-type, a greisen-type, and a pegmatite-type deposit. Re-Os ages obtained for molybdenites from northeastern, central, and southwestern Japan are 100-130 Ma, 50-75 Ma, and ca. 10 Ma, respectively, reflecting the ages of regional igneous activities in individual areas. For vein-type ore deposits, Re-Os ages for molybdenites agree with Rb-Sr whole-rock ages of host granitoids, while they are 3-12 Ma older than K-Ar mineral ages of the host rocks. On the other hand, Re-Os ages of molybdenites from skarn-, pegmatite-, and greisen-type ore deposits agree with K-Ar ages of the host rocks. The comparison of Re-Os ages for molybdenites with Rb-Sr and K-Ar ages of host rocks in vein-type deposits suggests that Re-Os closure temperature for vein molybdenite is close to whole-rock Rb-Sr closure temperature for host granitic rocks, i.e., roughly estimated to be around 500 degrees C, and higher than K-Ar closure temperature for host granodiorites, i.e., 230-370 degrees C, if the thermal history of vein molybdenites is essentially equivalent to that of host rocks. One possible explanation for age discrepancies of 3-12 Ma between Re-Os ages for molybdenites and K-Ar ages for the wall rocks, observed in vein-type molybdenum deposits, is that later thermal events after formation of molybdenum ores may reset K-Ar ages. Hydrothermal alteration might have occurred in such a temperature condition as to disturb K-Ar mineral systems in wall rocks and made them younger but not the Re-Os system in molybdenite. The other explanation might be that the age discrepancies correspond to a cooling interval from ca. 500 to 300 degrees C of host granitoid. On the other hand, the agreement of Re-Os ages of molybdenites and K-Ar ages of host rocks in skarn-, pegmatite-, and greisen-type deposits in this study indicates no later disturbance for K-Ar system in the wall rock or the rapid cooling of the ore and wall rocks after the formation of molybdenite deposits.	KUMAMOTO UNIV,FAC SCI,DEPT EARTH SCI,KUMAMOTO 860,JAPAN; UNIV ELECTROCOMMUN,DEPT CHEM,CHOFU,TOKYO 182,JAPAN	Suzuki, K (reprint author), UNIV TOKYO,GRAD SCH ARTS & SCI,DEPT GEN SYST STUDIES,MEGURO KU,KOMABA,TOKYO 153,JAPAN.						MCCANDLESS TE, 1993, GEOCHIM COSMOCHIM AC, V57, P889, DOI 10.1016/0016-7037(93)90176-W; WALKER RJ, 1991, EARTH PLANET SC LETT, V105, P416, DOI 10.1016/0012-821X(91)90182-H; STEIGER RH, 1977, EARTH PLANET SC LETT, V36, P359, DOI 10.1016/0012-821X(77)90060-7; BERGER GW, 1981, GEOCHIM COSMOCHIM AC, V45, P795, DOI 10.1016/0016-7037(81)90109-5; BURTON KW, 1990, CONTRIB MINERAL PETR, V106, P66, DOI 10.1007/BF00306409; HARRISON TM, 1982, GEOCHIM COSMOCHIM AC, V46, P1811, DOI 10.1016/0016-7037(82)90120-X; WALKER RJ, 1994, GEOCHIM COSMOCHIM AC, V58, P4179, DOI 10.1016/0016-7037(94)90272-0; NAKAI S, 1990, NATURE, V346, P354, DOI 10.1038/346354a0; MCCANDLESS TE, 1993, SCIENCE, V261, P1282, DOI 10.1126/science.261.5126.1282; DODSON MH, 1973, CONTRIB MINERAL PETR, V40, P259, DOI 10.1007/BF00373790; Faure G., 1986, PRINCIPLES ISOTOPE G, P93; GANGULY J, 1987, EARTH PLANET SC LETT, V81, P338, DOI 10.1016/0012-821X(87)90121-X; HARRISON TM, 1981, CONTRIB MINERAL PETR, V78, P324; Hirata T., 1988, ICP INFORM NEWSL, V13, P731; HORAN MF, 1993, GEOCHIM COSMOCHIM AC, V58, P257; IGARASHI T, 1961, REP GEOL SURV JAPAN, V190, P34; Ishihara S., 1978, J GEOL SOC LONDON, V135, P389, DOI 10.1144/gsjgs.135.4.0389; Ishihara S., 1973, MINING GEOL, V23, P13; ISHIHARA S, 1971, GEOL SOC JAPAN J, V77, P441; ISHIHARA S, 1968, MIN GEOL, V18, P257; ISHIHARA S, 1989, GEOCHEM J, V23, P85; ISHIHARA S, 1971, REPT GEOL SURV JAPAN, V239, P1; *JAER, 1990, 1989 SURV REP REM RA, P1; *JAER, 1988, 1987 SURV REP REM RA, P1; *JAP AG EN RES, 1987, 1986 SURV REP REM RA, P1; Kawano Y., 1965, J JAPANESE ASS MINER, V54, P162; Kawano Y., 1965, J JPN ASS MINERAL, V53, P143; LINDNER M, 1989, GEOCHIM COSMOCHIM AC, V53, P1597, DOI 10.1016/0016-7037(89)90241-X; LUCK JM, 1982, EARTH PLANET SC LETT, V61, P291, DOI 10.1016/0012-821X(82)90060-7; MARCABTONIO F, 1993, GEOCHIM COSMOCHIM AC, V58, P1007; MASUDA A, 1986, GEOCHEM J, V20, P233; NAKAZAWA Z, 1953, B GEOL SURV JAPAN, V4, P625; SANTOSH M, 1994, J GEOL SOC INDIA, V43, P585; SHIBATA K, 1974, ECON GEOL, V69, P1207; SHIBATA K, 1962, B GEOL SURV J, V13, P709; SHIBATA K, 1979, GEOCHEM J, V13, P113; SUITO W, 1966, MIN GEOL, V16, P38; SUZUKI K, 1993, GEOCHIM COSMOCHIM AC, V57, P1625, DOI 10.1016/0016-7037(93)90021-N; SUZUKI K, 1995, P 8 INT S WAT ROCK I, P117; SUZUKI K, 1993, P JPN ACAD B-PHYS, V69, P79, DOI 10.2183/pjab.69.79; SUZUKI K, 1990, P JPN ACAD B-PHYS, V66, P173, DOI 10.2183/pjab.66.173; SUZUKI K, 1992, ANALYST, V117, P1151, DOI 10.1039/an9921701151; TERADA K, 1971, GEOCHEM J, V9, P123; Tsunoda K., 1995, RESOUR GEOL, V45, P111; TSUNODA K, 1993, MEM FAC LIB ART ED Y, V44, P49; WATANABE M, 1942, J JAPAN ASS PETROL M, V28, P104; YAMAMOTO T, 1954, GEOL REPT HIROSHIMA, V4, P1	47	90	119	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB	0016-7037			GEOCHIM COSMOCHIM AC	Geochim. Cosmochim. Acta	AUG	1996	60	16					3151	3159		10.1016/0016-7037(96)00164-0		9	Geochemistry & Geophysics	Geochemistry & Geophysics	VC980	WOS:A1996VC98000017		
J	Kawakatsu, H				Kawakatsu, H			Observability of the isotropic component of a moment tensor	GEOPHYSICAL JOURNAL INTERNATIONAL			English	Article						body waves; deep focus earthquakes; earthquake-source mechanism; global seismology; normal modes; surface waves	DEEP EARTHQUAKES; SEISMIC SOURCES; COLOMBIAN EARTHQUAKE; SOURCE PARAMETERS; SOURCE MODELS; SINGLE FORCE; JULY 31; INVERSION; MECHANISM; SPECTRA	The observability of the isotropic component of a general moment tensor is investigated by carefully examining its resolvability from the other components. It is shown that the portion of seismograms between the first P-wave arrival and just before the arrival of the first surface wavetrain, which contains many different body-wave phases, can be used to constrain the isotropic component of deep earthquakes. CMT inversion using this portion of the seismogram for major deep earthquakes has revealed that there is no significant isotropic component for deep earthquakes. This conclusion contradicts some earlier studies, for example Dziewonski & Gilbert (1974), who found significant isotropic components of deep earthquakes by analysing normal-mode data. It is shown that the isotropic component of deep earthquakes cannot be resolved independently from the vertical CLVD component of the moment tensor by analysing the type of normal-mode data above 2 mHz that previous researchers used. At the same time, however, the possibility of resolving the isotropic component using normal-mode data below 2 mHz is suggested.		Kawakatsu, H (reprint author), UNIV TOKYO,EARTHQUAKE RES INST,TOKYO 113,JAPAN.						Aki K., 1980, QUANTITATIVE SEISMOL; KAWAKATSU H, 1991, NATURE, V351, P50, DOI 10.1038/351050a0; KNOPOFF L, 1970, J GEOPHYS RES, V75, P4957, DOI 10.1029/JB075i026p04957; KANAMORI H, 1982, J GEOPHYS RES, V87, P5422, DOI 10.1029/JB087iB07p05422; DZIEWONSKI AM, 1983, J GEOPHYS RES, V88, P3247; SILVER PG, 1982, GEOPHYS J ROY ASTR S, V70, P755; BACKUS G, 1976, GEOPHYS J ROY ASTR S, V46, P341, DOI 10.1111/j.1365-246X.1976.tb04162.x; GILBERT F, 1975, PHILOS T R SOC A, V278, P187, DOI 10.1098/rsta.1975.0025; Dziewonski A., 1983, EARTHQUAKES OBSERVAT, P45; DZIEWONSKI AM, 1984, PHYS EARTH PLANET IN, V34, P209, DOI 10.1016/0031-9201(84)90062-1; DZIEWONS.AM, 1974, NATURE, V247, P185, DOI 10.1038/247185a0; DZIEWONSKI AM, 1981, J GEOPHYS RES, V86, P2825, DOI 10.1029/JB086iB04p02825; EKSTROM G, 1993, IRIS NEWSLETTER, V12, P4; EKSTROM G, 1986, GEOPHYS RES LETT, V13, P173, DOI 10.1029/GL013i003p00173; GELLER RJ, 1974, NATURE, V252, P28, DOI 10.1038/252028a0; GIARDINI D, 1983, P E FERMI INT SCH PH, V85, P345; Gilbert F., 1971, GEOPHYS J ROY ASTR S, V22, P223; GILBERT F, 1973, PHILOS T R SOC A, V274, P369, DOI 10.1098/rsta.1973.0065; HARA T, 1996, UNPUB GEOPHYS J INT; HARA T, 1995, GEOPHYS RES LETT, V22, P2265, DOI 10.1029/95GL01602; HART RS, 1975, NATURE, V253, P333, DOI 10.1038/253333a0; KANMORI H, 1981, PHYS EARTH PLANET IN, V27, P8; KAWAKATSU H, 1995, GEOPHYS RES LETT, V22, P2569, DOI 10.1029/95GL02341; KAWAKATSU H, 1989, J GEOPHYS RES-SOLID, V94, P12363, DOI 10.1029/JB094iB09p12363; KENNETT BLN, 1976, GEOPHYS J ROY ASTR S, V44, P471, DOI 10.1111/j.1365-246X.1976.tb03668.x; KUGE K, 1990, GEOPHYS RES LETT, V17, P227, DOI 10.1029/GL017i003p00227; MASTERS G, 1983, PHILOS T R SOC A, V308, P479, DOI 10.1098/rsta.1983.0016; MENDIGUREN JA, 1978, GEOPHYS J ROY ASTR S, V55, P539, DOI 10.1111/j.1365-246X.1978.tb05926.x; OKAL EA, 1979, PHYS EARTH PLANET IN, V18, P176, DOI 10.1016/0031-9201(79)90113-4; Riedesel M. A., 1985, THESIS U CALIFORNIA; RIEDESEL MA, 1989, B SEISMOL SOC AM, V79, P85; SIPKIN SA, 1994, GEOPHYS RES LETT, V21, P1667, DOI 10.1029/94GL01429; TAKEI Y, 1995, GEOPHYS J INT, V121, P641, DOI 10.1111/j.1365-246X.1995.tb06428.x; TAKEI Y, 1994, GEOPHYS J INT, V118, P20, DOI 10.1111/j.1365-246X.1994.tb04672.x; TANIMOTO T, 1987, GEOPHYS J INT, V89, P713, DOI 10.1111/j.1365-246X.1987.tb05189.x; VASCO DW, 1989, GEOPHYS J INT, V97, P1, DOI 10.1111/j.1365-246X.1989.tb00480.x	36	22	22	BLACKWELL SCIENCE LTD	OXFORD	OSNEY MEAD, OXFORD, OXON, ENGLAND OX2 0EL	0956-540X			GEOPHYS J INT	Geophys. J. Int.	AUG	1996	126	2					525	544		10.1111/j.1365-246X.1996.tb05308.x		20	Geochemistry & Geophysics	Geochemistry & Geophysics	VB843	WOS:A1996VB84300017		
J	Miyagawa, S; Kawasaki, S; Makuuchi, M				Miyagawa, S; Kawasaki, S; Makuuchi, M			Comparison of the characteristics of hepatocellular carcinoma between hepatitis B and C viral infection: Tumor multicentricity in cirrhotic liver with hepatitis C	HEPATOLOGY			English	Article							VIRUS; PREVALENCE	Clinicopathological and prognostic features in patients who had undergone hepatectomy for hepatocellular carcinoma (HCC) were examined in relation to viral infection, Among 175 patients, cirrhosis was diagnosed histologically in 134, while 41 had noncirrhotic livers, One hundred twenty-four patients were positive for antibody to hepatitis C virus (anti-HCV) (HC group), 32 for hepatitis B virus surface antigen (HBsAg) (HE group), and 19 negative for both anti-HCV and HBsAg (non-B, non-C group). In the HE group, the mean patient age was significantly younger, and liver function in terms of the plasma retention rate of indocyanine green at 15 minutes and the serum total bilirubin level was significantly better than in either the HC or the non-B, non-C group, Seventeen patients had synchronous multicentric HCCs: the HC group showing a significantly higher incidence than the HE group (P < .05). In the HC group, the proportion of cirrhotic liver in patients with multicentric HCCs was significantly larger than in patients with unicentric HCC (P < .05). No significant differences in disease-free survival rate after hepatectomy were observed between the three groups. The present retrospective study of surgically treated patients showed that anti-HCV-positive HCCs tended to occur in older individuals who showed worse liver function and a higher incidence of cancer multicentricity compared with HBsAg-positive HCCs. The prognosis of anti-HCV-positive HCCs, which had the disadvantageous characteristic of multicentricity, did not differ hom that of HBsAg-positive HCCs.	UNIV TOKYO,SCH MED,DEPT SURG 2,TOKYO 113,JAPAN	Miyagawa, S (reprint author), SHINSHU UNIV,SCH MED,DEPT SURG 1,3-1-1 ASAHI,MATSUMOTO,NAGANO 390,JAPAN.		幕内, 雅敏/A-2140-2012				SAKAMOTO M, 1991, HUM PATHOL, V22, P172, DOI 10.1016/0046-8177(91)90039-R; TAKENAKA K, 1995, HEPATOLOGY, V22, P20, DOI 10.1016/0270-9139(95)90347-X; EDMONDSON HA, 1954, CANCER, V7, P462, DOI 10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO;2-E; CHISARI FV, 1989, CELL, V59, P1145, DOI 10.1016/0092-8674(89)90770-8; KENMOCHI K, 1987, LIVER, V7, P18; SHIRATORI Y, 1995, HEPATOLOGY, V22, P1027, DOI 10.1016/0270-9139(95)90605-3; OKUDA K, 1992, HEPATOLOGY, V15, P948, DOI 10.1002/hep.1840150532; KANAI T, 1987, CANCER, V60, P810, DOI 10.1002/1097-0142(19870815)60:4<810::AID-CNCR2820600417>3.0.CO;2-1; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; TAKANO S, 1995, HEPATOLOGY, V21, P650; ARAKAWA M, 1986, GASTROENTEROLOGY, V91, P198; BRECHOT C, 1981, LANCET, V2, P765; BRUIX J, 1989, LANCET, V2, P1004; KIYASAWA K, 1990, HEPATOLOGY, V12, P671; *LIV CANC STUD GRO, 1992, GEN RUL CLIN PATH ST, P1; NAKASHIMA T, 1982, HUM PATHOL, V13, P563; TAKENAKA K, 1994, HEPATOLOGY, V19, P889, DOI 10.1016/0270-9139(94)90288-7; TSUDA H, 1992, CANCER RES, V52, P1505; TSUKUMA H, 1993, NEW ENGL J MED, V328, P1797, DOI 10.1056/NEJM199306243282501; TWU JS, 1989, J VIROL, V63, P2857; WATANABE J, 1990, VOX SANG, V59, P86	21	126	129	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399	0270-9139			HEPATOLOGY	Hepatology	AUG	1996	24	2					307	310				4	Gastroenterology & Hepatology	Gastroenterology & Hepatology	VA629	WOS:A1996VA62900004		
J	Kogure, K; Zhang, YQ; Kanzaki, M; Omata, W; Mine, T; Kojima, I				Kogure, K; Zhang, YQ; Kanzaki, M; Omata, W; Mine, T; Kojima, I			Intravenous administration of follistatin: Delivery to the liver and effect on liver regeneration after partial hepatectomy	HEPATOLOGY			English	Article							ACTIVIN-BINDING PROTEIN; GLUCAGON-INFUSION; INSULIN; HEPATITIS; FAILURE; DNA	When 1 mu g I-125-follistatin was administered into a rat intravenously, radioactivity levels in serum decreased rapidly, Analysis with a biexponential equation showed that the initial half-life and the terminal half-life were 4.0 and 130.8 minutes, respectively, After 2 hours of infusion, approximately 9% of the follistatin infused remained in the liver, which was much more than that in kidney, spleen, pancreas, intestine, or lung. Autoradiography of the liver obtained at 24 hours of infusion revealed that numerous grains were located in parenchymal cells, Radioactivity of I-125-follistatin in the liver remained elevated until 72 hours and declined markedly thereafter, When a booster shot of I-125-follistatin was administered at 72 hours, radioactivity in the liver at 120 hours was markedly increased compared with that in rats that received a single shot of I-125-follistatin. We then examined the effect of intravenous infusion of follistatin on liver regeneration after hepatectomy of 70%. Immediately after the hepatectomy, either 1 mu g follistatin or saline was infused intravenously. In some rats, a booster shot was infused at 72 hours. After 120 hours of hepatectomy of 70%, remnant liver weight, liver regeneration rate, and DNA content were significantly (P <.0.5) higher in rats that received a booster shot of follistatin at 72 hours than those in control rats, These results indicate that follistatin administered intravenously accumulates in the liver and promotes liver regeneration after partial hepatectomy.	GUNMA UNIV,INST MOL & CELLULAR REGULAT,MAEBASHI,GUMMA 371,JAPAN; GUNMA UNIV,SCH MED,DEPT SURG 1,MAEBASHI,GUMMA 371,JAPAN; UNIV TOKYO,SCH MED,DEPT INTERNAL MED 4,TOKYO 112,JAPAN							KOGURE K, 1995, GASTROENTEROLOGY, V108, P1136, DOI 10.1016/0016-5085(95)90212-0; Higgins GM, 1931, ARCH PATHOL, V12, P186; MICHALOPOULOS GK, 1990, FASEB J, V4, P176; NAKAMURA T, 1990, SCIENCE, V247, P836, DOI 10.1126/science.2106159; NAKAMURA T, 1991, J BIOL CHEM, V266, P19432; BAKER AL, 1981, GASTROENTEROLOGY, V80, P1410; BYVOET P, 1966, ANAL BIOCHEM, V15, P31, DOI 10.1016/0003-2697(66)90244-2; DEPAOLO LV, 1991, P SOC EXP BIOL MED, V198, P500; FARIVAR M, 1976, NEW ENGL J MED, V295, P1517, DOI 10.1056/NEJM197612302952706; FARNWORTH UM, 1993, MOL CELL ENDOCRINOL, V91, P1; Fishback F, 1929, ARCH PATHOL, V7, P956; HARRISON PM, 1990, J HEPATOL, V10, P332, DOI 10.1016/0168-8278(90)90141-D; HINEGARD.RT, 1971, ANAL BIOCHEM, V39, P197, DOI 10.1016/0003-2697(71)90476-3; ISHIKI Y, 1992, HEPATOLOGY, V16, P127; JASPAN JB, 1984, ARCH INTERN MED, V144, P2075, DOI 10.1001/archinte.144.10.2075; LABRECQUE D, 1994, AM J GASTROENTEROL, V89, pS86; YASUDA H, 1993, J CLIN INVEST, V92, P1491, DOI 10.1172/JCI116727; YING SY, 1988, ENDOCR REV, V9, P267	18	49	55	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399	0270-9139			HEPATOLOGY	Hepatology	AUG	1996	24	2					361	366				6	Gastroenterology & Hepatology	Gastroenterology & Hepatology	VA629	WOS:A1996VA62900012		
J	Zhang, YQ; Kanzaki, M; Mashima, H; Mine, T; Kojima, I				Zhang, YQ; Kanzaki, M; Mashima, H; Mine, T; Kojima, I			Characterization of the activin receptor in cultured rat hepatocytes	HEPATOLOGY			English	Article							ERYTHROID-DIFFERENTIATION FACTOR; FOLLICLE-STIMULATING-HORMONE; LEUKEMIA-CELL-LINE; TGF-BETA FAMILY; SERINE KINASE; A BINDING; CLONING; FOLLISTATIN; PROTEIN; COMPLEX	Activin A is an autocrine inhibitor of initiation of DNA synthesis in rat hepatocytes. The present study was conducted to characterize the cell-surface receptors for activin A in cultured rat hepatocytes by measuring I-125-activin A binding, Scatchard analysis of I-125-activin A binding indicated the existence of two classes of binding sites with apparent Ma values of 3 x 10(-10) mol/L and 3.5 x 10(-9) mol/L. Pretreatment of the cells with heparitinase reduced the number of low-affinity binding sites, whereas pretreatment with excess exogenous follistatin increased the number of low-affinity binding sites. Affinity cross-linking of I-125-activin A to hepatocytes-revealed distinct protein complexes with molecular weights of approximately 48, 65, and 85 kd, which may represent cross-linked cell-bound follistatin, type I and type II activin receptors, respectively, Another band with a molecular weight of 180 kd was also found, which may represent the type III activin receptor. When hepatocytes were cultured with epidermal growth factor (EGF), both high- and low-affinity binding sites increased at 12 hours without altering their affinities, At 60 hours of the incubation with EGF, the high-affinity binding sites decreased while the number of low-affinity binding sites increased slightly. These results indicate that two classes of I-125-activin A binding sites exist in cultured hepatocytes: the high-affinity binding site may represent oligomeric complex of the type I and type II receptors, and at least part of the low-affinity binding site may represent cell-bound follistatin. The number of activin receptors in hepatocytes is increased after the stimulation with EGF.	GUNMA UNIV,INST MOL & CELLULAR REGULAT,DEPT CELL BIOL,MAEBASHI,GUMMA 371,JAPAN; UNIV TOKYO,SCH MED,DEPT INTERNAL MED 4,TOKYO 112,JAPAN							GREEN JBA, 1990, NATURE, V347, P391, DOI 10.1038/347391a0; KOGURE K, 1995, GASTROENTEROLOGY, V108, P1136, DOI 10.1016/0016-5085(95)90212-0; FRANZEN P, 1993, CELL, V75, P681, DOI 10.1016/0092-8674(93)90489-D; VALE W, 1986, NATURE, V321, P776, DOI 10.1038/321776a0; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; LING N, 1986, NATURE, V321, P779, DOI 10.1038/321779a0; MATHEWS LS, 1991, CELL, V65, P973, DOI 10.1016/0092-8674(91)90549-E; ATTISANO L, 1993, CELL, V75, P671, DOI 10.1016/0092-8674(93)90488-C; NAKAMURA T, 1991, J BIOL CHEM, V266, P19432; ATTISANO L, 1992, CELL, V68, P97, DOI 10.1016/0092-8674(92)90209-U; BERRY MN, 1969, J CELL BIOL, V43, P506, DOI 10.1083/jcb.43.3.506; CAMPEN CA, 1988, BIOCHEM BIOPH RES CO, V157, P844, DOI 10.1016/S0006-291X(88)80326-7; CENTRELLA M, 1991, MOL CELL BIOL, V11, P250; HASHIMOTO M, 1990, BIOCHEM BIOPH RES CO, V173, P193, DOI 10.1016/S0006-291X(05)81040-X; HINO M, 1989, J BIOL CHEM, V264, P10309; HOTTEN G, 1995, BIOCHEM BIOPH RES CO, V206, P608, DOI 10.1006/bbrc.1995.1086; HULLY JR, 1994, HEPATOLOGY, V20, P854, DOI 10.1002/hep.1840200413; KANZAKI M, 1994, BIOCHEM BIOPH RES CO, V202, P422, DOI 10.1006/bbrc.1994.1945; KATAYAMA T, 1990, MOL CELL ENDOCRINOL, V69, P179, DOI 10.1016/0303-7207(90)90011-V; MASSAGUE J, 1987, CELL, V49, P437, DOI 10.1016/0092-8674(87)90443-0; MATHEWS LS, 1994, ENDOCR REV, V15, P310, DOI 10.1210/er.15.3.310; MCCARTHY SA, 1994, J BIOL CHEM, V269, P3909; MINE T, 1989, ENDOCRINOLOGY, V125, P586; NISHIMURA M, 1991, BIOCHEM BIOPH RES CO, V181, P1042, DOI 10.1016/0006-291X(91)92042-I; ODA S, 1995, BIOCHEM BIOPH RES CO, V210, P581, DOI 10.1006/bbrc.1995.1699; PANSTAN IH, 1981, ANN REV PHYSL, V43, P239; SCHWALL RH, 1993, HEPATOLOGY, V18, P347, DOI 10.1016/0270-9139(93)90018-I; SUGINO H, 1988, J BIOL CHEM, V263, P15249; YASUDA H, 1993, J CLIN INVEST, V92, P1491, DOI 10.1172/JCI116727; YING SY, 1988, ENDOCR REV, V9, P267	30	13	15	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399	0270-9139			HEPATOLOGY	Hepatology	AUG	1996	24	2					446	450				5	Gastroenterology & Hepatology	Gastroenterology & Hepatology	VA629	WOS:A1996VA62900025		
J	Nakatome, M; Honda, K; Tun, Z; Kato, Y; Harihara, S; Omoto, K; Misawa, S; Gerelsaikhan, T; Nyamkhishig, S; Dashnyam, B; Batsuuri, J; Wakasugi, C				Nakatome, M; Honda, K; Tun, Z; Kato, Y; Harihara, S; Omoto, K; Misawa, S; Gerelsaikhan, T; Nyamkhishig, S; Dashnyam, B; Batsuuri, J; Wakasugi, C			Genetic polymorphism of the 3' VNTR region of the human dopaminergic function gene DAT1 (human dopamine transporter gene) in the Mongolian population	HUMAN BIOLOGY			English	Article						VNTR polymorphism; DAT1; polymerase chain reaction (PCR); Mongolian population	JAPANESE POPULATION; PARKINSONS-DISEASE; SCHIZOPHRENIA; COCAINE; AMPLIFICATION; ASSOCIATION; ALCOHOLISM; RECEPTORS; ALLELE; ABUSE	The hypervariable region of the dopamine transporter gene (DAT1) was amplified from samples in the Mongolian population. This region includes a variable number of tandem repeats of a 40-bp core unit in the 3' untranslated region of DAT1. Vandenbergh et al. (1992) reported variability in the number of repeats of this 3' flanking region ranging from 3 to 11 times in white and black populations, We examined polymorphism at the DAT1 locus in 78 native Mongolian subjects. We found alleles with 7 to 13 repeats, which is different from the findings of Vandenbergh et al. (1992). The allele distribution of the Mongolian population is similar to that in the Japanese population, reported previously by Nakatome et al. (1995), Chi-square analysis showed a significant lack of homogeneity between our findings in Mongolian subjects and those reported previously in white and black populations. The DAT1 locus was estimated to have a heterozygosity index of 14.1%, and the polymorphic information content was calculated to be 0.16.	UNIV TOKYO,GRAD SCH SCI,DEPT BIOL SCI,TOKYO 113,JAPAN; INT RES CTR JAPANESE RES,KYOTO,JAPAN; UNIV TSUKUBA,DEPT LEGAL MED,INST SOCIAL MED,TSUKUBA,IBARAKI 305,JAPAN; MONGOLIAN ACAD SCI,INST BIOTECHNOL,DEPT BIOL MOL,ULAANBAATAR,MONGOL PEO REP; MONGOLIAN STATE MED UNIV,NATL CTR ANTHROPOL,DEPT GENET,ULAANBAATAR,MONGOL PEO REP	Nakatome, M (reprint author), OSAKA UNIV,SCH MED,DEPT LEGAL MED,2-2 YAMADAOKA,SUITA,OSAKA 565,JAPAN.						SANO A, 1993, HUM GENET, V91, P405; HORN AS, 1990, PROG NEUROBIOL, V34, P387, DOI 10.1016/0301-0082(90)90033-D; DAVIS KL, 1991, AM J PSYCHIAT, V148, P1474; GIROS B, 1993, TRENDS PHARMACOL SCI, V14, P43, DOI 10.1016/0165-6147(93)90029-J; DACKIS CA, 1985, NEUROSCI BIOBEHAV R, V9, P469, DOI 10.1016/0149-7634(85)90022-3; VANDENBERGH DJ, 1992, GENOMICS, V14, P1104, DOI 10.1016/S0888-7543(05)80138-7; GIROS B, 1992, MOL PHARMACOL, V42, P383; COOK EH, 1995, AM J HUM GENET, V56, P993; RITZ MC, 1987, SCIENCE, V237, P1219, DOI 10.1126/science.2820058; SMITH SS, 1992, ARCH GEN PSYCHIAT, V49, P723; BYERLEY W, 1993, HUM HERED, V43, P319, DOI 10.1159/000154151; DAVID B, 1980, AM J HUM GENET, V32, P314; DEVOR EJ, 1989, ANNU REV GENET, V23, P19, DOI 10.1146/annurev.genet.23.1.19; FISHER RA, 1951, HEREDITY, V5, P95, DOI 10.1038/hdy.1951.5; GELERNTER J, 1994, NEUROPSYCHOPHARMACOL, V11, P195, DOI 10.1038/sj.npp.1380106; GOTTESMAN II, 1991, SCHIZOPHRENIA GENETI; HONDA K, 1995, INT J LEGAL MED, V108, P43, DOI 10.1007/BF01845617; Maniatis T., 1982, MOL CLONING; NAKAGOME Y, 1992, ANN HUM GENET, V56, P311, DOI 10.1111/j.1469-1809.1992.tb01158.x; NAKATOME M, 1995, HUM HERED, V45, P262, DOI 10.1159/000154310; PERSICO AM, 1993, BIOL PSYCHIAT, V34, P265, DOI 10.1016/0006-3223(93)90081-N; PICKENS RW, 1991, ARCH GEN PSYCHIAT, V48, P19; RAND S, 1992, INT J LEGAL MED, V104, P329, DOI 10.1007/BF01369552; SINGER HS, 1991, ANN NEUROL, V30, P558, DOI 10.1002/ana.410300408; SNYDER SH, 1991, NATURE, V354, P187, DOI 10.1038/354187a0; SNYDER SH, 1986, NEUROLOGY, V36, P250; STOKER NG, 1985, NUCLEIC ACIDS RES, V13, P4613, DOI 10.1093/nar/13.13.4613; SUGIYAMA E, 1993, INT J LEGAL MED, V106, P111, DOI 10.1007/BF01225228; TAO L, 1994, PSYCHIAT RES, V52, P17; UHL GR, 1990, EUR NEUROL, V30, P21, DOI 10.1159/000117170; WEIFFENBACH B, 1991, GENOMICS, V10, P173, DOI 10.1016/0888-7543(91)90498-4; WYATT RJ, 1988, SCHIZOPHR RES, V1, P3, DOI 10.1016/0920-9964(88)90034-5	32	15	15	WAYNE STATE UNIV PRESS	DETROIT	4809 WOODWARD AVE, DETROIT, MI 48201-1309	0018-7143			HUM BIOL	Hum. Biol.	AUG	1996	68	4					509	515				7	Biology; Genetics & Heredity	Life Sciences & Biomedicine - Other Topics; Genetics & Heredity	VB526	WOS:A1996VB52600002		
J	Yamauchi, T; Nishimaki, H; Furusaka, A; Tanaka, T; Hayashi, S; Tamemoto, H; Taylar, S; Tobe, K; Kadowaki, T; Nishiyama, M				Yamauchi, T; Nishimaki, H; Furusaka, A; Tanaka, T; Hayashi, S; Tamemoto, H; Taylar, S; Tobe, K; Kadowaki, T; Nishiyama, M			Anti-IRS-1 monoclonal antibody, 6G5, cross-reacts to IRS-2	HYBRIDOMA			English	Article							INSULIN-RECEPTOR SUBSTRATE-1; LIVER-REGENERATION; EXPRESSION; GENE; MICE; PROTEIN	We previously reported the production of anti-IRS-l monoclonal antibodies against human IRS-1 C-terminal portion, One of anti IRS-1 monoclonal antibodies, 6G5, was found to immunologically cross-react with IRS-2, which has been reported recently. The data presented here provide information arising from the use of the anti-IRS-1 MAb, 6G5; this MAb was found to be a useful reagent in studying the functional role of IRSs in the insulin-signaling system.	JIKEI UNIV,SCH MED,DEPT BIOCHEM 2,MINATO KU,TOKYO,JAPAN; JIKEI UNIV,SCH MED,DAISAN HOSP,DEPT INTERNAL MED,TOKYO,JAPAN; UNIV TOKYO,FAC MED,DEPT INTERNAL MED 3,TOKYO 113,JAPAN; NIDDK,DIABET BRANCH,NIH,BETHESDA,MD 20892							TAMEMOTO H, 1994, NATURE, V372, P182, DOI 10.1038/372182a0; ARAKI E, 1994, NATURE, V372, P186, DOI 10.1038/372186a0; SUN XJ, 1991, NATURE, V352, P73, DOI 10.1038/352073a0; SUN XJ, 1995, NATURE, V377, P173, DOI 10.1038/377173a0; TOBE K, 1995, J BIOL CHEM, V270, P5698; WHITE MF, 1994, J BIOL CHEM, V269, P1; FURUSAKA A, 1995, BIOCHEM BIOPH RES CO, V216, P284, DOI 10.1006/bbrc.1995.2622; FURUSAKA A, 1994, CANCER LETT, V84, P85, DOI 10.1016/0304-3835(94)90361-1; NISHIYAMA M, 1994, GENOMICS, V20, P139, DOI 10.1006/geno.1994.1143; NISHIYAMA M, 1992, BIOCHEM BIOPH RES CO, V183, P280, DOI 10.1016/0006-291X(92)91640-C; SASAKI Y, 1993, J BIOL CHEM, V268, P3805	11	2	2	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538	0272-457X			HYBRIDOMA	Hybridoma	AUG	1996	15	4					307	309		10.1089/hyb.1996.15.307		3	Biochemical Research Methods; Biotechnology & Applied Microbiology; Immunology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Immunology	VG641	WOS:A1996VG64100008		
J	Schell, M; Bimberg, D; Kamiya, T				Schell, M; Bimberg, D; Kamiya, T			On the locking range of hybridly mode-locked semiconductor lasers	IEEE PHOTONICS TECHNOLOGY LETTERS			English	Article							PULSE GENERATION; BANDWIDTH	We theoretically investigate the locking range of hybridly mode-locked semiconductor lasers with a DBR section as a reflector. The DBR coupling constant and length are crucial in determining the locking range3. At constant pulse width, the tuning range of the repetition frequency can be increased by a factor of 3 by using a strongly coupled, long DBR rather than a short and weakly coupled DBR. For a 30 GHz cavity and a pulse width of 5 ps, a locking range of 2.5% is predicted after optimization. We explain the increase in the locking range as a consequence of the dispersion inherent to a DBR. In addition, the pulses are found to be asymmetric, depending on the DBR parameters.	UNIV TOKYO,DEPT ELECTR ENGN,BUNKYO KU,TOKYO 113,JAPAN	Schell, M (reprint author), TECH UNIV BERLIN,INST FESTKORPERPHYS,HARDENBERGSTR 36,SEKR PN 5-2,D-10623 BERLIN,GERMANY.						AHMED Z, 1993, IEEE J QUANTUM ELECT, V29, P1714, DOI 10.1109/3.234426; CHEN YK, 1992, IEEE J QUANTUM ELECT, V28, P2176; ARAHIRA S, 1994, OPT LETT, V19, P834, DOI 10.1364/OL.19.000834; BRORSON SD, 1995, P C LAS EL CLEO PAC; DERICKSON DJ, 1992, IEEE J QUANTUM ELECT, V28, P2186, DOI 10.1109/3.159527; LIU H, COMMUNICATION; MORTON PA, 1993, IEEE PHOTONIC TECH L, V5, P28, DOI 10.1109/68.185050; SCHELL M, 1995, C LAS EL CLEO PAC RI; SCHELL M, 1995, APPL PHYS LETT, V67, P1797, DOI 10.1063/1.115062; Schell M, 1996, IEEE J QUANTUM ELECT, V32, P1180, DOI 10.1109/3.517018; STELMAKH N, 1993, ELECTRON LETT, V29, P160, DOI 10.1049/el:19930108; SUEMATSU Y, 1985, SEMICONDUCTORS SEM B, V22, P215; WEBER AG, 1992, IEEE J QUANTUM ELECT, V28, P2220, DOI 10.1109/3.159529; YU J, 1995, ELECTRON LETT, V31, P2008, DOI 10.1049/el:19951348; YU J, 1994, APPL PHYS LETT, V65, P2395, DOI 10.1063/1.112686; ZHAI L, 1995, IEEE J QUANTUM ELECT, V31, P1998, DOI 10.1109/3.469281	16	3	3	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	NEW YORK	345 E 47TH ST, NEW YORK, NY 10017-2394	1041-1135			IEEE PHOTONIC TECH L	IEEE Photonics Technol. Lett.	AUG	1996	8	8					1004	1006		10.1109/68.508718		3	Engineering, Electrical & Electronic; Optics; Physics, Applied	Engineering; Optics; Physics	UY957	WOS:A1996UY95700014		
J	Liu, YH; Arimoto, S				Liu, YH; Arimoto, S			Distributively controlling two robots handling an object in the task space without any communication	IEEE TRANSACTIONS ON AUTOMATIC CONTROL			English	Article							ADAPTIVE-CONTROL; MANIPULATORS	Two distributed cooperation controllers are presented for trajectory tracking of two manipulators which are cooperatively handling an object. The controllers control the positions of the robots distributively by using the trajectory error of the object in the task space. In the first controller, the internal force between the object and a manipulator is controlled only by a feedforward of the desired force, The second controller uses a force feedback, No communication is required between the manipulators in both the controllers. Their globally and exponentially asymptotic stabilities are guaranteed by Lyapunov functions.	UNIV TOKYO,DEPT MATH ENGN & INFORMAT PHYS,BUNKYO KU,TOKYO 113,JAPAN	Liu, YH (reprint author), CHINESE UNIV HONG KONG,DEPT MECH & AUTOMAT ENGN,SHATIN,HONG KONG.		Liu, Yun-Hui/B-7441-2008				SLOTINE JJE, 1987, INT J ROBOT RES, V6, P49, DOI 10.1177/027836498700600303; FUJII S, 1975, 4TH P IFTOMM WORLD C, P411; HSU P, 1989, IEEE T ROBOTIC AUTOM, P1234; KHATIB O, 1987, IEEE T ROBOTIC AUTOM, V3, P43; KOSUGE K, 1993, P RSJ ANN C, P705; LIU YH, 1995, P IEEE INT C INT ROB; LIU YH, 1995, IEEE INT CONF ROBOT, P905, DOI 10.1109/ROBOT.1995.525398; NAKANO E, 1974, 4TH P INT S IND ROB, P251; NANIWA T, 1994, P INT C INT ROB SYST, P695; PENG Z, 1994, P JSME C ROB MECH, P821; TARN TJ, 1987, IEEE T ROBOTIC AUTOM, P7; Uchiyama M., 1987, Proceedings of the 1987 IEEE International Conference on Robotics and Automation (Cat. No.87CH2413-3); YAO B, 1993, PROCEEDINGS : IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND AUTOMATION, VOLS 1-3, P624, DOI 10.1109/ROBOT.1993.292048; YOSHIKAWA T, 1989, P IEEE C ROB AUT, P1091	14	27	27	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	NEW YORK	345 E 47TH ST, NEW YORK, NY 10017-2394	0018-9286			IEEE T AUTOMAT CONTR	IEEE Trans. Autom. Control	AUG	1996	41	8					1193	1198				6	Automation & Control Systems; Engineering, Electrical & Electronic	Automation & Control Systems; Engineering	VC472	WOS:A1996VC47200011		
J	Michishita, K; Ishii, M; Hongo, Y				Michishita, K; Ishii, M; Hongo, Y			Induced voltage on an overhead wire associated with inclined return-stroke channel model experiment on finitely conductive ground	IEEE TRANSACTIONS ON ELECTROMAGNETIC COMPATIBILITY			English	Article							LIGHTNING-INDUCED VOLTAGES; POWER-LINES	Experiments on the lightning-induced voltage waveforms on an overhead wire influenced by an inclined return stroke channel are carried out outdoors with a reduced-scale model, The measured voltages are compared with those calculated by solving the Telegrapher's equation in combination with numerical calculation of electric fields associated with return-stroke currents, and the validity of the calculations is verified. The,effect of the ground conductivity on the lightning-induced voltage waveform is studied based on numerical calculations and is found to be dependent on the position of the return-stroke channel relative to the overhead wire. When a return stroke hits the ground close to the end of the overhead wife, the influence of the ground conductivity on the induced voltage waveform is significant irrespective of the inclination or the direction of the lightning channel. The degree of the influence is dependent on the Inclination and the direction of the channel when a return stroke hits the ground on the side of the overhead wire.	UNIV TOKYO,INST IND SCI,TOKYO 106,JAPAN; TOHOKU ELECT POWER CO,R&D CTR,SENDAI,MIYAGI 981,JAPAN	Michishita, K (reprint author), SHIZUOKA UNIV,DEPT ELECT & ELECT ENGN,HAMAMATSU,SHIZUOKA 432,JAPAN.						AGRAWAL AK, 1980, IEEE T ELECTROMAGN C, V22, P119, DOI 10.1109/TEMC.1980.303824; Norton KA, 1937, P IRE, V25, P1203, DOI 10.1109/JRPROC.1937.228544; SAKAKIBARA A, 1989, IEEE T POWER DELIVER, V4, P683, DOI 10.1109/61.19261; COORAY V, 1994, IEEE T ELECTROMAGN C, V36, P179, DOI 10.1109/15.305462; GEORGIADIS N, 1992, IEEE T ELECTROMAGN C, V34, P451, DOI 10.1109/15.179278; IMAI Y, 1990, P 20 INT C LIGHTN PR; ISHII M, 1994, IEEE T POWER DELIVER, V9, P109, DOI 10.1109/61.277685; Koga H., 1979, Transactions of the Institute of Electronics and Communication Engineers of Japan, Section E (English), VE62; LYTLE RJ, 1974, UCRL51688 LAWR LIV L; MASTER MJ, 1984, IEEE T POWER AP SYST, V103, P2502, DOI 10.1109/TPAS.1984.318405; MICHISHITA K, 1994, P 22 INT C LIGHTN PR; MICHISHITA K, 1992, P 21 INT C LIGHTN PR; NUCCI CA, 1990, J GEOPHYS RES-ATMOS, V95, P20395, DOI 10.1029/JD095iD12p20395; RUBINSTEIN M, 1994, IEEE T ELECTROMAGN C, V36, P134, DOI 10.1109/15.293277; Rusck S., 1958, T ROYAL I TECHNOL; Stratton J. A., 1941, ELECTROMAGNETIC THEO; TADA T, 1984, T IEE JAPAN B, V104, P85; Vance E. F., 1987, COUPLING SHIELDED CA; YOKOYAMA S, 1986, IEEE T POWER DELIVER, V1, P129, DOI 10.1109/TPWRD.1986.4307943; Zeddam A., 1987, Electromagnetics, V7, DOI 10.1080/02726348708908197	20	8	8	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	NEW YORK	345 E 47TH ST, NEW YORK, NY 10017-2394	0018-9375			IEEE T ELECTROMAGN C	IEEE Trans. Electromagn. Compat.	AUG	1996	38	3					507	513		10.1109/15.536083		7	Engineering, Electrical & Electronic; Telecommunications	Engineering; Telecommunications	VF250	WOS:A1996VF25000036		
J	Mogi, K; Kitsuregawa, M				Mogi, K; Kitsuregawa, M			Virtual striping: A storage management scheme with dynamic striping	IEICE TRANSACTIONS ON INFORMATION AND SYSTEMS			English	Article						disk array; storage management; RAIDS		RAIDS disk arrays provide high performance and high reliability for reasonable cost. However RAIDS suffers a performance penalty during block updates. In this paper, we propose a method to improve the small write performance of RAIDS disk arrays, named Virtual Striping. Instead of updating each block independently, this method buffers a number of updates, generates a new stripe composed of the newly updated blocks, then writes the full stripe back to disk. In order to make free space for write operations, new garbage collection strategy is employed, where the linkage of blocks in a parity stripe is changed in Virtual Striping. The LFS (log-structured file system) based storage management scheme also writes new block onto large Free area, which uses copying garbage collection. In this paper, we compare the performance of both methods through simulation. Although the write cost of Virtual Striping is more than that of the LFS based method, Virtual Striping has better performance than the LFS based method. This is due to the high efficiency of garbage collection in Virtual Striping.		Mogi, K (reprint author), UNIV TOKYO, INST IND SCI, 7-22-1 ROPPONGI, TOKYO 106, JAPAN.						BHIDE A, 1992, 17879 RC IBM RES DIV; CHEN PM, 1990, 17TH ANNUAL INTERNATIONAL SYMPOSIUM ON COMPUTER ARCHITECTURE, P322, DOI 10.1109/ISCA.1990.134542; Gray J., 1990, P 16 INT C VER LARG, P148; Holland M., 1992, P 5 INT C ARCH SUPP, P23, DOI 10.1145/143365.143383; MENON J, 1993, CONF PROC INT SYMP C, P76; MENON J, 1992, P 25 HAW INT C SYST, V1, P74; Mogi K., 1994, Proceedings of the Third International Conference on Parallel and Distributed Information Systems (Cat. No.94TH0668-4), DOI 10.1109/PDIS.1994.331736; Patterson D. A., 1988, P ACM SIGMOD INT C M, P109, DOI DOI 10.1145/50202.50214; ROSENBLUM M, 1991, 13TH P ACM S OP SYST, P1; SELTZER M, 1990, 1990 P WINT USENIX C, P313; Stodolsky D., 1993, P 20 ANN INT S COMP, P64; YU PS, 1993, 19041 RC IBM RES DIV; 1991, Patent No. 9116711	13	0	0	IEICE-INST ELECTRONICS INFORMATION COMMUNICATIONS ENG	TOKYO	KIKAI-SHINKO-KAIKAN BLDG MINATO-KU SHIBAKOEN 3 CHOME, TOKYO, 105, JAPAN	0916-8532			IEICE T INF SYST	IEICE Trans. Inf. Syst.	AUG	1996	E79D	8					1086	1092				7	Computer Science, Information Systems; Computer Science, Software Engineering	Computer Science	VE446	WOS:A1996VE44600010		
J	Nakamura, T; Koyama, M; Yoneyama, A; Higashihara, M; Kawakami, T; Yamamura, H; Sada, K; Okumura, K; Kurokawa, K				Nakamura, T; Koyama, M; Yoneyama, A; Higashihara, M; Kawakami, T; Yamamura, H; Sada, K; Okumura, K; Kurokawa, K			Signal transduction through mu kappa B-cell receptors expressed on pre-B cells is different from that through B-cell receptors on mature B cells	IMMUNOLOGY			English	Article							PROTEIN-TYROSINE KINASE(S); ANTIGEN-RECEPTOR; CROSS-LINKING; PHOSPHATIDYLINOSITOL 3-KINASE; MAJOR SUBSTRATE; LYMPHOCYTES-B; LIGHT-CHAINS; SURFACE IGM; ACTIVATION; LINES	We introduced kappa light chain genes into pre-B cells to increase the surface mu HC expression, and established transfectants expressing mature type of B-cell receptors (BCR) on pre-B-cell surfaces. Since the cytoplasmic conformations of the reconstituted BCR and intrinsic pre-B-cell receptor (pre-BCR) are identical, they would be connected with the identical signal transduction pathways in pre-B cells. By using the transfectants, we revealed that the reconstituted BCR on pre-B cells was functionally equivalent to BCR on mature B cells in terms of the induction of intracellular Ca++ mobilization. However, we found that the signal-transduction pathways through BCR on pre-B cells were quantitatively different from those of BCR on mature B cells in two ways. First, cross-linkage of the reconstituted BCR on pre-B cells induced preferential tyrosine phosphorylation of p120 and p100, which was not observed when BCR on mature B cells was cross-linked. Second, BC-R in pre-B cells was physically associated with a larger amount of phosphatidylinositol-3 kinase (PI-3K) than BCR in mature B cells in spite of the fact that both pre-B and B cells expressed a similar amount of PI-3K in cytoplasm. Signals through pre-BCR and BCR are known to cause distinct biological effects in B-cell development. The biochemical features in the downstream of reconstituted BCR on pre-B cells, which we revealed in this study, will be of help in understanding the mechanism of functional differences between pre-BCR and BCR.	UNIV TOKYO,FAC MED,DEPT INTERNAL MED 1,MINATO KU,TOKYO 108,JAPAN; LA JOLLA INST ALLERGY & IMMUNOL,LA JOLLA,CA; KOBE UNIV,SCH MED,DEPT BIOCHEM,KOBE 650,JAPAN; JUNTENDO UNIV,SCH MED,DEPT IMMUNOL,TOKYO 113,JAPAN	Nakamura, T (reprint author), UNIV TOKYO,INST MED SCI,DEPT INFECT DIS & APPL IMMUNOL,MINATO KU,4-6-1 SHIROGANEDAI,TOKYO 108,JAPAN.		Sada, Kiyonao/H-7373-2015	Sada, Kiyonao/0000-0001-6124-3100			JUSTEMENT LB, 1990, J IMMUNOL, V144, P3272; OKAMOTO M, 1992, J EXP MED, V175, P71, DOI 10.1084/jem.175.1.71; WECHSLER RJ, 1995, J IMMUNOL, V154, P1919; KUROSAKI T, 1994, J EXP MED, V179, P1725, DOI 10.1084/jem.179.5.1725; TAKATA M, 1994, EMBO J, V13, P1341; YAMANASHI Y, 1992, P NATL ACAD SCI USA, V89, P1118, DOI 10.1073/pnas.89.3.1118; AOKI Y, 1994, P NATL ACAD SCI USA, V91, P4204, DOI 10.1073/pnas.91.10.4204; BIGUET C, 1994, J BIOL CHEM, V269, P28865; BROUNS GS, 1993, EUR J IMMUNOL, V23, P1088, DOI 10.1002/eji.1830230517; CARTER RH, 1991, P NATL ACAD SCI USA, V88, P2475; COSTA TE, 1992, J EXP MED, V175, P1669, DOI 10.1084/jem.175.6.1669; EHLICH A, 1993, CELL, V72, P695, DOI 10.1016/0092-8674(93)90398-A; FUKAMACHI H, 1994, J IMMUNOL, V152, P642; HAASNER D, 1994, INT IMMUNOL, V6, P21, DOI 10.1093/intimm/6.1.21; HARTLEY SB, 1993, CELL, V72, P325, DOI 10.1016/0092-8674(93)90111-3; HEMPEL WM, 1992, J IMMUNOL, V148, P3021; HENDERSHOT L, 1984, J IMMUNOL, V132, P502; KITAMURA D, 1992, CELL, V69, P823, DOI 10.1016/0092-8674(92)90293-L; LASSOUED K, 1993, CELL, V73, P73, DOI 10.1016/0092-8674(93)90161-I; MA A, 1992, EMBO J, V11, P2727; MARUYAMA S, 1985, J IMMUNOL, V135, P192; MISENER V, 1991, INT IMMUNOL, V3, P1129, DOI 10.1093/intimm/3.11.1129; NAKAMURA T, 1992, P NATL ACAD SCI USA, V89, P8522, DOI 10.1073/pnas.89.18.8522; NAKAMURA T, 1993, INT IMMUNOL, V5, P1309, DOI 10.1093/intimm/5.10.1309; NOMURA J, 1991, INT IMMUNOL, V3, P117, DOI 10.1093/intimm/3.2.117; OKADA T, 1994, J BIOL CHEM, V269, P3563; PARRY SL, 1994, J IMMUNOL, V152, P2821; PLEIMAN CM, 1994, P NATL ACAD SCI USA, V91, P4268, DOI 10.1073/pnas.91.10.4268; TSUBATA T, 1992, INT IMMUNOL, V4, P637, DOI 10.1093/intimm/4.6.637; YAMANASHI Y, 1993, P NATL ACAD SCI USA, V90, P3631, DOI 10.1073/pnas.90.8.3631; YATOMI Y, 1990, BIOCHEM BIOPH RES CO, V171, P109, DOI 10.1016/0006-291X(90)91363-W	31	3	3	BLACKWELL SCIENCE LTD	OXFORD	OSNEY MEAD, OXFORD, OXON, ENGLAND OX2 0EL	0019-2805			IMMUNOLOGY	Immunology	AUG	1996	88	4					593	599		10.1046/j.1365-2567.1996.d01-681.x		7	Immunology	Immunology	VB623	WOS:A1996VB62300018		
J	Yano, S; Doi, M; Kato, M; Okura, I; Nagano, T; Yamamoto, Y; Tanase, T				Yano, S; Doi, M; Kato, M; Okura, I; Nagano, T; Yamamoto, Y; Tanase, T			Successful isolation and X-ray crystal structure of (tris(N-L-rhamnosyl-2-aminoethyl)amine)(sulfate) nickel(II) hydrate trimethanol solvate: [Ni((L-Rha)(3)-tren)(SO4)]center dot H2O center dot 3CH(3)OH	INORGANICA CHIMICA ACTA			English	Article						N-glycoside complexes; nickel complexes; sulfate chelate complexes; crystal structures	COBALT(III) COMPLEXES; SUGAR UNITS; ETHYLENEDIAMINE; LIGANDS; ALDOSE	We have succeeded in the isolation and X-ray crystal structure determination of the octahedral nickel(II) complex [Ni((L-Rha)(3)-tren) (SO4)]. H2O . 3CH(3)OH (tren = tris(2-aminoethyl)amine; Rha = rhamnose) containing an N-glycoside derived from the reaction of L-Rha and tren. Crystal data: C27H62N4O20SNi, M(r) = 853.56, orthorhombic, space group P2(1)2(1)2(1), a = 16.035(4), b = 16.670(7), c = 15.38(1) Angstrom, Z = 4.	TOKYO INST TECHNOL,DEPT BIOENGN,MIDORI KU,YOKOHAMA,KANAGAWA 227,JAPAN; UNIV TOKYO,FAC PHARMACEUT SCI,BUNKYO KU,TOKYO 113,JAPAN; TOHO UNIV,FAC SCI,DEPT CHEM,FUNABASHI,CHIBA 274,JAPAN	Yano, S (reprint author), NARA WOMENS UNIV,FAC SCI,DEPT CHEM,NARA 630,JAPAN.		Kato, Masako/D-7778-2012				TANASE T, 1988, INORG CHEM, V27, P4085, DOI 10.1021/ic00296a004; GILMORE CJ, 1984, J APPL CRYSTALLOGR, V17, P42, DOI 10.1107/S0021889884010992; ISHIDA K, 1989, J CHEM SOC DA, V7, P1241; ISHIDA K, 1988, J AM CHEM SOC, V110, P2015, DOI 10.1021/ja00214a084; ISHIDA K, 1989, J AM CHEM SOC, V111, P1599, DOI 10.1021/ja00187a011; Kennedy JF, 1983, BIOACTIVE CARBOHYDRA; Lehninger A. L., 1982, PRINCIPLES BIOCH; Maillard LC, 1912, CR HEBD ACAD SCI, V154, P66; NOLTMANN EA, 1970, ENZYMES, V3, P271; ROOT RL, 1985, J AM CHEM SOC, V107, P2997, DOI 10.1021/ja00296a041; SACCONI L, 1968, TRANSIT METAL CHEM, V4, P210; TAMASE T, UNPUB INORG CHEM; TANASE T, 1993, J CHEM SOC DALTON, P2645, DOI 10.1039/dt9930002645; TANASE T, 1994, INORG CHEM, V33, P5, DOI 10.1021/ic00079a003; Wilkinson G., 1966, ADV INORGANIC CHEM; YANO S, 1993, J CHEM SOC DALTON, P1699, DOI 10.1039/dt9930001699; YANO S, 1988, COORDIN CHEM REV, V92, P113, DOI 10.1016/0010-8545(88)85007-0; YANO S, 1987, CHEM LETT, P2153, DOI 10.1246/cl.1987.2153	18	6	6	ELSEVIER SCIENCE SA LAUSANNE	LAUSANNE 1	PO BOX 564, 1001 LAUSANNE 1, SWITZERLAND	0020-1693			INORG CHIM ACTA	Inorg. Chim. Acta	AUG 1	1996	249	1					1	3		10.1016/0020-1693(96)05193-6		3	Chemistry, Inorganic & Nuclear	Chemistry	VA945	WOS:A1996VA94500001		
J	Kitani, S; Teshima, R; Nonomura, Y; Morita, Y; Ito, K				Kitani, S; Teshima, R; Nonomura, Y; Morita, Y; Ito, K			The effect of okadaic acid on histamine release, cell morphology and phosphorylation in rat basophilic leukemia (RBL-2H3) cells, human basophils and rat peritoneal mast cells	INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY			English	Article						okadaic acid; basophil; mast cell; phosphorylation; IgE	PROTEIN-KINASE-C; AFFINITY IGE RECEPTOR; MYOSIN LIGHT CHAIN; CALCIUM SIGNAL; 2H3 CELLS; PHOSPHATASES; SECRETION; INHIBITORS; STIMULATION; ENHANCEMENT	To study the involvement of serine/threonine phosphatase in the signal transduction of mast cells, we examined the effects of okadaic acid (OA), an inhibitor of type-1 and -2A phosphatase on histamine release, cell morphology, calcium influx and protein phosphorylation of rat basophilic leukemia (RBL-2H3) cells, human basophils and rat peritoneal mast cells. OA inhibited IgE-mediated histamine release from RBL-2H3 cells and human basophils dose-dependently. There was a remarkable enhancement of IgE-mediated histamine release when rat peritoneal mast cells were suboptimally challenged. OA induced a marked change of cell features, detached RBL-2H3 cells from plastic well and kept the 18- and 68-kD proteins phosphorlyated. These findings show that phosphatase may play a role in the modulation of secretion in mast cells.	UNIV TOKYO,SCH MED,DEPT INTERNAL MED & PHYS THERAPY,TOKYO 113,JAPAN; UNIV TOKYO,SCH MED,DEPT PHARMACOL 1,TOKYO 113,JAPAN; NATL INST HYG SCI,DIV BIOCHEM & IMMUNOCHEM,TOKYO 158,JAPAN			Kitani, Seiichi/O-1848-2014				DUNNETT CW, 1980, J AM STAT ASSOC, V75, P789, DOI 10.2307/2287160; COHEN P, 1989, J BIOL CHEM, V264, P21435; BEAVEN MA, 1984, J BIOL CHEM, V259, P7129; KITANI S, 1991, J BIOL CHEM, V266, P1903; METZGER H, 1986, ANNU REV IMMUNOL, V4, P419, DOI 10.1146/annurev.immunol.4.1.419; BASCIANO LK, 1986, J BIOL CHEM, V261, P1823; BEAVEN MA, 1988, PROG ALLERGY, V42, P123; BEAVEN MA, 1984, J BIOL CHEM, V259, P7137; BENHAMOU M, 1990, P NATL ACAD SCI USA, V87, P5327, DOI 10.1073/pnas.87.14.5327; BIALOJAN C, 1988, BIOCHEM J, V256, P283; BOTANA LM, 1993, BIOCHEM PHARMACOL, V45, P2311, DOI 10.1016/0006-2952(93)90204-A; COHEN P, 1990, TRENDS BIOCHEM SCI, V15, P98, DOI 10.1016/0968-0004(90)90192-E; DING JB, 1992, J BIOL CHEM, V267, P6442; ENERBACK L, 1980, J IMMUNOL METHODS, V39, P135, DOI 10.1016/0022-1759(80)90302-6; ESTEVEZ MD, 1994, BIOCHEM PHARMACOL, V47, P591, DOI 10.1016/0006-2952(94)90194-5; GARCIAGIL M, 1986, J IMMUNOL, V136, P3825; GOTH A, 1971, SCIENCE, V173, P1034, DOI 10.1126/science.173.4001.1034; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HEDMAN H, 1992, J IMMUNOL, V149, P2295; HIGASHIHARA M, 1992, FEBS LETT, V307, P206, DOI 10.1016/0014-5793(92)80768-C; KARAKI H, 1989, BRIT J PHARMACOL, V98, P590; KITANI S, 1988, J IMMUNOL, V140, P2585; KITANI S, 1992, BIOCHEM BIOPH RES CO, V183, P48, DOI 10.1016/0006-291X(92)91607-R; LIN PY, 1991, J IMMUNOL, V146, P1609; LUDOWYKE RI, 1989, J BIOL CHEM, V264, P12492; MACKINTOSH C, 1989, BIOCHEM J, V262, P335; MIRON S, 1992, CELL IMMUNOL, V144, P182, DOI 10.1016/0008-8749(92)90235-H; MORITA Y, 1988, ALLERGY, V43, P100, DOI 10.1111/j.1398-9995.1988.tb00401.x; MORITA Y, 1981, J IMMUNOL, V127, P1339; PEACHELL PT, 1993, J IMMUNOL, V151, P3808; SAKAMOTO N, 1994, BIOCHIM BIOPHYS ACTA, V121, P291; SIEGHART W, 1978, NATURE, V275, P329, DOI 10.1038/275329a0; Siraganian RP, 1986, MANUAL CLIN LAB IMMU, P675; SIRAGANI.RP, 1974, ANAL BIOCHEM, V57, P383, DOI 10.1016/0003-2697(74)90093-1; SULLIVAN TJ, 1975, J IMMUNOL, V115, P278; TAFFS RE, 1991, J IMMUNOL, V147, P722; TAKEI M, 1993, J PHARM PHARMACOL, V45, P750; TESHIMA R, 1989, MOL IMMUNOL, V26, P641; TESHIMA R, 1991, CHEM PHARM BULL, V39, P747; THEOHARIDES TC, 1980, SCIENCE, V207, P80, DOI 10.1126/science.6153130	40	11	11	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1018-2438			INT ARCH ALLERGY IMM	Int. Arch. Allergy Immunol.	AUG	1996	110	4					339	347				9	Allergy; Immunology	Allergy; Immunology	UZ722	WOS:A1996UZ72200007		
J	Kuwahara, K; Kawai, T; Mitsuyoshi, S; Matsuo, Y; Kikuchi, H; ImajohOhmi, S; Hashimoto, E; Inui, S; Cooper, MD; Sakaguchi, N				Kuwahara, K; Kawai, T; Mitsuyoshi, S; Matsuo, Y; Kikuchi, H; ImajohOhmi, S; Hashimoto, E; Inui, S; Cooper, MD; Sakaguchi, N			Cross-linking of B cell antigen receptor-related structure of pre-B cell lines induces tyrosine phosphorylation of p85 and p110 subunits and activation of phosphatidylinositol 3-kinase	INTERNATIONAL IMMUNOLOGY			English	Article						B cell differentiation; phosphatidylinositol 3-kinase; pre-B cell; signal transduction	SURROGATE LIGHT-CHAIN; PROTEIN-KINASE-C; LYN-DEFICIENT MICE; SIGNAL-TRANSDUCTION; MOLECULAR-CLONING; LYMPHOCYTES-B; MB-1 MOLECULE; MEMBRANE IMMUNOGLOBULIN; AUTOIMMUNE-DISEASE; PROTEOLYZED FORMS	To understand the function of a cell antigen receptor (BCR)-related complex on pre-B cells (pre-BCR, V-pre-B/lambda 5/mu heavy chain/lg-alpha/lg-beta), we examined pre-BCR- and BCR-mediated signaling events in human and mouse pre-B (Nalm-6, 697, NFS-5), immature B (IgM(+) Daudi, WEHI-231) and mature B (IgM(+)IgD(+) BALL1) cell lines, Anti-mu cross-linking induced tyrosine phosphorylation of the cytoplasmic proteins in each cell type, but did not induce a detectable Ca2+ mobilization response in pre-B cells, While the pre-B cells expressed Syk protein at levels similar to those found in a cell lines, pre-BCR cross-linkage did not induce phosphorylation of Syk tyrosine residues, Different protein kinase C isozymes were expressed by pre-B (PKC-alpha), immature B (PKC-alpha and -beta) and mature B (PKC-beta) cell lines, Anti-mu cross-linking induced PKC translocation from the cytosolic to the membrane compartment in immature and mature a cells, but did not have this effect in a pre-B cell line, Anti-mu cross-linking induced tyrosine phosphorylation of the p85 and p110 subunits of phophatidylinositol 3-kinase (Pl3-kinase) in both pre-B and a cell lines, but the pre-BCR induced Pl3-kinase activation was Syk independent, Ligation of the pre-BCR complex thus triggers a characteristic signaling pattern in pre-B cells.	KUMAMOTO UNIV,SCH MED,DEPT IMMUNOL,KUMAMOTO 860,JAPAN; TOTTORI UNIV,FAC MED,SCH LIFE SCI,DEPT PATHOL BIOCHEM,YONAGO,TOTTORI 683,JAPAN; HAYASHIBARA BIOCHEM IND INC,FUJISAKI CELL CTR,OKAYAMA 702,JAPAN; UNIV TOKYO,INST MED SCI,MINATO KU,TOKYO 108,JAPAN; TOTTORI UNIV,FAC MED,DEPT IMMUNOL,YONAGO,TOTTORI 683,JAPAN; UNIV ALABAMA,HOWARD HUGHES MED INST,DEPT MED,BIRMINGHAM,AL 35294; UNIV ALABAMA,HOWARD HUGHES MED INST,DEPT PEDIAT,BIRMINGHAM,AL 35294; UNIV ALABAMA,HOWARD HUGHES MED INST,DEPT PATHOL,BIRMINGHAM,AL 35294; UNIV ALABAMA,HOWARD HUGHES MED INST,DEPT MICROBIOL,BIRMINGHAM,AL 35294							ALT FW, 1992, IMMUNOL TODAY, V13, P306, DOI 10.1016/0167-5699(92)90043-7; HILES ID, 1992, CELL, V70, P419, DOI 10.1016/0092-8674(92)90166-A; HOMBACH J, 1990, NATURE, V343, P760, DOI 10.1038/343760a0; MELCHERS F, 1993, IMMUNOL TODAY, V14, P60, DOI 10.1016/0167-5699(93)90060-X; CHENG AM, 1995, NATURE, V378, P303, DOI 10.1038/378303a0; TANIGUCHI T, 1991, J BIOL CHEM, V266, P15790; HIBBS ML, 1995, CELL, V83, P301, DOI 10.1016/0092-8674(95)90171-X; CLARK MR, 1992, SCIENCE, V258, P123, DOI 10.1126/science.1439759; OTSU M, 1991, CELL, V65, P91, DOI 10.1016/0092-8674(91)90411-Q; NISHIZUMI H, 1995, IMMUNITY, V3, P549, DOI 10.1016/1074-7613(95)90126-4; KUDO A, 1987, EMBO J, V6, P2267; TURNER M, 1995, NATURE, V378, P298, DOI 10.1038/378298a0; SAKAGUCHI N, 1986, NATURE, V324, P579, DOI 10.1038/324579a0; TAKATA M, 1994, EMBO J, V13, P1341; DYMECKI SM, 1990, SCIENCE, V247, P332, DOI 10.1126/science.2404338; YAMANASHI Y, 1992, P NATL ACAD SCI USA, V89, P1118, DOI 10.1073/pnas.89.3.1118; AOKI Y, 1994, P NATL ACAD SCI USA, V91, P10606, DOI 10.1073/pnas.91.22.10606; AOKI Y, 1994, P NATL ACAD SCI USA, V91, P4204, DOI 10.1073/pnas.91.10.4204; BOSSY D, 1993, INT IMMUNOL, V5, P467, DOI 10.1093/intimm/5.5.467; BROUNS GS, 1993, EUR J IMMUNOL, V23, P1088, DOI 10.1002/eji.1830230517; BURKHARDT AL, 1991, P NATL ACAD SCI USA, V88, P7410, DOI 10.1073/pnas.88.16.7410; CAMPBELL KS, 1991, P NATL ACAD SCI USA, V88, P3982, DOI 10.1073/pnas.88.9.3982; CAMPBELL MA, 1992, MOL CELL BIOL, V12, P2315; CANTLEY LC, 1991, CELL, V64, P281, DOI 10.1016/0092-8674(91)90639-G; CHEN ZZ, 1986, J IMMUNOL, V136, P2300; EHLICH A, 1993, CELL, V72, P695, DOI 10.1016/0092-8674(93)90398-A; FINDLEY HW, 1982, BLOOD, V60, P1305; GOLD MR, 1994, J IMMUNOL, V153, P2369; GOLD MR, 1992, J IMMUNOL, V148, P2012; HATA A, 1994, MOL CELL BIOL, V14, P7306; HERMANSON GG, 1988, P NATL ACAD SCI USA, V85, P6890, DOI 10.1073/pnas.85.18.6890; HUTCHCROFT JE, 1992, J BIOL CHEM, V267, P8613; IGARASHI H, 1994, J IMMUNOL, V153, P2381; INUI S, 1995, J IMMUNOL, V154, P2714; KARASUYAMA H, 1994, CELL, V77, P133, DOI 10.1016/0092-8674(94)90241-0; KARASUYAMA H, 1993, J EXP MED, V178, P469, DOI 10.1084/jem.178.2.469; KIKUCHI H, 1995, BBA-MOL CELL RES, V1269, P253, DOI 10.1016/0167-4889(95)00127-3; KIKUCHI H, 1993, BIOCHIM BIOPHYS ACTA, V1162, P171, DOI 10.1016/0167-4838(93)90144-G; KITAMURA D, 1992, CELL, V69, P823, DOI 10.1016/0092-8674(92)90293-L; KUDO A, 1989, PROGR IMMUNOLOGY, V7, P339; KUWAHARA K, 1993, BIOCHEM BIOPH RES CO, V197, P1563, DOI 10.1006/bbrc.1993.2656; KUWAHARA K, 1994, J IMMUNOL, V152, P2742; LASSOUED K, 1993, CELL, V73, P73, DOI 10.1016/0092-8674(93)90161-I; LAW CL, 1994, J BIOL CHEM, V269, P12310; MATSUO T, 1993, J IMMUNOL, V150, P3766; MATSUO T, 1991, J IMMUNOL, V146, P1584; Matsuo Y, 1988, Hum Cell, V1, P263; MELCHERS F, 1989, COLD SH Q B, V54, P183; NOMURA J, 1991, INT IMMUNOL, V3, P117, DOI 10.1093/intimm/3.2.117; PLEIMAN CM, 1994, IMMUNOL TODAY, V15, P393, DOI 10.1016/0167-5699(94)90267-4; RETH MG, 1984, NATURE, V312, P418, DOI 10.1038/312418a0; SAKAGUCHI N, 1993, ADV IMMUNOL, V54, P337, DOI 10.1016/S0065-2776(08)60538-6; SAKAGUCHI N, 1988, EMBO J, V7, P3457; SAKAGUCHI N, 1986, EMBO J, V5, P2139; SAXTON TM, 1994, J IMMUNOL, V153, P623; SIDORENKO SP, 1995, P NATL ACAD SCI USA, V92, P359, DOI 10.1073/pnas.92.2.359; TAKEMORI T, 1990, EMBO J, V9, P2493; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; YAMANASHI Y, 1993, P NATL ACAD SCI USA, V90, P3631, DOI 10.1073/pnas.90.8.3631; YAMANASHI Y, 1991, SCIENCE, V251, P192, DOI 10.1126/science.1702903; YANAGI S, 1994, EUR J BIOCHEM, V224, P329, DOI 10.1111/j.1432-1033.1994.00329.x	61	25	25	OXFORD UNIV PRESS UNITED KINGDOM	OXFORD	WALTON ST JOURNALS DEPT, OXFORD, ENGLAND OX2 6DP	0953-8178			INT IMMUNOL	Int. Immunol.	AUG	1996	8	8					1273	1285		10.1093/intimm/8.8.1273		13	Immunology	Immunology	VE109	WOS:A1996VE10900011		
J	Tamiya, N; Araki, S; Kobayashi, Y; Yamashita, K; Murata, K; Yano, E				Tamiya, N; Araki, S; Kobayashi, Y; Yamashita, K; Murata, K; Yano, E			Gender difference in the utilization and users' characteristics of community rehabilitation programs for cerebrovascular disease patients in Japan	INTERNATIONAL JOURNAL FOR QUALITY IN HEALTH CARE			English	Article							SOCIAL SUPPORTS; SEX; WOMEN; CARE; MEN; OLD	The purpose of this study was to see whether there was gender difference in the utilization of a community rehabilitation program for cerebrovascular disease (CVD) patients in Japan and to examine factors affecting this gender difference. For CVD patients who participated in 16 community rehabilitation programs in the Saitama prefecture (n = 190), we studied their clinical and functional status, socioeconomic conditions, the degree of family support, and their use of rehabilitation and transportation services. The general characteristics of the programs and the type of transportation services they offered were also surveyed, The female proportion of all the program participants was 34.2% and its proportion tended to be smaller when their ADL level was worse, However, such difference by gender lessened after the participants were stratified by the type of transportation services and by such conditions as being accompanied by a family member during transportation. Copyright (C) 1996 Elsevier Science Ltd.	UNIV TOKYO,DEPT PUBL HLTH,TOKYO,JAPAN; UNIV TSUKUBA,INST COMMUNITY MED,IBARAKI,OSAKA,JAPAN	Tamiya, N (reprint author), TEIKYO UNIV,SCH MED,DEPT PUBL HLTH,2-11-1 KAGA ITABASHI,TOKYO 173,JAPAN.						BAROLSKY SM, 1979, CIRCULATION, V60, P1021; LIANG J, 1983, J GERONTOL, V38, P181; LAWTON MP, 1969, GERONTOLOGIST, V9, P179; KATZ S, 1970, GERONTOLOGIST, V10, P20; ARLING G, 1987, J GERONTOL, V42, P107; *BUR CENS, 1993, HISPANIC AM TODAY, P6; *BUR HLTH SOCIAL W, 1990, NETAKILI ZERO WO MEZ, P10; *BUR PUBL HLTH, 1990, ROUJ HOK HOU NI YOR, P56; *BUR SOC WELF, 1987, SHAK FUK KIS CHOS, P115; Hasegawa K, 1974, SEISHIN IGAKU, V16, P965; *HLTH WELF STAT AS, 1993, KOKUMIN FUKUSHI NO D; *HLTH WELF STAT AS, 1995, KOK EIS NO DOK, P38; *HLTH WELF STAT AS, 1994, KOK EIS NO DOK, P124; Irizarry A, 1988, P R Health Sci J, V7, P215; Kai I, 1991, Asia Pac J Public Health, V5, P221; KOBAYASHI Y, 1993, SOC SCI MED, V3, P343; KOHEN JA, 1983, GERONTOLOGIST, V23, P57; MARCUS AC, 1982, J HEALTH SOC BEHAV, V23, P186, DOI 10.2307/2136628; SAFRAN DG, 1994, HEALTH SERV RES, V28, P729; Schuster P M, 1991, Rehabil Nurs, V16, P248; *STAT INF DEP MIN, 1990, VIT STAT TOK; *STAT INF DEP MIN, 1990, PAT SURV, V2; VERBRUGGE LM, 1981, MED CARE, V19, P609, DOI 10.1097/00005650-198106000-00005	23	3	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB	1353-4505			INT J QUAL HEALTH C	Int. J. Qual. Health Care	AUG	1996	8	4					359	366		10.1093/intqhc/8.4.359		8	Health Care Sciences & Services; Health Policy & Services	Health Care Sciences & Services	VV055	WOS:A1996VV05500006		
J	Nakamura, Y; Kawai, C; Moss, AJ; Raubertas, RF; Brown, MW; Kinoshita, M; Sasayama, S; Nonogi, H; Omae, T; Tamaki, S; Fujita, M; Tanaka, N; Hosoda, S; Inoue, H; Sugimoto, T; Iinuma, H; Kato, K; Tamaki, N; Sugiura, N				Nakamura, Y; Kawai, C; Moss, AJ; Raubertas, RF; Brown, MW; Kinoshita, M; Sasayama, S; Nonogi, H; Omae, T; Tamaki, S; Fujita, M; Tanaka, N; Hosoda, S; Inoue, H; Sugimoto, T; Iinuma, H; Kato, K; Tamaki, N; Sugiura, N			Comparison between Japan and North America in the post-hospital course after recovery from an acute coronary event	INTERNATIONAL JOURNAL OF CARDIOLOGY			English	Article						ischemic heart disease; Japan; North America; cox analysis	ISCHEMIC-HEART-DISEASE; MORTALITY; DECLINE	We compared the post-hospital prognosis after an acute coronary event (acute myocardial infarction and unstable angina) in 106 patients in Japan vs. 789 patients in North America who were prospectively enrolled in the Multicenter Study of Myocardial Ischemia and were followed-up for an average of 26 months per patients. Risk factors more frequent in Japan were older age, males and smoking at enrolment, but the rest of many risk factors were similar. After adjusting for differences in clinical and medication variables, Cox analyses indicated patients in North America had a significantly greater risk of experiencing a primary end-point (cardiac death, non-fatal myocardial infarction or unstable angina) than patients in Japan (hazard ratio [North America:Japan] = 3.1, P = 0.003). There was a non-significant trend in the restricted end-points (cardiac death or non-fatal myocardial infarction) with North America having more frequent events than Japan (hazard ratio = 2.2, P = 0.12). The long-term outcome after recovery from an acute coronary event is more favorable in Japan than in North America, mostly due to a reduction in subsequent hospitalization for unstable angina. The reason for these findings cannot be explained by differences in the measured risk factors or medications.	KYOTO UNIV,FAC MED,DEPT INTERNAL MED,DIV 3,KYOTO,JAPAN; KYOTO UNIV,FAC MED,DEPT NUCL MED,KYOTO,JAPAN; UNIV ROCHESTER,MED CTR,ROCHESTER,NY 14642; TOYAMA MED & PHARMACEUT UNIV,DEPT INTERNAL MED 2,TOYAMA,JAPAN; NATL CARDIOVASC CTR,SUITA,OSAKA 565,JAPAN; TAKEDA HOSP,TAKEDA,JAPAN; TOKYO WOMENS MED COLL,DEPT CARIOL,TOKYO 162,JAPAN; UNIV TOKYO,SCH MED,DEPT MED 2,TOKYO,JAPAN; CARDIOVASC INST,TOKYO,JAPAN; MULTICTR MYOCARDIAL ISCHEMIA RES GRP,TOKYO,JAPAN	Nakamura, Y (reprint author), SHIGA UNIV MED SCI,DEPT INTERNAL MED 1,OTSU,SHIGA 52021,JAPAN.		Hiroshi, Nonogi/D-8345-2011				COX DR, 1972, J R STAT SOC B, V34, P187; CALIFF RM, 1985, J AM COLL CARDIOL, V5, P1055; GOLDMAN L, 1984, ANN INTERN MED, V101, P825; GORE I, 1962, AM J CARDIOL, V10, P400, DOI 10.1016/0002-9149(62)90328-4; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KEYS A., 1970, Circulation, V41, P186; MOSS AJ, 1993, JAMA-J AM MED ASSOC, V269, P2379, DOI 10.1001/jama.269.18.2379; SAITO M, 1987, AM HEART J, V113, P891, DOI 10.1016/0002-8703(87)90049-4; *SAS STAT SOFTW, 1991, P217 SAS STAT SOFTW; SIMONS LA, 1986, AM J CARDIOL, V57, pG5, DOI 10.1016/0002-9149(86)90659-4; STERN MP, 1979, ANN INTERN MED, V91, P630; UEMURA K, 1988, World Health Statistics Quarterly, V41, P155; 1988, NEW ENGL J MED, V319, P385	13	13	13	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	0167-5273			INT J CARDIOL	Int. J. Cardiol.	AUG	1996	55	3					245	254		10.1016/0167-5273(96)02701-5		10	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	VG243	WOS:A1996VG24300004		
J	Hashimoto, Y; Tanaka, M; Hata, A; Kakuta, T; Maruyama, Y; Numano, F				Hashimoto, Y; Tanaka, M; Hata, A; Kakuta, T; Maruyama, Y; Numano, F			Four years follow-up study in patients with Takayasu arteritis and severe aortic regurgitation; Assessment by echocardiography	INTERNATIONAL JOURNAL OF CARDIOLOGY			English	Article; Proceedings Paper	International Conference on Takayasu Arteritis	OCT 12-13, 1995	SINGAPORE, SINGAPORE	Japanese Minist Educ Sports & Culture, Int Sci Res Program		Takayasu arteritis; aortic regurgitation; follow-up; echocardiography; left ventricular hypertrophy	DISEASE	We prospectively performed the follow-up study in 11 female patients with Takayasu arteritis and severe aortic regurgitation by echocardiography. A mean follow-up period was 4 years. The inflammatory state was controlled in all patients. Antihypertensive agents including beta-blocker were administered in nine patients. Heart failure did not progress in all patients except one. No candidate for cardiac surgery appeared during the follow-up period, Aortic root diameter, left atrial, left ventricular end-diastolic and end-systolic dimensions, wall thickness, left ventricular mass, and percent fractional shortening of the left ventricle showed no significant change in echocardiography. These data indicate that left ventricular disturbance might be slowly progressive in patients with Takayasu arteritis and severe aortic regurgitation. Systemic hypertension and the inflammatory state should be well controlled in managing the patients, beta-blocker might be useful in some patients with Takayasu arteritis and severe aortic regurgitation. Further follow-up is necessary for the decision of the cardiac surgical indication.		Hashimoto, Y (reprint author), UNIV TOKYO,SCH MED,DEPT INTERNAL MED 3,BUNKYO KU,1-5-45 YUSHIMA,TOKYO 113,JAPAN.						*AM SOC ECH COMM S, 1989, J AM SOC ECHOCARDIOG, V2, P358; SUBRAMANYAN R, 1989, CIRCULATION, V80, P429; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; PERRY GJ, 1987, J AM COLL CARDIOL, V9, P952; FRANZ IW, 1981, J HYPERTENS       S4, V5, pS415; HASHIMOTO Y, 1991, AM J CARDIOL, V67, P879, DOI 10.1016/0002-9149(91)90623-S; HASHIMOTO Y, 1992, CARDIOLOGY, V80, P180, DOI 10.1159/000175001; ISHIKAWA K, 1981, AM J CARDIOL, V47, P1026, DOI 10.1016/0002-9149(81)90208-3; MOROOKA S, 1984, AM J CARDIOL, V53, P859, DOI 10.1016/0002-9149(84)90420-X; RAHKO PS, 1989, ANN INTERN MED, V111, P466; SUZUKI A, 1989, CIRCULATION S1, V80, P122; WHITE WB, 1989, AM HEART J, V117, P145, DOI 10.1016/0002-8703(89)90669-8	12	7	7	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	0167-5273			INT J CARDIOL	Int. J. Cardiol.	AUG	1996	54			S			S173	S176				4	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	WV415	WOS:A1996WV41500020		
J	Ariizumi, T; Komazaki, S; Asashima, M; Malacinski, GM				Ariizumi, T; Komazaki, S; Asashima, M; Malacinski, GM			Activin treated urodele ectoderm: A model experimental system for cardiogenesis	INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY			English	Article						urodele heart induction; activin-treated heart; amphibian heart culture; urodele cardiogenesis; newt heart development	ERYTHROID-DIFFERENTIATION FACTOR; XENOPUS-LAEVIS; CYNOPS-PYRRHOGASTER; IN-VITRO; INDUCTION; NEWT; GASTRULA; MESODERM; ENDODERM; EXPLANTS	The tissue interactions which comprise the inductive phenomena associated with urodele heart morphogenesis are relatively well understood. In order to take full advantage of the experimental potential of this system formulation of an in vitro tissue culture system would be very helpful. Herein are described conditions for culturing Cynops pyrrhogaster early gastrula ectoderm tissue in the presence of the peptide growth factor activin. Two-week old explant cultures frequently displayed beating heart-like rudiments within. The beating frequency was measured and the extent to which cytodifferentiation mimicked normal heart differentiation assessed. Both measurements provided optimistic assessments which should encourage further exploitation of this model system.	UNIV TOKYO,DEPT BIOL,TOKYO 153,JAPAN; SAITAMA MED SCH,DEPT ANAT 2,MOROYAMA,SAITAMA 35004,JAPAN; INDIANA UNIV,DEPT BIOL,BLOOMINGTON,IN 47401							Neff AW, 1996, INT J DEV BIOL, V40, P719; MURATA M, 1988, P NATL ACAD SCI USA, V85, P2434, DOI 10.1073/pnas.85.8.2434; SUGI Y, 1995, DEV BIOL, V168, P567, DOI 10.1006/dbio.1995.1102; ARIIZUMI T, 1995, ROUX ARCH DEV BIOL, V204, P427, DOI 10.1007/BF00360850; ARIIZUMI T, 1991, International Journal of Developmental Biology, V35, P407; ARIIZUMI T, 1994, DEV GROWTH DIFFER, V36, P499; ASASHIMA M, 1994, DEV GROWTH DIFFER, V36, P343; ASASHIMA M, 1991, P NATL ACAD SCI USA, V88, P6511, DOI 10.1073/pnas.88.15.6511; ASASHIMA M, 1990, ROUX ARCH DEV BIOL, V198, P330, DOI 10.1007/BF00383771; BODMER R, 1995, TRENDS CARDIOVAS MED, V5, P21, DOI 10.1016/1050-1738(94)00032-Q; COX WG, 1985, DIFFERENTIATION, V58, P269; HAMA T, 1985, DEV GROWTH DIFFER, V27, P419; JACOBSON AG, 1988, DEVELOPMENT, V104, P341; LOGAN M, 1993, DEVELOPMENT, V118, P865; MUSLIN AJ, 1991, DEVELOPMENT, V112, P1095; Okada YK, 1947, JPN J EXP MORPHOL, V3, P1; STANIER DYR, 1994, TRENDS CARDIOVAS MED, V4, P207; TAGUCHI M, 1989, CELL DIFFER DEV, V27, P95, DOI 10.1016/0922-3371(89)90739-9; UEHARA M, 1989, J MOL CELL CARDIOL, V21, P709, DOI 10.1016/0022-2828(89)90612-3	19	24	24	UNIV BASQUE COUNTRY PRESS	BILBAO	POST BOX 1397, E-48080 BILBAO, SPAIN	0214-6282			INT J DEV BIOL	Int. J. Dev. Biol.	AUG	1996	40	4					715	718				4	Developmental Biology	Developmental Biology	VE441	WOS:A1996VE44100014		
J	Kobayashi, Y; Uehara, S; Inamori, K; Shirato, R; Ozawa, K; Sklar, J; Asano, S				Kobayashi, Y; Uehara, S; Inamori, K; Shirato, R; Ozawa, K; Sklar, J; Asano, S			Hemophagocytosis as a para-neoplastic syndrome in NK cell leukemia	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						NK cell leukemia; LGL leukemia; interferon-gamma; hemophagocytic syndrome	EPSTEIN-BARR-VIRUS; ACUTE LYMPHOBLASTIC-LEUKEMIA; LARGE GRANULAR LYMPHOCYTES; BLOOD MONONUCLEAR-CELLS; NATURAL-KILLER-CELLS; MALIGNANT HISTIOCYTOSIS; CLONAL ANALYSIS; VIRAL-DNA; LYMPHOMA; CYTOKINES	Hemophagocytic syndrome is a proliferative disorder of an activated monocyte-macrophage system and is characterized by fever, hepato-splenomegaly and pancytopenia. The serum level of interferon-gamma in the syndrome is increased but its origin is unknown, Here we describe a case of NK cell leukemia with hemophagocytic syndrome with elevated serum level of interferon-gamma. The levels of various cytokines were monitored during the course and statistic analysis was performed, To identify the clonal component, the NK cell fraction was sorted from the mononuclear layer and was subjected to Southern blot hybridization with a probe for EB virus tandem repeats. The fraction was also stimulated with interleukin-2 and the level of interferon-gamma in the conditioned medium was measured. Levels of M-CSF and interferon-gamma were significantly correlated with the degree of clinical manifestations and laboratory data. Southern blot hybridization revealed monoclonality of an NK cell fraction. The fraction also released interferon-gamma, Since macrophage can be activated through cytokines, the hemophagocytosis might have been triggered by factor(s) released from the abnormal NK cell clone at least in this case.		Kobayashi, Y (reprint author), UNIV TOKYO,INST MED SCI,DEPT HEMATOL & ONCOL,TOKYO,JAPAN.						LOUGHRAN TP, 1993, BLOOD, V82, P1; VOGELSTEIN B, 1987, CANCER RES, V47, P4806; FALINI B, 1990, BLOOD, V75, P434; HART DNJ, 1992, BLOOD, V79, P2116; JOHNSTON RB, 1988, NEW ENGL J MED, V318, P747, DOI 10.1056/NEJM198803243181205; RAABTRAUB N, 1986, CELL, V47, P883, DOI 10.1016/0092-8674(86)90803-2; BANCROFT GJ, 1993, CURR OPIN IMMUNOL, V5, P503, DOI 10.1016/0952-7915(93)90030-V; KAWAHA K, 1989, J CLIN INVEST, V84, P51, DOI 10.1172/JCI114168; ARAI K, 1990, ANNU REV BIOCHEM, V59, P783, DOI 10.1146/annurev.biochem.59.1.783; PACE JL, 1983, J IMMUNOL, V130, P2011; GRUSS HJ, 1995, BLOOD, V85, P3378; CLEARY ML, 1988, BLOOD, V72, P349; DEMETRI GD, 1989, BLOOD, V74, P940; FAVARA BE, 1991, SEMIN ONCOL, V18, P3; FUJIWARA F, 1993, AM J PEDIAT HEMATOL, V15, P92; GIFFORD GE, 1987, J NATL CANCER I, V78, P121; HSU SM, 1993, HUM PATHOL, V24, P1040, DOI 10.1016/0046-8177(93)90183-H; IMASHUKU S, 1991, BRIT J HAEMATOL, V79, P132, DOI 10.1111/j.1365-2141.1991.tb08029.x; JAFFE ES, 1983, AM J MED, V75, P741, DOI 10.1016/0002-9343(83)90402-3; KAYE PM, 1992, INFECT IMMUN, V60, P4335; KITA M, 1992, MICROBIOL IMMUNOL, V36, P507; LANIER LL, 1992, IMMUNOL TODAY, V13, P392, DOI 10.1016/0167-5699(92)90087-N; LEVINE EG, 1991, SEMIN ONCOL, V18, P39; LIANG DC, 1986, CANCER, V58, P1289, DOI 10.1002/1097-0142(19860915)58:6<1289::AID-CNCR2820580619>3.0.CO;2-H; LOUGHRAN TP, 1993, BLOOD, V81, P2723; MANOHARAN A, 1981, SCAND J HAEMATOL, V26, P5; MENDELSOHN J, 1991, HARRISONS PRINCIPLES, P1576; METCALF D, 1986, BLOOD, V67, P257; MYERS TJ, 1988, ANN INTERN MED, V109, P504; OHNO T, 1988, CANCER, V62, P1918, DOI 10.1002/1097-0142(19881101)62:9<1918::AID-CNCR2820620909>3.0.CO;2-8; OKUDA T, 1991, AM J HEMATOL, V38, P321, DOI 10.1002/ajh.2830380412; OSHIMI K, 1985, J EXP MED, V162, P472, DOI 10.1084/jem.162.2.472; OSHIMI K, 1993, LEUKEMIA, V7, P782; SHERIDAN W, 1988, BLOOD, V72, P1701; SHIOHARA M, 1993, JPN J CLIN HEMATOL, V34, P1573; SONE S, 1991, CHEST, V99, P377, DOI 10.1378/chest.99.2.377; TAKASAKI N, 1987, CANCER, V59, P424, DOI 10.1002/1097-0142(19870201)59:3<424::AID-CNCR2820590312>3.0.CO;2-J; VALLENGA E, 1988, BLOOD, V71, P1529	38	15	16	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	0925-5710			INT J HEMATOL	Int. J. Hematol.	AUG	1996	64	2					135	142				8	Hematology	Hematology	VG226	WOS:A1996VG22600008		
J	Matsuno, Y; Tsutsumi, A; Yoshida, K				Matsuno, Y; Tsutsumi, A; Yoshida, K			Electrode performance of fixed and fluidized bed electrodes for a molten carbonate fuel cell anode	INTERNATIONAL JOURNAL OF HYDROGEN ENERGY			English	Article								The electrode performance of molten carbonate fuel cell (MCFC) anodes using three-dimensional electrodes has been studied to validate the potential of such electrodes for MCFC systems. Polarization characteristics of three-dimensional electrodes have been investigated experimentally in a half cell of 42 mm i.d. and 500 mm height with an air/CO2/gold reference electrode at 923 K. In the fixed-bed electrode, polarization consisted of mainly diffusion polarization. In the fluidized-bed electrode, there was less diffusion polarization by virtue of the high mass-transfer rate. A one-dimensional model was used to analyze the effective resistance of the particle phase, rho(m), in the three-dimensional electrodes. The effective resistance of the particle phase in the fluidized-bed electrode was found to be three to four times larger than that of the fixed-bed electrode. It was found that the electrode performance of three-dimensional electrodes was competitive with that of porous gas diffusion electrodes. Copyright (C) 1996 International Association for Hydrogen Energy.		Matsuno, Y (reprint author), UNIV TOKYO,DEPT CHEM SYST ENGN,BUNKYO KU,TOKYO 113,JAPAN.		Tsutsumi, Atsushi/K-8988-2012	Tsutsumi, Atsushi/0000-0001-9679-4383			NEWMAN JS, 1962, J ELECTROCHEM SOC, V109, P1183, DOI 10.1149/1.2425269; Appleby A. J., 1989, FUEL CELL HDB; BERENT T, 1971, J APPL CHEM BIOTECHN, V21, P71; DELARUE RE, 1959, J ELECTROCHEM SOC, V106, P827; Fan L.S., 1989, GAS LIQUID SOLID FLU; FLEISCHM.M, 1971, J ELECTROANAL CHEM, V29, P211, DOI 10.1016/0368-1874(71)85073-6; KUSAKABE K, 1981, J CHEM ENG JPN, V14, P208, DOI 10.1252/jcej.14.208; LEONARD G, 1965, I EC FUNDAM, V4, P321; LU SH, 1984, J ELECTROCHEM SOC, V131, P2827, DOI 10.1149/1.2115427; Maru H.C., 1984, MOLTEN SALT TECHNIQU, V2; MATSUNO Y, 1995, INT J HYDROGEN ENERG, V20, P601, DOI 10.1016/0360-3199(94)00104-8; OHSHIMA S, 1977, KAGAKUKOUGAKU RONBUN, V3, P406; PLOMP L, 1994, FUEL CELL SEMINAR PR, P164; SELMAN JR, 1983, ADV MOLTEN SALT CHEM, V4, P159; TANAKA H, 1971, J ELECTROANAL CHEM, V137, P2798; TSUTSUMI A, 1991, AICHE 1991 ANN M LOS, pE104; VOGEL WM, 1977, J ELECTROCHEM SOC, V124, P1305, DOI 10.1149/1.2133588; YUH CY, 1980, J ELECTROCHEM SOC, V139, P1373	18	4	5	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB	0360-3199			INT J HYDROGEN ENERG	Int. J. Hydrog. Energy	AUG	1996	21	8					663	671		10.1016/0360-3199(95)00127-1		9	Chemistry, Physical; Electrochemistry; Energy & Fuels	Chemistry; Electrochemistry; Energy & Fuels	UX973	WOS:A1996UX97300004		
J	Wang, FG; Kawashima, N; Suzuki, M				Wang, FG; Kawashima, N; Suzuki, M			Nonequilibrium relaxation of the 3D +/-J EA model	INTERNATIONAL JOURNAL OF MODERN PHYSICS C-PHYSICS AND COMPUTERS			English	Article						+/-J spin glasses; auto and replica correlation functions; damage spreading	ISING SPIN-GLASSES; DYNAMICAL PHASE-TRANSITIONS; CRITICAL EXPONENTS; DAMAGE; FERROMAGNET; DIMENSIONS; BEHAVIOR	By studying correlation functions of two replicas with the damage spreading method, the spin glass transition temperature of the 3D +/- J EA model is evaluated by using Campbell's criterion D(T-g, t --> infinity) = 1/2 or q(d)(AB)(T-g,t --> infinity) = 0, where D and q(d)(AB) are the Hamming distance and the overlap of the two replicas, respectively. The two replicas evolve with the same series of the random numbers and with initial spin-configurations related to each other by S-i(A)(t = 0) = -S-i(B)(t = 0) (for all i). From our simulational data for system sizes up to L = 64, the spin glass transition temperature is estimated as T-g = 1.18 +/- 0.06. The replica simulational method and the damage spreading method are compared with each other. The relaxation exponents of the magnetization and the correlation functions are also estimated in the vicinity of T-g on a large lattice and the dynamical critical exponent z is estimated as z similar or equal to 6.0.	SHANGHAI JIAO TONG UNIV,DEPT APPL PHYS,SHANGHAI 200030,PEOPLES R CHINA	Wang, FG (reprint author), UNIV TOKYO,DEPT PHYS,TOKYO 113,JAPAN.						ANDREICHENKO VB, 1992, J PHYS A-MATH GEN, V25, pL283, DOI 10.1088/0305-4470/25/6/003; EDWARDS SF, 1975, J PHYS F MET PHYS, V5, P965, DOI 10.1088/0305-4608/5/5/017; DERRIDA B, 1989, PHYS REP, V184, P207, DOI 10.1016/0370-1573(89)90039-2; JANSSEN HK, 1989, Z PHYS B CON MAT, V73, P539, DOI 10.1007/BF01319383; OGIELSKI AT, 1985, PHYS REV B, V32, P7384, DOI 10.1103/PhysRevB.32.7384; BINDER K, 1986, REV MOD PHYS, V58, P801, DOI 10.1103/RevModPhys.58.801; CAMPBELL IA, 1994, PHYS REV LETT, V72, P1291, DOI 10.1103/PhysRevLett.72.1291; GRASSBERGER P, 1995, PHYSICA A, V214, P547, DOI 10.1016/0378-4371(94)00285-2; SUZUKI M, 1977, PROG THEOR PHYS, V58, P1151, DOI 10.1143/PTP.58.1151; DERRIDA B, 1987, EUROPHYS LETT, V4, P657, DOI 10.1209/0295-5075/4/6/004; BHATT RN, 1985, PHYS REV LETT, V54, P924, DOI 10.1103/PhysRevLett.54.924; BHATT RN, 1988, PHYS REV B, V37, P5606, DOI 10.1103/PhysRevB.37.5606; BHATT RN, 1992, EUROPHYS LETT, V20, P59, DOI 10.1209/0295-5075/20/1/011; BLUNDELL RE, 1992, J PHYS A-MATH GEN, V25, pL733, DOI 10.1088/0305-4470/25/12/005; BRAY AJ, 1988, PHYS REV LETT, V60, P720, DOI 10.1103/PhysRevLett.60.720; CAMPBELL IA, 1993, EUROPHYS LETT, V21, P959, DOI 10.1209/0295-5075/21/9/014; CAMPBELL IA, 1991, PHYSICA A, V178, P29, DOI 10.1016/0378-4371(91)90073-L; CAMPBELL IA, 1990, EUROPHYS LETT, V13, P587, DOI 10.1209/0295-5075/13/7/003; CHIKYU T, PREPRINT; CXERNER P, UNPUB PHYS REV B; DEALMEIDA RMC, 1995, J PHYS I, V5, P355, DOI 10.1051/jp1:1995106; Grassberger P, 1996, INT J MOD PHYS C, V7, P89, DOI 10.1142/S0129183196000090; HERRMANN HJ, 1992, MONTE CARLO METHOD C, P93; HUSE DA, 1989, PHYS REV B, V40, P304, DOI 10.1103/PhysRevB.40.304; ITO N, 1993, PHYSICA A, V192, P604, DOI 10.1016/0378-4371(93)90111-G; ITO N, 1993, PHYSICA A, V196, P591, DOI 10.1016/0378-4371(93)90036-4; Jan N., 1994, ANN REV COMPUTATIONA, P1; JAN N, 1994, J STAT PHYS, V75, P1197, DOI 10.1007/BF02186765; Kawashima N, 1996, PHYS REV B, V53, pR484, DOI 10.1103/PhysRevB.53.R484; LI ZB, 1995, PHYS REV LETT, V74, P3396, DOI 10.1103/PhysRevLett.74.3396; Linke A, 1995, PHYSICA A, V222, P205, DOI 10.1016/0378-4371(95)00343-6; MARINARI E, 1994, J PHYS A-MATH GEN, V27, P2687, DOI 10.1088/0305-4470/27/8/008; NEUMANN AU, 1988, J PHYS-PARIS, V49, P1647, DOI 10.1051/jphys:0198800490100164700; OGIELSKI AT, 1985, PHYS REV LETT, V54, P928, DOI 10.1103/PhysRevLett.54.928; Rieger H., 1995, ANN REV COMPUTATIONA, P295; STAUFFER D, 1992, PHYSICA A, V186, P197, DOI 10.1016/0378-4371(92)90375-Z; SUZUKI M, 1977, PROG THEOR PHYS, V58, P1142, DOI 10.1143/PTP.58.1142; WANG FG, 1995, J PHYS A-MATH GEN, V28, P4543, DOI 10.1088/0305-4470/28/16/012; Wang F, 1996, EUROPHYS LETT, V33, P165, DOI 10.1209/epl/i1996-00316-7; Wang FG, 1996, PHYSICA A, V223, P34, DOI 10.1016/0378-4371(95)00344-4; WANG FG, 1995, PHYSICA A, V220, P534, DOI 10.1016/0378-4371(95)00263-7	41	2	2	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	JOURNAL DEPT PO BOX 128 FARRER ROAD, SINGAPORE 9128, SINGAPORE	0129-1831			INT J MOD PHYS C	Int. J. Mod. Phys. C-Phys. Comput.	AUG	1996	7	4					573	594		10.1142/S012918319600048X		22	Computer Science, Interdisciplinary Applications; Physics, Mathematical	Computer Science; Physics	VD311	WOS:A1996VD31100007		
J	Sasaki, T; Kaga, K; Ohira, Y; Ogawa, Y; Fukushima, Y				Sasaki, T; Kaga, K; Ohira, Y; Ogawa, Y; Fukushima, Y			Temporal bone and brain stem histopathological findings in Cornelia de Lange syndrome	INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY			English	Article						Cornelia de Lange syndrome; temporal bone pathology; brain stem pathology		The temporal bone and the brain stem of an infant with Cornelia de Lange syndrome, aged 9 months, were studied histopathologically. Abnormalities in the inner ear included short cochlea, dilated vestibule, and mesenchyme-filled perilymphatic spaces of the vestibule and semicircular canals. The inner and outer hair cells were normal. Many spiral ganglion cells, which normally would be located in the canal of Rosenthal, were seen in the internal auditory meatus. Some of the vestibular ganglion cells intruded into the facial nerve. The facial nerve formed a loose curve and the geniculum was difficult to recognize. The middle ear was filled with mesenchyme, and there was marked dehiscence of the facial canal. The brain stem, particularly the pens, was smaller than normal, while the fourth ventricle was dilated. The microscopic observation of the pens revealed weak staining with Luxol Fast Blue and decreased number of oligodendroglia. These findings suggested the malformation of the myelin of transverse fibers.	TEIKYO UNIV,DEPT OTOLARYNGOL,ITABASHI KU,TOKYO 173,JAPAN; CHILDRENS MED CTR,DIV PATHOL,IWATSUKI,SAITAMA 339,JAPAN; SHINSHU UNIV,DEPT HYG & MED GENET,MATSUMOTO,NAGANO 390,JAPAN	Sasaki, T (reprint author), UNIV TOKYO,DEPT OTOLARYNGOL,BUNKYO KU,7-3-1 HONGO,TOKYO 113,JAPAN.						Brachmann W, 1916, JB KINDERKEILK, V84, P224; de Lange C, 1933, ARCHIVES MEDICIN ENF, V36, P713; EGELUND EP, 1987, J LARYNGOL OTOL, V101, P1276, DOI 10.1017/S0022215100103652; FRANCE NE, 1969, ACTA PAEDIATR SCAND, V58, P470, DOI 10.1111/j.1651-2227.1969.tb04748.x; KAGA K, 1995, INT J PEDIATR OTORHI, V31, P137, DOI 10.1016/0165-5876(94)01078-C; KENNA MA, 1990, PEDIAT OTOLARYNGOLOG, P77; MARRES HAM, 1989, INT J PEDIATR OTORHI, V18, P31, DOI 10.1016/0165-5876(89)90228-0; MATSUMURA M, 1981, J OTOLARYNGOL JPN, V84, P815; YAMANOBE S, 1989, PRACT OTOL S, V32, P100	9	7	7	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	0165-5876			INT J PEDIATR OTORHI	Int. J. Pediatr. Otorhinolaryngol.	AUG	1996	36	3					195	204		10.1016/0165-5876(96)01339-0		10	Otorhinolaryngology; Pediatrics	Otorhinolaryngology; Pediatrics	VD106	WOS:A1996VD10600001		
J	Kaga, K; Ichimura, K; Kitazumi, E; Kodama, K; Tamai, F				Kaga, K; Ichimura, K; Kitazumi, E; Kodama, K; Tamai, F			Auditory brainstem responses in infants and children with anoxic brain damage due to near-suffocation or near-drowning	INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY			English	Article						auditory brainstem response; near-suffocation; near-drowning; anoxic brain damage	STEM	We studied auditory brainstem responses (ABRs) of sixteen infants and children with brain damage after anoxic accidents due to near-suffocation or near-drowning. The patients manifested cerebral palsy, mental retardation and/or epilepsy and showed poor responses in the behavioral audiometry. Auditory brainstem responses were abnormal in five of the patients in the near-drowning group (waves I, II and III only were present in three patients and the amplitudes of waves IV and V were low in two patients) but normal in most of the patients in the near-suffocation group. This difference in the ABRs between the two groups suggest that in infants and children anoxic brain damage due to near-drowning might involve not only the cerebral cortex and subcortical white matter but also the upper brainstem and midbrain.	NATL REHABIL CTR HANDICAPPED CHILDREN,TOKYO,JAPAN; HIROSHIMA PREFECTURAL COLL HLTH & WELF,HIROSHIMA,JAPAN	Kaga, K (reprint author), UNIV TOKYO,FAC MED,DEPT OTOLARYNGOL,BUNKYO KU,HONGO 7-3-1,TOKYO 113,JAPAN.						JEWETT DL, 1971, BRAIN, V94, P681, DOI 10.1093/brain/94.4.681; LEECH RW, 1977, ARCH NEUROL-CHICAGO, V34, P109; HASHIMOTO I, 1981, BRAIN, V104, P841, DOI 10.1093/brain/104.4.841; Brierley JB, 1984, GREENFIELDS NEUROPAT, P125; Buch N H, 1966, Acta Otolaryngol, V61, P387, DOI 10.3109/00016486609127075; DUBLIN WB, 1976, FUNDAMENTALS SENSORI, P190; HECOX KE, 1981, NEUROLOGY, V31, P1429; KAGA K, 1979, INT J PEDIATR OTORHI, V1, P255, DOI 10.1016/0165-5876(79)90020-X; MOLLER R, 1987, AUDITORY BRAINSTEM R, P13; MURRAY RR, 1984, AM J NEURORADIOL, V5, P177; ORLOWSKI JP, 1979, JACEP-J AM COLL EMER, V8, P176, DOI 10.1016/S0361-1124(79)80121-5; TAYLOR SB, 1985, RADIOLOGY, V156, P641	12	7	7	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	0165-5876			INT J PEDIATR OTORHI	Int. J. Pediatr. Otorhinolaryngol.	AUG	1996	36	3					231	239		10.1016/0165-5876(96)01355-9		9	Otorhinolaryngology; Pediatrics	Otorhinolaryngology; Pediatrics	VD106	WOS:A1996VD10600004		
J	Rubio, CA; Kato, Y; Hirota, T; Muto, T				Rubio, CA; Kato, Y; Hirota, T; Muto, T			Histologic classification of endoscopically removed flat colorectal polyps: A multicentric study	JAPANESE JOURNAL OF CANCER RESEARCH			English	Article						flat polyp; colon; classification; histology	LARGE-BOWEL; TUBULAR ADENOMAS; COLON; ADENOCARCINOMAS; CANCER; MUCOSA; RECTUM	A total of 594 flat colorectal polyps, removed at endoscopy, were histologically classified into non-neoplastic (n=49) and neoplastic (n=545) polyps. Non-neoplastic polyps were subdivided into metaplastic (n=45) and hyperplastic (n=4), whereas neoplastic polyps were subdivided into adenomas (n=481), intramucosal carcinomas (n=28) and invasive adenocarcinomas (n=36). Several adenoma phenotypes were discerned: tubular (n=375), serrated (n=59), villous (n=39), mixed (n=7) and fenestrated (n=1). Intramucosal carcinomas were subdivided into tubular (n=26) and serrated (n=2), and invasive adenocarcinomas into tubular (n=32), serrated (n=3) and fenestrated (n=1). The microscopic characteristics of each histologic phenotype described in this' communication are defined and illustrated.	JAPANESE FDN CANC RES,INST CANC,DEPT PATHOL,TOSHIMA KU,TOKYO 170,JAPAN; TOKYO MED COLL HOSP,DEPT PATHOL,SHINJUKU KU,TOKYO 160,JAPAN; UNIV TOKYO,DEPT SURG,BUNKYO KU,TOKYO 113,JAPAN	Rubio, CA (reprint author), KAROLINSKA INST,DEPT PATHOL,GASTROINTESTINAL PATHOL RES LAB,S-17176 STOCKHOLM,SWEDEN.						ADACHI M, 1988, DIS COLON RECTUM, V31, P236, DOI 10.1007/BF02552553; MUTO T, 1975, CANCER, V36, P2251, DOI 10.1002/cncr.2820360944; FENOGLIOPREISER CM, 1991, COLON RECTAL SURG, V2, P234; ISHIGURO T, 1992, STOMACH INTEST TOKYO, V27, P633; JACKMAN RJ, 1951, SURG GYNECOL OBSTET, V93, P327; JARAMILLO E, 1995, GASTROINTEST ENDOSC, V42, P114, DOI 10.1016/S0016-5107(95)70066-8; KUDO S, 1993, ENDOSCOPY, V25, P455, DOI 10.1055/s-2007-1010367; LYNCH HT, 1992, DIS COLON RECTUM, V35, P411, DOI 10.1007/BF02049396; MUTO T, 1985, DIS COLON RECTUM, V28, P847, DOI 10.1007/BF02555490; NATHANSON SD, 1994, DIS COLON RECTUM, V37, P527; RUBIO C, 1994, J SURG ONCOL, V56, P59, DOI 10.1002/jso.2930560114; RUBIO C, 1994, DIS COLON RECTUM, V37, P1300, DOI 10.1007/BF02257801; RUBIO CA, 1995, J CANC RES CLIN ONCO, V21, P571; Rubio C A, 1995, In Vivo, V9, P173; Rubio CA, 1996, JPN J CANCER RES, V87, P109; RUBIO CA, 1995, JPN J CANCER RES, V86, P756; Rubio C. A., 1994, Journal of Environmental Pathology Toxicology and Oncology, V13, P191; Rubio CA, 1996, IN VIVO, V10, P383; RUBIO CA, 1991, PATHOL RES PRACT, V187, P508; Rubio CA, 1996, JPN J CANCER RES, V87, P305; RUBIO CA, 1995, DIS COLON RECTUM, V38, P1075, DOI 10.1007/BF02133981; WADA R, 1992, ACTA PATHOL JAPON, V42, P579; WATANABE T, 1993, DIS COLON RECTUM, V36, P548, DOI 10.1007/BF02049860; WOLBER RA, 1991, HUM PATHOL, V22, P70, DOI 10.1016/0046-8177(91)90064-V	24	20	20	JAPANESE CANCER ASSOCIATION	TOKYO	EDITORIAL OFFICE 7TH FLOOR, JOHKOH BLDG 2-23-11, KOISHIKAWA, TOKYO 112, JAPAN	0910-5050			JPN J CANCER RES	Jpn. J. Cancer Res.	AUG	1996	87	8					849	855				7	Oncology	Oncology	VE703	WOS:A1996VE70300011		
J	Yamaguchi, A; Hisano, M				Yamaguchi, A; Hisano, M			The availability of personality traits in the hierarchical structure: An exploration of the ''basic level''	JAPANESE JOURNAL OF PSYCHOLOGY			Japanese	Article						hierarchical structure; personality traits; big five; cognitive complexity; category availability; basic level		Personality traits have a structure that is hierarchically organized in terms of trait abstractness. Which level of the hierarchy is most available to the person perceiver? We started out with Four levels, and tried to determine which was most available and therefore became the ''basic level'', as in the Rosch, Mervis, Gray, Johnson, and Boyes-Braem's natural categories (1976). Two methods were employed. First, rating of trait descriptiveness showed that information effectiveness was relatively high at the second level from the top. Second, subjects preferred the same level when they described target persons. These results suggested that a ''basic level'' indeed existed in the hierarchy of personality traits. However, social desirability of traits and who the target person was also affected the results. Implications are discussed about theories of cognitive style, especially cognitive complexity, which assume the generality of our cognitive system and have been in confusion with contradictory findings.		Yamaguchi, A (reprint author), UNIV TOKYO,FAC EDUC,DEPT EDUC PSYCHOL,BUNKYO KU,TOKYO 113,JAPAN.						ROSCH E, 1976, COGNITIVE PSYCHOL, V8, P382, DOI 10.1016/0010-0285(76)90013-X; BIERI J, 1955, J Abnorm Psychol, V51, P263, DOI 10.1037/h0043308; Crockett W H, 1965, Prog Exp Pers Res, V2, P47; HAMPSON SE, 1986, J PERS SOC PSYCHOL, V51, P37, DOI 10.1037//0022-3514.51.1.37; JOHN OP, 1991, J PERS SOC PSYCHOL, V60, P348, DOI 10.1037//0022-3514.60.3.348; Kelly G. A., 1955, PSYCHOL PERSONAL CON; LANDFIELD AW, 1977, NEBRASKA S MOTIVATIO, P133	7	0	0	JAPAN PSYCHOL ASSOC	TOKYO	2-40-14-902 HONGO BUNKYO-KU, TOKYO 113, JAPAN	0021-5236			JPN J PSYCHOL	Jpn. J. Psychol.	AUG	1996	67	3					195	203				9	Psychology; Psychology, Multidisciplinary	Psychology	VJ461	WOS:A1996VJ46100005		
J	Kurohmaru, M; Maeda, S; Suda, A; Hondo, E; Ogawa, K; Endo, H; Kimura, J; Yamada, J; Rerkamnuaychoke, W; ChungsamarnYart, N; Hayashi, Y; Nishida, T				Kurohmaru, M; Maeda, S; Suda, A; Hondo, E; Ogawa, K; Endo, H; Kimura, J; Yamada, J; Rerkamnuaychoke, W; ChungsamarnYart, N; Hayashi, Y; Nishida, T			An ultrastructural and lectin-histochemical study on the seminiferous epithelium of the common tree shrew (Tupaia glis)	JOURNAL OF ANATOMY			English	Article						mitochondria; testis	SPERMATOGENIC CELLS; SUNCUS-MURINUS; BINDING-SITES; RAT TESTIS; MUSK SHREW; EPIDIDYMIS; BELANGERI; PATTERN	The seminiferous epithelium of the common tree shrew (Tupaia glis) was investigated using transmission electron microscopy and lectin-histochemistry. It was compared with that of shrews examined in previous studies. Some peculiar structures were detected in the tree shrew spermatid at the electron microscopic level. The most characteristic feature was the disposition of mitochondria in early spermatids. In cap and early acrosome-phase spermatids, mitochondria accumulated in one area of the spermatid cytoplasm and then dispersed in the late acrosome phase. Subsequently they again clustered to form the middle piece of spermatozoa. While the lamellar structure was clearly seen in the caudal region of the spermatid nucleus, it gradually disappeared during the process of elongation. The dilated area in the postacrosomal space of early round spermatids was also characteristic. The dilation was not detected in elongated spermatids. These structures were not recognised in the seminiferous epithelium of shrews. With respect to lectin histochemistry, the binding patterns in the spermatid acrosome of the tree shrew were similar to those of the musk shrew. However, PNA and BPA, which reacted with the Sertoli cell cytoplasm of the musk shrew, showed no reaction in the tree shrew Sertoli cell. Thus, except for some lectin binding patterns in the spermatid acrosome, no close similarity was recognised in the morphology of the seminiferous epithelium between tree shrews and shrews.	OBIHIRO UNIV AGR & VET MED,DEPT VET ANAT,OBIHIRO,HOKKAIDO 080,JAPAN; MUSEUM NAT SCI,DEPT ZOOL,TOKYO,JAPAN; NIHON UNIV,DEPT ANAT & PHYSIOL,TOKYO,JAPAN; KASETSART UNIV,DEPT VET ANAT,BANGKOK,THAILAND; NIHON UNIV,DEPT VET ANAT,TOKYO,JAPAN	Kurohmaru, M (reprint author), UNIV TOKYO,FAC AGR,DEPT VET ANAT,BUNKYO KU,TOKYO 113,JAPAN.						ADACHI Y, 1992, EXP ANIM TOKYO, V41, P295; KUROHMARU M, 1991, J VET MED SCI, V53, P893; ARYA M, 1986, AM J ANAT, V175, P449, DOI 10.1002/aja.1001750405; ARYA M, 1985, J ANDROL, V6, P230; ARYA M, 1984, ANDROLOGIA, V16, P495; COLLINS PM, 1987, BIOL REPROD, V37, P261, DOI 10.1095/biolreprod37.2.261; COLLINS PM, 1987, CELL TISSUE RES, V250, P681; ENDO H, 1995, J ANAT, V187, P347; Guraya S. S., 1987, BIOL SPERMATOGENESIS; JOHNSON GD, 1981, J IMMUNOL METHODS, V43, P349, DOI 10.1016/0022-1759(81)90183-6; KUROHMARU M, 1994, J ANAT, V185, P503; KUROHMARU M, 1995, J ANAT, V187, P323; LEE MC, 1985, ANAT REC, V212, P282, DOI 10.1002/ar.1092120310; MALMI R, 1987, INT J ANDROL, V10, P157, DOI 10.1111/j.1365-2605.1987.tb00177.x; MALMI R, 1987, ANDROLOGIA, V19, P322; RATTNER JB, 1971, J ULTRA MOL STRUCT R, V36, P1, DOI 10.1016/S0022-5320(71)80084-9; RERKAMNUAYCHOKE W, 1991, J ANAT, V178, P1; RUSSELL L, 1977, TISSUE CELL, V9, P751, DOI 10.1016/0040-8166(77)90040-4; RUSSELL L, 1977, TISSUE CELL, V9, P475, DOI 10.1016/0040-8166(77)90007-6; Russell L.D., 1990, HISTOLOGICAL HISTOPA; YAMAMOTO N, 1982, ACTA HISTOCHEM CYTOC, V15, P139	21	12	12	CAMBRIDGE UNIV PRESS	NEW YORK	40 WEST 20TH STREET, NEW YORK, NY 10011-4211	0021-8782			J ANAT	J. Anat.	AUG	1996	189		1				87	95				9	Anatomy & Morphology	Anatomy & Morphology	VE664	WOS:A1996VE66400009		
J	Nakajima, T; Hayasaka, T; Higurashi, A; Hashida, G; MoharramNejad, N; Najafi, Y; Valavi, H				Nakajima, T; Hayasaka, T; Higurashi, A; Hashida, G; MoharramNejad, N; Najafi, Y; Valavi, H			Aerosol optical properties in the Iranian region obtained by ground-based solar radiation measurements in the summer of 1991	JOURNAL OF APPLIED METEOROLOGY			English	Article							KUWAIT OIL FIRES; CLIMATE RESPONSE; SMOKE; THICKNESS; WELLS; PLUME	Solar radiation measurements were made using sun photometers and pyranometers during 31 May-7 June 1991 at several places in iran and during 12 June-17 September 1991 at a fixed place, Bushehr, Iran. in the first period the aerosol optical thickness had values about 0.4 at the wavelength of 0.5 mu m in the coastal area and about 0.2 in the plateau area. The Angstrom's exponent, which is the slope of optical thickness spectrum, had values around 1 for large city areas and less than 0.5 for inland arid areas. Chemical analyses of sampled air indicate an effect of fossil fuel burning from local sources. Such optical and chemical characteristics of atmospheres suggest that soil-derived coarse particles contributed considerably to the atmospheric turbidity in arid areas, whereas an active generation of aerosols was dominant near large cities. Significant rises in atmospheric turbidity were observed in the earlier part of the second period al Bushehr about once a week with a duration of about one day, which may have been caused by smoke from oil-well fires in Kuwait. The aerosol optical thickness in these events had values of about 1.5, which is equivalent to a columnar aerosol volume of 4.4 x 10(-4) cm(3) cm(-2). The absorption index ranged from 0.005 to 0.02 with several peaks reaching 0.1 in the second period. These peaks can be attributed to prevailing smoke particles. In spite of the large variety of optical thicknesses and absorption indices, there existed stable power-law size distributions with an exponent about 3.7.	TOHOKU UNIV, FAC SCI, SENDAI, MIYAGI 980, JAPAN; DEPT ENVIRONM IRAN, TEHRAN, IRAN	Nakajima, T (reprint author), UNIV TOKYO, CTR CLIMATE SYST RES, MEGURO KU, 4-6-1 KOMABA, TOKYO 153, JAPAN.		Nakajima, Teruyuki/H-2370-2013	Nakajima, Teruyuki/0000-0002-9042-504X			CARLSON TN, 1980, J ATMOS SCI, V37, P193, DOI 10.1175/1520-0469(1980)037<0193:RHRFSD>2.0.CO;2; MITCHELL JFB, 1995, NATURE, V376, P501, DOI 10.1038/376501a0; KAUFMAN YJ, 1993, J APPL METEOROL, V32, P729, DOI 10.1175/1520-0450(1993)032<0729:EOASOC>2.0.CO;2; CAHILL TA, 1992, J GEOPHYS RES-ATMOS, V97, P14513; BAKAN S, 1991, NATURE, V351, P367, DOI 10.1038/351367a0; CHARLSON RJ, 1992, SCIENCE, V255, P423, DOI 10.1126/science.255.5043.423; FOUQUART Y, 1987, J CLIM APPL METEOROL, V26, P28, DOI 10.1175/1520-0450(1987)026<0028:OOSARO>2.0.CO;2; BROWNING KA, 1991, NATURE, V351, P363, DOI 10.1038/351363a0; STOWE LL, 1992, GEOPHYS RES LETT, V19, P159, DOI 10.1029/91GL02958; MINNIS P, 1993, SCIENCE, V259, P1411, DOI 10.1126/science.259.5100.1411; JOHNSON DW, 1991, NATURE, V353, P617, DOI 10.1038/353617a0; NAKAJIMA T, 1986, J QUANT SPECTROSC RA, V35, P13, DOI 10.1016/0022-4073(86)90088-9; ASANO S, 1993, J METEOROL SOC JPN, V71, P165; BOX MA, 1981, J ATMOS SCI, V38, P1037, DOI 10.1175/1520-0469(1981)038<1037:AATMSI>2.0.CO;2; Duce RA, 1995, DAHL WS ENV, V17, P43; HUSAIN T, 1994, ATMOS ENVIRON, V28, P2149, DOI 10.1016/1352-2310(94)90357-3; HUSAIN T, 1994, ATMOS ENVIRON, V28, P2211, DOI 10.1016/1352-2310(94)90361-1; JOSEPH JH, 1975, J APPL METEOROL, V14, P1389, DOI 10.1175/1520-0450(1975)014<1389:TROATB>2.0.CO;2; KING MD, 1979, J ATMOS SCI, V36, P163, DOI 10.1175/1520-0469(1979)036<0163:DOTGAA>2.0.CO;2; Lacis AA, 1995, DAHL WS ENV, V17, P11; LANGNER J, 1992, NATURE, V359, P712, DOI 10.1038/359712a0; MARYON RH, 1994, ATMOS ENVIRON, V28, P2019, DOI 10.1016/1352-2310(94)90471-5; NAKAJIMA T, 1983, APPL OPTICS, V22, P2951; NAKAJIMA T, 1986, APPL OPTICS, V25, P4374; NAKAJIMA T, 1989, J METEOROL SOC JPN, V67, P279; PILEWSKIE P, 1992, J GEOPHYS RES-ATMOS, V97, P14541; RAO CRN, 1988, AEROSOLS CLIMATE, P69; SHIOBARA M, 1994, J APPL METEOROL, V33, P672, DOI 10.1175/1520-0450(1994)033<0672:EOCOTF>2.0.CO;2; TANRE D, 1988, J GEOPHYS RES-ATMOS, V93, P14223, DOI 10.1029/JD093iD11p14223; WEISS RE, 1992, J GEOPHYS RES-ATMOS, V97, P14527; WEISS RE, 1992, J GEOPHYS RES-ATMOS, V97, P14537; YOUNG AT, 1981, J APPL METEOROL, V20, P328, DOI 10.1175/1520-0450(1981)020<0328:OTRSOD>2.0.CO;2	32	32	34	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	0894-8763			J APPL METEOROL	J. Appl. Meteorol.	AUG	1996	35	8					1265	1278		10.1175/1520-0450(1996)035<1265:AOPITI>2.0.CO;2		14	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	VE128	WOS:A1996VE12800009		
J	Naito, K; Wada, N; Inoue, S; Nishi, T				Naito, K; Wada, N; Inoue, S; Nishi, T			Studies on oil distribution in polymer blends	JOURNAL OF APPLIED POLYMER SCIENCE			English	Article								Oils and resins are widely used in rubber industries to improve or control the mechanical properties, viscoelastic behavior, processability, and tackiness of a rubber compound. Very few fundamental studies have been reported on the function and the mechanism of oils and resins in a rubber mixture. In this article oil or resin distribution to each phase in an immiscible binary elastomer blend was studied by measuring the change of thermodynamical parameters, such as glass transition temperature, melting point of crystallines, and heat at melt of each polymer component. Several independent approaches give consistent results. It was found that aromatic oil was favorably distributed to the polystyrene-butadiene (SBR) phase of an SBR/natural rubber (NR) blend. Similarly, unequal distribution of resin in a blend was observed for a natural resin (rosin) and a petroleum resin. (C) 1996 John Wiles & Sons, Inc.	BRIDGESTONE FIRESTONE INC,NASHVILLE,TN 37214; UNIV TOKYO,FAC ENGN,DEPT APPL PHYS,BUNKYO KU,TOKYO 113,JAPAN	Naito, K (reprint author), BRIDGESTONE CORP,DIV RES & DEV,3-1-1 OGAWAHIGASHI,KODAIRA,TOKYO 187,JAPAN.		Nishi, Toshio/A-8112-2010	Nishi, Toshio/0000-0001-7997-0875			FUJITA H, 1961, J CHEM PHYS, V34, P393, DOI 10.1063/1.1700962; HEINER K, 1994, TIRE TECHNOLOGY INT; Mandelkern L., 1964, CRYSTALLIZATION POLY; *NIPP GOM KYOUK, 1993, HDB RUBB IND; NISHI T, 1971, NIPPON GOMU KYOUKAIS, V44, P502	5	6	6	JOHN WILEY & SONS INC	NEW YORK	605 THIRD AVE, NEW YORK, NY 10158-0012	0021-8995			J APPL POLYM SCI	J. Appl. Polym. Sci.	AUG 1	1996	61	5					755	762				8	Polymer Science	Polymer Science	UU474	WOS:A1996UU47400006		
J	Ozawa, Y; Kasuga, A; Nomaguchi, H; Maruyama, T; Kasatani, T; Shimada, A; Takei, I; Miyazaki, J; Saruta, T				Ozawa, Y; Kasuga, A; Nomaguchi, H; Maruyama, T; Kasatani, T; Shimada, A; Takei, I; Miyazaki, J; Saruta, T			Detection of autoantibodies to the pancreatic islet heat shock protein 60 in insulin-dependent diabetes mellitus	JOURNAL OF AUTOIMMUNITY			English	Article						heat shock protein 60; insulin-dependent diabetes mellitus; autoantibody; rheumatoid arthritis; ELISA	65-KILODALTON MYCOBACTERIAL ANTIGEN; JUVENILE RHEUMATOID-ARTHRITIS; GLUTAMIC-ACID DECARBOXYLASE; CELL ANTIBODIES; AUTOIMMUNE-DISEASE; IMMUNE-RESPONSES; ASSOCIATION; THERAPY; IDDM; ATHEROSCLEROSIS	Autoantibodies against heat shock protein (hsp) 60 have been reported to be detected in sera of non-obese diabetic mice, in an experimental model of IDDM. However, there are only a few studies which have examined IDDM patients for antibodies against mammalian hsp60. We produced murine hsp60 derived from pancreatic beta cells which has high homology to human hsp60 and examined antibodies against the hsp60 in IDDM patients using an enzyme-linked immunosorbent assay. We extended the analysis to patients with other immune-mediated diseases and non-insulin-dependent diabetes mellitus (NIDDM). Positive sera for hsp60 antibody were more frequently detected in 13 out of 84 IDDM (15.5%) and 5 out of 25 rheumatoid arthritis patients (20%), when compared to healthy subjects (1/85; 1.2%, P < 0.001 and P < 0.01, respectively). The levels of hsp60 antibodies of IDDM (0.218 +/- 0.227) and rheumatoid arthritis patients (0.259 +/- 0.191) were significantly higher than those of healthy subjects (0.076 +/- 0.131, P < 0.001, P < 0.01, respectively). Patients with slowly progressive IDDM (n = 26), autoimmune thyroid disease (n = 42), or NIDDM (n = 40) had levels of hsp60 antibodies similar to those in healthy subjects. We found no relationship between the levels of hsp60 antibodies and islet cell antibodies (ICA) or antibodies to glutamic acid decarboxylase (GAD65) in IDDM patients. In conclusion, hsp60 antibodies were detected in Japanese IDDM as well as in rheumatoid arthritis patients. Although the positivity was low, the detection of hsp60 antibodies may be helpful for diagnosis of IDDM especially in GAD65 Ab- or ICA-negative Japanese patients. (C) 1996 Academic Press Limited	TOKYO DENRYOKU HOSP, DEPT INTERNAL MED, TOKYO, JAPAN; NATL INST LEPROSY RES, TOKYO, JAPAN; ICHIKAMA GEN HOSP TOKYO, COLL DENT, DEPT INTERNAL MED, CHIBA, JAPAN; UNIV TOKYO, FAC MED, DEPT DIS RELATED GENE REGULAT RES SANDOZ, TOKYO, JAPAN; TOHOKU UNIV, INST DEV AGING & CANC, DEPT MOL EMBRYOL, MIYAGI, JAPAN	Ozawa, Y (reprint author), KEIO UNIV, SCH MED, DEPT INTERNAL MED, SHINJUKU KU, 35 SHINANOMACHI, TOKYO 160, JAPAN.		Miyazaki, Jun-ichi/N-1976-2015	Miyazaki, Jun-ichi/0000-0003-2475-589X			ALBANI S, 1994, J PEDIATR-US, V124, P561, DOI 10.1016/S0022-3476(05)83134-8; BOTTAZZO GF, 1974, LANCET, V2, P1279; BAEKKESKOV S, 1990, NATURE, V347, P151, DOI 10.1038/347151a0; BAEKKESKOV S, 1987, J CLIN INVEST, V79, P926, DOI 10.1172/JCI112903; KOBAYASHI T, 1993, DIABETES CARE, V16, P780, DOI 10.2337/diacare.16.5.780; TISCH R, 1993, NATURE, V366, P72, DOI 10.1038/366072a0; BONIFACIO E, 1988, J IMMUNOL METHODS, V106, P83, DOI 10.1016/0022-1759(88)90274-8; WICK G, 1995, IMMUNOL TODAY, V16, P27, DOI 10.1016/0167-5699(95)80067-0; DEGRAEFFMEEDER ER, 1991, LANCET, V337, P1368, DOI 10.1016/0140-6736(91)93057-G; ELIAS D, 1991, P NATL ACAD SCI USA, V88, P3088, DOI 10.1073/pnas.88.8.3088; JINDAL S, 1989, MOL CELL BIOL, V9, P2279; FEIGE U, 1991, SPRINGER SEMIN IMMUN, V13, P99, DOI 10.1007/BF01225281; DANIELI MG, 1992, CLIN IMMUNOL IMMUNOP, V64, P121, DOI 10.1016/0090-1229(92)90189-U; PALMER JP, 1983, SCIENCE, V222, P1337, DOI 10.1126/science.6362005; KAUFMANN SHE, 1987, EUR J IMMUNOL, V17, P351, DOI 10.1002/eji.1830170308; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126; [Anonymous], 1979, DIABETES, V28, P1039; VANEDEN W, 1988, NATURE, V331, P171; Kasuga A, 1996, J AUTOIMMUN, V9, P105, DOI 10.1006/jaut.1996.0013; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; ATKINSON MA, 1991, J CLIN INVEST, V87, P721, DOI 10.1172/JCI115051; BACAESTRADA ME, 1994, DIGEST DIS SCI, V39, P498, DOI 10.1007/BF02088334; BAEKKESKOV S, 1982, NATURE, V298, P167, DOI 10.1038/298167a0; BINGLEY PJ, 1994, DIABETES, V43, P1304, DOI 10.2337/diabetes.43.11.1304; BRUDZYNSKI K, 1993, DIABETES, V42, P908, DOI 10.2337/diabetes.42.6.908; CHRISTIE MR, 1993, J CLIN INVEST, V92, P240, DOI 10.1172/JCI116556; DUDANI AK, 1989, INFECT IMMUN, V57, P2786; EISENBARTH GS, 1986, NEW ENGL J MED, V314, P1360; ELIAS D, 1990, P NATL ACAD SCI USA, V87, P1576, DOI 10.1073/pnas.87.4.1576; ELIAS D, 1994, LANCET, V343, P704, DOI 10.1016/S0140-6736(94)91582-2; GOTTSATER A, 1993, DIABETES CARE, V16, P902, DOI 10.2337/diacare.16.6.902; Guana C d, 1988, GENE, V67, P21; HAKALA M, 1992, J RHEUMATOL, V19, P856; JONES DB, 1993, IMMUNOL TODAY, V14, P115, DOI 10.1016/0167-5699(93)90210-C; JONES DB, 1990, LANCET, V336, P583, DOI 10.1016/0140-6736(90)93390-B; KASUGA A, 1996, IN PRESS ACTA DIABET, V33; KUGLIN B, 1990, DIABETOLOGIA, V33, P636; LOTSCHER E, 1990, NUCLEIC ACIDS RES, V18, P7153, DOI 10.1093/nar/18.23.7153; MACCUISH AC, 1974, LANCET, V2, P1529; MAINA CV, 1988, GENE, V74, P365, DOI 10.1016/0378-1119(88)90170-9; MARTIN S, 1995, DIABETOLOGIA, V38, P351, DOI 10.1007/BF00400641; OHHASHI T, 1991, J CHROMATOGR, V585, P153, DOI 10.1016/0021-9673(91)85069-R; SCHMIDLI RS, 1994, DIABETES, V43, P1005, DOI 10.2337/diabetes.43.8.1005; TUN RYM, 1994, DIABETIC MED, V11, P66; XU QB, 1993, LANCET, V341, P255, DOI 10.1016/0140-6736(93)92613-X; YAMAGUCHI H, 1992, APMIS, V100, P957	46	30	32	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0896-8411	1095-9157		J AUTOIMMUN	J. Autoimmun.	AUG	1996	9	4					517	524		10.1006/jaut.1996.0069		8	Immunology	Immunology	VC545	WOS:A1996VC54500009		
J	Zenno, S; Koike, H; Kumar, AN; Jayaraman, R; Tanokura, M; Saigo, K				Zenno, S; Koike, H; Kumar, AN; Jayaraman, R; Tanokura, M; Saigo, K			Biochemical characterization of NfsA, the Escherichia coli major nitroreductase exhibiting a high amino acid sequence homology to Frp, a Vibrio harveyi flavin oxidoreductase	JOURNAL OF BACTERIOLOGY			English	Article							FMN OXIDOREDUCTASES; BENECKEA-HARVEYI; GENE; PURIFICATION; CLONING; NADH; IDENTIFICATION; BACTERIA; FISCHERI; PROTEIN	We identified the nfsA gene, encoding the major oxygen-insensitive nitroreductase in Escherichia coli, and determined its position on the E. coli map to be 19 min. We also purified its gene product, NfsA, to homogeneity. It was suggested that NfsA is a nonglobular protein with a molecular weight of 26,799 and is associated tightly with a flavin mononucleotide. Its amino acid sequence is highly similar to that of Frp, a flavin oxidoreductase from Vibrio harveyi (B. Lei, M. Liu, S. Huang, and S.-C. Tu, J. Bacteriol. 176:3552-3558, 1994), an observation supporting the notion that E. coli nitroreductase and luminescent-bacterium flavin reductase families are intimately related in evolution. Although no appreciable sequence similarity was detected between two E. coli nitroreductases, NfsA and NfsB, NfsA exhibited a low level of the flavin reductase activity and a broad electron acceptor specificity similar to those of NfsB. NfsA reduced nitrofurazone by a ping-pong Bi-Bi mechanism possibly to generate a two-electron transfer product.	UNIV TOKYO,GRAD SCH SCI,BIOTECHNOL RES CTR,BUNKYO KU,TOKYO 113,JAPAN; CHISSO CORP,YOKOHAMA RES CTR,YOKOHAMA,KANAGAWA 236,JAPAN; MADURAI KAMARAJ UNIV,SCH BIOL SCI,MADURAI 625021,TAMIL NADU,INDIA	Zenno, S (reprint author), UNIV TOKYO,GRAD SCH SCI,DEPT BIOCHEM & BIOPHYS,BUNKYO KU,7-3-1 HONGO,TOKYO 113,JAPAN.						BACHMANN BJ, 1990, MICROBIOL REV, V54, P130; JABLONSKI E, 1978, BIOCHEMISTRY-US, V17, P672, DOI 10.1021/bi00597a018; CHUNG CT, 1989, P NATL ACAD SCI USA, V86, P2172, DOI 10.1073/pnas.86.7.2172; HASTINGS JW, 1985, ADV MICROB PHYSIOL, V26, P235, DOI 10.1016/S0065-2911(08)60398-7; OHNISHI K, 1994, J BIOL CHEM, V269, P31418; BREW K, 1975, J BIOL CHEM, V250, P1434; MCCALLA DR, 1978, J BACTERIOL, V133, P10; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; BRYANT C, 1991, J BIOL CHEM, V266, P4119; BRYANT DW, 1981, CAN J MICROBIOL, V27, P81; CHOU PY, 1978, ANNU REV BIOCHEM, V47, P25; GAVIN JJ, 1966, ARCH BIOCHEM BIOPHYS, V113, P399, DOI 10.1016/0003-9861(66)90205-0; Inouye S, 1991, Protein Expr Purif, V2, P122, DOI 10.1016/1046-5928(91)90060-V; JABLONSKI E, 1977, BIOCHEMISTRY-US, V16, P2932, DOI 10.1021/bi00632a020; KANG WK, 1989, MOL GEN GENET, V217, P281, DOI 10.1007/BF02464894; KOHARA Y, 1987, CELL, V50, P495, DOI 10.1016/0092-8674(87)90503-4; KUMAR AN, 1991, J BIOSCIENCE, V16, P145, DOI 10.1007/BF02703367; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEI BF, 1994, J BACTERIOL, V176, P3552; MESSING J, 1982, GENE, V19, P269, DOI 10.1016/0378-1119(82)90016-6; PETERSON FJ, 1979, J BIOL CHEM, V254, P4009; ROSENBERG M, 1979, ANNU REV GENET, V13, P319, DOI 10.1146/annurev.ge.13.120179.001535; Sambrook J., 1989, MOL CLONING LAB MANU; Schwartz R. M., 1978, ATLAS PROTEIN SEQ S3, V5, P353; SHINE J, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1342, DOI 10.1073/pnas.71.4.1342; UEMORI T, 1993, J BIOCHEM-TOKYO, V113, P401; ZENNO S, IN PRESS J BIOCH; ZENNO S, 1994, J BACTERIOL, V176, P3544; ZENNO S, 1994, J BACTERIOL, V176, P3536; Zenno SH, 1996, J BACTERIOL, V178, P4731	31	114	117	AMER SOC MICROBIOLOGY	WASHINGTON	1325 MASSACHUSETTS AVENUE, NW, WASHINGTON, DC 20005-4171	0021-9193			J BACTERIOL	J. Bacteriol.	AUG	1996	178	15					4508	4514				7	Microbiology	Microbiology	UZ047	WOS:A1996UZ04700019		
J	Uchiya, KI; Tohsuji, M; Nikai, T; Sugihara, H; Sasakawa, C				Uchiya, KI; Tohsuji, M; Nikai, T; Sugihara, H; Sasakawa, C			Identification and characterization of phoN-Sf, a gene on the large plasmid of Shigella flexneri 2a encoding a nonspecific phosphatase	JOURNAL OF BACTERIOLOGY			English	Article							CONGO RED BINDING; ESCHERICHIA-COLI; ALKALINE-PHOSPHATASE; ACID-PHOSPHATASE; NUCLEOTIDE-SEQUENCE; VIRULENCE GENE; TRANSCRIPTIONAL ACTIVATION; SALMONELLA-TYPHIMURIUM; MOLECULAR-CLONING; EPITHELIAL-CELLS	A gene encoding a nonspecific phosphatase, named PhoN-Sf, was identified on the large virulence plasmid (pMYSH6000) of Shigella flexneri 2a YSH6000. The phosphatase activity in YSH6000 was observed under high-phosphate conditions. However, it was found that low-phosphate conditions induced a slightly higher level of activity. The nucleotide sequence of the phoN-Sf region cloned from pMYSH6000 possessing the phoN-Sf gene encoded 249 amino acids with a typical signal sequence at the N terminus, The deduced amino acid sequence of the PhoN-Sf protein revealed significant homology to sequences of nonspecific acid phosphatases of other bacteria, such as Providencia stuartii (PhoN, 83.2%), Morganella morganii (PhoC, 80.6%), Salmonella typhimurium (PhoN, 47.8%), and Zymomonas mobilis (PhoC, 34.8%). The PhoN-Sf protein was purified, and its biochemical properties were characterized. The apparent molecular mass of the protein on sodium dodecyl sulfate-polyacrylamide gel electrophoresis was calculated to be 27 kDa, The 20 amino acids at the N terminus corresponded to the 20 amino acid residues following the putative signal sequence of PhoN-Sf protein deduced from the nucleotide sequence. The PhoN-Sf activity had a pH optimum of 6.6, and the optimum temperature was 37 degrees C. The enzymatic activity was inhibited by diisopropyl fluorophosphate, N-bromosuccinimide, or dithiothreitol but not by EDTA. The subcellular localization of the PhoN-Sf protein in YSH6000 revealed that the protein was found predominantly in the periplasm. Examination of Shigella and enteroinvasive Escherichia coli strains for PhoN-Sf production by immunoblotting with the PhoN-specific antibody and for the presence of phoN-Sf DNA by using a phoN-Sf probe indicated that approximately one-half of the strains possessed the phoN-Sf gene on the large plasmid and expressed the PhoN-Sf protein. The Tn5 insertion mutants of YSH6000 possessing phoN-Sf::Tn5 still retained wild-type levels of invasiveness, as well as the subsequent spreading capacity in MK2 epithelial cell monolayers, thus suggesting that the PhoN-Sf activity is not involved in expression of the virulence phenotypes of Shigella strains under in vitro conditions.	MEIJO UNIV,FAC PHARM,DEPT MICROBIOL,TENPAKU KU,NAGOYA,AICHI 468,JAPAN; UNIV TOKYO,INST MED SCI,DEPT BACTERIOL,MINATO KU,TOKYO 108,JAPAN							ALLAOUI A, 1992, MOL MICROBIOL, V6, P1605, DOI 10.1111/j.1365-2958.1992.tb00885.x; ALLAOUI A, 1992, J BACTERIOL, V174, P7661; ANDREWS GP, 1991, INFECT IMMUN, V59, P1997; ADLER B, 1989, MOL MICROBIOL, V3, P627, DOI 10.1111/j.1365-2958.1989.tb00210.x; CHANG CN, 1986, GENE, V44, P121; MAKINO S, 1986, CELL, V46, P551, DOI 10.1016/0092-8674(86)90880-9; GROISMAN EA, 1993, EMBO J, V12, P3779; SASAKAWA C, 1986, INFECT IMMUN, V54, P32; SANSONETTI PJ, 1982, INFECT IMMUN, V35, P852; DASSA E, 1982, J BIOL CHEM, V257, P6669; TOBE T, 1991, MOL MICROBIOL, V5, P887, DOI 10.1111/j.1365-2958.1991.tb00762.x; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; LETT MC, 1989, J BACTERIOL, V171, P353; MAKINO K, 1989, J MOL BIOL, V210, P551, DOI 10.1016/0022-2836(89)90131-9; ARGAST M, 1980, J BACTERIOL, V143, P142; BAUDRY B, 1988, MICROB PATHOGENESIS, V4, P345, DOI 10.1016/0882-4010(88)90062-9; BENJELLOUNTOUIMI Z, 1995, MOL MICROBIOL, V17, P123, DOI 10.1111/j.1365-2958.1995.mmi_17010123.x; BHARGAVA T, 1995, CURR SCI INDIA, V68, P293; Britton HTS, 1931, J CHEM SOC, P1456, DOI 10.1039/jr9310001456; BUYSSE JM, 1987, J BACTERIOL, V169, P2561; FALKOW S, 1963, J BACTERIOL, V86, P1251; HARTMAN AB, 1990, J BACTERIOL, V172, P1905; INOUYE H, 1977, P NATL ACAD SCI USA, V74, P1440, DOI 10.1073/pnas.74.4.1440; KASAHARA M, 1991, J BACTERIOL, V173, P6760; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEVINTHAL C, 1962, P NATL ACAD SCI USA, V48, P1230, DOI 10.1073/pnas.48.7.1230; MAKINO K, 1988, J MOL BIOL, V203, P85, DOI 10.1016/0022-2836(88)90093-9; MAKINO S, 1988, MICROB PATHOGENESIS, V5, P267, DOI 10.1016/0882-4010(88)90099-X; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; NAKATA N, 1992, MOL MICROBIOL, V6, P2387, DOI 10.1111/j.1365-2958.1992.tb01413.x; POND JL, 1989, J BACTERIOL, V171, P767; SAKAI T, 1986, INFECT IMMUN, V51, P476; SAKAI T, 1986, INFECT IMMUN, V54, P395; Sambrook J., 1989, MOL CLONING LAB MANU; SANSONETTI PJ, 1981, INFECT IMMUN, V34, P75; SASAKAWA C, 1982, J MOL BIOL, V159, P257, DOI 10.1016/0022-2836(82)90495-8; SASAKAWA C, UNPUB; SASAKAWA C, 1986, INFECT IMMUN, V51, P470; SASAKAWA C, 1989, MOL MICROBIOL, V3, P1191, DOI 10.1111/j.1365-2958.1989.tb00269.x; SASAKAWA C, 1995, REV MED MICROBIOL, V6, P257; SASAKAWA C, 1993, J BACTERIOL, V175, P2334; SCHOLTEN M, 1995, MOL MICROBIOL, V15, P247, DOI 10.1111/j.1365-2958.1995.tb02239.x; SILVA RM, 1988, INFECT IMMUN, V56, P836; THALLER MC, 1994, MICROBIOL-SGM, V140, P1341; TOMMASSEN J, 1980, J BACTERIOL, V143, P151; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; UCHIYA K, UNPUB; UCHIYA KI, 1995, MOL MICROBIOL, V17, P241, DOI 10.1111/j.1365-2958.1995.mmi_17020241.x; VENKATESAN MM, 1992, J BACTERIOL, V174, P1990; VENKATESAN MM, 1988, P NATL ACAD SCI USA, V85, P9317, DOI 10.1073/pnas.85.23.9317	50	19	19	AMER SOC MICROBIOLOGY	WASHINGTON	1325 MASSACHUSETTS AVENUE, NW, WASHINGTON, DC 20005-4171	0021-9193			J BACTERIOL	J. Bacteriol.	AUG	1996	178	15					4548	4554				7	Microbiology	Microbiology	UZ047	WOS:A1996UZ04700024		
J	Zenno, SH; Koike, H; Tanokura, M; Saigo, K				Zenno, SH; Koike, H; Tanokura, M; Saigo, K			Conversion of NfsB, a minor Escherichia coli nitroreductase, to a flavin reductase similar in biochemical properties to FRase I, the major flavin reductase in Vibrio fischeri, by a single amino acid substitution	JOURNAL OF BACTERIOLOGY			English	Article							NAD(P)H-FLAVIN OXIDOREDUCTASE; ENTEROBACTER-CLOACAE; NUCLEOTIDE-SEQUENCE; GENE; PURIFICATION; EXPRESSION; PLASMID; ENZYME; DNA	NfsB is an oxygen-insensitive nitroreductase of Escherichia coli with significant amino acid sequence homology to the major flavin reductase (FRase I) of Vibrio fischeri. Here, we show that NfsB is convertible to an FRase I-like flavin reductase three times as active as the authentic FRase I by a single amino acid substitution in the least-conserved region.	UNIV TOKYO,BIOTECHNOL RES CTR,BUNKYO KU,TOKYO 106,JAPAN; CHISSO CORP,YOKOHAMA RES CTR,KANAZAWA KU,YOKOHAMA,KANAGAWA 236,JAPAN	Zenno, SH (reprint author), UNIV TOKYO,GRAD SCH SCI,DEPT BIOCHEM & BIOPHYS,BUNKYO KU,7-3-1 HONGO,TOKYO 106,JAPAN.						ANLEZARK GM, 1992, BIOCHEM PHARMACOL, V44, P2289, DOI 10.1016/0006-2952(92)90671-5; BRYANT C, 1991, J BIOL CHEM, V266, P4126; OHNISHI K, 1994, J BIOL CHEM, V269, P31418; BRYANT C, 1991, J BIOL CHEM, V266, P4119; FONTECAVE M, 1987, J BIOL CHEM, V262, P12325; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leung DW, 1989, TECHNIQUE, V1, P11; MESSING J, 1982, GENE, V19, P269, DOI 10.1016/0378-1119(82)90016-6; MICHAEL NP, 1994, FEMS MICROBIOL LETT, V124, P195, DOI 10.1016/0378-1097(94)90249-6; SPYROU G, 1991, J BACTERIOL, V173, P3673; VIEIRA J, 1987, METHOD ENZYMOL, V153, P3; WATANABE M, 1990, NUCLEIC ACIDS RES, V18, P1059, DOI 10.1093/nar/18.4.1059; ZENNO S, IN PRESS J BIOCH; ZENNO S, 1994, J BACTERIOL, V176, P3536	14	37	38	AMER SOC MICROBIOLOGY	WASHINGTON	1325 MASSACHUSETTS AVENUE, NW, WASHINGTON, DC 20005-4171	0021-9193			J BACTERIOL	J. Bacteriol.	AUG	1996	178	15					4731	4733				3	Microbiology	Microbiology	UZ047	WOS:A1996UZ04700050		
J	Miera, N; Ishida, N; Hoshino, M; Yamauchi, M; Hara, T; Ayusawa, D; Kawakita, M				Miera, N; Ishida, N; Hoshino, M; Yamauchi, M; Hara, T; Ayusawa, D; Kawakita, M			Human UDP-galactose translocator: Molecular cloning of a complementary DNA that complements the genetic defect of a mutant cell line deficient in UDP-galactose translocator	JOURNAL OF BIOCHEMISTRY			English	Article						CDC91; Golgi apparatus; UDP-galactose; UDP-galactose translocator; ZK370.7	GOLGI VESICLE MEMBRANES; ACID TRANSPORT; MESSENGER-RNAS; SIALIC-ACID; GLYCOSYLATION; AMPLIFICATION; APPARATUS; FM3A; IDENTIFICATION; EXPRESSION	We have cloned a cDNA that codes for a putative human UDP-galactose translocator (UGT) protein, The cDNA contained an open reading frame of 1,179 base pairs encoding a novel protein of 393 amino acids, Introduction of the open reading frame sequence into a UGT-deficient mouse cell line, Had-1, complemented the genetic defect of the mutant, namely the inability to transport UDP-galactose from the cytosol to the Golgi lumen, as judged from the lectin-sensitivity spectrum of the transformant, To our knowledge, this is the first mammalian nucleotide-sugar translocator whose cDNA sequence has been described.	TOKYO METROPOLITAN INST MED SCI RINSHOKEN,DEPT PHYSIOL CHEM,BUNKYO KU,TOKYO 113,JAPAN; NATL INST RADIOL SCI,DIV GENET,INAGE KU,CHIBA 260,JAPAN; UNIV TOKYO,INST MOL & CELLULAR BIOSCI,BUNKYO KU,TOKYO 113,JAPAN; YOKOHAMA CITY UNIV,KIHARA INST BIOL RES,TOTSUKA KU,YOKOHAMA,KANAGAWA 244,JAPAN							PISTOCCHI R, 1993, J BIOL CHEM, V268, P146; DEUTSCHER SL, 1984, CELL, V39, P295, DOI 10.1016/0092-8674(84)90007-2; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; STANLEY P, 1985, MOL CELL BIOL, V5, P923; FROHMAN MA, 1993, METHOD ENZYMOL, V218, P340; TAKEBE Y, 1988, MOL CELL BIOL, V8, P466; PERSSON B, 1994, J MOL BIOL, V237, P182, DOI 10.1006/jmbi.1994.1220; NAKAI K, 1992, GENOMICS, V14, P897, DOI 10.1016/S0888-7543(05)80111-9; AYUSAWA D, 1983, J BIOL CHEM, V258, P48; BRILES EB, 1977, J BIOL CHEM, V252, P1107; BUCKLER AJ, 1991, P NATL ACAD SCI USA, V88, P4005, DOI 10.1073/pnas.88.9.4005; DEUTSCHER SL, 1986, J BIOL CHEM, V261, P96; EDWARDS JBDM, 1991, NUCLEIC ACIDS RES, V19, P5227, DOI 10.1093/nar/19.19.5227; HARA T, 1989, J VIROL, V63, P182; HARA T, 1989, J BIOCHEM-TOKYO, V106, P236; HARA T, 1993, SOMAT CELL MOLEC GEN, V19, P571, DOI 10.1007/BF01233383; HERSCOVICS A, 1993, FASEB J, V7, P540; HIRSCHBERG CB, 1987, ANNU REV BIOCHEM, V56, P63, DOI 10.1146/annurev.biochem.56.1.63; ISHIDA N, 1992, J CLIN INVEST, V89, P1431, DOI 10.1172/JCI115732; KOZAK M, 1991, J BIOL CHEM, V266, P19867; MILLA ME, 1992, J BIOL CHEM, V267, P103; TAKI T, 1991, CANCER RES, V51, P1701; WILSON R, 1994, NATURE, V368, P32, DOI 10.1038/368032a0	23	3	3	JAPAN BIOCHEMICAL SOC	TOKYO	ISHIKAWA BLDG-3F 25-16 HONGO-5-CHOME, TOKYO TOKYO 113, JAPAN	0021-924X			J BIOCHEM-TOKYO	J. Biochem. (Tokyo)	AUG	1996	120	2					236	241				6	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	VC489	WOS:A1996VC48900005		
J	Hirasawa, A; Athauda, SBP; Takahashi, K				Hirasawa, A; Athauda, SBP; Takahashi, K			Purification and characterization of turtle pepsinogen and pepsin	JOURNAL OF BIOCHEMISTRY			English	Article						amino acid sequence; cDNA sequence; pepsin; pepsinogen; turtle	AMINO-ACID-SEQUENCE; ACTIVATION PEPTIDE SEGMENT; JAPANESE MONKEY PEPSINOGEN; RAT GASTRIC-MUCOSA; PORCINE PEPSINOGEN; NUCLEOTIDE-SEQUENCE; MOLECULAR EVOLUTION; RABBIT PEPSINOGENS; CHICKEN PEPSINOGEN; SWINE PEPSINOGEN	Pepsinogen was purified from the gastric mucosa of soft-shelled turtle (Trionyx sinensis) by a series of chromatographies on DEAE-cellulose, Sephadex 6-100, and Q-Sepharose. Upon chromatography on Q-Sepharose, it was separated into nine isoforms. These isoforms showed a relative molecular mass of approximately 43,000 Da on sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and isoforms 4 through 9 contained carbohydrate (approx. 2% each). Insofar as they were examined, their NH2-terminal sequences differed only in showing substitution at a few positions. At pH 2.0, they were rapidly activated to the corresponding isoforms of pepsin in a stepwise manner. The nine isoforms showed similar specific activity toward hemoglobin and hydrolyzed N-acetyl-L-phenylalanyl-L-diiodotyrosine, a good substrate for pepsin A, at somewhat different rates. They were inhibited by pepstatin to various extents, more strongly than human pepsin C but less strongly than human pepsin A. All isoforms appeared to have similar cleavage specificity toward oxidized insulin B chain, which resembled those of both human pepsins A and C. A cDNA clone for one of the zymogen isoforms was isolated and sequenced. The amino acid sequence thus deduced was more homologous with those of mammalian pepsinogens A than those of mammalian pepsinogens C or prochymosin.	TOKYO UNIV PHARM & LIFE SCI,SCH LIFE SCI,HACHIOJI,TOKYO 19203,JAPAN; UNIV TOKYO,GRAD SCH SCI,DEPT BIOPHYS & BIOCHEM,BUNKYO KU,TOKYO 113,JAPAN							HARTSUCK JA, 1992, PROTEINS, V13, P1, DOI 10.1002/prot.340130102; TANG J, 1973, P NATL ACAD SCI USA, V70, P3437, DOI 10.1073/pnas.70.12.3437; Anson ML, 1938, J GEN PHYSIOL, V22, P79, DOI 10.1085/jgp.22.1.79; SIELECKI AR, 1991, J MOL BIOL, V219, P671, DOI 10.1016/0022-2836(91)90664-R; BARTLETT GR, 1959, J BIOL CHEM, V234, P466; MOORE S, 1963, J BIOL CHEM, V238, P235; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; MOORE SA, 1995, J MOL BIOL, V247, P466, DOI 10.1006/jmbi.1994.0154; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; JAMES MNG, 1986, NATURE, V319, P33, DOI 10.1038/319033a0; BOHAK Z, 1969, J BIOL CHEM, V244, P4638; ATHAUDA SBP, 1989, J BIOCHEM-TOKYO, V106, P920; BAUDYS M, 1983, EUR J BIOCHEM, V136, P89, DOI 10.1111/j.1432-1033.1983.tb07709.x; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; FOLTMANN B, 1977, P NATL ACAD SCI USA, V74, P2321, DOI 10.1073/pnas.74.6.2321; FOLTMANN B, 1981, ESSAYS BIOCHEM, V17, P52; FURIHATA C, 1972, BIOCHEM BIOPH RES CO, V47, P705, DOI 10.1016/0006-291X(72)90549-9; GRUNSTEIN M, 1975, P NATL ACAD SCI USA, V72, P3961, DOI 10.1073/pnas.72.10.3961; HAYANO T, 1988, J BIOL CHEM, V263, P1382; HAYASHI K, 1988, J BIOCHEM-TOKYO, V103, P290; Huynh TV, 1985, DNA CLONING TECHNIQU, V1, P49; ICHIHARA Y, 1986, EUR J BIOCHEM, V161, P7, DOI 10.1111/j.1432-1033.1986.tb10117.x; ISHIHARA T, 1989, J BIOL CHEM, V264, P10193; KAGEYAMA T, 1978, J BIOCHEM-TOKYO, V84, P771; KAGEYAMA T, 1976, J BIOCHEM-TOKYO, V79, P455; KAGEYAMA T, 1987, EUR J BIOCHEM, V165, P483, DOI 10.1111/j.1432-1033.1987.tb11464.x; KAGEYAMA T, 1982, J BIOCHEM-TOKYO, V92, P1179; KAGEYAMA T, 1992, J BIOL CHEM, V267, P16450; KAGEYAMA T, 1986, J BIOL CHEM, V261, P4406; KAGEYAMA T, 1989, J BIOCH, V105, P12; KAGEYAMA T, 1985, J BIOCHEM-TOKYO, V97, P1235; KAGEYAMA T, 1983, J BIOCHEM-TOKYO, V94, P1557; KAGEYAMA T, 1977, BIOCHEM BIOPH RES CO, V74, P789, DOI 10.1016/0006-291X(77)90372-2; KAGEYAMA T, 1984, EUR J BIOCHEM, V141, P261, DOI 10.1111/j.1432-1033.1984.tb08186.x; KAGEYAMA T, 1980, J BIOCHEM-TOKYO, V88, P9; KAGEYAMA T, 1980, J BIOCHEM-TOKYO, V88, P571; KAGEYAMA T, 1980, J BIOCHEM-TOKYO, V88, P635; KAGEYAMA T, 1976, J BIOCHEM-TOKYO, V80, P983; KAGEYAMA T, 1990, J BIOL CHEM, V265, P17031; KAGEYAMA T, 1986, J BIOL CHEM, V261, P4395; KUCHINO Y, 1984, PROTEIN NUCLEIC ACID, V29, P294; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MATSUZAKI O, 1988, BIOMED RES-TOKYO, V9, P515; ONG EB, 1968, J BIOL CHEM, V243, P6104; PEDERSEN VB, 1973, FEBS LETT, V35, P255, DOI 10.1016/0014-5793(73)80298-4; SAMLOFF IM, 1969, GASTROENTEROLOGY, V57, P659; SOGAWA K, 1983, J BIOL CHEM, V258, P5306; STEPANOV VM, 1973, BIOCHEM BIOPH RES CO, V54, P1164, DOI 10.1016/0006-291X(73)90814-0; Takahashi K., 1985, ASPARTIC PROTEINASES, P265; Tang J., 1970, METHOD ENZYMOL, V19, P406; TANJI M, 1988, EUR J BIOCHEM, V177, P251, DOI 10.1111/j.1432-1033.1988.tb14369.x; TSUKAGOSHI N, 1988, GENE, V65, P285; YAKABE E, 1991, J BIOL CHEM, V266, P22436	54	19	20	JAPAN BIOCHEMICAL SOC	TOKYO	ISHIKAWA BLDG-3F 25-16 HONGO-5-CHOME, TOKYO TOKYO 113, JAPAN	0021-924X			J BIOCHEM-TOKYO	J. Biochem. (Tokyo)	AUG	1996	120	2					407	414				8	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	VC489	WOS:A1996VC48900028		
J	Yamanushi, T; Hirata, A; Oka, T; Nakano, A				Yamanushi, T; Hirata, A; Oka, T; Nakano, A			Characterization of yeast sar1 temperature-sensitive mutants, which are defective in protein transport from the endoplasmic reticulum	JOURNAL OF BIOCHEMISTRY			English	Article						Golgi apparatus; protein secretion; small GTPase; Saccharomyces cerevisiae; vesicular transport	SACCHAROMYCES-CEREVISIAE; GOLGI TRANSPORT; ER; GTPASE	SARI encodes a low molecular weight GTPase that is essential in the early process of vesicular transport in the secretory pathway. By random and site-directed mutagenesis of the SAR1 gene, we have obtained three temperature-sensitive mutants, N132I, E112K, and D32G. They all show a defect in transport from the endoplasmic reticulum to the Golgi apparatus, and accumulate endoplasmic reticulum membranes at the restrictive temperature. This is consistent with our previous observations in vivo on a galactose-shutoff mutant as well as the in vitro results, and provides powerful tools for further genetic analyses.	UNIV TOKYO,GRAD SCH SCI,DEPT BIOL SCI,BUNKYO KU,TOKYO 113,JAPAN; UNIV TOKYO,INST MOL & CELLULAR BIOSCI,BUNKYO KU,TOKYO 113,JAPAN			Nakano, Akihiko/C-6185-2009				AMOR JC, 1994, NATURE, V372, P704; SIKORSKI RS, 1989, GENETICS, V122, P19; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; DENFERT C, 1992, EMBO J, V11, P4205; FERRONOVICK S, 1993, ANNU REV CELL BIOL, V9, P575; KESZENMANPEREYRA D, 1988, CURR GENET, V13, P21, DOI 10.1007/BF00365751; KUGE O, 1994, J CELL BIOL, V125, P51, DOI 10.1083/jcb.125.1.51; NAKANO A, 1989, J CELL BIOL, V109, P2677, DOI 10.1083/jcb.109.6.2677; NAKANO A, 1994, J BIOCHEM-TOKYO, V116, P243; NISHIKAWA S, 1990, J BIOL CHEM, V265, P7440; OKA T, 1994, J CELL BIOL, V124, P425, DOI 10.1083/jcb.124.4.425; OKA T, 1991, J CELL BIOL, V114, P671, DOI 10.1083/jcb.114.4.671; ORCI L, 1993, NATURE, V364, P732, DOI 10.1038/364732a0; SCHAUER I, 1985, J CELL BIOL, V100, P1664, DOI 10.1083/jcb.100.5.1664; SUN GH, 1992, J CELL BIOL, V119, P1625, DOI 10.1083/jcb.119.6.1625	16	17	18	JAPAN BIOCHEMICAL SOC	TOKYO	ISHIKAWA BLDG-3F 25-16 HONGO-5-CHOME, TOKYO TOKYO 113, JAPAN	0021-924X			J BIOCHEM-TOKYO	J. Biochem. (Tokyo)	AUG	1996	120	2					452	458				7	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	VC489	WOS:A1996VC48900033		
J	Lloyd, SE; Pearce, SHS; Igarashi, T; Thakker, RV				Lloyd, SE; Pearce, SHS; Igarashi, T; Thakker, RV			Hypercalciuric nephrocalcinosis in Japanese children due to mutations of the renal chloride channel (CLCN5).	JOURNAL OF BONE AND MINERAL RESEARCH			English	Meeting Abstract									HAMMERSMITH HOSP,MRC,MOLEC ENDOCRINOL GRP,LONDON,ENGLAND; UNIV TOKYO,DEPT PEDIAT,TOKYO,JAPAN								0	0	0	BLACKWELL SCIENCE INC	CAMBRIDGE	238 MAIN ST, CAMBRIDGE, MA 02142	0884-0431			J BONE MINER RES	J. Bone Miner. Res.	AUG	1996	11			1			17	17				1	Endocrinology & Metabolism	Endocrinology & Metabolism	VA495	WOS:A1996VA49500017		
J	Kodama, Y; Takeuchi, Y; Suzawa, M; Fukumoto, S; Kurokawa, T; Murayama, H; Yamato, H; Matsumoto, T				Kodama, Y; Takeuchi, Y; Suzawa, M; Fukumoto, S; Kurokawa, T; Murayama, H; Yamato, H; Matsumoto, T			Reduced expression of interleukin-11 from bone marrow stromal cells of senescence-accelerated mice (SAM-P6): A role for impaired osteoblast and osteoclast formation.	JOURNAL OF BONE AND MINERAL RESEARCH			English	Meeting Abstract									UNIV TOKYO,SCH MED,TOKYO 112,JAPAN; KUREHA BIOMED RES LABS,TOKYO 112,JAPAN								0	0	0	BLACKWELL SCIENCE INC	CAMBRIDGE	238 MAIN ST, CAMBRIDGE, MA 02142	0884-0431			J BONE MINER RES	J. Bone Miner. Res.	AUG	1996	11			1			41	41				1	Endocrinology & Metabolism	Endocrinology & Metabolism	VA495	WOS:A1996VA49500041		
J	Hoshi, K; Amizuka, N; Sako, T; Kurokawa, T; Ozawa, H				Hoshi, K; Amizuka, N; Sako, T; Kurokawa, T; Ozawa, H			Fibroblasts in spinal ligaments differentiate into chondrocytes pathologically by exogenous bone morphogenetic protein-2.	JOURNAL OF BONE AND MINERAL RESEARCH			English	Meeting Abstract									NIIGATA UNIV,DEPT ORAL ANAT 1,NIIGATA 951,JAPAN; UNIV TOKYO,DEPT ORTHOP SURG,TOKYO 113,JAPAN; KAGOSHIMA UNIV,DEPT ORTHOP SURG,KAGOSHIMA 890,JAPAN								0	0	0	BLACKWELL SCIENCE INC	CAMBRIDGE	238 MAIN ST, CAMBRIDGE, MA 02142	0884-0431			J BONE MINER RES	J. Bone Miner. Res.	AUG	1996	11			1			51	51				1	Endocrinology & Metabolism	Endocrinology & Metabolism	VA495	WOS:A1996VA49500050		
